
<html>
	<head>
		<meta http-equiv="Content-Type" content="text/html;charset=utf-8">	
		<style type="text/css">
			table {
			    border-collapse: collapse;
				font-family: arial, helvetica, sans-serif;
			}

			table, th, td {
			    border: 1px solid #C0C0C0;
				font-family: arial, helvetica, sans-serif;
			}
		</style>
	</head>
	<body><table class="tablesorter">
<thead><tr><th>Document Date</th><th>Contributor</th><th>Headline</th><th>Language</th><th>Pages</th><th>Tickers</th><th>Company Names</th><th>Category</th><th>Countries</th><th>Industries</th><th>Regions</th><th>Subjects</th><th>Report Styles</th><th>Author</th></tr>
</thead><tbody><tr class="even"><td class="leftalignment">01/15/2022</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for AMGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">01/15/2022</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 582</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 45253H101 / 00847G705 / 803607100 / 26979610 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / 65487U108 / N90064101 / 14147L108 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 16961L106 / 654405109 / 03890D108 / 192010106 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101 / 603693102 / 09063M205</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Nkarta Inc / Uniqure NV / Cardiff Oncology Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc / Mink Therapeutics Inc / Bionomics Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Canada / Switzerland / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Sarah Schram / Emily Ozpinar / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">01/13/2022</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">High Grade Coverage Report : A summary of credit analyst recommendations in the Healthcare sector</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AMGN.O / BSX.N / BAX.N / BDX.N / BMY.N / CAH.N / CI.N / CVS.N / JNJ.N / LLY.N / MCK.N / MRK.N / TMO.N / DGX.N / HUM.N / GILD.O / UNH.N / LH.N / ABC.N / BIIB.O / ABBV.N / ZTS.N / PRGO.N / ANTM.N / VTRS.O</td><td class="leftalignment">Amgen Inc / Boston Scientific Corp / Baxter International Inc / Becton Dickinson and Co / Bristol-Myers Squibb Co / Cardinal Health Inc / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Mckesson Corp / Merck & Co Inc / Thermo Fisher Scientific Inc / Quest Diagnostics Inc / Humana Inc / Gilead Sciences Inc / UnitedHealth Group Inc / Laboratory Corporation of America Holdings / Amerisourcebergen Corp / Biogen Inc / Abbvie Inc / Zoetis Inc / Perrigo Company PLC / Anthem Inc / Viatris Inc</td><td class="leftalignment">FIXED INCOME - CORPORATES</td><td class="leftalignment">United Kingdom / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brett Gibson / Mr. Matthew Bonner</td></tr>
<tr class="odd"><td class="leftalignment">01/12/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">5671735 / 0925288 / 2516152 / 2023607 / 2050832 / 2222631 / 2270726 / 2542049 / 2317087 / 2670519 / 2455965 / 2457864 / 2471950 / 2689560 / 2048804 / 2440637 / 2799351 / 2829601 / 2980906 / B3D7K31 / B03PGL4 / 2390817 / B783TY6 / B7VD3F2 / BFDV8K0 / BVVN4Q8 / BYY8XK8 / BJ1FD74 / BGCYWN8 / BFZ1K46 / BLGJ610 / BJJMGL2 / BKTNTR9 / BYQHPK7 / BWY52P3 / BYY88Y7 / BL71K91 / BYNQ369 / BMXXBD9 / BMYRFV6 / BMFPHK2 / BMBSNX0</td><td class="leftalignment">Sanofi SA / GlaxoSmithKline PLC / Eli Lilly and Co / Amgen Inc / Ameren Corp / Cooper Companies Inc / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Exelon Corp / Biogen Inc / ImmunoGen Inc / Incyte Corp / PG&E Corp / Pinnacle West Capital Corp / CenterPoint Energy Inc / Sinclair Broadcast Group Inc / Southern Co / Foot Locker Inc / Discovery Inc / NorthWestern Corp / Gray Television Inc / Aptiv PLC / Duke Energy Corp / MacroGenics Inc / Eversource Energy / WEC Energy Group Inc / Revolve Group Inc / Xencor Inc / Spotify Technology SA / Warner Music Group Corp / Fox Corp / ViacomCBS Inc / Zymeworks Inc / Blueprint Medicines Corp / Alphabet Inc / Revolution Medicines Inc / Albertsons Companies Inc / Figs Inc / Procept Biorobotics Corp / ThredUp Inc / IronNet Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / France / United Kingdom / Luxembourg / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">01/12/2022</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">2022 HC Conf Day 2 Recap : Credit Takeaways from the 40th Annual J.P. Morgan Conference</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / ABBV.N / BDX.N / CI.N / CVS.N / LLY.N / MCK.N / TMO.N / LH.N</td><td class="leftalignment">Amgen Inc / Abbvie Inc / Becton Dickinson and Co / Cigna Corp / CVS Health Corp / Eli Lilly and Co / Mckesson Corp / Thermo Fisher Scientific Inc / Laboratory Corporation of America Holdings</td><td class="leftalignment">FIXED INCOME - CORPORATES</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / FIXED INCOME/DEBT RESEARCH / Equity</td><td class="leftalignment">Brett Gibson / Mr. Matthew Bonner</td></tr>
<tr class="odd"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">VRTX/ABBV/LLY/AMGN — Day 2 Takeaways</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AMGN.O / ABBV.N / LLY.N / VRTX.OQ / VRTX.O</td><td class="leftalignment">Amgen Inc / Abbvie Inc / Eli Lilly and Co / Vertex Pharmaceuticals Inc / Vertex Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="even"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">RVMD - BUY - Management Discussion Highlights Two New KRAS(ON) Product Candidates, Initial RMC-5552 (mTORC1i) Clinical Data, Pipeline Progress</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BL71K91 / 2023607 / BBPK0J0</td><td class="leftalignment">Revolution Medicines Inc / Amgen Inc / Mirati Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Paul Jeng, Ph.D. / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="odd"><td class="leftalignment">01/11/2022</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Amgen Inc : Live from The J.P. Morgan Healthcare Conference</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Ms. Tiffany Sun / Manish Jajoo</td></tr>
<tr class="even"><td class="leftalignment">01/11/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">AMGN: Takeaways From JPM Conversation; Building on Drugging the Undruggable</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Dec 31, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">111</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2455965 / 2471950 / 2623911 / 2684703 / 2730190 / 7103065 / B6RS2B3 / B7F2TY6 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Biogen Inc / Incyte Corp / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Clovis Oncology Inc / Puma Biotechnology Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">01/10/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - January 10, 2022</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">US0188021085 / US0236081024 / US0255371017 / US0311621009 / US1101221083 / US1258961002 / US1264081035 / US1270971039 / US1475281036 / US22160K1051 / US2333311072 / US25179M1036 / US25746U1097 / US26875P1012 / US29364G1031 / US30161N1019 / US30231G1022 / US3755581036 / US4062161017 / US45337C1027 / US4592001014 / US5010441013 / US5324571083 / US56418H1005 / US6267171022 / US64125C1099 / US65473P1057 / US6558441084 / US6745991058 / US7170811035 / US7237871071 / US7445731067 / US75281A1097 / US75886F1075 / US7703231032 / AN8068571086 / US8168511090 / US8425871071 / US8454671095 / US87612E1064 / US8851601018 / US9078181081 / US92276F1003 / US92532F1003 / US9746371007 / US98389B1008 / CA1363751027 / CA4530384086 / CA5649051078 / CA1363851017 / US1667641005 / US5658491064 / CA0636711016 / US0017441017 / US20825C1045 / US15189T1079 / US2274831047 / US09062X1037 / CA67072Q1046 / CA2265331074 / US6293775085 / US0534841012 / US1011211018 / US2644115055 / CA6993202069 / CA0906971035 / CA4495861060 / US42809H1077 / BMG383271050 / US4219461047 / US49427F1084 / US89785X1019 / US2120151012 / US38500T1016 / US26884L1098 / CA22576C1014 / CA8672241079 / US58933Y1055 / CA15135U1093 / CA69946Q1046 / US65339F1012 / US78454L1008 / CA5527041084 / CA9237251058 / CA07317Q1054 / CA00208D4084 / CA2927661025 / CA0985461049 / CA7170461064 / CA00829Q1019 / US26441C2044 / CA89156V1067 / US69327R1014 / US72919P2020 / CA4013393042 / CA1348082035 / CA96467A2002 / CA87505Y4094 / CA3565001086 / US70509V1008 / CA04682R1073 / US5764852050 / US29355A1079 / US25278X1090 / CA4882951060 / US71943U1043 / US60468T1051 / US03674X1063 / CA14150G4007 / CA7397211086 / US65341B1061 / US29444U7000 / US30040W1080 / US83417M1045 / US4278255009 / US92939U1060 / US86771W1053 / US0130911037 / US2057683029 / US13462K1097 / US15136A1025 / GB00BDSFG982 / CA46016U1084 / US92840M1027 / US05722G1004 / US12653C1080 / CA35905B1076 / US00191U1025 / US83200N1037 / US87484T1088 / US0937121079 / US08579X1019 / CA7241121077 / CA6744822033 / US86745K1043 / US69047Q1022 / CA4220961078 / CA84678A1021 / US5168062058 / US13123X5086 / CA89055A2039 / US0412421085 / US62955J1034 / US1651677353 / US03743Q1085 / CA00791P1071 / US1374041093</td><td class="leftalignment">Alliant Energy Corp / Ameren Corp / American Electric Power Company Inc / Amgen Inc / Bristol-Myers Squibb Co / CMS Energy Corp / CSX Corp / Coterra Energy Inc / Caseys General Stores Inc / Costco Wholesale Corp / DTE Energy Co / Devon Energy Corp / Dominion Energy Inc / EOG Resources Inc / Entergy Corp / Exelon Corp / Exxon Mobil Corp / Gilead Sciences Inc / Halliburton Co / Incyte Corp / International Business Machines Corp / Kroger Co / Eli Lilly and Co / ManpowerGroup Inc / Murphy Oil Corp / Neurocrine Biosciences Inc / NiSource Inc / Norfolk Southern Corp / Occidental Petroleum Corp / Pfizer Inc / Pioneer Natural Resources Co / Public Service Enterprise Group Inc / Range Resources Corp / Regeneron Pharmaceuticals Inc / Robert Half International Inc / Schlumberger NV / Sempra Energy / Southern Co / Southwestern Energy Co / Target Corp / Thor Industries Inc / Union Pacific Corp / Ventas Inc / Vertex Pharmaceuticals Inc / Winnebago Industries Inc / Xcel Energy Inc / Canadian National Railway Co / Imperial Oil Ltd / Maple Leaf Foods Inc / Canadian Natural Resources Ltd / Chevron Corp / Marathon Oil Corp / Bank of Montreal / AMN Healthcare Services Inc / Conocophillips / CenterPoint Energy Inc / Cross Country Healthcare Inc / Biogen Inc / Nuvista Energy Ltd / Crew Energy Inc / NRG Energy Inc / Avalonbay Communities Inc / Boston Properties Inc / Duke Realty Corp / Paramount Resources Ltd / Birchcliff Energy Ltd / IGM Financial Inc / Hess Corp / GeoPark Ltd / Healthcare Realty Trust Inc / Kilroy Realty Corp / TrueBlue Inc / Continental Resources Inc / Gran Tierra Energy Inc / EQT Corp / Crescent Point Energy Corp / Suncor Energy Inc / Merck & Co Inc / Cenovus Energy Inc / Parex Resources Inc / Nextera Energy Inc / SM Energy Co / MEG Energy Corp / Vermilion Energy Inc / Baytex Energy Corp / ARC Resources Ltd / Enerplus Corp / Bonterra Energy Corp / Peyto Exploration & Development Corp / Africa Oil Corp / Duke Energy Corp / Tourmaline Oil Corp / PDC Energy Inc / Plug Power Inc / Guardian Capital Group Ltd / Canacol Energy Ltd / Whitecap Resources Inc / Tamarack Valley Energy Ltd / Freehold Royalties Ltd / Pebblebrook Hotel Trust / Athabasca Oil Corp / Matador Resources Co / Enphase Energy Inc / Diamondback Energy Inc / Kelt Exploration Ltd / Physicians Realty Trust / Mirati Therapeutics Inc / Antero Resources Corp / Cardinal Energy Ltd (Alberta) / Prairiesky Royalty Ltd / Nextera Energy Partners LP / Equinix Inc / Eversource Energy / Solaredge Technologies Inc / Hersha Hospitality Trust / WEC Energy Group Inc / Sunrun Inc / Albertsons Companies Inc / Comstock Resources Inc / Camping World Holdings Inc / Centennial Resource Development Inc / TechnipFMC PLC / International Petroleum Corp / Vistra Corp / Baker Hughes Co / CNX Resources Corp / Frontera Energy Corp / ASGN Inc / Smartsheet Inc / Talos Energy Inc / Bloom Energy Corp / Berry Corporation (Bry) / Pipestone Energy Corp / Obsidian Energy Ltd / Sunnova Energy International Inc / Ovintiv Inc / Headwater Exploration Inc / Spartan Delta Corp / Laredo Petroleum Inc / Callon Petroleum Co / Topaz Energy Corp / Arko Corp. / Nov Inc / Chesapeake Energy Corp / APA Corp (US) / Advantage Energy Ltd / Candel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / United Kingdom / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">01/10/2022</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - January 10, 2022</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">AES.N / AIG.N / ALV.N / AU.N / BOX.N / CCI.N / CI.N / CL.N / CVS.N / EIX.N / F.N / FSR.N / GM.N / KBH.N / MAS.N / MO.N / NEM.N / OREP.PA / PHM.N / SO.N / T.N / TOL.N / VC.N / PG.N / HUM.N / FNV.N / CPB.N / TEN.N / CMCSA.O / AMGN.O / THC.N / UHS.N / AGI.N / UNH.N / BWA.N / LEA.N / PNM.N / DISH.O / LEN.N / VMC.N / PCG.N / AEM.N / AMT.N / KGC.N / WHR.N / NG.L / VZ.N / HCA.N / EXEL.O / CYH.N / XEL.N / DHI.N / CINF.O / APH.N / EXC.N / AXL.N / RPM.N / IRT.N / VTR.N / MRD.TO / BMRN.O / EXE.TO / REGN.O / ENR.N / MHK.N / CAR_u.TO / NCR.N / TEL.N / GFI.N / CPK.N / CHE.N / CDE.N / HL.N / ST.N / SKY.N / SWN.N / PLUG.OQ / SEM.N / GPN.N / RGLD.O / CASY.O / AMED.O / PAAS.O / EQIX.O / GOLD.N / SMU_U.TO / REI_u.TO / MRC.TO / MRT_u.TO / HR_u.TO / CUF_u.TO / HOT_u.TO / AP_u.TO / CSH_u.TO / D_u.TO / DPM.TO / CRT_u.TO / EDV.TO / BEI_u.TO / CG.TO / BECN.O / DLR.N / VIAC.O / IAG.N / 416515104 / GMS.N / LHCG.O / BKD.N / FIS.N / CRR_u.TO / MA.N / OC.N / EHTH.O / AUY.N / AX_u.TO / IIP_u.TO / ENSG.O / DAN.N / NGD.A / ADUS.OQ / EGO.N / AR.TO / SPB.N / NWH_u.TO / TXG.TO / NEE.N / MTOR.N / ATD.TO / FBHS.N / ACHC.O / MRG_u.TO / PANW.N / MDLZ.OQ / DIR_u.TO / GRT_u.TO / TPH.N / TSLA.N / BLDR.N / TMUS.N / TMHC.N / MR_u.TO / CHP_u.TO / BEP.N / 81762P102 / DOOR.N / PLZ_u.TO / IBP.N / 922475108 / BTG.N / NEP.N / ANTM.N / WBA.N / SUM.N / SIA.TO / PYPL.OQ / SRU_u.TO / RUN.O / SGRY.O / SQ.N / SITE.N / KMP_u.TO / APR_U.TO / TWLO.N / OR.N / ADNT.N / JELD.N / SAND.N / VST.N / WPM.N / SSRM.O / KL.N / APTV.N / EHC.N / EQX.TO / COLD.N / WELL.N / SMAR.N / VNE.N / MI_U.TO / HOMU.TO / CRWD.O / NOVA.N / GMAB.O / CRNC.OQ / PNTG.OQ / FCR_u.TO / AZEK.N / WTRG.N / SLQT.N / AHCO.O / WMG.OQ / NKLA.OQ / FOUR.N / ERE_u.TO / GOCO.O / DCT.O / AEP.OQ / GATO.N / RIDE.OQ / MAX.N / LSPD.N / PUBM.O / DFH.OQ / AFRM.O / CHK.OQ / COUR.N / TSP.OQ / AVAH.OQ / TFPM.TO / FLYW.O / BHG.N / TRMR.OQ / CNM.N / COOK.N / FLNC.OQ / RIVN.OQ / IOT.N</td><td class="leftalignment">AES Corp / American International Group Inc / Autoliv Inc / AngloGold Ashanti Ltd / Box Inc / Crown Castle International Corp / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Edison International / Ford Motor Co / Fisker Inc / General Motors Co / KB Home / Masco Corp / Altria Group Inc / Newmont Corporation / L'Oreal SA / Pultegroup Inc / Southern Co / AT&T Inc / Toll Brothers Inc / Visteon Corp / Procter & Gamble Co / Humana Inc / Franco-Nevada Corp / Campbell Soup Co / Tenneco Inc / Comcast Corp / Amgen Inc / Tenet Healthcare Corp / Universal Health Services Inc / Alamos Gold Inc / UnitedHealth Group Inc / Borgwarner Inc / Lear Corp / PNM Resources Inc / DISH Network Corp / Lennar Corp / Vulcan Materials Co / PG&E Corp / Agnico Eagle Mines Ltd / American Tower Corp / Kinross Gold Corp / Whirlpool Corp / National Grid PLC / Verizon Communications Inc / HCA Healthcare Inc / Exelixis Inc / Community Health Systems Inc / Xcel Energy Inc / D R Horton Inc / Cincinnati Financial Corp / Amphenol Corp / Exelon Corp / American Axle & Manufacturing Holdings Inc / RPM International Inc / Independence Realty Trust Inc / Ventas Inc / Melcor Developments Ltd / Biomarin Pharmaceutical Inc / Extendicare Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Mohawk Industries Inc / Canadian Apartment Properties Real Estate Investment Trust / NCR Corp / TE Connectivity Ltd / Gold Fields Ltd / Chesapeake Utilities Corp / Chemed Corp / Coeur Mining Inc / Hecla Mining Co / Sensata Technologies Holding PLC / Skyline Champion Corp / Southwestern Energy Co / Plug Power Inc / Select Medical Holdings Corp / Global Payments Inc / Royal Gold Inc / Caseys General Stores Inc / Amedisys Inc / Pan American Silver Corp / Equinix Inc / Barrick Gold Corp / Summit Industrial Income REIT / RioCan Real Estate Investment Trust / Morguard Corp / Morguard Real Estate Investment Trust / H&R Real Estate Investment Trust / Cominar Real Estate Investment Trust / American Hotel Income Properties REIT LP / Allied Properties Real Estate Investment Trust / Chartwell Retirement Residences / Dream Office Real Estate Investment Trust / Dundee Precious Metals Inc / CT Real Estate Investment Trust / Endeavour Mining PLC / Boardwalk Real Estate Investment Trust / Centerra Gold Inc / Beacon Roofing Supply Inc / Digital Realty Trust Inc / ViacomCBS Inc / IAMGOLD Corp / Hartford Financial Services Group Inc / GMS Inc / LHC Group Inc / Brookdale Senior Living Inc / Fidelity National Information Services Inc / Crombie Real Estate Investment Trust / Mastercard Inc / Owens Corning / eHealth Inc / Yamana Gold Inc / Artis Real Estate Investment Trust / InterRent Real Estate Investment Trust / Ensign Group Inc / Dana Inc / New Gold Inc / Addus Homecare Corp / Eldorado Gold Corp / Argonaut Gold Inc / Spectrum Brands Holdings Inc / NorthWest Healthcare Properties REIT / Torex Gold Resources Inc / Nextera Energy Inc / Meritor Inc / Alimentation Couche-Tard Inc / Fortune Brands Home & Security Inc / Acadia Healthcare Company Inc / Morguard North American Residential Real Estate Investment Trust / Palo Alto Networks Inc / Mondelez International Inc / Dream Industrial Real Estate Investment Trust / Granite Real Estate Investment Trust / Tri Pointe Homes Inc (Delaware) / Tesla Inc / Builders FirstSource Inc / T-Mobile US Inc / Taylor Morrison Home Corp / Melcor Real Estate Investment Trust / Choice Properties Real Estate Investment Trust / Brookfield Renewable Partners LP / ServiceNow Inc / Masonite International Corp / Plaza Retail REIT / Installed Building Products Inc / Veeva Systems Inc / B2Gold Corp / Nextera Energy Partners LP / Anthem Inc / Walgreens Boots Alliance Inc / Summit Materials Inc / Sienna Senior Living Inc / PayPal Holdings Inc / SmartCentres Real Estate Investment Trust / Sunrun Inc / Surgery Partners Inc / Block Inc / SiteOne Landscape Supply Inc / Killam Apartment REIT / Automotive Properties Real Estate Investment Trust / Twilio Inc / Osisko Gold Royalties Ltd / Adient PLC / JELD-WEN Holding Inc / Sandstorm Gold Ltd / Vistra Corp / Wheaton Precious Metals Corp / SSR Mining Inc / Kirkland Lake Gold Ltd / Aptiv PLC / Encompass Health Corp / Equinox Gold Corp / Americold Realty Trust / Welltower Inc / Smartsheet Inc / Veoneer Inc / Minto Apartment Real Estate Investment Trust / BSR Real Estate Investment Trust / CrowdStrike Holdings Inc / Sunnova Energy International Inc / Genmab A/S / Cerence Inc / Pennant Group Inc / First Capital Real Estate Investment Trust / Azek Company Inc / Essential Utilities Inc / SelectQuote Inc / Adapthealth Corp / Warner Music Group Corp / Nikola Corp / Shift4 Payments Inc / European Residential REIT / Gohealth Inc / Duck Creek Technologies Inc / American Electric Power Company Inc / Gatos Silver Inc / Lordstown Motors Corp / Mediaalpha Inc / Lightspeed Commerce Inc / PubMatic Inc / Dream Finders Homes Inc / Affirm Holdings Inc / Chesapeake Energy Corp / Coursera Inc / TuSimple Holdings Inc / Aveanna Healthcare Holdings Inc / Triple Flag Precious Metals Corp / Flywire Corp / Bright Health Group Inc / Tremor International Ltd / Core & Main Inc / Traeger Inc / Fluence Energy Inc / Rivian Automotive Inc / Samsara Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Denmark / France / United Kingdom / Ireland / Israel / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">01/10/2022</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Amgen Inc (AMGN) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">669</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="odd"><td class="leftalignment">01/08/2022</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / BMRN.O / REGN.O / GMAB.O</td><td class="leftalignment">Amgen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="even"><td class="leftalignment">01/08/2022</td><td class="leftalignment">New Constructs, LLC</td><td class="leftalignment">Amgen Inc.: Updated Model: Credit Rating - Unbiased Research Based on Superior Data</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY / COMPANY UPDATE / COMPANY REPORT / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/08/2022</td><td class="leftalignment">New Constructs, LLC</td><td class="leftalignment">AMGN: Updated Model: Forensic Stock Earnings & Valuation</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY / COMPANY UPDATE / COMPANY REPORT / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/08/2022</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 581</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 45253H101 / 00847G705 / 803607100 / 26979610 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / 65487U108 / N90064101 / 14147L108 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 16961L106 / 654405109 / 03890D108 / 192010106 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101 / 603693102</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Nkarta Inc / Uniqure NV / Cardiff Oncology Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc / Mink Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Canada / Switzerland / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Sarah Schram / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GILD-US -  Dividend Quality Analysis, for the period ended December 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD.O / BIOb / JNJ / LLY / MRK / PFE / AMGN.O / ILMN.O / VRTX.O / BIIB.O / ABBV.K</td><td class="leftalignment">Gilead Sciences Inc / Bio Rad Laboratories Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Illumina Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MRK-US -  Dividend Quality Analysis, for the period ended January 07,2022.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK / ABT / BMY / JNJ / LLY / NVS / PFE / AMGN.O / GSK / TEVA.K / SNY.O</td><td class="leftalignment">Merck & Co Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">CYTR-US - Fundamental Analysis, for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">CYTR.PK / JNJ / NVS / AMGN.O / GSK / CRIS.O / SGEN.O / CLDX.O / NWBO.PK / AOLS.PK / STEM.K</td><td class="leftalignment">CytRx Corp / Johnson & Johnson / Novartis AG / Amgen Inc / GlaxoSmithKline PLC / Curis Inc / Seagen Inc / Celldex Therapeutics Inc / Northwest Biotherapeutics Inc / Aeolus Pharmaceuticals Inc / Stem Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">IDRA-US - Fundamental Analysis, for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">IDRA.O / ABT / JNJ / MRK / PFE / AMGN.O / AGEN.O / LGND.O / BIIB.O / DVAX.O / CLDX.O</td><td class="leftalignment">Idera Pharmaceuticals Inc / Abbott Laboratories / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Amgen Inc / Agenus Inc / Ligand Pharmaceuticals Inc / Biogen Inc / Dynavax Technologies Corp / Celldex Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">CTIC-US - Fundamental Analysis, for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">CTIC.O / BAX / BMY / LLY / NVS / AMGN.O / INCY.O / TEVA.K</td><td class="leftalignment">CTI Biopharma Corp / Baxter International Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Novartis AG / Amgen Inc / Incyte Corp / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">CVM-US - Fundamental Analysis, for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">CVM / EBS / JNJ / AMGN.O / CRIS.O / BCRX.O / XNCR.O / CASI.O / TTNP.O / TEVA.K / CYTR.PK</td><td class="leftalignment">CEL-SCI Corp / Emergent BioSolutions Inc / Johnson & Johnson / Amgen Inc / Curis Inc / BioCryst Pharmaceuticals Inc / Xencor Inc / CASI Pharmaceuticals Inc / Titan Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / CytRx Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Suspending Research Coverage</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">03116210 / 00287Y10 / 71708110 / 92532F10 / 37555810 / 75886F10 / 80105N10 / 40637H10 / 31572Q80 / 75046920 / G3910J11 / 61776010 / G8807B10 / 04539610 / 68386J20 / G7627910</td><td class="leftalignment">Amgen Inc / Abbvie Inc / Pfizer Inc / Vertex Pharmaceuticals Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Sanofi SA / Halozyme Therapeutics Inc / FibroGen Inc / Radius Health Inc / GlaxoSmithKline PLC / MorphoSys AG / Theravance Biopharma Inc / Assembly Biosciences Inc / Opthea Ltd / Roivant Sciences Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Cayman Islands / Germany / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jim Kelly</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Evan’s Weekly Dose of Targeted Therapy & Video - CMS AD NCD & JPM Preview</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US09062X1037 / US58933Y1055 / US60468T1051 / US1374041093</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Merck & Co Inc / Mirati Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Week in Review - December 24, 2021 to January 7, 2022</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US8336351056 / US0091581068 / US0126531013 / US0234361089 / US0311621009 / US0536111091 / US1101221083 / US2017231034 / US2788651006 / US3755581036 / US3976241071 / US4128221086 / US4180561072 / US4282911084 / US4448591028 / US45337C1027 / US4601461035 / US5324571083 / US5463471053 / US56418H1005 / US5719032022 / US5770811025 / US64125C1099 / US6516391066 / US6703461052 / US6935061076 / US6951561090 / US7170811035 / US7310681025 / US7496851038 / US7549071030 / US75886F1075 / US7703231032 / US7802871084 / US8243481061 / US8581191009 / US9113121068 / US92276F1003 / US92532F1003 / US9621661043 / US98389B1008 / CA25822C2058 / CA1469001053 / CA0679011084 / CA9528451052 / US9129091081 / CA51925D1069 / CA13677F1018 / CA0641491075 / CA6330671034 / CA7800871021 / US0017441017 / US37940X1028 / US2274831047 / US09062X1037 / US46625H1005 / US0605051046 / US20451N1019 / US9604131022 / US0534841012 / US29476L1070 / US7588491032 / US2971781057 / US1331311027 / US1508701034 / US2538681030 / CA8911605092 / CA1360691010 / US1011211018 / US2644115055 / US9290421091 / US5543821012 / US8288061091 / US44107P1049 / US7376301039 / US57636Q1040 / CA1375761048 / US29472R1086 / US8666741041 / US74460D1090 / US59522J1034 / US9026531049 / US30225T1025 / US35471R1068 / US4219461047 / US5021751020 / US63633D1046 / US5500211090 / US89785X1019 / CA3518581051 / US92826C8394 / US58502B1061 / US58933Y1055 / NL0009434992 / US74340W1036 / US2296631094 / US92936U1097 / CA55903Q1046 / US76131N1019 / US70509V1008 / CA38045Y1025 / US16208T1025 / US78573L1061 / US74965L1017 / US23283R1005 / CA05577W2004 / US71943U1043 / US60468T1051 / US9660842041 / US02665T3068 / US45378A1060 / US11120U1051 / US02005N1000 / US1785871013 / CA45868C1095 / US14174T1079 / BMG0750C1082 / US8621211007 / US42225P5017 / US29444U7000 / US27616P1030 / US9840171030 / US6378701063 / US9741551033 / US1638511089 / US4278255009 / US96145D1054 / US70450Y1038 / CA8485101031 / US95040Q1040 / US8522341036 / 100607060 / US45688C1071 / US53223X1072 / US0441861046 / CA26829L1076 / US7005171050 / US43300A2033 / US46187W1071 / CA9628791027 / GB00BF3ZNS54 / US87105L1044 / CA53680Q2071 / US46590V1008 / CA2960061091 / US3610081057 / CA8585221051 / US29261A1007 / US00191U1025 / US83200N1037 / US48251W1045 / CA4039254079 / US53814L1089 / IE00BZ12WP82 / CA13000C2058 / US2605571031 / GB00BJT16S69 / US73757R1023 / US26614N1028 / US5012701026 / US42250P1030 / CA92625W5072 / US14316J1088 / US47012E4035 / US69526K1051 / CA67079A1021 / US15202L1070 / CA00076T1057 / US11135E2037 / US00848J1043 / BMG6964L1072 / US0708301041 / US71844V2016 / US27923Q1094 / AU0000193666 / US4576791085</td><td class="leftalignment">Sociedad Quimica y Minera de Chile SA / Air Products and Chemicals Inc / Albemarle Corp / Amedisys Inc / Amgen Inc / Avery Dennison Corp / Bristol-Myers Squibb Co / Commercial Metals Co / Ecolab Inc / Gilead Sciences Inc / Greif Inc / Harley-Davidson Inc / Hasbro Inc / Hexcel Corp / Humana Inc / Incyte Corp / International Paper Co / Eli Lilly and Co / Louisiana-Pacific Corp / ManpowerGroup Inc / Marriott International Inc / Mattel Inc / Neurocrine Biosciences Inc / Newmont Corporation / Nucor Corp / PPG Industries Inc / Packaging Corp of America / Pfizer Inc / Polaris Inc / RPM International Inc / Rayonier Inc / Regeneron Pharmaceuticals Inc / Robert Half International Inc / Royal Gold Inc / Sherwin-Williams Co / Steel Dynamics Inc / United Parcel Service Inc / Ventas Inc / Vertex Pharmaceuticals Inc / Weyerhaeuser Co / Xcel Energy Inc / Dorel Industries Inc / Cascades Inc / Barrick Gold Corp / West Fraser Timber Co Ltd / United States Steel Corp / Laurentian Bank of Canada / Canadian Western Bank / Bank of Nova Scotia / National Bank of Canada / Royal Bank of Canada / AMN Healthcare Services Inc / Global Payments Inc / Cross Country Healthcare Inc / Biogen Inc / JPMorgan Chase & Co / Bank of America Corp / Compass Minerals International Inc / Westlake Chemical Corp / Avalonbay Communities Inc / Equity Residential / Regency Centers Corp / Essex Property Trust Inc / Camden Property Trust / Celanese Corp / Digital Realty Trust Inc / Toronto-Dominion Bank / Canadian Imperial Bank of Commerce / Boston Properties Inc / Duke Realty Corp / Vornado Realty Trust / Macerich Co / Simon Property Group Inc / Host Hotels & Resorts Inc / Potlatchdeltic Corp / Mastercard Inc / Canfor Corp / Equity LifeStyle Properties Inc / Sun Communities Inc / Public Storage / Mid-America Apartment Communities Inc / UDR Inc / Extra Space Storage Inc / Franklin Street Properties Corp / Healthcare Realty Trust Inc / LTC Properties Inc / National Health Investors Inc / Lululemon Athletica Inc / TrueBlue Inc / Franco-Nevada Corp / Visa Inc / MEDNAX Inc / Merck & Co Inc / LyondellBasell Industries NV / Prologis Inc / CubeSmart / WP Carey Inc / MAG Silver Corp / Retail Opportunity Investments Corp / Pebblebrook Hotel Trust / GoGold Resources Inc / Chatham Lodging Trust / Sabra Health Care REIT Inc / RLJ Lodging Trust / CyrusOne Inc / BRP Inc / Physicians Realty Trust / Mirati Therapeutics Inc / Whitestone REIT / American Homes 4 Rent / Independence Realty Trust Inc / Brixmor Property Group Inc / Ally Financial Inc / City Office REIT Inc / Interfor Corp / CareTrust REIT Inc / Axalta Coating Systems Ltd / STORE Capital Corp / Healthcare Trust Of America Inc / Equinix Inc / Easterly Government Properties Inc / Xenia Hotels & Resorts Inc / National Storage Affiliates Trust / Wingstop Inc / Chemours Co / Hersha Hospitality Trust / Westrock Co / PayPal Holdings Inc / Spin Master Corp / Welltower Inc / Block Inc / First-Citizens Bank & Trust Co / Ingevity Corp / Life Storage Inc / Ashland Global Holdings Inc / ECN Capital Corp / Park Hotels & Resorts Inc / Hilton Worldwide Holdings Inc / Invitation Homes Inc / Wheaton Precious Metals Corp / Venator Materials PLC / Switch Inc / Lithium Americas Corp / JBG SMITH Properties / Ero Copper Corp / Funko Inc / Stelco Holdings Inc / Encompass Health Corp / ASGN Inc / Smartsheet Inc / KKR & Co Inc / H&R Real Estate Investment Trust / Livent Corp / Linde PLC / Calibre Mining Corp / Dow Inc / Tronox Holdings PLC / Postal Realty Trust Inc / Dupont De Nemours Inc / Kura Sushi USA Inc / Healthpeak Properties Inc / Victoria Gold Corp / Carlyle Group Inc / JAKKS Pacific Inc / Pactiv Evergreen Inc / Nuvei Corp / Centerspace / Abc Technologies Holdings Inc / Broadstone Net Lease Inc / Agiliti Inc / Paysafe Ltd / Bath & Body Works Inc / Phillips Edison & Co Inc / Ecovyst Inc / Allkem Ltd / Innovid Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Chile / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended December 31, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 80105N10 / 771195104 / 58933Y10 / 00287Y10 / 45781M10 / G3910J11 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Sanofi SA / Roche Holding AG / Merck & Co Inc / Abbvie Inc / Innoviva Inc / GlaxoSmithKline PLC / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / INCY.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Incyte Corp / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon / Leonid Timashev</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AIN / CARS / FISV=US / LLY=US / AMGN=US / BMY=US / TWTR=US / AMZN=US / EBAY=US / GILD=US / PEB=US / H=US / CRM=US / V=US / MTN=US / VRM=US / MAR=US / EXPE=US / TNL=US / HLT=US / HUM=US / CVS=US / W=US / STZ=US / DV=US / AIR=US / ATRO=US / BLL=US / B=US / BMRN=US / CHH=US / CCK=US / CW=US / DRH=US / DCO=US / EEFT=US / HEI=US / HXL=US / TREE=US / MRCY=US / NRDS=US / REGN=US / ROLL=US / SHOP=US / SFT=US / SNAP=US / TRIP=US / TGI=US / TRUE=US / VSEC=US / VRTX=US / WIX=US / WEX=US / FOUR=US / GPN=US / PYPL=US / BKNG=US / PRI=US / FB=US / MTCH=US / SPR=US / EVOP=US / MQ / DKS=US / PTON=US / BIIB=US / FLT=US / MOG.A=US / APP=US / SHO=US / BLDR=US / FIS=US / TDG=US / HST=US / MA=US / WU=US / KTOS=US / WH=US / IAC=US / 45665G303 / HGV=US / GDOT=US / WWD=US / PCRX=US / RLJ=US / VAC=US / ANGI=US / RHP=US / SSTK=US / ABBV=US / GOOGL=US / BABA=US / AFMD=US / CMPR=US / BVH=US / WBA=US / GDDY=US / ETSY=US / AJRD=US / BWXT=US / ZG=US / SQ=US / IBEX=US / NTLA=US / TTD=US / CRSP=US / TRVG=US / PK=US / PLYA=US / AYX=US / CVNA=US / YEXT=US / RDFN=US / CARG=US / SFIX=US / ROOT=US / MAXR=US / GSKY=US / FTDR=US / EB=US / AXNX=US / LYFT=US / UBER=US / LSPD=US / APLT=US / LHX=US / RPAY=US / ONEW=US / SPCE=US / AZEK=US / TSHA / PAYA=US / ABNB=US / DASH=US / AFRM=US / VMEO=US / MNTV=US / SQSP=US / 00152K101</td><td class="leftalignment">Albany International Corp / Cars.com Inc / Fiserv Inc / Eli Lilly and Co / Amgen Inc / Bristol-Myers Squibb Co / Twitter Inc / Amazon.com Inc / eBay Inc / Gilead Sciences Inc / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Salesforce.Com Inc / Visa Inc / Vail Resorts Inc / Vroom Inc / Marriott International Inc / Expedia Group Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Humana Inc / CVS Health Corp / Wayfair Inc / Constellation Brands Inc / DoubleVerify Holdings Inc / AAR Corp / Astronics Corp / Ball Corp / Barnes Group Inc / Biomarin Pharmaceutical Inc / Choice Hotels International Inc / Crown Holdings Inc / Curtiss-Wright Corp / Diamondrock Hospitality Co / Ducommun Inc / Euronet Worldwide Inc / HEICO Corp / Hexcel Corp / Lendingtree Inc / Mercury Systems Inc / Nerdwallet Inc / Regeneron Pharmaceuticals Inc / RBC Bearings Inc / Shopify Inc / Shift Technologies Inc / Snap Inc / Tripadvisor Inc / Triumph Group Inc / TrueCar Inc / VSE Corp / Vertex Pharmaceuticals Inc / Wix.Com Ltd / WEX Inc / Shift4 Payments Inc / Global Payments Inc / PayPal Holdings Inc / Booking Holdings Inc / Primerica Inc / Meta Platforms Inc / Match Group Inc / Spirit AeroSystems Holdings Inc / EVO Payments Inc / Marqeta Inc / DICK'S Sporting Goods Inc / Peloton Interactive Inc / Biogen Inc / Fleetcor Technologies Inc / Moog Inc / Applovin Corp / Sunstone Hotel Investors Inc / Builders FirstSource Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Host Hotels & Resorts Inc / Mastercard Inc / Western Union Co / Kratos Defense and Security Solutions Inc / Wyndham Hotels & Resorts Inc / IAC/Interactivecorp / Infinity Pharmaceuticals Inc / Hilton Grand Vacations Inc / Green Dot Corp / Woodward Inc / Pacira Biosciences Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Angi Inc / Ryman Hospitality Properties Inc / Shutterstock Inc / Abbvie Inc / Alphabet Inc / Alibaba Group Holding Ltd / Affimed NV / Cimpress PLC / Bluegreen Vacations Holding Corp / Walgreens Boots Alliance Inc / GoDaddy Inc / ETSY Inc / Aerojet Rocketdyne Holdings Inc / BWX Technologies Inc / Zillow Group Inc / Block Inc / Ibex Ltd / Intellia Therapeutics Inc / Trade Desk Inc / CRISPR Therapeutics AG / Trivago NV / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Alteryx Inc / Carvana Co / Yext Inc / Redfin Corp / CarGurus Inc / Stitch Fix Inc / Root Inc / Maxar Technologies Inc / GreenSky Inc / Frontdoor Inc / Eventbrite Inc / Axonics Inc / Lyft Inc / Uber Technologies Inc / Lightspeed Commerce Inc / Applied Therapeutics Inc / L3harris Technologies Inc / Repay Holdings Corp / OneWater Marine Inc / Virgin Galactic Holdings Inc / Azek Company Inc / Taysha Gene Therapies Inc / Paya Holdings Inc / Airbnb Inc / DoorDash Inc / Affirm Holdings Inc / Vimeo Inc / Momentive Global Inc / Squarespace Inc / AKA Brands Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">2434209 / 2000019 / 2023607 / 2085878 / 2206657 / 2270726 / 2670519 / 2100920 / 2623911 / 2632003 / 2684703 / 2825933 / 2931034 / 2170473 / 2857817 / B3D7K31 / B0796X4 / 2949758 / B7TL820 / B4MG4Z6 / BBPK0J0 / B95N910 / BK0VHF6 / BWTN5N1 / BFZ1K46 / BYXJQG9 / BJFSR99 / BKTNTR9 / BJXBP30 / BYYWPW6 / BZ1LFG7 / BYY88Y7 / BL71K91 / BGDQ8B3 / BMGGJK8 / BLF0CW7 / BNLYBF3 / BMVBZF5 / BP2P6L0</td><td class="leftalignment">Home Depot Inc / Amazon.com Inc / Amgen Inc / Bed Bath & Beyond Inc / Coca-Cola Co / Walt Disney Co / Exelon Corp / FirstEnergy Corp / Neurocrine Biosciences Inc / New York Times Co / Pfizer Inc / South Jersey Industries Inc / Vertex Pharmaceuticals Inc / Constellation Brands Inc / Netflix Inc / Discovery Inc / Dexcom Inc / Nexstar Media Group Inc / Meta Platforms Inc / AMC Networks Inc / Mirati Therapeutics Inc / PTC Inc / IDEAYA Biosciences Inc / ETSY Inc / Spotify Technology SA / Spire Inc / Revance Therapeutics Inc / ViacomCBS Inc / Turning Point Therapeutics Inc / Beigene Ltd / Roku Inc / Alphabet Inc / Revolution Medicines Inc / Axonics Inc / Valneva SE / Repare Therapeutics Inc / Erasca Inc / Immuneering Corp / Tango Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / France / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - January 7, 2022</td><td class="leftalignment">English</td><td class="rightalignment">52</td><td class="leftalignment">US8336351056 / US0126531013 / US0311621009 / US1101221083 / US3755581036 / US4448591028 / US45337C1027 / US5324571083 / US5463471053 / US5719032022 / US64125C1099 / US6516391066 / US7170811035 / US7549071030 / US75886F1075 / US7802871084 / US92276F1003 / US92532F1003 / US9621661043 / US98389B1008 / CA0679011084 / CA9528451052 / US09062X1037 / US9604131022 / US0534841012 / US29476L1070 / US7588491032 / US2538681030 / US1011211018 / US2644115055 / US5543821012 / US8288061091 / US44107P1049 / US7376301039 / CA1375761048 / US29472R1086 / US8666741041 / US74460D1090 / US9026531049 / US30225T1025 / US35471R1068 / US4219461047 / US63633D1046 / CA3518581051 / US58933Y1055 / NL0009434992 / US74340W1036 / US2296631094 / US92936U1097 / US70509V1008 / US16208T1025 / US78573L1061 / US71943U1043 / US60468T1051 / CA45868C1095 / US14174T1079 / US42225P5017 / US29444U7000 / US27616P1030 / US9840171030 / US6378701063 / US4278255009 / US95040Q1040 / US53223X1072 / US7005171050 / US43300A2033 / CA9628791027 / US87105L1044 / CA53680Q2071 / CA2960061091 / US53814L1089 / CA13000C2058 / US2605571031 / US73757R1023 / US5012701026 / US42250P1030 / CA92625W5072 / US15202L1070 / US11135E2037 / US0708301041 / AU0000193666</td><td class="leftalignment">Sociedad Quimica y Minera de Chile SA / Albemarle Corp / Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Humana Inc / Incyte Corp / Eli Lilly and Co / Louisiana-Pacific Corp / Marriott International Inc / Neurocrine Biosciences Inc / Newmont Corporation / Pfizer Inc / Rayonier Inc / Regeneron Pharmaceuticals Inc / Royal Gold Inc / Ventas Inc / Vertex Pharmaceuticals Inc / Weyerhaeuser Co / Xcel Energy Inc / Barrick Gold Corp / West Fraser Timber Co Ltd / Biogen Inc / Westlake Chemical Corp / Avalonbay Communities Inc / Equity Residential / Regency Centers Corp / Digital Realty Trust Inc / Boston Properties Inc / Duke Realty Corp / Macerich Co / Simon Property Group Inc / Host Hotels & Resorts Inc / Potlatchdeltic Corp / Canfor Corp / Equity LifeStyle Properties Inc / Sun Communities Inc / Public Storage / UDR Inc / Extra Space Storage Inc / Franklin Street Properties Corp / Healthcare Realty Trust Inc / National Health Investors Inc / Franco-Nevada Corp / Merck & Co Inc / LyondellBasell Industries NV / Prologis Inc / CubeSmart / WP Carey Inc / Pebblebrook Hotel Trust / Chatham Lodging Trust / Sabra Health Care REIT Inc / Physicians Realty Trust / Mirati Therapeutics Inc / Interfor Corp / CareTrust REIT Inc / Healthcare Trust Of America Inc / Equinix Inc / Easterly Government Properties Inc / Xenia Hotels & Resorts Inc / National Storage Affiliates Trust / Hersha Hospitality Trust / Welltower Inc / Life Storage Inc / Park Hotels & Resorts Inc / Hilton Worldwide Holdings Inc / Wheaton Precious Metals Corp / Switch Inc / Lithium Americas Corp / Ero Copper Corp / Livent Corp / Calibre Mining Corp / Dow Inc / Postal Realty Trust Inc / Kura Sushi USA Inc / Healthpeak Properties Inc / Victoria Gold Corp / Centerspace / Broadstone Net Lease Inc / Bath & Body Works Inc / Allkem Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Chile / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">What's Next in Biotech? I Gotta Have More Cowbell: RAS Pathway Hyperactivation via DUSP4/6 Induces Synthetic Lethality & Overcomes Drug Resistance</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2023607 / BBPK0J0 / BK0VHF6 / BZ1LFB2 / BJXBP30 / BYYWPW6 / BL71K91 / BLF0CW7 / BNLYBF3 / BMVBZF5 / BP2P6L0</td><td class="leftalignment">Amgen Inc / Mirati Therapeutics Inc / IDEAYA Biosciences Inc / Deciphera Pharmaceuticals Inc / Turning Point Therapeutics Inc / Beigene Ltd / Revolution Medicines Inc / Repare Therapeutics Inc / Erasca Inc / Immuneering Corp / Tango Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Germany / Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Paul Jeng, Ph.D. / Yige Guo, Ph.D. / Kelsey Goodwin</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">FY2022 Large-Cap Biotech Preview</td><td class="leftalignment">English</td><td class="rightalignment">55</td><td class="leftalignment">AMGN=US / BIIB=US / LLY=US / BMY=US / GILD=US / BMRN=US / REGN=US / VRTX=US / ABBV=US</td><td class="leftalignment">Amgen Inc / Biogen Inc / Eli Lilly and Co / Bristol-Myers Squibb Co / Gilead Sciences Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Navigating the Virtual Circus: Expectations and Mgmt Qs for Next Week's Conf.</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US09062X1037 / US58933Y1055 / US60468T1051</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Merck & Co Inc / Mirati Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">01/06/2022</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Starting With a Bang: Fund Flows Positive Into 2022</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 04016X101 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105 / 670703107</td><td class="leftalignment">Amgen Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / argenx SE / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc / Nuvalent Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">01/06/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Modest price increases from MRK and AMGN's Tezspire WAC Price</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AMGN.OQ / MRK.N / MRK=US / AMGN=US</td><td class="leftalignment">Amgen Inc / Merck & Co Inc / Merck & Co Inc / Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">01/06/2022</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Amgen Inc.(AMGN) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">031162100</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">01/05/2022</td><td class="leftalignment">Kailash Concepts</td><td class="leftalignment">BUY & SELL Lists - SP500</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ABBV.N / AFRM.OQ / AEE.N / BA.N / CMS.N / CRM.N / ECL.N / HLT.N / PFE.N / SC.N / TXT.N / U.N / ACI.N / SCI.N / DIS.N / WLK.N / AFG.N / IPG.N / SPOT.N / RCL.N / IFF.N / FNF.N / PCG.N / DVN.N / NRG.N / ATO.N / LNT.N / AME.N / UDR.N / MKC.N / HRL.N / GME.N / TDY.N / COP.N / INTC.OQ / AMGN.OQ / AGL.N / FISV.OQ / HOLX.OQ / RJF.N / RGEN.OQ / QCOM.OQ / NTAP.OQ / TPR.N / NUAN.OQ / MRVL.OQ / ILMN.OQ / PA1436583006 / MNST.OQ / MOH.N / LVS.N / LBTYK.OQ / CME.OQ / STX.OQ / NXPI.OQ / CZR.OQ / CAR.OQ / Z.OQ / RNG.N / LBRDK.O / TDOC.N / PEN.N / TWLO.N / SNAP.N / INVH.N / CVNA.N / ROKU.OQ / XEL.OQ / SYNH.OQ / VICI.N / CDAY.N / KDP.N / FTCH.N / UBER.N / TXG.OQ / PTON.OQ / WTRG.N / DKNG.OQ / PLTR.N / RBLX.N / XM.OQ / CPNG.N</td><td class="leftalignment">Abbvie Inc / Affirm Holdings Inc / Ameren Corp / Boeing Co / CMS Energy Corp / Salesforce.Com Inc / Ecolab Inc / Hilton Worldwide Holdings Inc / Pfizer Inc / Santander Consumer USA Holdings Inc / Textron Inc / Unity Software Inc / Albertsons Companies Inc / Service Corporation International / Walt Disney Co / Westlake Chemical Corp / American Financial Group Inc / Interpublic Group of Companies Inc / Spotify Technology SA / Royal Caribbean Cruises Ltd / International Flavors & Fragrances Inc / Fidelity National Financial Inc / PG&E Corp / Devon Energy Corp / NRG Energy Inc / Atmos Energy Corp / Alliant Energy Corp / AMETEK Inc / UDR Inc / McCormick & Company Inc / Hormel Foods Corp / GameStop Corp / Teledyne Technologies Inc / Conocophillips / Intel Corp / Amgen Inc / agilon health Inc / Fiserv Inc / Hologic Inc / Raymond James Financial Inc / Repligen Corp / Qualcomm Inc / NetApp Inc / Tapestry Inc / Nuance Communications Inc / Marvell Technology Inc / Illumina Inc / Carnival Corp / Monster Beverage Corp / Molina Healthcare Inc / Las Vegas Sands Corp / Liberty Global PLC / CME Group Inc / Seagate Technology Holdings PLC / NXP Semiconductors NV / Caesars Entertainment Inc / Avis Budget Group Inc / Zillow Group Inc / RingCentral Inc / Liberty Broadband Corp / Teladoc Health Inc / Penumbra Inc / Twilio Inc / Snap Inc / Invitation Homes Inc / Carvana Co / Roku Inc / Xcel Energy Inc / Syneos Health Inc / VICI Properties Inc / Ceridian HCM Holding Inc / Keurig Dr Pepper Inc / Farfetch Ltd / Uber Technologies Inc / 10X Genomics Inc / Peloton Interactive Inc / Essential Utilities Inc / DraftKings Inc / Palantir Technologies Inc / Roblox Corp / Qualtrics International Inc / Coupang Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United Kingdom / Ireland / Korea, Republic of / Liberia / Luxembourg / Netherlands / Panama / United States</td><td class="leftalignment">Advertising / Aerospace / Apparel & Textiles / Automotive / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Chemicals / Consumer / Defense / Electrical / Electronics / Financial Services / Food / Healthcare / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Media / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Services / Technology / Transportation / Utilities / Oil & Gas / Internet</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">01/05/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AAP / AR / AZO / BBY / BMY.N / BP.N / CHD / CL / CLR / CLX / CNX / COP / CPE / CVX / DVN / EL / EOG / EQT / FND / HD / HES / KMB / KO / LLY.N / LOW / MGY / MRK.N / MRO / MUR / OLN / OXY / PFE.N / PG / PXD / RH / RRC / SLB.N / SM / SPB / STZ / SWN / TAP.N / W / WLK / WLL / WSM / CNQ.TO / GILD.O / AMGN.O / HAL.N / EPC / MGM.N / SU.TO / BBBY.O / XOM / LBRT.N / PENN.O / LPI / REGN.O / VRTX.O / TSCO.O / COCO.O / SMG.N / WYNN.O / MNST.O / ORLY.O / WOOF.O / BIIB.O / NOV.N / RDSb / NOG.A / CZR.O / BKR.N / ESTE.K / MTDR.K / PDCE.O / AMBA.O / FANG.O / ABBV.N / GTLS.N / COTY.K / CIVI.K / TCON.O / CDEV.O / CVNA.K / IOVA.O / EYE.O / PEP.O / INSP.K / KDP.N / AVRO.O / BRY.O / NWL.O / FLTRF.L / OAS.O / OVV.N / DKNG.O / VRM.O / CTRA.K / GRWG.O / SFT.O / BALY.N / RSI.N / HYFM.O / CHK.O / JOAN.O / ZVIA.N / WEBR.N</td><td class="leftalignment">Advance Auto Parts Inc / Antero Resources Corp / Autozone Inc / Best Buy Co Inc / Bristol-Myers Squibb Co / BP PLC / Church & Dwight Co Inc / Colgate-Palmolive Co / Continental Resources Inc / Clorox Co / CNX Resources Corp / Conocophillips / Callon Petroleum Co / Chevron Corp / Devon Energy Corp / Estee Lauder Companies Inc / EOG Resources Inc / EQT Corp / Floor & Decor Holdings Inc / Home Depot Inc / Hess Corp / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lowe's Companies Inc / Magnolia Oil & Gas Corp / Merck & Co Inc / Marathon Oil Corp / Murphy Oil Corp / Olin Corp / Occidental Petroleum Corp / Pfizer Inc / Procter & Gamble Co / Pioneer Natural Resources Co / RH / Range Resources Corp / Schlumberger NV / SM Energy Co / Spectrum Brands Holdings Inc / Constellation Brands Inc / Southwestern Energy Co / Molson Coors Beverage Co / Wayfair Inc / Westlake Chemical Corp / Whiting Petroleum Corp / Williams-Sonoma Inc / Canadian Natural Resources Ltd / Gilead Sciences Inc / Amgen Inc / Halliburton Co / Edgewell Personal Care Co / MGM Resorts International / Suncor Energy Inc / Bed Bath & Beyond Inc / Exxon Mobil Corp / Liberty Oilfield Services Inc / Penn National Gaming Inc / Laredo Petroleum Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Tractor Supply Co / Vita Coco Company Inc / Scotts Miracle-Gro Co / Wynn Resorts Ltd / Monster Beverage Corp / O'Reilly Automotive Inc / Petco Health and Wellness Company Inc / Biogen Inc / Nov Inc / Royal Dutch Shell PLC / Northern Oil and Gas Inc / Caesars Entertainment Inc / Baker Hughes Co / Earthstone Energy Inc / Matador Resources Co / PDC Energy Inc / Ambarella Inc / Diamondback Energy Inc / Abbvie Inc / Chart Industries Inc / Coty Inc / Civitas Resources Inc / TRACON Pharmaceuticals Inc / Centennial Resource Development Inc / Carvana Co / Iovance Biotherapeutics Inc / National Vision Holdings Inc / PepsiCo Inc / Inspire Medical Systems Inc / Keurig Dr Pepper Inc / AVROBIO Inc / Berry Corporation (Bry) / Newell Brands Inc / Flutter Entertainment PLC / Oasis Petroleum Inc / Ovintiv Inc / DraftKings Inc / Vroom Inc / Coterra Energy Inc / GrowGeneration Corp / Shift Technologies Inc / Bally's Corp / Rush Street Interactive Inc / Hydrofarm Holdings Group Inc / Chesapeake Energy Corp / Joann Inc / Zevia PBC / Weber Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / United Kingdom / Ireland / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/05/2022</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - January 5, 2022</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">CAS.TO / CVS.N / F.N / FLS.N / GE.N / GM.N / RYN.N / WY.N / CFP.TO / LPX.N / AMGN.O / ETN.N / DHR.N / UNH.N / WCC.N / DOV.N / IEX.N / ROP.N / HON.N / MMM.N / EMR.N / ADCT.N / GWW.N / HCA.N / EXEL.O / CYH.N / JCI.N / ARNA.O / AME.N / BMRN.O / REGN.O / JHX.AX / GGG.N / PNR.N / TT.N / LNG.A / SGEN.OQ / IMGN.O / LIFE.O / NTR.N / NVT.N / WEF.TO / MWA.N / CLW.N / ADN.TO / PCH.O / CTT.N / IFP.TO / XYL.N / RFP.N / KPT.TO / PRTA.O / AGIO.O / CFF.TO / MESO.O / FTV.N / ATKR.N / UN01.DE / ATNX.O / AQUA.N / GTES.N / GMAB.O / EPAC.N / CARR.N / NRIX.OQ / NUVB.N / TTEF.PA</td><td class="leftalignment">Cascades Inc / CVS Health Corp / Ford Motor Co / Flowserve Corp / General Electric Co / General Motors Co / Rayonier Inc / Weyerhaeuser Co / Canfor Corp / Louisiana-Pacific Corp / Amgen Inc / Eaton Corporation PLC / Danaher Corp / UnitedHealth Group Inc / Wesco International Inc / Dover Corp / IDEX Corp / Roper Technologies Inc / Honeywell International Inc / 3M Co / Emerson Electric Co / ADC Therapeutics SA / W W Grainger Inc / HCA Healthcare Inc / Exelixis Inc / Community Health Systems Inc / Johnson Controls International PLC / Arena Pharmaceuticals Inc / AMETEK Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / James Hardie Industries PLC / Graco Inc / Pentair PLC / Trane Technologies PLC / Cheniere Energy Inc / Seagen Inc / ImmunoGen Inc / aTyr Pharma Inc / Nutrien Ltd / nVent Electric PLC / Western Forest Products Inc / Mueller Water Products Inc / Clearwater Paper Corp / Acadian Timber Corp / Potlatchdeltic Corp / CatchMark Timber Trust Inc / Interfor Corp / Xylem Inc / Resolute Forest Products Inc / KP Tissue Inc / Prothena Corporation PLC / Agios Pharmaceuticals Inc / Conifex Timber Inc / Mesoblast Ltd / Fortive Corp / Atkore Inc / Uniper SE / Athenex Inc / Evoqua Water Technologies Corp / Gates Industrial Corporation PLC / Genmab A/S / Enerpac Tool Group Corp / Carrier Global Corp / Nurix Therapeutics Inc / Nuvation Bio Inc / TotalEnergies SE</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / Germany / Denmark / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">01/05/2022</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: 1Q22 Prep Pack - key questions for mgmt teams across our coverage universe</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AMGN.O / ADCT.N / EXEL.O / ARNA.O / BMRN.O / REGN.O / SGEN.OQ / IMGN.O / LIFE.O / PRTA.O / AGIO.O / MESO.O / ATNX.O / GMAB.O / NRIX.OQ / NUVB.N</td><td class="leftalignment">Amgen Inc / ADC Therapeutics SA / Exelixis Inc / Arena Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Seagen Inc / ImmunoGen Inc / aTyr Pharma Inc / Prothena Corporation PLC / Agios Pharmaceuticals Inc / Mesoblast Ltd / Athenex Inc / Genmab A/S / Nurix Therapeutics Inc / Nuvation Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Switzerland / Denmark / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="odd"><td class="leftalignment">01/05/2022</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Rating Update for Amgen Inc</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="even"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Biopharma—Feedback From our Recent Launch; Slides attached–CC TMRW (1/5) 10:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">BMY.N / LLY.N / MRK.N / PFE.N / GILD.O / AMGN.O / REGN.O / VRTX.O / BIIB.O / ABBV.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / China / Croatia / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="odd"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Probes Reporter</td><td class="leftalignment">Watch List: 78 US Companies with Undisclosed SEC Probes</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">HBAN.OQ / KOP.N / AAN.N / BBY.N / CL.N / COF.N / CVS.N / F.N / HLT.N / SLB.N / T.N / TMO.N / BEN.N / THC.N / GBX.N / REV.N / ADM.N / VLO.N / UPS.N / KR.N / XOM.N / NKE.N / TGT.N / XL.N / AMP.N / ARW.N / ATO.N / TWTR.N / HAE.N / STL.N / OMI.N / CVX.N / TDY.N / AMGN.OQ / COLL.OQ / GNTX.OQ / REGN.OQ / BBBY.OQ / GILD.OQ / COST.OQ / NKTR.OQ / MYGN.OQ / SSNC.OQ / CTXS.OQ / AMZN.OQ / NVDA.OQ / PLUG.OQ / CHTR.OQ / BCO.N / CVGI.OQ / BBW.N / RUSHA.OQ / NDAQ.OQ / THS.N / SPWR.OQ / MA.N / SIX.N / AON.N / BX.N / INO.OQ / SCHW.N / EXPR.N / DDD.N / GRPN.OQ / FB.OQ / TROX.N / COTY.N / CTG.OQ / MGNX.OQ / LADR.N / TWOU.OQ / FGEN.OQ / ANTM.N / PFX.N / HOPE.OQ / DXC.N / IQV.N / WELL.N / TLRY.OQ / ALLO.OQ / US29350E1047 / LYFT.O / CTVA.N</td><td class="leftalignment">Huntington Bancshares Inc / Koppers Holdings Inc / Aaron's Company Inc / Best Buy Co Inc / Colgate-Palmolive Co / Capital One Financial Corp / CVS Health Corp / Ford Motor Co / Hilton Worldwide Holdings Inc / Schlumberger NV / AT&T Inc / Thermo Fisher Scientific Inc / Franklin Resources Inc / Tenet Healthcare Corp / Greenbrier Companies Inc / Revlon Inc / Archer-Daniels-Midland Co / Valero Energy Corp / United Parcel Service Inc / Kroger Co / Exxon Mobil Corp / Nike Inc / Target Corp / XL Fleet Corp / Ameriprise Financial Inc / Arrow Electronics Inc / Atmos Energy Corp / Twitter Inc / Haemonetics Corp / Sterling Bancorp / Owens & Minor Inc / Chevron Corp / Teledyne Technologies Inc / Amgen Inc / Collegium Pharmaceutical Inc / Gentex Corp / Regeneron Pharmaceuticals Inc / Bed Bath & Beyond Inc / Gilead Sciences Inc / Costco Wholesale Corp / Nektar Therapeutics / Myriad Genetics Inc / SS&C Technologies Holdings Inc / Citrix Systems Inc / Amazon.com Inc / NVIDIA Corp / Plug Power Inc / Charter Communications Inc / Brinks Co / Commercial Vehicle Group Inc / Build-A-Bear Workshop Inc / Rush Enterprises Inc / Nasdaq Inc / TreeHouse Foods Inc / SunPower Corp / Mastercard Inc / Six Flags Entertainment Corp / Aon PLC / Blackstone Inc / Inovio Pharmaceuticals Inc / Charles Schwab Corp / Express Inc / 3D Systems Corp / Groupon Inc / Meta Platforms Inc / Tronox Holdings PLC / Coty Inc / Computer Task Group Inc / MacroGenics Inc / Ladder Capital Corp / 2U Inc / FibroGen Inc / Anthem Inc / PhenixFIN Corp / Hope Bancorp Inc / DXC Technology Co / IQVIA Holdings Inc / Welltower Inc / Tilray Brands Inc / Allogene Therapeutics Inc / Enochian Biosciences Inc / Lyft Inc / Corteva Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Ireland / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">January "Monthly Controversies" report & '22 Outlook</td><td class="leftalignment">English</td><td class="rightalignment">163</td><td class="leftalignment">US0311621009 / US09062X1037 / FR0000120578 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US3755581036 / US5324571083 / US7170811035 / US75886F1075 / US7802592060 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Gilead Sciences Inc / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Royal Dutch Shell PLC / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang</td></tr>
<tr class="odd"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / HD=US / BLD=US / CMA=US / MTN=US / LOW=US / PB=US / EWBC=US / SPOT=US / UMPQ=US / LEG=US / VMC=US / MLM=US / SWIM=US / BLL=US / CCK=US / GFF=US / GPOR=US / IBP=US / MAS=US / MHK=US / PACW=US / WAL=US / CFR=US / FMBI=US / SNV=US / ZION=US / SIVB=US / CNM=US / SSB=US / RF=US / CATY=US / PNFP=US / OGN / TCBI=US / TPX=US / FNB=US / EXP=US / FHN=US / BECN=US / TXRH=US / BLDR=US / GMS=US / CMG=US / XPO=US / PGTI=US / AWI=US / OC=US / AMRX=US / CADE=US / PRPL=US / TREX=US / FBHS=US / TILE=US / NDLS=US / SHAK=US / WING=US / LOB=US / 82982L103 / JELD=US / MBIN=US / HWC=US / OZK=US / APLT=US / FERG=US / AZEK=US / VTRS=US / DASH=US / SNPO=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / TopBuild Corp / Comerica Inc / Vail Resorts Inc / Lowe's Companies Inc / Prosperity Bancshares Inc / East West Bancorp Inc / Spotify Technology SA / Umpqua Holdings Corp / Leggett & Platt Inc / Vulcan Materials Co / Martin Marietta Materials Inc / Latham Group Inc / Ball Corp / Crown Holdings Inc / Griffon Corp / Gulfport Energy Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / PacWest Bancorp / Western Alliance Bancorp / Cullen/Frost Bankers Inc / First Midwest Bancorp Inc / Synovus Financial Corp / Zions Bancorporation NA / SVB Financial Group / Core & Main Inc / SouthState Corp / Regions Financial Corp / Cathay General Bancorp / Pinnacle Financial Partners Inc / Organon & Co / Texas Capital Bancshares Inc / Tempur Sealy International Inc / FNB Corp / Eagle Materials Inc / First Horizon Corp / Beacon Roofing Supply Inc / Texas Roadhouse Inc / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / XPO Logistics Inc / PGT Innovations Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Cadence Bank / Purple Innovation Inc / Trex Company Inc / Fortune Brands Home & Security Inc / Interface Inc / Noodles & Co / Shake Shack Inc / Wingstop Inc / Live Oak Bancshares Inc / SiteOne Landscape Supply Inc / JELD-WEN Holding Inc / Merchants Bancorp / Hancock Whitney Corp / Bank Ozk / Applied Therapeutics Inc / Ferguson PLC / Azek Company Inc / Viatris Inc / DoorDash Inc / Snap One Holdings Corp</td><td class="leftalignment"></td><td class="leftalignment">Luxembourg / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/04/2022</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Omicron Drives Unprecedented Number of Infections, Potentially Offsetting Decreased Severity; Oral Antivirals Get EUAs</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 45253H101 / 00847G705 / 803607100 / 26979610 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 16961L106 / 654405109 / 03890D108 / 192010106 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Sarah Schram / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">INBX: INBRX-106 Ph1 Part 3: Dose Escalation Combo Well-Tolerated, Program Progressing</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">INBX.OQ / BMY.N / AZN.L / AMGN.OQ / INCY.OQ / AGEN.OQ</td><td class="leftalignment">Inhibrx Inc / Bristol-Myers Squibb Co / AstraZeneca PLC / Amgen Inc / Incyte Corp / Agenus Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Judah C. Frommer / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: 2022 Event Analysis (1): Readouts for major drug candidates; Shionogi has leftover results from 2021, focus on Daiichi Sankyo</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">4507.T / 4568.T / 4502.T / 4503.T / 4519.T / 4523.T / PFE.N / 4506.T / 4151.T / AMGN.OQ / SGEN.OQ / 4578.T</td><td class="leftalignment">Shionogi & Co Ltd / Daiichi Sankyo Co Ltd / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Pfizer Inc / Sumitomo Dainippon Pharma Co Ltd / Kyowa Kirin Co Ltd / Amgen Inc / Seagen Inc / Otsuka Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 2022イベントアナリシス①：主要な開発品のリードアウト一覧～2021年からの積み残しで塩野義、注目度で第一三共</td><td class="leftalignment">Japanese</td><td class="rightalignment">9</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / PFE.N / 4506.T / 4151.T / AMGN.OQ / NVAX.OQ / SGEN.OQ / 4568.T / 4578.T</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Pfizer Inc / Sumitomo Dainippon Pharma Co Ltd / Kyowa Kirin Co Ltd / Amgen Inc / Novavax Inc / Seagen Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">01/03/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Dec 24, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">112</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2455965 / 2471950 / 2623911 / 2684703 / 2730190 / 7103065 / B6RS2B3 / B7F2TY6 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Biogen Inc / Incyte Corp / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Clovis Oncology Inc / Puma Biotechnology Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">01/03/2022</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Short Interest Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AMGN.O / VRTX.O</td><td class="leftalignment">Amgen Inc / Vertex Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Yinglu Zhang</td></tr>
<tr class="even"><td class="leftalignment">01/03/2022</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">William Blair Biopharma Catalyst Watch First Quarter 2022</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">014442107 / 03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 45253H101 / 00847G705 / 803607100 / 26979610 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 16961L106 / 654405109 / 03890D108 / 192010106 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101 / 603693102</td><td class="leftalignment">Alector Inc / Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc / Mink Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Sarah Schram / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / John Boyle / Lachlan Hanbury-Brown / Mr. Rob Andrew, CFA</td></tr>
<tr class="odd"><td class="leftalignment">01/03/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / OGN / AMRX=US / VTRS=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Organon & Co / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregory D. Fraser / Ms. Robyn S. Karnauskas / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">01/03/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">2000019 / 2023607 / 2437071 / 2216850 / 2222631 / 2542049 / 2576941 / 2328915 / 2455965 / 2457864 / 2657802 / 2989301 / 4595739 / 2713317 / B616C79 / BCZS820 / BFDV8K0 / BBPK0J0 / B3V9F12 / BP4GNK9 / BYZLV46 / BF4VBS8 / BK0VHF6 / BDHF4K6 / BZBY005 / BJLKVS6 / BYZR4X4 / BGCYWN8 / BJXBP30 / BYQHPK7 / BYYWPW6 / BDVLM39 / BDZ30Q0 / BJMLSD2 / BYTJZL1 / BK71LV3 / BMPRZV5 / BMC5RV6 / BNG3RZ7 / BMZ9Z11 / BMXXBD9 / BLF0CW7 / BFYVZ75 / BJLV8T9 / BMW5084 / BP0TJN7 / BMW5LX6</td><td class="leftalignment">Amazon.com Inc / Amgen Inc / Biomarin Pharmaceutical Inc / Consolidated Edison Inc / Cooper Companies Inc / Dominion Energy Inc / Exelixis Inc / Nextera Energy Inc / Biogen Inc / ImmunoGen Inc / OGE Energy Corp / TJX Companies Inc / Genmab A/S / ACADIA Pharmaceuticals Inc / Tesla Inc / Fate Therapeutics Inc / MacroGenics Inc / Mirati Therapeutics Inc / PVH Corp / SAGE Therapeutics Inc / InflaRx NV / BioXcel Therapeutics Inc / IDEAYA Biosciences Inc / CRISPR Therapeutics AG / Merus NV / Phathom Pharmaceuticals Inc / Axsome Therapeutics Inc / Xencor Inc / Turning Point Therapeutics Inc / Zymeworks Inc / Beigene Ltd / argenx SE / Arvinas Inc / Karuna Therapeutics Inc / Zogenix Inc / Relmada Therapeutics Inc / Kymera Therapeutics Inc / Adicet Bio Inc / Leslie's Inc / Prometheus Biosciences Inc / Figs Inc / Repare Therapeutics Inc / Seelos Therapeutics Inc / Celldex Therapeutics Inc / PMV Pharmaceuticals Inc / Xponential Fitness Inc / Eliem Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">01/03/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Previewing 2022 - IMGN, MRUS Best Ideas; KYMR, ACET, IDYA Top Picks</td><td class="leftalignment">English</td><td class="rightalignment">118</td><td class="leftalignment">BMC5RV6 / BWY4XV3 / IDYA.OQ / IMGN.OQ / KYMR.OQ / MRUS.OQ / 2023607 / 2576941 / 2457864 / 2471950 / 4595739 / 2982924 / BCZS820 / BFDV8K0 / BBPK0J0 / ADAP.OQ / BFZNYB7 / BK0VHF6 / BDHF4K6 / BZBY005 / BZ1LFB2 / BKS3SM8 / BMQ5T49 / BGCYWN8 / BKVDFF7 / BJXBP30 / BYQHPK7 / BYYWPW6 / BJ9NFQ3 / BWY52P3 / BL71K91 / BDZ30Q0 / BN2R582 / BDD1B07 / BMPRZV5 / BMDJ397 / BN2RM92 / BLF0CW7 / BP7KZP7 / BMW5084 / BNLYJ60 / BNLYBF3 / BMVBZF5 / BP2P6L0 / BMV6Y64</td><td class="leftalignment">Adicet Bio Inc / Adaptimmune Therapeutics PLC / IDEAYA Biosciences Inc / ImmunoGen Inc / Kymera Therapeutics Inc / Merus NV / Amgen Inc / Exelixis Inc / ImmunoGen Inc / Incyte Corp / Genmab A/S / Spectrum Pharmaceuticals Inc / Fate Therapeutics Inc / MacroGenics Inc / Mirati Therapeutics Inc / Adaptimmune Therapeutics PLC / Allogene Therapeutics Inc / IDEAYA Biosciences Inc / CRISPR Therapeutics AG / Merus NV / Deciphera Pharmaceuticals Inc / IGM Biosciences Inc / Zentalis Pharmaceuticals Inc / Xencor Inc / Oric Pharmaceuticals Inc / Turning Point Therapeutics Inc / Zymeworks Inc / Beigene Ltd / Neoleukin Therapeutics Inc / Blueprint Medicines Corp / Revolution Medicines Inc / Arvinas Inc / Relay Therapeutics Inc / Rubius Therapeutics Inc / Kymera Therapeutics Inc / Bolt Biotherapeutics Inc / Rain Therapeutics Inc / Repare Therapeutics Inc / Monte Rosa Therapeutics Inc / PMV Pharmaceuticals Inc / Imago BioSciences Inc / Erasca Inc / Immuneering Corp / Tango Therapeutics Inc / Xilio Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin / Yige Guo, Ph.D. / Paul Jeng, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">01/03/2022</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Korea Healthcare Sector: Korea Healthcare Monthly Tracker: Jan 2022</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">000100.KS / 145020.KQ / JNJ.N / PFE.N / AZN.L / AMGN.OQ / NVAX.OQ / 006280.KS / TEVA.N / MRNA.OQ / 068270.KS / 086900.KQ / 207940.KS / 091990.KQ / 302440.KS</td><td class="leftalignment">Yuhan Corp / Hugel Inc / Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / Amgen Inc / Novavax Inc / Green Cross Corp / Teva Pharmaceutical Industries Ltd / Moderna Inc / Celltrion Inc / Medy Tox Inc / Samsung Biologics Co Ltd / Celltrion Healthcare Co Ltd / SK Bioscience Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="odd"><td class="leftalignment">01/02/2022</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">1H22 Biopharma Catalyst Calendar</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">375558103 / 031162100 / 766559603 / 09062X103 / 92532F100 / 09061G101 / 75886F107 / 30161Q104 / 02043Q107 / 036642106 / 09058V103 / 40637H109 / 45253H101 / 45665G303 / 68375N103 / 00287Y109 / 29251M106 / 23282W605 / G50871105 / 03835T200 / 78667J108 / 03209R103 / 16383L106 / 868459108 / 90400D108 / 31189P102 / 00461U105 / 45845P108 / 04280A100 / 09627Y109 / 52187K101 / G11196105 / 81750R102 / 462260100 / 558868105 / 68404V100 / 98401F105 / 23284F105 / 03168L105 / 80706P103 / 29014R103 / 039697107 / 140755109 / H17182108 / 67576A100 / 761330109 / 41358P106 / 87808K106 / 483347100 / 37890U108 / 29668H708 / 68906L105 / 04016X101 / 87184Q107 / 481116101 / 59935V107 / 03836N103 / 869367102 / BY2Z0H7 / 69242L106 / 44975P103 / 64049K104 / 60770K107 / 65343E108 / 05337M104 / 04522R101 / 492327101 / 359616109 / 05454B105 / 729139105 / 00972D105 / 760273102 / 00973J101 / 282559103 / 02155H200 / 03969T109 / 24344T101 / 80810D103 / 92243A200 / 74366E102 / 00166B105 / 45790W108 / 04335A105 / 23257D103 / 76029N106 / 4525EP101 / 46565G104 / 52490G102 / 75382E109 / 38341P102 / 501575104 / 14147L108 / 53272L103 / 67080M103 / 73730P108 / 26818M108 / 81181C104 / 019818103 / 83422E105 / 50107A104 / 01626L105 / 74006W108 / 38942Q103 / 68236R103 / M47364100 / 00773J103 / G59665102 / 92556V106 / 03890D108 / 03835L207 / 413197104 / 002120202 / 14888D208 / 19240Q201 / 98872L102 / 49705R105 / 00288U106 / 38406L103 / 92941V209 / 57055L107 / 45256X103 / 207523101 / 00449L102 / 75974E103 / 09077A106 / 75082Q105 / 23954D109 / 15673T100 / 61225M102 / 730541109 / 670703107 / 68217N105 / 87978U108 / 00032Q104</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Exelixis Inc / Alnylam Pharmaceuticals Inc / Antares Pharma Inc / BioCryst Pharmaceuticals Inc / Halozyme Therapeutics Inc / ImmunoGen Inc / Infinity Pharmaceuticals Inc / OPKO Health Inc / Abbvie Inc / Enanta Pharmaceuticals Inc / Cytokinetics Inc / Jazz Pharmaceuticals PLC / Aptose Biosciences Inc / SAGE Therapeutics Inc / Amphastar Pharmaceuticals Inc / ChemoCentryx Inc / Supernus Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Fate Therapeutics Inc / Aclaris Therapeutics Inc / Intercept Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Blueprint Medicines Corp / Leap Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Seres Therapeutics Inc / Iovance Biotherapeutics Inc / Madrigal Pharmaceuticals Inc / OptiNose Inc / Xencor Inc / CytomX Therapeutics Inc / Amneal Pharmaceuticals Inc / Scholar Rock Holding Corp / Eloxx Pharmaceuticals Inc / Ardelyx Inc / Cara Therapeutics Inc / CRISPR Therapeutics AG / Ocular Therapeutix Inc / Revance Therapeutics Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / Kaleido Biosciences Inc / Global Blood Therapeutics Inc / ESSA Pharma Inc / Otonomy Inc / argenx SE / Syros Pharmaceuticals Inc / Jounce Therapeutics Inc / Milestone Pharmaceuticals Inc / Aptinyx Inc / Sutro Biopharma Inc / PureTech Health PLC / Oyster Point Pharma Inc / I-Mab / Neoleukin Therapeutics Inc / Moderna Inc / NextCure Inc / Avadel Pharmaceuticals PLC / Aslan Pharmaceuticals Ltd / Keros Therapeutics Inc / Fulcrum Therapeutics Inc / Axcella Health Inc / Pliant Therapeutics Inc / Akebia Therapeutics Inc / Repare Therapeutics Inc / Akouos Inc / 89Bio Inc / Altimmune Inc / Arcturus Therapeutics Holdings Inc / Deciphera Pharmaceuticals Inc / Schrodinger Inc / Vaxart Inc / Protagonist Therapeutics Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Arvinas Inc / Cymabay Therapeutics Inc / Replimune Group Inc / Immunic Inc / Iteos Therapeutics Inc / Legend Biotech Corp / Rapt Therapeutics Inc / Gossamer Bio Inc / Kymera Therapeutics Inc / Cardiff Oncology Inc / Liminal BioSciences Inc / Nurix Therapeutics Inc / Poseida Therapeutics Inc / Dyne Therapeutics Inc / Seagen Inc / Allovir Inc / Solid Biosciences Inc / Kronos Bio Inc / Aligos Therapeutics Inc / Praxis Precision Medicines Inc / Graybug Vision Inc / Oncorus Inc / Gamida Cell Ltd / Aeglea Bio Therapeutics Inc / MeiraGTx Holdings PLC / Viatris Inc / Aravive Inc / Aptevo Therapeutics Inc / Harmony Biosciences Holdings Inc / aTyr Pharma Inc / Catalyst Biosciences Inc / Cogent Biosciences Inc / Yumanity Therapeutics Inc / Kinnate Biopharma Inc / Abcellera Biologics Inc / Gracell Biotechnologies Inc / Vyne Therapeutics Inc / Marker Therapeutics Inc / Immunitybio Inc / Connect Biopharma Holdings Ltd / Achilles Therapeutics PLC / Reneo Pharmaceuticals Inc / Biomea Fusion Inc / Rain Therapeutics Inc / Day One Biopharmaceuticals Inc / Century Therapeutics Inc / Monte Rosa Therapeutics Inc / POINT Biopharma Global Inc / Nuvalent Inc / Omega Therapeutics Inc / Tempest Therapeutics Inc / Aadi Bioscience Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / Ireland / Israel / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">David A. Amsellem / Joseph Catanzaro, PhD / Mr. Do G. Kim / Yasmeen Rahimi, Ph.D. / Mr. Christopher J. Raymond / Edward A. Tenthoff / Mr. Allison M. Bratzel, CFA</td></tr>
<tr class="even"><td class="leftalignment">01/01/2022</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for AMGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">01/01/2022</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 580</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 45253H101 / 00847G705 / 803607100 / 26979610 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 16961L106 / 654405109 / 03890D108 / 192010106 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101 / 603693102</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc / Mink Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Sarah Schram / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">12/31/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Amgen increases 0.9% in FY 2021</td><td class="leftalignment">English</td><td class="rightalignment">64</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">12/31/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Amgen gains 6.0% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">12/31/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / INCY.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Incyte Corp / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon / Leonid Timashev</td></tr>
<tr class="odd"><td class="leftalignment">12/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">HZNP-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">HZNP.O / MRK / PFE / AMGN.O / RDY / AZN.O / RDUS.O</td><td class="leftalignment">Horizon Therapeutics PLC / Merck & Co Inc / Pfizer Inc / Amgen Inc / Dr Reddy's Laboratories Ltd / AstraZeneca PLC / Radius Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / India / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">12/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">REGN-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">REGN.O / JNJ / NVS / AMGN.O / BIIB.O / ALNY.O / SNY.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Johnson & Johnson / Novartis AG / Amgen Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">12/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GILD-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">GILD.O / BIOb / JNJ / LLY / MRK / PFE / AMGN.O / ILMN.O / VRTX.O / BIIB.O / ABBV.K</td><td class="leftalignment">Gilead Sciences Inc / Bio Rad Laboratories Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Illumina Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">12/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AMGN.O / ABT / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">12/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABBV-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ABBV.K / BMY / LLY / PFE / GILD.O / AMGN.O / GSK / NBIX.O / AZN.O / BIIB.O</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / GlaxoSmithKline PLC / Neurocrine Biosciences Inc / AstraZeneca PLC / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">12/30/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Ending the Year on a Positive Note - Biotech Inflows Close Out 2021</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 04016X101 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105 / 670703107</td><td class="leftalignment">Amgen Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / argenx SE / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc / Nuvalent Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">12/30/2021</td><td class="leftalignment">Crispidea</td><td class="leftalignment">Amgen Inc. (AMGN) - Growth from innovative products</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">RESEARCH OVERVIEW</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / ASSET MANAGEMENT / CAPITALIZATION / EARNINGS/FINANCIAL STATEMENTS / MERGER/ACQUISITION/DIVESTITURE / MISCELLANEOUS / CHANGE IN RECOMMENDATION / GROWTH / PORTFOLIO STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Rimi Murarka / Ms. Shejal Ajmera</td></tr>
<tr class="even"><td class="leftalignment">12/30/2021</td><td class="leftalignment">MarketLine</td><td class="leftalignment">Amgen, Inc.</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT / EARNINGS/FINANCIAL STATEMENTS / TUESDAY / STRATEGIC ANALYSIS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">MarketLine Independent Re</td></tr>
<tr class="odd"><td class="leftalignment">12/30/2021</td><td class="leftalignment">MarketLine</td><td class="leftalignment">Amgen, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report</td><td class="leftalignment">English</td><td class="rightalignment">379</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT / EARNINGS/FINANCIAL STATEMENTS / TUESDAY / STRATEGIC ANALYSIS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">MarketLine Independent Re</td></tr>
<tr class="even"><td class="leftalignment">12/29/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Biotech 2021 Recap and Predictions for 2022</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">04683R106 / 09061G101 / 03116210 / 64125C109 / 110122108 / 09062X103 / 640268108 / 30161Q104 / 45337C102 / 45253H101 / 00847G705 / 803607100 / 26979610 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 16961L106 / 654405109 / 03890D108 / 192010106 / 151205200 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101 / 603693102</td><td class="leftalignment">Atea Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Celyad Oncology SA / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc / Mink Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Sarah Schram / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">12/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PFE-US Company reports financial results for the quarter ended October 03,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PFE / ABT / BMY / JNJ / LLY / MRK / NVS / AMGN.O / GSK / AZN.O</td><td class="leftalignment">Pfizer Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">12/27/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Dec 17, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">111</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2455965 / 2471950 / 2623911 / 2684703 / 2730190 / 7103065 / B6RS2B3 / B7F2TY6 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Biogen Inc / Incyte Corp / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Clovis Oncology Inc / Puma Biotechnology Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">12/27/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Race to the Bottom? Which Biopharma Has Most LOE Risk in 2025-30 Period?</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">71708110 / 92532F10 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 80105N10 / 58933Y10 / 00287Y10 / G3910J11</td><td class="leftalignment">Pfizer Inc / Vertex Pharmaceuticals Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Sanofi SA / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC</td><td class="leftalignment"></td><td class="leftalignment">Australia / China / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Daniel Tarjan, Ph.D. / Na Sun</td></tr>
<tr class="even"><td class="leftalignment">12/26/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Nice Stocking Stuffer - Fund Flows Decidedly Positive This Week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 04016X101 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / argenx SE / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">12/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for AMGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">12/24/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Week in Review - December 17 to 24, 2021</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US02553E1064 / US0311621009 / US0530151036 / US0584981064 / US0936711052 / US1101221083 / US2017231034 / US2371941053 / US3647601083 / US3703341046 / US3755581036 / US45337C1027 / US5324571083 / US5951121038 / US64125C1099 / US6541061031 / US6556641008 / US6703461052 / US7043261079 / US7170811035 / US75886F1075 / US7782961038 / US8000131040 / US8168511090 / US8270481091 / US8354951027 / US8581191009 / US8589121081 / US8725401090 / US9170471026 / US9182041080 / US92276F1003 / US92532F1003 / US9746371007 / CA1249003098 / CA8029121057 / CA30150P1099 / CA1469001053 / CA9528451052 / US9129091081 / CA51925D1069 / CA13677F1018 / CA0636711016 / CA0641491075 / CA6330671034 / CA7800871021 / US2283681060 / US2274831047 / US09062X1037 / US0534841012 / US29476L1070 / US2971781057 / CA8911605092 / CA1360691010 / US74144T1088 / US1011211018 / US2644115055 / US9290421091 / CA6445351068 / US9043111072 / US7376301039 / CA1375761048 / US9026531049 / US25960P1093 / US49427F1084 / CA3499151080 / US5500211090 / US02913V1035 / US90384S3031 / US3886891015 / US58933Y1055 / US18538R1032 / US74340W1036 / US6936561009 / US7512121010 / CA07380N1042 / CA96145A2002 / US4440971095 / US78573L1061 / GB00B11DNM70 / US60468T1051 / US1220171060 / US2921041065 / US1785871013 / CA45868C1095 / US14174T1079 / US96145D1054 / US72703H1014 / US95040Q1040 / CA26829L1076 / US7495271071 / CA9628791027 / US8760301072 / US8608971078 / US63845R1077 / CA8585221051 / US03843E1047 / KYG370921069 / VGG1890L1076 / US73757R1023 / US76156B1070 / US88339P1012 / CA29446Y5020 / US70614W1009 / CA04302L1004 / US82575P1075 / US26484T1060 / US15202L1070 / US60646V1052 / US0708301041 / US9264001028 / US89269P1030 / US94770D1028 / US53190C1027 / US1374041093</td><td class="leftalignment">American Eagle Outfitters Inc / Amgen Inc / Automatic Data Processing Inc / Ball Corp / H & R Block Inc / Bristol-Myers Squibb Co / Commercial Metals Co / Darden Restaurants Inc / Gap Inc / General Mills Inc / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Micron Technology Inc / Neurocrine Biosciences Inc / Nike Inc / Nordstrom Inc / Nucor Corp / Paychex Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Ross Stores Inc / Sanderson Farms Inc / Sempra Energy / Silgan Holdings Inc / Sonoco Products Co / Steel Dynamics Inc / Stericycle Inc / TJX Companies Inc / Urban Outfitters Inc / VF Corp / Ventas Inc / Vertex Pharmaceuticals Inc / Winnebago Industries Inc / CCL Industries Inc / Saputo Inc / Exco Technologies Ltd / Cascades Inc / West Fraser Timber Co Ltd / United States Steel Corp / Laurentian Bank of Canada / Canadian Western Bank / Bank of Montreal / Bank of Nova Scotia / National Bank of Canada / Royal Bank of Canada / Crown Holdings Inc / Cross Country Healthcare Inc / Biogen Inc / Avalonbay Communities Inc / Equity Residential / Essex Property Trust Inc / Toronto-Dominion Bank / Canadian Imperial Bank of Commerce / T Rowe Price Group Inc / Boston Properties Inc / Duke Realty Corp / Vornado Realty Trust / New Gold Inc / Under Armour Inc / Potlatchdeltic Corp / Canfor Corp / UDR Inc / Douglas Emmett Inc / Kilroy Realty Corp / Fortuna Silver Mines Inc / Lululemon Athletica Inc / American Public Education Inc / Ulta Beauty Inc / Graphic Packaging Holding Co / Merck & Co Inc / Clearwater Paper Corp / Prologis Inc / PVH Corp / Ralph Lauren Corp / Bear Creek Mining Corp / Westshore Terminals Investment Corp / Hudson Pacific Properties Inc / Sabra Health Care REIT Inc / Horizonte Minerals PLC / Mirati Therapeutics Inc / Burlington Stores Inc / Empire State Realty Trust Inc / City Office REIT Inc / Interfor Corp / CareTrust REIT Inc / Westrock Co / Planet Fitness Inc / Welltower Inc / ECN Capital Corp / REV Group Inc / Wheaton Precious Metals Corp / Tapestry Inc / Stitch Fix Inc / National Vision Holdings Inc / Stelco Holdings Inc / Aquestive Therapeutics Inc / Galaxy Digital Holdings Ltd / Capri Holdings Ltd / Postal Realty Trust Inc / Revolve Group Inc / RealReal Inc / Equinox Gold Corp / Peloton Interactive Inc / Artemis Gold Inc / Sibanye Stillwater Ltd / Dun & Bradstreet Holdings Inc / Centerspace / Mister Car Wash Inc / Bath & Body Works Inc / Victoria's Secret & Co / Traeger Inc / Weber Inc / Life Time Group Holdings Inc / Candel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / United Kingdom / United States / Virgin Islands, British / South Africa</td><td class="leftalignment"></td><td class="leftalignment">Africa / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">12/24/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 579</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 45253H101 / 00847G705 / 803607100 / 26979610 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 16961L106 / 654405109 / 03890D108 / 192010106 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101 / 603693102</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc / Mink Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Sarah Schram / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">12/24/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / INCY.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Incyte Corp / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon / Leonid Timashev</td></tr>
<tr class="odd"><td class="leftalignment">12/23/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AMGN.O / BMRN.O / REGN.O / AGIO.O</td><td class="leftalignment">Amgen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Agios Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="even"><td class="leftalignment">12/23/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">There’s No Biopharma Without M&A; Dip in Deals in 2021 Does Not Make a Trend</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">71708110 / 92532F10 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 80105N10 / 58933Y10 / 00287Y10 / G3910J11</td><td class="leftalignment">Pfizer Inc / Vertex Pharmaceuticals Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Sanofi SA / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC</td><td class="leftalignment"></td><td class="leftalignment">Australia / China / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Daniel Tarjan, Ph.D. / Na Sun</td></tr>
<tr class="odd"><td class="leftalignment">12/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MOLN.S: Molecular Partners - Model update post CMD. Major catalyst of COVID data due early 22. CSe 60% POS $1b , NPV SFr 6.5/shr</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">MOLN.S / JNJ.N / LLY.N / PFE.N / AZN.L / ROG.S / NOVN.S / GSK.L / AMGN.OQ / REGN.OQ / ABBV.N / ARGX.OQ</td><td class="leftalignment">Molecular Partners AG / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Roche Holding AG / Novartis AG / GlaxoSmithKline PLC / Amgen Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / argenx SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">12/22/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Dec 22 2021</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">DE0006969603 / US09061G1013 / US0311621009 / US0718131099 / US1101221083 / US1311931042 / US1985161066 / US2435371073 / US3755581036 / US45253H1014 / US45337C1027 / US4781601046 / US64125C1099 / US6541061031 / US66987V1098 / US75886F1075 / US7782961038 / US8006771062 / US8305661055 / US8725401090 / US87612E1064 / US9021041085 / US9139031002 / US9182041080 / US92532F1003 / US3448491049 / US6402681083 / US21036P1084 / US2533931026 / US09062X1037 / US0042251084 / US02043Q1076 / US9043111072 / BREMBRACNOR4 / US4103451021 / US03152W1099 / US5500211090 / US36315X1019 / US58933Y1055 / US46333X1081 / US13100M5094 / DE000A1EWWW0 / US29082A1079 / US40412C1018 / US6936561009 / US7512121010 / US00287Y1091 / US09609G1004 / US8036071004 / US4576693075 / US74587V1070 / US45845P1084 / US29428V1044 / US69366J2006 / US29664W1053 / US00847X1046 / US60468T1051 / US1220171060 / US4277461020 / US90400D1081 / NL0010696654 / US0396971071 / US78667J1088 / US2681582019 / US09627Y1091 / US81750R1023 / US37890U1088 / US50127T1097 / US05464T1043 / US4622221004 / US28106W1036 / US87164F1057 / US00773U1088 / US5588681057 / CH0334081137 / BMG637AM1024 / US01345P1066 / US74967X1037 / US6904691010 / US04016X1019 / US76243J1051 / US4622601007 / US5011471027 / US03753U1060 / US77313F1066 / US4380831077 / US2997341035 / US80706P1030 / US89610F1012 / US01671P1003 / US9842411095 / US39868T1051 / US0197701065 / US98585X1046 / US68570P1012 / US85205L1070 / US92764N1028 / US7027121000 / US0843101017 / US75943R1023 / US02875D1090 / US07373B1098 / US56854Q2003 / US81181C1045 / US74006W1080 / US55406W1036 / US30260D1037 / US38870X1046 / KYG7614L1095 / US98422T1007 / US01675A1097</td><td class="leftalignment">Puma SE / Biomarin Pharmaceutical Inc / Amgen Inc / Baxter International Inc / Bristol-Myers Squibb Co / Callaway Golf Co / Columbia Sportswear Co / Deckers Outdoor Corp / Gilead Sciences Inc / ImmunoGen Inc / Incyte Corp / Johnson & Johnson / Neurocrine Biosciences Inc / Nike Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Ross Stores Inc / Sangamo Therapeutics Inc / Skechers USA Inc / TJX Companies Inc / Target Corp / II-VI Inc / Universal Health Services Inc / VF Corp / Vertex Pharmaceuticals Inc / Foot Locker Inc / Nektar Therapeutics / Constellation Brands Inc / DICK'S Sporting Goods Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Under Armour Inc / Embraer SA / HanesBrands Inc / Amicus Therapeutics Inc / Lululemon Athletica Inc / Galapagos NV / Merck & Co Inc / Ironwood Pharmaceuticals Inc / Calix Inc / Adidas AG / Embraer SA / HCA Healthcare Inc / PVH Corp / Ralph Lauren Corp / Abbvie Inc / bluebird bio Inc / Sarepta Therapeutics Inc / Insmed Inc / Puma Biotechnology Inc / Intercept Pharmaceuticals Inc / Epizyme Inc / PTC Therapeutics Inc / Esperion Therapeutics Inc / Agios Pharmaceuticals Inc / Mirati Therapeutics Inc / Burlington Stores Inc / Heron Therapeutics Inc / Ultragenyx Pharmaceutical Inc / Uniqure NV / Ardelyx Inc / SAGE Therapeutics Inc / Dynavax Technologies Corp / Blueprint Medicines Corp / Seres Therapeutics Inc / Global Blood Therapeutics Inc / Kura Oncology Inc / Axsome Therapeutics Inc / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Syndax Pharmaceuticals Inc / Adverum Biotechnologies Inc / Madrigal Pharmaceuticals Inc / CRISPR Therapeutics AG / Myovant Sciences Ltd / Albireo Pharma Inc / RH / Ovid Therapeutics Inc / argenx SE / Rhythm Pharmaceuticals Inc / Iovance Biotherapeutics Inc / Krystal Biotech Inc / Apellis Pharmaceuticals Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Evelo Biosciences Inc / Scholar Rock Holding Corp / Tricida Inc / Allakos Inc / Y-mAbs Therapeutics Inc / Gritstone bio Inc / Allogene Therapeutics Inc / Yeti Holdings Inc / Orchard Therapeutics PLC / SpringWorks Therapeutics Inc / Vir Biotechnology Inc / Passage Bio Inc / Berkeley Lights Inc / Relay Therapeutics Inc / American Outdoor Brands Inc / Beam Global / Marinus Pharmaceuticals Inc / Seagen Inc / Praxis Precision Medicines Inc / MYT Netherlands Parent BV / Figs Inc / Graphite Bio Inc / Rockley Photonics Holdings Ltd / Xilio Therapeutics Inc / Allbirds Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Brazil / Switzerland / Cayman Islands / Germany / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">12/22/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AAPL / AGCO / ALLO / AMGN / AMT / APPS / AXP / BYND / C.N / CCI / CHTR / CME / COF / CSII / DISH / DNLI / EA / FISV / FOCS / GE / GS / ICE / INTC.O / JPM.N / MA / MCO / MS / MSFT / NET / ORCL / RNG / RXT / SAGE / SAP / SEIC / SONY / T / TTWO / V / VCTR / AMZN.O / CMCSA.O / NICE / MSCI / CSCO.O / FIS / ATVI.O / TRIT / NVDA.O / EGAN / RDWR / HEAR / KLR / SQ / AKAM / EQIX / VZ / NFLX / LUMN / FDS.N / GPN / LFUS.O / DOX.O / PYPL / VRNT / NDAQ / OSIS.O / CALM.OQ / ABMD.O / TEAM.O / SIVB.O / ALCO.O / BIIB / 459200101 / 316773100 / CYTK.O / GOOG.O / SPGI / ACAD.O / G02602103 / 029899101 / 36467W109 / CCOI / COIN / 02043Q107 / STX.OQ / VFF.TO / SWAV / LMNR.O / 695127100 / ZNGA / FB.O / WDAY / TMUS / FDEV.L / FIVN.O / 82655M107 / 83587F202 / 174610105 / IONS.O / RMR.O / ACST.V / CLLS.O / ATUS.K / APLS.O / EGHT.K / ZS.O / BILI.O / AVYA.K / CBOE.K / FSLY / KRTX / CMBM / ONDS.OQ / APPH / DOCN / HUYA.K / HON.O / CLNN.O / OTLY / LOCL.k</td><td class="leftalignment">Apple Inc / AGCO Corp / Allogene Therapeutics Inc / Amgen Inc / American Tower Corp / Digital Turbine Inc / American Express Co / Beyond Meat Inc / Citigroup Inc / Crown Castle International Corp / Charter Communications Inc / CME Group Inc / Capital One Financial Corp / Cardiovascular Systems Inc / DISH Network Corp / Denali Therapeutics Inc / Electronic Arts Inc / Fiserv Inc / Focus Financial Partners Inc / General Electric Co / Goldman Sachs Group Inc / Intercontinental Exchange Inc / Intel Corp / JPMorgan Chase & Co / Mastercard Inc / Moody's Corp / Morgan Stanley / Microsoft Corp / Cloudflare Inc / Oracle Corp / RingCentral Inc / Rackspace Technology Inc / SAGE Therapeutics Inc / SAP SE / SEI Investments Co / Sony Group Corp / AT&T Inc / Take-Two Interactive Software Inc / Visa Inc / Victory Capital Holdings Inc / Amazon.com Inc / Comcast Corp / Nice Ltd / MSCI Inc / Cisco Systems Inc / Fidelity National Information Services Inc / Activision Blizzard Inc / Triterras Inc / NVIDIA Corp / eGain Corp / Radware Ltd / Turtle Beach Corp / Kaleyra Inc / Block Inc / Akamai Technologies Inc / Equinix Inc / Verizon Communications Inc / Netflix Inc / Lumen Technologies Inc / Factset Research Systems Inc / Global Payments Inc / Littelfuse Inc / Amdocs Ltd / PayPal Holdings Inc / Verint Systems Inc / Nasdaq Inc / OSI Systems Inc / Cal-Maine Foods Inc / ABIOMED Inc / Atlassian Corporation PLC / SVB Financial Group / Alico Inc / Biogen Inc / International Business Machines Corp / Fifth Third Bancorp / Cytokinetics Inc / Alphabet Inc / S&P Global Inc / ACADIA Pharmaceuticals Inc / Amdocs Ltd / American States Water Co / GameStop Corp / Cogent Communications Holdings Inc / Coinbase Global Inc / Alnylam Pharmaceuticals Inc / Seagate Technology Holdings PLC / Village Farms International Inc / Shockwave Medical Inc / Limoneira Co / Pacira Biosciences Inc / Zynga Inc / Meta Platforms Inc / Workday Inc / T-Mobile US Inc / Frontier Developments PLC / Five9 Inc / Sify Technologies Ltd / Sorrento Therapeutics Inc / Citizens Financial Group Inc / Ionis Pharmaceuticals Inc / RMR Group Inc / Acasti Pharma Inc / Cellectis SA / Altice USA Inc / Apellis Pharmaceuticals Inc / 8x8 Inc / Zscaler Inc / Bilibili Inc / Avaya Holdings Corp / Cboe Global Markets Inc / Fastly Inc / Karuna Therapeutics Inc / Cambium Networks Corp / Ondas Holdings Inc / AppHarvest Inc / DigitalOcean Holdings Inc / HUYA Inc / Honeywell International Inc / Clene Inc. / Oatly Group AB / Local Bounti Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Germany / France / United Kingdom / India / Ireland / Israel / Japan / Sweden / United States / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/22/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Top 10 Potential Surprises Of 2022</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">US09062X1037 / US89610F1012 / US09061G1013 / US0311621009 / US1101221083 / US3755581036 / US45253H1014 / US45337C1027 / US4781601046 / US64125C1099 / US66987V1098 / US75886F1075 / US8006771062 / US92532F1003 / US6402681083 / US21036P1084 / US0042251084 / US02043Q1076 / US03152W1099 / US36315X1019 / US58933Y1055 / US46333X1081 / US00287Y1091 / US09609G1004 / US8036071004 / US4576693075 / US74587V1070 / US45845P1084 / US29428V1044 / US69366J2006 / US29664W1053 / US00847X1046 / US60468T1051 / US4277461020 / US90400D1081 / NL0010696654 / US0396971071 / US78667J1088 / US2681582019 / US09627Y1091 / US81750R1023 / US37890U1088 / US50127T1097 / US05464T1043 / US4622221004 / US28106W1036 / US87164F1057 / US00773U1088 / US5588681057 / CH0334081137 / BMG637AM1024 / US01345P1066 / US6904691010 / US04016X1019 / US76243J1051 / US4622601007 / US5011471027 / US03753U1060 / US6760791060 / US77313F1066 / US4380831077 / US2997341035 / US80706P1030 / US01671P1003 / US9842411095 / US39868T1051 / US0197701065 / US68570P1012 / US85205L1070 / US92764N1028 / US7027121000 / US75943R1023 / US56854Q2003 / US81181C1045 / US74006W1080 / US38870X1046 / US98422T1007</td><td class="leftalignment">Biogen Inc / Tricida Inc / Biomarin Pharmaceutical Inc / Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / ImmunoGen Inc / Incyte Corp / Johnson & Johnson / Neurocrine Biosciences Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Nektar Therapeutics / Constellation Brands Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Amicus Therapeutics Inc / Galapagos NV / Merck & Co Inc / Ironwood Pharmaceuticals Inc / Abbvie Inc / bluebird bio Inc / Sarepta Therapeutics Inc / Insmed Inc / Puma Biotechnology Inc / Intercept Pharmaceuticals Inc / Epizyme Inc / PTC Therapeutics Inc / Esperion Therapeutics Inc / Agios Pharmaceuticals Inc / Mirati Therapeutics Inc / Heron Therapeutics Inc / Ultragenyx Pharmaceutical Inc / Uniqure NV / Ardelyx Inc / SAGE Therapeutics Inc / Dynavax Technologies Corp / Blueprint Medicines Corp / Seres Therapeutics Inc / Global Blood Therapeutics Inc / Kura Oncology Inc / Axsome Therapeutics Inc / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Syndax Pharmaceuticals Inc / Adverum Biotechnologies Inc / Madrigal Pharmaceuticals Inc / CRISPR Therapeutics AG / Myovant Sciences Ltd / Albireo Pharma Inc / Ovid Therapeutics Inc / argenx SE / Rhythm Pharmaceuticals Inc / Iovance Biotherapeutics Inc / Krystal Biotech Inc / Apellis Pharmaceuticals Inc / Odonate Therapeutics Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Evelo Biosciences Inc / Scholar Rock Holding Corp / Allakos Inc / Y-mAbs Therapeutics Inc / Gritstone bio Inc / Allogene Therapeutics Inc / Orchard Therapeutics PLC / SpringWorks Therapeutics Inc / Vir Biotechnology Inc / Passage Bio Inc / Relay Therapeutics Inc / Marinus Pharmaceuticals Inc / Seagen Inc / Praxis Precision Medicines Inc / Graphite Bio Inc / Xilio Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Cowen Biotechnology Team</td></tr>
<tr class="odd"><td class="leftalignment">12/21/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BSX=US / NKE=US / LLY=US / PFE=US / AMGN=US / HD=US / MCD=US / WEN=US / MDT=US / BLD=US / PEB=US / H=US / CRM=US / MTN=US / LOW=US / IART=US / MAR=US / LEG=US / TNL=US / VMC=US / HLT=US / MANH=US / MLM=US / PATH=US / SWIM=US / CBRL=US / CCL=US / KIDS=US / CHH=US / DRI=US / DRH=US / GFF=US / IBP=US / MAS=US / MHK=US / VRTX=US / PYPL=US / CNM=US / APPN=US / DIN=US / BDSI=US / DKS=US / OGN / BIIB=US / TPX=US / EXP=US / NUVA=US / BECN=US / TXRH=US / SHO=US / PLAY=US / DENN=US / BLDR=US / GMS=US / SIBN=US / CMG=US / HST=US / PGTI=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / WH=US / JACK=US / TREX=US / OLO=US / HGV=US / RLJ=US / VAC=US / FBHS=US / GMED=US / RHP=US / TILE=US / NDLS=US / LOCO=US / VCEL=US / NVRO=US / SHAK=US / ZBH=US / WING=US / SPNE=US / PEN=US / 82982L103 / EVBG=US / IRTC=US / CRSP=US / PK=US / JELD=US / PLYA=US / SMAR=US / AXNX=US / LYFT=US / UBER=US / FERG=US / AZEK=US / AZYO=US / VTRS=US / DASH=US / DNUT=US / SNPO=US / ROIV=US</td><td class="leftalignment">Boston Scientific Corp / Nike Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / McDonald's Corp / Wendys Co / Medtronic PLC / TopBuild Corp / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Salesforce.Com Inc / Vail Resorts Inc / Lowe's Companies Inc / Integra Lifesciences Holdings Corp / Marriott International Inc / Leggett & Platt Inc / Travel + Leisure Co / Vulcan Materials Co / Hilton Worldwide Holdings Inc / Manhattan Associates Inc / Martin Marietta Materials Inc / UiPath Inc / Latham Group Inc / Cracker Barrel Old Country Store Inc / Carnival Corp / OrthoPediatrics Corp / Choice Hotels International Inc / Darden Restaurants Inc / Diamondrock Hospitality Co / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Vertex Pharmaceuticals Inc / PayPal Holdings Inc / Core & Main Inc / Appian Corp / Dine Brands Global Inc / BioDelivery Sciences International Inc / DICK'S Sporting Goods Inc / Organon & Co / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / NuVasive Inc / Beacon Roofing Supply Inc / Texas Roadhouse Inc / Sunstone Hotel Investors Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / SI-BONE Inc / Chipotle Mexican Grill Inc / Host Hotels & Resorts Inc / PGT Innovations Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Wyndham Hotels & Resorts Inc / Jack in the Box Inc / Trex Company Inc / Olo Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Fortune Brands Home & Security Inc / Globus Medical Inc / Ryman Hospitality Properties Inc / Interface Inc / Noodles & Co / El Pollo Loco Holdings Inc / Vericel Corp / Nevro Corp / Shake Shack Inc / Zimmer Biomet Holdings Inc / Wingstop Inc / SeaSpine Holdings Corp / Penumbra Inc / SiteOne Landscape Supply Inc / Everbridge Inc / iRhythm Technologies Inc / CRISPR Therapeutics AG / Park Hotels & Resorts Inc / JELD-WEN Holding Inc / Playa Hotels & Resorts NV / Smartsheet Inc / Axonics Inc / Lyft Inc / Uber Technologies Inc / Ferguson PLC / Azek Company Inc / Aziyo Biologics Inc / Viatris Inc / DoorDash Inc / Krispy Kreme Inc / Snap One Holdings Corp / Roivant Sciences Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Ireland / Netherlands / Panama / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/21/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Omicron Eclipses Delta to Become Dominant in U.S., Increased Transmissibility a Concern but Boosters Remain Effective</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 45253H101 / 00847G705 / 803607100 / 26979610 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 16961L106 / 654405109 / 03890D108 / 192010106 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Sarah Schram / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">12/21/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - December 21, 2021</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AIR.N / BA.N / BAC.N / BK.N / BMO.TO / BOX.N / C.N / COF.N / CRM.N / FITB.O / JPM.N / KEY.N / L.TO / MSFT.O / NTRS.O / PNC.N / USB.N / WFC.N / CERN.O / CMA.N / AMGN.O / HEI.N / HBAN.O / GS.N / NICE.O / MRU.TO / STT.N / AKAM.O / HXL.N / MRCY.O / MTB.N / WN.TO / NET.N / GPK.N / RF.N / DCO.N / DOL.TO / FRC.N / VSEC.OQ / SIVB.O / BLUE.O / CASY.O / EMPA.TO / BIIB.O / SAP.TO / MFI.TO / TFC.N / ACAD.O / MS.N / TDG.N / CTCa.TO / SPR.N / AVAV.OQ / KTOS.OQ / CLW.N / PANW.N / ITCI.O / PLC.TO / COUP.N / RYAM.N / CFG.N / HUBS.N / WRK.N / ATZ.TO / DBX.O / ZM.O / FSLY.N / CRWD.O / PTVE.O / NBLY.TO / PET.TO</td><td class="leftalignment">AAR Corp / Boeing Co / Bank of America Corp / Bank of New York Mellon Corp / Bank of Montreal / Box Inc / Citigroup Inc / Capital One Financial Corp / Salesforce.Com Inc / Fifth Third Bancorp / JPMorgan Chase & Co / KeyCorp / Loblaw Companies Ltd / Microsoft Corp / Northern Trust Corp / PNC Financial Services Group Inc / US Bancorp / Wells Fargo & Co / Cerner Corp / Comerica Inc / Amgen Inc / HEICO Corp / Huntington Bancshares Inc / Goldman Sachs Group Inc / Nice Ltd / Metro Inc / State Street Corp / Akamai Technologies Inc / Hexcel Corp / Mercury Systems Inc / M&T Bank Corp / George Weston Ltd / Cloudflare Inc / Graphic Packaging Holding Co / Regions Financial Corp / Ducommun Inc / Dollarama Inc / First Republic Bank / VSE Corp / SVB Financial Group / bluebird bio Inc / Caseys General Stores Inc / Empire Company Ltd / Biogen Inc / Saputo Inc / Maple Leaf Foods Inc / Truist Financial Corp / ACADIA Pharmaceuticals Inc / Morgan Stanley / TransDigm Group Inc / Canadian Tire Corporation Ltd / Spirit AeroSystems Holdings Inc / AeroVironment Inc / Kratos Defense and Security Solutions Inc / Clearwater Paper Corp / Palo Alto Networks Inc / Intra-Cellular Therapies Inc / Park Lawn Corp / Coupa Software Inc / Rayonier Advanced Materials Inc / Citizens Financial Group Inc / HubSpot Inc / Westrock Co / Aritzia Inc / Dropbox Inc / Zoom Video Communications Inc / Fastly Inc / CrowdStrike Holdings Inc / Pactiv Evergreen Inc / Neighbourly Pharmacy Inc / Pet Valu Holdings Ltd</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">12/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Timely approvals expand AMGN's I&I franchise into 2022</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Kennen MacKay, PHD</td></tr>
<tr class="odd"><td class="leftalignment">12/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Dec 10, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">111</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2455965 / 2471950 / 2623911 / 2684703 / 2730190 / 7103065 / B6RS2B3 / B7F2TY6 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Biogen Inc / Incyte Corp / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Clovis Oncology Inc / Puma Biotechnology Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">12/20/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Despite broad label, Otezla could still face pressure from tapinarof</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AMGN=US / ROIV=US</td><td class="leftalignment">Amgen Inc / Roivant Sciences Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="odd"><td class="leftalignment">12/20/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AMGN / LOVE</td><td class="leftalignment">Amgen Inc / Lovesac Co</td><td class="leftalignment"></td><td class="leftalignment">Japan / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/20/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Tezspire Approval Provides Breath of Fresh Air</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Jay Olson, CFA, III / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="odd"><td class="leftalignment">12/20/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / OGN / AMRX=US / VTRS=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Organon & Co / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregory D. Fraser / Ms. Robyn S. Karnauskas / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">12/20/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Tezspire Approved Early but Initial Label Has Limitations</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">03116210 / 04635310</td><td class="leftalignment">Amgen Inc / AstraZeneca PLC</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals / Biotechnology</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun / Anna Baran, CFA / Daniel Tarjan, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">12/19/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Tezepelumab US Approval Comes Ahead of Schedule</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">031162100</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">12/18/2021</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Amgen Inc (AMGN) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">712</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="odd"><td class="leftalignment">12/18/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 578</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101 / 603693102</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc / Mink Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / John Boyle / Sarah Schram / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers / Lachlan Hanbury-Brown</td></tr>
<tr class="even"><td class="leftalignment">12/17/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Evan’s Weekly Dose of Targeted Therapy & Video - ASH & 2022 Outlook Edition</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US09062X1037 / US58933Y1055 / US60468T1051 / US1374041093</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Merck & Co Inc / Mirati Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">12/17/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Week in Review - December 10 to 17, 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">GB0007188757 / CA4509131088 / AU000000CIA2 / GB0000456144 / US00724F1012 / US0236081024 / US0311621009 / US0351282068 / US0383361039 / US0394831020 / US0536111091 / US0584981064 / US1101221083 / US1264081035 / US1564311082 / US2017231034 / US31428X1063 / US3755581036 / US38059T1060 / US3976241071 / US4227041062 / US5324571083 / US5463471053 / US6516391066 / US65473P1057 / US6703461052 / US7170811035 / US7445731067 / US7802871084 / US8581191009 / US92276F1003 / US9746371007 / US98389B1008 / CA13321L1085 / CA6979001089 / CA8787422044 / CA2918434077 / CA0679011084 / US9129091081 / CA51925D1069 / CA13677F1018 / CA1349211054 / CA0636711016 / CA0641491075 / CA8765111064 / CA3359341052 / US20825C1045 / US35671D8570 / AU000000FMG4 / US09062X1037 / CA98462Y1007 / US02043Q1076 / CA5503721063 / US15135B1017 / US0534841012 / US29476L1070 / US2971781057 / CA39138C1068 / CA4436281022 / CA1360691010 / US3546131018 / US74144T1088 / US09247X1019 / US44107P1049 / CA95083R1001 / US40637H1095 / CA1375761048 / US74460D1090 / CA0209361009 / CA32076V1031 / CA2483561072 / GB00B1FW5029 / US30225T1025 / CA0966311064 / CA29258Y1034 / CA1999101001 / CA2271071094 / CA3499151080 / GB00B1XZS820 / CA14068G1046 / CA82835P1036 / CA46071W2058 / BMG491BT1088 / CA3518581051 / GB00B2QPKJ12 / GB0004300496 / US26884L1098 / US91912E1055 / US1921085049 / IE00B4BNMY34 / CA69946Q1046 / CA66510M2040 / CA0985461049 / JE00B4T3BW64 / US2296631094 / CA54928Q1081 / AU000000EVN4 / US00287Y1091 / CA0194561027 / CA04315L1058 / US09739D1000 / JE00B5TT1872 / US09609G1004 / CA78165J1057 / CA55903Q1046 / CA04364G1063 / CA7852461093 / CA3449112018 / CA07380N1042 / CA1348082035 / CA3874371147 / CA3807381049 / CA87505Y4094 / CA0805581091 / CA9323971023 / CA0158571053 / CA0213611001 / CA16141A1030 / CA6752221037 / CA21750U1012 / CA80013R2063 / CA04016A1012 / CA11777Q2099 / CA8661201167 / CA38045Y1025 / US16208T1025 / CA5054401073 / US45845P1084 / CA0266951064 / CA33812R1091 / CA17039A1066 / CA46579R1047 / US45378A1060 / CA65340P1062 / US31189P1021 / IE00BJ3V9050 / US03820J1007 / CA45868C1095 / CA26153P1045 / CA1264621006 / CA7397211086 / US14174T1079 / CA68827L1013 / US78667J1088 / CA30606C1086 / IE00BQPVQZ61 / CA5503711080 / US30040W1080 / CA74273V1067 / US6378701063 / AU000000S320 / US4278255009 / CA0115321089 / CA05329M1041 / US95040Q1040 / CA8283631015 / CY0106002112 / AU000000NST8 / CA4991131083 / CA6882811046 / CA8910546032 / US53223X1072 / CA31730E1016 / CA89621C1059 / US0138721065 / CA68634K1066 / US43300A2033 / GB00B67KBV28 / US75134P3038 / CA86816U1066 / US23355L1061 / US93627C1018 / US7045511000 / CA9628791027 / CY0103562118 / CA7847301032 / LU1701428291 / US03753U1060 / CA2960061091 / CA7766521099 / CA8585221051 / US92645B1035 / US3843135084 / US03168L1052 / US2997341035 / CA05585D1033 / US03836N1037 / CA0717341071 / US03843E1047 / CA4039254079 / US04335A1051 / CA38119T8077 / CA13000C2058 / US03990B1017 / CA72765Q8829 / US1255231003 / CA2849025093 / CA45075E1043 / US63253R2013 / AU0000018236 / CA7426943006 / CA57776F4050 / US09260D1072 / CA5625684025 / CA48086P1009 / US30205M1018 / CA29446Y5020 / US03768E1055 / AU0000004772 / CA92625W5072 / FR0013467479 / CA59124U6051 / CA31890B1031 / US14316J1088 / US82575P1075 / CA36352H1001 / US03940R1077 / CA70137W1086 / US44862P1093 / CA83419D2014 / CA67079A1021 / US12529R1077 / US3773201062 / CA9004352071 / US3680361090 / CA64782A1075 / CA00288U1066 / CA36261G1028 / US15202L1070 / US24343R1068 / CA65401N1078 / US90364P1057 / AU0000143729 / CA65532M6062 / GB00BL6K5J42 / CA50202P1053 / CA65343M2094 / US1374041093 / CA0156581070 / CA24477T1003 / CA22289D1078 / CA89531J7868</td><td class="leftalignment">Rio Tinto PLC / IAMGOLD Corp / Champion Iron Ltd / Antofagasta PLC / Adobe Inc / Ameren Corp / Amgen Inc / AngloGold Ashanti Ltd / Aptargroup Inc / Archer-Daniels-Midland Co / Avery Dennison Corp / Ball Corp / Bristol-Myers Squibb Co / CSX Corp / Century Aluminum Co / Commercial Metals Co / FedEx Corp / Gilead Sciences Inc / Gold Fields Ltd / Greif Inc / Hecla Mining Co / Eli Lilly and Co / Louisiana-Pacific Corp / Newmont Corporation / NiSource Inc / Nucor Corp / Pfizer Inc / Public Service Enterprise Group Inc / Royal Gold Inc / Steel Dynamics Inc / Ventas Inc / Winnebago Industries Inc / Xcel Energy Inc / Cameco Corp / Pan American Silver Corp / Teck Resources Ltd / Empire Company Ltd / Barrick Gold Corp / United States Steel Corp / Laurentian Bank of Canada / Canadian Western Bank / Canadian Apartment Properties Real Estate Investment Trust / Bank of Montreal / Bank of Nova Scotia / Taseko Mines Ltd / First Quantum Minerals Ltd / Conocophillips / Freeport-McMoRan Inc / Fortescue Metals Group Ltd / Biogen Inc / Yamana Gold Inc / Alnylam Pharmaceuticals Inc / Lundin Mining Corp / Centene Corp / Avalonbay Communities Inc / Equity Residential / Essex Property Trust Inc / Great-West Lifeco Inc / Hudbay Minerals Inc / Canadian Imperial Bank of Commerce / Franklin Resources Inc / T Rowe Price Group Inc / BlackRock Inc / Host Hotels & Resorts Inc / Wesdome Gold Mines Ltd / Halozyme Therapeutics Inc / Canfor Corp / Public Storage / Altius Minerals Corp / First Majestic Silver Corp / Denison Mines Corp / Hochschild Mining PLC / Extra Space Storage Inc / Boardwalk Real Estate Investment Trust / Endeavour Silver Corp / Cominar Real Estate Investment Trust / Crombie Real Estate Investment Trust / Fortuna Silver Mines Inc / Anglo American PLC / Capstone Mining Corp / Silvercorp Metals Inc / InterRent Real Estate Investment Trust / Invesco Ltd / Franco-Nevada Corp / Fresnillo PLC / Pan African Resources PLC / EQT Corp / Vale SA / Coeur Mining Inc / Accenture PLC / Parex Resources Inc / Northern Dynasty Minerals Ltd / Bonterra Energy Corp / Glencore PLC / CubeSmart / Lucara Diamond Corp / Evolution Mining Ltd / Abbvie Inc / Allied Properties Real Estate Investment Trust / Artis Real Estate Investment Trust / Boise Cascade Co / Centamin PLC / bluebird bio Inc / Rupert Resources Ltd / MAG Silver Corp / Ascot Resources Ltd / Sabina Gold & Silver Corp / Foran Mining Corp / Bear Creek Mining Corp / Canacol Energy Ltd / Granite Real Estate Investment Trust / Gold Standard Ventures Corp / Tamarack Valley Energy Ltd / Belo Sun Mining Corp / Wallbridge Mining Company Ltd / Algonquin Power & Utilities Corp / AltaGas Ltd / Chartwell Retirement Residences / OceanaGold Corp / Copper Mountain Mining Corp / Sandstorm Gold Ltd / Argonaut Gold Inc / B2Gold Corp / Summit Industrial Income REIT / GoGold Resources Inc / Chatham Lodging Trust / Labrador Iron Ore Royalty Corp / Intercept Pharmaceuticals Inc / American Hotel Income Properties REIT LP / Fission Uranium Corp / Choice Properties Real Estate Investment Trust / Ivanhoe Mines Ltd / Independence Realty Trust Inc / Nexgen Energy Ltd / Fate Therapeutics Inc / Endo International PLC / Applied Genetic Technologies Corp / Interfor Corp / Dream Office Real Estate Investment Trust / CT Real Estate Investment Trust / Prairiesky Royalty Ltd / CareTrust REIT Inc / Osisko Gold Royalties Ltd / SAGE Therapeutics Inc / Falco Resources Ltd / Horizon Therapeutics PLC / Lundin Gold Inc / Eversource Energy / Probe Metals Inc / National Storage Affiliates Trust / South32 Ltd / Hersha Hospitality Trust / Alamos Gold Inc / Automotive Properties Real Estate Investment Trust / Welltower Inc / Silvercrest Metals Inc / Atalaya Mining PLC / Northern Star Resources Ltd / K92 Mining Inc / Osisko Mining Inc / Torex Gold Resources Inc / Life Storage Inc / Filo Mining Corp / Trilogy Metals Inc / Alcoa Corp / Orla Mining Ltd / Hilton Worldwide Holdings Inc / Central Asia Metals PLC / Ramaco Resources Inc / Superior Gold Inc / DXC Technology Co / Warrior Met Coal Inc / Peabody Energy Corp / Wheaton Precious Metals Corp / Tharisa PLC / SSR Mining Inc / Nexa Resources SA / Apellis Pharmaceuticals Inc / Ero Copper Corp / Roots Corp / Stelco Holdings Inc / Victory Capital Holdings Inc / GrafTech International Ltd / Amneal Pharmaceuticals Inc / Evelo Biosciences Inc / BSR Real Estate Investment Trust / Aptinyx Inc / Bausch Health Companies Inc / Aquestive Therapeutics Inc / H&R Real Estate Investment Trust / Arvinas Inc / Golden Star Resources Ltd / Calibre Mining Corp / Ares Management Corp / Platinum Group Metals Ltd / Cigna Corp / Eldorado Gold Corp / iA Financial Corporation Inc / NAK Kazatomprom AO / Nickel Mines Ltd / PRO Real Estate Investment Trust / Maverix Metals Inc / Blackstone Inc / Mandalay Resources Corp / Josemaria Resources Inc / Exicure Inc / Equinox Gold Corp / Apollo Global Management Inc / Adriatic Metals PLC / Victoria Gold Corp / Constellium SE / Metalla Royalty & Streaming Ltd / First Capital Real Estate Investment Trust / Carlyle Group Inc / Sibanye Stillwater Ltd / Galiano Gold Inc / Arch Resources Inc / Parkland Corp / Hycroft Mining Holding Corporation / Solaris Resources Inc / Nuvei Corp / C4 Therapeutics Inc / Glatfelter Corp / Turquoise Hill Resources Ltd / Gatos Silver Inc / New Pacific Metals Corp / Abcellera Biologics Inc / G Mining Ventures Corp / Centerspace / Decibel Therapeutics Inc / Nickel 28 Capital Corp / UiPath Inc / Sunrise Energy Metals Ltd / Nomad Royalty Company Ltd / Endeavour Mining PLC / Li-Cycle Holdings Corp / NextSource Materials Inc / Candel Therapeutics Inc / Algoma Steel Group Inc / Definity Financial Corp / Coveo Solutions Inc / Trevali Mining Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Cyprus / France / United Kingdom / Ireland / Kazakhstan / Luxembourg / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">12/17/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended December 10, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 66987V10 / 75886F10 / 09062X10 / 478160104 / 80105N10 / 58933Y10 / 00287Y10 / 45781M10 / G3910J11 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Sanofi SA / Merck & Co Inc / Abbvie Inc / Innoviva Inc / GlaxoSmithKline PLC / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">12/17/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon / Leonid Timashev</td></tr>
<tr class="even"><td class="leftalignment">12/17/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 17, 2021</td><td class="leftalignment">English</td><td class="rightalignment">62</td><td class="leftalignment">IL0006290147 / US00724F1012 / US0311621009 / US0383361039 / US0584981064 / US1101221083 / US31428X1063 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US81211K1007 / US8581191009 / US92532F1003 / CA59162N1096 / CA5394811015 / CA2918434077 / US9129091081 / CA1349211054 / US7665596034 / US09062X1037 / US02043Q1076 / US3546131018 / US74144T1088 / US09247X1019 / US40637H1095 / CA1375761048 / CA0966311064 / CA6179141065 / CA1999101001 / CA7669101031 / CA2271071094 / CA46071W2058 / BMG491BT1088 / IE00B4BNMY34 / US58933Y1055 / CA0985461049 / JE00B4T3BW64 / US00287Y1091 / CA0194561027 / CA04315L1058 / US09609G1004 / CA3874371147 / CA16141A1030 / IE00B4Q5ZN47 / CA8661201167 / CA38045Y1025 / CA6674951059 / US6951271005 / US45845P1084 / CA0266951064 / CA58546R1091 / CA17039A1066 / US60468T1051 / US45378A1060 / US31189P1021 / CA72820F1036 / IE00BJ3V9050 / US03820J1007 / CA26153P1045 / CA1264621006 / US78667J1088 / IE00BQPVQZ61 / US92686J1060 / CA8310211005 / CA82621K1021 / CA83179X1087 / CA05329M1041 / US4622221004 / CA49410M1023 / US5588681057 / US68404V1008 / US03753U1060 / CA46136U1030 / IL0011417206 / US92645B1035 / US03168L1052 / US2997341035 / CA05585D1033 / US80706P1030 / US03836N1037 / US48251W1045 / CA0717341071 / CA60448E1034 / US76029N1063 / US03843E1047 / CA4039254079 / US04335A1051 / US50015M1099 / US03990B1017 / CA2849025093 / US62921N1054 / CA7426943006 / US61775R1059 / US09260D1072 / US03768E1055 / US71722W1071 / CA92625W5072 / CA31890B1031 / US14316J1088 / US80810D1037 / US6544051096 / IL0011326795 / CA67079A1021 / US12529R1077 / US3773201062 / CA33843T1084 / US92556V1061 / CA00288U1066 / CA65342N3159 / US67080N1019 / US24343R1068 / US4718711033 / US1374041093</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Adobe Inc / Amgen Inc / Aptargroup Inc / Ball Corp / Bristol-Myers Squibb Co / FedEx Corp / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Sealed Air Corp / Steel Dynamics Inc / Vertex Pharmaceuticals Inc / Metro Inc / Loblaw Companies Ltd / Empire Company Ltd / United States Steel Corp / Canadian Apartment Properties Real Estate Investment Trust / Rigel Pharmaceuticals Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Franklin Resources Inc / T Rowe Price Group Inc / BlackRock Inc / Halozyme Therapeutics Inc / Canfor Corp / Boardwalk Real Estate Investment Trust / Morguard Real Estate Investment Trust / Cominar Real Estate Investment Trust / RioCan Real Estate Investment Trust / Crombie Real Estate Investment Trust / InterRent Real Estate Investment Trust / Invesco Ltd / Accenture PLC / Merck & Co Inc / Bonterra Energy Corp / Glencore PLC / Abbvie Inc / Allied Properties Real Estate Investment Trust / Artis Real Estate Investment Trust / bluebird bio Inc / Granite Real Estate Investment Trust / Chartwell Retirement Residences / Jazz Pharmaceuticals PLC / Summit Industrial Income REIT / GoGold Resources Inc / NorthWest Healthcare Properties REIT / Pacira Biosciences Inc / Intercept Pharmaceuticals Inc / American Hotel Income Properties REIT LP / Melcor Real Estate Investment Trust / Choice Properties Real Estate Investment Trust / Mirati Therapeutics Inc / Independence Realty Trust Inc / Fate Therapeutics Inc / Plaza Retail REIT / Endo International PLC / Applied Genetic Technologies Corp / Dream Office Real Estate Investment Trust / CT Real Estate Investment Trust / SAGE Therapeutics Inc / Horizon Therapeutics PLC / Viking Therapeutics Inc / Slate Office REIT / Sienna Senior Living Inc / SmartCentres Real Estate Investment Trust / Automotive Properties Real Estate Investment Trust / Ionis Pharmaceuticals Inc / Killam Apartment REIT / Madrigal Pharmaceuticals Inc / OptiNose Inc / Apellis Pharmaceuticals Inc / Invesque Inc / Sol Gel Technologies Ltd / Victory Capital Holdings Inc / Amneal Pharmaceuticals Inc / Evelo Biosciences Inc / BSR Real Estate Investment Trust / Scholar Rock Holding Corp / Aptinyx Inc / KKR & Co Inc / Bausch Health Companies Inc / Minto Apartment Real Estate Investment Trust / Replimune Group Inc / Aquestive Therapeutics Inc / H&R Real Estate Investment Trust / Arvinas Inc / Kodiak Sciences Inc / Ares Management Corp / Eldorado Gold Corp / NGM Biopharmaceuticals Inc / PRO Real Estate Investment Trust / Morphic Holding Inc / Blackstone Inc / Apollo Global Management Inc / Phathom Pharmaceuticals Inc / Victoria Gold Corp / First Capital Real Estate Investment Trust / Carlyle Group Inc / Schrodinger Inc / 9 Meters Biopharma Inc / PolyPid Ltd / Nuvei Corp / C4 Therapeutics Inc / Glatfelter Corp / Flagship Communities Real Estate Investment Trust / Viatris Inc / Abcellera Biologics Inc / Nexus Real Estate Investment Trust / Nuvation Bio Inc / Decibel Therapeutics Inc / Jasper Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Ireland / Israel / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">12/17/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Biopharma Growth Crisis? Lower & Slower Growth Ahead as Major LOEs Loom</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">92532F10 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 80105N10 / 58933Y10 / 00287Y10 / G3910J11</td><td class="leftalignment">Vertex Pharmaceuticals Inc / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Sanofi SA / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC</td><td class="leftalignment"></td><td class="leftalignment">Australia / China / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Daniel Tarjan, Ph.D. / Na Sun</td></tr>
<tr class="even"><td class="leftalignment">12/17/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">2022 BioPharma Outlook: A Light at the End of the Tunnel as Sector Sentiment Likely to Improve</td><td class="leftalignment">English</td><td class="rightalignment">89</td><td class="leftalignment">IL0006290147 / US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US7665596034 / US09062X1037 / US02043Q1076 / US40637H1095 / US58933Y1055 / US00287Y1091 / US09609G1004 / IE00B4Q5ZN47 / US6951271005 / US45845P1084 / US60468T1051 / US31189P1021 / IE00BJ3V9050 / US03820J1007 / US78667J1088 / IE00BQPVQZ61 / US92686J1060 / US4622221004 / US5588681057 / US68404V1008 / US03753U1060 / IL0011417206 / US03168L1052 / US2997341035 / US80706P1030 / US03836N1037 / CA0717341071 / US76029N1063 / US03843E1047 / US04335A1051 / US50015M1099 / US62921N1054 / US61775R1059 / US71722W1071 / US80810D1037 / US6544051096 / IL0011326795 / US12529R1077 / US92556V1061 / CA00288U1066 / US67080N1019 / US24343R1068 / US4718711033 / US1374041093</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Halozyme Therapeutics Inc / Merck & Co Inc / Abbvie Inc / bluebird bio Inc / Jazz Pharmaceuticals PLC / Pacira Biosciences Inc / Intercept Pharmaceuticals Inc / Mirati Therapeutics Inc / Fate Therapeutics Inc / Endo International PLC / Applied Genetic Technologies Corp / SAGE Therapeutics Inc / Horizon Therapeutics PLC / Viking Therapeutics Inc / Ionis Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / OptiNose Inc / Apellis Pharmaceuticals Inc / Sol Gel Technologies Ltd / Amneal Pharmaceuticals Inc / Evelo Biosciences Inc / Scholar Rock Holding Corp / Aptinyx Inc / Bausch Health Companies Inc / Replimune Group Inc / Aquestive Therapeutics Inc / Arvinas Inc / Kodiak Sciences Inc / NGM Biopharmaceuticals Inc / Morphic Holding Inc / Phathom Pharmaceuticals Inc / Schrodinger Inc / 9 Meters Biopharma Inc / PolyPid Ltd / C4 Therapeutics Inc / Viatris Inc / Abcellera Biologics Inc / Nuvation Bio Inc / Decibel Therapeutics Inc / Jasper Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Mr. Gary Nachman / Matthew Luchini</td></tr>
<tr class="odd"><td class="leftalignment">12/16/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Flip the Script - Biotech Inflows Return</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 04016X101 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / argenx SE / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">12/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ZNTL - BUY - R&D Day Highlights Plans to Pursue Broad Opp'ty with Best-in-Class WEE1 Inhibitor & a New Pipeline Program</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMQ5T49 / 0925288 / 2023607</td><td class="leftalignment">Zentalis Pharmaceuticals Inc / GlaxoSmithKline PLC / Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Paul Jeng, Ph.D. / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="odd"><td class="leftalignment">12/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for AMGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">12/15/2021</td><td class="leftalignment">TheScreener</td><td class="leftalignment">AMGEN sees an upgrade to Slightly Positive due to a better fundamental star rating</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">12/15/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">New Surveys Indicate Rapidly Evolving I&I Landscape; Still See Rinvoq Upside</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">031162100 / 75886F107 / 00287Y109 / 00461U105</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Aclaris Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">12/14/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US0311621009 / US75886F1075 / PAYO / US02043Q1076 / US37890U1088 / US0400476075</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc / Payoneer Global Inc / Alnylam Pharmaceuticals Inc / Global Blood Therapeutics Inc / Arena Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">12/14/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / DIS=US / HD=US / INTC=US / MCD=US / ADI=US / AMD=US / GBT=US / PG=US / WEN=US / BLD=US / TXN=US / NVDA=US / MPWR=US / LOW=US / CHKP=US / DIOD=US / XLNX=US / LEG=US / TTMI=US / SEIC=US / VMC=US / BKI=US / CVS=US / MLM=US / APH=US / SWIM=US / ARW=US / AVGO=US / AVT=US / CBRL=US / DRI=US / EQT=US / GFF=US / IBP=US / MAS=US / DOC=US / MCHP=US / MHK=US / STRA=US / FORG=US / NET=US / FAF=US / CNM=US / FB=US / AUTL=US / DIN=US / OGN / RPD=US / TPX=US / EXP=US / BDC=US / BECN=US / TXRH=US / PLAY=US / DENN=US / BLDR=US / GMS=US / CMG=US / TDG=US / PGTI=US / AWI=US / TEL=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / IAC=US / JACK=US / TREX=US / NXPI=US / LPLA=US / FBHS=US / ANGI=US / PANW=US / QLYS=US / BERY=US / TILE=US / NDLS=US / FATE=US / VRNS=US / LOCO=US / SHAK=US / ON=US / WING=US / ZS=US / MIME=US / 82982L103 / JELD=US / OKTA=US / SAIL=US / TENB=US / CRWD=US / FERG=US / AZEK=US / VTRS=US / RBLX=US / KNBE=US / VMEO=US / REPX=US / SNPO=US / MNDT=US / GTLB=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Walt Disney Co / Home Depot Inc / Intel Corp / McDonald's Corp / Analog Devices Inc / Advanced Micro Devices Inc / Global Blood Therapeutics Inc / Procter & Gamble Co / Wendys Co / TopBuild Corp / Texas Instruments Inc / NVIDIA Corp / Monolithic Power Systems Inc / Lowe's Companies Inc / Check Point Software Technologies Ltd / Diodes Inc / Xilinx Inc / Leggett & Platt Inc / TTM Technologies Inc / SEI Investments Co / Vulcan Materials Co / Black Knight Inc / CVS Health Corp / Martin Marietta Materials Inc / Amphenol Corp / Latham Group Inc / Arrow Electronics Inc / Broadcom Inc / Avnet Inc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / EQT Corp / Griffon Corp / Installed Building Products Inc / Masco Corp / Physicians Realty Trust / Microchip Technology Inc / Mohawk Industries Inc / Strategic Education Inc / ForgeRock Inc / Cloudflare Inc / First American Financial Corp / Core & Main Inc / Meta Platforms Inc / Autolus Therapeutics PLC / Dine Brands Global Inc / Organon & Co / Rapid7 Inc / Tempur Sealy International Inc / Eagle Materials Inc / Belden Inc / Beacon Roofing Supply Inc / Texas Roadhouse Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / TransDigm Group Inc / PGT Innovations Inc / Armstrong World Industries Inc / TE Connectivity Ltd / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / IAC/Interactivecorp / Jack in the Box Inc / Trex Company Inc / NXP Semiconductors NV / LPL Financial Holdings Inc / Fortune Brands Home & Security Inc / Angi Inc / Palo Alto Networks Inc / Qualys Inc / Berry Global Group Inc / Interface Inc / Noodles & Co / Fate Therapeutics Inc / Varonis Systems Inc / El Pollo Loco Holdings Inc / Shake Shack Inc / ON Semiconductor Corp / Wingstop Inc / Zscaler Inc / Mimecast Ltd / SiteOne Landscape Supply Inc / JELD-WEN Holding Inc / Okta Inc / SailPoint Technologies Holdings Inc / Tenable Holdings Inc / CrowdStrike Holdings Inc / Ferguson PLC / Azek Company Inc / Viatris Inc / Roblox Corp / Knowbe4 Inc / Vimeo Inc / Riley Exploration Permian Inc / Snap One Holdings Corp / Mandiant Inc / GitLab Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / United Kingdom / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US -  Dividend Quality Analysis, for the period ended December 08,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / ABT / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">LLY-US -  Dividend Quality Analysis, for the period ended December 10,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">LLY / BMY / JNJ / MRK / NVS / PFE / AMGN.O / GSK / AZN.O / ABBV.K / SNY.O</td><td class="leftalignment">Eli Lilly and Co / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ORIC - BUY - Preclinical Data Highlight ORIC-533 (CD73i) Potential in Multiple Myeloma; Pipeline Advancing with 3 New Trials to Commence by Early 2022</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BKVDFF7 / 0989529 / 2126335 / 2516152 / 2023607 / 7103065</td><td class="leftalignment">Oric Pharmaceuticals Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Novartis AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Paul Jeng, Ph.D. / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">It's beginning to look a lot like M&A (we hope)</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US0400476075 / US0311621009 / US75886F1075</td><td class="leftalignment">Arena Pharmaceuticals Inc / Amgen Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Dec 3, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">111</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2455965 / 2471950 / 2623911 / 2684703 / 2730190 / 7103065 / B6RS2B3 / B7F2TY6 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Biogen Inc / Incyte Corp / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Clovis Oncology Inc / Puma Biotechnology Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Pfizer/Arena Deal Signals Start to Immuno-Inflammation Diversification by Big Pharma and Big Biotech</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">00461U105 / 01671P100 / 03116210 / 110122108 / 49372L100</td><td class="leftalignment">Aclaris Therapeutics Inc / Allakos Inc / Amgen Inc / Bristol-Myers Squibb Co / Kezar Life Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Matt Phipps, PHD / Lachlan Hanbury-Brown / John Boyle / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / OGN / AMRX=US / VTRS=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Organon & Co / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregory D. Fraser / Ms. Robyn S. Karnauskas / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 13, 2021</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">US0311621009 / US0394831020 / US0536111091 / US1101221083 / US1266501006 / US3755581036 / US3976241071 / US45337C1027 / US5324571083 / US5719032022 / US64125C1099 / US65473P1057 / US7170811035 / US7445731067 / US75886F1075 / US92276F1003 / US92532F1003 / US98389B1008 / CA51925D1069 / US09062X1037 / US15135B1017 / US0534841012 / US29476L1070 / US2971781057 / US44107P1049 / US74460D1090 / US9026531049 / US30225T1025 / US58933Y1055 / US65339F1012 / US2296631094 / US09609G1004 / US70509V1008 / US16208T1025 / US60468T1051 / US14174T1079 / US9840171030 / US30040W1080 / US6378701063 / US4278255009 / US95040Q1040 / US53223X1072 / US7005171050 / US43300A2033 / US03753U1060 / US04335A1051 / US15202L1070 / US4718711033 / US1374041093 / CA24477T1003 / CA22289D1078</td><td class="leftalignment">Amgen Inc / Archer-Daniels-Midland Co / Avery Dennison Corp / Bristol-Myers Squibb Co / CVS Health Corp / Gilead Sciences Inc / Greif Inc / Incyte Corp / Eli Lilly and Co / Marriott International Inc / Neurocrine Biosciences Inc / NiSource Inc / Pfizer Inc / Public Service Enterprise Group Inc / Regeneron Pharmaceuticals Inc / Ventas Inc / Vertex Pharmaceuticals Inc / Xcel Energy Inc / Laurentian Bank of Canada / Biogen Inc / Centene Corp / Avalonbay Communities Inc / Equity Residential / Essex Property Trust Inc / Host Hotels & Resorts Inc / Public Storage / UDR Inc / Extra Space Storage Inc / Merck & Co Inc / Nextera Energy Inc / CubeSmart / bluebird bio Inc / Pebblebrook Hotel Trust / Chatham Lodging Trust / Mirati Therapeutics Inc / CareTrust REIT Inc / Xenia Hotels & Resorts Inc / Eversource Energy / National Storage Affiliates Trust / Hersha Hospitality Trust / Welltower Inc / Life Storage Inc / Park Hotels & Resorts Inc / Hilton Worldwide Holdings Inc / Apellis Pharmaceuticals Inc / Arvinas Inc / Centerspace / Jasper Therapeutics Inc / Candel Therapeutics Inc / Definity Financial Corp / Coveo Solutions Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">AJG / ALL / AM / AMT / AR / AXP / BA.N / BAX / BMY.N / CB / CCI / CLR / CNC.N / CNX / COO / CPE / CPK / CRM.N / CVS.N / D / DG / DGX / DK / DLR / DVN / DY / EOG / EQT / HD / HEP / HIG / IFF / KNX / LOW / MCHP.O / MGY / MMP / MRK.N / MRO / OKE / OLN / OXY / PFE.N / PGR / PNM / PXD / QCOM.O / RKT / RMBS.O / RNG / RRC / SJI / SLG / SM / SWN / T / TFX / TOL / USM / WES / WLK / WLL / ASND.O / AMZN.O / GILD.O / ET / AMGN.O / EW / IRM / MGM.N / ADBE.O / PAA.N / SBAC.O / MXL / ADI.O / VZ / NWN / ARNA.O / SMTC.O / SLAB.O / SNPS.O / DLTR.O / BYD.N / ARGX.O / PENN.O / ISRG.O / LPI / CHDN.O / REGN.O / VRTX.O / MRVL.O / SMG.N / WYNN.O / SIVB.O / DIOD.O / ACGL.O / EQIX.O / OMCL.O / SWKS.O / BIIB.O / DKL / LVS.N / CDNS.O / CNSL.O / CLMT.O / CCOI.O / NOG.A / WRB.N / TSLA.O / NXPI.O / CZR.O / HZNP.O / ESTE.K / MTDR.K / TRGP.K / PDCE.O / AMBA.O / FANG.O / MPLX.K / ABBV.N / PFSI.K / PSXP.K / LGIH.O / FIVN.O / RXDX.O / AFMD.O / SHLX.K / NVRO.K / QRVO.O / CIVI.K / PBFX.K / ON.O / CYAD.O / GBT.O / TMUS.O / RRR.O / EVBG.O / UNIT.O / CLLS.O / CDEV.O / WDAY.O / HESM.K / RYTM.O / SWCH.K / APLS.O / EGHT.K / AUTL.O / BRY.O / KZR.O / AXNX.O / SWAV.O / ZM.O / FLTRF.L / RTLR.O / MORF.O / CABA.O / OAS.O / OVV.N / PGEN.O / BEAM.O / DKNG.O / ZI.O / CTRA.K / GRWG.O / 45258J102 / NWE.O / LUMN.K / BALY.N / ALGM.O / RSI.N / HYFM.O / GRCL.O / CHK.O / HMPT.O / DBRG.N / BLND.N / YOU.N / WKME.O / KLTR.O / WOLF.N / RIVN.O</td><td class="leftalignment">Arthur J Gallagher & Co / Allstate Corp / Antero Midstream Corp / American Tower Corp / Antero Resources Corp / American Express Co / Boeing Co / Baxter International Inc / Bristol-Myers Squibb Co / Chubb Ltd / Crown Castle International Corp / Continental Resources Inc / Centene Corp / CNX Resources Corp / Cooper Companies Inc / Callon Petroleum Co / Chesapeake Utilities Corp / Salesforce.Com Inc / CVS Health Corp / Dominion Energy Inc / Dollar General Corp / Quest Diagnostics Inc / Delek US Holdings Inc / Digital Realty Trust Inc / Devon Energy Corp / Dycom Industries Inc / EOG Resources Inc / EQT Corp / Home Depot Inc / Holly Energy Partners LP / Hartford Financial Services Group Inc / International Flavors & Fragrances Inc / Knight-Swift Transportation Holdings Inc / Lowe's Companies Inc / Microchip Technology Inc / Magnolia Oil & Gas Corp / Magellan Midstream Partners LP / Merck & Co Inc / Marathon Oil Corp / ONEOK Inc / Olin Corp / Occidental Petroleum Corp / Pfizer Inc / Progressive Corp / PNM Resources Inc / Pioneer Natural Resources Co / Qualcomm Inc / Rocket Companies Inc / Rambus Inc / RingCentral Inc / Range Resources Corp / South Jersey Industries Inc / SL Green Realty Corp / SM Energy Co / Southwestern Energy Co / AT&T Inc / Teleflex Inc / Toll Brothers Inc / United States Cellular Corp / Western Midstream Partners LP / Westlake Chemical Corp / Whiting Petroleum Corp / Ascendis Pharma A/S / Amazon.com Inc / Gilead Sciences Inc / Energy Transfer LP / Amgen Inc / Edwards Lifesciences Corp / Iron Mountain Inc / MGM Resorts International / Adobe Inc / Plains All American Pipeline LP / SBA Communications Corp / Maxlinear Inc / Analog Devices Inc / Verizon Communications Inc / Northwest Natural Holding Co / Arena Pharmaceuticals Inc / Semtech Corp / Silicon Laboratories Inc / Synopsys Inc / Dollar Tree Inc / Boyd Gaming Corp / argenx SE / Penn National Gaming Inc / Intuitive Surgical Inc / Laredo Petroleum Inc / Churchill Downs Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Marvell Technology Inc / Scotts Miracle-Gro Co / Wynn Resorts Ltd / SVB Financial Group / Diodes Inc / Arch Capital Group Ltd / Equinix Inc / Omnicell Inc / Skyworks Solutions Inc / Biogen Inc / Delek Logistics Partners LP / Las Vegas Sands Corp / Cadence Design Systems Inc / Consolidated Communications Holdings Inc / Calumet Specialty Products Partners LP / Cogent Communications Holdings Inc / Northern Oil and Gas Inc / W R Berkley Corp / Tesla Inc / NXP Semiconductors NV / Caesars Entertainment Inc / Horizon Therapeutics PLC / Earthstone Energy Inc / Matador Resources Co / Targa Resources Corp / PDC Energy Inc / Ambarella Inc / Diamondback Energy Inc / MPLX LP / Abbvie Inc / PennyMac Financial Services Inc / Phillips 66 Partners LP / LGI Homes Inc / Five9 Inc / Prometheus Biosciences Inc / Affimed NV / Shell Midstream Partners LP / Nevro Corp / Qorvo Inc / Civitas Resources Inc / PBF Logistics LP / ON Semiconductor Corp / Celyad Oncology SA / Global Blood Therapeutics Inc / T-Mobile US Inc / Red Rock Resorts Inc / Everbridge Inc / Uniti Group Inc / Cellectis SA / Centennial Resource Development Inc / Workday Inc / Hess Midstream LP / Rhythm Pharmaceuticals Inc / Switch Inc / Apellis Pharmaceuticals Inc / 8x8 Inc / Autolus Therapeutics PLC / Berry Corporation (Bry) / Kezar Life Sciences Inc / Axonics Inc / Shockwave Medical Inc / Zoom Video Communications Inc / Flutter Entertainment PLC / Rattler Midstream LP / Morphic Holding Inc / Cabaletta Bio Inc / Oasis Petroleum Inc / Ovintiv Inc / Precigen Inc / Beam Therapeutics Inc / DraftKings Inc / ZoomInfo Technologies Inc / Coterra Energy Inc / GrowGeneration Corp / Immunovant Inc / NorthWestern Corp / Lumen Technologies Inc / Bally's Corp / Allegro Microsystems Inc / Rush Street Interactive Inc / Hydrofarm Holdings Group Inc / Gracell Biotechnologies Inc / Chesapeake Energy Corp / Home Point Capital Inc / DigitalBridge Group Inc / Blend Labs Inc / Clear Secure Inc / Walkme Ltd / Kaltura Inc / Wolfspeed Inc / Rivian Automotive Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Alto Neuroscience Inc.: Our Q&A With Management</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101 / 603693102</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc / Mink Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Myles R. R. Minter / Sarah Schram</td></tr>
<tr class="even"><td class="leftalignment">12/12/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Next Two Weeks In Pharmaceuticals - Monday, December 13 – Sunday, December 26</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">US0311621009 / US0463531089 / US37733W1053 / US4781601046 / US5324571083 / US7711951043 / US98978V1035 / US28414H1032</td><td class="leftalignment">Amgen Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Roche Holding AG / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">12/12/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 577</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101 / 603693102</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc / Mink Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Sarah Schram / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">12/10/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Wells Express: Weekly Highlights—December 10, 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">AJG / ALL / AM / AR / BA.N / BAX / BMY.N / CB / CLR / CNX / COO / CPK / CRM.N / D / DG / DK / DVN / EOG / EQT / HD / HEP / HIG / LOW / MMP / MRK.N / OKE / OLN / OXY / PFE.N / PGR / RRC / SJI / SLG / SWN / WES / ASND.O / AMZN.O / GILD.O / ET / AMGN.O / EW / PAA.N / ADI.O / NWN / ARNA.O / ARGX.O / ISRG.O / REGN.O / VRTX.O / SMG.N / SIVB.O / ACGL.O / OMCL.O / BIIB.O / DKL / CLMT.O / WRB.N / TSLA.O / HZNP.O / TRGP.K / FANG.O / MPLX.K / ABBV.N / PSXP.K / LGIH.O / RXDX.O / SHLX.K / NVRO.K / CIVI.K / PBFX.K / CDEV.O / HESM.K / RYTM.O / APLS.O / BRY.O / KZR.O / AXNX.O / SWAV.O / RTLR.O / MORF.O / CABA.O / CTRA.K / GRWG.O / 45258J102 / HYFM.O / CHK.O / RIVN.O</td><td class="leftalignment">Arthur J Gallagher & Co / Allstate Corp / Antero Midstream Corp / Antero Resources Corp / Boeing Co / Baxter International Inc / Bristol-Myers Squibb Co / Chubb Ltd / Continental Resources Inc / CNX Resources Corp / Cooper Companies Inc / Chesapeake Utilities Corp / Salesforce.Com Inc / Dominion Energy Inc / Dollar General Corp / Delek US Holdings Inc / Devon Energy Corp / EOG Resources Inc / EQT Corp / Home Depot Inc / Holly Energy Partners LP / Hartford Financial Services Group Inc / Lowe's Companies Inc / Magellan Midstream Partners LP / Merck & Co Inc / ONEOK Inc / Olin Corp / Occidental Petroleum Corp / Pfizer Inc / Progressive Corp / Range Resources Corp / South Jersey Industries Inc / SL Green Realty Corp / Southwestern Energy Co / Western Midstream Partners LP / Ascendis Pharma A/S / Amazon.com Inc / Gilead Sciences Inc / Energy Transfer LP / Amgen Inc / Edwards Lifesciences Corp / Plains All American Pipeline LP / Analog Devices Inc / Northwest Natural Holding Co / Arena Pharmaceuticals Inc / argenx SE / Intuitive Surgical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Scotts Miracle-Gro Co / SVB Financial Group / Arch Capital Group Ltd / Omnicell Inc / Biogen Inc / Delek Logistics Partners LP / Calumet Specialty Products Partners LP / W R Berkley Corp / Tesla Inc / Horizon Therapeutics PLC / Targa Resources Corp / Diamondback Energy Inc / MPLX LP / Abbvie Inc / Phillips 66 Partners LP / LGI Homes Inc / Prometheus Biosciences Inc / Shell Midstream Partners LP / Nevro Corp / Civitas Resources Inc / PBF Logistics LP / Centennial Resource Development Inc / Hess Midstream LP / Rhythm Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Berry Corporation (Bry) / Kezar Life Sciences Inc / Axonics Inc / Shockwave Medical Inc / Rattler Midstream LP / Morphic Holding Inc / Cabaletta Bio Inc / Coterra Energy Inc / GrowGeneration Corp / Immunovant Inc / Hydrofarm Holdings Group Inc / Chesapeake Energy Corp / Rivian Automotive Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / Denmark / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Adam Muro / Alexandra Green / Dian Yuan</td></tr>
<tr class="odd"><td class="leftalignment">12/10/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">ABT / ACI / AIG / AJG / ALC / ALL / AM / AMAT.O / AMT / AON / AR / ARW / BA.N / BAX / BDX / BEP / BK / BMY.N / BP.N / BSX / CB / CLR / CMA / CNX / COO / COP / COST.O / CPK / CRM.N / CVX / D / DG / DK / DVN / EOG / EQT / F.N / FITB.O / GM.N / HD / HEP / HES / HFC / HIG / INTC.O / JNJ / KLAC.O / KR / LNC / LOW / LRCX.O / MCHP.O / MDT / MET / MMC / MMP / MPC / MRK.N / MUR / NTRS.O / OGE / OKE / OLN / OXY / PEN / PFE.N / PGR / PNC / PRU / PSX / QCOM.O / RE / RKT / RMBS.O / RNG / RNR / RRC / SJI / SLB.N / SLG / STT / SWN / SYK / TFC / TFX / TRV / VLO / WES / WMB / WMT / XLNX.O / ASND.O / AMZN.O / CNQ.TO / GILD.O / ET / AMGN.O / EW / BRO / AAPL.O / CSCO.O / HAL.N / NVDA.O / SU.TO / XOM / PAA.N / PBF / MXL / LBRT.N / IART.O / AMD.O / ADI.O / NWN / NTAP.O / ARNA.O / BJ.N / SMTC.O / SLAB.O / SNPS.O / ARGX.O / AXS / ISRG.O / REGN.O / VRTX.O / MU.O / MRVL.O / HPQ / HPE / AVGO.O / BE.N / SMG.N / FCEL.OQ / PLUG.OQ / SIVB.O / BLUE.O / DIOD.O / MMSI.O / ACGL.O / MKSI.O / OMCL.O / SWKS.O / BIIB.O / DKL / VIAC.O / NOV.N / BLDP.OQ / RDSb / DXCM.O / CDNS.O / STX.O / CLMT.O / CVLT.O / PODD.O / TNDM.OQ / WRB.N / JNPR.K / TSLA.O / NXPI.O / LUNG.O / BKR.N / HZNP.O / WDC.O / TRGP.K / AMBA.O / FANG.O / MPLX.K / UIHC.O / ABBV.N / GTLS.N / VOYA.K / PFSI.K / RNA.O / PSXP.K / FATE.O / LGIH.O / RXDX.O / ANET.K / AFMD.O / SHLX.K / NVRO.K / QRVO.O / CIVI.K / PBFX.K / ON.O / GKOS.K / ZBH / CYAD.O / PSTG.K / NVCR.O / IONS.O / WLTW.O / EDIT.O / NTLA.O / NTNX.O / CLLS.O / CDEV.O / BHF.O / IOVA.O / HESM.K / RYTM.O / APLS.O / EQH / AVT.O / INSP.K / AUTL.O / BRY.O / KZR.O / STRO.O / AXNX.O / DELL.K / SWAV.O / RTLR.O / MORF.O / CHWY.K / BRP.O / CABA.O / PGEN.O / NARI.O / AVNT.K / CTRA.K / BEPC.K / GRWG.O / 45258J102 / ASO.O / EAR.O / ROOT.O / ALGM.O / HYFM.O / GRCL.O / CHK.O / HMPT.O / NPCE.O / RYAN.N / RXST.O / WOLF.N / ARBE.O / RIVN.O</td><td class="leftalignment">Abbott Laboratories / Albertsons Companies Inc / American International Group Inc / Arthur J Gallagher & Co / Alcon AG / Allstate Corp / Antero Midstream Corp / Applied Materials Inc / American Tower Corp / Aon PLC / Antero Resources Corp / Arrow Electronics Inc / Boeing Co / Baxter International Inc / Becton Dickinson and Co / Brookfield Renewable Partners LP / Bank of New York Mellon Corp / Bristol-Myers Squibb Co / BP PLC / Boston Scientific Corp / Chubb Ltd / Continental Resources Inc / Comerica Inc / CNX Resources Corp / Cooper Companies Inc / Conocophillips / Costco Wholesale Corp / Chesapeake Utilities Corp / Salesforce.Com Inc / Chevron Corp / Dominion Energy Inc / Dollar General Corp / Delek US Holdings Inc / Devon Energy Corp / EOG Resources Inc / EQT Corp / Ford Motor Co / Fifth Third Bancorp / General Motors Co / Home Depot Inc / Holly Energy Partners LP / Hess Corp / HollyFrontier Corp / Hartford Financial Services Group Inc / Intel Corp / Johnson & Johnson / KLA Corp / Kroger Co / Lincoln National Corp / Lowe's Companies Inc / Lam Research Corp / Microchip Technology Inc / Medtronic PLC / MetLife Inc / Marsh & McLennan Companies Inc / Magellan Midstream Partners LP / Marathon Petroleum Corp / Merck & Co Inc / Murphy Oil Corp / Northern Trust Corp / OGE Energy Corp / ONEOK Inc / Olin Corp / Occidental Petroleum Corp / Penumbra Inc / Pfizer Inc / Progressive Corp / PNC Financial Services Group Inc / Prudential Financial Inc / Phillips 66 / Qualcomm Inc / Everest Re Group Ltd / Rocket Companies Inc / Rambus Inc / RingCentral Inc / Renaissancere Holdings Ltd / Range Resources Corp / South Jersey Industries Inc / Schlumberger NV / SL Green Realty Corp / State Street Corp / Southwestern Energy Co / Stryker Corp / Truist Financial Corp / Teleflex Inc / Travelers Companies Inc / Valero Energy Corp / Western Midstream Partners LP / Williams Companies Inc / Walmart Inc / Xilinx Inc / Ascendis Pharma A/S / Amazon.com Inc / Canadian Natural Resources Ltd / Gilead Sciences Inc / Energy Transfer LP / Amgen Inc / Edwards Lifesciences Corp / Brown & Brown Inc / Apple Inc / Cisco Systems Inc / Halliburton Co / NVIDIA Corp / Suncor Energy Inc / Exxon Mobil Corp / Plains All American Pipeline LP / PBF Energy Inc / Maxlinear Inc / Liberty Oilfield Services Inc / Integra Lifesciences Holdings Corp / Advanced Micro Devices Inc / Analog Devices Inc / Northwest Natural Holding Co / NetApp Inc / Arena Pharmaceuticals Inc / BJ's Wholesale Club Holdings Inc / Semtech Corp / Silicon Laboratories Inc / Synopsys Inc / argenx SE / AXIS Capital Holdings Ltd / Intuitive Surgical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Micron Technology Inc / Marvell Technology Inc / HP Inc / Hewlett Packard Enterprise Co / Broadcom Inc / Bloom Energy Corp / Scotts Miracle-Gro Co / Fuelcell Energy Inc / Plug Power Inc / SVB Financial Group / bluebird bio Inc / Diodes Inc / Merit Medical Systems Inc / Arch Capital Group Ltd / MKS Instruments Inc / Omnicell Inc / Skyworks Solutions Inc / Biogen Inc / Delek Logistics Partners LP / ViacomCBS Inc / Nov Inc / Ballard Power Systems Inc / Royal Dutch Shell PLC / Dexcom Inc / Cadence Design Systems Inc / Seagate Technology Holdings PLC / Calumet Specialty Products Partners LP / Commvault Systems Inc / Insulet Corp / Tandem Diabetes Care Inc / W R Berkley Corp / Juniper Networks Inc / Tesla Inc / NXP Semiconductors NV / Pulmonx Corp / Baker Hughes Co / Horizon Therapeutics PLC / Western Digital Corp / Targa Resources Corp / Ambarella Inc / Diamondback Energy Inc / MPLX LP / United Insurance Holdings Corp / Abbvie Inc / Chart Industries Inc / Voya Financial Inc / PennyMac Financial Services Inc / Avidity Biosciences Inc / Phillips 66 Partners LP / Fate Therapeutics Inc / LGI Homes Inc / Prometheus Biosciences Inc / Arista Networks Inc / Affimed NV / Shell Midstream Partners LP / Nevro Corp / Qorvo Inc / Civitas Resources Inc / PBF Logistics LP / ON Semiconductor Corp / Glaukos Corp / Zimmer Biomet Holdings Inc / Celyad Oncology SA / Pure Storage Inc / Novocure Ltd / Ionis Pharmaceuticals Inc / Willis Towers Watson PLC / Editas Medicine Inc / Intellia Therapeutics Inc / Nutanix Inc / Cellectis SA / Centennial Resource Development Inc / Brighthouse Financial Inc / Iovance Biotherapeutics Inc / Hess Midstream LP / Rhythm Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Equitable Holdings Inc / Avnet Inc / Inspire Medical Systems Inc / Autolus Therapeutics PLC / Berry Corporation (Bry) / Kezar Life Sciences Inc / Sutro Biopharma Inc / Axonics Inc / Dell Technologies Inc / Shockwave Medical Inc / Rattler Midstream LP / Morphic Holding Inc / Chewy Inc / BRP Group Inc / Cabaletta Bio Inc / Precigen Inc / Inari Medical Inc / Avient Corp / Coterra Energy Inc / Brookfield Renewable Corp / GrowGeneration Corp / Immunovant Inc / Academy Sports and Outdoors Inc / Eargo Inc / Root Inc / Allegro Microsystems Inc / Hydrofarm Holdings Group Inc / Gracell Biotechnologies Inc / Chesapeake Energy Corp / Home Point Capital Inc / Neuropace Inc / Ryan Specialty Group Holdings Inc / Rxsight Inc / Wolfspeed Inc / Arbe Robotics Ltd / Rivian Automotive Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / United States / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/10/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Evan’s Weekly Dose of Targeted Therapy & Video Link - ASH & Launch Feedback</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US09062X1037 / US58933Y1055 / US60468T1051 / US1374041093</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Merck & Co Inc / Mirati Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">12/10/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Week in Review - December 3 to 10, 2021</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AU000000CIA2 / US0079031078 / US0091581068 / US0311621009 / US0383361039 / US1101221083 / US1264081035 / US1266501006 / US1270971039 / US1475281036 / US1844961078 / US2017231034 / US22160K1051 / US2372661015 / US25179M1036 / US26875P1012 / US30231G1022 / US31428X1063 / US3755581036 / US38059T1060 / US3976241071 / US4404521001 / US4433201062 / US4456581077 / US45337C1027 / US4581401001 / US4601461035 / US5324571083 / US56418H1005 / US5962781010 / US6267171022 / US64125C1099 / US6558441084 / US6703461052 / US6745991058 / US6819191064 / US68389X1054 / US7170811035 / US7237871071 / US75281A1097 / US8454671095 / US8851601018 / US9024941034 / US9078181081 / US9113121068 / CA53278L1076 / CA1363751027 / CA29250N1050 / CA0977512007 / CA4530384086 / CA8787422044 / CA1247651088 / CA2918434077 / CA1469001053 / CA0679011084 / CA1363851017 / CA0099051009 / CA7029251088 / CA8959451037 / US1667641005 / CA13645T1003 / US5658491064 / CA13677F1018 / US0017441017 / US20825C1045 / US2274831047 / US09062X1037 / CA8676EP1086 / CA2052491057 / US14040H1059 / BMG169621056 / CA67072Q1046 / CA2265331074 / US6293775085 / CA98462Y1007 / US02043Q1076 / CA4969024047 / CA5503721063 / US15135B1017 / US0534841012 / US29476L1070 / US2971781057 / US1331311027 / CA8935781044 / CA2935701078 / US12008R1077 / CA6993202069 / US8288061091 / US1252691001 / US12541W2098 / CA1125851040 / CA0906971035 / US42809H1077 / US57636Q1040 / CA30041N1078 / US59522J1034 / BMG383271050 / US9026531049 / CA2945051027 / CA6179141065 / CA14068G1046 / US5500211090 / US3932221043 / US3886891015 / US2120151012 / US38500T1016 / US26884L1098 / CA6252841045 / CA89154B1022 / CA9838911027 / CA22576C1014 / CA8672241079 / CA25675T1075 / CA15135U1093 / CA69946Q1046 / US65339F1012 / US78454L1008 / CA5527041084 / CA9237251058 / CA07317Q1054 / CA00208D4084 / CA2927661025 / CA0985461049 / CA7170461064 / US98986T1088 / CA00829Q1019 / US30303M1027 / US4571871023 / CA7063271034 / US6092071058 / US00287Y1091 / CA89156V1067 / US1091941005 / JE00B5TT1872 / US09609G1004 / US69327R1014 / CA04364G1063 / CA02215R1073 / CA1348082035 / CA96467A2002 / CA87505Y4094 / CA8204391079 / CA0805581091 / CA0213611001 / CA3565001086 / CA69338U1012 / CA74061A1084 / CA96145A2002 / CA09202D2077 / IE00B4Q5ZN47 / CA38045Y1025 / CA81373C1023 / CA04682R1073 / CA29269R1055 / CA3748252069 / US5764852050 / US25278X1090 / CA4882951060 / CA46579R1047 / US31189P1021 / US03674X1063 / US2267181046 / US1630921096 / CA14150G4007 / US02005N1000 / US14174T1079 / IE00BQPVQZ61 / US2383371091 / CA0089118776 / BMG0750C1082 / CA8310211005 / US1638511089 / CA83179X1087 / US95040Q1040 / US4622221004 / CA17040T3001 / US2057683029 / BMG162341090 / US13462K1097 / US15136A1025 / CA87241L1094 / CA46016U1084 / CA85859H1055 / CA6632782083 / CA15713J1049 / US12653C1080 / US8608971078 / CA35905B1076 / US03753U1060 / CA2960061091 / US00191U1025 / US11135F1012 / US87484T1088 / US76029N1063 / US34417P1003 / US08579X1019 / US04335A1051 / VGG1890L1076 / CA7241121077 / CA14179V5036 / US22052L1044 / CA6744822033 / US03768E1055 / US70614W1009 / US91734M1036 / CA31890B1031 / US69047Q1022 / US80810D1037 / MHY0436Q1098 / CA36168Q1046 / CA4220961078 / US03940R1077 / CA84678A1021 / US5168062058 / US05478C1053 / CA2674881040 / US13123X5086 / CA67079A1021 / CA89055A2039 / US23821D1000 / CA74022D4075 / US03750L1098 / US86333M1080 / US15202L1070 / CA83615X4075 / CA1295844056 / US78440X8048 / US1651677353 / US03743Q1085 / US90364P1057 / CA5362211040 / US44891N2080 / US92719V1008 / CA65532M6062 / CA00791P1071 / CA24874B1085 / US60646V1052 / CA03253E1079 / IE0003LFZ4U7 / CA53229C1077 / US98955K1043 / US4718711033 / US1374041093 / CA23344V1085 / CA0156581070</td><td class="leftalignment">Champion Iron Ltd / Advanced Micro Devices Inc / Air Products and Chemicals Inc / Amgen Inc / Aptargroup Inc / Bristol-Myers Squibb Co / CSX Corp / CVS Health Corp / Coterra Energy Inc / Caseys General Stores Inc / Clean Harbors Inc / Commercial Metals Co / Costco Wholesale Corp / Darling Ingredients Inc / Devon Energy Corp / EOG Resources Inc / Exxon Mobil Corp / FedEx Corp / Gilead Sciences Inc / Gold Fields Ltd / Greif Inc / Hormel Foods Corp / Hub Group Inc / J B Hunt Transport Services Inc / Incyte Corp / Intel Corp / International Paper Co / Eli Lilly and Co / ManpowerGroup Inc / Middleby Corp / Murphy Oil Corp / Neurocrine Biosciences Inc / Norfolk Southern Corp / Nucor Corp / Occidental Petroleum Corp / Omnicom Group Inc / Oracle Corp / Pfizer Inc / Pioneer Natural Resources Co / Range Resources Corp / Southwestern Energy Co / Thor Industries Inc / Tyson Foods Inc / Union Pacific Corp / United Parcel Service Inc / Linamar Corp / Canadian National Railway Co / Enbridge Inc / Bombardier Inc / Imperial Oil Ltd / Teck Resources Ltd / CAE Inc / Empire Company Ltd / Cascades Inc / Barrick Gold Corp / Canadian Natural Resources Ltd / AKITA Drilling Ltd / Pason Systems Inc / Trican Well Service Ltd / Chevron Corp / Canadian Pacific Railway Ltd / Marathon Oil Corp / Canadian Western Bank / AMN Healthcare Services Inc / Conocophillips / Cross Country Healthcare Inc / Biogen Inc / Sunopta Inc / Computer Modelling Group Ltd / Capital One Financial Corp / Bunge Ltd / Nuvista Energy Ltd / Crew Energy Inc / NRG Energy Inc / Yamana Gold Inc / Alnylam Pharmaceuticals Inc / Kinross Gold Corp / Lundin Mining Corp / Centene Corp / Avalonbay Communities Inc / Equity Residential / Essex Property Trust Inc / Camden Property Trust / Transcontinental Inc / Ensign Energy Services Inc / Builders FirstSource Inc / Paramount Resources Ltd / Simon Property Group Inc / CF Industries Holdings Inc / CH Robinson Worldwide Inc / Brookfield Asset Management Inc / Birchcliff Energy Ltd / Hess Corp / Mastercard Inc / Evertz Technologies Ltd / Mid-America Apartment Communities Inc / GeoPark Ltd / UDR Inc / Equitable Group Inc / Morguard Real Estate Investment Trust / Capstone Mining Corp / Lululemon Athletica Inc / Green Plains Inc / Graphic Packaging Holding Co / Continental Resources Inc / Gran Tierra Energy Inc / EQT Corp / Mullen Group Ltd / Total Energy Services Inc / Xebec Adsorption Inc / Crescent Point Energy Corp / Suncor Energy Inc / Dollarama Inc / Cenovus Energy Inc / Parex Resources Inc / Nextera Energy Inc / SM Energy Co / MEG Energy Corp / Vermilion Energy Inc / Baytex Energy Corp / ARC Resources Ltd / Enerplus Corp / Bonterra Energy Corp / Peyto Exploration & Development Corp / Zynga Inc / Africa Oil Corp / Meta Platforms Inc / Ingredion Inc / Pembina Pipeline Corp / Mondelez International Inc / Abbvie Inc / Tourmaline Oil Corp / Bright Horizons Family Solutions Inc / Centamin PLC / bluebird bio Inc / PDC Energy Inc / Ascot Resources Ltd / Altus Group Ltd / Canacol Energy Ltd / Whitecap Resources Inc / Tamarack Valley Energy Ltd / Shawcor Ltd / Belo Sun Mining Corp / AltaGas Ltd / Freehold Royalties Ltd / PHX Energy Services Corp / Premium Brands Holdings Corp / Westshore Terminals Investment Corp / Black Diamond Group Ltd / Jazz Pharmaceuticals PLC / GoGold Resources Inc / Secure Energy Services Inc / Athabasca Oil Corp / Enerflex Ltd / Gibson Energy Inc / Matador Resources Co / Diamondback Energy Inc / Kelt Exploration Ltd / Ivanhoe Mines Ltd / Fate Therapeutics Inc / Antero Resources Corp / Criteo SA / Chegg Inc / Cardinal Energy Ltd (Alberta) / Ally Financial Inc / CareTrust REIT Inc / Horizon Therapeutics PLC / Dave & Buster's Entertainment Inc / Air Canada / Axalta Coating Systems Ltd / Slate Office REIT / Chemours Co / SmartCentres Real Estate Investment Trust / Welltower Inc / Ionis Pharmaceuticals Inc / Chorus Aviation Inc / Comstock Resources Inc / Brookfield Business Partners LP / Camping World Holdings Inc / Centennial Resource Development Inc / TFI International Inc / International Petroleum Corp / Step Energy Services Ltd / North West Company Inc / CES Energy Solutions Corp / CNX Resources Corp / Stitch Fix Inc / Frontera Energy Corp / Apellis Pharmaceuticals Inc / Ero Copper Corp / ASGN Inc / Broadcom Inc / Talos Energy Inc / Replimune Group Inc / Focus Financial Partners Inc / Berry Corporation (Bry) / Arvinas Inc / Capri Holdings Ltd / Pipestone Energy Corp / Cargojet Inc / Corteva Inc / Obsidian Energy Ltd / Apollo Global Management Inc / Peloton Interactive Inc / US Ecology Inc / First Capital Real Estate Investment Trust / Ovintiv Inc / Schrodinger Inc / Atlas Corp / GFL Environmental Inc / Headwater Exploration Inc / Arch Resources Inc / Spartan Delta Corp / Laredo Petroleum Inc / Azek Company Inc / Dye & Durham Ltd / Callon Petroleum Co / Nuvei Corp / Topaz Energy Corp / Datto Holding Corp / Precision Drilling Corp / Apartment Income REIT Corp / Stride Inc / Centerspace / Source Energy Services Ltd / Calfrac Well Services Ltd / SL Green Realty Corp / Chesapeake Energy Corp / APA Corp (US) / UiPath Inc / Lion Electric Co / IAC/Interactivecorp / Vimeo Inc / Nomad Royalty Company Ltd / Advantage Energy Ltd / dentalcorp Holdings Ltd / Mister Car Wash Inc / Anaergia Inc / Dole PLC / Lightspeed Commerce Inc / Zevia PBC / Jasper Therapeutics Inc / Candel Therapeutics Inc / D2L Inc / Algoma Steel Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / France / Ireland / United States / Virgin Islands, British / South Africa / Marshall Islands / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">12/10/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended December 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">AZN / 71708110 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 80105N10 / 58933Y10 / 00287Y10 / G3910J11 / 45845P10</td><td class="leftalignment">AstraZeneca PLC / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Sanofi SA / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">12/10/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon / Leonid Timashev</td></tr>
<tr class="even"><td class="leftalignment">12/10/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">AMGN: Key Takeaways from Our Biopharma Spotlight: Global Large Cap Event</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">03116210</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun / Anna Baran, CFA / Daniel Tarjan, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">12/10/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Amgen Inc.</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="even"><td class="leftalignment">12/09/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Let it Bleed; Four Straight Weeks of Biotech Outflows</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 04016X101 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / argenx SE / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">12/09/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Institutional ownership of AMGN at Sep 30: 522 (25%) exits from Amgen</td><td class="leftalignment">English</td><td class="rightalignment">68</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">12/09/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AJG / ALL / AR / BMY.N / CB / CNX / DOW / DVN / EOG / EQT / HIG / LH / MRK.N / PFE.N / PGR / RRC / SWN / GILD.O / AMGN.O / EW / REGN.O / VRTX.O / ACGL.O / BIIB.O / SBNY.O / WRB.N / FANG.O / ABBV.N / LGIH.O / AFMD.O / ROKU.O / CTRA.K / CHK.O / VZIO.N</td><td class="leftalignment">Arthur J Gallagher & Co / Allstate Corp / Antero Resources Corp / Bristol-Myers Squibb Co / Chubb Ltd / CNX Resources Corp / Dow Inc / Devon Energy Corp / EOG Resources Inc / EQT Corp / Hartford Financial Services Group Inc / Laboratory Corporation of America Holdings / Merck & Co Inc / Pfizer Inc / Progressive Corp / Range Resources Corp / Southwestern Energy Co / Gilead Sciences Inc / Amgen Inc / Edwards Lifesciences Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Arch Capital Group Ltd / Biogen Inc / Signature Bank / W R Berkley Corp / Diamondback Energy Inc / Abbvie Inc / LGI Homes Inc / Affimed NV / Roku Inc / Coterra Energy Inc / Chesapeake Energy Corp / Vizio Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/09/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Wells Express: Morning Research Highlights—December 9, 2021</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AJG / ALL / AR / BMY.N / CB / CNX / DOW / DVN / EOG / EQT / HIG / MRK.N / PFE.N / PGR / RRC / SWN / GILD.O / AMGN.O / EW / REGN.O / VRTX.O / ACGL.O / BIIB.O / SBNY.O / WRB.N / FANG.O / ABBV.N / LGIH.O / ROKU.O / CTRA.K / CHK.O / VZIO.N</td><td class="leftalignment">Arthur J Gallagher & Co / Allstate Corp / Antero Resources Corp / Bristol-Myers Squibb Co / Chubb Ltd / CNX Resources Corp / Dow Inc / Devon Energy Corp / EOG Resources Inc / EQT Corp / Hartford Financial Services Group Inc / Merck & Co Inc / Pfizer Inc / Progressive Corp / Range Resources Corp / Southwestern Energy Co / Gilead Sciences Inc / Amgen Inc / Edwards Lifesciences Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Arch Capital Group Ltd / Biogen Inc / Signature Bank / W R Berkley Corp / Diamondback Energy Inc / Abbvie Inc / LGI Homes Inc / Roku Inc / Coterra Energy Inc / Chesapeake Energy Corp / Vizio Holding Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Adam Muro / Alexandra Green / Dian Yuan</td></tr>
<tr class="even"><td class="leftalignment">12/09/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Amgen Inc.(AMGN) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">031162100</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AJG / BMY.N / EMN / H / KO / LLY.N / MRK.N / OLN / PFE.N / PK / RKT / S.N / SWK / ASND.O / AMZN.O / HT / GILD.O / AMGN.O / EW / ARNA.O / CHH.N / GSK.N / ARGX.O / BMRN.O / REGN.O / VRTX.O / DOL.TO / SIVB.O / BIIB.O / SHO.N / HST.N / HZNP.O / SRPT.O / RHP.N / ABBV.N / PFSI.K / QURE.O / RXDX.O / XHR.N / APLE.N / RYTM.O / SFIX.O / APLS.O / KZR.O / MORF.O / CABA.O / 45258J102 / HMPT.O</td><td class="leftalignment">Arthur J Gallagher & Co / Bristol-Myers Squibb Co / Eastman Chemical Co / Hyatt Hotels Corp / Coca-Cola Co / Eli Lilly and Co / Merck & Co Inc / Olin Corp / Pfizer Inc / Park Hotels & Resorts Inc / Rocket Companies Inc / SentinelOne Inc / Stanley Black & Decker Inc / Ascendis Pharma A/S / Amazon.com Inc / Hersha Hospitality Trust / Gilead Sciences Inc / Amgen Inc / Edwards Lifesciences Corp / Arena Pharmaceuticals Inc / Choice Hotels International Inc / GlaxoSmithKline PLC / argenx SE / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Dollarama Inc / SVB Financial Group / Biogen Inc / Sunstone Hotel Investors Inc / Host Hotels & Resorts Inc / Horizon Therapeutics PLC / Sarepta Therapeutics Inc / Ryman Hospitality Properties Inc / Abbvie Inc / PennyMac Financial Services Inc / Uniqure NV / Prometheus Biosciences Inc / Xenia Hotels & Resorts Inc / Apple Hospitality REIT Inc / Rhythm Pharmaceuticals Inc / Stitch Fix Inc / Apellis Pharmaceuticals Inc / Kezar Life Sciences Inc / Morphic Holding Inc / Cabaletta Bio Inc / Immunovant Inc / Home Point Capital Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Denmark / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">The Skies Are Clearing but Stock Selection Still Important</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">BMY.N / MRK.N / PFE.N / GILD.O / AMGN.O / REGN.O / VRTX.O / BIIB.O / ABBV.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / China / Croatia / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="odd"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">AMGN: Near-Term Challenges to I&I Business and Lack of Catalysts Keep Us on Sidelines; Initiate with Equal Weight</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="even"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">December 2021 "Monthly Controversies" Report</td><td class="leftalignment">English</td><td class="rightalignment">165</td><td class="leftalignment">US0311621009 / US09062X1037 / FR0000120578 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US3755581036 / US5324571083 / US7170811035 / US75886F1075 / US7802592060 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Gilead Sciences Inc / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Royal Dutch Shell PLC / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang</td></tr>
<tr class="odd"><td class="leftalignment">12/08/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 8, 2021</td><td class="leftalignment">English</td><td class="rightalignment">58</td><td class="leftalignment">US0091581068 / US0311621009 / US1101221083 / US2017231034 / US2372661015 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US8718291078 / US8851601018 / US9078181081 / US9111631035 / US92532F1003 / US9746371007 / CA29250N1050 / CA1247651088 / CA2918434077 / US09062X1037 / BMG169621056 / US6293775085 / US12008R1077 / US1252691001 / CA6179141065 / US58933Y1055 / US65339F1012 / CA04364G1063 / CA0805581091 / CA38045Y1025 / US85208M1027 / US60468T1051 / US2383371091 / US1638511089 / US4622221004 / US13462K1097 / US8608971078 / US80810D1037 / US92719V1008 / US1374041093</td><td class="leftalignment">Air Products and Chemicals Inc / Amgen Inc / Bristol-Myers Squibb Co / Commercial Metals Co / Darling Ingredients Inc / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Sysco Corp / Thor Industries Inc / Union Pacific Corp / United Natural Foods Inc / Vertex Pharmaceuticals Inc / Winnebago Industries Inc / Enbridge Inc / CAE Inc / Empire Company Ltd / Biogen Inc / Bunge Ltd / NRG Energy Inc / Builders FirstSource Inc / CF Industries Holdings Inc / Morguard Real Estate Investment Trust / Merck & Co Inc / Nextera Energy Inc / Ascot Resources Ltd / Belo Sun Mining Corp / GoGold Resources Inc / Sprouts Farmers Market Inc / Mirati Therapeutics Inc / Dave & Buster's Entertainment Inc / Chemours Co / Ionis Pharmaceuticals Inc / Camping World Holdings Inc / Stitch Fix Inc / Schrodinger Inc / Vimeo Inc / Candel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">12/08/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Feedback From Our Launch: PFE’s Longer-Term COVID Benefit Clearer w/ Omicron</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">PFE.N / US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US09062X1037 / US58933Y1055 / US60468T1051 / US1374041093</td><td class="leftalignment">Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Merck & Co Inc / Mirati Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">12/07/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US -  Dividend Quality Analysis, for the period ended September 08,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / ABT / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">12/07/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PFE-US -  Dividend Quality Analysis, for the period ended December 06,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE / ABT / BMY / JNJ / LLY / MRK / NVS / AMGN.O / GSK / AZN.O</td><td class="leftalignment">Pfizer Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">12/07/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / HD=US / INTC=US / MCD=US / AMD=US / IP=US / WEN=US / BLD=US / KMI=US / PEB=US / SLG=US / H=US / MTN=US / LOW=US / IGT=US / BYD=US / MAR=US / LEG=US / TNL=US / VMC=US / MGM=US / HLT=US / PENN=US / RCL=US / MLM=US / UNH=US / AMED=US / SWIM=US / CBRL=US / ELY=US / CCL=US / FUN=US / CHH=US / DRI=US / DRH=US / GFF=US / IBP=US / MAS=US / MHK=US / REGN=US / WGO=US / SGMS=US / SIVB=US / CNM=US / NLS=US / COP=US / AUTL=US / VICI=US / DIN=US / MGP=US / OGN / BCO=US / MRNS=US / RRR=US / PRG=US / TPX=US / EXP=US / CZR=US / BECN=US / TXRH=US / SHO=US / PLAY=US / DENN=US / BLDR=US / GMS=US / CMG=US / REX=US / HST=US / PGTI=US / AWI=US / OC=US / SAIC=US / AMRX=US / TAST=US / QSR=US / WRK=US / PRPL=US / WH=US / JACK=US / AGS=US / TREX=US / HGV=US / LPLA=US / VAC=US / FBHS=US / RHP=US / FANG=US / TILE=US / NCLH=US / NDLS=US / FOXF=US / FATE=US / GLPI=US / COUP=US / LOCO=US / AFMD=US / BVH=US / SHAK=US / WING=US / EVRI=US / 82982L103 / 50189K103 / JELD=US / IOVA=US / ALLO=US / HARP=US / FERG=US / GMAB=US / ONEW=US / DKNG=US / AZEK=US / BALY=US / VTRS=US / CELU=US / ROCC=US / SNPO=US / HLLY=US / PKG=U / GTLB=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / Intel Corp / McDonald's Corp / Advanced Micro Devices Inc / International Paper Co / Wendys Co / TopBuild Corp / Kinder Morgan Inc / Pebblebrook Hotel Trust / SL Green Realty Corp / Hyatt Hotels Corp / Vail Resorts Inc / Lowe's Companies Inc / International Game Technology PLC / Boyd Gaming Corp / Marriott International Inc / Leggett & Platt Inc / Travel + Leisure Co / Vulcan Materials Co / MGM Resorts International / Hilton Worldwide Holdings Inc / Penn National Gaming Inc / Royal Caribbean Cruises Ltd / Martin Marietta Materials Inc / UnitedHealth Group Inc / Amedisys Inc / Latham Group Inc / Cracker Barrel Old Country Store Inc / Callaway Golf Co / Carnival Corp / Cedar Fair LP / Choice Hotels International Inc / Darden Restaurants Inc / Diamondrock Hospitality Co / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Regeneron Pharmaceuticals Inc / Winnebago Industries Inc / Scientific Games Corp / SVB Financial Group / Core & Main Inc / Nautilus Inc / Conocophillips / Autolus Therapeutics PLC / VICI Properties Inc / Dine Brands Global Inc / MGM Growth Properties LLC / Organon & Co / Brinks Co / Marinus Pharmaceuticals Inc / Red Rock Resorts Inc / PROG Holdings Inc / Tempur Sealy International Inc / Eagle Materials Inc / Caesars Entertainment Inc / Beacon Roofing Supply Inc / Texas Roadhouse Inc / Sunstone Hotel Investors Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Host Hotels & Resorts Inc / PGT Innovations Inc / Armstrong World Industries Inc / Owens Corning / Science Applications International Corp / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Westrock Co / Purple Innovation Inc / Wyndham Hotels & Resorts Inc / Jack in the Box Inc / PlayAGS Inc / Trex Company Inc / Hilton Grand Vacations Inc / LPL Financial Holdings Inc / Marriott Vacations Worldwide Corp / Fortune Brands Home & Security Inc / Ryman Hospitality Properties Inc / Diamondback Energy Inc / Interface Inc / Norwegian Cruise Line Holdings Ltd / Noodles & Co / Fox Factory Holding Corp / Fate Therapeutics Inc / Gaming and Leisure Properties Inc / Coupa Software Inc / El Pollo Loco Holdings Inc / Affimed NV / Bluegreen Vacations Holding Corp / Shake Shack Inc / Wingstop Inc / Everi Holdings Inc / SiteOne Landscape Supply Inc / LCI Industries / JELD-WEN Holding Inc / Iovance Biotherapeutics Inc / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / Ferguson PLC / Genmab A/S / OneWater Marine Inc / DraftKings Inc / Azek Company Inc / Bally's Corp / Viatris Inc / Celularity Inc / Ranger Oil Corp / Snap One Holdings Corp / Holley Inc / Packaging Corp of America / GitLab Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Denmark / United Kingdom / Liberia / Netherlands / Panama / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/07/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Amid Seasonal Delta-Driven Wave; Clarity on Omicron’s Impact on Vaccines, Trajectory, and Disease Severity in Near Term</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Sarah Schram / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">12/06/2021</td><td class="leftalignment">Kailash Concepts</td><td class="leftalignment">BUY & SELL Lists - SP500</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ABBV.N / AFRM.OQ / AEE.N / CE.N / ECL.N / ED.N / HLT.N / PFE.N / SC.N / TXT.N / U.N / USB.N / ACI.N / BKI.N / SCI.N / DIS.N / WLK.N / AFG.N / IFF.N / FNF.N / VMC.N / PCG.N / DVN.N / ATO.N / LNT.N / AME.N / UDR.N / MKC.N / HRL.N / GME.N / TDY.N / COP.N / INTC.OQ / AMGN.OQ / FISV.OQ / HOLX.OQ / RJF.N / RGEN.OQ / POOL.OQ / TPR.N / UHAL.OQ / STLD.OQ / NUAN.OQ / PA1436583006 / MNST.OQ / MOH.N / LVS.N / PODD.OQ / LBTYK.OQ / CME.OQ / AVGO.OQ / NEE.N / CAR.OQ / Z.OQ / RNG.N / SYF.N / LBRDK.O / TW.OQ / TDOC.N / SITE.N / TWLO.N / TTD.OQ / COUP.OQ / SNAP.N / INVH.N / CVNA.N / ROKU.OQ / XEL.OQ / VICI.N / DOCU.OQ / CDAY.N / KDP.N / FTCH.N / UBER.N / TXG.OQ / PTON.OQ / WTRG.N / DKNG.OQ / ZI.OQ / PLTR.N / RBLX.N / CPNG.N</td><td class="leftalignment">Abbvie Inc / Affirm Holdings Inc / Ameren Corp / Celanese Corp / Ecolab Inc / Consolidated Edison Inc / Hilton Worldwide Holdings Inc / Pfizer Inc / Santander Consumer USA Holdings Inc / Textron Inc / Unity Software Inc / US Bancorp / Albertsons Companies Inc / Black Knight Inc / Service Corporation International / Walt Disney Co / Westlake Chemical Corp / American Financial Group Inc / International Flavors & Fragrances Inc / Fidelity National Financial Inc / Vulcan Materials Co / PG&E Corp / Devon Energy Corp / Atmos Energy Corp / Alliant Energy Corp / AMETEK Inc / UDR Inc / McCormick & Company Inc / Hormel Foods Corp / GameStop Corp / Teledyne Technologies Inc / Conocophillips / Intel Corp / Amgen Inc / Fiserv Inc / Hologic Inc / Raymond James Financial Inc / Repligen Corp / Pool Corp / Tapestry Inc / Amerco / Steel Dynamics Inc / Nuance Communications Inc / Carnival Corp / Monster Beverage Corp / Molina Healthcare Inc / Las Vegas Sands Corp / Insulet Corp / Liberty Global PLC / CME Group Inc / Broadcom Inc / Nextera Energy Inc / Avis Budget Group Inc / Zillow Group Inc / RingCentral Inc / Synchrony Financial / Liberty Broadband Corp / Tradeweb Markets Inc / Teladoc Health Inc / SiteOne Landscape Supply Inc / Twilio Inc / Trade Desk Inc / Coupa Software Inc / Snap Inc / Invitation Homes Inc / Carvana Co / Roku Inc / Xcel Energy Inc / VICI Properties Inc / DocuSign Inc / Ceridian HCM Holding Inc / Keurig Dr Pepper Inc / Farfetch Ltd / Uber Technologies Inc / 10X Genomics Inc / Peloton Interactive Inc / Essential Utilities Inc / DraftKings Inc / ZoomInfo Technologies Inc / Palantir Technologies Inc / Roblox Corp / Coupang Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United Kingdom / Korea, Republic of / Panama / United States</td><td class="leftalignment">Aerospace / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Consumer / Defense / Electrical / Electronics / Financial Services / Food / Healthcare / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Media / Metals & Minerals / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Technology / Transportation / Utilities / Wholesale / Oil & Gas / Internet</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">12/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Nov 26, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">111</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">12/06/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / OGN / AMRX=US / VTRS=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Organon & Co / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregory D. Fraser / Ms. Robyn S. Karnauskas / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">12/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">STARTING IN 30 MINUTES: KOL Call on Prostate Cancer Landscape and Emerging Therapeutics</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">5671735 / 0989529 / 2023607 / 2778844 / 2475833 / 2576941 / 2684703 / 2730190 / 7103065 / BFDV8K0 / BGCYWN8 / BKVDFF7 / BDZ30Q0</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Amgen Inc / Merck & Co Inc / Johnson & Johnson / Exelixis Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / MacroGenics Inc / Xencor Inc / Oric Pharmaceuticals Inc / Arvinas Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Mr. Seamus Fernandez / Yige Guo, Ph.D. / Kelsey Goodwin / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">12/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">2000019 / 2023607 / 2486813 / 2778844 / 2065159 / 2270726 / 2542049 / 2317087 / 2632003 / 2657802 / 2689560 / 2684703 / 2048804 / 2730190 / 2440637 / 2829601 / 7103065 / 2857817 / B02R1L6 / B5B1S13 / B7TL820 / B7VD3F2 / B7JYSG3 / BBGVT40 / BDZCRX3 / BFLR866 / BFZCHN7 / BXDZ9Z0 / BD8DJ71 / BJ2Z0H2 / BZ8FPH3 / BYZM6C2 / BFZ1K46 / BMYML02 / BLGJ610 / BJJMGL2 / BKTNTR9 / BGSP7M9 / BJVR9Y9 / BYY88Y7 / BRJ3GY4 / BMDCDP2 / BN7K304 / BNTB3N8 / BKPGJQ1 / BNKGXX2 / BMDW0R3 / BYQBFJ8</td><td class="leftalignment">Amazon.com Inc / Amgen Inc / Kellogg Co / Merck & Co Inc / Autodesk Inc / Walt Disney Co / Dominion Energy Inc / Entergy Corp / New York Times Co / OGE Energy Corp / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / CenterPoint Energy Inc / Southern Co / Novartis AG / Netflix Inc / ALLETE Inc / Dollar General Corp / Meta Platforms Inc / Duke Energy Corp / Guidewire Software Inc / News Corp / RingCentral Inc / Twitter Inc / Wix.Com Ltd / Shopify Inc / Snap Inc / Pinterest Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Spotify Technology SA / DraftKings Inc / Warner Music Group Corp / Fox Corp / ViacomCBS Inc / Zoom Video Communications Inc / iHeartMedia Inc / Alphabet Inc / Xenon Pharmaceuticals Inc / Bigcommerce Holdings Inc / Academy Sports and Outdoors Inc / Vizio Holding Corp / Squarespace Inc / Verve Therapeutics Inc / Weave Communications Inc / Arrowhead Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Israel / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">12/06/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - December 6, 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AES.N / AFL.N / AIG.N / ALV.N / BMO.TO / BOX.N / CB.N / CL.N / CRM.N / EIX.N / F.N / FITB.O / FSR.N / GM.N / NA / PD.N / RYN.N / SO.N / T.N / VC.N / BFb.N / WY.N / TEN.N / CMCSA.O / AMGN.O / DIS.N / BWA.N / LEA.N / PNM.N / DT.N / DV.N / ENEI.MI / EPC.N / AMT.N / CONE.O / VZ.N / XEL.N / LNC.N / APH.N / FISV.O / V.N / AXL.N / ACN.N / JKHY.O / AJG.N / BMRN.O / REGN.O / SRG.MI / PRU.N / NCR.N / TEL.N / CPK.N / ST.N / SR.N / O.N / PLUG.OQ / GPN.N / IMGN.O / LIFE.O / CASY.O / ACGL.O / EQIX.O / ATDb.TO / DLR.N / 416515104 / FIS.N / MA.N / WU.N / AON.N / GETP.PA / DAN.N / ENV.N / NEE.N / NXT.AX / PCH.O / PKI.TO / CTT.N / MTOR.N / SPLK.OQ / FFHu.TO / INFA.N / TSLA.N / TMUS.N / BEP.N / AGIO.O / 81762P102 / 922475108 / NEP.N / HUBS.N / SQ.N / SCWX.O / ADNT.N / GDS.O / OKTA.OQ / OVID.O / WOW.N / ATNX.O / APTV.N / ZS.OQ / SMAR.N / VNE.N / FOCS.O / ESTC.N / CRWD.O / CRNC.OQ / WTRG.N / AHCO.O / VMD.OQ / NKLA.OQ / FOUR.N / IBEX.O / LUMN.N / AEP.OQ / RIDE.OQ / LSPD.N / AFRM.O / OLO.N / NAPA.N / COUR.N / PATH.N / TSP.OQ / FLYW.O / TASK.O / TRMR.OQ / RYAN.N / BASE.OQ / RIVN.OQ</td><td class="leftalignment">AES Corp / Aflac Inc / American International Group Inc / Autoliv Inc / Bank of Montreal / Box Inc / Chubb Ltd / Colgate-Palmolive Co / Salesforce.Com Inc / Edison International / Ford Motor Co / Fifth Third Bancorp / Fisker Inc / General Motors Co / National Bank of Canada / PagerDuty Inc / Rayonier Inc / Southern Co / AT&T Inc / Visteon Corp / Brown-Forman Corp / Weyerhaeuser Co / Tenneco Inc / Comcast Corp / Amgen Inc / Walt Disney Co / Borgwarner Inc / Lear Corp / PNM Resources Inc / Dynatrace Inc / DoubleVerify Holdings Inc / Enel SpA / Edgewell Personal Care Co / American Tower Corp / CyrusOne Inc / Verizon Communications Inc / Xcel Energy Inc / Lincoln National Corp / Amphenol Corp / Fiserv Inc / Visa Inc / American Axle & Manufacturing Holdings Inc / Accenture PLC / Jack Henry & Associates Inc / Arthur J Gallagher & Co / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Snam SpA / Prudential Financial Inc / NCR Corp / TE Connectivity Ltd / Chesapeake Utilities Corp / Sensata Technologies Holding PLC / Spire Inc / Realty Income Corp / Plug Power Inc / Global Payments Inc / ImmunoGen Inc / aTyr Pharma Inc / Caseys General Stores Inc / Arch Capital Group Ltd / Equinix Inc / Alimentation Couche-Tard Inc / Digital Realty Trust Inc / Hartford Financial Services Group Inc / Fidelity National Information Services Inc / Mastercard Inc / Western Union Co / Aon PLC / Getlink SE / Dana Inc / Envestnet Inc / Nextera Energy Inc / NEXTDC Ltd / Potlatchdeltic Corp / Parkland Corp / CatchMark Timber Trust Inc / Meritor Inc / Splunk Inc / Fairfax Financial Holdings Ltd / Informatica Inc / Tesla Inc / T-Mobile US Inc / Brookfield Renewable Partners LP / Agios Pharmaceuticals Inc / ServiceNow Inc / Veeva Systems Inc / Nextera Energy Partners LP / HubSpot Inc / Block Inc / SecureWorks Corp / Adient PLC / GDS Holdings Ltd / Okta Inc / Ovid Therapeutics Inc / WideOpenWest Inc / Athenex Inc / Aptiv PLC / Zscaler Inc / Smartsheet Inc / Veoneer Inc / Focus Financial Partners Inc / Elastic NV / CrowdStrike Holdings Inc / Cerence Inc / Essential Utilities Inc / Adapthealth Corp / Viemed Healthcare Inc / Nikola Corp / Shift4 Payments Inc / Ibex Ltd / Lumen Technologies Inc / American Electric Power Company Inc / Lordstown Motors Corp / Lightspeed Commerce Inc / Affirm Holdings Inc / Olo Inc / Duckhorn Portfolio Inc / Coursera Inc / UiPath Inc / TuSimple Holdings Inc / Flywire Corp / Taskus Inc / Tremor International Ltd / Ryan Specialty Group Holdings Inc / Couchbase Inc / Rivian Automotive Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / Italy / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">12/06/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Ada's Insights-Quant Strategy: U.S. Return Decomposition-Dec. 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">ALB.N / ALK.N / BA.N / BAC.N / BMY.N / C.N / CCL.N / CL.N / EOG.N / F.N / FLT.N / GE.N / GPS.N / IBM.N / JNJ.N / JPM.N / KO.N / LLY.N / MDT.N / OXY.N / PFE.N / PM.N / RHI.N / T.N / TMO.N / WFC.N / SPG.N / NUE.N / DIS.N / UNH.N / TFX.N / UNP.N / RCL.N / HD.N / LOW.N / MRO.N / XOM.N / DVN.N / NKE.N / IT.N / GWW.N / VZ.N / DVA.N / V.N / ACN.N / TWTR.N / HPQ.N / COP.N / INTC.OQ / AOS.N / ADBE.OQ / AMGN.OQ / AAPL.OQ / ADSK.OQ / FISV.OQ / KLAC.OQ / ATVI.OQ / MSFT.OQ / SIVB.OQ / XLNX.OQ / ODFL.OQ / QCOM.OQ / INTU.OQ / COST.OQ / INCY.OQ / PENN.OQ / DLTR.OQ / DISH.OQ / POOL.OQ / CTXS.OQ / AMZN.OQ / NVDA.OQ / MTCH.OQ / GPN.N / VRTX.OQ / WYNN.OQ / CMCSA.OQ / EXR.N / MKTX.OQ / LVS.N / VIAC.OQ / DISCA.OQ / FIS.N / STX.AX / MA.N / WU.N / IPGP.OQ / MRNA.OQ / AVGO.OQ / FTNT.OQ / TSLA.OQ / AMD.OQ / ENPH.OQ / FANG.OQ / PTC.OQ / NCLH.N / GOOGL.OQ / ANET.N / ETSY.OQ / ZBH.N / PYPL.OQ / TMUS.OQ / LW.N / FB.PS / TER.OQ / APA.OQ / VTRS.OQ</td><td class="leftalignment">Albemarle Corp / Alaska Air Group Inc / Boeing Co / Bank of America Corp / Bristol-Myers Squibb Co / Citigroup Inc / Carnival Corp / Colgate-Palmolive Co / EOG Resources Inc / Ford Motor Co / Fleetcor Technologies Inc / General Electric Co / Gap Inc / International Business Machines Corp / Johnson & Johnson / JPMorgan Chase & Co / Coca-Cola Co / Eli Lilly and Co / Medtronic PLC / Occidental Petroleum Corp / Pfizer Inc / Philip Morris International Inc / Robert Half International Inc / AT&T Inc / Thermo Fisher Scientific Inc / Wells Fargo & Co / Simon Property Group Inc / Nucor Corp / Walt Disney Co / UnitedHealth Group Inc / Teleflex Inc / Union Pacific Corp / Royal Caribbean Cruises Ltd / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / Exxon Mobil Corp / Devon Energy Corp / Nike Inc / Gartner Inc / W W Grainger Inc / Verizon Communications Inc / DaVita Inc / Visa Inc / Accenture PLC / Twitter Inc / HP Inc / Conocophillips / Intel Corp / A O Smith Corp / Adobe Inc / Amgen Inc / Apple Inc / Autodesk Inc / Fiserv Inc / KLA Corp / Activision Blizzard Inc / Microsoft Corp / SVB Financial Group / Xilinx Inc / Old Dominion Freight Line Inc / Qualcomm Inc / Intuit Inc / Costco Wholesale Corp / Incyte Corp / Penn National Gaming Inc / Dollar Tree Inc / DISH Network Corp / Pool Corp / Citrix Systems Inc / Amazon.com Inc / NVIDIA Corp / Match Group Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Wynn Resorts Ltd / Comcast Corp / Extra Space Storage Inc / Marketaxess Holdings Inc / Las Vegas Sands Corp / ViacomCBS Inc / Discovery Inc / Fidelity National Information Services Inc / Strike Energy Ltd / Mastercard Inc / Western Union Co / IPG Photonics Corp / Moderna Inc / Broadcom Inc / Fortinet Inc / Tesla Inc / Advanced Micro Devices Inc / Enphase Energy Inc / Diamondback Energy Inc / PTC Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / Arista Networks Inc / ETSY Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / T-Mobile US Inc / Lamb Weston Holdings Inc / San Miguel Food and Beverage Inc / Teradyne Inc / APA Corp (US) / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Ireland / Liberia / Panama / Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Jonathan N. Golub, CFA / Mr. Manish G. Bangard / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="even"><td class="leftalignment">12/04/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AMGN.O / BMRN.O / REGN.O / IMGN.O / LIFE.O / AGIO.O / ATNX.O</td><td class="leftalignment">Amgen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / ImmunoGen Inc / aTyr Pharma Inc / Agios Pharmaceuticals Inc / Athenex Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="odd"><td class="leftalignment">12/04/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 576</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101 / 603693102</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc / Mink Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Sarah Schram / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">12/03/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended November 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">AZN / 11012210 / 71708110 / 00846U10 / 88162420 / 37555810 / 03116210 / 66987V10 / 75886F10 / 53245710 / 09062X10 / 478160104 / 30161Q104 / 80105N10 / NOVO B / 771195104 / 58933Y10 / 00287Y10 / 45781M10 / G3910J11 / 45845P10</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Pfizer Inc / Agilent Technologies Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Amgen Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Biogen Inc / Johnson & Johnson / Exelixis Inc / Sanofi SA / Novo Nordisk A/S / Roche Holding AG / Merck & Co Inc / Abbvie Inc / Innoviva Inc / GlaxoSmithKline PLC / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">12/03/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">KOL Call Starting in 30 Mins, We're Talking Lipids and Blockbuster Opportunity for New Lipids Treatments</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">5671735 / 0989529 / 2023607 / 2778844 / 2730190 / 7103065 / BHC8X90 / BNKGXX2</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Amgen Inc / Merck & Co Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Novo Nordisk A/S / Verve Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Debjit Chattopadhyay, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">12/03/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">REMINDER: KOL Call on Prostate Cancer Landscape and Emerging Therapeutics at 10:00 AM ET on December 6th, 2021</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">5671735 / 0989529 / 2023607 / 2778844 / 2475833 / 2576941 / 2684703 / 2730190 / 7103065 / BFDV8K0 / BGCYWN8 / BKVDFF7 / BDZ30Q0</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Amgen Inc / Merck & Co Inc / Johnson & Johnson / Exelixis Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / MacroGenics Inc / Xencor Inc / Oric Pharmaceuticals Inc / Arvinas Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Mr. Seamus Fernandez / Yige Guo, Ph.D. / Kelsey Goodwin / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">12/03/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">12/03/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Live@PSC: Recaps of Fireside Chats with ABBV, AMGN, BMRN and REGN</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AMGN.OQ / ABBV.N / BMRN.OQ / REGN.OQ / 031162100 / 09061G101 / 75886F107 / 00287Y109</td><td class="leftalignment">Amgen Inc / Abbvie Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Amgen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">12/02/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Bleeding Continues - Third Straight Week of Biotech Outflows</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 04016X101 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / argenx SE / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">12/01/2021</td><td class="leftalignment">Probes Reporter</td><td class="leftalignment">Watch List: 77 US Companies with Undisclosed SEC Probes</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AAN.N / T.N / AEP.N / CL.N / COF.N / CVS.N / F.N / HLT.N / SLB.N / TMO.N / BEN.N / THC.N / REV.N / ADM.N / VLO.N / UPS.N / KR.N / XOM.N / NKE.N / TGT.N / XL.N / SNN.N / AMP.N / ARW.N / ATO.N / TWTR.N / HAE.N / OMI.N / CVX.N / TDY.N / AMGN.OQ / COLL.OQ / GNTX.OQ / HBAN.OQ / REGN.OQ / BBBY.OQ / GILD.OQ / COST.OQ / NKTR.OQ / MYGN.OQ / SSNC.OQ / CTXS.OQ / AMZN.OQ / NVDA.OQ / PLUG.OQ / CHTR.OQ / CVGI.OQ / RUSHA.OQ / NDAQ.OQ / THS.N / SPWR.OQ / KOP.N / MA.N / SIX.N / AON.N / BX.N / INO.OQ / BGCP.OQ / SCHW.N / EXPR.N / GRPN.OQ / FB.OQ / COTY.N / CTG.OQ / MGNX.OQ / BRX.N / LADR.N / TWOU.OQ / FGEN.OQ / ANTM.N / PFX.N / HOPE.OQ / DXC.N / IQV.N / WELL.N / TLRY.OQ / ALLO.OQ / US29350E1047 / LYFT.O / CTVA.N</td><td class="leftalignment">Aaron's Company Inc / AT&T Inc / American Electric Power Company Inc / Colgate-Palmolive Co / Capital One Financial Corp / CVS Health Corp / Ford Motor Co / Hilton Worldwide Holdings Inc / Schlumberger NV / Thermo Fisher Scientific Inc / Franklin Resources Inc / Tenet Healthcare Corp / Revlon Inc / Archer-Daniels-Midland Co / Valero Energy Corp / United Parcel Service Inc / Kroger Co / Exxon Mobil Corp / Nike Inc / Target Corp / XL Fleet Corp / Smith & Nephew PLC / Ameriprise Financial Inc / Arrow Electronics Inc / Atmos Energy Corp / Twitter Inc / Haemonetics Corp / Owens & Minor Inc / Chevron Corp / Teledyne Technologies Inc / Amgen Inc / Collegium Pharmaceutical Inc / Gentex Corp / Huntington Bancshares Inc / Regeneron Pharmaceuticals Inc / Bed Bath & Beyond Inc / Gilead Sciences Inc / Costco Wholesale Corp / Nektar Therapeutics / Myriad Genetics Inc / SS&C Technologies Holdings Inc / Citrix Systems Inc / Amazon.com Inc / NVIDIA Corp / Plug Power Inc / Charter Communications Inc / Commercial Vehicle Group Inc / Rush Enterprises Inc / Nasdaq Inc / TreeHouse Foods Inc / SunPower Corp / Koppers Holdings Inc / Mastercard Inc / Six Flags Entertainment Corp / Aon PLC / Blackstone Inc / Inovio Pharmaceuticals Inc / BGC Partners Inc / Charles Schwab Corp / Express Inc / Groupon Inc / Meta Platforms Inc / Coty Inc / Computer Task Group Inc / MacroGenics Inc / Brixmor Property Group Inc / Ladder Capital Corp / 2U Inc / FibroGen Inc / Anthem Inc / PhenixFIN Corp / Hope Bancorp Inc / DXC Technology Co / IQVIA Holdings Inc / Welltower Inc / Tilray Brands Inc / Allogene Therapeutics Inc / Enochian Biosciences Inc / Lyft Inc / Corteva Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom / Ireland / United States / Curaçao</td><td class="leftalignment">Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Chemicals / Consumer / Defense / Electrical / Electronics / Financial Services / Food / Healthcare / Household Products / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Technology / Telecommunications / Transportation / Utilities / Wholesale / Oil & Gas</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">12/01/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">AMGN.OQ - Event Transcript of Amgen Inc conference call, Dec. 01, 2021 / 1:00PM ET</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Sign Up for Hearty Fridays - KOL Call Series: 12/3 at 11:30am ET, We're Talking Lipids and Blockbuster Opportunity for New Lipids Treatments</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">5671735 / 0989529 / 2023607 / 2778844 / 2730190 / 7103065 / BHC8X90 / BNKGXX2</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Amgen Inc / Merck & Co Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Novo Nordisk A/S / Verve Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Debjit Chattopadhyay, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">12/01/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Big Biopharma Will Have $500Bn in Gross Cash to Deploy YE22 - Get Set for M&A</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AZN / 71708110 / 92532F10 / 37555810 / 03116210 / 75886F10 / 478160104 / 80105N10 / 58933Y10 / 00287Y10 / 09075V10 / 60770K10 / G3910J11</td><td class="leftalignment">AstraZeneca PLC / Pfizer Inc / Vertex Pharmaceuticals Inc / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Johnson & Johnson / Sanofi SA / Merck & Co Inc / Abbvie Inc / BioNTech SE / Moderna Inc / GlaxoSmithKline PLC</td><td class="leftalignment"></td><td class="leftalignment">Germany / France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Daniel Tarjan, Ph.D. / Na Sun</td></tr>
<tr class="even"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">AMGN.OQ - Event Transcript of Amgen Inc conference call, Nov. 30, 2021 / 5:10PM ET</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Monthly Update - Monthly: Amgen (AMGN: $198.88) loses $9 billion in MCap in November, biggest drop in Medical/Biomedical sector</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / HD=US / MCD=US / TWTR=US / PG=US / WEN=US / BLD=US / LOW=US / SWN=US / EXPE=US / LEG=US / VMC=US / MLM=US / SWIM=US / BLL=US / CBRL=US / CHD=US / DRI=US / GFF=US / IBP=US / MAS=US / MHK=US / OI=US / REGI=US / SGMO=US / SEE=US / TRIP=US / BKNG=US / SIVB=US / CNM=US / FB=US / DIN=US / MGNI=US / PNFP=US / RGF=US / OGN / MNST=US / TPX=US / EXP=US / BECN=US / TXRH=US / PLAY=US / FRPT=US / DENN=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / JACK=US / TREX=US / FBHS=US / BERY=US / TILE=US / NDLS=US / FATE=US / 00770K202 / LOCO=US / AFMD=US / SHAK=US / WING=US / 82982L103 / IRTC=US / TRVG=US / JELD=US / YEXT=US / FERG=US / BRBR=US / AZEK=US / VTRS=US / ABNB=US / 67421J108 / DNUT=US / SNPO=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / McDonald's Corp / Twitter Inc / Procter & Gamble Co / Wendys Co / TopBuild Corp / Lowe's Companies Inc / Southwestern Energy Co / Expedia Group Inc / Leggett & Platt Inc / Vulcan Materials Co / Martin Marietta Materials Inc / Latham Group Inc / Ball Corp / Cracker Barrel Old Country Store Inc / Church & Dwight Co Inc / Darden Restaurants Inc / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / O-I Glass Inc / Renewable Energy Group Inc / Sangamo Therapeutics Inc / Sealed Air Corp / Tripadvisor Inc / Booking Holdings Inc / SVB Financial Group / Core & Main Inc / Meta Platforms Inc / Dine Brands Global Inc / Magnite Inc / Pinnacle Financial Partners Inc / Real Good Food Company Inc / Organon & Co / Monster Beverage Corp / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Texas Roadhouse Inc / Dave & Buster's Entertainment Inc / Freshpet Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Jack in the Box Inc / Trex Company Inc / Fortune Brands Home & Security Inc / Berry Global Group Inc / Interface Inc / Noodles & Co / Fate Therapeutics Inc / Aemetis Inc / El Pollo Loco Holdings Inc / Affimed NV / Shake Shack Inc / Wingstop Inc / SiteOne Landscape Supply Inc / iRhythm Technologies Inc / Trivago NV / JELD-WEN Holding Inc / Yext Inc / Ferguson PLC / Bellring Brands Inc / Azek Company Inc / Viatris Inc / Airbnb Inc / Oatly Group AB / Krispy Kreme Inc / Snap One Holdings Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">207940.KS: Samsung Biologics Co., Ltd. - A focused large-scale biologics specialist</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">207940.KS / 4901.T / BAX.N / JNJ.N / PFE.N / TMO.N / AZN.L / SASY.PA / ROG.S / DHR.N / 1177.HK / TEVA.TA / MRCG.DE / LONN.S / SATG.DE / BANB.S / GSK.L / NVS.N / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / NVAX.OQ / 005930.KS / 000100.KS / 008930.KS / SFZN.S / BIIB.OQ / 006280.KS / TEVA.N / EBS.N / MRNA.OQ / 068270.KS / 1099.HK / 032830.KS / 128940.KS / ABBV.N / CTLT.N / 196170.KQ / 028260.KS / 2269.HK / 091990.KQ / 302440.KS</td><td class="leftalignment">Samsung Biologics Co Ltd / Fujifilm Holdings Corp / Baxter International Inc / Johnson & Johnson / Pfizer Inc / Thermo Fisher Scientific Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Danaher Corp / Sino Biopharmaceutical Ltd / Teva Pharmaceutical Industries Ltd / Merck KGaA / Lonza Group AG / Sartorius AG / Bachem Holding AG / GlaxoSmithKline PLC / Novartis AG / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Novavax Inc / Samsung Electronics Co Ltd / Yuhan Corp / Hanmi Science Co Ltd / Siegfried Holding AG / Biogen Inc / Green Cross Corp / Teva Pharmaceutical Industries Ltd / Emergent BioSolutions Inc / Moderna Inc / Celltrion Inc / Sinopharm Group Co Ltd / Samsung Life Insurance Co Ltd / Hanmi Pharm Co Ltd / Abbvie Inc / Catalent Inc / Alteogen Inc / Samsung C&T Corp / WuXi Biologics (Cayman) Inc / Celltrion Healthcare Co Ltd / SK Bioscience Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / Germany / France / United Kingdom / Israel / Japan / Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="even"><td class="leftalignment">11/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Nov 19, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">11/29/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / OGN / AMRX=US / VTRS=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Organon & Co / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregory D. Fraser / Ms. Robyn S. Karnauskas / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">11/29/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AAPL / ACN / AMGN / AXP / COF / DFS / EVER / GS / INTC.O / INTU / MSFT / NET / NKE / NOW / SAP / TREE / AMZN.O / EW / NVDA.O / AKAM / AMD.O / CSTL.O / CRTO.O / EXAS.O / CARG / 459200101 / GOOG.O / SPGI / Z.O / HALO.O / LULU / ANGI.O / FB.O / WDAY / PERI.O / VCEL.O / NVTA.K / TTD.O / UAA / FSLY / DMTK.O / PUBM.O / TBLA.O / NRDS.O</td><td class="leftalignment">Apple Inc / Accenture PLC / Amgen Inc / American Express Co / Capital One Financial Corp / Discover Financial Services / EverQuote Inc / Goldman Sachs Group Inc / Intel Corp / Intuit Inc / Microsoft Corp / Cloudflare Inc / Nike Inc / ServiceNow Inc / SAP SE / Lendingtree Inc / Amazon.com Inc / Edwards Lifesciences Corp / NVIDIA Corp / Akamai Technologies Inc / Advanced Micro Devices Inc / Castle Biosciences Inc / Criteo SA / Exact Sciences Corp / CarGurus Inc / International Business Machines Corp / Alphabet Inc / S&P Global Inc / Zillow Group Inc / Halozyme Therapeutics Inc / Lululemon Athletica Inc / Angi Inc / Meta Platforms Inc / Workday Inc / Perion Network Ltd / Vericel Corp / Invitae Corp / Trade Desk Inc / Under Armour Inc / Fastly Inc / DermTech Inc / PubMatic Inc / Taboola.com Ltd / Nerdwallet Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / France / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/29/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - November 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AES.N / CVS.N / EIX.N / NEM.N / RTO.L / SO.N / T.N / TMX.N / AMGN.O / DUK.N / AGI.N / ENB.TO / SU.TO / PCG.N / AMT.N / CONE.O / NG.L / VZ.N / EXEL.O / XEL.N / DSGX.O / ADSK.O / REGN.O / SRG.MI / CPK.N / ROL.N / SGEN.OQ / RGLD.O / EQIX.O / DLR.N / VMW.N / AR.TO / NEE.N / NXT.AX / INFA.N / TMUS.N / BEP.N / AGIO.O / NEP.N / WBA.N / MESO.O / TWLO.N / NTNX.O / GDS.O / SAND.N / OKTA.OQ / WPM.N / ZS.OQ / ESTC.N / ZM.O / CRWD.O / GMAB.O / WTRG.N / LUMN.N / AEP.OQ / FLNC.OQ</td><td class="leftalignment">AES Corp / CVS Health Corp / Edison International / Newmont Corporation / Rentokil Initial PLC / Southern Co / AT&T Inc / Terminix Global Holdings Inc / Amgen Inc / Duke Energy Corp / Alamos Gold Inc / Enbridge Inc / Suncor Energy Inc / PG&E Corp / American Tower Corp / CyrusOne Inc / National Grid PLC / Verizon Communications Inc / Exelixis Inc / Xcel Energy Inc / Descartes Systems Group Inc / Autodesk Inc / Regeneron Pharmaceuticals Inc / Snam SpA / Chesapeake Utilities Corp / Rollins Inc / Seagen Inc / Royal Gold Inc / Equinix Inc / Digital Realty Trust Inc / VMware Inc / Argonaut Gold Inc / Nextera Energy Inc / NEXTDC Ltd / Informatica Inc / T-Mobile US Inc / Brookfield Renewable Partners LP / Agios Pharmaceuticals Inc / Nextera Energy Partners LP / Walgreens Boots Alliance Inc / Mesoblast Ltd / Twilio Inc / Nutanix Inc / GDS Holdings Ltd / Sandstorm Gold Ltd / Okta Inc / Wheaton Precious Metals Corp / Zscaler Inc / Elastic NV / Zoom Video Communications Inc / CrowdStrike Holdings Inc / Genmab A/S / Essential Utilities Inc / Lumen Technologies Inc / American Electric Power Company Inc / Fluence Energy Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Cayman Islands / Denmark / United Kingdom / Italy / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">11/28/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Second Straight Week of Negative Biotech Fund Flows</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">11/27/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / EXEL.O / REGN.O / SGEN.OQ / AGIO.O / MESO.O / GMAB.O</td><td class="leftalignment">Amgen Inc / Exelixis Inc / Regeneron Pharmaceuticals Inc / Seagen Inc / Agios Pharmaceuticals Inc / Mesoblast Ltd / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Australia / Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="even"><td class="leftalignment">11/27/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward 575</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101 / 603693102</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc / Mink Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Sarah Schram / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">11/27/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Bent But Not Broken</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">AMGN / SPGI / HALO.O / LULU / VCEL.O / TTD.O</td><td class="leftalignment">Amgen Inc / S&P Global Inc / Halozyme Therapeutics Inc / Lululemon Athletica Inc / Vericel Corp / Trade Desk Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Financial Services</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / QUANANTITATIVE/TECH RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ari Wald, CFA, CMT</td></tr>
<tr class="even"><td class="leftalignment">11/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">Hong Kong / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">11/26/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ALLO / AMGN / C.N / DE / ICE / INCY / NBIX / NKE / QCOM.O / RARE / SEIC / VCTR / GILD.O / TRIT / ALKS.O / SQ / ARNA.O / FDS.N / SGEN / UTHR.O / BMRN.O / REGN.O / VRTX.O / NDAQ / NKTR / LIFE.O / MSTR.O / PHAR.O / BIIB / MNKD.O / SPGI / ACAD.O / ALNY.O / COIN / MRNA.O / SRPT.O / TGTX.OQ / FATE.O / ARGX.BR / INO.O / GLPG.O / IONS.O / CLLS.O / APLS.O / CBOE.K / TPTX.O / NBSE.O / ONCT.O / OPT.O / FSTX.O / VIRX.O / GANX.O / 390320109 / ATXS.O</td><td class="leftalignment">Allogene Therapeutics Inc / Amgen Inc / Citigroup Inc / Deere & Co / Intercontinental Exchange Inc / Incyte Corp / Neurocrine Biosciences Inc / Nike Inc / Qualcomm Inc / Ultragenyx Pharmaceutical Inc / SEI Investments Co / Victory Capital Holdings Inc / Gilead Sciences Inc / Triterras Inc / Alkermes Plc / Block Inc / Arena Pharmaceuticals Inc / Factset Research Systems Inc / Seagen Inc / United Therapeutics Corp / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Nasdaq Inc / Nektar Therapeutics / aTyr Pharma Inc / Microstrategy Inc / Pharming Group NV / Biogen Inc / MannKind Corp / S&P Global Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Coinbase Global Inc / Moderna Inc / Sarepta Therapeutics Inc / TG Therapeutics Inc / Fate Therapeutics Inc / argenx SE / Inovio Pharmaceuticals Inc / Galapagos NV / Ionis Pharmaceuticals Inc / Cellectis SA / Apellis Pharmaceuticals Inc / Cboe Global Markets Inc / Turning Point Therapeutics Inc / NeuBase Therapeutics Inc / Oncternal Therapeutics Inc / Opthea Ltd / F-Star Therapeutics Inc / Viracta Therapeutics Inc / Gain Therapeutics Inc / Great Elm Capital Corp / Astria Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Cayman Islands / France / Ireland / Netherlands / El Salvador / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/26/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Post-3Q21 Biotech Review</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ALLO / AMGN / INCY / NBIX / RARE / GILD.O / ALKS.O / ARNA.O / SGEN / UTHR.O / BMRN.O / REGN.O / VRTX.O / NKTR / LIFE.O / PHAR.O / BIIB / MNKD.O / ACAD.O / ALNY.O / MRNA.O / SRPT.O / TGTX.OQ / FATE.O / ARGX.BR / INO.O / GLPG.O / IONS.O / CLLS.O / APLS.O / TPTX.O / NBSE.O / ONCT.O / OPT.O / FSTX.O / VIRX.O / GANX.O / 390320109 / ATXS.O</td><td class="leftalignment">Allogene Therapeutics Inc / Amgen Inc / Incyte Corp / Neurocrine Biosciences Inc / Ultragenyx Pharmaceutical Inc / Gilead Sciences Inc / Alkermes Plc / Arena Pharmaceuticals Inc / Seagen Inc / United Therapeutics Corp / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Nektar Therapeutics / aTyr Pharma Inc / Pharming Group NV / Biogen Inc / MannKind Corp / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Moderna Inc / Sarepta Therapeutics Inc / TG Therapeutics Inc / Fate Therapeutics Inc / argenx SE / Inovio Pharmaceuticals Inc / Galapagos NV / Ionis Pharmaceuticals Inc / Cellectis SA / Apellis Pharmaceuticals Inc / Turning Point Therapeutics Inc / NeuBase Therapeutics Inc / Oncternal Therapeutics Inc / Opthea Ltd / F-Star Therapeutics Inc / Viracta Therapeutics Inc / Gain Therapeutics Inc / Great Elm Capital Corp / Astria Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / Sweden / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim / Eka Gigauri</td></tr>
<tr class="odd"><td class="leftalignment">11/24/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">ASH 2021 Meeting Planner</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">375558103 / 031162100 / 75886F107 / 02043Q107 / 45253H101 / 00287Y109 / 03835T200 / 31189P102 / 09627Y109 / 462260100 / 98401F105 / 41358P106 / 37890U108 / 04016X101 / 87184Q107 / 869367102 / 44975P103 / 64049K104 / 65343E108 / 492327101 / 359616109 / 80810D103 / 74366E102 / 00166B105 / 04335A105 / 46565G104 / 501575104 / 14147L108 / 67080M103 / 73730P108 / 81181C104 / 019818103 / 50107A104 / M47364100 / 03835L207 / 19240Q201 / 38406L103 / 45256X103 / 75082Q105 / 15673T100</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / ImmunoGen Inc / Abbvie Inc / Aptose Biosciences Inc / Fate Therapeutics Inc / Blueprint Medicines Corp / Iovance Biotherapeutics Inc / Xencor Inc / Harpoon Therapeutics Inc / Global Blood Therapeutics Inc / argenx SE / Syros Pharmaceuticals Inc / Sutro Biopharma Inc / I-Mab / Neoleukin Therapeutics Inc / NextCure Inc / Keros Therapeutics Inc / Fulcrum Therapeutics Inc / Schrodinger Inc / Protagonist Therapeutics Inc / ALX Oncology Holdings Inc / Arvinas Inc / Iteos Therapeutics Inc / Kymera Therapeutics Inc / Cardiff Oncology Inc / Nurix Therapeutics Inc / Poseida Therapeutics Inc / Seagen Inc / Allovir Inc / Kronos Bio Inc / Gamida Cell Ltd / Aptevo Therapeutics Inc / Cogent Biosciences Inc / Gracell Biotechnologies Inc / Immunitybio Inc / Rain Therapeutics Inc / Century Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / China / Cayman Islands / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Joseph Catanzaro, PhD / Mr. Do G. Kim / Yasmeen Rahimi, Ph.D. / Mr. Christopher J. Raymond / Edward A. Tenthoff</td></tr>
<tr class="even"><td class="leftalignment">11/23/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">DNB / FISV=US / LLY=US / PFE=US / AMGN=US / HD=US / MCD=US / OXY=US / RRC=US / EFX=US / WEN=US / AMZN=US / BLD=US / DVN=US / APA=US / CPE=US / EOG=US / REI=US / TRU=US / V=US / XOM=US / CRK=US / LOW=US / WLL=US / PXD=US / MGY=US / SWN=US / MUR=US / MRO=US / EXPE=US / LEG=US / VMC=US / BKI=US / MLM=US / UNH=US / PATH=US / SWIM=US / HRT=US / CBRL=US / CTRA=US / CENT=US / CNX=US / CSGP=US / DRI=US / EQT=US / EEFT=US / GFF=US / GPOR=US / IBP=US / MAS=US / MHK=US / PCTY=US / SSNC=US / TRIP=US / WEX=US / FOUR=US / CVX=US / GPN=US / PYPL=US / BKNG=US / CNM=US / FB=US / VNO=US / EVOP=US / COP=US / APPN=US / DIN=US / INST=US / MQ / OGN / FLT=US / TPX=US / EXP=US / BECN=US / TXRH=US / PLAY=US / DENN=US / XM=US / BLDR=US / GMS=US / CMG=US / FIS=US / MA=US / PGTI=US / WU=US / AWI=US / OC=US / AMRX=US / TAST=US / CENTA=US / QSR=US / CLR=US / PRPL=US / KTOS=US / NOG=US / JACK=US / VRSK=US / TREX=US / AR=US / OAS=US / GDOT=US / ESTE=US / FBHS=US / MTDR=US / PDCE=US / FANG=US / TILE=US / NDLS=US / GOOGL=US / VNOM=US / COUP=US / LOCO=US / AFMD=US / CIVI=US / SHAK=US / AJRD=US / WING=US / SQ=US / IBEX=US / 82982L103 / CDEV=US / TRVG=US / JELD=US / SBOW=US / MAXR=US / UBER=US / LSPD=US / FERG=US / LHX=US / RPAY=US / OVV=US / SPCE=US / AZEK=US / PAYA=US / VTRS=US / ABNB=US / AFRM=US / ROCC=US / COUR=US / REPX=US / SNPO=US / UDMY=US</td><td class="leftalignment">Dun & Bradstreet Holdings Inc / Fiserv Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / McDonald's Corp / Occidental Petroleum Corp / Range Resources Corp / Equifax Inc / Wendys Co / Amazon.com Inc / TopBuild Corp / Devon Energy Corp / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / TransUnion / Visa Inc / Exxon Mobil Corp / Comstock Resources Inc / Lowe's Companies Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / Marathon Oil Corp / Expedia Group Inc / Leggett & Platt Inc / Vulcan Materials Co / Black Knight Inc / Martin Marietta Materials Inc / UnitedHealth Group Inc / UiPath Inc / Latham Group Inc / HireRight Holdings Corp / Cracker Barrel Old Country Store Inc / Coterra Energy Inc / Central Garden & Pet Co / CNX Resources Corp / CoStar Group Inc / Darden Restaurants Inc / EQT Corp / Euronet Worldwide Inc / Griffon Corp / Gulfport Energy Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Paylocity Holding Corp / SS&C Technologies Holdings Inc / Tripadvisor Inc / WEX Inc / Shift4 Payments Inc / Chevron Corp / Global Payments Inc / PayPal Holdings Inc / Booking Holdings Inc / Core & Main Inc / Meta Platforms Inc / Vornado Realty Trust / EVO Payments Inc / Conocophillips / Appian Corp / Dine Brands Global Inc / Instructure Holdings Inc / Marqeta Inc / Organon & Co / Fleetcor Technologies Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Texas Roadhouse Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Qualtrics International Inc / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / Fidelity National Information Services Inc / Mastercard Inc / PGT Innovations Inc / Western Union Co / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Central Garden & Pet Co / Restaurant Brands International Inc / Continental Resources Inc / Purple Innovation Inc / Kratos Defense and Security Solutions Inc / Northern Oil and Gas Inc / Jack in the Box Inc / Verisk Analytics Inc / Trex Company Inc / Antero Resources Corp / Oasis Petroleum Inc / Green Dot Corp / Earthstone Energy Inc / Fortune Brands Home & Security Inc / Matador Resources Co / PDC Energy Inc / Diamondback Energy Inc / Interface Inc / Noodles & Co / Alphabet Inc / Viper Energy Partners LP / Coupa Software Inc / El Pollo Loco Holdings Inc / Affimed NV / Civitas Resources Inc / Shake Shack Inc / Aerojet Rocketdyne Holdings Inc / Wingstop Inc / Block Inc / Ibex Ltd / SiteOne Landscape Supply Inc / Centennial Resource Development Inc / Trivago NV / JELD-WEN Holding Inc / SilverBow Resources Inc / Maxar Technologies Inc / Uber Technologies Inc / Lightspeed Commerce Inc / Ferguson PLC / L3harris Technologies Inc / Repay Holdings Corp / Ovintiv Inc / Virgin Galactic Holdings Inc / Azek Company Inc / Paya Holdings Inc / Viatris Inc / Airbnb Inc / Affirm Holdings Inc / Ranger Oil Corp / Coursera Inc / Riley Exploration Permian Inc / Snap One Holdings Corp / Udemy Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/23/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Seasonal COVID-19 Wave Continues as Holidays Approach, Thankful for Broad Adult Booster Approval, Ramping Up Pediatric Shots</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Sarah Schram / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">11/23/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2681511 / 2000019 / 2023607 / 2293819 / 2778844 / 2050832 / 2026242 / 2270726 / 2317087 / 2670519 / 2415204 / 2623911 / 2684703 / 2967589 / 7103065 / 2170473 / 2857817 / B3D7K31 / 2855930 / BBPK0J0 / BZ07BW4 / BZ1LFB2 / BJ1FD74 / BWTN5N1 / BFD20M9 / BFZ1K46 / BYXJQG9 / BKTNTR9 / BYY88Y7 / BJMLSD2 / BD5GSZ4 / BM8NHS1 / BP2P6L0 / BMFPHK2 / BL6G4S4</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / PepsiCo Inc / Amazon.com Inc / Amgen Inc / eBay Inc / Merck & Co Inc / Ameren Corp / American Electric Power Company Inc / Walt Disney Co / Entergy Corp / Exelon Corp / Hawaiian Electric Industries Inc / Neurocrine Biosciences Inc / Pfizer Inc / Williams-Sonoma Inc / Novartis AG / Constellation Brands Inc / Netflix Inc / Discovery Inc / Overstock.com Inc / Mirati Therapeutics Inc / Monster Beverage Corp / Deciphera Pharmaceuticals Inc / Revolve Group Inc / ETSY Inc / Farfetch Ltd / Spotify Technology SA / Spire Inc / ViacomCBS Inc / Alphabet Inc / Karuna Therapeutics Inc / Infrastructure and Energy Alternatives Inc / Adagio Therapeutics Inc / Tango Therapeutics Inc / ThredUp Inc / Poshmark Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">11/22/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Amgen Inc: Ownership Timelines & Shareholder Analytics (November 2021)</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">11/22/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Takeaways From Fireside Chat; Focus on SLN360 APOLLO Data in First Quarter 2022; GEMINI-I Data Presentation at ASH</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">03116210 / 462222100</td><td class="leftalignment">Amgen Inc / Ionis Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Myles R. R. Minter / Sarah Schram</td></tr>
<tr class="odd"><td class="leftalignment">11/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Nov 12, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">11/22/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / OGN / AMRX=US / VTRS=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Organon & Co / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregory D. Fraser / Ms. Robyn S. Karnauskas / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">11/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Nov 12: Focus on Tagrisso</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Harry Thomas Da Sephton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">11/21/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Amgen Inc: Investor Targeting - November 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">11/20/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 574</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101 / 603693102</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc / Mink Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Sarah Schram / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">11/19/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">AHA 2021 Recap: Milvexian Effective as Focus Turns to SSP Trial Bleed Rates; REVERSE-IT Hits; Oral PCSK9 Decent Without Food</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">110122108 / 717224109 / 03116210 / 462222100 / 77313F106</td><td class="leftalignment">Bristol-Myers Squibb Co / PhaseBio Pharmaceuticals Inc / Amgen Inc / Ionis Pharmaceuticals Inc / Rocket Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Myles R. R. Minter / Matt Phipps, PHD / Mr. Raju Prasad, PHD / Sami Corwin, PHD / Sarah Schram / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="odd"><td class="leftalignment">11/19/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Week in Review - November 12 to 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">GB0007188757 / CA4509131088 / AU000000CIA2 / US8336351056 / GB0000456144 / US0311621009 / US0341641035 / US0351282068 / US0383361039 / US0394831020 / US0530151036 / US1101221083 / US1564311082 / US1924461023 / US2017231034 / US2310211063 / US3755581036 / US38059T1060 / US4227041062 / US45337C1027 / US4891701009 / US5324571083 / US64125C1099 / US6516391066 / US6703461052 / US67066G1040 / US7170811035 / US75886F1075 / US7782961038 / US7802871084 / US8581191009 / US87612E1064 / US9024941034 / US92532F1003 / US9311421039 / CA13321L1085 / CA59162N1096 / CA5394811015 / CA4296951094 / CA9611485090 / CA85472N1096 / CA90457D1006 / CA4609191032 / CA5649051078 / CA6979001089 / CA78460T1057 / CA8787422044 / CA0679011084 / US9129091081 / CA3039011026 / CA1349211054 / CA8765111064 / US0017441017 / CA3359341052 / CA09950M3003 / CA00762V1094 / US2274831047 / US35671D8570 / AU000000FMG4 / US09062X1037 / BMG169621056 / US20451N1019 / CA98462Y1007 / CA56501R1064 / CA4969024047 / CA5503721063 / CA4436281022 / US1011211018 / CA6445351068 / CA95083R1001 / CA0906971035 / US8666741041 / CA0209361009 / CA32076V1031 / CA2483561072 / GB00B1FW5029 / CA0966311064 / CA29258Y1034 / CA4369131079 / CA3499151080 / GB00B1XZS820 / CA14068G1046 / CA82835P1036 / CA3518581051 / BMG162521014 / US00507V1098 / GB00B2QPKJ12 / CA86828P1036 / US91912E1055 / US1921085049 / IE00B4BNMY34 / US58933Y1055 / CA07317Q1054 / CA00208D4084 / CA66510M2040 / CA0985461049 / JE00B4T3BW64 / US74340W1036 / US95058W1009 / CA54928Q1081 / CA00829Q1019 / AU000000EVN4 / JE00B5TT1872 / US09609G1004 / US98138H1014 / CA78165J1057 / CA55903Q1046 / CA04364G1063 / CA7852461093 / CA3449112018 / CA07380N1042 / CA3807381049 / CA0805581091 / CA9323971023 / CA16141A1030 / CA6752221037 / CA21750U1012 / CA80013R2063 / CA04016A1012 / CA11777Q2099 / CA38045Y1025 / CA6674951059 / CA04682R1073 / US16208T1025 / CA89531J1093 / GB00B11DNM70 / US29355A1079 / US8486371045 / US6974351057 / US08579W1036 / CA5054401073 / US23283R1005 / CA33812R1091 / US60468T1051 / CA46579R1047 / CA65340P1062 / US31189P1021 / US03674X1063 / US11120U1051 / CA92938W2022 / CA68827L1013 / CA30606C1086 / CA5503711080 / US29444U7000 / CA74273V1067 / CA82621K1021 / AU000000S320 / CA0115321089 / CA83179X1087 / CA83125J1049 / CA05329M1041 / US72703H1014 / CA8283631015 / CY0106002112 / CA19239C1068 / AU000000NST8 / CA17040T3001 / CA4991131083 / CA6882811046 / CA8910546032 / US5588681057 / CA31730E1016 / CA89621C1059 / US0441861046 / US15136A1025 / US0138721065 / CA68634K1066 / GB00B67KBV28 / US75134P3038 / CA86816U1066 / US93627C1018 / US7045511000 / CA75601Y1007 / CA9628791027 / CY0103562118 / CA7847301032 / CA15713J1049 / CA53680Q2071 / US68404V1008 / LU1701428291 / CA2960061091 / CA8585221051 / CA46136U1030 / US00191U1025 / US3843135084 / US76029N1063 / US08579X1019 / KYG370921069 / CA38119T8077 / CA13000C2058 / CA72765Q8829 / CA2849025093 / US63253R2013 / AU0000018236 / CA7426943006 / CA33767E2024 / CA57776F4050 / US26614N1028 / CA5625684025 / CA48086P1009 / US2681501092 / CA29446Y5020 / AU0000004772 / CA92625W5072 / FR0013467479 / CA59124U6051 / US82575P1075 / MHY0436Q1098 / CA4220961078 / CA3901437093 / CA36352H1001 / US6544051096 / US03940R1077 / CA70137W1086 / US44862P1093 / US05478C1053 / US7501021056 / CA33843T1084 / CA9004352071 / US3680361090 / CA64782A1075 / US87969B1017 / US03750L1098 / CA36261G1028 / CA65401N1078 / US11135E2037 / CA55292X1087 / AU0000143729 / US00848J1043 / US05356F1057 / CA53227W1059 / CA65532M6062 / CA00791P1071 / CA24874B1085 / GB00BL6K5J42 / CA66979W8429 / US45828L1089 / US0708301041 / US9264001028 / US98955K1043 / US89269P1030 / US9778521024 / US4718711033 / US1374041093 / 116833187</td><td class="leftalignment">Rio Tinto PLC / IAMGOLD Corp / Champion Iron Ltd / Sociedad Quimica y Minera de Chile SA / Antofagasta PLC / Amgen Inc / Andersons Inc / AngloGold Ashanti Ltd / Aptargroup Inc / Archer-Daniels-Midland Co / Automatic Data Processing Inc / Bristol-Myers Squibb Co / Century Aluminum Co / Cognizant Technology Solutions Corp / Commercial Metals Co / Cummins Inc / Gilead Sciences Inc / Gold Fields Ltd / Hecla Mining Co / Incyte Corp / Kennametal Inc / Eli Lilly and Co / Neurocrine Biosciences Inc / Newmont Corporation / Nucor Corp / NVIDIA Corp / Pfizer Inc / Regeneron Pharmaceuticals Inc / Ross Stores Inc / Royal Gold Inc / Steel Dynamics Inc / Target Corp / Tyson Foods Inc / Vertex Pharmaceuticals Inc / Walmart Inc / Cameco Corp / Metro Inc / Loblaw Companies Ltd / High Liner Foods Inc / George Weston Ltd / Stantec Inc / Uni-Select Inc / Intertape Polymer Group Inc / Maple Leaf Foods Inc / Pan American Silver Corp / SNC-Lavalin Group Inc / Teck Resources Ltd / Barrick Gold Corp / United States Steel Corp / Fairfax Financial Holdings Ltd / Canadian Apartment Properties Real Estate Investment Trust / Taseko Mines Ltd / AMN Healthcare Services Inc / First Quantum Minerals Ltd / Boralex Inc / Aecon Group Inc / Cross Country Healthcare Inc / Freeport-McMoRan Inc / Fortescue Metals Group Ltd / Biogen Inc / Bunge Ltd / Compass Minerals International Inc / Yamana Gold Inc / Manulife Financial Corp / Kinross Gold Corp / Lundin Mining Corp / Hudbay Minerals Inc / Boston Properties Inc / New Gold Inc / Wesdome Gold Mines Ltd / Birchcliff Energy Ltd / Sun Communities Inc / Altius Minerals Corp / First Majestic Silver Corp / Denison Mines Corp / Hochschild Mining PLC / Boardwalk Real Estate Investment Trust / Endeavour Silver Corp / Home Capital Group Inc / Fortuna Silver Mines Inc / Anglo American PLC / Capstone Mining Corp / Silvercorp Metals Inc / Franco-Nevada Corp / Brookfield Infrastructure Partners LP / Activision Blizzard Inc / Fresnillo PLC / Superior Plus Corp / Vale SA / Coeur Mining Inc / Accenture PLC / Merck & Co Inc / Baytex Energy Corp / ARC Resources Ltd / Northern Dynasty Minerals Ltd / Bonterra Energy Corp / Glencore PLC / Prologis Inc / Wendys Co / Lucara Diamond Corp / Africa Oil Corp / Evolution Mining Ltd / Centamin PLC / bluebird bio Inc / Workday Inc / Rupert Resources Ltd / MAG Silver Corp / Ascot Resources Ltd / Sabina Gold & Silver Corp / Foran Mining Corp / Bear Creek Mining Corp / Gold Standard Ventures Corp / Belo Sun Mining Corp / Wallbridge Mining Company Ltd / Chartwell Retirement Residences / OceanaGold Corp / Copper Mountain Mining Corp / Sandstorm Gold Ltd / Argonaut Gold Inc / B2Gold Corp / GoGold Resources Inc / NorthWest Healthcare Properties REIT / Athabasca Oil Corp / Chatham Lodging Trust / Trevali Mining Corp / Horizonte Minerals PLC / Enphase Energy Inc / Splunk Inc / Palo Alto Networks Inc / Berry Global Group Inc / Labrador Iron Ore Royalty Corp / CyrusOne Inc / Fission Uranium Corp / Mirati Therapeutics Inc / Ivanhoe Mines Ltd / Nexgen Energy Ltd / Fate Therapeutics Inc / Antero Resources Corp / Brixmor Property Group Inc / WSP Global Inc / Osisko Gold Royalties Ltd / Falco Resources Ltd / Lundin Gold Inc / Equinix Inc / Probe Metals Inc / Sienna Senior Living Inc / South32 Ltd / Alamos Gold Inc / SmartCentres Real Estate Investment Trust / Sleep Country Canada Holdings Inc / Automotive Properties Real Estate Investment Trust / Planet Fitness Inc / Silvercrest Metals Inc / Atalaya Mining PLC / Cogeco Communications Inc / Northern Star Resources Ltd / Chorus Aviation Inc / K92 Mining Inc / Osisko Mining Inc / Torex Gold Resources Inc / Madrigal Pharmaceuticals Inc / Filo Mining Corp / Trilogy Metals Inc / Ashland Global Holdings Inc / Centennial Resource Development Inc / Alcoa Corp / Orla Mining Ltd / Central Asia Metals PLC / Ramaco Resources Inc / Superior Gold Inc / Warrior Met Coal Inc / Peabody Energy Corp / Real Matters Inc / Wheaton Precious Metals Corp / Tharisa PLC / SSR Mining Inc / CES Energy Solutions Corp / Lithium Americas Corp / OptiNose Inc / Nexa Resources SA / Ero Copper Corp / Stelco Holdings Inc / Invesque Inc / ASGN Inc / GrafTech International Ltd / Replimune Group Inc / Berry Corporation (Bry) / Galaxy Digital Holdings Ltd / Golden Star Resources Ltd / Calibre Mining Corp / Platinum Group Metals Ltd / Eldorado Gold Corp / NAK Kazatomprom AO / Nickel Mines Ltd / PRO Real Estate Investment Trust / FirstService Corp / Maverix Metals Inc / Dupont De Nemours Inc / Mandalay Resources Corp / Josemaria Resources Inc / Dynatrace Inc / Equinox Gold Corp / Adriatic Metals PLC / Victoria Gold Corp / Constellium SE / Metalla Royalty & Streaming Ltd / Sibanye Stillwater Ltd / Atlas Corp / Headwater Exploration Inc / Great Bear Resources Ltd / Galiano Gold Inc / 9 Meters Biopharma Inc / Arch Resources Inc / Parkland Corp / Hycroft Mining Holding Corporation / Azek Company Inc / Rackspace Technology Inc / Flagship Communities Real Estate Investment Trust / Turquoise Hill Resources Ltd / Gatos Silver Inc / New Pacific Metals Corp / Telos Corp / Apartment Income REIT Corp / G Mining Ventures Corp / Nickel 28 Capital Corp / Broadstone Net Lease Inc / MDA Ltd / Sunrise Energy Metals Ltd / Agiliti Inc / Aveanna Healthcare Holdings Inc / LifeWorks Inc / Nomad Royalty Company Ltd / Advantage Energy Ltd / dentalcorp Holdings Ltd / Endeavour Mining PLC / Nouveau Monde Graphite Inc / Integral Ad Science Holding Corp / Bath & Body Works Inc / Victoria's Secret & Co / Zevia PBC / Traeger Inc / Wolfspeed Inc / Jasper Therapeutics Inc / Candel Therapeutics Inc / NextSource Materials Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Chile / Cayman Islands / Cyprus / France / United Kingdom / Ireland / Kazakhstan / Luxembourg / United States / South Africa / Marshall Islands / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">11/19/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--Nov. 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">ACA / AMGN / ATRC / CGEN / CSII / EPIX / GE / ICPT / INCY / MBIO / RAD / WMT / ONEM.O / RLMD / FMTX / BWAY.O / SSNC.O / CUE / NKTR / CCRN.O / ABMD.O / ICAD.O / AMED.O / EXAS.O / ANGN.O / PHAR.O / BIIB / 478160104 / 00846U101 / 868168105 / NUVA.O / GOOG.O / CMMB / FREQ / DXCM.O / LHCG.O / MBRX.O / CBAY / HUMA / PODD.O / 02043Q107 / TNDM.O / ENSG.O / 483548103 / MRNA.O / VERO / BLRX / ADUS.O / GLAXOSM.LG / AGIO / FATE.O / TRVN / MDWD.O / 02005N100 / RXDX.O / CASI.O / VBLT.O / EVH / CFMS.O / CRBP.O / 100063846 / NVTA.K / EDIT / MDGL / CRSP / VREX / URGN.O / PLXP.O / IOVA / KALA.O / MTEM.O / VERU.O / SVRA.O / 720795103 / FIXX.O / MIST.O / TMDX / IDYA.O / DMTK.O / PNTG.O / ETNB.O / GMDA / BCYC / ZNTL.O / NMTR.O / NNOX / CMPS.OQ / HGEN.O / PMVP / AYLA / PRTG.O / SNSE.O / IMCR.O / VIRX.O / NKTX.O / 03823M100 / GANX.O / US00449L1026 / RZLT.O / SERA.OQ / ATXS.O / MDNA.O / JSPR.O</td><td class="leftalignment">Arcosa Inc / Amgen Inc / AtriCure Inc / Compugen Ltd / Cardiovascular Systems Inc / ESSA Pharma Inc / General Electric Co / Intercept Pharmaceuticals Inc / Incyte Corp / Mustang Bio Inc / Rite Aid Corp / Walmart Inc / 1Life Healthcare Inc / Relmada Therapeutics Inc / Forma Therapeutics Holdings Inc / Brainsway Ltd / SS&C Technologies Holdings Inc / Cue Biopharma Inc / Nektar Therapeutics / Cross Country Healthcare Inc / ABIOMED Inc / ICAD Inc / Amedisys Inc / Exact Sciences Corp / Angion Biomedica Corp / Pharming Group NV / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / NuVasive Inc / Alphabet Inc / Chemomab Therapeutics Ltd / Frequency Therapeutics Inc / Dexcom Inc / LHC Group Inc / Moleculin Biotech Inc / Cymabay Therapeutics Inc / Humacyte Inc / Insulet Corp / Alnylam Pharmaceuticals Inc / Tandem Diabetes Care Inc / Ensign Group Inc / Kaman Corp / Moderna Inc / Venus Concept Inc / BioLine RX Ltd / Addus Homecare Corp / Glaxo Smithkline Consumer Nigeria PLC / Agios Pharmaceuticals Inc / Fate Therapeutics Inc / Trevena Inc / Mediwound Ltd / Ally Financial Inc / Prometheus Biosciences Inc / CASI Pharmaceuticals Inc / Vascular Biogenics Ltd / Evolent Health Inc / Conformis Inc / Corbus Pharmaceuticals Holdings Inc / Truist Financial Corp / Invitae Corp / Editas Medicine Inc / Madrigal Pharmaceuticals Inc / CRISPR Therapeutics AG / Varex Imaging Corp / Urogen Pharma Ltd / PLx Pharma Inc / Iovance Biotherapeutics Inc / Kala Pharmaceuticals Inc / Molecular Templates Inc / Veru Inc / Savara Inc / Pieris Pharmaceuticals Inc / Homology Medicines Inc / Milestone Pharmaceuticals Inc / Transmedics Group Inc / IDEAYA Biosciences Inc / DermTech Inc / Pennant Group Inc / 89Bio Inc / Gamida Cell Ltd / Bicycle Therapeutics PLC / Zentalis Pharmaceuticals Inc / 9 Meters Biopharma Inc / Nano-X Imaging Ltd / Compass Pathways PLC / Humanigen Inc / PMV Pharmaceuticals Inc / Ayala Pharmaceuticals Inc / Portage Biotech Inc / Sensei Biotherapeutics Inc / Immunocore Holdings PLC / Viracta Therapeutics Inc / Nkarta Inc / Applied Minerals Inc / Gain Therapeutics Inc / Achilles Therapeutics PLC / Rezolute Inc / Sera Prognostics Inc / Astria Therapeutics Inc / Medicenna Therapeutics Corp / Jasper Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / United Kingdom / Israel / Nigeria / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/19/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended November 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">11/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">11/19/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - November 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">64</td><td class="leftalignment">US8336351056 / US0311621009 / US0383361039 / US1101221083 / US1270971039 / US1924461023 / US25179M1036 / US30231G1022 / US3755581036 / US4062161017 / US45337C1027 / US5324571083 / US64125C1099 / US6745991058 / US7170811035 / US7237871071 / US75281A1097 / US75886F1075 / US7782961038 / AN8068571086 / US81211K1007 / US89531P1057 / US92532F1003 / CA9611485090 / US1667641005 / US5658491064 / US20825C1045 / US09062X1037 / US42809H1077 / US58933Y1055 / US09609G1004 / US98138H1014 / US34964C1062 / US6974351057 / US08579W1036 / US60468T1051 / US03674X1063 / US2057683029 / GB00BDSFG982 / US87484T1088 / US26614N1028 / US69047Q1022 / US05478C1053 / CA33843T1084 / US62955J1034 / US1651677353 / US45828L1089 / US1374041093</td><td class="leftalignment">Sociedad Quimica y Minera de Chile SA / Amgen Inc / Aptargroup Inc / Bristol-Myers Squibb Co / Coterra Energy Inc / Cognizant Technology Solutions Corp / Devon Energy Corp / Exxon Mobil Corp / Gilead Sciences Inc / Halliburton Co / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Occidental Petroleum Corp / Pfizer Inc / Pioneer Natural Resources Co / Range Resources Corp / Regeneron Pharmaceuticals Inc / Ross Stores Inc / Schlumberger NV / Sealed Air Corp / Trex Company Inc / Vertex Pharmaceuticals Inc / George Weston Ltd / Chevron Corp / Marathon Oil Corp / Conocophillips / Biogen Inc / Hess Corp / Merck & Co Inc / bluebird bio Inc / Workday Inc / Fortune Brands Home & Security Inc / Palo Alto Networks Inc / Berry Global Group Inc / Mirati Therapeutics Inc / Antero Resources Corp / Comstock Resources Inc / TechnipFMC PLC / Talos Energy Inc / Dupont De Nemours Inc / Ovintiv Inc / Azek Company Inc / Flagship Communities Real Estate Investment Trust / Nov Inc / Chesapeake Energy Corp / Integral Ad Science Holding Corp / Candel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Chile / United Kingdom / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">11/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">US Healthcare Reform: Impact of Build Back Better on global branded pharma</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">4502.T / 4503.T / BMY.N / JNJ.N / LLY.N / PFE.N / RECI.MI / AZN.L / SASY.PA / ROG.S / LUN.CO / NOVOB.CO / NOVN.S / MRCG.DE / 4768.T / GSK.L / UCB.BR / AMGN.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / BMRN.OQ / BIIB.OQ / IPN.PA / TEVA.N / ORNBV.HE / ALM.MC / GRLS.MC / BAYGN.DE / ABBV.N / VIFN.S</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / Merck KGaA / Otsuka Corp / GlaxoSmithKline PLC / Ucb SA / Amgen Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Biomarin Pharmaceutical Inc / Biogen Inc / Ipsen SA / Teva Pharmaceutical Industries Ltd / Orion Oyj / Almirall SA / Grifols SA / Bayer AG / Abbvie Inc / Vifor Pharma AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Israel / Italy / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Herr. Christoph Gretler / Mr. Matt S. Miksic / Mr. Fumiyoshi Sakai / Mr. Tiago Fauth</td></tr>
<tr class="odd"><td class="leftalignment">11/18/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">A Swing and a Miss - Biotech Fund Flows Turn Negative</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">11/18/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Bullish on BioPharma as We Emerge From COVID-19: Finding Alpha in the Sector That Saved the World</td><td class="leftalignment">English</td><td class="rightalignment">74</td><td class="leftalignment">US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US09062X1037 / US58933Y1055 / US60468T1051 / US1374041093</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Merck & Co Inc / Mirati Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">11/18/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Initiating at Mkt: Biotech’s Bellwether but Emerging Competition Gives Us Pause</td><td class="leftalignment">English</td><td class="rightalignment">50</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">11/18/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Initiating at OP: ‘Greatness Knows Itself’; Adagrasib to Reign Supreme in G12C</td><td class="leftalignment">English</td><td class="rightalignment">44</td><td class="leftalignment">US60468T1051 / US0311621009</td><td class="leftalignment">Mirati Therapeutics Inc / Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">11/16/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABBV-US -  Dividend Quality Analysis, for the period ended November 15,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ABBV.K / BMY / LLY / PFE / GILD.O / AMGN.O / GSK / NBIX.O / AZN.O / BIIB.O</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / GlaxoSmithKline PLC / Neurocrine Biosciences Inc / AstraZeneca PLC / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">11/16/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Third-Quarter Earnings; Focus on SLN360 SAD Data From APOLLO in First Quarter 2022; SLN124 GEMINI-I Data at ASH in December</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 462222100</td><td class="leftalignment">Amgen Inc / Ionis Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Myles R. R. Minter / Sarah Schram</td></tr>
<tr class="odd"><td class="leftalignment">11/16/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / HD=US / MCD=US / WEN=US / DT=US / CMA=US / AMT=US / EOG=US / CONE=US / CCI=US / PB=US / UMPQ=US / ADS=US / TNL=US / WTFC=US / SWIM=US / CBRL=US / DRI=US / DRH=US / PDM=US / SBAC=US / WAL=US / HTH=US / HIW=US / ABCB=US / CUZ=US / FBK=US / DIN=US / OGN / TCBI=US / FHN=US / NUVA=US / TXRH=US / PLAY=US / WMG=US / DENN=US / CMG=US / MA=US / SIX=US / AMRX=US / TAST=US / QSR=US / NMTR=US / WH=US / JACK=US / HGV=US / LPLA=US / RLJ=US / VAC=US / SPLK=US / GMED=US / NDLS=US / FATE=US / LOCO=US / BVH=US / SHAK=US / WING=US / SPNE=US / SWCH=US / MBIN=US / BTAI=US / OSMT=US / VTRS=US / AVAH=US / 67421J108 / DBRG=US / SNPO=US / ROIV=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / McDonald's Corp / Wendys Co / Dynatrace Inc / Comerica Inc / American Tower Corp / EOG Resources Inc / CyrusOne Inc / Crown Castle International Corp / Prosperity Bancshares Inc / Umpqua Holdings Corp / Alliance Data Systems Corp / Travel + Leisure Co / Wintrust Financial Corp / Latham Group Inc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Diamondrock Hospitality Co / Piedmont Office Realty Trust Inc / SBA Communications Corp / Western Alliance Bancorp / Hilltop Holdings Inc / Highwoods Properties Inc / Ameris Bancorp / Cousins Properties Inc / FB Financial Corp / Dine Brands Global Inc / Organon & Co / Texas Capital Bancshares Inc / First Horizon Corp / NuVasive Inc / Texas Roadhouse Inc / Dave & Buster's Entertainment Inc / Warner Music Group Corp / Denny's Corp / Chipotle Mexican Grill Inc / Mastercard Inc / Six Flags Entertainment Corp / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / 9 Meters Biopharma Inc / Wyndham Hotels & Resorts Inc / Jack in the Box Inc / Hilton Grand Vacations Inc / LPL Financial Holdings Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Splunk Inc / Globus Medical Inc / Noodles & Co / Fate Therapeutics Inc / El Pollo Loco Holdings Inc / Bluegreen Vacations Holding Corp / Shake Shack Inc / Wingstop Inc / SeaSpine Holdings Corp / Switch Inc / Merchants Bancorp / BioXcel Therapeutics Inc / Osmotica Pharmaceuticals PLC / Viatris Inc / Aveanna Healthcare Holdings Inc / Oatly Group AB / DigitalBridge Group Inc / Snap One Holdings Corp / Roivant Sciences Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Ireland / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Next-Gen Interleukin Primer - Cranking Up the Thermostat as Winter Weather Approaches</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">5671735 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2457864 / 2471950 / 2730190 / 7103065 / 2982924 / B6RS2B3 / BCZS820 / BFDV8K0 / BBPK0J0 / B7F2TY6 / BFZNYB7 / BK0VHF6 / BDHF4K6 / BZBY005 / BZ1LFB2 / BKS3SM8 / BMQ5T49 / BGCYWN8 / BWFKZT2 / BKVDFF7 / BG31GH0 / BJXBP30 / BYQHPK7 / BYYWPW6 / BJ9NFQ3 / BWY52P3 / BL71K91 / BDZ30Q0 / BWY4XV3 / BN2R582 / BDD1B07 / BMPRZV5 / BMC5RV6 / BF3NP05 / BMDJ397 / BN2RM92 / BLF0CW7 / BP7KZP7 / BMW5084 / BNLYJ60 / BNLYBF3 / BMVBZF5 / BP2P6L0 / BMV6Y64</td><td class="leftalignment">Sanofi SA / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / ImmunoGen Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Novartis AG / Spectrum Pharmaceuticals Inc / Clovis Oncology Inc / Fate Therapeutics Inc / MacroGenics Inc / Mirati Therapeutics Inc / Puma Biotechnology Inc / Allogene Therapeutics Inc / IDEAYA Biosciences Inc / CRISPR Therapeutics AG / Merus NV / Deciphera Pharmaceuticals Inc / IGM Biosciences Inc / Zentalis Pharmaceuticals Inc / Xencor Inc / Cellectis SA / Oric Pharmaceuticals Inc / Y-mAbs Therapeutics Inc / Turning Point Therapeutics Inc / Zymeworks Inc / Beigene Ltd / Neoleukin Therapeutics Inc / Blueprint Medicines Corp / Revolution Medicines Inc / Arvinas Inc / Adaptimmune Therapeutics PLC / Relay Therapeutics Inc / Rubius Therapeutics Inc / Kymera Therapeutics Inc / Adicet Bio Inc / Mersana Therapeutics Inc / Bolt Biotherapeutics Inc / Rain Therapeutics Inc / Repare Therapeutics Inc / Monte Rosa Therapeutics Inc / PMV Pharmaceuticals Inc / Imago BioSciences Inc / Erasca Inc / Immuneering Corp / Tango Therapeutics Inc / Xilio Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Paul Jeng, Ph.D. / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">11/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MOLN.S: Molecular Partners - COVID DARPin shows no benefit in hospitalised patients. Ambulatory data due 1Q22</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MOLN.S / AMGN.OQ / REGN.OQ</td><td class="leftalignment">Molecular Partners AG / Amgen Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">11/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4151.T: Kyowa Kirin - Revising down forecasts, initial bullish view now requires revisions</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">4151.T / AMGN.OQ</td><td class="leftalignment">Kyowa Kirin Co Ltd / Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">11/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4151.T: 協和キリン - 業績予想下方修正：従来見通しの修正が不可避となった</td><td class="leftalignment">Japanese</td><td class="rightalignment">10</td><td class="leftalignment">4151.T / AMGN.OQ</td><td class="leftalignment">Kyowa Kirin Co Ltd / Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">11/16/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Will Amgen Inc Deliver Long-Term Returns?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="odd"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for AMGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Nov 5, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">AMGN.OQ - Event Transcript of Amgen Inc conference call, Nov. 15, 2021 / 2:15PM ET</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / OGN / AMRX=US / VTRS=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Organon & Co / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregory D. Fraser / Ms. Robyn S. Karnauskas / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Argus Research Corporation</td><td class="leftalignment">Argus Analyst Report, AMGN</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / COMPANY UPDATE / COMPANY REPORT / ESTIMATE CHANGES</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David H. Toung</td></tr>
<tr class="even"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">AAPL / AMGN / AMT / ATRC / AXP / AZO / CCI / CGEN / CHTR / CSII / CSL / DG / DLTR / DM / EL / FOCS / GS / INCY / LOW / MSFT / NET / NKE / ORLY / PX.N / ROK / SBUX / SPB / T / TH / V / WH / AMZN.O / CMCSA.O / CHKP.O / EW / CSCO.O / NVDA.O / ADBE.O / RDWR / SQ / AKAM / MPWR.O / VECO.O / RLMD / IART.O / FMTX / ADI.O / EQIX / VZ / NFLX / PLUG.O / UTHR.O / TXN.O / AYI / MRVL.O / AVGO.O / NDAQ / NKTR / ABMD.O / TEAM.O / 478160104 / DPZ / GOOG.O / CMMB / SPGI / DXCM.O / CCOI / XPO / HUMA / PODD.O / LULU / ULTA / TNDM.O / VERO / NXPI.O / ENPH.O / FB.O / CG.O / WDAY / TMUS / PANW.O / WIX.O / RXDX.O / GDDY.K / EDIT / TTD.O / CRSP / HLNE.O / IOVA / ROKU.O / MDB.O / EGHT.K / ZS.O / CBOE.K / LOVE / TMDX / FSLY / CRWD.O / FVRR.K / BCYC / ZNTL.O / CMPS.OQ / HGEN.O / PMVP / STEP.O / GCMG.O / NKTX.O / US00449L1026 / RZLT.O / MDNA.O</td><td class="leftalignment">Apple Inc / Amgen Inc / American Tower Corp / AtriCure Inc / American Express Co / Autozone Inc / Crown Castle International Corp / Compugen Ltd / Charter Communications Inc / Cardiovascular Systems Inc / Carlisle Companies Inc / Dollar General Corp / Dollar Tree Inc / Desktop Metal Inc / Estee Lauder Companies Inc / Focus Financial Partners Inc / Goldman Sachs Group Inc / Incyte Corp / Lowe's Companies Inc / Microsoft Corp / Cloudflare Inc / Nike Inc / O'Reilly Automotive Inc / P10 Inc / Rockwell Automation Inc / Starbucks Corp / Spectrum Brands Holdings Inc / AT&T Inc / Target Hospitality Corp / Visa Inc / Wyndham Hotels & Resorts Inc / Amazon.com Inc / Comcast Corp / Check Point Software Technologies Ltd / Edwards Lifesciences Corp / Cisco Systems Inc / NVIDIA Corp / Adobe Inc / Radware Ltd / Block Inc / Akamai Technologies Inc / Monolithic Power Systems Inc / Veeco Instruments Inc / Relmada Therapeutics Inc / Integra Lifesciences Holdings Corp / Forma Therapeutics Holdings Inc / Analog Devices Inc / Equinix Inc / Verizon Communications Inc / Netflix Inc / Plug Power Inc / United Therapeutics Corp / Texas Instruments Inc / Acuity Brands Inc / Marvell Technology Inc / Broadcom Inc / Nasdaq Inc / Nektar Therapeutics / ABIOMED Inc / Atlassian Corporation PLC / Johnson & Johnson / Domino's Pizza Inc / Alphabet Inc / Chemomab Therapeutics Ltd / S&P Global Inc / Dexcom Inc / Cogent Communications Holdings Inc / XPO Logistics Inc / Humacyte Inc / Insulet Corp / Lululemon Athletica Inc / Ulta Beauty Inc / Tandem Diabetes Care Inc / Venus Concept Inc / NXP Semiconductors NV / Enphase Energy Inc / Meta Platforms Inc / Carlyle Group Inc / Workday Inc / T-Mobile US Inc / Palo Alto Networks Inc / Wix.Com Ltd / Prometheus Biosciences Inc / GoDaddy Inc / Editas Medicine Inc / Trade Desk Inc / CRISPR Therapeutics AG / Hamilton Lane Inc / Iovance Biotherapeutics Inc / Roku Inc / MongoDB Inc / 8x8 Inc / Zscaler Inc / Cboe Global Markets Inc / Lovesac Co / Transmedics Group Inc / Fastly Inc / CrowdStrike Holdings Inc / Fiverr International Ltd / Bicycle Therapeutics PLC / Zentalis Pharmaceuticals Inc / Compass Pathways PLC / Humanigen Inc / PMV Pharmaceuticals Inc / StepStone Group Inc / GCM Grosvenor Inc / Nkarta Inc / Achilles Therapeutics PLC / Rezolute Inc / Medicenna Therapeutics Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Amgen(AMGN) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">031162100</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">JNJ Move Provides Valuation Perspective</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AMGN / JNJ.N / AMGN.OQ / 478160104</td><td class="leftalignment">Amgen Inc / Johnson & Johnson / Amgen Inc / Johnson & Johnson</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="odd"><td class="leftalignment">11/15/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - November 15, 2021</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AFL.N / AIG.N / ALV.N / CB.N / CCI.N / CL.N / CP.TO / EDP.LS / EOG.N / F.N / FSR.N / GM.N / MSFT.O / NA / NSC.N / PFE.N / T.N / VC.N / PXD.N / GILD.O / TEN.N / WLL.N / AMGN.O / INCY.O / THC.N / FER.MC / CNR.TO / DUK.N / BWA.N / LEA.N / FE.N / DISH.O / CSX.N / UNP.N / NICE.O / DV.N / MRO.N / PCG.N / PAA.N / DVN.N / EPC.N / SBAC.O / AMT.N / JAZZ.O / CONE.O / MTG.N / RDN.N / VZ.N / LNC.N / APH.N / RRC.N / EQT.N / V.N / OKE.N / AXL.N / AWK.N / IG.MI / EPAY.O / AJG.N / REGN.O / VRTX.O / SRG.MI / PRU.N / SM.N / TEL.N / GFI.N / COP.N / CPE.N / ST.N / SWN.N / SR.N / CRC.N / PEGA.OQ / PLUG.OQ / GPN.N / LIFE.O / CASY.O / ACGL.O / PAAS.O / EQIX.O / ATDb.TO / BIIB.O / DPM.TO / EDV.TO / TRN.MI / DLR.N / ACAD.O / 416515104 / FIS.N / CCOI.O / MA.N / EHTH.O / AON.N / CLR.N / DAN.N / NOG.A / EDPR.LS / PHR.N / PKI.TO / MSP.N / MTOR.N / MTDR.N / SRPT.O / PANW.N / FFHu.TO / FANG.O / ABBV.N / KPT.TO / TSLA.N / TMUS.N / PTCT.O / 81762P102 / ESNT.N / XNCR.OQ / ITCI.O / SAGE.OQ / HQY.OQ / NMIH.O / NEWR.N / GLPG.O / TDOC.N / PYPL.OQ / RGNX.O / SPGI.N / TTD.O / ADNT.N / AQN.N / UNIT.O / CDEV.O / ESTE.N / WOW.N / ATNX.O / SAIL.N / APTV.N / SMAR.N / VRCA.OQ / ITRM.O / OPRX.OQ / VNE.N / HCAT.OQ / GMAB.O / CRNC.OQ / PNTG.OQ / IGMS.O / OAS.OQ / NKLA.OQ / APA.OQ / FOUR.N / NRIX.OQ / RXT.OQ / GOCO.O / IBEX.O / PLTR.N / AEP.OQ / SPRB.OQ / BSY.O / GATO.N / GDRX.O / MCFE.OQ / RIDE.OQ / MAX.N / TLMD.OQ / LSPD.N / PUBM.O / TIXT.TO / AFRM.O / NUVB.N / CHK.OQ / OLO.N / PATH.N / PSFE.N / TSP.OQ / TFPM.TO / FLYW.O / BHG.N / XMTR.OQ / TASK.O / TRMR.OQ / EVCM.O / NABL.N / RYAN.N / TWKS.OQ / GTLB.OQ / ROCC.O</td><td class="leftalignment">Aflac Inc / American International Group Inc / Autoliv Inc / Chubb Ltd / Crown Castle International Corp / Colgate-Palmolive Co / Canadian Pacific Railway Ltd / EDP Energias de Portugal SA / EOG Resources Inc / Ford Motor Co / Fisker Inc / General Motors Co / Microsoft Corp / National Bank of Canada / Norfolk Southern Corp / Pfizer Inc / AT&T Inc / Visteon Corp / Pioneer Natural Resources Co / Gilead Sciences Inc / Tenneco Inc / Whiting Petroleum Corp / Amgen Inc / Incyte Corp / Tenet Healthcare Corp / Ferrovial SA / Canadian National Railway Co / Duke Energy Corp / Borgwarner Inc / Lear Corp / FirstEnergy Corp / DISH Network Corp / CSX Corp / Union Pacific Corp / Nice Ltd / DoubleVerify Holdings Inc / Marathon Oil Corp / PG&E Corp / Plains All American Pipeline LP / Devon Energy Corp / Edgewell Personal Care Co / SBA Communications Corp / American Tower Corp / Jazz Pharmaceuticals PLC / CyrusOne Inc / MGIC Investment Corp / Radian Group Inc / Verizon Communications Inc / Lincoln National Corp / Amphenol Corp / Range Resources Corp / EQT Corp / Visa Inc / ONEOK Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Italgas SpA / Bottomline Technologies Inc / Arthur J Gallagher & Co / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Snam SpA / Prudential Financial Inc / SM Energy Co / TE Connectivity Ltd / Gold Fields Ltd / Conocophillips / Callon Petroleum Co / Sensata Technologies Holding PLC / Southwestern Energy Co / Spire Inc / California Resources Corp / Pegasystems Inc / Plug Power Inc / Global Payments Inc / aTyr Pharma Inc / Caseys General Stores Inc / Arch Capital Group Ltd / Pan American Silver Corp / Equinix Inc / Alimentation Couche-Tard Inc / Biogen Inc / Dundee Precious Metals Inc / Endeavour Mining PLC / Terna Rete Elettrica Nazionale SpA / Digital Realty Trust Inc / ACADIA Pharmaceuticals Inc / Hartford Financial Services Group Inc / Fidelity National Information Services Inc / Cogent Communications Holdings Inc / Mastercard Inc / eHealth Inc / Aon PLC / Continental Resources Inc / Dana Inc / Northern Oil and Gas Inc / EDP Renovaveis SA / Phreesia Inc / Parkland Corp / Datto Holding Corp / Meritor Inc / Matador Resources Co / Sarepta Therapeutics Inc / Palo Alto Networks Inc / Fairfax Financial Holdings Ltd / Diamondback Energy Inc / Abbvie Inc / KP Tissue Inc / Tesla Inc / T-Mobile US Inc / PTC Therapeutics Inc / ServiceNow Inc / Essent Group Ltd / Xencor Inc / Intra-Cellular Therapies Inc / SAGE Therapeutics Inc / Healthequity Inc / NMI Holdings Inc / New Relic Inc / Galapagos NV / Teladoc Health Inc / PayPal Holdings Inc / Regenxbio Inc / S&P Global Inc / Trade Desk Inc / Adient PLC / Algonquin Power & Utilities Corp / Uniti Group Inc / Centennial Resource Development Inc / Earthstone Energy Inc / WideOpenWest Inc / Athenex Inc / SailPoint Technologies Holdings Inc / Aptiv PLC / Smartsheet Inc / Verrica Pharmaceuticals Inc / Iterum Therapeutics PLC / OPTIMIZERx Corp / Veoneer Inc / Health Catalyst Inc / Genmab A/S / Cerence Inc / Pennant Group Inc / IGM Biosciences Inc / Oasis Petroleum Inc / Nikola Corp / APA Corp (US) / Shift4 Payments Inc / Nurix Therapeutics Inc / Rackspace Technology Inc / Gohealth Inc / Ibex Ltd / Palantir Technologies Inc / American Electric Power Company Inc / Spruce Biosciences Inc / Bentley Systems Inc / Gatos Silver Inc / Goodrx Holdings Inc / Mcafee Corp / Lordstown Motors Corp / Mediaalpha Inc / Soc Telemed Inc / Lightspeed Commerce Inc / PubMatic Inc / Telus International Cda Inc / Affirm Holdings Inc / Nuvation Bio Inc / Chesapeake Energy Corp / Olo Inc / UiPath Inc / Paysafe Ltd / TuSimple Holdings Inc / Triple Flag Precious Metals Corp / Flywire Corp / Bright Health Group Inc / Xometry Inc / Taskus Inc / Tremor International Ltd / EverCommerce Inc / N-Able Inc / Ryan Specialty Group Holdings Inc / Thoughtworks Holding Inc / GitLab Inc / Ranger Oil Corp</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Denmark / Spain / United Kingdom / Ireland / Israel / Italy / Portugal / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">AZN.L: AstraZeneca - 3Q21 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">AZN.L / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / GSK.L / AMGN.OQ / REGN.OQ / GILD.OQ / BMRN.OQ / VRTX.OQ / BIIB.OQ / BAYGN.DE</td><td class="leftalignment">AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Amgen Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Bayer AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Harry Thomas Da Sephton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">11/14/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Amgen Inc: Peer Group Analytics - Q3 FY2021</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">11/13/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / REGN.O / LIFE.O / ATNX.O / GMAB.O / NRIX.OQ / NUVB.N</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc / aTyr Pharma Inc / Athenex Inc / Genmab A/S / Nurix Therapeutics Inc / Nuvation Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="odd"><td class="leftalignment">11/13/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 573</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101 / 603693102</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc / Mink Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">11/12/2021</td><td class="leftalignment">Validea</td><td class="leftalignment">Validea Guru Analysis Report for AMGN. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">031162100</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / QUANANTITATIVE/TECH RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">11/12/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended November 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">11/12/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Starting in 30 MINS: 10:00 am ET, We're Talking PAH Market, Merck/Acceleron, and $5B+ Opportunity for New Treatments</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK.N / 5671735 / 0989529 / 2023607 / 2778844 / 2730190 / 7103065 / BHC8X90 / BNKGXX2</td><td class="leftalignment">Merck & Co Inc / Sanofi SA / AstraZeneca PLC / Amgen Inc / Merck & Co Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Novo Nordisk A/S / Verve Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Debjit Chattopadhyay, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">11/12/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">11/12/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fireside Chat With Management Team on Monday, November 22, 11:00 a.m. ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">03116210 / 462222100</td><td class="leftalignment">Amgen Inc / Ionis Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Myles R. R. Minter / Sarah Schram</td></tr>
<tr class="odd"><td class="leftalignment">11/12/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">AHA Preview: Flip the REVERSE-IT Card for Bentracimab; First Look at Oral Factor XIa and PCSK9 Inhibitors; RP-A501 Danon Data</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">110122108 / 717224109 / 03116210 / 462222100 / 77313F106</td><td class="leftalignment">Bristol-Myers Squibb Co / PhaseBio Pharmaceuticals Inc / Amgen Inc / Ionis Pharmaceuticals Inc / Rocket Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Myles R. R. Minter / Mr. Raju Prasad, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers / Sarah Schram / Sami Corwin, PHD</td></tr>
<tr class="even"><td class="leftalignment">11/11/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Healthy Biotech Inflows Continue for a Third Straight Week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">11/11/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK=US / LLY=US / LSI=US / AMGN=US / BMY=US / DIS=US / MCD=US / WEN=US / PLD=US / BLDP=US / AMZN=US / GILD=US / PEB=US / REI=US / PLUG=US / H=US / V=US / MTN=US / ENR=US / VRM=US / MAR=US / TNL=US / HLT=US / AKR=US / HUM=US / EQR=US / AMK=US / SWIM=US / CBRL=US / CHH=US / DRI=US / DRH=US / MAIN=US / NTST=US / PDM=US / SGMO=US / SHOP=US / FORG=US / VRTX=US / WIX=US / FOUR=US / AEL=US / GPN=US / HIW=US / SNV=US / ADC=US / FRT=US / INTA=US / OHI=US / SRC=US / REG=US / ENSG=US / BRX=US / DIN=US / ACVA=US / MQ / CRD.B=US / APP=US / SHO=US / PLAY=US / DENN=US / ESMT=US / SCPL=US / CMG=US / HST=US / MA=US / RPRX=US / GPRE=US / OC=US / CPRX=US / TAST=US / QSR=US / LUMN=US / WH=US / JACK=US / UTZ=US / BLND=US / HGV=US / SBRA=US / APTS=US / RLJ=US / VAC=US / ZNGA=US / SPLK=US / MEIP=US / RHP=US / NDLS=US / VRNS=US / 00770K202 / LOCO=US / AFMD=US / BVH=US / SHAK=US / CHCT=US / WING=US / MCFT=US / SQ=US / WVE=US / PK=US / PLYA=US / OKTA=US / ROOT=US / BTAI=US / AMTB=US / LSPD=US / ARQT=US / TSHA / DASH=US / AFRM=US / SHLS=US / HLLY=US / OLPX=US / GTLB=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Life Storage Inc / Amgen Inc / Bristol-Myers Squibb Co / Walt Disney Co / McDonald's Corp / Wendys Co / Prologis Inc / Ballard Power Systems Inc / Amazon.com Inc / Gilead Sciences Inc / Pebblebrook Hotel Trust / Ring Energy Inc / Plug Power Inc / Hyatt Hotels Corp / Visa Inc / Vail Resorts Inc / Energizer Holdings Inc / Vroom Inc / Marriott International Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Acadia Realty Trust / Humana Inc / Equity Residential / AssetMark Financial Holdings Inc / Latham Group Inc / Cracker Barrel Old Country Store Inc / Choice Hotels International Inc / Darden Restaurants Inc / Diamondrock Hospitality Co / Main Street Capital Corp / Netstreit Corp / Piedmont Office Realty Trust Inc / Sangamo Therapeutics Inc / Shopify Inc / ForgeRock Inc / Vertex Pharmaceuticals Inc / Wix.Com Ltd / Shift4 Payments Inc / American Equity Investment Life Holding Co / Global Payments Inc / Highwoods Properties Inc / Synovus Financial Corp / Agree Realty Corp / Federal Realty Investment Trust / Intapp Inc / Omega Healthcare Investors Inc / Spirit Realty Capital Inc / Regency Centers Corp / Ensign Group Inc / Brixmor Property Group Inc / Dine Brands Global Inc / ACV Auctions Inc / Marqeta Inc / Crawford & Co / Applovin Corp / Sunstone Hotel Investors Inc / Dave & Buster's Entertainment Inc / Denny's Corp / EngageSmart Inc / Sciplay Corp / Chipotle Mexican Grill Inc / Host Hotels & Resorts Inc / Mastercard Inc / Royalty Pharma PLC / Green Plains Inc / Owens Corning / Catalyst Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Lumen Technologies Inc / Wyndham Hotels & Resorts Inc / Jack in the Box Inc / UTZ Brands Inc / Blend Labs Inc / Hilton Grand Vacations Inc / Sabra Health Care REIT Inc / Preferred Apartment Communities Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Zynga Inc / Splunk Inc / MEI Pharma Inc / Ryman Hospitality Properties Inc / Noodles & Co / Varonis Systems Inc / Aemetis Inc / El Pollo Loco Holdings Inc / Affimed NV / Bluegreen Vacations Holding Corp / Shake Shack Inc / Community Healthcare Trust Inc / Wingstop Inc / Mastercraft Boat Holdings Inc / Block Inc / WAVE Life Sciences Ltd / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Okta Inc / Root Inc / BioXcel Therapeutics Inc / Amerant Bancorp Inc / Lightspeed Commerce Inc / Arcutis Biotherapeutics Inc / Taysha Gene Therapies Inc / DoorDash Inc / Affirm Holdings Inc / Shoals Technologies Group Inc / Holley Inc / Olaplex Holdings Inc / GitLab Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Israel / Netherlands / Singapore / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/11/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">MEDACorp Derm Survey Shows Large Unmet Need & Opportunity for Novel Topicals</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">45337C10 / 03116210 / 75886F10 / F5548N10 / 00461U10 / ROIV</td><td class="leftalignment">Incyte Corp / Amgen Inc / Regeneron Pharmaceuticals Inc / Sanofi SA / Aclaris Therapeutics Inc / Roivant Sciences Ltd</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Andrew Berens, M.D. / Mr. Thomas J. Smith / Anna Baran, CFA / Christopher Liu, Pharm.D. / Mike Kratky, CFA</td></tr>
<tr class="odd"><td class="leftalignment">11/11/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">4031976 / 0989529 / 2516152 / 2000019 / 2023607 / 2640147 / 2778844 / 2222631 / 2270726 / 2542049 / 2684703 / 4595739 / 2857817 / 2982924 / B7TL820 / BCZS820 / BBPK0J0 / BDZCRX3 / BFLR866 / BFZCHN7 / BYVYD43 / BF4VBS8 / BFZNYB7 / BDHF4K6 / BJXBP41 / BMQ5T49 / BYY88Y7 / BL71K91 / BYP71H7 / BRJ3GY4 / BN2R582 / BYQCZ35 / BMPRZV5 / BMC5RV6 / BFY7DC4 / BNTB3N8 / BMFPJK6 / BN2RM92 / BMGGJK8 / BMF1LH5 / BMXXBD9 / BLF0CW7 / BP7KZP7 / BNLYJ60 / BNLYBF3 / BMDTR28</td><td class="leftalignment">Adidas AG / AstraZeneca PLC / Eli Lilly and Co / Amazon.com Inc / Amgen Inc / Nike Inc / Merck & Co Inc / Cooper Companies Inc / Walt Disney Co / Dominion Energy Inc / Pfizer Inc / Genmab A/S / Netflix Inc / Spectrum Pharmaceuticals Inc / Meta Platforms Inc / Fate Therapeutics Inc / Mirati Therapeutics Inc / RingCentral Inc / Twitter Inc / Wix.Com Ltd / Performance Food Group Co / BioXcel Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Alcon AG / Zentalis Pharmaceuticals Inc / Alphabet Inc / Revolution Medicines Inc / National Vision Holdings Inc / Xenon Pharmaceuticals Inc / Relay Therapeutics Inc / Madison Square Garden Sports Corp / Kymera Therapeutics Inc / Adicet Bio Inc / Altimmune Inc / Vizio Holding Corp / ACV Auctions Inc / Rain Therapeutics Inc / Valneva SE / Honest Company Inc / Figs Inc / Repare Therapeutics Inc / Monte Rosa Therapeutics Inc / Imago BioSciences Inc / Erasca Inc / First Watch Restaurant Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Germany / Denmark / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">11/11/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MEDX.S: Medmix - Mixing growth and repositioning opportunities: initiate at Outperform</td><td class="leftalignment">English</td><td class="rightalignment">62</td><td class="leftalignment">MEDX.S / ABT.N / BDX.N / EL.N / LLY.N / LVMH.PA / MDT.N / OREP.PA / PG.N / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / MMM.N / MRCG.DE / WST.N / GSK.L / ATR.N / UCB.BR / AMGN.OQ / NDSN.OQ / PDCO.OQ / XRAY.OQ / HSIC.OQ / SUN.S / FIN.S / DAE.S / YPSN.S / GXIG.DE / CLTN.S / ABBV.N / COTY.N / SFSN.S / SENSI.S / AVTR.N / NVST.N</td><td class="leftalignment">Medmix Ltd / Abbott Laboratories / Becton Dickinson and Co / Estee Lauder Companies Inc / Eli Lilly and Co / LVMH Moet Hennessy Louis Vuitton SE / Medtronic PLC / L'Oreal SA / Procter & Gamble Co / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / 3M Co / Merck KGaA / West Pharmaceutical Services Inc / GlaxoSmithKline PLC / Aptargroup Inc / Ucb SA / Amgen Inc / Nordson Corp / Patterson Companies Inc / DENTSPLY SIRONA Inc / Henry Schein Inc / Sulzer AG / Georg Fischer AG / Daetwyler Holding AG / Ypsomed Holding AG / Gerresheimer AG / Coltene Holding AG / Abbvie Inc / Coty Inc / SFS Group AG / Sensirion Holding AG / Avantor Inc / Envista Holdings Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Conglomerates / Manufacturing</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Herr. Christoph Gretler / Herr Patrick Laager</td></tr>
<tr class="odd"><td class="leftalignment">11/11/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">HCM: HUTCHMED (China) Limited - Three targeted oncology drugs present bright globalisation prospect; initiate with OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">67</td><td class="leftalignment">0013.HK / HCM.OQ / 1093.HK / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / 1177.HK / MRCG.DE / NVS.N / AMGN.OQ / INCY.OQ / RIGL.OQ / RO.S / BSLN.S / 600276.SS / 4568.T / 002422.SZ / ABBV.N / EPZM.OQ / BGNE.OQ / TPB.N / 300558.SZ / 6160.HK / 1801.HK / IMAB.OQ</td><td class="leftalignment">HUTCHMED (China) Ltd / HUTCHMED (China) Ltd / CSPC Pharmaceutical Group Ltd / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Sino Biopharmaceutical Ltd / Merck KGaA / Novartis AG / Amgen Inc / Incyte Corp / Rigel Pharmaceuticals Inc / Roche Holding AG / Basilea Pharmaceutica AG / Jiangsu Hengrui Pharmaceuticals Co Ltd / Daiichi Sankyo Co Ltd / Sichuan Kelun Pharmaceutical Co Ltd / Abbvie Inc / Epizyme Inc / Beigene Ltd / Turning Point Brands Inc / Betta Pharmaceuticals Co Ltd / Beigene Ltd / Innovent Biologics Inc / I-Mab</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / Germany / France / United Kingdom / Hong Kong / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">11/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">SPPI - NEUTRAL - Poziotinib NDA in 4Q, but Emerging Competition May Limit Opp'ty; Rolontis CMC Fix Underway, but Value Prop. Remains Unclear to Us</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2982924 / 2023607</td><td class="leftalignment">Spectrum Pharmaceuticals Inc / Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Paul Jeng, Ph.D. / Kelsey Goodwin / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="odd"><td class="leftalignment">11/10/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Common threads from investor feedback on Treg competitive landscape</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AMGN=US / LLY=US / MRK=US / BMY=US / GILD=US / SGMO=US</td><td class="leftalignment">Amgen Inc / Eli Lilly and Co / Merck & Co Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Sangamo Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Nicole Germino / Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">11/10/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Down but Not Out? Imminent FDA Meeting Will Likely Decide Roxa’s Fate</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">31572Q80 / 71708110 / 03116210 / 00287Y10</td><td class="leftalignment">FibroGen Inc / Pfizer Inc / Amgen Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Daniel Tarjan, Ph.D. / Anna Baran, CFA / Na Sun</td></tr>
<tr class="odd"><td class="leftalignment">11/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">0989529 / 2868165 / 2000019 / 2023607 / 2050832 / 2026242 / 2219224 / 2280220 / 2270726 / 2542049 / 2829515 / 2317087 / 2670519 / 2328915 / 2100920 / 2415204 / 2645409 / 2657802 / 2689560 / 2680905 / 2048804 / 2707677 / 2138158 / 2829601 / 4595739 / B17HG57 / B19FQ48 / 2857817 / B3D7K31 / B03PGL4 / B7TL820 / B4MG4Z6 / B7VD3F2 / B83YYY6 / BBPK0J0 / B87ZMX0 / B95N910 / B424494 / BVVN4Q8 / BYVFC94 / BP4GNK9 / BK0VHF6 / BD9GVY0 / BK7Y2V9 / BZ00V34 / BYQNYR5 / BFMXGR0 / BJJMGL2 / BJFSR99 / BKTNTR9 / BDFZSP1 / BJXBP30 / BZ1LFG7 / BWY52P3 / BJMLSD2 / BM8MM05 / BFY7DC4 / BMDJ085 / BMDJ397 / BNTB3N8 / BMV31Q4 / BN2RM92 / BKPGJQ1 / BNKGXX2 / BJLV8T9 / BMVBZF5 / BP2P6L0 / BMW5LX6 / BF0QTY9</td><td class="leftalignment">AstraZeneca PLC / Sysco Corp / Amazon.com Inc / Amgen Inc / Ameren Corp / American Electric Power Company Inc / CMS Energy Corp / DTE Energy Co / Walt Disney Co / Dominion Energy Inc / Edison International / Entergy Corp / Exelon Corp / Nextera Energy Inc / FirstEnergy Corp / Hawaiian Electric Industries Inc / NiSource Inc / OGE Energy Corp / PG&E Corp / PPL Corp / Pinnacle West Capital Corp / Public Service Enterprise Group Inc / Sempra Energy / Southern Co / Genmab A/S / Cardiovascular Systems Inc / Amicus Therapeutics Inc / Netflix Inc / Discovery Inc / NorthWestern Corp / Meta Platforms Inc / AMC Networks Inc / Duke Energy Corp / ICAD Inc / Mirati Therapeutics Inc / Palo Alto Networks Inc / PTC Inc / Splunk Inc / Eversource Energy / US Foods Holding Corp / SAGE Therapeutics Inc / IDEAYA Biosciences Inc / Zai Lab Ltd / Akero Therapeutics Inc / Zscaler Inc / Senseonics Holdings Inc / Evergy Inc / Fox Corp / Revance Therapeutics Inc / ViacomCBS Inc / Okta Inc / Turning Point Therapeutics Inc / Roku Inc / Blueprint Medicines Corp / Karuna Therapeutics Inc / Madison Square Garden Entertainment Corp / Altimmune Inc / Shoals Technologies Group Inc / Bolt Biotherapeutics Inc / Vizio Holding Corp / Audacy Inc / Rain Therapeutics Inc / Squarespace Inc / Verve Therapeutics Inc / Celldex Therapeutics Inc / Immuneering Corp / Tango Therapeutics Inc / Eliem Therapeutics Inc / Chicken Soup for The Soul Entertainment Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Denmark / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">11/10/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Come On In, The Water’s Fine!</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">375558103 / 031162100 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 90400D108 / 00461U105 / 00166B105 / 46565G104 / 49705R105 / 670703107</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / ALX Oncology Holdings Inc / Iteos Therapeutics Inc / Kinnate Biopharma Inc / Nuvalent Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Who Is Coming Up Short?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AMGN / BMY / GILD / JNJ / LLY / MRK / PFE / ACRS / UTHR / ACRX / BIIB / ABBV / AERI / ALDX</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Aclaris Therapeutics Inc / United Therapeutics Corp / AcelRx Pharmaceuticals Inc / Biogen Inc / Abbvie Inc / Aerie Pharmaceuticals Inc / Aldeyra Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AMGN / AMT / CCI / DISH / AMZN.O / WPRT.O / TMUS / 83417M104 / MSGS / MSGE / CMPS.OQ / SNSE.O / ATER / EVAX.O</td><td class="leftalignment">Amgen Inc / American Tower Corp / Crown Castle International Corp / DISH Network Corp / Amazon.com Inc / Westport Fuel Systems Inc / T-Mobile US Inc / Solaredge Technologies Inc / Madison Square Garden Sports Corp / Madison Square Garden Entertainment Corp / Compass Pathways PLC / Sensei Biotherapeutics Inc / Aterian Inc / Evaxion Biotech A/S</td><td class="leftalignment"></td><td class="leftalignment">Canada / Denmark / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Model Update</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">11/09/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">3Q: Lead Asset IND Submission On Track for 4Q</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">87583X10 / 71708110 / 03116210 / 75886F10 / 00287Y10</td><td class="leftalignment">Tango Therapeutics Inc / Pfizer Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Andrew Berens, M.D. / Christopher Liu, Pharm.D. / Ken Shields</td></tr>
<tr class="odd"><td class="leftalignment">11/09/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Inflections Suggest Early Stages of Seasonal COVID-19 Wave; Growing Armamentarium to Blunt Future Spikes in Severe Disease</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Sarah Schram / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">AAPL / AMGN / BKI / BOLT / DNLI / EA / FISV / INTC.O / JKHY / JPM.N / MA / MRTX / MSFT / NOW / ORCL / PRTA / RNG / SAP / SONY / TH / TTWO / V / VGR / WMT / WSC / AMZN.O / EBAY.O / MWA / FIS / ATVI.O / NVDA.O / ADBE.O / HEAR / MPWR.O / AMD.O / NFLX / ADSK.O / FRPT / GPN / PYPL / MRVL.O / AVGO.O / HELE.OQ / FRSH.OQ / INTA.O / BIIB / GOOG.O / 36467W109 / CCOI / 771195104 / SWAV / AMRS.O / ZNGA / FB.O / WDAY / FDEV.L / WIX.O / 82655M107 / NVRO / VCEL.O / TTD.O / COUP.O / BL.O / TCMD / AVDL.O / ROKU.O / APLS.O / BILI.O / DOCU.O / ORIC.O / ZI.OQ / KDNY.O / PUBM.O / XM.O / HUYA.K / 010196103 / SOFI / EVCM.O / CGTX.OQ / ENVX.O / CWAN.N / JSPR.O</td><td class="leftalignment">Apple Inc / Amgen Inc / Black Knight Inc / Bolt Biotherapeutics Inc / Denali Therapeutics Inc / Electronic Arts Inc / Fiserv Inc / Intel Corp / Jack Henry & Associates Inc / JPMorgan Chase & Co / Mastercard Inc / Mirati Therapeutics Inc / Microsoft Corp / ServiceNow Inc / Oracle Corp / Prothena Corporation PLC / RingCentral Inc / SAP SE / Sony Group Corp / Target Hospitality Corp / Take-Two Interactive Software Inc / Visa Inc / Vector Group Ltd / Walmart Inc / Willscot Mobile Mini Holdings Corp / Amazon.com Inc / eBay Inc / Mueller Water Products Inc / Fidelity National Information Services Inc / Activision Blizzard Inc / NVIDIA Corp / Adobe Inc / Turtle Beach Corp / Monolithic Power Systems Inc / Advanced Micro Devices Inc / Netflix Inc / Autodesk Inc / Freshpet Inc / Global Payments Inc / PayPal Holdings Inc / Marvell Technology Inc / Broadcom Inc / Helen of Troy Ltd / Freshworks Inc / Intapp Inc / Biogen Inc / Alphabet Inc / GameStop Corp / Cogent Communications Holdings Inc / Roche Holding AG / Shockwave Medical Inc / Amyris Inc / Zynga Inc / Meta Platforms Inc / Workday Inc / Frontier Developments PLC / Wix.Com Ltd / Sify Technologies Ltd / Nevro Corp / Vericel Corp / Trade Desk Inc / Coupa Software Inc / Blackline Inc / Tactile Systems Technology Inc / Avadel Pharmaceuticals PLC / Roku Inc / Apellis Pharmaceuticals Inc / Bilibili Inc / DocuSign Inc / Oric Pharmaceuticals Inc / ZoomInfo Technologies Inc / Chinook Therapeutics Inc / PubMatic Inc / Qualtrics International Inc / HUYA Inc / Aksys Ltd / SoFi Technologies Inc / EverCommerce Inc / Cognition Therapeutics Inc / Enovix Corp / Clearwater Analytics Holdings Inc / Jasper Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / Cayman Islands / Germany / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">INSP / US0311621009 / US0042251084 / US31189P1021 / US75615P1030 / US0400476075 / US03753U1060 / US03969F1093 / US38341P1021 / US86150R1077 / CA23126M1023</td><td class="leftalignment">Inspire Medical Systems Inc / Amgen Inc / ACADIA Pharmaceuticals Inc / Fate Therapeutics Inc / Reata Pharmaceuticals Inc / Arena Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Arcus Biosciences Inc / Gossamer Bio Inc / Stoke Therapeutics Inc / Curaleaf Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">11/09/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">3Q Update - Focus On 2L Monotherapy Launch Post 1L PoC</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">60468T105 / 03116210</td><td class="leftalignment">Mirati Therapeutics Inc / Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Silvan Tuerkcan</td></tr>
<tr class="odd"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">3Q Update Highlights Progress on Multiple Fronts</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRTX / AMGN</td><td class="leftalignment">Mirati Therapeutics Inc / Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">XNCR - BUY - Early Signs of Efficacy for XmAb306 as Pipeline Heads into Near-Term Data; Vibecotamab Discontinuation Unsurprising, in Our View</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BGCYWN8 / 2126335 / 2023607 / 7103065</td><td class="leftalignment">Xencor Inc / Bristol-Myers Squibb Co / Amgen Inc / Novartis AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Kelsey Goodwin / Yige Guo, Ph.D. / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">3Q update: top-line results for RAMP 201 and RAMP 202 expected 1H22</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">VSTM / US0311621009</td><td class="leftalignment">Verastem Inc / Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek</td></tr>
<tr class="even"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Sign Up for Hearty Fridays - KOL Call Series: 11/12 at 10:00 am ET, We're Talking PAH Market, Merck/Acceleron, and $5B+ Opportunity for New Treatments</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK.N / 5671735 / 0989529 / 2023607 / 2778844 / 2730190 / 7103065 / BHC8X90 / BNKGXX2</td><td class="leftalignment">Merck & Co Inc / Sanofi SA / AstraZeneca PLC / Amgen Inc / Merck & Co Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Novo Nordisk A/S / Verve Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Debjit Chattopadhyay, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Oct 29, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">11/08/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - November 8, 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">AES.N / AFL.N / AIG.N / AXP.N / BAC.N / BK.N / C.N / CB.N / CC.N / CI.N / CL.N / COF.N / CVS.N / EIX.N / FITB.O / FMS.N / JPM.N / KEY.N / MSFT.O / NTRS.O / PNC.N / PNW.N / SO.N / T.N / T.TO / USB.N / WFC.N / FR.N / HUM.N / TEN.N / CHKP.O / AMGN.O / RBA.N / DUK.N / PNM.N / ENB.TO / TRP.TO / DISH.O / GS.N / DV.N / PCG.N / EPC.N / ADCT.N / SBAC.O / AMT.N / CONE.O / VZ.N / STT.N / EXEL.O / JCI.N / XEL.N / ARNA.O / LNC.N / EXC.N / V.N / AXL.N / EGP.N / PLD.N / EPAY.O / WSP.TO / MTB.N / JKHY.O / AJG.N / REGN.O / PRU.N / NET.N / SSNC.O / RF.N / CPK.N / LTC.N / AMH.N / SEM.N / SGEN.OQ / GPN.N / BLUE.O / CASY.O / ACGL.O / AMED.O / EQIX.O / STN.TO / ATDb.TO / SNC.TO / TFC.N / DLR.N / 416515104 / LHCG.O / IHS.N / BKD.N / MS.N / FIS.N / CCOI.O / MA.N / AON.N / BGS.N / PPL.TO / VMW.N / NOG.A / SII.TO / 759351604 / JACK.OQ / SWI.N / ADUS.OQ / FTNT.O / ENV.N / NEE.N / ERF.TO / PKI.TO / STAG.N / ANGI.OQ / SPLK.OQ / PANW.N / QLYS.O / FFHu.TO / ALLY.N / TMUS.N / PRTA.O / BEP.N / AGIO.O / ESNT.N / XNCR.OQ / VRNS.O / QTWO.N / NEP.N / CFG.N / GLPG.O / PYPL.OQ / RPD.O / SGRY.O / SQ.N / MIME.OQ / IONS.O / TRHC.OQ / SCWX.O / BBU.N / TTD.O / GDS.O / UNIT.O / OKTA.OQ / WOW.N / BHF.O / ATNX.O / SAIL.N / ZS.OQ / ESTC.N / CRWD.O / GMAB.O / PING.N / DDOG.O / PNTG.OQ / NLOK.O / WTRG.N / SLQT.N / AHCO.O / VMD.OQ / APA.OQ / FOUR.N / JAMF.O / LUMN.N / PLTR.N / AEP.OQ / MCFE.OQ / LSPD.N / PUBM.O / TIXT.TO / AFRM.O / OLO.N / PSFE.N / FLYW.O / TASK.O / TRMR.OQ / RYAN.N / GTLB.OQ / ROCC.O</td><td class="leftalignment">AES Corp / Aflac Inc / American International Group Inc / American Express Co / Bank of America Corp / Bank of New York Mellon Corp / Citigroup Inc / Chubb Ltd / Chemours Co / Cigna Corp / Colgate-Palmolive Co / Capital One Financial Corp / CVS Health Corp / Edison International / Fifth Third Bancorp / Fresenius Medical Care AG & Co KGaA / JPMorgan Chase & Co / KeyCorp / Microsoft Corp / Northern Trust Corp / PNC Financial Services Group Inc / Pinnacle West Capital Corp / Southern Co / AT&T Inc / Telus Corp / US Bancorp / Wells Fargo & Co / First Industrial Realty Trust Inc / Humana Inc / Tenneco Inc / Check Point Software Technologies Ltd / Amgen Inc / Ritchie Bros Auctioneers Inc / Duke Energy Corp / PNM Resources Inc / Enbridge Inc / TC Energy Corp / DISH Network Corp / Goldman Sachs Group Inc / DoubleVerify Holdings Inc / PG&E Corp / Edgewell Personal Care Co / ADC Therapeutics SA / SBA Communications Corp / American Tower Corp / CyrusOne Inc / Verizon Communications Inc / State Street Corp / Exelixis Inc / Johnson Controls International PLC / Xcel Energy Inc / Arena Pharmaceuticals Inc / Lincoln National Corp / Exelon Corp / Visa Inc / American Axle & Manufacturing Holdings Inc / Eastgroup Properties Inc / Prologis Inc / Bottomline Technologies Inc / WSP Global Inc / M&T Bank Corp / Jack Henry & Associates Inc / Arthur J Gallagher & Co / Regeneron Pharmaceuticals Inc / Prudential Financial Inc / Cloudflare Inc / SS&C Technologies Holdings Inc / Regions Financial Corp / Chesapeake Utilities Corp / LTC Properties Inc / American Homes 4 Rent / Select Medical Holdings Corp / Seagen Inc / Global Payments Inc / bluebird bio Inc / Caseys General Stores Inc / Arch Capital Group Ltd / Amedisys Inc / Equinix Inc / Stantec Inc / Alimentation Couche-Tard Inc / SNC-Lavalin Group Inc / Truist Financial Corp / Digital Realty Trust Inc / Hartford Financial Services Group Inc / LHC Group Inc / IHS Holding Ltd / Brookdale Senior Living Inc / Morgan Stanley / Fidelity National Information Services Inc / Cogent Communications Holdings Inc / Mastercard Inc / Aon PLC / B&G Foods Inc / Pembina Pipeline Corp / VMware Inc / Northern Oil and Gas Inc / Sprott Inc / Reinsurance Group of America Inc / Jack in the Box Inc / SolarWinds Corp / Addus Homecare Corp / Fortinet Inc / Envestnet Inc / Nextera Energy Inc / Enerplus Corp / Parkland Corp / STAG Industrial Inc / Angi Inc / Splunk Inc / Palo Alto Networks Inc / Qualys Inc / Fairfax Financial Holdings Ltd / Ally Financial Inc / T-Mobile US Inc / Prothena Corporation PLC / Brookfield Renewable Partners LP / Agios Pharmaceuticals Inc / Essent Group Ltd / Xencor Inc / Varonis Systems Inc / Q2 Holdings Inc / Nextera Energy Partners LP / Citizens Financial Group Inc / Galapagos NV / PayPal Holdings Inc / Rapid7 Inc / Surgery Partners Inc / Block Inc / Mimecast Ltd / Ionis Pharmaceuticals Inc / Tabula Rasa HealthCare Inc / SecureWorks Corp / Brookfield Business Partners LP / Trade Desk Inc / GDS Holdings Ltd / Uniti Group Inc / Okta Inc / WideOpenWest Inc / Brighthouse Financial Inc / Athenex Inc / SailPoint Technologies Holdings Inc / Zscaler Inc / Elastic NV / CrowdStrike Holdings Inc / Genmab A/S / Ping Identity Holding Corp / Datadog Inc / Pennant Group Inc / NortonLifeLock Inc / Essential Utilities Inc / SelectQuote Inc / Adapthealth Corp / Viemed Healthcare Inc / APA Corp (US) / Shift4 Payments Inc / Jamf Holding Corp / Lumen Technologies Inc / Palantir Technologies Inc / American Electric Power Company Inc / Mcafee Corp / Lightspeed Commerce Inc / PubMatic Inc / Telus International Cda Inc / Affirm Holdings Inc / Olo Inc / Paysafe Ltd / Flywire Corp / Taskus Inc / Tremor International Ltd / Ryan Specialty Group Holdings Inc / GitLab Inc / Ranger Oil Corp</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / Ireland / Israel / Mauritius / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">CADL: Credit Suisse Healthcare Conference: Fireside Chat Takeaways</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">CADL.OQ / AMGN.OQ / FBRX.OQ</td><td class="leftalignment">Candel Therapeutics Inc / Amgen Inc / Forte Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Judah C. Frommer / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">JSPR: Multiple Shots on the HCT Goal; Initiating with an Outperform Rating and a $15 Target Price</td><td class="leftalignment">English</td><td class="rightalignment">36</td><td class="leftalignment">JSPR.OQ / AMGN.OQ / GILD.OQ / CLDX.OQ</td><td class="leftalignment">Jasper Therapeutics Inc / Amgen Inc / Gilead Sciences Inc / Celldex Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Judah C. Frommer / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">11/06/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AMGN.O / ADCT.N / EXEL.O / ARNA.O / REGN.O / SGEN.OQ / PRTA.O / AGIO.O / ATNX.O / GMAB.O</td><td class="leftalignment">Amgen Inc / ADC Therapeutics SA / Exelixis Inc / Arena Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Seagen Inc / Prothena Corporation PLC / Agios Pharmaceuticals Inc / Athenex Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="even"><td class="leftalignment">11/06/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 572</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Sarah Schram / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">11/05/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">PODD - 3Q as Expected; Initial 2022 Outlook Highlights Delayed Impact of O5 Launch</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">B1XGNW4 / 2023607 / BF3W461</td><td class="leftalignment">Insulet Corp / Amgen Inc / Tandem Diabetes Care Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Chris Pasquale / Devin Geiman / Catherine Lynch</td></tr>
<tr class="even"><td class="leftalignment">11/05/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Nov. 05, 2021</td><td class="leftalignment">English</td><td class="rightalignment">50</td><td class="leftalignment">AAPL / ALLO / AMGN / ATRC / CRY / CSII / EXEL / GBT / ICPT / INCY / INSP / IRTC / NBIX / OM / RARE / SAGE / ASND.O / GILD.O / EW / IART.O / SGEN / UTHR.O / PCSA.O / BMRN.O / DRRX.O / REGN.O / VRTX.O / NKTR / CCRN.O / STAA.O / AMED.O / EXAS.O / BIIB / 478160104 / MNKD.O / CMMB / ALNY.O / DXCM.O / LHCG.O / INFI.O / PODD.O / TNDM.O / MRNA.O / 771195104 / ADUS.O / SWAV / SRPT.O / AGIO / FATE.O / AERI.O / 02005N100 / AGRX.O / RXDX.O / APTO.O / AUPH.O / CFMS.O / VKTX / IONS.O / 04280A100 / MDGL / VRAY / NTLA / CRSP / IOVA / ATNX.O / 720795103 / PRVB.O / ORTX.O / BNGO.O / ARVN / XFOR.O / TMDX / PSNL.O / BCYC / ORIC.O / HGEN.O / 03823M100 / CLNN.O / CGTX.OQ</td><td class="leftalignment">Apple Inc / Allogene Therapeutics Inc / Amgen Inc / AtriCure Inc / CryoLife Inc / Cardiovascular Systems Inc / Exelixis Inc / Global Blood Therapeutics Inc / Intercept Pharmaceuticals Inc / Incyte Corp / Inspire Medical Systems Inc / iRhythm Technologies Inc / Neurocrine Biosciences Inc / Outset Medical Inc / Ultragenyx Pharmaceutical Inc / SAGE Therapeutics Inc / Ascendis Pharma A/S / Gilead Sciences Inc / Edwards Lifesciences Corp / Integra Lifesciences Holdings Corp / Seagen Inc / United Therapeutics Corp / Processa Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / DURECT Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Nektar Therapeutics / Cross Country Healthcare Inc / STAAR Surgical Co / Amedisys Inc / Exact Sciences Corp / Biogen Inc / Johnson & Johnson / MannKind Corp / Chemomab Therapeutics Ltd / Alnylam Pharmaceuticals Inc / Dexcom Inc / LHC Group Inc / Infinity Pharmaceuticals Inc / Insulet Corp / Tandem Diabetes Care Inc / Moderna Inc / Roche Holding AG / Addus Homecare Corp / Shockwave Medical Inc / Sarepta Therapeutics Inc / Agios Pharmaceuticals Inc / Fate Therapeutics Inc / Aerie Pharmaceuticals Inc / Ally Financial Inc / Agile Therapeutics Inc / Prometheus Biosciences Inc / Aptose Biosciences Inc / Aurinia Pharmaceuticals Inc / Conformis Inc / Viking Therapeutics Inc / Ionis Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / ViewRay Inc / Intellia Therapeutics Inc / CRISPR Therapeutics AG / Iovance Biotherapeutics Inc / Athenex Inc / Pieris Pharmaceuticals Inc / Provention Bio Inc / Orchard Therapeutics PLC / Bionano Genomics Inc / Arvinas Inc / X4 Pharmaceuticals Inc / Transmedics Group Inc / Personalis Inc / Bicycle Therapeutics PLC / Oric Pharmaceuticals Inc / Humanigen Inc / Applied Minerals Inc / Clene Inc. / Cognition Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended October 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">11012210 / 71708110 / 00846U10 / 88162420 / 04635310 / 37555810 / 03116210 / 66987V10 / 75886F10 / 53245710 / 09062X10 / 478160104 / 30161Q104 / 771195104 / 58933Y10 / 00287Y10 / 45781M10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Bristol-Myers Squibb Co / Pfizer Inc / Agilent Technologies Inc / Teva Pharmaceutical Industries Ltd / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Biogen Inc / Johnson & Johnson / Exelixis Inc / Roche Holding AG / Merck & Co Inc / Abbvie Inc / Innoviva Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">11/05/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">11/05/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Amgen Inc: Information Content of Earnings Releases 2016-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BGNE - NEUTRAL - Product Sales Beat Driven by Brukinsa While Tislelizumab Growth in China Slowed Down, May Raise Concerns</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BYYWPW6 / 0989529 / 2126335 / 2023607</td><td class="leftalignment">Beigene Ltd / AstraZeneca PLC / Bristol-Myers Squibb Co / Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Paul Jeng, Ph.D. / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="odd"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Let the Good Times Roll - Another Week of Biotech Inflows</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">11/04/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Amgen up 3.5% from 4 week low</td><td class="leftalignment">English</td><td class="rightalignment">36</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Amgen Inc: Capital Deployment Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">11/04/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Amgen Inc Investment Status Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="odd"><td class="leftalignment">11/04/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">The Coming SERD Showdown in Texas: SABCS Planner and Preview</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">71708110 / 45253H10 / 04635310 / 37555810 / 03116210 / 75046920 / 98401F10 / 76029N10 / 55609910 / 04685N10 / 03969F10 / F5548N10 / 98943L10 / 98985W10</td><td class="leftalignment">Pfizer Inc / ImmunoGen Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Radius Health Inc / Xencor Inc / Replimune Group Inc / MacroGenics Inc / Athenex Inc / Arcus Biosciences Inc / Sanofi SA / Zentalis Pharmaceuticals Inc / Zymeworks Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Andrew Berens, M.D. / Jonathan Chang, Ph.D., CFA / Daniel Tarjan, Ph.D. / Christopher Liu, Pharm.D. / Faisal Khurshid</td></tr>
<tr class="even"><td class="leftalignment">11/03/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BMY-US -  Dividend Quality Analysis, for the period ended November 01,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY / JNJ / LLY / MRK / NVS / PFE / AMGN.O / AZN.O / BIIB.O / ABBV.K / SNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / AstraZeneca PLC / Biogen Inc / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">11/03/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">AAPL / AMGN / AOS / APP / APPS / CSWC / DISH / ECL / HRB / INCY / INSP / INTC.O / IRTC / IS / KLAC.O / MSFT / PNR / RNG / ROK / RSI / RXN / SAGE / T / U / WMT / WTS / MWA / ATVI.O / AKAM / VECO.O / IART.O / VZ / AQUA / GPN / REGN.O / VRTX.O / FRSH.OQ / AMED.O / EXAS.O / BIIB / 478160104 / DENN.O / LHCG.O / XPO / INFI.O / Z.O / 88162G103 / MRNA.O / ADUS.O / XYL / TMUS / AGRX.O / RXDX.O / SEDG.O / VRAY / TTD.O / UAA / EGHT.K / 83417M104 / FRG.O / DKNG / CGTX.OQ</td><td class="leftalignment">Apple Inc / Amgen Inc / A O Smith Corp / Applovin Corp / Digital Turbine Inc / Capital Southwest Corp / DISH Network Corp / Ecolab Inc / H & R Block Inc / Incyte Corp / Inspire Medical Systems Inc / Intel Corp / iRhythm Technologies Inc / Ironsource Ltd / KLA Corp / Microsoft Corp / Pentair PLC / RingCentral Inc / Rockwell Automation Inc / Rush Street Interactive Inc / Zurn Water Solutions Corp / SAGE Therapeutics Inc / AT&T Inc / Unity Software Inc / Walmart Inc / Watts Water Technologies Inc / Mueller Water Products Inc / Activision Blizzard Inc / Akamai Technologies Inc / Veeco Instruments Inc / Integra Lifesciences Holdings Corp / Verizon Communications Inc / Evoqua Water Technologies Corp / Global Payments Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Freshworks Inc / Amedisys Inc / Exact Sciences Corp / Biogen Inc / Johnson & Johnson / Denny's Corp / LHC Group Inc / XPO Logistics Inc / Infinity Pharmaceuticals Inc / Zillow Group Inc / Tetra Tech Inc / Moderna Inc / Addus Homecare Corp / Xylem Inc / T-Mobile US Inc / Agile Therapeutics Inc / Prometheus Biosciences Inc / Solaredge Technologies Inc / ViewRay Inc / Trade Desk Inc / Under Armour Inc / 8x8 Inc / Solaredge Technologies Inc / Franchise Group Inc / DraftKings Inc / Cognition Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/03/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Nov 03 2021</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">GB0007980591 / US00971T1016 / US0234361089 / US0311621009 / US0556221044 / US1570851014 / US1985161066 / US2358511028 / US25179M1036 / US30161Q1040 / US3021301094 / US3695501086 / US5184151042 / US62855J1043 / US6541061031 / US7140461093 / US8835561023 / US92532F1003 / US9418481035 / US30063P1057 / US5645631046 / US1167941087 / US2533931026 / US9043111072 / US57636Q1040 / US3020811044 / US92932M1018 / US5500211090 / US00507V1098 / US5218652049 / NL0009538784 / US69404D1081 / US56585A1025 / US7512121010 / US29414B1044 / US9837931008 / US8725901040 / US5253271028 / US5560991094 / US90400D1081 / US14862Q1004 / US70432V1026 / CA0089118776 / US83417M1045 / US86881A1007 / KYG4740B1059 / US02156B1035 / US23355L1061 / US1468691027 / US05351X1019 / US55087P1049 / US05352A1007 / US04965G1094 / US69047Q1022 / US92537N1081 / CH0499880968 / US57667L1070 / US12769G1004 / US90364P1057 / IL0011754137 / 50066V107</td><td class="leftalignment">BP PLC / Akamai Technologies Inc / Amedisys Inc / Amgen Inc / BP PLC / Cerus Corp / Columbia Sportswear Co / Danaher Corp / Devon Energy Corp / Exelixis Inc / Expeditors International of Washington Inc / General Dynamics Corp / Lattice Semiconductor Corp / Myriad Genetics Inc / Nike Inc / PerkinElmer Inc / Thermo Fisher Scientific Inc / Vertex Pharmaceuticals Inc / Waters Corp / Exact Sciences Corp / ManTech International Corp / Bruker Corp / DICK'S Sporting Goods Inc / Under Armour Inc / Mastercard Inc / Exlservice Holdings Inc / WNS (Holdings) Ltd / Lululemon Athletica Inc / Activision Blizzard Inc / Lear Corp / NXP Semiconductors NV / Pacific Biosciences of California Inc / Marathon Petroleum Corp / Ralph Lauren Corp / Epam Systems Inc / XPO Logistics Inc / T-Mobile US Inc / Leidos Holdings Inc / MacroGenics Inc / Ultragenyx Pharmaceutical Inc / Castlight Health Inc / Paycom Software Inc / Air Canada / Solaredge Technologies Inc / Surgery Partners Inc / Ichor Holdings Ltd / Alteryx Inc / DXC Technology Co / Carvana Co / Avaya Holdings Corp / Lyft Inc / Avantor Inc / Atreca Inc / Ovintiv Inc / Vertiv Holdings Co / ADC Therapeutics SA / Match Group Inc / Caesars Entertainment Inc / UiPath Inc / Taboola.com Ltd / KORE Group Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">11/03/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">FISV=US / BSX=US / CACI=US / LSI=US / PFE=US / AMGN=US / AMZN=US / T=US / BLD=US / DVN=US / INCY=US / AKAM=US / CHTR=US / CONE=US / VZ=US / CRK=US / IART=US / FMS=US / MGY=US / LEG=US / ATVI=US / KFRC=US / CMCSA=US / MLM=US / ARCC=US / AIZ=US / AMED=US / DCO=US / EQIX=US / GPOR=US / MAIN=US / MPLX=US / MRCY=US / ASGN=US / OKE=US / ORCC=US / RARE=US / REGI=US / RHI=US / SBAC=US / SGMO=US / SEE=US / VRTX=US / SAGE=US / EPD=US / GPN=US / MANT=US / PYPL=US / DCP=US / MTCH=US / SRC=US / COP=US / RRR=US / MMP=US / CZR=US / KAR=US / AINV=US / HURN=US / BAH=US / DENN=US / NSP=US / FIS=US / XPO=US / WU=US / ICFI=US / PNNT=US / LLNW=US / PAGP=US / IAA=US / CWH=US / NXPI=US / FANG=US / TMUS=US / LDOS=US / NMIH=US / TSLX=US / VNOM=US / 70806A106 / DEA=US / SEDG=US / NXRT=US / GSBD=US / NSA=US / CHCT=US / ZG=US / NVCR=US / MIME=US / 82982L103 / GXO=US / IRTC=US / TVTY=US / 50189K103 / AYX=US / SWCH=US / DCPH=US / EOLS=US / KDP=US / BHC=US / FSK=US / LYFT=US / PLMR=US / OVV=US / COUR=US</td><td class="leftalignment">Fiserv Inc / Boston Scientific Corp / CACI International Inc / Life Storage Inc / Pfizer Inc / Amgen Inc / Amazon.com Inc / AT&T Inc / TopBuild Corp / Devon Energy Corp / Incyte Corp / Akamai Technologies Inc / Charter Communications Inc / CyrusOne Inc / Verizon Communications Inc / Comstock Resources Inc / Integra Lifesciences Holdings Corp / Fresenius Medical Care AG & Co KGaA / Magnolia Oil & Gas Corp / Leggett & Platt Inc / Activision Blizzard Inc / Kforce Inc / Comcast Corp / Martin Marietta Materials Inc / Ares Capital Corp / Assurant Inc / Amedisys Inc / Ducommun Inc / Equinix Inc / Gulfport Energy Corp / Main Street Capital Corp / MPLX LP / Mercury Systems Inc / ASGN Inc / ONEOK Inc / Owl Rock Capital Corp / Ultragenyx Pharmaceutical Inc / Renewable Energy Group Inc / Robert Half International Inc / SBA Communications Corp / Sangamo Therapeutics Inc / Sealed Air Corp / Vertex Pharmaceuticals Inc / SAGE Therapeutics Inc / Enterprise Products Partners LP / Global Payments Inc / ManTech International Corp / PayPal Holdings Inc / DCP Midstream LP / Match Group Inc / Spirit Realty Capital Inc / Conocophillips / Red Rock Resorts Inc / Magellan Midstream Partners LP / Caesars Entertainment Inc / KAR Auction Services Inc / Apollo Investment Corp / Huron Consulting Group Inc / Booz Allen Hamilton Holding Corp / Denny's Corp / Insperity Inc / Fidelity National Information Services Inc / XPO Logistics Inc / Western Union Co / ICF International Inc / Pennantpark Investment Corp / Limelight Networks Inc / Plains GP Holdings LP / IAA Inc / Camping World Holdings Inc / NXP Semiconductors NV / Diamondback Energy Inc / T-Mobile US Inc / Leidos Holdings Inc / NMI Holdings Inc / Sixth Street Specialty Lending Inc / Viper Energy Partners LP / PennantPark Floating Rate Capital Ltd / Easterly Government Properties Inc / Solaredge Technologies Inc / NexPoint Residential Trust Inc / Goldman Sachs BDC Inc / National Storage Affiliates Trust / Community Healthcare Trust Inc / Zillow Group Inc / Novocure Ltd / Mimecast Ltd / SiteOne Landscape Supply Inc / GXO Logistics Inc / iRhythm Technologies Inc / Tivity Health Inc / LCI Industries / Alteryx Inc / Switch Inc / Deciphera Pharmaceuticals Inc / Evolus Inc / Keurig Dr Pepper Inc / Bausch Health Companies Inc / FS KKR Capital Corp / Lyft Inc / Palomar Holdings Inc / Ovintiv Inc / Coursera Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Germany / Luxembourg / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/03/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Stormclouds of Competition, Price and Payment Erosion Growing – Mktpfrm, $216</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">03116210</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Na Sun / Daniel Tarjan, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">11/03/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US0311621009 / US1101221083 / US2666051048 / US4448591028 / US45337C1027 / US92532F1003 / US7665596034 / US40637H1095 / US14862Q1004 / CA1380351009 / US88870R1023 / US88688T1007 / CA39342L1085 / CA58507M1077 / CA22587M1068 / CA89788C1041 / CA23126M1023 / CA00489Y6001</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / DURECT Corp / Humana Inc / Incyte Corp / Vertex Pharmaceuticals Inc / Rigel Pharmaceuticals Inc / Halozyme Therapeutics Inc / Castlight Health Inc / Canopy Growth Corp / Tivity Health Inc / Tilray Brands Inc / Green Thumb Industries Inc / Medmen Enterprises Inc / Cresco Labs Inc / Trulieve Cannabis Corp / Curaleaf Holdings Inc / Acreage Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">11/03/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">2021 ESMO-IO Planner</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">45337C10 / 04635310 / 03116210 / 640268108 / 58933Y10 / 76029N10 / 09075V10 / 45781K20 / 59045L10 / N4444510 / N5749R10 / 09770210 / 82835W10 / 37230320</td><td class="leftalignment">Incyte Corp / AstraZeneca PLC / Amgen Inc / Nektar Therapeutics / Merck & Co Inc / Replimune Group Inc / BioNTech SE / Innate Pharma SA / Mersana Therapeutics Inc / Immatics NV / Merus NV / Bolt Biotherapeutics Inc / Silverback Therapeutics Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Germany / Denmark / France / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daina Graybosch, Ph.D. / Jonathan Chang, Ph.D., CFA / Andrew Berens, M.D. / Jeffrey La Rosa / Dilip Joseph / Faisal Khurshid / Nick Huang / Christopher Liu, Pharm.D. / Ken Shields</td></tr>
<tr class="odd"><td class="leftalignment">11/03/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Pulse Call Takeaways: Co-Stims Are Coming & Could Even Get Crowded</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">45337C10 / 03116210 / 75886F10 / 478160104 / 98401F10 / 09075V10 / N5749R10 / 30315R10 / 37230320 / 60853G10</td><td class="leftalignment">Incyte Corp / Amgen Inc / Regeneron Pharmaceuticals Inc / Johnson & Johnson / Xencor Inc / BioNTech SE / Merus NV / F-Star Therapeutics Inc / Genmab A/S / Molecular Partners AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / United Kingdom / Hong Kong / Israel / Japan / Netherlands / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Daina Graybosch, Ph.D. / Anna Baran, CFA / Na Sun / Daniel Tarjan, Ph.D. / Dilip Joseph / Jeffrey La Rosa</td></tr>
<tr class="even"><td class="leftalignment">11/03/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">5671735 / 2868165 / 2516152 / 2681511 / 2000019 / 2023607 / 2486813 / 2973821 / 2544960 / 2437071 / 2219224 / 2206657 / 2208073 / 2829515 / 2037170 / 2317087 / 2576941 / 2328915 / 2100920 / 2459202 / 2471950 / 2645409 / 2689560 / 2684703 / 2048804 / 2707677 / 2931034 / B0PZN11 / B02R1L6 / B570P91 / B5B2106 / B4Y1MH7 / B6197Q2 / 2949758 / B3SWPT2 / B7TL820 / B4V9661 / B8CKK03 / BJ0KXV4 / BYY8XK8 / BYVYD43 / BYVFC94 / BP4GNK9 / BJF8Q81 / BZ1LFB2 / BD8DJ71 / BJ2Z0H2 / BYWMQJ2 / BL95N25 / BZ1LFG7 / BYY88Y7 / BDT5KT5 / BFWGXQ7 / BP84RX0 / BD72R64 / BFY7DC4 / BMZ9Z11 / BNTB3N8 / BMFPJK6 / BJ62Z18</td><td class="leftalignment">Sanofi SA / Sysco Corp / Eli Lilly and Co / PepsiCo Inc / Amazon.com Inc / Amgen Inc / Kellogg Co / Alliant Energy Corp / Beasley Broadcast Group Inc / Biomarin Pharmaceutical Inc / CMS Energy Corp / Coca-Cola Co / Copart Inc / Edison International / 8x8 Inc / Entergy Corp / Exelixis Inc / Nextera Energy Inc / FirstEnergy Corp / IDEXX Laboratories Inc / Incyte Corp / NiSource Inc / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / Public Service Enterprise Group Inc / Vertex Pharmaceuticals Inc / Under Armour Inc / ALLETE Inc / Lear Corp / Fortinet Inc / KAR Auction Services Inc / Generac Holdings Inc / Nexstar Media Group Inc / Ameresco Inc / Meta Platforms Inc / Ralph Lauren Corp / Mondelez International Inc / ONE Gas Inc / WEC Energy Group Inc / Performance Food Group Co / US Foods Holding Corp / SAGE Therapeutics Inc / IAA Inc / Deciphera Pharmaceuticals Inc / Snap Inc / Pinterest Inc / Alteryx Inc / Phibro Animal Health Corp / Roku Inc / Alphabet Inc / Inspire Medical Systems Inc / Container Store Group Inc / Townsquare Media Inc / Liberty Media Corp / Altimmune Inc / Prometheus Biosciences Inc / Vizio Holding Corp / ACV Auctions Inc / Ultragenyx Pharmaceutical Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">11/03/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">3Q Take: COVID Recovery Story Continues, but with Steady Revenue Performance vs. Expectations</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek</td></tr>
<tr class="even"><td class="leftalignment">11/03/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - November 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">AXP.N / CNA.L / COF.N / DD.N / EL.N / F.N / GM.N / NA / SRCL.O / TMX.N / WMB.N / ZION.O / CMA.N / TRI.N / GILD.O / LPX.N / AMGN.O / ETN.N / HBAN.O / LEA.N / ADCT.N / SHW.N / OI.N / EXEL.O / AKAM.O / PACW.O / NNN.N / MRCY.O / EPD.N / AME.N / REGN.O / VRTX.O / COP.N / DCO.N / MKL.N / DFS.N / HCC.N / ADC.N / O.N / ADS.N / GPN.N / SIVB.O / COLB.O / AMED.O / WTFC.O / NTR.N / MOS.N / HUN.N / WAL.N / WU.N / PRTS.OQ / VMW.N / CLW.N / ADUS.OQ / VRSK.O / LYB.N / XYL.N / SLM.OQ / MDLZ.OQ / ALLY.N / MPLX.N / USAC.N / PRMW.N / BTG.N / RYAM.N / SAGE.OQ / SYF.N / CTLT.N / NMIH.O / CIGI.O / ZG.O / SGRY.O / RGNX.O / AROC.N / MIME.OQ / ORSTED.CO / BHC.N / LYFT.O / REYN.O / VMD.OQ / PLTR.N / 900435207 / CHK.OQ / COUR.N / ACCA.OL / 120681711</td><td class="leftalignment">American Express Co / Centrica PLC / Capital One Financial Corp / Dupont De Nemours Inc / Estee Lauder Companies Inc / Ford Motor Co / General Motors Co / National Bank of Canada / Stericycle Inc / Terminix Global Holdings Inc / Williams Companies Inc / Zions Bancorporation NA / Comerica Inc / Thomson Reuters Corp / Gilead Sciences Inc / Louisiana-Pacific Corp / Amgen Inc / Eaton Corporation PLC / Huntington Bancshares Inc / Lear Corp / ADC Therapeutics SA / Sherwin-Williams Co / O-I Glass Inc / Exelixis Inc / Akamai Technologies Inc / PacWest Bancorp / National Retail Properties Inc / Mercury Systems Inc / Enterprise Products Partners LP / AMETEK Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Conocophillips / Ducommun Inc / Markel Corp / Discover Financial Services / Warrior Met Coal Inc / Agree Realty Corp / Realty Income Corp / Alliance Data Systems Corp / Global Payments Inc / SVB Financial Group / Columbia Banking System Inc / Amedisys Inc / Wintrust Financial Corp / Nutrien Ltd / Mosaic Co / Huntsman Corp / Western Alliance Bancorp / Western Union Co / Carparts.Com Inc / VMware Inc / Clearwater Paper Corp / Addus Homecare Corp / Verisk Analytics Inc / LyondellBasell Industries NV / Xylem Inc / SLM Corp / Mondelez International Inc / Ally Financial Inc / MPLX LP / USA Compression Partners LP / Primo Water Corp / B2Gold Corp / Rayonier Advanced Materials Inc / SAGE Therapeutics Inc / Synchrony Financial / Catalent Inc / NMI Holdings Inc / Colliers International Group Inc / Zillow Group Inc / Surgery Partners Inc / Regenxbio Inc / Archrock Inc / Mimecast Ltd / Orsted A/S / Bausch Health Companies Inc / Lyft Inc / Reynolds Consumer Products Inc / Viemed Healthcare Inc / Palantir Technologies Inc / Turquoise Hill Resources Ltd / Chesapeake Energy Corp / Coursera Inc / Aker Carbon Capture ASA / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / United Kingdom / Ireland / Netherlands / Norway / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">11/03/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Third-Quarter Slight Top-Line Beat Aided by Sales Deductions; Positive Lumakras First Full Quarter</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">11/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Price Action: November 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">AAP.N / AIG.N / ALL.N / APD.N / BDX.N / CAH.N / CI.N / CVS.N / EOG.N / PFE.N / PNW.N / SO.N / WMT.N / PXD.N / HUM.N / MET.N / DUK.N / DIS.N / D.N / KIM.N / TSN.N / SYY.N / IFF.N / HD.N / EMR.N / JCI.N / DHI.N / SRE.N / ATO.N / VTR.N / COP.N / AMGN.OQ / JKHY.OQ / REGN.OQ / TT.N / QCOM.OQ / MCHP.OQ / TPR.N / ANSS.OQ / ILMN.OQ / EQIX.OQ / FIS.N / TDG.N / MRNA.OQ / FTNT.OQ / MSI.N / EA.OQ / ZTS.N / MAR.OQ / PYPL.OQ / WRK.N / APTV.N / BKNG.OQ / CTVA.N / EXC.OQ / VTRS.OQ</td><td class="leftalignment">Advance Auto Parts Inc / American International Group Inc / Allstate Corp / Air Products and Chemicals Inc / Becton Dickinson and Co / Cardinal Health Inc / Cigna Corp / CVS Health Corp / EOG Resources Inc / Pfizer Inc / Pinnacle West Capital Corp / Southern Co / Walmart Inc / Pioneer Natural Resources Co / Humana Inc / MetLife Inc / Duke Energy Corp / Walt Disney Co / Dominion Energy Inc / Kimco Realty Corp / Tyson Foods Inc / Sysco Corp / International Flavors & Fragrances Inc / Home Depot Inc / Emerson Electric Co / Johnson Controls International PLC / D R Horton Inc / Sempra Energy / Atmos Energy Corp / Ventas Inc / Conocophillips / Amgen Inc / Jack Henry & Associates Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Qualcomm Inc / Microchip Technology Inc / Tapestry Inc / ANSYS Inc / Illumina Inc / Equinix Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Moderna Inc / Fortinet Inc / Motorola Solutions Inc / Electronic Arts Inc / Zoetis Inc / Marriott International Inc / PayPal Holdings Inc / Westrock Co / Aptiv PLC / Booking Holdings Inc / Corteva Inc / Exelon Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">11/03/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">AMGN - AMGN 3Q21 postview: COVID recovery slower than expected as biosimilars and some core growth products falter</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">11/03/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Amgen Inc : 3Q Snapshot - Lumakras in Focus as the Quest for Sustainable New Growth Drivers Continues</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Mr. Thomas Deal / Ms. Tiffany Sun / Manish Jajoo</td></tr>
<tr class="odd"><td class="leftalignment">11/03/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">3Q Update Validates New Launch Cycles</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AMGN / REGN.O / 478160104</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc / Johnson & Johnson</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">P&L Leverage Delivers But Growth Headwinds are Mounting</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">031162100</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">AMGN - NEUTRAL - Top & Bottom Line Above Consensus; Narrowing Guidance for Revenue & EPS; Volume Growth Significantly Offset by Price Pressures</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">2023607 / BBPK0J0 / BYYWPW6</td><td class="leftalignment">Amgen Inc / Mirati Therapeutics Inc / Beigene Ltd</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Kelsey Goodwin / Yige Guo, Ph.D. / Paul Jeng, Ph.D. / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="even"><td class="leftalignment">11/02/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Q3:21 post-call: revenue in-line with estimates, but guidance updates favors bottom-line</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Kennen MacKay, PHD</td></tr>
<tr class="odd"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Narrowed FY2021 guidance; preparing for near-term launches and watching pipeline evolve</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN=US</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q3 Beat Despite Ongoing Covid Impact, Lumakras Launch Off To Strong Start</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Yaron Werber, M.D., MD / Gabriel Schneider, M.D. / Brendan Smith, Ph.D. / Eve Reilly, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">11/02/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Amgen Inc : First Look at 3Q Results</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Mr. Thomas Deal / Ms. Tiffany Sun</td></tr>
<tr class="even"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Probes Reporter</td><td class="leftalignment">Watch List: 73 US Companies with Undisclosed SEC Probes</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AAN.N / T.N / AEP.N / CL.N / COF.N / F.N / HLT.N / SLB.N / TMO.N / BEN.N / THC.N / REV.N / ADM.N / VLO.N / UPS.N / KR.N / XOM.N / NKE.N / SNN.N / AMP.N / ARW.N / ATO.N / TWTR.N / TUP.N / OMI.N / CVX.N / TDY.N / AMGN.OQ / COLL.OQ / GNTX.OQ / HBAN.OQ / MGPI.OQ / REGN.OQ / SEIC.OQ / GILD.OQ / COST.OQ / NKTR.OQ / MYGN.OQ / SSNC.OQ / CTXS.OQ / AMZN.OQ / NVDA.OQ / PLUG.OQ / CHTR.OQ / CVGI.OQ / RUSHA.OQ / NDAQ.OQ / THS.N / SPWR.OQ / KOP.N / MA.N / SIX.N / AON.N / BX.N / INO.OQ / BGCP.OQ / UTL.N / SCHW.N / EXPR.N / MSI.N / GRPN.OQ / FB.OQ / COTY.N / CTG.OQ / MGNX.OQ / BRX.N / LADR.N / TWOU.OQ / ANTM.N / PFX.N / MFIN.OQ / HOPE.OQ / DXC.N / IQV.N / WELL.N / TLRY.OQ / ALLO.OQ / US29350E1047 / LYFT.O / CTVA.N</td><td class="leftalignment">Aaron's Company Inc / AT&T Inc / American Electric Power Company Inc / Colgate-Palmolive Co / Capital One Financial Corp / Ford Motor Co / Hilton Worldwide Holdings Inc / Schlumberger NV / Thermo Fisher Scientific Inc / Franklin Resources Inc / Tenet Healthcare Corp / Revlon Inc / Archer-Daniels-Midland Co / Valero Energy Corp / United Parcel Service Inc / Kroger Co / Exxon Mobil Corp / Nike Inc / Smith & Nephew PLC / Ameriprise Financial Inc / Arrow Electronics Inc / Atmos Energy Corp / Twitter Inc / Tupperware Brands Corp / Owens & Minor Inc / Chevron Corp / Teledyne Technologies Inc / Amgen Inc / Collegium Pharmaceutical Inc / Gentex Corp / Huntington Bancshares Inc / MGP Ingredients Inc / Regeneron Pharmaceuticals Inc / SEI Investments Co / Gilead Sciences Inc / Costco Wholesale Corp / Nektar Therapeutics / Myriad Genetics Inc / SS&C Technologies Holdings Inc / Citrix Systems Inc / Amazon.com Inc / NVIDIA Corp / Plug Power Inc / Charter Communications Inc / Commercial Vehicle Group Inc / Rush Enterprises Inc / Nasdaq Inc / TreeHouse Foods Inc / SunPower Corp / Koppers Holdings Inc / Mastercard Inc / Six Flags Entertainment Corp / Aon PLC / Blackstone Inc / Inovio Pharmaceuticals Inc / BGC Partners Inc / Unitil Corp / Charles Schwab Corp / Express Inc / Motorola Solutions Inc / Groupon Inc / Meta Platforms Inc / Coty Inc / Computer Task Group Inc / MacroGenics Inc / Brixmor Property Group Inc / Ladder Capital Corp / 2U Inc / Anthem Inc / PhenixFIN Corp / Medallion Financial Corp / Hope Bancorp Inc / DXC Technology Co / IQVIA Holdings Inc / Welltower Inc / Tilray Brands Inc / Allogene Therapeutics Inc / Enochian Biosciences Inc / Lyft Inc / Corteva Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom / Ireland / United States / Curaçao</td><td class="leftalignment">Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Chemicals / Consumer / Defense / Electrical / Electronics / Financial Services / Food / Healthcare / Household Products / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Technology / Telecommunications / Transportation / Utilities / Wholesale / Oil & Gas</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Acquisdata</td><td class="leftalignment">Amgen</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">AMGN=US</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE / OPERATING RESULTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Acquisdata Research Team</td></tr>
<tr class="even"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">AMGN.OQ - Event Brief of Amgen Inc conference call, Nov. 02, 2021 / 5:00PM ET</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">AMGN.OQ - Event Transcript of Amgen Inc conference call, Nov. 02, 2021 / 5:00PM ET</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Q321 First Take: EPS Beats Handily Even With Slight Product Revenue Miss</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">11/02/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Short Interest Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">GILD.O / AMGN.O / REGN.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Yinglu Zhang</td></tr>
<tr class="even"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Zephirin Group, Inc.</td><td class="leftalignment">Zephirin Group View: The Dating Game - Key Quarterly Earnings on November 2, 2021</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LYFT.OQ / BP.L / DD.N / EIX.N / EL.N / IBM.N / PEG.N / PFE.N / SEE.N / SLB.N / STE.N / WAT.N / ROK.N / HAL.N / ETN.N / LEA.N / CMI.N / AIZ.N / PGR.N / WEC.N / XOM.N / DVN.N / IT.N / PKI.N / MLM.N / OKE.N / AWK.N / AME.N / PRU.N / COP.N / AMGN.OQ / AAPL.OQ / ATVI.OQ / MSFT.OQ / SBUX.OQ / IDXX.OQ / INCY.OQ / HSIC.OQ / AMZN.OQ / ZBRA.OQ / AKAM.OQ / MTCH.OQ / GPN.N / VRTX.OQ / 0700.HK / RDSa.L / WU.N / 9999.HK / ES.N / VRSK.OQ / GNRC.N / CZR.OQ / MPC.N / BKR.N / XYL.N / MDLZ.OQ / LDOS.N / FMCC.PK / CTLT.N / ZG.OQ / TMUS.OQ / RACE.MI / PUMP.N / PINS.N / BYND.OQ / UBER.N / ZM.OQ / AMCR.N / 9988.HK / 9618.HK / ABNB.OQ</td><td class="leftalignment">Lyft Inc / BP PLC / Dupont De Nemours Inc / Edison International / Estee Lauder Companies Inc / International Business Machines Corp / Public Service Enterprise Group Inc / Pfizer Inc / Sealed Air Corp / Schlumberger NV / STERIS plc / Waters Corp / Rockwell Automation Inc / Halliburton Co / Eaton Corporation PLC / Lear Corp / Cummins Inc / Assurant Inc / Progressive Corp / WEC Energy Group Inc / Exxon Mobil Corp / Devon Energy Corp / Gartner Inc / PerkinElmer Inc / Martin Marietta Materials Inc / ONEOK Inc / American Water Works Company Inc / AMETEK Inc / Prudential Financial Inc / Conocophillips / Amgen Inc / Apple Inc / Activision Blizzard Inc / Microsoft Corp / Starbucks Corp / IDEXX Laboratories Inc / Incyte Corp / Henry Schein Inc / Amazon.com Inc / Zebra Technologies Corp / Akamai Technologies Inc / Match Group Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Tencent Holdings Ltd / Royal Dutch Shell PLC / Western Union Co / NetEase Inc / Eversource Energy / Verisk Analytics Inc / Generac Holdings Inc / Caesars Entertainment Inc / Marathon Petroleum Corp / Baker Hughes Co / Xylem Inc / Mondelez International Inc / Leidos Holdings Inc / Federal Home Loan Mortgage Corp / Catalent Inc / Zillow Group Inc / T-Mobile US Inc / Ferrari NV / ProPetro Holding Corp / Pinterest Inc / Beyond Meat Inc / Uber Technologies Inc / Zoom Video Communications Inc / Amcor PLC / Alibaba Group Holding Ltd / JD.Com Inc / Airbnb Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United Kingdom / Ireland / Netherlands / United States / Jersey / Curaçao</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Communications / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Office Equipment / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Semiconductors / Services / Shipping & Shipbuilding / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment">INVESTMENT STRATEGY / CAPITALIZATION / GOVERNMENT RELATIONS/REGULATIONS / MISCELLANEOUS / SMALL CAPITAL / GOVERNMENTS / RELATIVE VALUE / TRADING / GROWTH / INDEX / PORTFOLIO STRATEGY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Longdley Zephirin</td></tr>
<tr class="odd"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">FISV=US / MRK=US / WMB=US / LLY=US / PFE=US / AMGN=US / BMY=US / KO=US / MCD=US / OXY=US / ADI=US / RRC=US / GBT=US / WEN=US / DVN=US / INCY=US / TXN=US / GILD=US / APA=US / CPE=US / EOG=US / REI=US / XOM=US / CRK=US / WLL=US / PXD=US / DIOD=US / MGY=US / SWN=US / SCOR=US / MUR=US / MRO=US / EXPE=US / LEG=US / SEIC=US / KFRC=US / AMK=US / BNL=US / CBRL=US / ENV=US / CTRA=US / CNX=US / DRI=US / EQT=US / EXEL=US / GPOR=US / HZO=US / MCHP=US / REGI=US / SBAC=US / SSNC=US / TRIP=US / WIX=US / CVX=US / PSA=US / SPG=US / CGEN=US / BKNG=US / ADC=US / CUZ=US / VNO=US / CRTO=US / COP=US / BRX=US / DIN=US / MGNI=US / OGN / JRVR=US / BIIB=US / TXRH=US / PLAY=US / DENN=US / NSP=US / CMG=US / REX=US / FIS=US / GPRE=US / AMRX=US / TAST=US / QSR=US / CLR=US / TIL=US / NOG=US / EPRT=US / JACK=US / RCUS=US / GNRC=US / AR=US / OAS=US / NXPI=US / LPLA=US / ESTE=US / BCEI=US / MTDR=US / PDCE=US / RHP=US / FANG=US / ABBV=US / NDLS=US / ANIP=US / FATE=US / VRNS=US / 00770K202 / VNOM=US / LOCO=US / SHAK=US / ON=US / BWXT=US / WING=US / MCFT=US / WLTW=US / GXO=US / CDEV=US / CRSP=US / TRVG=US / JELD=US / SBOW=US / IOVA=US / FOCS=US / HARP=US / TCRR=US / NXTC=US / GMAB=US / PNTG=US / OVV=US / ZI=US / VTRS=US / ABNB=US / CELU=US / ROCC=US / REPX=US</td><td class="leftalignment">Fiserv Inc / Merck & Co Inc / Williams Companies Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Coca-Cola Co / McDonald's Corp / Occidental Petroleum Corp / Analog Devices Inc / Range Resources Corp / Global Blood Therapeutics Inc / Wendys Co / Devon Energy Corp / Incyte Corp / Texas Instruments Inc / Gilead Sciences Inc / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Exxon Mobil Corp / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Diodes Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Comscore Inc / Murphy Oil Corp / Marathon Oil Corp / Expedia Group Inc / Leggett & Platt Inc / SEI Investments Co / Kforce Inc / AssetMark Financial Holdings Inc / Bunzl plc / Cracker Barrel Old Country Store Inc / Envestnet Inc / Coterra Energy Inc / CNX Resources Corp / Darden Restaurants Inc / EQT Corp / Exelixis Inc / Gulfport Energy Corp / MarineMax Inc / Microchip Technology Inc / Renewable Energy Group Inc / SBA Communications Corp / SS&C Technologies Holdings Inc / Tripadvisor Inc / Wix.Com Ltd / Chevron Corp / Public Storage / Simon Property Group Inc / Compugen Ltd / Booking Holdings Inc / Agree Realty Corp / Cousins Properties Inc / Vornado Realty Trust / Criteo SA / Conocophillips / Brixmor Property Group Inc / Dine Brands Global Inc / Magnite Inc / Organon & Co / James River Group Holdings Ltd / Biogen Inc / Texas Roadhouse Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Insperity Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Fidelity National Information Services Inc / Green Plains Inc / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / Instil Bio Inc / Northern Oil and Gas Inc / Essential Properties Realty Trust Inc / Jack in the Box Inc / Arcus Biosciences Inc / Generac Holdings Inc / Antero Resources Corp / Oasis Petroleum Inc / NXP Semiconductors NV / LPL Financial Holdings Inc / Earthstone Energy Inc / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Ryman Hospitality Properties Inc / Diamondback Energy Inc / Abbvie Inc / Noodles & Co / ANI Pharmaceuticals Inc / Fate Therapeutics Inc / Varonis Systems Inc / Aemetis Inc / Viper Energy Partners LP / El Pollo Loco Holdings Inc / Shake Shack Inc / ON Semiconductor Corp / BWX Technologies Inc / Wingstop Inc / Mastercraft Boat Holdings Inc / Willis Towers Watson PLC / GXO Logistics Inc / Centennial Resource Development Inc / CRISPR Therapeutics AG / Trivago NV / JELD-WEN Holding Inc / SilverBow Resources Inc / Iovance Biotherapeutics Inc / Focus Financial Partners Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / NextCure Inc / Genmab A/S / Pennant Group Inc / Ovintiv Inc / ZoomInfo Technologies Inc / Viatris Inc / Airbnb Inc / Celularity Inc / Ranger Oil Corp / Riley Exploration Permian Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Style Comparisons: November 2, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">AAP.N / AIG.N / ALL.N / APD.N / BDX.N / CAH.N / CI.N / CVS.N / DD.N / EL.N / EOG.N / PFE.N / PNW.N / SO.N / PXD.N / HUM.N / ROK.N / MET.N / ETN.N / DUK.N / DIS.N / D.N / KIM.N / TSN.N / SYY.N / IFF.N / EMR.N / JCI.N / DHI.N / SRE.N / PSA.N / ATO.N / VTR.N / PRU.N / COP.N / AMGN.OQ / JKHY.OQ / ATVI.OQ / REGN.OQ / TT.N / IDXX.OQ / QCOM.OQ / MCHP.OQ / DISH.OQ / TPR.N / ANSS.OQ / MTCH.OQ / ILMN.OQ / EQIX.OQ / GPN.N / VRTX.OQ / FIS.N / MRNA.OQ / FTNT.OQ / NXPI.OQ / MSI.N / MPC.N / EA.OQ / ZTS.N / MAR.OQ / PYPL.OQ / WRK.N / TMUS.OQ / APTV.N / BKNG.OQ / CTVA.N / EXC.OQ / VTRS.OQ</td><td class="leftalignment">Advance Auto Parts Inc / American International Group Inc / Allstate Corp / Air Products and Chemicals Inc / Becton Dickinson and Co / Cardinal Health Inc / Cigna Corp / CVS Health Corp / Dupont De Nemours Inc / Estee Lauder Companies Inc / EOG Resources Inc / Pfizer Inc / Pinnacle West Capital Corp / Southern Co / Pioneer Natural Resources Co / Humana Inc / Rockwell Automation Inc / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Walt Disney Co / Dominion Energy Inc / Kimco Realty Corp / Tyson Foods Inc / Sysco Corp / International Flavors & Fragrances Inc / Emerson Electric Co / Johnson Controls International PLC / D R Horton Inc / Sempra Energy / Public Storage / Atmos Energy Corp / Ventas Inc / Prudential Financial Inc / Conocophillips / Amgen Inc / Jack Henry & Associates Inc / Activision Blizzard Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / DISH Network Corp / Tapestry Inc / ANSYS Inc / Match Group Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Fidelity National Information Services Inc / Moderna Inc / Fortinet Inc / NXP Semiconductors NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Zoetis Inc / Marriott International Inc / PayPal Holdings Inc / Westrock Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / Corteva Inc / Exelon Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Ada's Insights-Quant Strategy: U.S. Return Decomposition-Nov. 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">ALB.N / BAC.N / BMY.N / CL.N / CRM.N / EOG.N / F.N / FDX.N / FMC.N / JPM.N / LLY.N / LMT.N / NEM.N / OXY.N / PNW.N / RHI.N / T.N / TMO.N / WFC.N / SPG.N / PXD.N / NUE.N / CPB.N / DIS.N / UNH.N / D.N / MGM.N / CLX.N / HD.N / MRO.N / WEC.N / XOM.N / DVN.N / IT.N / VZ.N / V.N / MKC.N / HRL.N / CVX.N / COP.N / ADBE.OQ / AMGN.OQ / AAPL.OQ / AMAT.OQ / CSCO.OQ / FISV.OQ / ATVI.OQ / MSFT.OQ / SIVB.OQ / ODFL.OQ / QCOM.OQ / INTU.OQ / INCY.OQ / PENN.OQ / CTXS.OQ / AMZN.OQ / NVDA.OQ / ISRG.OQ / GPN.N / VRTX.OQ / NFLX.OQ / WYNN.OQ / EXR.N / MOS.N / MKTX.OQ / LVS.N / DISCA.OQ / FIS.N / STX.AX / MA.N / WU.N / IPGP.OQ / FTNT.OQ / TSLA.OQ / MPC.N / FANG.OQ / GOOGL.OQ / TMUS.OQ / LW.N / XEL.OQ / FB.PS / AEP.OQ / VTRS.OQ / BBWI.N</td><td class="leftalignment">Albemarle Corp / Bank of America Corp / Bristol-Myers Squibb Co / Colgate-Palmolive Co / Salesforce.Com Inc / EOG Resources Inc / Ford Motor Co / FedEx Corp / FMC Corp / JPMorgan Chase & Co / Eli Lilly and Co / Lockheed Martin Corp / Newmont Corporation / Occidental Petroleum Corp / Pinnacle West Capital Corp / Robert Half International Inc / AT&T Inc / Thermo Fisher Scientific Inc / Wells Fargo & Co / Simon Property Group Inc / Pioneer Natural Resources Co / Nucor Corp / Campbell Soup Co / Walt Disney Co / UnitedHealth Group Inc / Dominion Energy Inc / MGM Resorts International / Clorox Co / Home Depot Inc / Marathon Oil Corp / WEC Energy Group Inc / Exxon Mobil Corp / Devon Energy Corp / Gartner Inc / Verizon Communications Inc / Visa Inc / McCormick & Company Inc / Hormel Foods Corp / Chevron Corp / Conocophillips / Adobe Inc / Amgen Inc / Apple Inc / Applied Materials Inc / Cisco Systems Inc / Fiserv Inc / Activision Blizzard Inc / Microsoft Corp / SVB Financial Group / Old Dominion Freight Line Inc / Qualcomm Inc / Intuit Inc / Incyte Corp / Penn National Gaming Inc / Citrix Systems Inc / Amazon.com Inc / NVIDIA Corp / Intuitive Surgical Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Netflix Inc / Wynn Resorts Ltd / Extra Space Storage Inc / Mosaic Co / Marketaxess Holdings Inc / Las Vegas Sands Corp / Discovery Inc / Fidelity National Information Services Inc / Strike Energy Ltd / Mastercard Inc / Western Union Co / IPG Photonics Corp / Fortinet Inc / Tesla Inc / Marathon Petroleum Corp / Diamondback Energy Inc / Alphabet Inc / T-Mobile US Inc / Lamb Weston Holdings Inc / Xcel Energy Inc / San Miguel Food and Beverage Inc / American Electric Power Company Inc / Viatris Inc / Bath & Body Works Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Jonathan N. Golub, CFA / Mr. Manish G. Bangard / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="even"><td class="leftalignment">11/02/2021</td><td class="leftalignment">ValuEngine, Inc</td><td class="leftalignment">ValuEngine Rating and Forecast Report for AMGN</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Paul Henneman</td></tr>
<tr class="odd"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for AMGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">11/01/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Amgen in bottom 4% performers of NASDAQ-100 Index in past quarter; Sumitomo Mitsui Trust Holdings, Inc. drops 9.2%</td><td class="leftalignment">English</td><td class="rightalignment">76</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">A.N / AAP / AAPL / ACA / ACI / ACN / ADS / AGCO / AIG.N / AIT / AKR / ALLO / AMGN / AMH / AMT / AOS / APPS / ARCC / ASML.AS / ATRC / AXP / AZO / BBY / BCLI / BIO / BJ / BKH / BKI / BKNG / BSET / BYND / C.N / CAKE / CCI / DE / FISV / OM / ALSN / ASND.O / AMZN.O / ATVI.O / ASTE.O / CBRL.O / ADBE.O / ALKS.O / AKAM / AHH / AMBA / AMKR.O / CDK / AMD.O / ADI.O / AQUA / CAMT.O / ARNA.O / CRNT.O / BLDP.O / ADSK.O / ALPN / BRKS.O / CBSH.O / ALGN.O / AVID.O / BLK.N / ARLP.O / BMRN.O / AMSC.O / AYI / AGEN.O / AVGO.O / BLFS / AZPN.OQ / CALM.OQ / AMRN.OQ / CCRN.O / ASYS.O / ABMD.O / ALCO.O / AMWD.O / APOG.O / CAMP.O / AAON.O / BCRX.O / AMED.O / ANSS.O / BDSI.O / BIIB / CARG / 02553E106 / BLKB.O / BJRI / ANGO.O / ACAD.O / BIDU.O / ALNY.O / 029899101 / CDNS.O / CBAY / CCOI / 089302103 / ATNI.O / ALLT.O / AIMC / 02043Q107 / 016255101 / 124805102 / 29076N206 / ATEC.O / CDXC / BLRX / ADUS.O / BCPC.O / CAC.O / CDXS.O / AOSL.O / AMRS.O / 02364V107 / ANGI.O / CCXI / BCOV.O / BLMN.O / 98138H101 / ANIP.O / AGIO / BRX.N / AERI.O / ARMK / CARA.O / AGRX.O / ARDX.O / ARGX.BR / ALDX.O / AFMD.O / APTO.O / ADMA.OQ / AUPH.O / ATEN.K / ABEO.OQ / APPF.O / BLD.N / BWXT.K / AGFS / BLBD.O / AVXL.O / ADAP.O / BPMC.O / AQMS.O / AXSM.O / BABA.K / PHARN.PA / BL.O / ACIU.O / AVDL.O / AKTS.O / APPN.O / ATNX.O / ACER.O / APLS.O / CAAP / BLNK.O / BSIG.N / BTAI.O / BILI.O / AVT.O / CBOE.K / ANIX / BNGO.O / ARVN / BYSI.O / 861780104 / BCYC / ABST.TO / BEST.K / ATXS.O / 45254C200 / 766883102 / 07831X107</td><td class="leftalignment">Agilent Technologies Inc / Advance Auto Parts Inc / Apple Inc / Arcosa Inc / Albertsons Companies Inc / Accenture PLC / Alliance Data Systems Corp / AGCO Corp / American International Group Inc / Applied Industrial Technologies Inc / Acadia Realty Trust / Allogene Therapeutics Inc / Amgen Inc / American Homes 4 Rent / American Tower Corp / A O Smith Corp / Digital Turbine Inc / Ares Capital Corp / ASML Holding NV / AtriCure Inc / American Express Co / Autozone Inc / Best Buy Co Inc / Brainstorm Cell Therapeutics Inc / Bio Rad Laboratories Inc / BJ's Wholesale Club Holdings Inc / Black Hills Corp / Black Knight Inc / Booking Holdings Inc / Bassett Furniture Industries Inc / Beyond Meat Inc / Citigroup Inc / Cheesecake Factory Inc / Crown Castle International Corp / Deere & Co / Fiserv Inc / Outset Medical Inc / Allison Transmission Holdings Inc / Ascendis Pharma A/S / Amazon.com Inc / Activision Blizzard Inc / Astec Industries Inc / Cracker Barrel Old Country Store Inc / Adobe Inc / Alkermes Plc / Akamai Technologies Inc / Armada Hoffler Properties Inc / Ambarella Inc / Amkor Technology Inc / CDK Global Inc / Advanced Micro Devices Inc / Analog Devices Inc / Evoqua Water Technologies Corp / Camtek Ltd / Arena Pharmaceuticals Inc / Ceragon Networks Ltd / Ballard Power Systems Inc / Autodesk Inc / Alpine Immune Sciences Inc / Azenta Inc / Commerce Bancshares Inc / Align Technology Inc / Avid Technology Inc / BlackRock Inc / Alliance Resource Partners LP / Biomarin Pharmaceutical Inc / American Superconductor Corp / Acuity Brands Inc / Agenus Inc / Broadcom Inc / BioLife Solutions Inc / Aspen Technology Inc / Cal-Maine Foods Inc / Amarin Corporation PLC / Cross Country Healthcare Inc / Amtech Systems Inc / ABIOMED Inc / Alico Inc / American Woodmark Corp / Apogee Enterprises Inc / CalAmp Corp / Aaon Inc / BioCryst Pharmaceuticals Inc / Amedisys Inc / ANSYS Inc / BioDelivery Sciences International Inc / Biogen Inc / CarGurus Inc / American Eagle Outfitters Inc / Blackbaud Inc / BJ's Restaurants Inc / AngioDynamics Inc / ACADIA Pharmaceuticals Inc / Baidu Inc / Alnylam Pharmaceuticals Inc / American States Water Co / Cadence Design Systems Inc / Cymabay Therapeutics Inc / Cogent Communications Holdings Inc / Big Lots Inc / ATN International Inc / Allot Ltd / Altra Industrial Motion Corp / Alnylam Pharmaceuticals Inc / Align Technology Inc / CBIZ Inc / eMagin Corp / Alphatec Holdings Inc / Chromadex Corp / BioLine RX Ltd / Addus Homecare Corp / Balchem Corp / Camden National Corp / Codexis Inc / Alpha and Omega Semiconductor Ltd / Amyris Inc / America First Multifamily Investors LP / Angi Inc / ChemoCentryx Inc / Brightcove Inc / Bloomin' Brands Inc / Workday Inc / ANI Pharmaceuticals Inc / Agios Pharmaceuticals Inc / Brixmor Property Group Inc / Aerie Pharmaceuticals Inc / Aramark / Cara Therapeutics Inc / Agile Therapeutics Inc / Ardelyx Inc / argenx SE / Aldeyra Therapeutics Inc / Affimed NV / Aptose Biosciences Inc / ADMA Biologics Inc / Aurinia Pharmaceuticals Inc / A10 Networks Inc / Abeona Therapeutics Inc / Appfolio Inc / TopBuild Corp / BWX Technologies Inc / AgroFresh Solutions Inc / Blue Bird Corp / Anavex Life Sciences Corp / Adaptimmune Therapeutics PLC / Blueprint Medicines Corp / Aqua Metals Inc / Axsome Therapeutics Inc / Alibaba Group Holding Ltd / Pharnext SA / Blackline Inc / AC Immune SA / Avadel Pharmaceuticals PLC / Akoustis Technologies Inc / Appian Corp / Athenex Inc / Acer Therapeutics Inc / Apellis Pharmaceuticals Inc / Corporacion America Airports SA / Blink Charging Co / Brightsphere Investment Group Inc / BioXcel Therapeutics Inc / Bilibili Inc / Avnet Inc / Cboe Global Markets Inc / Anixa Biosciences Inc / Bionano Genomics Inc / Arvinas Inc / Beyondspring Inc / StoneCastle Financial Corp / Bicycle Therapeutics PLC / Absolute Software Corp / BEST Inc / Astria Therapeutics Inc / Immune Pharmaceuticals Inc / RINO International Corp / Bellatora Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / India / Ireland / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/01/2021</td><td class="leftalignment">MacroRisk Analytics/EconomicInvestor</td><td class="leftalignment">The Economy Matters for AMGN</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">031162100</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Oct 22, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / OGN / AMRX=US / VTRS=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Organon & Co / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregory D. Fraser / Ms. Robyn S. Karnauskas / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">SCM.N / HD.N / LOW.N / NKE.N / VZ.N / BJ.N / KMX.N / AMGN.OQ / AAPL.OQ / ASTE.OQ / DIOD.OQ / CRVL.OQ / REGN.OQ / TRMB.OQ / QDEL.OQ / MNRO.OQ / AMSC.OQ / ORLY.OQ / GILD.OQ / VRTS.OQ / FCEL.OQ / ITRI.OQ / INCY.OQ / NATI.OQ / POOL.OQ / NBIX.OQ / CALM.OQ / EEFT.OQ / AMZN.OQ / MKTW.OQ / EXTR.OQ / UTHR.OQ / BMRN.OQ / PLUG.OQ / CHTR.OQ / MTCH.OQ / EXEL.OQ / MRVL.OQ / ARRY.OQ / SGEN.OQ / OSUR.OQ / VRTX.OQ / NFLX.OQ / CMCSA.OQ / PEB.NZ / ALNY.OQ / MPWR.OQ / LHCG.OQ / ATRC.OQ / SPWR.OQ / IOSP.OQ / ATNI.OQ / BIG.N / EHTH.OQ / CSIQ.OQ / FSLR.OQ / FRPT.OQ / LULU.OQ / AGCO.N / CODI.N / XPO.N / DOX.OQ / SAGE.OQ / WW.OQ / FND.N / FOCS.OQ / A71.F / ZWS.N</td><td class="leftalignment">Stellus Capital Investment Corp / Home Depot Inc / Lowe's Companies Inc / Nike Inc / Verizon Communications Inc / BJ's Wholesale Club Holdings Inc / Carmax Inc / Amgen Inc / Apple Inc / Astec Industries Inc / Diodes Inc / CorVel Corp / Regeneron Pharmaceuticals Inc / Trimble Inc / Quidel Corp / Monro Inc / American Superconductor Corp / O'Reilly Automotive Inc / Gilead Sciences Inc / Virtus Investment Partners Inc / Fuelcell Energy Inc / Itron Inc / Incyte Corp / National Instruments Corp / Pool Corp / Neurocrine Biosciences Inc / Cal-Maine Foods Inc / Euronet Worldwide Inc / Amazon.com Inc / MarketWise Inc / Extreme Networks Inc / United Therapeutics Corp / Biomarin Pharmaceutical Inc / Plug Power Inc / Charter Communications Inc / Match Group Inc / Exelixis Inc / Marvell Technology Inc / Array Technologies Inc / Seagen Inc / OraSure Technologies Inc / Vertex Pharmaceuticals Inc / Netflix Inc / Comcast Corp / Pacific Edge Ltd / Alnylam Pharmaceuticals Inc / Monolithic Power Systems Inc / LHC Group Inc / AtriCure Inc / SunPower Corp / Innospec Inc / ATN International Inc / Big Lots Inc / eHealth Inc / Canadian Solar Inc / First Solar Inc / Freshpet Inc / Lululemon Athletica Inc / AGCO Corp / Compass Diversified Holdings / XPO Logistics Inc / Amdocs Ltd / SAGE Therapeutics Inc / WW International Inc / Floor & Decor Holdings Inc / Focus Financial Partners Inc / Ascendis Pharma A/S / Zurn Water Solutions Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / Denmark / Ireland / Israel / Luxembourg / Netherlands / New Zealand / United States / Guernsey</td><td class="leftalignment">Automotive / Biotechnology / Broadcasting & Cable / Consumer / Financial Services / Healthcare / Info. Tech./Peripheral / Leisure & Entertainment / Machinery / Retailing</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Upgrading to Outperform, $200 PT</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ALNY.O / AMGN / EXEL / INCY / NBIX / ASND.O / GILD.O / SGEN / UTHR.O / BMRN.O / REGN.O / VRTX.O / BIIB / MRNA.O / SRPT.O / 04280A100</td><td class="leftalignment">Alnylam Pharmaceuticals Inc / Amgen Inc / Exelixis Inc / Incyte Corp / Neurocrine Biosciences Inc / Ascendis Pharma A/S / Gilead Sciences Inc / Seagen Inc / United Therapeutics Corp / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Moderna Inc / Sarepta Therapeutics Inc / Arrowhead Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Leland Gershell, MD, Ph.D. / Trevor Allred</td></tr>
<tr class="odd"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Oct 22</td><td class="leftalignment">English</td><td class="rightalignment">36</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Calendar: November 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AEE.N / AIG.N / ALB.N / APD.N / BDX.N / BEN.AX / CAH.N / CI.N / CVS.N / DD.N / EL.N / EOG.N / FLT.N / MCK.N / PFE.N / PNW.N / SO.N / WMB.N / SPG.N / PXD.N / HUM.N / ROK.N / MET.N / ETN.N / DUK.N / DIS.N / CMI.N / D.N / PH.N / KIM.N / CLX.N / SYY.N / IFF.N / VNO.N / EMR.N / WEC.N / XOM.N / MTD.N / JCI.N / DHI.N / SRE.N / PSA.N / ATO.N / AWK.N / AME.N / VTR.N / CVX.N / PRU.N / L.N / COP.N / AMGN.OQ / JKHY.OQ / HOLX.OQ / ATVI.OQ / REGN.OQ / TT.N / IDXX.OQ / QCOM.OQ / MCHP.OQ / O.N / DISH.OQ / TPR.N / ANSS.OQ / SBAC.OQ / MTCH.OQ / ILMN.OQ / EQIX.OQ / GPN.N / VRTX.OQ / MNST.OQ / MOS.N / FIS.N / ES.N / MRNA.OQ / VRSK.OQ / FTNT.OQ / NXPI.OQ / MSI.N / MPC.N / EA.OQ / FANG.OQ / ZTS.N / LEGN.DE / CDW.OQ / MAR.OQ / ANET.N / ETSY.OQ / ZBH.N / PYPL.OQ / WRK.N / TMUS.OQ / APTV.N / BKNG.OQ / WELL.N / CTVA.N / EXC.OQ / VTRS.OQ</td><td class="leftalignment">Ameren Corp / American International Group Inc / Albemarle Corp / Air Products and Chemicals Inc / Becton Dickinson and Co / Bendigo and Adelaide Bank Ltd / Cardinal Health Inc / Cigna Corp / CVS Health Corp / Dupont De Nemours Inc / Estee Lauder Companies Inc / EOG Resources Inc / Fleetcor Technologies Inc / Mckesson Corp / Pfizer Inc / Pinnacle West Capital Corp / Southern Co / Williams Companies Inc / Simon Property Group Inc / Pioneer Natural Resources Co / Humana Inc / Rockwell Automation Inc / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Walt Disney Co / Cummins Inc / Dominion Energy Inc / Parker-Hannifin Corp / Kimco Realty Corp / Clorox Co / Sysco Corp / International Flavors & Fragrances Inc / Vornado Realty Trust / Emerson Electric Co / WEC Energy Group Inc / Exxon Mobil Corp / Mettler-Toledo International Inc / Johnson Controls International PLC / D R Horton Inc / Sempra Energy / Public Storage / Atmos Energy Corp / American Water Works Company Inc / AMETEK Inc / Ventas Inc / Chevron Corp / Prudential Financial Inc / Loews Corp / Conocophillips / Amgen Inc / Jack Henry & Associates Inc / Hologic Inc / Activision Blizzard Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Realty Income Corp / DISH Network Corp / Tapestry Inc / ANSYS Inc / SBA Communications Corp / Match Group Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Mosaic Co / Fidelity National Information Services Inc / Eversource Energy / Moderna Inc / Verisk Analytics Inc / Fortinet Inc / NXP Semiconductors NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Diamondback Energy Inc / Zoetis Inc / LEG Immobilien SE / CDW Corp / Marriott International Inc / Arista Networks Inc / ETSY Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / Westrock Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / Welltower Inc / Corteva Inc / Exelon Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Germany / Ireland / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">10/31/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Key Considerations Ahead of 3Q Results</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AMGN</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MRK-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK / ABT / BMY / JNJ / LLY / NVS / PFE / AMGN.O / GSK / TEVA.K / SNY.O</td><td class="leftalignment">Merck & Co Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">10/29/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Biotechnology : 3Q Earnings Season: What's on Tap for the Week Ahead</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">AMGN.O / MRNA.O / INCY.O / REGN.O / VRTX.O / RARE.O / CLVS.O / SAGE.O / PBYI.O / JNCE.O / ALLO.O</td><td class="leftalignment">Amgen Inc / Moderna Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Clovis Oncology Inc / SAGE Therapeutics Inc / Puma Biotechnology Inc / Jounce Therapeutics Inc / Allogene Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Mr. Thomas Deal / Ms. Tiffany Sun / Manish Jajoo</td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended October 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">10/29/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief: October 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AIG.N / APD.N / BDX.N / BEN.AX / CAH.N / CI.N / CL.N / CVS.N / DD.N / EL.N / EOG.N / MCK.N / PFE.N / PNW.N / SO.N / WMB.N / SPG.N / WY.N / PXD.N / HUM.N / ROK.N / MET.N / ETN.N / DUK.N / DIS.N / D.N / KIM.N / RCL.N / CLX.N / SYY.N / IFF.N / VNO.N / EMR.N / XOM.N / GWW.N / JCI.N / DHI.N / SRE.N / PSA.N / ATO.N / CHD.N / VTR.N / CVX.N / PRU.N / L.N / COP.N / AMGN.OQ / AAPL.OQ / CERN.OQ / JKHY.OQ / HOLX.OQ / ATVI.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / O.N / DISH.OQ / TPR.N / ANSS.OQ / AMZN.OQ / SBAC.OQ / CHTR.OQ / MTCH.OQ / ILMN.OQ / EQIX.OQ / GPN.N / VRTX.OQ / CMCSA.OQ / MOS.N / FIS.N / AON.N / ES.N / MRNA.OQ / FTNT.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / FANG.OQ / ABBV.N / ZTS.N / MAR.OQ / ANET.N / PYPL.OQ / WRK.N / TMUS.OQ / APTV.N / BKNG.OQ / CBOE.Z / NWL.OQ / CTVA.N / EXC.OQ / VTRS.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / Becton Dickinson and Co / Bendigo and Adelaide Bank Ltd / Cardinal Health Inc / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / Estee Lauder Companies Inc / EOG Resources Inc / Mckesson Corp / Pfizer Inc / Pinnacle West Capital Corp / Southern Co / Williams Companies Inc / Simon Property Group Inc / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Rockwell Automation Inc / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Walt Disney Co / Dominion Energy Inc / Kimco Realty Corp / Royal Caribbean Cruises Ltd / Clorox Co / Sysco Corp / International Flavors & Fragrances Inc / Vornado Realty Trust / Emerson Electric Co / Exxon Mobil Corp / W W Grainger Inc / Johnson Controls International PLC / D R Horton Inc / Sempra Energy / Public Storage / Atmos Energy Corp / Church & Dwight Co Inc / Ventas Inc / Chevron Corp / Prudential Financial Inc / Loews Corp / Conocophillips / Amgen Inc / Apple Inc / Cerner Corp / Jack Henry & Associates Inc / Hologic Inc / Activision Blizzard Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Realty Income Corp / DISH Network Corp / Tapestry Inc / ANSYS Inc / Amazon.com Inc / SBA Communications Corp / Charter Communications Inc / Match Group Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Comcast Corp / Mosaic Co / Fidelity National Information Services Inc / Aon PLC / Eversource Energy / Moderna Inc / Fortinet Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / Marriott International Inc / Arista Networks Inc / PayPal Holdings Inc / Westrock Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / Cboe Global Markets Inc / Newell Brands Inc / Corteva Inc / Exelon Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Ireland / Liberia / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Back on Track - Biotech Inflows Return</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ARE-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMY / LLY / PFE / GILD.O / AMGN.O / ILMN.O / THRX.O / ALNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Theseus Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Turkey / United States</td><td class="leftalignment">Real Estate</td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">CYTR-US - Fundamental Analysis, for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">CYTR.PK / JNJ / NVS / AMGN.O / GSK / CRIS.O / SGEN.O / MRNA.O / CLDX.O / NWBO.PK / AOLS.PK</td><td class="leftalignment">CytRx Corp / Johnson & Johnson / Novartis AG / Amgen Inc / GlaxoSmithKline PLC / Curis Inc / Seagen Inc / Moderna Inc / Celldex Therapeutics Inc / Northwest Biotherapeutics Inc / Aeolus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">IDRA-US - Fundamental Analysis, for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">IDRA.O / ABT / JNJ / MRK / PFE / AMGN.O / AGEN.O / LGND.O / BIIB.O / DVAX.O / CLDX.O</td><td class="leftalignment">Idera Pharmaceuticals Inc / Abbott Laboratories / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Amgen Inc / Agenus Inc / Ligand Pharmaceuticals Inc / Biogen Inc / Dynavax Technologies Corp / Celldex Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ZIOP-US - Fundamental Analysis, for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ZIOP.O / BAX / BMY / AMGN.O / CYTR.PK</td><td class="leftalignment">ZIOPHARM Oncology Inc / Baxter International Inc / Bristol-Myers Squibb Co / Amgen Inc / CytRx Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">AIN / FISV=US / BSX=US / CACI=US / AMGN=US / BMY=US / HD=US / KO=US / MCD=US / AMD=US / RRC=US / IP=US / AVB=US / DT=US / EBAY=US / PEB=US / H=US / CONE=US / NOVA=US / MTN=US / CRK=US / CHKP=US / PB=US / VRM=US / XLNX=US / BYD=US / MAR=US / SPOT=US / TTMI=US / TNL=US / MGM=US / HLT=US / PENN=US / EQR=US / CI=US / AIR=US / APH=US / ATRO=US / BLL=US / B=US / BMRN=US / CHH=US / CYH=US / CCK=US / CW=US / DRH=US / DCO=US / EQT=US / HEI=US / HXL=US / NOW=US / MAS=US / MCRI=US / MNRO=US / ASGN=US / PDM=US / REGN=US / ROLL=US / SLGN=US / SFT=US / VSEC=US / SGMS=US / R=US / MAA=US / SSB=US / SPR=US / DRE=US / ENSG=US / AMSF=US / BCO=US / MOH=US / MOG.A=US / CZR=US / EXR=US / SHO=US / FIS=US / HST=US / SIX=US / PAG=US / TEL=US / OC=US / EHC=US / WH=US / 45665G303 / INSE / AR=US / HGV=US / NXPI=US / WWD=US / RLJ=US / VAC=US / MTDR=US / RHP=US / ABBV=US / NDLS=US / LDOS=US / NEWR=US / BVH=US / LOB=US / EVRI=US / EVBG=US / PK=US / PLYA=US / CVNA=US / GSHD=US / FTDR=US / HARP=US / DDOG=US / TSHA / NGMS=US</td><td class="leftalignment">Albany International Corp / Fiserv Inc / Boston Scientific Corp / CACI International Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / Coca-Cola Co / McDonald's Corp / Advanced Micro Devices Inc / Range Resources Corp / International Paper Co / Avalonbay Communities Inc / Dynatrace Inc / eBay Inc / Pebblebrook Hotel Trust / Hyatt Hotels Corp / CyrusOne Inc / Sunnova Energy International Inc / Vail Resorts Inc / Comstock Resources Inc / Check Point Software Technologies Ltd / Prosperity Bancshares Inc / Vroom Inc / Xilinx Inc / Boyd Gaming Corp / Marriott International Inc / Spotify Technology SA / TTM Technologies Inc / Travel + Leisure Co / MGM Resorts International / Hilton Worldwide Holdings Inc / Penn National Gaming Inc / Equity Residential / Cigna Corp / AAR Corp / Amphenol Corp / Astronics Corp / Ball Corp / Barnes Group Inc / Biomarin Pharmaceutical Inc / Choice Hotels International Inc / Community Health Systems Inc / Crown Holdings Inc / Curtiss-Wright Corp / Diamondrock Hospitality Co / Ducommun Inc / EQT Corp / HEICO Corp / Hexcel Corp / ServiceNow Inc / Masco Corp / Monarch Casino & Resort Inc / Monro Inc / ASGN Inc / Piedmont Office Realty Trust Inc / Regeneron Pharmaceuticals Inc / RBC Bearings Inc / Silgan Holdings Inc / Shift Technologies Inc / VSE Corp / Scientific Games Corp / Ryder System Inc / Mid-America Apartment Communities Inc / SouthState Corp / Spirit AeroSystems Holdings Inc / Duke Realty Corp / Ensign Group Inc / Amerisafe Inc / Brinks Co / Molina Healthcare Inc / Moog Inc / Caesars Entertainment Inc / Extra Space Storage Inc / Sunstone Hotel Investors Inc / Fidelity National Information Services Inc / Host Hotels & Resorts Inc / Six Flags Entertainment Corp / Penske Automotive Group Inc / TE Connectivity Ltd / Owens Corning / Encompass Health Corp / Wyndham Hotels & Resorts Inc / Infinity Pharmaceuticals Inc / Inspired Entertainment Inc / Antero Resources Corp / Hilton Grand Vacations Inc / NXP Semiconductors NV / Woodward Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Matador Resources Co / Ryman Hospitality Properties Inc / Abbvie Inc / Noodles & Co / Leidos Holdings Inc / New Relic Inc / Bluegreen Vacations Holding Corp / Live Oak Bancshares Inc / Everi Holdings Inc / Everbridge Inc / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Carvana Co / Goosehead Insurance Inc / Frontdoor Inc / Harpoon Therapeutics Inc / Datadog Inc / Taysha Gene Therapies Inc / NeoGames SA</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Global Comparison: October 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AAP.N / AIG.N / APD.N / BDX.N / BEN.AX / CAH.N / CI.N / CL.N / CVS.N / DD.N / EL.N / EOG.N / KO.N / MCK.N / MO.N / PFE.N / PNW.N / SO.N / WMB.N / SPG.N / WY.N / PXD.N / HUM.N / ROK.N / MET.N / ETN.N / DUK.N / DIS.N / D.N / CAT.N / KIM.N / RCL.N / CLX.N / MCD.N / SYY.N / IFF.N / VNO.N / SYK.N / ITW.N / EMR.N / VMC.N / XOM.N / AMT.N / LIN.N / GWW.N / JCI.N / DHI.N / SRE.N / PSA.N / ATO.N / CHD.N / VTR.N / CVX.N / MCO.N / PRU.N / L.N / NWS.AX / COP.N / AMGN.OQ / AAPL.OQ / CERN.OQ / JKHY.OQ / HOLX.OQ / ATVI.OQ / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / SBAC.OQ / CHTR.OQ / MTCH.OQ / ILMN.OQ / EQIX.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / MOS.N / DXCM.OQ / ICE.N / FIS.N / AON.N / ES.N / MRNA.OQ / NWSA.OQ / FTNT.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / FANG.OQ / ABBV.N / ZTS.N / MAR.OQ / ANET.N / PYPL.OQ / WRK.N / TMUS.OQ / APTV.N / BKNG.OQ / CBOE.Z / CTVA.N / EXC.OQ / CARR.N / VTRS.OQ</td><td class="leftalignment">Advance Auto Parts Inc / American International Group Inc / Air Products and Chemicals Inc / Becton Dickinson and Co / Bendigo and Adelaide Bank Ltd / Cardinal Health Inc / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / Estee Lauder Companies Inc / EOG Resources Inc / Coca-Cola Co / Mckesson Corp / Altria Group Inc / Pfizer Inc / Pinnacle West Capital Corp / Southern Co / Williams Companies Inc / Simon Property Group Inc / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Rockwell Automation Inc / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Walt Disney Co / Dominion Energy Inc / Caterpillar Inc / Kimco Realty Corp / Royal Caribbean Cruises Ltd / Clorox Co / McDonald's Corp / Sysco Corp / International Flavors & Fragrances Inc / Vornado Realty Trust / Stryker Corp / Illinois Tool Works Inc / Emerson Electric Co / Vulcan Materials Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / W W Grainger Inc / Johnson Controls International PLC / D R Horton Inc / Sempra Energy / Public Storage / Atmos Energy Corp / Church & Dwight Co Inc / Ventas Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / News Corp / Conocophillips / Amgen Inc / Apple Inc / Cerner Corp / Jack Henry & Associates Inc / Hologic Inc / Activision Blizzard Inc / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / SBA Communications Corp / Charter Communications Inc / Match Group Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / Dexcom Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / Aon PLC / Eversource Energy / Moderna Inc / News Corp / Fortinet Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / Marriott International Inc / Arista Networks Inc / PayPal Holdings Inc / Westrock Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / Cboe Global Markets Inc / Corteva Inc / Exelon Corp / Carrier Global Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Ireland / Liberia / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="even"><td class="leftalignment">10/27/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">U.S. Generics Soft; Still Struggling With LT EBITDA Visibility</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">881624209 / 031162100 / 00287Y109 / 03168L105 / 92556V106</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Abbvie Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">David A. Amsellem / Zachary Sachar / Isaac C. Somekh</td></tr>
<tr class="odd"><td class="leftalignment">10/27/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Hitting The Reset Button On Our PT (Now $17/Sh) As We Think Through Catalysts & Competition</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">HARP=US / AMGN=US / REGN=US / ABBV=US</td><td class="leftalignment">Harpoon Therapeutics Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Asthika Goonewardene / Billal Jahangiri</td></tr>
<tr class="even"><td class="leftalignment">10/27/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US00846U1016 / US0311621009 / US03753U1060 / US74374N1028 / TSHA</td><td class="leftalignment">Agilent Technologies Inc / Amgen Inc / Apellis Pharmaceuticals Inc / Provention Bio Inc / Taysha Gene Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">10/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Price Action: October 27, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AIG.N / APD.N / BA.N / BDX.N / BEN.AX / BMY.N / BSX.N / CAH.N / CI.N / CL.N / CVS.N / DD.N / EL.N / EOG.N / F.N / GM.N / KO.N / MCK.N / MO.N / NSC.N / PFE.N / PNW.N / SO.N / WMB.N / SPG.N / WY.N / PXD.N / HUM.N / ROK.N / MET.N / ETN.N / DUK.N / D.N / PH.N / CAT.N / KIM.N / RCL.N / CLX.N / MCD.N / SYY.N / IFF.N / VNO.N / SYK.N / ITW.N / EMR.N / VMC.N / XOM.N / AMT.N / LIN.N / GWW.N / JCI.N / DHI.N / SRE.N / PSA.N / V.N / EW.N / CHD.N / VTR.N / CVX.N / MCO.N / PRU.N / L.N / NWS.AX / COP.N / AMGN.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / JKHY.OQ / HOLX.OQ / KLAC.OQ / ATVI.OQ / MSFT.OQ / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / SBAC.OQ / CHTR.OQ / MTCH.OQ / ILMN.OQ / EQIX.OQ / ALGN.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / MOS.N / DXCM.OQ / ICE.N / FIS.N / ADP.PA / AON.N / ES.N / MRNA.OQ / CME.OQ / NWSA.OQ / FTNT.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / ZTS.N / MAR.OQ / NCLH.N / GOOGL.OQ / ANET.N / PYPL.OQ / WRK.N / TMUS.OQ / APTV.N / BKNG.OQ / CBOE.Z / CTVA.N / EXC.OQ / CARR.N / VTRS.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / Boeing Co / Becton Dickinson and Co / Bendigo and Adelaide Bank Ltd / Bristol-Myers Squibb Co / Boston Scientific Corp / Cardinal Health Inc / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / Estee Lauder Companies Inc / EOG Resources Inc / Ford Motor Co / General Motors Co / Coca-Cola Co / Mckesson Corp / Altria Group Inc / Norfolk Southern Corp / Pfizer Inc / Pinnacle West Capital Corp / Southern Co / Williams Companies Inc / Simon Property Group Inc / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Rockwell Automation Inc / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Dominion Energy Inc / Parker-Hannifin Corp / Caterpillar Inc / Kimco Realty Corp / Royal Caribbean Cruises Ltd / Clorox Co / McDonald's Corp / Sysco Corp / International Flavors & Fragrances Inc / Vornado Realty Trust / Stryker Corp / Illinois Tool Works Inc / Emerson Electric Co / Vulcan Materials Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / W W Grainger Inc / Johnson Controls International PLC / D R Horton Inc / Sempra Energy / Public Storage / Visa Inc / Edwards Lifesciences Corp / Church & Dwight Co Inc / Ventas Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / News Corp / Conocophillips / Amgen Inc / Apple Inc / Cerner Corp / Fiserv Inc / Jack Henry & Associates Inc / Hologic Inc / KLA Corp / Activision Blizzard Inc / Microsoft Corp / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / SBA Communications Corp / Charter Communications Inc / Match Group Inc / Illumina Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / Dexcom Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / Aeroports de Paris SA / Aon PLC / Eversource Energy / Moderna Inc / CME Group Inc / News Corp / Fortinet Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / Marriott International Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / Arista Networks Inc / PayPal Holdings Inc / Westrock Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / Cboe Global Markets Inc / Corteva Inc / Exelon Corp / Carrier Global Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / France / Ireland / Liberia / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="even"><td class="leftalignment">10/27/2021</td><td class="leftalignment">Valens Research</td><td class="leftalignment">Valens Equity Insights and Inflections - 2021 10 26</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">CBRL.OQ / FOXF.OQ / EL.N / GM.N / WCC.N / LOW.N / UPS.N / MMM.N / XOM.N / AMT.N / COP.N / AMGN.OQ / FISV.OQ / SBUX.OQ / AMED.OQ / CHTR.OQ / CMCSA.OQ / COTY.N / IONS.OQ / TWLO.N / DKNG.OQ</td><td class="leftalignment">Cracker Barrel Old Country Store Inc / Fox Factory Holding Corp / Estee Lauder Companies Inc / General Motors Co / Wesco International Inc / Lowe's Companies Inc / United Parcel Service Inc / 3M Co / Exxon Mobil Corp / American Tower Corp / Conocophillips / Amgen Inc / Fiserv Inc / Starbucks Corp / Amedisys Inc / Charter Communications Inc / Comcast Corp / Coty Inc / Ionis Pharmaceuticals Inc / Twilio Inc / DraftKings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Air Transportation / Automotive / Biotechnology / Broadcasting & Cable / Conglomerates / Consumer / Healthcare / Lodging & Restaurants / Real Estate / Retailing / Technology / Wholesale / Oil & Gas / Internet</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION / MORNING COMMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Valens Research</td></tr>
<tr class="odd"><td class="leftalignment">10/26/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ARE-US -  Dividend Quality Analysis, for the period ended October 15,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY / LLY / PFE / GILD.O / AMGN.O / ILMN.O / THRX.O / ALNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Theseus Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Turkey / United States</td><td class="leftalignment">Real Estate</td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/26/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GILD-US -  Dividend Quality Analysis, for the period ended September 29,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD.O / BIOb / JNJ / LLY / MRK / PFE / AMGN.O / ILMN.O / VRTX.O / BIIB.O / ABBV.K</td><td class="leftalignment">Gilead Sciences Inc / Bio Rad Laboratories Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Illumina Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">10/26/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MRK-US -  Dividend Quality Analysis, for the period ended October 07,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK / ABT / BMY / JNJ / LLY / NVS / PFE / AMGN.O / GSK / TEVA.K / SNY.O</td><td class="leftalignment">Merck & Co Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/26/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">ARO-C3 development plan allows for quick de-risking of the mechanism and multiple paths to market</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ARWR / US0311621009 / US03753U1060</td><td class="leftalignment">Arrowhead Pharmaceuticals Inc / Amgen Inc / Apellis Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek</td></tr>
<tr class="odd"><td class="leftalignment">10/26/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Short Interest in Biotechnology Stocks</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US0311621009 / US3755581036 / US75886F1075 / US92532F1003 / US7665596034 / US02043Q1076 / US40637H1095 / US09609G1004 / US45845P1084 / US31189P1021 / US03820J1007 / US92686J1060 / US09627Y1091 / US4622221004 / US5588681057 / US03753U1060 / US2997341035 / US80706P1030 / US76029N1063 / US04335A1051 / US2936141033 / US50015M1099 / US85789A1051 / US62921N1054 / US61775R1059 / US30205M1018 / US80810D1037 / US12529R1077 / CA00288U1066 / US67080N1019 / US24343R1068</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Rigel Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Halozyme Therapeutics Inc / bluebird bio Inc / Intercept Pharmaceuticals Inc / Fate Therapeutics Inc / Applied Genetic Technologies Corp / Viking Therapeutics Inc / Blueprint Medicines Corp / Ionis Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Evelo Biosciences Inc / Scholar Rock Holding Corp / Replimune Group Inc / Arvinas Inc / Entasis Therapeutics Holdings Inc / Kodiak Sciences Inc / Stealth BioTherapeutics Corp / NGM Biopharmaceuticals Inc / Morphic Holding Inc / Exicure Inc / Schrodinger Inc / C4 Therapeutics Inc / Abcellera Biologics Inc / Nuvation Bio Inc / Decibel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Matthew Luchini / Jin Lee</td></tr>
<tr class="even"><td class="leftalignment">10/26/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US0311621009 / US75886F1075 / US02043Q1076 / US45845P1084 / IL0011313900</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Galmed Pharmaceuticals Ltd</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">10/26/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Broad Domestic Declines Continue With No Signals of Seasonally Driven Wave, FDA Authorizes Moderna and JNJ Boosters</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">10/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Style Comparisons: October 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AIG.N / APD.N / BA.N / BDX.N / BMY.N / BSX.N / CB.N / CI.N / CL.N / COF.N / CVS.N / DD.N / ECL.N / EL.N / EOG.N / F.N / GE.N / GM.N / KMB.N / KO.N / LLY.N / LMT.N / MCK.N / MO.N / NSC.N / PFE.N / PNW.N / SO.N / WMB.N / SPG.N / WY.N / PXD.N / HUM.N / ROK.N / MET.N / ETN.N / DUK.N / D.N / PH.N / CAT.N / KIM.N / RCL.N / CLX.N / MCD.N / SYY.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / EMR.N / VMC.N / XOM.N / AMT.N / LIN.N / SHW.N / GWW.N / JCI.N / SRE.N / PWR.N / PSA.N / V.N / EW.N / CHD.N / VTR.N / CVX.N / MCO.N / PRU.N / L.N / NWS.AX / COP.N / AMGN.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / HOLX.OQ / KLAC.OQ / ATVI.OQ / MSFT.OQ / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / SBAC.OQ / CHTR.OQ / MTCH.OQ / ILMN.OQ / EQIX.OQ / ALGN.OQ / GPN.N / VRTX.OQ / MNST.OQ / TXN.OQ / CMCSA.OQ / MOS.N / DXCM.OQ / ICE.N / FIS.N / ADP.PA / AON.N / MRNA.OQ / CME.OQ / NWSA.OQ / FTNT.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / ZTS.N / LEGN.DE / MAR.OQ / GOOGL.OQ / ANET.N / PYPL.OQ / TMUS.OQ / APTV.N / BKNG.OQ / FB.PS / CTVA.N / EXC.OQ / RTX.N / CARR.N / VTRS.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / Boeing Co / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Cigna Corp / Colgate-Palmolive Co / Capital One Financial Corp / CVS Health Corp / Dupont De Nemours Inc / Ecolab Inc / Estee Lauder Companies Inc / EOG Resources Inc / Ford Motor Co / General Electric Co / General Motors Co / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Mckesson Corp / Altria Group Inc / Norfolk Southern Corp / Pfizer Inc / Pinnacle West Capital Corp / Southern Co / Williams Companies Inc / Simon Property Group Inc / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Rockwell Automation Inc / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Dominion Energy Inc / Parker-Hannifin Corp / Caterpillar Inc / Kimco Realty Corp / Royal Caribbean Cruises Ltd / Clorox Co / McDonald's Corp / Sysco Corp / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Emerson Electric Co / Vulcan Materials Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Sherwin-Williams Co / W W Grainger Inc / Johnson Controls International PLC / Sempra Energy / Quanta Services Inc / Public Storage / Visa Inc / Edwards Lifesciences Corp / Church & Dwight Co Inc / Ventas Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / News Corp / Conocophillips / Amgen Inc / Apple Inc / Cerner Corp / Fiserv Inc / Hologic Inc / KLA Corp / Activision Blizzard Inc / Microsoft Corp / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / SBA Communications Corp / Charter Communications Inc / Match Group Inc / Illumina Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Texas Instruments Inc / Comcast Corp / Mosaic Co / Dexcom Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / Aeroports de Paris SA / Aon PLC / Moderna Inc / CME Group Inc / News Corp / Fortinet Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / LEG Immobilien SE / Marriott International Inc / Alphabet Inc / Arista Networks Inc / PayPal Holdings Inc / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / San Miguel Food and Beverage Inc / Corteva Inc / Exelon Corp / Raytheon Technologies Corp / Carrier Global Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / Ireland / Liberia / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">10/25/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BIIB-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BIIB.O / BIO / JNJ / PFE / GILD.O / AMGN.O / ILMN.O / ACOR.O / ABBV.K / QGEN.K / SNY.O</td><td class="leftalignment">Biogen Inc / Bio Rad Laboratories Inc / Johnson & Johnson / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Acorda Therapeutics Inc / Abbvie Inc / Qiagen NV / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for AMGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">A Target That May Check Off All the Boxes; Upcoming Histology Data is Key Inflection Point</td><td class="leftalignment">English</td><td class="rightalignment">54</td><td class="leftalignment">ETNB / US0311621009 / US75886F1075 / US02043Q1076 / US45845P1084 / IL0011313900</td><td class="leftalignment">89Bio Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Galmed Pharmaceuticals Ltd</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Research Digest</td><td class="leftalignment">Ms. Kristen Kluska</td></tr>
<tr class="even"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Oct 15, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">10/25/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - October 25, 2021</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">ALV.N / AXP.N / BAC.N / BK.N / C.N / CB.N / CCI.N / CL.N / COF.N / EL.N / F.N / FITB.O / FOUG.PA / FSR.N / GM.N / JPM.N / KEY.N / KMB.N / KO.N / MO.N / NTRS.O / PNC.N / PNW.N / SGEF.PA / SLB.N / T.N / USB.N / VC.N / WFC.N / PEP.N / BFb.N / PG.N / CNQ.TO / TEN.N / CMCSA.O / RCIb.TO / CHKP.O / AMGN.O / ETR.N / THC.N / BWA.N / LEA.N / ROP.N / K.N / DT.N / DISH.O / EPR.N / GS.N / CLX.N / CAG.N / HON.N / VLO.N / GIS.N / HSY.N / EPC.N / AMT.N / WHR.N / CONE.O / OLN.N / VZ.N / STT.N / HCA.N / STZ.N / AMP.N / LNC.N / APH.N / FISV.O / V.N / AXL.N / CHD.N / MTB.N / VTR.N / SAM.N / CTSH.O / AJG.N / BMRN.O / REGN.O / ENR.N / PRU.N / NCR.N / TEL.N / SSNC.O / RF.N / ST.N / CRC.N / PLUG.OQ / GPN.N / FFBC.O / CASY.O / EQIX.O / ATDb.TO / TFC.N / 416515104 / WAL.N / LHCG.O / DRX.L / MS.N / FIS.N / MA.N / AON.N / IVZ.N / BGS.N / DAN.N / AAV.TO / SPB.N / WCP.TO / FHI.N / MTOR.N / BKR.N / SPLK.OQ / FFHu.TO / MDLZ.OQ / ALLY.N / APAM.N / TSLA.N / TMUS.N / COTY.N / 81762P102 / QURE.O / VRNS.O / ARES.N / CFG.N / ANTM.N / PYPL.OQ / SQ.N / RMR.OQ / MP1.AX / TWLO.N / UN01.DE / ADNT.N / ATUS.N / ATNX.O / APTV.N / COLD.N / WELL.N / VCTR.N / BSIG.N / VNE.N / KDP.N / BHC.N / NWL.O / PINS.N / GMAB.O / CRNC.OQ / OAS.OQ / VMD.OQ / NKLA.OQ / FOUR.N / JAMF.O / RIDE.OQ / LSPD.N / NAPA.N / OSO.N / TSP.OQ / OTLY.O / TRMR.OQ / RYAN.N / COOK.N / BASE.OQ / CWAN.N</td><td class="leftalignment">Autoliv Inc / American Express Co / Bank of America Corp / Bank of New York Mellon Corp / Citigroup Inc / Chubb Ltd / Crown Castle International Corp / Colgate-Palmolive Co / Capital One Financial Corp / Estee Lauder Companies Inc / Ford Motor Co / Fifth Third Bancorp / Eiffage SA / Fisker Inc / General Motors Co / JPMorgan Chase & Co / KeyCorp / Kimberly-Clark Corp / Coca-Cola Co / Altria Group Inc / Northern Trust Corp / PNC Financial Services Group Inc / Pinnacle West Capital Corp / Vinci SA / Schlumberger NV / AT&T Inc / US Bancorp / Visteon Corp / Wells Fargo & Co / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Canadian Natural Resources Ltd / Tenneco Inc / Comcast Corp / Rogers Communications Inc / Check Point Software Technologies Ltd / Amgen Inc / Entergy Corp / Tenet Healthcare Corp / Borgwarner Inc / Lear Corp / Roper Technologies Inc / Kellogg Co / Dynatrace Inc / DISH Network Corp / EPR Properties / Goldman Sachs Group Inc / Clorox Co / Conagra Brands Inc / Honeywell International Inc / Valero Energy Corp / General Mills Inc / Hershey Co / Edgewell Personal Care Co / American Tower Corp / Whirlpool Corp / CyrusOne Inc / Olin Corp / Verizon Communications Inc / State Street Corp / HCA Healthcare Inc / Constellation Brands Inc / Ameriprise Financial Inc / Lincoln National Corp / Amphenol Corp / Fiserv Inc / Visa Inc / American Axle & Manufacturing Holdings Inc / Church & Dwight Co Inc / M&T Bank Corp / Ventas Inc / Boston Beer Company Inc / Cognizant Technology Solutions Corp / Arthur J Gallagher & Co / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Prudential Financial Inc / NCR Corp / TE Connectivity Ltd / SS&C Technologies Holdings Inc / Regions Financial Corp / Sensata Technologies Holding PLC / California Resources Corp / Plug Power Inc / Global Payments Inc / First Financial Bancorp / Caseys General Stores Inc / Equinix Inc / Alimentation Couche-Tard Inc / Truist Financial Corp / Hartford Financial Services Group Inc / Western Alliance Bancorp / LHC Group Inc / Drax Group PLC / Morgan Stanley / Fidelity National Information Services Inc / Mastercard Inc / Aon PLC / Invesco Ltd / B&G Foods Inc / Dana Inc / Advantage Energy Ltd / Spectrum Brands Holdings Inc / Whitecap Resources Inc / Federated Hermes Inc / Meritor Inc / Baker Hughes Co / Splunk Inc / Fairfax Financial Holdings Ltd / Mondelez International Inc / Ally Financial Inc / Artisan Partners Asset Management Inc / Tesla Inc / T-Mobile US Inc / Coty Inc / ServiceNow Inc / Uniqure NV / Varonis Systems Inc / Ares Management Corp / Citizens Financial Group Inc / Anthem Inc / PayPal Holdings Inc / Block Inc / RMR Group Inc / Megaport Ltd / Twilio Inc / Uniper SE / Adient PLC / Altice USA Inc / Athenex Inc / Aptiv PLC / Americold Realty Trust / Welltower Inc / Victory Capital Holdings Inc / Brightsphere Investment Group Inc / Veoneer Inc / Keurig Dr Pepper Inc / Bausch Health Companies Inc / Newell Brands Inc / Pinterest Inc / Genmab A/S / Cerence Inc / Oasis Petroleum Inc / Viemed Healthcare Inc / Nikola Corp / Shift4 Payments Inc / Jamf Holding Corp / Lordstown Motors Corp / Lightspeed Commerce Inc / Duckhorn Portfolio Inc / Olo Inc / TuSimple Holdings Inc / Oatly Group AB / Tremor International Ltd / Ryan Specialty Group Holdings Inc / Traeger Inc / Couchbase Inc / Clearwater Analytics Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Germany / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / Sweden / United States / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Calendar: October 25, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AEE.N / AIG.N / ALB.N / APD.N / AXP.N / BA.N / BAX.N / BDX.N / BMY.N / BSX.N / CB.N / CI.N / CL.N / CNC.N / COF.N / CVS.N / DD.N / ECL.N / EL.N / EOG.N / F.N / FLT.N / GE.N / GM.N / KMB.N / KO.N / LLY.N / LMT.N / MCK.N / MO.N / NEM.N / NSC.N / PFE.N / PNW.N / SO.N / TEL.PS / WMB.N / SPG.N / WY.N / PXD.N / HUM.N / ROK.N / UHS.N / MET.N / ADML.L / ETN.N / DUK.N / CMI.N / D.N / GD.N / PH.N / CAT.N / KIM.N / RCL.N / CLX.N / MCD.N / SYY.N / YUM.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / EMR.N / VMC.N / WEC.N / XOM.N / AMT.N / RMD.N / MTD.N / LIN.N / SHW.N / PKG.N / BLL.N / GWW.N / JCI.N / APH.N / SRE.N / PWR.N / PSA.N / V.N / EW.N / AWK.N / ARE.N / CHD.N / TWTR.N / AME.N / VTR.N / CVX.N / MCO.N / PRU.N / L.N / NWS.AX / COP.N / AMGN.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / HOLX.OQ / KLAC.OQ / ATVI.OQ / MSFT.OQ / BRO.N / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / ORLY.OQ / GILD.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / EBAY.OQ / SBAC.OQ / CHTR.OQ / MTCH.OQ / ILMN.OQ / EQIX.OQ / ALGN.OQ / GPN.N / VRTX.OQ / MNST.OQ / TXN.OQ / SWKS.O / CMCSA.OQ / MOS.N / DLR.N / DXCM.OQ / CDNS.OQ / ICE.N / FIS.N / ADP.PA / AON.N / ES.N / MRNA.OQ / CME.OQ / NWSA.OQ / MSCI.N / VRSK.OQ / FTNT.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / ZTS.N / LEGN.DE / CDW.OQ / MAR.OQ / GOOGL.OQ / ANET.N / ETSY.OQ / ZBH.N / TMUS.OQ / APTV.N / BKNG.OQ / WELL.N / FB.PS / CBOE.Z / NWL.OQ / CTVA.N / EXC.OQ / RTX.N / CARR.N / OTIS.N / AEP.OQ / HON.OQ</td><td class="leftalignment">Ameren Corp / American International Group Inc / Albemarle Corp / Air Products and Chemicals Inc / American Express Co / Boeing Co / Baxter International Inc / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Cigna Corp / Colgate-Palmolive Co / Centene Corp / Capital One Financial Corp / CVS Health Corp / Dupont De Nemours Inc / Ecolab Inc / Estee Lauder Companies Inc / EOG Resources Inc / Ford Motor Co / Fleetcor Technologies Inc / General Electric Co / General Motors Co / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Mckesson Corp / Altria Group Inc / Newmont Corporation / Norfolk Southern Corp / Pfizer Inc / Pinnacle West Capital Corp / Southern Co / PLDT Inc / Williams Companies Inc / Simon Property Group Inc / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Rockwell Automation Inc / Universal Health Services Inc / MetLife Inc / Admiral Group PLC / Eaton Corporation PLC / Duke Energy Corp / Cummins Inc / Dominion Energy Inc / General Dynamics Corp / Parker-Hannifin Corp / Caterpillar Inc / Kimco Realty Corp / Royal Caribbean Cruises Ltd / Clorox Co / McDonald's Corp / Sysco Corp / Yum! Brands Inc / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Emerson Electric Co / Vulcan Materials Co / WEC Energy Group Inc / Exxon Mobil Corp / American Tower Corp / Resmed Inc / Mettler-Toledo International Inc / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Ball Corp / W W Grainger Inc / Johnson Controls International PLC / Amphenol Corp / Sempra Energy / Quanta Services Inc / Public Storage / Visa Inc / Edwards Lifesciences Corp / American Water Works Company Inc / Alexandria Real Estate Equities Inc / Church & Dwight Co Inc / Twitter Inc / AMETEK Inc / Ventas Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / News Corp / Conocophillips / Amgen Inc / Apple Inc / Cerner Corp / Fiserv Inc / Hologic Inc / KLA Corp / Activision Blizzard Inc / Microsoft Corp / Brown & Brown Inc / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / O'Reilly Automotive Inc / Gilead Sciences Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / eBay Inc / SBA Communications Corp / Charter Communications Inc / Match Group Inc / Illumina Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Texas Instruments Inc / Skyworks Solutions Inc / Comcast Corp / Mosaic Co / Digital Realty Trust Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / Aeroports de Paris SA / Aon PLC / Eversource Energy / Moderna Inc / CME Group Inc / News Corp / MSCI Inc / Verisk Analytics Inc / Fortinet Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / LEG Immobilien SE / CDW Corp / Marriott International Inc / Alphabet Inc / Arista Networks Inc / ETSY Inc / Zimmer Biomet Holdings Inc / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / Welltower Inc / San Miguel Food and Beverage Inc / Cboe Global Markets Inc / Newell Brands Inc / Corteva Inc / Exelon Corp / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / American Electric Power Company Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Ireland / Liberia / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">China Healthcare Sector: China PD-(L)1 on the move: Picking long-term winners in a competitive race</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">BGNE.OQ / 1877.HK / BMY.N / LLY.N / PFE.N / AZN.L / SASY.PA / ROG.S / 1177.HK / GSK.L / NVS.N / AMGN.OQ / CHRS.OQ / REGN.OQ / INCY.OQ / AGEN.OQ / 600276.SS / 0950.HK / 002437.SZ / 300003.SZ / MRTX.OQ / ZLAB.OQ / 6160.HK / 1801.HK</td><td class="leftalignment">Beigene Ltd / Shanghai Junshi Biosciences Co Ltd / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Sino Biopharmaceutical Ltd / GlaxoSmithKline PLC / Novartis AG / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Incyte Corp / Agenus Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Lee's Pharmaceutical Holdings Ltd / Harbin Gloria Pharmaceuticals Co Ltd / Lepu Medical Technology Beijing Co Ltd / Mirati Therapeutics Inc / Zai Lab Ltd / Beigene Ltd / Innovent Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">10/23/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / BMRN.O / REGN.O / ATNX.O / GMAB.O</td><td class="leftalignment">Amgen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Athenex Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="odd"><td class="leftalignment">10/23/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 570</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">10/23/2021</td><td class="leftalignment">Valens Research</td><td class="leftalignment">AMGN - Embedded Expectations Analysis - 2021 10 22</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">CAPITALIZATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Valens Research</td></tr>
<tr class="odd"><td class="leftalignment">10/22/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Navigating Project Optimus Recap: Shift to Earlier Dose-Randomization; Intelligent Trial Design Could Lessen Timeline Impacts</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">10/22/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended October 15, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">10/22/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">10/22/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">R&D Day Highlights mRNAi GOLD Expanding Into PV With Longer Than Expected Duration of Action; 2-3 INDs per Year by 2023</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 45337C102 / 462222100</td><td class="leftalignment">Amgen Inc / Incyte Corp / Ionis Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Myles R. R. Minter</td></tr>
<tr class="odd"><td class="leftalignment">10/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief: October 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AIG.N / APD.N / AXP.N / BA.N / BDX.N / BMY.N / BSX.N / CB.N / CI.N / CL.N / COF.N / CVS.N / DD.N / ECL.N / EL.N / F.N / FCX.N / GE.N / GM.N / KMB.N / KO.N / LLY.N / LMT.N / MCK.N / MO.N / NSC.N / PFE.N / SLB.N / SO.N / T.N / WMB.N / SPG.N / WY.N / PXD.N / HUM.N / ROK.N / UHS.N / MET.N / ETN.N / DUK.N / DHR.N / ROP.N / CAT.N / RCL.N / CLX.N / MCD.N / SYY.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / EMR.N / XOM.N / AMT.N / LIN.N / SHW.N / PKG.N / HCA.N / VFC.N / PSA.N / V.N / EW.N / ARE.N / CHD.N / CVX.N / MCO.N / PRU.N / L.N / RF.N / COP.N / INTC.OQ / AMGN.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / HOLX.OQ / KLAC.OQ / ATVI.OQ / MSFT.OQ / BRO.N / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / ANSS.OQ / AMZN.OQ / SBAC.OQ / CHTR.OQ / MTCH.OQ / ILMN.OQ / EQIX.OQ / ALGN.OQ / GPN.N / VRTX.OQ / TXN.OQ / CMCSA.OQ / MOS.N / DXCM.OQ / CDNS.OQ / ICE.N / CMG.N / FIS.N / STX.AX / ADP.PA / AON.N / MRNA.OQ / CME.OQ / VRSK.OQ / FTNT.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / ZTS.N / LEGN.DE / MAR.OQ / GOOGL.OQ / ANET.N / TMUS.OQ / APTV.N / BKNG.OQ / WELL.N / FB.PS / CTVA.N / EXC.OQ / RTX.N / CARR.N / OTIS.N / HON.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / American Express Co / Boeing Co / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Cigna Corp / Colgate-Palmolive Co / Capital One Financial Corp / CVS Health Corp / Dupont De Nemours Inc / Ecolab Inc / Estee Lauder Companies Inc / Ford Motor Co / Freeport-McMoRan Inc / General Electric Co / General Motors Co / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Mckesson Corp / Altria Group Inc / Norfolk Southern Corp / Pfizer Inc / Schlumberger NV / Southern Co / AT&T Inc / Williams Companies Inc / Simon Property Group Inc / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Rockwell Automation Inc / Universal Health Services Inc / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Danaher Corp / Roper Technologies Inc / Caterpillar Inc / Royal Caribbean Cruises Ltd / Clorox Co / McDonald's Corp / Sysco Corp / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Emerson Electric Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / HCA Healthcare Inc / VF Corp / Public Storage / Visa Inc / Edwards Lifesciences Corp / Alexandria Real Estate Equities Inc / Church & Dwight Co Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Regions Financial Corp / Conocophillips / Intel Corp / Amgen Inc / Apple Inc / Cerner Corp / Fiserv Inc / Hologic Inc / KLA Corp / Activision Blizzard Inc / Microsoft Corp / Brown & Brown Inc / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / ANSYS Inc / Amazon.com Inc / SBA Communications Corp / Charter Communications Inc / Match Group Inc / Illumina Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Texas Instruments Inc / Comcast Corp / Mosaic Co / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Chipotle Mexican Grill Inc / Fidelity National Information Services Inc / Strike Energy Ltd / Aeroports de Paris SA / Aon PLC / Moderna Inc / CME Group Inc / Verisk Analytics Inc / Fortinet Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / LEG Immobilien SE / Marriott International Inc / Alphabet Inc / Arista Networks Inc / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / Welltower Inc / San Miguel Food and Beverage Inc / Corteva Inc / Exelon Corp / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Switzerland / Germany / France / Ireland / Liberia / Netherlands / Philippines / United States / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="even"><td class="leftalignment">10/22/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">New PCP Migraine Survey Paints Increasingly Bullish Nurtec Picture</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">031162100 / 00287Y109 / G11196105</td><td class="leftalignment">Amgen Inc / Abbvie Inc / Biohaven Pharmaceutical Holding Company Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">10/21/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Back to the Hurt Locker: Biotech Outflows Return</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">10/21/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Amgen Inc.(AMGN) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">031162100</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">10/21/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Increasing SERD Royalties, Looking for Full Data to Clarify Safety; PT to $29</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">75046920 / 04635310 / 03116210 / F5548N10</td><td class="leftalignment">Radius Health Inc / AstraZeneca PLC / Amgen Inc / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Daniel Tarjan, Ph.D. / Na Sun / Anna Baran, CFA</td></tr>
<tr class="even"><td class="leftalignment">10/21/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Price Action: October 21, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BMY.N / BSX.N / CB.N / CL.N / COF.N / CVS.N / DD.N / DOW.N / ECL.N / EL.N / FCX.N / GE.N / GM.N / KMB.N / KO.N / LLY.N / LMT.N / LUV.N / MCK.N / MMC.N / MO.N / NSC.N / PFE.N / SLB.N / T.N / WMB.N / SPG.N / WY.N / PXD.N / HUM.N / NUE.N / ROK.N / UHS.N / MET.N / ETN.N / DHR.N / GD.N / ROP.N / CAT.N / UNP.N / CLX.N / MCD.N / SYY.N / VLO.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / EMR.N / XOM.N / AMT.N / LIN.N / SHW.N / PKG.N / VZ.N / HCA.N / JCI.N / VFC.N / PSA.N / V.N / EW.N / ARE.N / CHD.N / CVX.N / MCO.N / PRU.N / L.N / RF.N / COP.N / INTC.OQ / AMGN.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / HOLX.OQ / KLAC.OQ / ATVI.OQ / MSFT.OQ / BRO.N / TROW.OQ / SIVB.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / GILD.OQ / TSCO.OQ / O.N / AMZN.OQ / SBAC.OQ / CHTR.OQ / MTCH.OQ / EQIX.OQ / ALGN.OQ / GPN.N / VRTX.OQ / TXN.OQ / CMCSA.OQ / MOS.N / DXCM.OQ / CDNS.OQ / ICE.N / CMG.N / STX.AX / ADP.PA / AON.N / CME.OQ / MSCI.N / VRSK.OQ / TSLA.OQ / NXPI.OQ / LYB.N / MSI.N / KEY.TO / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / LEGN.DE / MAR.OQ / GOOGL.OQ / ANET.N / TMUS.OQ / IQV.N / BKNG.OQ / FB.PS / CTVA.N / EXC.OQ / RTX.N / CARR.N / OTIS.N / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Colgate-Palmolive Co / Capital One Financial Corp / CVS Health Corp / Dupont De Nemours Inc / Dow Inc / Ecolab Inc / Estee Lauder Companies Inc / Freeport-McMoRan Inc / General Electric Co / General Motors Co / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Mckesson Corp / Marsh & McLennan Companies Inc / Altria Group Inc / Norfolk Southern Corp / Pfizer Inc / Schlumberger NV / AT&T Inc / Williams Companies Inc / Simon Property Group Inc / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Nucor Corp / Rockwell Automation Inc / Universal Health Services Inc / MetLife Inc / Eaton Corporation PLC / Danaher Corp / General Dynamics Corp / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / Clorox Co / McDonald's Corp / Sysco Corp / Valero Energy Corp / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Emerson Electric Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Verizon Communications Inc / HCA Healthcare Inc / Johnson Controls International PLC / VF Corp / Public Storage / Visa Inc / Edwards Lifesciences Corp / Alexandria Real Estate Equities Inc / Church & Dwight Co Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Regions Financial Corp / Conocophillips / Intel Corp / Amgen Inc / Apple Inc / Cerner Corp / Fiserv Inc / Hologic Inc / KLA Corp / Activision Blizzard Inc / Microsoft Corp / Brown & Brown Inc / T Rowe Price Group Inc / SVB Financial Group / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Gilead Sciences Inc / Tractor Supply Co / Realty Income Corp / Amazon.com Inc / SBA Communications Corp / Charter Communications Inc / Match Group Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Texas Instruments Inc / Comcast Corp / Mosaic Co / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Chipotle Mexican Grill Inc / Strike Energy Ltd / Aeroports de Paris SA / Aon PLC / CME Group Inc / MSCI Inc / Verisk Analytics Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Keyera Corp / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / LEG Immobilien SE / Marriott International Inc / Alphabet Inc / Arista Networks Inc / T-Mobile US Inc / IQVIA Holdings Inc / Booking Holdings Inc / San Miguel Food and Beverage Inc / Corteva Inc / Exelon Corp / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / Germany / France / Ireland / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Oct 20 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">SE0000108656 / US09061G1013 / US00971T1016 / US0311621009 / US1924461023 / US2786421030 / US30161Q1040 / US3755581036 / US4062161017 / US4282911084 / US4433201062 / US45253H1014 / US45337C1027 / US4567881085 / US4781601046 / US64125C1099 / US75886F1075 / US91307C1027 / US92343V1044 / US92532F1003 / CA1363751027 / US64110L1061 / US2948216088 / US20030N1019 / US09062X1037 / US0042251084 / US02043Q1076 / US2538681030 / US00206R1023 / US3020811044 / US29089Q1058 / US92932M1018 / NL0000687663 / US87874R1005 / US53261M1045 / US03152W1099 / BMG3922B1072 / US90384S3031 / US25470M1099 / IE00B4BNMY34 / US46333X1081 / US9100471096 / US29414B1044 / NL0010273215 / US8725901040 / US09609G1004 / US8036071004 / US4576693075 / US6951271005 / US00912X3026 / US74587V1070 / US45845P1084 / US23283R1005 / US29428V1044 / US69366J2006 / US29664W1053 / US4277461020 / US5034596040 / US90400D1081 / KYG8807B1068 / LU0974299876 / US78667J1088 / US0994061002 / US2681582019 / US31572Q8087 / CA89620X5064 / US29444U7000 / US09627Y1091 / US12685J1051 / US37890U1088 / US4622221004 / US07725L1026 / US16119P1084 / US36165L1089 / US2067871036 / US23355L1061 / IL0011407140 / US02156K1034 / US87105L1044 / US76243J1051 / US5011471027 / US77313F1066 / US89854H1023 / US09354A1007 / US05455M1009 / US29260V1052 / US0197701065 / US61775R1059 / US85205L1070 / US39813G1094 / US4432011082 / US65487U1088 / US07373B1098 / US20451W1018 / US69353Y1038 / US81181C1045 / US50107A1043 / KYG3902L1095 / US74767V1098 / US7761531083 / US15961R1059 / US25401T1088 / US30052F1003 / US88546E1055</td><td class="leftalignment">Telefonaktiebolaget LM Ericsson / Biomarin Pharmaceutical Inc / Akamai Technologies Inc / Amgen Inc / Cognizant Technology Solutions Corp / eBay Inc / Exelixis Inc / Gilead Sciences Inc / Halliburton Co / Hexcel Corp / Hub Group Inc / ImmunoGen Inc / Incyte Corp / Infosys Ltd / Johnson & Johnson / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / United Therapeutics Corp / Verizon Communications Inc / Vertex Pharmaceuticals Inc / Canadian National Railway Co / Netflix Inc / Telefonaktiebolaget LM Ericsson / Comcast Corp / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Digital Realty Trust Inc / AT&T Inc / Exlservice Holdings Inc / Emergent BioSolutions Inc / WNS (Holdings) Ltd / AerCap Holdings NV / TechTarget Inc / Limelight Networks Inc / Amicus Therapeutics Inc / Genpact Ltd / Ulta Beauty Inc / DISH Network Corp / Accenture PLC / Ironwood Pharmaceuticals Inc / United Airlines Holdings Inc / Epam Systems Inc / ASML Holding NV / T-Mobile US Inc / bluebird bio Inc / Sarepta Therapeutics Inc / Insmed Inc / Pacira Biosciences Inc / Air Lease Corp / Puma Biotechnology Inc / Intercept Pharmaceuticals Inc / CyrusOne Inc / Epizyme Inc / PTC Therapeutics Inc / Esperion Therapeutics Inc / Heron Therapeutics Inc / La Jolla Pharmaceutical Co / Ultragenyx Pharmaceutical Inc / Theravance Biopharma Inc / Globant SA / SAGE Therapeutics Inc / Boot Barn Holdings Inc / Dynavax Technologies Corp / FibroGen Inc / Pfizer Inc / Equinix Inc / Blueprint Medicines Corp / Cable One Inc / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Beigene Ltd / Charter Communications Inc / GDS Holdings Ltd / Conduent Inc / DXC Technology Co / Urogen Pharma Ltd / Altice USA Inc / Switch Inc / Rhythm Pharmaceuticals Inc / Krystal Biotech Inc / Rocket Pharmaceuticals Inc / TTEC Holdings Inc / Blink Charging Co / AVROBIO Inc / Endava PLC / Allogene Therapeutics Inc / Morphic Holding Inc / SpringWorks Therapeutics Inc / Grid Dynamics Holdings Inc / Howmet Aerospace Inc / Nkarta Inc / Beam Global / Compass Pathways PLC / PMV Pharmaceuticals Inc / Seagen Inc / Kronos Bio Inc / GDS Holdings Ltd / Quantumscape Corp / Romeo Power Inc / ChargePoint Holdings Inc / DigitalBridge Group Inc / EVgo Inc / Thoughtworks Holding Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Cayman Islands / United Kingdom / India / Ireland / Israel / Luxembourg / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q3 Earnings Preview: Wishing For A Biotech Rally To End 2021</td><td class="leftalignment">English</td><td class="rightalignment">285</td><td class="leftalignment">US09061G1013 / US0311621009 / US30161Q1040 / US3755581036 / US45337C1027 / US64125C1099 / US75886F1075 / US91307C1027 / US92532F1003 / US09062X1037 / US0042251084 / US02043Q1076 / US29089Q1058 / US03152W1099 / US46333X1081 / US8036071004 / US4576693075 / US6951271005 / US74587V1070 / US45845P1084 / US29428V1044 / US69366J2006 / US29664W1053 / US4277461020 / US5034596040 / US90400D1081 / KYG8807B1068 / US78667J1088 / US2681582019 / US31572Q8087 / US09627Y1091 / US37890U1088 / US4622221004 / US07725L1026 / IL0011407140 / US76243J1051 / US05455M1009 / US61775R1059 / US81181C1045</td><td class="leftalignment">Biomarin Pharmaceutical Inc / Amgen Inc / Exelixis Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Emergent BioSolutions Inc / Amicus Therapeutics Inc / Ironwood Pharmaceuticals Inc / Sarepta Therapeutics Inc / Insmed Inc / Pacira Biosciences Inc / Puma Biotechnology Inc / Intercept Pharmaceuticals Inc / Epizyme Inc / PTC Therapeutics Inc / Esperion Therapeutics Inc / Heron Therapeutics Inc / La Jolla Pharmaceutical Co / Ultragenyx Pharmaceutical Inc / Theravance Biopharma Inc / SAGE Therapeutics Inc / Dynavax Technologies Corp / FibroGen Inc / Blueprint Medicines Corp / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Beigene Ltd / Urogen Pharma Ltd / Rhythm Pharmaceuticals Inc / AVROBIO Inc / Morphic Holding Inc / Seagen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Cayman Islands / Germany / Denmark / United Kingdom / Ireland / Israel / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Cowen Biotechnology Team</td></tr>
<tr class="odd"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Amgen Inc.</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="even"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Global Comparison: October 20, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BMY.N / BSX.N / CB.N / CL.N / COF.N / DD.N / DOW.N / ECL.N / EL.N / F.N / FCX.N / GE.N / GM.N / IBM.N / JNJ.N / KMB.N / KO.N / LLY.N / LMT.N / LUV.N / MCK.N / MMC.N / MO.N / NSC.N / PFE.N / PPG.N / SLB.N / T.N / WMB.N / SPG.N / PG.N / WY.N / NUE.N / ROK.N / UHS.N / ETN.N / DHR.N / ROP.N / CAT.N / UNP.N / CLX.N / MCD.N / VLO.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / XOM.N / AMT.N / LIN.N / SHW.N / PKG.N / VZ.N / HCA.N / VFC.N / KMI.N / EFX.N / PSA.N / V.N / EW.N / ARE.N / CHD.N / CVX.N / MCO.N / PRU.N / RF.N / COP.N / INTC.OQ / AMGN.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / HOLX.OQ / KLAC.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / NTRS.OQ / BRO.N / TROW.OQ / SIVB.OQ / SBUX.OQ / IDXX.OQ / GILD.OQ / DFS.N / TSCO.OQ / O.N / AMZN.OQ / CHTR.OQ / MTCH.OQ / ALGN.OQ / GPN.N / VRTX.OQ / NFLX.OQ / TXN.OQ / CMCSA.OQ / BIIB.OQ / MOS.N / NDAQ.OQ / DXCM.OQ / CDNS.OQ / ICE.N / CMG.N / STX.AX / ADP.PA / AON.N / CME.OQ / MSCI.N / VRSK.OQ / NEE.N / TSLA.OQ / NXPI.OQ / LYB.N / MSI.N / KEY.TO / MPC.N / PSX.N / NOW.N / FANG.OQ / ABBV.N / LEGN.DE / GOOGL.OQ / ANET.N / ANTM.N / TMUS.OQ / CSX.OQ / IQV.N / FB.PS / RTX.N / CARR.N / OTIS.N / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Colgate-Palmolive Co / Capital One Financial Corp / Dupont De Nemours Inc / Dow Inc / Ecolab Inc / Estee Lauder Companies Inc / Ford Motor Co / Freeport-McMoRan Inc / General Electric Co / General Motors Co / International Business Machines Corp / Johnson & Johnson / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Mckesson Corp / Marsh & McLennan Companies Inc / Altria Group Inc / Norfolk Southern Corp / Pfizer Inc / PPG Industries Inc / Schlumberger NV / AT&T Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Weyerhaeuser Co / Nucor Corp / Rockwell Automation Inc / Universal Health Services Inc / Eaton Corporation PLC / Danaher Corp / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / Clorox Co / McDonald's Corp / Valero Energy Corp / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Verizon Communications Inc / HCA Healthcare Inc / VF Corp / Kinder Morgan Inc / Equifax Inc / Public Storage / Visa Inc / Edwards Lifesciences Corp / Alexandria Real Estate Equities Inc / Church & Dwight Co Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Regions Financial Corp / Conocophillips / Intel Corp / Amgen Inc / Apple Inc / Cerner Corp / Fiserv Inc / Hologic Inc / KLA Corp / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / Northern Trust Corp / Brown & Brown Inc / T Rowe Price Group Inc / SVB Financial Group / Starbucks Corp / IDEXX Laboratories Inc / Gilead Sciences Inc / Discover Financial Services / Tractor Supply Co / Realty Income Corp / Amazon.com Inc / Charter Communications Inc / Match Group Inc / Align Technology Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Netflix Inc / Texas Instruments Inc / Comcast Corp / Biogen Inc / Mosaic Co / Nasdaq Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Chipotle Mexican Grill Inc / Strike Energy Ltd / Aeroports de Paris SA / Aon PLC / CME Group Inc / MSCI Inc / Verisk Analytics Inc / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Keyera Corp / Marathon Petroleum Corp / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / LEG Immobilien SE / Alphabet Inc / Arista Networks Inc / Anthem Inc / T-Mobile US Inc / CSX Corp / IQVIA Holdings Inc / San Miguel Food and Beverage Inc / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / Germany / France / Ireland / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Korea Healthcare Sector - Readacross from JNJ 3Q21 results and Roche/Atea's Ph-2 update on oral COVID drug candidate</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">068270.KS / 091990.KQ / JNJ.N / MRK.N / PFE.N / AMGN.OQ / 000100.KS / RO.S / 006280.KS / MRNA.OQ</td><td class="leftalignment">Celltrion Inc / Celltrion Healthcare Co Ltd / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Amgen Inc / Yuhan Corp / Roche Holding AG / Green Cross Corp / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Korea, Republic of / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="even"><td class="leftalignment">10/19/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Amgen Inc: Intraday vs Overnight Returns 2016-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">10/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Oct 19 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">MOGa / HEI.N / FR0000054470 / BE0165385973 / US0079031078 / US0123481089 / US01741R1023 / US0311621009 / US0382221051 / US0463531089 / US0970231058 / US0997241064 / US1101221083 / US1442851036 / US2358511028 / US2855121099 / US3695501086 / US37733W1053 / US4228061093 / US4282911084 / US4385161066 / US4523271090 / US4781601046 / US5128071082 / US5324571083 / US5398301094 / US55306N1046 / US5949181045 / US6668071029 / US66987V1098 / US6701002056 / US7170811035 / US7475251036 / US7711951043 / US8356993076 / US8740541094 / US8835561023 / US8968181011 / US91307C1027 / US9807451037 / CA0977512007 / IL0010824113 / JP3435000009 / US92343X1000 / US80105N1054 / US1167941087 / US6098391054 / US8936411003 / US8485741099 / US00507V1098 / CA9609083097 / CA0585861085 / US58933Y1055 / US5218652049 / US34959E1091 / US1920051067 / US88160R1014 / US69404D1081 / US29082A1079 / US92839U2069 / US4464131063 / JE00B783TY65 / US03027X1000 / US98986T1088 / US29414B1044 / US00287Y1091 / US98978V1035 / US81762P1021 / US72919P2020 / US6974351057 / US63009R1095 / US29664W1053 / US60468T1051 / NL0010696654 / US9222801022 / US09062W2044 / US98936J1016 / US04523Y1055 / US22822V1017 / US30050B1017 / GB00BZ09BD16 / US98138J2069 / US07725L1026 / US90138F1021 / US78410G1040 / US23355L1061 / US03236M2008 / US98980G1022 / US92336X1090 / US2575541055 / US01671P1003 / US28414H1032 / US90184D1000 / IL0011571556 / US03828A1016 / US22788C1053 / US5024311095 / US88025U1097 / US18915M1071 / US85205L1070 / US1567271093 / US4432011082 / US75513E1010 / US6541101050 / GB00BMVP7Y09 / US75943R1023 / US8334451098 / US03044L1052 / US22041X1028 / US38246G1085 / US33813J1060 / US81578P1066 / US00810F1066 / US72815L1070 / US67080N1019 / LU2314763264 / US49926T1043 / US90089L1089 / US90364P1057 / US68622V1061 / US23954D1090 / US81730H1095 / US28489L1044 / US30049H1023 / IL0011786154 / US3696043013 / US75340L1044 / US00091E1091 / CA50202P1053 / US45254E1073 / IL0011794802 / US34631B1017 / US90240B1061 / IL0011796625 / US00152K1016 / US8852601090 / US1095041000 / US2297901009</td><td class="leftalignment">Moog Inc / HEICO Corp / Ubisoft Entertainment SA / Melexis NV / Advanced Micro Devices Inc / Albany International Corp / Allegheny Technologies Inc / Amgen Inc / Applied Materials Inc / AstraZeneca PLC / Boeing Co / Borgwarner Inc / Bristol-Myers Squibb Co / Carpenter Technology Corp / Danaher Corp / Electronic Arts Inc / General Dynamics Corp / GlaxoSmithKline PLC / HEICO Corp / Hexcel Corp / Honeywell International Inc / Illumina Inc / Johnson & Johnson / Lam Research Corp / Eli Lilly and Co / Lockheed Martin Corp / MKS Instruments Inc / Microsoft Corp / Northrop Grumman Corp / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Qualcomm Inc / Roche Holding AG / Sony Group Corp / Take-Two Interactive Software Inc / Thermo Fisher Scientific Inc / Triumph Group Inc / United Therapeutics Corp / Woodward Inc / Bombardier Inc / Check Point Software Technologies Ltd / Sony Group Corp / Verint Systems Inc / Sanofi SA / Bruker Corp / Monolithic Power Systems Inc / TransDigm Group Inc / Spirit AeroSystems Holdings Inc / Activision Blizzard Inc / Westport Fuel Systems Inc / Ballard Power Systems Inc / Merck & Co Inc / Lear Corp / Fortinet Inc / Codexis Inc / Tesla Inc / Pacific Biosciences of California Inc / Embraer SA / Visteon Corp / Huntington Ingalls Industries Inc / Aptiv PLC / American Tower Corp / Zynga Inc / Epam Systems Inc / Abbvie Inc / Zoetis Inc / ServiceNow Inc / Plug Power Inc / Palo Alto Networks Inc / NanoString Technologies Inc / Esperion Therapeutics Inc / Mirati Therapeutics Inc / Uniqure NV / Varonis Systems Inc / BioLife Solutions Inc / Zendesk Inc / Aspen Aerogels Inc / Crown Castle International Corp / Evolent Health Inc / Atlassian Corporation PLC / Workhorse Group Inc / Beigene Ltd / Twilio Inc / SBA Communications Corp / DXC Technology Co / Amyris Inc / Zscaler Inc / Veoneer Inc / Domo Inc / Allakos Inc / Elanco Animal Health Inc / Twist Bioscience Corp / Tufin Software Technologies Ltd / Applied Therapeutics Inc / CrowdStrike Holdings Inc / L3harris Technologies Inc / 10X Genomics Inc / Cloudflare Inc / SpringWorks Therapeutics Inc / Cerence Inc / Howmet Aerospace Inc / Raytheon Technologies Corp / Nikola Corp / Royalty Pharma PLC / Relay Therapeutics Inc / Snowflake Inc. / American Well Corp / Corsair Gaming Inc / Goodrx Holdings Inc / Fisker Inc / Seer Inc / AerSale Corp / Playtika Holding Corp / Nuvation Bio Inc / Arrival SA / Knowbe4 Inc / TuSimple Holdings Inc / UiPath Inc / Organon & Co / Day One Biopharmaceuticals Inc / SentinelOne Inc / Electric Last Mile Solutions Inc / Evolv Technologies Holdings Inc / REE Automotive Ltd / General Electric Co / Rapid Micro Biosystems Inc / Absci Corp / Li-Cycle Holdings Corp / Immuneering Corp / Cellebrite DI Ltd / ForgeRock Inc / Tyra Biosciences Inc / Arbe Robotics Ltd / AKA Brands Holding Corp / Thorne Healthtech Inc / Brilliant Earth Group Inc / Cue Health Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Brazil / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Japan / Luxembourg / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">10/18/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Highlights From KOL Call on FGFR, BRAF and Other Targeted Therapy Approaches</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US0311621009 / US7170811035 / US60468T1051 / US07725L1026 / US85205L1070 / US75943R1023 / US67080N1019 / US23954D1090 / US45254E1073 / US90240B1061</td><td class="leftalignment">Amgen Inc / Pfizer Inc / Mirati Therapeutics Inc / Beigene Ltd / SpringWorks Therapeutics Inc / Relay Therapeutics Inc / Nuvation Bio Inc / Day One Biopharmaceuticals Inc / Immuneering Corp / Tyra Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Cayman Islands / Germany / Denmark / United Kingdom / Ireland / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Cowen Biotechnology Team</td></tr>
<tr class="odd"><td class="leftalignment">10/18/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Oct 8, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">10/18/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">3Q21 EPS preview - model changes & updated perspectives</td><td class="leftalignment">English</td><td class="rightalignment">80</td><td class="leftalignment">US0311621009 / US09062X1037 / FR0000120578 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US3755581036 / US5324571083 / US7170811035 / US75886F1075 / US7802592060 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Gilead Sciences Inc / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Royal Dutch Shell PLC / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">10/18/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - October 18, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">AEP.N / AES.N / BCE.TO / CB.N / CMS.N / ECL.N / EIX.N / EL.N / IBE.MC / KO.N / MAS.N / PNC.N / PNW.N / RIO.L / SO.N / T.N / T.TO / TOTF.PA / CMCSA.O / SJRb.TO / RCIb.TO / AMGN.O / AAL.L / DUK.N / QBRb.TO / UNH.N / CCA.TO / K.N / DISH.O / GS.N / CLX.N / VMC.N / PCG.N / EPC.N / ADCT.N / WHR.N / CONE.O / NG.L / VZ.N / EXEL.O / AKAM.O / XEL.N / STZ.N / LNC.N / V.N / NWN.N / UDR.N / DB1Gn.DE / AJG.N / BMRN.O / REGN.O / ENR.N / PRU.N / MHK.N / CEY.L / NCR.N / GFI.N / CNP.N / BLU.N / CPK.N / SKY.N / SGEN.OQ / GPN.N / LIFE.O / EQIX.O / BIIB.O / TFC.N / EDV.TO / BECN.O / DLR.N / 416515104 / GMS.N / BLDR.O / FIS.N / MA.N / OC.N / AON.N / ATL.MI / BGS.N / PPL.TO / HOCM.L / FRES.L / EDPR.LS / SPB.N / NEE.N / NXT.AX / PCRX.O / CTT.N / GLEN.L / TRL.TO / FBHS.N / POLYP.L / FFHu.TO / TMUS.N / UKWG.L / PRTA.O / BEP.N / DOOR.N / IBP.N / HUBS.N / NEWR.N / WBA.N / SUM.N / EVA.N / PYPL.OQ / SQ.N / SITE.N / IONS.O / JELD.N / ATNX.O / GMAB.O / AZEK.N / WTRG.N / FOUR.N / NRIX.OQ / DCT.O / LSPD.N / NAPA.N / OTLY.O / RYAN.N / CNM.N / TWKS.OQ / THRN.OQ</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / BCE Inc / Chubb Ltd / CMS Energy Corp / Ecolab Inc / Edison International / Estee Lauder Companies Inc / Iberdrola SA / Coca-Cola Co / Masco Corp / PNC Financial Services Group Inc / Pinnacle West Capital Corp / Rio Tinto PLC / Southern Co / AT&T Inc / Telus Corp / TotalEnergies SE / Comcast Corp / Shaw Communications Inc / Rogers Communications Inc / Amgen Inc / Anglo American PLC / Duke Energy Corp / Quebecor Inc / UnitedHealth Group Inc / Cogeco Communications Inc / Kellogg Co / DISH Network Corp / Goldman Sachs Group Inc / Clorox Co / Vulcan Materials Co / PG&E Corp / Edgewell Personal Care Co / ADC Therapeutics SA / Whirlpool Corp / CyrusOne Inc / National Grid PLC / Verizon Communications Inc / Exelixis Inc / Akamai Technologies Inc / Xcel Energy Inc / Constellation Brands Inc / Lincoln National Corp / Visa Inc / Northwest Natural Holding Co / UDR Inc / Deutsche Boerse AG / Arthur J Gallagher & Co / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Prudential Financial Inc / Mohawk Industries Inc / Centamin PLC / NCR Corp / Gold Fields Ltd / CenterPoint Energy Inc / BELLUS Health Inc / Chesapeake Utilities Corp / Skyline Champion Corp / Seagen Inc / Global Payments Inc / aTyr Pharma Inc / Equinix Inc / Biogen Inc / Truist Financial Corp / Endeavour Mining PLC / Beacon Roofing Supply Inc / Digital Realty Trust Inc / Hartford Financial Services Group Inc / GMS Inc / Builders FirstSource Inc / Fidelity National Information Services Inc / Mastercard Inc / Owens Corning / Aon PLC / Atlantia SpA / B&G Foods Inc / Pembina Pipeline Corp / Hochschild Mining PLC / Fresnillo PLC / EDP Renovaveis SA / Spectrum Brands Holdings Inc / Nextera Energy Inc / NEXTDC Ltd / Pacira Biosciences Inc / CatchMark Timber Trust Inc / Glencore PLC / Trilogy International Partners Inc / Fortune Brands Home & Security Inc / Polymetal International PLC / Fairfax Financial Holdings Ltd / T-Mobile US Inc / Greencoat UK Wind PLC / Prothena Corporation PLC / Brookfield Renewable Partners LP / Masonite International Corp / Installed Building Products Inc / HubSpot Inc / New Relic Inc / Walgreens Boots Alliance Inc / Summit Materials Inc / Enviva Inc / PayPal Holdings Inc / Block Inc / SiteOne Landscape Supply Inc / Ionis Pharmaceuticals Inc / JELD-WEN Holding Inc / Athenex Inc / Genmab A/S / Azek Company Inc / Essential Utilities Inc / Shift4 Payments Inc / Nurix Therapeutics Inc / Duck Creek Technologies Inc / Lightspeed Commerce Inc / Duckhorn Portfolio Inc / Oatly Group AB / Ryan Specialty Group Holdings Inc / Core & Main Inc / Thoughtworks Holding Inc / Thorne Healthtech Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / China / Germany / Denmark / Spain / United Kingdom / Ireland / Italy / Sweden / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">10/16/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / ADCT.N / EXEL.O / BMRN.O / REGN.O / SGEN.OQ / LIFE.O / PRTA.O / ATNX.O / GMAB.O / NRIX.OQ</td><td class="leftalignment">Amgen Inc / ADC Therapeutics SA / Exelixis Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Seagen Inc / aTyr Pharma Inc / Prothena Corporation PLC / Athenex Inc / Genmab A/S / Nurix Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="odd"><td class="leftalignment">10/16/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 569</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for AMGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--October15, 2021</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">A.N / AXP.N / CRY.N / JNJ.N / WMT.N / SUP.N / ABMD.OQ / AMGN.OQ / REGN.OQ / STAA.OQ / ICUI.OQ / IDXX.OQ / MMSI.OQ / GILD.OQ / ANIK.OQ / XRAY.OQ / INCY.OQ / IART.OQ / INMD.OQ / AMED.OQ / SSNC.OQ / CERS.OQ / SRDX.OQ / UTHR.OQ / BMRN.OQ / ISRG.OQ / ALGN.OQ / SGEN.OQ / OSUR.OQ / CCRN.OQ / VRTX.OQ / NUVA.OQ / ANGO.OQ / MNKD.OQ / DXCM.OQ / LHCG.OQ / ATRC.OQ / LMAT.OQ / ARAY.OQ / BLRX.TA / PODD.OQ / MASI.OQ / KIDS.OQ / ENSG.OQ / ADUS.OQ / PCRX.OQ / KAMN.N / TMD.TO / SRPT.OQ / ALLY.N / AXGN.OQ / FATE.OQ / FLXN.OQ / BLFS.OQ / GOOGL.OQ / XENT.OQ / SIEN.OQ / VCEL.OQ / EVH.N / SPNE.OQ / CYRX.OQ / IRTC.OQ / ALLO.OQ / SWAV.OQ / BEAM.OQ / VERO.OQ / ONEM.OQ / HUMA.OQ</td><td class="leftalignment">Agilent Technologies Inc / American Express Co / CryoLife Inc / Johnson & Johnson / Walmart Inc / Superior Industries International Inc / ABIOMED Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / STAAR Surgical Co / ICU Medical Inc / IDEXX Laboratories Inc / Merit Medical Systems Inc / Gilead Sciences Inc / Anika Therapeutics Inc / DENTSPLY SIRONA Inc / Incyte Corp / Integra Lifesciences Holdings Corp / Inmode Ltd / Amedisys Inc / SS&C Technologies Holdings Inc / Cerus Corp / Surmodics Inc / United Therapeutics Corp / Biomarin Pharmaceutical Inc / Intuitive Surgical Inc / Align Technology Inc / Seagen Inc / OraSure Technologies Inc / Cross Country Healthcare Inc / Vertex Pharmaceuticals Inc / NuVasive Inc / AngioDynamics Inc / MannKind Corp / Dexcom Inc / LHC Group Inc / AtriCure Inc / LeMaitre Vascular Inc / Accuray Inc / BioLine RX Ltd / Insulet Corp / Masimo Corp / OrthoPediatrics Corp / Ensign Group Inc / Addus Homecare Corp / Pacira Biosciences Inc / Kaman Corp / Titan Medical Inc / Sarepta Therapeutics Inc / Ally Financial Inc / AxoGen Inc / Fate Therapeutics Inc / Pacira Biosciences Inc / BioLife Solutions Inc / Alphabet Inc / Intersect Ent Inc / Sientra Inc / Vericel Corp / Evolent Health Inc / SeaSpine Holdings Corp / Cryoport Inc / iRhythm Technologies Inc / Allogene Therapeutics Inc / Shockwave Medical Inc / Beam Therapeutics Inc / Venus Concept Inc / 1Life Healthcare Inc / Humacyte Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / France / Israel / United States</td><td class="leftalignment">Biotechnology / Consumer / Engineering & Construction / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">10/15/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Navigating Project Optimus: Panel Discussion on FDA Initiative on Finding the Optimal Dose, October 21, 11:00 a.m. ET</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">03116210 / 110122108 / 09062X103 / 45337C102 / 00847G705 / 268158201 / 04651310 / 00887A105 / 67022C106 / 720795103 / 49372L100 / 05280R100 / 717224109 / N5749R100 / 16961L106 / 192010106 / 13089P101 / 30315R107 / 45175G108</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Biogen Inc / Incyte Corp / Agenus Inc / Dynavax Technologies Corp / Atara Biotherapeutics Inc / Aileron Therapeutics Inc / NuCana PLC / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / PhaseBio Pharmaceuticals Inc / Merus NV / Chinook Therapeutics Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / F-Star Therapeutics Inc / Ikena Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Hunter Rogers / Mr. Tim F. Lugo / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">10/15/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended October 8, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">10/15/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">10/15/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Third Quarter 2021 Biotechnology Earnings Preview</td><td class="leftalignment">English</td><td class="rightalignment">50</td><td class="leftalignment">03116210 / 09062X103 / 64125C109 / 110122108 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 803607100 / 26979610 / 00847L10 / 268158201 / 31572Q80 / 76133010 / 462222100 / 19459J104 / G11196105 / 69366J200 / 09609G100 / 37890U108 / 81181C104 / 91864C107</td><td class="leftalignment">Amgen Inc / Biogen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Biohaven Pharmaceutical Holding Company Ltd / PTC Therapeutics Inc / bluebird bio Inc / Global Blood Therapeutics Inc / Seagen Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US0311621009 / US2666051048 / US3755581036 / US45337C1027 / US75886F1075 / US92532F1003 / US09062X1037 / US88322Q1085 / IL0011313900</td><td class="leftalignment">Amgen Inc / DURECT Corp / Gilead Sciences Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / TG Therapeutics Inc / Galmed Pharmaceuticals Ltd</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AXP / V / 5671735 / 0989529 / 2126335 / 2516152 / 2000019 / 2023607 / 2778844 / 2026242 / 2437071 / 2280220 / 2270726 / 2317087 / 2576941 / 2455965 / 2471950 / 2623911 / 2632003 / 2048804 / 2730190 / 2825933 / 2931034 / 4595739 / B00FWN1 / B1F76F9 / B19FQ48 / 2713317 / B01SD70 / 2857817 / B3D7K31 / B7TL820 / BBFL7S1 / B8DPDT7 / BQPVQZ6 / BXDZ9Z0 / BZ1LFB2 / BD8DJ71 / BMQ5T49 / BFZ1K46 / BJJMGL2 / BKTNTR9 / BZ05388 / BDFZSP1 / BK6N347 / BFWK4R7 / BYYWPW6 / BWY52P3 / BYY88Y7 / BDZ30Q0 / BYTJZL1 / BNRQM83 / BJ62Z18</td><td class="leftalignment">American Express Co / Visa Inc / Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Amgen Inc / Merck & Co Inc / American Electric Power Company Inc / Biomarin Pharmaceutical Inc / DTE Energy Co / Walt Disney Co / Entergy Corp / Exelixis Inc / Biogen Inc / Incyte Corp / Neurocrine Biosciences Inc / New York Times Co / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / South Jersey Industries Inc / Vertex Pharmaceuticals Inc / Genmab A/S / Alnylam Pharmaceuticals Inc / Western Union Co / Amicus Therapeutics Inc / ACADIA Pharmaceuticals Inc / Domino's Pizza Inc / Netflix Inc / Discovery Inc / Meta Platforms Inc / bluebird bio Inc / Sarepta Therapeutics Inc / Horizon Therapeutics PLC / Shopify Inc / Deciphera Pharmaceuticals Inc / Snap Inc / Zentalis Pharmaceuticals Inc / Spotify Technology SA / Fox Corp / ViacomCBS Inc / Global Blood Therapeutics Inc / Okta Inc / Uber Technologies Inc / PagSeguro Digital Ltd / Beigene Ltd / Blueprint Medicines Corp / Alphabet Inc / Arvinas Inc / Zogenix Inc / Petco Health and Wellness Company Inc / Ultragenyx Pharmaceutical Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Denmark / France / United Kingdom / Ireland / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Guggenheim Biotech 3Q 2021 Earnings Preview</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">4595739 / 2471950 / 2023607 / 2437071 / 2576941 / 2455965 / 2623911 / 2730190 / 2931034 / B00FWN1 / B19FQ48 / 2713317 / BBFL7S1 / B8DPDT7 / BQPVQZ6 / BZ1LFB2 / BZ05388 / BYYWPW6 / BWY52P3 / BYTJZL1 / BJ62Z18</td><td class="leftalignment">Genmab A/S / Incyte Corp / Amgen Inc / Biomarin Pharmaceutical Inc / Exelixis Inc / Biogen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Amicus Therapeutics Inc / ACADIA Pharmaceuticals Inc / bluebird bio Inc / Sarepta Therapeutics Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Global Blood Therapeutics Inc / Beigene Ltd / Blueprint Medicines Corp / Zogenix Inc / Ultragenyx Pharmaceutical Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Germany / Denmark / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Guggenheim Biot Research / Mr. Charles Zhu, Ph.D., III / Debjit Chattopadhyay, Ph.D. / Michael W. Schmidt, Ph.D., PHD / Mr. Yatin Suneja / Yige Guo, Ph.D. / Kelsey Goodwin / Paul Jeng, Ph.D. / Mr. Eddie Hickman, Ph.D. / Evan Taddeo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">3Q Large Cap Preview: New World Order is Navigating Consistent COVID-19 Trends to the Base Business</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US0311621009 / US09062X1037 / US3755581036 / US45337C1027 / US75886F1075 / US92532F1003</td><td class="leftalignment">Amgen Inc / Biogen Inc / Gilead Sciences Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">10/15/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Biotech Q3:21 Earnings Preview</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">AMGN.O / ADCT.N / EXEL.O / BMRN.O / REGN.O / SGEN.OQ / PBYI.OQ / GMAB.O</td><td class="leftalignment">Amgen Inc / ADC Therapeutics SA / Exelixis Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Seagen Inc / Puma Biotechnology Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="odd"><td class="leftalignment">10/14/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Here Comes The Sun: Biotech Inflows Return</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105 / 670703107</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc / Nuvalent Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">10/13/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AAPL / ADS / ALLO / AMGN / AOS / ASML.AS / AXP / BEAM / BLUE / CME / COF / CSL / DCI / DFS / DOV / EA / FLS / FOCS / GGG / ICE / IEX / INTC.O / ITT / KLAC.O / LECO / LRCX.O / MSFT / PNR / QCOM.O / RMR / RXN / SAP / SONY / TTWO / V / VCTR / WTS / MWA / GILD.O / CBOE / ATVI.O / NVDA.O / HEAR / MPWR.O / VECO.O / AMD.O / ADI.O / NFLX / CEVA / SYF / LSCC.O / SMTC.O / TXN.O / BMRN.O / CRUS.O / VRTX.O / MRVL.O / AVGO.O / NDAQ / XLNX.OQ / SWKS.O / 36467W109 / AIMC / 514766104 / NXPI.O / XYL / ZNGA / FDEV.L / 82655M107 / QRVO.O / SPXC / NTLA / CRSP / AKTS.O / MTEM.O / BILI.O / MGTA / FIXX.O / CRWD.O / 84764T304 / HUYA.K / 010196103 / JSPR.O</td><td class="leftalignment">Apple Inc / Alliance Data Systems Corp / Allogene Therapeutics Inc / Amgen Inc / A O Smith Corp / ASML Holding NV / American Express Co / Beam Therapeutics Inc / bluebird bio Inc / CME Group Inc / Capital One Financial Corp / Carlisle Companies Inc / Donaldson Company Inc / Discover Financial Services / Dover Corp / Electronic Arts Inc / Flowserve Corp / Focus Financial Partners Inc / Graco Inc / Intercontinental Exchange Inc / IDEX Corp / Intel Corp / ITT Inc / KLA Corp / Lincoln Electric Holdings Inc / Lam Research Corp / Microsoft Corp / Pentair PLC / Qualcomm Inc / RMR Group Inc / Zurn Water Solutions Corp / SAP SE / Sony Group Corp / Take-Two Interactive Software Inc / Visa Inc / Victory Capital Holdings Inc / Watts Water Technologies Inc / Mueller Water Products Inc / Gilead Sciences Inc / Cboe Global Markets Inc / Activision Blizzard Inc / NVIDIA Corp / Turtle Beach Corp / Monolithic Power Systems Inc / Veeco Instruments Inc / Advanced Micro Devices Inc / Analog Devices Inc / Netflix Inc / CEVA Inc / Synchrony Financial / Lattice Semiconductor Corp / Semtech Corp / Texas Instruments Inc / Biomarin Pharmaceutical Inc / Cirrus Logic Inc / Vertex Pharmaceuticals Inc / Marvell Technology Inc / Broadcom Inc / Nasdaq Inc / Xilinx Inc / Skyworks Solutions Inc / GameStop Corp / Altra Industrial Motion Corp / Landec Corp / NXP Semiconductors NV / Xylem Inc / Zynga Inc / Frontier Developments PLC / Sify Technologies Ltd / Qorvo Inc / SPX Corp / Intellia Therapeutics Inc / CRISPR Therapeutics AG / Akoustis Technologies Inc / Molecular Templates Inc / Bilibili Inc / Magenta Therapeutics Inc / Homology Medicines Inc / CrowdStrike Holdings Inc / Speed Commerce Inc / HUYA Inc / Aksys Ltd / Jasper Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / Germany / United Kingdom / India / Ireland / Japan / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/13/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2023607 / 2778844 / 2050832 / 2206657 / 2317087 / 2684703 / 2799351 / 2825933 / 2900335 / 7103065 / 2712013 / B121557 / 2857817 / 2598246 / B3SWPT2 / B7TL820 / BCZS820 / B7577T2 / BVVN4Q8 / BFZNYB7 / BDHF4K6 / BZ1LFB2 / BR4T3B3 / BZ8VJQ8 / BJFSR99 / BKTNTR9 / BZ1LFG7 / BYY88Y7 / BN4RD42 / BNTB3N8 / BMVBZF5 / 120483382</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Amgen Inc / Merck & Co Inc / Ameren Corp / Coca-Cola Co / Entergy Corp / Pfizer Inc / Sinclair Broadcast Group Inc / South Jersey Industries Inc / Tractor Supply Co / Novartis AG / Global Payments Inc / Mastercard Inc / Netflix Inc / Neogenomics Inc / Ameresco Inc / Meta Platforms Inc / Fate Therapeutics Inc / Renewable Energy Group Inc / Eversource Energy / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Deciphera Pharmaceuticals Inc / HubSpot Inc / Vistra Corp / Revance Therapeutics Inc / ViacomCBS Inc / Roku Inc / Alphabet Inc / CureVac NV / Vizio Holding Corp / Immuneering Corp / Procept Biorobotics Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">10/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Oct 01</td><td class="leftalignment">English</td><td class="rightalignment">44</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">10/12/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Ideal for Those Seeking New Blood; Initiate at Outperform</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">JSPR.O / AMGN / BEAM / BLUE / GILD.O / VRTX.O / NTLA / MTEM.O / MGTA</td><td class="leftalignment">Jasper Therapeutics Inc / Amgen Inc / Beam Therapeutics Inc / bluebird bio Inc / Gilead Sciences Inc / Vertex Pharmaceuticals Inc / Intellia Therapeutics Inc / Molecular Templates Inc / Magenta Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">10/12/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Short Interest Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">GILD.O / AMGN.O / REGN.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Yinglu Zhang</td></tr>
<tr class="odd"><td class="leftalignment">10/12/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Oct 1, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">10/12/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Renewed Optimism With Broad Domestic Declines, Oral Antiviral Success, and Near-Term Vaccine Authorization for Children</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">10/12/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Hold on Tight! Soft Biopharma Q3 Coming as Pandemic Pressures Persist, FX Fades</td><td class="leftalignment">English</td><td class="rightalignment">95</td><td class="leftalignment">03116210 / 00287Y10 / 71708110 / 92532F10 / 37555810 / 75886F10 / 75046920 / G3910J11 / 61776010 / F5548N10</td><td class="leftalignment">Amgen Inc / Abbvie Inc / Pfizer Inc / Vertex Pharmaceuticals Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Radius Health Inc / GlaxoSmithKline PLC / MorphoSys AG / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">Germany / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Na Sun / Daniel Tarjan, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">10/12/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">ENA Recap: KRAS Combo Updates Underwhelm, TEAD Development Picks Up, and Other Tidbits of Interest From the Conference</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">03116210 / 00887A105 / 67022C106 / 192010106 / 45175G108</td><td class="leftalignment">Amgen Inc / Aileron Therapeutics Inc / NuCana PLC / Codiak BioSciences, Inc. / Ikena Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Raju Prasad, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers / Sami Corwin, PHD</td></tr>
<tr class="odd"><td class="leftalignment">10/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">EFTR: Addressing Large Markets with Novel Targets; Initiating with an Outperform Rating and a $20 Target Price</td><td class="leftalignment">English</td><td class="rightalignment">42</td><td class="leftalignment">EFTR.OQ / BMY.N / PFE.N / SASY.PA / ROG.S / AMGN.OQ / NKTR.OQ / SGEN.OQ / MRTX.OQ / ADXS.OQ / IOVA.OQ / MNK.N^J20 / BCAB.OQ</td><td class="leftalignment">eFFECTOR Therapeutics Inc / Bristol-Myers Squibb Co / Pfizer Inc / Sanofi SA / Roche Holding AG / Amgen Inc / Nektar Therapeutics / Seagen Inc / Mirati Therapeutics Inc / Advaxis Inc / Iovance Biotherapeutics Inc / Mallinckrodt PLC / Bioatla Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Judah C. Frommer / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">10/11/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Short Interest in Biotechnology Stocks</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US0311621009 / US3755581036 / US75886F1075 / US92532F1003 / US7665596034 / US02043Q1076 / US40637H1095 / US09609G1004 / US45845P1084 / US31189P1021 / US03820J1007 / US92686J1060 / US09627Y1091 / US4622221004 / US5588681057 / US03753U1060 / US2997341035 / US80706P1030 / US76029N1063 / US04335A1051 / US2936141033 / US50015M1099 / US85789A1051 / US62921N1054 / US61775R1059 / US30205M1018 / US80810D1037 / US12529R1077 / CA00288U1066 / US67080N1019 / US24343R1068</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Rigel Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Halozyme Therapeutics Inc / bluebird bio Inc / Intercept Pharmaceuticals Inc / Fate Therapeutics Inc / Applied Genetic Technologies Corp / Viking Therapeutics Inc / Blueprint Medicines Corp / Ionis Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Evelo Biosciences Inc / Scholar Rock Holding Corp / Replimune Group Inc / Arvinas Inc / Entasis Therapeutics Holdings Inc / Kodiak Sciences Inc / Stealth BioTherapeutics Corp / NGM Biopharmaceuticals Inc / Morphic Holding Inc / Exicure Inc / Schrodinger Inc / C4 Therapeutics Inc / Abcellera Biologics Inc / Nuvation Bio Inc / Decibel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Matthew Luchini / Jin Lee</td></tr>
<tr class="odd"><td class="leftalignment">10/11/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Amgen sinks 8.1% in 2021</td><td class="leftalignment">English</td><td class="rightalignment">73</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">10/11/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">AAPL / ACI / AGCO / ALLO / AMGN / ATRC / AXP / AZO / CSL / DE / DG / EA / EL / FDX / FOCS / FTR / ICE / INCY / LOW / NET / NKE / NOW / RSI / SBUX / SONY / TRMB / UPS / V / WH / AMZN.O / GXO / GNSS / GILD.O / EW / MSCI / CBOE / GENI / NVDA.O / ADBE.O / RMD / SQ / MPWR.O / VG / IART.O / ADI.O / NFLX / PLUG.O / ADSK.O / SGEN / UTHR.O / ARRY.O / FCEL.O / TXN.O / EXPD.O / BMRN.O / AMSC.O / REGN.O / VRTX.O / MRVL.O / AVGO.O / NDAQ / TEAM.O / ITRI.O / BIIB / DPZ / MNKD.O / SPGI / DXCM.O / SPWR.O / XPO / CSIQ.O / FSLR.O / LULU / ULTA / WPRT.O / TWIN.O / TSLA.O / PCYO.O / NXPI.O / AMRS.O / ENPH.O / FB.O / CG.O / WDAY / CNHI / FATE.O / XENT / QRVO.O / SEDG.O / RUN.O / WKHS.O / AQMS.O / FLGT.O / CRSP / AQB / ROKU.O / MDB.O / LOVE / TPTX.O / CRWD.O / DKNG / 02081G201 / VLDR.O / SHLS.O / APPH / NKTX.O / TSP.O / ENVX.O / LILM.O / MDNA.O</td><td class="leftalignment">Apple Inc / Albertsons Companies Inc / AGCO Corp / Allogene Therapeutics Inc / Amgen Inc / AtriCure Inc / American Express Co / Autozone Inc / Carlisle Companies Inc / Deere & Co / Dollar General Corp / Electronic Arts Inc / Estee Lauder Companies Inc / FedEx Corp / Focus Financial Partners Inc / Frontier Communications Parent Inc / Intercontinental Exchange Inc / Incyte Corp / Lowe's Companies Inc / Cloudflare Inc / Nike Inc / ServiceNow Inc / Rush Street Interactive Inc / Starbucks Corp / Sony Group Corp / Trimble Inc / United Parcel Service Inc / Visa Inc / Wyndham Hotels & Resorts Inc / Amazon.com Inc / GXO Logistics Inc / Genasys Inc / Gilead Sciences Inc / Edwards Lifesciences Corp / MSCI Inc / Cboe Global Markets Inc / Genius Sports Ltd / NVIDIA Corp / Adobe Inc / Resmed Inc / Block Inc / Monolithic Power Systems Inc / Vonage Holdings Corp / Integra Lifesciences Holdings Corp / Analog Devices Inc / Netflix Inc / Plug Power Inc / Autodesk Inc / Seagen Inc / United Therapeutics Corp / Array Technologies Inc / Fuelcell Energy Inc / Texas Instruments Inc / Expeditors International of Washington Inc / Biomarin Pharmaceutical Inc / American Superconductor Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Marvell Technology Inc / Broadcom Inc / Nasdaq Inc / Atlassian Corporation PLC / Itron Inc / Biogen Inc / Domino's Pizza Inc / MannKind Corp / S&P Global Inc / Dexcom Inc / SunPower Corp / XPO Logistics Inc / Canadian Solar Inc / First Solar Inc / Lululemon Athletica Inc / Ulta Beauty Inc / Westport Fuel Systems Inc / Twin Disc Inc / Tesla Inc / Pure Cycle Corp / NXP Semiconductors NV / Amyris Inc / Enphase Energy Inc / Meta Platforms Inc / Carlyle Group Inc / Workday Inc / CNH Industrial NV / Fate Therapeutics Inc / Intersect Ent Inc / Qorvo Inc / Solaredge Technologies Inc / Sunrun Inc / Workhorse Group Inc / Aqua Metals Inc / Fulgent Genetics Inc / CRISPR Therapeutics AG / AquaBounty Technologies Inc / Roku Inc / MongoDB Inc / Lovesac Co / Turning Point Therapeutics Inc / CrowdStrike Holdings Inc / DraftKings Inc / Alphatec Holdings Inc / Velodyne Lidar Inc / Shoals Technologies Group Inc / AppHarvest Inc / Nkarta Inc / TuSimple Holdings Inc / Enovix Corp / Lilium NV / Medicenna Therapeutics Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / United Kingdom / Japan / Netherlands / United States / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/11/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Large Cap Medtech</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AMGN / INCY / SYK / GILD.O / EW / RMD / SGEN / BMRN.O / REGN.O / VRTX.O / BIIB / XENT</td><td class="leftalignment">Amgen Inc / Incyte Corp / Stryker Corp / Gilead Sciences Inc / Edwards Lifesciences Corp / Resmed Inc / Seagen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Intersect Ent Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steven M. Lichtman / David Kuang</td></tr>
<tr class="even"><td class="leftalignment">10/11/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">V / 2000019 / 2023607 / 2778844 / 2045623 / 2065159 / 2270726 / 2829515 / 2317087 / 2328915 / 2415204 / 2455965 / 2459020 / 2689560 / 2138158 / 2825933 / 2928683 / 2857817 / B7TL820 / B7VD3F2 / BBPK0J0 / B87ZMX0 / B95N910 / BDZCRX3 / BFZCHN7 / BYZLV46 / BXDZ9Z0 / BZ00V34 / BR4T3B3 / BLGJ610 / BDFZSP1 / BGSP7M9 / BFWK4R7 / BL95N25 / BD6D4Y5 / BWY52P3 / BYY88Y7 / BL71K91 / BN2R582 / BM8MM05 / BMDCDP2 / BKPGJQ1 / BLF0CW7 / BJLV8T9 / 120483382</td><td class="leftalignment">Visa Inc / Amazon.com Inc / Amgen Inc / Merck & Co Inc / ANSYS Inc / Autodesk Inc / Walt Disney Co / Edison International / Entergy Corp / Nextera Energy Inc / Hawaiian Electric Industries Inc / Biogen Inc / Intuit Inc / PG&E Corp / Sempra Energy / South Jersey Industries Inc / VF Corp / Netflix Inc / Meta Platforms Inc / Duke Energy Corp / Mirati Therapeutics Inc / Palo Alto Networks Inc / PTC Inc / RingCentral Inc / Wix.Com Ltd / InflaRx NV / Shopify Inc / Zscaler Inc / HubSpot Inc / Warner Music Group Corp / Okta Inc / Zoom Video Communications Inc / PagSeguro Digital Ltd / Phibro Animal Health Corp / Altair Engineering Inc / Blueprint Medicines Corp / Alphabet Inc / Revolution Medicines Inc / Relay Therapeutics Inc / Madison Square Garden Entertainment Corp / Bigcommerce Holdings Inc / Squarespace Inc / Repare Therapeutics Inc / Celldex Therapeutics Inc / Procept Biorobotics Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">10/11/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - October 11, 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">ALV.N / CAS.TO / CB.N / EL.N / ELE.MC / F.N / FSR.N / GM.N / IBE.MC / KBH.N / KO.N / MSFT.O / NA / PHM.N / RYN.N / T.N / TOL.N / VC.N / WY.N / CFP.TO / GILD.O / TEN.N / CMCSA.O / AMGN.O / INCY.O / FER.MC / BWA.N / LEA.N / K.N / DISH.O / LEN.N / CLX.N / EPC.N / AMT.N / SIRI.O / CONE.O / VZ.N / EXEL.O / DHI.N / ARNA.O / STZ.N / LNC.N / APH.N / FISV.O / CHTR.O / AXL.N / BC.N / AJG.N / REGN.O / ENR.N / VRTX.O / JHX.AX / PRU.N / NCR.N / TEL.N / SSNC.O / CHE.N / PII.N / ST.N / SWN.N / PLUG.OQ / GPN.N / AMED.O / BIIB.O / DPM.TO / DLR.N / 416515104 / LHCG.O / BKD.N / FIS.N / HOG.N / MERC.O / AON.N / BGS.N / DAN.N / NOG.A / CLW.N / ADUS.OQ / SPB.N / TXG.TO / PCH.O / CFX.TO / CTT.N / MTOR.N / RFP.N / SRPT.O / PANW.N / FFHu.TO / KPT.TO / TPH.N / TSLA.N / ENTA.O / TMUS.N / TMHC.N / PTCT.O / PRTA.O / 81762P102 / QTWO.N / 922475108 / RYAM.N / RGNX.O / SQ.N / MESO.O / RACE.MI / ADVM.OQ / ADNT.N / ESTE.N / WOW.N / ATUS.N / ORSTED.CO / APTV.N / VNE.N / FOCS.O / ZM.O / FSLY.N / CRWD.O / GMAB.O / DOCU.N / CRNC.OQ / PNTG.OQ / ETNB.O / AHCO.O / NKLA.OQ / FOUR.N / RXT.OQ / LUMN.N / RIDE.OQ / LSPD.N / DFH.OQ / AFRM.O / PSFE.N / TSP.OQ / OTLY.O / FLYW.O / TASK.O / RYAN.N / TWKS.OQ</td><td class="leftalignment">Autoliv Inc / Cascades Inc / Chubb Ltd / Estee Lauder Companies Inc / Endesa SA / Ford Motor Co / Fisker Inc / General Motors Co / Iberdrola SA / KB Home / Coca-Cola Co / Microsoft Corp / National Bank of Canada / Pultegroup Inc / Rayonier Inc / AT&T Inc / Toll Brothers Inc / Visteon Corp / Weyerhaeuser Co / Canfor Corp / Gilead Sciences Inc / Tenneco Inc / Comcast Corp / Amgen Inc / Incyte Corp / Ferrovial SA / Borgwarner Inc / Lear Corp / Kellogg Co / DISH Network Corp / Lennar Corp / Clorox Co / Edgewell Personal Care Co / American Tower Corp / Sirius XM Holdings Inc / CyrusOne Inc / Verizon Communications Inc / Exelixis Inc / D R Horton Inc / Arena Pharmaceuticals Inc / Constellation Brands Inc / Lincoln National Corp / Amphenol Corp / Fiserv Inc / Charter Communications Inc / American Axle & Manufacturing Holdings Inc / Brunswick Corp / Arthur J Gallagher & Co / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Vertex Pharmaceuticals Inc / James Hardie Industries PLC / Prudential Financial Inc / NCR Corp / TE Connectivity Ltd / SS&C Technologies Holdings Inc / Chemed Corp / Polaris Inc / Sensata Technologies Holding PLC / Southwestern Energy Co / Plug Power Inc / Global Payments Inc / Amedisys Inc / Biogen Inc / Dundee Precious Metals Inc / Digital Realty Trust Inc / Hartford Financial Services Group Inc / LHC Group Inc / Brookdale Senior Living Inc / Fidelity National Information Services Inc / Harley-Davidson Inc / Mercer International Inc / Aon PLC / B&G Foods Inc / Dana Inc / Northern Oil and Gas Inc / Clearwater Paper Corp / Addus Homecare Corp / Spectrum Brands Holdings Inc / Torex Gold Resources Inc / Potlatchdeltic Corp / Canfor Pulp Products Inc / CatchMark Timber Trust Inc / Meritor Inc / Resolute Forest Products Inc / Sarepta Therapeutics Inc / Palo Alto Networks Inc / Fairfax Financial Holdings Ltd / KP Tissue Inc / Tri Pointe Homes Inc (Delaware) / Tesla Inc / Enanta Pharmaceuticals Inc / T-Mobile US Inc / Taylor Morrison Home Corp / PTC Therapeutics Inc / Prothena Corporation PLC / ServiceNow Inc / Q2 Holdings Inc / Veeva Systems Inc / Rayonier Advanced Materials Inc / Regenxbio Inc / Block Inc / Mesoblast Ltd / Ferrari NV / Adverum Biotechnologies Inc / Adient PLC / Earthstone Energy Inc / WideOpenWest Inc / Altice USA Inc / Orsted A/S / Aptiv PLC / Veoneer Inc / Focus Financial Partners Inc / Zoom Video Communications Inc / Fastly Inc / CrowdStrike Holdings Inc / Genmab A/S / DocuSign Inc / Cerence Inc / Pennant Group Inc / 89Bio Inc / Adapthealth Corp / Nikola Corp / Shift4 Payments Inc / Rackspace Technology Inc / Lumen Technologies Inc / Lordstown Motors Corp / Lightspeed Commerce Inc / Dream Finders Homes Inc / Affirm Holdings Inc / Paysafe Ltd / TuSimple Holdings Inc / Oatly Group AB / Flywire Corp / Taskus Inc / Ryan Specialty Group Holdings Inc / Thoughtworks Holding Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Denmark / Spain / United Kingdom / Ireland / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">10/11/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Triple Meeting: Takeaways from Plenary Sessions</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 90041T10 / 60468T10</td><td class="leftalignment">Amgen Inc / Turning Point Therapeutics Inc / Mirati Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Austria / Canada / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Andrew Berens, M.D. / Christopher Liu, Pharm.D. / Ken Shields</td></tr>
<tr class="odd"><td class="leftalignment">10/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">AMGN, MRTX (both NEUTRAL) - Disappointing Lumakras Combo with Mekinist (MEKi) & Gilotrif (EGFRi) Raises Importance of PD-1 & SHP2 Combos, in Our View</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">2023607 / BBPK0J0</td><td class="leftalignment">Amgen Inc / Mirati Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Kelsey Goodwin / Yige Guo, Ph.D. / Paul Jeng, Ph.D. / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="even"><td class="leftalignment">10/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">RPTX - BUY - Early RP-3500 Data Misses Investor Expectations but Supports RP2D Expansion & Combos; Maintain BUY on Valuation & Catalyst Lineup</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BLF0CW7 / 0989529 / 0925288 / 2023607 / 2684703 / BK0VHF6 / BP2P6L0</td><td class="leftalignment">Repare Therapeutics Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Amgen Inc / Pfizer Inc / IDEAYA Biosciences Inc / Tango Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">10/09/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / EXEL.O / ARNA.O / REGN.O / PRTA.O / MESO.O / GMAB.O</td><td class="leftalignment">Amgen Inc / Exelixis Inc / Arena Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Prothena Corporation PLC / Mesoblast Ltd / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Australia / Denmark / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="even"><td class="leftalignment">10/09/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 568</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">10/08/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--Oct 08 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">ALLO / AMGN / ATRC / CSII / DNLI / INCY / INSP / IRTC / ROG / SAGE / CNSP.O / EW / FMTX / ARNA.O / UTHR.O / MRNS / NOVN.O / AMED.O / BIIB / 478160104 / CORT.O / MNKD.O / LHCG.O / 02043Q107 / ENSG.O / SWAV / MCRB / RDHL.O / MDWD.O / TBPH.O / RXDX.O / VCEL.O / IONS.O / PTGX.O / XFOR.O / TPTX.O / TMDX / BCYC / ORIC.O / PHGE.K / AMTI.O / TSHA.O / LABP.O / 03823M100 / US00449L1026</td><td class="leftalignment">Allogene Therapeutics Inc / Amgen Inc / AtriCure Inc / Cardiovascular Systems Inc / Denali Therapeutics Inc / Incyte Corp / Inspire Medical Systems Inc / iRhythm Technologies Inc / Rogers Corp / SAGE Therapeutics Inc / CNS Pharmaceuticals Inc / Edwards Lifesciences Corp / Forma Therapeutics Holdings Inc / Arena Pharmaceuticals Inc / United Therapeutics Corp / Marinus Pharmaceuticals Inc / Novan Inc / Amedisys Inc / Biogen Inc / Johnson & Johnson / Corcept Therapeutics Inc / MannKind Corp / LHC Group Inc / Alnylam Pharmaceuticals Inc / Ensign Group Inc / Shockwave Medical Inc / Seres Therapeutics Inc / Redhill Biopharma Ltd / Mediwound Ltd / Theravance Biopharma Inc / Prometheus Biosciences Inc / Vericel Corp / Ionis Pharmaceuticals Inc / Protagonist Therapeutics Inc / X4 Pharmaceuticals Inc / Turning Point Therapeutics Inc / Transmedics Group Inc / Bicycle Therapeutics PLC / Oric Pharmaceuticals Inc / Biomx Inc / Applied Molecular Transport Inc. / Taysha Gene Therapies Inc / Landos Biopharma Inc / Applied Minerals Inc / Achilles Therapeutics PLC</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">10/08/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">10/08/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">October 2021 "Monthly Controversies" Report</td><td class="leftalignment">English</td><td class="rightalignment">166</td><td class="leftalignment">US0311621009 / US09062X1037 / FR0000120578 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US3755581036 / US5324571083 / US7170811035 / US75886F1075 / US7802592060 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Gilead Sciences Inc / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Royal Dutch Shell PLC / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">10/08/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended October 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">10/08/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Triple Meeting: Day 1 Key Takeaways</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">03116210 / 09627Y10 / 24344T10 / 34633R10 / 60468T10 / 19240Q20 / 87583X10</td><td class="leftalignment">Amgen Inc / Blueprint Medicines Corp / Deciphera Pharmaceuticals Inc / Forma Therapeutics Holdings Inc / Mirati Therapeutics Inc / Cogent Biosciences Inc / Tango Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Austria / Canada / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Andrew Berens, M.D. / Christopher Liu, Pharm.D. / Ken Shields</td></tr>
<tr class="even"><td class="leftalignment">10/07/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">When It Rains, It Pours: Another Week of Big Biotech Outflows</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">10/07/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Amgen Inc : Initial KRAS Combo Data Disappoint</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Manish Jajoo</td></tr>
<tr class="even"><td class="leftalignment">10/07/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Biotechnology Fourth-Quarter Catalyst Watch Call: Monday, October 11, at 12:00 p.m. ET</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">10/07/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Initial G12C Combo Data In NSCLC Underwhelming But Does Not Derail Hope w/PD1</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US0311621009 / US60468T1051</td><td class="leftalignment">Amgen Inc / Mirati Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Yaron Werber, M.D., MD / Gabriel Schneider, M.D. / Brendan Smith, Ph.D. / Eve Reilly, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">10/07/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Third-Quarter Grand Rounds: A Review of Financing, Regulatory, and Business Development Activity</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">03116210 / 09062X103 / 110122108 / 45337C102 / 31572Q80 / 76133010 / 00461U105 / G11196105 / 01671P100 / 501147102 / 77313F106 / 05464T104 / G10830100 / 16961L106 / 89422G107</td><td class="leftalignment">Amgen Inc / Biogen Inc / Bristol-Myers Squibb Co / Incyte Corp / FibroGen Inc / Revance Therapeutics Inc / Aclaris Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Allakos Inc / Krystal Biotech Inc / Rocket Pharmaceuticals Inc / Axsome Therapeutics Inc / Beyondspring Inc / Chinook Therapeutics Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">10/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">V / 0925288 / 2126335 / 2516152 / 2000019 / 2023607 / 2026242 / 2732635 / 2222631 / 2270726 / 2542049 / 2317087 / 2121352 / 2415204 / 2515030 / 2684703 / 2048804 / 2730190 / 2825933 / 2943523 / 2503529 / 2181334 / 2170473 / B00FWN1 / 2769796 / 2857817 / B5B2106 / B7TL820 / B7VD3F2 / B8DPDT7 / BVVN4Q8 / BYW36M8 / BFZNYB7 / BD8DJ71 / BQT3XY6 / BZ1HM42 / BNFWR44 / BR4T3B3 / BFZ1K46 / BZ1LFG7 / BYY88Y7 / BKC9SX3 / BZ0P3Z5 / BNTB3N8 / BMGGJK8 / BM8NHS1</td><td class="leftalignment">Visa Inc / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Amgen Inc / American Electric Power Company Inc / AutoNation Inc / Cooper Companies Inc / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Group 1 Automotive Inc / Hawaiian Electric Industries Inc / Lithia Motors Inc / Pfizer Inc / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / South Jersey Industries Inc / Penske Automotive Group Inc / World Wrestling Entertainment Inc / Check Point Software Technologies Ltd / Constellation Brands Inc / Alnylam Pharmaceuticals Inc / Fidelity National Information Services Inc / Netflix Inc / Fortinet Inc / Meta Platforms Inc / Duke Energy Corp / Sarepta Therapeutics Inc / Eversource Energy / PayPal Holdings Inc / Allogene Therapeutics Inc / Snap Inc / Cyberark Software Ltd / Adyen NV / Worldline SA / HubSpot Inc / Spotify Technology SA / Roku Inc / Alphabet Inc / Arcturus Therapeutics Holdings Inc / Tegna Inc / Vizio Holding Corp / Valneva SE / Adagio Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">10/07/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Initiating At Neutral: Current Asset Mix Gives Us Pause</td><td class="leftalignment">English</td><td class="rightalignment">50</td><td class="leftalignment">68622V106 / 717081103 / 031162100 / 09062X103 / 881624209 / 75886F107 / 216648402 / 58933Y105 / 00287Y109 / G30401106 / G97822103 / 03168L105 / 071734107 / 30048L104 / 92556V106</td><td class="leftalignment">Organon & Co / Pfizer Inc / Amgen Inc / Biogen Inc / Teva Pharmaceutical Industries Ltd / Regeneron Pharmaceuticals Inc / Cooper Companies Inc / Merck & Co Inc / Abbvie Inc / Endo International PLC / Perrigo Company PLC / Amneal Pharmaceuticals Inc / Bausch Health Companies Inc / Evofem Biosciences Inc / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">David A. Amsellem / Zachary Sachar / Isaac C. Somekh</td></tr>
<tr class="odd"><td class="leftalignment">10/06/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Targeted Oncology: Key Titles at the 2021 Triple Meeting</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">45337C10 / 03116210 / 90041T10 / 09627Y10 / 24344T10 / 81181C10 / 34633R10 / 60468T10 / 19240Q20 / N5749R10 / 49705R10</td><td class="leftalignment">Incyte Corp / Amgen Inc / Turning Point Therapeutics Inc / Blueprint Medicines Corp / Deciphera Pharmaceuticals Inc / Seagen Inc / Forma Therapeutics Holdings Inc / Mirati Therapeutics Inc / Cogent Biosciences Inc / Merus NV / Kinnate Biopharma Inc</td><td class="leftalignment"></td><td class="leftalignment">Austria / Canada / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Andrew Berens, M.D. / Christopher Liu, Pharm.D. / Ken Shields</td></tr>
<tr class="even"><td class="leftalignment">10/05/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US0311621009 / US0042251084 / US40637H1095 / US23282W6057 / US46116X1019 / US75615P1030 / US24823R1059 / US22663K1079 / US6700024010 / US30068X1037</td><td class="leftalignment">Amgen Inc / ACADIA Pharmaceuticals Inc / Halozyme Therapeutics Inc / Cytokinetics Inc / Intra-Cellular Therapies Inc / Reata Pharmaceuticals Inc / Denali Therapeutics Inc / Crinetics Pharmaceuticals Inc / Novavax Inc / Exagen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">10/05/2021</td><td class="leftalignment">Kailash Concepts</td><td class="leftalignment">BUY & SELL Lists - SP500</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ACI.N / AFRM.OQ / ALL.N / CRM.N / ECL.N / EIX.N / HLT.N / IBM.N / PFE.N / SC.N / TXT.N / U.N / USB.N / PXD.N / DELL.N / BKI.N / DIS.N / AFG.N / IPG.N / SPOT.N / GS.N / RCL.N / KR.N / PCG.N / WHR.N / DVA.N / PWR.N / CHD.N / HRL.N / CVX.N / GME.N / INTC.OQ / AMGN.OQ / FISV.OQ / TYL.N / WSO.N / QCOM.OQ / GILD.OQ / DFS.N / PLUG.OQ / MOH.N / OPEN.OQ / OSH.N / MKTX.OQ / LVS.N / MELI.OQ / LBTYK.OQ / CME.OQ / STX.OQ / NEE.N / TSLA.OQ / FB.OQ / RNG.N / SNOW.N / FIVN.OQ / SYF.N / CTLT.N / KEYS.N / LBRDK.O / TDOC.N / TWLO.N / TTD.OQ / COUP.OQ / SNAP.N / CVNA.N / ROKU.OQ / PAGS.N / CDAY.N / FTCH.N / UBER.N / TXG.OQ / PTON.OQ / PLTR.N / DASH.N</td><td class="leftalignment">Albertsons Companies Inc / Affirm Holdings Inc / Allstate Corp / Salesforce.Com Inc / Ecolab Inc / Edison International / Hilton Worldwide Holdings Inc / International Business Machines Corp / Pfizer Inc / Santander Consumer USA Holdings Inc / Textron Inc / Unity Software Inc / US Bancorp / Pioneer Natural Resources Co / Dell Technologies Inc / Black Knight Inc / Walt Disney Co / American Financial Group Inc / Interpublic Group of Companies Inc / Spotify Technology SA / Goldman Sachs Group Inc / Royal Caribbean Cruises Ltd / Kroger Co / PG&E Corp / Whirlpool Corp / DaVita Inc / Quanta Services Inc / Church & Dwight Co Inc / Hormel Foods Corp / Chevron Corp / GameStop Corp / Intel Corp / Amgen Inc / Fiserv Inc / Tyler Technologies Inc / Watsco Inc / Qualcomm Inc / Gilead Sciences Inc / Discover Financial Services / Plug Power Inc / Molina Healthcare Inc / Opendoor Technologies Inc / Oak Street Health Inc / Marketaxess Holdings Inc / Las Vegas Sands Corp / Mercadolibre Inc / Liberty Global PLC / CME Group Inc / Seagate Technology Holdings PLC / Nextera Energy Inc / Tesla Inc / Meta Platforms Inc / RingCentral Inc / Snowflake Inc. / Five9 Inc / Synchrony Financial / Catalent Inc / Keysight Technologies Inc / Liberty Broadband Corp / Teladoc Health Inc / Twilio Inc / Trade Desk Inc / Coupa Software Inc / Snap Inc / Carvana Co / Roku Inc / PagSeguro Digital Ltd / Ceridian HCM Holding Inc / Farfetch Ltd / Uber Technologies Inc / 10X Genomics Inc / Peloton Interactive Inc / Palantir Technologies Inc / DoorDash Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Argentina / Brazil / Cayman Islands / United Kingdom / Ireland / Liberia / Luxembourg / United States</td><td class="leftalignment">Advertising / Aerospace / Appliances / Automotive / Banks / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Consumer / Defense / Electrical / Electronics / Engineering & Construction / Financial Services / Food / Healthcare / Household Products / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Media / Pharmaceuticals / Retailing / Semiconductors / Technology / Utilities / Wholesale / Oil & Gas / Internet</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">10/05/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">AAPL / ACI / AMGN / BJ / BYND / COST / DG / DLTR / EA / EL / ELF / INCY / INSP / KR / MSFT / QCOM.O / ROG / SAGE / SONY / TSCO / TTWO / WMT / WSM / CNSP.O / ATVI.O / NVDA.O / HEAR / NFLX / ARNA.O / FRPT / UTZ / NOVN.O / TEAM.O / NDSN.O / BIIB / 478160104 / MAIN.N / 36467W109 / 02043Q107 / ULTA / MCRB / ZNGA / RDHL.O / FDEV.L / 82655M107 / TBPH.O / RXDX.O / IONS.O / PTGX.O / BILI.O / XFOR.O / ZM.O / PHGE.K / AMTI.O / ASAN.K / LABP.O / HUYA.K / 03823M100 / OTLY / MNDY.O / KLTR.O</td><td class="leftalignment">Apple Inc / Albertsons Companies Inc / Amgen Inc / BJ's Wholesale Club Holdings Inc / Beyond Meat Inc / Costco Wholesale Corp / Dollar General Corp / Dollar Tree Inc / Electronic Arts Inc / Estee Lauder Companies Inc / elf Beauty Inc / Incyte Corp / Inspire Medical Systems Inc / Kroger Co / Microsoft Corp / Qualcomm Inc / Rogers Corp / SAGE Therapeutics Inc / Sony Group Corp / Tractor Supply Co / Take-Two Interactive Software Inc / Walmart Inc / Williams-Sonoma Inc / CNS Pharmaceuticals Inc / Activision Blizzard Inc / NVIDIA Corp / Turtle Beach Corp / Netflix Inc / Arena Pharmaceuticals Inc / Freshpet Inc / UTZ Brands Inc / Novan Inc / Atlassian Corporation PLC / Nordson Corp / Biogen Inc / Johnson & Johnson / Main Street Capital Corp / GameStop Corp / Alnylam Pharmaceuticals Inc / Ulta Beauty Inc / Seres Therapeutics Inc / Zynga Inc / Redhill Biopharma Ltd / Frontier Developments PLC / Sify Technologies Ltd / Theravance Biopharma Inc / Prometheus Biosciences Inc / Ionis Pharmaceuticals Inc / Protagonist Therapeutics Inc / Bilibili Inc / X4 Pharmaceuticals Inc / Zoom Video Communications Inc / Biomx Inc / Applied Molecular Transport Inc. / Asana Inc / Landos Biopharma Inc / HUYA Inc / Applied Minerals Inc / Oatly Group AB / Monday.Com Ltd / Kaltura Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United Kingdom / India / Israel / Japan / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/05/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Oct 5 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US0116591092 / US01741R1023 / US0234361089 / US0311621009 / US0530151036 / US23918K1088 / US3695501086 / US4448591028 / US6541061031 / US7043261079 / US8308791024 / US8447411088 / US91324P1021 / US9139031002 / US9182041080 / US98956P1021 / US3448491049 / US4771431016 / US64110L1061 / US4198791018 / US60855R1005 / US2533931026 / US15135B1017 / US50187A1079 / US9043111072 / PAP310761054 / US01748X1028 / US2473617023 / US9100471096 / US40412C1018 / US00404A1097 / US8485771021 / US21240E1055 / US02376R1023 / US70438V1061 / US70432V1026 / CA0089118776 / US0367521038 / US9283771007 / US86881A1007 / US03782L1017 / US15677J1088 / US5904791358 / US1255231003 / US8317541063 / US67181A1079 / US18914F1030 / US73739W1045 / US6877931096 / US82671G1004 / US45784A1043 / US35909R1086 / US01625V1044 / US74276R1023 / US00857U1079 / US53228F1012 / US10920V1070 / US70435P1021 / US13781Y1038 / US14171W1036</td><td class="leftalignment">Alaska Air Group Inc / Allegheny Technologies Inc / Amedisys Inc / Amgen Inc / Automatic Data Processing Inc / DaVita Inc / General Dynamics Corp / Humana Inc / Nike Inc / Paychex Inc / SkyWest Inc / Southwest Airlines Co / UnitedHealth Group Inc / Universal Health Services Inc / VF Corp / Zimmer Biomet Holdings Inc / Foot Locker Inc / JetBlue Airways Corp / Netflix Inc / Hawaiian Holdings Inc / Molina Healthcare Inc / DICK'S Sporting Goods Inc / Centene Corp / LHC Group Inc / Under Armour Inc / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / United Airlines Holdings Inc / HCA Healthcare Inc / Acadia Healthcare Company Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Paylocity Holding Corp / Paycom Software Inc / Air Canada / Anthem Inc / Vista Outdoor Inc / Surgery Partners Inc / Appian Corp / Ceridian HCM Holding Inc / Mesa Air Group Inc / Cigna Corp / Smith & Wesson Brands Inc / Oak Street Health Inc / Clover Health Investments Corp / Poshmark Inc / Oscar Health Inc / Signify Health Inc / InnovAge Holding Corp / Frontier Group Holdings Inc / Alignment Healthcare Inc / Privia Health Group Inc / agilon health Inc / Lifestance Health Group Inc / Bright Health Group Inc / Paycor HCM Inc / Cano Health Inc / CareMax Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Mexico / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">10/05/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / MCD=US / WEN=US / MDT=US / PATH=US / CBRL=US / DRI=US / MHK=US / REGI=US / SAGE=US / OPT=US / CGEN=US / KRT=US / APPN=US / DIN=US / OGN / BIIB=US / NUVA=US / PLAY=US / DENN=US / CMG=US / REX=US / GPRE=US / AWI=US / AMRX=US / TAST=US / QSR=US / JACK=US / PCRX=US / ESTE=US / TILE=US / NDLS=US / FEYE=US / ARCB=US / 00770K202 / LOCO=US / SHAK=US / WING=US / CRMD.US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / McDonald's Corp / Wendys Co / Medtronic PLC / UiPath Inc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Mohawk Industries Inc / Renewable Energy Group Inc / SAGE Therapeutics Inc / Opthea Ltd / Compugen Ltd / Karat Packaging Inc / Appian Corp / Dine Brands Global Inc / Organon & Co / Biogen Inc / NuVasive Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Chipotle Mexican Grill Inc / REX American Resources Corp / Green Plains Inc / Armstrong World Industries Inc / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Jack in the Box Inc / Pacira Biosciences Inc / Earthstone Energy Inc / Interface Inc / Noodles & Co / Mandiant Inc / ArcBest Corp / Aemetis Inc / El Pollo Loco Holdings Inc / Shake Shack Inc / Wingstop Inc / CorMedix Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/05/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - October 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AEP.N / CNA.L / CP.TO / DD.N / EIX.N / GE.N / PNN.L / SMIN.L / SVT.L / WEIR.L / LPX.N / AMGN.O / CNR.TO / CSX.N / TV.TO / DVN.N / SHW.N / EXC.N / RPM.N / FTS.TO / EMA.TO / ALFA.ST / SLF.TO / HCC.N / RUS.TO / FM.TO / 878742204 / 35671D857 / ISBC.O / CS.TO / 443628102 / 550372106 / NCU.TO / GETP.PA / NEE.N / XYL.N / 505440107 / BHLB.N / 46579R104 / XNCR.OQ / CIA.TO / CFG.N / AXTA.N / VACN.S / STLC.TO / NEXA.TO / MOCORP.HE / 900435207 / NAPA.N</td><td class="leftalignment">American Electric Power Company Inc / Centrica PLC / Canadian Pacific Railway Ltd / Dupont De Nemours Inc / Edison International / General Electric Co / Pennon Group PLC / Smiths Group PLC / Severn Trent PLC / Weir Group PLC / Louisiana-Pacific Corp / Amgen Inc / Canadian National Railway Co / CSX Corp / Trevali Mining Corp / Devon Energy Corp / Sherwin-Williams Co / Exelon Corp / RPM International Inc / Fortis Inc / Emera Inc / Alfa Laval AB / Sun Life Financial Inc / Warrior Met Coal Inc / Russel Metals Inc / First Quantum Minerals Ltd / Teck Resources Ltd / Freeport-McMoRan Inc / Investors Bancorp Inc / Capstone Mining Corp / Hudbay Minerals Inc / Lundin Mining Corp / Nevada Copper Corp / Getlink SE / Nextera Energy Inc / Xylem Inc / Labrador Iron Ore Royalty Corp / Berkshire Hills Bancorp Inc / Ivanhoe Mines Ltd / Xencor Inc / Champion Iron Ltd / Citizens Financial Group Inc / Axalta Coating Systems Ltd / VAT Group AG / Stelco Holdings Inc / Nexa Resources SA / Metso Outotec Corp / Turquoise Hill Resources Ltd / Duckhorn Portfolio Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Finland / France / United Kingdom / Luxembourg / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">10/05/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Robust early- and late-stage inflammation pipeline</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">10/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: October 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">AIG.N / AIRP.PA / ALB.N / AN.N / AXP.N / BA.N / BAC.N / BMY.N / CB.N / CCI.N / CI.N / CL.N / COF.N / CRM.N / EOG.N / F.N / FDX.N / FMC.N / GM.N / GPS.N / JPM.N / KO.N / LLY.N / MMC.N / NEM.N / OXY.N / PFE.N / PHM.N / PPCJ.J / RHI.N / SC.N / T.N / TMO.N / WFC.N / WMT.N / ACI.N / AA.N / PG.N / HUM.N / NUE.N / DHR.N / DIS.N / UNH.N / DE.N / PGR.N / CAT.N / DT.N / IPG.N / UNP.N / SPOT.N / GS.N / CLX.N / MCD.N / HD.N / LOW.N / MRO.N / UPS.N / MMM.N / XOM.N / DVN.N / NKE.N / OLN.N / IT.N / TGT.N / VZ.N / HCA.N / WST.N / MUR.N / HRB.N / ORCL.N / VFC.N / PWR.N / V.N / ACN.N / WSM.N / JLL.N / HAE.N / SAM.N / CRL.N / CVX.N / COP.N / INTC.OQ / ADPT.OQ / ADBE.OQ / AMGN.OQ / AAPL.OQ / AMAT.OQ / AGL.N / CSCO.OQ / COHR.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / TEAM.OQ / RGEN.OQ / SIVB.OQ / ZION.OQ / CACC.OQ / QCOM.OQ / INTU.OQ / COST.OQ / INCY.OQ / PENN.OQ / AMED.OQ / PCTY.OQ / CTXS.OQ / AMZN.OQ / TTWO.OQ / LNG.A / MRCY.OQ / NVDA.OQ / PACW.OQ / ISRG.OQ / ILMN.OQ / ARRY.OQ / EXAS.OQ / GPN.N / FITB.OQ / VRTX.OQ / NFLX.OQ / DKS.N / WYNN.OQ / BIIB.OQ / TPX.N / TFC.N / SBNY.OQ / ACAD.OQ / MOS.N / MKTX.OQ / MPWR.OQ / LVS.N / DXCM.OQ / WAL.N / DISCA.OQ / MS.N / CMG.N / FIS.N / STX.AX / MA.N / IPGP.OQ / AON.N / CLR.N / BX.N / PAG.N / TDC.N / TNDM.OQ / MRNA.OQ / BIO.N / SWI.N / SCHW.N / FTNT.OQ / MU.OQ / GNRC.N / NEE.N / TSLA.OQ / TRGP.N / NLSN.N / Z.OQ / AMD.OQ / SLM.OQ / ENPH.OQ / ZNGA.OQ / EPAM.N / PSX.N / WDC.OQ / NOW.N / SRPT.OQ / PANW.N / FANG.OQ / RNG.N / COMM.OQ / WIX.OQ / SNOW.N / GOOGL.OQ / PAYC.N / SAGE.OQ / GLOB.N / CTLT.N / HUBS.N / TDOC.N / PYPL.OQ / OLLI.OQ / NVCR.OQ / PSTG.N / TMUS.OQ / IONS.OQ / TWLO.N / COUP.OQ / LW.N / ATUS.N / IOVA.OQ / ROKU.OQ / CBRE.N / FB.PS / STNE.OQ / CTRA.N / TER.OQ / NWL.OQ / PINS.N / BYND.OQ / ZM.OQ / FSLY.N / PTON.OQ / DDOG.OQ / SPCE.N / LMND.N / GOCO.OQ / AMWL.N / VTRS.OQ / LFG.AX / PSFE.N / TSP.OQ / BBWI.N</td><td class="leftalignment">American International Group Inc / L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Albemarle Corp / AutoNation Inc / American Express Co / Boeing Co / Bank of America Corp / Bristol-Myers Squibb Co / Chubb Ltd / Crown Castle International Corp / Cigna Corp / Colgate-Palmolive Co / Capital One Financial Corp / Salesforce.Com Inc / EOG Resources Inc / Ford Motor Co / FedEx Corp / FMC Corp / General Motors Co / Gap Inc / JPMorgan Chase & Co / Coca-Cola Co / Eli Lilly and Co / Marsh & McLennan Companies Inc / Newmont Corporation / Occidental Petroleum Corp / Pfizer Inc / Pultegroup Inc / PPC Ltd / Robert Half International Inc / Santander Consumer USA Holdings Inc / AT&T Inc / Thermo Fisher Scientific Inc / Wells Fargo & Co / Walmart Inc / Albertsons Companies Inc / Alcoa Corp / Procter & Gamble Co / Humana Inc / Nucor Corp / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Deere & Co / Progressive Corp / Caterpillar Inc / Dynatrace Inc / Interpublic Group of Companies Inc / Union Pacific Corp / Spotify Technology SA / Goldman Sachs Group Inc / Clorox Co / McDonald's Corp / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / United Parcel Service Inc / 3M Co / Exxon Mobil Corp / Devon Energy Corp / Nike Inc / Olin Corp / Gartner Inc / Target Corp / Verizon Communications Inc / HCA Healthcare Inc / West Pharmaceutical Services Inc / Murphy Oil Corp / H & R Block Inc / Oracle Corp / VF Corp / Quanta Services Inc / Visa Inc / Accenture PLC / Williams-Sonoma Inc / Jones Lang LaSalle Inc / Haemonetics Corp / Boston Beer Company Inc / Charles River Laboratories International Inc / Chevron Corp / Conocophillips / Intel Corp / Adaptive Biotechnologies Corp / Adobe Inc / Amgen Inc / Apple Inc / Applied Materials Inc / agilon health Inc / Cisco Systems Inc / Coherent Inc / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / Atlassian Corporation PLC / Repligen Corp / SVB Financial Group / Zions Bancorporation NA / Credit Acceptance Corp / Qualcomm Inc / Intuit Inc / Costco Wholesale Corp / Incyte Corp / Penn National Gaming Inc / Amedisys Inc / Paylocity Holding Corp / Citrix Systems Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Cheniere Energy Inc / Mercury Systems Inc / NVIDIA Corp / PacWest Bancorp / Intuitive Surgical Inc / Illumina Inc / Array Technologies Inc / Exact Sciences Corp / Global Payments Inc / Fifth Third Bancorp / Vertex Pharmaceuticals Inc / Netflix Inc / DICK'S Sporting Goods Inc / Wynn Resorts Ltd / Biogen Inc / Tempur Sealy International Inc / Truist Financial Corp / Signature Bank / ACADIA Pharmaceuticals Inc / Mosaic Co / Marketaxess Holdings Inc / Monolithic Power Systems Inc / Las Vegas Sands Corp / Dexcom Inc / Western Alliance Bancorp / Discovery Inc / Morgan Stanley / Chipotle Mexican Grill Inc / Fidelity National Information Services Inc / Strike Energy Ltd / Mastercard Inc / IPG Photonics Corp / Aon PLC / Continental Resources Inc / Blackstone Inc / Penske Automotive Group Inc / Teradata Corp / Tandem Diabetes Care Inc / Moderna Inc / Bio Rad Laboratories Inc / SolarWinds Corp / Charles Schwab Corp / Fortinet Inc / Micron Technology Inc / Generac Holdings Inc / Nextera Energy Inc / Tesla Inc / Targa Resources Corp / Nielsen Holdings PLC / Zillow Group Inc / Advanced Micro Devices Inc / SLM Corp / Enphase Energy Inc / Zynga Inc / Epam Systems Inc / Phillips 66 / Western Digital Corp / ServiceNow Inc / Sarepta Therapeutics Inc / Palo Alto Networks Inc / Diamondback Energy Inc / RingCentral Inc / CommScope Holding Company Inc / Wix.Com Ltd / Snowflake Inc. / Alphabet Inc / Paycom Software Inc / SAGE Therapeutics Inc / Globant SA / Catalent Inc / HubSpot Inc / Teladoc Health Inc / PayPal Holdings Inc / Ollie's Bargain Outlet Holdings Inc / Novocure Ltd / Pure Storage Inc / T-Mobile US Inc / Ionis Pharmaceuticals Inc / Twilio Inc / Coupa Software Inc / Lamb Weston Holdings Inc / Altice USA Inc / Iovance Biotherapeutics Inc / Roku Inc / CBRE Group Inc / San Miguel Food and Beverage Inc / StoneCo Ltd / Coterra Energy Inc / Teradyne Inc / Newell Brands Inc / Pinterest Inc / Beyond Meat Inc / Zoom Video Communications Inc / Fastly Inc / Peloton Interactive Inc / Datadog Inc / Virgin Galactic Holdings Inc / Lemonade Inc / Gohealth Inc / American Well Corp / Viatris Inc / Liberty Financial Group Ltd / Paysafe Ltd / TuSimple Holdings Inc / Bath & Body Works Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / Luxembourg / Philippines / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="even"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">EADV Event Highlights Inflammation Portfolio</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AMGN</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / PORTFOLIO/ASSET STRATEGIES</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="odd"><td class="leftalignment">10/04/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Inflammation portfolio slated to become an increasingly important growth driver as pipeline matures</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / PORTFOLIO/ASSET STRATEGIES</td><td class="leftalignment">Kennen MacKay, PHD</td></tr>
<tr class="even"><td class="leftalignment">10/04/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">EADV Updates: Opzelura Stays TRUE in Phase III; OX40 Scratches the Itch for Non-JAK Targets; Deucrava PASI-s Durability Test</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">110122108 / 45337C102 / 03116210</td><td class="leftalignment">Bristol-Myers Squibb Co / Incyte Corp / Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="odd"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">AMG 451 Data at EADV Highlight Benefit of Targeting OX40 in Atopic Dermatitis</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Yaron Werber, M.D., MD / Gabriel Schneider, M.D. / Brendan Smith, Ph.D. / Eve Reilly, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Inflammation portfolio is an underappreciated opportunity; key takeaways from today's call</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AMGN=US</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / PORTFOLIO/ASSET STRATEGIES</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="odd"><td class="leftalignment">10/04/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">OX40 in atopic derm - Amgen vs Sanofi</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat / Michael DiFiore</td></tr>
<tr class="even"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">‘451 Looks Competitive in AD But Dupi Bar is High</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Sep 24, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / OGN / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Organon & Co / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Positive AMG451 (anti-OX40) data in atopic dermatitis; awaiting more details on durability</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AMGN=US</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">AMGN.OQ - Event Transcript of Amgen Inc conference call, Oct. 04, 2021 / 8:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/04/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">Industrials Calendar : October-December 2021</td><td class="leftalignment">English</td><td class="rightalignment">42</td><td class="leftalignment">ACF / AIRP.PA / BAX.N / BDX.N / BHP.AX / BMWG.DE / BMY.N / CC.N / CCK.N / CCL.N / CE.N / CRH.L / DSMN.AS / EPED.PA / F.N / FGP.L / GM.N / GOG.L / HEIG.DE / JNJ.N / LHAG.DE / LLY.N / MCK.N / MRK.N / MWDP.PA / NEX.L / PFE.N / PLOF.PA / RENA.PA / RIO.AX / RR.L / RYA.I / SAPJ.J / SAS.ST / SCHN.PA / SGC.L / SGOB.PA / SMIN.L / SOLB.BR / SYD.AX / TCFP.PA / TMO.N / VLLP.PA / VOLVb.ST / VOWG.DE / WBSV.VI / STERV.HE / AIRF.PA / CONG.DE / AZN.L / AMGN.O / AAL.L / SASY.PA / TKAG.DE / ROG.S / SIEGn.F / NOVN.S / MG.TO / FMEG.DE / BZU.MI / MRCG.DE / MGA.N / PSHG_p.DE / OI.N / BLL.N / GLAX.NS / PKI.N / FREG.DE / RXL.PA / EZJ.L / SUP.N / GSK.L / ESI.N / CC@US / MHK.N / TAMO.BO / FLWS.O / VOES.VI / MT.N / LXSG.DE / HUN.N / SAF.PA / TUIGn.DE / MT.AS / LEGD.PA / TEVA.N / SKG.I / MNDI.L / DAIGn.DE / BAES.L / BAYGn.DE / BASFn.DE / GLEN.L / CAR.O / SDFGn.DE / METSB.HE / LKQ.O / XPO.N / GT.O / ABBV.N / GEST.MC / EVKn.DE / CSTM.N / CTLT.N / EUCAR.PA / ZBH.N / 1COV.DE / HLAG.DE / NVGR.LS / ADNT.N / BHC.N / VTRS.O / HON.O</td><td class="leftalignment">Acrow Formwork and Construction Services Ltd / L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Baxter International Inc / Becton Dickinson and Co / BHP Group Ltd / Bayerische Motoren Werke AG / Bristol-Myers Squibb Co / Chemours Co / Crown Holdings Inc / Carnival Corp / Celanese Corp / CRH PLC / Koninklijke DSM NV / Faurecia SE / Ford Motor Co / FirstGroup PLC / General Motors Co / Go-Ahead Group PLC / HeidelbergCement AG / Johnson & Johnson / Deutsche Lufthansa AG / Eli Lilly and Co / Mckesson Corp / Merck & Co Inc / Wendel SE / National Express Group PLC / Pfizer Inc / Compagnie Plastic Omnium SE / Renault SA / Rio Tinto Ltd / Rolls-Royce Holdings PLC / Ryanair Holdings PLC / Sappi Ltd / SAS AB / Schneider Electric SE / Stagecoach Group PLC / Compagnie de Saint Gobain SA / Smiths Group PLC / Solvay SA / Sydney Airport / Thales SA / Thermo Fisher Scientific Inc / Vallourec SA / Volvo AB / Volkswagen AG / Wienerberger AG / Stora Enso Oyj / Air France KLM SA / Continental AG / AstraZeneca PLC / Amgen Inc / Anglo American PLC / Sanofi SA / thyssenkrupp AG / Roche Holding AG / Siemens AG / Novartis AG / Magna International Inc / Fresenius Medical Care AG & Co KGaA / Buzzi Unicem SpA / Merck KGaA / Magna International Inc / Porsche Automobil Holding SE / O-I Glass Inc / Ball Corp / GlaxoSmithKline Pharmaceuticals Ltd / PerkinElmer Inc / Fresenius SE & Co KGaA / Rexel SA / Easyjet PLC / Superior Industries International Inc / GlaxoSmithKline PLC / Element Solutions Inc / Chemours Co / Mohawk Industries Inc / Tata Motors Ltd / 1-800-Flowers.Com Inc / voestalpine AG / ArcelorMittal SA / Lanxess AG / Huntsman Corp / Safran SA / TUI AG / ArcelorMittal SA / Legrand SA / Teva Pharmaceutical Industries Ltd / Smurfit Kappa Group PLC / Mondi PLC / Daimler AG / BAE Systems PLC / Bayer AG / BASF SE / Glencore PLC / Avis Budget Group Inc / K&S AG / Metsa Board Oyj / LKQ Corp / XPO Logistics Inc / Goodyear Tire & Rubber Co / Abbvie Inc / Gestamp Automocion SA / Evonik Industries AG / Constellium SE / Catalent Inc / Europcar Mobility Group SA / Zimmer Biomet Holdings Inc / Covestro AG / Hapag Lloyd AG / Navigator Company SA / Adient PLC / Bausch Health Companies Inc / Viatris Inc / Honeywell International Inc</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">Australia / Austria / Belgium / Canada / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Hong Kong / India / Ireland / Israel / Italy / Luxembourg / Netherlands / Norway / Panama / Portugal / Sweden / United States / South Africa / Jersey</td><td class="leftalignment">Aerospace / Air Transportation / Automotive / Biotechnology / Building & Building Materials / Chemicals / Conglomerates / Consumer / Containers & Packing / Defense / Electrical / Energy / Engineering & Construction / Financial Services / Healthcare / Household Products / Industrial Materials / Leisure & Entertainment / Lodging & Restaurants / Machinery / Manufacturing / Metals & Minerals / Paper & Forest Products / Pharmaceuticals / Railroads / Retailing / Shipping & Shipbuilding / Tire & Rubber / Transportation / Wholesale / Oil & Gas</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Danielle Ward / Benjamin Defay / Stephanie Vincent / Ed McGuinness / Mr. Adam Bodor</td></tr>
<tr class="even"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / OXY=US / RRC=US / DVN=US / INCY=US / APA=US / CPE=US / EOG=US / REI=US / CRM=US / XOM=US / CRK=US / WLL=US / PXD=US / HSII=US / MGY=US / SWN=US / MUR=US / MRO=US / KFRC=US / MANH=US / STZ=US / KFY=US / AMN=US / PATH=US / BLL=US / ENV=US / COLL=US / CNX=US / CCK=US / EQT=US / GPOR=US / MAN=US / ASGN=US / RHI=US / CVX=US / CCRN=US / FB=US / COP=US / BDSI=US / RNG=US / MIC=US / FRPT=US / XM=US / NSP=US / CLR=US / NOG=US / AR=US / OAS=US / BLND=US / ESTE=US / BCEI=US / MTDR=US / PDCE=US / FANG=US / FATE=US / CNCE=US / QTWO=US / VNOM=US / GSBD=US / CDEV=US / PVAC=US / ANAB=US / OKTA=US / SBOW=US / DCPH=US / OVV=US / ARQT=US / NCNO=US / BIGC=US / REPX=US / 67421J108 / DBRG=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Occidental Petroleum Corp / Range Resources Corp / Devon Energy Corp / Incyte Corp / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Salesforce.Com Inc / Exxon Mobil Corp / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Heidrick & Struggles International Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / Marathon Oil Corp / Kforce Inc / Manhattan Associates Inc / Constellation Brands Inc / Korn Ferry / AMN Healthcare Services Inc / UiPath Inc / Ball Corp / Envestnet Inc / Collegium Pharmaceutical Inc / CNX Resources Corp / Crown Holdings Inc / EQT Corp / Gulfport Energy Corp / ManpowerGroup Inc / ASGN Inc / Robert Half International Inc / Chevron Corp / Cross Country Healthcare Inc / Meta Platforms Inc / Conocophillips / BioDelivery Sciences International Inc / RingCentral Inc / Macquarie Infrastructure Holdings LLC / Freshpet Inc / Qualtrics International Inc / Insperity Inc / Continental Resources Inc / Northern Oil and Gas Inc / Antero Resources Corp / Oasis Petroleum Inc / Blend Labs Inc / Earthstone Energy Inc / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Diamondback Energy Inc / Fate Therapeutics Inc / Concert Pharmaceuticals Inc / Q2 Holdings Inc / Viper Energy Partners LP / Goldman Sachs BDC Inc / Centennial Resource Development Inc / Ranger Oil Corp / AnaptysBio Inc / Okta Inc / SilverBow Resources Inc / Deciphera Pharmaceuticals Inc / Ovintiv Inc / Arcutis Biotherapeutics Inc / nCino Inc / Bigcommerce Holdings Inc / Riley Exploration Permian Inc / Oatly Group AB / DigitalBridge Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Luxembourg / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/04/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - October 4, 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AEP.N / AES.N / AIG.N / ALV.N / BAC.N / BATS.L / BK.N / C.N / CAS.TO / CB.N / CCI.N / CL.N / EIX.N / EL.N / F.N / FGP.L / FITB.O / FSR.N / GM.N / IBE.MC / JPM.N / KEY.N / KMB.N / KO.N / MO.N / NTRS.O / PEG.N / PERP.PA / PNC.N / RWEG.DE / SO.N / T.N / USB.N / VC.N / WFC.N / PEP.N / PG.N / LPX.N / TEN.N / AMGN.O / INCY.O / DUK.N / BWA.N / LEA.N / K.N / DISH.O / SU.TO / GS.N / CLX.N / CAG.N / BEIG.DE / PCG.N / HSY.N / EPC.N / ADCT.N / SBAC.O / AMT.N / GIBa.TO / CONE.O / VZ.N / STT.N / EXEL.O / XEL.N / ARNA.O / STZ.N / LNC.N / APH.N / AXL.N / CHD.N / NWN.N / MTB.N / BC.N / GIL.N / SAM.N / AJG.N / REGN.O / ENR.N / PRU.N / TEL.N / RF.N / CPK.N / PII.N / ST.N / CRC.N / PLUG.OQ / SGEN.OQ / MNST.O / BPOP.O / ACGL.O / EQIX.O / ATDb.TO / TFC.N / DLR.N / 416515104 / SJW.N / DRX.L / MS.N / HOG.N / AON.N / BGS.N / DAN.N / CLW.N / SPB.N / NEE.N / MTOR.N / RFP.N / FFHu.TO / MDLZ.OQ / KPT.TO / TSLA.N / PRMW.N / TMUS.N / COTY.N / PRTA.O / BEP.N / PLC.TO / CFG.N / FEVR.L / ZG.O / RGNX.O / RACE.MI / ADVM.OQ / ADNT.N / UNIT.O / VST.N / ATNX.O / APTV.N / VNE.N / KDP.N / NWL.O / GMAB.O / CRNC.OQ / OAS.OQ / WTRG.N / REYN.O / NKLA.OQ / NRIX.OQ / LUMN.N / RIDE.OQ / WFG.N / TSP.OQ / OTLY.O / RYAN.N / COOK.N / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / American International Group Inc / Autoliv Inc / Bank of America Corp / British American Tobacco PLC / Bank of New York Mellon Corp / Citigroup Inc / Cascades Inc / Chubb Ltd / Crown Castle International Corp / Colgate-Palmolive Co / Edison International / Estee Lauder Companies Inc / Ford Motor Co / FirstGroup PLC / Fifth Third Bancorp / Fisker Inc / General Motors Co / Iberdrola SA / JPMorgan Chase & Co / KeyCorp / Kimberly-Clark Corp / Coca-Cola Co / Altria Group Inc / Northern Trust Corp / Public Service Enterprise Group Inc / Pernod Ricard SA / PNC Financial Services Group Inc / Rwe AG / Southern Co / AT&T Inc / US Bancorp / Visteon Corp / Wells Fargo & Co / PepsiCo Inc / Procter & Gamble Co / Louisiana-Pacific Corp / Tenneco Inc / Amgen Inc / Incyte Corp / Duke Energy Corp / Borgwarner Inc / Lear Corp / Kellogg Co / DISH Network Corp / Suncor Energy Inc / Goldman Sachs Group Inc / Clorox Co / Conagra Brands Inc / Beiersdorf AG / PG&E Corp / Hershey Co / Edgewell Personal Care Co / ADC Therapeutics SA / SBA Communications Corp / American Tower Corp / CGI Inc / CyrusOne Inc / Verizon Communications Inc / State Street Corp / Exelixis Inc / Xcel Energy Inc / Arena Pharmaceuticals Inc / Constellation Brands Inc / Lincoln National Corp / Amphenol Corp / American Axle & Manufacturing Holdings Inc / Church & Dwight Co Inc / Northwest Natural Holding Co / M&T Bank Corp / Brunswick Corp / Gildan Activewear Inc / Boston Beer Company Inc / Arthur J Gallagher & Co / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Prudential Financial Inc / TE Connectivity Ltd / Regions Financial Corp / Chesapeake Utilities Corp / Polaris Inc / Sensata Technologies Holding PLC / California Resources Corp / Plug Power Inc / Seagen Inc / Monster Beverage Corp / Popular Inc / Arch Capital Group Ltd / Equinix Inc / Alimentation Couche-Tard Inc / Truist Financial Corp / Digital Realty Trust Inc / Hartford Financial Services Group Inc / SJW Group / Drax Group PLC / Morgan Stanley / Harley-Davidson Inc / Aon PLC / B&G Foods Inc / Dana Inc / Clearwater Paper Corp / Spectrum Brands Holdings Inc / Nextera Energy Inc / Meritor Inc / Resolute Forest Products Inc / Fairfax Financial Holdings Ltd / Mondelez International Inc / KP Tissue Inc / Tesla Inc / Primo Water Corp / T-Mobile US Inc / Coty Inc / Prothena Corporation PLC / Brookfield Renewable Partners LP / Park Lawn Corp / Citizens Financial Group Inc / Fevertree Drinks PLC / Zillow Group Inc / Regenxbio Inc / Ferrari NV / Adverum Biotechnologies Inc / Adient PLC / Uniti Group Inc / Vistra Corp / Athenex Inc / Aptiv PLC / Veoneer Inc / Keurig Dr Pepper Inc / Newell Brands Inc / Genmab A/S / Cerence Inc / Oasis Petroleum Inc / Essential Utilities Inc / Reynolds Consumer Products Inc / Nikola Corp / Nurix Therapeutics Inc / Lumen Technologies Inc / Lordstown Motors Corp / West Fraser Timber Co Ltd / TuSimple Holdings Inc / Oatly Group AB / Ryan Specialty Group Holdings Inc / Traeger Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Ireland / Netherlands / Puerto Rico / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Sep 24</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4151.T: Kyowa Kirin - Online briefing on Phase II study data for atopic dermatitis treatment KHK4083</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">4151.T / SASY.PA / AMGN.OQ</td><td class="leftalignment">Kyowa Kirin Co Ltd / Sanofi SA / Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Weekly review/outlook (4 October-): JCR Pharmaceuticals up sharply, Shionogi still gaining, sector outperformed TOPIX</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">4502.T / 4507.T / 4503.T / 4519.T / 4523.T / 4528.T / 4543.T / BMY.N / 4516.T / 4506.T / 4536.T / ROG.S / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / AMGN.OQ / 2413.T / 4568.T / MRNA.OQ / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Shionogi & Co Ltd / Astellas Pharma Inc / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Roche Holding AG / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / Amgen Inc / M3 Inc / Daiichi Sankyo Co Ltd / Moderna Inc / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4151.T: 協和キリン - アトピー性皮膚炎治療薬KHK4083のフェーズ2データ説明会を開催</td><td class="leftalignment">Japanese</td><td class="rightalignment">6</td><td class="leftalignment">4151.T / SASY.PA / AMGN.OQ</td><td class="leftalignment">Kyowa Kirin Co Ltd / Sanofi SA / Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 週間レビューと見通し（10月4日～）: JCRファーマ急進、塩野義は続伸、医薬品セクターはTOPIX対比アウトパフォーム</td><td class="leftalignment">Japanese</td><td class="rightalignment">10</td><td class="leftalignment">4507.T / 4552.T / 4502.T / 4503.T / 4519.T / 4523.T / 4528.T / 4543.T / BMY.N / 4516.T / 4506.T / 4536.T / ROG.S / 4151.T / 4553.T / 4540.T / 6869.T / 4541.T / AMGN.OQ / 2413.T / 4568.T / MRNA.OQ / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">Shionogi & Co Ltd / JCR Pharmaceuticals Co Ltd / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Roche Holding AG / Kyowa Kirin Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / Amgen Inc / M3 Inc / Daiichi Sankyo Co Ltd / Moderna Inc / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">10/03/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Key Questions for Management 10.3.21</td><td class="leftalignment">English</td><td class="rightalignment">82</td><td class="leftalignment">00365410 / 28176E10 / 62855J10 / 01988P10 / 00282410 / 45337C10 / 75991610 / 09061G10 / 86366710 / 71708110 / 00846U10 / 44485910 / 45253H10 / 07181310 / 10113710 / 04635310 / 43644010 / 64125C10 / 37555810 / 15678210 / 03116210 / 75886F10 / 46120E60 / 11679410 / M2572210 / 45232710 / 02343610 / 09062X10 / 01625510 / 30063P10 / 478160104 / 640268108 / 075887109 / 00422510 / 02043Q10 / 67070410 / 40637H10 / 207410101 / 205306103 / 45784P10 / 25213110 / 50187A10 / 58502B10 / 04963C20 / 03152W10 / 64049M20 / 58933Y10 / 02311120 / 14161910 / G0176710 / 45766930 / G5087110 / 80360710 / 74051N10 / 05463X10 / 45780L10 / 82621J10 / 31572Q80 / 87918A10 / 46185L10 / 00653A107 / 04351P101 / 03675210 / 75046920 / 00287Y10 / 40412C10 / G5960L10 / 46222210 / 18946410 / 04004760 / 21232630 / 04280A10 / 05337M104 / 23283X20 / 40131M10 / 604749101 / 63230710 / 71944F10 / 45773010 / 05358830 / 38942Q10 / 76029N10 / 41358P10 / N9006410 / 67181A10 / 42226A10 / 68269G10 / 00437E10 / 74939710 / 58949210 / 09627Y10 / 68071010 / 30052C10 / 09075V10 / 60770K10 / 74340E10 / 42225T10 / 00289Y10 / 00773U10 / 01981810 / 05455M10 / 09609G10 / 10806X10 / 45826J10 / 75901B10 / 77313F10 / 05464T10 / 05156V10 / 75615P10 / 16383L10 / 55609910 / N0104510 / 14843C10 / 01438T10 / 74374N10 / 51654410 / 31189P10 / 07725L10 / H0026310 / 00847X10 / 24344T10 / 29428V10 / 37890U10 / 81181C10 / G1119610 / 40422M10 / 04685N10 / 13089P10 / 34633R10 / 37242740 / 38341P10 / 43906K10 / 45781K20 / 46565G10 / 48576U10 / 50127T10 / 61776010 / 60468T10 / 03969F10 / 05370A10 / 78116T10 / 76155X10 / 45845P10 / 4525EP10 / 78667J10 / 82710M10 / 46116X10 / 74366E10 / 37957720 / 22905030 / G8807B10 / 90400D10 / 64157F10 / 74766Q10 / 69014510 / 35961610 / 55886810 / 05454B10 / 49232710 / 22663K10 / 05465P10 / 00461U10 / 04539610 / 81727U10 / 59045L10 / 01671P10 / 68621F10 / 45249V10 / F4373810 / 45332Y10 / 80405P10 / N4482110 / 75955J40 / 56400P70 / 28255910 / 87808K10 / 87166L10 / 03836N10 / 23257D10 / 40434H20 / 28617K10 / 29446K10 / 83422E10 / 03824M10 / N1976T10 / 36322Q10 / N4444510 / 45258J10 / 48349710 / 56854Q20 / 65343C10 / 74623710 / 75974E10 / 16961L10 / 65443P10 / 82939910 / 87410C10 / 19240Q20 / 00288U10 / 36870G10 / 64128810 / 00404A10 / N6960510 / 28036F10 / 51506910 / N5749R10 / 24343R10 / 75629V10 / 26622P10 / 52634L10 / 23003110 / 49705R10 / 38246G10 / 85209E10 / 25056L10 / 09770210 / 82835W10 / N5151710 / 78349D10 / 68386J20 / 30315R10 / 37230320 / 14203810 / 75382E10 / 29251M10 / 81064810 / G637AM10 / 15117B20 / 00038020 / 82489T10 / 00653Q10 / 12552310 / 04683R10 / 01626L10 / 20752310 / 28623U10 / 28658R10 / 38870X10 / 95075A10 / 15673T10 / 60853G10 / 87427V10</td><td class="leftalignment">ABIOMED Inc / Edwards Lifesciences Corp / Myriad Genetics Inc / Allscripts Healthcare Solutions Inc / Abbott Laboratories / Incyte Corp / Repligen Corp / Biomarin Pharmaceutical Inc / Stryker Corp / Pfizer Inc / Agilent Technologies Inc / Humana Inc / ImmunoGen Inc / Baxter International Inc / Boston Scientific Corp / AstraZeneca PLC / Hologic Inc / Neurocrine Biosciences Inc / Gilead Sciences Inc / Cerner Corp / Amgen Inc / Regeneron Pharmaceuticals Inc / Intuitive Surgical Inc / Bruker Corp / Compugen Ltd / Illumina Inc / Amedisys Inc / Biogen Inc / Align Technology Inc / Exact Sciences Corp / Johnson & Johnson / Nektar Therapeutics / Becton Dickinson and Co / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / NuVasive Inc / Halozyme Therapeutics Inc / Conmed Corp / Computer Programs and Systems Inc / Insulet Corp / Dexcom Inc / LHC Group Inc / MEDNAX Inc / AtriCure Inc / Amicus Therapeutics Inc / Neogenomics Inc / Merck & Co Inc / Amarin Corporation PLC / Cardiovascular Systems Inc / Alkermes Plc / Insmed Inc / Jazz Pharmaceuticals PLC / Sarepta Therapeutics Inc / Premier Inc / AxoGen Inc / Inogen Inc / Sientra Inc / FibroGen Inc / Teladoc Health Inc / Invitae Corp / Adaptimmune Therapeutics PLC / Ascendis Pharma A/S / Anthem Inc / Radius Health Inc / Abbvie Inc / HCA Healthcare Inc / Medtronic PLC / Ionis Pharmaceuticals Inc / Clovis Oncology Inc / Arena Pharmaceuticals Inc / ContraFect Corp / Arrowhead Pharmaceuticals Inc / Avadel Pharmaceuticals PLC / Cytosorbents Corp / Guardant Health Inc / Mirum Pharmaceuticals Inc / Natera Inc / Phreesia Inc / Inspire Medical Systems Inc / Aveo Pharmaceuticals Inc / Graybug Vision Inc / Replimune Group Inc / Harpoon Therapeutics Inc / Uniqure NV / Oak Street Health Inc / Healthequity Inc / 1Life Healthcare Inc / Accolade Inc / R1 RCM Inc / Mereo Biopharma Group PLC / Blueprint Medicines Corp / Olink Holding AB (publ) / Evolus Inc / BioNTech SE / Moderna Inc / Progyny Inc / Health Catalyst Inc / Abeona Therapeutics Inc / Adverum Biotechnologies Inc / Allovir Inc / AVROBIO Inc / bluebird bio Inc / BridgeBio Pharma Inc / Intellia Therapeutics Inc / Regenxbio Inc / Rocket Pharmaceuticals Inc / Axsome Therapeutics Inc / Aurinia Pharmaceuticals Inc / Reata Pharmaceuticals Inc / ChemoCentryx Inc / MacroGenics Inc / Affimed NV / Castle Biosciences Inc / Aldeyra Therapeutics Inc / Provention Bio Inc / Lantheus Holdings Inc / Fate Therapeutics Inc / Beigene Ltd / AC Immune SA / Agios Pharmaceuticals Inc / Deciphera Pharmaceuticals Inc / Epizyme Inc / Global Blood Therapeutics Inc / Seagen Inc / Biohaven Pharmaceutical Holding Company Ltd / H Lundbeck A/S / Athenex Inc / Calithera Biosciences Inc / Forma Therapeutics Holdings Inc / Genocea Biosciences Inc / Gossamer Bio Inc / HOOKIPA Pharma Inc / Innate Pharma SA / Iteos Therapeutics Inc / Karyopharm Therapeutics Inc / Kura Oncology Inc / MorphoSys AG / Mirati Therapeutics Inc / Arcus Biosciences Inc / Avidity Biosciences Inc / Rubius Therapeutics Inc / Revolution Medicines Inc / Intercept Pharmaceuticals Inc / Immunic Inc / SAGE Therapeutics Inc / Silk Road Medical Inc / Intra-Cellular Therapies Inc / Protagonist Therapeutics Inc / Globus Medical Inc / Cryoport Inc / Theravance Biopharma Inc / Ultragenyx Pharmaceutical Inc / Nevro Corp / Quanterix Corp / Outset Medical Inc / Fulcrum Therapeutics Inc / Madrigal Pharmaceuticals Inc / Axcella Health Inc / Keros Therapeutics Inc / Crinetics Pharmaceuticals Inc / Axonics Inc / Aclaris Therapeutics Inc / Assembly Biosciences Inc / Senseonics Holdings Inc / Mersana Therapeutics Inc / Allakos Inc / Organogenesis Holdings Inc / Imara Inc / Genfit SA / Inari Medical Inc / Satsuma Pharmaceuticals Inc / InflaRx NV / Relmada Therapeutics Inc / MannKind Corp / 89Bio Inc / TCR2 Therapeutics Inc / Synlogic Inc / Aptinyx Inc / Cymabay Therapeutics Inc / HTG Molecular Diagnostics Inc / Eledon Pharmaceuticals Inc / Equillium Inc / Solid Biosciences Inc / Applied Molecular Transport Inc. / Centogene NV / Galecto Inc / Immatics NV / Immunovant Inc / Kalvista Pharmaceuticals Inc / Marinus Pharmaceuticals Inc / NextGen Healthcare Inc / PureTech Health PLC / Reneo Pharmaceuticals Inc / Chinook Therapeutics Inc / 908 Devices Inc. / Sio Gene Therapies Inc / Talaris Therapeutics Inc / Cogent Biosciences Inc / Abcellera Biologics Inc / Gemini Therapeutics Inc / Neuropace Inc / Acadia Healthcare Company Inc / Pharvaris NV / Edgewise Therapeutics Inc / Landos Biopharma Inc / Merus NV / Decibel Therapeutics Inc / Recursion Pharmaceuticals Inc / Doximity Inc / LENSAR Inc / Cullinan Oncology Inc / Kinnate Biopharma Inc / Goodrx Holdings Inc / Spruce Biosciences Inc / Design Therapeutics Inc / Bolt Biotherapeutics Inc / Silverback Therapeutics Inc / LAVA Therapeutics NV / Rxsight Inc / Opthea Ltd / F-Star Therapeutics Inc / Genmab A/S / Caribou Biosciences Inc / Rapt Therapeutics Inc / Enanta Pharmaceuticals Inc / scPharmaceuticals Inc / Myovant Sciences Ltd / Celldex Therapeutics Inc / Abcam PLC / Shockwave Medical Inc / Adapthealth Corp / Cigna Corp / Atea Pharmaceuticals Inc / Aligos Therapeutics Inc / Connect Biopharma Holdings Ltd / Elevation Oncology Inc / Eliem Therapeutics Inc / Graphite Bio Inc / Werewolf Therapeutics Inc / Century Therapeutics Inc / Molecular Partners AG / Talkspace Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / Sweden / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Equ Research</td></tr>
<tr class="even"><td class="leftalignment">10/02/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / ADCT.N / EXEL.O / ARNA.O / REGN.O / SGEN.OQ / PRTA.O / ATNX.O / GMAB.O / NRIX.OQ</td><td class="leftalignment">Amgen Inc / ADC Therapeutics SA / Exelixis Inc / Arena Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Seagen Inc / Prothena Corporation PLC / Athenex Inc / Genmab A/S / Nurix Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="odd"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for AMGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Probes Reporter</td><td class="leftalignment">Watch List: 75 US Companies with Undisclosed SEC Probes</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AAN.N / T.N / AEP.N / CL.N / COF.N / F.N / HLT.N / SLB.N / TMO.N / BEN.N / THC.N / REV.N / ADM.N / VLO.N / UPS.N / KR.N / XOM.N / NKE.N / SNN.N / AMP.N / ARW.N / ATO.N / TWTR.N / TUP.N / OMI.N / CVX.N / TDY.N / AMGN.OQ / CSCO.OQ / COLL.OQ / GNTX.OQ / HBAN.OQ / MGPI.OQ / REGN.OQ / SEIC.OQ / GILD.OQ / COST.OQ / NKTR.OQ / MYGN.OQ / SSNC.OQ / CTXS.OQ / AMZN.OQ / NVDA.OQ / CHTR.OQ / TNP.N / CVGI.OQ / RUSHA.OQ / NDAQ.OQ / THS.N / SPWR.OQ / KOP.N / MA.N / SIX.N / AON.N / BX.N / INO.OQ / BGCP.OQ / UTL.N / SCHW.N / MSI.N / GRPN.OQ / FB.OQ / COTY.N / CTG.OQ / BRX.N / TWOU.OQ / ANTM.N / PFX.N / MFIN.OQ / DXC.N / IQV.N / WELL.N / TLRY.OQ / ALLO.OQ / US29350E1047 / LYFT.O / CTVA.N</td><td class="leftalignment">Aaron's Company Inc / AT&T Inc / American Electric Power Company Inc / Colgate-Palmolive Co / Capital One Financial Corp / Ford Motor Co / Hilton Worldwide Holdings Inc / Schlumberger NV / Thermo Fisher Scientific Inc / Franklin Resources Inc / Tenet Healthcare Corp / Revlon Inc / Archer-Daniels-Midland Co / Valero Energy Corp / United Parcel Service Inc / Kroger Co / Exxon Mobil Corp / Nike Inc / Smith & Nephew PLC / Ameriprise Financial Inc / Arrow Electronics Inc / Atmos Energy Corp / Twitter Inc / Tupperware Brands Corp / Owens & Minor Inc / Chevron Corp / Teledyne Technologies Inc / Amgen Inc / Cisco Systems Inc / Collegium Pharmaceutical Inc / Gentex Corp / Huntington Bancshares Inc / MGP Ingredients Inc / Regeneron Pharmaceuticals Inc / SEI Investments Co / Gilead Sciences Inc / Costco Wholesale Corp / Nektar Therapeutics / Myriad Genetics Inc / SS&C Technologies Holdings Inc / Citrix Systems Inc / Amazon.com Inc / NVIDIA Corp / Charter Communications Inc / Tsakos Energy Navigation Ltd / Commercial Vehicle Group Inc / Rush Enterprises Inc / Nasdaq Inc / TreeHouse Foods Inc / SunPower Corp / Koppers Holdings Inc / Mastercard Inc / Six Flags Entertainment Corp / Aon PLC / Blackstone Inc / Inovio Pharmaceuticals Inc / BGC Partners Inc / Unitil Corp / Charles Schwab Corp / Motorola Solutions Inc / Groupon Inc / Meta Platforms Inc / Coty Inc / Computer Task Group Inc / Brixmor Property Group Inc / 2U Inc / Anthem Inc / PhenixFIN Corp / Medallion Financial Corp / DXC Technology Co / IQVIA Holdings Inc / Welltower Inc / Tilray Brands Inc / Allogene Therapeutics Inc / Enochian Biosciences Inc / Lyft Inc / Corteva Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / United Kingdom / Greece / Ireland / United States / Curaçao</td><td class="leftalignment">Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Chemicals / Consumer / Defense / Electronics / Financial Services / Food / Healthcare / Household Products / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Technology / Telecommunications / Transportation / Utilities / Wholesale / Oil & Gas</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">10/01/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 567</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">10/01/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended September 24, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">10/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">10/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - October 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CCO.TO / DGE.L / NA / PD.N / SGEF.PA / STO.AX / AMZN.O / CNQ.TO / GILD.O / AMGN.O / AAL.L / ADCT.N / KGC.N / EXEL.O / ALA.TO / ARNA.O / RRC.N / KMX.N / ADSK.O / EPD.N / BMRN.O / REGN.O / VRTX.O / MCO.N / CEY.L / COP.N / SWN.N / CRC.N / LNG.A / SGEN.OQ / IMGN.O / RGLD.O / CASY.O / ATDb.TO / BIIB.O / FM.TO / NST.AX / 878742204 / EDV.TO / NTR.N / MOS.N / NESTE.HE / RDSb.L / DRX.L / SES.TO / CS.TO / 443628102 / HOCM.L / SLR.AX / OSK.TO / INO.OQ / ARX.TO / VALE.N / CVE.TO / BHPB.L / NEE.N / TOU.TO / GLEN.L / XYL.N / TVE.TO / FB.O / PANW.N / ENTA.O / PTCT.O / PRTA.O / AGIO.O / 46579R104 / GOOGL.O / CIA.TO / S32.AX / MESO.O / SPGI.N / AZRE.N / AKERBP.OL / PBYI.OQ / AQN.N / SNAP.N / SSRM.O / KL.N / ATNX.O / ZS.OQ / VRCA.OQ / PINS.N / ZM.O / CRWD.O / GMAB.O / ADT1.L / MGNI.OQ / NRIX.OQ / MTCR.O / NUVB.N / PATH.N / TSP.OQ / ANE.MC</td><td class="leftalignment">Cameco Corp / Diageo PLC / National Bank of Canada / PagerDuty Inc / Vinci SA / Santos Ltd / Amazon.com Inc / Canadian Natural Resources Ltd / Gilead Sciences Inc / Amgen Inc / Anglo American PLC / ADC Therapeutics SA / Kinross Gold Corp / Exelixis Inc / AltaGas Ltd / Arena Pharmaceuticals Inc / Range Resources Corp / Carmax Inc / Autodesk Inc / Enterprise Products Partners LP / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Moody's Corp / Centamin PLC / Conocophillips / Southwestern Energy Co / California Resources Corp / Cheniere Energy Inc / Seagen Inc / ImmunoGen Inc / Royal Gold Inc / Caseys General Stores Inc / Alimentation Couche-Tard Inc / Biogen Inc / First Quantum Minerals Ltd / Northern Star Resources Ltd / Teck Resources Ltd / Endeavour Mining PLC / Nutrien Ltd / Mosaic Co / Neste Oyj / Royal Dutch Shell PLC / Drax Group PLC / Secure Energy Services Inc / Capstone Mining Corp / Hudbay Minerals Inc / Hochschild Mining PLC / Silver Lake Resources Ltd / Osisko Mining Inc / Inovio Pharmaceuticals Inc / ARC Resources Ltd / Vale SA / Cenovus Energy Inc / BHP Group PLC / Nextera Energy Inc / Tourmaline Oil Corp / Glencore PLC / Xylem Inc / Tamarack Valley Energy Ltd / Meta Platforms Inc / Palo Alto Networks Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Prothena Corporation PLC / Agios Pharmaceuticals Inc / Ivanhoe Mines Ltd / Alphabet Inc / Champion Iron Ltd / South32 Ltd / Mesoblast Ltd / S&P Global Inc / Azure Power Global Ltd / Aker BP ASA / Puma Biotechnology Inc / Algonquin Power & Utilities Corp / Snap Inc / SSR Mining Inc / Kirkland Lake Gold Ltd / Athenex Inc / Zscaler Inc / Verrica Pharmaceuticals Inc / Pinterest Inc / Zoom Video Communications Inc / CrowdStrike Holdings Inc / Genmab A/S / Adriatic Metals PLC / Magnite Inc / Nurix Therapeutics Inc / Metacrine Inc / Nuvation Bio Inc / UiPath Inc / TuSimple Holdings Inc / Corporacion Acciona Energias Renovables SA</td><td class="leftalignment"></td><td class="leftalignment">Australia / Brazil / Canada / Switzerland / Denmark / Spain / Finland / France / United Kingdom / Ireland / Mauritius / Norway / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">10/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Revisiting remaining catalysts for Biotech in Q4:21 and year-end</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AMGN.O / ADCT.N / EXEL.O / ARNA.O / BMRN.O / REGN.O / SGEN.OQ / IMGN.O / PRTA.O / AGIO.O / MESO.O / PBYI.OQ / ATNX.O / GMAB.O / NRIX.OQ / NUVB.N</td><td class="leftalignment">Amgen Inc / ADC Therapeutics SA / Exelixis Inc / Arena Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Seagen Inc / ImmunoGen Inc / Prothena Corporation PLC / Agios Pharmaceuticals Inc / Mesoblast Ltd / Puma Biotechnology Inc / Athenex Inc / Genmab A/S / Nurix Therapeutics Inc / Nuvation Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Switzerland / Denmark / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="even"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Korea Healthcare Sector: Korea Healthcare Monthly Tracker: Oct 2021</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">000100.KS / 145020.KQ / JNJ.N / PFE.N / AZN.L / AMGN.OQ / NVAX.OQ / 006280.KS / BION.BO / TEVA.N / MRNA.OQ / 068270.KS / 086900.KQ / 0460.HK / ABBV.N / 207940.KS / 091990.KQ</td><td class="leftalignment">Yuhan Corp / Hugel Inc / Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / Amgen Inc / Novavax Inc / Green Cross Corp / Biocon Ltd / Teva Pharmaceutical Industries Ltd / Moderna Inc / Celltrion Inc / Medy Tox Inc / Sihuan Pharmaceutical Holdings Group Ltd / Abbvie Inc / Samsung Biologics Co Ltd / Celltrion Healthcare Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / United Kingdom / India / Israel / Korea, Republic of / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="odd"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">4Q21 Biopharma Catalyst Calendar</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">CBIO.OQ / 031162100 / 64125C109 / 766559603 / 09062X103 / 09061G101 / 75886F107 / AADI / 02043Q107 / 09058V103 / 40637H109 / 45253H101 / 45665G303 / 00287Y109 / 29251M106 / 023111206 / 45773H201 / 03835T200 / 189464100 / 78667J108 / 03209R103 / 16383L106 / 90400D108 / 31189P102 / 00461U105 / 45845P108 / 04280A100 / 09627Y109 / 00771V108 / 01345P106 / 52187K101 / G11196105 / 462260100 / 558868105 / 98401F105 / 23284F105 / 29014R103 / 039697107 / H17182108 / 67576A100 / 761330109 / 41358P106 / 483347100 / 37890U108 / 269796108 / 088786108 / G46188101 / 29668H708 / 68906L105 / 04016X101 / 62921N105 / 87184Q107 / 481116101 / 03836N103 / 869367102 / BY2Z0H7 / 69242L106 / 44975P103 / 64049K104 / 60770K107 / 65343E108 / 05337M104 / 04522R101 / 492327101 / 359616109 / 729139105 / 00972D105 / 760273102 / 282559103 / 02155H200 / 03969T109 / 24344T101 / 604749101 / 92243A200 / 00166B105 / 576810105 / 45790W108 / 04335A105 / 23257D103 / 4525EP101 / 46565G104 / 501575104 / 14147L108 / 67080M103 / 73730P108 / 26818M108 / 81181C104 / 019818103 / 83422E105 / 50107A104 / 01626L105 / 74006W108 / 38942Q103 / 68236R103 / M47364100 / 00773J103 / G59665102 / 03890D108 / 55028X109 / 03835L207 / 14888D208 / 19240Q201 / 98872L102 / 49705R105 / 38406L103 / 81728A108 / 92941V209 / 57055L107 / 45256X103 / 207523101 / 00449L102 / 09077A106 / 75082Q105 / 15673T100 / 670703107 / 87990A106 / 87978U108</td><td class="leftalignment">Catalyst Biosciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Aadi Bioscience Inc / Alnylam Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Halozyme Therapeutics Inc / ImmunoGen Inc / Infinity Pharmaceuticals Inc / Abbvie Inc / Enanta Pharmaceuticals Inc / Amarin Corporation PLC / Inovio Pharmaceuticals Inc / Aptose Biosciences Inc / Clovis Oncology Inc / SAGE Therapeutics Inc / Amphastar Pharmaceuticals Inc / ChemoCentryx Inc / Ultragenyx Pharmaceutical Inc / Fate Therapeutics Inc / Aclaris Therapeutics Inc / Intercept Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Blueprint Medicines Corp / Aerie Pharmaceuticals Inc / Albireo Pharma Inc / Leap Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Iovance Biotherapeutics Inc / Madrigal Pharmaceuticals Inc / Xencor Inc / CytomX Therapeutics Inc / Eloxx Pharmaceuticals Inc / Ardelyx Inc / CRISPR Therapeutics AG / Ocular Therapeutix Inc / Revance Therapeutics Inc / Harpoon Therapeutics Inc / Kaleido Biosciences Inc / Global Blood Therapeutics Inc / Eagle Pharmaceuticals Inc / Bicycle Therapeutics PLC / Horizon Therapeutics PLC / ESSA Pharma Inc / Otonomy Inc / argenx SE / NGM Biopharmaceuticals Inc / Syros Pharmaceuticals Inc / Jounce Therapeutics Inc / Aptinyx Inc / Sutro Biopharma Inc / PureTech Health PLC / Oyster Point Pharma Inc / I-Mab / Neoleukin Therapeutics Inc / Moderna Inc / NextCure Inc / Avadel Pharmaceuticals PLC / Aslan Pharmaceuticals Ltd / Keros Therapeutics Inc / Fulcrum Therapeutics Inc / Pliant Therapeutics Inc / Akebia Therapeutics Inc / Repare Therapeutics Inc / 89Bio Inc / Altimmune Inc / Arcturus Therapeutics Holdings Inc / Deciphera Pharmaceuticals Inc / Mirum Pharmaceuticals Inc / Vaxart Inc / ALX Oncology Holdings Inc / Matinas BioPharma Holdings Inc / Inozyme Pharma Inc / Arvinas Inc / Cymabay Therapeutics Inc / Immunic Inc / Iteos Therapeutics Inc / Kymera Therapeutics Inc / Cardiff Oncology Inc / Nurix Therapeutics Inc / Poseida Therapeutics Inc / Dyne Therapeutics Inc / Seagen Inc / Allovir Inc / Solid Biosciences Inc / Kronos Bio Inc / Aligos Therapeutics Inc / Praxis Precision Medicines Inc / Graybug Vision Inc / Oncorus Inc / Gamida Cell Ltd / Aeglea Bio Therapeutics Inc / MeiraGTx Holdings PLC / Aravive Inc / Lumos Pharma Inc / Aptevo Therapeutics Inc / Catalyst Biosciences Inc / Cogent Biosciences Inc / Yumanity Therapeutics Inc / Kinnate Biopharma Inc / Gracell Biotechnologies Inc / Sensei Biotherapeutics Inc / Vyne Therapeutics Inc / Marker Therapeutics Inc / Immunitybio Inc / Connect Biopharma Holdings Ltd / Achilles Therapeutics PLC / Biomea Fusion Inc / Rain Therapeutics Inc / Century Therapeutics Inc / Nuvalent Inc / Tenaya Therapeutics Inc / Tempest Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / Ireland / Israel / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">David A. Amsellem / Joseph Catanzaro, PhD / Yasmeen Rahimi, Ph.D. / Mr. Christopher J. Raymond / Edward A. Tenthoff</td></tr>
<tr class="even"><td class="leftalignment">09/30/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Reversal of Fortune - Biotech Fund Flows Turn Negative</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">09/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Amgen tumbles 12% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">09/30/2021</td><td class="leftalignment">UniCredit Research</td><td class="leftalignment">Euro Credit Pilot - Good news priced in (September 2021)</td><td class="leftalignment">English</td><td class="rightalignment">56</td><td class="leftalignment">US88579Y1010 / AEGN.AS / AIRP.PA / AKZO.AS / ALSO.PA / ALV.N / ALVG.DE / ANZ.AX / APD.N / ASML.AS / ATCOA.ST / AXAF.PA / BAC.N / BARC.L / BKT.MC / BMWG.DE / BNPP.PA / BNS.TO / BOUY.PA / BP.L / BT.L / C.N / CAPP.PA / CARR.PA / CBA.AX / CBKG.DE / CCH.L / CM.TO / CNPP.PA / CRH.I / DANO.PA / DEO.N / DSMN.AS / EDP.LS / ENI.MI / ERICb.ST / ERST.VI / FREG.F / GASI.MI / GE.N / GM.N / HEIG.F / HEIN.AS / HSBA.L / IBE.MC / IBM.N / KPN.AS / LLOY.L / LVMH.PA / MAP.MC / MDBI.MI / MGA / MICP.PA / MRK.N / PRTP.PA / SAN.MC / T.N / CONG.DE / AZN.L / AMGN.O / FER.MC / AAL.L / GS.N / ACE.MI / DBKGn.DE / MCD.N / FMEG.DE / BZU.MI / ENEI.MI / MRCG.DE / DTEGn.F / BBVA.MC / BTI.N / IFXGn.DE / FR0000064578 / FR0000035081 / ISS.CO / CARLb.CO / ADEN.S / HNRGn.DE / DPWGn.DE / IG.MI / GSK.L / BAB.L / AMXL.MX / EUFI.PA / JCDX.PA / GB0008220112 / SE0000455057 / US1101221083 / US2987361092 / US3377381088 / US4943681035 / US5949181045 / JP3116000005 / CAGR.PA / AMA.MC / DANSKE.CO / CH0013841017 / ARLG.DE / ENAG.MC / AV.L / US20030N1019 / US02209S1033 / EBKG.DE / JYSK.CO / MAERSKb.CO / HRA.MI / CAIV.VI / US46625H1005 / INGA.AS / LXSG.DE / BTGGg.F / GB0033986497 / ELI.BR / EDF.PA / ETL.PA / GAZP.MM / US31620M1062 / AKE.PA / ISP.MI / DWNG.DE / DK0060079531 / AU000000GMG2 / SABE.MC / CNE1000001Z5 / CNE1000002H1 / FR0010690156 / BNRGN.DE / IREE.MI / CNE100000KC0 / CABK.MC / US03027X1000 / LEGN.DE / GYC.DE / 1COV.DE / IMB.L / SE0009922164 / BIRG.I / BMG2178K1009 / BAWG.VI / LU0251710041 / AT0000BAWAG2 / AIBG.I / AIG.A / NL00150006R6</td><td class="leftalignment">3M Co / Aegon NV / L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Akzo Nobel NV / Alstom SA / Autoliv Inc / Allianz SE / Australia and New Zealand Banking Group Ltd / Air Products and Chemicals Inc / ASML Holding NV / Atlas Copco AB / AXA SA / Bank of America Corp / Barclays PLC / Bankinter SA / Bayerische Motoren Werke AG / BNP Paribas SA / Bank of Nova Scotia / Bouygues SA / BP PLC / BT Group PLC / Citigroup Inc / Capgemini SE / Carrefour SA / Commonwealth Bank of Australia / Commerzbank AG / Coca Cola HBC AG / Canadian Imperial Bank of Commerce / CNP Assurances SA / CRH PLC / Danone SA / Diageo PLC / Koninklijke DSM NV / EDP Energias de Portugal SA / Eni SpA / Telefonaktiebolaget LM Ericsson / Erste Group Bank AG / Fresenius SE & Co KGaA / Assicurazioni Generali SpA / General Electric Co / General Motors Co / HeidelbergCement AG / Heineken NV / HSBC Holdings PLC / Iberdrola SA / International Business Machines Corp / Koninklijke KPN NV / Lloyds Banking Group PLC / LVMH Moet Hennessy Louis Vuitton SE / Mapfre SA / Mediobanca Banca di Credito Finanziario SpA / Magna International Inc / Compagnie Generale des Etablissements Michelin SCA / Merck & Co Inc / Kering SA / Banco Santander SA / AT&T Inc / Continental AG / AstraZeneca PLC / Amgen Inc / Ferrovial SA / Anglo American PLC / Goldman Sachs Group Inc / Acea SpA / Deutsche Bank AG / McDonald's Corp / Fresenius Medical Care AG & Co KGaA / Buzzi Unicem SpA / Enel SpA / Merck KGaA / Deutsche Telekom AG / Banco Bilbao Vizcaya Argentaria SA / British American Tobacco PLC / Infineon Technologies AG / Covivio SA / Icade SA / Iss A/S / Carlsberg A/S / Adecco Group AG / Hannover Rueck SE / Deutsche Post AG / Italgas SpA / GlaxoSmithKline PLC / Babcock International Group PLC / America Movil SAB de CV / Eurofins Scientific SE / JCDecaux SA / DS Smith PLC / Fastighets AB Balder / Bristol-Myers Squibb Co / Euronet Worldwide Inc / Fiserv Inc / Kimberly-Clark Corp / Microsoft Corp / Asahi Group Holdings Ltd / Credit Agricole SA / Amadeus IT Group SA / Danske Bank A/S / Lonza Group AG / Aareal Bank AG / Enagas SA / Aviva PLC / Comcast Corp / Altria Group Inc / EnBW Energie Baden Wuerttemberg AG / Jyske Bank A/S / AP Moeller - Maersk A/S / Hera SpA / CA Immobilien Anlagen AG / JPMorgan Chase & Co / ING Groep NV / Lanxess AG / Bertelsmann SE & Co KGaA / ITV PLC / Elia Group SA / Electricite de France SA / Eutelsat Communications SA / Gazprom PAO / Fidelity National Information Services Inc / Arkema SA / Intesa Sanpaolo SpA / Deutsche Wohnen SE / DSV A/S / Goodman Group / Banco de Sabadell SA / Bank of China Ltd / China Construction Bank Corp / Aeroports de Paris SA / Brenntag SE / Iren SpA / China National Chemical Engineering Co Ltd / Caixabank SA / American Tower Corp / LEG Immobilien SE / Grand City Properties SA / Covestro AG / Imperial Brands PLC / Essity AB (publ) / Bank of Ireland Group PLC / CK Infrastructure Holdings Ltd / BAWAG Group AG / CPI Property Group SA / BAWAG Group AG / Aib Group PLC / American International Group Inc / Ctp NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Austria / Belgium / Bermuda / Canada / Switzerland / China / Czech Republic / Germany / Denmark / Spain / Finland / France / United Kingdom / Greece / Hungary / Ireland / Italy / Japan / Luxembourg / Mexico / Netherlands / Norway / New Zealand / Poland / Portugal / Russian Federation / Slovakia / Sweden / United States / Jersey</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Communications / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Office Equipment / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Semiconductors / Services / Shipping & Shipbuilding / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment">MISCELLANEOUS / CHANGE IN RECOMMENDATION / MODELS / PORTFOLIO STRATEGY / CREDIT</td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / MARKET / COUNTRY RESEARCH / PORTFOLIO/ASSET STRATEGIES / Research Digest / Equity</td><td class="leftalignment">Herr Gianfranco Arcovito / Herr Christian Aust / Herr Tobias Keller / Herr. Stefan Kolek / Herr Sven Kreitmair, CFA / Herr. Franz Rudolf / Herr Jonathan Schroer / Frau. Jana Schuler / Frau Silke Stegemann / Herr Natalie Tehrani Monfared / Herr. Michael Teig</td></tr>
<tr class="odd"><td class="leftalignment">09/30/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK=US / AMGN=US / CMA=US / PEB=US / AKAM=US / H=US / MTN=US / CHKP=US / PB=US / VRM=US / EWBC=US / TRMK=US / MAR=US / UMPQ=US / TNL=US / HLT=US / WTFC=US / BL=US / CHH=US / CSTR=US / DRH=US / ABG=US / OI=US / PACW=US / SFT=US / WAL=US / HTH=US / BXS=US / CFB=US / CFR=US / FMBI=US / SNV=US / ZION=US / SIVB=US / ABCB=US / BOKF=US / FBK=US / ASB=US / SSB=US / RF=US / CATY=US / FFIN=US / GBCI=US / SBSI=US / UCBI=US / PNFP=US / SBCF=US / BIIB=US / TCBI=US / FNB=US / FHN=US / SHO=US / RNST=US / SIBN=US / HST=US / CADE=US / WH=US / HTA=US / HGV=US / SBRA=US / RLJ=US / VAC=US / PANW=US / RHP=US / ABBV=US / IBTX=US / LOB=US / ACBI=US / ZS=US / EDIT=US / PK=US / PLYA=US / CVNA=US / NCNA=US / MBIN=US / HWC=US / OZK=US / AMTB=US / CRWD=US / FERG=US / ARQT=US / ABNB=US / SSBK=US</td><td class="leftalignment">Merck & Co Inc / Amgen Inc / Comerica Inc / Pebblebrook Hotel Trust / Akamai Technologies Inc / Hyatt Hotels Corp / Vail Resorts Inc / Check Point Software Technologies Ltd / Prosperity Bancshares Inc / Vroom Inc / East West Bancorp Inc / Trustmark Corp / Marriott International Inc / Umpqua Holdings Corp / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Wintrust Financial Corp / Blackline Inc / Choice Hotels International Inc / CapStar Financial Holdings Inc / Diamondrock Hospitality Co / Asbury Automotive Group Inc / O-I Glass Inc / PacWest Bancorp / Shift Technologies Inc / Western Alliance Bancorp / Hilltop Holdings Inc / Cadence Bank / Crossfirst Bankshares Inc / Cullen/Frost Bankers Inc / First Midwest Bancorp Inc / Synovus Financial Corp / Zions Bancorporation NA / SVB Financial Group / Ameris Bancorp / BOK Financial Corp / FB Financial Corp / Associated Banc-Corp / SouthState Corp / Regions Financial Corp / Cathay General Bancorp / First Financial Bankshares Inc / Glacier Bancorp Inc / Southside Bancshares Inc / United Community Banks Inc / Pinnacle Financial Partners Inc / Seacoast Banking Corporation of Florida / Biogen Inc / Texas Capital Bancshares Inc / FNB Corp / First Horizon Corp / Sunstone Hotel Investors Inc / Renasant Corp / SI-BONE Inc / Host Hotels & Resorts Inc / Cadence Bank / Wyndham Hotels & Resorts Inc / Healthcare Trust Of America Inc / Hilton Grand Vacations Inc / Sabra Health Care REIT Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Palo Alto Networks Inc / Ryman Hospitality Properties Inc / Abbvie Inc / Independent Bank Group Inc / Live Oak Bancshares Inc / Atlantic Capital Bancshares Inc / Zscaler Inc / Editas Medicine Inc / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Carvana Co / NuCana PLC / Merchants Bancorp / Hancock Whitney Corp / Bank Ozk / Amerant Bancorp Inc / CrowdStrike Holdings Inc / Ferguson PLC / Arcutis Biotherapeutics Inc / Airbnb Inc / Southern States Bancshares Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/30/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Competition in Atopic Dermatitis Heating Up, but Nothing Challenges Dupi</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">71708110 / 03116210 / 75886F10 / 00287Y10 / F5548N10</td><td class="leftalignment">Pfizer Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Na Sun / Daniel Tarjan, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">09/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker - Wegovy launch insights: For The Week Ended Sep 17</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">09/30/2021</td><td class="leftalignment">CRD Global</td><td class="leftalignment">Sustco Score Report: Amgen Inc. SEPTEMPBER 2021</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">MISCELLANEOUS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Environmental, Social, Governance</td><td class="leftalignment">CRD Global</td></tr>
<tr class="odd"><td class="leftalignment">09/29/2021</td><td class="leftalignment">S3 Partners</td><td class="leftalignment">S3 Analytics: Biotech Short Selling Recap</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRNA.OQ / AMGN.OQ / REGN.OQ / GILD.OQ / NVAX.OQ / BMRN.OQ / EXAS.OQ / VRTX.OQ / BIIB.OQ / ALNY.OQ / SRPT.OQ / ABBV.N / MRTX.OQ / FATE.OQ / NVTA.N / NTRA.OQ / NTLA.OQ / 6160.HK / BBIO.OQ / 22UAy.DE</td><td class="leftalignment">Moderna Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Novavax Inc / Biomarin Pharmaceutical Inc / Exact Sciences Corp / Vertex Pharmaceuticals Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Sarepta Therapeutics Inc / Abbvie Inc / Mirati Therapeutics Inc / Fate Therapeutics Inc / Invitae Corp / Natera Inc / Intellia Therapeutics Inc / Beigene Ltd / BridgeBio Pharma Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / Germany / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">EQUITY</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Ihor Dusaniwsky</td></tr>
<tr class="even"><td class="leftalignment">09/28/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Amgen Inc.(AMGN) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">031162100</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">09/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Therapeutic Categories Outlook</td><td class="leftalignment">English</td><td class="rightalignment">3956</td><td class="leftalignment">US0311621009 / US0463531089 / US1101221083 / US30161Q1040 / US3755581036 / US37733W1053 / US4781601046 / US5324571083 / US66987V1098 / US7170811035 / US75886F1075 / US7711951043 / US91307C1027 / US92532F1003 / US80105N1054 / US09062X1037 / US58933Y1055 / IE00BJ3V9050</td><td class="leftalignment">Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Exelixis Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Regeneron Pharmaceuticals Inc / Roche Holding AG / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Sanofi SA / Biogen Inc / Merck & Co Inc / Endo International PLC</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Health Care Team</td></tr>
<tr class="even"><td class="leftalignment">09/28/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">William Blair Biopharma Catalyst Watch Fourth Quarter 2021</td><td class="leftalignment">English</td><td class="rightalignment">54</td><td class="leftalignment">00444P108 / 654405109 / 03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 16961L106 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109</td><td class="leftalignment">Acer Therapeutics Inc / 9 Meters Biopharma Inc / Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Chinook Therapeutics Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">09/28/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Boosters Approved for High Risk and Elderly, Cases in South and West Decline, 5- to 11-Year-Old Data Positive</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / John Boyle / Lachlan Hanbury-Brown / Sami Corwin, PHD / Mr. Rob Andrew, CFA</td></tr>
<tr class="even"><td class="leftalignment">09/27/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">New Migraine Survey Indicates Ongoing Upside for Oral CGRPs - Nurtec Especially</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">031162100 / 00287Y109 / G11196105</td><td class="leftalignment">Amgen Inc / Abbvie Inc / Biohaven Pharmaceutical Holding Company Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">09/27/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">AMGN.OQ - Event Transcript of Amgen Inc conference call, Sep. 27, 2021 / 2:00PM ET</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/27/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Sep 17, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">09/27/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - September 27, 2021</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AEP.N / AES.N / ALV.N / CAS.TO / CB.N / CNA.L / CRM.N / EIX.N / EL.N / F.N / FSR.N / GM.N / KO.N / PD.N / RWEG.DE / SO.N / T.N / VC.N / SSE.L / TEN.N / CMCSA.O / AMGN.O / DUK.N / BWA.N / LEA.N / REE.MC / K.N / DISH.O / ADBE.O / NICE.O / CLX.N / PCG.N / EPC.N / AMT.N / VZ.N / HCA.N / XEL.N / ARNA.O / STZ.N / LNC.N / APH.N / FISV.O / AXL.N / ACN.N / NWN.N / BC.N / AJG.N / REGN.O / ENR.N / PRU.N / NCR.N / TEL.N / ENAG.MC / CNP.N / CPK.N / PII.N / ST.N / PLUG.OQ / SGEN.OQ / GPN.N / IMGN.O / CASY.O / EQIX.O / ATDb.TO / DLR.N / 416515104 / SJW.N / FIS.N / HOG.N / EHTH.O / AON.N / BGS.N / DAN.N / SPB.N / NEE.N / MTOR.N / IFP.TO / XYL.N / FFHu.TO / TSLA.N / TMUS.N / BEP.N / PYPL.OQ / RACE.MI / MP1.AX / TWLO.N / ADNT.N / UNIT.O / APTV.N / VNE.N / ESTC.N / FSK.N / ZM.O / FSLY.N / GMAB.O / DOCU.N / CRNC.OQ / OAS.OQ / WTRG.N / NKLA.OQ / FOUR.N / RXT.OQ / LUMN.N / RIDE.OQ / LSPD.N / WFG.N / TSP.OQ / OTLY.O / RYAN.N</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Autoliv Inc / Cascades Inc / Chubb Ltd / Centrica PLC / Salesforce.Com Inc / Edison International / Estee Lauder Companies Inc / Ford Motor Co / Fisker Inc / General Motors Co / Coca-Cola Co / PagerDuty Inc / Rwe AG / Southern Co / AT&T Inc / Visteon Corp / SSE PLC / Tenneco Inc / Comcast Corp / Amgen Inc / Duke Energy Corp / Borgwarner Inc / Lear Corp / Red Electrica Corporacion SA / Kellogg Co / DISH Network Corp / Adobe Inc / Nice Ltd / Clorox Co / PG&E Corp / Edgewell Personal Care Co / American Tower Corp / Verizon Communications Inc / HCA Healthcare Inc / Xcel Energy Inc / Arena Pharmaceuticals Inc / Constellation Brands Inc / Lincoln National Corp / Amphenol Corp / Fiserv Inc / American Axle & Manufacturing Holdings Inc / Accenture PLC / Northwest Natural Holding Co / Brunswick Corp / Arthur J Gallagher & Co / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Prudential Financial Inc / NCR Corp / TE Connectivity Ltd / Enagas SA / CenterPoint Energy Inc / Chesapeake Utilities Corp / Polaris Inc / Sensata Technologies Holding PLC / Plug Power Inc / Seagen Inc / Global Payments Inc / ImmunoGen Inc / Caseys General Stores Inc / Equinix Inc / Alimentation Couche-Tard Inc / Digital Realty Trust Inc / Hartford Financial Services Group Inc / SJW Group / Fidelity National Information Services Inc / Harley-Davidson Inc / eHealth Inc / Aon PLC / B&G Foods Inc / Dana Inc / Spectrum Brands Holdings Inc / Nextera Energy Inc / Meritor Inc / Interfor Corp / Xylem Inc / Fairfax Financial Holdings Ltd / Tesla Inc / T-Mobile US Inc / Brookfield Renewable Partners LP / PayPal Holdings Inc / Ferrari NV / Megaport Ltd / Twilio Inc / Adient PLC / Uniti Group Inc / Aptiv PLC / Veoneer Inc / Elastic NV / FS KKR Capital Corp / Zoom Video Communications Inc / Fastly Inc / Genmab A/S / DocuSign Inc / Cerence Inc / Oasis Petroleum Inc / Essential Utilities Inc / Nikola Corp / Shift4 Payments Inc / Rackspace Technology Inc / Lumen Technologies Inc / Lordstown Motors Corp / Lightspeed Commerce Inc / West Fraser Timber Co Ltd / TuSimple Holdings Inc / Oatly Group AB / Ryan Specialty Group Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Germany / Denmark / Spain / United Kingdom / Ireland / Israel / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">09/27/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">NeuroNavigator: Advancing Targeted Neurology With Genetic Insights Into Neuroinflammation</td><td class="leftalignment">English</td><td class="rightalignment">68</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Myles R. R. Minter / Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="odd"><td class="leftalignment">09/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for AMGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">09/25/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / ARNA.O / REGN.O / SGEN.OQ / IMGN.O / GMAB.O</td><td class="leftalignment">Amgen Inc / Arena Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Seagen Inc / ImmunoGen Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="odd"><td class="leftalignment">09/24/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Short Interest in Biotechnology Stocks</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US0311621009 / US3755581036 / US75886F1075 / US92532F1003 / US7665596034 / US02043Q1076 / US40637H1095 / US09609G1004 / US45845P1084 / US31189P1021 / US03820J1007 / US92686J1060 / US09627Y1091 / US4622221004 / US5588681057 / US03753U1060 / US2997341035 / US80706P1030 / US76029N1063 / US04335A1051 / US2936141033 / US50015M1099 / US85789A1051 / US62921N1054 / US61775R1059 / US30205M1018 / US80810D1037 / US12529R1077 / CA00288U1066 / US67080N1019 / US24343R1068</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Rigel Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Halozyme Therapeutics Inc / bluebird bio Inc / Intercept Pharmaceuticals Inc / Fate Therapeutics Inc / Applied Genetic Technologies Corp / Viking Therapeutics Inc / Blueprint Medicines Corp / Ionis Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Evelo Biosciences Inc / Scholar Rock Holding Corp / Replimune Group Inc / Arvinas Inc / Entasis Therapeutics Holdings Inc / Kodiak Sciences Inc / Stealth BioTherapeutics Corp / NGM Biopharmaceuticals Inc / Morphic Holding Inc / Exicure Inc / Schrodinger Inc / C4 Therapeutics Inc / Abcellera Biologics Inc / Nuvation Bio Inc / Decibel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Matthew Luchini / Jin Lee</td></tr>
<tr class="even"><td class="leftalignment">09/24/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 566</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">09/24/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">ESMO Recap: Enchanting Data From Enhertu, CD73 Excitement, Ensuing KRAS Battle, and Emerging New Targets</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">110122108 / G10830100 / 03116210 / 09062X103 / 640268108 / 30161Q104 / 45337C102 / 45253H101 / 00847G705 / 803607100 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 462222100 / 19459J104 / G11196105 / 00887A105 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 720795103 / 49372L100 / 05280R100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 37890U108 / 03836N103 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / 73730P108 / 81181C104 / 877619106 / 00507W206 / 92840H202 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101</td><td class="leftalignment">Bristol-Myers Squibb Co / Beyondspring Inc / Amgen Inc / Biogen Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Global Blood Therapeutics Inc / Aptinyx Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Poseida Therapeutics Inc / Seagen Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Tim F. Lugo / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">09/24/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--Sept. 24, 2021</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">ACA / AMN / BSX / CHE / CI / CNC / CVS / HUM / MDT / RAD / SGE.L / UNH / WMT / GILD.O / AMGN.O / NOVN.S / HCA.N / CYH.N / DRRX.O / RIGL.O / SSNC.O / ISR / SRDX.O / INCY.OQ / EPIX.OQ / SGMO.OQ / CCRN.O / ICAD.O / LIFE.O / MMSI.O / AMED.O / BIIB.O / 478160104 / 00846U101 / 868168105 / CORT.O / CRTX.O / ATRC.OQ / LHCG.O / CYCC.OQ / INFI.OQ / LMAT.O / 02043Q107 / ENSG.OQ / TNDM.O / SLP.OQ / 483548103 / SPRO.OQ / MRNA.O / TMDX.OQ / MD.N / 771195104 / CSII.O / ADUS.O / USPH.N / GLAXOSM.LG / SRPT.O / MRTX.OQ / AERI.O / TRVN.O / GOOGL.O / ALDX.OQ / 02005N100 / AGRX.OQ / CASI.OQ / MRNS.O / INO.O / VBLT.O / NVRO.N / EVH.N / TDOC.N / CFMS.O / VYGR.OQ / 100063846 / IONS.OQ / SSKN.OQ / SYRS.OQ / SLNO.OQ / PLXP.O / VERU.OQ / ACHV.O / MTEM.O / SVRA.O / ATNX.O / NCNA.O / SYBX.O / DNLI.OQ / CUE.OQ / 720795103 / PRVB.OQ / ORTX.OQ / SWAV.O / XFOR.OQ / PDSB.OQ / BWAY.TA / ORGO.O / ONCT.OQ / BCYC.O / A71.F / XAIR.OQ / PSNL.O / NBSE.O / DMTK.O / FREQ.OQ / PNTG.OQ / BXRX.OQ / ONEM.OQ / ORIC.OQ / ZNTL.OQ / US97382D3035 / AYLA.O / HGEN.O / US74275C2052 / ABST.TO / PRTG.OQ / REGW.M3 / 03823M100 / RZLT.O / HUMA.OQ / ATXS.OQ / CRXT.OQ</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Boston Scientific Corp / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Medtronic PLC / Rite Aid Corp / Sage Group PLC / UnitedHealth Group Inc / Walmart Inc / Gilead Sciences Inc / Amgen Inc / Novartis AG / HCA Healthcare Inc / Community Health Systems Inc / DURECT Corp / Rigel Pharmaceuticals Inc / SS&C Technologies Holdings Inc / IsoRay Inc / Surmodics Inc / Incyte Corp / ESSA Pharma Inc / Sangamo Therapeutics Inc / Cross Country Healthcare Inc / ICAD Inc / aTyr Pharma Inc / Merit Medical Systems Inc / Amedisys Inc / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / Corcept Therapeutics Inc / Cortexyme Inc / AtriCure Inc / LHC Group Inc / Cyclacel Pharmaceuticals Inc / Infinity Pharmaceuticals Inc / LeMaitre Vascular Inc / Alnylam Pharmaceuticals Inc / Ensign Group Inc / Tandem Diabetes Care Inc / Simulations Plus Inc / Kaman Corp / Spero Therapeutics Inc / Moderna Inc / Transmedics Group Inc / MEDNAX Inc / Roche Holding AG / Cardiovascular Systems Inc / Addus Homecare Corp / US Physical Therapy Inc / Glaxo Smithkline Consumer Nigeria PLC / Sarepta Therapeutics Inc / Mirati Therapeutics Inc / Aerie Pharmaceuticals Inc / Trevena Inc / Alphabet Inc / Aldeyra Therapeutics Inc / Ally Financial Inc / Agile Therapeutics Inc / CASI Pharmaceuticals Inc / Marinus Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / Vascular Biogenics Ltd / Nevro Corp / Evolent Health Inc / Teladoc Health Inc / Conformis Inc / Voyager Therapeutics Inc / Truist Financial Corp / Ionis Pharmaceuticals Inc / STRATA Skin Sciences Inc / Syros Pharmaceuticals Inc / Soleno Therapeutics Inc / PLx Pharma Inc / Veru Inc / Achieve Life Sciences Inc / Molecular Templates Inc / Savara Inc / Athenex Inc / NuCana PLC / Synlogic Inc / Denali Therapeutics Inc / Cue Biopharma Inc / Pieris Pharmaceuticals Inc / Provention Bio Inc / Orchard Therapeutics PLC / Shockwave Medical Inc / X4 Pharmaceuticals Inc / PDS Biotechnology Corp / Brainsway Ltd / Organogenesis Holdings Inc / Oncternal Therapeutics Inc / Bicycle Therapeutics PLC / Ascendis Pharma A/S / Beyond Air Inc / Personalis Inc / NeuBase Therapeutics Inc / DermTech Inc / Frequency Therapeutics Inc / Pennant Group Inc / Baudax Bio Inc / 1Life Healthcare Inc / Oric Pharmaceuticals Inc / Zentalis Pharmaceuticals Inc / Windtree Therapeutics Inc / Ayala Pharmaceuticals Inc / Humanigen Inc / Processa Pharmaceuticals Inc / Absolute Software Corp / Portage Biotech Inc / Regency World Consulting Ltd / Applied Minerals Inc / Rezolute Inc / Humacyte Inc / Astria Therapeutics Inc / Clarus Therapeutics Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / United Kingdom / India / Ireland / Israel / Nigeria / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/24/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended September 17, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">09/24/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">09/24/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Sustainable Growth With A Late Stage Innovation Pipeline</td><td class="leftalignment">English</td><td class="rightalignment">73</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Yaron Werber, M.D., MD / Gabriel Schneider, M.D. / Brendan Smith, Ph.D. / Eve Reilly, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">09/23/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">They May Be Small, But Biotech Inflows Return</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">09/22/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Post-ESMO 2021: NSCLC MEDACorp Pulse Call Takeaways</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">04635310 / 03116210 / 478160104 / 58933Y10 / 90041T10 / 55609910 / 45781K20 / 46565G10 / 60468T10 / 03969F10 / 23003110</td><td class="leftalignment">AstraZeneca PLC / Amgen Inc / Johnson & Johnson / Merck & Co Inc / Turning Point Therapeutics Inc / MacroGenics Inc / Innate Pharma SA / Iteos Therapeutics Inc / Mirati Therapeutics Inc / Arcus Biosciences Inc / Cullinan Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Andrew Berens, M.D. / Jonathan Chang, Ph.D., CFA / Daina Graybosch, Ph.D. / Christopher Liu, Pharm.D. / Faisal Khurshid / Dilip Joseph / Ken Shields / Daniel Tarjan, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">09/22/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">Takeaways from Mirati's ESMO Update and Discussions With Management</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">60468T105 / 03116210</td><td class="leftalignment">Mirati Therapeutics Inc / Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Silvan Tuerkcan</td></tr>
<tr class="odd"><td class="leftalignment">09/21/2021</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Amgen Inc (AMGN) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">579</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="even"><td class="leftalignment">09/21/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">FDX / KKR / MSFT.O / GILD.O / AMGN.O / AAPL.O / NVDA.O / HEAR.O / UPS.N / EXPD.O / RIGL.O / ATVI.OQ / TTWO.OQ / SGMO.OQ / NFLX.O / BIIB.O / CRTX.O / 36467W109 / XPO / 02043Q107 / MRNA.O / GLAXOSM.LG / TSLA.O / ZNGA.O / EA.O / CG.O / MRTX.OQ / FDEV.L / 82655M107 / G29183103 / 02005N100 / MRNS.O / VYGR.OQ / IONS.OQ / SYRS.OQ / APL.PS / SLNO.OQ / VERU.OQ / MTEM.O / ATNX.O / SYBX.O / DNLI.OQ / BILI.O / ORTX.OQ / ORGO.O / BCYC.O / PRTG.OQ / REGW.M3 / HUYA.K / 03823M100 / TBLA.OQ</td><td class="leftalignment">FedEx Corp / KKR & Co Inc / Microsoft Corp / Gilead Sciences Inc / Amgen Inc / Apple Inc / NVIDIA Corp / Turtle Beach Corp / United Parcel Service Inc / Expeditors International of Washington Inc / Rigel Pharmaceuticals Inc / Activision Blizzard Inc / Take-Two Interactive Software Inc / Sangamo Therapeutics Inc / Netflix Inc / Biogen Inc / Cortexyme Inc / GameStop Corp / XPO Logistics Inc / Alnylam Pharmaceuticals Inc / Moderna Inc / Glaxo Smithkline Consumer Nigeria PLC / Tesla Inc / Zynga Inc / Electronic Arts Inc / Carlyle Group Inc / Mirati Therapeutics Inc / Frontier Developments PLC / Sify Technologies Ltd / Eaton Corporation PLC / Ally Financial Inc / Marinus Pharmaceuticals Inc / Voyager Therapeutics Inc / Ionis Pharmaceuticals Inc / Syros Pharmaceuticals Inc / Apollo Global Capital Inc / Soleno Therapeutics Inc / Veru Inc / Molecular Templates Inc / Athenex Inc / Synlogic Inc / Denali Therapeutics Inc / Bilibili Inc / Orchard Therapeutics PLC / Organogenesis Holdings Inc / Bicycle Therapeutics PLC / Portage Biotech Inc / Regency World Consulting Ltd / HUYA Inc / Applied Minerals Inc / Taboola.com Ltd</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United Kingdom / India / Ireland / Israel / Nigeria / Philippines / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/21/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2681511 / 2023607 / 2778844 / 2026242 / 2270726 / 2317087 / 2100920 / 2689560 / 2684703 / 2730190 / 2842255 / 2098876 / 7103065 / B121557 / 2769796 / 2857817 / B7TL820 / B4MG4Z6 / BBPK0J0 / B7577T2 / B8DPDT7 / BVVN4Q8 / BYVY8G0 / BYW36M8 / BHC8X90 / BFMXGR0 / BKTNTR9 / BZ1LFG7 / BYY88Y7 / BNTB3N8</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / PepsiCo Inc / Amgen Inc / Merck & Co Inc / American Electric Power Company Inc / Walt Disney Co / Entergy Corp / FirstEnergy Corp / PG&E Corp / Pfizer Inc / Regeneron Pharmaceuticals Inc / Starbucks Corp / Yum! Brands Inc / Novartis AG / Mastercard Inc / Fidelity National Information Services Inc / Netflix Inc / Meta Platforms Inc / AMC Networks Inc / Mirati Therapeutics Inc / Renewable Energy Group Inc / Sarepta Therapeutics Inc / Eversource Energy / Alphabet Inc / PayPal Holdings Inc / Novo Nordisk A/S / Evergy Inc / ViacomCBS Inc / Roku Inc / Alphabet Inc / Vizio Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">09/21/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Post ESMO 2021: GI Cancer MEDACorp Pulse Call Takeaways</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">45337C10 / 03116210 / 55609910 / 07725L10 / 60468T10 / 76155X10 / 98887Q10 / 98985W10</td><td class="leftalignment">Incyte Corp / Amgen Inc / MacroGenics Inc / Beigene Ltd / Mirati Therapeutics Inc / Revolution Medicines Inc / Zai Lab Ltd / Zymeworks Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Andrew Berens, M.D. / Geoffrey Porges, MBBS / Jonathan Chang, Ph.D., CFA / Christopher Liu, Pharm.D. / Anna Baran, CFA / Faisal Khurshid / Na Sun / Ken Shields / Daniel Tarjan, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">09/21/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - September 21, 2021</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ANA.MC / CB.N / CCI.N / CI.N / CNA.L / DD.N / ECL.N / EL.N / GM.N / KO.N / PNC.N / PPG.N / SLB.N / TOTF.PA / USB.N / VC.N / HUM.N / AMGN.O / WCC.N / MCD.N / VLO.N / GIS.N / AMT.N / CONE.O / SHW.N / HCA.N / MDRX.O / ARNA.O / AMP.N / SRE.N / EXC.N / FISV.O / PLD.N / AME.N / REGN.O / VRNT.O / COP.N / BKH.N / DFS.N / SEM.N / GPN.N / MNST.O / JCOM.O / EQIX.O / BIIB.O / TFC.N / DLR.N / GMS.N / BAM.N / ARWR.O / 025676206 / ISBC.O / SLRS.MC / ENSG.O / DAN.N / BIP.N / JACK.OQ / MSCI.N / ADUS.OQ / NXT.AX / BKU.N / PCRX.O / MTOR.N / STAG.N / MTDR.N / MDLZ.OQ / APAM.N / BEP.N / DOOR.N / ESNT.N / IBP.N / VRNS.O / QTWO.N / NMIH.O / AXTA.N / RPD.O / MIME.OQ / MP1.AX / SPGI.N / ATKR.N / KNSL.OQ / BBU.N / UN01.DE / GDS.O / GREG.MC / RCM.OQ / ORSTED.CO / AQUA.N / APTV.N / CDMO.OQ / EAF.N / VRCA.OQ / FOCS.O / HCAT.OQ / APRE.OQ / CARR.N / OTIS.N / ANE.MC</td><td class="leftalignment">Acciona SA / Chubb Ltd / Crown Castle International Corp / Cigna Corp / Centrica PLC / Dupont De Nemours Inc / Ecolab Inc / Estee Lauder Companies Inc / General Motors Co / Coca-Cola Co / PNC Financial Services Group Inc / PPG Industries Inc / Schlumberger NV / TotalEnergies SE / US Bancorp / Visteon Corp / Humana Inc / Amgen Inc / Wesco International Inc / McDonald's Corp / Valero Energy Corp / General Mills Inc / American Tower Corp / CyrusOne Inc / Sherwin-Williams Co / HCA Healthcare Inc / Allscripts Healthcare Solutions Inc / Arena Pharmaceuticals Inc / Ameriprise Financial Inc / Sempra Energy / Exelon Corp / Fiserv Inc / Prologis Inc / AMETEK Inc / Regeneron Pharmaceuticals Inc / Verint Systems Inc / Conocophillips / Black Hills Corp / Discover Financial Services / Select Medical Holdings Corp / Global Payments Inc / Monster Beverage Corp / Ziff Davis Inc / Equinix Inc / Biogen Inc / Truist Financial Corp / Digital Realty Trust Inc / GMS Inc / Brookfield Asset Management Inc / Arrowhead Pharmaceuticals Inc / American Equity Investment Life Holding Co / Investors Bancorp Inc / Solaria Energia y Medio Ambiente SA / Ensign Group Inc / Dana Inc / Brookfield Infrastructure Partners LP / Jack in the Box Inc / MSCI Inc / Addus Homecare Corp / NEXTDC Ltd / BankUnited Inc / Pacira Biosciences Inc / Meritor Inc / STAG Industrial Inc / Matador Resources Co / Mondelez International Inc / Artisan Partners Asset Management Inc / Brookfield Renewable Partners LP / Masonite International Corp / Essent Group Ltd / Installed Building Products Inc / Varonis Systems Inc / Q2 Holdings Inc / NMI Holdings Inc / Axalta Coating Systems Ltd / Rapid7 Inc / Mimecast Ltd / Megaport Ltd / S&P Global Inc / Atkore Inc / Kinsale Capital Group Inc / Brookfield Business Partners LP / Uniper SE / GDS Holdings Ltd / Grenergy Renovables SA / R1 RCM Inc / Orsted A/S / Evoqua Water Technologies Corp / Aptiv PLC / Avid Bioservices Inc / GrafTech International Ltd / Verrica Pharmaceuticals Inc / Focus Financial Partners Inc / Health Catalyst Inc / Aprea Therapeutics Inc / Carrier Global Corp / Otis Worldwide Corp / Corporacion Acciona Energias Renovables SA</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / Spain / United Kingdom / United States / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">KRAS Race Intensifies in CRC</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">MRTX.OQ / AMGN.O</td><td class="leftalignment">Mirati Therapeutics Inc / Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="odd"><td class="leftalignment">09/20/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Adagrasib Updates Keep Efficacy Numerically Higher, but Within Margin of Error</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Sep 10, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">09/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">KRAS G12C competition heats up with new data in NSCLC threatening AMGN's Lumakras</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Kennen MacKay, PHD</td></tr>
<tr class="even"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Big VSTM weekend - robust durability data for ovarian combo and new AMGN partnership</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AMGN.OQ / VSTM / US0311621009</td><td class="leftalignment">Amgen Inc / Verastem Inc / Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">FISV=US / PEP=US / AMGN=US / CAG=US / KO=US / OXY=US / RRC=US / EFX=US / CL=US / PG=US / DVN=US / APA=US / CPE=US / EOG=US / REI=US / H=US / TRU=US / XOM=US / CRK=US / WLL=US / PXD=US / ENR=US / MGY=US / SWN=US / MUR=US / MAR=US / MRO=US / HLT=US / MANH=US / NWL=US / CI=US / FLO=US / MAC=US / STZ=US / CHD=US / COLL=US / CNX=US / EPC=US / EQT=US / EXEL=US / GPOR=US / HAIN=US / PCTY=US / REGN=US / SMG=US / CVX=US / POST=US / OPT=US / SGMS=US / GPN=US / CFR=US / EGP=US / FRT=US / INTA=US / KIM=US / EVOP=US / COP=US / BRX=US / INST=US / MGPI=US / BDSI=US / MQ / MNST=US / NOMD=US / MOH=US / FLT=US / FRPT=US / THS=US / MPW=US / FIS=US / HST=US / ELF=US / CENTA=US / CLR=US / NOG=US / RCUS=US / AAN=US / UTZ=US / OLO=US / AR=US / OAS=US / ESTE=US / BCEI=US / MTDR=US / PDCE=US / RHP=US / FANG=US / MODN=US / FIVN=US / VNOM=US / HUBS=US / MCFT=US / SQ=US / EDIT=US / ADVM=US / CDEV=US / PK=US / PVAC=US / SBOW=US / PETQ=US / SFIX=US / KDP=US / KOD=US / TCRR=US / LSPD=US / RPAY=US / BRBR=US / GMAB=US / OVV=US / REYN=US / PAYA=US / HYFM=US / AFRM=US / REPX=US / 67421J108 / DNUT=US / PYCR=US / EWCZ=US</td><td class="leftalignment">Fiserv Inc / PepsiCo Inc / Amgen Inc / Conagra Brands Inc / Coca-Cola Co / Occidental Petroleum Corp / Range Resources Corp / Equifax Inc / Colgate-Palmolive Co / Procter & Gamble Co / Devon Energy Corp / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Hyatt Hotels Corp / TransUnion / Exxon Mobil Corp / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Energizer Holdings Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / Marriott International Inc / Marathon Oil Corp / Hilton Worldwide Holdings Inc / Manhattan Associates Inc / Newell Brands Inc / Cigna Corp / Flowers Foods Inc / Macerich Co / Constellation Brands Inc / Church & Dwight Co Inc / Collegium Pharmaceutical Inc / CNX Resources Corp / Edgewell Personal Care Co / EQT Corp / Exelixis Inc / Gulfport Energy Corp / Hain Celestial Group Inc / Paylocity Holding Corp / Regeneron Pharmaceuticals Inc / Scotts Miracle-Gro Co / Chevron Corp / Post Holdings Inc / Opthea Ltd / Scientific Games Corp / Global Payments Inc / Cullen/Frost Bankers Inc / Eastgroup Properties Inc / Federal Realty Investment Trust / Intapp Inc / Kimco Realty Corp / EVO Payments Inc / Conocophillips / Brixmor Property Group Inc / Instructure Holdings Inc / MGP Ingredients Inc / BioDelivery Sciences International Inc / Marqeta Inc / Monster Beverage Corp / Nomad Foods Ltd / Molina Healthcare Inc / Fleetcor Technologies Inc / Freshpet Inc / TreeHouse Foods Inc / Medical Properties Trust Inc / Fidelity National Information Services Inc / Host Hotels & Resorts Inc / elf Beauty Inc / Central Garden & Pet Co / Continental Resources Inc / Northern Oil and Gas Inc / Arcus Biosciences Inc / Aaron's Company Inc / UTZ Brands Inc / Olo Inc / Antero Resources Corp / Oasis Petroleum Inc / Earthstone Energy Inc / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Ryman Hospitality Properties Inc / Diamondback Energy Inc / Model N Inc / Five9 Inc / Viper Energy Partners LP / HubSpot Inc / Mastercraft Boat Holdings Inc / Block Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / Centennial Resource Development Inc / Park Hotels & Resorts Inc / Ranger Oil Corp / SilverBow Resources Inc / PetIQ Inc / Stitch Fix Inc / Keurig Dr Pepper Inc / Kodiak Sciences Inc / TCR2 Therapeutics Inc / Lightspeed Commerce Inc / Repay Holdings Corp / Bellring Brands Inc / Genmab A/S / Ovintiv Inc / Reynolds Consumer Products Inc / Paya Holdings Inc / Hydrofarm Holdings Group Inc / Affirm Holdings Inc / Riley Exploration Permian Inc / Oatly Group AB / Krispy Kreme Inc / Paycor HCM Inc / European Wax Center Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Denmark / Luxembourg / Sweden / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">V / 0989529 / 2126335 / 2681511 / 2000019 / 2023607 / 2640147 / 2778844 / 2270726 / 2542049 / 2829515 / 2317087 / 2576941 / 2689560 / 2684703 / 2440637 / B1F76F9 / B121557 / 2857817 / 2983563 / B5B2106 / 2982924 / BBPK0J0 / B95N910 / B7577T2 / BFLR866 / BVVN4Q8 / BYNZGK1 / BZ1LFB2 / BKS3SM8 / BNFWR44 / BMQ5T49 / BKVDFF7 / BLGJ610 / BFMXGR0 / BJJMGL2 / BKTNTR9 / BD6JX35 / BN2R582 / BQXZP64 / BLF0CW7 / BMVBZF5</td><td class="leftalignment">Visa Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / PepsiCo Inc / Amazon.com Inc / Amgen Inc / Nike Inc / Merck & Co Inc / Walt Disney Co / Dominion Energy Inc / Edison International / Entergy Corp / Exelixis Inc / PG&E Corp / Pfizer Inc / CenterPoint Energy Inc / Western Union Co / Mastercard Inc / Netflix Inc / Carmax Inc / Fortinet Inc / Spectrum Pharmaceuticals Inc / Mirati Therapeutics Inc / PTC Inc / Renewable Energy Group Inc / Twitter Inc / Eversource Energy / Block Inc / Deciphera Pharmaceuticals Inc / IGM Biosciences Inc / Worldline SA / Zentalis Pharmaceuticals Inc / Oric Pharmaceuticals Inc / Warner Music Group Corp / Evergy Inc / Fox Corp / ViacomCBS Inc / Krystal Biotech Inc / Relay Therapeutics Inc / Wayfair Inc / Repare Therapeutics Inc / Immuneering Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">09/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - September 20, 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AEP.N / AES.N / ALV.N / CAS.TO / CB.N / CNA.L / EIX.N / EL.N / F.N / FSR.N / GM.N / KBH.N / KO.N / SO.N / T.N / VC.N / SSE.L / PXD.N / HUM.N / TEN.N / CMCSA.O / AMGN.O / ETR.N / RBA.N / CNR.TO / BWA.N / LEA.N / K.N / DISH.O / LEN.N / CLX.N / PCG.N / EPC.N / ADCT.N / AMT.N / NG.L / VZ.N / EXEL.O / XEL.N / ARNA.O / STZ.N / LNC.N / APH.N / EXC.N / FISV.O / V.N / AXL.N / ACN.N / NWN.N / BC.N / AJG.N / REGN.O / ENR.N / SRG.MI / PRU.N / NCR.N / TEL.N / CPK.N / GTY.N / PII.N / ST.N / AMH.N / PLUG.OQ / SGEN.OQ / GPN.N / CASY.O / JCOM.O / EQIX.O / ATDb.TO / DLR.N / 416515104 / SJW.N / FIS.N / MA.N / HOG.N / AON.N / BGS.N / DAN.N / EONGn.DE / NGD.A / SPB.N / NEE.N / MTOR.N / IFP.TO / PANW.N / FFHu.TO / TSLA.N / TMUS.N / RNW.TO / RACE.MI / TRHC.OQ / MP1.AX / ADNT.N / INVH.N / UNIT.O / ATNX.O / APTV.N / EQX.TO / VNE.N / NTGY.MC / ZM.O / GMAB.O / CRNC.OQ / WTRG.N / NKLA.OQ / FOUR.N / MGNI.OQ / RXT.OQ / IBEX.O / LUMN.N / RIDE.OQ / LSPD.N / PUBM.O / WFG.N / NUVB.N / PSFE.N / TSP.OQ / OTLY.O / RYAN.N</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Autoliv Inc / Cascades Inc / Chubb Ltd / Centrica PLC / Edison International / Estee Lauder Companies Inc / Ford Motor Co / Fisker Inc / General Motors Co / KB Home / Coca-Cola Co / Southern Co / AT&T Inc / Visteon Corp / SSE PLC / Pioneer Natural Resources Co / Humana Inc / Tenneco Inc / Comcast Corp / Amgen Inc / Entergy Corp / Ritchie Bros Auctioneers Inc / Canadian National Railway Co / Borgwarner Inc / Lear Corp / Kellogg Co / DISH Network Corp / Lennar Corp / Clorox Co / PG&E Corp / Edgewell Personal Care Co / ADC Therapeutics SA / American Tower Corp / National Grid PLC / Verizon Communications Inc / Exelixis Inc / Xcel Energy Inc / Arena Pharmaceuticals Inc / Constellation Brands Inc / Lincoln National Corp / Amphenol Corp / Exelon Corp / Fiserv Inc / Visa Inc / American Axle & Manufacturing Holdings Inc / Accenture PLC / Northwest Natural Holding Co / Brunswick Corp / Arthur J Gallagher & Co / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Snam SpA / Prudential Financial Inc / NCR Corp / TE Connectivity Ltd / Chesapeake Utilities Corp / Getty Realty Corp / Polaris Inc / Sensata Technologies Holding PLC / American Homes 4 Rent / Plug Power Inc / Seagen Inc / Global Payments Inc / Caseys General Stores Inc / Ziff Davis Inc / Equinix Inc / Alimentation Couche-Tard Inc / Digital Realty Trust Inc / Hartford Financial Services Group Inc / SJW Group / Fidelity National Information Services Inc / Mastercard Inc / Harley-Davidson Inc / Aon PLC / B&G Foods Inc / Dana Inc / E.ON SE / New Gold Inc / Spectrum Brands Holdings Inc / Nextera Energy Inc / Meritor Inc / Interfor Corp / Palo Alto Networks Inc / Fairfax Financial Holdings Ltd / Tesla Inc / T-Mobile US Inc / TransAlta Renewables Inc / Ferrari NV / Tabula Rasa HealthCare Inc / Megaport Ltd / Adient PLC / Invitation Homes Inc / Uniti Group Inc / Athenex Inc / Aptiv PLC / Equinox Gold Corp / Veoneer Inc / Naturgy Energy Group SA / Zoom Video Communications Inc / Genmab A/S / Cerence Inc / Essential Utilities Inc / Nikola Corp / Shift4 Payments Inc / Magnite Inc / Rackspace Technology Inc / Ibex Ltd / Lumen Technologies Inc / Lordstown Motors Corp / Lightspeed Commerce Inc / PubMatic Inc / West Fraser Timber Co Ltd / Nuvation Bio Inc / Paysafe Ltd / TuSimple Holdings Inc / Oatly Group AB / Ryan Specialty Group Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Germany / Denmark / Spain / United Kingdom / Ireland / Italy / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">09/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">ESMO ’21 update: KRAS G12C competitor data bests AMGN’s Lumakras in CRC but NSCLC is still our focus</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Kennen MacKay, PHD</td></tr>
<tr class="odd"><td class="leftalignment">09/19/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Lumakras broad combo strategy could be key differentiator; we continue to wait and see</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AMGN=US</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">09/19/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">First Take: Adagrasib CRC Results Strong in Mono and Combo</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">60468T105 / 03116210</td><td class="leftalignment">Mirati Therapeutics Inc / Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Silvan Tuerkcan</td></tr>
<tr class="odd"><td class="leftalignment">09/19/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">AMGN - AMGN: KRYSTAL-1 data raises concerns as MRTX prepares to turn the card on NSCLC monotherapy on Monday</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">09/18/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Mackay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AMGN.O / ADCT.N / EXEL.O / ARNA.O / REGN.O / SGEN.OQ / ATNX.O / GMAB.O / NUVB.N</td><td class="leftalignment">Amgen Inc / ADC Therapeutics SA / Exelixis Inc / Arena Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Seagen Inc / Athenex Inc / Genmab A/S / Nuvation Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="odd"><td class="leftalignment">09/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">LLY-US -  Dividend Quality Analysis, for the period ended September 10,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">LLY / BMY / JNJ / MRK / NVS / PFE / AMGN.O / GSK / AZN.O / ABBV.K / SNY.O</td><td class="leftalignment">Eli Lilly and Co / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">09/17/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">PFE / PRTA / US0311621009 / US88688T1007 / US12482W1018 / CA05156X8843</td><td class="leftalignment">Pfizer Inc / Prothena Corporation PLC / Amgen Inc / Tilray Brands Inc / cbdMD Inc / Aurora Cannabis Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">09/17/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 565</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">09/17/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--Sept. 17, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">ACA / AMN / BSX / CHE / CI / CNC / CVS / HUM / MDT / RAD / UNH / WMT / AMGN.O / RMD.N / HCA.N / CYH.N / INSP.N / EW.N / SSNC.O / UTHR.OQ / CCRN.O / LIFE.O / AMED.O / BIIB.O / 00846U101 / 868168105 / NUVA.O / MNKD.O / ATRC.OQ / DXCM.O / LHCG.O / ENSG.OQ / 483548103 / MD.N / CSII.O / ADUS.O / USPH.N / MDXG.O / PRTA.OQ / AERI.O / GOOGL.O / 02005N100 / EVH.N / TDOC.N / MCRB.OQ / ZBH.N / APLS.OQ / 100063846 / EDIT.OQ / IRTC.OQ / ACIU.O / ATNX.O / 720795103 / ORTX.OQ / SWAV.O / ISEE.O / ORGO.O / PNTG.OQ / ONEM.OQ / 14888D208 / RZLT.O</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Boston Scientific Corp / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Medtronic PLC / Rite Aid Corp / UnitedHealth Group Inc / Walmart Inc / Amgen Inc / Resmed Inc / HCA Healthcare Inc / Community Health Systems Inc / Inspire Medical Systems Inc / Edwards Lifesciences Corp / SS&C Technologies Holdings Inc / United Therapeutics Corp / Cross Country Healthcare Inc / aTyr Pharma Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / NuVasive Inc / MannKind Corp / AtriCure Inc / Dexcom Inc / LHC Group Inc / Ensign Group Inc / Kaman Corp / MEDNAX Inc / Cardiovascular Systems Inc / Addus Homecare Corp / US Physical Therapy Inc / MiMedx Group Inc / Prothena Corporation PLC / Aerie Pharmaceuticals Inc / Alphabet Inc / Ally Financial Inc / Evolent Health Inc / Teladoc Health Inc / Seres Therapeutics Inc / Zimmer Biomet Holdings Inc / Apellis Pharmaceuticals Inc / Truist Financial Corp / Editas Medicine Inc / iRhythm Technologies Inc / AC Immune SA / Athenex Inc / Pieris Pharmaceuticals Inc / Orchard Therapeutics PLC / Shockwave Medical Inc / Iveric Bio Inc / Organogenesis Holdings Inc / Pennant Group Inc / 1Life Healthcare Inc / Catalyst Biosciences Inc / Rezolute Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/17/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended September 10, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">09/17/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">09/17/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AMT / BKI / CCI.N / COST.O / DLR / FDS / FND / JPM / MCO / MSFT.O / NICE.TA / NKE / QCOM.O / T.N / W / WFC.N / WMT / AMZN.O / AMGN.O / AAPL.O / DISH.O / KLR / HEAR.O / RDWR.O / CHTR.O / NUAN.O / DOX.O / NET.N / ATVI.OQ / CSGS.OQ / TTWO.OQ / AKAM.OQ / VRNT.OQ / EGAN.O / AMED.O / EQIX.O / NFLX.O / GPRO.O / 92343V104 / 20030N101 / NDAQ.O / 36467W109 / ICE.N / CCOI.O / LLNW.OQ / LULU.O / ULTA.O / AMD.OQ / ZNGA.O / EA.O / FB.O / FIVE.OQ / RNG.N / FDEV.L / GOOGL.O / FIVN.O / 82655M107 / APPS.O / ETSY.O / ZG.OQ / TMUS.OQ / SPGI.K / BABA.K / TWLO.K / UAA / CVNA.N / ROKU.O / MDB.O / WSC.OQ / VICp.V / EGHT.K / OSS.O / BILI.O / LOVE.OQ / CBOE.Z / PRPL.O / ZM.OQ / CMBM.OQ / FSLY.K / VG.O / CXDO.O / RXT.O / ONDS.OQ / PRCH.OQ / LMND.K / HUYA.K / DOMA.N</td><td class="leftalignment">American Tower Corp / Black Knight Inc / Crown Castle International Corp / Costco Wholesale Corp / Digital Realty Trust Inc / Factset Research Systems Inc / Floor & Decor Holdings Inc / JPMorgan Chase & Co / Moody's Corp / Microsoft Corp / Nice Ltd / Nike Inc / Qualcomm Inc / AT&T Inc / Wayfair Inc / Wells Fargo & Co / Walmart Inc / Amazon.com Inc / Amgen Inc / Apple Inc / DISH Network Corp / Kaleyra Inc / Turtle Beach Corp / Radware Ltd / Charter Communications Inc / Nuance Communications Inc / Amdocs Ltd / Cloudflare Inc / Activision Blizzard Inc / CSG Systems International Inc / Take-Two Interactive Software Inc / Akamai Technologies Inc / Verint Systems Inc / eGain Corp / Amedisys Inc / Equinix Inc / Netflix Inc / GoPro Inc / Verizon Communications Inc / Comcast Corp / Nasdaq Inc / GameStop Corp / Intercontinental Exchange Inc / Cogent Communications Holdings Inc / Limelight Networks Inc / Lululemon Athletica Inc / Ulta Beauty Inc / Advanced Micro Devices Inc / Zynga Inc / Electronic Arts Inc / Meta Platforms Inc / Five Below Inc / RingCentral Inc / Frontier Developments PLC / Alphabet Inc / Five9 Inc / Sify Technologies Ltd / Digital Turbine Inc / ETSY Inc / Zillow Group Inc / T-Mobile US Inc / S&P Global Inc / Alibaba Group Holding Ltd / Twilio Inc / Under Armour Inc / Carvana Co / Roku Inc / MongoDB Inc / Willscot Mobile Mini Holdings Corp / Victory Capital Corp / 8x8 Inc / One Stop Systems Inc / Bilibili Inc / Lovesac Co / Cboe Global Markets Inc / Purple Innovation Inc / Zoom Video Communications Inc / Cambium Networks Corp / Fastly Inc / Vonage Holdings Corp / Crexendo Inc / Rackspace Technology Inc / Ondas Holdings Inc / Porch Group Inc / Lemonade Inc / HUYA Inc / Doma Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / India / Israel / United States / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/17/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AMGN=US / AMZN=US / INCY=US / NVDA=US / MPWR=US / VRM=US / EXPE=US / W=US / AJG=US / SNAP=US / THO=US / TRIP=US / WIX=US / WGO=US / BKNG=US / FB=US / KRT=US / MKL=US / MTCH=US / VNO=US / APPN=US / PTON=US / JRVR=US / TCBI=US / APP=US / CWH=US / KNSL=US / ANGI=US / FANG=US / GOOGL=US / BABA=US / CMPR=US / GDDY=US / ZG=US / 50189K103 / CVNA=US / SFIX=US / LAZY=US / BTAI=US / FOCS=US / FTDR=US / LYFT=US / UBER=US / TCRR=US / PLMR=US / VMEO=US / MNTV=US</td><td class="leftalignment">Amgen Inc / Amazon.com Inc / Incyte Corp / NVIDIA Corp / Monolithic Power Systems Inc / Vroom Inc / Expedia Group Inc / Wayfair Inc / Arthur J Gallagher & Co / Snap Inc / Thor Industries Inc / Tripadvisor Inc / Wix.Com Ltd / Winnebago Industries Inc / Booking Holdings Inc / Meta Platforms Inc / Karat Packaging Inc / Markel Corp / Match Group Inc / Vornado Realty Trust / Appian Corp / Peloton Interactive Inc / James River Group Holdings Ltd / Texas Capital Bancshares Inc / Applovin Corp / Camping World Holdings Inc / Kinsale Capital Group Inc / Angi Inc / Diamondback Energy Inc / Alphabet Inc / Alibaba Group Holding Ltd / Cimpress PLC / GoDaddy Inc / Zillow Group Inc / LCI Industries / Carvana Co / Stitch Fix Inc / Lazydays Holdings Inc / BioXcel Therapeutics Inc / Focus Financial Partners Inc / Frontdoor Inc / Lyft Inc / Uber Technologies Inc / TCR2 Therapeutics Inc / Palomar Holdings Inc / Vimeo Inc / Momentive Global Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Cayman Islands / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/17/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Lumakras Plus Vectibix Looks Good in 3L CRC; Pivotal Design for Bema Has Risks</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">03116210</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun / Anna Baran, CFA</td></tr>
<tr class="even"><td class="leftalignment">09/17/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">V / 2516152 / 2681511 / 2000019 / 2023607 / 2008154 / 2497406 / 2778844 / 2216850 / 2270726 / 2317087 / 2328915 / 2100920 / 2459020 / 2689560 / 2707677 / 2730190 / 2212922 / 2857817 / B3D7K31 / B5B2106 / B7TL820 / BBPK0J0 / B87ZMX0 / B7577T2 / B424494 / BFLR866 / BVVN4Q8 / BYW36M8 / BF4VBS8 / BXDZ9Z0 / BF5L3T2 / BYNZGK1 / BZ00V34 / BZ1LFG7 / BYY88Y7 / BRJ3GY4 / BM8NHS1</td><td class="leftalignment">Visa Inc / Eli Lilly and Co / PepsiCo Inc / Amazon.com Inc / Amgen Inc / Adobe Inc / Kroger Co / Merck & Co Inc / Consolidated Edison Inc / Walt Disney Co / Entergy Corp / Nextera Energy Inc / FirstEnergy Corp / Intuit Inc / PG&E Corp / Public Service Enterprise Group Inc / Regeneron Pharmaceuticals Inc / NRG Energy Inc / Netflix Inc / Discovery Inc / Fortinet Inc / Meta Platforms Inc / Mirati Therapeutics Inc / Palo Alto Networks Inc / Renewable Energy Group Inc / Splunk Inc / Twitter Inc / Eversource Energy / PayPal Holdings Inc / BioXcel Therapeutics Inc / Shopify Inc / Elanco Animal Health Inc / Block Inc / Zscaler Inc / Roku Inc / Alphabet Inc / Xenon Pharmaceuticals Inc / Adagio Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">09/17/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - September 17, 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AHT.L / AU.N / BB.N / CCK.N / FMC.N / GE.N / GM.N / MAS.N / NEM.N / PPG.N / SCHN.PA / WEIR.L / SSE.L / CFP.TO / FNV.N / LPX.N / AMGN.O / AGI.N / WLK.N / WCC.N / IEX.N / ROP.N / EPR.N / CLX.N / AEM.N / KGC.N / OLN.N / SHW.N / JCI.N / NNN.N / CHD.N / AME.N / MTB.N / FTT.TO / CEY.L / GPK.N / GFI.N / CDE.N / GTY.N / GGG.N / HL.N / ST.N / ADC.N / O.N / WPC.N / PLUG.OQ / COA.L / CCLb.TO / RGLD.O / PAAS.O / GOLD.N / TIH.TO / TFC.N / DPM.TO / EDV.TO / NTR.N / CG.TO / NVT.N / MOS.N / IAG.N / SRC.N / BLDR.O / CFR.S / MWA.N / AUY.N / HOCM.L / GETP.PA / OSK.TO / FRES.L / NGD.A / EGO.N / CVE.TO / SBB.TO / AR.TO / TXG.TO / SIL.TO / PVG.TO / CJT.TO / MOZ.TO / POLYP.L / XYL.N / BERY.N / BTG.N / ZALG.DE / GWB.N / AXTA.N / ATKR.N / OR.N / SAND.N / WPM.N / SSRM.O / VNTR.N / KL.N / RHIM.L / AQUA.N / APTV.N / EQX.TO / GTES.N / EAF.N / BROG.OQ / TFII.N / GFL.N / CARR.N / MOCORP.HE / MTCR.O / GATO.N / WFG.N / TFPM.TO</td><td class="leftalignment">Ashtead Group PLC / AngloGold Ashanti Ltd / BlackBerry Ltd / Crown Holdings Inc / FMC Corp / General Electric Co / General Motors Co / Masco Corp / Newmont Corporation / PPG Industries Inc / Schneider Electric SE / Weir Group PLC / SSE PLC / Canfor Corp / Franco-Nevada Corp / Louisiana-Pacific Corp / Amgen Inc / Alamos Gold Inc / Westlake Chemical Corp / Wesco International Inc / IDEX Corp / Roper Technologies Inc / EPR Properties / Clorox Co / Agnico Eagle Mines Ltd / Kinross Gold Corp / Olin Corp / Sherwin-Williams Co / Johnson Controls International PLC / National Retail Properties Inc / Church & Dwight Co Inc / AMETEK Inc / M&T Bank Corp / Finning International Inc / Centamin PLC / Graphic Packaging Holding Co / Gold Fields Ltd / Coeur Mining Inc / Getty Realty Corp / Graco Inc / Hecla Mining Co / Sensata Technologies Holding PLC / Agree Realty Corp / Realty Income Corp / WP Carey Inc / Plug Power Inc / Coats Group PLC / CCL Industries Inc / Royal Gold Inc / Pan American Silver Corp / Barrick Gold Corp / Toromont Industries Ltd / Truist Financial Corp / Dundee Precious Metals Inc / Endeavour Mining PLC / Nutrien Ltd / Centerra Gold Inc / nVent Electric PLC / Mosaic Co / IAMGOLD Corp / Spirit Realty Capital Inc / Builders FirstSource Inc / Compagnie Financiere Richemont SA / Mueller Water Products Inc / Yamana Gold Inc / Hochschild Mining PLC / Getlink SE / Osisko Mining Inc / Fresnillo PLC / New Gold Inc / Eldorado Gold Corp / Cenovus Energy Inc / Sabina Gold & Silver Corp / Argonaut Gold Inc / Torex Gold Resources Inc / Silvercrest Metals Inc / Pretium Resources Inc / Cargojet Inc / Marathon Gold Corp / Polymetal International PLC / Xylem Inc / Berry Global Group Inc / B2Gold Corp / Zalando SE / Great Western Bancorp Inc / Axalta Coating Systems Ltd / Atkore Inc / Osisko Gold Royalties Ltd / Sandstorm Gold Ltd / Wheaton Precious Metals Corp / SSR Mining Inc / Venator Materials PLC / Kirkland Lake Gold Ltd / RHI Magnesita NV / Evoqua Water Technologies Corp / Aptiv PLC / Equinox Gold Corp / Gates Industrial Corporation PLC / GrafTech International Ltd / Brooge Energy Ltd / TFI International Inc / GFL Environmental Inc / Carrier Global Corp / Metso Outotec Corp / Metacrine Inc / Gatos Silver Inc / West Fraser Timber Co Ltd / Triple Flag Precious Metals Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Germany / Finland / France / United Kingdom / Ireland / Netherlands / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">09/16/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">ESMO '21 update: 1st Lumakras combo data support safety/efficacy but additional combos are still key</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Kennen MacKay, PHD</td></tr>
<tr class="odd"><td class="leftalignment">09/16/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">KRAS Combo Debut Impresses in 3L+ CRC</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">09/16/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Another Week of Moderate Biotech Outflows</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">09/16/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">LUMAKRAS/Vectibix combination is path forward in colorectal cancer at ESMO</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">09/16/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Initial Lumakras Combination Data in CRC Suggests Enhanced Activity; Mirati to Show its Hand On Sunday</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="odd"><td class="leftalignment">09/16/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Has Amgen KRAS left an opening?</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="even"><td class="leftalignment">09/16/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Lumakras broad combo strategy could be how AMGN succeeds</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AMGN=US</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="odd"><td class="leftalignment">09/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">AMGN (NEUTRAL), MRTX (NEUTRAL) - Sotorasib + EGFR Data Encouraging, Sets Efficacy Bar for MRTX on Sunday; Final Ph II NSCLC Data Confirmed for Monday</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AMGN.OQ / MRTX.OQ / 2023607 / BBPK0J0</td><td class="leftalignment">Amgen Inc / Mirati Therapeutics Inc / Amgen Inc / Mirati Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Kelsey Goodwin / Yige Guo, Ph.D. / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="even"><td class="leftalignment">09/16/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">KRAS G12C CRC Data Solid, Supports Potential In This Setting</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US0311621009 / US60468T1051</td><td class="leftalignment">Amgen Inc / Mirati Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Yaron Werber, M.D., MD / Gabriel Schneider, M.D. / Brendan Smith, Ph.D. / Eve Reilly, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">09/16/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Lumakras CRC Combo Beats Single Agent; Commercial Opportunity Still TBD However</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">031162100</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">09/16/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">AMGN.OQ - Event Transcript of Amgen Inc conference call, Sep. 16, 2021 / 8:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/16/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Lumakras + Vectibix combo in CRC shows benefit in ORR, still lagging on DCR vs adagrasib</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AMGN=US</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">09/16/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / BSX=US / LLY=US / AMGN=US / BMY=US / HD=US / MDT=US / GILD=US / PEB=US / H=US / MTN=US / LOW=US / IGT=US / MAR=US / ADS=US / TTWO=US / TNL=US / ATVI=US / HLT=US / CLI=US / CHH=US / DRH=US / EXEL=US / MHK=US / HOOK=US / REGN=US / SGMO=US / TRIP=US / SGMS=US / CNM=US / MTCH=US / IGMS=US / STRO=US / APP=US / SHO=US / HST=US / WH=US / TIL=US / HGV=US / RLJ=US / VAC=US / ZNGA=US / EA=US / RHP=US / TILE=US / AERI=US / BWXT=US / PEN=US / IBEX=US / TTD=US / PK=US / PLYA=US / CVNA=US / NCNA=US / DCPH=US / GSKY=US / BTAI=US / TCRR=US / GMAB=US / RBLX=US / MNTV=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Eli Lilly and Co / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / Medtronic PLC / Gilead Sciences Inc / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Vail Resorts Inc / Lowe's Companies Inc / International Game Technology PLC / Marriott International Inc / Alliance Data Systems Corp / Take-Two Interactive Software Inc / Travel + Leisure Co / Activision Blizzard Inc / Hilton Worldwide Holdings Inc / Veris Residential Inc / Choice Hotels International Inc / Diamondrock Hospitality Co / Exelixis Inc / Mohawk Industries Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Tripadvisor Inc / Scientific Games Corp / Core & Main Inc / Match Group Inc / IGM Biosciences Inc / Sutro Biopharma Inc / Applovin Corp / Sunstone Hotel Investors Inc / Host Hotels & Resorts Inc / Wyndham Hotels & Resorts Inc / Instil Bio Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Zynga Inc / Electronic Arts Inc / Ryman Hospitality Properties Inc / Interface Inc / Aerie Pharmaceuticals Inc / BWX Technologies Inc / Penumbra Inc / Ibex Ltd / Trade Desk Inc / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Carvana Co / NuCana PLC / Deciphera Pharmaceuticals Inc / GreenSky Inc / BioXcel Therapeutics Inc / TCR2 Therapeutics Inc / Genmab A/S / Roblox Corp / Momentive Global Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Denmark / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for AMGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">09/15/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech & Pharma: Truist Securities ESMO Planner Highlights 130+ Datapoints of Interest</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">MRK=US / LLY=US / AMGN=US / BMY=US / GILD=US / EXEL=US / HOOK=US / REGN=US / IGMS=US / STRO=US / TIL=US / NCNA=US / DCPH=US / BTAI=US / TCRR=US / GMAB=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Exelixis Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / IGM Biosciences Inc / Sutro Biopharma Inc / Instil Bio Inc / NuCana PLC / Deciphera Pharmaceuticals Inc / BioXcel Therapeutics Inc / TCR2 Therapeutics Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Denmark / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Asthika Goonewardene / Ms. Robyn S. Karnauskas / Billal Jahangiri / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">09/15/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">ESMO Abstract Highlights and Virtual Conference Itinerary</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">03116210 / 00887A105 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109</td><td class="leftalignment">Amgen Inc / Aileron Therapeutics Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Tim F. Lugo / Mr. Raju Prasad, PHD</td></tr>
<tr class="even"><td class="leftalignment">09/14/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">AMGN.OQ - Event Transcript of Amgen Inc conference call, Sep. 14, 2021 / 2:45PM ET</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/14/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Labor Day Holiday Clouds Preliminary Domestic Declines, Focus on Imminent Pfizer Adolescent Vaccine Data and Booster Debate</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">09/14/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">V / 5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2023607 / 2778844 / 2026242 / 2270726 / 2317087 / 2670519 / 2328915 / 2459020 / 2689560 / 2684703 / 2440637 / 7103065 / B121557 / 2212922 / 2857817 / 2982924 / B7VD3F2 / BFDV8K0 / BBPK0J0 / B95N910 / BVVN4Q8 / BYW36M8 / BZ1LFB2 / BJXBP30 / BYQHPK7 / BYYWPW6 / BZ1LFG7 / BJDX8Y8 / BWY4XV3 / BGT0PL8 / BNTB3N8 / BMGGJK8</td><td class="leftalignment">Visa Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Amgen Inc / Merck & Co Inc / American Electric Power Company Inc / Walt Disney Co / Entergy Corp / Exelon Corp / Nextera Energy Inc / Intuit Inc / PG&E Corp / Pfizer Inc / CenterPoint Energy Inc / Novartis AG / Mastercard Inc / NRG Energy Inc / Netflix Inc / Spectrum Pharmaceuticals Inc / Duke Energy Corp / MacroGenics Inc / Mirati Therapeutics Inc / PTC Inc / Eversource Energy / PayPal Holdings Inc / Deciphera Pharmaceuticals Inc / Turning Point Therapeutics Inc / Zymeworks Inc / Beigene Ltd / Roku Inc / Mirum Pharmaceuticals Inc / Adaptimmune Therapeutics PLC / DiaMedica Therapeutics Inc / Vizio Holding Corp / Valneva SE</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">09/13/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Sep 03, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">09/13/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ESMO Poster Abstracts Highlight Incremental Updates Across Our Coverage - ADAP, AMGN, DCPH, SPPI, SGEN, BGNE, ZYME, MGNX</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.OQ / ADAP.OQ / DCPH.OQ / MGNX.OQ / SPPI.OQ / ZYME.N / 2023607 / 2982924 / BFDV8K0 / BBPK0J0 / BZ1LFB2 / BYQHPK7 / BYYWPW6 / BWY4XV3 / BN2RM92</td><td class="leftalignment">Amgen Inc / Adaptimmune Therapeutics PLC / Deciphera Pharmaceuticals Inc / MacroGenics Inc / Spectrum Pharmaceuticals Inc / Zymeworks Inc / Amgen Inc / Spectrum Pharmaceuticals Inc / MacroGenics Inc / Mirati Therapeutics Inc / Deciphera Pharmaceuticals Inc / Zymeworks Inc / Beigene Ltd / Adaptimmune Therapeutics PLC / Rain Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Germany / Denmark / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Etzer Darout / Mr. Charles Zhu, Ph.D., III / Yige Guo, Ph.D. / Kelsey Goodwin / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">09/13/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Key Targeted Oncology Takeaways from WCLC 2021 Weekend</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">04635310 / 03116210 / 18946410 / 07725L10 / 60468T10 / 23003110</td><td class="leftalignment">AstraZeneca PLC / Amgen Inc / Clovis Oncology Inc / Beigene Ltd / Mirati Therapeutics Inc / Cullinan Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Austria / Canada / China / Cayman Islands / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Andrew Berens, M.D. / Christopher Liu, Pharm.D.</td></tr>
<tr class="even"><td class="leftalignment">09/10/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Short Interest in Biotechnology Stocks</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US0311621009 / US3755581036 / US75886F1075 / US92532F1003 / US7665596034 / US02043Q1076 / US40637H1095 / US09609G1004 / US45845P1084 / US31189P1021 / US03820J1007 / US92686J1060 / US09627Y1091 / US4622221004 / US5588681057 / US03753U1060 / US2997341035 / US80706P1030 / US76029N1063 / US04335A1051 / US2936141033 / US50015M1099 / US85789A1051 / US62921N1054 / US61775R1059 / US30205M1018 / US80810D1037 / US12529R1077 / CA00288U1066 / US67080N1019 / US24343R1068</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Rigel Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Halozyme Therapeutics Inc / bluebird bio Inc / Intercept Pharmaceuticals Inc / Fate Therapeutics Inc / Applied Genetic Technologies Corp / Viking Therapeutics Inc / Blueprint Medicines Corp / Ionis Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Evelo Biosciences Inc / Scholar Rock Holding Corp / Replimune Group Inc / Arvinas Inc / Entasis Therapeutics Holdings Inc / Kodiak Sciences Inc / Stealth BioTherapeutics Corp / NGM Biopharmaceuticals Inc / Morphic Holding Inc / Exicure Inc / Schrodinger Inc / C4 Therapeutics Inc / Abcellera Biologics Inc / Nuvation Bio Inc / Decibel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Matthew Luchini / Jin Lee / Nick Lenard</td></tr>
<tr class="odd"><td class="leftalignment">09/10/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 564</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">09/10/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended September 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">09/10/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">09/10/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Amgen Inc.(AMGN) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">031162100</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">09/09/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Small, Hopefully Brief Pause in the Action; Modest Biotech Outflows This Week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">09/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AMGN=US / HD=US / ADI=US / RRC=US / BLD=US / TXN=US / LOW=US / LEG=US / KFY=US / PATH=US / ARW=US / AVT=US / FUN=US / CPRT=US / IBP=US / MHK=US / INTA=US / TPX=US / REX=US / PRPL=US / AR=US / FBHS=US / MEIP=US / DBRG=US / HLLY=US</td><td class="leftalignment">Amgen Inc / Home Depot Inc / Analog Devices Inc / Range Resources Corp / TopBuild Corp / Texas Instruments Inc / Lowe's Companies Inc / Leggett & Platt Inc / Korn Ferry / UiPath Inc / Arrow Electronics Inc / Avnet Inc / Cedar Fair LP / Copart Inc / Installed Building Products Inc / Mohawk Industries Inc / Intapp Inc / Tempur Sealy International Inc / REX American Resources Corp / Purple Innovation Inc / Antero Resources Corp / Fortune Brands Home & Security Inc / MEI Pharma Inc / DigitalBridge Group Inc / Holley Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/09/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - September 9, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">CNA.L / F.N / FOUG.PA / GM.N / PD.TO / RWEG.DE / SGEF.PA / SLB.N / SSE.L / TEN.N / AMGN.O / HAL.N / LBRT.N / SHW.N / JCI.N / HP.N / DSGX.O / ESI.TO / SAM.N / NBR.N / PTEN.O / PSI.TO / GPN.N / EFX.TO / CASY.O / TCW.TO / CFW.TO / SCL.TO / NOV.N / LHCG.O / DRX.L / SES.TO / ATL.MI / NCU.TO / DAN.N / EDPR.LS / CEU.TO / SLS.TO / MTOR.N / BKR.N / 46579R104 / HQY.OQ / UN01.DE / STEP.TO / CDMO.OQ / NTGY.MC / MGNI.OQ / PTVE.O / COOK.N / BASE.OQ</td><td class="leftalignment">Centrica PLC / Ford Motor Co / Eiffage SA / General Motors Co / Precision Drilling Corp / Rwe AG / Vinci SA / Schlumberger NV / SSE PLC / Tenneco Inc / Amgen Inc / Halliburton Co / Liberty Oilfield Services Inc / Sherwin-Williams Co / Johnson Controls International PLC / Helmerich and Payne Inc / Descartes Systems Group Inc / Ensign Energy Services Inc / Boston Beer Company Inc / Nabors Industries Ltd / Patterson-UTI Energy Inc / Pason Systems Inc / Global Payments Inc / Enerflex Ltd / Caseys General Stores Inc / Trican Well Service Ltd / Calfrac Well Services Ltd / Shawcor Ltd / Nov Inc / LHC Group Inc / Drax Group PLC / Secure Energy Services Inc / Atlantia SpA / Nevada Copper Corp / Dana Inc / EDP Renovaveis SA / CES Energy Solutions Corp / Solaris Resources Inc / Meritor Inc / Baker Hughes Co / Ivanhoe Mines Ltd / Healthequity Inc / Uniper SE / Step Energy Services Ltd / Avid Bioservices Inc / Naturgy Energy Group SA / Magnite Inc / Pactiv Evergreen Inc / Traeger Inc / Couchbase Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Germany / Spain / France / United Kingdom / Ireland / Italy / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">09/08/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">IASLC WCLC Lumakras update focuses on brain met/genomics as we await combo & competitive updates</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Kennen MacKay, PHD</td></tr>
<tr class="odd"><td class="leftalignment">09/08/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Setting realistic expectations for risk/reward; reiterating conviction in the story; new PT $8/sh</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">MEIP=US / AMGN=US</td><td class="leftalignment">MEI Pharma Inc / Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino</td></tr>
<tr class="even"><td class="leftalignment">09/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PFE-US -  Dividend Quality Analysis, for the period ended September 07,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE / ABT / BMY / JNJ / LLY / MRK / NVS / AMGN.O / GSK / AZN.O</td><td class="leftalignment">Pfizer Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">09/08/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">AMGN.OQ - Event Transcript of Amgen Inc conference call, Sep. 08, 2021 / 1:25PM ET</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/08/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">FDA’s JAK Warnings Create Opportunity for Novel Drugs in 2nd Line Atopic Derm</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">45337C10 / 71708110 / 03116210 / 75886F10 / CNTB / 00287Y10 / 04004760 / 00461U10 / 51506910 / 75382E10</td><td class="leftalignment">Incyte Corp / Pfizer Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Connect Biopharma Holdings Ltd / Abbvie Inc / Arena Pharmaceuticals Inc / Aclaris Therapeutics Inc / Landos Biopharma Inc / Rapt Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Mr. Thomas J. Smith / Anna Baran, CFA / Na Sun / Mike Kratky, CFA / Nat Charoensook, Ph.D., CFA</td></tr>
<tr class="odd"><td class="leftalignment">09/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Aug 27, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">09/07/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended August 27, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">09/07/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Sep 7 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">FR0000120578 / GB0009895292 / FR0000054470 / GB0009252882 / DE0006969603 / US09061G1013 / CH0012032048 / CH0012005267 / US0116591092 / US0311621009 / US0463531089 / US1101221083 / US1311931042 / US14149Y1082 / US1985161066 / US2435371073 / US2855121099 / US3377381088 / US3755581036 / US37733W1053 / US45337C1027 / US5324571083 / US58155Q1031 / US6541061031 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US7782961038 / US8305661055 / US8308791024 / US8447411088 / US8725401090 / US8740541094 / US9182041080 / US03073E1055 / US3448491049 / US37940X1028 / US4771431016 / US4198791018 / US80105N1054 / US2533931026 / US09062X1037 / US9043111072 / US31620M1062 / US1314761032 / US4103451021 / PAP310761054 / US29089Q1058 / US01748X1028 / US2473617023 / US5500211090 / US00507V1098 / DE000A0DJ6J9 / US58933Y1055 / US9100471096 / DE000A1EWWW0 / US6936561009 / US7512121010 / JE00B783TY65 / US98986T1088 / US00287Y1091 / US85916J4094 / US41068X1000 / US8485771021 / US21240E1055 / US1220171060 / US02376R1023 / DK0060534915 / CA0089118776 / US83417M1045 / US00653A1079 / VGG312491084 / US5904791358 / US98585X1046 / US89377M1099 / US26142R1041 / US02875D1090 / US04271T1007 / US82489W1071 / US30320C1036 / US1241551027 / US30260D1037 / US68622V1061</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Ubisoft Entertainment SA / GlaxoSmithKline PLC / Puma SE / Biomarin Pharmaceutical Inc / Roche Holding AG / Novartis AG / Alaska Air Group Inc / Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Callaway Golf Co / Cardinal Health Inc / Columbia Sportswear Co / Deckers Outdoor Corp / Electronic Arts Inc / Fiserv Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Incyte Corp / Eli Lilly and Co / Mckesson Corp / Nike Inc / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Ross Stores Inc / Skechers USA Inc / SkyWest Inc / Southwest Airlines Co / TJX Companies Inc / Take-Two Interactive Software Inc / VF Corp / Amerisourcebergen Corp / Foot Locker Inc / Global Payments Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / DICK'S Sporting Goods Inc / Biogen Inc / Under Armour Inc / Fidelity National Information Services Inc / Calumet Specialty Products Partners LP / HanesBrands Inc / Copa Holdings SA / Emergent BioSolutions Inc / Allegiant Travel Co / Delta Air Lines Inc / Lululemon Athletica Inc / Activision Blizzard Inc / SMA Solar Technology AG / Merck & Co Inc / United Airlines Holdings Inc / Adidas AG / PVH Corp / Ralph Lauren Corp / Aptiv PLC / Zynga Inc / Abbvie Inc / Stereotaxis Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / Burlington Stores Inc / American Airlines Group Inc / Novo Nordisk A/S / Air Canada / Solaredge Technologies Inc / Adaptimmune Therapeutics PLC / Establishment Labs Holdings Inc / Mesa Air Group Inc / Yeti Holdings Inc / Transmedics Group Inc / DraftKings Inc / American Outdoor Brands Inc / Array Technologies Inc / Shoals Technologies Group Inc / FTC Solar Inc / Butterfly Network Inc / Figs Inc / Organon & Co</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Germany / Denmark / France / United Kingdom / Mexico / Panama / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">09/07/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - September 7, 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AC.TO / AEP.N / AES.N / ALV.N / CCK.N / CF.N / CI.N / CP.TO / DCC.L / DFDS.CO / ECM.L / EIX.N / F.N / FLS.N / FMC.N / FSR.N / GM.N / MAS.N / PD.N / PHM.N / PPG.N / RWEG.DE / SCHN.PA / SO.N / T.N / TOL.N / VC.N / WEIR.L / CONG.DE / CFP.TO / GILD.O / LPX.N / TEN.N / CMCSA.O / AMGN.O / INCY.O / ETR.N / THC.N / CNR.TO / BWA.N / LEA.N / WLK.N / WCC.N / DOV.N / IEX.N / ROP.N / DISH.O / ITP.TO / UNP.N / SIEGn.DE / DV.N / MMM.N / VMC.N / ADCT.N / MGA.N / CONE.O / OLN.N / SHW.N / VZ.N / JCI.N / XEL.N / ARNA.O / APH.N / FISV.O / ADSK.O / V.N / AXL.N / IG.MI / RSG.N / NBIX.O / NWN.N / BC.N / FTS.TO / BMRN.O / REGN.O / VRTX.O / EMA.TO / NCR.N / TEL.N / GPK.N / ALFA.ST / CNP.N / WCN.N / BLU.N / CPK.N / GGG.N / PNR.N / PII.N / ST.N / SKY.N / PLUG.OQ / SGEN.OQ / GPN.N / COA.L / SGSN.S / CCLb.TO / BCRX.O / AMED.O / ICPT.O / EQIX.O / SCHN.S / BIIB.O / NTR.N / NVT.N / MOS.N / BECN.O / DLR.N / ACAD.O / GMS.N / BUCN.S / BLDR.O / LHCG.O / SJW.N / FIS.N / MA.N / MWA.N / HOG.N / H.TO / DAIGn.DE / GETP.PA / DAN.N / TXG.TO / NEE.N / CJT.TO / MTOR.N / XYL.N / EFN.TO / SRPT.O / BERY.N / TPH.N / TSLA.N / ENTA.O / TMUS.N / PTCT.O / DOOR.N / IBP.N / ITCI.O / VRNS.O / 922475108 / SAGE.OQ / AXTA.N / GLPG.O / GBT.OQ / SITE.N / MESO.O / RACE.MI / SCWX.O / ATKR.N / AZRE.N / BBU.N / NTNX.O / ADNT.N / AQN.N / OKTA.OQ / WOW.N / VNTR.N / RHIM.L / ORSTED.CO / AQUA.N / APTV.N / GTES.N / ZS.OQ / SMAR.N / DBX.O / EAF.N / ITRM.O / VNE.N / PRVB.O / ZM.O / MORF.OQ / CRWD.O / DOCU.N / APRE.OQ / CRNC.OQ / EPAC.N / WTRG.N / TFII.N / GFL.N / CARR.N / NKLA.OQ / FOUR.N / MOCORP.HE / ASAN.N / MTCR.O / RIDE.OQ / LSPD.N / DFH.OQ / WFG.N / AFRM.O / PATH.N / TSP.OQ / 9VC.F / PWSC.N / BASE.OQ</td><td class="leftalignment">Air Canada / American Electric Power Company Inc / AES Corp / Autoliv Inc / Crown Holdings Inc / CF Industries Holdings Inc / Cigna Corp / Canadian Pacific Railway Ltd / DCC PLC / DFDS AS / Electrocomponents PLC / Edison International / Ford Motor Co / Flowserve Corp / FMC Corp / Fisker Inc / General Motors Co / Masco Corp / PagerDuty Inc / Pultegroup Inc / PPG Industries Inc / Rwe AG / Schneider Electric SE / Southern Co / AT&T Inc / Toll Brothers Inc / Visteon Corp / Weir Group PLC / Continental AG / Canfor Corp / Gilead Sciences Inc / Louisiana-Pacific Corp / Tenneco Inc / Comcast Corp / Amgen Inc / Incyte Corp / Entergy Corp / Tenet Healthcare Corp / Canadian National Railway Co / Borgwarner Inc / Lear Corp / Westlake Chemical Corp / Wesco International Inc / Dover Corp / IDEX Corp / Roper Technologies Inc / DISH Network Corp / Intertape Polymer Group Inc / Union Pacific Corp / Siemens AG / DoubleVerify Holdings Inc / 3M Co / Vulcan Materials Co / ADC Therapeutics SA / Magna International Inc / CyrusOne Inc / Olin Corp / Sherwin-Williams Co / Verizon Communications Inc / Johnson Controls International PLC / Xcel Energy Inc / Arena Pharmaceuticals Inc / Amphenol Corp / Fiserv Inc / Autodesk Inc / Visa Inc / American Axle & Manufacturing Holdings Inc / Italgas SpA / Republic Services Inc / Neurocrine Biosciences Inc / Northwest Natural Holding Co / Brunswick Corp / Fortis Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Emera Inc / NCR Corp / TE Connectivity Ltd / Graphic Packaging Holding Co / Alfa Laval AB / CenterPoint Energy Inc / Waste Connections Inc / BELLUS Health Inc / Chesapeake Utilities Corp / Graco Inc / Pentair PLC / Polaris Inc / Sensata Technologies Holding PLC / Skyline Champion Corp / Plug Power Inc / Seagen Inc / Global Payments Inc / Coats Group PLC / SGS SA / CCL Industries Inc / BioCryst Pharmaceuticals Inc / Amedisys Inc / Intercept Pharmaceuticals Inc / Equinix Inc / Schindler Holding AG / Biogen Inc / Nutrien Ltd / nVent Electric PLC / Mosaic Co / Beacon Roofing Supply Inc / Digital Realty Trust Inc / ACADIA Pharmaceuticals Inc / GMS Inc / Bucher Industries AG / Builders FirstSource Inc / LHC Group Inc / SJW Group / Fidelity National Information Services Inc / Mastercard Inc / Mueller Water Products Inc / Harley-Davidson Inc / Hydro One Ltd / Daimler AG / Getlink SE / Dana Inc / Torex Gold Resources Inc / Nextera Energy Inc / Cargojet Inc / Meritor Inc / Xylem Inc / Element Fleet Management Corp / Sarepta Therapeutics Inc / Berry Global Group Inc / Tri Pointe Homes Inc (Delaware) / Tesla Inc / Enanta Pharmaceuticals Inc / T-Mobile US Inc / PTC Therapeutics Inc / Masonite International Corp / Installed Building Products Inc / Intra-Cellular Therapies Inc / Varonis Systems Inc / Veeva Systems Inc / SAGE Therapeutics Inc / Axalta Coating Systems Ltd / Galapagos NV / Global Blood Therapeutics Inc / SiteOne Landscape Supply Inc / Mesoblast Ltd / Ferrari NV / SecureWorks Corp / Atkore Inc / Azure Power Global Ltd / Brookfield Business Partners LP / Nutanix Inc / Adient PLC / Algonquin Power & Utilities Corp / Okta Inc / WideOpenWest Inc / Venator Materials PLC / RHI Magnesita NV / Orsted A/S / Evoqua Water Technologies Corp / Aptiv PLC / Gates Industrial Corporation PLC / Zscaler Inc / Smartsheet Inc / Dropbox Inc / GrafTech International Ltd / Iterum Therapeutics PLC / Veoneer Inc / Provention Bio Inc / Zoom Video Communications Inc / Morphic Holding Inc / CrowdStrike Holdings Inc / DocuSign Inc / Aprea Therapeutics Inc / Cerence Inc / Enerpac Tool Group Corp / Essential Utilities Inc / TFI International Inc / GFL Environmental Inc / Carrier Global Corp / Nikola Corp / Shift4 Payments Inc / Metso Outotec Corp / Asana Inc / Metacrine Inc / Lordstown Motors Corp / Lightspeed Commerce Inc / Dream Finders Homes Inc / West Fraser Timber Co Ltd / Affirm Holdings Inc / UiPath Inc / TuSimple Holdings Inc / ATAI Life Sciences NV / PowerSchool Holdings Inc / Couchbase Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Canada / Switzerland / Germany / Denmark / Finland / France / United Kingdom / Ireland / Italy / Mauritius / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">09/07/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">09/07/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">ESMO Congress 2021 Planner</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">031162100 / 75886F107 / 30161Q104 / 00287Y109 / 189464100 / 52187K101 / 87184Q107 / 24344T101 / 00166B105 / 81181C104</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc / Exelixis Inc / Abbvie Inc / Clovis Oncology Inc / Leap Therapeutics Inc / Syros Pharmaceuticals Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Seagen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Joseph Catanzaro, PhD / Mr. Christopher J. Raymond / Edward A. Tenthoff</td></tr>
<tr class="odd"><td class="leftalignment">09/03/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 563</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / John Boyle / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers / Lachlan Hanbury-Brown</td></tr>
<tr class="even"><td class="leftalignment">09/03/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended August 27, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">09/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: September 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">AIRP.PA / ALB.N / AXP.N / BA.N / BAC.N / BAX.N / CB.N / CI.N / CL.N / CNC.N / COF.N / CRM.N / EOG.N / F.N / FDX.N / FMC.N / GM.N / GPS.N / IBM.N / JNJ.N / JPM.N / LLY.N / LMT.N / MDT.N / OXY.N / PFE.N / PM.N / PPCJ.J / RHI.N / SC.N / SLB.N / T.N / TMO.N / U.N / WAT.N / WFC.N / WMT.N / ACI.N / SPG.N / PG.N / HUM.N / NUE.N / CPB.N / HAL.N / DHR.N / UNH.N / IPG.N / SPOT.N / GS.N / CLX.N / VLO.N / HD.N / LOW.N / MRO.N / JWN.N / UPS.N / KR.N / PCG.N / XOM.N / DVN.N / AMT.N / OLN.N / IT.N / TGT.N / VZ.N / HCA.N / WST.N / MUR.N / JCI.N / ORCL.N / VFC.N / V.N / ACN.N / WSM.N / PLD.N / JLL.N / HAE.N / SAM.N / BLK.N / CRL.N / CVX.N / IRM.N / COP.N / INTC.OQ / CTSH.OQ / ADPT.OQ / ADBE.OQ / AMGN.OQ / AAPL.OQ / AMAT.OQ / CSCO.OQ / COHR.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / TEAM.OQ / REGN.OQ / RGEN.OQ / QDEL.OQ / SNPS.OQ / CACC.OQ / QCOM.OQ / INTU.OQ / COST.OQ / INCY.OQ / PENN.OQ / DLTR.OQ / AMED.OQ / PCTY.OQ / CTXS.OQ / STLD.OQ / AMZN.OQ / TTWO.OQ / MRCY.OQ / ERIE.OQ / NVDA.OQ / PLUG.OQ / MTCH.OQ / ISRG.OQ / BLUE.OQ / GRMN.OQ / ARRY.OQ / EXAS.OQ / GPN.N / VRTX.OQ / NFLX.OQ / DKS.N / WYNN.OQ / CMCSA.OQ / TPX.N / SBNY.OQ / ACAD.OQ / EXR.N / MKTX.OQ / MPWR.OQ / LVS.N / NOV.N / DXCM.OQ / MS.N / CMG.N / FIS.N / STX.AX / HES.N / MA.N / IPGP.OQ / AON.N / CLR.N / BX.N / JAZZ.OQ / TDC.N / MRNA.OQ / BIO.N / SWI.N / SCHW.N / FTNT.OQ / MU.OQ / GNRC.N / NEE.N / TSLA.OQ / Z.OQ / AMD.OQ / SLM.OQ / ENPH.OQ / EPAM.N / PSX.N / NOW.N / SRPT.OQ / FANG.OQ / ABBV.N / BLDR.N / RNG.N / COMM.OQ / WIX.OQ / SNOW.N / GOOGL.OQ / PAYC.N / ARES.N / SAGE.OQ / GLOB.N / CTLT.N / HUBS.N / TDOC.N / PYPL.OQ / NVCR.OQ / PSTG.N / IONS.OQ / TWLO.N / COUP.OQ / LW.N / AYX.N / IOVA.OQ / ROKU.OQ / ZS.OQ / FB.PS / STNE.OQ / NFE.OQ / LYFT.OQ / PINS.N / BYND.OQ / ZM.OQ / FSLY.N / PTON.OQ / DDOG.OQ / SPCE.N / LMND.N / GOCO.OQ / AMWL.N / VTRS.OQ / MRVI.OQ / PSFE.N / TSP.OQ / BBWI.N</td><td class="leftalignment">L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Albemarle Corp / American Express Co / Boeing Co / Bank of America Corp / Baxter International Inc / Chubb Ltd / Cigna Corp / Colgate-Palmolive Co / Centene Corp / Capital One Financial Corp / Salesforce.Com Inc / EOG Resources Inc / Ford Motor Co / FedEx Corp / FMC Corp / General Motors Co / Gap Inc / International Business Machines Corp / Johnson & Johnson / JPMorgan Chase & Co / Eli Lilly and Co / Lockheed Martin Corp / Medtronic PLC / Occidental Petroleum Corp / Pfizer Inc / Philip Morris International Inc / PPC Ltd / Robert Half International Inc / Santander Consumer USA Holdings Inc / Schlumberger NV / AT&T Inc / Thermo Fisher Scientific Inc / Unity Software Inc / Waters Corp / Wells Fargo & Co / Walmart Inc / Albertsons Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Humana Inc / Nucor Corp / Campbell Soup Co / Halliburton Co / Danaher Corp / UnitedHealth Group Inc / Interpublic Group of Companies Inc / Spotify Technology SA / Goldman Sachs Group Inc / Clorox Co / Valero Energy Corp / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / Nordstrom Inc / United Parcel Service Inc / Kroger Co / PG&E Corp / Exxon Mobil Corp / Devon Energy Corp / American Tower Corp / Olin Corp / Gartner Inc / Target Corp / Verizon Communications Inc / HCA Healthcare Inc / West Pharmaceutical Services Inc / Murphy Oil Corp / Johnson Controls International PLC / Oracle Corp / VF Corp / Visa Inc / Accenture PLC / Williams-Sonoma Inc / Prologis Inc / Jones Lang LaSalle Inc / Haemonetics Corp / Boston Beer Company Inc / BlackRock Inc / Charles River Laboratories International Inc / Chevron Corp / Iron Mountain Inc / Conocophillips / Intel Corp / Cognizant Technology Solutions Corp / Adaptive Biotechnologies Corp / Adobe Inc / Amgen Inc / Apple Inc / Applied Materials Inc / Cisco Systems Inc / Coherent Inc / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / Atlassian Corporation PLC / Regeneron Pharmaceuticals Inc / Repligen Corp / Quidel Corp / Synopsys Inc / Credit Acceptance Corp / Qualcomm Inc / Intuit Inc / Costco Wholesale Corp / Incyte Corp / Penn National Gaming Inc / Dollar Tree Inc / Amedisys Inc / Paylocity Holding Corp / Citrix Systems Inc / Steel Dynamics Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Mercury Systems Inc / Erie Indemnity Co / NVIDIA Corp / Plug Power Inc / Match Group Inc / Intuitive Surgical Inc / bluebird bio Inc / Garmin Ltd / Array Technologies Inc / Exact Sciences Corp / Global Payments Inc / Vertex Pharmaceuticals Inc / Netflix Inc / DICK'S Sporting Goods Inc / Wynn Resorts Ltd / Comcast Corp / Tempur Sealy International Inc / Signature Bank / ACADIA Pharmaceuticals Inc / Extra Space Storage Inc / Marketaxess Holdings Inc / Monolithic Power Systems Inc / Las Vegas Sands Corp / Nov Inc / Dexcom Inc / Morgan Stanley / Chipotle Mexican Grill Inc / Fidelity National Information Services Inc / Strike Energy Ltd / Hess Corp / Mastercard Inc / IPG Photonics Corp / Aon PLC / Continental Resources Inc / Blackstone Inc / Jazz Pharmaceuticals PLC / Teradata Corp / Moderna Inc / Bio Rad Laboratories Inc / SolarWinds Corp / Charles Schwab Corp / Fortinet Inc / Micron Technology Inc / Generac Holdings Inc / Nextera Energy Inc / Tesla Inc / Zillow Group Inc / Advanced Micro Devices Inc / SLM Corp / Enphase Energy Inc / Epam Systems Inc / Phillips 66 / ServiceNow Inc / Sarepta Therapeutics Inc / Diamondback Energy Inc / Abbvie Inc / Builders FirstSource Inc / RingCentral Inc / CommScope Holding Company Inc / Wix.Com Ltd / Snowflake Inc. / Alphabet Inc / Paycom Software Inc / Ares Management Corp / SAGE Therapeutics Inc / Globant SA / Catalent Inc / HubSpot Inc / Teladoc Health Inc / PayPal Holdings Inc / Novocure Ltd / Pure Storage Inc / Ionis Pharmaceuticals Inc / Twilio Inc / Coupa Software Inc / Lamb Weston Holdings Inc / Alteryx Inc / Iovance Biotherapeutics Inc / Roku Inc / Zscaler Inc / San Miguel Food and Beverage Inc / StoneCo Ltd / New Fortress Energy Inc / Lyft Inc / Pinterest Inc / Beyond Meat Inc / Zoom Video Communications Inc / Fastly Inc / Peloton Interactive Inc / Datadog Inc / Virgin Galactic Holdings Inc / Lemonade Inc / Gohealth Inc / American Well Corp / Viatris Inc / Maravai LifeSciences Holdings Inc / Paysafe Ltd / TuSimple Holdings Inc / Bath & Body Works Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / Luxembourg / Philippines / United States / South Africa / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">09/02/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Biotech Inflows Keep on Rollin'</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">09/02/2021</td><td class="leftalignment">Probes Reporter</td><td class="leftalignment">Watch List: 78 US Companies with Undisclosed SEC Probes</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AAN.N / T.N / AEP.N / BAC.N / CL.N / COF.N / CRM.N / F.N / HLT.N / SLB.N / TMO.N / BEN.N / THC.N / REV.N / ADM.N / VLO.N / UPS.N / KR.N / XOM.N / NKE.N / SNN.N / AMP.N / ARW.N / ATO.N / TWTR.N / TUP.N / OMI.N / CVX.N / TDY.N / AMGN.OQ / CSCO.OQ / COLL.OQ / GNTX.OQ / HBAN.OQ / MGPI.OQ / REGN.OQ / SEIC.OQ / GILD.OQ / COST.OQ / NKTR.OQ / MYGN.OQ / SSNC.OQ / CTXS.OQ / AMZN.OQ / NVDA.OQ / CHTR.OQ / TNP.N / NFLX.OQ / CVGI.OQ / RUSHA.OQ / NDAQ.OQ / THS.N / SPWR.OQ / KOP.N / MA.N / SIX.N / AON.N / BX.N / INO.OQ / BGCP.OQ / UTL.N / SCHW.N / MSI.N / GRPN.OQ / FB.OQ / COTY.N / CTG.OQ / BRX.N / TWOU.OQ / ANTM.N / NTRA.OQ / PFX.N / MFIN.OQ / DXC.N / IQV.N / WELL.N / TLRY.OQ / ALLO.OQ / US29350E1047 / LYFT.O / CTVA.N</td><td class="leftalignment">Aaron's Company Inc / AT&T Inc / American Electric Power Company Inc / Bank of America Corp / Colgate-Palmolive Co / Capital One Financial Corp / Salesforce.Com Inc / Ford Motor Co / Hilton Worldwide Holdings Inc / Schlumberger NV / Thermo Fisher Scientific Inc / Franklin Resources Inc / Tenet Healthcare Corp / Revlon Inc / Archer-Daniels-Midland Co / Valero Energy Corp / United Parcel Service Inc / Kroger Co / Exxon Mobil Corp / Nike Inc / Smith & Nephew PLC / Ameriprise Financial Inc / Arrow Electronics Inc / Atmos Energy Corp / Twitter Inc / Tupperware Brands Corp / Owens & Minor Inc / Chevron Corp / Teledyne Technologies Inc / Amgen Inc / Cisco Systems Inc / Collegium Pharmaceutical Inc / Gentex Corp / Huntington Bancshares Inc / MGP Ingredients Inc / Regeneron Pharmaceuticals Inc / SEI Investments Co / Gilead Sciences Inc / Costco Wholesale Corp / Nektar Therapeutics / Myriad Genetics Inc / SS&C Technologies Holdings Inc / Citrix Systems Inc / Amazon.com Inc / NVIDIA Corp / Charter Communications Inc / Tsakos Energy Navigation Ltd / Netflix Inc / Commercial Vehicle Group Inc / Rush Enterprises Inc / Nasdaq Inc / TreeHouse Foods Inc / SunPower Corp / Koppers Holdings Inc / Mastercard Inc / Six Flags Entertainment Corp / Aon PLC / Blackstone Inc / Inovio Pharmaceuticals Inc / BGC Partners Inc / Unitil Corp / Charles Schwab Corp / Motorola Solutions Inc / Groupon Inc / Meta Platforms Inc / Coty Inc / Computer Task Group Inc / Brixmor Property Group Inc / 2U Inc / Anthem Inc / Natera Inc / PhenixFIN Corp / Medallion Financial Corp / DXC Technology Co / IQVIA Holdings Inc / Welltower Inc / Tilray Brands Inc / Allogene Therapeutics Inc / Enochian Biosciences Inc / Lyft Inc / Corteva Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / United Kingdom / Greece / Ireland / United States / Curaçao</td><td class="leftalignment">Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Chemicals / Consumer / Defense / Electronics / Financial Services / Food / Healthcare / Household Products / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Technology / Telecommunications / Transportation / Utilities / Wholesale / Oil & Gas</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">09/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for AMGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">08/31/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Monthly Update - Monthly: Amgen (AMGN: $225.53) wipes off $9 billion in MCap in August, highest loser in Medical/Biomedical sector</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">08/31/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Preliminary Signs of Domestic Inflection, Awaiting Return to School Impact, Fall Seasonality, and Booster Rollout</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">08/30/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Aug 20, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">08/30/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - August 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AEP.N / AES.N / ALV.N / CMS.N / CRM.N / EIX.N / EL.N / F.N / FSR.N / GM.N / KO.N / PD.N / SO.N / VC.N / TEN.N / AMGN.O / DUK.N / BWA.N / LEA.N / K.N / CLX.N / PCG.N / EPC.N / ADCT.N / CONE.O / EXEL.O / XEL.N / ARNA.O / STZ.N / CINF.O / APH.N / FISV.O / ADSK.O / AXL.N / NWN.N / BC.N / BMRN.O / REGN.O / ENR.N / FTT.TO / NCR.N / TEL.N / CPK.N / MKL.N / PII.N / RLI.N / ST.N / PLUG.OQ / GPN.N / CASY.O / ATDb.TO / TIH.TO / DLR.N / WAL.N / SJW.N / FIS.N / HOG.N / BGS.N / DAN.N / WRB.N / SPB.N / NEE.N / NXT.AX / MTOR.N / FFHu.TO / TSLA.N / COTY.N / BEP.N / AGIO.O / RACE.MI / ADNT.N / OKTA.OQ / AY.O / APTV.N / VNE.N / ZM.O / CRWD.O / CRNC.OQ / WTRG.N / NKLA.OQ / FOUR.N / MGNI.OQ / RIDE.OQ / LSPD.N / AFRM.O / TSP.OQ / OTLY.O / RYAN.N / PWSC.N</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Autoliv Inc / CMS Energy Corp / Salesforce.Com Inc / Edison International / Estee Lauder Companies Inc / Ford Motor Co / Fisker Inc / General Motors Co / Coca-Cola Co / PagerDuty Inc / Southern Co / Visteon Corp / Tenneco Inc / Amgen Inc / Duke Energy Corp / Borgwarner Inc / Lear Corp / Kellogg Co / Clorox Co / PG&E Corp / Edgewell Personal Care Co / ADC Therapeutics SA / CyrusOne Inc / Exelixis Inc / Xcel Energy Inc / Arena Pharmaceuticals Inc / Constellation Brands Inc / Cincinnati Financial Corp / Amphenol Corp / Fiserv Inc / Autodesk Inc / American Axle & Manufacturing Holdings Inc / Northwest Natural Holding Co / Brunswick Corp / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Finning International Inc / NCR Corp / TE Connectivity Ltd / Chesapeake Utilities Corp / Markel Corp / Polaris Inc / Rli Corp / Sensata Technologies Holding PLC / Plug Power Inc / Global Payments Inc / Caseys General Stores Inc / Alimentation Couche-Tard Inc / Toromont Industries Ltd / Digital Realty Trust Inc / Western Alliance Bancorp / SJW Group / Fidelity National Information Services Inc / Harley-Davidson Inc / B&G Foods Inc / Dana Inc / W R Berkley Corp / Spectrum Brands Holdings Inc / Nextera Energy Inc / NEXTDC Ltd / Meritor Inc / Fairfax Financial Holdings Ltd / Tesla Inc / Coty Inc / Brookfield Renewable Partners LP / Agios Pharmaceuticals Inc / Ferrari NV / Adient PLC / Okta Inc / Atlantica Sustainable Infrastructure PLC / Aptiv PLC / Veoneer Inc / Zoom Video Communications Inc / CrowdStrike Holdings Inc / Cerence Inc / Essential Utilities Inc / Nikola Corp / Shift4 Payments Inc / Magnite Inc / Lordstown Motors Corp / Lightspeed Commerce Inc / Affirm Holdings Inc / TuSimple Holdings Inc / Oatly Group AB / Ryan Specialty Group Holdings Inc / PowerSchool Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / United Kingdom / Ireland / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">08/28/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Mackay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / ADCT.N / EXEL.O / ARNA.O / REGN.O / AGIO.O</td><td class="leftalignment">Amgen Inc / ADC Therapeutics SA / Exelixis Inc / Arena Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Agios Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="even"><td class="leftalignment">08/27/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Amgen Inc.</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">08/27/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 562</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">08/27/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended August 20, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">08/27/2021</td><td class="leftalignment">Vermilion Technical Research</td><td class="leftalignment">Short Shots - Charts highlighted: ATI, AEM, NEM, MKSI, BLBD, BWA, CMCO, MOD, ENS, IEP, IIVI, AJRD, LMT, BRKS, HMC, IRBT, ATVI, TTTWO, VITL, RPM,.SBTX, RDY, AMGN, BAX, CPB, CAG, GIS, KHC, UTZ, CL, and CENTA</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">AMGN.OQ / AEM.TO / AJRD.N / ATVI.OQ / BAX.N / BLBD.OQ / BRKS.OQ / BWA.N / CAG.N / CENT.OQ / CL.N / CMCO.OQ / CPB.N / ENS.N / IEP.OQ / IIVI.OQ / IRBT.OQ / KHC.OQ / LMT.N / MKSI.OQ / MOD.N / NEM.N / RPM.N / ATI.N / UTZ.N / RDY.CD</td><td class="leftalignment">Amgen Inc / Agnico Eagle Mines Ltd / Aerojet Rocketdyne Holdings Inc / Activision Blizzard Inc / Baxter International Inc / Blue Bird Corp / Azenta Inc / Borgwarner Inc / Conagra Brands Inc / Central Garden & Pet Co / Colgate-Palmolive Co / Columbus McKinnon Corp / Campbell Soup Co / EnerSys / Icahn Enterprises LP / II-VI Inc / iRobot Corp / Kraft Heinz Co / Lockheed Martin Corp / MKS Instruments Inc / Modine Manufacturing Co / Newmont Corporation / RPM International Inc / Allegheny Technologies Inc / UTZ Brands Inc / Ready Set Gold Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">STRATEGY / TECHNICAL ANALYSIS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">David P. Nicoski, CMT</td></tr>
<tr class="even"><td class="leftalignment">08/27/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">08/26/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Biotech Inflows Come Roaring Back</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">08/26/2021</td><td class="leftalignment">Crispidea</td><td class="leftalignment">Amgen Inc. iAMGN) - Competition in biosimilars</td><td class="leftalignment">English</td><td class="rightalignment">42</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">RESEARCH OVERVIEW</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / ASSET MANAGEMENT / CAPITALIZATION / EARNINGS/FINANCIAL STATEMENTS / MERGER/ACQUISITION/DIVESTITURE / MISCELLANEOUS / CHANGE IN RECOMMENDATION / GROWTH</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Rimi Murarka / Ms. Shejal Ajmera</td></tr>
<tr class="odd"><td class="leftalignment">08/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">V / 2516152 / 2023607 / 2486813 / 2065159 / 2942605 / 2280220 / 2270726 / 2542049 / 2317087 / 2576941 / 2670519 / 2328915 / 2342034 / 2459020 / 2689560 / 2048804 / 2503529 / 2822019 / B125XQ6 / B0T7YX2 / B28TS42 / B03PGL4 / 2982924 / B4N0JJ6 / B7TL820 / B7VD3F2 / BBPK0J0 / BVVN4Q8 / BFZ1K46 / BMYML02 / BJJMGL2 / BYXJQG9 / BKTNTR9 / BYQHPK7 / BYYWPW6 / BL95N25 / BZ1LFG7 / BDZ30Q0 / BMPRZV5 / BD72R64 / BNTB3N8 / BP7KZP7</td><td class="leftalignment">Visa Inc / Eli Lilly and Co / Amgen Inc / Kellogg Co / Autodesk Inc / Avista Corp / DTE Energy Co / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Exelixis Inc / Exelon Corp / Nextera Energy Inc / Fiserv Inc / Intuit Inc / PG&E Corp / Pinnacle West Capital Corp / World Wrestling Entertainment Inc / Advance Auto Parts Inc / Portland General Electric Co / Live Nation Entertainment Inc / Ulta Beauty Inc / NorthWestern Corp / Spectrum Pharmaceuticals Inc / Visteon Corp / Meta Platforms Inc / Duke Energy Corp / Mirati Therapeutics Inc / Eversource Energy / Spotify Technology SA / DraftKings Inc / Fox Corp / Spire Inc / ViacomCBS Inc / Zymeworks Inc / Beigene Ltd / Phibro Animal Health Corp / Roku Inc / Arvinas Inc / Kymera Therapeutics Inc / Liberty Media Corp / Vizio Holding Corp / Monte Rosa Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">08/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for AMGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">08/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Aug 13</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">08/24/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">EGRX-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">EGRX.O / BMY / JNJ / LLY / NVS / AMGN.O / GSK / TEVA.K</td><td class="leftalignment">Eagle Pharmaceuticals Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Amgen Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/24/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Short Interest in Biotechnology Stocks</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US0311621009 / US3755581036 / US75886F1075 / US92532F1003 / US7665596034 / US02043Q1076 / US40637H1095 / US09609G1004 / US45845P1084 / US31189P1021 / US03820J1007 / US92686J1060 / US09627Y1091 / US4622221004 / US5588681057 / US03753U1060 / US2997341035 / US80706P1030 / US76029N1063 / US04335A1051 / US2936141033 / US50015M1099 / US85789A1051 / US62921N1054 / US61775R1059 / US30205M1018 / US80810D1037 / US12529R1077 / CA00288U1066 / US67080N1019 / US24343R1068</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Rigel Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Halozyme Therapeutics Inc / bluebird bio Inc / Intercept Pharmaceuticals Inc / Fate Therapeutics Inc / Applied Genetic Technologies Corp / Viking Therapeutics Inc / Blueprint Medicines Corp / Ionis Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Evelo Biosciences Inc / Scholar Rock Holding Corp / Replimune Group Inc / Arvinas Inc / Entasis Therapeutics Holdings Inc / Kodiak Sciences Inc / Stealth BioTherapeutics Corp / NGM Biopharmaceuticals Inc / Morphic Holding Inc / Exicure Inc / Schrodinger Inc / C4 Therapeutics Inc / Abcellera Biologics Inc / Nuvation Bio Inc / Decibel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Matthew Luchini / Nick Lenard / Jin Lee</td></tr>
<tr class="even"><td class="leftalignment">08/24/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">CTIC-US - Fundamental Analysis, for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">CTIC.O / BAX / BMY / LLY / NVS / AMGN.O / INCY.O / TEVA.K</td><td class="leftalignment">CTI Biopharma Corp / Baxter International Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Novartis AG / Amgen Inc / Incyte Corp / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/24/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Event analysis 3: Packed schedule of events, focus on new drug-related events</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4528.T / 4543.T / 4516.T / 4506.T / 4536.T / 4151.T / AMGN.OQ / SGEN.OQ / 4568.T</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / Amgen Inc / Seagen Inc / Daiichi Sankyo Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">08/24/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: イベントアナリシス③：これからイベント目白押し、新薬関連のイベントに注目</td><td class="leftalignment">Japanese</td><td class="rightalignment">6</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4528.T / 4543.T / 4516.T / 4506.T / 4536.T / 4151.T / AMGN.OQ / SGEN.OQ / 4568.T</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / Amgen Inc / Seagen Inc / Daiichi Sankyo Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">08/23/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Aug 13, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">08/22/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Amgen Inc: Ownership Timelines & Shareholder Analytics (August 2021)</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">08/20/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MRK-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK / ABT / BMY / JNJ / LLY / NVS / PFE / AMGN.O / GSK / TEVA.K / SNY.O</td><td class="leftalignment">Merck & Co Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/20/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 561</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">08/20/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--August 20, 2021</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">4502.T / ACA / AMN / BSX / CHE / CI / CNC / CRY.N / CVS / HUM / IVC / MDT / RAD / ROG / SYK / UNH / WMT / GILD.O / AMGN.O / NOVN.S / HCA.N / CYH.N / EW.N / SSNC.O / ISR / SRDX.O / NOVN.OQ / EPIX.OQ / ICPT.OQ / ISRG.OQ / CCRN.O / ICAD.O / AMED.O / EXAS.O / BIIB.O / 478160104 / 00846U101 / 868168105 / ANGO.OQ / MBRX.OQ / ATRC.OQ / LHCG.O / BLRX.TA / ENSG.OQ / 483548103 / MRNA.O / MD.N / 771195104 / CSII.O / ADUS.O / USPH.N / MDXG.O / AXGN.O / FATE.OQ / GOOGL.O / CBAY.OQ / MRNS.O / VBLT.O / CATB.OQ / EVH.N / TDOC.N / ZBH.N / SPNE.O / 100063846 / SSKN.OQ / VREX.OQ / 45780L104 / IPIX.PK / MBIO.OQ / CUE.OQ / 720795103 / MOTS.O / ORTX.OQ / SWAV.O / BWAY.TA / FREQ.OQ / PNTG.OQ / APRE.O / VERO.O / ETNB.O / AYLA.O / FMTX.O / NNOX.O / 03823M100 / N69603145</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Arcosa Inc / AMN Healthcare Services Inc / Boston Scientific Corp / Chemed Corp / Cigna Corp / Centene Corp / CryoLife Inc / CVS Health Corp / Humana Inc / Invacare Corp / Medtronic PLC / Rite Aid Corp / Rogers Corp / Stryker Corp / UnitedHealth Group Inc / Walmart Inc / Gilead Sciences Inc / Amgen Inc / Novartis AG / HCA Healthcare Inc / Community Health Systems Inc / Edwards Lifesciences Corp / SS&C Technologies Holdings Inc / IsoRay Inc / Surmodics Inc / Novan Inc / ESSA Pharma Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / Cross Country Healthcare Inc / ICAD Inc / Amedisys Inc / Exact Sciences Corp / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / AngioDynamics Inc / Moleculin Biotech Inc / AtriCure Inc / LHC Group Inc / BioLine RX Ltd / Ensign Group Inc / Kaman Corp / Moderna Inc / MEDNAX Inc / Roche Holding AG / Cardiovascular Systems Inc / Addus Homecare Corp / US Physical Therapy Inc / MiMedx Group Inc / AxoGen Inc / Fate Therapeutics Inc / Alphabet Inc / Cymabay Therapeutics Inc / Marinus Pharmaceuticals Inc / Vascular Biogenics Ltd / Astria Therapeutics Inc / Evolent Health Inc / Teladoc Health Inc / Zimmer Biomet Holdings Inc / SeaSpine Holdings Corp / Truist Financial Corp / STRATA Skin Sciences Inc / Varex Imaging Corp / Inogen Inc / Innovation Pharmaceuticals Inc / Mustang Bio Inc / Cue Biopharma Inc / Pieris Pharmaceuticals Inc / Motus GI Holdings Inc / Orchard Therapeutics PLC / Shockwave Medical Inc / Brainsway Ltd / Frequency Therapeutics Inc / Pennant Group Inc / Aprea Therapeutics Inc / Venus Concept Inc / 89Bio Inc / Ayala Pharmaceuticals Inc / Forma Therapeutics Holdings Inc / Nano-X Imaging Ltd / Applied Minerals Inc / Pharming Group NV</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / United Kingdom / Ireland / Israel / Japan / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/20/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended August 13, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">08/20/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Matthew Luchini / Nick Lenard / Jin Lee</td></tr>
<tr class="even"><td class="leftalignment">08/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">08/19/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Another Week, Another Outflow - Fund Flow Stays Negative This Week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">08/19/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">INTC.O / IVC / MSFT.O / QCOM.O / ROG / SYK / AMGN.O / NVDA.O / HEAR.O / MPWR.O / SMTC.O / AVGO.O / CSCO.OQ / CRUS.OQ / ATVI.OQ / NOVN.OQ / XLNX.OQ / TTWO.OQ / ADS.N / SWKS.OQ / TXN.OQ / EXAS.O / NFLX.O / BIIB.O / 478160104 / 00846U101 / 36467W109 / BLRX.TA / 514766104 / MRNA.O / 771195104 / NXPI.O / AMD.OQ / ZNGA.O / EA.O / ADI.OQ / FDEV.L / 82655M107 / CBAY.OQ / ZBH.N / 45780L104 / IPIX.PK / BILI.O / APRE.O / DKNG.O / 84764T304 / HUYA.K / 03823M100</td><td class="leftalignment">Intel Corp / Invacare Corp / Microsoft Corp / Qualcomm Inc / Rogers Corp / Stryker Corp / Amgen Inc / NVIDIA Corp / Turtle Beach Corp / Monolithic Power Systems Inc / Semtech Corp / Broadcom Inc / Cisco Systems Inc / Cirrus Logic Inc / Activision Blizzard Inc / Novan Inc / Xilinx Inc / Take-Two Interactive Software Inc / Alliance Data Systems Corp / Skyworks Solutions Inc / Texas Instruments Inc / Exact Sciences Corp / Netflix Inc / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / GameStop Corp / BioLine RX Ltd / Landec Corp / Moderna Inc / Roche Holding AG / NXP Semiconductors NV / Advanced Micro Devices Inc / Zynga Inc / Electronic Arts Inc / Analog Devices Inc / Frontier Developments PLC / Sify Technologies Ltd / Cymabay Therapeutics Inc / Zimmer Biomet Holdings Inc / Inogen Inc / Innovation Pharmaceuticals Inc / Bilibili Inc / Aprea Therapeutics Inc / DraftKings Inc / Speed Commerce Inc / HUYA Inc / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United Kingdom / India / Israel / Japan / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/19/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Key products increased by 2-3%; Otezla +2.4% since Jan 2021</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AMGN=US</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">08/18/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">CHRS-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">CHRS.O / AMGN.O / ARNA.O / RGEN.O / ACOR.O</td><td class="leftalignment">Coherus BioSciences Inc / Amgen Inc / Arena Pharmaceuticals Inc / Repligen Corp / Acorda Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/18/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Precision Targeting for the Guardian of the Genome; Initiate at Perform</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">PMVP / ROG / AMGN.O / NOVN.OQ / EXAS.O / 478160104 / 00846U101 / 771195104 / IPIX.PK / APRE.O / 03823M100</td><td class="leftalignment">PMV Pharmaceuticals Inc / Rogers Corp / Amgen Inc / Novan Inc / Exact Sciences Corp / Johnson & Johnson / Agilent Technologies Inc / Roche Holding AG / Innovation Pharmaceuticals Inc / Aprea Therapeutics Inc / Applied Minerals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Jeff M. Jones, Ph.D. / Leland Gershell, MD, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">08/18/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">As We Expected, Q2 Beats and Raises for Biopharma and Stocks Now Repricing</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">71708110 / 92532F10 / 37555810 / 03116210 / 75886F10 / 00287Y10 / G3910J11 / F5548N10</td><td class="leftalignment">Pfizer Inc / Vertex Pharmaceuticals Inc / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Na Sun</td></tr>
<tr class="odd"><td class="leftalignment">08/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">QURE-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">QURE.O / AMGN.O / SGMO.O / BMRN.O / BLUE.O / RNA.O / SNY.O</td><td class="leftalignment">Uniqure NV / Amgen Inc / Sangamo Therapeutics Inc / Biomarin Pharmaceutical Inc / bluebird bio Inc / Avidity Biosciences Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">LGND-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">LGND.O / BAX / BMY / JNJ / LLY / MRK / PFE / AMGN.O / GSK / SPPI.O</td><td class="leftalignment">Ligand Pharmaceuticals Inc / Baxter International Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Spectrum Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">XNCR-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">XNCR.O / JNJ / MRK / AMGN.O / SGEN.O / ABBV.K / MGNX.O</td><td class="leftalignment">Xencor Inc / Johnson & Johnson / Merck & Co Inc / Amgen Inc / Seagen Inc / Abbvie Inc / MacroGenics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/17/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">How Big Is the Mid-2020’s LOE Problem? Are More Deals Coming?</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">03116210</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun / Anna Baran, CFA</td></tr>
<tr class="odd"><td class="leftalignment">08/17/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Delta Continues to Drive Domestic and Global Growth; Early Signs From Back to School in Low Vaccination Areas Concerning</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">08/17/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Will Amgen Inc Deliver Long-Term Returns?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="odd"><td class="leftalignment">08/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Aug 6, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">08/16/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Amgen Inc.(AMGN) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">031162100</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">08/16/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">BioInsights Virtual West Coast Bus Tour Roundup</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">031162100 / 64125C109 / 881624209 / 09061G101 / 90400D108 / 462260100 / 98401F105 / 37890U108 / 29668H708 / 03969T109 / 74366E102 / 00166B105 / 73730P108 / 50107A104 / 25056L103</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Teva Pharmaceutical Industries Ltd / Biomarin Pharmaceutical Inc / Ultragenyx Pharmaceutical Inc / Iovance Biotherapeutics Inc / Xencor Inc / Global Blood Therapeutics Inc / ESSA Pharma Inc / Arcturus Therapeutics Holdings Inc / Protagonist Therapeutics Inc / ALX Oncology Holdings Inc / Poseida Therapeutics Inc / Kronos Bio Inc / Design Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Germany / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">David A. Amsellem / Joseph Catanzaro, PhD / Yasmeen Rahimi, Ph.D. / Mr. Christopher J. Raymond / Edward A. Tenthoff</td></tr>
<tr class="even"><td class="leftalignment">08/16/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">2Q Update: Third Asset (PI3Kα) Moving Closer to Clinic</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">75943R102 / 45337C10 / 03116210 / 60468T105</td><td class="leftalignment">Relay Therapeutics Inc / Incyte Corp / Amgen Inc / Mirati Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Silvan Tuerkcan</td></tr>
<tr class="odd"><td class="leftalignment">08/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for AMGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">08/13/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 560</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">08/13/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">The Weekender</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">45337C10 / 03116210 / 09058V10 / 00422510 / 40637H10 / 84763A108 / 29251M106 / M25722105 / 23282W605 / 89620X506 / 98978L204 / 60468T105 / 45845P108 / 09627Y109 / 81750R102 / 29604W108 / 29664W105 / 462260100 / 45826J105 / 040047607 / 558868105 / 23306J101 / 12648L601 / 89532E109 / 603380106 / 54142F102 / 019770106 / H17182108 / 67576A100 / 483347100 / 299734103 / 90041T108 / 22053A107 / 088786108 / 50127T109 / 04016X101 / 87184Q107 / 185063104 / 869367102 / 65343E108 / 37148K100 / 02155H200 / 24344T101 / 48576A100 / 74366E102 / 75943R102 / 03843E104 / 43906K100 / 03824M109 / 74017N105 / 56854Q200 / 81181C104 / 21900C308 / 517125100 / 877619106 / 07160F107 / 007002108 / M47364100 / 617760202 / N71542109 / 45168K405 / 206022105 / 92790C104 / 76200L309</td><td class="leftalignment">Incyte Corp / Amgen Inc / BioCryst Pharmaceuticals Inc / ACADIA Pharmaceuticals Inc / Halozyme Therapeutics Inc / Spectrum Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Compugen Ltd / Cytokinetics Inc / Pfizer Inc / Zogenix Inc / Mirati Therapeutics Inc / Intercept Pharmaceuticals Inc / Blueprint Medicines Corp / Seres Therapeutics Inc / Erytech Pharma SA / Esperion Therapeutics Inc / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Arena Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / DBV Technologies SA / CTI Biopharma Corp / Trevena Inc / Minerva Neurosciences Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Ocular Therapeutix Inc / Kaleido Biosciences Inc / Evelo Biosciences Inc / Turning Point Therapeutics Inc / Cortexyme Inc / Bicycle Therapeutics PLC / Kura Oncology Inc / argenx SE / Syros Pharmaceuticals Inc / Clearside Biomedical Inc / Sutro Biopharma Inc / NextCure Inc / Generation Bio Co / Altimmune Inc / Deciphera Pharmaceuticals Inc / Karuna Therapeutics Inc / Protagonist Therapeutics Inc / Relay Therapeutics Inc / Aquestive Therapeutics Inc / HOOKIPA Pharma Inc / Applied Molecular Transport Inc. / Precigen Inc / Marinus Pharmaceuticals Inc / Seagen Inc / CorMedix Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Baudax Bio Inc / Adicet Bio Inc / Gamida Cell Ltd / MorphoSys AG / ProQR Therapeutics NV / Idera Pharmaceuticals Inc / Concert Pharmaceuticals Inc / Viridian Therapeutics Inc / Rezolute Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Reni J. J. Benjamin, PhD, PHD / Mr. Jason N. N. Butler, PhD, PHD / Mr. Silvan Tuerkcan / Mr. Jonathan P. Wolleben / Mr. Roy Buchanan, PhD, PHD / Mr. Gobind Singh, MD, PhD</td></tr>
<tr class="even"><td class="leftalignment">08/13/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended August 6, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">08/13/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--August 13, 2021</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">4502.T / ACA / AMN / BAX / BSX / CHE / CI / CNC / CVS / HUM / KR / MDT / RAD / UNH / WMT / ACI.N / GILD.O / AMGN.O / NOVN.S / RMD.N / HCA.N / CYH.N / INSP.N / EW.N / SSNC.O / ICPT.OQ / UTHR.OQ / EXEL.OQ / ISRG.OQ / BLUE.OQ / VRTX.OQ / CCRN.O / LIFE.O / AMED.O / EXAS.O / BIIB.O / 478160104 / 00846U101 / 868168105 / MBRX.OQ / MNKD.O / ATRC.OQ / LHCG.O / CYCC.OQ / B8FGn.DE / ALCLS.PA / 02043Q107 / ENSG.OQ / 483548103 / TMDX.OQ / BBI.O / MD.N / 771195104 / ADUS.O / SVA.O / USPH.N / GLAXOSM.LG / ENTA.O / PRTA.OQ / MRTX.OQ / FATE.OQ / TRVN.O / GOOGL.O / MDWD.O / 02005N100 / CASI.OQ / XENT.OQ / CLRB.OQ / MRNS.O / INO.O / VCEL.O / EVH.N / TDOC.N / GKOS.K / MMD.WA / APLS.OQ / 100063846 / IONS.OQ / FLGT.OQ / MDGL.O / SRRA.O / PLXP.O / IOVA.OQ / ALPN.O / VERU.OQ / ACHV.O / MTEM.O / SVRA.O / SYBX.O / FIXX.OQ / 720795103 / ALLO.OQ / MRKR.OQ / SWAV.O / PDSB.OQ / 21833P103 / BWAY.TA / TPTX.O / ORGO.O / IDYA.OQ / ONCT.OQ / BCYC.O / XAIR.OQ / PNTG.OQ / RLMD.OQ / ORIC.OQ / HGEN.O / NNOX.O</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Arcosa Inc / AMN Healthcare Services Inc / Baxter International Inc / Boston Scientific Corp / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Kroger Co / Medtronic PLC / Rite Aid Corp / UnitedHealth Group Inc / Walmart Inc / Albertsons Companies Inc / Gilead Sciences Inc / Amgen Inc / Novartis AG / Resmed Inc / HCA Healthcare Inc / Community Health Systems Inc / Inspire Medical Systems Inc / Edwards Lifesciences Corp / SS&C Technologies Holdings Inc / Intercept Pharmaceuticals Inc / United Therapeutics Corp / Exelixis Inc / Intuitive Surgical Inc / bluebird bio Inc / Vertex Pharmaceuticals Inc / Cross Country Healthcare Inc / aTyr Pharma Inc / Amedisys Inc / Exact Sciences Corp / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / Moleculin Biotech Inc / MannKind Corp / AtriCure Inc / LHC Group Inc / Cyclacel Pharmaceuticals Inc / Biofrontera AG / Cellectis SA / Alnylam Pharmaceuticals Inc / Ensign Group Inc / Kaman Corp / Transmedics Group Inc / Brickell Biotech Inc / MEDNAX Inc / Roche Holding AG / Addus Homecare Corp / Sinovac Biotech Ltd / US Physical Therapy Inc / Glaxo Smithkline Consumer Nigeria PLC / Enanta Pharmaceuticals Inc / Prothena Corporation PLC / Mirati Therapeutics Inc / Fate Therapeutics Inc / Trevena Inc / Alphabet Inc / Mediwound Ltd / Ally Financial Inc / CASI Pharmaceuticals Inc / Intersect Ent Inc / Cellectar Biosciences Inc / Marinus Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / Vericel Corp / Evolent Health Inc / Teladoc Health Inc / Glaukos Corp / Milestone Medical Inc / Apellis Pharmaceuticals Inc / Truist Financial Corp / Ionis Pharmaceuticals Inc / Fulgent Genetics Inc / Madrigal Pharmaceuticals Inc / Sierra Oncology Inc / PLx Pharma Inc / Iovance Biotherapeutics Inc / Alpine Immune Sciences Inc / Veru Inc / Achieve Life Sciences Inc / Molecular Templates Inc / Savara Inc / Synlogic Inc / Homology Medicines Inc / Pieris Pharmaceuticals Inc / Allogene Therapeutics Inc / Marker Therapeutics Inc / Shockwave Medical Inc / PDS Biotechnology Corp / Corbus Pharmaceuticals Holdings Inc / Brainsway Ltd / Turning Point Therapeutics Inc / Organogenesis Holdings Inc / IDEAYA Biosciences Inc / Oncternal Therapeutics Inc / Bicycle Therapeutics PLC / Beyond Air Inc / Pennant Group Inc / Relmada Therapeutics Inc / Oric Pharmaceuticals Inc / Humanigen Inc / Nano-X Imaging Ltd</td><td class="leftalignment"></td><td class="leftalignment">Antigua and Barbuda / Switzerland / Germany / France / United Kingdom / Ireland / Israel / Japan / Nigeria / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/13/2021</td><td class="leftalignment">Argus Research Corporation</td><td class="leftalignment">Argus Analyst Report, AMGN</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AMGN</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / COMPANY UPDATE / COMPANY REPORT / ESTIMATE CHANGES / PRICE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David H. Toung</td></tr>
<tr class="odd"><td class="leftalignment">08/13/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">08/13/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - August 13, 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AEP.N / AES.N / BAC.N / BK.N / BOX.N / C.N / CMS.N / CNA.L / COF.N / ED.N / EIX.N / EL.N / EOG.N / FITB.O / JPM.N / KEY.N / KMB.N / NTRS.O / PEG.N / PNC.N / PNW.N / SGEF.PA / SO.N / USB.N / WFC.N / CMA.N / PXD.N / WLL.N / AMGN.O / ETR.N / DUK.N / DIS.N / HBAN.O / D.N / FE.N / PNM.N / K.N / GS.N / MRO.N / PCG.N / PPL.N / DVN.N / RKT.N / STT.N / HCA.N / CYH.N / XEL.N / SRE.N / EXC.N / RRC.N / EQT.N / NLY.N / AWK.N / NWN.N / MTB.N / REGN.O / SWIR.O / SM.N / GFI.N / RF.N / COP.N / CNP.N / CPE.N / BKH.N / CPK.N / FRC.N / SWN.N / SR.N / CRC.N / SEM.N / SIVB.O / AMED.O / TFC.N / BAM.N / SJW.N / BKD.N / MS.N / CLR.N / BIP.N / NOG.A / UTL.N / ADUS.OQ / SPB.N / NEE.N / PEY.TO / TWO.N / MTDR.N / ACHC.O / FANG.O / COTY.N / BEP.N / ARES.N / NEP.N / SAGE.OQ / CFG.N / SGRY.O / BBU.N / AQN.N / PVAC.O / CDEV.O / ESTE.N / VST.N / WPM.N / ORSTED.CO / AY.O / CWEN.N / NWL.O / FIXX.O / APRE.OQ / PNTG.OQ / ETNB.O / OAS.OQ / AZEK.N / WTRG.N / SBSW.N / IGIC.OQ / APA.OQ / PLTR.N / GDRX.O / TLMD.OQ / SHC.OQ / ABNB.OQ / DASH.N / CHK.OQ / OTLY.O / FA.OQ / XMTR.OQ</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Bank of America Corp / Bank of New York Mellon Corp / Box Inc / Citigroup Inc / CMS Energy Corp / Centrica PLC / Capital One Financial Corp / Consolidated Edison Inc / Edison International / Estee Lauder Companies Inc / EOG Resources Inc / Fifth Third Bancorp / JPMorgan Chase & Co / KeyCorp / Kimberly-Clark Corp / Northern Trust Corp / Public Service Enterprise Group Inc / PNC Financial Services Group Inc / Pinnacle West Capital Corp / Vinci SA / Southern Co / US Bancorp / Wells Fargo & Co / Comerica Inc / Pioneer Natural Resources Co / Whiting Petroleum Corp / Amgen Inc / Entergy Corp / Duke Energy Corp / Walt Disney Co / Huntington Bancshares Inc / Dominion Energy Inc / FirstEnergy Corp / PNM Resources Inc / Kellogg Co / Goldman Sachs Group Inc / Marathon Oil Corp / PG&E Corp / PPL Corp / Devon Energy Corp / Rocket Companies Inc / State Street Corp / HCA Healthcare Inc / Community Health Systems Inc / Xcel Energy Inc / Sempra Energy / Exelon Corp / Range Resources Corp / EQT Corp / Annaly Capital Management Inc / American Water Works Company Inc / Northwest Natural Holding Co / M&T Bank Corp / Regeneron Pharmaceuticals Inc / Sierra Wireless Inc / SM Energy Co / Gold Fields Ltd / Regions Financial Corp / Conocophillips / CenterPoint Energy Inc / Callon Petroleum Co / Black Hills Corp / Chesapeake Utilities Corp / First Republic Bank / Southwestern Energy Co / Spire Inc / California Resources Corp / Select Medical Holdings Corp / SVB Financial Group / Amedisys Inc / Truist Financial Corp / Brookfield Asset Management Inc / SJW Group / Brookdale Senior Living Inc / Morgan Stanley / Continental Resources Inc / Brookfield Infrastructure Partners LP / Northern Oil and Gas Inc / Unitil Corp / Addus Homecare Corp / Spectrum Brands Holdings Inc / Nextera Energy Inc / Peyto Exploration & Development Corp / Two Harbors Investment Corp / Matador Resources Co / Acadia Healthcare Company Inc / Diamondback Energy Inc / Coty Inc / Brookfield Renewable Partners LP / Ares Management Corp / Nextera Energy Partners LP / SAGE Therapeutics Inc / Citizens Financial Group Inc / Surgery Partners Inc / Brookfield Business Partners LP / Algonquin Power & Utilities Corp / Ranger Oil Corp / Centennial Resource Development Inc / Earthstone Energy Inc / Vistra Corp / Wheaton Precious Metals Corp / Orsted A/S / Atlantica Sustainable Infrastructure PLC / Clearway Energy Inc / Newell Brands Inc / Homology Medicines Inc / Aprea Therapeutics Inc / Pennant Group Inc / 89Bio Inc / Oasis Petroleum Inc / Azek Company Inc / Essential Utilities Inc / Sibanye Stillwater Ltd / International General Insurance Holdings Ltd / APA Corp (US) / Palantir Technologies Inc / Goodrx Holdings Inc / Soc Telemed Inc / Sotera Health Co / Airbnb Inc / DoorDash Inc / Chesapeake Energy Corp / Oatly Group AB / First Advantage Corp / Xometry Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Denmark / France / United Kingdom / Sweden / United States / South Africa</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">08/12/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">EXEL-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">EXEL.O / BMY / JNJ / MRK / PFE / AMGN.O / GSK / CRIS.O / AVEO.O / SNY.O</td><td class="leftalignment">Exelixis Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Curis Inc / Aveo Pharmaceuticals Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/12/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">KNBWY-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">KNBWY.PK / BUD / CCU / CCU.SN / SAM / AMGN.O / STZb / TAPa / HEINY.PK</td><td class="leftalignment">Kirin Holdings Co Ltd / Anheuser Busch Inbev SA / Compania Cervecerias Unidas SA / Compania Cervecerias Unidas SA / Boston Beer Company Inc / Amgen Inc / Constellation Brands Inc / Molson Coors Beverage Co / Heineken NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Chile / Japan / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/12/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Brief (We Hope) Pause in the Action – Fund Flow Turns Negative This Week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">08/12/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Short Interest Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AMGN.O / REGN.O</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Yinglu Zhang</td></tr>
<tr class="odd"><td class="leftalignment">08/12/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">First-Half Earnings; Timelines for APOLLO and GEMINI Data Slightly Pushed but Collaborations Progressing Ahead of R&D Day</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 462222100</td><td class="leftalignment">Amgen Inc / Ionis Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Myles R. R. Minter</td></tr>
<tr class="even"><td class="leftalignment">08/12/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">0989529 / 2023607 / 2486813 / 2778844 / 2190750 / 2270726 / 2328915 / 2100920 / 2415204 / 2689560 / 2684703 / 2829601 / 2931034 / 2503529 / 4595739 / B1F76F9 / B0T7YX2 / B3D7K31 / B4MG4Z6 / B3NXMJ9 / BFZCHN7 / BYVY8G0 / BYVFC94 / BYW36M8 / BQT3XY6 / BMYML02 / BLGJ610 / BJJMGL2 / BKTNTR9 / BYY88Y7 / BL71K91 / BRJ3GY4 / BLBLMD5 / BD72R64 / BMC8SQ7 / BMZ9Z11 / BMFPJK6 / BD5GSZ4 / BMBP1Q0</td><td class="leftalignment">AstraZeneca PLC / Amgen Inc / Kellogg Co / Merck & Co Inc / Chesapeake Utilities Corp / Walt Disney Co / Nextera Energy Inc / FirstEnergy Corp / Hawaiian Electric Industries Inc / PG&E Corp / Pfizer Inc / Southern Co / Vertex Pharmaceuticals Inc / World Wrestling Entertainment Inc / Genmab A/S / Western Union Co / Live Nation Entertainment Inc / Discovery Inc / AMC Networks Inc / Wendys Co / Wix.Com Ltd / Alphabet Inc / US Foods Holding Corp / PayPal Holdings Inc / Cyberark Software Ltd / DraftKings Inc / Warner Music Group Corp / Fox Corp / ViacomCBS Inc / Alphabet Inc / Revolution Medicines Inc / Xenon Pharmaceuticals Inc / Array Technologies Inc / Liberty Media Corp / BTRS Holdings Inc / Prometheus Biosciences Inc / ACV Auctions Inc / Infrastructure and Energy Alternatives Inc / Flywire Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Denmark / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">08/11/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">BKI / CRM.N / MSFT.O / NCR / NOW / 4716.T / AMZN.O / AMGN.O / ADBE.O / SAPG.DE / HEAR.O / CTAS.O / CRTO.OQ / ATVI.OQ / OSIS.OQ / TTWO.OQ / IDCC.O / SEIC.O / PCTY.O / NFLX.O / GPRO.O / 36467W109 / 02043Q107 / ZNGA.O / EA.O / FB.O / PERI.O / RNG.N / MRTX.OQ / FDEV.L / ARMK.K / GOOGL.O / 82655M107 / PAYC.K / MRNS.O / HUBS.K / SHOP.K / GDDY.K / QUOT.K / TTD.OQ / OKTA.O / ALPN.O / WDAY.O / BILI.O / EVER.OQ / MRKR.OQ / ZM.OQ / XAIR.OQ / ORIC.OQ / BILL.K / NNOX.O / HUYA.K / 30260D103</td><td class="leftalignment">Black Knight Inc / Salesforce.Com Inc / Microsoft Corp / NCR Corp / ServiceNow Inc / Oracle Corp Japan / Amazon.com Inc / Amgen Inc / Adobe Inc / SAP SE / Turtle Beach Corp / Cintas Corp / Criteo SA / Activision Blizzard Inc / OSI Systems Inc / Take-Two Interactive Software Inc / InterDigital Inc / SEI Investments Co / Paylocity Holding Corp / Netflix Inc / GoPro Inc / GameStop Corp / Alnylam Pharmaceuticals Inc / Zynga Inc / Electronic Arts Inc / Meta Platforms Inc / Perion Network Ltd / RingCentral Inc / Mirati Therapeutics Inc / Frontier Developments PLC / Aramark / Alphabet Inc / Sify Technologies Ltd / Paycom Software Inc / Marinus Pharmaceuticals Inc / HubSpot Inc / Shopify Inc / GoDaddy Inc / Quotient Technology Inc / Trade Desk Inc / Okta Inc / Alpine Immune Sciences Inc / Workday Inc / Bilibili Inc / EverQuote Inc / Marker Therapeutics Inc / Zoom Video Communications Inc / Beyond Air Inc / Oric Pharmaceuticals Inc / Bill.com Holdings Inc / Nano-X Imaging Ltd / HUYA Inc / Figs Inc</td><td class="leftalignment"></td><td class="leftalignment">Albania / Canada / Cayman Islands / Germany / France / United Kingdom / India / Israel / Japan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/11/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AMGN=US / DIS=US / DVN=US / REI=US / WLL=US / PB=US / EWBC=US / UMPQ=US / MRO=US / HCA=US / EQT=US / MAIN=US / PACW=US / VRTX=US / WAL=US / WW=US / WIX=US / BXS=US / AEL=US / FMBI=US / SNV=US / R=US / CATY=US / COP=US / MRNS=US / IGMS=US / TCBI=US / FNB=US / APTX=US / FHN=US / TDG=US / CPRX=US / CLR=US / APEI=US / OLO=US / BCEI=US / PDCE=US / FANG=US / VOYA=US / PTCT=US / MTNB=US / ASMB=US / OSH=US / RLMD=US / ADVM=US / PVAC=US / HWC=US / BTAI=US / OZK=US / ALLO=US / KOD=US / TCRR=US / XAIR=US / IMVT=US / PNTG=US / ARQT=US</td><td class="leftalignment">Amgen Inc / Walt Disney Co / Devon Energy Corp / Ring Energy Inc / Whiting Petroleum Corp / Prosperity Bancshares Inc / East West Bancorp Inc / Umpqua Holdings Corp / Marathon Oil Corp / HCA Healthcare Inc / EQT Corp / Main Street Capital Corp / PacWest Bancorp / Vertex Pharmaceuticals Inc / Western Alliance Bancorp / WW International Inc / Wix.Com Ltd / Cadence Bank / American Equity Investment Life Holding Co / First Midwest Bancorp Inc / Synovus Financial Corp / Ryder System Inc / Cathay General Bancorp / Conocophillips / Marinus Pharmaceuticals Inc / IGM Biosciences Inc / Texas Capital Bancshares Inc / FNB Corp / Aptinyx Inc / First Horizon Corp / TransDigm Group Inc / Catalyst Pharmaceuticals Inc / Continental Resources Inc / American Public Education Inc / Olo Inc / Civitas Resources Inc / PDC Energy Inc / Diamondback Energy Inc / Voya Financial Inc / PTC Therapeutics Inc / Matinas BioPharma Holdings Inc / Assembly Biosciences Inc / Oak Street Health Inc / Relmada Therapeutics Inc / Adverum Biotechnologies Inc / Ranger Oil Corp / Hancock Whitney Corp / BioXcel Therapeutics Inc / Bank Ozk / Allogene Therapeutics Inc / Kodiak Sciences Inc / TCR2 Therapeutics Inc / Beyond Air Inc / Immunovant Inc / Pennant Group Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/10/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">2Q Update Informs Adagrasib Filing Timeline</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRTX.OQ / AMGN.O</td><td class="leftalignment">Mirati Therapeutics Inc / Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">08/10/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Short Interest in Biotechnology Stocks</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US0311621009 / US3755581036 / US75886F1075 / US92532F1003 / US7665596034 / US02043Q1076 / US40637H1095 / US09609G1004 / US45845P1084 / US31189P1021 / US03820J1007 / US92686J1060 / US09627Y1091 / US4622221004 / US5588681057 / US03753U1060 / US2997341035 / US80706P1030 / US76029N1063 / US04335A1051 / US2936141033 / US50015M1099 / US85789A1051 / US62921N1054 / US61775R1059 / US30205M1018 / US80810D1037 / US12529R1077 / CA00288U1066 / US67080N1019 / US24343R1068</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Rigel Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Halozyme Therapeutics Inc / bluebird bio Inc / Intercept Pharmaceuticals Inc / Fate Therapeutics Inc / Applied Genetic Technologies Corp / Viking Therapeutics Inc / Blueprint Medicines Corp / Ionis Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Evelo Biosciences Inc / Scholar Rock Holding Corp / Replimune Group Inc / Arvinas Inc / Entasis Therapeutics Holdings Inc / Kodiak Sciences Inc / Stealth BioTherapeutics Corp / NGM Biopharmaceuticals Inc / Morphic Holding Inc / Exicure Inc / Schrodinger Inc / C4 Therapeutics Inc / Abcellera Biologics Inc / Nuvation Bio Inc / Decibel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Matthew Luchini / Jin Lee / Nick Lenard</td></tr>
<tr class="odd"><td class="leftalignment">08/10/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Tapinarof psoriasis NDA accepted, increased competitive pressure on Otezla, in our view</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AMGN=US</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">08/10/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / DIS=US / HD=US / MCD=US / OXY=US / RRC=US / WEN=US / T=US / BLD=US / DVN=US / APA=US / CPE=US / EOG=US / REI=US / XOM=US / CRK=US / LOW=US / WLL=US / PXD=US / ENR=US / MGY=US / SWN=US / SCOR=US / MUR=US / SPOT=US / MRO=US / LEG=US / VMC=US / EQR=US / MLM=US / DISH=US / SWIM=US / CBRL=US / ELY=US / CNX=US / DRI=US / EQT=US / GFF=US / GPOR=US / IBP=US / MAS=US / MHK=US / REGI=US / CVX=US / SGMS=US / BKNG=US / DCP=US / NHI=US / PRA=US / NLS=US / COP=US / DIN=US / TPX=US / EXP=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / SCPL=US / CMG=US / PGTI=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / CLR=US / PNNT=US / PRPL=US / APEI=US / NOG=US / JACK=US / TREX=US / AR=US / OAS=US / BLND=US / APTS=US / ESTE=US / FBHS=US / BCEI=US / MTDR=US / PDCE=US / FANG=US / TILE=US / MODN=US / NDLS=US / HTRG=US / VNOM=US / 70806A106 / LOCO=US / OSH=US / SHAK=US / GSBD=US / WING=US / CABO=US / AXSM=US / 82982L103 / TTD=US / EVBG=US / CDEV=US / PVAC=US / ANAB=US / JELD=US / SBOW=US / SAIL=US / RTLR=US / FERG=US / RPAY=US / PNTG=US / OVV=US / DKNG=US / AZEK=US / PAYA=US / AZYO=US / BALY=US / VTRS=US / REPX=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Walt Disney Co / Home Depot Inc / McDonald's Corp / Occidental Petroleum Corp / Range Resources Corp / Wendys Co / AT&T Inc / TopBuild Corp / Devon Energy Corp / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Exxon Mobil Corp / Comstock Resources Inc / Lowe's Companies Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Energizer Holdings Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Comscore Inc / Murphy Oil Corp / Spotify Technology SA / Marathon Oil Corp / Leggett & Platt Inc / Vulcan Materials Co / Equity Residential / Martin Marietta Materials Inc / DISH Network Corp / Latham Group Inc / Cracker Barrel Old Country Store Inc / Callaway Golf Co / CNX Resources Corp / Darden Restaurants Inc / EQT Corp / Griffon Corp / Gulfport Energy Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Renewable Energy Group Inc / Chevron Corp / Scientific Games Corp / Booking Holdings Inc / DCP Midstream LP / National Health Investors Inc / ProAssurance Corp / Nautilus Inc / Conocophillips / Dine Brands Global Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Sciplay Corp / Chipotle Mexican Grill Inc / PGT Innovations Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / Pennantpark Investment Corp / Purple Innovation Inc / American Public Education Inc / Northern Oil and Gas Inc / Jack in the Box Inc / Trex Company Inc / Antero Resources Corp / Oasis Petroleum Inc / Blend Labs Inc / Preferred Apartment Communities Inc / Earthstone Energy Inc / Fortune Brands Home & Security Inc / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Diamondback Energy Inc / Interface Inc / Model N Inc / Noodles & Co / Heritage Insurance Holdings Inc / Viper Energy Partners LP / PennantPark Floating Rate Capital Ltd / El Pollo Loco Holdings Inc / Oak Street Health Inc / Shake Shack Inc / Goldman Sachs BDC Inc / Wingstop Inc / Cable One Inc / Axsome Therapeutics Inc / SiteOne Landscape Supply Inc / Trade Desk Inc / Everbridge Inc / Centennial Resource Development Inc / Ranger Oil Corp / AnaptysBio Inc / JELD-WEN Holding Inc / SilverBow Resources Inc / SailPoint Technologies Holdings Inc / Rattler Midstream LP / Ferguson PLC / Repay Holdings Corp / Pennant Group Inc / Ovintiv Inc / DraftKings Inc / Azek Company Inc / Paya Holdings Inc / Aziyo Biologics Inc / Bally's Corp / Viatris Inc / Riley Exploration Permian Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Luxembourg / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ERAS (BUY) - ERASe CAncer with a Deep RAS/MAPK-Focused Pipeline - Initiating Coverage with a BUY Rating and $25 PT</td><td class="leftalignment">English</td><td class="rightalignment">95</td><td class="leftalignment">BNLYBF3 / 5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2369174 / 2455965 / 2684703 / 2573083 / 2931034 / 7103065 / 2713317 / BBFL7S1 / BBPK0J0 / BD9GVY0 / BDHF4K6 / BZ1LFB2 / BZ8FPH3 / BWY52P3 / BL71K91 / BDZ30Q0 / BN2R582 / BMPRZV5 / BMDJ397 / BN2RM92 / BP7KZP7</td><td class="leftalignment">Erasca Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Gilead Sciences Inc / Biogen Inc / Pfizer Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Novartis AG / ACADIA Pharmaceuticals Inc / bluebird bio Inc / Mirati Therapeutics Inc / Zai Lab Ltd / CRISPR Therapeutics AG / Deciphera Pharmaceuticals Inc / Editas Medicine Inc / Blueprint Medicines Corp / Revolution Medicines Inc / Arvinas Inc / Relay Therapeutics Inc / Kymera Therapeutics Inc / Bolt Biotherapeutics Inc / Rain Therapeutics Inc / Monte Rosa Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="even"><td class="leftalignment">08/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharma Food for Thought : US healthcare in FY22 Budget Resolution bill & latest touted FDA Commissioner candidate tough views on pricing</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">4502.T / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / ROG.S / LUN.CO / NOVOB.CO / NOVN.S / MRCG.DE / UCB.BR / AMGN.OQ / REGN.OQ / GILD.OQ / INCY.OQ / BMRN.OQ / BIIB.OQ / IPN.PA / TEVA.N / ALM.MC / BAYGN.DE / ABBV.N / VIFN.S</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / Merck KGaA / Ucb SA / Amgen Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Biomarin Pharmaceutical Inc / Biogen Inc / Ipsen SA / Teva Pharmaceutical Industries Ltd / Almirall SA / Bayer AG / Abbvie Inc / Vifor Pharma AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">08/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregory D. Fraser / Ms. Robyn S. Karnauskas / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">08/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending July 30, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">08/09/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - August 9, 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">AEP.N / AES.N / AIG.N / ALB.N / ALV.N / CL.N / EIX.N / EL.N / F.N / FLS.N / FSR.N / GM.N / KMB.N / KO.N / MO.N / PNW.N / RYN.N / SO.N / SRCL.O / T.N / VC.N / PEP.N / BFb.N / PG.N / WY.N / GILD.O / CPB.N / LPX.N / TEN.N / WLL.N / CMCSA.O / AMGN.O / DUK.N / BWA.N / LEA.N / K.N / DISH.O / CLX.N / CAG.N / MRO.N / GIS.N / PCG.N / HSY.N / EPC.N / ADCT.N / SBAC.O / AMT.N / JAZZ.O / CONE.O / RKT.N / SGMO.O / VZ.N / EXEL.O / XEL.N / ARNA.O / STZ.N / APH.N / FDS.N / FISV.O / CHTR.O / AXL.N / CHD.N / EPAY.O / NWN.N / BC.N / SAM.N / OPTN.O / REGN.O / ENR.N / NCR.N / TEL.N / ENDP.O / CPK.N / HL.N / PII.N / ST.N / SR.N / AMH.N / PLUG.OQ / GPN.N / ONC.TO / MNST.O / CASY.O / JCOM.O / EQIX.O / ATDb.TO / EDV.TO / MNKD.OQ / NVT.N / DLR.N / IAG.N / WEF.TO / SJW.N / BKD.N / FIS.N / CCOI.O / 025676206 / TEVA.N / HOG.N / ATL.MI / BGS.N / PPL.TO / DAN.N / SII.TO / SPB.N / TXG.TO / NEE.N / CIO.N / PCH.O / ERF.TO / PCRX.O / CTT.N / MTOR.N / IFP.TO / MDLZ.OQ / GRT_u.TO / TSLA.N / PRGO.N / PRMW.N / ENTA.O / TMUS.N / UKWG.L / VOYA.N / DOO.TO / COTY.N / PRTA.O / BEP.N / ESNT.N / FLXN.O / BTG.N / GLPG.O / SQ.N / RACE.MI / ADVM.OQ / BBU.N / ADNT.N / LGFB.N / PBYI.OQ / SAND.N / UNIT.O / WPM.N / WOW.N / SSRM.O / BHF.O / ATNX.O / SAIL.N / APTV.N / AMRX.N / VNE.N / KDP.N / AQST.O / NWL.O / 269796108 / CTVA.N / APRE.OQ / CRNC.OQ / WTRG.N / REYN.O / NKLA.OQ / FOUR.N / MGNI.OQ / RXT.OQ / JAMF.O / LUMN.N / PTVE.O / BSY.O / RIDE.OQ / VTRS.OQ / LSPD.N / PUBM.O / NAPA.N / OSO.N / TSP.OQ / OTLY.O / FLYW.O / TASK.O / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / American International Group Inc / Albemarle Corp / Autoliv Inc / Colgate-Palmolive Co / Edison International / Estee Lauder Companies Inc / Ford Motor Co / Flowserve Corp / Fisker Inc / General Motors Co / Kimberly-Clark Corp / Coca-Cola Co / Altria Group Inc / Pinnacle West Capital Corp / Rayonier Inc / Southern Co / Stericycle Inc / AT&T Inc / Visteon Corp / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Weyerhaeuser Co / Gilead Sciences Inc / Campbell Soup Co / Louisiana-Pacific Corp / Tenneco Inc / Whiting Petroleum Corp / Comcast Corp / Amgen Inc / Duke Energy Corp / Borgwarner Inc / Lear Corp / Kellogg Co / DISH Network Corp / Clorox Co / Conagra Brands Inc / Marathon Oil Corp / General Mills Inc / PG&E Corp / Hershey Co / Edgewell Personal Care Co / ADC Therapeutics SA / SBA Communications Corp / American Tower Corp / Jazz Pharmaceuticals PLC / CyrusOne Inc / Rocket Companies Inc / Sangamo Therapeutics Inc / Verizon Communications Inc / Exelixis Inc / Xcel Energy Inc / Arena Pharmaceuticals Inc / Constellation Brands Inc / Amphenol Corp / Factset Research Systems Inc / Fiserv Inc / Charter Communications Inc / American Axle & Manufacturing Holdings Inc / Church & Dwight Co Inc / Bottomline Technologies Inc / Northwest Natural Holding Co / Brunswick Corp / Boston Beer Company Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / NCR Corp / TE Connectivity Ltd / Endo International PLC / Chesapeake Utilities Corp / Hecla Mining Co / Polaris Inc / Sensata Technologies Holding PLC / Spire Inc / American Homes 4 Rent / Plug Power Inc / Global Payments Inc / Oncolytics Biotech Inc / Monster Beverage Corp / Caseys General Stores Inc / Ziff Davis Inc / Equinix Inc / Alimentation Couche-Tard Inc / Endeavour Mining PLC / MannKind Corp / nVent Electric PLC / Digital Realty Trust Inc / IAMGOLD Corp / Western Forest Products Inc / SJW Group / Brookdale Senior Living Inc / Fidelity National Information Services Inc / Cogent Communications Holdings Inc / American Equity Investment Life Holding Co / Teva Pharmaceutical Industries Ltd / Harley-Davidson Inc / Atlantia SpA / B&G Foods Inc / Pembina Pipeline Corp / Dana Inc / Sprott Inc / Spectrum Brands Holdings Inc / Torex Gold Resources Inc / Nextera Energy Inc / City Office REIT Inc / Potlatchdeltic Corp / Enerplus Corp / Pacira Biosciences Inc / CatchMark Timber Trust Inc / Meritor Inc / Interfor Corp / Mondelez International Inc / Granite Real Estate Investment Trust / Tesla Inc / Perrigo Company PLC / Primo Water Corp / Enanta Pharmaceuticals Inc / T-Mobile US Inc / Greencoat UK Wind PLC / Voya Financial Inc / BRP Inc / Coty Inc / Prothena Corporation PLC / Brookfield Renewable Partners LP / Essent Group Ltd / Pacira Biosciences Inc / B2Gold Corp / Galapagos NV / Block Inc / Ferrari NV / Adverum Biotechnologies Inc / Brookfield Business Partners LP / Adient PLC / Lions Gate Entertainment Corp / Puma Biotechnology Inc / Sandstorm Gold Ltd / Uniti Group Inc / Wheaton Precious Metals Corp / WideOpenWest Inc / SSR Mining Inc / Brighthouse Financial Inc / Athenex Inc / SailPoint Technologies Holdings Inc / Aptiv PLC / Amneal Pharmaceuticals Inc / Veoneer Inc / Keurig Dr Pepper Inc / Aquestive Therapeutics Inc / Newell Brands Inc / Eagle Pharmaceuticals Inc / Corteva Inc / Aprea Therapeutics Inc / Cerence Inc / Essential Utilities Inc / Reynolds Consumer Products Inc / Nikola Corp / Shift4 Payments Inc / Magnite Inc / Rackspace Technology Inc / Jamf Holding Corp / Lumen Technologies Inc / Pactiv Evergreen Inc / Bentley Systems Inc / Lordstown Motors Corp / Viatris Inc / Lightspeed Commerce Inc / PubMatic Inc / Duckhorn Portfolio Inc / Olo Inc / TuSimple Holdings Inc / Oatly Group AB / Flywire Corp / Taskus Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / United Kingdom / Ireland / Israel / Italy / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">08/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Jul 30</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">08/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - BeiGene: Strong main product sales growth in 2Q21; Catalyst rich 2H21 providing upside. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BGNE.OQ / 6160.HK / AMGN.OQ / 600276.SS</td><td class="leftalignment">Beigene Ltd / Beigene Ltd / Amgen Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">08/09/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">2Q21 Update - Mirati Back In Driver Seat In 2H21</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">60468T105 / 03116210</td><td class="leftalignment">Mirati Therapeutics Inc / Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Silvan Tuerkcan</td></tr>
<tr class="odd"><td class="leftalignment">08/07/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Mackay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / EXEL.O / ARNA.O / REGN.O / PRTA.O / PBYI.OQ / ATNX.O</td><td class="leftalignment">Amgen Inc / Exelixis Inc / Arena Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Prothena Corporation PLC / Puma Biotechnology Inc / Athenex Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="even"><td class="leftalignment">08/07/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Amgen Inc: Peer Group Analytics - Q2 FY2021</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">INCY-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">INCY.O / LLY / NVS / PFE / AMGN.O / CTIC.O / LGND.O / GERN.O / AVEO.O / ARDX.O</td><td class="leftalignment">Incyte Corp / Eli Lilly and Co / Novartis AG / Pfizer Inc / Amgen Inc / CTI Biopharma Corp / Ligand Pharmaceuticals Inc / Geron Corp / Aveo Pharmaceuticals Inc / Ardelyx Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">HZNP-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">HZNP.O / MRK / PFE / AMGN.O / RDY / AZN.O / RDUS.O</td><td class="leftalignment">Horizon Therapeutics PLC / Merck & Co Inc / Pfizer Inc / Amgen Inc / Dr Reddy's Laboratories Ltd / AstraZeneca PLC / Radius Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / India / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">REGN-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">REGN.O / JNJ / NVS / AMGN.O / BIIB.O / ALNY.O / SNY.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Johnson & Johnson / Novartis AG / Amgen Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GILD-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">GILD.O / BIOb / JNJ / LLY / MRK / PFE / AMGN.O / ILMN.O / VRTX.O / BIIB.O / ABBV.K</td><td class="leftalignment">Gilead Sciences Inc / Bio Rad Laboratories Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Illumina Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AMGN.O / ABT / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABBV-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ABBV.K / BMY / LLY / PFE / GILD.O / AMGN.O / GSK / NBIX.O / AZN.O / BIIB.O</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / GlaxoSmithKline PLC / Neurocrine Biosciences Inc / AstraZeneca PLC / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">LLY-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">LLY / BMY / JNJ / MRK / NVS / PFE / AMGN.O / GSK / AZN.O / ABBV.K / SNY.O</td><td class="leftalignment">Eli Lilly and Co / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BMY-US -  Dividend Quality Analysis, for the period ended August 02,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY / JNJ / LLY / MRK / NVS / PFE / AMGN.O / AZN.O / BIIB.O / ABBV.K / SNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / AstraZeneca PLC / Biogen Inc / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Model Update</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">Validea</td><td class="leftalignment">Validea Guru Analysis Report for AMGN. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">031162100</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / QUANANTITATIVE/TECH RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended July 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--August 06, 2021</td><td class="leftalignment">English</td><td class="rightalignment">49</td><td class="leftalignment">BSX / CI / CVS / GE / MDT / SGE.L / SYK / AMGN.O / AAPL.O / NOVN.S / RMD.N / INSP.N / EW.N / INCY.OQ / NBIX.OQ / UTHR.OQ / EXEL.OQ / VRTX.OQ / NKTR.O / CCRN.O / ICAD.O / STAA.O / AMED.O / BIIB.O / ALNY.OQ / MNKD.O / ACAD.O / ATRC.OQ / DXCM.O / LHCG.O / PODD.O / 02043Q107 / TNDM.O / SPRO.OQ / MRNA.O / TMDX.OQ / 771195104 / CSII.O / ADUS.O / FATE.OQ / AERI.O / CNCE.OQ / FLXN.OQ / ALDX.OQ / MDWD.O / XENT.OQ / VBIV.O / MRNS.O / APS.TO / OTIC.O / NVRO.N / VCEL.O / VRAY.OQ / MCRB.OQ / CERC.OQ / GKOS.K / ZBH.N / CFMS.O / GBT.OQ / APLS.OQ / EDIT.OQ / NTLA.O / SYRS.OQ / TCMD.OQ / IRTC.OQ / VREX.OQ / URGN.O / IOVA.OQ / KALA.O / ATNX.O / FENC.O / NCNA.O / 720795103 / PRVB.OQ / BNGO.OQ / ARVN.OQ / ALLO.OQ / ORTX.OQ / CRSP.BN / SWAV.O / XFOR.OQ / ISEE.O / KRTX.OQ / PSNL.O / DMTK.O / BXRX.OQ / HGEN.O / REGW.M3 / 03823M100 / N69603145</td><td class="leftalignment">Boston Scientific Corp / Cigna Corp / CVS Health Corp / General Electric Co / Medtronic PLC / Sage Group PLC / Stryker Corp / Amgen Inc / Apple Inc / Novartis AG / Resmed Inc / Inspire Medical Systems Inc / Edwards Lifesciences Corp / Incyte Corp / Neurocrine Biosciences Inc / United Therapeutics Corp / Exelixis Inc / Vertex Pharmaceuticals Inc / Nektar Therapeutics / Cross Country Healthcare Inc / ICAD Inc / STAAR Surgical Co / Amedisys Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / MannKind Corp / ACADIA Pharmaceuticals Inc / AtriCure Inc / Dexcom Inc / LHC Group Inc / Insulet Corp / Alnylam Pharmaceuticals Inc / Tandem Diabetes Care Inc / Spero Therapeutics Inc / Moderna Inc / Transmedics Group Inc / Roche Holding AG / Cardiovascular Systems Inc / Addus Homecare Corp / Fate Therapeutics Inc / Aerie Pharmaceuticals Inc / Concert Pharmaceuticals Inc / Pacira Biosciences Inc / Aldeyra Therapeutics Inc / Mediwound Ltd / Intersect Ent Inc / VBI Vaccines Inc / Marinus Pharmaceuticals Inc / Aptose Biosciences Inc / Otonomy Inc / Nevro Corp / Vericel Corp / ViewRay Inc / Seres Therapeutics Inc / Avalo Therapeutics Inc / Glaukos Corp / Zimmer Biomet Holdings Inc / Conformis Inc / Global Blood Therapeutics Inc / Apellis Pharmaceuticals Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Syros Pharmaceuticals Inc / Tactile Systems Technology Inc / iRhythm Technologies Inc / Varex Imaging Corp / Urogen Pharma Ltd / Iovance Biotherapeutics Inc / Kala Pharmaceuticals Inc / Athenex Inc / Fennec Pharmaceuticals Inc / NuCana PLC / Pieris Pharmaceuticals Inc / Provention Bio Inc / Bionano Genomics Inc / Arvinas Inc / Allogene Therapeutics Inc / Orchard Therapeutics PLC / CRISPR Therapeutics AG / Shockwave Medical Inc / X4 Pharmaceuticals Inc / Iveric Bio Inc / Karuna Therapeutics Inc / Personalis Inc / DermTech Inc / Baudax Bio Inc / Humanigen Inc / Regency World Consulting Ltd / Applied Minerals Inc / Pharming Group NV</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / United Kingdom / India / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 559</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">36</td><td class="leftalignment">AXP / V / 4031976 / 5671735 / 2023607 / 2486813 / 2640147 / 2778844 / 2002305 / 2003698 / 2050832 / 2045623 / 2942605 / 2544960 / 2219224 / 2206657 / 2216850 / 2037170 / 2317087 / 2576941 / 2670519 / 2328915 / 2342034 / 2613990 / 2471950 / 2630513 / 2645409 / 2657802 / 2689560 / 2680905 / 2684703 / 2048804 / 2730190 / 2440637 / 2138158 / 2825933 / 2829601 / 2928683 / 2503529 / B1F76F9 / 2212922 / B19FQ48 / B0T7YX2 / B02R1L6 / 2390817 / B7TL820 / B4MG4Z6 / B783TY6 / B7VD3F2 / BBPK0J0 / BBGVT40 / B7577T2 / BDZCRX3 / B95WG16 / BZ07BW4 / BYZLV46 / BYNZGK1 / BZBY005 / BD8DJ71 / BJ1FD74 / BKTHM05 / BR4T3B3 / BMYML02 / BFMXGR0 / BJJMGL2 / BFNR303 / BYXJQG9 / BZ8VJQ8 / BJFSR99 / BFXC911 / BKTNTR9 / BJVR9Y9 / BYWMQJ2 / BYYWPW6 / BHZSB82 / BP3YM85 / BD6D4Y5 / BJ9NFQ3 / BZ1LFG7 / BYY88Y7 / BF3W461 / BYSGPK2 / BKX9VD3 / BJDX8Y8 / BYWVTY5 / BMVWYW8 / BDZ30Q0 / BJMLSD2 / BYTJZL1 / BJTJGC4 / BG0Q4Y1 / BF3N4P3 / BQXZP64 / BMDCDP2 / BYXB1Y8 / BGDQ8B3 / BD72R64 / BNTB3N8 / BMGGJK8 / BKPGJQ1 / BJLV8T9</td><td class="leftalignment">American Express Co / Visa Inc / Adidas AG / Sanofi SA / Amgen Inc / Kellogg Co / Nike Inc / Merck & Co Inc / Abbott Laboratories / ABIOMED Inc / Ameren Corp / ANSYS Inc / Avista Corp / Beasley Broadcast Group Inc / CMS Energy Corp / Coca-Cola Co / Consolidated Edison Inc / 8x8 Inc / Entergy Corp / Exelixis Inc / Exelon Corp / Nextera Energy Inc / Fiserv Inc / Illumina Inc / Incyte Corp / New Jersey Resources Corp / NiSource Inc / OGE Energy Corp / PG&E Corp / PPL Corp / Pfizer Inc / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / CenterPoint Energy Inc / Sempra Energy / South Jersey Industries Inc / Southern Co / VF Corp / World Wrestling Entertainment Inc / Western Union Co / NRG Energy Inc / Amicus Therapeutics Inc / Live Nation Entertainment Inc / ALLETE Inc / Gray Television Inc / Meta Platforms Inc / AMC Networks Inc / Aptiv PLC / Duke Energy Corp / Mirati Therapeutics Inc / News Corp / Renewable Energy Group Inc / RingCentral Inc / Zoetis Inc / Monster Beverage Corp / InflaRx NV / Block Inc / Merus NV / Snap Inc / Revolve Group Inc / Passage Bio Inc / HubSpot Inc / DraftKings Inc / Evergy Inc / Fox Corp / Northwest Natural Holding Co / Spire Inc / Vistra Corp / Revance Therapeutics Inc / Guardant Health Inc / ViacomCBS Inc / iHeartMedia Inc / Alteryx Inc / Beigene Ltd / Covetrus Inc / Trupanion Inc / Altair Engineering Inc / Neoleukin Therapeutics Inc / Roku Inc / Alphabet Inc / Tandem Diabetes Care Inc / ViewRay Inc / Arcutis Biotherapeutics Inc / Mirum Pharmaceuticals Inc / CytomX Therapeutics Inc / Protara Therapeutics Inc / Arvinas Inc / Karuna Therapeutics Inc / Zogenix Inc / Kontoor Brands Inc / Exicure Inc / Arena Pharmaceuticals Inc / Wayfair Inc / Bigcommerce Holdings Inc / Sunrun Inc / Axonics Inc / Liberty Media Corp / Vizio Holding Corp / Valneva SE / Squarespace Inc / Celldex Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Germany / France / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Glitter in the Sky, Glitter in my Eyes - 6th Straight Week of Inflows</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">08/05/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Q2 2021: Amgen sequential quarterly profits hit by 72% fall</td><td class="leftalignment">English</td><td class="rightalignment">71</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">08/05/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Amgen down 5.8% from 1 week high</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Acquisdata</td><td class="leftalignment">Amgen</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">AMGN=US</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Acquisdata Research Team</td></tr>
<tr class="even"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Reflecting on stock volatility after the print - stable business with some new launches, less focused on tax dispute</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / T=US / DVN=US / CMA=US / GILD=US / PEB=US / APA=US / CPE=US / EOG=US / H=US / V=US / MTN=US / CRK=US / WLL=US / PB=US / MGY=US / EWBC=US / TRMK=US / MAR=US / UMPQ=US / MRO=US / TNL=US / KFRC=US / VMC=US / MGM=US / HLT=US / UNM=US / CVS=US / RCL=US / UNH=US / MAC=US / WTFC=US / AIZ=US / AMED=US / AMN=US / APH=US / FUN=US / CENT=US / KIDS=US / CHH=US / CSTR=US / CW=US / DRH=US / EEFT=US / MPLX=US / DOC=US / ASGN=US / OKE=US / PACW=US / RHI=US / SGMO=US / SMG=US / TGI=US / WAL=US / HTH=US / BXS=US / CCRN=US / FNF=US / BKNG=US / CFB=US / CFR=US / FMBI=US / SNV=US / ZION=US / SIVB=US / ABCB=US / BOKF=US / DCP=US / FRT=US / FBK=US / JAZZ=US / MTCH=US / ASB=US / SSB=US / SPR=US / RF=US / CRTO=US / CATY=US / FFIN=US / GBCI=US / SBSI=US / EVOP=US / UCBI=US / VICI=US / ECPG=US / MGP=US / PNFP=US / SBCF=US / BDSI=US / JRVR=US / RPD=US / BIIB=US / FLT=US / TCBI=US / FNB=US / FHN=US / KAR=US / BDC=US / SHO=US / RNST=US / LHCG=US / CHNG=US / HST=US / MA=US / GPRE=US / ELF=US / WU=US / TEL=US / CADE=US / WH=US / IAC=US / PSN=US / JACK=US / SWI=US / VRSK=US / OAS=US / HGV=US / SBRA=US / RLJ=US / ESTE=US / VAC=US / ANGI=US / EA=US / PDCE=US / GMED=US / RHP=US / FANG=US / ABBV=US / IBTX=US / TMUS=US / FATE=US / TSLX=US / HUBS=US / VCEL=US / NVRO=US / UPLD=US / GDDY=US / ETSY=US / LOB=US / EVRI=US / ACBI=US / EDIT=US / 82982L103 / VVV=US / PK=US / PVAC=US / TVTY=US / 50189K103 / PLYA=US / SBOW=US / PETQ=US / ROKU=US / MBIN=US / MAXR=US / EOLS=US / HWC=US / OZK=US / FTDR=US / ALLO=US / AMTB=US / UBER=US / RTLR=US / IMVT=US / 100017125</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / AT&T Inc / Devon Energy Corp / Comerica Inc / Gilead Sciences Inc / Pebblebrook Hotel Trust / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Hyatt Hotels Corp / Visa Inc / Vail Resorts Inc / Comstock Resources Inc / Whiting Petroleum Corp / Prosperity Bancshares Inc / Magnolia Oil & Gas Corp / East West Bancorp Inc / Trustmark Corp / Marriott International Inc / Umpqua Holdings Corp / Marathon Oil Corp / Travel + Leisure Co / Kforce Inc / Vulcan Materials Co / MGM Resorts International / Hilton Worldwide Holdings Inc / Unum Group / CVS Health Corp / Royal Caribbean Cruises Ltd / UnitedHealth Group Inc / Macerich Co / Wintrust Financial Corp / Assurant Inc / Amedisys Inc / AMN Healthcare Services Inc / Amphenol Corp / Cedar Fair LP / Central Garden & Pet Co / OrthoPediatrics Corp / Choice Hotels International Inc / CapStar Financial Holdings Inc / Curtiss-Wright Corp / Diamondrock Hospitality Co / Euronet Worldwide Inc / MPLX LP / Physicians Realty Trust / ASGN Inc / ONEOK Inc / PacWest Bancorp / Robert Half International Inc / Sangamo Therapeutics Inc / Scotts Miracle-Gro Co / Triumph Group Inc / Western Alliance Bancorp / Hilltop Holdings Inc / Cadence Bank / Cross Country Healthcare Inc / Fidelity National Financial Inc / Booking Holdings Inc / Crossfirst Bankshares Inc / Cullen/Frost Bankers Inc / First Midwest Bancorp Inc / Synovus Financial Corp / Zions Bancorporation NA / SVB Financial Group / Ameris Bancorp / BOK Financial Corp / DCP Midstream LP / Federal Realty Investment Trust / FB Financial Corp / Jazz Pharmaceuticals PLC / Match Group Inc / Associated Banc-Corp / SouthState Corp / Spirit AeroSystems Holdings Inc / Regions Financial Corp / Criteo SA / Cathay General Bancorp / First Financial Bankshares Inc / Glacier Bancorp Inc / Southside Bancshares Inc / EVO Payments Inc / United Community Banks Inc / VICI Properties Inc / Encore Capital Group Inc / MGM Growth Properties LLC / Pinnacle Financial Partners Inc / Seacoast Banking Corporation of Florida / BioDelivery Sciences International Inc / James River Group Holdings Ltd / Rapid7 Inc / Biogen Inc / Fleetcor Technologies Inc / Texas Capital Bancshares Inc / FNB Corp / First Horizon Corp / KAR Auction Services Inc / Belden Inc / Sunstone Hotel Investors Inc / Renasant Corp / LHC Group Inc / Change Healthcare Inc / Host Hotels & Resorts Inc / Mastercard Inc / Green Plains Inc / elf Beauty Inc / Western Union Co / TE Connectivity Ltd / Cadence Bank / Wyndham Hotels & Resorts Inc / IAC/Interactivecorp / Parsons Corp / Jack in the Box Inc / SolarWinds Corp / Verisk Analytics Inc / Oasis Petroleum Inc / Hilton Grand Vacations Inc / Sabra Health Care REIT Inc / RLJ Lodging Trust / Earthstone Energy Inc / Marriott Vacations Worldwide Corp / Angi Inc / Electronic Arts Inc / PDC Energy Inc / Globus Medical Inc / Ryman Hospitality Properties Inc / Diamondback Energy Inc / Abbvie Inc / Independent Bank Group Inc / T-Mobile US Inc / Fate Therapeutics Inc / Sixth Street Specialty Lending Inc / HubSpot Inc / Vericel Corp / Nevro Corp / Upland Software Inc / GoDaddy Inc / ETSY Inc / Live Oak Bancshares Inc / Everi Holdings Inc / Atlantic Capital Bancshares Inc / Editas Medicine Inc / SiteOne Landscape Supply Inc / Valvoline Inc / Park Hotels & Resorts Inc / Ranger Oil Corp / Tivity Health Inc / LCI Industries / Playa Hotels & Resorts NV / SilverBow Resources Inc / PetIQ Inc / Roku Inc / Merchants Bancorp / Maxar Technologies Inc / Evolus Inc / Hancock Whitney Corp / Bank Ozk / Frontdoor Inc / Allogene Therapeutics Inc / Amerant Bancorp Inc / Uber Technologies Inc / Rattler Midstream LP / Immunovant Inc / SVB Financial Group</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / France / Ireland / Liberia / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Amgen Inc: Information Content of Earnings Releases 2015-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Takeaways from mgmt on IRS dispute and Otezla; stock reaction overblown in our view</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AMGN=US</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Amgen Inc: Capital Deployment Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech: SMID-Cap Oncology Take-Aways From Big-Cap 2Q21 Earnings</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / GILD=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Asthika Goonewardene</td></tr>
<tr class="even"><td class="leftalignment">08/04/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Lackluster Quarter, No Lumakras Numbers, but Pipeline Still Capturing Attention</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">03116210</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun</td></tr>
<tr class="odd"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">AME / CMI / CRM.N / GE / KKR / MDT / MSFT.O / NCR / NICE.TA / SCM.N / SGE.L / T.N / URI / AMZN.O / AMGN.O / AAPL.O / FIS / NVDA.O / DTE.N / HEAR.O / NOVN.S / VECO.O / INSP.N / CSCO.OQ / ATVI.OQ / INCY.OQ / NBIX.OQ / TTWO.OQ / AKAM.OQ / MGRC.O / NFLX.O / BIIB.O / 92343V104 / AYX / ALNY.OQ / DENN.O / 36467W109 / SPWR.O / ADUS.O / ANGI.O / ZNGA.O / EA.O / RNG.N / FDEV.L / GOOGL.O / 82655M107 / PAYC.K / SABR.O / MRNS.O / NEWR.K / ZBH.N / GBT.OQ / ZG.OQ / IAC.O / BABA.K / APL.PS / UAA / VREX.OQ / HLNE.OQ / WSC.OQ / EGHT.K / BILI.O / XFOR.OQ / ZM.OQ / FSLY.K / VG.O / HUYA.K / 390320109</td><td class="leftalignment">AMETEK Inc / Cummins Inc / Salesforce.Com Inc / General Electric Co / KKR & Co Inc / Medtronic PLC / Microsoft Corp / NCR Corp / Nice Ltd / Stellus Capital Investment Corp / Sage Group PLC / AT&T Inc / United Rentals Inc / Amazon.com Inc / Amgen Inc / Apple Inc / Fidelity National Information Services Inc / NVIDIA Corp / DTE Energy Co / Turtle Beach Corp / Novartis AG / Veeco Instruments Inc / Inspire Medical Systems Inc / Cisco Systems Inc / Activision Blizzard Inc / Incyte Corp / Neurocrine Biosciences Inc / Take-Two Interactive Software Inc / Akamai Technologies Inc / McGrath RentCorp / Netflix Inc / Biogen Inc / Verizon Communications Inc / Alteryx Inc / Alnylam Pharmaceuticals Inc / Denny's Corp / GameStop Corp / SunPower Corp / Addus Homecare Corp / Angi Inc / Zynga Inc / Electronic Arts Inc / RingCentral Inc / Frontier Developments PLC / Alphabet Inc / Sify Technologies Ltd / Paycom Software Inc / Sabre Corp / Marinus Pharmaceuticals Inc / New Relic Inc / Zimmer Biomet Holdings Inc / Global Blood Therapeutics Inc / Zillow Group Inc / IAC/Interactivecorp / Alibaba Group Holding Ltd / Apollo Global Capital Inc / Under Armour Inc / Varex Imaging Corp / Hamilton Lane Inc / Willscot Mobile Mini Holdings Corp / 8x8 Inc / Bilibili Inc / X4 Pharmaceuticals Inc / Zoom Video Communications Inc / Fastly Inc / Vonage Holdings Corp / HUYA Inc / Great Elm Capital Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / China / Cayman Islands / United Kingdom / India / Ireland / Israel / Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Aug 04 2021</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">DE0006231004 / US00971T1016 / US0311001004 / US0311621009 / US1570851014 / US25179M1036 / US3021301094 / US4234521015 / US5184151042 / US5398301094 / US5950171042 / US62855J1043 / US64125C1099 / US6745991058 / US9182041080 / US9807451037 / NL0000200384 / US98956P1021 / US02043Q1076 / US0491642056 / US9043111072 / US5380341090 / US00922R1059 / US00507V1098 / US25470F1049 / US25470F3029 / US39304D1028 / NL0009538784 / US69404D1081 / US7512121010 / US8676524064 / US7185461040 / IE00B4Q5ZN47 / US64051T1007 / PR30040P1032 / US00847X1046 / US14862Q1004 / US70432V1026 / KYG8807B1068 / US64829B1008 / US23283X2062 / US46185L1035 / US37890U1088 / US02081G2012 / US15136A1025 / KYG4740B1059 / US23753F1075 / US7493971052 / US02156B1035 / US24665A1034 / US8760301072 / US89854H1023 / VGG1890L1076 / US0144421072 / US98420X1037 / US55087P1049 / US5024311095 / US5502411037 / US5738741041 / US98985X1000 / US44891N2080 / US92719V1008</td><td class="leftalignment">Infineon Technologies AG / Akamai Technologies Inc / AMETEK Inc / Amgen Inc / Cerus Corp / Devon Energy Corp / Expeditors International of Washington Inc / Helmerich and Payne Inc / Lattice Semiconductor Corp / Lockheed Martin Corp / Microchip Technology Inc / Myriad Genetics Inc / Neurocrine Biosciences Inc / Occidental Petroleum Corp / VF Corp / Woodward Inc / Core Laboratories NV / Zimmer Biomet Holdings Inc / Alnylam Pharmaceuticals Inc / Atlas Air Worldwide Holdings Inc / Under Armour Inc / Live Nation Entertainment Inc / Air Transport Services Group Inc / Activision Blizzard Inc / Discovery Inc / Discovery Inc / Green Dot Corp / NXP Semiconductors NV / Pacific Biosciences of California Inc / Ralph Lauren Corp / SunPower Corp / Phillips 66 / Jazz Pharmaceuticals PLC / NeoPhotonics Corp / Evertec Inc / Agios Pharmaceuticals Inc / Castlight Health Inc / Paycom Software Inc / Theravance Biopharma Inc / New Relic Inc / Cytosorbents Corp / Invitae Corp / Global Blood Therapeutics Inc / Alphatec Holdings Inc / Centennial Resource Development Inc / Ichor Holdings Ltd / Daseke Inc / R1 RCM Inc / Alteryx Inc / Delek US Holdings Inc / Tapestry Inc / TTEC Holdings Inc / Capri Holdings Ltd / Alector Inc / X4 Pharmaceuticals Inc / Lyft Inc / L3harris Technologies Inc / Lumen Technologies Inc / Marvell Technology Inc / Zymergen Inc / IAC/Interactivecorp / Vimeo Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Germany / Ireland / Netherlands / Puerto Rico / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">DNB / WMB=US / CACI=US / LLY=US / LSI=US / AMGN=US / OXY=US / GBT=US / AMZN=US / BLD=US / DVN=US / INCY=US / PEB=US / AKAM=US / H=US / V=US / CRK=US / PXD=US / PAA=US / IGT=US / MAR=US / LEG=US / ATVI=US / KFRC=US / HLT=US / BKI=US / CVS=US / AIZ=US / BNL=US / CSGP=US / DVA=US / AJG=US / MRCY=US / MCHP=US / OKE=US / SAGE=US / PSA=US / BXS=US / MANT=US / MTCH=US / SRC=US / COP=US / MRNS=US / BIIB=US / RNG=US / CZR=US / KAR=US / SHO=US / BAH=US / DENN=US / SPWR=US / FIS=US / HST=US / MA=US / GPRE=US / ICFI=US / SAIC=US / CADE=US / CLR=US / LUMN=US / PAGP=US / IAA=US / KTOS=US / CWH=US / PSN=US / HTA=US / TREX=US / OAS=US / NXPI=US / GDOT=US / PCRX=US / RLJ=US / VAC=US / RHP=US / FANG=US / NDLS=US / LDOS=US / NMIH=US / VNOM=US / BABA=US / NEWR=US / WBA=US / WK=US / DEA=US / NSA=US / CHCT=US / ZBH=US / SQ=US / MIME=US / WLTW=US / 82982L103 / CDEV=US / PVAC=US / 50189K103 / AYX=US / SWCH=US / LYFT=US / LHX=US / OPCH=US / ZI=US / COUR-US</td><td class="leftalignment">Dun & Bradstreet Holdings Inc / Williams Companies Inc / CACI International Inc / Eli Lilly and Co / Life Storage Inc / Amgen Inc / Occidental Petroleum Corp / Global Blood Therapeutics Inc / Amazon.com Inc / TopBuild Corp / Devon Energy Corp / Incyte Corp / Pebblebrook Hotel Trust / Akamai Technologies Inc / Hyatt Hotels Corp / Visa Inc / Comstock Resources Inc / Pioneer Natural Resources Co / Plains All American Pipeline LP / International Game Technology PLC / Marriott International Inc / Leggett & Platt Inc / Activision Blizzard Inc / Kforce Inc / Hilton Worldwide Holdings Inc / Black Knight Inc / CVS Health Corp / Assurant Inc / Bunzl plc / CoStar Group Inc / DaVita Inc / Arthur J Gallagher & Co / Mercury Systems Inc / Microchip Technology Inc / ONEOK Inc / SAGE Therapeutics Inc / Public Storage / Cadence Bank / ManTech International Corp / Match Group Inc / Spirit Realty Capital Inc / Conocophillips / Marinus Pharmaceuticals Inc / Biogen Inc / RingCentral Inc / Caesars Entertainment Inc / KAR Auction Services Inc / Sunstone Hotel Investors Inc / Booz Allen Hamilton Holding Corp / Denny's Corp / SunPower Corp / Fidelity National Information Services Inc / Host Hotels & Resorts Inc / Mastercard Inc / Green Plains Inc / ICF International Inc / Science Applications International Corp / Cadence Bank / Continental Resources Inc / Lumen Technologies Inc / Plains GP Holdings LP / IAA Inc / Kratos Defense and Security Solutions Inc / Camping World Holdings Inc / Parsons Corp / Healthcare Trust Of America Inc / Trex Company Inc / Oasis Petroleum Inc / NXP Semiconductors NV / Green Dot Corp / Pacira Biosciences Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Ryman Hospitality Properties Inc / Diamondback Energy Inc / Noodles & Co / Leidos Holdings Inc / NMI Holdings Inc / Viper Energy Partners LP / Alibaba Group Holding Ltd / New Relic Inc / Walgreens Boots Alliance Inc / Workiva Inc / Easterly Government Properties Inc / National Storage Affiliates Trust / Community Healthcare Trust Inc / Zimmer Biomet Holdings Inc / Block Inc / Mimecast Ltd / Willis Towers Watson PLC / SiteOne Landscape Supply Inc / Centennial Resource Development Inc / Ranger Oil Corp / LCI Industries / Alteryx Inc / Switch Inc / Lyft Inc / L3harris Technologies Inc / Option Care Health Inc / ZoomInfo Technologies Inc / Coursera Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United Kingdom / Ireland / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">2Q21 results: pipeline advancing and await more details on Lumakras launch</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN=US</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">0989529 / 0925288 / 2434209 / 2516152 / 2681511 / 2000019 / 2023607 / 2486813 / 2778844 / 2229126 / 2208073 / 2270726 / 2829515 / 2670519 / 2328915 / 2100920 / 2471950 / 2623911 / 2657802 / 2689560 / 2684703 / 2048804 / 2707677 / 2730190 / 2829601 / 2853688 / 7103065 / 2783815 / 2712013 / B00FWN1 / B0PZN11 / B121557 / 2769796 / 2857817 / B0T7YX2 / B2R3PV1 / B3D7K31 / B4Y1MH7 / 2390817 / B44C366 / B3SWPT2 / B4V9661 / BJ0KXV4 / BDZCRX3 / BFLR866 / BFZCHN7 / BYY8XK8 / BYVY8G0 / BTF8CF0 / BP4GNK9 / BYW36M8 / BYNZGK1 / BJT1RW7 / BD9GVY0 / BJF8Q81 / BZ1LFB2 / BR4T3B3 / BJ2Z0H2 / BLGJ610 / BJJMGL2 / BZ05388 / BDT5KT5 / BKC9SX3 / BFWGXQ7 / BP84RX0 / 021513106 / BNTB3N8</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Home Depot Inc / Eli Lilly and Co / PepsiCo Inc / Amazon.com Inc / Amgen Inc / Kellogg Co / Merck & Co Inc / Columbia Sportswear Co / Copart Inc / Walt Disney Co / Edison International / Exelon Corp / Nextera Energy Inc / FirstEnergy Corp / Incyte Corp / Neurocrine Biosciences Inc / OGE Energy Corp / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / Public Service Enterprise Group Inc / Regeneron Pharmaceuticals Inc / Southern Co / Stryker Corp / Novartis AG / Zimmer Biomet Holdings Inc / Global Payments Inc / Alnylam Pharmaceuticals Inc / Under Armour Inc / Mastercard Inc / Fidelity National Information Services Inc / Netflix Inc / Live Nation Entertainment Inc / American Water Works Company Inc / Discovery Inc / KAR Auction Services Inc / Gray Television Inc / Heska Corp / Ameresco Inc / Ralph Lauren Corp / ONE Gas Inc / RingCentral Inc / Twitter Inc / Wix.Com Ltd / WEC Energy Group Inc / Alphabet Inc / Restaurant Brands International Inc / SAGE Therapeutics Inc / PayPal Holdings Inc / Block Inc / Lyft Inc / Zai Lab Ltd / IAA Inc / Deciphera Pharmaceuticals Inc / HubSpot Inc / Pinterest Inc / Warner Music Group Corp / Fox Corp / Global Blood Therapeutics Inc / Inspire Medical Systems Inc / Arcturus Therapeutics Holdings Inc / Container Store Group Inc / Townsquare Media Inc / Alto Ingredients Inc / Vizio Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">08/04/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - August 4, 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">BP.L / ENI.MI / F.N / GM.N / REP.MC / SEE.N / STO.AX / TOTF.PA / WMB.N / CNQ.TO / LPX.N / AMGN.O / INCY.O / ETN.N / DT.N / CLX.N / MMM.N / XOM.N / DVN.N / EPC.N / JAZZ.O / ALA.TO / DVA.N / RRC.N / EPD.N / NBIX.O / AME.N / WSP.TO / DNB.N / CVX.N / NCR.N / COP.N / MKL.N / CRC.N / LNG.A / MNST.O / STN.TO / SNC.TO / NVT.N / MOS.N / SCL.TO / NESTE.HE / RDSb.L / BLDR.O / ALNY.O / DRX.L / FIS.N / SES.TO / GALP.LS / OC.N / CLR.N / BGS.N / ARX.TO / SWI.N / ADUS.OQ / FICO.N / VRSK.O / CVE.TO / NEE.N / TOU.TO / PCRX.O / XYL.N / TVE.TO / ACHC.O / USAC.N / PRMW.N / RYAM.N / SAGE.OQ / NMIH.O / 03835T200 / GBT.OQ / MIME.OQ / ATKR.N / AZRE.N / AKERBP.OL / AQN.N / RCM.OQ / ORSTED.CO / AQUA.N / NEXA.TO / NTGY.MC / BHC.N / ETRN.N / LYFT.O / UBER.N / 2222.SE / VMD.OQ / NKLA.OQ / AKES.OL / LUMN.N / SKLZ.N / CLVT.N / COUR.N / BHG.N / 120681711</td><td class="leftalignment">BP PLC / Eni SpA / Ford Motor Co / General Motors Co / Repsol SA / Sealed Air Corp / Santos Ltd / TotalEnergies SE / Williams Companies Inc / Canadian Natural Resources Ltd / Louisiana-Pacific Corp / Amgen Inc / Incyte Corp / Eaton Corporation PLC / Dynatrace Inc / Clorox Co / 3M Co / Exxon Mobil Corp / Devon Energy Corp / Edgewell Personal Care Co / Jazz Pharmaceuticals PLC / AltaGas Ltd / DaVita Inc / Range Resources Corp / Enterprise Products Partners LP / Neurocrine Biosciences Inc / AMETEK Inc / WSP Global Inc / Dun & Bradstreet Holdings Inc / Chevron Corp / NCR Corp / Conocophillips / Markel Corp / California Resources Corp / Cheniere Energy Inc / Monster Beverage Corp / Stantec Inc / SNC-Lavalin Group Inc / nVent Electric PLC / Mosaic Co / Shawcor Ltd / Neste Oyj / Royal Dutch Shell PLC / Builders FirstSource Inc / Alnylam Pharmaceuticals Inc / Drax Group PLC / Fidelity National Information Services Inc / Secure Energy Services Inc / Galp Energia SGPS SA / Owens Corning / Continental Resources Inc / B&G Foods Inc / ARC Resources Ltd / SolarWinds Corp / Addus Homecare Corp / Fair Isaac Corp / Verisk Analytics Inc / Cenovus Energy Inc / Nextera Energy Inc / Tourmaline Oil Corp / Pacira Biosciences Inc / Xylem Inc / Tamarack Valley Energy Ltd / Acadia Healthcare Company Inc / USA Compression Partners LP / Primo Water Corp / Rayonier Advanced Materials Inc / SAGE Therapeutics Inc / NMI Holdings Inc / Aptose Biosciences Inc / Global Blood Therapeutics Inc / Mimecast Ltd / Atkore Inc / Azure Power Global Ltd / Aker BP ASA / Algonquin Power & Utilities Corp / R1 RCM Inc / Orsted A/S / Evoqua Water Technologies Corp / Nexa Resources SA / Naturgy Energy Group SA / Bausch Health Companies Inc / Equitrans Midstream Corp / Lyft Inc / Uber Technologies Inc / Saudi Arabian Oil Co / Viemed Healthcare Inc / Nikola Corp / Aker Solutions ASA / Lumen Technologies Inc / Skillz Inc / CLARIVATE PLC / Coursera Inc / Bright Health Group Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Denmark / Spain / Finland / United Kingdom / Ireland / Italy / Luxembourg / Mauritius / Norway / Portugal / Saudi Arabia / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">08/04/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Second Quarter Largely in Line; Focus on Lumakras but Pricing Pressure Seen Across Many Key Products</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">03116210</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Style Comparisons: August 4, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">A.N / AIG.N / APD.N / BDX.N / BR.N / CF.N / CI.N / CVS.N / ED.N / EOG.N / GM.N / LLY.N / MCK.N / STE.N / WMT.N / MET.N / DUK.N / DIS.N / D.N / TSN.N / SYY.N / IFF.N / HD.N / EMR.N / RMD.N / BLL.N / VTR.N / AMGN.OQ / REGN.OQ / TT.N / DISH.OQ / ANSS.OQ / EBAY.OQ / ILMN.OQ / MNST.OQ / VIAC.OQ / TDG.N / MSI.N / MPC.N / EA.OQ / ZTS.N / PRGO.N / CDW.OQ / NCLH.N / ETSY.OQ / KHC.OQ / APTV.N / BKNG.OQ / CTVA.N / EXC.OQ / VTRS.OQ</td><td class="leftalignment">Agilent Technologies Inc / American International Group Inc / Air Products and Chemicals Inc / Becton Dickinson and Co / Broadridge Financial Solutions Inc / CF Industries Holdings Inc / Cigna Corp / CVS Health Corp / Consolidated Edison Inc / EOG Resources Inc / General Motors Co / Eli Lilly and Co / Mckesson Corp / STERIS plc / Walmart Inc / MetLife Inc / Duke Energy Corp / Walt Disney Co / Dominion Energy Inc / Tyson Foods Inc / Sysco Corp / International Flavors & Fragrances Inc / Home Depot Inc / Emerson Electric Co / Resmed Inc / Ball Corp / Ventas Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / DISH Network Corp / ANSYS Inc / eBay Inc / Illumina Inc / Monster Beverage Corp / ViacomCBS Inc / TransDigm Group Inc / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Zoetis Inc / Perrigo Company PLC / CDW Corp / Norwegian Cruise Line Holdings Ltd / ETSY Inc / Kraft Heinz Co / Aptiv PLC / Booking Holdings Inc / Corteva Inc / Exelon Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Ireland / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">AMGN - AMGN 2Q21 postview: COVID continues and pricing pressure weighs on key franchises</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">031162100</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">08/04/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Amgen Inc : 2Q Snapshot - Ok Quarter But Still Waiting on the Emergence of Reliable Growth Drivers</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott</td></tr>
<tr class="odd"><td class="leftalignment">08/04/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">High Grade Healthcare : 2Q21 Earnings (AMGN, LLY, ZBH) — What Mattered for Credit</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AMGN.O / LLY.N</td><td class="leftalignment">Amgen Inc / Eli Lilly and Co</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / FIXED INCOME/DEBT RESEARCH</td><td class="leftalignment">Brett Gibson / Mr. Matthew Bonner</td></tr>
<tr class="even"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">2Q Update Highlights Revenue Growth and Pipeline Progress</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="odd"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q2 Rebounds Above Expectations, Lumakras Launch Off To Impressive Start</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Yaron Werber, M.D., MD / Gabriel Schneider, M.D. / Brendan Smith, Ph.D. / Eve Reilly, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">08/03/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Q2:21 post-call: Q2 beat on COVID-19 growth rebound, but uncertainty prevents guide raise</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Kennen MacKay, PHD</td></tr>
<tr class="odd"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Operational Progress, But Signs of Competitive Pressure Mounting</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">031162100</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">08/03/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Q2 & KRAS tidbits</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="odd"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">AMGN (NEUTRAL) - Revenue in Line While EPS Beats; Continued Recovery from Pandemic but L/T Growth Concerns Persist</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">2023607</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="even"><td class="leftalignment">08/03/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Amgen Inc : First Look at 2Q Results</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott</td></tr>
<tr class="odd"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">AMGN.OQ - Event Brief of Amgen Inc conference call, Aug. 03, 2021 / 5:00PM ET</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">AMGN.OQ - Event Transcript of Amgen Inc conference call, Aug. 03, 2021 / 5:00PM ET</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Q221 First Take: Not Lighting the World on Fire, But After Q121, We'll Take It</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Zephirin Group, Inc.</td><td class="leftalignment">Zephirin Group View: The Dating Game - Key Quarterly Earnings on August 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LYFT.OQ / BP.L / DD.N / FMC.N / IBM.N / LLY.N / OXY.N / PEG.N / RL.N / SEE.N / SLB.N / WAT.N / BEN.N / HAL.N / ETN.N / CMI.N / AIZ.N / PGR.N / CLX.N / UNM.N / WEC.N / XOM.N / DVN.N / IT.N / DVA.N / PSA.N / OKE.N / AME.N / DNB.N / PRU.N / COP.N / AMGN.OQ / AAPL.OQ / EXPD.OQ / ATVI.OQ / MSFT.OQ / SBUX.OQ / MCHP.OQ / INCY.OQ / HSIC.OQ / AMZN.OQ / ZBRA.OQ / AKAM.OQ / 0700.HK / RDSa.L / LYV.N / FIS.N / IPGP.OQ / 9999.HK / VRSK.OQ / CZR.OQ / BKR.N / XYL.N / PSXP.N / LDOS.N / MAR.OQ / TSLX.N / PAYC.N / ZBH.N / PINS.N / BYND.OQ / UBER.N / ZM.OQ / LHX.N / PEAK.N / 9988.HK / J.N / 9618.HK / HST.OQ / ABNB.OQ / WTY.F</td><td class="leftalignment">Lyft Inc / BP PLC / Dupont De Nemours Inc / FMC Corp / International Business Machines Corp / Eli Lilly and Co / Occidental Petroleum Corp / Public Service Enterprise Group Inc / Ralph Lauren Corp / Sealed Air Corp / Schlumberger NV / Waters Corp / Franklin Resources Inc / Halliburton Co / Eaton Corporation PLC / Cummins Inc / Assurant Inc / Progressive Corp / Clorox Co / Unum Group / WEC Energy Group Inc / Exxon Mobil Corp / Devon Energy Corp / Gartner Inc / DaVita Inc / Public Storage / ONEOK Inc / AMETEK Inc / Dun & Bradstreet Holdings Inc / Prudential Financial Inc / Conocophillips / Amgen Inc / Apple Inc / Expeditors International of Washington Inc / Activision Blizzard Inc / Microsoft Corp / Starbucks Corp / Microchip Technology Inc / Incyte Corp / Henry Schein Inc / Amazon.com Inc / Zebra Technologies Corp / Akamai Technologies Inc / Tencent Holdings Ltd / Royal Dutch Shell PLC / Live Nation Entertainment Inc / Fidelity National Information Services Inc / IPG Photonics Corp / NetEase Inc / Verisk Analytics Inc / Caesars Entertainment Inc / Baker Hughes Co / Xylem Inc / Phillips 66 Partners LP / Leidos Holdings Inc / Marriott International Inc / Sixth Street Specialty Lending Inc / Paycom Software Inc / Zimmer Biomet Holdings Inc / Pinterest Inc / Beyond Meat Inc / Uber Technologies Inc / Zoom Video Communications Inc / L3harris Technologies Inc / Healthpeak Properties Inc / Alibaba Group Holding Ltd / Jacobs Engineering Group Inc / JD.Com Inc / Host Hotels & Resorts Inc / Airbnb Inc / Willis Towers Watson PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United Kingdom / Ireland / United States / Curaçao</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Communications / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Office Equipment / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Semiconductors / Services / Shipping & Shipbuilding / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment">INVESTMENT STRATEGY / CAPITALIZATION / GOVERNMENT RELATIONS/REGULATIONS / MISCELLANEOUS / SMALL CAPITAL / GOVERNMENTS / RELATIVE VALUE / TRADING / GROWTH / INDEX / PORTFOLIO STRATEGY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Longdley Zephirin</td></tr>
<tr class="odd"><td class="leftalignment">08/03/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Delta Continues to Drive Domestic and Global Growth; Vaccines Continue to Show Efficacy Despite Breakthrough Infections</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / John Boyle / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers / Lachlan Hanbury-Brown</td></tr>
<tr class="even"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: August 2021</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">AIRP.PA / ALB.N / ALK.N / AXP.N / BA.N / BAC.N / BAX.N / BDX.N / C.N / CCL.N / CI.N / COF.N / CRM.N / DAL.N / FCX.N / GM.N / GPS.N / JNJ.N / JPM.N / KMB.N / LLY.N / LSI.N / LUV.N / MDT.N / MO.N / NEM.N / PFE.N / PM.N / SC.N / T.N / TMO.N / U.N / WAT.N / WFC.N / PG.N / NUE.N / CPB.N / W.N / AAL.L / DHR.N / DIS.N / UNH.N / CMI.N / D.N / DE.N / CAT.N / MGM.N / SPOT.N / GS.N / CLX.N / CAG.N / GIS.N / PCG.N / XOM.N / DVN.N / RMD.N / NKE.N / OLN.N / IT.N / TGT.N / RKT.N / PKI.N / VZ.N / WST.N / MUR.N / KSS.N / ORCL.N / PWR.N / COG.N / EFX.N / V.N / EW.N / CPT.N / HWM.N / ACN.N / PLD.N / CHD.N / AIV.N / HAE.N / MKC.N / MAA.N / LB.TO / SAM.N / BLK.N / CRL.N / CVX.N / MHK.N / GME.N / INTC.OQ / ADBE.OQ / ANAT.OQ / AMGN.OQ / AAPL.OQ / AMAT.OQ / CSCO.OQ / ATVI.OQ / MSFT.OQ / PBCT.OQ / TEAM.OQ / REGN.OQ / SIVB.OQ / QDEL.OQ / CACC.OQ / IDXX.OQ / QCOM.OQ / SMG.N / INTU.OQ / GILD.OQ / DFS.N / COST.OQ / CPRT.OQ / INCY.OQ / NKTR.OQ / PENN.OQ / DLTR.OQ / POOL.OQ / TPR.N / NBIX.OQ / CTXS.OQ / AMZN.OQ / MANH.OQ / NVDA.OQ / BMRN.OQ / TREE.OQ / EXEL.OQ / ISRG.OQ / BLUE.OQ / ARRY.OQ / EXAS.OQ / ALGN.OQ / VRTX.OQ / JBLU.OQ / DKS.N / WYNN.OQ / CMCSA.OQ / TPX.N / TFC.N / ACAD.OQ / CG.TO / DPZ.N / MOS.N / DLR.N / LVS.N / DXCM.OQ / WAL.N / DISCA.OQ / MS.N / STX.AX / MA.N / IVZ.N / TDC.N / MRNA.OQ / MSCI.N / AVGO.OQ / FTNT.OQ / MU.OQ / GNRC.N / TSLA.OQ / Z.OQ / AMD.OQ / SLM.OQ / ENPH.OQ / TRIP.OQ / EPAM.N / SPLK.OQ / PSX.N / SRPT.OQ / GMED.N / ALLY.N / PRGO.N / COTY.N / COMM.OQ / NCLH.N / GOOGL.OQ / SAGE.OQ / HUBS.N / WBA.OQ / TDOC.N / PYPL.OQ / GBT.OQ / IONS.OQ / RETA.OQ / COUP.OQ / LW.N / AYX.N / DXC.N / CVNA.N / IOVA.OQ / AXON.OQ / WDAY.OQ / ROKU.OQ / BKNG.OQ / CBRE.N / FB.PS / CPRI.N / NFE.OQ / PINS.N / FSLY.N / CRWD.OQ / RTX.N / LMND.N / GOCO.OQ / CVAC.OQ / AMWL.N / PLTR.N / VTRS.OQ / TSP.OQ / HON.OQ</td><td class="leftalignment">L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Albemarle Corp / Alaska Air Group Inc / American Express Co / Boeing Co / Bank of America Corp / Baxter International Inc / Becton Dickinson and Co / Citigroup Inc / Carnival Corp / Cigna Corp / Capital One Financial Corp / Salesforce.Com Inc / Delta Air Lines Inc / Freeport-McMoRan Inc / General Motors Co / Gap Inc / Johnson & Johnson / JPMorgan Chase & Co / Kimberly-Clark Corp / Eli Lilly and Co / Life Storage Inc / Southwest Airlines Co / Medtronic PLC / Altria Group Inc / Newmont Corporation / Pfizer Inc / Philip Morris International Inc / Santander Consumer USA Holdings Inc / AT&T Inc / Thermo Fisher Scientific Inc / Unity Software Inc / Waters Corp / Wells Fargo & Co / Procter & Gamble Co / Nucor Corp / Campbell Soup Co / Wayfair Inc / Anglo American PLC / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Cummins Inc / Dominion Energy Inc / Deere & Co / Caterpillar Inc / MGM Resorts International / Spotify Technology SA / Goldman Sachs Group Inc / Clorox Co / Conagra Brands Inc / General Mills Inc / PG&E Corp / Exxon Mobil Corp / Devon Energy Corp / Resmed Inc / Nike Inc / Olin Corp / Gartner Inc / Target Corp / Rocket Companies Inc / PerkinElmer Inc / Verizon Communications Inc / West Pharmaceutical Services Inc / Murphy Oil Corp / Kohls Corp / Oracle Corp / Quanta Services Inc / Coterra Energy Inc / Equifax Inc / Visa Inc / Edwards Lifesciences Corp / Camden Property Trust / Howmet Aerospace Inc / Accenture PLC / Prologis Inc / Church & Dwight Co Inc / Apartment Investment and Management Co / Haemonetics Corp / McCormick & Company Inc / Mid-America Apartment Communities Inc / Laurentian Bank of Canada / Boston Beer Company Inc / BlackRock Inc / Charles River Laboratories International Inc / Chevron Corp / Mohawk Industries Inc / GameStop Corp / Intel Corp / Adobe Inc / American National Group Inc / Amgen Inc / Apple Inc / Applied Materials Inc / Cisco Systems Inc / Activision Blizzard Inc / Microsoft Corp / People's United Financial Inc / Atlassian Corporation PLC / Regeneron Pharmaceuticals Inc / SVB Financial Group / Quidel Corp / Credit Acceptance Corp / IDEXX Laboratories Inc / Qualcomm Inc / Scotts Miracle-Gro Co / Intuit Inc / Gilead Sciences Inc / Discover Financial Services / Costco Wholesale Corp / Copart Inc / Incyte Corp / Nektar Therapeutics / Penn National Gaming Inc / Dollar Tree Inc / Pool Corp / Tapestry Inc / Neurocrine Biosciences Inc / Citrix Systems Inc / Amazon.com Inc / Manhattan Associates Inc / NVIDIA Corp / Biomarin Pharmaceutical Inc / Lendingtree Inc / Exelixis Inc / Intuitive Surgical Inc / bluebird bio Inc / Array Technologies Inc / Exact Sciences Corp / Align Technology Inc / Vertex Pharmaceuticals Inc / JetBlue Airways Corp / DICK'S Sporting Goods Inc / Wynn Resorts Ltd / Comcast Corp / Tempur Sealy International Inc / Truist Financial Corp / ACADIA Pharmaceuticals Inc / Centerra Gold Inc / Domino's Pizza Inc / Mosaic Co / Digital Realty Trust Inc / Las Vegas Sands Corp / Dexcom Inc / Western Alliance Bancorp / Discovery Inc / Morgan Stanley / Strike Energy Ltd / Mastercard Inc / Invesco Ltd / Teradata Corp / Moderna Inc / MSCI Inc / Broadcom Inc / Fortinet Inc / Micron Technology Inc / Generac Holdings Inc / Tesla Inc / Zillow Group Inc / Advanced Micro Devices Inc / SLM Corp / Enphase Energy Inc / Tripadvisor Inc / Epam Systems Inc / Splunk Inc / Phillips 66 / Sarepta Therapeutics Inc / Globus Medical Inc / Ally Financial Inc / Perrigo Company PLC / Coty Inc / CommScope Holding Company Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / SAGE Therapeutics Inc / HubSpot Inc / Walgreens Boots Alliance Inc / Teladoc Health Inc / PayPal Holdings Inc / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Reata Pharmaceuticals Inc / Coupa Software Inc / Lamb Weston Holdings Inc / Alteryx Inc / DXC Technology Co / Carvana Co / Iovance Biotherapeutics Inc / Axon Enterprise Inc / Workday Inc / Roku Inc / Booking Holdings Inc / CBRE Group Inc / San Miguel Food and Beverage Inc / Capri Holdings Ltd / New Fortress Energy Inc / Pinterest Inc / Fastly Inc / CrowdStrike Holdings Inc / Raytheon Technologies Corp / Lemonade Inc / Gohealth Inc / CureVac NV / American Well Corp / Palantir Technologies Inc / Viatris Inc / TuSimple Holdings Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / France / United Kingdom / Ireland / Luxembourg / Netherlands / Panama / Philippines / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4151.T: Kyowa Kirin - 1H FY12/21 results: Slightly negative surprise due to earnings dip despite growth in sales</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">4151.T / AMGN.OQ</td><td class="leftalignment">Kyowa Kirin Co Ltd / Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Revisions: August 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">AIG.N / APD.N / BDX.N / CF.N / CI.N / CVS.N / DD.N / ED.N / EOG.N / GM.N / LLY.N / MCK.N / STE.N / MET.N / ETN.N / DUK.N / CMI.N / D.N / TSN.N / SYY.N / IFF.N / EMR.N / RMD.N / BLL.N / PSA.N / AME.N / VTR.N / PRU.N / COP.N / AMGN.OQ / ATVI.OQ / REGN.OQ / TT.N / MCHP.OQ / DISH.OQ / ANSS.OQ / EBAY.OQ / SBAC.OQ / EXPE.OQ / ILMN.OQ / MNST.OQ / VIAC.OQ / FIS.N / TDG.N / NXPI.OQ / MSI.N / MPC.N / EA.OQ / PSX.N / ZTS.N / PRGO.N / CDW.OQ / MAR.OQ / NCLH.N / ETSY.OQ / ZBH.N / KHC.OQ / APTV.N / BKNG.OQ / CTVA.N / EXC.OQ / VTRS.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / Becton Dickinson and Co / CF Industries Holdings Inc / Cigna Corp / CVS Health Corp / Dupont De Nemours Inc / Consolidated Edison Inc / EOG Resources Inc / General Motors Co / Eli Lilly and Co / Mckesson Corp / STERIS plc / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Cummins Inc / Dominion Energy Inc / Tyson Foods Inc / Sysco Corp / International Flavors & Fragrances Inc / Emerson Electric Co / Resmed Inc / Ball Corp / Public Storage / AMETEK Inc / Ventas Inc / Prudential Financial Inc / Conocophillips / Amgen Inc / Activision Blizzard Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Microchip Technology Inc / DISH Network Corp / ANSYS Inc / eBay Inc / SBA Communications Corp / Expedia Group Inc / Illumina Inc / Monster Beverage Corp / ViacomCBS Inc / Fidelity National Information Services Inc / TransDigm Group Inc / NXP Semiconductors NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / Zoetis Inc / Perrigo Company PLC / CDW Corp / Marriott International Inc / Norwegian Cruise Line Holdings Ltd / ETSY Inc / Zimmer Biomet Holdings Inc / Kraft Heinz Co / Aptiv PLC / Booking Holdings Inc / Corteva Inc / Exelon Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Ireland / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4151.T: 協和キリン - 1H決算：ややネガティブサプライズ的な増収減益決算</td><td class="leftalignment">Japanese</td><td class="rightalignment">6</td><td class="leftalignment">4151.T / AMGN.OQ</td><td class="leftalignment">Kyowa Kirin Co Ltd / Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">08/03/2021</td><td class="leftalignment">ValuEngine, Inc</td><td class="leftalignment">ValuEngine Rating and Forecast Report for AMGN</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Paul Henneman</td></tr>
<tr class="odd"><td class="leftalignment">08/02/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Amgen Inc Investment Status Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="even"><td class="leftalignment">08/02/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending July 23, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">08/02/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ALB.N / BAC.N / BE / BSX / C.N / CAT / CLH / CMI / COF / DAN / DE / ENS / GS / INTC.O / JCI / JEF / JPM / LRCX.O / MDT / MS / NEP / ORA / PNC.N / RSG / URI / USB / WFC.N / WM / AMGN.O / BWA.N / NVDA.O / SQ / MPWR.O / GWW.N / EW.N / PZZA.O / IO.N / FCEL.O / ALGN.O / CREE.O / AOS.N / AMSC.OQ / INCY.OQ / NBIX.OQ / PLUG.OQ / EXPE.OQ / VRTX.OQ / SIVB.O / TRMB.O / ITRI.O / 364760108 / 316773100 / DPZ / ATRC.OQ / G02602103 / 029899101 / SPWR.O / XPO / CSIQ.O / FSLR.O / IVZ / TMDX.OQ / TWIN.O / AGCO.K / TSLA.O / AMRC.K / AMRS.OQ / QSR.TO / TRIP.O / ENPH.O / 501797104 / HASI.N / PTC.O / 174610105 / QRVO.O / WING.O / SEDG.O / RUN.O / WKHS.O / WCN.TO / AQMS.O / WPRT.TO / 00973N102 / AQB.O / APTV.K / 83417M104 / BKNG.O / CBOE.Z / CWENa.K / CRSP.BN / 00972D105 / AVNT.K / 02081G201 / RWRh.V / HGEN.O / 010196103</td><td class="leftalignment">Albemarle Corp / Bank of America Corp / Bloom Energy Corp / Boston Scientific Corp / Citigroup Inc / Caterpillar Inc / Clean Harbors Inc / Cummins Inc / Capital One Financial Corp / Dana Inc / Deere & Co / EnerSys / Goldman Sachs Group Inc / Intel Corp / Johnson Controls International PLC / Jefferies Financial Group Inc / JPMorgan Chase & Co / Lam Research Corp / Medtronic PLC / Morgan Stanley / Nextera Energy Partners LP / Ormat Technologies Inc / PNC Financial Services Group Inc / Republic Services Inc / United Rentals Inc / US Bancorp / Wells Fargo & Co / Waste Management Inc / Amgen Inc / Borgwarner Inc / NVIDIA Corp / Block Inc / Monolithic Power Systems Inc / W W Grainger Inc / Edwards Lifesciences Corp / Papa John's International Inc / ION Geophysical Corp / Fuelcell Energy Inc / Align Technology Inc / Wolfspeed Inc / A O Smith Corp / American Superconductor Corp / Incyte Corp / Neurocrine Biosciences Inc / Plug Power Inc / Expedia Group Inc / Vertex Pharmaceuticals Inc / SVB Financial Group / Trimble Inc / Itron Inc / Gap Inc / Fifth Third Bancorp / Domino's Pizza Inc / AtriCure Inc / Amdocs Ltd / American States Water Co / SunPower Corp / XPO Logistics Inc / Canadian Solar Inc / First Solar Inc / Invesco Ltd / Transmedics Group Inc / Twin Disc Inc / AGCO Corp / Tesla Inc / Ameresco Inc / Amyris Inc / Restaurant Brands International Inc / Tripadvisor Inc / Enphase Energy Inc / Bath & Body Works Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / PTC Inc / Citizens Financial Group Inc / Qorvo Inc / Wingstop Inc / Solaredge Technologies Inc / Sunrun Inc / Workhorse Group Inc / Waste Connections Inc / Aqua Metals Inc / Westport Fuel Systems Inc / Akoustis Technologies Inc / AquaBounty Technologies Inc / Aptiv PLC / Solaredge Technologies Inc / Booking Holdings Inc / Cboe Global Markets Inc / Clearway Energy Inc / CRISPR Therapeutics AG / Akebia Therapeutics Inc / Avient Corp / Alphatec Holdings Inc / Strathmore Plus Energy Corp / Humanigen Inc / Aksys Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Ireland / United States / Jersey / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/02/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - August 2, 2021</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">AAP.N / AEP.N / AES.N / ALV.N / BARC.L / BBY.N / CL.N / COST.O / DFDS.CO / EIX.N / EL.N / F.N / FLS.N / FLT.N / FMS.N / GE.N / GM.N / GPS.N / HTG.L / KMB.N / KO.N / L.TO / MO.N / MSFT.O / PEG.N / RL.N / SO.N / T.N / VC.N / WMT.N / PEP.N / CERN.O / ACI.N / BFb.N / PG.N / WY.N / CFP.TO / CPB.N / TEN.N / CMCSA.O / AMGN.O / UHS.N / DHR.N / BWA.N / LEA.N / WCC.N / DOV.N / IEX.N / ROP.N / ENB.TO / K.N / DT.N / DISH.O / CLX.N / CAG.N / HON.N / HD.N / LOW.N / MMM.N / GIS.N / EMR.N / HSY.N / EPC.N / AMT.N / NKE.N / CONE.O / MRU.TO / GWW.N / VZ.N / JCI.N / ARNA.O / STZ.N / VFC.N / APH.N / TJX.N / AZO.N / KMX.N / FISV.O / V.N / CPT.N / ROST.O / CHTR.O / AXL.N / DLTR.O / DG.N / CHD.N / ESS.N / NWN.N / AME.N / ANF.N / BC.N / GPC.N / PVH.N / SAM.N / CTSH.O / FRAG.DE / BMRN.O / REGN.O / ENR.N / VRTX.O / FTT.TO / MHK.N / SM.N / NCR.N / TEL.N / URBN.O / SSNC.O / WG.L / TSCO.O / CPK.N / CHE.N / GGG.N / PNR.N / PII.N / ST.N / SWN.N / TT.N / SEM.N / SGEN.OQ / GPN.N / DKS.N / PFS.N / MNST.O / IMGN.O / CASY.O / ORLY.O / AMED.O / EQIX.O / ATDb.TO / TIH.TO / NVT.N / DLR.N / LHCG.O / PFC.L / SJW.N / FIS.N / MA.N / MWA.N / HOG.N / MERC.O / PRTS.OQ / AEO.N / 3IN.L / AON.N / BGS.N / LULU.O / GETP.PA / ENSG.O / DAN.N / PBF.N / SWI.N / ADUS.OQ / SPB.N / ENV.N / NEE.N / NXT.AX / CFX.TO / SUBC.OL / CTT.N / MTOR.N / GLEN.L / IFP.TO / ACHC.O / SPLK.OQ / RFP.N / FIVE.OQ / FFHu.TO / MDLZ.OQ / ABBV.N / TSLA.N / PRMW.N / TMUS.N / COTY.N / PRTA.O / BEP.N / AGIO.O / 81762P102 / BURL.N / LB.N / PLC.TO / COUP.N / VRNS.O / QTWO.N / NEP.N / SHLX.N / AENA.MC / EVA.N / PYPL.OQ / OLLI.OQ / AROC.N / SQ.N / MIME.OQ / MESO.O / RACE.MI / SRENH.S / FTV.N / TWLO.N / ATKR.N / TTD.O / ADNT.N / UAA.N / PBYI.OQ / RCM.OQ / GOOS.TO / DXC.N / VST.N / ATUS.N / AQUA.N / APTV.N / EHC.N / GTES.N / BSIG.N / SMAR.N / DBX.O / VNE.N / NTGY.MC / KDP.N / BHC.N / FOCS.O / ESTC.N / NWL.O / AVTR.N / NOVA.N / PING.N / DDOG.O / CRNC.OQ / EPAC.N / PNTG.OQ / REYN.O / CARR.N / NKLA.OQ / FOUR.N / MGNI.OQ / AKES.OL / RXT.OQ / IBEX.O / ACC-ME.OL / LUMN.N / ASAN.N / 900435207 / LSPD.N / WFG.N / TIXT.TO / AFRM.O / TE.PA / NAPA.N / OTLY.O / EVCM.O / 120681711</td><td class="leftalignment">Advance Auto Parts Inc / American Electric Power Company Inc / AES Corp / Autoliv Inc / Barclays PLC / Best Buy Co Inc / Colgate-Palmolive Co / Costco Wholesale Corp / DFDS AS / Edison International / Estee Lauder Companies Inc / Ford Motor Co / Flowserve Corp / Fleetcor Technologies Inc / Fresenius Medical Care AG & Co KGaA / General Electric Co / General Motors Co / Gap Inc / Hunting PLC / Kimberly-Clark Corp / Coca-Cola Co / Loblaw Companies Ltd / Altria Group Inc / Microsoft Corp / Public Service Enterprise Group Inc / Ralph Lauren Corp / Southern Co / AT&T Inc / Visteon Corp / Walmart Inc / PepsiCo Inc / Cerner Corp / Albertsons Companies Inc / Brown-Forman Corp / Procter & Gamble Co / Weyerhaeuser Co / Canfor Corp / Campbell Soup Co / Tenneco Inc / Comcast Corp / Amgen Inc / Universal Health Services Inc / Danaher Corp / Borgwarner Inc / Lear Corp / Wesco International Inc / Dover Corp / IDEX Corp / Roper Technologies Inc / Enbridge Inc / Kellogg Co / Dynatrace Inc / DISH Network Corp / Clorox Co / Conagra Brands Inc / Honeywell International Inc / Home Depot Inc / Lowe's Companies Inc / 3M Co / General Mills Inc / Emerson Electric Co / Hershey Co / Edgewell Personal Care Co / American Tower Corp / Nike Inc / CyrusOne Inc / Metro Inc / W W Grainger Inc / Verizon Communications Inc / Johnson Controls International PLC / Arena Pharmaceuticals Inc / Constellation Brands Inc / VF Corp / Amphenol Corp / TJX Companies Inc / Autozone Inc / Carmax Inc / Fiserv Inc / Visa Inc / Camden Property Trust / Ross Stores Inc / Charter Communications Inc / American Axle & Manufacturing Holdings Inc / Dollar Tree Inc / Dollar General Corp / Church & Dwight Co Inc / Essex Property Trust Inc / Northwest Natural Holding Co / AMETEK Inc / Abercrombie & Fitch Co / Brunswick Corp / Genuine Parts Co / PVH Corp / Boston Beer Company Inc / Cognizant Technology Solutions Corp / Fraport AG Frankfurt Airport Services Worldwide / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Vertex Pharmaceuticals Inc / Finning International Inc / Mohawk Industries Inc / SM Energy Co / NCR Corp / TE Connectivity Ltd / Urban Outfitters Inc / SS&C Technologies Holdings Inc / John Wood Group PLC / Tractor Supply Co / Chesapeake Utilities Corp / Chemed Corp / Graco Inc / Pentair PLC / Polaris Inc / Sensata Technologies Holding PLC / Southwestern Energy Co / Trane Technologies PLC / Select Medical Holdings Corp / Seagen Inc / Global Payments Inc / DICK'S Sporting Goods Inc / Provident Financial Services Inc / Monster Beverage Corp / ImmunoGen Inc / Caseys General Stores Inc / O'Reilly Automotive Inc / Amedisys Inc / Equinix Inc / Alimentation Couche-Tard Inc / Toromont Industries Ltd / nVent Electric PLC / Digital Realty Trust Inc / LHC Group Inc / Petrofac Ltd / SJW Group / Fidelity National Information Services Inc / Mastercard Inc / Mueller Water Products Inc / Harley-Davidson Inc / Mercer International Inc / Carparts.Com Inc / American Eagle Outfitters Inc / 3I Infrastructure PLC / Aon PLC / B&G Foods Inc / Lululemon Athletica Inc / Getlink SE / Ensign Group Inc / Dana Inc / PBF Energy Inc / SolarWinds Corp / Addus Homecare Corp / Spectrum Brands Holdings Inc / Envestnet Inc / Nextera Energy Inc / NEXTDC Ltd / Canfor Pulp Products Inc / Subsea 7 SA / CatchMark Timber Trust Inc / Meritor Inc / Glencore PLC / Interfor Corp / Acadia Healthcare Company Inc / Splunk Inc / Resolute Forest Products Inc / Five Below Inc / Fairfax Financial Holdings Ltd / Mondelez International Inc / Abbvie Inc / Tesla Inc / Primo Water Corp / T-Mobile US Inc / Coty Inc / Prothena Corporation PLC / Brookfield Renewable Partners LP / Agios Pharmaceuticals Inc / ServiceNow Inc / Burlington Stores Inc / Bath & Body Works Inc / Park Lawn Corp / Coupa Software Inc / Varonis Systems Inc / Q2 Holdings Inc / Nextera Energy Partners LP / Shell Midstream Partners LP / Aena SME SA / Enviva Inc / PayPal Holdings Inc / Ollie's Bargain Outlet Holdings Inc / Archrock Inc / Block Inc / Mimecast Ltd / Mesoblast Ltd / Ferrari NV / Swiss Re AG / Fortive Corp / Twilio Inc / Atkore Inc / Trade Desk Inc / Adient PLC / Under Armour Inc / Puma Biotechnology Inc / R1 RCM Inc / Canada Goose Holdings Inc / DXC Technology Co / Vistra Corp / Altice USA Inc / Evoqua Water Technologies Corp / Aptiv PLC / Encompass Health Corp / Gates Industrial Corporation PLC / Brightsphere Investment Group Inc / Smartsheet Inc / Dropbox Inc / Veoneer Inc / Naturgy Energy Group SA / Keurig Dr Pepper Inc / Bausch Health Companies Inc / Focus Financial Partners Inc / Elastic NV / Newell Brands Inc / Avantor Inc / Sunnova Energy International Inc / Ping Identity Holding Corp / Datadog Inc / Cerence Inc / Enerpac Tool Group Corp / Pennant Group Inc / Reynolds Consumer Products Inc / Carrier Global Corp / Nikola Corp / Shift4 Payments Inc / Magnite Inc / Aker Solutions ASA / Rackspace Technology Inc / Ibex Ltd / Aker Carbon Capture ASA / Lumen Technologies Inc / Asana Inc / Turquoise Hill Resources Ltd / Lightspeed Commerce Inc / West Fraser Timber Co Ltd / Telus International Cda Inc / Affirm Holdings Inc / Technip Energies NV / Duckhorn Portfolio Inc / Oatly Group AB / EverCommerce Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Ireland / Luxembourg / Netherlands / Norway / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">08/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Calendar: August 2, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">AEE.N / AES.N / AIG.N / APD.N / BDX.N / BR.N / CAH.N / CF.N / CI.N / CVS.N / DD.N / ED.N / EOG.N / FLT.N / GM.N / LLY.N / MCK.N / PEG.N / STE.N / WMB.N / SPG.N / PG.N / PXD.N / MET.N / ETN.N / DUK.N / DIS.N / CMI.N / D.N / PH.N / TSN.N / SYY.N / IFF.N / VNO.N / EMR.N / VMC.N / WEC.N / XOM.N / RMD.N / BLL.N / PSA.N / AWK.N / LEG.N / AME.N / VTR.N / CVX.N / PRU.N / L.N / COP.N / AMGN.OQ / ATVI.OQ / REGN.OQ / TT.N / MCHP.OQ / O.N / DISH.OQ / ANSS.OQ / TTWO.OQ / EBAY.OQ / ZBRA.OQ / SBAC.OQ / EXPE.OQ / ILMN.OQ / GPN.N / MNST.OQ / MOS.N / VIAC.OQ / FIS.N / TDG.N / PPL.TO / VRSK.OQ / NXPI.OQ / MSI.N / MPC.N / EA.OQ / PSX.N / WDC.OQ / FANG.OQ / ZTS.N / PRGO.N / CDW.OQ / MAR.OQ / NCLH.N / ANET.N / QRVO.OQ / ETSY.OQ / ZBH.N / KHC.OQ / WLTW.OQ / APTV.N / BKNG.OQ / CTVA.N / EXC.OQ / VTRS.OQ</td><td class="leftalignment">Ameren Corp / AES Corp / American International Group Inc / Air Products and Chemicals Inc / Becton Dickinson and Co / Broadridge Financial Solutions Inc / Cardinal Health Inc / CF Industries Holdings Inc / Cigna Corp / CVS Health Corp / Dupont De Nemours Inc / Consolidated Edison Inc / EOG Resources Inc / Fleetcor Technologies Inc / General Motors Co / Eli Lilly and Co / Mckesson Corp / Public Service Enterprise Group Inc / STERIS plc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Walt Disney Co / Cummins Inc / Dominion Energy Inc / Parker-Hannifin Corp / Tyson Foods Inc / Sysco Corp / International Flavors & Fragrances Inc / Vornado Realty Trust / Emerson Electric Co / Vulcan Materials Co / WEC Energy Group Inc / Exxon Mobil Corp / Resmed Inc / Ball Corp / Public Storage / American Water Works Company Inc / Leggett & Platt Inc / AMETEK Inc / Ventas Inc / Chevron Corp / Prudential Financial Inc / Loews Corp / Conocophillips / Amgen Inc / Activision Blizzard Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Microchip Technology Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Take-Two Interactive Software Inc / eBay Inc / Zebra Technologies Corp / SBA Communications Corp / Expedia Group Inc / Illumina Inc / Global Payments Inc / Monster Beverage Corp / Mosaic Co / ViacomCBS Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Pembina Pipeline Corp / Verisk Analytics Inc / NXP Semiconductors NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / Western Digital Corp / Diamondback Energy Inc / Zoetis Inc / Perrigo Company PLC / CDW Corp / Marriott International Inc / Norwegian Cruise Line Holdings Ltd / Arista Networks Inc / Qorvo Inc / ETSY Inc / Zimmer Biomet Holdings Inc / Kraft Heinz Co / Willis Towers Watson PLC / Aptiv PLC / Booking Holdings Inc / Corteva Inc / Exelon Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Ireland / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">08/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">PMVP - Precision Oncology Against Mutant p53 - The Next KRAS? Initiating Coverage with a BUY Rating and $56 PT</td><td class="leftalignment">English</td><td class="rightalignment">36</td><td class="leftalignment">BMW5084 / 0989529 / 2126335 / 2023607 / 2684703 / 7103065 / BCBVTX1 / BN2RM92</td><td class="leftalignment">PMV Pharmaceuticals Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Amgen Inc / Pfizer Inc / Novartis AG / Agios Pharmaceuticals Inc / Rain Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">08/01/2021</td><td class="leftalignment">Probes Reporter</td><td class="leftalignment">Watch List: 79 US Companies with Undisclosed SEC Probes</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AMZN.OQ / T.N / AEP.N / BAC.N / CL.N / COF.N / CRM.N / F.N / HLT.N / PNC.N / SLB.N / TMO.N / BEN.N / THC.N / REV.N / ADM.N / VLO.N / UPS.N / KR.N / XOM.N / NKE.N / SNN.N / AMP.N / ARW.N / ATO.N / TWTR.N / TUP.N / OMI.N / CVX.N / TDY.N / AMGN.OQ / CSCO.OQ / GNTX.OQ / HBAN.OQ / MGPI.OQ / REGN.OQ / ROL.N / SEIC.OQ / RARE.OQ / GILD.OQ / COST.OQ / NKTR.OQ / AZPN.OQ / MYGN.OQ / SSNC.OQ / CTXS.OQ / NVDA.OQ / CHTR.OQ / TNP.N / NFLX.OQ / EGBN.OQ / CVGI.OQ / RUSHA.OQ / NDAQ.OQ / THS.N / KOP.N / MA.N / SIX.N / AON.N / BX.N / INO.OQ / BGCP.OQ / UTL.N / SCHW.N / MSI.N / GRPN.OQ / FB.OQ / COTY.N / CTG.OQ / ANTM.N / NTRA.OQ / PYPL.OQ / PFX.N / MFIN.OQ / DXC.N / IQV.N / WELL.N / TLRY.OQ / US29350E1047 / LYFT.O / CTVA.N</td><td class="leftalignment">Amazon.com Inc / AT&T Inc / American Electric Power Company Inc / Bank of America Corp / Colgate-Palmolive Co / Capital One Financial Corp / Salesforce.Com Inc / Ford Motor Co / Hilton Worldwide Holdings Inc / PNC Financial Services Group Inc / Schlumberger NV / Thermo Fisher Scientific Inc / Franklin Resources Inc / Tenet Healthcare Corp / Revlon Inc / Archer-Daniels-Midland Co / Valero Energy Corp / United Parcel Service Inc / Kroger Co / Exxon Mobil Corp / Nike Inc / Smith & Nephew PLC / Ameriprise Financial Inc / Arrow Electronics Inc / Atmos Energy Corp / Twitter Inc / Tupperware Brands Corp / Owens & Minor Inc / Chevron Corp / Teledyne Technologies Inc / Amgen Inc / Cisco Systems Inc / Gentex Corp / Huntington Bancshares Inc / MGP Ingredients Inc / Regeneron Pharmaceuticals Inc / Rollins Inc / SEI Investments Co / Ultragenyx Pharmaceutical Inc / Gilead Sciences Inc / Costco Wholesale Corp / Nektar Therapeutics / Aspen Technology Inc / Myriad Genetics Inc / SS&C Technologies Holdings Inc / Citrix Systems Inc / NVIDIA Corp / Charter Communications Inc / Tsakos Energy Navigation Ltd / Netflix Inc / Eagle Bancorp Inc / Commercial Vehicle Group Inc / Rush Enterprises Inc / Nasdaq Inc / TreeHouse Foods Inc / Koppers Holdings Inc / Mastercard Inc / Six Flags Entertainment Corp / Aon PLC / Blackstone Inc / Inovio Pharmaceuticals Inc / BGC Partners Inc / Unitil Corp / Charles Schwab Corp / Motorola Solutions Inc / Groupon Inc / Meta Platforms Inc / Coty Inc / Computer Task Group Inc / Anthem Inc / Natera Inc / PayPal Holdings Inc / PhenixFIN Corp / Medallion Financial Corp / DXC Technology Co / IQVIA Holdings Inc / Welltower Inc / Tilray Brands Inc / Enochian Biosciences Inc / Lyft Inc / Corteva Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / United Kingdom / Greece / Ireland / United States / Curaçao</td><td class="leftalignment">Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Chemicals / Consumer / Defense / Electronics / Financial Services / Food / Healthcare / Household Products / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Services / Technology / Telecommunications / Transportation / Utilities / Wholesale / Oil & Gas</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">08/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for AMGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">07/31/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Mackay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AMGN.O / ARNA.O / BMRN.O / REGN.O / SGEN.OQ / IMGN.O / PRTA.O / AGIO.O / MESO.O / PBYI.OQ</td><td class="leftalignment">Amgen Inc / Arena Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Seagen Inc / ImmunoGen Inc / Prothena Corporation PLC / Agios Pharmaceuticals Inc / Mesoblast Ltd / Puma Biotechnology Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="even"><td class="leftalignment">07/31/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Momentum an Attractive Mid-Cycle Idea</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">ALB.N / LRCX.O / URI / AMGN.O / NVDA.O / MPWR.O / ALGN.O / INCY.OQ / NBIX.OQ / EXPE.OQ / SIVB.O / TRMB.O / 364760108 / IVZ / TSLA.O / ENPH.O / 501797104 / PTC.O / QRVO.O / 00973N102 / APTV.K / 83417M104 / 00972D105 / 010196103</td><td class="leftalignment">Albemarle Corp / Lam Research Corp / United Rentals Inc / Amgen Inc / NVIDIA Corp / Monolithic Power Systems Inc / Align Technology Inc / Incyte Corp / Neurocrine Biosciences Inc / Expedia Group Inc / SVB Financial Group / Trimble Inc / Gap Inc / Invesco Ltd / Tesla Inc / Enphase Energy Inc / Bath & Body Works Inc / PTC Inc / Qorvo Inc / Akoustis Technologies Inc / Aptiv PLC / Solaredge Technologies Inc / Akebia Therapeutics Inc / Aksys Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / United States / Jersey</td><td class="leftalignment">Financial Services</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Ari Wald, CFA, CMT</td></tr>
<tr class="odd"><td class="leftalignment">07/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Amgen down 1.6% from 7 week high</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">07/30/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 558</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">07/30/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended July 23, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">07/30/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">IN 2 HOURS: Join Our Healthcare Small/Mid Cap 2Q21 Preview</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">US0311621009 / US3755581036 / US45337C1027 / US75886F1075 / US92532F1003 / US09062X1037</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">07/30/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">07/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Price Action: July 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">AIG.N / APD.N / BDX.N / BR.N / CF.N / CI.N / CL.N / CVS.N / DD.N / ED.N / EOG.N / GM.N / LLY.N / MCK.N / MRK.N / STE.N / WMB.N / SPG.N / PG.N / PXD.N / MET.N / ETN.N / DUK.N / DIS.N / CMI.N / D.N / PH.N / CAT.N / TSN.N / SYY.N / IFF.N / VNO.N / ITW.N / EMR.N / XOM.N / RMD.N / LIN.N / BLL.N / JCI.N / PSA.N / AWK.N / LEG.N / AME.N / VTR.N / CVX.N / PRU.N / L.N / COP.N / AMGN.OQ / ATVI.OQ / REGN.OQ / TT.N / IDXX.OQ / MCHP.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / TTWO.OQ / EBAY.OQ / SBAC.OQ / CHTR.OQ / EXPE.OQ / ILMN.OQ / GPN.N / MNST.OQ / CMCSA.OQ / MOS.N / VIAC.OQ / FIS.N / TDG.N / AON.N / ES.N / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / FANG.OQ / ABBV.N / ZTS.N / PRGO.N / MAR.OQ / NCLH.N / ANET.N / ZBH.N / KHC.OQ / APTV.N / BKNG.OQ / CTVA.N / EXC.OQ / VTRS.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / Becton Dickinson and Co / Broadridge Financial Solutions Inc / CF Industries Holdings Inc / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / Consolidated Edison Inc / EOG Resources Inc / General Motors Co / Eli Lilly and Co / Mckesson Corp / Merck & Co Inc / STERIS plc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Walt Disney Co / Cummins Inc / Dominion Energy Inc / Parker-Hannifin Corp / Caterpillar Inc / Tyson Foods Inc / Sysco Corp / International Flavors & Fragrances Inc / Vornado Realty Trust / Illinois Tool Works Inc / Emerson Electric Co / Exxon Mobil Corp / Resmed Inc / Linde PLC / Ball Corp / Johnson Controls International PLC / Public Storage / American Water Works Company Inc / Leggett & Platt Inc / AMETEK Inc / Ventas Inc / Chevron Corp / Prudential Financial Inc / Loews Corp / Conocophillips / Amgen Inc / Activision Blizzard Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / IDEXX Laboratories Inc / Microchip Technology Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / Take-Two Interactive Software Inc / eBay Inc / SBA Communications Corp / Charter Communications Inc / Expedia Group Inc / Illumina Inc / Global Payments Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / ViacomCBS Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Aon PLC / Eversource Energy / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / Perrigo Company PLC / Marriott International Inc / Norwegian Cruise Line Holdings Ltd / Arista Networks Inc / Zimmer Biomet Holdings Inc / Kraft Heinz Co / Aptiv PLC / Booking Holdings Inc / Corteva Inc / Exelon Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Ireland / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">07/29/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PFE-US Company reports financial results for the quarter ended July 04,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PFE / ABT / BMY / JNJ / LLY / MRK / NVS / AMGN.O / GSK / AZN.O</td><td class="leftalignment">Pfizer Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">The Trend is Your Friend – Fifth Straight Week of Biotech Inflows</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">ABEO, CLDX, EVLO, PHGE - Broad Dermatology Breakfast Discussion | 7/30 @ 8-9:30am ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US00289Y1073 / US15117B2025 / US0311621009 / US45337C1027 / US75886F1075 / ABEO.OQ / US0400476075 / US75382E1091</td><td class="leftalignment">Abeona Therapeutics Inc / Celldex Therapeutics Inc / Amgen Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Abeona Therapeutics Inc / Arena Pharmaceuticals Inc / Rapt Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Kristen Kluska</td></tr>
<tr class="even"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief: U.S. vs. ROW: July 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AIG.N / APD.N / BDX.N / CF.N / CI.N / CL.N / CVS.N / DD.N / ED.N / EOG.N / GM.N / LLY.N / MCK.N / MO.N / MRK.N / PFE.N / SO.N / STE.N / WMB.N / SPG.N / PG.N / PXD.N / MET.N / ETN.N / DUK.N / CMI.N / D.N / PH.N / CAT.N / RCL.N / TSN.N / SYY.N / IFF.N / VNO.N / ITW.N / EMR.N / XOM.N / AMT.N / RMD.N / LIN.N / BLL.N / JCI.N / PSA.N / EW.N / AWK.N / LEG.N / AME.N / VTR.N / CVX.N / PRU.N / L.N / COP.N / AMGN.OQ / KLAC.OQ / ATVI.OQ / TROW.OQ / REGN.OQ / TT.N / IDXX.OQ / MCHP.OQ / GILD.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / TTWO.OQ / EBAY.OQ / SBAC.OQ / CHTR.OQ / EXPE.OQ / ILMN.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / MOS.N / DLR.N / VIAC.OQ / DXCM.OQ / ICE.N / FIS.N / TDG.N / AON.N / ES.N / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / FANG.OQ / ABBV.N / ZTS.N / PRGO.N / MAR.OQ / NCLH.N / ANET.N / ZBH.N / PYPL.OQ / KHC.OQ / TMUS.OQ / APTV.N / BKNG.OQ / FB.PS / CTVA.N / EXC.OQ / VTRS.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / Becton Dickinson and Co / CF Industries Holdings Inc / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / Consolidated Edison Inc / EOG Resources Inc / General Motors Co / Eli Lilly and Co / Mckesson Corp / Altria Group Inc / Merck & Co Inc / Pfizer Inc / Southern Co / STERIS plc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Cummins Inc / Dominion Energy Inc / Parker-Hannifin Corp / Caterpillar Inc / Royal Caribbean Cruises Ltd / Tyson Foods Inc / Sysco Corp / International Flavors & Fragrances Inc / Vornado Realty Trust / Illinois Tool Works Inc / Emerson Electric Co / Exxon Mobil Corp / American Tower Corp / Resmed Inc / Linde PLC / Ball Corp / Johnson Controls International PLC / Public Storage / Edwards Lifesciences Corp / American Water Works Company Inc / Leggett & Platt Inc / AMETEK Inc / Ventas Inc / Chevron Corp / Prudential Financial Inc / Loews Corp / Conocophillips / Amgen Inc / KLA Corp / Activision Blizzard Inc / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / IDEXX Laboratories Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / Take-Two Interactive Software Inc / eBay Inc / SBA Communications Corp / Charter Communications Inc / Expedia Group Inc / Illumina Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / Digital Realty Trust Inc / ViacomCBS Inc / Dexcom Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Aon PLC / Eversource Energy / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / Perrigo Company PLC / Marriott International Inc / Norwegian Cruise Line Holdings Ltd / Arista Networks Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / Kraft Heinz Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / San Miguel Food and Beverage Inc / Corteva Inc / Exelon Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Ireland / Liberia / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">07/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ARE-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMY / LLY / PFE / GILD.O / AMGN.O / ILMN.O / ALNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Alnylam Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Turkey / United States</td><td class="leftalignment">Real Estate</td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">07/28/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Small/Mid Cap 2Q Preview Call on 7/30 @ 10 AM ET</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">US0311621009 / US3755581036 / US45337C1027 / US75886F1075 / US92532F1003 / US09062X1037</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">07/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jul 28 2021</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">BE0165385973 / US0079031078 / US0123481089 / US0311621009 / US0323325045 / US0378331005 / US0382221051 / US0463531089 / US0997241064 / US1101221083 / US1265011056 / US1985161066 / US2435371073 / US37733W1053 / US45167R1041 / US4657411066 / US48203R1041 / US5128071082 / US5324571083 / US5370081045 / US55306N1046 / US5949181045 / US6541061031 / US66987V1098 / US6745991058 / US7170811035 / US7237871071 / US7711951043 / US8552441094 / US8636671013 / US8807701029 / US9113121068 / US9282981086 / US98956P1021 / US00508Y1029 / US4198791018 / US80105N1054 / US6098391054 / US6866881021 / US12541W2098 / US9043111072 / US42330P1075 / US3364331070 / US5500211090 / US92826C8394 / US00507V1098 / DE000A0DJ6J9 / CA9609083097 / CA0585861085 / US58933Y1055 / US5218652049 / US13100M5094 / US88160R1014 / US92839U2069 / US8676524064 / JE00B783TY65 / US00287Y1091 / US72919P2020 / US5764852050 / US29355A1079 / US41068X1000 / IE00BLS09M33 / US83417M1045 / US89400J1079 / US87918A1051 / US02079K1079 / US98138J2069 / US87266J1043 / CH0371153492 / US92336X1090 / US0937121079 / US04206A1016 / KY30744W1070 / US98585X1046 / US35952H6018 / US76156B1070 / US86150R1077 / US88339P1012 / US70614W1009 / US1567271093 / US69047Q1022 / US75513E1010 / US6541101050 / US04271T1007 / US33813J1060 / US74767V1098 / US62955J1034 / US73739W1045 / US55406W1036 / US82489W1071 / US03783T1034 / LU2314763264 / US90089L1089 / US30320C1036 / US83089J1088 / US30260D1037</td><td class="leftalignment">Melexis NV / Advanced Micro Devices Inc / Albany International Corp / Amgen Inc / Amtech Systems Inc / Apple Inc / Applied Materials Inc / AstraZeneca PLC / Borgwarner Inc / Bristol-Myers Squibb Co / CTS Corp / Columbia Sportswear Co / Deckers Outdoor Corp / GlaxoSmithKline PLC / IDEX Corp / Itron Inc / Juniper Networks Inc / Lam Research Corp / Eli Lilly and Co / Littelfuse Inc / MKS Instruments Inc / Microsoft Corp / Nike Inc / Novartis AG / Occidental Petroleum Corp / Pfizer Inc / Pioneer Natural Resources Co / Roche Holding AG / Starbucks Corp / Stryker Corp / Teradyne Inc / United Parcel Service Inc / Vishay Intertechnology Inc / Zimmer Biomet Holdings Inc / Acuity Brands Inc / Hawaiian Holdings Inc / Sanofi SA / Monolithic Power Systems Inc / Ormat Technologies Inc / CH Robinson Worldwide Inc / Under Armour Inc / Helix Energy Solutions Group Inc / First Solar Inc / Lululemon Athletica Inc / Visa Inc / Activision Blizzard Inc / SMA Solar Technology AG / Westport Fuel Systems Inc / Ballard Power Systems Inc / Merck & Co Inc / Lear Corp / Calix Inc / Tesla Inc / Visteon Corp / SunPower Corp / Aptiv PLC / Abbvie Inc / Plug Power Inc / Matador Resources Co / Enphase Energy Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / Pentair PLC / Solaredge Technologies Inc / TransUnion / Teladoc Health Inc / Alphabet Inc / Workhorse Group Inc / TPI Composites Inc / Landis+Gyr Group AG / Veoneer Inc / Bloom Energy Corp / Arlo Technologies Inc / Farfetch Ltd / Yeti Holdings Inc / Fuelcell Energy Inc / Revolve Group Inc / Stoke Therapeutics Inc / RealReal Inc / Peloton Interactive Inc / Cerence Inc / Ovintiv Inc / Raytheon Technologies Corp / Nikola Corp / Array Technologies Inc / Fisker Inc / Quantumscape Corp / Nov Inc / Poshmark Inc / MYT Netherlands Parent BV / Shoals Technologies Group Inc / AppHarvest Inc / Arrival SA / TuSimple Holdings Inc / FTC Solar Inc / Skywater Technology Inc / Figs Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Luxembourg / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">07/28/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">AIN / FISV=US / BSX=US / AMGN=US / ADI=US / AMD=US / EFX=US / BXP=US / TRU=US / V=US / SYK=US / SWN=US / XLNX=US / BRO=US / BYD=US / SPOT=US / MRO=US / ATVI=US / MANH=US / EQR=US / KFY=US / APH=US / BL=US / CSGP=US / EEFT=US / AJG=US / ABG=US / HXL=US / MAT=US / MEDP=US / PII=US / REGI=US / ST=US / HTH=US / AEL=US / HIW=US / FNF=US / CNC=US / EGP=US / EPR=US / FFIN=US / OGN / EXR=US / DLR=US / RNST=US / REX=US / MA=US / GPRE=US / WU=US / AWI=US / TEL=US / EHC=US / AAN=US / 45665G303 / NXPI=US / BCEI=US / MTDR=US / ENPH=US / PDCE=US / SSTK=US / IBTX=US / CEQP=US / GOOGL=US / FIVN=US / 00770K202 / RLMD=US / GDDY=US / NXRT=US / AJRD=US / TDOC=US / ZG=US / WLTW=US / GDS=US / RDFN=US / MPWR-US / IQV=US / EQH=US / TENB=US / OVV=US / BIGC=US / TSHA</td><td class="leftalignment">Albany International Corp / Fiserv Inc / Boston Scientific Corp / Amgen Inc / Analog Devices Inc / Advanced Micro Devices Inc / Equifax Inc / Boston Properties Inc / TransUnion / Visa Inc / Stryker Corp / Southwestern Energy Co / Xilinx Inc / Brown & Brown Inc / Boyd Gaming Corp / Spotify Technology SA / Marathon Oil Corp / Activision Blizzard Inc / Manhattan Associates Inc / Equity Residential / Korn Ferry / Amphenol Corp / Blackline Inc / CoStar Group Inc / Euronet Worldwide Inc / Arthur J Gallagher & Co / Asbury Automotive Group Inc / Hexcel Corp / Mattel Inc / Medpace Holdings Inc / Polaris Inc / Renewable Energy Group Inc / Sensata Technologies Holding PLC / Hilltop Holdings Inc / American Equity Investment Life Holding Co / Highwoods Properties Inc / Fidelity National Financial Inc / Centene Corp / Eastgroup Properties Inc / EPR Properties / First Financial Bankshares Inc / Organon & Co / Extra Space Storage Inc / Digital Realty Trust Inc / Renasant Corp / REX American Resources Corp / Mastercard Inc / Green Plains Inc / Western Union Co / Armstrong World Industries Inc / TE Connectivity Ltd / Encompass Health Corp / Aaron's Company Inc / Infinity Pharmaceuticals Inc / NXP Semiconductors NV / Civitas Resources Inc / Matador Resources Co / Enphase Energy Inc / PDC Energy Inc / Shutterstock Inc / Independent Bank Group Inc / Crestwood Equity Partners LP / Alphabet Inc / Five9 Inc / Aemetis Inc / Relmada Therapeutics Inc / GoDaddy Inc / NexPoint Residential Trust Inc / Aerojet Rocketdyne Holdings Inc / Teladoc Health Inc / Zillow Group Inc / Willis Towers Watson PLC / GDS Holdings Ltd / Redfin Corp / Monolithic Power Systems Inc / IQVIA Holdings Inc / Equitable Holdings Inc / Tenable Holdings Inc / Ovintiv Inc / Bigcommerce Holdings Inc / Taysha Gene Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / Cayman Islands / United Kingdom / Ireland / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">07/28/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Teneobio acquisition expands AMGN's IO pipeline</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US0311621009 / US3755581036</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">07/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Style Comparisons: July 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AIG.N / APD.N / BA.N / BDX.N / BMY.N / CF.N / CI.N / CL.N / CVS.N / DD.N / ED.N / EOG.N / GM.N / LLY.N / MCK.N / MO.N / MRK.N / NSC.N / PFE.N / SO.N / STE.N / TMO.N / WMB.N / SPG.N / PG.N / PXD.N / MET.N / ETN.N / DUK.N / CMI.N / D.N / PH.N / CAT.N / RCL.N / MCD.N / TSN.N / IFF.N / VNO.N / ITW.N / EMR.N / XOM.N / AMT.N / RMD.N / LIN.N / BLL.N / JCI.N / PSA.N / EW.N / AWK.N / LEG.N / AME.N / VTR.N / CVX.N / MCO.N / PRU.N / L.N / COP.N / AMGN.OQ / AAPL.OQ / KLAC.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / TROW.OQ / REGN.OQ / TT.N / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / TTWO.OQ / SBAC.OQ / CHTR.OQ / EXPE.OQ / ILMN.OQ / EQIX.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / MOS.N / DLR.N / VIAC.OQ / DXCM.OQ / ICE.N / FIS.N / TDG.N / ADP.PA / AON.N / ES.N / CME.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / ZTS.N / MAR.OQ / NCLH.N / GOOGL.OQ / ANET.N / ZBH.N / PYPL.OQ / KHC.OQ / TMUS.OQ / APTV.N / BKNG.OQ / FB.PS / CTVA.N / EXC.OQ / VTRS.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / Boeing Co / Becton Dickinson and Co / Bristol-Myers Squibb Co / CF Industries Holdings Inc / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / Consolidated Edison Inc / EOG Resources Inc / General Motors Co / Eli Lilly and Co / Mckesson Corp / Altria Group Inc / Merck & Co Inc / Norfolk Southern Corp / Pfizer Inc / Southern Co / STERIS plc / Thermo Fisher Scientific Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Cummins Inc / Dominion Energy Inc / Parker-Hannifin Corp / Caterpillar Inc / Royal Caribbean Cruises Ltd / McDonald's Corp / Tyson Foods Inc / International Flavors & Fragrances Inc / Vornado Realty Trust / Illinois Tool Works Inc / Emerson Electric Co / Exxon Mobil Corp / American Tower Corp / Resmed Inc / Linde PLC / Ball Corp / Johnson Controls International PLC / Public Storage / Edwards Lifesciences Corp / American Water Works Company Inc / Leggett & Platt Inc / AMETEK Inc / Ventas Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Conocophillips / Amgen Inc / Apple Inc / KLA Corp / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / Take-Two Interactive Software Inc / SBA Communications Corp / Charter Communications Inc / Expedia Group Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / Digital Realty Trust Inc / ViacomCBS Inc / Dexcom Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Aeroports de Paris SA / Aon PLC / Eversource Energy / CME Group Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / Marriott International Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / Arista Networks Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / Kraft Heinz Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / San Miguel Food and Beverage Inc / Corteva Inc / Exelon Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / France / Ireland / Liberia / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Teneobio Fits Strategically — This Is The Type of Deal AMGN Should Be Doing</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Yaron Werber, M.D., MD / Gabriel Schneider, M.D. / Brendan Smith, Ph.D. / Eve Reilly, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Heavy chain antibodies vs BiTES: read from acquisition and mgmt color</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AMGN=US</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our KOL Breakfast to Discuss Topics in Dermatology on Friday, July 30, at 8:00 AM ET</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ACRS / JNJ / LLY / US0311621009 / US45337C1027 / US75886F1075 / US00289Y1073 / US0400476075 / US15117B2025 / US75382E1091 / ARQT / VYNE</td><td class="leftalignment">Aclaris Therapeutics Inc / Johnson & Johnson / Eli Lilly and Co / Amgen Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Abeona Therapeutics Inc / Arena Pharmaceuticals Inc / Celldex Therapeutics Inc / Rapt Therapeutics Inc / Arcutis Biotherapeutics Inc / Vyne Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Ms. Jennifer M. Kim / Brandon Folkes, CFA / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Revisions: July 27, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AIG.N / APD.N / BA.N / BDX.N / BMY.N / BSX.N / CB.N / CF.N / CI.N / CL.N / CVS.N / DD.N / ED.N / EOG.N / FLT.N / GE.N / GM.N / LLY.N / LMT.N / MCK.N / MO.N / MRK.N / NSC.N / PFE.N / SO.N / TMO.N / WMB.N / SPG.N / PG.N / PXD.N / MET.N / ETN.N / DUK.N / CMI.N / D.N / PH.N / CAT.N / MCD.N / TSN.N / IFF.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / EMR.N / XOM.N / AMT.N / RMD.N / LIN.N / SHW.N / BLL.N / JCI.N / VFC.N / PSA.N / V.N / EW.N / AWK.N / LEG.N / AME.N / VTR.N / CVX.N / MCO.N / PRU.N / L.N / COP.N / AMGN.OQ / AAPL.OQ / FISV.OQ / KLAC.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / TTWO.OQ / SBAC.OQ / CHTR.OQ / EXPE.OQ / ILMN.OQ / EQIX.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / MOS.N / DLR.N / VIAC.OQ / DXCM.OQ / ICE.N / FIS.N / TDG.N / ADP.PA / PPL.TO / ES.N / CME.OQ / TSLA.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / ZTS.N / MAR.OQ / NCLH.N / GOOGL.OQ / ANET.N / ZBH.N / PYPL.OQ / KHC.OQ / TMUS.OQ / APTV.N / BKNG.OQ / FB.PS / CTVA.N / EXC.OQ / RTX.N / VTRS.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / Boeing Co / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / CF Industries Holdings Inc / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / Consolidated Edison Inc / EOG Resources Inc / Fleetcor Technologies Inc / General Electric Co / General Motors Co / Eli Lilly and Co / Lockheed Martin Corp / Mckesson Corp / Altria Group Inc / Merck & Co Inc / Norfolk Southern Corp / Pfizer Inc / Southern Co / Thermo Fisher Scientific Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Cummins Inc / Dominion Energy Inc / Parker-Hannifin Corp / Caterpillar Inc / McDonald's Corp / Tyson Foods Inc / International Flavors & Fragrances Inc / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Emerson Electric Co / Exxon Mobil Corp / American Tower Corp / Resmed Inc / Linde PLC / Sherwin-Williams Co / Ball Corp / Johnson Controls International PLC / VF Corp / Public Storage / Visa Inc / Edwards Lifesciences Corp / American Water Works Company Inc / Leggett & Platt Inc / AMETEK Inc / Ventas Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Conocophillips / Amgen Inc / Apple Inc / Fiserv Inc / KLA Corp / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / Take-Two Interactive Software Inc / SBA Communications Corp / Charter Communications Inc / Expedia Group Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / Digital Realty Trust Inc / ViacomCBS Inc / Dexcom Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Aeroports de Paris SA / Pembina Pipeline Corp / Eversource Energy / CME Group Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / Marriott International Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / Arista Networks Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / Kraft Heinz Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / San Miguel Food and Beverage Inc / Corteva Inc / Exelon Corp / Raytheon Technologies Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / France / Ireland / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Jul 16: Focus on Almirall's US TRx trends</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">ALM.MC / 4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Almirall SA / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / France / United Kingdom / India / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">07/26/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">EXEL-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">EXEL.O / BMY / JNJ / MRK / PFE / AMGN.O / GSK / CRIS.O / AVEO.O / SNY.O</td><td class="leftalignment">Exelixis Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Curis Inc / Aveo Pharmaceuticals Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">07/26/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BIIB-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BIIB.O / BIO / JNJ / PFE / GILD.O / AMGN.O / ILMN.O / ACOR.O / ABBV.K / QGEN.K / SNY.O</td><td class="leftalignment">Biogen Inc / Bio Rad Laboratories Inc / Johnson & Johnson / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Acorda Therapeutics Inc / Abbvie Inc / Qiagen NV / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US0311621009 / US3741631036 / US45337C1027 / US64125C1099 / US75886F1075 / US0042251084 / US40637H1095 / US23282W6057 / US1407551092 / US46116X1019 / CA31447P1009 / US00289Y1073 / US05464T1043 / US0327973006 / US75615P1030 / US0400476075 / US24823R1059 / US22663K1079 / US15117B2025 / US85789A1051 / US6700024010 / US75382E1091</td><td class="leftalignment">Amgen Inc / Geron Corp / Incyte Corp / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / ACADIA Pharmaceuticals Inc / Halozyme Therapeutics Inc / Cytokinetics Inc / Cara Therapeutics Inc / Intra-Cellular Therapies Inc / Fennec Pharmaceuticals Inc / Abeona Therapeutics Inc / Axsome Therapeutics Inc / Anavex Life Sciences Corp / Reata Pharmaceuticals Inc / Arena Pharmaceuticals Inc / Denali Therapeutics Inc / Crinetics Pharmaceuticals Inc / Celldex Therapeutics Inc / Stealth BioTherapeutics Corp / Novavax Inc / Rapt Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending July 16, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Friday 7/30: Join Our Broad Dermatology In-Person Breakfast</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US0311621009 / US0400476075 / US45337C1027 / US75886F1075 / US00289Y1073 / US15117B2025 / US75382E1091</td><td class="leftalignment">Amgen Inc / Arena Pharmaceuticals Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Abeona Therapeutics Inc / Celldex Therapeutics Inc / Rapt Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Calendar: July 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AEE.N / AES.N / AIG.N / AXP.N / BA.N / BAX.N / BDX.N / BMY.N / BSX.N / CAH.N / CB.N / CI.N / CL.N / CNC.N / CVS.N / DD.N / ECL.N / ED.N / EOG.N / F.N / FLT.N / GE.N / GM.N / KMB.N / LLY.N / LMT.N / MCK.N / MO.N / MRK.N / NSC.N / OXY.N / PEG.N / PFE.N / SO.N / TEL.PS / TMO.N / WMB.N / SPG.N / PG.N / WY.N / PXD.N / HUM.N / UHS.N / MET.N / ADML.L / ETN.N / DUK.N / CMI.N / D.N / GD.N / PH.N / K.N / CAT.N / MCD.N / IFF.N / YUM.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / EMR.N / VMC.N / WEC.N / XOM.N / AMT.N / RMD.N / LIN.N / SHW.N / PKG.N / BLL.N / GWW.N / JCI.N / AMP.N / VFC.N / PSA.N / V.N / EW.N / AWK.N / ARE.N / LEG.N / CHD.N / AME.N / VTR.N / CVX.N / MCO.N / PRU.N / L.N / COP.N / CNP.N / HAYS.L / AMGN.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / KLAC.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / DISH.OQ / ANSS.OQ / AMZN.OQ / TTWO.OQ / ZBRA.OQ / FFIV.OQ / SBAC.OQ / CHTR.OQ / EXPE.OQ / ILMN.OQ / EQIX.OQ / ALGN.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / MOS.N / DLR.N / VIAC.OQ / DXCM.OQ / CDNS.OQ / ICE.N / FIS.N / TDG.N / ADP.PA / PPL.TO / ES.N / CME.OQ / MSCI.N / VRSK.OQ / TSLA.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / WDC.OQ / NOW.N / FANG.OQ / ABBV.N / ZTS.N / CDW.OQ / MAR.OQ / NCLH.N / GOOGL.OQ / ANET.N / QRVO.OQ / ETSY.OQ / ZBH.N / PYPL.OQ / KHC.OQ / TMUS.OQ / IQV.N / APTV.N / XEL.OQ / BKNG.OQ / WELL.N / FB.PS / CBOE.Z / CTVA.N / EXC.OQ / RTX.N / CARR.N / OTIS.N / HON.OQ</td><td class="leftalignment">Ameren Corp / AES Corp / American International Group Inc / American Express Co / Boeing Co / Baxter International Inc / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Cardinal Health Inc / Chubb Ltd / Cigna Corp / Colgate-Palmolive Co / Centene Corp / CVS Health Corp / Dupont De Nemours Inc / Ecolab Inc / Consolidated Edison Inc / EOG Resources Inc / Ford Motor Co / Fleetcor Technologies Inc / General Electric Co / General Motors Co / Kimberly-Clark Corp / Eli Lilly and Co / Lockheed Martin Corp / Mckesson Corp / Altria Group Inc / Merck & Co Inc / Norfolk Southern Corp / Occidental Petroleum Corp / Public Service Enterprise Group Inc / Pfizer Inc / Southern Co / PLDT Inc / Thermo Fisher Scientific Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Universal Health Services Inc / MetLife Inc / Admiral Group PLC / Eaton Corporation PLC / Duke Energy Corp / Cummins Inc / Dominion Energy Inc / General Dynamics Corp / Parker-Hannifin Corp / Kellogg Co / Caterpillar Inc / McDonald's Corp / International Flavors & Fragrances Inc / Yum! Brands Inc / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Emerson Electric Co / Vulcan Materials Co / WEC Energy Group Inc / Exxon Mobil Corp / American Tower Corp / Resmed Inc / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Ball Corp / W W Grainger Inc / Johnson Controls International PLC / Ameriprise Financial Inc / VF Corp / Public Storage / Visa Inc / Edwards Lifesciences Corp / American Water Works Company Inc / Alexandria Real Estate Equities Inc / Leggett & Platt Inc / Church & Dwight Co Inc / AMETEK Inc / Ventas Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Conocophillips / CenterPoint Energy Inc / Hays PLC / Amgen Inc / Apple Inc / Cerner Corp / Fiserv Inc / KLA Corp / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / DISH Network Corp / ANSYS Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Zebra Technologies Corp / F5 Inc / SBA Communications Corp / Charter Communications Inc / Expedia Group Inc / Illumina Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / Digital Realty Trust Inc / ViacomCBS Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Aeroports de Paris SA / Pembina Pipeline Corp / Eversource Energy / CME Group Inc / MSCI Inc / Verisk Analytics Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / Western Digital Corp / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / CDW Corp / Marriott International Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / Arista Networks Inc / Qorvo Inc / ETSY Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / Kraft Heinz Co / T-Mobile US Inc / IQVIA Holdings Inc / Aptiv PLC / Xcel Energy Inc / Booking Holdings Inc / Welltower Inc / San Miguel Food and Beverage Inc / Cboe Global Markets Inc / Corteva Inc / Exelon Corp / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / France / United Kingdom / Ireland / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ABOS: A Differentiated A  Approach; Initiate with an Outperform Rating, $26 Target Price</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">ABOS.OQ / 4523.T / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / ROG.S / NOVN.S / AMGN.OQ / BIIB.OQ / PRTA.OQ / ACIU.OQ</td><td class="leftalignment">Acumen Pharmaceuticals Inc / Eisai Co Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Roche Holding AG / Novartis AG / Amgen Inc / Biogen Inc / Prothena Corporation PLC / AC Immune SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Ireland / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Judah C. Frommer / Mark Connolly / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">07/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for AMGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">07/25/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Amgen Inc: Valuation Landscape 2006-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">07/23/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our KOL Breakfast to Discuss Topics in Dermatology on Friday, July 30, at 8:00 AM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE / JNJ / LLY / ACRS / US0311621009 / US45337C1027 / US75886F1075 / US00289Y1073 / US0400476075 / US15117B2025 / US75382E1091 / VYNE</td><td class="leftalignment">Pfizer Inc / Johnson & Johnson / Eli Lilly and Co / Aclaris Therapeutics Inc / Amgen Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Abeona Therapeutics Inc / Arena Pharmaceuticals Inc / Celldex Therapeutics Inc / Rapt Therapeutics Inc / Vyne Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Ms. Jennifer M. Kim / Brandon Folkes, CFA / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">07/23/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">ABEO, CLDX, EVLO, PHGE - Broad Dermatology Breakfast Discussion | 7/30 @ 8-9:30am ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US00289Y1073 / US15117B2025 / US0311621009 / US45337C1027 / US75886F1075 / ABEO.OQ / US0400476075 / US75382E1091</td><td class="leftalignment">Abeona Therapeutics Inc / Celldex Therapeutics Inc / Amgen Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Abeona Therapeutics Inc / Arena Pharmaceuticals Inc / Rapt Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Kristen Kluska</td></tr>
<tr class="odd"><td class="leftalignment">07/23/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 557</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">07/23/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--July 23, 2021</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">ACA / AMN / BAX / BSX / CHE / CI / CNC / CRY.N / CVS / HAE / HUM / MDT / RAD / SYK / UNH / WMT / AMZN.O / AMGN.O / TFX.N / ANIK.O / RMD.N / XRAY.O / HCA.N / CYH.N / COO.N / INSP.N / CERS.O / EW.N / ALGN.O / OSUR.O / ISR / SRDX.O / ABMD.OQ / ICUI.OQ / INCY.OQ / IART.OQ / ISRG.OQ / CCRN.O / STAA.O / IDXX.O / INMD.O / MMSI.O / AMED.O / BIIB.O / 025816109 / 478160104 / 00846U101 / 868168105 / ANGO.OQ / NUVA.O / 749685103 / ATRC.OQ / DXCM.O / LHCG.O / B8FGn.DE / LMAT.O / ARAY.O / PODD.O / MASI.O / ENSG.OQ / KIDS.O / 483548103 / TMDX.OQ / MD.N / CSII.O / ADUS.O / USPH.N / SRPT.O / GMED.K / AXGN.O / GOOGL.O / MDWD.O / AGRX.OQ / XENT.OQ / NVRO.N / SIEN.O / VCEL.O / VRAY.OQ / EVH.N / TDOC.N / MCRB.OQ / GKOS.K / ZBH.N / CFMS.O / SPNE.O / 100063846 / SSKN.OQ / SENS.A / SYRS.OQ / TCMD.OQ / FLGT.OQ / IRTC.OQ / SRTS.O / VREX.OQ / 45780L104 / URGN.O / PLXP.O / 720795103 / ARVN.OQ / SWAV.O / XAIR.OQ / PNTG.OQ / VERO.O / ONEM.OQ / NNOX.O</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Baxter International Inc / Boston Scientific Corp / Chemed Corp / Cigna Corp / Centene Corp / CryoLife Inc / CVS Health Corp / Haemonetics Corp / Humana Inc / Medtronic PLC / Rite Aid Corp / Stryker Corp / UnitedHealth Group Inc / Walmart Inc / Amazon.com Inc / Amgen Inc / Teleflex Inc / Anika Therapeutics Inc / Resmed Inc / DENTSPLY SIRONA Inc / HCA Healthcare Inc / Community Health Systems Inc / Cooper Companies Inc / Inspire Medical Systems Inc / Cerus Corp / Edwards Lifesciences Corp / Align Technology Inc / OraSure Technologies Inc / IsoRay Inc / Surmodics Inc / ABIOMED Inc / ICU Medical Inc / Incyte Corp / Integra Lifesciences Holdings Corp / Intuitive Surgical Inc / Cross Country Healthcare Inc / STAAR Surgical Co / IDEXX Laboratories Inc / Inmode Ltd / Merit Medical Systems Inc / Amedisys Inc / Biogen Inc / American Express Co / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / AngioDynamics Inc / NuVasive Inc / RPM International Inc / AtriCure Inc / Dexcom Inc / LHC Group Inc / Biofrontera AG / LeMaitre Vascular Inc / Accuray Inc / Insulet Corp / Masimo Corp / Ensign Group Inc / OrthoPediatrics Corp / Kaman Corp / Transmedics Group Inc / MEDNAX Inc / Cardiovascular Systems Inc / Addus Homecare Corp / US Physical Therapy Inc / Sarepta Therapeutics Inc / Globus Medical Inc / AxoGen Inc / Alphabet Inc / Mediwound Ltd / Agile Therapeutics Inc / Intersect Ent Inc / Nevro Corp / Sientra Inc / Vericel Corp / ViewRay Inc / Evolent Health Inc / Teladoc Health Inc / Seres Therapeutics Inc / Glaukos Corp / Zimmer Biomet Holdings Inc / Conformis Inc / SeaSpine Holdings Corp / Truist Financial Corp / STRATA Skin Sciences Inc / Senseonics Holdings Inc / Syros Pharmaceuticals Inc / Tactile Systems Technology Inc / Fulgent Genetics Inc / iRhythm Technologies Inc / Sensus Healthcare Inc / Varex Imaging Corp / Inogen Inc / Urogen Pharma Ltd / PLx Pharma Inc / Pieris Pharmaceuticals Inc / Arvinas Inc / Shockwave Medical Inc / Beyond Air Inc / Pennant Group Inc / Venus Concept Inc / 1Life Healthcare Inc / Nano-X Imaging Ltd</td><td class="leftalignment"></td><td class="leftalignment">Germany / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">07/23/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended July 16, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">07/23/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">07/23/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - July 23, 2021</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">BB.N / COF.N / FITB.O / IP.N / MMC.N / PD.TO / RWEG.DE / SGEF.PA / T.N / CFP.TO / LPX.N / FN.TO / POW.TO / CHKP.O / AMGN.O / THC.N / FER.MC / CLS.N / DHR.N / DT.N / DISH.O / UNP.N / DV.N / MRO.N / WHR.N / JAZZ.O / GIBa.TO / VLY.N / EXEL.O / DHI.N / DSGX.O / RRC.N / FDS.N / EFX.N / EQT.N / CHTR.O / DNB.N / OTEX.O / BMRN.O / STL.N / REGN.O / SWIR.O / JHX.AX / AIF.TO / MCO.N / CIX.TO / GGG.N / RLI.N / SWN.N / WBS.N / DFS.N / TRU.N / SGEN.OQ / X.TO / SIVB.O / BPOP.O / BIIB.O / HCG.TO / DPZ.N / IGM.TO / WEF.TO / DISCA.O / BAM.N / 35671D857 / CSU.TO / MERC.O / EXPN.L / CLR.N / CBRO.L / WRB.N / SII.TO / MSCI.N / IFC.TO / FICO.N / VRSK.O / FSZ.TO / CHW.TO / NLSN.N / IFP.TO / MTDR.N / SLM.OQ / EFN.TO / RFP.N / ADT.N / FANG.O / TPH.N / TMUS.N / PTCT.O / ISV.TO / EQB.TO / KXS.TO / ASB.N / SHOP.N / OMF.N / UBSG.S / MTRO.L / SPGI.N / ADVM.OQ / BBU.N / ECN.TO / ENGH.TO / ONEX.TO / CADE.N / FOOD.TO / APTV.N / 05971J102 / VNE.N / GMAB.O / 260557103 / PAGPA.L / AD_u.TO / NVEIu.TO / LSPD.N / WFG.N / TIXT.TO / MAGT.TO / DBM.TO</td><td class="leftalignment">BlackBerry Ltd / Capital One Financial Corp / Fifth Third Bancorp / International Paper Co / Marsh & McLennan Companies Inc / Precision Drilling Corp / Rwe AG / Vinci SA / AT&T Inc / Canfor Corp / Louisiana-Pacific Corp / First National Financial Corp / Power Corporation of Canada / Check Point Software Technologies Ltd / Amgen Inc / Tenet Healthcare Corp / Ferrovial SA / Celestica Inc / Danaher Corp / Dynatrace Inc / DISH Network Corp / Union Pacific Corp / DoubleVerify Holdings Inc / Marathon Oil Corp / Whirlpool Corp / Jazz Pharmaceuticals PLC / CGI Inc / Valley National Bancorp / Exelixis Inc / D R Horton Inc / Descartes Systems Group Inc / Range Resources Corp / Factset Research Systems Inc / Equifax Inc / EQT Corp / Charter Communications Inc / Dun & Bradstreet Holdings Inc / Open Text Corp / Biomarin Pharmaceutical Inc / Sterling Bancorp / Regeneron Pharmaceuticals Inc / Sierra Wireless Inc / James Hardie Industries PLC / Altus Group Ltd / Moody's Corp / CI Financial Corp / Graco Inc / Rli Corp / Southwestern Energy Co / Webster Financial Corp / Discover Financial Services / TransUnion / Seagen Inc / TMX Group Ltd / SVB Financial Group / Popular Inc / Biogen Inc / Home Capital Group Inc / Domino's Pizza Inc / IGM Financial Inc / Western Forest Products Inc / Discovery Inc / Brookfield Asset Management Inc / Freeport-McMoRan Inc / Constellation Software Inc / Mercer International Inc / Experian PLC / Continental Resources Inc / Close Brothers Group PLC / W R Berkley Corp / Sprott Inc / MSCI Inc / Intact Financial Corp / Fair Isaac Corp / Verisk Analytics Inc / Fiera Capital Corp / Chesswood Group Ltd / Nielsen Holdings PLC / Interfor Corp / Matador Resources Co / SLM Corp / Element Fleet Management Corp / Resolute Forest Products Inc / ADT Inc / Diamondback Energy Inc / Tri Pointe Homes Inc (Delaware) / T-Mobile US Inc / PTC Therapeutics Inc / Information Services Corp / Equitable Group Inc / Kinaxis Inc / Associated Banc-Corp / Shopify Inc / OneMain Holdings Inc / UBS Group AG / Metro Bank PLC / S&P Global Inc / Adverum Biotechnologies Inc / Brookfield Business Partners LP / ECN Capital Corp / Enghouse Systems Ltd / Onex Corp / Cadence Bank / Goodfood Market Corp / Aptiv PLC / Cadence Bank / Veoneer Inc / Genmab A/S / Dow Inc / Paragon Banking Group PLC / Alaris Equity Partners Income Trust / Nuvei Corp / Lightspeed Commerce Inc / West Fraser Timber Co Ltd / Telus International Cda Inc / Magnet Forensics Inc / Doman Building Materials Group Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Ireland / Israel / Puerto Rico / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">07/23/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Biotech Q2:21 Earnings Preview</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AMGN.O / EXEL.O / BMRN.O / REGN.O / SGEN.OQ / GMAB.O</td><td class="leftalignment">Amgen Inc / Exelixis Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Seagen Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="odd"><td class="leftalignment">07/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief: July 23, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">ABT.N / AEE.N / AES.N / AIG.N / AXP.N / BA.N / BDX.N / BMY.N / BSX.N / CB.N / CI.N / CL.N / CVS.N / DD.N / EOG.N / GE.N / GM.N / KMB.N / LLY.N / LMT.N / MCK.N / MO.N / MRK.N / NSC.N / PEG.N / PFE.N / SLB.N / SO.N / TMO.N / WMB.N / SPG.N / PG.N / PXD.N / UHS.N / MET.N / ETN.N / DUK.N / DHR.N / CMI.N / ROP.N / CAT.N / UNP.N / MCD.N / IFF.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / EMR.N / XOM.N / AMT.N / RMD.N / LIN.N / SHW.N / PKG.N / BLL.N / JCI.N / AMP.N / VFC.N / PSA.N / V.N / EW.N / AWK.N / ARE.N / LEG.N / TWTR.N / AME.N / CVX.N / MCO.N / PRU.N / L.N / RF.N / COP.N / HAYS.L / INTC.OQ / AMGN.OQ / AAPL.OQ / FISV.OQ / KLAC.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / ANSS.OQ / AMZN.OQ / TTWO.OQ / FFIV.OQ / SBAC.OQ / CHTR.OQ / ILMN.OQ / EQIX.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / MOS.N / DLR.N / VIAC.OQ / DXCM.OQ / CDNS.OQ / ICE.N / FIS.N / TDG.N / ADP.PA / PPL.TO / ES.N / CME.OQ / NEE.N / TSLA.OQ / NXPI.OQ / LYB.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / ZTS.N / GOOGL.OQ / ANET.N / ZBH.N / PYPL.OQ / KHC.OQ / TMUS.OQ / APTV.N / BKNG.OQ / FB.PS / EXC.OQ / RTX.N / OTIS.N / HON.OQ</td><td class="leftalignment">Abbott Laboratories / Ameren Corp / AES Corp / American International Group Inc / American Express Co / Boeing Co / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / EOG Resources Inc / General Electric Co / General Motors Co / Kimberly-Clark Corp / Eli Lilly and Co / Lockheed Martin Corp / Mckesson Corp / Altria Group Inc / Merck & Co Inc / Norfolk Southern Corp / Public Service Enterprise Group Inc / Pfizer Inc / Schlumberger NV / Southern Co / Thermo Fisher Scientific Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / Universal Health Services Inc / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Danaher Corp / Cummins Inc / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / McDonald's Corp / International Flavors & Fragrances Inc / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Emerson Electric Co / Exxon Mobil Corp / American Tower Corp / Resmed Inc / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Ball Corp / Johnson Controls International PLC / Ameriprise Financial Inc / VF Corp / Public Storage / Visa Inc / Edwards Lifesciences Corp / American Water Works Company Inc / Alexandria Real Estate Equities Inc / Leggett & Platt Inc / Twitter Inc / AMETEK Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Regions Financial Corp / Conocophillips / Hays PLC / Intel Corp / Amgen Inc / Apple Inc / Fiserv Inc / KLA Corp / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / ANSYS Inc / Amazon.com Inc / Take-Two Interactive Software Inc / F5 Inc / SBA Communications Corp / Charter Communications Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / Digital Realty Trust Inc / ViacomCBS Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Aeroports de Paris SA / Pembina Pipeline Corp / Eversource Energy / CME Group Inc / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / Alphabet Inc / Arista Networks Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / Kraft Heinz Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / San Miguel Food and Beverage Inc / Exelon Corp / Raytheon Technologies Corp / Otis Worldwide Corp / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / Ireland / Netherlands / Philippines / United States / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Mo’ Money, Mo’ Problems? Big Time Inflows Continue</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">07/22/2021</td><td class="leftalignment">BB Banco de Investimento S.A.</td><td class="leftalignment">Monitor Diário BDRX-07/22/2021</td><td class="leftalignment">Portuguese</td><td class="rightalignment">8</td><td class="leftalignment">AMGN / MELI / BABA</td><td class="leftalignment">Amgen Inc / Mercadolibre Inc / Alibaba Group Holding Ltd</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">RESEARCH SUMMARY / MARKET / COUNTRY-SPECIFIC / EQUITY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Jose Roberto dos Anjos / Renato Od</td></tr>
<tr class="even"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">CCI.N / CVS / EL.N / GGG / INTC.O / MSFT.O / QCOM.O / RXN / T.N / AMZN.O / AMGN.O / DISH.O / SAPG.DE / HEAR.O / MPWR.O / SMTC.O / LSTR.O / AVGO.O / CRUS.OQ / ATVI.OQ / XLNX.OQ / TTWO.OQ / SWKS.OQ / TXN.OQ / SEIC.O / NFLX.O / 92343V104 / 20030N101 / NDAQ.O / 36467W109 / ULTA.O / 514766104 / NXPI.O / ZNGA.O / EA.O / ADI.OQ / FB.O / SRPT.O / FDEV.L / ARMK.K / GOOGL.O / 82655M107 / AGRX.OQ / TDOC.N / TMUS.OQ / SPGI.K / TTD.OQ / ROKU.O / STM.BN / BILI.O / ONEM.OQ / 84764T304 / HUYA.K</td><td class="leftalignment">Crown Castle International Corp / CVS Health Corp / Estee Lauder Companies Inc / Graco Inc / Intel Corp / Microsoft Corp / Qualcomm Inc / Zurn Water Solutions Corp / AT&T Inc / Amazon.com Inc / Amgen Inc / DISH Network Corp / SAP SE / Turtle Beach Corp / Monolithic Power Systems Inc / Semtech Corp / Landstar System Inc / Broadcom Inc / Cirrus Logic Inc / Activision Blizzard Inc / Xilinx Inc / Take-Two Interactive Software Inc / Skyworks Solutions Inc / Texas Instruments Inc / SEI Investments Co / Netflix Inc / Verizon Communications Inc / Comcast Corp / Nasdaq Inc / GameStop Corp / Ulta Beauty Inc / Landec Corp / NXP Semiconductors NV / Zynga Inc / Electronic Arts Inc / Analog Devices Inc / Meta Platforms Inc / Sarepta Therapeutics Inc / Frontier Developments PLC / Aramark / Alphabet Inc / Sify Technologies Ltd / Agile Therapeutics Inc / Teladoc Health Inc / T-Mobile US Inc / S&P Global Inc / Trade Desk Inc / Roku Inc / STMicroelectronics NV / Bilibili Inc / 1Life Healthcare Inc / Speed Commerce Inc / HUYA Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Germany / United Kingdom / India / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Price Action: July 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BMY.N / BSX.N / CB.N / CL.N / COF.N / CVS.N / DD.N / DOW.N / EOG.N / FCX.N / GE.N / GM.N / JNJ.N / KMB.N / KO.N / LLY.N / LMT.N / LUV.N / MCK.N / MMC.N / MO.N / MRK.N / NEM.N / NSC.N / PEG.N / PFE.N / SLB.N / SO.N / TMO.N / WMB.N / SPG.N / PG.N / PXD.N / UHS.N / MET.N / ETN.N / DHR.N / CMI.N / ROP.N / CAT.N / UNP.N / MCD.N / VNO.N / SYK.N / UPS.N / WM.N / MMM.N / EMR.N / XOM.N / AMT.N / LIN.N / SHW.N / PKG.N / VZ.N / JCI.N / DHI.N / AMP.N / VFC.N / PSA.N / V.N / EW.N / AWK.N / ARE.N / LEG.N / TWTR.N / AME.N / CVX.N / MCO.N / PRU.N / L.N / RF.N / COP.N / HAYS.L / INTC.OQ / AMGN.OQ / AAPL.OQ / FISV.OQ / KLAC.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / TROW.OQ / SIVB.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / ANSS.OQ / AMZN.OQ / TTWO.OQ / FFIV.OQ / SBAC.OQ / CHTR.OQ / EQIX.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / BIIB.OQ / MOS.N / DLR.N / DXCM.OQ / CDNS.OQ / ICE.N / FIS.N / TDG.N / ADP.PA / ES.N / CME.OQ / NEE.N / TSLA.OQ / NXPI.OQ / LYB.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / GOOGL.OQ / ANET.N / ZBH.N / PYPL.OQ / KHC.OQ / TMUS.OQ / BKNG.OQ / FB.PS / EXC.OQ / RTX.N / OTIS.N / AEP.OQ / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Colgate-Palmolive Co / Capital One Financial Corp / CVS Health Corp / Dupont De Nemours Inc / Dow Inc / EOG Resources Inc / Freeport-McMoRan Inc / General Electric Co / General Motors Co / Johnson & Johnson / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Mckesson Corp / Marsh & McLennan Companies Inc / Altria Group Inc / Merck & Co Inc / Newmont Corporation / Norfolk Southern Corp / Public Service Enterprise Group Inc / Pfizer Inc / Schlumberger NV / Southern Co / Thermo Fisher Scientific Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / Universal Health Services Inc / MetLife Inc / Eaton Corporation PLC / Danaher Corp / Cummins Inc / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / McDonald's Corp / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / 3M Co / Emerson Electric Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Verizon Communications Inc / Johnson Controls International PLC / D R Horton Inc / Ameriprise Financial Inc / VF Corp / Public Storage / Visa Inc / Edwards Lifesciences Corp / American Water Works Company Inc / Alexandria Real Estate Equities Inc / Leggett & Platt Inc / Twitter Inc / AMETEK Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Regions Financial Corp / Conocophillips / Hays PLC / Intel Corp / Amgen Inc / Apple Inc / Fiserv Inc / KLA Corp / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / T Rowe Price Group Inc / SVB Financial Group / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / ANSYS Inc / Amazon.com Inc / Take-Two Interactive Software Inc / F5 Inc / SBA Communications Corp / Charter Communications Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Biogen Inc / Mosaic Co / Digital Realty Trust Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Aeroports de Paris SA / Eversource Energy / CME Group Inc / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Alphabet Inc / Arista Networks Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / Kraft Heinz Co / T-Mobile US Inc / Booking Holdings Inc / San Miguel Food and Beverage Inc / Exelon Corp / Raytheon Technologies Corp / Otis Worldwide Corp / American Electric Power Company Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Global ESG Research: What ESG investors buy and sell</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">0270.HK / 2330.TW / ALVG.DE / ASML.AS / CRDA.L / DANO.PA / HDBK.BO / IBE.MC / IMI.L / MRK.N / OREP.PA / RAND.AS / SAPG.F / SCHN.PA / TMO.N / ULVR.L / VWS.CO / PG.N / AZN.L / SASY.PA / ROG.S / DHR.N / UNH.N / PH.N / SIEGN.DE / INFY.BO / NOVOB.CO / HD.N / LOW.N / WM.N / ITW.N / AMT.N / IFXGN.DE / LIN.N / DPWGN.DE / V.N / AWK.N / ACN.N / EUFI.PA / 2454.TW / DSV.CO / 1211.HK / GOCP.BO / 1477.TW / ADBE.OQ / AMGN.OQ / AAPL.OQ / MSFT.OQ / TT.N / AMZN.OQ / TXN.OQ / 005930.KS / 006400.KS / 051910.KS / 051900.KS / 035420.KS / NESN.S / 0700.HK / 2318.HK / 0939.HK / 2382.HK / BIDU.OQ / TAL.N / SBER.MM / MA.N / 601318.SS / SOON.S / 601939.SS / 0968.HK / GNRC.N / TSLA.OQ / NXPI.OQ / 002594.SZ / XYL.N / EPAM.N / GOOGL.OQ / JD.OQ / BABA.N / SEDG.OQ / LIGHT.AS / KCRA.HE / ORSTED.CO / 3690.HK / CCEPC.AS</td><td class="leftalignment">Guangdong Investment Ltd / Taiwan Semiconductor Manufacturing Co Ltd / Allianz SE / ASML Holding NV / Croda International PLC / Danone SA / HDFC Bank Ltd / Iberdrola SA / IMI PLC / Merck & Co Inc / L'Oreal SA / Randstad NV / SAP SE / Schneider Electric SE / Thermo Fisher Scientific Inc / Unilever PLC / Vestas Wind Systems A/S / Procter & Gamble Co / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Danaher Corp / UnitedHealth Group Inc / Parker-Hannifin Corp / Siemens AG / Infosys Ltd / Novo Nordisk A/S / Home Depot Inc / Lowe's Companies Inc / Waste Management Inc / Illinois Tool Works Inc / American Tower Corp / Infineon Technologies AG / Linde PLC / Deutsche Post AG / Visa Inc / American Water Works Company Inc / Accenture PLC / Eurofins Scientific SE / MediaTek Inc / DSV A/S / BYD Co Ltd / Godrej Consumer Products Ltd / Makalot Industrial Co Ltd / Adobe Inc / Amgen Inc / Apple Inc / Microsoft Corp / Trane Technologies PLC / Amazon.com Inc / Texas Instruments Inc / Samsung Electronics Co Ltd / Samsung SDI Co Ltd / LG Chem Ltd / LG Household & Healthcare Ltd / Naver Corp / Nestle SA / Tencent Holdings Ltd / Ping An Insurance Group Co of China Ltd / China Construction Bank Corp / Sunny Optical Technology Group Co Ltd / Baidu Inc / TAL Education Group / Sberbank Rossii PAO / Mastercard Inc / Ping An Insurance Group Co of China Ltd / Sonova Holding AG / China Construction Bank Corp / Xinyi Solar Holdings Ltd / Generac Holdings Inc / Tesla Inc / NXP Semiconductors NV / BYD Co Ltd / Xylem Inc / Epam Systems Inc / Alphabet Inc / JD.Com Inc / Alibaba Group Holding Ltd / Solaredge Technologies Inc / Signify NV / Konecranes Abp / Orsted A/S / Meituan / Coca-Cola Europacific Partners PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / Germany / Denmark / Spain / Finland / France / United Kingdom / Hong Kong / India / Ireland / Korea, Republic of / Luxembourg / Netherlands / Russian Federation / Taiwan / United States</td><td class="leftalignment">Conglomerates / Manufacturing</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity / Environmental, Social, Governance</td><td class="leftalignment">Eugene Klerk / Akanksha Kharbanda / Ms. Betty Jiang / Phineas Glover / Bahar Sezer Longworth</td></tr>
<tr class="odd"><td class="leftalignment">07/21/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Key Considerations Ahead of 2Q Results</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">07/21/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jul 21 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">FR0000054470 / US09061G1013 / US8816242098 / US00971T1016 / US02553E1064 / US0311621009 / US0366421065 / US09058V1035 / US30161Q1040 / US3755581036 / US4062161017 / US45337C1027 / US64125C1099 / US66987V1098 / US75886F1075 / US8305661055 / US91307C1027 / US92532F1003 / CA1363751027 / US64110L1061 / US09062X1037 / US0042251084 / US02043Q1076 / US2538681030 / US1696561059 / US29089Q1058 / US2521311074 / US45784P1012 / US53261M1045 / US03152W1099 / US0231112063 / US7181721090 / US46333X1081 / US9100471096 / US4464131063 / NL0010273215 / US5017971046 / US8036071004 / US4576693075 / US88338N1072 / IE00B4Q5ZN47 / US6951271005 / US74587V1070 / US8684591089 / US45845P1084 / US23283R1005 / US29428V1044 / US69366J2006 / US29664W1053 / US00771V1089 / US4277461020 / US5034596040 / US90400D1081 / US7613301099 / IE00BJ3V9050 / KYG8807B1068 / US78667J1088 / IE00BQPVQZ61 / US19249H1032 / US2681582019 / US31572Q8087 / CA89620X5064 / US29444U7000 / US09627Y1091 / US37890U1088 / US4622221004 / US07725L1026 / US87184Q1076 / US36165L1089 / NL0012169213 / IL0011407140 / VGG111961055 / US04016X1019 / US87105L1044 / US8753722037 / US76243J1051 / US68404V1008 / US05455M1009 / CA0717341071 / KY30744W1070 / US8740602052 / US61775R1059 / US85205L1070 / US65487U1088 / US69353Y1038 / US81181C1045 / US55406W1036 / US92941V2097 / US25401T1088 / US35909D1090</td><td class="leftalignment">Ubisoft Entertainment SA / Biomarin Pharmaceutical Inc / Teva Pharmaceutical Industries Ltd / Akamai Technologies Inc / American Eagle Outfitters Inc / Amgen Inc / Antares Pharma Inc / BioCryst Pharmaceuticals Inc / Exelixis Inc / Gilead Sciences Inc / Halliburton Co / Incyte Corp / Neurocrine Biosciences Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Skechers USA Inc / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Canadian National Railway Co / Netflix Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Digital Realty Trust Inc / Chipotle Mexican Grill Inc / Emergent BioSolutions Inc / Dexcom Inc / Insulet Corp / Limelight Networks Inc / Amicus Therapeutics Inc / Amarin Corporation PLC / Philip Morris International Inc / Ironwood Pharmaceuticals Inc / United Airlines Holdings Inc / Huntington Ingalls Industries Inc / ASML Holding NV / Bath & Body Works Inc / Sarepta Therapeutics Inc / Insmed Inc / TherapeuticsMD Inc / Jazz Pharmaceuticals PLC / Pacira Biosciences Inc / Puma Biotechnology Inc / Supernus Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / CyrusOne Inc / Epizyme Inc / PTC Therapeutics Inc / Esperion Therapeutics Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / La Jolla Pharmaceutical Co / Ultragenyx Pharmaceutical Inc / Revance Therapeutics Inc / Endo International PLC / Theravance Biopharma Inc / SAGE Therapeutics Inc / Horizon Therapeutics PLC / Coherus BioSciences Inc / Dynavax Technologies Corp / FibroGen Inc / Pfizer Inc / Equinix Inc / Blueprint Medicines Corp / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Beigene Ltd / Syros Pharmaceuticals Inc / GDS Holdings Ltd / Qiagen NV / Urogen Pharma Ltd / Biohaven Pharmaceutical Holding Company Ltd / argenx SE / Switch Inc / Tandem Diabetes Care Inc / Rhythm Pharmaceuticals Inc / OptiNose Inc / AVROBIO Inc / Bausch Health Companies Inc / Farfetch Ltd / Takeda Pharmaceutical Co Ltd / Morphic Holding Inc / SpringWorks Therapeutics Inc / Nkarta Inc / PMV Pharmaceuticals Inc / Seagen Inc / MYT Netherlands Parent BV / Vyne Therapeutics Inc / DigitalBridge Group Inc / Frontier Communications Parent Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / Japan / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">07/21/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Second Quarter 2021 Biotechnology Earnings Preview: Sector Trading in Line as Earnings Kicks Off and New Products Approved</td><td class="leftalignment">English</td><td class="rightalignment">57</td><td class="leftalignment">G11196105 / 09061G101 / 03116210 / 64125C109 / 110122108 / 09062X103 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 803607100 / 26979610 / 00847L10 / 268158201 / 31572Q80 / 76133010 / 462222100 / 19459J104 / 69366J200 / 09609G100 / 37890U108 / 517125100 / 74006W108</td><td class="leftalignment">Biohaven Pharmaceutical Holding Company Ltd / Biomarin Pharmaceutical Inc / Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / PTC Therapeutics Inc / bluebird bio Inc / Global Blood Therapeutics Inc / Larimar Therapeutics Inc / Praxis Precision Medicines Inc</td><td class="leftalignment"></td><td class="leftalignment">United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">07/21/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q2 Earnings Preview: Hoping That Solid Financials Are What The Doctor Ordered</td><td class="leftalignment">English</td><td class="rightalignment">238</td><td class="leftalignment">US09061G1013 / US0311621009 / US30161Q1040 / US3755581036 / US45337C1027 / US64125C1099 / US75886F1075 / US91307C1027 / US92532F1003 / US09062X1037 / US0042251084 / US02043Q1076 / US29089Q1058 / US03152W1099 / US46333X1081 / US8036071004 / US4576693075 / US6951271005 / US74587V1070 / US45845P1084 / US29428V1044 / US69366J2006 / US29664W1053 / US4277461020 / US5034596040 / US90400D1081 / KYG8807B1068 / US78667J1088 / US2681582019 / US31572Q8087 / US09627Y1091 / US37890U1088 / US4622221004 / US07725L1026 / IL0011407140 / US76243J1051 / US05455M1009 / US61775R1059 / US81181C1045</td><td class="leftalignment">Biomarin Pharmaceutical Inc / Amgen Inc / Exelixis Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Emergent BioSolutions Inc / Amicus Therapeutics Inc / Ironwood Pharmaceuticals Inc / Sarepta Therapeutics Inc / Insmed Inc / Pacira Biosciences Inc / Puma Biotechnology Inc / Intercept Pharmaceuticals Inc / Epizyme Inc / PTC Therapeutics Inc / Esperion Therapeutics Inc / Heron Therapeutics Inc / La Jolla Pharmaceutical Co / Ultragenyx Pharmaceutical Inc / Theravance Biopharma Inc / SAGE Therapeutics Inc / Dynavax Technologies Corp / FibroGen Inc / Blueprint Medicines Corp / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Beigene Ltd / Urogen Pharma Ltd / Rhythm Pharmaceuticals Inc / AVROBIO Inc / Morphic Holding Inc / Seagen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Cayman Islands / Germany / Denmark / United Kingdom / Ireland / Israel / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Biotechnology Team</td></tr>
<tr class="odd"><td class="leftalignment">07/21/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief: U.S. vs. ROW: July 21, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BMY.N / BSX.N / CB.N / CCI.N / CL.N / COF.N / DD.N / DOW.N / FCX.N / GE.N / JNJ.N / KMB.N / KO.N / LLY.N / LMT.N / LUV.N / MMC.N / MO.N / MRK.N / NEM.N / NSC.N / PEG.N / PFE.N / PM.N / SLB.N / SO.N / TMO.N / WMB.N / SPG.N / PG.N / PXD.N / UHS.N / ETN.N / DHR.N / CMI.N / ROP.N / CAT.N / UNP.N / MCD.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / XOM.N / AMT.N / LIN.N / SHW.N / PKG.N / VZ.N / JCI.N / DHI.N / AMP.N / VFC.N / KMI.N / EFX.N / PSA.N / V.N / EW.N / AWK.N / ARE.N / LEG.N / TWTR.N / AME.N / MTB.N / CVX.N / MCO.N / PRU.N / L.N / RF.N / COP.N / HAYS.L / INTC.OQ / AMGN.OQ / AAPL.OQ / FISV.OQ / KLAC.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / NTRS.OQ / TROW.OQ / SIVB.OQ / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / DFS.N / O.N / AMZN.OQ / TTWO.OQ / FFIV.OQ / SBAC.OQ / CHTR.OQ / ISRG.OQ / EQIX.OQ / GPN.N / VRTX.OQ / NFLX.OQ / TXN.OQ / CMCSA.OQ / BIIB.OQ / MOS.N / DLR.N / MKTX.OQ / NDAQ.OQ / DXCM.OQ / CDNS.OQ / ICE.N / FIS.N / STX.AX / ADP.PA / ES.N / CME.OQ / NEE.N / TSLA.OQ / NXPI.OQ / LYB.N / PSX.N / NOW.N / FANG.OQ / ABBV.N / GOOGL.OQ / ANET.N / ANTM.N / ZBH.N / PYPL.OQ / TMUS.OQ / CSX.OQ / FB.PS / RTX.N / OTIS.N / AEP.OQ / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Crown Castle International Corp / Colgate-Palmolive Co / Capital One Financial Corp / Dupont De Nemours Inc / Dow Inc / Freeport-McMoRan Inc / General Electric Co / Johnson & Johnson / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Marsh & McLennan Companies Inc / Altria Group Inc / Merck & Co Inc / Newmont Corporation / Norfolk Southern Corp / Public Service Enterprise Group Inc / Pfizer Inc / Philip Morris International Inc / Schlumberger NV / Southern Co / Thermo Fisher Scientific Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / Universal Health Services Inc / Eaton Corporation PLC / Danaher Corp / Cummins Inc / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / McDonald's Corp / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Verizon Communications Inc / Johnson Controls International PLC / D R Horton Inc / Ameriprise Financial Inc / VF Corp / Kinder Morgan Inc / Equifax Inc / Public Storage / Visa Inc / Edwards Lifesciences Corp / American Water Works Company Inc / Alexandria Real Estate Equities Inc / Leggett & Platt Inc / Twitter Inc / AMETEK Inc / M&T Bank Corp / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Regions Financial Corp / Conocophillips / Hays PLC / Intel Corp / Amgen Inc / Apple Inc / Fiserv Inc / KLA Corp / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / Northern Trust Corp / T Rowe Price Group Inc / SVB Financial Group / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Discover Financial Services / Realty Income Corp / Amazon.com Inc / Take-Two Interactive Software Inc / F5 Inc / SBA Communications Corp / Charter Communications Inc / Intuitive Surgical Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Netflix Inc / Texas Instruments Inc / Comcast Corp / Biogen Inc / Mosaic Co / Digital Realty Trust Inc / Marketaxess Holdings Inc / Nasdaq Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / Strike Energy Ltd / Aeroports de Paris SA / Eversource Energy / CME Group Inc / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Alphabet Inc / Arista Networks Inc / Anthem Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / T-Mobile US Inc / CSX Corp / San Miguel Food and Beverage Inc / Raytheon Technologies Corp / Otis Worldwide Corp / American Electric Power Company Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Switzerland / France / United Kingdom / Ireland / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">07/20/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Delta, Now Dominant in the U.S., Is Driving Domestic and Global Growth; Regions With Low Vaccination Rates at Greatest Risk</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / John Boyle / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers / Lachlan Hanbury-Brown</td></tr>
<tr class="odd"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">2Q21 EPS preview - model changes & updated perspectives</td><td class="leftalignment">English</td><td class="rightalignment">79</td><td class="leftalignment">031162100 / 09062X103 / 5671735 / 0989529 / 0925288 / 7103065 / 7110388 / 717081103 / 375558103 / 110122108 / 532457108 / 75886F107 / 58933Y105 / 00287Y109</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AIN / AN=US / MRK=US / LLY=US / PEP=US / PFE=US / AMGN=US / CAG=US / HD=US / KO=US / MCD=US / TWTR=US / CL=US / PG=US / WEN=US / PLD=US / T=US / BLD=US / INCY=US / TEVA=US / APA=US / LOW=US / ENR=US / CHRS=US / BRO=US / LEG=US / ATVI=US / VMC=US / NWL=US / MLM=US / FLO=US / STZ=US / DISH=US / WTFC=US / AIR=US / SWIM=US / ATRO=US / B=US / BMRN=US / CBRL=US / CENT=US / CHD=US / CW=US / DRI=US / DCO=US / EPC=US / AJG=US / GFF=US / HAIN=US / HEI=US / HXL=US / IBP=US / MAS=US / MRCY=US / MHK=US / PACW=US / REGI=US / ROLL=US / SMG=US / SNAP=US / TGI=US / VSEC=US / WIX=US / POST=US / ZION=US / FB=US / FBK=US / SPR=US / NTRA=US / DIN=US / MGP=US / MGPI=US / MNST=US / NOMD=US / RPD=US / RNG=US / TPX=US / MOG.A=US / EXP=US / BECN=US / PLAY=US / FRPT=US / DENN=US / THS=US / BLDR=US / GMS=US / CMG=US / REX=US / TDG=US / PGTI=US / GPRE=US / ELF=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / KTOS=US / TIL=US / JACK=US / AAN=US / UTZ=US / TREX=US / WWD=US / FBHS=US / TILE=US / NDLS=US / FIVN=US / 00770K202 / LOCO=US / NVRO=US / SHAK=US / AJRD=US / BWXT=US / WING=US / WLTW=US / 82982L103 / JELD=US / IOVA=US / PETQ=US / MAXR=US / KDP=US / FERG=US / LHX=US / BRBR=US / REYN=US / SPCE=US / AZEK=US / VTRS=US / HYFM=US / 67421J108</td><td class="leftalignment">Albany International Corp / AutoNation Inc / Merck & Co Inc / Eli Lilly and Co / PepsiCo Inc / Pfizer Inc / Amgen Inc / Conagra Brands Inc / Home Depot Inc / Coca-Cola Co / McDonald's Corp / Twitter Inc / Colgate-Palmolive Co / Procter & Gamble Co / Wendys Co / Prologis Inc / AT&T Inc / TopBuild Corp / Incyte Corp / Teva Pharmaceutical Industries Ltd / APA Corp (US) / Lowe's Companies Inc / Energizer Holdings Inc / Coherus BioSciences Inc / Brown & Brown Inc / Leggett & Platt Inc / Activision Blizzard Inc / Vulcan Materials Co / Newell Brands Inc / Martin Marietta Materials Inc / Flowers Foods Inc / Constellation Brands Inc / DISH Network Corp / Wintrust Financial Corp / AAR Corp / Latham Group Inc / Astronics Corp / Barnes Group Inc / Biomarin Pharmaceutical Inc / Cracker Barrel Old Country Store Inc / Central Garden & Pet Co / Church & Dwight Co Inc / Curtiss-Wright Corp / Darden Restaurants Inc / Ducommun Inc / Edgewell Personal Care Co / Arthur J Gallagher & Co / Griffon Corp / Hain Celestial Group Inc / HEICO Corp / Hexcel Corp / Installed Building Products Inc / Masco Corp / Mercury Systems Inc / Mohawk Industries Inc / PacWest Bancorp / Renewable Energy Group Inc / RBC Bearings Inc / Scotts Miracle-Gro Co / Snap Inc / Triumph Group Inc / VSE Corp / Wix.Com Ltd / Post Holdings Inc / Zions Bancorporation NA / Meta Platforms Inc / FB Financial Corp / Spirit AeroSystems Holdings Inc / Natera Inc / Dine Brands Global Inc / MGM Growth Properties LLC / MGP Ingredients Inc / Monster Beverage Corp / Nomad Foods Ltd / Rapid7 Inc / RingCentral Inc / Tempur Sealy International Inc / Moog Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Freshpet Inc / Denny's Corp / TreeHouse Foods Inc / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / TransDigm Group Inc / PGT Innovations Inc / Green Plains Inc / elf Beauty Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Kratos Defense and Security Solutions Inc / Instil Bio Inc / Jack in the Box Inc / Aaron's Company Inc / UTZ Brands Inc / Trex Company Inc / Woodward Inc / Fortune Brands Home & Security Inc / Interface Inc / Noodles & Co / Five9 Inc / Aemetis Inc / El Pollo Loco Holdings Inc / Nevro Corp / Shake Shack Inc / Aerojet Rocketdyne Holdings Inc / BWX Technologies Inc / Wingstop Inc / Willis Towers Watson PLC / SiteOne Landscape Supply Inc / JELD-WEN Holding Inc / Iovance Biotherapeutics Inc / PetIQ Inc / Maxar Technologies Inc / Keurig Dr Pepper Inc / Ferguson PLC / L3harris Technologies Inc / Bellring Brands Inc / Reynolds Consumer Products Inc / Virgin Galactic Holdings Inc / Azek Company Inc / Viatris Inc / Hydrofarm Holdings Group Inc / Oatly Group AB</td><td class="leftalignment"></td><td class="leftalignment">Canada / Ireland / Israel / Luxembourg / Sweden / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">07/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - July 20, 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">EDP.LS / EOG.N / NA / OXB.L / RIO.L / SGEF.PA / ZION.O / GILD.O / AMGN.O / INCY.O / UNH.N / EVTG.DE / SGMO.O / VZ.N / EXEL.O / ARNA.O / AMP.N / DPH.L / NBIX.O / WSP.TO / BMRN.O / REGN.O / ABC.N / VRTX.O / ENAG.MC / BLU.N / HCC.N / AMH.N / SGEN.OQ / IMGN.O / HOOK.O / BLUE.O / BCRX.O / ICPT.O / STN.TO / BIIB.O / IGO.AX / FMG.AX / SNC.TO / FM.TO / 878742204 / SPI.L / ACAD.O / ALNY.O / 35671D857 / ARWR.O / CS.TO / 443628102 / AUY.N / 550372106 / IVZ.N / CVSG.L / INO.OQ / OZL.AX / TCN.TO / SLS.TO / FHI.N / SRPT.O / CLINC.L / 505440107 / APAM.N / ENTA.O / PTCT.O / PRTA.O / AGIO.O / 46579R104 / KPTI.O / XNCR.OQ / ITCI.O / QURE.O / CIA.TO / ARES.N / SAGE.OQ / MOLN.S / 03835T200 / AENA.MC / CRBP.OQ / GLPG.O / GBT.OQ / RPD.O / RGNX.O / WVE.OQ / MESO.O / RMR.OQ / IONS.O / EDIT.O / ADVM.OQ / NTLA.O / CRSP.OQ / CTEC.L / PBYI.OQ / INVH.N / OVID.O / ATNX.O / VCTR.N / BSIG.N / ITRM.O / PRVB.O / MGTX.O / GMDA.OQ / HNSA.ST / NBSE.OQ / ZM.O / FIXX.O / KRTX.OQ / MORF.OQ / NOVA.N / GMAB.O / APRE.OQ / IGMS.O / ETNB.O / BEAM.O / APA.OQ / NRIX.OQ / SPRB.OQ / MTCR.O / GATO.N / GDRX.O / ALOO.O / 900435207 / NUVB.N / BHG.N / 9VC.F</td><td class="leftalignment">EDP Energias de Portugal SA / EOG Resources Inc / National Bank of Canada / Oxford BioMedica PLC / Rio Tinto PLC / Vinci SA / Zions Bancorporation NA / Gilead Sciences Inc / Amgen Inc / Incyte Corp / UnitedHealth Group Inc / Evotec SE / Sangamo Therapeutics Inc / Verizon Communications Inc / Exelixis Inc / Arena Pharmaceuticals Inc / Ameriprise Financial Inc / Dechra Pharmaceuticals PLC / Neurocrine Biosciences Inc / WSP Global Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Amerisourcebergen Corp / Vertex Pharmaceuticals Inc / Enagas SA / BELLUS Health Inc / Warrior Met Coal Inc / American Homes 4 Rent / Seagen Inc / ImmunoGen Inc / HOOKIPA Pharma Inc / bluebird bio Inc / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Stantec Inc / Biogen Inc / IGO Ltd / Fortescue Metals Group Ltd / SNC-Lavalin Group Inc / First Quantum Minerals Ltd / Teck Resources Ltd / Spire Healthcare Group PLC / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Freeport-McMoRan Inc / Arrowhead Pharmaceuticals Inc / Capstone Mining Corp / Hudbay Minerals Inc / Yamana Gold Inc / Lundin Mining Corp / Invesco Ltd / CVS Group PLC / Inovio Pharmaceuticals Inc / OZ Minerals Ltd / Tricon Residential Inc / Solaris Resources Inc / Federated Hermes Inc / Sarepta Therapeutics Inc / Clinigen Group PLC / Labrador Iron Ore Royalty Corp / Artisan Partners Asset Management Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Prothena Corporation PLC / Agios Pharmaceuticals Inc / Ivanhoe Mines Ltd / Karyopharm Therapeutics Inc / Xencor Inc / Intra-Cellular Therapies Inc / Uniqure NV / Champion Iron Ltd / Ares Management Corp / SAGE Therapeutics Inc / Molecular Partners AG / Aptose Biosciences Inc / Aena SME SA / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / Global Blood Therapeutics Inc / Rapid7 Inc / Regenxbio Inc / WAVE Life Sciences Ltd / Mesoblast Ltd / RMR Group Inc / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / Intellia Therapeutics Inc / CRISPR Therapeutics AG / ConvaTec Group PLC / Puma Biotechnology Inc / Invitation Homes Inc / Ovid Therapeutics Inc / Athenex Inc / Victory Capital Holdings Inc / Brightsphere Investment Group Inc / Iterum Therapeutics PLC / Provention Bio Inc / MeiraGTx Holdings PLC / Gamida Cell Ltd / Hansa Biopharma AB / NeuBase Therapeutics Inc / Zoom Video Communications Inc / Homology Medicines Inc / Karuna Therapeutics Inc / Morphic Holding Inc / Sunnova Energy International Inc / Genmab A/S / Aprea Therapeutics Inc / IGM Biosciences Inc / 89Bio Inc / Beam Therapeutics Inc / APA Corp (US) / Nurix Therapeutics Inc / Spruce Biosciences Inc / Metacrine Inc / Gatos Silver Inc / Goodrx Holdings Inc / Allogene Therapeutics Inc / Turquoise Hill Resources Ltd / Nuvation Bio Inc / Bright Health Group Inc / ATAI Life Sciences NV</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Ireland / Israel / Netherlands / Portugal / Singapore / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">07/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">2021 RBC Biotech Halftime Report: Negativity May Create Long-Term Opportunity</td><td class="leftalignment">English</td><td class="rightalignment">105</td><td class="leftalignment">NA / OXB.L / GILD.O / AMGN.O / INCY.O / EVTG.DE / SGMO.O / EXEL.O / ARNA.O / DPH.L / NBIX.O / BMRN.O / REGN.O / ABC.N / VRTX.O / BLU.N / SGEN.OQ / IMGN.O / HOOK.O / BLUE.O / BCRX.O / ICPT.O / BIIB.O / SPI.L / ACAD.O / ALNY.O / ARWR.O / CVSG.L / INO.OQ / SRPT.O / CLINC.L / ENTA.O / PTCT.O / PRTA.O / AGIO.O / KPTI.O / XNCR.OQ / ITCI.O / QURE.O / SAGE.OQ / MOLN.S / 03835T200 / CRBP.OQ / GLPG.O / GBT.OQ / RGNX.O / WVE.OQ / MESO.O / IONS.O / EDIT.O / ADVM.OQ / NTLA.O / CRSP.OQ / CTEC.L / PBYI.OQ / OVID.O / ATNX.O / ITRM.O / PRVB.O / MGTX.O / GMDA.OQ / HNSA.ST / NBSE.OQ / FIXX.O / KRTX.OQ / MORF.OQ / GMAB.O / APRE.OQ / IGMS.O / ETNB.O / BEAM.O / NRIX.OQ / SPRB.OQ / MTCR.O / ALOO.O / NUVB.N / 9VC.F</td><td class="leftalignment">National Bank of Canada / Oxford BioMedica PLC / Gilead Sciences Inc / Amgen Inc / Incyte Corp / Evotec SE / Sangamo Therapeutics Inc / Exelixis Inc / Arena Pharmaceuticals Inc / Dechra Pharmaceuticals PLC / Neurocrine Biosciences Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Amerisourcebergen Corp / Vertex Pharmaceuticals Inc / BELLUS Health Inc / Seagen Inc / ImmunoGen Inc / HOOKIPA Pharma Inc / bluebird bio Inc / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Spire Healthcare Group PLC / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / CVS Group PLC / Inovio Pharmaceuticals Inc / Sarepta Therapeutics Inc / Clinigen Group PLC / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Prothena Corporation PLC / Agios Pharmaceuticals Inc / Karyopharm Therapeutics Inc / Xencor Inc / Intra-Cellular Therapies Inc / Uniqure NV / SAGE Therapeutics Inc / Molecular Partners AG / Aptose Biosciences Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / Global Blood Therapeutics Inc / Regenxbio Inc / WAVE Life Sciences Ltd / Mesoblast Ltd / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / Intellia Therapeutics Inc / CRISPR Therapeutics AG / ConvaTec Group PLC / Puma Biotechnology Inc / Ovid Therapeutics Inc / Athenex Inc / Iterum Therapeutics PLC / Provention Bio Inc / MeiraGTx Holdings PLC / Gamida Cell Ltd / Hansa Biopharma AB / NeuBase Therapeutics Inc / Homology Medicines Inc / Karuna Therapeutics Inc / Morphic Holding Inc / Genmab A/S / Aprea Therapeutics Inc / IGM Biosciences Inc / 89Bio Inc / Beam Therapeutics Inc / Nurix Therapeutics Inc / Spruce Biosciences Inc / Metacrine Inc / Allogene Therapeutics Inc / Nuvation Bio Inc / ATAI Life Sciences NV</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Canada / Switzerland / Cayman Islands / Germany / Denmark / United Kingdom / Ireland / Israel / Netherlands / Singapore / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Jack Reynolds-Clark / Yinglu Zhang / Jackie Yan / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Mr. Charles Weston / Stephen Mallon / Leonid Timashev / David Szeto / Lisa Walter</td></tr>
<tr class="odd"><td class="leftalignment">07/20/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Biotechnology : 2Q21 Earnings Preview</td><td class="leftalignment">English</td><td class="rightalignment">52</td><td class="leftalignment">ACAD.O / ALKS.O / GILD.O / AMGN.O / INCY.O / BMRN.O / REGN.O / VRTX.O / RARE.O / SGEN.O / BIIB.O / MRNA.O / CLVS.O / SAGE.O / NVCR.O / PBYI.O / BNTX.O</td><td class="leftalignment">ACADIA Pharmaceuticals Inc / Alkermes Plc / Gilead Sciences Inc / Amgen Inc / Incyte Corp / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Seagen Inc / Biogen Inc / Moderna Inc / Clovis Oncology Inc / SAGE Therapeutics Inc / Novocure Ltd / Puma Biotechnology Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / Ireland / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Manish Jajoo</td></tr>
<tr class="even"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending July 09, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Amgen Inc: Intraday vs Overnight Returns 2016-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">07/19/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Key Takeaways From Day 2 of the 2021 William Blair Biotech Focus Conference</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">110122108 / 268158201 / 03116210 / 64125C109 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101</td><td class="leftalignment">Bristol-Myers Squibb Co / Dynavax Technologies Corp / Amgen Inc / Neurocrine Biosciences Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GLUE (BUY) - Molecular Glue - Differentiated Approach to Targeted Protein Degradation - Initiating Coverage with a BUY Rating and $30 Price Target</td><td class="leftalignment">English</td><td class="rightalignment">68</td><td class="leftalignment">BP7KZP7 / 5671735 / 0989529 / 0925288 / 2126335 / 2023607 / 2369174 / 2455965 / 2684703 / 2573083 / 2931034 / 7103065 / BBFL7S1 / BDHF4K6 / BZ8FPH3 / BWY52P3 / BDZ30Q0 / BN2R582 / BDD1B07 / BMPRZV5 / BMDJ397 / BN2RM92</td><td class="leftalignment">Monte Rosa Therapeutics Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Amgen Inc / Gilead Sciences Inc / Biogen Inc / Pfizer Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Novartis AG / bluebird bio Inc / CRISPR Therapeutics AG / Editas Medicine Inc / Blueprint Medicines Corp / Arvinas Inc / Relay Therapeutics Inc / Rubius Therapeutics Inc / Kymera Therapeutics Inc / Bolt Biotherapeutics Inc / Rain Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin</td></tr>
<tr class="odd"><td class="leftalignment">07/16/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US0311621009 / US1266501006 / US1567821046 / US3755581036 / US4448591028 / US45337C1027 / US75886F1075 / US92532F1003 / US09062X1037 / US15135B1017 / US0367521038 / US1255231003</td><td class="leftalignment">Amgen Inc / CVS Health Corp / Cerner Corp / Gilead Sciences Inc / Humana Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Centene Corp / Anthem Inc / Cigna Corp</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">07/16/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Small/Mid Cap 2Q Preview Call on 7/30 @ 10 AM ET</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">US0311621009 / US3755581036 / US45337C1027 / US75886F1075 / US92532F1003 / US09062X1037</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">07/16/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--July 16, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">4502.T / ACA / AMN / BSX / CHE / CI / CNC / CVS / HUM / KR / MDT / RAD / SGE.L / UNH / WMT / ACI.N / GILD.O / AMGN.O / NOVN.S / RMD.N / HCA.N / CYH.N / INSP.N / EW.N / NBIX.OQ / ICPT.OQ / EXEL.OQ / VRTX.OQ / CCRN.O / AMED.O / BIIB.O / 00846U101 / 868168105 / ALNY.OQ / MBRX.OQ / ACAD.O / ATRC.OQ / LHCG.O / 02043Q107 / ENSG.OQ / SLP.OQ / 483548103 / TMDX.OQ / MD.N / 771195104 / ADUS.O / USPH.N / ENTA.O / PRTA.OQ / MRTX.OQ / FATE.OQ / MGNX.O / GOOGL.O / 02005N100 / CBAY.OQ / VKTX.O / EVH.N / TDOC.N / GKOS.K / 100063846 / IONS.OQ / EDIT.OQ / NTLA.O / IRTC.OQ / MDGL.O / PLXP.O / VERU.OQ / MTEM.O / 720795103 / ARVN.OQ / ALLO.OQ / CRSP.BN / BCYC.O / PNTG.OQ / REGW.M3</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Arcosa Inc / AMN Healthcare Services Inc / Boston Scientific Corp / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Kroger Co / Medtronic PLC / Rite Aid Corp / Sage Group PLC / UnitedHealth Group Inc / Walmart Inc / Albertsons Companies Inc / Gilead Sciences Inc / Amgen Inc / Novartis AG / Resmed Inc / HCA Healthcare Inc / Community Health Systems Inc / Inspire Medical Systems Inc / Edwards Lifesciences Corp / Neurocrine Biosciences Inc / Intercept Pharmaceuticals Inc / Exelixis Inc / Vertex Pharmaceuticals Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / Alnylam Pharmaceuticals Inc / Moleculin Biotech Inc / ACADIA Pharmaceuticals Inc / AtriCure Inc / LHC Group Inc / Alnylam Pharmaceuticals Inc / Ensign Group Inc / Simulations Plus Inc / Kaman Corp / Transmedics Group Inc / MEDNAX Inc / Roche Holding AG / Addus Homecare Corp / US Physical Therapy Inc / Enanta Pharmaceuticals Inc / Prothena Corporation PLC / Mirati Therapeutics Inc / Fate Therapeutics Inc / MacroGenics Inc / Alphabet Inc / Ally Financial Inc / Cymabay Therapeutics Inc / Viking Therapeutics Inc / Evolent Health Inc / Teladoc Health Inc / Glaukos Corp / Truist Financial Corp / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Intellia Therapeutics Inc / iRhythm Technologies Inc / Madrigal Pharmaceuticals Inc / PLx Pharma Inc / Veru Inc / Molecular Templates Inc / Pieris Pharmaceuticals Inc / Arvinas Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Bicycle Therapeutics PLC / Pennant Group Inc / Regency World Consulting Ltd</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / India / Ireland / Japan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/16/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">STARTING IN 1 HOUR (11 AM ET): Cantor Healthcare Large Cap 2Q2021 Preview</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">US0311621009 / US3755581036 / US45337C1027 / US75886F1075 / US92532F1003 / US09062X1037</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">07/16/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Biopharma / IQVIA Script Trends for the Week Ended July 9, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">07/16/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US7665596034 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Rigel Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Matthew Luchini / Jin Lee</td></tr>
<tr class="odd"><td class="leftalignment">07/16/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 556</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">07/16/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">07/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Innovent: Creative collaboration deal benefiting both Innovent and Ascentage. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">1801.HK / LLY.N / 2196.HK / AMGN.OQ / BGNE.OQ</td><td class="leftalignment">Innovent Biologics Inc / Eli Lilly and Co / Shanghai Fosun Pharmaceutical Group Co Ltd / Amgen Inc / Beigene Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">07/15/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">2Q21 Large Cap Earnings Preview: We Expect Fewer Surprises and a Recovery in Earnings from COVID</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US0311621009 / US75886F1075 / US3755581036 / US45337C1027 / US92532F1003 / US09062X1037</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Vertex Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">07/15/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US0311621009 / US3755581036 / US45337C1027 / US75886F1075 / US0400476075 / US03969F1093 / US75382E1091</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Arena Pharmaceuticals Inc / Arcus Biosciences Inc / Rapt Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">07/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for AMGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">07/15/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Don’t Look Now, But Last Week Saw Biggest Biotech Inflows of the Year</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">07/15/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Amgen Inc.(AMGN) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">031162100</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">07/15/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BAC.N / C.N / CRM.N / CVS / DG / INTC.O / KR / MSFT.O / SGE.L / T.N / USB / WFC.N / WMT / ACI.N / 4716.T / AMZN.O / AMGN.O / DISH.O / SAPG.DE / HEAR.O / INTU.O / NOVN.S / GWW.N / SBUX.O / ATVI.OQ / SNPS.OQ / NBIX.OQ / TTWO.OQ / ICPT.OQ / EXEL.OQ / PRGS.O / NFLX.O / BIIB.O / 459200101 / ACAD.O / CDNS.O / 36467W109 / VMW / TMDX.OQ / 771195104 / ZNGA.O / EA.O / ENTA.O / MRTX.OQ / FDEV.L / GOOGL.O / 82655M107 / CBAY.OQ / VKTX.O / EDIT.OQ / NTLA.O / BABA.K / MDGL.O / OTEX.TO / PLXP.O / BILI.O / CRSP.BN / HUYA.K</td><td class="leftalignment">Bank of America Corp / Citigroup Inc / Salesforce.Com Inc / CVS Health Corp / Dollar General Corp / Intel Corp / Kroger Co / Microsoft Corp / Sage Group PLC / AT&T Inc / US Bancorp / Wells Fargo & Co / Walmart Inc / Albertsons Companies Inc / Oracle Corp Japan / Amazon.com Inc / Amgen Inc / DISH Network Corp / SAP SE / Turtle Beach Corp / Intuit Inc / Novartis AG / W W Grainger Inc / Starbucks Corp / Activision Blizzard Inc / Synopsys Inc / Neurocrine Biosciences Inc / Take-Two Interactive Software Inc / Intercept Pharmaceuticals Inc / Exelixis Inc / Progress Software Corp / Netflix Inc / Biogen Inc / International Business Machines Corp / ACADIA Pharmaceuticals Inc / Cadence Design Systems Inc / GameStop Corp / VMware Inc / Transmedics Group Inc / Roche Holding AG / Zynga Inc / Electronic Arts Inc / Enanta Pharmaceuticals Inc / Mirati Therapeutics Inc / Frontier Developments PLC / Alphabet Inc / Sify Technologies Ltd / Cymabay Therapeutics Inc / Viking Therapeutics Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Alibaba Group Holding Ltd / Madrigal Pharmaceuticals Inc / Open Text Corp / PLx Pharma Inc / Bilibili Inc / CRISPR Therapeutics AG / HUYA Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / United Kingdom / India / Japan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/15/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our KOL Conference Call to Discuss Current and Developing Treatments in Atopic Dermatitis and Psoriasis TODAY at 12 PM ET</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US0311621009 / US45337C1027 / US75886F1075 / US0400476075 / US75382E1091</td><td class="leftalignment">Amgen Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Arena Pharmaceuticals Inc / Rapt Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">07/15/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Exploring the Link Between R&D Productivity and Valuation</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">SGE.L / AMGN.O / NBIX.OQ / ICPT.OQ / EXEL.OQ / BIIB.O / ACAD.O / ENTA.O / MRTX.OQ / CBAY.OQ / VKTX.O / EDIT.OQ / NTLA.O / MDGL.O / CRSP.BN</td><td class="leftalignment">Sage Group PLC / Amgen Inc / Neurocrine Biosciences Inc / Intercept Pharmaceuticals Inc / Exelixis Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Mirati Therapeutics Inc / Cymabay Therapeutics Inc / Viking Therapeutics Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Madrigal Pharmaceuticals Inc / CRISPR Therapeutics AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">07/14/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">7/16 @ 11am ET: Cantor Healthcare Large Cap 2Q21 Preview Conference Call</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">US0311621009 / US3755581036 / US45337C1027 / US75886F1075 / US92532F1003 / US09062X1037</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">07/14/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Lung Cancer Survey Takeaways : Perspectives on KRAS G12C Class, TTF and PD1 Market Dynamics</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AMGN.O / REGN.O / NVCR.O</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc / Novocure Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott</td></tr>
<tr class="even"><td class="leftalignment">07/14/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">2021 Lung Cancer Survey Takeaways : Perspectives on KRAS G12C Class, TTF and PD1 Market Dynamics</td><td class="leftalignment">English</td><td class="rightalignment">57</td><td class="leftalignment">AMGN.O / NVCR.O / REGN.O</td><td class="leftalignment">Amgen Inc / Novocure Ltd / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott</td></tr>
<tr class="odd"><td class="leftalignment">07/14/2021</td><td class="leftalignment">Valens Research</td><td class="leftalignment">Valens Equity Insights and Inflections - 2021 07 13</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">BLKB.OQ / CVS.N / BMY.N / CAH.N / GE.N / LLY.N / WMT.N / CPB.N / LOW.N / AMT.N / AMGN.OQ / AMAT.OQ / CASY.OQ / CGNX.OQ / SJM.N / INTU.OQ / AMZN.OQ / MTCH.OQ / SIX.N / VRSK.OQ / ZM.OQ</td><td class="leftalignment">Blackbaud Inc / CVS Health Corp / Bristol-Myers Squibb Co / Cardinal Health Inc / General Electric Co / Eli Lilly and Co / Walmart Inc / Campbell Soup Co / Lowe's Companies Inc / American Tower Corp / Amgen Inc / Applied Materials Inc / Caseys General Stores Inc / Cognex Corp / J M Smucker Co / Intuit Inc / Amazon.com Inc / Match Group Inc / Six Flags Entertainment Corp / Verisk Analytics Inc / Zoom Video Communications Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Conglomerates / Electronics / Food / Healthcare / Info. Tech./Software / Leisure & Entertainment / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Services</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION / MORNING COMMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Valens Research</td></tr>
<tr class="even"><td class="leftalignment">07/13/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Our Q&A With Management of Crescendo Biologics, a Novel Multispecific T-Cell Enhancer Biotherapeutic Company</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">03116210 / 110122108 / 640268108 / 30161Q104 / 45337C102 / 45253H101 / 00847G705 / 15117K103 / 04651310 / 00887A105 / 816212104 / 09609G100 / 67022C106 / 603380106 / 720795103 / 49372L100 / 05280R100 / 019770106 / H17182108 / 74019P108 / N5749R100 / G10830100 / 81181C104 / 00507W206 / 03890D108 / 192010106 / 13089P101 / 151205200 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Nektar Therapeutics / Exelixis Inc / Incyte Corp / ImmunoGen Inc / Agenus Inc / Cellectis SA / Atara Biotherapeutics Inc / Aileron Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Precision BioSciences Inc / Merus NV / Beyondspring Inc / Seagen Inc / Actinium Pharmaceuticals Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="odd"><td class="leftalignment">07/13/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / HD=US / INTC=US / MCD=US / OXY=US / ADI=US / AMD=US / RRC=US / WEN=US / AMZN=US / BLD=US / DVN=US / TXN=US / TEVA=US / NVDA=US / APA=US / CPE=US / EOG=US / REI=US / XOM=US / CRK=US / LOW=US / WLL=US / PXD=US / PB=US / DIOD=US / MGY=US / SWN=US / XLNX=US / MUR=US / CHRS=US / BRO=US / UMPQ=US / MRO=US / LEG=US / TTMI=US / VMC=US / MLM=US / APH=US / SWIM=US / ARW=US / AVGO=US / AVT=US / CBRL=US / CERN=US / CNX=US / DRI=US / EQT=US / GFF=US / IBP=US / MAN=US / MAS=US / MCHP=US / MHK=US / PACW=US / REGI=US / ST=US / WAL=US / CVX=US / BXS=US / SNV=US / FB=US / CATY=US / COP=US / DIN=US / BIIB=US / TCBI=US / TPX=US / FNB=US / EXP=US / FHN=US / BDC=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / AWI=US / TEL=US / OC=US / AMRX=US / TAST=US / QSR=US / CLR=US / PRPL=US / NOG=US / IAC=US / JACK=US / TREX=US / AR=US / OAS=US / NXPI=US / ESTE=US / FBHS=US / ANGI=US / BCEI=US / MTDR=US / PDCE=US / FANG=US / TILE=US / NDLS=US / GOOGL=US / 00770K202 / VNOM=US / LOCO=US / SHAK=US / ON=US / WING=US / WLTW=US / EDIT=US / 82982L103 / CDEV=US / PVAC=US / JELD=US / SBOW=US / MPWR-US / HWC=US / OZK=US / RTLR=US / FERG=US / GMAB=US / OVV=US / AZEK=US / VTRS=US / VMEO=US / REPX=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / Intel Corp / McDonald's Corp / Occidental Petroleum Corp / Analog Devices Inc / Advanced Micro Devices Inc / Range Resources Corp / Wendys Co / Amazon.com Inc / TopBuild Corp / Devon Energy Corp / Texas Instruments Inc / Teva Pharmaceutical Industries Ltd / NVIDIA Corp / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Exxon Mobil Corp / Comstock Resources Inc / Lowe's Companies Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Prosperity Bancshares Inc / Diodes Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Xilinx Inc / Murphy Oil Corp / Coherus BioSciences Inc / Brown & Brown Inc / Umpqua Holdings Corp / Marathon Oil Corp / Leggett & Platt Inc / TTM Technologies Inc / Vulcan Materials Co / Martin Marietta Materials Inc / Amphenol Corp / Latham Group Inc / Arrow Electronics Inc / Broadcom Inc / Avnet Inc / Cracker Barrel Old Country Store Inc / Cerner Corp / CNX Resources Corp / Darden Restaurants Inc / EQT Corp / Griffon Corp / Installed Building Products Inc / ManpowerGroup Inc / Masco Corp / Microchip Technology Inc / Mohawk Industries Inc / PacWest Bancorp / Renewable Energy Group Inc / Sensata Technologies Holding PLC / Western Alliance Bancorp / Chevron Corp / Cadence Bank / Synovus Financial Corp / Meta Platforms Inc / Cathay General Bancorp / Conocophillips / Dine Brands Global Inc / Biogen Inc / Texas Capital Bancshares Inc / Tempur Sealy International Inc / FNB Corp / Eagle Materials Inc / First Horizon Corp / Belden Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / TE Connectivity Ltd / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / Purple Innovation Inc / Northern Oil and Gas Inc / IAC/Interactivecorp / Jack in the Box Inc / Trex Company Inc / Antero Resources Corp / Oasis Petroleum Inc / NXP Semiconductors NV / Earthstone Energy Inc / Fortune Brands Home & Security Inc / Angi Inc / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Diamondback Energy Inc / Interface Inc / Noodles & Co / Alphabet Inc / Aemetis Inc / Viper Energy Partners LP / El Pollo Loco Holdings Inc / Shake Shack Inc / ON Semiconductor Corp / Wingstop Inc / Willis Towers Watson PLC / Editas Medicine Inc / SiteOne Landscape Supply Inc / Centennial Resource Development Inc / Ranger Oil Corp / JELD-WEN Holding Inc / SilverBow Resources Inc / Monolithic Power Systems Inc / Hancock Whitney Corp / Bank Ozk / Rattler Midstream LP / Ferguson PLC / Genmab A/S / Ovintiv Inc / Azek Company Inc / Viatris Inc / Vimeo Inc / Riley Exploration Permian Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / United Kingdom / Ireland / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending July 02, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">07/12/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Biosimilar Erosion of Branded Biologics, a Potential Source of Upside for ABBV?</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">ABBV.N / 03116210 / 478160104 / 00287Y10</td><td class="leftalignment">Abbvie Inc / Amgen Inc / Johnson & Johnson / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun / Anna Baran, CFA</td></tr>
<tr class="odd"><td class="leftalignment">07/12/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - July 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AEP.N / AES.N / AXP.N / CCI.N / CI.N / COF.N / CVS.N / EDP.LS / EIX.N / ELE.MC / IBE.MC / IP.N / MRK.N / NA / PB.N / PFE.N / REP.MC / SO.N / T.N / ZION.O / PEP.N / CMA.N / WY.N / HUM.N / CFP.TO / GILD.O / CMCSA.O / AMGN.O / INCY.O / DUK.N / HBAN.O / UNH.N / NICE.O / CAG.N / PCG.N / CONE.O / VZ.N / VLY.N / SNV.N / PACW.O / FISV.O / V.N / AWK.N / NBIX.O / NWN.N / STL.N / VRTX.O / NCR.N / CPE.N / CFR.N / BLU.N / CPK.N / FRC.N / WBS.N / FCF.N / DFS.N / ADS.N / SGEN.OQ / GPN.N / PFS.N / FFBC.O / PBCT.O / SIVB.O / WSBC.O / HOOK.O / CASY.O / BOKF.O / BCRX.O / COLB.O / WTFC.O / ICPT.O / EQIX.O / TCBI.O / ATDb.TO / BIIB.O / SJ.TO / MTL.TO / FHN.N / DPZ.N / DLR.N / ACAD.O / WEF.TO / WAL.N / DISCA.O / SJW.N / BKD.N / CMG.N / FIS.N / ISBC.O / MA.N / GALP.LS / INO.OQ / HOMB.O / AND.TO / INPP.L / NEE.N / NXT.AX / PCH.O / CJT.TO / CFX.TO / BKU.N / PCRX.O / IFP.TO / WTE.TO / SLM.OQ / RFP.N / SRPT.O / ALLY.N / NYCB.N / ENTA.O / TMUS.N / PTCT.O / BEP.N / ONB.OQ / KPTI.O / XNCR.OQ / ITCI.O / FLXN.O / AGRX.O / SYF.N / GWB.N / ANTM.N / ASB.N / 03835T200 / 78667J108 / CRBP.OQ / GLPG.O / PYPL.OQ / GBT.OQ / MP1.AX / PVAC.O / CADE.N / OVID.O / ATNX.O / 05971J102 / ITRM.O / NTGY.MC / PRVB.O / GMDA.OQ / LSPD.TO / NBSE.OQ / KRTX.OQ / MORF.OQ / APRE.OQ / IGMS.O / ETNB.O / WTRG.N / TFII.N / FOUR.N / DCT.O / SPRB.OQ / MTCR.O / WFG.N / TASK.O</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / American Express Co / Crown Castle International Corp / Cigna Corp / Capital One Financial Corp / CVS Health Corp / EDP Energias de Portugal SA / Edison International / Endesa SA / Iberdrola SA / International Paper Co / Merck & Co Inc / National Bank of Canada / Prosperity Bancshares Inc / Pfizer Inc / Repsol SA / Southern Co / AT&T Inc / Zions Bancorporation NA / PepsiCo Inc / Comerica Inc / Weyerhaeuser Co / Humana Inc / Canfor Corp / Gilead Sciences Inc / Comcast Corp / Amgen Inc / Incyte Corp / Duke Energy Corp / Huntington Bancshares Inc / UnitedHealth Group Inc / Nice Ltd / Conagra Brands Inc / PG&E Corp / CyrusOne Inc / Verizon Communications Inc / Valley National Bancorp / Synovus Financial Corp / PacWest Bancorp / Fiserv Inc / Visa Inc / American Water Works Company Inc / Neurocrine Biosciences Inc / Northwest Natural Holding Co / Sterling Bancorp / Vertex Pharmaceuticals Inc / NCR Corp / Callon Petroleum Co / Cullen/Frost Bankers Inc / BELLUS Health Inc / Chesapeake Utilities Corp / First Republic Bank / Webster Financial Corp / First Commonwealth Financial Corp / Discover Financial Services / Alliance Data Systems Corp / Seagen Inc / Global Payments Inc / Provident Financial Services Inc / First Financial Bancorp / People's United Financial Inc / SVB Financial Group / WesBanco Inc / HOOKIPA Pharma Inc / Caseys General Stores Inc / BOK Financial Corp / BioCryst Pharmaceuticals Inc / Columbia Banking System Inc / Wintrust Financial Corp / Intercept Pharmaceuticals Inc / Equinix Inc / Texas Capital Bancshares Inc / Alimentation Couche-Tard Inc / Biogen Inc / Stella-Jones Inc / Mullen Group Ltd / First Horizon Corp / Domino's Pizza Inc / Digital Realty Trust Inc / ACADIA Pharmaceuticals Inc / Western Forest Products Inc / Western Alliance Bancorp / Discovery Inc / SJW Group / Brookdale Senior Living Inc / Chipotle Mexican Grill Inc / Fidelity National Information Services Inc / Investors Bancorp Inc / Mastercard Inc / Galp Energia SGPS SA / Inovio Pharmaceuticals Inc / Home BancShares Inc / Andlauer Healthcare Group Inc / International Public Partnerships Ltd / Nextera Energy Inc / NEXTDC Ltd / Potlatchdeltic Corp / Cargojet Inc / Canfor Pulp Products Inc / BankUnited Inc / Pacira Biosciences Inc / Interfor Corp / Westshore Terminals Investment Corp / SLM Corp / Resolute Forest Products Inc / Sarepta Therapeutics Inc / Ally Financial Inc / New York Community Bancorp Inc / Enanta Pharmaceuticals Inc / T-Mobile US Inc / PTC Therapeutics Inc / Brookfield Renewable Partners LP / Old National Bancorp / Karyopharm Therapeutics Inc / Xencor Inc / Intra-Cellular Therapies Inc / Pacira Biosciences Inc / Agile Therapeutics Inc / Synchrony Financial / Great Western Bancorp Inc / Anthem Inc / Associated Banc-Corp / Aptose Biosciences Inc / SAGE Therapeutics Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / PayPal Holdings Inc / Global Blood Therapeutics Inc / Megaport Ltd / Ranger Oil Corp / Cadence Bank / Ovid Therapeutics Inc / Athenex Inc / Cadence Bank / Iterum Therapeutics PLC / Naturgy Energy Group SA / Provention Bio Inc / Gamida Cell Ltd / Lightspeed Commerce Inc / NeuBase Therapeutics Inc / Karuna Therapeutics Inc / Morphic Holding Inc / Aprea Therapeutics Inc / IGM Biosciences Inc / 89Bio Inc / Essential Utilities Inc / TFI International Inc / Shift4 Payments Inc / Duck Creek Technologies Inc / Spruce Biosciences Inc / Metacrine Inc / West Fraser Timber Co Ltd / Taskus Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Canada / Spain / Ireland / Israel / Portugal / United States / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Jul 02, 2021: Focus on Shingrix trends</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">07/10/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Mackay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / SGEN.OQ / ATNX.O</td><td class="leftalignment">Amgen Inc / Seagen Inc / Athenex Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Michael Murray / Jackie Yan</td></tr>
<tr class="even"><td class="leftalignment">07/09/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--July 9, 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">ACA / AMN / BSX / CHE / CI / CNC / CVS / HUM / MDT / RAD / UNH / WMT / AMGN.O / RMD.N / HCA.N / CYH.N / INSP.N / EW.N / ICPT.OQ / ISRG.OQ / CCRN.O / STAA.O / INMD.O / AMED.O / BIIB.O / 478160104 / 00846U101 / 868168105 / ATRC.OQ / DXCM.O / LHCG.O / 02043Q107 / ENSG.OQ / TNDM.O / KIDS.O / 483548103 / TMDX.OQ / MD.N / CSII.O / ADUS.O / USPH.N / MRTX.OQ / GOOGL.O / NVRO.N / EVH.N / TDOC.N / 100063846 / SENS.A / MDGL.O / ATNX.O / TXMD.O / 720795103 / PRVB.OQ / SWAV.O / A71.F / PNTG.OQ / HGEN.O / 03823M100</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Boston Scientific Corp / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Medtronic PLC / Rite Aid Corp / UnitedHealth Group Inc / Walmart Inc / Amgen Inc / Resmed Inc / HCA Healthcare Inc / Community Health Systems Inc / Inspire Medical Systems Inc / Edwards Lifesciences Corp / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / Cross Country Healthcare Inc / STAAR Surgical Co / Inmode Ltd / Amedisys Inc / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / AtriCure Inc / Dexcom Inc / LHC Group Inc / Alnylam Pharmaceuticals Inc / Ensign Group Inc / Tandem Diabetes Care Inc / OrthoPediatrics Corp / Kaman Corp / Transmedics Group Inc / MEDNAX Inc / Cardiovascular Systems Inc / Addus Homecare Corp / US Physical Therapy Inc / Mirati Therapeutics Inc / Alphabet Inc / Nevro Corp / Evolent Health Inc / Teladoc Health Inc / Truist Financial Corp / Senseonics Holdings Inc / Madrigal Pharmaceuticals Inc / Athenex Inc / TherapeuticsMD Inc / Pieris Pharmaceuticals Inc / Provention Bio Inc / Shockwave Medical Inc / Ascendis Pharma A/S / Pennant Group Inc / Humanigen Inc / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">Denmark / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">07/09/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 555</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">07/09/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended July 2, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">07/09/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">07/08/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Big Wheel Keep On Turnin': Biotech Inflows Continue</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">07/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GILD-US -  Dividend Quality Analysis, for the period ended June 29,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD.O / JNJ / LLY / MRK / PFE / AMGN.O / ILMN.O / VRTX.O / BIIB.O / ABBV.K</td><td class="leftalignment">Gilead Sciences Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Illumina Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">07/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MRK-US -  Dividend Quality Analysis, for the period ended July 07,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK / ABT / BMY / JNJ / LLY / NVS / PFE / AMGN.O / GSK / TEVA.K / SNY.O</td><td class="leftalignment">Merck & Co Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">07/08/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">7/16 @ 11am ET: Cantor Healthcare Large Cap 2Q21 Preview Conference Call</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">US0311621009 / US3755581036 / US45337C1027 / US75886F1075 / US92532F1003 / US09062X1037</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">07/07/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">INTC.O / MDT / MSFT.O / UNH / TME / AMGN.O / NVDA.O / HEAR.O / ATVI.OQ / TTWO.OQ / NFLX.O / BIDU.O / DXCM.O / 36467W109 / TSLA.O / AMD.OQ / ZNGA.O / EA.O / MRTX.OQ / 82655M107 / SENS.A / BABA.K / ATNX.O / BILI.O / IQ.O / PRVB.OQ / A71.F / TCOM.O / BLCT.OQ / HUYA.K</td><td class="leftalignment">Intel Corp / Medtronic PLC / Microsoft Corp / UnitedHealth Group Inc / Tencent Music Entertainment Group / Amgen Inc / NVIDIA Corp / Turtle Beach Corp / Activision Blizzard Inc / Take-Two Interactive Software Inc / Netflix Inc / Baidu Inc / Dexcom Inc / GameStop Corp / Tesla Inc / Advanced Micro Devices Inc / Zynga Inc / Electronic Arts Inc / Mirati Therapeutics Inc / Sify Technologies Ltd / Senseonics Holdings Inc / Alibaba Group Holding Ltd / Athenex Inc / Bilibili Inc / iQIYI Inc / Provention Bio Inc / Ascendis Pharma A/S / Trip.com Group Ltd / BlueCity Holdings Ltd / HUYA Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Denmark / India / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">07/07/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Domestic Spread of Delta Variant Reverses Downward Trends in Regions With Low Vaccination, Global Spread Driving Broad Growth</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / John Boyle / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers / Lachlan Hanbury-Brown</td></tr>
<tr class="even"><td class="leftalignment">07/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: July 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">ABT.N / AL.N / ALK.N / AXP.N / BA.N / BAC.N / BDX.N / C.N / CL.N / COF.N / CRM.N / CVS.N / DAL.N / ECL.N / EIX.N / EOG.N / F.N / GPS.N / IBM.N / JPM.N / KO.N / LLY.N / LUV.N / MO.N / OXY.N / PFE.N / PM.N / SC.N / SEE.N / T.N / U.N / WFC.N / WMT.N / SPG.N / PG.N / NUE.N / CPB.N / AAL.L / DHR.N / DIS.N / UNH.N / CMI.N / DE.N / CAT.N / SPOT.N / GS.N / CLX.N / HD.N / LOW.N / MRO.N / UPS.N / PCG.N / XOM.N / DVN.N / AMT.N / RMD.N / NKE.N / OLN.N / IT.N / TGT.N / RKT.N / BLL.N / VZ.N / NYT.N / WST.N / MUR.N / HRB.N / ORCL.N / VFC.N / NEU.N / EFX.N / EQT.N / V.N / ACN.N / WSM.N / ESI.N / HAE.N / LB.TO / SAM.N / BLK.N / CRL.N / CVX.N / COP.N / INTC.OQ / CTSH.OQ / ADPT.OQ / ADBE.OQ / ANAT.OQ / AMGN.OQ / AAPL.OQ / AMAT.OQ / CSCO.OQ / COHR.OQ / FISV.OQ / HOLX.OQ / HBAN.OQ / LRCX.OQ / MSFT.OQ / ROL.N / THO.N / ALKS.OQ / QDEL.OQ / IDXX.OQ / QCOM.OQ / SMG.N / INTU.OQ / COST.OQ / NKTR.OQ / PENN.OQ / DLTR.OQ / POOL.OQ / CTXS.OQ / AMZN.OQ / TTWO.OQ / MRCY.OQ / CSGP.OQ / ERIE.OQ / NVDA.OQ / FFIV.OQ / TREE.OQ / EXEL.OQ / ISRG.OQ / BLUE.OQ / ARRY.OQ / GPN.N / VRTX.OQ / JBLU.OQ / NFLX.OQ / DKS.N / CMCSA.OQ / TFC.N / SBNY.OQ / ACAD.OQ / CG.TO / DPZ.N / MKTX.OQ / LVS.N / DISCA.OQ / MS.N / STX.AX / RPRX.OQ / HES.N / IVZ.N / CLR.N / TDC.N / ES.N / MRNA.OQ / LOPE.OQ / MSCI.N / VRSK.OQ / SCHW.N / FTNT.OQ / MU.OQ / GNRC.N / NEE.N / TSLA.OQ / TRGP.N / APO.N / AMD.OQ / SLM.OQ / ENPH.OQ / TRIP.OQ / SPLK.OQ / SRPT.OQ / ADT.N / FANG.OQ / BFAM.N / RNG.N / COMM.OQ / MAR.OQ / GOOGL.OQ / PAYC.N / SAGE.OQ / HUBS.N / TDOC.N / PYPL.OQ / BWXT.K / PEN.N / NVCR.OQ / TMUS.OQ / IONS.OQ / IAC.OQ / NTNX.OQ / RETA.OQ / COUP.OQ / AYX.N / DXC.N / IOVA.OQ / WDAY.OQ / ROKU.OQ / SWCH.N / IQV.N / BKNG.OQ / FB.PS / UAL.OQ / STNE.OQ / FSLY.N / CRWD.OQ / PTON.OQ / NLOK.OQ / RTX.N / AMWL.N / VTRS.OQ / PLTK.OQ</td><td class="leftalignment">Abbott Laboratories / Air Lease Corp / Alaska Air Group Inc / American Express Co / Boeing Co / Bank of America Corp / Becton Dickinson and Co / Citigroup Inc / Colgate-Palmolive Co / Capital One Financial Corp / Salesforce.Com Inc / CVS Health Corp / Delta Air Lines Inc / Ecolab Inc / Edison International / EOG Resources Inc / Ford Motor Co / Gap Inc / International Business Machines Corp / JPMorgan Chase & Co / Coca-Cola Co / Eli Lilly and Co / Southwest Airlines Co / Altria Group Inc / Occidental Petroleum Corp / Pfizer Inc / Philip Morris International Inc / Santander Consumer USA Holdings Inc / Sealed Air Corp / AT&T Inc / Unity Software Inc / Wells Fargo & Co / Walmart Inc / Simon Property Group Inc / Procter & Gamble Co / Nucor Corp / Campbell Soup Co / Anglo American PLC / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Cummins Inc / Deere & Co / Caterpillar Inc / Spotify Technology SA / Goldman Sachs Group Inc / Clorox Co / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / United Parcel Service Inc / PG&E Corp / Exxon Mobil Corp / Devon Energy Corp / American Tower Corp / Resmed Inc / Nike Inc / Olin Corp / Gartner Inc / Target Corp / Rocket Companies Inc / Ball Corp / Verizon Communications Inc / New York Times Co / West Pharmaceutical Services Inc / Murphy Oil Corp / H & R Block Inc / Oracle Corp / VF Corp / NewMarket Corp / Equifax Inc / EQT Corp / Visa Inc / Accenture PLC / Williams-Sonoma Inc / Element Solutions Inc / Haemonetics Corp / Laurentian Bank of Canada / Boston Beer Company Inc / BlackRock Inc / Charles River Laboratories International Inc / Chevron Corp / Conocophillips / Intel Corp / Cognizant Technology Solutions Corp / Adaptive Biotechnologies Corp / Adobe Inc / American National Group Inc / Amgen Inc / Apple Inc / Applied Materials Inc / Cisco Systems Inc / Coherent Inc / Fiserv Inc / Hologic Inc / Huntington Bancshares Inc / Lam Research Corp / Microsoft Corp / Rollins Inc / Thor Industries Inc / Alkermes Plc / Quidel Corp / IDEXX Laboratories Inc / Qualcomm Inc / Scotts Miracle-Gro Co / Intuit Inc / Costco Wholesale Corp / Nektar Therapeutics / Penn National Gaming Inc / Dollar Tree Inc / Pool Corp / Citrix Systems Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Mercury Systems Inc / CoStar Group Inc / Erie Indemnity Co / NVIDIA Corp / F5 Inc / Lendingtree Inc / Exelixis Inc / Intuitive Surgical Inc / bluebird bio Inc / Array Technologies Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / JetBlue Airways Corp / Netflix Inc / DICK'S Sporting Goods Inc / Comcast Corp / Truist Financial Corp / Signature Bank / ACADIA Pharmaceuticals Inc / Centerra Gold Inc / Domino's Pizza Inc / Marketaxess Holdings Inc / Las Vegas Sands Corp / Discovery Inc / Morgan Stanley / Strike Energy Ltd / Royalty Pharma PLC / Hess Corp / Invesco Ltd / Continental Resources Inc / Teradata Corp / Eversource Energy / Moderna Inc / Grand Canyon Education Inc / MSCI Inc / Verisk Analytics Inc / Charles Schwab Corp / Fortinet Inc / Micron Technology Inc / Generac Holdings Inc / Nextera Energy Inc / Tesla Inc / Targa Resources Corp / Apollo Global Management Inc / Advanced Micro Devices Inc / SLM Corp / Enphase Energy Inc / Tripadvisor Inc / Splunk Inc / Sarepta Therapeutics Inc / ADT Inc / Diamondback Energy Inc / Bright Horizons Family Solutions Inc / RingCentral Inc / CommScope Holding Company Inc / Marriott International Inc / Alphabet Inc / Paycom Software Inc / SAGE Therapeutics Inc / HubSpot Inc / Teladoc Health Inc / PayPal Holdings Inc / BWX Technologies Inc / Penumbra Inc / Novocure Ltd / T-Mobile US Inc / Ionis Pharmaceuticals Inc / IAC/Interactivecorp / Nutanix Inc / Reata Pharmaceuticals Inc / Coupa Software Inc / Alteryx Inc / DXC Technology Co / Iovance Biotherapeutics Inc / Workday Inc / Roku Inc / Switch Inc / IQVIA Holdings Inc / Booking Holdings Inc / San Miguel Food and Beverage Inc / United Airlines Holdings Inc / StoneCo Ltd / Fastly Inc / CrowdStrike Holdings Inc / Peloton Interactive Inc / NortonLifeLock Inc / Raytheon Technologies Corp / American Well Corp / Viatris Inc / Playtika Holding Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Cayman Islands / United Kingdom / Ireland / Luxembourg / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">07/07/2021</td><td class="leftalignment">Valens Research</td><td class="leftalignment">AMGN - Embedded Expectations Analysis - 2021 07 06</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">CAPITALIZATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Valens Research</td></tr>
<tr class="even"><td class="leftalignment">07/06/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">A Primer on the First Mover Advantage in Oncology</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AMGN.O / MRTX.OQ</td><td class="leftalignment">Amgen Inc / Mirati Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="odd"><td class="leftalignment">07/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending June 25, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">07/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Guggenheim Biotech 2Q 2021 Earnings Preview</td><td class="leftalignment">English</td><td class="rightalignment">44</td><td class="leftalignment">4595739 / 2471950 / 2023607 / 2437071 / 2576941 / 2369174 / 2455965 / 2623911 / 2730190 / 2931034 / 5531000 / B00FWN1 / B19FQ48 / 2713317 / BCBVTX1 / BBFL7S1 / BFDV8K0 / B8DPDT7 / BZ1LFB2 / B0SDJB4 / BG31GH0 / BZ05388 / BYYWPW6 / BWY52P3 / BYTJZL1</td><td class="leftalignment">Genmab A/S / Incyte Corp / Amgen Inc / Biomarin Pharmaceutical Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / MorphoSys AG / Alnylam Pharmaceuticals Inc / Amicus Therapeutics Inc / ACADIA Pharmaceuticals Inc / Agios Pharmaceuticals Inc / bluebird bio Inc / MacroGenics Inc / Sarepta Therapeutics Inc / Deciphera Pharmaceuticals Inc / Zealand Pharma A/S / Y-mAbs Therapeutics Inc / Global Blood Therapeutics Inc / Beigene Ltd / Blueprint Medicines Corp / Zogenix Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Germany / Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Guggenheim Biot Research / Mr. Eddie Hickman, Ph.D. / Debjit Chattopadhyay, Ph.D. / Mr. Etzer Darout / Michael W. Schmidt, Ph.D., PHD / Mr. Yatin Suneja / Mr. Charles Zhu, Ph.D., III / Paul Jeng, Ph.D. / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/05/2021</td><td class="leftalignment">Corporate Watchdog Reports</td><td class="leftalignment">Watchdog Report: AMGN - Now with Critical / Key Audit Matters</td><td class="leftalignment">English</td><td class="rightalignment">43</td><td class="leftalignment">AMGN</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Joseph Burke</td></tr>
<tr class="even"><td class="leftalignment">07/05/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - July 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">US00724F1012 / US0231351067 / US0311621009 / US4227041062 / US56418H1005 / US5949181045 / US67066G1040 / US7703231032 / CA3180714048 / CA6979001089 / CA0084741085 / CA9528451052 / CA1363851017 / CA6837151068 / US0017441017 / US2274831047 / US35671D8570 / US46625H1005 / CA32076V1031 / GB00B1FW5029 / CA3499151080 / US89785X1019 / US1921085049 / CA25675T1075 / US1729674242 / US00287Y1091 / CA81373C1023 / CA49448Q1090 / US70450Y1038 / CA04045U1021 / US00191U1025 / CA53227R1064 / CA5362211040 / CA55940P1018 / CA24874B1085</td><td class="leftalignment">Adobe Inc / Amazon.com Inc / Amgen Inc / Hecla Mining Co / ManpowerGroup Inc / Microsoft Corp / NVIDIA Corp / Robert Half International Inc / Finning International Inc / Pan American Silver Corp / Agnico Eagle Mines Ltd / West Fraser Timber Co Ltd / Canadian Natural Resources Ltd / Open Text Corp / AMN Healthcare Services Inc / Cross Country Healthcare Inc / Freeport-McMoRan Inc / JPMorgan Chase & Co / First Majestic Silver Corp / Hochschild Mining PLC / Fortuna Silver Mines Inc / TrueBlue Inc / Coeur Mining Inc / Dollarama Inc / Citigroup Inc / Abbvie Inc / Secure Energy Services Inc / Kinaxis Inc / PayPal Holdings Inc / Aritzia Inc / ASGN Inc / Lightspeed Commerce Inc / Lion Electric Co / Magnet Forensics Inc / dentalcorp Holdings Ltd</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">07/02/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 554</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / John Boyle / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers / Lachlan Hanbury-Brown</td></tr>
<tr class="even"><td class="leftalignment">07/02/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Portfolio Strategy - Investment Strategy Portfolios – July 2021</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US00724F1012 / US0231351067 / US0311621009 / US5949181045 / US67066G1040 / CA3180714048 / CA0084741085 / CA9528451052 / CA6837151068 / US35671D8570 / US46625H1005 / CA25675T1075 / US1729674242 / US00287Y1091 / CA49448Q1090 / US70450Y1038 / CA04045U1021 / CA53227R1064 / CA5362211040 / CA55940P1018 / CA24874B1085</td><td class="leftalignment">Adobe Inc / Amazon.com Inc / Amgen Inc / Microsoft Corp / NVIDIA Corp / Finning International Inc / Agnico Eagle Mines Ltd / West Fraser Timber Co Ltd / Open Text Corp / Freeport-McMoRan Inc / JPMorgan Chase & Co / Dollarama Inc / Citigroup Inc / Abbvie Inc / Kinaxis Inc / PayPal Holdings Inc / Aritzia Inc / Lightspeed Commerce Inc / Lion Electric Co / Magnet Forensics Inc / dentalcorp Holdings Ltd</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / PORTFOLIO/ASSET STRATEGIES / Investment Strategy / Equity</td><td class="leftalignment">Mr. Brian G. Belski / Ryan Bohren</td></tr>
<tr class="odd"><td class="leftalignment">07/02/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended June 25, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">07/02/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">07/02/2021</td><td class="leftalignment">Probes Reporter</td><td class="leftalignment">Jul-2021 Watch List: 82 US Companies with Undisclosed SEC Probes</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">AMZN.OQ / T.N / AEP.N / BAC.N / CL.N / COF.N / CRM.N / F.N / HLT.N / PNC.N / SLB.N / BEN.N / THC.N / REV.N / ADM.N / VLO.N / UPS.N / KR.N / XOM.N / NKE.N / SNN.N / AMP.N / ARW.N / ATO.N / TWTR.N / TUP.N / OMI.N / CVX.N / TDY.N / AMGN.OQ / CSCO.OQ / GNTX.OQ / HBAN.OQ / MGPI.OQ / REGN.OQ / ROL.N / SEIC.OQ / RARE.OQ / MNRO.OQ / GILD.OQ / COST.OQ / NKTR.OQ / AZPN.OQ / MYGN.OQ / SSNC.OQ / CTXS.OQ / NVDA.OQ / CHTR.OQ / TNP.N / NFLX.OQ / EGBN.OQ / CVGI.OQ / RUSHA.OQ / NDAQ.OQ / MA.N / SIX.N / AON.N / BX.N / INO.OQ / BGCP.OQ / UTL.N / SCHW.N / MSI.N / GRPN.OQ / FB.OQ / COTY.N / CTG.OQ / ANTM.N / NTRA.OQ / PYPL.OQ / PFX.N / MFIN.OQ / DXC.N / IQV.N / WELL.N / TLRY.OQ / US29350E1047 / LYFT.O</td><td class="leftalignment">Amazon.com Inc / AT&T Inc / American Electric Power Company Inc / Bank of America Corp / Colgate-Palmolive Co / Capital One Financial Corp / Salesforce.Com Inc / Ford Motor Co / Hilton Worldwide Holdings Inc / PNC Financial Services Group Inc / Schlumberger NV / Franklin Resources Inc / Tenet Healthcare Corp / Revlon Inc / Archer-Daniels-Midland Co / Valero Energy Corp / United Parcel Service Inc / Kroger Co / Exxon Mobil Corp / Nike Inc / Smith & Nephew PLC / Ameriprise Financial Inc / Arrow Electronics Inc / Atmos Energy Corp / Twitter Inc / Tupperware Brands Corp / Owens & Minor Inc / Chevron Corp / Teledyne Technologies Inc / Amgen Inc / Cisco Systems Inc / Gentex Corp / Huntington Bancshares Inc / MGP Ingredients Inc / Regeneron Pharmaceuticals Inc / Rollins Inc / SEI Investments Co / Ultragenyx Pharmaceutical Inc / Monro Inc / Gilead Sciences Inc / Costco Wholesale Corp / Nektar Therapeutics / Aspen Technology Inc / Myriad Genetics Inc / SS&C Technologies Holdings Inc / Citrix Systems Inc / NVIDIA Corp / Charter Communications Inc / Tsakos Energy Navigation Ltd / Netflix Inc / Eagle Bancorp Inc / Commercial Vehicle Group Inc / Rush Enterprises Inc / Nasdaq Inc / Mastercard Inc / Six Flags Entertainment Corp / Aon PLC / Blackstone Inc / Inovio Pharmaceuticals Inc / BGC Partners Inc / Unitil Corp / Charles Schwab Corp / Motorola Solutions Inc / Groupon Inc / Meta Platforms Inc / Coty Inc / Computer Task Group Inc / Anthem Inc / Natera Inc / PayPal Holdings Inc / PhenixFIN Corp / Medallion Financial Corp / DXC Technology Co / IQVIA Holdings Inc / Welltower Inc / Tilray Brands Inc / Enochian Biosciences Inc / Lyft Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / United Kingdom / Greece / Ireland / United States / Curaçao</td><td class="leftalignment">Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Consumer / Defense / Electronics / Financial Services / Healthcare / Household Products / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Services / Technology / Telecommunications / Transportation / Utilities / Wholesale / Oil & Gas</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">07/02/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">2021 DC Day Review: Expect Incremental Policy Reform, Strong Support for Value-Based Care, Tech-Enabled Novel Delivery Models</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">85891210 / 42190610 / 76115210 / 80640710 / 03116210 / 64125C109 / 002824100 / 110122108 / 09062X103 / 50540R409 / 74834L100 / 159864107 / 09061G101 / 703395103 / 640268108 / 075887109 / 20530610 / 30063P105 / 216648402 / 28176E108 / 30161Q104 / 45337C102 / 23918K108 / 038336103 / 852312305 / 023436108 / 589584101 / 955306105 / 50187A107 / 436440101 / 003654100 / 09060J106 / 252131107 / 42222N103 / 45253H101 / 640491106 / 74838J101 / 759916109 / 90337L108 / 45784P101 / 58502B106 / 141619106 / 64049M20 / 40412C101 / 00847G705 / 92857F107 / 00404A109 / 88033G407 / 803607100 / G4705A100 / 74051N10 / 92337F10 / 26979610 / 45780L10 / 14862Q100 / 006739106 / 00430H102 / 00847L10 / 045396108 / 14880610 / 82621J10 / 268158201 / 31572Q80 / 76133010 / G5960L103 / 78667J108 / 30050B10 / 98978L204 / 37732210 / 15117K103 / 87918A10 / 46185L10 / 04651310 / 00461U105 / 462222100 / 19459J104 / 70975L107 / 64157F103 / 87357P100 / 58506Q109 / 01345P106 / 88870R102 / N72482123 / 690469101 / G11196105 / 00887A105 / 69366J200 / 46266C105 / 816212104 / 09609G100 / 450056106 / 67022C106 / 29261A100 / 87166B102 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 873379101 / 501147102 / 37890U108 / 40131M109 / 90184D100 / 05352A100 / 00650F109 / 77313F106 / 03836N103 / 717224109 / 88025U109 / 30068X103 / 15912K100 / 07373V105 / 68404L201 / 42225T107 / 05464T104 / 922107107 / 55234L105 / 71944F106 / 68269G107 / 74019P108 / 37148K100 / 64131A105 / 48576A100 / N5749R100 / 084310101 / 005111109 / 00437E102 / G10830100 / 24984K105 / 73730P108 / 81181C104 / 04537Y109 / 517125100 / 877619106 / 74006W108 / 67181A107 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 270087109 / 192010106 / 13089P101 / 151205200 / 09075X108 / 68401U204 / 04683R106 / 78472F101 / 000380204 / 89422G107 / 56600D107 / 15687V109 / 65443P102 / 54948U105 / 82671G100 / 45784A104 / 30315R107 / 01625V104 / 45175G108 / 00857U107 / 74276R102 / 91864C107 / 98985X100</td><td class="leftalignment">Stericycle Inc / Healthcare Services Group Inc / Resmed Inc / Henry Schein Inc / Amgen Inc / Neurocrine Biosciences Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Biogen Inc / Laboratory Corporation of America Holdings / Quest Diagnostics Inc / Charles River Laboratories International Inc / Biomarin Pharmaceutical Inc / Patterson Companies Inc / Nektar Therapeutics / Becton Dickinson and Co / Computer Programs and Systems Inc / Exact Sciences Corp / Cooper Companies Inc / Edwards Lifesciences Corp / Exelixis Inc / Incyte Corp / DaVita Inc / Aptargroup Inc / STAAR Surgical Co / Amedisys Inc / Meridian Bioscience Inc / West Pharmaceutical Services Inc / LHC Group Inc / Hologic Inc / ABIOMED Inc / BioDelivery Sciences International Inc / Dexcom Inc / HealthStream Inc / ImmunoGen Inc / Neogen Corp / Quidel Corp / Repligen Corp / US Physical Therapy Inc / Insulet Corp / MEDNAX Inc / Cardiovascular Systems Inc / Neogenomics Inc / HCA Healthcare Inc / Agenus Inc / Vocera Communications Inc / Acadia Healthcare Company Inc / Tenet Healthcare Corp / Sarepta Therapeutics Inc / ICON PLC / Premier Inc / Veracyte Inc / Eagle Pharmaceuticals Inc / Inogen Inc / Castlight Health Inc / Addus Homecare Corp / Accelerate Diagnostics Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Catalent Inc / Sientra Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / Medtronic PLC / SAGE Therapeutics Inc / Evolent Health Inc / Zogenix Inc / Glaukos Corp / Cellectis SA / Teladoc Health Inc / Invitae Corp / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Penumbra Inc / Nevro Corp / Tactile Systems Technology Inc / Medpace Holdings Inc / Albireo Pharma Inc / Tivity Health Inc / Qiagen NV / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / IQVIA Holdings Inc / Selecta Biosciences Inc / bluebird bio Inc / iRhythm Technologies Inc / NuCana PLC / Encompass Health Corp / Syneos Health Inc / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Tabula Rasa HealthCare Inc / Krystal Biotech Inc / Global Blood Therapeutics Inc / Guardant Health Inc / Twist Bioscience Corp / Avantor Inc / Adaptive Biotechnologies Corp / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / 10X Genomics Inc / Exagen Inc / Change Healthcare Inc / Beam Therapeutics Inc / Option Care Health Inc / Health Catalyst Inc / Axsome Therapeutics Inc / Vapotherm Inc / Lyra Therapeutics Inc / Phreesia Inc / 1Life Healthcare Inc / Precision BioSciences Inc / Generation Bio Co / Neuronetics Inc / Karuna Therapeutics Inc / Merus NV / Berkeley Lights Inc / Acutus Medical Inc / Accolade Inc / Beyondspring Inc / DermTech Inc / Poseida Therapeutics Inc / Seagen Inc / Aspira Women's Health Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Oak Street Health Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Eargo Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Biodesix Inc / OPTIMIZERx Corp / Atea Pharmaceuticals Inc / Soc Telemed Inc / Abcam PLC / Travere Therapeutics Inc / Maravai LifeSciences Holdings Inc / Certara Inc / 908 Devices Inc. / Lucira Health Inc / Signify Health Inc / InnovAge Holding Corp / F-Star Therapeutics Inc / Alignment Healthcare Inc / Ikena Oncology Inc / agilon health Inc / Privia Health Group Inc / Vaccitech PLC / Zymergen Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Ryan S. Daniels, CFA / Mr. Raju Prasad, PHD / John C. Kreger, III / Andy T. Hsieh, PHD / Ms. Margaret Kaczor / Brian D. Weinstein, CFA / Mr. Tim F. Lugo / Mr. Matt Larew / Matt Phipps, PHD / Mr. Myles R. R. Minter</td></tr>
<tr class="odd"><td class="leftalignment">07/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for AMGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">07/01/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Don’t Call it a Comeback; Biotech Inflows Return</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">07/01/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Amgen up 0.06% from 6 week low</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">07/01/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Lots to Write Home About – 2H21 Shaping Up as a Catalyst Rich Period</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">CBIO.OQ / 031162100 / 64125C109 / 766559603 / 09062X103 / 881624209 / 92532F100 / 09061G101 / 75886F107 / 30161Q104 / 02043Q107 / 036642106 / 09058V103 / 40637H109 / 45253H101 / 45665G303 / 68375N103 / 00287Y109 / 29251M106 / 23282W605 / G30401106 / 023111206 / G50871105 / 45773H201 / 189464100 / 78667J108 / 03209R103 / 16383L106 / 90400D108 / 31189P102 / 00461U105 / 45845P108 / 04280A100 / 09627Y109 / 00771V108 / 01345P106 / 52187K101 / G11196105 / 81750R102 / 462260100 / 558868105 / 805111101 / 98401F105 / 23284F105 / 03168L105 / 29014R103 / 039697107 / 140755109 / H17182108 / 67576A100 / 761330109 / 41358P106 / 483347100 / 37890U108 / 269796108 / 87166L100 / 088786108 / 29668H708 / 68906L105 / 04016X101 / 62921N105 / 87184Q107 / 481116101 / 03836N103 / 869367102 / BY2Z0H7 / 69242L106 / 44975P103 / 60770K107 / 65343E108 / 05337M104 / 04522R101 / 492327101 / 359616109 / 729139105 / 00972D105 / 760273102 / 282559103 / 02083G100 / 02155H200 / 03969T109 / 24344T101 / 604749101 / 92243A200 / 74366E102 / 00166B105 / 576810105 / 45790W108 / 04335A105 / 23257D103 / 4525EP101 / 46565G104 / 75382E109 / 501575104 / 14147L108 / 53272L103 / 67080M103 / 73730P108 / 26818M108 / 81181C104 / 019818103 / 50107A104 / 74006W108 / 38942Q103 / 68236R103 / M47364100 / 00773J103 / G59665102 / 03890D108 / 55028X109 / 14888D208 / 19240Q201 / 98872L102 / 49705R105 / 38406L103 / 81728A108 / 57055L107 / 45256X103 / 207523101 / 00449L102 / 09077A106 / 75082Q105</td><td class="leftalignment">Catalyst Biosciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Teva Pharmaceutical Industries Ltd / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Exelixis Inc / Alnylam Pharmaceuticals Inc / Antares Pharma Inc / BioCryst Pharmaceuticals Inc / Halozyme Therapeutics Inc / ImmunoGen Inc / Infinity Pharmaceuticals Inc / OPKO Health Inc / Abbvie Inc / Enanta Pharmaceuticals Inc / Cytokinetics Inc / Endo International PLC / Amarin Corporation PLC / Jazz Pharmaceuticals PLC / Inovio Pharmaceuticals Inc / Clovis Oncology Inc / SAGE Therapeutics Inc / Amphastar Pharmaceuticals Inc / ChemoCentryx Inc / Ultragenyx Pharmaceutical Inc / Fate Therapeutics Inc / Aclaris Therapeutics Inc / Intercept Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Blueprint Medicines Corp / Aerie Pharmaceuticals Inc / Albireo Pharma Inc / Leap Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Seres Therapeutics Inc / Iovance Biotherapeutics Inc / Madrigal Pharmaceuticals Inc / Savara Inc / Xencor Inc / CytomX Therapeutics Inc / Amneal Pharmaceuticals Inc / Eloxx Pharmaceuticals Inc / Ardelyx Inc / Cara Therapeutics Inc / CRISPR Therapeutics AG / Ocular Therapeutix Inc / Revance Therapeutics Inc / Harpoon Therapeutics Inc / Kaleido Biosciences Inc / Global Blood Therapeutics Inc / Eagle Pharmaceuticals Inc / Synlogic Inc / Bicycle Therapeutics PLC / ESSA Pharma Inc / Otonomy Inc / argenx SE / NGM Biopharmaceuticals Inc / Syros Pharmaceuticals Inc / Jounce Therapeutics Inc / Aptinyx Inc / Sutro Biopharma Inc / PureTech Health PLC / Oyster Point Pharma Inc / I-Mab / Moderna Inc / NextCure Inc / Avadel Pharmaceuticals PLC / Aslan Pharmaceuticals Ltd / Keros Therapeutics Inc / Fulcrum Therapeutics Inc / Pliant Therapeutics Inc / Akebia Therapeutics Inc / Repare Therapeutics Inc / 89Bio Inc / Alpine Immune Sciences Inc / Altimmune Inc / Arcturus Therapeutics Holdings Inc / Deciphera Pharmaceuticals Inc / Mirum Pharmaceuticals Inc / Vaxart Inc / Protagonist Therapeutics Inc / ALX Oncology Holdings Inc / Matinas BioPharma Holdings Inc / Inozyme Pharma Inc / Arvinas Inc / Cymabay Therapeutics Inc / Immunic Inc / Iteos Therapeutics Inc / Rapt Therapeutics Inc / Kymera Therapeutics Inc / Cardiff Oncology Inc / Liminal BioSciences Inc / Nurix Therapeutics Inc / Poseida Therapeutics Inc / Dyne Therapeutics Inc / Seagen Inc / Allovir Inc / Kronos Bio Inc / Praxis Precision Medicines Inc / Graybug Vision Inc / Oncorus Inc / Gamida Cell Ltd / Aeglea Bio Therapeutics Inc / MeiraGTx Holdings PLC / Aravive Inc / Lumos Pharma Inc / Catalyst Biosciences Inc / Cogent Biosciences Inc / Yumanity Therapeutics Inc / Kinnate Biopharma Inc / Gracell Biotechnologies Inc / Sensei Biotherapeutics Inc / Marker Therapeutics Inc / Immunitybio Inc / Connect Biopharma Holdings Ltd / Achilles Therapeutics PLC / Biomea Fusion Inc / Rain Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / Ireland / Israel / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">David A. Amsellem / Joseph Catanzaro, PhD / Yasmeen Rahimi, Ph.D. / Mr. Christopher J. Raymond / Edward A. Tenthoff</td></tr>
<tr class="odd"><td class="leftalignment">07/01/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Deep Genomics, Inc.: Our Q&A With Management</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 92247510 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 90184D100 / 77313F106 / 03836N103 / 717224109 / 88025U109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 000380204 / 89422G107 / 56600D107 / 65443P102 / 30315R107 / 45175G108 / 91864C107 / 98985X100</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Veeva Systems Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Twist Bioscience Corp / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / 10X Genomics Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Abcam PLC / Travere Therapeutics Inc / Maravai LifeSciences Holdings Inc / 908 Devices Inc. / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Zymergen Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Myles R. R. Minter</td></tr>
<tr class="even"><td class="leftalignment">06/30/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Amgen dips 1.7% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">72</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">06/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Amgen dips 1.7% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">06/30/2021</td><td class="leftalignment">CRD Global</td><td class="leftalignment">Sustco Score Report: Amgen Inc. JUNE 2021</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">MISCELLANEOUS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Environmental, Social, Governance</td><td class="leftalignment">CRD Global</td></tr>
<tr class="odd"><td class="leftalignment">06/29/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Amgen Inc.(AMGN) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">031162100</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">06/29/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AIN / LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / WEN=US / BLD=US / INCY=US / LOW=US / LEG=US / LSTR=US / VMC=US / HUM=US / MLM=US / AMED=US / SWIM=US / CBRL=US / DRI=US / EXEL=US / GFF=US / HXL=US / IBP=US / MAS=US / MHK=US / REGI=US / VRTX=US / SPR=US / DIN=US / OGN / BIIB=US / TPX=US / EXP=US / BECN=US / PLAY=US / DENN=US / LHCG=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / SAIA=US / AWI=US / OC=US / TAST=US / QSR=US / PRPL=US / EHC=US / JACK=US / TREX=US / WWD=US / FBHS=US / ABBV=US / TILE=US / NDLS=US / ARCB=US / 00770K202 / LOCO=US / SHAK=US / RLMD=US / ETSY=US / WING=US / EDIT=US / NTLA=US / 82982L103 / CRSP=US / JELD=US / FERG=US / PNTG=US / ARQT=US / AZEK=US / AVAH=US</td><td class="leftalignment">Albany International Corp / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Wendys Co / TopBuild Corp / Incyte Corp / Lowe's Companies Inc / Leggett & Platt Inc / Landstar System Inc / Vulcan Materials Co / Humana Inc / Martin Marietta Materials Inc / Amedisys Inc / Latham Group Inc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Exelixis Inc / Griffon Corp / Hexcel Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Renewable Energy Group Inc / Vertex Pharmaceuticals Inc / Spirit AeroSystems Holdings Inc / Dine Brands Global Inc / Organon & Co / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / LHC Group Inc / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / Saia Inc / Armstrong World Industries Inc / Owens Corning / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Encompass Health Corp / Jack in the Box Inc / Trex Company Inc / Woodward Inc / Fortune Brands Home & Security Inc / Abbvie Inc / Interface Inc / Noodles & Co / ArcBest Corp / Aemetis Inc / El Pollo Loco Holdings Inc / Shake Shack Inc / Relmada Therapeutics Inc / ETSY Inc / Wingstop Inc / Editas Medicine Inc / Intellia Therapeutics Inc / SiteOne Landscape Supply Inc / CRISPR Therapeutics AG / JELD-WEN Holding Inc / Ferguson PLC / Pennant Group Inc / Arcutis Biotherapeutics Inc / Azek Company Inc / Aveanna Healthcare Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2000019 / 2023607 / 2113393 / 2280220 / 2270726 / 2576941 / 2670519 / 2100920 / 2369174 / 2455965 / 2471950 / 2689560 / 2672689 / 2684703 / 2707677 / 2138158 / 2825933 / 2829601 / 7103065 / 2857817 / B125XQ6 / B3D7K31 / B7TL820 / B4MG4Z6 / B7VD3F2 / BCZS820 / BDZCRX3 / BYVY8G0 / BYW36M8 / BFZNYB7 / BK0VHF6 / BDHF4K6 / BHC8X90 / BD8DJ71 / BMQ5T49 / BWFKZT2 / BJJMGL2 / BKTNTR9 / BGSP7M9</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Amgen Inc / Boston Beer Company Inc / DTE Energy Co / Walt Disney Co / Exelixis Inc / Exelon Corp / FirstEnergy Corp / Gilead Sciences Inc / Biogen Inc / Incyte Corp / PG&E Corp / Patterson Companies Inc / Pfizer Inc / Public Service Enterprise Group Inc / Sempra Energy / South Jersey Industries Inc / Southern Co / Novartis AG / Netflix Inc / Portland General Electric Co / Discovery Inc / Meta Platforms Inc / AMC Networks Inc / Duke Energy Corp / Fate Therapeutics Inc / RingCentral Inc / Alphabet Inc / PayPal Holdings Inc / Allogene Therapeutics Inc / IDEAYA Biosciences Inc / CRISPR Therapeutics AG / Novo Nordisk A/S / Snap Inc / Zentalis Pharmaceuticals Inc / Cellectis SA / Fox Corp / ViacomCBS Inc / Zoom Video Communications Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending June 18, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">06/28/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Final Reminder: Virtual Washington, D.C. Day - This Wednesday, June 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">85891210 / 42190610 / 76115210 / 80640710 / 03116210 / 7333378 / 64125C109 / 002824100 / 110122108 / 09062X103 / 50540R409 / 74834L100 / 159864107 / 09061G101 / 703395103 / 640268108 / 075887109 / 20530610 / 30063P105 / 216648402 / 28176E108 / 30161Q104 / 45337C102 / 23918K108 / 038336103 / 852312305 / 023436108 / 589584101 / 955306105 / 50187A107 / 436440101 / 003654100 / 016255101 / 09060J106 / 252131107 / 42222N103 / 45168D104 / 45253H101 / 640491106 / 74838J101 / 759916109 / 90337L108 / 45784P101 / 58502B106 / 141619106 / 64049M20 / 40412C101 / 00847G705 / 92857F107 / 00404A109 / 88033G407 / 803607100 / G4705A100 / 74051N10 / 98978V10 / 92337F10 / 26979610 / 45780L10 / 14862Q100 / 006739106 / 00430H102 / 00847L10 / 045396108 / 14880610 / 82621J10 / 268158201 / 31572Q80 / 76133010 / G5960L103 / 78667J108 / 30050B10 / 98978L204 / 37732210 / 15117K103 / 87918A10 / 46185L10 / 04651310 / 00461U105 / 462222100 / 19459J104 / 24906P109 / 70975L107 / 64157F103 / 87357P100 / 58506Q109 / 01345P106 / 88870R102 / N72482123 / 690469101 / G11196105 / 00887A105 / 69366J200 / 46266C105 / 816212104 / 09609G100 / 450056106 / 67022C106 / 29261A100 / 87166B102 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / 28414H103 / H17182108 / 873379101 / 501147102 / 37890U108 / 40131M109 / 22304C100 / 05352A100 / 00650F109 / 77313F106 / 03836N103 / 717224109 / 83192H106 / 88025U109 / 30068X103 / 15912K100 / 29415F104 / 07373V105 / 68404L201 / 42225T107 / 05464T104 / 922107107 / 55234L105 / 71944F106 / 68269G107 / 74019P108 / 37148K100 / 64131A105 / 48576A100 / N5749R100 / 084310101 / 005111109 / 00437E102 / G10830100 / 24984K105 / 73730P108 / 81181C104 / 04537Y109 / 517125100 / 877619106 / 74006W108 / 67181A107 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 270087109 / 192010106 / 13089P101 / 151205200 / 09075X108 / 68401U204 / 04683R106 / 78472F101 / 000380204 / 89422G107 / 56600D107 / 15687V109 / 65443P102 / 54948U105 / 82671G100 / 45784A104 / 30315R107 / 01625V104 / 45175G108 / 00857U107 / 74276R102 / 91864C107</td><td class="leftalignment">Stericycle Inc / Healthcare Services Group Inc / Resmed Inc / Henry Schein Inc / Amgen Inc / Lonza Group AG / Neurocrine Biosciences Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Biogen Inc / Laboratory Corporation of America Holdings / Quest Diagnostics Inc / Charles River Laboratories International Inc / Biomarin Pharmaceutical Inc / Patterson Companies Inc / Nektar Therapeutics / Becton Dickinson and Co / Computer Programs and Systems Inc / Exact Sciences Corp / Cooper Companies Inc / Edwards Lifesciences Corp / Exelixis Inc / Incyte Corp / DaVita Inc / Aptargroup Inc / STAAR Surgical Co / Amedisys Inc / Meridian Bioscience Inc / West Pharmaceutical Services Inc / LHC Group Inc / Hologic Inc / ABIOMED Inc / Align Technology Inc / BioDelivery Sciences International Inc / Dexcom Inc / HealthStream Inc / IDEXX Laboratories Inc / ImmunoGen Inc / Neogen Corp / Quidel Corp / Repligen Corp / US Physical Therapy Inc / Insulet Corp / MEDNAX Inc / Cardiovascular Systems Inc / Neogenomics Inc / HCA Healthcare Inc / Agenus Inc / Vocera Communications Inc / Acadia Healthcare Company Inc / Tenet Healthcare Corp / Sarepta Therapeutics Inc / ICON PLC / Premier Inc / Zoetis Inc / Veracyte Inc / Eagle Pharmaceuticals Inc / Inogen Inc / Castlight Health Inc / Addus Homecare Corp / Accelerate Diagnostics Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Catalent Inc / Sientra Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / Medtronic PLC / SAGE Therapeutics Inc / Evolent Health Inc / Zogenix Inc / Glaukos Corp / Cellectis SA / Teladoc Health Inc / Invitae Corp / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / DENTSPLY SIRONA Inc / Penumbra Inc / Nevro Corp / Tactile Systems Technology Inc / Medpace Holdings Inc / Albireo Pharma Inc / Tivity Health Inc / Qiagen NV / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / IQVIA Holdings Inc / Selecta Biosciences Inc / bluebird bio Inc / iRhythm Technologies Inc / NuCana PLC / Encompass Health Corp / Syneos Health Inc / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / Elanco Animal Health Inc / CRISPR Therapeutics AG / Tabula Rasa HealthCare Inc / Krystal Biotech Inc / Global Blood Therapeutics Inc / Guardant Health Inc / Covetrus Inc / Avantor Inc / Adaptive Biotechnologies Corp / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / SmileDirectClub Inc / 10X Genomics Inc / Exagen Inc / Change Healthcare Inc / Envista Holdings Corp / Beam Therapeutics Inc / Option Care Health Inc / Health Catalyst Inc / Axsome Therapeutics Inc / Vapotherm Inc / Lyra Therapeutics Inc / Phreesia Inc / 1Life Healthcare Inc / Precision BioSciences Inc / Generation Bio Co / Neuronetics Inc / Karuna Therapeutics Inc / Merus NV / Berkeley Lights Inc / Acutus Medical Inc / Accolade Inc / Beyondspring Inc / DermTech Inc / Poseida Therapeutics Inc / Seagen Inc / Aspira Women's Health Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Oak Street Health Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Eargo Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Biodesix Inc / OPTIMIZERx Corp / Atea Pharmaceuticals Inc / Soc Telemed Inc / Abcam PLC / Travere Therapeutics Inc / Maravai LifeSciences Holdings Inc / Certara Inc / 908 Devices Inc. / Lucira Health Inc / Signify Health Inc / InnovAge Holding Corp / F-Star Therapeutics Inc / Alignment Healthcare Inc / Ikena Oncology Inc / agilon health Inc / Privia Health Group Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Ryan S. Daniels, CFA / Brian D. Weinstein, CFA / Andy T. Hsieh, PHD / Ms. Margaret Kaczor / John C. Kreger, III / Mr. Matt Larew / Mr. Tim F. Lugo / Mr. Myles R. R. Minter / Matt Phipps, PHD / Mr. Raju Prasad, PHD</td></tr>
<tr class="even"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Tracking the JAKs</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / BMY=US / INCY=US / ABBV=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Abbvie Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">06/28/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Next-Gen Lipid Nanoparticle Drug Delivery Under the Microscope; Discussion With Dan Siegwart, Ph.D., June 29, 12:00 p.m. ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 88025U109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 000380204 / 89422G107 / 56600D107 / 65443P102 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / 10X Genomics Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Abcam PLC / Travere Therapeutics Inc / Maravai LifeSciences Holdings Inc / 908 Devices Inc. / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Raju Prasad, PHD / Mr. Myles R. R. Minter / Mr. Matt Larew / Sami Corwin, PHD / Max Smock</td></tr>
<tr class="even"><td class="leftalignment">06/28/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - June 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AEP.N / AES.N / CCI.N / EDP.LS / EIX.N / ELE.MC / IBE.MC / IP.N / MRK.N / PD.N / PFE.N / PNN.L / RWEG.DE / SO.N / T.N / SSE.L / DRE.N / TRI.N / GILD.O / CMCSA.O / AMGN.O / INCY.O / DUK.N / REE.MC / GIS.N / JAZZ.O / CONE.O / NG.L / VZ.N / EXEL.O / KMX.N / AWK.N / NWN.N / BMRN.O / REGN.O / ENAG.MC / ENDP.O / CPK.N / PEGA.OQ / SEM.N / CASY.O / EQIX.O / ATDb.TO / BIIB.O / DLR.N / WEF.TO / ALNY.O / DISCA.O / SJW.N / DRX.L / TEVA.N / SLRS.MC / EONGn.DE / BHPB.L / NEE.N / CIO.N / SPLK.OQ / ABBV.N / TMUS.N / PRTA.O / BEP.N / ESNT.N / NEP.N / DEA.N / 78667J108 / EDIT.O / NTLA.O / TWLO.N / UN01.DE / NTNX.O / CRSP.OQ / GREG.MC / VST.N / ORSTED.CO / EHC.N / SMAR.N / DBX.O / CWEN.N / OSMT.O / 269796108 / ZM.O / FSLY.N / GMAB.O / DOCU.N / WTRG.N / BEAM.O / IGIC.OQ</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Crown Castle International Corp / EDP Energias de Portugal SA / Edison International / Endesa SA / Iberdrola SA / International Paper Co / Merck & Co Inc / PagerDuty Inc / Pfizer Inc / Pennon Group PLC / Rwe AG / Southern Co / AT&T Inc / SSE PLC / Duke Realty Corp / Thomson Reuters Corp / Gilead Sciences Inc / Comcast Corp / Amgen Inc / Incyte Corp / Duke Energy Corp / Red Electrica Corporacion SA / General Mills Inc / Jazz Pharmaceuticals PLC / CyrusOne Inc / National Grid PLC / Verizon Communications Inc / Exelixis Inc / Carmax Inc / American Water Works Company Inc / Northwest Natural Holding Co / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Enagas SA / Endo International PLC / Chesapeake Utilities Corp / Pegasystems Inc / Select Medical Holdings Corp / Caseys General Stores Inc / Equinix Inc / Alimentation Couche-Tard Inc / Biogen Inc / Digital Realty Trust Inc / Western Forest Products Inc / Alnylam Pharmaceuticals Inc / Discovery Inc / SJW Group / Drax Group PLC / Teva Pharmaceutical Industries Ltd / Solaria Energia y Medio Ambiente SA / E.ON SE / BHP Group PLC / Nextera Energy Inc / City Office REIT Inc / Splunk Inc / Abbvie Inc / T-Mobile US Inc / Prothena Corporation PLC / Brookfield Renewable Partners LP / Essent Group Ltd / Nextera Energy Partners LP / Easterly Government Properties Inc / SAGE Therapeutics Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Twilio Inc / Uniper SE / Nutanix Inc / CRISPR Therapeutics AG / Grenergy Renovables SA / Vistra Corp / Orsted A/S / Encompass Health Corp / Smartsheet Inc / Dropbox Inc / Clearway Energy Inc / Osmotica Pharmaceuticals PLC / Eagle Pharmaceuticals Inc / Zoom Video Communications Inc / Fastly Inc / Genmab A/S / DocuSign Inc / Essential Utilities Inc / Beam Therapeutics Inc / International General Insurance Holdings Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Germany / Denmark / Spain / United Kingdom / Ireland / Israel / Portugal / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Jun 18, 2021</td><td class="leftalignment">English</td><td class="rightalignment">46</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ / MNK.N^J20</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc / Mallinckrodt PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">06/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Mackay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / EXEL.O / BMRN.O / PRTA.O / GMAB.O</td><td class="leftalignment">Amgen Inc / Exelixis Inc / Biomarin Pharmaceutical Inc / Prothena Corporation PLC / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Denmark / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Michael Murray</td></tr>
<tr class="odd"><td class="leftalignment">06/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for AMGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">06/25/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 553</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">06/25/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended June 18, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">06/25/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">06/24/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Six In a Row - Biotech Outflows Continue</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">06/24/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Video Call to Discuss Current and Developing Treatments in Atopic Dermatitis and Psoriasis on Thursday, July 15 at 12PM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ARQT.O / JNJ / LLY / PFE / AMGN.O / INCY.O / ARNA.O / REGN.O / ACRS.O / EVLO.O / RAPT.O / PHGE.K / VYNE.O</td><td class="leftalignment">Arcutis Biotherapeutics Inc / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Incyte Corp / Arena Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Aclaris Therapeutics Inc / Evelo Biosciences Inc / Rapt Therapeutics Inc / Biomx Inc / Vyne Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">06/24/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">William Blair Biopharma Catalyst Watch Third Quarter 2021</td><td class="leftalignment">English</td><td class="rightalignment">51</td><td class="leftalignment">54142F102 / 73730P108 / 03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 00847G705 / 803607100 / 26979610 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 04651310 / 462222100 / 01345P106 / 00887A105 / 69366J200 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 92686J106 / 37890U108 / 77313F106 / 717224109 / 05464T104 / 48576A100 / G10830100 / 81181C104 / 517125100 / 74006W108 / 92840H202 / 03890D108 / 192010106 / 13089P101 / 04683R106 / 89422G107 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">LogicBio Therapeutics Inc / Poseida Therapeutics Inc / Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Atara Biotherapeutics Inc / Ionis Pharmaceuticals Inc / Albireo Pharma Inc / Aileron Therapeutics Inc / PTC Therapeutics Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Viking Therapeutics Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / PhaseBio Pharmaceuticals Inc / Axsome Therapeutics Inc / Karuna Therapeutics Inc / Beyondspring Inc / Seagen Inc / Larimar Therapeutics Inc / Praxis Precision Medicines Inc / VistaGen Therapeutics Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">06/24/2021</td><td class="leftalignment">The Wall Street Transcript</td><td class="leftalignment">Risk/Reward Equation Points to Picks in Malls, Homebuilding, Pharma</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ALL.N / AXP.N / BAC.N / JPM.N / MRK.N / PFE.N / SPG.N / PGR.N / LEN.N / HD.N / TGT.N / DHI.N / MAC.N / AMGN.OQ / AAPL.OQ / COST.OQ / AMZN.OQ / CRI.N / GOOG.OQ / CMG.N / CLR.N / NVR.N / UBER.N</td><td class="leftalignment">Allstate Corp / American Express Co / Bank of America Corp / JPMorgan Chase & Co / Merck & Co Inc / Pfizer Inc / Simon Property Group Inc / Progressive Corp / Lennar Corp / Home Depot Inc / Target Corp / D R Horton Inc / Macerich Co / Amgen Inc / Apple Inc / Costco Wholesale Corp / Amazon.com Inc / Carter's Inc / Alphabet Inc / Chipotle Mexican Grill Inc / Continental Resources Inc / NVR Inc / Uber Technologies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">No Industry</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / ASSET MANAGEMENT / ECONOMIC ANALYSIS / FUNDAMENTAL ANALYSIS / PORTFOLIO STRATEGY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">The Wall St Transcript</td></tr>
<tr class="odd"><td class="leftalignment">06/22/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / WEN=US / BLD=US / INCY=US / GILD=US / LOW=US / LEG=US / VMC=US / MLM=US / SWIM=US / CBRL=US / CW=US / DRI=US / GFF=US / IBP=US / MAS=US / MHK=US / CRTO=US / DIN=US / TPX=US / EXP=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / CMG=US / PGTI=US / AWI=US / OC=US / TAST=US / QSR=US / PRPL=US / JACK=US / RCUS=US / TREX=US / FBHS=US / ABBV=US / TILE=US / NDLS=US / 00770K202 / LOCO=US / UPLD=US / SHAK=US / WING=US / EVRI=US / 82982L103 / JELD=US / FOCS=US / UBER=US / FERG=US / ARQT=US / AZEK=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Wendys Co / TopBuild Corp / Incyte Corp / Gilead Sciences Inc / Lowe's Companies Inc / Leggett & Platt Inc / Vulcan Materials Co / Martin Marietta Materials Inc / Latham Group Inc / Cracker Barrel Old Country Store Inc / Curtiss-Wright Corp / Darden Restaurants Inc / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Criteo SA / Dine Brands Global Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / PGT Innovations Inc / Armstrong World Industries Inc / Owens Corning / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Jack in the Box Inc / Arcus Biosciences Inc / Trex Company Inc / Fortune Brands Home & Security Inc / Abbvie Inc / Interface Inc / Noodles & Co / Aemetis Inc / El Pollo Loco Holdings Inc / Upland Software Inc / Shake Shack Inc / Wingstop Inc / Everi Holdings Inc / SiteOne Landscape Supply Inc / JELD-WEN Holding Inc / Focus Financial Partners Inc / Uber Technologies Inc / Ferguson PLC / Arcutis Biotherapeutics Inc / Azek Company Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / France / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/22/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">First-Dose Vaccinations Settle in at 500K Per Day, Domestic COVID-19 Metrics Continue to Improve Despite Spread of Variants</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">06/21/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Reminder: Virtual Washington, D.C. Day - June 30, 2021; Updated Full Agenda</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">85891210 / 42190610 / 76115210 / 80640710 / 03116210 / 7333378 / 64125C109 / 002824100 / 110122108 / 09062X103 / 50540R409 / 74834L100 / 159864107 / 09061G101 / 703395103 / 640268108 / 075887109 / 20530610 / 30063P105 / 216648402 / 28176E108 / 30161Q104 / 45337C102 / 23918K108 / 038336103 / 852312305 / 023436108 / 589584101 / 955306105 / 50187A107 / 436440101 / 003654100 / 016255101 / 09060J106 / 252131107 / 42222N103 / 45168D104 / 45253H101 / 640491106 / 74838J101 / 759916109 / 90337L108 / 45784P101 / 58502B106 / 141619106 / 64049M20 / 40412C101 / 00847G705 / 92857F107 / 00404A109 / 88033G407 / 803607100 / G4705A100 / 74051N10 / 98978V10 / 92337F10 / 26979610 / 45780L10 / 14862Q100 / 006739106 / 00430H102 / 00847L10 / 045396108 / 14880610 / 82621J10 / 268158201 / 31572Q80 / 76133010 / G5960L103 / 78667J108 / 30050B10 / 98978L204 / 37732210 / 15117K103 / 87918A10 / 46185L10 / 04651310 / 00461U105 / 462222100 / 19459J104 / 24906P109 / 70975L107 / 64157F103 / 87357P100 / 58506Q109 / 01345P106 / 88870R102 / N72482123 / 690469101 / G11196105 / 00887A105 / 69366J200 / 46266C105 / 816212104 / 09609G100 / 450056106 / 67022C106 / 29261A100 / 87166B102 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / 28414H103 / H17182108 / 873379101 / 501147102 / 37890U108 / 40131M109 / 22304C100 / 05352A100 / 00650F109 / 77313F106 / 03836N103 / 717224109 / 83192H106 / 88025U109 / 30068X103 / 15912K100 / 29415F104 / 07373V105 / 68404L201 / 42225T107 / 05464T104 / 922107107 / 55234L105 / 71944F106 / 68269G107 / 74019P108 / 37148K100 / 64131A105 / 48576A100 / N5749R100 / 084310101 / 005111109 / 00437E102 / G10830100 / 24984K105 / 73730P108 / 81181C104 / 04537Y109 / 517125100 / 877619106 / 74006W108 / 67181A107 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 270087109 / 192010106 / 13089P101 / 151205200 / 09075X108 / 68401U204 / 04683R106 / 78472F101 / 000380204 / 89422G107 / 56600D107 / 15687V109 / 65443P102 / 54948U105 / 82671G100 / 45784A104 / 30315R107 / 01625V104 / 45175G108 / 00857U107 / 74276R102 / 91864C107</td><td class="leftalignment">Stericycle Inc / Healthcare Services Group Inc / Resmed Inc / Henry Schein Inc / Amgen Inc / Lonza Group AG / Neurocrine Biosciences Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Biogen Inc / Laboratory Corporation of America Holdings / Quest Diagnostics Inc / Charles River Laboratories International Inc / Biomarin Pharmaceutical Inc / Patterson Companies Inc / Nektar Therapeutics / Becton Dickinson and Co / Computer Programs and Systems Inc / Exact Sciences Corp / Cooper Companies Inc / Edwards Lifesciences Corp / Exelixis Inc / Incyte Corp / DaVita Inc / Aptargroup Inc / STAAR Surgical Co / Amedisys Inc / Meridian Bioscience Inc / West Pharmaceutical Services Inc / LHC Group Inc / Hologic Inc / ABIOMED Inc / Align Technology Inc / BioDelivery Sciences International Inc / Dexcom Inc / HealthStream Inc / IDEXX Laboratories Inc / ImmunoGen Inc / Neogen Corp / Quidel Corp / Repligen Corp / US Physical Therapy Inc / Insulet Corp / MEDNAX Inc / Cardiovascular Systems Inc / Neogenomics Inc / HCA Healthcare Inc / Agenus Inc / Vocera Communications Inc / Acadia Healthcare Company Inc / Tenet Healthcare Corp / Sarepta Therapeutics Inc / ICON PLC / Premier Inc / Zoetis Inc / Veracyte Inc / Eagle Pharmaceuticals Inc / Inogen Inc / Castlight Health Inc / Addus Homecare Corp / Accelerate Diagnostics Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Catalent Inc / Sientra Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / Medtronic PLC / SAGE Therapeutics Inc / Evolent Health Inc / Zogenix Inc / Glaukos Corp / Cellectis SA / Teladoc Health Inc / Invitae Corp / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / DENTSPLY SIRONA Inc / Penumbra Inc / Nevro Corp / Tactile Systems Technology Inc / Medpace Holdings Inc / Albireo Pharma Inc / Tivity Health Inc / Qiagen NV / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / IQVIA Holdings Inc / Selecta Biosciences Inc / bluebird bio Inc / iRhythm Technologies Inc / NuCana PLC / Encompass Health Corp / Syneos Health Inc / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / Elanco Animal Health Inc / CRISPR Therapeutics AG / Tabula Rasa HealthCare Inc / Krystal Biotech Inc / Global Blood Therapeutics Inc / Guardant Health Inc / Covetrus Inc / Avantor Inc / Adaptive Biotechnologies Corp / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / SmileDirectClub Inc / 10X Genomics Inc / Exagen Inc / Change Healthcare Inc / Envista Holdings Corp / Beam Therapeutics Inc / Option Care Health Inc / Health Catalyst Inc / Axsome Therapeutics Inc / Vapotherm Inc / Lyra Therapeutics Inc / Phreesia Inc / 1Life Healthcare Inc / Precision BioSciences Inc / Generation Bio Co / Neuronetics Inc / Karuna Therapeutics Inc / Merus NV / Berkeley Lights Inc / Acutus Medical Inc / Accolade Inc / Beyondspring Inc / DermTech Inc / Poseida Therapeutics Inc / Seagen Inc / Aspira Women's Health Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Oak Street Health Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Eargo Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Biodesix Inc / OPTIMIZERx Corp / Atea Pharmaceuticals Inc / Soc Telemed Inc / Abcam PLC / Travere Therapeutics Inc / Maravai LifeSciences Holdings Inc / Certara Inc / 908 Devices Inc. / Lucira Health Inc / Signify Health Inc / InnovAge Holding Corp / F-Star Therapeutics Inc / Alignment Healthcare Inc / Ikena Oncology Inc / agilon health Inc / Privia Health Group Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Ryan S. Daniels, CFA / Brian D. Weinstein, CFA / Andy T. Hsieh, PHD / Ms. Margaret Kaczor / John C. Kreger, III / Mr. Matt Larew / Mr. Tim F. Lugo / Mr. Myles R. R. Minter / Matt Phipps, PHD / Mr. Raju Prasad, PHD</td></tr>
<tr class="even"><td class="leftalignment">06/21/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending June 11, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">06/21/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Tracking the JAKs</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / BMY=US / INCY=US / ABBV=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Abbvie Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">06/21/2021</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Amgen Inc (AMGN) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">573</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="odd"><td class="leftalignment">06/18/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 552</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">06/18/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended June 11, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">06/18/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">06/18/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AMGN=US / AMZN=US / T=US / DVN=US / GILD=US / PEB=US / H=US / MTN=US / VRM=US / MAR=US / SPOT=US / EXPE=US / LEG=US / TNL=US / MGM=US / HLT=US / W=US / DV=US / AMN=US / CBRL=US / CHH=US / DRH=US / AJG=US / MHK=US / SGMO=US / SNAP=US / TRIP=US / TGI=US / WIX=US / NET=US / CCRN=US / BKNG=US / FAF=US / FB=US / OHI=US / UCBI=US / PTON=US / TPX=US / CZR=US / APP=US / SHO=US / HST=US / MA=US / GPRE=US / CLR=US / PRPL=US / WH=US / OLO=US / HGV=US / RLJ=US / VAC=US / ANGI=US / RHP=US / TILE=US / FATE=US / GOOGL=US / MTNB=US / BABA=US / CMPR=US / GDDY=US / VKTX=US / WLTW=US / PK=US / PLYA=US / CVNA=US / SFIX=US / FOCS=US / FTDR=US / FSK=US / LYFT=US / UBER=US / APLT=US / FSKR=US / VMEO=US</td><td class="leftalignment">Amgen Inc / Amazon.com Inc / AT&T Inc / Devon Energy Corp / Gilead Sciences Inc / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Vail Resorts Inc / Vroom Inc / Marriott International Inc / Spotify Technology SA / Expedia Group Inc / Leggett & Platt Inc / Travel + Leisure Co / MGM Resorts International / Hilton Worldwide Holdings Inc / Wayfair Inc / DoubleVerify Holdings Inc / AMN Healthcare Services Inc / Cracker Barrel Old Country Store Inc / Choice Hotels International Inc / Diamondrock Hospitality Co / Arthur J Gallagher & Co / Mohawk Industries Inc / Sangamo Therapeutics Inc / Snap Inc / Tripadvisor Inc / Triumph Group Inc / Wix.Com Ltd / Cloudflare Inc / Cross Country Healthcare Inc / Booking Holdings Inc / First American Financial Corp / Meta Platforms Inc / Omega Healthcare Investors Inc / United Community Banks Inc / Peloton Interactive Inc / Tempur Sealy International Inc / Caesars Entertainment Inc / Applovin Corp / Sunstone Hotel Investors Inc / Host Hotels & Resorts Inc / Mastercard Inc / Green Plains Inc / Continental Resources Inc / Purple Innovation Inc / Wyndham Hotels & Resorts Inc / Olo Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Angi Inc / Ryman Hospitality Properties Inc / Interface Inc / Fate Therapeutics Inc / Alphabet Inc / Matinas BioPharma Holdings Inc / Alibaba Group Holding Ltd / Cimpress PLC / GoDaddy Inc / Viking Therapeutics Inc / Willis Towers Watson PLC / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Carvana Co / Stitch Fix Inc / Focus Financial Partners Inc / Frontdoor Inc / FS KKR Capital Corp / Lyft Inc / Uber Technologies Inc / Applied Therapeutics Inc / FS KKR Capital Corp / Vimeo Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Ireland / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/17/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Science Talk Provides Incremental Preclinical Updates; 2H21 SHP2 Updates Next</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">76155X10 / 03116210 / 60468T10 / F5548N10</td><td class="leftalignment">Revolution Medicines Inc / Amgen Inc / Mirati Therapeutics Inc / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jonathan Chang, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">06/17/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Let It Go, Let It Go - Biotech Outflows Continue</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">06/17/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Mgmt color on Aimovig transfer of US biz to AMGN bodes well operationally</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AMGN=US</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">06/17/2021</td><td class="leftalignment">UniCredit Research</td><td class="leftalignment">Euro Credit Pilot - Credit remains solid (June 2021)</td><td class="leftalignment">English</td><td class="rightalignment">57</td><td class="leftalignment">US88579Y1010 / AEGN.AS / AIRP.PA / AKZO.AS / ALSO.PA / ALV.N / ALVG.DE / ANZ.AX / APD.N / ASML.AS / ATCOA.ST / AXAF.PA / BAC.N / BARC.L / BKT.MC / BMWG.DE / BNPP.PA / BNS.TO / BOUY.PA / BP.L / BT.L / C.N / CAPP.PA / CARR.PA / CBA.AX / CBKG.DE / CCH.L / CM.TO / CNPP.PA / CRH.I / DANO.PA / DEO.N / DSMN.AS / EDP.LS / ENI.MI / ERICb.ST / ERST.VI / FREG.F / GASI.MI / GE.N / GM.N / HEIG.F / HEIN.AS / HSBA.L / IBE.MC / IBM.N / KPN.AS / LLOY.L / LVMH.PA / MAP.MC / MDBI.MI / MGA / MICP.PA / MOLB.BU / MRK.N / MUVGn.DE / NAB.AX / PRTP.PA / SAN.MC / T.N / CONG.DE / AZN.L / AMGN.O / FER.MC / AAL.L / GS.N / ACE.MI / DBKGn.DE / MCD.N / FMEG.DE / BZU.MI / ENEI.MI / MRCG.DE / DTEGn.F / BBVA.MC / BTI.N / IFXGn.DE / FR0000064578 / FR0000035081 / ISS.CO / CARLb.CO / ADEN.S / HNRGn.DE / DPWGn.DE / IG.MI / GSK.L / BAB.L / AMXL.MX / EUFI.PA / JCDX.PA / GB0008220112 / SE0000455057 / US1101221083 / US2987361092 / US3377381088 / US4943681035 / US5949181045 / JP3116000005 / CAGR.PA / AMA.MC / DANSKE.CO / CH0013841017 / ARLG.DE / ENAG.MC / AV.L / US20030N1019 / US02209S1033 / EBKG.DE / JYSK.CO / MAERSKb.CO / HRA.MI / CAIV.VI / US46625H1005 / INGA.AS / LXSG.DE / BTGGg.F / GB0033986497 / JP3885780001 / MTXGn.DE / ELI.BR / EDF.PA / ETL.PA / MS.N / GAZP.MM / US31620M1062 / AKE.PA / ISP.MI / DWNG.DE / DK0060079531 / AU000000GMG2 / SABE.MC / CNE1000001Z5 / CNE1000002H1 / FR0010690156 / BNRGN.DE / IREE.MI / CNE100000KC0 / CABK.MC / US03027X1000 / MDLZ.OQ / LEGN.DE / GYC.DE / 1COV.DE / IMB.L / SE0009922164 / BIRG.I / BMG2178K1009 / BAWG.VI / LU0251710041 / AT0000BAWAG2 / AIBG.I / AIG.A / NL00150006R6</td><td class="leftalignment">3M Co / Aegon NV / L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Akzo Nobel NV / Alstom SA / Autoliv Inc / Allianz SE / Australia and New Zealand Banking Group Ltd / Air Products and Chemicals Inc / ASML Holding NV / Atlas Copco AB / AXA SA / Bank of America Corp / Barclays PLC / Bankinter SA / Bayerische Motoren Werke AG / BNP Paribas SA / Bank of Nova Scotia / Bouygues SA / BP PLC / BT Group PLC / Citigroup Inc / Capgemini SE / Carrefour SA / Commonwealth Bank of Australia / Commerzbank AG / Coca Cola HBC AG / Canadian Imperial Bank of Commerce / CNP Assurances SA / CRH PLC / Danone SA / Diageo PLC / Koninklijke DSM NV / EDP Energias de Portugal SA / Eni SpA / Telefonaktiebolaget LM Ericsson / Erste Group Bank AG / Fresenius SE & Co KGaA / Assicurazioni Generali SpA / General Electric Co / General Motors Co / HeidelbergCement AG / Heineken NV / HSBC Holdings PLC / Iberdrola SA / International Business Machines Corp / Koninklijke KPN NV / Lloyds Banking Group PLC / LVMH Moet Hennessy Louis Vuitton SE / Mapfre SA / Mediobanca Banca di Credito Finanziario SpA / Magna International Inc / Compagnie Generale des Etablissements Michelin SCA / MOL Magyar Olajes Gazipari Nyrt / Merck & Co Inc / Muenchener Rueckversicherungs Gesellschaft in Muenchen AG / National Australia Bank Ltd / Kering SA / Banco Santander SA / AT&T Inc / Continental AG / AstraZeneca PLC / Amgen Inc / Ferrovial SA / Anglo American PLC / Goldman Sachs Group Inc / Acea SpA / Deutsche Bank AG / McDonald's Corp / Fresenius Medical Care AG & Co KGaA / Buzzi Unicem SpA / Enel SpA / Merck KGaA / Deutsche Telekom AG / Banco Bilbao Vizcaya Argentaria SA / British American Tobacco PLC / Infineon Technologies AG / Covivio SA / Icade SA / Iss A/S / Carlsberg A/S / Adecco Group AG / Hannover Rueck SE / Deutsche Post AG / Italgas SpA / GlaxoSmithKline PLC / Babcock International Group PLC / America Movil SAB de CV / Eurofins Scientific SE / JCDecaux SA / DS Smith PLC / Fastighets AB Balder / Bristol-Myers Squibb Co / Euronet Worldwide Inc / Fiserv Inc / Kimberly-Clark Corp / Microsoft Corp / Asahi Group Holdings Ltd / Credit Agricole SA / Amadeus IT Group SA / Danske Bank A/S / Lonza Group AG / Aareal Bank AG / Enagas SA / Aviva PLC / Comcast Corp / Altria Group Inc / EnBW Energie Baden Wuerttemberg AG / Jyske Bank A/S / AP Moeller - Maersk A/S / Hera SpA / CA Immobilien Anlagen AG / JPMorgan Chase & Co / ING Groep NV / Lanxess AG / Bertelsmann SE & Co KGaA / ITV PLC / Mizuho Financial Group Inc / MTU Aero Engines AG / Elia Group SA / Electricite de France SA / Eutelsat Communications SA / Morgan Stanley / Gazprom PAO / Fidelity National Information Services Inc / Arkema SA / Intesa Sanpaolo SpA / Deutsche Wohnen SE / DSV A/S / Goodman Group / Banco de Sabadell SA / Bank of China Ltd / China Construction Bank Corp / Aeroports de Paris SA / Brenntag SE / Iren SpA / China National Chemical Engineering Co Ltd / Caixabank SA / American Tower Corp / Mondelez International Inc / LEG Immobilien SE / Grand City Properties SA / Covestro AG / Imperial Brands PLC / Essity AB (publ) / Bank of Ireland Group PLC / CK Infrastructure Holdings Ltd / BAWAG Group AG / CPI Property Group SA / BAWAG Group AG / Aib Group PLC / American International Group Inc / Ctp NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Austria / Belgium / Bermuda / Canada / Switzerland / China / Czech Republic / Germany / Denmark / Spain / Finland / France / United Kingdom / Greece / Hungary / Ireland / Italy / Japan / Luxembourg / Mexico / Netherlands / Norway / New Zealand / Poland / Portugal / Russian Federation / Slovakia / Sweden / United States / Jersey</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Communications / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Office Equipment / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Semiconductors / Services / Shipping & Shipbuilding / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment">MISCELLANEOUS / CHANGE IN RECOMMENDATION / MODELS / PORTFOLIO STRATEGY / CREDIT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / PORTFOLIO/ASSET STRATEGIES</td><td class="leftalignment">Herr Gianfranco Arcovito / Herr Christian Aust / Herr Tobias Keller / Herr. Stefan Kolek / Herr Sven Kreitmair, CFA / Frau Silke Stegemann / Herr Natalie Tehrani Monfared / Herr. Michael Teig</td></tr>
<tr class="odd"><td class="leftalignment">06/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for AMGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">06/15/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">GSK Licensing Deal Hugely Validating for EOS-448 and TIGIT</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">11012210 / 45337C10 / 71708110 / 04635310 / 37555810 / 03116210 / 66987V10 / 75886F10 / 53245710 / M2572210 / 09062X10 / 478160104 / 640268108 / 771195104 / 58933Y10 / 92337C10 / 04651310 / 75046920 / 00287Y10 / 98401F10 / ITOS.OQ / 58949210 / 09627Y10 / 07725L10 / G3910J11 / 81181C10 / K3967W10 / 46565G10 / 61776010 / 03969F10 / F5548N10 / 48111610</td><td class="leftalignment">Bristol-Myers Squibb Co / Incyte Corp / Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Compugen Ltd / Biogen Inc / Johnson & Johnson / Nektar Therapeutics / Roche Holding AG / Merck & Co Inc / Verastem Inc / Atara Biotherapeutics Inc / Radius Health Inc / Abbvie Inc / Xencor Inc / Iteos Therapeutics Inc / Mereo Biopharma Group PLC / Blueprint Medicines Corp / Beigene Ltd / GlaxoSmithKline PLC / Seagen Inc / Genmab A/S / Iteos Therapeutics Inc / MorphoSys AG / Arcus Biosciences Inc / Sanofi SA / Jounce Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Daina Graybosch, Ph.D. / Geoffrey Porges, MBBS / Jeffrey La Rosa / Anna Baran, CFA</td></tr>
<tr class="odd"><td class="leftalignment">06/15/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / BMY=US / MCD=US / OXY=US / RRC=US / WEN=US / DVN=US / INCY=US / APA=US / CPE=US / EOG=US / REI=US / XOM=US / CRK=US / WLL=US / PXD=US / PB=US / IGT=US / MGY=US / SWN=US / MUR=US / EWBC=US / BRO=US / BYD=US / UMPQ=US / MRO=US / EXPE=US / MGM=US / PENN=US / CBRL=US / CNX=US / DRI=US / EQIX=US / EQT=US / AJG=US / MCRI=US / PACW=US / REGI=US / TRIP=US / WAL=US / CVX=US / SGMS=US / BXS=US / BKNG=US / SNV=US / FBK=US / MKL=US / PRA=US / CATY=US / COP=US / DIN=US / PNFP=US / RRR=US / JRVR=US / BIIB=US / TCBI=US / FNB=US / CZR=US / PLAY=US / DENN=US / NSP=US / CMG=US / REX=US / GPRE=US / TAST=US / QSR=US / CLR=US / NMTR=US / NOG=US / JACK=US / KNSL=US / AR=US / ESTE=US / BCEI=US / MTDR=US / MEIP=US / PDCE=US / FANG=US / ABBV=US / NDLS=US / FATE=US / 00770K202 / VNOM=US / LOCO=US / SHAK=US / DEA=US / WING=US / ARGX=US / WLTW=US / CDEV=US / TRVG=US / PVAC=US / SBOW=US / HWC=US / OZK=US / RTLR=US / AHCO=US / OVV=US / ARQT=US / DKNG=US / ZI=US / BALY=US / ABNB=US / VMEO=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / McDonald's Corp / Occidental Petroleum Corp / Range Resources Corp / Wendys Co / Devon Energy Corp / Incyte Corp / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Exxon Mobil Corp / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Prosperity Bancshares Inc / International Game Technology PLC / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / East West Bancorp Inc / Brown & Brown Inc / Boyd Gaming Corp / Umpqua Holdings Corp / Marathon Oil Corp / Expedia Group Inc / MGM Resorts International / Penn National Gaming Inc / Cracker Barrel Old Country Store Inc / CNX Resources Corp / Darden Restaurants Inc / Equinix Inc / EQT Corp / Arthur J Gallagher & Co / Monarch Casino & Resort Inc / PacWest Bancorp / Renewable Energy Group Inc / Tripadvisor Inc / Western Alliance Bancorp / Chevron Corp / Scientific Games Corp / Cadence Bank / Booking Holdings Inc / Synovus Financial Corp / FB Financial Corp / Markel Corp / ProAssurance Corp / Cathay General Bancorp / Conocophillips / Dine Brands Global Inc / Pinnacle Financial Partners Inc / Red Rock Resorts Inc / James River Group Holdings Ltd / Biogen Inc / Texas Capital Bancshares Inc / FNB Corp / Caesars Entertainment Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Insperity Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Green Plains Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / 9 Meters Biopharma Inc / Northern Oil and Gas Inc / Jack in the Box Inc / Kinsale Capital Group Inc / Antero Resources Corp / Earthstone Energy Inc / Civitas Resources Inc / Matador Resources Co / MEI Pharma Inc / PDC Energy Inc / Diamondback Energy Inc / Abbvie Inc / Noodles & Co / Fate Therapeutics Inc / Aemetis Inc / Viper Energy Partners LP / El Pollo Loco Holdings Inc / Shake Shack Inc / Easterly Government Properties Inc / Wingstop Inc / argenx SE / Willis Towers Watson PLC / Centennial Resource Development Inc / Trivago NV / Ranger Oil Corp / SilverBow Resources Inc / Hancock Whitney Corp / Bank Ozk / Rattler Midstream LP / Adapthealth Corp / Ovintiv Inc / Arcutis Biotherapeutics Inc / DraftKings Inc / ZoomInfo Technologies Inc / Bally's Corp / Airbnb Inc / Vimeo Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending June 04, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Tracking the JAKs</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / BMY=US / INCY=US / ABBV=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Abbvie Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">06/14/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - June 14, 2021</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">US0311621009 / US92532F1003 / US9621661043 / CA78460T1057 / CA9528451052 / US2274831047 / US7665596034 / US02043Q1076 / US40637H1095 / CA1375761048 / CA89156V1067 / US31189P1021 / CA45868C1095 / NL0010872420 / US72703H1014 / US4622221004 / CA91822J1030 / US0441861046 / CA7766521099 / US2997341035 / US80706P1030 / US76029N1063 / US61775R1059 / US30205M1018 / US70614W1009 / US75382E1091 / US80810D1037 / US1628181083 / US89422G1076 / CA00288U1066 / JE00BMVMZ478 / US67080N1019 / CA64016L1013</td><td class="leftalignment">Amgen Inc / Vertex Pharmaceuticals Inc / Weyerhaeuser Co / SNC-Lavalin Group Inc / West Fraser Timber Co Ltd / Cross Country Healthcare Inc / Rigel Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Halozyme Therapeutics Inc / Canfor Corp / Tourmaline Oil Corp / Fate Therapeutics Inc / Interfor Corp / Affimed NV / Planet Fitness Inc / Ionis Pharmaceuticals Inc / VBI Vaccines Inc / Ashland Global Holdings Inc / Roots Corp / Evelo Biosciences Inc / Scholar Rock Holding Corp / Replimune Group Inc / Morphic Holding Inc / Exicure Inc / Peloton Interactive Inc / Rapt Therapeutics Inc / Schrodinger Inc / Checkmate Pharmaceuticals Inc / Travere Therapeutics Inc / Abcellera Biologics Inc / Atotech Ltd / Nuvation Bio Inc / Neighbourly Pharmacy Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">06/14/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">To RSV or Not to RSV? Prevention Could Generate $10bn in Vaccine Sales 2030</td><td class="leftalignment">English</td><td class="rightalignment">51</td><td class="leftalignment">G3910J11 / F5548N10 / 71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / 60770K10</td><td class="leftalignment">GlaxoSmithKline PLC / Sanofi SA / Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Na Sun</td></tr>
<tr class="even"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Global Equity Strategy: Pricing power: A global assessment</td><td class="leftalignment">English</td><td class="rightalignment">44</td><td class="leftalignment">0268.HK / 0358.HK / 0670.HK / 0902.HK / 0991.HK / 1128.HK / 2002.TW / 2376.TW / 6501.T / 6503.T / 6753.T / 6902.T / 7201.T / 7203.T / 7259.T / 7261.T / 7270.T / AALI.JK / ABC.AX / ACCP.PA / AGL.AX / AKZO.AS / ASPN.BO / ASSAB.ST / BA.N / BATS.L / BBL.BK / BBLF.BK / BEL.PS / BEN.AX / BH.BK / BNZL.L / BPCL.BO / BRIT.BO / CCL.N / CIT.N / CPG.L / CWK.L / DAIR.SI / DAL.N / DCC.L / DGE.L / EPED.PA / ESCO.BO / EXHO.PA / F.N / GM.N / HALC.BO / HEIN.AS / HLL.BO / LUV.N / PM.N / RR.L / SECUB.ST / SETI.KL / SLB.N / SMIN.L / SN.L / STEG.SI / SWMA.ST / SYD.AX / T.N / TCFP.PA / TISC.BO / TMO.N / TSCO.L / ULE.L / URC.PS / VENM.SI / VERB.VI / VLOF.PA / WLSNC.AS / WMT.N / WPP.L / AIRF.PA / FLO.N / 6113.T / 2602.T / AIR.PA / CPB.N / 9914.TW / HAL.N / 5333.T / 9719.T / AAL.L / SCI.N / TKAG.DE / DHR.N / UNH.N / LOG.MC / 4704.T / TSN.N / SYY.N / VLO.N / HLI.N / 0694.HK / BLD.AX / 0857.HK / 4755.T / GIVN.S / VZ.N / AMP.N / BOQ.AX / EZJ.L / DPWGN.DE / EICH.BO / 0883.HK / IGG.L / 4732.NG / 6965.T / 600104.SS / ALU.AX / FPH.NZ / 2600.HK / TPGC.KL / TVSM.BO / 600019.SS / ONGC.NS / 1211.HK / 600011.SS / 600036.SS / 000001.SZ / 000625.SZ / 600115.SS / EBO.NZ / AMGN.OQ / EXPD.OQ / GNTX.OQ / GGG.N / BBBY.OQ / CHRW.OQ / AKAM.OQ / 600362.SS / COLOB.CO / 000725.SZ / 010950.KS / 005930.KS / 066570.KS / 055550.KS / 005490.KS / 051910.KS / 000270.KS / 005380.KS / 051900.KS / 046890.KQ / 000100.KS / 011200.KS / 036570.KS / STMN.S / 2328.HK / RWS.L / 0451.HK / 2333.HK / 035420.KS / 600010.SS / 5949.T / 000425.SZ / 000999.SZ / 600521.SS / PDNI.KL / 034220.KS / TOP.BK / 0753.HK / 600066.SS / SAF.PA / 3328.HK / HLS.AX / 2777.HK / TUIGN.DE / 3333.HK / NVTK.MM / 600835.SS / QQ.L / MT.AS / CENTEL.BK / HIMX.OQ / MMS.AX / 601111.SS / 3968.HK / HBI.N / WU.N / UNSP.BO / BMA.N / 601991.SS / SY1G.DE / 601328.SS / 3993.HK / 601600.SS / BAES.L / GL9.I / VNM.HM / 601857.SS / 002242.SZ / 105560.KS / 086900.KQ / 1928.HK / 0960.HK / 1691.HK / 601607.SS / 300073.SZ / MSN.HM / BAH.N / SWM.AX / ERW.BK / 2607.HK / 002594.SZ / 601633.SS / SHEN.SI / TRIP.OQ / 603993.SS / VGI.BK / 2013.HK / WPHB.KL / AMC.N / TNET.N / INDV.L / AUTOA.L / ENGIE.PA / XRO.AX / CWY.AX / A2M.AX / BGNE.OQ / ASCL.L / 2296.T / FORTUM.HE / 251270.KS / ESSITYB.ST / 603305.SS / 3994.T / 6060.HK / HFGG.DE / SIPR.KL / 601138.SS / VNE.N / 6160.HK / 1801.HK / 1877.HK / NWL.OQ / 6669.TW / 5401.NG / AWC.BK / 4475.T / 4478.T / 688396.SS / STGT.BK / ENR1N.DE / 1952.HK / DRR.AX / AFRM.OQ / STLA.MI</td><td class="leftalignment">Kingdee International Software Group Co Ltd / Jiangxi Copper Co Ltd / China Eastern Airlines Corp Ltd / Huaneng Power International Inc / Datang International Power Generation Co Ltd / Wynn Macau Ltd / China Steel Corp / Gigabyte Technology Co Ltd / Hitachi Ltd / Mitsubishi Electric Corp / Sharp Corp / Denso Corp / Nissan Motor Co Ltd / Toyota Motor Corp / Aisin Corp / Mazda Motor Corp / Subaru Corp / Astra Agro Lestari Tbk PT / Adbri Ltd / Accor SA / AGL Energy Ltd / Akzo Nobel NV / Asian Paints Ltd / Assa Abloy AB / Boeing Co / British American Tobacco PLC / Bangkok Bank PCL / Bangkok Bank PCL / Belle Corp / Bendigo and Adelaide Bank Ltd / Bumrungrad Hospital PCL / Bunzl plc / Bharat Petroleum Corporation Ltd / Britannia Industries Ltd / Carnival Corp / First-Citizens Bank & Trust Co / Compass Group PLC / Cranswick PLC / Dairy Farm International Holdings Ltd / Delta Air Lines Inc / DCC PLC / Diageo PLC / Faurecia SE / Escorts Ltd / Sodexo SA / Ford Motor Co / General Motors Co / Hindalco Industries Ltd / Heineken NV / Hindustan Unilever Ltd / Southwest Airlines Co / Philip Morris International Inc / Rolls-Royce Holdings PLC / Securitas AB / S P Setia Bhd / Schlumberger NV / Smiths Group PLC / Smith & Nephew PLC / Singapore Technologies Engineering Ltd / Swedish Match AB / Sydney Airport / AT&T Inc / Thales SA / Tata Steel Ltd / Thermo Fisher Scientific Inc / Tesco PLC / Ultra Electronics Holdings PLC / Universal Robina Corp / Venture Corporation Ltd / Verbund AG / Valeo SE / Wolters Kluwer NV / Walmart Inc / WPP PLC / Air France KLM SA / Flowers Foods Inc / Amada Co Ltd / Nisshin OilliO Group Ltd / Airbus SE / Campbell Soup Co / Merida Industry Co Ltd / Halliburton Co / NGK Insulators Ltd / SCSK Corp / Anglo American PLC / Service Corporation International / thyssenkrupp AG / Danaher Corp / UnitedHealth Group Inc / Compania de Distribucion Integral Logista Holdings SA / Trend Micro Inc / Tyson Foods Inc / Sysco Corp / Valero Energy Corp / Houlihan Lokey Inc / Beijing Capital International Airport Co Ltd / Boral Ltd / PetroChina Co Ltd / Rakuten Group Inc / Givaudan SA / Verizon Communications Inc / Ameriprise Financial Inc / Bank of Queensland Ltd / Easyjet PLC / Deutsche Post AG / Eicher Motors Ltd / CNOOC Ltd / IG Group Holdings PLC / USS Co Ltd / Hamamatsu Photonics KK / SAIC Motor Corp Ltd / Altium Ltd / Fisher & Paykel Healthcare Corporation Ltd / Aluminum Corp of China Ltd / Top Glove Corporation Bhd / TVS Motor Company Ltd / Baoshan Iron & Steel Co Ltd / Oil and Natural Gas Corporation Ltd / BYD Co Ltd / Huaneng Power International Inc / China Merchants Bank Co Ltd / Ping An Bank Co Ltd / Chongqing Changan Automobile Co Ltd / China Eastern Airlines Corp Ltd / EBOS Group Ltd / Amgen Inc / Expeditors International of Washington Inc / Gentex Corp / Graco Inc / Bed Bath & Beyond Inc / CH Robinson Worldwide Inc / Akamai Technologies Inc / Jiangxi Copper Co Ltd / Coloplast A/S / BOE Technology Group Co Ltd / S-Oil Corp / Samsung Electronics Co Ltd / LG Electronics Inc / Shinhan Financial Group Co Ltd / Posco / LG Chem Ltd / Kia Corp / Hyundai Motor Co / LG Household & Healthcare Ltd / Seoul Semiconductor Co Ltd / Yuhan Corp / HMM Co Ltd / NCSOFT Corp / Straumann Holding AG / PICC Property and Casualty Co Ltd / RWS Holdings PLC / GCL New Energy Holdings Ltd / Great Wall Motor Co Ltd / Naver Corp / Inner Mongolia BaoTou Steel Union Co Ltd / Unipres Corp / XCMG Construction Machinery Co Ltd / China Resources Sanjiu Medical & Pharmaceutical Co Ltd / Zhejiang Huahai Pharmaceutical Co Ltd / Padini Holdings Berhad / LG Display Co Ltd / Thai Oil PCL / Air China Ltd / Yutong Bus Co Ltd / Safran SA / Bank of Communications Co Ltd / Healius Ltd / Guangzhou R&F Properties Co Ltd / TUI AG / China Evergrande Group / Novatek PAO / Shanghai Mechanical & Electrical Industry Co Ltd / Qinetiq Group PLC / ArcelorMittal SA / Central Plaza Hotel PCL / Himax Technologies Inc / Mcmillan Shakespeare Ltd / Air China Ltd / China Merchants Bank Co Ltd / HanesBrands Inc / Western Union Co / United Spirits Ltd / Banco Macro SA / Datang International Power Generation Co Ltd / Symrise AG / Bank of Communications Co Ltd / China Molybdenum Co Ltd / Aluminum Corp of China Ltd / BAE Systems PLC / Glanbia PLC / Vietnam Dairy Products JSC / PetroChina Co Ltd / Joyoung Co Ltd / KB Financial Group Inc / Medy Tox Inc / Sands China Ltd / Longfor Group Holdings Ltd / JS Global Lifestyle Co Ltd / Shanghai Pharmaceuticals Holding Co Ltd / Beijing Easpring Material Technology CO LTD / Masan Group Corp / Booz Allen Hamilton Holding Corp / Seven West Media Ltd / Erawan Group PCL / Shanghai Pharmaceuticals Holding Co Ltd / BYD Co Ltd / Great Wall Motor Co Ltd / Sheng Siong Group Ltd / Tripadvisor Inc / China Molybdenum Co Ltd / VGI PCL / Weimob Inc / Westports Holdings Bhd / AMC Entertainment Holdings Inc / TriNet Group Inc / Indivior PLC / Auto Trader Group PLC / Engie SA / Xero Ltd / Cleanaway Waste Management Ltd / A2 Milk Company Ltd / Beigene Ltd / Ascential PLC / Itoham Yonekyu Holdings Inc / Fortum Oyj / Netmarble Corp / Essity AB (publ) / Ningbo Xusheng Auto Technology Co Ltd / Money Forward Inc / ZhongAn Online P & C Insurance Co Ltd / Hellofresh SE / Sime Darby Property Bhd / Foxconn Industrial Internet Co Ltd / Veoneer Inc / Beigene Ltd / Innovent Biologics Inc / Shanghai Junshi Biosciences Co Ltd / Newell Brands Inc / Wiwynn Corp / Nippon Steel Corp / Asset World Corp PCL / Hennge KK / freee KK / China Resources Microelectronics Ltd / Sri Trang Gloves (Thailand) PCL / Siemens Energy AG / Everest Medicines Ltd / Deterra Royalties Ltd / Affirm Holdings Inc / Stellantis NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Argentina / Australia / Austria / Bermuda / Switzerland / China / Cayman Islands / Germany / Denmark / Spain / Finland / France / United Kingdom / Hong Kong / Indonesia / India / Ireland / Japan / Korea, Republic of / Luxembourg / Malaysia / Netherlands / New Zealand / Panama / Philippines / Russian Federation / Singapore / Sweden / Thailand / Taiwan / United States / Vietnam / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia / Global</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / PORTFOLIO/ASSET STRATEGIES / Investment Strategy / Equity</td><td class="leftalignment">Mr. Andrew W. Garthwaite / Mr Robert C. Griffiths / Mr Mengyuan Yuan / Asim Ali</td></tr>
<tr class="odd"><td class="leftalignment">06/11/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Coverage Suspended</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Bert X. Powell, CFA</td></tr>
<tr class="even"><td class="leftalignment">06/11/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Coverage Discontinued/Suspended/Transferred</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">US0311621009 / US92532F1003 / US7665596034 / US02043Q1076 / US40637H1095 / US31189P1021 / NL0010872420 / US4622221004 / CA91822J1030 / US80706P1030 / US76029N1063 / US61775R1059 / US30205M1018 / US75382E1091 / US80810D1037 / US1628181083 / US89422G1076 / CA00288U1066 / US67080N1019</td><td class="leftalignment">Amgen Inc / Vertex Pharmaceuticals Inc / Rigel Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Halozyme Therapeutics Inc / Fate Therapeutics Inc / Affimed NV / Ionis Pharmaceuticals Inc / VBI Vaccines Inc / Scholar Rock Holding Corp / Replimune Group Inc / Morphic Holding Inc / Exicure Inc / Rapt Therapeutics Inc / Schrodinger Inc / Checkmate Pharmaceuticals Inc / Travere Therapeutics Inc / Abcellera Biologics Inc / Nuvation Bio Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Bert X. Powell, CFA</td></tr>
<tr class="odd"><td class="leftalignment">06/11/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Reminder: Virtual Washington, D.C. Day - June 30, 2021; Full Agenda Now Available</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">85891210 / 42190610 / 76115210 / 80640710 / 03116210 / 7333378 / 64125C109 / 002824100 / 110122108 / 09062X103 / 50540R409 / 74834L100 / 159864107 / 09061G101 / 703395103 / 640268108 / 075887109 / 20530610 / 30063P105 / 216648402 / 28176E108 / 30161Q104 / 45337C102 / 23918K108 / 038336103 / 852312305 / 023436108 / 589584101 / 955306105 / 50187A107 / 436440101 / 003654100 / 016255101 / 09060J106 / 252131107 / 42222N103 / 45168D104 / 45253H101 / 640491106 / 74838J101 / 759916109 / 90337L108 / 45784P101 / 58502B106 / 141619106 / 64049M20 / 40412C101 / 00847G705 / 92857F107 / 00404A109 / 88033G407 / 803607100 / G4705A100 / 74051N10 / 98978V10 / 92337F10 / 26979610 / 45780L10 / 14862Q100 / 006739106 / 00430H102 / 00847L10 / 045396108 / 14880610 / 82621J10 / 268158201 / 31572Q80 / 76133010 / G5960L103 / 78667J108 / 30050B10 / 98978L204 / 37732210 / 15117K103 / 87918A10 / 46185L10 / 04651310 / 00461U105 / 462222100 / 19459J104 / 24906P109 / 70975L107 / 64157F103 / 87357P100 / 58506Q109 / 01345P106 / 88870R102 / N72482123 / 690469101 / G11196105 / 00887A105 / 69366J200 / 46266C105 / 816212104 / 09609G100 / 450056106 / 67022C106 / 29261A100 / 87166B102 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / 28414H103 / H17182108 / 873379101 / 501147102 / 37890U108 / 40131M109 / 22304C100 / 05352A100 / 00650F109 / 77313F106 / 03836N103 / 717224109 / 83192H106 / 88025U109 / 30068X103 / 15912K100 / 29415F104 / 07373V105 / 68404L201 / 42225T107 / 05464T104 / 922107107 / 55234L105 / 71944F106 / 68269G107 / 74019P108 / 37148K100 / 64131A105 / 48576A100 / N5749R100 / 084310101 / 005111109 / 00437E102 / G10830100 / 24984K105 / 73730P108 / 81181C104 / 04537Y109 / 517125100 / 877619106 / 74006W108 / 67181A107 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 270087109 / 192010106 / 13089P101 / 151205200 / 09075X108 / 68401U204 / 04683R106 / 78472F101 / 000380204 / 89422G107 / 56600D107 / 15687V109 / 65443P102 / 54948U105 / 82671G100 / 45784A104 / 30315R107 / 01625V104 / 45175G108 / 00857U107 / 74276R102 / 91864C107</td><td class="leftalignment">Stericycle Inc / Healthcare Services Group Inc / Resmed Inc / Henry Schein Inc / Amgen Inc / Lonza Group AG / Neurocrine Biosciences Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Biogen Inc / Laboratory Corporation of America Holdings / Quest Diagnostics Inc / Charles River Laboratories International Inc / Biomarin Pharmaceutical Inc / Patterson Companies Inc / Nektar Therapeutics / Becton Dickinson and Co / Computer Programs and Systems Inc / Exact Sciences Corp / Cooper Companies Inc / Edwards Lifesciences Corp / Exelixis Inc / Incyte Corp / DaVita Inc / Aptargroup Inc / STAAR Surgical Co / Amedisys Inc / Meridian Bioscience Inc / West Pharmaceutical Services Inc / LHC Group Inc / Hologic Inc / ABIOMED Inc / Align Technology Inc / BioDelivery Sciences International Inc / Dexcom Inc / HealthStream Inc / IDEXX Laboratories Inc / ImmunoGen Inc / Neogen Corp / Quidel Corp / Repligen Corp / US Physical Therapy Inc / Insulet Corp / MEDNAX Inc / Cardiovascular Systems Inc / Neogenomics Inc / HCA Healthcare Inc / Agenus Inc / Vocera Communications Inc / Acadia Healthcare Company Inc / Tenet Healthcare Corp / Sarepta Therapeutics Inc / ICON PLC / Premier Inc / Zoetis Inc / Veracyte Inc / Eagle Pharmaceuticals Inc / Inogen Inc / Castlight Health Inc / Addus Homecare Corp / Accelerate Diagnostics Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Catalent Inc / Sientra Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / Medtronic PLC / SAGE Therapeutics Inc / Evolent Health Inc / Zogenix Inc / Glaukos Corp / Cellectis SA / Teladoc Health Inc / Invitae Corp / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / DENTSPLY SIRONA Inc / Penumbra Inc / Nevro Corp / Tactile Systems Technology Inc / Medpace Holdings Inc / Albireo Pharma Inc / Tivity Health Inc / Qiagen NV / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / IQVIA Holdings Inc / Selecta Biosciences Inc / bluebird bio Inc / iRhythm Technologies Inc / NuCana PLC / Encompass Health Corp / Syneos Health Inc / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / Elanco Animal Health Inc / CRISPR Therapeutics AG / Tabula Rasa HealthCare Inc / Krystal Biotech Inc / Global Blood Therapeutics Inc / Guardant Health Inc / Covetrus Inc / Avantor Inc / Adaptive Biotechnologies Corp / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / SmileDirectClub Inc / 10X Genomics Inc / Exagen Inc / Change Healthcare Inc / Envista Holdings Corp / Beam Therapeutics Inc / Option Care Health Inc / Health Catalyst Inc / Axsome Therapeutics Inc / Vapotherm Inc / Lyra Therapeutics Inc / Phreesia Inc / 1Life Healthcare Inc / Precision BioSciences Inc / Generation Bio Co / Neuronetics Inc / Karuna Therapeutics Inc / Merus NV / Berkeley Lights Inc / Acutus Medical Inc / Accolade Inc / Beyondspring Inc / DermTech Inc / Poseida Therapeutics Inc / Seagen Inc / Aspira Women's Health Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Oak Street Health Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Eargo Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Biodesix Inc / OPTIMIZERx Corp / Atea Pharmaceuticals Inc / Soc Telemed Inc / Abcam PLC / Travere Therapeutics Inc / Maravai LifeSciences Holdings Inc / Certara Inc / 908 Devices Inc. / Lucira Health Inc / Signify Health Inc / InnovAge Holding Corp / F-Star Therapeutics Inc / Alignment Healthcare Inc / Ikena Oncology Inc / agilon health Inc / Privia Health Group Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Ryan S. Daniels, CFA / Brian D. Weinstein, CFA / Andy T. Hsieh, PHD / Ms. Margaret Kaczor / John C. Kreger, III / Mr. Matt Larew / Mr. Tim F. Lugo / Mr. Myles R. R. Minter / Matt Phipps, PHD / Mr. Raju Prasad, PHD</td></tr>
<tr class="even"><td class="leftalignment">06/11/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--June 11, 2021</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">ACA / AMN / BSX / CHE / CI / CNC / CVS / HUM / MDT / RAD / UNH / WMT / AMGN.O / NOVN.S / RMD.N / HCA.N / CYH.N / INSP.N / EW.N / BCRX.OQ / ICPT.OQ / UTHR.OQ / BLUE.OQ / CCRN.O / ICAD.O / AMED.O / CGEN.O / BIIB.O / 00846U101 / 868168105 / MNKD.O / ATRC.OQ / LHCG.O / ENSG.OQ / 483548103 / TMDX.OQ / MD.N / 771195104 / ADUS.O / USPH.N / PRTA.OQ / FATE.OQ / GOOGL.O / MDWD.O / CASI.OQ / CLRB.OQ / VCEL.O / EVH.N / TDOC.N / APLS.OQ / 100063846 / IOVA.OQ / ALPN.O / VERU.OQ / KALA.O / ATNX.O / 720795103 / PDSB.OQ / ONCT.OQ / NBSE.O / PNTG.OQ / ETNB.O / REGW.M3 / 03823M100</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Boston Scientific Corp / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Medtronic PLC / Rite Aid Corp / UnitedHealth Group Inc / Walmart Inc / Amgen Inc / Novartis AG / Resmed Inc / HCA Healthcare Inc / Community Health Systems Inc / Inspire Medical Systems Inc / Edwards Lifesciences Corp / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / United Therapeutics Corp / bluebird bio Inc / Cross Country Healthcare Inc / ICAD Inc / Amedisys Inc / Compugen Ltd / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / MannKind Corp / AtriCure Inc / LHC Group Inc / Ensign Group Inc / Kaman Corp / Transmedics Group Inc / MEDNAX Inc / Roche Holding AG / Addus Homecare Corp / US Physical Therapy Inc / Prothena Corporation PLC / Fate Therapeutics Inc / Alphabet Inc / Mediwound Ltd / CASI Pharmaceuticals Inc / Cellectar Biosciences Inc / Vericel Corp / Evolent Health Inc / Teladoc Health Inc / Apellis Pharmaceuticals Inc / Truist Financial Corp / Iovance Biotherapeutics Inc / Alpine Immune Sciences Inc / Veru Inc / Kala Pharmaceuticals Inc / Athenex Inc / Pieris Pharmaceuticals Inc / PDS Biotechnology Corp / Oncternal Therapeutics Inc / NeuBase Therapeutics Inc / Pennant Group Inc / 89Bio Inc / Regency World Consulting Ltd / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / India / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="odd"><td class="leftalignment">06/11/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended June 4, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">06/11/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 551</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">06/11/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="even"><td class="leftalignment">06/11/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto</td></tr>
<tr class="odd"><td class="leftalignment">06/11/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">ABCs of ASCO: Adjuvant Advances, BCMA CAR and Bispecific Bonanza, CD137 Comeback, Dual IO Developments, EGFR Exon20 Excites</td><td class="leftalignment">English</td><td class="rightalignment">48</td><td class="leftalignment">00847G705 / 00887A105 / 03116210 / 110122108 / 640268108 / 30161Q104 / 45337C102 / 45253H101 / 15117K103 / 04651310 / 816212104 / 09609G100 / 67022C106 / 720795103 / 49372L100 / 05280R100 / 019770106 / H17182108 / 717224109 / 74019P108 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 00507W206 / 03890D108 / 192010106 / 13089P101 / 151205200 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">Agenus Inc / Aileron Therapeutics Inc / Amgen Inc / Bristol-Myers Squibb Co / Nektar Therapeutics / Exelixis Inc / Incyte Corp / ImmunoGen Inc / Cellectis SA / Atara Biotherapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allogene Therapeutics Inc / CRISPR Therapeutics AG / PhaseBio Pharmaceuticals Inc / Precision BioSciences Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Actinium Pharmaceuticals Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Mr. Myles R. R. Minter / Mr. Rob Andrew, CFA / Mr. Hunter Rogers / Sami Corwin, PHD</td></tr>
<tr class="even"><td class="leftalignment">06/11/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jun 11 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">FR0000054470 / DE0006969603 / US00724F1012 / US0311621009 / US1311931042 / US1985161066 / US2435371073 / US2546871060 / US2855121099 / US6541061031 / US68389X1054 / US7782961038 / US8305661055 / US8725401090 / US8740541094 / US9182041080 / US91913Y1001 / US92532F1003 / US3448491049 / US2533931026 / US2538681030 / US9043111072 / US1314761032 / US4103451021 / US5500211090 / US00507V1098 / US25470F1049 / US25470F3029 / DE000A1EWWW0 / US4361061082 / US56585A1025 / US6936561009 / US7512121010 / US03027X1000 / US98986T1088 / US7185461040 / US69318G1067 / US81762P1021 / US23283R1005 / US60468T1051 / US1220171060 / US69888T2078 / US22822V1017 / US29444U7000 / US90138F1021 / US91325V1089 / US24665A1034 / US87105L1044 / US4622601007 / US19626G1085 / US2575541055 / CA39342L1085 / US98585X1046 / US35137L1052 / US35952H6018 / US02875D1090 / US8334451098 / US72815L1070 / US49926T1043</td><td class="leftalignment">Ubisoft Entertainment SA / Puma SE / Adobe Inc / Amgen Inc / Callaway Golf Co / Columbia Sportswear Co / Deckers Outdoor Corp / Walt Disney Co / Electronic Arts Inc / Nike Inc / Oracle Corp / Ross Stores Inc / Skechers USA Inc / TJX Companies Inc / Take-Two Interactive Software Inc / VF Corp / Valero Energy Corp / Vertex Pharmaceuticals Inc / Foot Locker Inc / DICK'S Sporting Goods Inc / Digital Realty Trust Inc / Under Armour Inc / Calumet Specialty Products Partners LP / HanesBrands Inc / Lululemon Athletica Inc / Activision Blizzard Inc / Discovery Inc / Discovery Inc / Adidas AG / HollyFrontier Corp / Marathon Petroleum Corp / PVH Corp / Ralph Lauren Corp / American Tower Corp / Zynga Inc / Phillips 66 / PBF Energy Inc / ServiceNow Inc / CyrusOne Inc / Mirati Therapeutics Inc / Burlington Stores Inc / Par Pacific Holdings Inc / Crown Castle International Corp / Equinix Inc / Twilio Inc / Uniti Group Inc / Delek US Holdings Inc / Switch Inc / Iovance Biotherapeutics Inc / DigitalBridge Group Inc / Domo Inc / Green Thumb Industries Inc / Yeti Holdings Inc / Fox Corp / Fuelcell Energy Inc / American Outdoor Brands Inc / Snowflake Inc. / Playtika Holding Corp / Knowbe4 Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Germany / France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">06/11/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - June 11, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">CCI.N / CNA.L / DFDS.CO / KBH.N / MAS.N / PHM.N / RWEG.DE / TOL.N / VOLVb.ST / AVB.N / DRE.N / FR.N / CMCSA.O / AMGN.O / AAL.L / DISH.O / EPR.N / LEN.N / AMT.N / CONE.O / RDN.N / DHI.N / FISV.O / V.N / CPT.N / CHTR.O / ARE.N / EGP.N / PLD.N / ESS.N / UDR.N / SUI.N / KRC.N / MAA.N / VTR.N / VRTX.O / CEY.L / ENAG.MC / APF.L / PNR.N / LTC.N / PEGA.OQ / AMH.N / GPN.N / JCOM.O / EQIX.O / BIIB.O / DLR.N / ELS.N / MPW.N / DISCA.O / FIS.N / ARWR.O / MA.N / 3IN.L / DAIGn.DE / HOCM.L / VALE.N / BHPB.L / CIO.N / GLEN.L / STAG.N / POLYP.L / TPH.N / TMHC.N / PRTA.O / DOC.N / CTLT.N / CTRE.O / 03835T200 / DEA.N / GBT.OQ / SQ.N / TWLO.N / UNIT.O / ORSTED.CO / COLD.N / ILPT.O / SMAR.N / DBX.O / OPI.OQ / ZM.O / FSLY.N / DOCU.N / PEAK.N / ETNB.O / DHC.O / SBSW.N / IGIC.OQ / WMG.OQ / FOUR.N / DCT.O / DFH.OQ / COUR.N</td><td class="leftalignment">Crown Castle International Corp / Centrica PLC / DFDS AS / KB Home / Masco Corp / Pultegroup Inc / Rwe AG / Toll Brothers Inc / Volvo AB / Avalonbay Communities Inc / Duke Realty Corp / First Industrial Realty Trust Inc / Comcast Corp / Amgen Inc / Anglo American PLC / DISH Network Corp / EPR Properties / Lennar Corp / American Tower Corp / CyrusOne Inc / Radian Group Inc / D R Horton Inc / Fiserv Inc / Visa Inc / Camden Property Trust / Charter Communications Inc / Alexandria Real Estate Equities Inc / Eastgroup Properties Inc / Prologis Inc / Essex Property Trust Inc / UDR Inc / Sun Communities Inc / Kilroy Realty Corp / Mid-America Apartment Communities Inc / Ventas Inc / Vertex Pharmaceuticals Inc / Centamin PLC / Enagas SA / Anglo Pacific Group PLC / Pentair PLC / LTC Properties Inc / Pegasystems Inc / American Homes 4 Rent / Global Payments Inc / Ziff Davis Inc / Equinix Inc / Biogen Inc / Digital Realty Trust Inc / Equity LifeStyle Properties Inc / Medical Properties Trust Inc / Discovery Inc / Fidelity National Information Services Inc / Arrowhead Pharmaceuticals Inc / Mastercard Inc / 3I Infrastructure PLC / Daimler AG / Hochschild Mining PLC / Vale SA / BHP Group PLC / City Office REIT Inc / Glencore PLC / STAG Industrial Inc / Polymetal International PLC / Tri Pointe Homes Inc (Delaware) / Taylor Morrison Home Corp / Prothena Corporation PLC / Physicians Realty Trust / Catalent Inc / CareTrust REIT Inc / Aptose Biosciences Inc / Easterly Government Properties Inc / Global Blood Therapeutics Inc / Block Inc / Twilio Inc / Uniti Group Inc / Orsted A/S / Americold Realty Trust / Industrial Logistics Properties Trust / Smartsheet Inc / Dropbox Inc / Office Properties Income Trust / Zoom Video Communications Inc / Fastly Inc / DocuSign Inc / Healthpeak Properties Inc / 89Bio Inc / Diversified Healthcare Trust / Sibanye Stillwater Ltd / International General Insurance Holdings Ltd / Warner Music Group Corp / Shift4 Payments Inc / Duck Creek Technologies Inc / Dream Finders Homes Inc / Coursera Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Brazil / Canada / Germany / Denmark / Spain / United Kingdom / Ireland / Sweden / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">06/10/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Coffee: What’s The Bar For KRAS G12Ci In 1L NSCLC?</td><td class="leftalignment">English</td><td class="rightalignment">71</td><td class="leftalignment">US0311621009 / US60468T1051</td><td class="leftalignment">Amgen Inc / Mirati Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Research Digest</td><td class="leftalignment">Yaron Werber, M.D., MD / Gabriel Schneider, M.D. / Brendan Smith, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">06/10/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Short Interest Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AMGN.O / BIIB.O</td><td class="leftalignment">Amgen Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Yinglu Zhang</td></tr>
<tr class="even"><td class="leftalignment">06/10/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Biotech Outflows Lessen, but Continue to Drag On</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">06/10/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US -  Dividend Quality Analysis, for the period ended June 08,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">06/09/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">AMGN.OQ - Event Transcript of Amgen Inc conference call, Jun. 09, 2021 / 4:40PM ET</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / LSI=US / PFE=US / AMGN=US / BMY=US / GBT=US / BLD=US / INCY=US / GL=US / GILD=US / PAA=US / CHRS=US / LEG=US / VMC=US / MLM=US / PATH=US / BNL=US / DRI=US / ENDP=US / IBP=US / MHK=US / NTST=US / REGN=US / THO=US / VRTX=US / HIW=US / BDN=US / PRI=US / EGP=US / KIM=US / MAA=US / UDR=US / DRE=US / AUTL=US / DIN=US / OGN / BCO=US / TPX=US / EXP=US / BECN=US / TXRH=US / BLDR=US / PGTI=US / OC=US / KTOS=US / TREX=US / OLO=US / APTS=US / MEIP=US / ABBV=US / TILE=US / HTRG=US / DEA=US / 82982L103 / CRSP=US / YEXT=US / COLD=US / EOLS=US / UBER=US / GMAB=US / AZEK=US / VTRS=US / DASH=US</td><td class="leftalignment">Merck & Co Inc / Life Storage Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Global Blood Therapeutics Inc / TopBuild Corp / Incyte Corp / Globe Life Inc / Gilead Sciences Inc / Plains All American Pipeline LP / Coherus BioSciences Inc / Leggett & Platt Inc / Vulcan Materials Co / Martin Marietta Materials Inc / UiPath Inc / Bunzl plc / Darden Restaurants Inc / Endo International PLC / Installed Building Products Inc / Mohawk Industries Inc / Netstreit Corp / Regeneron Pharmaceuticals Inc / Thor Industries Inc / Vertex Pharmaceuticals Inc / Highwoods Properties Inc / Brandywine Realty Trust / Primerica Inc / Eastgroup Properties Inc / Kimco Realty Corp / Mid-America Apartment Communities Inc / UDR Inc / Duke Realty Corp / Autolus Therapeutics PLC / Dine Brands Global Inc / Organon & Co / Brinks Co / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Texas Roadhouse Inc / Builders FirstSource Inc / PGT Innovations Inc / Owens Corning / Kratos Defense and Security Solutions Inc / Trex Company Inc / Olo Inc / Preferred Apartment Communities Inc / MEI Pharma Inc / Abbvie Inc / Interface Inc / Heritage Insurance Holdings Inc / Easterly Government Properties Inc / SiteOne Landscape Supply Inc / CRISPR Therapeutics AG / Yext Inc / Americold Realty Trust / Evolus Inc / Uber Technologies Inc / Genmab A/S / Azek Company Inc / Viatris Inc / DoorDash Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">V / 0989529 / 0925288 / 2126335 / 2000019 / 2023607 / 2778844 / 2973821 / 2026242 / 2219224 / 2270726 / 2829515 / 2317087 / 2342034 / 2455965 / 2471950 / 2689560 / 2680905 / 2684703 / 2705198 / 2707677 / 2829601 / 4595739 / 7103065 / B02R1L6 / B7TL820 / BBFL7S1 / B7VD3F2 / BFLR866 / BYVY8G0 / BYZLV46 / BXDZ9Z0 / BNFWR44 / BFMXGR0 / BKTNTR9 / BZ1LFG7 / BN7K304 / BMHR7K6</td><td class="leftalignment">Visa Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Amazon.com Inc / Amgen Inc / Merck & Co Inc / Alliant Energy Corp / American Electric Power Company Inc / CMS Energy Corp / Walt Disney Co / Edison International / Entergy Corp / Fiserv Inc / Biogen Inc / Incyte Corp / PG&E Corp / PPL Corp / Pfizer Inc / Progress Software Corp / Public Service Enterprise Group Inc / Southern Co / Genmab A/S / Novartis AG / ALLETE Inc / Meta Platforms Inc / bluebird bio Inc / Duke Energy Corp / Twitter Inc / Alphabet Inc / InflaRx NV / Shopify Inc / Worldline SA / Evergy Inc / ViacomCBS Inc / Roku Inc / Academy Sports and Outdoors Inc / Impel Neuropharma Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / France / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">06/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech & Pharma: Truist EHA Planner v2.0 Highlights 100+ Datapoints of Interest</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / BMY=US / GBT=US / INCY=US / GILD=US / REGN=US / VRTX=US / AUTL=US / MEIP=US / ABBV=US / CRSP=US / GMAB=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Global Blood Therapeutics Inc / Incyte Corp / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Autolus Therapeutics PLC / MEI Pharma Inc / Abbvie Inc / CRISPR Therapeutics AG / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Asthika Goonewardene / Ms. Robyn S. Karnauskas / Mr. Gregg Gilbert / Ms. Srikripa Devarakonda, PHD / Mr. Joon Lee, MD</td></tr>
<tr class="even"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BLUE, AMGN (NEUTRAL), GMAB.DC (BUY)- Read-through from ASCO MM Session Highlights Emerging Competition in Late Line; Darzalex Largely Shielded for Now</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.OQ / BLUE.OQ / 0925288 / 2126335 / 2023607 / 2475833 / 2684703 / 4595739 / BBFL7S1</td><td class="leftalignment">Amgen Inc / bluebird bio Inc / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Amgen Inc / Johnson & Johnson / Pfizer Inc / Genmab A/S / bluebird bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / Denmark / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Kelsey Goodwin / Yige Guo, Ph.D. / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="odd"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / WEN=US / AMZN=US / BLD=US / INCY=US / TEVA=US / MTN=US / LOW=US / PB=US / CHRS=US / LEG=US / VMC=US / MLM=US / AIR=US / SWIM=US / CBRL=US / CSTR=US / DRI=US / GFF=US / IBP=US / MAS=US / MHK=US / PACW=US / REGN=US / REGI=US / FOUR=US / CGEN=US / FMBI=US / SNV=US / SIVB=US / ABCB=US / FBK=US / SSB=US / RF=US / FFIN=US / GBCI=US / DIN=US / PNFP=US / SBCF=US / BIIB=US / TPX=US / EXP=US / BDC=US / BECN=US / PLAY=US / RNST=US / DENN=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / JACK=US / CLNY=US / TREX=US / FBHS=US / BCEI=US / ABBV=US / TILE=US / IBTX=US / NDLS=US / FATE=US / 00770K202 / COUP=US / LOCO=US / HQY=US / SHAK=US / WING=US / ARGX=US / ACBI=US / SQ=US / 82982L103 / TVTY=US / JELD=US / SFIX=US / HWC=US / BTAI=US / LSPD=US / FERG=US / OPCH=US / ARQT=US / AZEK=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Wendys Co / Amazon.com Inc / TopBuild Corp / Incyte Corp / Teva Pharmaceutical Industries Ltd / Vail Resorts Inc / Lowe's Companies Inc / Prosperity Bancshares Inc / Coherus BioSciences Inc / Leggett & Platt Inc / Vulcan Materials Co / Martin Marietta Materials Inc / AAR Corp / Latham Group Inc / Cracker Barrel Old Country Store Inc / CapStar Financial Holdings Inc / Darden Restaurants Inc / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / PacWest Bancorp / Regeneron Pharmaceuticals Inc / Renewable Energy Group Inc / Shift4 Payments Inc / Compugen Ltd / First Midwest Bancorp Inc / Synovus Financial Corp / SVB Financial Group / Ameris Bancorp / FB Financial Corp / SouthState Corp / Regions Financial Corp / First Financial Bankshares Inc / Glacier Bancorp Inc / Dine Brands Global Inc / Pinnacle Financial Partners Inc / Seacoast Banking Corporation of Florida / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Belden Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Renasant Corp / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Jack in the Box Inc / DigitalBridge Group Inc / Trex Company Inc / Fortune Brands Home & Security Inc / Civitas Resources Inc / Abbvie Inc / Interface Inc / Independent Bank Group Inc / Noodles & Co / Fate Therapeutics Inc / Aemetis Inc / Coupa Software Inc / El Pollo Loco Holdings Inc / Healthequity Inc / Shake Shack Inc / Wingstop Inc / argenx SE / Atlantic Capital Bancshares Inc / Block Inc / SiteOne Landscape Supply Inc / Tivity Health Inc / JELD-WEN Holding Inc / Stitch Fix Inc / Hancock Whitney Corp / BioXcel Therapeutics Inc / Lightspeed Commerce Inc / Ferguson PLC / Option Care Health Inc / Arcutis Biotherapeutics Inc / Azek Company Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/08/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Adult Vaccinations Near 65% as Record Lows Extend Across Key COVID-19 Metrics Domestically; Broad Global Declines Continue</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PFE-US -  Dividend Quality Analysis, for the period ended June 04,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE / ABT / BMY / JNJ / LLY / MRK / NVS / AMGN.O / GSK / AZN.O</td><td class="leftalignment">Pfizer Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">GB0009895292 / US0311621009 / US3755581036 / US23282W6057 / US24823R1059</td><td class="leftalignment">AstraZeneca PLC / Amgen Inc / Gilead Sciences Inc / Cytokinetics Inc / Denali Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending May 28, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Tracking the JAKs</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / BMY=US / INCY=US / ABBV=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Abbvie Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Register: Virtual Washington, D.C. Day - June 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">85891210 / 42190610 / 76115210 / 80640710 / 03116210 / 7333378 / 64125C109 / 002824100 / 110122108 / 09062X103 / 50540R409 / 74834L100 / 159864107 / 09061G101 / 703395103 / 640268108 / 075887109 / 20530610 / 30063P105 / 216648402 / 28176E108 / 30161Q104 / 45337C102 / 23918K108 / 038336103 / 852312305 / 023436108 / 589584101 / 955306105 / 50187A107 / 436440101 / 003654100 / 016255101 / 09060J106 / 252131107 / 42222N103 / 45168D104 / 45253H101 / 640491106 / 74838J101 / 759916109 / 90337L108 / 45784P101 / 58502B106 / 141619106 / 64049M20 / 40412C101 / 00847G705 / 92857F107 / 00404A109 / 88033G407 / 803607100 / G4705A100 / 74051N10 / 98978V10 / 92337F10 / 26979610 / 45780L10 / 14862Q100 / 006739106 / 00430H102 / 00847L10 / 045396108 / 14880610 / 82621J10 / 268158201 / 31572Q80 / 76133010 / G5960L103 / 78667J108 / 30050B10 / 98978L204 / 37732210 / 15117K103 / 87918A10 / 46185L10 / 04651310 / 00461U105 / 462222100 / 19459J104 / 24906P109 / 70975L107 / 64157F103 / 87357P100 / 58506Q109 / 01345P106 / 88870R102 / N72482123 / 690469101 / G11196105 / 00887A105 / 69366J200 / 46266C105 / 816212104 / 09609G100 / 450056106 / 67022C106 / 29261A100 / 87166B102 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / 28414H103 / H17182108 / 873379101 / 501147102 / 37890U108 / 40131M109 / 22304C100 / 05352A100 / 00650F109 / 77313F106 / 03836N103 / 717224109 / 83192H106 / 88025U109 / 30068X103 / 15912K100 / 29415F104 / 07373V105 / 68404L201 / 42225T107 / 05464T104 / 922107107 / 55234L105 / 71944F106 / 68269G107 / 74019P108 / 37148K100 / 64131A105 / 48576A100 / N5749R100 / 084310101 / 005111109 / 00437E102 / G10830100 / 24984K105 / 73730P108 / 81181C104 / 04537Y109 / 517125100 / 877619106 / 74006W108 / 67181A107 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 270087109 / 192010106 / 13089P101 / 151205200 / 09075X108 / 68401U204 / 04683R106 / 78472F101 / 000380204 / 89422G107 / 56600D107 / 15687V109 / 65443P102 / 54948U105 / 82671G100 / 45784A104 / 30315R107 / 01625V104 / 45175G108 / 00857U107 / 74276R102 / 91864C107</td><td class="leftalignment">Stericycle Inc / Healthcare Services Group Inc / Resmed Inc / Henry Schein Inc / Amgen Inc / Lonza Group AG / Neurocrine Biosciences Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Biogen Inc / Laboratory Corporation of America Holdings / Quest Diagnostics Inc / Charles River Laboratories International Inc / Biomarin Pharmaceutical Inc / Patterson Companies Inc / Nektar Therapeutics / Becton Dickinson and Co / Computer Programs and Systems Inc / Exact Sciences Corp / Cooper Companies Inc / Edwards Lifesciences Corp / Exelixis Inc / Incyte Corp / DaVita Inc / Aptargroup Inc / STAAR Surgical Co / Amedisys Inc / Meridian Bioscience Inc / West Pharmaceutical Services Inc / LHC Group Inc / Hologic Inc / ABIOMED Inc / Align Technology Inc / BioDelivery Sciences International Inc / Dexcom Inc / HealthStream Inc / IDEXX Laboratories Inc / ImmunoGen Inc / Neogen Corp / Quidel Corp / Repligen Corp / US Physical Therapy Inc / Insulet Corp / MEDNAX Inc / Cardiovascular Systems Inc / Neogenomics Inc / HCA Healthcare Inc / Agenus Inc / Vocera Communications Inc / Acadia Healthcare Company Inc / Tenet Healthcare Corp / Sarepta Therapeutics Inc / ICON PLC / Premier Inc / Zoetis Inc / Veracyte Inc / Eagle Pharmaceuticals Inc / Inogen Inc / Castlight Health Inc / Addus Homecare Corp / Accelerate Diagnostics Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Catalent Inc / Sientra Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / Medtronic PLC / SAGE Therapeutics Inc / Evolent Health Inc / Zogenix Inc / Glaukos Corp / Cellectis SA / Teladoc Health Inc / Invitae Corp / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / DENTSPLY SIRONA Inc / Penumbra Inc / Nevro Corp / Tactile Systems Technology Inc / Medpace Holdings Inc / Albireo Pharma Inc / Tivity Health Inc / Qiagen NV / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / IQVIA Holdings Inc / Selecta Biosciences Inc / bluebird bio Inc / iRhythm Technologies Inc / NuCana PLC / Encompass Health Corp / Syneos Health Inc / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / Elanco Animal Health Inc / CRISPR Therapeutics AG / Tabula Rasa HealthCare Inc / Krystal Biotech Inc / Global Blood Therapeutics Inc / Guardant Health Inc / Covetrus Inc / Avantor Inc / Adaptive Biotechnologies Corp / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / SmileDirectClub Inc / 10X Genomics Inc / Exagen Inc / Change Healthcare Inc / Envista Holdings Corp / Beam Therapeutics Inc / Option Care Health Inc / Health Catalyst Inc / Axsome Therapeutics Inc / Vapotherm Inc / Lyra Therapeutics Inc / Phreesia Inc / 1Life Healthcare Inc / Precision BioSciences Inc / Generation Bio Co / Neuronetics Inc / Karuna Therapeutics Inc / Merus NV / Berkeley Lights Inc / Acutus Medical Inc / Accolade Inc / Beyondspring Inc / DermTech Inc / Poseida Therapeutics Inc / Seagen Inc / Aspira Women's Health Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Oak Street Health Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Eargo Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Biodesix Inc / OPTIMIZERx Corp / Atea Pharmaceuticals Inc / Soc Telemed Inc / Abcam PLC / Travere Therapeutics Inc / Maravai LifeSciences Holdings Inc / Certara Inc / 908 Devices Inc. / Lucira Health Inc / Signify Health Inc / InnovAge Holding Corp / F-Star Therapeutics Inc / Alignment Healthcare Inc / Ikena Oncology Inc / agilon health Inc / Privia Health Group Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Ryan S. Daniels, CFA / Brian D. Weinstein, CFA / Andy T. Hsieh, PHD / Ms. Margaret Kaczor / John C. Kreger, III / Mr. Matt Larew / Mr. Tim F. Lugo / Mr. Myles R. R. Minter / Matt Phipps, PHD / Mr. Raju Prasad, PHD</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">STARTING SOON @ 12 PM ET: Join Our Virtual KOL Conference Call to Discuss ASCO Highlights</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US0311621009 / US31189P1021 / US3755581036 / US75886F1075 / US74587V1070 / US03969F1093</td><td class="leftalignment">Amgen Inc / Fate Therapeutics Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Puma Biotechnology Inc / Arcus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Emily Bodnar / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Latest ASP data provides some insight into biosimilar price trends</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">ALB.N / BE / BSX / CAT / CLH / CMI / CSL / DAN / DE / ENS / GGG / HON / INTC.O / JCI / MDT / NEP / NOW / ORA / PNR / QCOM.O / RSG / RXN / URI / WM / AMGN.O / AAPL.O / BWA.N / WTS.N / SQ / EW.N / IO.N / FCEL.O / CREE.O / AOS.N / AMSC.OQ / PLUG.OQ / TXN.OQ / TRMB.O / ITRI.O / LECO.O / MSTR.O / OSTK.O / ATRC.OQ / SPWR.O / CSIQ.O / FSLR.O / 20564W105 / TWIN.O / AGCO.K / TSLA.O / AMRC.K / AMRS.OQ / XYL / ENPH.O / HASI.N / FATE.OQ / WIX.O / GOOGL.O / SHOP.K / SEDG.O / RUN.O / SPXC.K / WKHS.O / WCN.TO / AQMS.O / TTD.OQ / WPRT.TO / TWLO.K / IOVA.OQ / ALPN.O / ATNX.O / APTV.K / BLNK.O / SMAR.K / CWENa.K / ZI.OQ / AVNT.K / RWRh.V</td><td class="leftalignment">Albemarle Corp / Bloom Energy Corp / Boston Scientific Corp / Caterpillar Inc / Clean Harbors Inc / Cummins Inc / Carlisle Companies Inc / Dana Inc / Deere & Co / EnerSys / Graco Inc / Honeywell International Inc / Intel Corp / Johnson Controls International PLC / Medtronic PLC / Nextera Energy Partners LP / ServiceNow Inc / Ormat Technologies Inc / Pentair PLC / Qualcomm Inc / Republic Services Inc / Zurn Water Solutions Corp / United Rentals Inc / Waste Management Inc / Amgen Inc / Apple Inc / Borgwarner Inc / Watts Water Technologies Inc / Block Inc / Edwards Lifesciences Corp / ION Geophysical Corp / Fuelcell Energy Inc / Wolfspeed Inc / A O Smith Corp / American Superconductor Corp / Plug Power Inc / Texas Instruments Inc / Trimble Inc / Itron Inc / Lincoln Electric Holdings Inc / Microstrategy Inc / Overstock.com Inc / AtriCure Inc / SunPower Corp / Canadian Solar Inc / First Solar Inc / Comscore Inc / Twin Disc Inc / AGCO Corp / Tesla Inc / Ameresco Inc / Amyris Inc / Xylem Inc / Enphase Energy Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / Fate Therapeutics Inc / Wix.Com Ltd / Alphabet Inc / Shopify Inc / Solaredge Technologies Inc / Sunrun Inc / SPX Corp / Workhorse Group Inc / Waste Connections Inc / Aqua Metals Inc / Trade Desk Inc / Westport Fuel Systems Inc / Twilio Inc / Iovance Biotherapeutics Inc / Alpine Immune Sciences Inc / Athenex Inc / Aptiv PLC / Blink Charging Co / Smartsheet Inc / Clearway Energy Inc / ZoomInfo Technologies Inc / Avient Corp / Strathmore Plus Energy Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Ireland / Israel / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - June 7 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">BE0165385973 / US0091581068 / US00971T1016 / US0116591092 / US0311621009 / US0323325045 / US0463531089 / US0997241064 / US1101221083 / US17275R1023 / US2310211063 / US34354P1057 / US37733W1053 / US45167R1041 / US4523271090 / US45337C1027 / US4657411066 / US4781601046 / US5324571083 / US66987V1098 / US6701002056 / US7010941042 / US7170811035 / US7711951043 / US7766961061 / US8308791024 / US8447411088 / US8835561023 / US92343V1044 / US9427491025 / CA8265161064 / US30063P1057 / US00508Y1029 / US4771431016 / US4198791018 / US80105N1054 / US64111Q1040 / US1281261099 / US79466L3024 / US6866881021 / US2538681030 / US00206R1023 / US6247581084 / PAP310761054 / US16115Q3083 / US3364331070 / US01748X1028 / US2473617023 / US53261M1045 / US90384S3031 / US1940141062 / DE000A0DJ6J9 / CA9609083097 / CA0585861085 / US58933Y1055 / US5218652049 / US88160R1014 / US9100471096 / US69404D1081 / US92839U2069 / US8676524064 / JE00B783TY65 / US98419M1009 / US00287Y1091 / US98978V1035 / US8725901040 / US72919P2020 / US64051T1007 / US29355A1079 / US23283R1005 / US41068X1000 / US8485771021 / US21240E1055 / US5560991094 / US02376R1023 / IE00BLS09M33 / US0404131064 / CA0089118776 / US29444U7000 / US46185L1035 / US83417M1045 / US6323071042 / US98138J2069 / US45073V1089 / US34959J1088 / US87266J1043 / US36165L1089 / US45782B1044 / NL0012169213 / US87105L1044 / US8760301072 / US30057T1051 / US4622601007 / US05351X1019 / CH0371153492 / US92336X1090 / US0937121079 / US5904791358 / US28414H1032 / KY30744W1070 / US40131M1099 / US35952H6018 / US71535D1063 / US1567271093 / US23725P2092 / US92537N1081 / US26142R1041 / US6541101050 / US12233L1070 / US04271T1007 / KYG3902L1095 / US5502411037 / US55406W1036 / US82489W1071 / US03783T1034 / LU2314763264 / US90089L1089 / US30320C1036</td><td class="leftalignment">Melexis NV / Air Products and Chemicals Inc / Akamai Technologies Inc / Alaska Air Group Inc / Amgen Inc / Amtech Systems Inc / AstraZeneca PLC / Borgwarner Inc / Bristol-Myers Squibb Co / Cisco Systems Inc / Cummins Inc / Flowserve Corp / GlaxoSmithKline PLC / IDEX Corp / Illumina Inc / Incyte Corp / Itron Inc / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Parker-Hannifin Corp / Pfizer Inc / Roche Holding AG / Roper Technologies Inc / SkyWest Inc / Southwest Airlines Co / Thermo Fisher Scientific Inc / Verizon Communications Inc / Watts Water Technologies Inc / Sierra Wireless Inc / Exact Sciences Corp / Acuity Brands Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / NETGEAR Inc / CalAmp Corp / Salesforce.Com Inc / Ormat Technologies Inc / Digital Realty Trust Inc / AT&T Inc / Mueller Water Products Inc / Copa Holdings SA / Chart Industries Inc / First Solar Inc / Allegiant Travel Co / Delta Air Lines Inc / Limelight Networks Inc / Ulta Beauty Inc / Colfax Corp / SMA Solar Technology AG / Westport Fuel Systems Inc / Ballard Power Systems Inc / Merck & Co Inc / Lear Corp / Tesla Inc / United Airlines Holdings Inc / Pacific Biosciences of California Inc / Visteon Corp / SunPower Corp / Aptiv PLC / Xylem Inc / Abbvie Inc / Zoetis Inc / T-Mobile US Inc / Plug Power Inc / NeoPhotonics Corp / Enphase Energy Inc / CyrusOne Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / MacroGenics Inc / American Airlines Group Inc / Pentair PLC / Arista Networks Inc / Air Canada / Equinix Inc / Invitae Corp / Solaredge Technologies Inc / Natera Inc / Workhorse Group Inc / ITT Inc / Fortive Corp / TPI Composites Inc / GDS Holdings Ltd / Inseego Corp / Qiagen NV / Switch Inc / Tapestry Inc / Evoqua Water Technologies Corp / Iovance Biotherapeutics Inc / Avaya Holdings Corp / Landis+Gyr Group AG / Veoneer Inc / Bloom Energy Corp / Mesa Air Group Inc / Elanco Animal Health Inc / Farfetch Ltd / Guardant Health Inc / Fuelcell Energy Inc / Personalis Inc / Cerence Inc / DarioHealth Corp / Vertiv Holdings Co / DraftKings Inc / Nikola Corp / Burning Rock Biotech Ltd / Array Technologies Inc / GDS Holdings Ltd / Lumen Technologies Inc / MYT Netherlands Parent BV / Shoals Technologies Group Inc / AppHarvest Inc / Arrival SA / TuSimple Holdings Inc / FTC Solar Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Luxembourg / Mexico / Netherlands / Panama / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Data Updates At ASCO ’21 Highlight Progress Of AMGN’s Innovative Pipeline</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Yaron Werber, M.D., MD / Gabriel Schneider, M.D. / Brendan Smith, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">FISV=US / MRK=US / LLY=US / PEP=US / AMGN=US / CAG=US / KO=US / CL=US / PG=US / T=US / INCY=US / GILD=US / ENR=US / MANH=US / NWL=US / FLO=US / STZ=US / PATH=US / ENV=US / CENT=US / CHD=US / COLL=US / EPC=US / HAIN=US / REGN=US / SMG=US / FOUR=US / POST=US / GPN=US / SNV=US / AUTL=US / MGNI=US / MGPI=US / BDSI=US / MNST=US / NOMD=US / BIIB=US / FRPT=US / DENN=US / THS=US / FIS=US / ELF=US / TIL=US / AAN=US / UTZ=US / OLO=US / MEIP=US / ABBV=US / FATE=US / COUP=US / SQ=US / NTLA=US / IOVA=US / PETQ=US / EQH=US / KDP=US / BTAI=US / HARP=US / LSPD=US / RPAY=US / BRBR=US / GMAB=US / REYN=US / ZI=US / BIGC=US / HYFM=US</td><td class="leftalignment">Fiserv Inc / Merck & Co Inc / Eli Lilly and Co / PepsiCo Inc / Amgen Inc / Conagra Brands Inc / Coca-Cola Co / Colgate-Palmolive Co / Procter & Gamble Co / AT&T Inc / Incyte Corp / Gilead Sciences Inc / Energizer Holdings Inc / Manhattan Associates Inc / Newell Brands Inc / Flowers Foods Inc / Constellation Brands Inc / UiPath Inc / Envestnet Inc / Central Garden & Pet Co / Church & Dwight Co Inc / Collegium Pharmaceutical Inc / Edgewell Personal Care Co / Hain Celestial Group Inc / Regeneron Pharmaceuticals Inc / Scotts Miracle-Gro Co / Shift4 Payments Inc / Post Holdings Inc / Global Payments Inc / Synovus Financial Corp / Autolus Therapeutics PLC / Magnite Inc / MGP Ingredients Inc / BioDelivery Sciences International Inc / Monster Beverage Corp / Nomad Foods Ltd / Biogen Inc / Freshpet Inc / Denny's Corp / TreeHouse Foods Inc / Fidelity National Information Services Inc / elf Beauty Inc / Instil Bio Inc / Aaron's Company Inc / UTZ Brands Inc / Olo Inc / MEI Pharma Inc / Abbvie Inc / Fate Therapeutics Inc / Coupa Software Inc / Block Inc / Intellia Therapeutics Inc / Iovance Biotherapeutics Inc / PetIQ Inc / Equitable Holdings Inc / Keurig Dr Pepper Inc / BioXcel Therapeutics Inc / Harpoon Therapeutics Inc / Lightspeed Commerce Inc / Repay Holdings Corp / Bellring Brands Inc / Genmab A/S / Reynolds Consumer Products Inc / ZoomInfo Technologies Inc / Bigcommerce Holdings Inc / Hydrofarm Holdings Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Denmark / United Kingdom / Luxembourg / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - June 7, 2021</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">US0311621009 / US25179M1036 / US3755581036 / US56418H1005 / US5949181045 / US6745991058 / US7703231032 / US92276F1003 / CA4530384086 / CA1247651088 / CA1363851017 / CA51925D1069 / CA13677F1018 / CA0636711016 / CA0641491075 / CA6330671034 / CA7800871021 / US0017441017 / US20825C1045 / US2274831047 / CA67072Q1046 / US79466L3024 / US0534841012 / US2538681030 / CA8911605092 / CA1360691010 / CA6993202069 / US8288061091 / US44107P1049 / CA0906971035 / US42809H1077 / US29472R1086 / US8666741041 / US74460D1090 / US4219461047 / US5021751020 / US63633D1046 / US89785X1019 / CA22576C1014 / CA15135U1093 / CA69946Q1046 / CA5527041084 / CA9237251058 / CA07317Q1054 / CA00208D4084 / CA2927661025 / CA7170461064 / CA4932711001 / CA89156V1067 / CA96467A2002 / US78573L1061 / CA3748252069 / US5764852050 / US23283R1005 / CA4882951060 / CA05577W2004 / US71943U1043 / US31189P1021 / CA7397211086 / US14174T1079 / US42225P5017 / US29444U7000 / US95040Q1040 / US37954A2042 / US43300A2033 / US05722G1004 / US00191U1025 / US15677J1088 / CA7241121077 / US73757R1023 / US42250P1030 / CA4220961078</td><td class="leftalignment">Amgen Inc / Devon Energy Corp / Gilead Sciences Inc / ManpowerGroup Inc / Microsoft Corp / Occidental Petroleum Corp / Robert Half International Inc / Ventas Inc / Imperial Oil Ltd / CAE Inc / Canadian Natural Resources Ltd / Laurentian Bank of Canada / Canadian Western Bank / Bank of Montreal / Bank of Nova Scotia / National Bank of Canada / Royal Bank of Canada / AMN Healthcare Services Inc / Conocophillips / Cross Country Healthcare Inc / Nuvista Energy Ltd / Salesforce.Com Inc / Avalonbay Communities Inc / Digital Realty Trust Inc / Toronto-Dominion Bank / Canadian Imperial Bank of Commerce / Paramount Resources Ltd / Simon Property Group Inc / Host Hotels & Resorts Inc / Birchcliff Energy Ltd / Hess Corp / Equity LifeStyle Properties Inc / Sun Communities Inc / Public Storage / Healthcare Realty Trust Inc / LTC Properties Inc / National Health Investors Inc / TrueBlue Inc / Crescent Point Energy Corp / Cenovus Energy Inc / Parex Resources Inc / MEG Energy Corp / Vermilion Energy Inc / Baytex Energy Corp / ARC Resources Ltd / Enerplus Corp / Peyto Exploration & Development Corp / Keyera Corp / Tourmaline Oil Corp / Whitecap Resources Inc / Sabra Health Care REIT Inc / Gibson Energy Inc / Matador Resources Co / CyrusOne Inc / Kelt Exploration Ltd / BRP Inc / Physicians Realty Trust / Fate Therapeutics Inc / Prairiesky Royalty Ltd / CareTrust REIT Inc / Healthcare Trust Of America Inc / Equinix Inc / Welltower Inc / Global Medical REIT Inc / Hilton Worldwide Holdings Inc / Baker Hughes Co / ASGN Inc / Ceridian HCM Holding Inc / Pipestone Energy Corp / Postal Realty Trust Inc / Healthpeak Properties Inc / Headwater Exploration Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">ASCO 2021: Key Takeaways for Diversified Biopharma</td><td class="leftalignment">English</td><td class="rightalignment">50</td><td class="leftalignment">03116210 / 37555810 / G3910J11 / 61776010 / F5548N10</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / MorphoSys AG / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">Germany / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Na Sun</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">5671735 / 0989529 / 2000019 / 2023607 / 2778844 / 2216850 / 2280220 / 2317087 / 2576941 / 2328915 / 2455965 / 2457864 / 2471950 / 2689560 / 2048804 / 2707677 / 2829601 / 2712013 / B1HMF22 / B03L311 / 2857817 / B125XQ6 / B1GKCH1 / B02R1L6 / B3D7K31 / B1XGNW4 / B0796X4 / B7TL820 / BCZS820 / BFDV8K0 / BBPK0J0 / B95N910 / BDZCRX3 / B424494 / B59DK93 / BFZCHN7 / BTN1Y11 / B6XZN93 / BXDZ9Z0 / BFZNYB7 / BD9GVY0 / BZBY005 / BFXCLC6 / BZ1LFB2 / BD8DJ71 / BQT3XY6 / BJLKVS6 / BYQNYR5 / BR4T3B3 / BMQ5T49 / BKVDFF7 / BLGJ610 / BFMXGR0 / BGSP7M9 / BYYWPW6 / BZ1LFG7 / BWY52P3 / BYY88Y7 / BL71K91 / BWY4XV3 / BN2R582 / BMDCDP2 / BGJRH57 / BYP0CD9 / BMDJ085 / BMDJ397 / BLP5YB5</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Amazon.com Inc / Amgen Inc / Merck & Co Inc / Consolidated Edison Inc / DTE Energy Co / Entergy Corp / Exelixis Inc / Nextera Energy Inc / Biogen Inc / ImmunoGen Inc / Incyte Corp / PG&E Corp / Pinnacle West Capital Corp / Public Service Enterprise Group Inc / Southern Co / Global Payments Inc / First Solar Inc / Ormat Technologies Inc / Netflix Inc / Portland General Electric Co / Canadian Solar Inc / ALLETE Inc / Discovery Inc / Insulet Corp / Dexcom Inc / Meta Platforms Inc / Fate Therapeutics Inc / MacroGenics Inc / Mirati Therapeutics Inc / PTC Inc / RingCentral Inc / Splunk Inc / SunPower Corp / Wix.Com Ltd / Medtronic PLC / Brookfield Renewable Partners LP / Shopify Inc / Allogene Therapeutics Inc / Zai Lab Ltd / Merus NV / Elastic NV / Deciphera Pharmaceuticals Inc / Snap Inc / Cyberark Software Ltd / Phathom Pharmaceuticals Inc / Senseonics Holdings Inc / HubSpot Inc / Zentalis Pharmaceuticals Inc / Oric Pharmaceuticals Inc / Warner Music Group Corp / Evergy Inc / Zoom Video Communications Inc / Beigene Ltd / Roku Inc / Blueprint Medicines Corp / Alphabet Inc / Revolution Medicines Inc / Adaptimmune Therapeutics PLC / Relay Therapeutics Inc / Bigcommerce Holdings Inc / Clearway Energy Inc / Avangrid Inc / Shoals Technologies Group Inc / Bolt Biotherapeutics Inc / Atlantica Sustainable Infrastructure PLC</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Cayman Islands / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - June 7, 2021</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AEP.N / AES.N / CL.N / CRM.N / DFDS.CO / EIX.N / EL.N / F.N / GM.N / IBE.MC / KMB.N / KO.N / MAS.N / MRK.N / NA / PD.N / PEG.N / SO.N / PEP.N / BFb.N / PG.N / CPB.N / AMGN.O / LEA.N / K.N / CLX.N / CAG.N / GIS.N / EPC.N / JAZZ.O / CONE.O / STZ.N / EXC.N / FISV.O / V.N / AWK.N / CHD.N / NWN.N / SAM.N / FRAG.DE / ENR.N / MHK.N / NCR.N / ENAG.MC / ENDP.O / CPK.N / ST.N / SWN.N / GPN.N / MNST.O / EQIX.O / 02209S103 / MNKD.OQ / DLR.N / 427866108 / BLDR.O / SJW.N / FIS.N / TEVA.N / BGS.N / GETP.PA / PHR.N / SPB.N / NEE.N / NXT.AX / PCRX.O / MDLZ.OQ / ABBV.N / TSLA.N / PRMW.N / COTY.N / DOOR.N / ESNT.N / SCWX.O / VST.N / APTV.N / SMAR.N / KDP.N / ESTC.N / NWL.O / ZM.O / CRNC.OQ / AZEK.N / WTRG.N / REYN.O / CARR.N / FOUR.N / ASAN.N / SUMO.O / VTRS.OQ / NAPA.N / PATH.N / DBM.TO / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Colgate-Palmolive Co / Salesforce.Com Inc / DFDS AS / Edison International / Estee Lauder Companies Inc / Ford Motor Co / General Motors Co / Iberdrola SA / Kimberly-Clark Corp / Coca-Cola Co / Masco Corp / Merck & Co Inc / National Bank of Canada / PagerDuty Inc / Public Service Enterprise Group Inc / Southern Co / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Campbell Soup Co / Amgen Inc / Lear Corp / Kellogg Co / Clorox Co / Conagra Brands Inc / General Mills Inc / Edgewell Personal Care Co / Jazz Pharmaceuticals PLC / CyrusOne Inc / Constellation Brands Inc / Exelon Corp / Fiserv Inc / Visa Inc / American Water Works Company Inc / Church & Dwight Co Inc / Northwest Natural Holding Co / Boston Beer Company Inc / Fraport AG Frankfurt Airport Services Worldwide / Energizer Holdings Inc / Mohawk Industries Inc / NCR Corp / Enagas SA / Endo International PLC / Chesapeake Utilities Corp / Sensata Technologies Holding PLC / Southwestern Energy Co / Global Payments Inc / Monster Beverage Corp / Equinix Inc / Altria Group Inc / MannKind Corp / Digital Realty Trust Inc / Hershey Co / Builders FirstSource Inc / SJW Group / Fidelity National Information Services Inc / Teva Pharmaceutical Industries Ltd / B&G Foods Inc / Getlink SE / Phreesia Inc / Spectrum Brands Holdings Inc / Nextera Energy Inc / NEXTDC Ltd / Pacira Biosciences Inc / Mondelez International Inc / Abbvie Inc / Tesla Inc / Primo Water Corp / Coty Inc / Masonite International Corp / Essent Group Ltd / SecureWorks Corp / Vistra Corp / Aptiv PLC / Smartsheet Inc / Keurig Dr Pepper Inc / Elastic NV / Newell Brands Inc / Zoom Video Communications Inc / Cerence Inc / Azek Company Inc / Essential Utilities Inc / Reynolds Consumer Products Inc / Carrier Global Corp / Shift4 Payments Inc / Asana Inc / Sumo Logic Inc / Viatris Inc / Duckhorn Portfolio Inc / UiPath Inc / Doman Building Materials Group Ltd / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Germany / Denmark / Spain / France / United Kingdom / Ireland / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">ASCO Presentations Provide Incremental Updates to Lumakras, Bemarituzumab, and AMG 757 Programs</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4151.T: 協和キリン - 業績予想上方修正、アムジェンとアトピー性皮膚炎治療薬KHK4083の共同開発・販売で提携</td><td class="leftalignment">Japanese</td><td class="rightalignment">10</td><td class="leftalignment">4151.T / AMGN.OQ</td><td class="leftalignment">Kyowa Kirin Co Ltd / Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4151.T: Kyowa Kirin - Raising our forecasts on tie-up with Amgen on atopic dermatitis treatment KHK4083</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AMGN.OQ / 4151.T</td><td class="leftalignment">Amgen Inc / Kyowa Kirin Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Weekly review and outlook (7 Jun-): Kyowa Kirin last week, Eisai this week</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">4151.T / 4503.T / 4523.T / 2593.T / 4502.T / 4507.T / 4519.T / 4528.T / 4543.T / BMY.N / 4516.T / 4506.T / 4536.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / AMGN.OQ / 2413.T / 4568.T / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">Kyowa Kirin Co Ltd / Astellas Pharma Inc / Eisai Co Ltd / Ito En Ltd / Takeda Pharmaceutical Co Ltd / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / Amgen Inc / M3 Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 週間レビューと見通し（6月7日～）: 先週は協和キリン、今週はエーザイ</td><td class="leftalignment">Japanese</td><td class="rightalignment">9</td><td class="leftalignment">2593.T / 4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / 4543.T / BMY.N / 4516.T / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / AMGN.OQ / 2413.T / 4568.T / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">Ito En Ltd / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / Amgen Inc / M3 Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare Sector - ASCO 2021: Key takeaway from weekend presentations (Part 1)</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">4502.T / BMY.N / MRK.N / AMGN.OQ / 600276.SS / ZLAB.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Merck & Co Inc / Amgen Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Zai Lab Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang</td></tr>
<tr class="odd"><td class="leftalignment">06/06/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">ASCO updates largely overshadowed by LUMAKRAS launch, which remains our focus</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Kennen MacKay, PHD / Michael Murray</td></tr>
<tr class="even"><td class="leftalignment">06/06/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">ASCO Update Provides Another First for Lumakras</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="odd"><td class="leftalignment">06/06/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">ASCO Takes: Psych! HPN424 Produces PSA Declines</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">HARP=US / AMGN=US / ABBV=US</td><td class="leftalignment">Harpoon Therapeutics Inc / Amgen Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Asthika Goonewardene / Avi Dahan</td></tr>
<tr class="even"><td class="leftalignment">06/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ASCO 2021 Takeaways - Incremental Updates in Our Coverage While Competitor Data Set the Stage for Upcoming News Flow</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">2023607 / 2576941 / 2457864 / 2471950 / BCZS820 / BFZNYB7 / BZ1LFB2 / BMQ5T49 / BKVDFF7 / BYYWPW6 / BWY52P3 / BL71K91 / BWY4XV3 / BN2R582 / BMDJ397</td><td class="leftalignment">Amgen Inc / Exelixis Inc / ImmunoGen Inc / Incyte Corp / Fate Therapeutics Inc / Allogene Therapeutics Inc / Deciphera Pharmaceuticals Inc / Zentalis Pharmaceuticals Inc / Oric Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Revolution Medicines Inc / Adaptimmune Therapeutics PLC / Relay Therapeutics Inc / Bolt Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">China / Cayman Islands / Germany / Denmark / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Etzer Darout / Yige Guo, Ph.D. / Kelsey Goodwin / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="odd"><td class="leftalignment">06/06/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">ASCO 2021: Incremental Updates Highlight Pipeline Opportunity</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Do G. Kim / Jameson Kao / Ikechukwu Oji</td></tr>
<tr class="even"><td class="leftalignment">06/04/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">HPN424 still escalating, but we see atttractive entry point into many 2H21 catalysts</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">HARP.OQ / US0311621009</td><td class="leftalignment">Harpoon Therapeutics Inc / Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Emma K. Nealon, III / Ms. Alethia R. Young</td></tr>
<tr class="odd"><td class="leftalignment">06/04/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Progress on various oncology assets for Amgen at ASCO; we view the updates as incrementally positive</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Emily Bodnar / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">06/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">AMGN ASCO Highlights: Lumakras mOS 12.5 months; sotorasib likely as combo for CRC</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AMGN=US</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">06/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">There Is More Work To Be Done With HPN424</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">HARP=US / AMGN=US</td><td class="leftalignment">Harpoon Therapeutics Inc / Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Asthika Goonewardene / Avi Dahan</td></tr>
<tr class="even"><td class="leftalignment">06/04/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">AMGN.OQ - Event Transcript of Amgen Inc conference call, Jun. 04, 2021 / 4:00PM ET</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/04/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 550</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">06/04/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">ASCO 2021 Generally Incremental for Our Covered Names</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">031162100 / 75886F107 / 24344T101 / 46565G104</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc / Deciphera Pharmaceuticals Inc / Iteos Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">06/04/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">MONDAY 6/7 @ 12 PM ET: Join Our Virtual KOL Conference Call to Discuss ASCO Highlights</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US0311621009 / US31189P1021 / US3755581036 / US75886F1075 / US74587V1070 / US03969F1093</td><td class="leftalignment">Amgen Inc / Fate Therapeutics Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Puma Biotechnology Inc / Arcus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Emily Bodnar / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">06/04/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--June 4, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ACA / AMN / CHE / CI / CNC / CVS / HUM / RAD / UNH / WMT / GILD.O / AMGN.O / HCA.N / CYH.N / COO.N / ICPT.OQ / UTHR.OQ / VRTX.OQ / CCRN.O / LIFE.O / AMED.O / BIIB.O / 478160104 / 00846U101 / 868168105 / DXCM.O / LHCG.O / ALCLS.PA / 02043Q107 / ENSG.OQ / TNDM.O / 483548103 / MRNA.O / TMDX.OQ / MD.N / 771195104 / ADUS.O / USPH.N / PRTA.OQ / TRVN.O / GOOGL.O / INO.O / VBLT.O / CATB.OQ / EVH.N / TDOC.N / 100063846 / IRTC.OQ / ATXI.OQ / 720795103 / ALLO.OQ / 21833P103 / BWAY.TA / ONCT.OQ / PSNL.O / NBSE.O / BXRX.OQ / ETNB.O / ORIC.OQ / HGEN.O / REGW.M3 / 03823M100</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Rite Aid Corp / UnitedHealth Group Inc / Walmart Inc / Gilead Sciences Inc / Amgen Inc / HCA Healthcare Inc / Community Health Systems Inc / Cooper Companies Inc / Intercept Pharmaceuticals Inc / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Cross Country Healthcare Inc / aTyr Pharma Inc / Amedisys Inc / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / Dexcom Inc / LHC Group Inc / Cellectis SA / Alnylam Pharmaceuticals Inc / Ensign Group Inc / Tandem Diabetes Care Inc / Kaman Corp / Moderna Inc / Transmedics Group Inc / MEDNAX Inc / Roche Holding AG / Addus Homecare Corp / US Physical Therapy Inc / Prothena Corporation PLC / Trevena Inc / Alphabet Inc / Inovio Pharmaceuticals Inc / Vascular Biogenics Ltd / Astria Therapeutics Inc / Evolent Health Inc / Teladoc Health Inc / Truist Financial Corp / iRhythm Technologies Inc / Avenue Therapeutics Inc / Pieris Pharmaceuticals Inc / Allogene Therapeutics Inc / Corbus Pharmaceuticals Holdings Inc / Brainsway Ltd / Oncternal Therapeutics Inc / Personalis Inc / NeuBase Therapeutics Inc / Baudax Bio Inc / 89Bio Inc / Oric Pharmaceuticals Inc / Humanigen Inc / Regency World Consulting Ltd / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / India / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="odd"><td class="leftalignment">06/04/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended May 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">06/04/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="odd"><td class="leftalignment">06/04/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">06/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">LSI=US / AMGN=US / MDT=US / AVB=US / PD=US / AMZN=US / PEB=US / H=US / MTN=US / VRM=US / MAR=US / SPOT=US / EXPE=US / TNL=US / ESS=US / HLT=US / EQR=US / WTFC=US / SWIM=US / AVGO=US / CHH=US / DRH=US / NTST=US / SNAP=US / TRIP=US / WIX=US / BKNG=US / ADC=US / CPT=US / EPR=US / FB=US / FRT=US / MAA=US / UDR=US / CRTO=US / DRE=US / BRX=US / PTON=US / APP=US / SHO=US / HST=US / SAIC=US / WH=US / IAC=US / EPRT=US / CLNY=US / HGV=US / NLSN=US / APTS=US / RLJ=US / VAC=US / CUBE=US / ANGI=US / RHP=US / FATE=US / GOOGL=US / BABA=US / CMPR=US / GDDY=US / NXRT=US / NSA=US / PK=US / ANAB=US / PLYA=US / CVNA=US / SFIX=US / FTDR=US / SVMK=US / LYFT=US / UBER=US / CRWD=US / AIRC=US / AVAH=US / VMEO=US</td><td class="leftalignment">Life Storage Inc / Amgen Inc / Medtronic PLC / Avalonbay Communities Inc / PagerDuty Inc / Amazon.com Inc / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Vail Resorts Inc / Vroom Inc / Marriott International Inc / Spotify Technology SA / Expedia Group Inc / Travel + Leisure Co / Essex Property Trust Inc / Hilton Worldwide Holdings Inc / Equity Residential / Wintrust Financial Corp / Latham Group Inc / Broadcom Inc / Choice Hotels International Inc / Diamondrock Hospitality Co / Netstreit Corp / Snap Inc / Tripadvisor Inc / Wix.Com Ltd / Booking Holdings Inc / Agree Realty Corp / Camden Property Trust / EPR Properties / Meta Platforms Inc / Federal Realty Investment Trust / Mid-America Apartment Communities Inc / UDR Inc / Criteo SA / Duke Realty Corp / Brixmor Property Group Inc / Peloton Interactive Inc / Applovin Corp / Sunstone Hotel Investors Inc / Host Hotels & Resorts Inc / Science Applications International Corp / Wyndham Hotels & Resorts Inc / IAC/Interactivecorp / Essential Properties Realty Trust Inc / DigitalBridge Group Inc / Hilton Grand Vacations Inc / Nielsen Holdings PLC / Preferred Apartment Communities Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / CubeSmart / Angi Inc / Ryman Hospitality Properties Inc / Fate Therapeutics Inc / Alphabet Inc / Alibaba Group Holding Ltd / Cimpress PLC / GoDaddy Inc / NexPoint Residential Trust Inc / National Storage Affiliates Trust / Park Hotels & Resorts Inc / AnaptysBio Inc / Playa Hotels & Resorts NV / Carvana Co / Stitch Fix Inc / Frontdoor Inc / Momentive Global Inc / Lyft Inc / Uber Technologies Inc / CrowdStrike Holdings Inc / Apartment Income REIT Corp / Aveanna Healthcare Holdings Inc / Vimeo Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / France / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/04/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US0311621009 / US1266501006 / US3755581036 / US4448591028 / US75886F1075 / US15135B1017 / US74587V1070 / US31189P1021 / US0367521038 / US03969F1093 / US1255231003 / US71944F1066</td><td class="leftalignment">Amgen Inc / CVS Health Corp / Gilead Sciences Inc / Humana Inc / Regeneron Pharmaceuticals Inc / Centene Corp / Puma Biotechnology Inc / Fate Therapeutics Inc / Anthem Inc / Arcus Biosciences Inc / Cigna Corp / Phreesia Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">06/04/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">0989529 / 2126335 / 2516152 / 2496113 / 2023607 / 2778844 / 2973821 / 2216850 / 2222631 / 2270726 / 2317087 / 2670519 / 2328915 / 2680905 / 2707677 / 2829601 / 7103065 / 2857817 / 2951452 / B0T7YX2 / B02R1L6 / B3D7K31 / B23FN39 / B7TL820 / B85KFY9 / B7JYSG3 / BBPK0J0 / BJ0KXV4 / B424494 / BYVY8G0 / BYW36M8 / BXDZ9Z0 / BKS3SM8 / BZ1HM42 / BFZ1K46 / BFMXGR0 / BJJMGL2 / BFWK4R7 / BL71K91 / BK71LY6 / BDRW1L7 / BKF9DQ8 / BNG3RZ7 / BMDJ085 / BMG5660 / BP8GHT2</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Kohls Corp / Amgen Inc / Merck & Co Inc / Alliant Energy Corp / Consolidated Edison Inc / Cooper Companies Inc / Walt Disney Co / Entergy Corp / Exelon Corp / Nextera Energy Inc / PPL Corp / Public Service Enterprise Group Inc / Southern Co / Novartis AG / Netflix Inc / J M Smucker Co / Live Nation Entertainment Inc / ALLETE Inc / Discovery Inc / Lululemon Athletica Inc / Meta Platforms Inc / Five Below Inc / Guidewire Software Inc / Mirati Therapeutics Inc / ONE Gas Inc / Splunk Inc / Alphabet Inc / PayPal Holdings Inc / Shopify Inc / IGM Biosciences Inc / Adyen NV / Spotify Technology SA / Evergy Inc / Fox Corp / PagSeguro Digital Ltd / Revolution Medicines Inc / WW International Inc / AnaptysBio Inc / Phreesia Inc / Leslie's Inc / Shoals Technologies Group Inc / Joann Inc / Vascular Biogenics Ltd</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">06/03/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">MRTX (NEUTRAL), AMGN (NEUTRAL) - Updating KRAS G12C Market Forecast & Valuation Post-Lumakras Approval</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">2023607 / BBPK0J0</td><td class="leftalignment">Amgen Inc / Mirati Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Yige Guo, Ph.D. / Kelsey Goodwin</td></tr>
<tr class="even"><td class="leftalignment">06/03/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Three in a Row: The Bleeding Continues</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">06/03/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">MONDAY 6/7 @ 12 PM ET: Join Our Virtual KOL Conference Call to Discuss ASCO Highlights</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US0311621009 / US31189P1021 / US3755581036 / US75886F1075 / US74587V1070 / US03969F1093</td><td class="leftalignment">Amgen Inc / Fate Therapeutics Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Puma Biotechnology Inc / Arcus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Emily Bodnar / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">06/03/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">AMGN.OQ - Event Transcript of Amgen Inc conference call, Jun. 03, 2021 / 1:30PM ET</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/03/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Competitor NDA filing in psoriasis could take some share from Otezla</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AMGN=US</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">06/03/2021</td><td class="leftalignment">Infinata</td><td class="leftalignment">Amgen, Inc. - Company Report</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Anguilla / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Infinata</td></tr>
<tr class="odd"><td class="leftalignment">06/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare Sector - New report: ASCO 2021 calendar-China biotech presentations to watch</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">1093.HK / BMY.N / JNJ.N / MRK.N / AZN.L / ROG.S / NOVN.S / AMGN.OQ / 600276.SS / 4568.T / MRTX.OQ / BGNE.OQ / ZLAB.OQ / 6160.HK / 1801.HK / 1877.HK / IMAB.OQ</td><td class="leftalignment">CSPC Pharmaceutical Group Ltd / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / AstraZeneca PLC / Roche Holding AG / Novartis AG / Amgen Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Daiichi Sankyo Co Ltd / Mirati Therapeutics Inc / Beigene Ltd / Zai Lab Ltd / Beigene Ltd / Innovent Biologics Inc / Shanghai Junshi Biosciences Co Ltd / I-Mab</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / United Kingdom / Hong Kong / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang</td></tr>
<tr class="even"><td class="leftalignment">06/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">China Healthcare Sector: ASCO 2021 calendar: China biotech presentations to watch</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">1093.HK / BMY.N / JNJ.N / MRK.N / AZN.L / ROG.S / NOVN.S / AMGN.OQ / 600276.SS / 4568.T / MRTX.OQ / BGNE.OQ / ZLAB.OQ / 6160.HK / 1801.HK / 1877.HK / IMAB.OQ</td><td class="leftalignment">CSPC Pharmaceutical Group Ltd / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / AstraZeneca PLC / Roche Holding AG / Novartis AG / Amgen Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Daiichi Sankyo Co Ltd / Mirati Therapeutics Inc / Beigene Ltd / Zai Lab Ltd / Beigene Ltd / Innovent Biologics Inc / Shanghai Junshi Biosciences Co Ltd / I-Mab</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / United Kingdom / Hong Kong / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang</td></tr>
<tr class="odd"><td class="leftalignment">06/02/2021</td><td class="leftalignment">Commerzbank Corporate Clients</td><td class="leftalignment">Morning Bite Flash</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">FR0000120578 / BE0003739530 / DE0006599905 / GB0009895292 / BE0003470755 / CH0010645932 / GB0009252882 / CH0012032113 / CH0012005267 / US0311621009 / US8835561023 / DE0007074007 / DE0007165631 / CH0013841017 / DE0005470405 / NL0000009827 / DE000WCH8881 / DE000SYM9999 / LU0775917882 / GB00BJFFLV09</td><td class="leftalignment">Sanofi SA / Ucb SA / Merck KGaA / AstraZeneca PLC / Solvay SA / Givaudan SA / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Amgen Inc / Thermo Fisher Scientific Inc / KWS SAAT SE & Co KgaA / Sartorius AG / Lonza Group AG / Lanxess AG / Koninklijke DSM NV / Wacker Chemie AG / Symrise AG / Grand City Properties SA / Croda International PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Switzerland / Germany / France / United Kingdom / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Herr. Ingo-Martin Schachel, CFA</td></tr>
<tr class="even"><td class="leftalignment">06/02/2021</td><td class="leftalignment">Commerzbank Corporate Clients</td><td class="leftalignment">Not running out of steam</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">DE0006599905 / FR0000120578 / BE0003739530 / GB0009895292 / BE0003470755 / CH0010645932 / GB0009252882 / CH0012032113 / CH0012005267 / US0311621009 / US8835561023 / DE0007165631 / CH0013841017 / DE0005470405 / NL0000009827 / DE000WCH8881 / DE000SYM9999 / GB00BJFFLV09</td><td class="leftalignment">Merck KGaA / Sanofi SA / Ucb SA / AstraZeneca PLC / Solvay SA / Givaudan SA / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Amgen Inc / Thermo Fisher Scientific Inc / Sartorius AG / Lonza Group AG / Lanxess AG / Koninklijke DSM NV / Wacker Chemie AG / Symrise AG / Croda International PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Switzerland / China / Germany / France / United Kingdom / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Herr Daniel Wendorff</td></tr>
<tr class="odd"><td class="leftalignment">06/02/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">AXP / COF / DFS / INTC.O / MS / MSFT.O / NPO / QCOM.O / T.N / 4716.T / GILD.O / AMGN.O / FIS / NVDA.O / SPOT.N / SQ / HEAR.O / LSCC.O / SMTC.O / FISV.O / GPN / AVGO.O / JKHY.OQ / ATVI.OQ / TTWO.OQ / UTHR.OQ / MRVL.OQ / VRTX.OQ / LIFE.O / BIIB.O / 92343V104 / 78442P106 / 36467W109 / 02043Q107 / MRNA.O / ZNGA.O / EA.O / AMBA.O / 82655M107 / G29183103 / INO.O / APPS.O / 63938C108 / CATB.OQ / PYPL.O / TMUS.OQ / TTD.OQ / IRTC.OQ / BILI.O / 21833P103 / ZM.OQ / ONCT.OQ / NBSE.O / SONM.O / REGW.M3 / HUYA.K / 03823M100</td><td class="leftalignment">American Express Co / Capital One Financial Corp / Discover Financial Services / Intel Corp / Morgan Stanley / Microsoft Corp / EnPro Industries Inc / Qualcomm Inc / AT&T Inc / Oracle Corp Japan / Gilead Sciences Inc / Amgen Inc / Fidelity National Information Services Inc / NVIDIA Corp / Spotify Technology SA / Block Inc / Turtle Beach Corp / Lattice Semiconductor Corp / Semtech Corp / Fiserv Inc / Global Payments Inc / Broadcom Inc / Jack Henry & Associates Inc / Activision Blizzard Inc / Take-Two Interactive Software Inc / United Therapeutics Corp / Marvell Technology Inc / Vertex Pharmaceuticals Inc / aTyr Pharma Inc / Biogen Inc / Verizon Communications Inc / SLM Corp / GameStop Corp / Alnylam Pharmaceuticals Inc / Moderna Inc / Zynga Inc / Electronic Arts Inc / Ambarella Inc / Sify Technologies Ltd / Eaton Corporation PLC / Inovio Pharmaceuticals Inc / Digital Turbine Inc / Navient Corp / Astria Therapeutics Inc / PayPal Holdings Inc / T-Mobile US Inc / Trade Desk Inc / iRhythm Technologies Inc / Bilibili Inc / Corbus Pharmaceuticals Holdings Inc / Zoom Video Communications Inc / Oncternal Therapeutics Inc / NeuBase Therapeutics Inc / Sonim Technologies Inc / Regency World Consulting Ltd / HUYA Inc / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / India / Ireland / Israel / Japan / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/02/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - June 2 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">US0028241000 / US0116591092 / US0311621009 / US0758871091 / US2371941053 / US3377381088 / US4663671091 / US48203R1041 / US5719032022 / US5801351017 / US7043261079 / US8552441094 / US9021041085 / US92343V1044 / US37940X1028 / US9884981013 / US4771431016 / US25754A2015 / US79466L3024 / US19239V3024 / US2090341072 / US00206R1023 / US31620M1062 / US1696561059 / US1717793095 / US92932M1018 / US01748X1028 / US87874R1005 / US88076W1036 / US92826C8394 / US4485791028 / US13100M5094 / US9100471096 / US95058W1009 / US30212P3038 / US8969452015 / US8725901040 / US04649U1025 / KYG037AX1015 / US8485771021 / US21240E1055 / US70432V1026 / JE00BLG2ZQ72 / CA0089118776 / CA76131D1033 / US8190471016 / US9741551033 / US70450Y1038 / US8522341036 / US89686D1054 / US43300A2033 / CA35805P1071 / US91325V1089 / US8760301072 / VGG273581030 / US09857L1089 / US46571Y1073 / KY30744W1070 / US05352A1007 / US76156B1070 / US18915M1071 / US89677Q1076 / US39813G1094 / US0090661010 / US73739W1045 / US55406W1036 / US35909R1086 / US5738741041 / US92719V1008</td><td class="leftalignment">Abbott Laboratories / Alaska Air Group Inc / Amgen Inc / Becton Dickinson and Co / Darden Restaurants Inc / Fiserv Inc / Jack in the Box Inc / Juniper Networks Inc / Marriott International Inc / McDonald's Corp / Paychex Inc / Starbucks Corp / II-VI Inc / Verizon Communications Inc / Global Payments Inc / Yum! Brands Inc / JetBlue Airways Corp / Domino's Pizza Inc / Salesforce.Com Inc / Cogent Communications Holdings Inc / Consolidated Communications Holdings Inc / AT&T Inc / Fidelity National Information Services Inc / Chipotle Mexican Grill Inc / Ciena Corp / WNS (Holdings) Ltd / Allegiant Travel Co / TechTarget Inc / Teradata Corp / Visa Inc / Hyatt Hotels Corp / Calix Inc / United Airlines Holdings Inc / Wendys Co / Expedia Group Inc / Tripadvisor Inc / T-Mobile US Inc / Asure Software Inc / Ambarella Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / Paycom Software Inc / Quotient Ltd / Air Canada / Restaurant Brands International Inc / Shake Shack Inc / Wingstop Inc / PayPal Holdings Inc / Block Inc / Trivago NV / Hilton Worldwide Holdings Inc / Freshii Inc / Uniti Group Inc / Tapestry Inc / Despegar.com Corp / Booking Holdings Inc / I3 Verticals Inc / Farfetch Ltd / Avantor Inc / Revolve Group Inc / Cloudflare Inc / Trip.com Group Ltd / Grid Dynamics Holdings Inc / Airbnb Inc / Poshmark Inc / MYT Netherlands Parent BV / Frontier Group Holdings Inc / Marvell Technology Inc / Vimeo Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Mexico / Netherlands / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">06/02/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / WEN=US / BLD=US / INCY=US / KMI=US / V=US / LOW=US / HSII=US / LEG=US / KFRC=US / VMC=US / MLM=US / KFY=US / AMN=US / SWIM=US / CBRL=US / DRI=US / GFF=US / IBP=US / MAN=US / MAS=US / MRCY=US / MHK=US / ASGN=US / REGI=US / RHI=US / SMG=US / SHOP=US / TRIP=US / CGEN=US / CCRN=US / PYPL=US / AVTR=US / CRTO=US / NFLX=US / DIN=US / PTON=US / RNG=US / TPX=US / EXP=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / NSP=US / CMG=US / REX=US / MA=US / PGTI=US / GPRE=US / AWI=US / OC=US / TAST=US / QSR=US / PRPL=US / KTOS=US / NXGN=US / JACK=US / TREX=US / FBHS=US / ABBV=US / TILE=US / NDLS=US / PTCT=US / CEQP=US / FATE=US / VCYT=US / 00770K202 / LOCO=US / SHAK=US / BWXT=US / WING=US / 100095108 / 82982L103 / IRTC=US / JELD=US / ROKU=US / SYNH=US / MAXR=US / BTAI=US / FERG=US / LHX=US / IMVT=US / ARQT=US / SPCE=US / FBRX=US / AZEK=US / AFRM=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Wendys Co / TopBuild Corp / Incyte Corp / Kinder Morgan Inc / Visa Inc / Lowe's Companies Inc / Heidrick & Struggles International Inc / Leggett & Platt Inc / Kforce Inc / Vulcan Materials Co / Martin Marietta Materials Inc / Korn Ferry / AMN Healthcare Services Inc / Latham Group Inc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Griffon Corp / Installed Building Products Inc / ManpowerGroup Inc / Masco Corp / Mercury Systems Inc / Mohawk Industries Inc / ASGN Inc / Renewable Energy Group Inc / Robert Half International Inc / Scotts Miracle-Gro Co / Shopify Inc / Tripadvisor Inc / Compugen Ltd / Cross Country Healthcare Inc / PayPal Holdings Inc / Avantor Inc / Criteo SA / Netflix Inc / Dine Brands Global Inc / Peloton Interactive Inc / RingCentral Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Insperity Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Mastercard Inc / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Kratos Defense and Security Solutions Inc / NextGen Healthcare Inc / Jack in the Box Inc / Trex Company Inc / Fortune Brands Home & Security Inc / Abbvie Inc / Interface Inc / Noodles & Co / PTC Therapeutics Inc / Crestwood Equity Partners LP / Fate Therapeutics Inc / Veracyte Inc / Aemetis Inc / El Pollo Loco Holdings Inc / Shake Shack Inc / BWX Technologies Inc / Wingstop Inc / Bank of America Corp / SiteOne Landscape Supply Inc / iRhythm Technologies Inc / JELD-WEN Holding Inc / Roku Inc / Syneos Health Inc / Maxar Technologies Inc / BioXcel Therapeutics Inc / Ferguson PLC / L3harris Technologies Inc / Immunovant Inc / Arcutis Biotherapeutics Inc / Virgin Galactic Holdings Inc / Forte Biosciences Inc / Azek Company Inc / Affirm Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / France / Israel / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/02/2021</td><td class="leftalignment">UniCredit Research</td><td class="leftalignment">Daily Credit Briefing</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">OMVV.VI / SHBA.ST / VOLVB.ST / AMGN.O / MRCG.DE / SWEDA.ST</td><td class="leftalignment">OMV AG / Svenska Handelsbanken AB / Volvo AB / Amgen Inc / Merck KGaA / Swedbank AB</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Austria / Germany / Israel / Sweden / United States</td><td class="leftalignment">Advertising / Aerospace / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Biotechnology / Broadcasting & Cable / Building & Building Materials / Conglomerates / Consumer / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Financial Services / Healthcare / Household Products / Industrial Materials / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Shipping & Shipbuilding / Tire & Rubber / Transportation / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION / MORNING COMMENTS / CREDIT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Research Digest</td><td class="leftalignment">Herr Christian Aust / Herr Sven Kreitmair, CFA / Frau Silke Stegemann / Herr. Franz Rudolf / Herr. Stefan Kolek / Herr Gianfranco Arcovito / Herr. Michael Teig</td></tr>
<tr class="odd"><td class="leftalignment">06/02/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - June 2, 2021</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">GB0007188757 / CA4509131088 / AU000000CIA2 / GB0000456144 / US0079031078 / US02553E1064 / US0311621009 / US0326541051 / US0351282068 / US1564311082 / US2017231034 / US22160K1051 / US2254471012 / US3647601083 / US38059T1060 / US4227041062 / US4581401001 / US5950171042 / US6516391066 / US6541061031 / US6556641008 / US6703461052 / US67066G1040 / US6821891057 / US7782961038 / US7802871084 / US8581191009 / US8725401090 / US8825081040 / US9170471026 / US9182041080 / US9839191015 / AU000000NCM7 / CA13321L1085 / CA8029121057 / CA6979001089 / CA8787422044 / CA0084741085 / CA0679011084 / US9129091081 / CA0641491075 / CA8765111064 / CA3359341052 / US35671D8570 / AU000000FMG4 / CA98462Y1007 / CA4969024047 / CA5503721063 / CA4436281022 / CA6445351068 / US9043111072 / CA95083R1001 / CA32076V1031 / CA2483561072 / GB00B1FW5029 / CA29258Y1034 / CA3499151080 / GB00B1XZS820 / CA14068G1046 / CA82835P1036 / US5500211090 / US90384S3031 / CA3518581051 / GB00B2QPKJ12 / US91912E1055 / US1921085049 / NL0009538784 / CA66510M2040 / JE00B4T3BW64 / US6936561009 / US7512121010 / CA54928Q1081 / AU000000EVN4 / US5017971046 / JE00B5TT1872 / CA78165J1057 / CA55903Q1046 / CA04364G1063 / CA7852461093 / CA07380N1042 / CA3807381049 / CA0805581091 / CA9323971023 / IE00B4Q5ZN47 / CA6752221037 / CA21750U1012 / CA80013R2063 / CA04016A1012 / CA11777Q2099 / CA38045Y1025 / CA89531J1093 / CA2210131058 / CA74139C1023 / US8486371045 / CA5054401073 / CA33812R1091 / CA05577W2004 / CA46579R1047 / CA65340P1062 / US1220171060 / CA68827L1013 / CA30606C1086 / BMG0750C1082 / CA5503711080 / CA74273V1067 / AU000000S320 / US1638511089 / CA0115321089 / US72703H1014 / CA8283631015 / CY0106002112 / AU000000NST8 / CA4991131083 / CA6882811046 / CA8910546032 / CA31730E1016 / CA89621C1059 / US0138721065 / CA49741E1007 / CA68634K1066 / GB00B67KBV28 / US75134P3038 / CA86816U1066 / US93627C1018 / US7045511000 / CA9628791027 / CY0103562118 / GB00BF3ZNS54 / CA7847301032 / US8760301072 / US8608971078 / LU1701428291 / CA2960061091 / US63845R1077 / CA8585221051 / US3843135084 / CA6568111067 / CA38119T8077 / CA13000C2058 / CA2849025093 / VGG1890L1076 / US63253R2013 / AU0000018236 / GB00BJT16S69 / CA57776F4050 / US76156B1070 / US88339P1012 / CA5625684025 / CA29446Y5020 / US70614W1009 / CA04302L1004 / AU0000004772 / CA92625W5072 / FR0013467479 / CA59124U6051 / US82575P1075 / CA3901437093 / CA36352H1001 / US03940R1077 / CA65532M2004 / US44862P1093 / CA9004352071 / US3680361090 / CA64782A1075 / CA65401N1078 / AU0000143729</td><td class="leftalignment">Rio Tinto PLC / IAMGOLD Corp / Champion Iron Ltd / Antofagasta PLC / Advanced Micro Devices Inc / American Eagle Outfitters Inc / Amgen Inc / Analog Devices Inc / AngloGold Ashanti Ltd / Century Aluminum Co / Commercial Metals Co / Costco Wholesale Corp / Wolfspeed Inc / Gap Inc / Gold Fields Ltd / Hecla Mining Co / Intel Corp / Microchip Technology Inc / Newmont Corporation / Nike Inc / Nordstrom Inc / Nucor Corp / NVIDIA Corp / ON Semiconductor Corp / Ross Stores Inc / Royal Gold Inc / Steel Dynamics Inc / TJX Companies Inc / Texas Instruments Inc / Urban Outfitters Inc / VF Corp / Xilinx Inc / Newcrest Mining Ltd / Cameco Corp / Saputo Inc / Pan American Silver Corp / Teck Resources Ltd / Agnico Eagle Mines Ltd / Barrick Gold Corp / United States Steel Corp / Bank of Nova Scotia / Taseko Mines Ltd / First Quantum Minerals Ltd / Freeport-McMoRan Inc / Fortescue Metals Group Ltd / Yamana Gold Inc / Kinross Gold Corp / Lundin Mining Corp / Hudbay Minerals Inc / New Gold Inc / Under Armour Inc / Wesdome Gold Mines Ltd / First Majestic Silver Corp / Denison Mines Corp / Hochschild Mining PLC / Endeavour Silver Corp / Fortuna Silver Mines Inc / Anglo American PLC / Capstone Mining Corp / Silvercorp Metals Inc / Lululemon Athletica Inc / Ulta Beauty Inc / Franco-Nevada Corp / Fresnillo PLC / Vale SA / Coeur Mining Inc / NXP Semiconductors NV / Northern Dynasty Minerals Ltd / Glencore PLC / PVH Corp / Ralph Lauren Corp / Lucara Diamond Corp / Evolution Mining Ltd / Bath & Body Works Inc / Centamin PLC / Rupert Resources Ltd / MAG Silver Corp / Ascot Resources Ltd / Sabina Gold & Silver Corp / Bear Creek Mining Corp / Gold Standard Ventures Corp / Belo Sun Mining Corp / Wallbridge Mining Company Ltd / Jazz Pharmaceuticals PLC / OceanaGold Corp / Copper Mountain Mining Corp / Sandstorm Gold Ltd / Argonaut Gold Inc / B2Gold Corp / GoGold Resources Inc / Trevali Mining Corp / Corvus Gold Inc / Pretium Resources Inc / Splunk Inc / Labrador Iron Ore Royalty Corp / Fission Uranium Corp / BRP Inc / Ivanhoe Mines Ltd / Nexgen Energy Ltd / Burlington Stores Inc / Osisko Gold Royalties Ltd / Falco Resources Ltd / Axalta Coating Systems Ltd / Lundin Gold Inc / Probe Metals Inc / South32 Ltd / Chemours Co / Alamos Gold Inc / Planet Fitness Inc / Silvercrest Metals Inc / Atalaya Mining PLC / Northern Star Resources Ltd / K92 Mining Inc / Osisko Mining Inc / Torex Gold Resources Inc / Filo Mining Corp / Trilogy Metals Inc / Alcoa Corp / Kirkland Lake Gold Ltd / Orla Mining Ltd / Central Asia Metals PLC / Ramaco Resources Inc / Superior Gold Inc / Warrior Met Coal Inc / Peabody Energy Corp / Wheaton Precious Metals Corp / Tharisa PLC / Venator Materials PLC / SSR Mining Inc / Tapestry Inc / Stitch Fix Inc / Nexa Resources SA / Ero Copper Corp / National Vision Holdings Inc / Stelco Holdings Inc / GrafTech International Ltd / North American Construction Group Ltd / Golden Star Resources Ltd / Calibre Mining Corp / Eldorado Gold Corp / Capri Holdings Ltd / NAK Kazatomprom AO / Nickel Mines Ltd / Tronox Holdings PLC / Maverix Metals Inc / Revolve Group Inc / RealReal Inc / Mandalay Resources Corp / Equinox Gold Corp / Peloton Interactive Inc / Artemis Gold Inc / Adriatic Metals PLC / Victoria Gold Corp / Constellium SE / Metalla Royalty & Streaming Ltd / Sibanye Stillwater Ltd / Great Bear Resources Ltd / Galiano Gold Inc / Arch Resources Inc / Nomad Royalty Company Ltd / Hycroft Mining Holding Corporation / Turquoise Hill Resources Ltd / Gatos Silver Inc / New Pacific Metals Corp / Nickel 28 Capital Corp / Sunrise Energy Metals Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Cayman Islands / Cyprus / France / United Kingdom / Ireland / Kazakhstan / Luxembourg / Netherlands / United States / Virgin Islands, British / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">06/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4151.T: 協和キリン - アムジェンとアトピー性皮膚炎治療薬KHK4083の共同開発・販売に関する契約を締結、ベストパートナーといえる選択</td><td class="leftalignment">Japanese</td><td class="rightalignment">8</td><td class="leftalignment">4151.T / AMGN.OQ</td><td class="leftalignment">Kyowa Kirin Co Ltd / Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">06/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4151.T: Kyowa Kirin - Signs agreement to jointly develop and market atopic dermatitis treatment KHK4083 with Amgen, best partners for each other</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AMGN.OQ / 4151.T</td><td class="leftalignment">Amgen Inc / Kyowa Kirin Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="even"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Post-1Q21 Biotech Review</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.O / AMGN.O / UTHR.OQ / VRTX.OQ / LIFE.O / BIIB.O / 02043Q107 / MRNA.O / INO.O / CATB.OQ / ONCT.OQ / NBSE.O / REGW.M3 / 03823M100</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / United Therapeutics Corp / Vertex Pharmaceuticals Inc / aTyr Pharma Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Moderna Inc / Inovio Pharmaceuticals Inc / Astria Therapeutics Inc / Oncternal Therapeutics Inc / NeuBase Therapeutics Inc / Regency World Consulting Ltd / Applied Minerals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / India / Israel / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim / Yichuan (Jackie Yan</td></tr>
<tr class="odd"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Laying foundation for Lumakras in oncology; atopic dermatitis collab could add upside</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AMGN=US</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Early Lumakras Approval Validates Unmet Need — OX40 Promising Target in AD</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Yaron Werber, M.D., MD / Gabriel Schneider, M.D. / Brendan Smith, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for AMGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">COST.O / EL.N / ELF / HELE.O / WMT / BYND.O / MWA / AMGN.O / CHD.N / LSTR.O / ULTA.O / FRPT.O / WEED.TO / LOVE.OQ / PRPL.O / GRWG.O</td><td class="leftalignment">Costco Wholesale Corp / Estee Lauder Companies Inc / elf Beauty Inc / Helen of Troy Ltd / Walmart Inc / Beyond Meat Inc / Mueller Water Products Inc / Amgen Inc / Church & Dwight Co Inc / Landstar System Inc / Ulta Beauty Inc / Freshpet Inc / Canopy Growth Corp / Lovesac Co / Purple Innovation Inc / GrowGeneration Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/01/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Amgen Inc : Amgen Ready to KRASh the Lung Cancer Market... and Now Perhaps Atopic Derm Too</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott</td></tr>
<tr class="even"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Rapid Approval Increases First Mover Advantage</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="odd"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">AMGN - AMGN: Conference call highlights on Lumakras approval and KHK4083 collaboration</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">031162100</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">06/01/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">my takeaways on KRAS label and OX40 in atopic derm</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="odd"><td class="leftalignment">06/01/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">KHK4083 Deal Brings Another Phase 3 Ready Asset With Lumakras Launch Ongoing</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Do G. Kim / Jameson Kao / Ikechukwu Oji</td></tr>
<tr class="even"><td class="leftalignment">06/01/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Lumakras Approval Comes Early; OX40 Antibody Deal Expands Immunology Franchise but How Competitive Is the Mechanism</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="odd"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending May 21, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">06/01/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended May 21, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Tracking the JAKs</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / BMY=US / INCY=US / ABBV=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Abbvie Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">AMGN.OQ - Event Brief of Amgen Inc conference call, Jun. 01, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">AMGN.OQ - Event Transcript of Amgen Inc conference call, Jun. 01, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AMGN=US / OXY=US / RRC=US / GBT=US / DVN=US / PEB=US / APA=US / CPE=US / EOG=US / REI=US / H=US / MTN=US / XOM=US / CRK=US / WLL=US / PXD=US / MGY=US / SWN=US / MUR=US / MAR=US / MRO=US / TTWO=US / TNL=US / ATVI=US / HLT=US / CHH=US / COLL=US / CNX=US / DRH=US / EQT=US / DOC=US / RARE=US / VRTX=US / CVX=US / SAGE=US / KRT=US / NHI=US / OHI=US / COP=US / BDSI=US / MRNS=US / BIIB=US / APTX=US / SHO=US / MPW=US / HST=US / CPRX=US / CLR=US / WH=US / NOG=US / HTA=US / AR=US / OAS=US / HGV=US / SBRA=US / RLJ=US / ESTE=US / VAC=US / ZNGA=US / BCEI=US / EA=US / MTDR=US / PDCE=US / RHP=US / FANG=US / VEEV=US / CNCE=US / VNOM=US / RLMD=US / VKTX=US / CHCT=US / ARGX=US / WVE=US / AXSM=US / EDIT=US / NTLA=US / ADVM=US / CDEV=US / CRSP=US / PK=US / PVAC=US / ANAB=US / PLYA=US / VRNA=US / SBOW=US / ARVN=US / RTLR=US / OVV=US / CRMD.US / ABNB=US / RBLX=US / REPX=US</td><td class="leftalignment">Amgen Inc / Occidental Petroleum Corp / Range Resources Corp / Global Blood Therapeutics Inc / Devon Energy Corp / Pebblebrook Hotel Trust / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Hyatt Hotels Corp / Vail Resorts Inc / Exxon Mobil Corp / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / Marriott International Inc / Marathon Oil Corp / Take-Two Interactive Software Inc / Travel + Leisure Co / Activision Blizzard Inc / Hilton Worldwide Holdings Inc / Choice Hotels International Inc / Collegium Pharmaceutical Inc / CNX Resources Corp / Diamondrock Hospitality Co / EQT Corp / Physicians Realty Trust / Ultragenyx Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Chevron Corp / SAGE Therapeutics Inc / Karat Packaging Inc / National Health Investors Inc / Omega Healthcare Investors Inc / Conocophillips / BioDelivery Sciences International Inc / Marinus Pharmaceuticals Inc / Biogen Inc / Aptinyx Inc / Sunstone Hotel Investors Inc / Medical Properties Trust Inc / Host Hotels & Resorts Inc / Catalyst Pharmaceuticals Inc / Continental Resources Inc / Wyndham Hotels & Resorts Inc / Northern Oil and Gas Inc / Healthcare Trust Of America Inc / Antero Resources Corp / Oasis Petroleum Inc / Hilton Grand Vacations Inc / Sabra Health Care REIT Inc / RLJ Lodging Trust / Earthstone Energy Inc / Marriott Vacations Worldwide Corp / Zynga Inc / Civitas Resources Inc / Electronic Arts Inc / Matador Resources Co / PDC Energy Inc / Ryman Hospitality Properties Inc / Diamondback Energy Inc / Veeva Systems Inc / Concert Pharmaceuticals Inc / Viper Energy Partners LP / Relmada Therapeutics Inc / Viking Therapeutics Inc / Community Healthcare Trust Inc / argenx SE / WAVE Life Sciences Ltd / Axsome Therapeutics Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / Centennial Resource Development Inc / CRISPR Therapeutics AG / Park Hotels & Resorts Inc / Ranger Oil Corp / AnaptysBio Inc / Playa Hotels & Resorts NV / Verona Pharma PLC / SilverBow Resources Inc / Arvinas Inc / Rattler Midstream LP / Ovintiv Inc / CorMedix Inc / Airbnb Inc / Roblox Corp / Riley Exploration Permian Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / Netherlands / Singapore / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">2360326 / 2000019 / 2023607 / 2973821 / 2065159 / 2270726 / 2542049 / 2272476 / 2317087 / 2670519 / 2100920 / 2457864 / 2630085 / 2707677 / 2746711 / 2829601 / 2989301 / 2857817 / B02R1L6 / B3D7K31 / 2598246 / BF311Y5 / BFDV8K0 / BBPK0J0 / BFLR866 / BFH3N85 / BYW36M8 / BXDZ9Z0 / BFZNYB7 / BFMXGR0 / BFNR303 / BGSP7M9 / BYY88Y7 / BM8MM05 / BYQCZ35 / BMDCDP2 / BMDJ085 / BMGGJK8 / BN2S6Y8 / BMF1LH5</td><td class="leftalignment">Gap Inc / Amazon.com Inc / Amgen Inc / Alliant Energy Corp / Autodesk Inc / Walt Disney Co / Dominion Energy Inc / Dollar Tree Inc / Entergy Corp / Exelon Corp / FirstEnergy Corp / ImmunoGen Inc / Neogen Corp / Public Service Enterprise Group Inc / Ross Stores Inc / Southern Co / TJX Companies Inc / Netflix Inc / ALLETE Inc / Discovery Inc / Neogenomics Inc / Burlington Stores Inc / MacroGenics Inc / Mirati Therapeutics Inc / Twitter Inc / Veeva Systems Inc / PayPal Holdings Inc / Shopify Inc / Allogene Therapeutics Inc / Evergy Inc / Northwest Natural Holding Co / Zoom Video Communications Inc / Alphabet Inc / Madison Square Garden Entertainment Corp / Madison Square Garden Sports Corp / Bigcommerce Holdings Inc / Shoals Technologies Group Inc / Valneva SE / Talaris Therapeutics Inc / Honest Company Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">06/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - June 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">AEP.N / AES.N / AKER.OL / BMO.TO / CAS.TO / CL.N / CM.TO / CRM.N / EDP.LS / EIX.N / EL.N / ELE.MC / IBE.MC / IP.N / KMB.N / KO.N / MRK.N / NA.TO / PD.N / PEG.N / PFE.N / RYN.N / SO.N / STO.AX / T.N / T.TO / TD.TO / PEP.N / DRE.N / FR.N / TRI.N / BFb.N / PG.N / WY.N / CFP.TO / CNQ.TO / GILD.O / CPB.N / LPX.N / CMCSA.O / AMGN.O / INCY.O / AAL.L / DUK.N / TRP.TO / K.N / DT.N / ADBE.O / SU.TO / CLX.N / CAG.N / DV.N / GIS.N / EPC.N / MGA.N / AMT.N / JAZZ.O / CONE.O / VZ.N / HCA.N / STZ.N / EXC.N / FISV.O / EQT.N / ADSK.O / EPD.N / AWK.N / EGP.N / PLD.N / NBIX.O / CHD.N / NWN.N / WSP.TO / SAM.N / ENR.N / VRTX.O / JHX.AX / CEY.L / NCR.N / VRNT.O / COP.N / CNP.N / WCN.N / CPK.N / DOL.TO / TYL.N / CRC.N / LNG.A / NTCT.OQ / GPN.N / MNST.O / EFX.TO / CCLb.TO / CASY.O / PCTY.O / ICPT.O / EQIX.O / ATDb.TO / BIIB.O / TIH.TO / 02209S103 / NTR.N / DLR.N / SCL.TO / ACAD.O / 427866108 / WEF.TO / RDSb.L / BAM.N / SJW.N / DRX.L / FIS.N / CSU.TO / MERC.O / 3IN.L / BGS.N / PPL.TO / HOCM.L / ARX.TO / UTL.N / CLW.N / VALE.N / IFC.TO / CVE.TO / ADN.TO / SPB.N / NEE.N / TOU.TO / NXT.AX / PCH.O / CFX.TO / FRU.TO / SXY.AX / CTT.N / STAG.N / IFP.TO / PXT.TO / POLYP.L / EFN.TO / SPLK.OQ / RFP.N / SRPT.O / PANW.N / MDLZ.OQ / ABBV.N / KPT.TO / PRMW.N / TMUS.N / COTY.N / PRTA.O / BEP.N / 81762P102 / CFF.TO / COUP.N / VRNS.O / QTWO.N / RYAM.N / HUBS.N / QSR.N / CAR.AX / 78667J108 / EVA.N / GLPG.O / WRK.N / IONS.O / NTNX.O / GDS.O / AQN.N / OKTA.OQ / WPM.N / ZS.OQ / SMAR.N / VRCA.OQ / ITRM.O / NTGY.MC / KDP.N / ESTC.N / NWL.O / ZM.O / MORF.OQ / CRWD.O / PING.N / FCR_u.TO / REYN.O / GFL.N / FOUR.N / ZI.O / AKES.OL / PLTR.N / ASAN.N / WFG.N / AFRM.O / TEEC.L / NAPA.N / PATH.N / AVAH.OQ / GIP.V / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Aker ASA / Bank of Montreal / Cascades Inc / Colgate-Palmolive Co / Canadian Imperial Bank of Commerce / Salesforce.Com Inc / EDP Energias de Portugal SA / Edison International / Estee Lauder Companies Inc / Endesa SA / Iberdrola SA / International Paper Co / Kimberly-Clark Corp / Coca-Cola Co / Merck & Co Inc / National Bank of Canada / PagerDuty Inc / Public Service Enterprise Group Inc / Pfizer Inc / Rayonier Inc / Southern Co / Santos Ltd / AT&T Inc / Telus Corp / Toronto-Dominion Bank / PepsiCo Inc / Duke Realty Corp / First Industrial Realty Trust Inc / Thomson Reuters Corp / Brown-Forman Corp / Procter & Gamble Co / Weyerhaeuser Co / Canfor Corp / Canadian Natural Resources Ltd / Gilead Sciences Inc / Campbell Soup Co / Louisiana-Pacific Corp / Comcast Corp / Amgen Inc / Incyte Corp / Anglo American PLC / Duke Energy Corp / TC Energy Corp / Kellogg Co / Dynatrace Inc / Adobe Inc / Suncor Energy Inc / Clorox Co / Conagra Brands Inc / DoubleVerify Holdings Inc / General Mills Inc / Edgewell Personal Care Co / Magna International Inc / American Tower Corp / Jazz Pharmaceuticals PLC / CyrusOne Inc / Verizon Communications Inc / HCA Healthcare Inc / Constellation Brands Inc / Exelon Corp / Fiserv Inc / EQT Corp / Autodesk Inc / Enterprise Products Partners LP / American Water Works Company Inc / Eastgroup Properties Inc / Prologis Inc / Neurocrine Biosciences Inc / Church & Dwight Co Inc / Northwest Natural Holding Co / WSP Global Inc / Boston Beer Company Inc / Energizer Holdings Inc / Vertex Pharmaceuticals Inc / James Hardie Industries PLC / Centamin PLC / NCR Corp / Verint Systems Inc / Conocophillips / CenterPoint Energy Inc / Waste Connections Inc / Chesapeake Utilities Corp / Dollarama Inc / Tyler Technologies Inc / California Resources Corp / Cheniere Energy Inc / Netscout Systems Inc / Global Payments Inc / Monster Beverage Corp / Enerflex Ltd / CCL Industries Inc / Caseys General Stores Inc / Paylocity Holding Corp / Intercept Pharmaceuticals Inc / Equinix Inc / Alimentation Couche-Tard Inc / Biogen Inc / Toromont Industries Ltd / Altria Group Inc / Nutrien Ltd / Digital Realty Trust Inc / Shawcor Ltd / ACADIA Pharmaceuticals Inc / Hershey Co / Western Forest Products Inc / Royal Dutch Shell PLC / Brookfield Asset Management Inc / SJW Group / Drax Group PLC / Fidelity National Information Services Inc / Constellation Software Inc / Mercer International Inc / 3I Infrastructure PLC / B&G Foods Inc / Pembina Pipeline Corp / Hochschild Mining PLC / ARC Resources Ltd / Unitil Corp / Clearwater Paper Corp / Vale SA / Intact Financial Corp / Cenovus Energy Inc / Acadian Timber Corp / Spectrum Brands Holdings Inc / Nextera Energy Inc / Tourmaline Oil Corp / NEXTDC Ltd / Potlatchdeltic Corp / Canfor Pulp Products Inc / Freehold Royalties Ltd / Senex Energy Ltd / CatchMark Timber Trust Inc / STAG Industrial Inc / Interfor Corp / Parex Resources Inc / Polymetal International PLC / Element Fleet Management Corp / Splunk Inc / Resolute Forest Products Inc / Sarepta Therapeutics Inc / Palo Alto Networks Inc / Mondelez International Inc / Abbvie Inc / KP Tissue Inc / Primo Water Corp / T-Mobile US Inc / Coty Inc / Prothena Corporation PLC / Brookfield Renewable Partners LP / ServiceNow Inc / Conifex Timber Inc / Coupa Software Inc / Varonis Systems Inc / Q2 Holdings Inc / Rayonier Advanced Materials Inc / HubSpot Inc / Restaurant Brands International Inc / Carsales.Com Ltd / SAGE Therapeutics Inc / Enviva Inc / Galapagos NV / Westrock Co / Ionis Pharmaceuticals Inc / Nutanix Inc / GDS Holdings Ltd / Algonquin Power & Utilities Corp / Okta Inc / Wheaton Precious Metals Corp / Zscaler Inc / Smartsheet Inc / Verrica Pharmaceuticals Inc / Iterum Therapeutics PLC / Naturgy Energy Group SA / Keurig Dr Pepper Inc / Elastic NV / Newell Brands Inc / Zoom Video Communications Inc / Morphic Holding Inc / CrowdStrike Holdings Inc / Ping Identity Holding Corp / First Capital Real Estate Investment Trust / Reynolds Consumer Products Inc / GFL Environmental Inc / Shift4 Payments Inc / ZoomInfo Technologies Inc / Aker Solutions ASA / Palantir Technologies Inc / Asana Inc / West Fraser Timber Co Ltd / Affirm Holdings Inc / Triple Point Energy Efficiency Infrastructure Company Plc / Duckhorn Portfolio Inc / UiPath Inc / Aveanna Healthcare Holdings Inc / Green Impact Partners Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Brazil / Canada / Cayman Islands / Spain / United Kingdom / Ireland / Netherlands / Norway / Portugal / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">05/31/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">AMGN (NEUTRAL) - Lumakras Approved ~3 Months Ahead of PDUFA as Expected; KRAS G12C Combinations and Longer Term Potential Key Investor Debate</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2023607</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Yige Guo, Ph.D. / Kelsey Goodwin</td></tr>
<tr class="even"><td class="leftalignment">05/31/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">AMGN's Lumakras Approved Early, Though Hepatotox May Be Achilles Heel</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AMGN.OQ / 60468T10 / 03116210 / MRTX.OQ</td><td class="leftalignment">Amgen Inc / Mirati Therapeutics Inc / Amgen Inc / Mirati Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Andrew Berens, M.D. / Christopher Liu, Pharm.D.</td></tr>
<tr class="odd"><td class="leftalignment">05/31/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - May 31, 2021</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">US0311621009 / US0936711052 / CA5592224011 / CA13677F1018 / CA6330671034 / US2283681060 / US0534841012 / US29476L1070 / US2971781057 / US1331311027 / CA95083R1001 / US59522J1034 / US9026531049 / US61775R1059 / US03750L1098</td><td class="leftalignment">Amgen Inc / H & R Block Inc / Magna International Inc / Canadian Western Bank / National Bank of Canada / Crown Holdings Inc / Avalonbay Communities Inc / Equity Residential / Essex Property Trust Inc / Camden Property Trust / Wesdome Gold Mines Ltd / Mid-America Apartment Communities Inc / UDR Inc / Morphic Holding Inc / Apartment Income REIT Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">05/29/2021</td><td class="leftalignment">Probes Reporter</td><td class="leftalignment">Watch List: 82 US Companies with Undisclosed SEC Probes</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">T.N / AEP.N / BAC.N / CL.N / COF.N / CRM.N / F.N / HLT.N / MDT.N / PNC.N / SLB.N / BEN.N / PG.N / THC.N / REV.N / ADM.N / VLO.N / UPS.N / KR.N / XOM.N / NKE.N / SNN.N / AMP.N / MTZ.N / ARW.N / ATO.N / TWTR.N / TUP.N / OMI.N / CVX.N / TDY.N / AMGN.OQ / CSCO.OQ / GNTX.OQ / MGPI.OQ / REGN.OQ / ROL.N / SEIC.OQ / RARE.OQ / MNRO.OQ / CAKE.OQ / GILD.OQ / COST.OQ / NKTR.OQ / AZPN.OQ / MYGN.OQ / SSNC.OQ / CTXS.OQ / AMZN.OQ / NVDA.OQ / CHTR.OQ / TNP.N / NFLX.OQ / EGBN.OQ / CVGI.OQ / RUSHA.OQ / NDAQ.OQ / MA.N / SIX.N / AON.N / BX.N / INO.OQ / BGCP.OQ / UTL.N / SCHW.N / MSI.N / MPC.N / GRPN.OQ / FB.OQ / COTY.N / CTG.OQ / ANTM.N / NTRA.OQ / PYPL.OQ / PFX.N / 100088979 / MFIN.OQ / DXC.N / IQV.N / WELL.N / TLRY.OQ / US29350E1047 / LYFT.O</td><td class="leftalignment">AT&T Inc / American Electric Power Company Inc / Bank of America Corp / Colgate-Palmolive Co / Capital One Financial Corp / Salesforce.Com Inc / Ford Motor Co / Hilton Worldwide Holdings Inc / Medtronic PLC / PNC Financial Services Group Inc / Schlumberger NV / Franklin Resources Inc / Procter & Gamble Co / Tenet Healthcare Corp / Revlon Inc / Archer-Daniels-Midland Co / Valero Energy Corp / United Parcel Service Inc / Kroger Co / Exxon Mobil Corp / Nike Inc / Smith & Nephew PLC / Ameriprise Financial Inc / MasTec Inc / Arrow Electronics Inc / Atmos Energy Corp / Twitter Inc / Tupperware Brands Corp / Owens & Minor Inc / Chevron Corp / Teledyne Technologies Inc / Amgen Inc / Cisco Systems Inc / Gentex Corp / MGP Ingredients Inc / Regeneron Pharmaceuticals Inc / Rollins Inc / SEI Investments Co / Ultragenyx Pharmaceutical Inc / Monro Inc / Cheesecake Factory Inc / Gilead Sciences Inc / Costco Wholesale Corp / Nektar Therapeutics / Aspen Technology Inc / Myriad Genetics Inc / SS&C Technologies Holdings Inc / Citrix Systems Inc / Amazon.com Inc / NVIDIA Corp / Charter Communications Inc / Tsakos Energy Navigation Ltd / Netflix Inc / Eagle Bancorp Inc / Commercial Vehicle Group Inc / Rush Enterprises Inc / Nasdaq Inc / Mastercard Inc / Six Flags Entertainment Corp / Aon PLC / Blackstone Inc / Inovio Pharmaceuticals Inc / BGC Partners Inc / Unitil Corp / Charles Schwab Corp / Motorola Solutions Inc / Marathon Petroleum Corp / Groupon Inc / Meta Platforms Inc / Coty Inc / Computer Task Group Inc / Anthem Inc / Natera Inc / PayPal Holdings Inc / PhenixFIN Corp / Huntington Bancshares Inc / Medallion Financial Corp / DXC Technology Co / IQVIA Holdings Inc / Welltower Inc / Tilray Brands Inc / Enochian Biosciences Inc / Lyft Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / United Kingdom / Greece / Ireland / United States / Curaçao</td><td class="leftalignment">Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Consumer / Defense / Electronics / Engineering & Construction / Financial Services / Healthcare / Household Products / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Services / Technology / Telecommunications / Transportation / Utilities / Wholesale / Oil & Gas</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">05/28/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Amgen Inc : FDA Grilling Up Some Good KRAS News... Lumakras Approved as Expected</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott</td></tr>
<tr class="even"><td class="leftalignment">05/28/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">KRAS Gets Drugged with Lumakras Approval -- Early, Broad Label Offers Upside</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">03116210</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun</td></tr>
<tr class="odd"><td class="leftalignment">05/28/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">LUMAKRAS gets early FDA approval as first KRAS G12C inhibitor</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Kennen MacKay, PHD / Michael Murray</td></tr>
<tr class="even"><td class="leftalignment">05/28/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Lumakras Receives Early NSCLC Approval</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Do G. Kim / Jameson Kao / Ikechukwu Oji</td></tr>
<tr class="odd"><td class="leftalignment">05/28/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Early FDA Approval for LUMAKRAS (sotorasib) in NSCLC; a First Win for KRAS Mutations</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Emily Bodnar / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">05/28/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Lumakras Approved Early - Label As Expected But Price a Bit Lower Than Thought</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">031162100</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">05/28/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Lumakras approved; could be a key growth driver longer-term</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AMGN=US</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">05/28/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 549</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">05/28/2021</td><td class="leftalignment">Argus Research Corporation</td><td class="leftalignment">Argus Analyst Report, AMGN</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AMGN</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / COMPANY UPDATE / COMPANY REPORT / ESTIMATE CHANGES</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David H. Toung</td></tr>
<tr class="even"><td class="leftalignment">05/28/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Amgen Inc.(AMGN) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">031162100</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">05/28/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="even"><td class="leftalignment">05/28/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto</td></tr>
<tr class="odd"><td class="leftalignment">05/28/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">V / 2434209 / 2681511 / 2094670 / 2023607 / 2973821 / 2065159 / 2206657 / 2270726 / 2657802 / 2689560 / 2680905 / 2048804 / 2707677 / 2829601 / B121557 / B125XQ6 / B02R1L6 / B28TS42 / B5B1S13 / B7TL820 / BFLR866 / BFH3N85 / BTN1Y11 / BYNZGK1 / BFZNYB7 / BJFSR88 / BFMXGR0 / BDFZSP1 / BD6D4Y5 / BYQCZ35 / BMDJ085</td><td class="leftalignment">Visa Inc / Home Depot Inc / PepsiCo Inc / Best Buy Co Inc / Amgen Inc / Alliant Energy Corp / Autodesk Inc / Coca-Cola Co / Walt Disney Co / OGE Energy Corp / PG&E Corp / PPL Corp / Pinnacle West Capital Corp / Public Service Enterprise Group Inc / Southern Co / Mastercard Inc / Portland General Electric Co / ALLETE Inc / Ulta Beauty Inc / Dollar General Corp / Meta Platforms Inc / Twitter Inc / Veeva Systems Inc / Medtronic PLC / Block Inc / Allogene Therapeutics Inc / Uniqure NV / Evergy Inc / Okta Inc / Altair Engineering Inc / Madison Square Garden Sports Corp / Shoals Technologies Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">05/27/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Outflows Continue</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">05/27/2021</td><td class="leftalignment">Probes Reporter</td><td class="leftalignment">Amgen – SEC Investigation Update</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">FIXED INCOME - CORPORATES</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Gavin</td></tr>
<tr class="even"><td class="leftalignment">05/27/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AMGN=US / DIS=US / MCD=US / AGL=US / AMZN=US / T=US / GILD=US / NVDA=US / PEB=US / H=US / MTN=US / VRM=US / SCOR=US / EWBC=US / BRO=US / MAR=US / UMPQ=US / TNL=US / HLT=US / WTFC=US / CHH=US / CW=US / DRH=US / DCO=US / AJG=US / MCRI=US / PACW=US / HOOK=US / REGN=US / WAL=US / HTH=US / SNOW=US / CGEN=US / BXS=US / FNF=US / CFB=US / SNV=US / ZION=US / SIVB=US / ABCB=US / BOKF=US / FBK=US / ASB=US / SSB=US / WRE=US / CATY=US / GBCI=US / REG=US / NFLX=US / ECPG=US / PNFP=US / SBCF=US / PRAA=US / STRO=US / BIIB=US / FNB=US / FHN=US / SHO=US / RNST=US / REX=US / HST=US / ELF=US / CADE=US / TAST=US / QSR=US / NMTR=US / WH=US / RCUS=US / HGV=US / NLSN=US / PCRX=US / RLJ=US / VAC=US / MEIP=US / RHP=US / ABBV=US / IBTX=US / FATE=US / NMIH=US / EVH=US / ACBI=US / PK=US / LGF.B=US / PLYA=US / OKTA=US / CVNA=US / ROKU=US / HWC=US / BTAI=US / OZK=US / ALLO=US / HARP=US / PLMR=US / HCAT=US / AVAH=US</td><td class="leftalignment">Amgen Inc / Walt Disney Co / McDonald's Corp / agilon health Inc / Amazon.com Inc / AT&T Inc / Gilead Sciences Inc / NVIDIA Corp / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Vail Resorts Inc / Vroom Inc / Comscore Inc / East West Bancorp Inc / Brown & Brown Inc / Marriott International Inc / Umpqua Holdings Corp / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Wintrust Financial Corp / Choice Hotels International Inc / Curtiss-Wright Corp / Diamondrock Hospitality Co / Ducommun Inc / Arthur J Gallagher & Co / Monarch Casino & Resort Inc / PacWest Bancorp / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Western Alliance Bancorp / Hilltop Holdings Inc / Snowflake Inc. / Compugen Ltd / Cadence Bank / Fidelity National Financial Inc / Crossfirst Bankshares Inc / Synovus Financial Corp / Zions Bancorporation NA / SVB Financial Group / Ameris Bancorp / BOK Financial Corp / FB Financial Corp / Associated Banc-Corp / SouthState Corp / Washington Real Estate Investment Trust / Cathay General Bancorp / Glacier Bancorp Inc / Regency Centers Corp / Netflix Inc / Encore Capital Group Inc / Pinnacle Financial Partners Inc / Seacoast Banking Corporation of Florida / PRA Group Inc / Sutro Biopharma Inc / Biogen Inc / FNB Corp / First Horizon Corp / Sunstone Hotel Investors Inc / Renasant Corp / REX American Resources Corp / Host Hotels & Resorts Inc / elf Beauty Inc / Cadence Bank / Carrols Restaurant Group Inc / Restaurant Brands International Inc / 9 Meters Biopharma Inc / Wyndham Hotels & Resorts Inc / Arcus Biosciences Inc / Hilton Grand Vacations Inc / Nielsen Holdings PLC / Pacira Biosciences Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / MEI Pharma Inc / Ryman Hospitality Properties Inc / Abbvie Inc / Independent Bank Group Inc / Fate Therapeutics Inc / NMI Holdings Inc / Evolent Health Inc / Atlantic Capital Bancshares Inc / Park Hotels & Resorts Inc / Lions Gate Entertainment Corp / Playa Hotels & Resorts NV / Okta Inc / Carvana Co / Roku Inc / Hancock Whitney Corp / BioXcel Therapeutics Inc / Bank Ozk / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / Palomar Holdings Inc / Health Catalyst Inc / Aveanna Healthcare Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/27/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - May 27, 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">ALV.N / BMO.TO / F.N / FCL.AX / MRK.N / PFE.N / TOL.N / AMGN.O / SU.TO / JAZZ.O / SGMO.O / NG.L / V.N / EXPE.O / WSM.N / EPAY.O / ANF.N / APT.AX / JKHY.O / VRTX.O / NCR.N / SSNC.O / ENDP.O / SKY.N / GPN.N / DKS.N / FIS.N / TEVA.N / AEO.N / ATL.MI / WDAY.N / ABBV.N / WIX.O / ZG.O / SQ.N / NTNX.O / OKTA.OQ / DXC.N / CVNA.N / RDFN.O / 00183L102 / ORSTED.CO / CARG.O / Z1P.AX / COLD.N / BKNG.O / VRCA.OQ / NXGN.O / LSPD.TO / LYFT.O / 269796108 / UBER.N / FVRR.N / SZL.AX / FOUR.N / IBEX.O / NVEIu.TO / ABNB.OQ / DASH.N / AFRM.O / PSFE.N / AVAH.OQ</td><td class="leftalignment">Autoliv Inc / Bank of Montreal / Ford Motor Co / FINEOS Corporation Holdings PLC / Merck & Co Inc / Pfizer Inc / Toll Brothers Inc / Amgen Inc / Suncor Energy Inc / Jazz Pharmaceuticals PLC / Sangamo Therapeutics Inc / National Grid PLC / Visa Inc / Expedia Group Inc / Williams-Sonoma Inc / Bottomline Technologies Inc / Abercrombie & Fitch Co / Afterpay Ltd / Jack Henry & Associates Inc / Vertex Pharmaceuticals Inc / NCR Corp / SS&C Technologies Holdings Inc / Endo International PLC / Skyline Champion Corp / Global Payments Inc / DICK'S Sporting Goods Inc / Fidelity National Information Services Inc / Teva Pharmaceutical Industries Ltd / American Eagle Outfitters Inc / Atlantia SpA / Workday Inc / Abbvie Inc / Wix.Com Ltd / Zillow Group Inc / Block Inc / Nutanix Inc / Okta Inc / DXC Technology Co / Carvana Co / Redfin Corp / Angi Inc / Orsted A/S / CarGurus Inc / Zip Co Ltd / Americold Realty Trust / Booking Holdings Inc / Verrica Pharmaceuticals Inc / NextGen Healthcare Inc / Lightspeed Commerce Inc / Lyft Inc / Eagle Pharmaceuticals Inc / Uber Technologies Inc / Fiverr International Ltd / Sezzle Inc / Shift4 Payments Inc / Ibex Ltd / Nuvei Corp / Airbnb Inc / DoorDash Inc / Affirm Holdings Inc / Paysafe Ltd / Aveanna Healthcare Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Denmark / United Kingdom / Ireland / Israel / Italy / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">05/27/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">ASCO May Kick Off HARP's Data Train - We Expect It To Deliver</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">HARP=US / AMGN=US / ABBV=US</td><td class="leftalignment">Harpoon Therapeutics Inc / Amgen Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Asthika Goonewardene / Avi Dahan</td></tr>
<tr class="odd"><td class="leftalignment">05/26/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">CTIC-US - Fundamental Analysis, for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">CTIC.O / BAX / BMY / LLY / NVS / AMGN.O / INCY.O / TEVA.K</td><td class="leftalignment">CTI Biopharma Corp / Baxter International Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Novartis AG / Amgen Inc / Incyte Corp / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">05/26/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Save the Date - Washington, D.C. Day - June 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">85891210 / 42190610 / 76115210 / 80640710 / 03116210 / 7333378 / 64125C109 / 002824100 / 110122108 / 09062X103 / 50540R409 / 74834L100 / 159864107 / 09061G101 / 703395103 / 640268108 / 075887109 / 20530610 / 30063P105 / 216648402 / 28176E108 / 30161Q104 / 45337C102 / 23918K108 / 038336103 / 852312305 / 023436108 / 589584101 / 955306105 / 50187A107 / 436440101 / 003654100 / 016255101 / 09060J106 / 252131107 / 42222N103 / 45168D104 / 45253H101 / 640491106 / 74838J101 / 759916109 / 90337L108 / 45784P101 / 58502B106 / 141619106 / 64049M20 / 40412C101 / 00847G705 / 92857F107 / 00404A109 / 88033G407 / 803607100 / G4705A100 / 74051N10 / 98978V10 / 92337F10 / 26979610 / 45780L10 / 14862Q100 / 006739106 / 00430H102 / 00847L10 / 045396108 / 14880610 / 82621J10 / 268158201 / 31572Q80 / 76133010 / G5960L103 / 78667J108 / 30050B10 / 98978L204 / 37732210 / 15117K103 / 87918A10 / 46185L10 / 04651310 / 00461U105 / 462222100 / 19459J104 / 24906P109 / 70975L107 / 64157F103 / 87357P100 / 58506Q109 / 01345P106 / 88870R102 / N72482123 / 690469101 / G11196105 / 00887A105 / 69366J200 / 46266C105 / 816212104 / 09609G100 / 450056106 / 67022C106 / 29261A100 / 87166B102 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / 28414H103 / H17182108 / 873379101 / 501147102 / 37890U108 / 40131M109 / 22304C100 / 05352A100 / 00650F109 / 77313F106 / 03836N103 / 717224109 / 83192H106 / 88025U109 / 30068X103 / 15912K100 / 29415F104 / 07373V105 / 68404L201 / 42225T107 / 05464T104 / 922107107 / 55234L105 / 71944F106 / 68269G107 / 74019P108 / 37148K100 / 64131A105 / 48576A100 / N5749R100 / 084310101 / 005111109 / 00437E102 / G10830100 / 24984K105 / 73730P108 / 81181C104 / 04537Y109 / 517125100 / 877619106 / 74006W108 / 67181A107 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 270087109 / 192010106 / 13089P101 / 151205200 / 09075X108 / 68401U204 / 04683R106 / 78472F101 / 000380204 / 89422G107 / 56600D107 / 15687V109 / 65443P102 / 54948U105 / 82671G100 / 45784A104 / 30315R107 / 01625V104 / 45175G108 / 00857U107 / 74276R102 / 91864C107</td><td class="leftalignment">Stericycle Inc / Healthcare Services Group Inc / Resmed Inc / Henry Schein Inc / Amgen Inc / Lonza Group AG / Neurocrine Biosciences Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Biogen Inc / Laboratory Corporation of America Holdings / Quest Diagnostics Inc / Charles River Laboratories International Inc / Biomarin Pharmaceutical Inc / Patterson Companies Inc / Nektar Therapeutics / Becton Dickinson and Co / Computer Programs and Systems Inc / Exact Sciences Corp / Cooper Companies Inc / Edwards Lifesciences Corp / Exelixis Inc / Incyte Corp / DaVita Inc / Aptargroup Inc / STAAR Surgical Co / Amedisys Inc / Meridian Bioscience Inc / West Pharmaceutical Services Inc / LHC Group Inc / Hologic Inc / ABIOMED Inc / Align Technology Inc / BioDelivery Sciences International Inc / Dexcom Inc / HealthStream Inc / IDEXX Laboratories Inc / ImmunoGen Inc / Neogen Corp / Quidel Corp / Repligen Corp / US Physical Therapy Inc / Insulet Corp / MEDNAX Inc / Cardiovascular Systems Inc / Neogenomics Inc / HCA Healthcare Inc / Agenus Inc / Vocera Communications Inc / Acadia Healthcare Company Inc / Tenet Healthcare Corp / Sarepta Therapeutics Inc / ICON PLC / Premier Inc / Zoetis Inc / Veracyte Inc / Eagle Pharmaceuticals Inc / Inogen Inc / Castlight Health Inc / Addus Homecare Corp / Accelerate Diagnostics Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Catalent Inc / Sientra Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / Medtronic PLC / SAGE Therapeutics Inc / Evolent Health Inc / Zogenix Inc / Glaukos Corp / Cellectis SA / Teladoc Health Inc / Invitae Corp / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / DENTSPLY SIRONA Inc / Penumbra Inc / Nevro Corp / Tactile Systems Technology Inc / Medpace Holdings Inc / Albireo Pharma Inc / Tivity Health Inc / Qiagen NV / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / IQVIA Holdings Inc / Selecta Biosciences Inc / bluebird bio Inc / iRhythm Technologies Inc / NuCana PLC / Encompass Health Corp / Syneos Health Inc / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / Elanco Animal Health Inc / CRISPR Therapeutics AG / Tabula Rasa HealthCare Inc / Krystal Biotech Inc / Global Blood Therapeutics Inc / Guardant Health Inc / Covetrus Inc / Avantor Inc / Adaptive Biotechnologies Corp / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / SmileDirectClub Inc / 10X Genomics Inc / Exagen Inc / Change Healthcare Inc / Envista Holdings Corp / Beam Therapeutics Inc / Option Care Health Inc / Health Catalyst Inc / Axsome Therapeutics Inc / Vapotherm Inc / Lyra Therapeutics Inc / Phreesia Inc / 1Life Healthcare Inc / Precision BioSciences Inc / Generation Bio Co / Neuronetics Inc / Karuna Therapeutics Inc / Merus NV / Berkeley Lights Inc / Acutus Medical Inc / Accolade Inc / Beyondspring Inc / DermTech Inc / Poseida Therapeutics Inc / Seagen Inc / Aspira Women's Health Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Oak Street Health Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Eargo Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Biodesix Inc / OPTIMIZERx Corp / Atea Pharmaceuticals Inc / Soc Telemed Inc / Abcam PLC / Travere Therapeutics Inc / Maravai LifeSciences Holdings Inc / Certara Inc / 908 Devices Inc. / Lucira Health Inc / Signify Health Inc / InnovAge Holding Corp / F-Star Therapeutics Inc / Alignment Healthcare Inc / Ikena Oncology Inc / agilon health Inc / Privia Health Group Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Ryan S. Daniels, CFA / Brian D. Weinstein, CFA / Andy T. Hsieh, PHD / Ms. Margaret Kaczor / John C. Kreger, III / Mr. Matt Larew / Mr. Tim F. Lugo / Mr. Myles R. R. Minter / Matt Phipps, PHD / Mr. Raju Prasad, PHD</td></tr>
<tr class="odd"><td class="leftalignment">05/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Short Interest Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AMGN.O / SGMO.O / VRTX.O</td><td class="leftalignment">Amgen Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Yinglu Zhang</td></tr>
<tr class="even"><td class="leftalignment">05/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / AMZN=US / T=US / INCY=US / GILD=US / VZ=US / CHRS=US / EWBC=US / MANH=US / MLM=US / DV=US / WTFC=US / AIZ=US / CBRL=US / ELY=US / EXEL=US / HEI=US / MAIN=US / OKE=US / HOOK=US / REGN=US / GOLF=US / CGEN=US / CFB=US / SNV=US / SIVB=US / ABCB=US / FB=US / FBK=US / SSB=US / GBCI=US / NLS=US / PNFP=US / SBCF=US / JRVR=US / STRO=US / RNG=US / IAC=US / RCUS=US / CLNY=US / KNSL=US / MEIP=US / ABBV=US / IBTX=US / TMUS=US / FATE=US / TSLX=US / ACBI=US / ZS=US / CRSP=US / IOVA=US / ATNX=US / DCPH=US / BTAI=US / OZK=US / FTDR=US / ALLO=US / HARP=US / UBER=US / GMAB=US / AVAH=US / VMEO=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Amazon.com Inc / AT&T Inc / Incyte Corp / Gilead Sciences Inc / Verizon Communications Inc / Coherus BioSciences Inc / East West Bancorp Inc / Manhattan Associates Inc / Martin Marietta Materials Inc / DoubleVerify Holdings Inc / Wintrust Financial Corp / Assurant Inc / Cracker Barrel Old Country Store Inc / Callaway Golf Co / Exelixis Inc / HEICO Corp / Main Street Capital Corp / ONEOK Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Acushnet Holdings Corp / Compugen Ltd / Crossfirst Bankshares Inc / Synovus Financial Corp / SVB Financial Group / Ameris Bancorp / Meta Platforms Inc / FB Financial Corp / SouthState Corp / Glacier Bancorp Inc / Nautilus Inc / Pinnacle Financial Partners Inc / Seacoast Banking Corporation of Florida / James River Group Holdings Ltd / Sutro Biopharma Inc / RingCentral Inc / IAC/Interactivecorp / Arcus Biosciences Inc / DigitalBridge Group Inc / Kinsale Capital Group Inc / MEI Pharma Inc / Abbvie Inc / Independent Bank Group Inc / T-Mobile US Inc / Fate Therapeutics Inc / Sixth Street Specialty Lending Inc / Atlantic Capital Bancshares Inc / Zscaler Inc / CRISPR Therapeutics AG / Iovance Biotherapeutics Inc / Athenex Inc / Deciphera Pharmaceuticals Inc / BioXcel Therapeutics Inc / Bank Ozk / Frontdoor Inc / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / Uber Technologies Inc / Genmab A/S / Aveanna Healthcare Holdings Inc / Vimeo Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / Denmark / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech & Pharma: Truist Securities ASCO Planner v2.0 Highlights ~200 Datapoints of Interest</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / INCY=US / GILD=US / CHRS=US / EXEL=US / HOOK=US / REGN=US / CGEN=US / STRO=US / RCUS=US / MEIP=US / ABBV=US / FATE=US / CRSP=US / IOVA=US / ATNX=US / DCPH=US / BTAI=US / ALLO=US / HARP=US / GMAB=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Gilead Sciences Inc / Coherus BioSciences Inc / Exelixis Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Compugen Ltd / Sutro Biopharma Inc / Arcus Biosciences Inc / MEI Pharma Inc / Abbvie Inc / Fate Therapeutics Inc / CRISPR Therapeutics AG / Iovance Biotherapeutics Inc / Athenex Inc / Deciphera Pharmaceuticals Inc / BioXcel Therapeutics Inc / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Asthika Goonewardene / Ms. Robyn S. Karnauskas / Mr. Gregg Gilbert / Ms. Srikripa Devarakonda, PHD / Mr. Joon Lee, MD</td></tr>
<tr class="even"><td class="leftalignment">05/26/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">ASCO 2021 Abstract Highlights and Virtual Conference Itinerary</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">03116210 / 00847G705 / 110122108 / 640268108 / 30161Q104 / 45337C102 / 45253H101 / 15117K103 / 04651310 / 462222100 / 00887A105 / 09609G100 / 67022C106 / 720795103 / 49372L100 / 05280R100 / 019770106 / H17182108 / 74019P108 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 00507W206 / 03890D108 / 192010106 / 13089P101 / 151205200 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">Amgen Inc / Agenus Inc / Bristol-Myers Squibb Co / Nektar Therapeutics / Exelixis Inc / Incyte Corp / ImmunoGen Inc / Cellectis SA / Atara Biotherapeutics Inc / Ionis Pharmaceuticals Inc / Aileron Therapeutics Inc / bluebird bio Inc / NuCana PLC / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Precision BioSciences Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Actinium Pharmaceuticals Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Mr. Myles R. R. Minter / Mr. Rob Andrew, CFA / Mr. Hunter Rogers / Sami Corwin, PHD</td></tr>
<tr class="odd"><td class="leftalignment">05/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for AMGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">05/25/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Amgen gains 7.1% in past quarter; Institutional Ownership up 2%</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">05/25/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">LLY=US / LSI=US / PFE=US / AMGN=US / BMY=US / MCD=US / WEN=US / INCY=US / CHKP=US / IART=US / MAC=US / BMRN=US / BNL=US / CBRL=US / CRL=US / DRI=US / EXEL=US / NOW=US / REGI=US / STOR=US / PSA=US / NET=US / OFC=US / SRC=US / NTRA=US / DIN=US / RPD=US / BIIB=US / EXR=US / BECN=US / PLAY=US / DENN=US / BLDR=US / CMG=US / REX=US / GPRE=US / EHTH=US / OC=US / TAST=US / QSR=US / JACK=US / NEO=US / CUBE=US / PANW=US / ABBV=US / NDLS=US / FEYE=US / VRNS=US / 00770K202 / LOCO=US / SHAK=US / NSA=US / WING=US / LOB=US / ZS=US / LGF.B=US / OKTA=US / YEXT=US / SAIL=US / TENB=US / CRWD=US / ARQT=US / 96758W101 / VTRS=US / ABNB=US / HYFM=US / HIMS=US / KNBE=US</td><td class="leftalignment">Eli Lilly and Co / Life Storage Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / McDonald's Corp / Wendys Co / Incyte Corp / Check Point Software Technologies Ltd / Integra Lifesciences Holdings Corp / Macerich Co / Biomarin Pharmaceutical Inc / Bunzl plc / Cracker Barrel Old Country Store Inc / Charles River Laboratories International Inc / Darden Restaurants Inc / Exelixis Inc / ServiceNow Inc / Renewable Energy Group Inc / STORE Capital Corp / Public Storage / Cloudflare Inc / Corporate Office Properties Trust / Spirit Realty Capital Inc / Natera Inc / Dine Brands Global Inc / Rapid7 Inc / Biogen Inc / Extra Space Storage Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Green Plains Inc / eHealth Inc / Owens Corning / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Jack in the Box Inc / Neogenomics Inc / CubeSmart / Palo Alto Networks Inc / Abbvie Inc / Noodles & Co / Mandiant Inc / Varonis Systems Inc / Aemetis Inc / El Pollo Loco Holdings Inc / Shake Shack Inc / National Storage Affiliates Trust / Wingstop Inc / Live Oak Bancshares Inc / Zscaler Inc / Lions Gate Entertainment Corp / Okta Inc / Yext Inc / SailPoint Technologies Holdings Inc / Tenable Holdings Inc / CrowdStrike Holdings Inc / Arcutis Biotherapeutics Inc / WideOpenWest Inc / Viatris Inc / Airbnb Inc / Hydrofarm Holdings Group Inc / Hims & Hers Health Inc / Knowbe4 Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/25/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Record Lows Across Key COVID-19 Metrics as Vaccinations Near 50% in United States; Situation in India Continues to Improve</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending May 14, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Tracking the JAKs</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / BMY=US / INCY=US / ABBV=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Abbvie Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser</td></tr>
<tr class="odd"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - May 24 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">NL0000226223 / DE0006231004 / US0079031078 / US0079731008 / US0116591092 / US0311001004 / US0311621009 / US0378331005 / US0382221051 / US0463531089 / US1101221083 / US1727551004 / US1925761066 / US37733W1053 / US4581401001 / US4781601046 / US4824801009 / US5012421013 / US5128071082 / US5184151042 / US5324571083 / US5370081045 / US55306N1046 / US5951121038 / US66987V1098 / US6701002056 / US67066G1040 / US7170811035 / US7392761034 / US7475251036 / US7711951043 / US7782961038 / US8308791024 / US8447411088 / US8610121027 / US8807701029 / US91347P1057 / US9282981086 / US9581021055 / US9699041011 / US4771431016 / US83088M1027 / US4198791018 / US80105N1054 / US3463751087 / US1572101053 / US90385V1070 / US79466L3024 / US6098391054 / US82706C1080 / PAP310761054 / US01748X1028 / US2473617023 / US58933Y1055 / US9100471096 / US0995021062 / US7512121010 / US00287Y1091 / NL0010273215 / US98978V1035 / US98138H1014 / US55405Y1001 / US8486371045 / KYG037AX1015 / US8485771021 / US21240E1055 / CH0210483332 / US02376R1023 / CA0089118776 / US74736K1016 / IE00BTN1Y115 / CA1380351009 / US40434L1052 / KYG4740B1059 / US74967X1037 / US11135F1012 / US2575541055 / US5904791358 / US28414H1032 / US24703L2025 / US85205L1070 / US75943R1023 / US8334451098 / US5738741041 / US30320C1036 / US83089J1088 / IE00BKVD2N49</td><td class="leftalignment">STMicroelectronics NV / Infineon Technologies AG / Advanced Micro Devices Inc / Advanced Energy Industries Inc / Alaska Air Group Inc / AMETEK Inc / Amgen Inc / Apple Inc / Applied Materials Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Cirrus Logic Inc / Cohu Inc / GlaxoSmithKline PLC / Intel Corp / Johnson & Johnson / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Lattice Semiconductor Corp / Eli Lilly and Co / Littelfuse Inc / MKS Instruments Inc / Micron Technology Inc / Novartis AG / Novo Nordisk A/S / NVIDIA Corp / Pfizer Inc / Power Integrations Inc / Qualcomm Inc / Roche Holding AG / Ross Stores Inc / SkyWest Inc / Southwest Airlines Co / STMicroelectronics NV / Teradyne Inc / Universal Display Corp / Vishay Intertechnology Inc / Western Digital Corp / Williams-Sonoma Inc / JetBlue Airways Corp / Skyworks Solutions Inc / Hawaiian Holdings Inc / Sanofi SA / FormFactor Inc / CEVA Inc / Ultra Clean Holdings Inc / Salesforce.Com Inc / Monolithic Power Systems Inc / Silicon Motion Technology Corp / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / United Airlines Holdings Inc / Booz Allen Hamilton Holding Corp / Ralph Lauren Corp / Abbvie Inc / ASML Holding NV / Zoetis Inc / Workday Inc / MACOM Technology Solutions Holdings Inc / Splunk Inc / Ambarella Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / Compagnie Financiere Richemont SA / American Airlines Group Inc / Air Canada / Qorvo Inc / Medtronic PLC / Canopy Growth Corp / HP Inc / Ichor Holdings Ltd / RH / Broadcom Inc / Domo Inc / Mesa Air Group Inc / Elanco Animal Health Inc / Dell Technologies Inc / SpringWorks Therapeutics Inc / Relay Therapeutics Inc / Snowflake Inc. / Marvell Technology Inc / FTC Solar Inc / Skywater Technology Inc / Seagate Technology Holdings PLC</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Mexico / Netherlands / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">05/24/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Highlights in NSCLC from our ASCO KOL Preview Day</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">03116210 / 478160104 / 58933Y10 / 74587V10 / 41358P10 / 09627Y10 / N0104510 / 60468T10</td><td class="leftalignment">Amgen Inc / Johnson & Johnson / Merck & Co Inc / Puma Biotechnology Inc / Harpoon Therapeutics Inc / Blueprint Medicines Corp / Affimed NV / Mirati Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Andrew Berens, M.D. / Geoffrey Porges, MBBS / Daina Graybosch, Ph.D. / Jonathan Chang, Ph.D., CFA</td></tr>
<tr class="odd"><td class="leftalignment">05/24/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Highlights in Genitourinary Cancers from our ASCO KOL Preview Day</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">03116210 / 58933Y10 / 41358P10 / 55609910 / 81181C10 / 03969F10</td><td class="leftalignment">Amgen Inc / Merck & Co Inc / Harpoon Therapeutics Inc / MacroGenics Inc / Seagen Inc / Arcus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Jonathan Chang, Ph.D., CFA / Daina Graybosch, Ph.D. / Geoffrey Porges, MBBS / Andrew Berens, M.D.</td></tr>
<tr class="even"><td class="leftalignment">05/23/2021</td><td class="leftalignment">The Business Research Company</td><td class="leftalignment">Amgen Inc. (Amgen) Company Briefing (COVID 19 Update)</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Department of Research</td></tr>
<tr class="odd"><td class="leftalignment">05/23/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Highlights From AMGN, RLAY and SWTX At Cowen’s 2nd Annual Oncology Summit</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US0311621009 / US85205L1070 / US75943R1023</td><td class="leftalignment">Amgen Inc / SpringWorks Therapeutics Inc / Relay Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Denmark / United Kingdom / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Yaron Werber, M.D., MD / Gabriel Schneider, M.D. / Brendan Smith, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">05/21/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">High Grade Healthcare : Updated Credit Views from the "USD HG Coverage and Rating Report"</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AMGN.O / ABC.N / BAX.N / BDX.N / BMY.N / BSX.N / CAH.N / CI.N / JNJ.N / LLY.N / MCK.N / MRK.N / DGX.N / HUM.N / GILD.O / UNH.N / LH.N / BIIB.O / ZTS.N / PRGO.N / ANTM.N / VTRS.O</td><td class="leftalignment">Amgen Inc / Amerisourcebergen Corp / Baxter International Inc / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Cardinal Health Inc / Cigna Corp / Johnson & Johnson / Eli Lilly and Co / Mckesson Corp / Merck & Co Inc / Quest Diagnostics Inc / Humana Inc / Gilead Sciences Inc / UnitedHealth Group Inc / Laboratory Corporation of America Holdings / Biogen Inc / Zoetis Inc / Perrigo Company PLC / Anthem Inc / Viatris Inc</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / FIXED INCOME/DEBT RESEARCH</td><td class="leftalignment">Brett Gibson / Mr. Matthew Bonner</td></tr>
<tr class="odd"><td class="leftalignment">05/21/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">AMGN.OQ - Event Transcript of Amgen Inc conference call, May 21, 2021 / 11:20AM ET</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/21/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--May 21, 2021</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">ACA / AMN / BSX / CHE / CI / CNC / CRY.N / CVS / HUM / MDT / RAD / SGE.L / UNH / WMT / GILD.O / AMGN.O / NOVN.S / HCA.N / CYH.N / EW.N / INCY.OQ / IART.OQ / EXEL.OQ / ISRG.OQ / CCRN.O / AMED.O / BIIB.O / 478160104 / 00846U101 / 868168105 / ATRC.OQ / LHCG.O / 02043Q107 / ENSG.OQ / 483548103 / TMDX.OQ / MD.N / CSII.O / ADUS.O / USPH.N / MRTX.OQ / GOOGL.O / XENT.OQ / CLRB.OQ / MRNS.O / CATB.OQ / EVH.N / TDOC.N / GBT.OQ / MMD.WA / APLS.OQ / 100063846 / IRTC.OQ / SRRA.O / PLXP.O / IOVA.OQ / ALPN.O / MBIO.OQ / NCNA.O / CUE.OQ / 720795103 / SURF.O / VCNX.OQ / MOTS.O / ALLO.OQ / ORTX.OQ / SWAV.O / PDSB.OQ / BWAY.TA / PNTG.OQ / IGMS.O / VERO.O / ORIC.OQ / AYLA.O / FMTX.O / REGW.M3</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Boston Scientific Corp / Chemed Corp / Cigna Corp / Centene Corp / CryoLife Inc / CVS Health Corp / Humana Inc / Medtronic PLC / Rite Aid Corp / Sage Group PLC / UnitedHealth Group Inc / Walmart Inc / Gilead Sciences Inc / Amgen Inc / Novartis AG / HCA Healthcare Inc / Community Health Systems Inc / Edwards Lifesciences Corp / Incyte Corp / Integra Lifesciences Holdings Corp / Exelixis Inc / Intuitive Surgical Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / AtriCure Inc / LHC Group Inc / Alnylam Pharmaceuticals Inc / Ensign Group Inc / Kaman Corp / Transmedics Group Inc / MEDNAX Inc / Cardiovascular Systems Inc / Addus Homecare Corp / US Physical Therapy Inc / Mirati Therapeutics Inc / Alphabet Inc / Intersect Ent Inc / Cellectar Biosciences Inc / Marinus Pharmaceuticals Inc / Astria Therapeutics Inc / Evolent Health Inc / Teladoc Health Inc / Global Blood Therapeutics Inc / Milestone Medical Inc / Apellis Pharmaceuticals Inc / Truist Financial Corp / iRhythm Technologies Inc / Sierra Oncology Inc / PLx Pharma Inc / Iovance Biotherapeutics Inc / Alpine Immune Sciences Inc / Mustang Bio Inc / NuCana PLC / Cue Biopharma Inc / Pieris Pharmaceuticals Inc / Surface Oncology Inc / Vaccinex Inc / Motus GI Holdings Inc / Allogene Therapeutics Inc / Orchard Therapeutics PLC / Shockwave Medical Inc / PDS Biotechnology Corp / Brainsway Ltd / Pennant Group Inc / IGM Biosciences Inc / Venus Concept Inc / Oric Pharmaceuticals Inc / Ayala Pharmaceuticals Inc / Forma Therapeutics Holdings Inc / Regency World Consulting Ltd</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / India / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="odd"><td class="leftalignment">05/21/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 548</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">05/21/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended May 14, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">05/21/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">05/21/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="odd"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US00846U1016 / US0311621009 / US2666051048 / US3755581036 / US75886F1075 / US02043Q1076 / US74587V1070 / IL0011313900 / CA68620P1018 / CA1380351009 / US03969F1093 / US88688T1007 / US15117B2025 / CA05156X8843 / US56854Q2003 / US40434H2031 / CA4283043079</td><td class="leftalignment">Agilent Technologies Inc / Amgen Inc / DURECT Corp / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Puma Biotechnology Inc / Galmed Pharmaceuticals Ltd / OrganiGram Holdings Inc / Canopy Growth Corp / Arcus Biosciences Inc / Tilray Brands Inc / Celldex Therapeutics Inc / Aurora Cannabis Inc / Marinus Pharmaceuticals Inc / HTG Molecular Diagnostics Inc / Hexo Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">All Good Things Must Come to an End - Biotech Outflows Return</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Amgen Inc: Ownership Timelines & Shareholder Analytics (May 2021)</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Conference Call to Discuss ASCO Highlights on 6/7 at 12 PM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AMGN.O / FATE.O / GILD.O / REGN.O / PBYI.O / RCUS.K</td><td class="leftalignment">Amgen Inc / Fate Therapeutics Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Puma Biotechnology Inc / Arcus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Emily Bodnar / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">INTC.O / MSFT.O / QCOM.O / RSG / WMT / YUM / AMGN.O / AAPL.O / HEAR.O / MPWR.O / SMTC.O / AYI / AVGO.O / CSCO.OQ / CRUS.OQ / ATVI.OQ / XLNX.OQ / INCY.OQ / TTWO.OQ / EXEL.OQ / SWKS.OQ / TXN.OQ / ATRC.OQ / 36467W109 / 514766104 / TSLA.O / NXPI.O / ZNGA.O / EA.O / ADI.OQ / 82655M107 / CLRB.OQ / SRRA.O / NCNA.O / BILI.O / ALLO.OQ / PDSB.OQ / 02081G201 / 84764T304 / HUYA.K</td><td class="leftalignment">Intel Corp / Microsoft Corp / Qualcomm Inc / Republic Services Inc / Walmart Inc / Yum! Brands Inc / Amgen Inc / Apple Inc / Turtle Beach Corp / Monolithic Power Systems Inc / Semtech Corp / Acuity Brands Inc / Broadcom Inc / Cisco Systems Inc / Cirrus Logic Inc / Activision Blizzard Inc / Xilinx Inc / Incyte Corp / Take-Two Interactive Software Inc / Exelixis Inc / Skyworks Solutions Inc / Texas Instruments Inc / AtriCure Inc / GameStop Corp / Landec Corp / Tesla Inc / NXP Semiconductors NV / Zynga Inc / Electronic Arts Inc / Analog Devices Inc / Sify Technologies Ltd / Cellectar Biosciences Inc / Sierra Oncology Inc / NuCana PLC / Bilibili Inc / Allogene Therapeutics Inc / PDS Biotechnology Corp / Alphatec Holdings Inc / Speed Commerce Inc / HUYA Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United Kingdom / India / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - May 20 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">FR0000077919 / US0126531013 / US0311621009 / US0530151036 / US1264081035 / US17275R1023 / US22284P1057 / US2310211063 / US30161Q1040 / US3614481030 / US3755581036 / US3936571013 / US4456581077 / US45253H1014 / US45337C1027 / US6558441084 / US66987V1098 / US6795801009 / US6937181088 / US7043261079 / US75886F1075 / US7782961038 / US8447411088 / US8725401090 / US87612E1064 / US8965221091 / US9029251066 / US9078181081 / US9297401088 / US9507551086 / CA1363751027 / CA13645T1003 / US3570231007 / US9043111072 / US78709Y1055 / US29089Q1058 / US9837931008 / US74587V1070 / US16934W1062 / US29428V1044 / US1220171060 / US5560991094 / US70438V1061 / US70432V1026 / US03937C1053 / US09627Y1091 / US00653A1079 / US07725L1026 / CA87241L1094 / US23753F1075 / US80689H1023 / US3621LQ1099 / US4990491049 / US8760301072 / CA53680Q2071 / US02083G1004 / US1010441053 / US67022C1062 / US4622601007 / VGG273581030 / US05351X1019 / SE0009414576 / US15677J1088 / US86877M2098 / US55910K1088 / US29260V1052 / US9842411095 / KY30744W1070 / US8693671021 / US40131M1099 / US0197701065 / US53814L1089 / US18453H1068 / CA16106R1091 / US09203E1055 / US92537N1081 / CH0499880968 / US05370A1088 / US81181C1045 / US74767V1098 / US55406W1036 / US15961R1059 / US49926T1043 / US83089J1088</td><td class="leftalignment">JCDecaux SA / Albemarle Corp / Amgen Inc / Automatic Data Processing Inc / CSX Corp / Cisco Systems Inc / Covenant Logistics Group Inc / Cummins Inc / Exelixis Inc / GATX Corp / Gilead Sciences Inc / Greenbrier Companies Inc / J B Hunt Transport Services Inc / ImmunoGen Inc / Incyte Corp / Norfolk Southern Corp / Novartis AG / Old Dominion Freight Line Inc / Paccar Inc / Paychex Inc / Regeneron Pharmaceuticals Inc / Ross Stores Inc / Southwest Airlines Co / TJX Companies Inc / Target Corp / Trinity Industries Inc / USA Truck Inc / Union Pacific Corp / Westinghouse Air Brake Technologies Corp / Werner Enterprises Inc / Canadian National Railway Co / Canadian Pacific Railway Ltd / FreightCar America Inc / Under Armour Inc / Saia Inc / Emergent BioSolutions Inc / XPO Logistics Inc / Puma Biotechnology Inc / Chimerix Inc / Epizyme Inc / Burlington Stores Inc / MacroGenics Inc / Paylocity Holding Corp / Paycom Software Inc / ArcBest Corp / Blueprint Medicines Corp / Adaptimmune Therapeutics PLC / Beigene Ltd / TFI International Inc / Daseke Inc / Schneider National Inc / G1 Therapeutics Inc / Knight-Swift Transportation Holdings Inc / Tapestry Inc / Lithium Americas Corp / Alpine Immune Sciences Inc / Boston Omaha Corp / NuCana PLC / Iovance Biotherapeutics Inc / Despegar.com Corp / Avaya Holdings Corp / Oncopeptides AB / Ceridian HCM Holding Inc / Surface Oncology Inc / Magenta Therapeutics Inc / Endava PLC / Y-mAbs Therapeutics Inc / Farfetch Ltd / Sutro Biopharma Inc / Guardant Health Inc / Allogene Therapeutics Inc / Livent Corp / Clear Channel Outdoor Holdings Inc / Charlotte's Web Holdings Inc / Black Diamond Therapeutics Inc / Vertiv Holdings Co / ADC Therapeutics SA / Avidity Biosciences Inc / Seagen Inc / Quantumscape Corp / MYT Netherlands Parent BV / ChargePoint Holdings Inc / Knowbe4 Inc / Skywater Technology Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Israel / Netherlands / Sweden / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AMGN=US / BMY=US / HD=US / ADI=US / T=US / GILD=US / AMT=US / PEB=US / H=US / MTN=US / VZ=US / LOW=US / MAR=US / ADS=US / TTWO=US / TNL=US / HLT=US / BMRN=US / CHH=US / CPRT=US / DRH=US / RARE=US / REGN=US / STRO=US / EXP=US / AWH / SHO=US / NSP=US / HST=US / WH=US / TIL=US / JACK=US / RCUS=US / HGV=US / RLJ=US / VAC=US / MEIP=US / RHP=US / FATE=US / 00770K202 / UPLD=US / VVV=US / PK=US / GDS=US / PLYA=US / IOVA=US / BTAI=US / ALLO=US / FERG=US / SPCE=US / KNBE=US</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / Analog Devices Inc / AT&T Inc / Gilead Sciences Inc / American Tower Corp / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Vail Resorts Inc / Verizon Communications Inc / Lowe's Companies Inc / Marriott International Inc / Alliance Data Systems Corp / Take-Two Interactive Software Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Biomarin Pharmaceutical Inc / Choice Hotels International Inc / Copart Inc / Diamondrock Hospitality Co / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sutro Biopharma Inc / Eagle Materials Inc / Aspira Women's Health Inc / Sunstone Hotel Investors Inc / Insperity Inc / Host Hotels & Resorts Inc / Wyndham Hotels & Resorts Inc / Instil Bio Inc / Jack in the Box Inc / Arcus Biosciences Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / MEI Pharma Inc / Ryman Hospitality Properties Inc / Fate Therapeutics Inc / Aemetis Inc / Upland Software Inc / Valvoline Inc / Park Hotels & Resorts Inc / GDS Holdings Ltd / Playa Hotels & Resorts NV / Iovance Biotherapeutics Inc / BioXcel Therapeutics Inc / Allogene Therapeutics Inc / Ferguson PLC / Virgin Galactic Holdings Inc / Knowbe4 Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Biotech Highlights From ASCO Abstracts</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US0311621009 / US30161Q1040 / US3755581036 / US45253H1014 / US45337C1027 / US66987V1098 / US75886F1075 / US74587V1070 / US16934W1062 / US29428V1044 / US5560991094 / US09627Y1091 / US00653A1079 / US3621LQ1099 / US02083G1004 / US4622601007 / SE0009414576 / US86877M2098 / US55910K1088 / US9842411095 / US8693671021 / CH0499880968 / US81181C1045</td><td class="leftalignment">Amgen Inc / Exelixis Inc / Gilead Sciences Inc / ImmunoGen Inc / Incyte Corp / Novartis AG / Regeneron Pharmaceuticals Inc / Puma Biotechnology Inc / Chimerix Inc / Epizyme Inc / MacroGenics Inc / Blueprint Medicines Corp / Adaptimmune Therapeutics PLC / G1 Therapeutics Inc / Alpine Immune Sciences Inc / Iovance Biotherapeutics Inc / Oncopeptides AB / Surface Oncology Inc / Magenta Therapeutics Inc / Y-mAbs Therapeutics Inc / Sutro Biopharma Inc / ADC Therapeutics SA / Seagen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Denmark / United Kingdom / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Cowen Biotechnology Team</td></tr>
<tr class="odd"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ASCO 2021 Abstracts Highlight Key Updates for 25 Stocks in Our Biotech Coverage</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">2023607 / 2576941 / 2369174 / 2457864 / 2471950 / 4595739 / 5531000 / 2982924 / BBFL7S1 / BCZS820 / BFDV8K0 / BBPK0J0 / BFZNYB7 / BZBY005 / BZ1LFB2 / BMQ5T49 / BKVDFF7 / BG31GH0 / BJXBP30 / BYYWPW6 / BWY52P3 / BL71K91 / BWY4XV3 / BN2R582 / BMDJ397</td><td class="leftalignment">Amgen Inc / Exelixis Inc / Gilead Sciences Inc / ImmunoGen Inc / Incyte Corp / Genmab A/S / MorphoSys AG / Spectrum Pharmaceuticals Inc / bluebird bio Inc / Fate Therapeutics Inc / MacroGenics Inc / Mirati Therapeutics Inc / Allogene Therapeutics Inc / Merus NV / Deciphera Pharmaceuticals Inc / Zentalis Pharmaceuticals Inc / Oric Pharmaceuticals Inc / Y-mAbs Therapeutics Inc / Turning Point Therapeutics Inc / Beigene Ltd / Blueprint Medicines Corp / Revolution Medicines Inc / Adaptimmune Therapeutics PLC / Relay Therapeutics Inc / Bolt Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Germany / Denmark / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Etzer Darout / Yige Guo, Ph.D. / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin / Paul Jeng, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">2021 Guggenheim ASCO Abstracts Review: Few Surprises Overall, but BMY's Relatlimab Looks Additive to Us</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BMY.N / 5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2684703 / 7103065 / BD9GVY0</td><td class="leftalignment">Bristol-Myers Squibb Co / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Pfizer Inc / Novartis AG / Zai Lab Ltd</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Michael W. Schmidt, Ph.D., PHD / Mr. Etzer Darout / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">ASCO 2021 Virtual Annual Meeting Abstracts Review</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">031162100 / 75886F107 / 30161Q104 / 45253H101 / 189464100 / 31189P102 / 09627Y109 / 81750R102 / 462260100 / 41358P106 / 869367102 / 44975P103 / 02083G100 / 24344T101 / 46565G104 / 38406L103 / 81728A108 / 45256X103</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc / Exelixis Inc / ImmunoGen Inc / Clovis Oncology Inc / Fate Therapeutics Inc / Blueprint Medicines Corp / Seres Therapeutics Inc / Iovance Biotherapeutics Inc / Harpoon Therapeutics Inc / Sutro Biopharma Inc / I-Mab / Alpine Immune Sciences Inc / Deciphera Pharmaceuticals Inc / Iteos Therapeutics Inc / Gracell Biotechnologies Inc / Sensei Biotherapeutics Inc / Immunitybio Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / China / Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Joseph Catanzaro, PhD / Mr. Christopher J. Raymond / Edward A. Tenthoff</td></tr>
<tr class="even"><td class="leftalignment">05/19/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">MEIP/RCUS have stellar data, stock could be up; but given the market condition -?</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GILD=US / MEIP.OQ / RCUS=US / AMGN=US / REGN=US / GILD.OQ / MEIP=US / FATE=US / BTAI=US</td><td class="leftalignment">Gilead Sciences Inc / MEI Pharma Inc / Arcus Biosciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / MEI Pharma Inc / Fate Therapeutics Inc / BioXcel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino</td></tr>
<tr class="odd"><td class="leftalignment">05/19/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">ASCO 2021 Abstracts Highlight Clinical Progress</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AMGN.O / INCY.OQ / EXEL.OQ / SRRA.O</td><td class="leftalignment">Amgen Inc / Incyte Corp / Exelixis Inc / Sierra Oncology Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Netherlands / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">05/19/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">ASCO: What's new and what we're paying attention to</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">GILD.O / AMGN.O / REGN.O / PBYI.O / RCUS.K</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Puma Biotechnology Inc / Arcus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">05/19/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">ASCO 2021 Abstracts: AMG 757 and Bema Updates Shows Continued Benefit</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Do G. Kim / Jameson Kao / Ikechukwu Oji</td></tr>
<tr class="even"><td class="leftalignment">05/18/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">New Primary Care/Migraine Survey Indicates Big Upside for Oral CGRPs</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">031162100 / 00287Y109 / G11196105</td><td class="leftalignment">Amgen Inc / Abbvie Inc / Biohaven Pharmaceutical Holding Company Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">05/18/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US0311621009 / US23282W6057 / US03820J1007</td><td class="leftalignment">Amgen Inc / Cytokinetics Inc / Applied Genetic Technologies Corp</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">05/18/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / BMY=US / DIS=US / HD=US / MCD=US / WEN=US / T=US / BLD=US / INCY=US / AMT=US / LOW=US / SCOR=US / LEG=US / VMC=US / MANH=US / MLM=US / UNH=US / AMN=US / SWIM=US / CBRL=US / DRI=US / GFF=US / IBP=US / MAS=US / MHK=US / REGI=US / CVX=US / CCRN=US / NFLX=US / DIN=US / MGNI=US / MRNS=US / TPX=US / EXP=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / AWI=US / OC=US / TAST=US / QSR=US / PRPL=US / JACK=US / CLNY=US / TREX=US / OLO=US / NLSN=US / FBHS=US / ABBV=US / TILE=US / NDLS=US / VCYT=US / 00770K202 / LOCO=US / SHAK=US / WING=US / 82982L103 / LGF.B=US / JELD=US / ROKU=US / FERG=US / ARQT=US / ZI=US / AZEK=US / HIMS=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Walt Disney Co / Home Depot Inc / McDonald's Corp / Wendys Co / AT&T Inc / TopBuild Corp / Incyte Corp / American Tower Corp / Lowe's Companies Inc / Comscore Inc / Leggett & Platt Inc / Vulcan Materials Co / Manhattan Associates Inc / Martin Marietta Materials Inc / UnitedHealth Group Inc / AMN Healthcare Services Inc / Latham Group Inc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Renewable Energy Group Inc / Chevron Corp / Cross Country Healthcare Inc / Netflix Inc / Dine Brands Global Inc / Magnite Inc / Marinus Pharmaceuticals Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Jack in the Box Inc / DigitalBridge Group Inc / Trex Company Inc / Olo Inc / Nielsen Holdings PLC / Fortune Brands Home & Security Inc / Abbvie Inc / Interface Inc / Noodles & Co / Veracyte Inc / Aemetis Inc / El Pollo Loco Holdings Inc / Shake Shack Inc / Wingstop Inc / SiteOne Landscape Supply Inc / Lions Gate Entertainment Corp / JELD-WEN Holding Inc / Roku Inc / Ferguson PLC / Arcutis Biotherapeutics Inc / ZoomInfo Technologies Inc / Azek Company Inc / Hims & Hers Health Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Luxembourg / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/18/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Record Lows Across Key COVID-19 Metrics Signal New Phase of Pandemic in United States; Early Sign of Waning Outbreak in India</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">05/18/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">KNBWY-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">KNBWY.PK / BUD / CCU / CCU.SN / SAM / AMGN.O / STZb / TAPa / HEINY.PK</td><td class="leftalignment">Kirin Holdings Co Ltd / Anheuser Busch Inbev SA / Compania Cervecerias Unidas SA / Compania Cervecerias Unidas SA / Boston Beer Company Inc / Amgen Inc / Constellation Brands Inc / Molson Coors Beverage Co / Heineken NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Chile / Japan / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">05/18/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">INCY-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">INCY.O / LLY / NVS / PFE / AMGN.O / CTIC.O / LGND.O / GERN.O / AVEO.O / ARDX.O</td><td class="leftalignment">Incyte Corp / Eli Lilly and Co / Novartis AG / Pfizer Inc / Amgen Inc / CTI Biopharma Corp / Ligand Pharmaceuticals Inc / Geron Corp / Aveo Pharmaceuticals Inc / Ardelyx Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">05/18/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABBV-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ABBV.K / BMY / LLY / PFE / GILD.O / AMGN.O / GSK / NBIX.O / AZN.O / BIIB.O</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / GlaxoSmithKline PLC / Neurocrine Biosciences Inc / AstraZeneca PLC / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">05/17/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Bang for the Buck – Ome’ Clinical Benefit Well Suited for Patients with Highest-Need Ejection-Fraction Deficits</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US23282W6057 / AMGN.O</td><td class="leftalignment">Cytokinetics Inc / Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Charles C. Duncan, Ph.D. / Mr. Pete Stavropoulos</td></tr>
<tr class="even"><td class="leftalignment">05/17/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending May 07, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">05/17/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Tracking the JAKs</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / BMY=US / INCY=US / ABBV=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Abbvie Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">05/17/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">ACA / ALB.N / BE / BIO / BOX.N / BSX / CAT / CLH / CMI / CRM.N / DAN / DE / ENS / JCI / MDT / MSFT.O / NEP / NOW / ORA / RBC / REV / RSG / SWI / T.N / WM / ZEN / 4716.T / AMZN.O / AMGN.O / BWA.N / ADBE.O / SAPG.DE / CRVL.O / MPWR.O / SMTC.O / ADSK.O / EW.N / FCEL.O / OSUR.O / CREE.O / CRUS.OQ / AMSC.OQ / VRTS.OQ / POOL.OQ / CALM.OQ / UTHR.OQ / PLUG.OQ / MRVL.OQ / PDFS.OQ / TRMB.O / QDEL.O / ITRI.O / NATI.O / AMED.O / PCTY.O / LPSN.O / NFLX.O / 478160104 / 20030N101 / 146229109 / ATRC.OQ / SPWR.O / ATNI.OQ / EHTH.O / CSIQ.O / FSLR.O / ENSG.OQ / ULTA.O / TMDX.OQ / FRPT.O / TWIN.O / BLN.V / CSII.O / AGCO.K / GNRC.K / TSLA.O / AMRC.K / AMRS.OQ / ZNGA.O / ENPH.O / FB.O / CG.O / FIVE.OQ / GMED.K / HASI.N / RNG.N / MRTX.OQ / FATE.OQ / GOOGL.O / PAYC.K / ARES.K / XENT.OQ / HUBS.K / VCEL.O / TBK.O / ETSY.O / SHOP.K / UQ1.F / SEDG.O / RUN.O / TMUS.OQ / APLS.OQ / MIME.OQ / WKHS.O / WCN.TO / AQMS.O / BABA.K / COUP.O / WPRT.TO / PLXP.O / ALPN.O / RDFN.O / MBIO.OQ / WDAY.O / ROKU.O / MDB.O / APTV.K / DOCU.O / LOVE.OQ / FOCS.OQ / CWENa.K / ORTX.OQ / SWAV.O / UBER.K / FVRR.K / BILL.K / AVNT.K / 02081G201 / FMTX.O / RWRh.V / 390320109</td><td class="leftalignment">Arcosa Inc / Albemarle Corp / Bloom Energy Corp / Bio Rad Laboratories Inc / Box Inc / Boston Scientific Corp / Caterpillar Inc / Clean Harbors Inc / Cummins Inc / Salesforce.Com Inc / Dana Inc / Deere & Co / EnerSys / Johnson Controls International PLC / Medtronic PLC / Microsoft Corp / Nextera Energy Partners LP / ServiceNow Inc / Ormat Technologies Inc / Regal Rexnord Corp / Revlon Inc / Republic Services Inc / SolarWinds Corp / AT&T Inc / Waste Management Inc / Zendesk Inc / Oracle Corp Japan / Amazon.com Inc / Amgen Inc / Borgwarner Inc / Adobe Inc / SAP SE / CorVel Corp / Monolithic Power Systems Inc / Semtech Corp / Autodesk Inc / Edwards Lifesciences Corp / Fuelcell Energy Inc / OraSure Technologies Inc / Wolfspeed Inc / Cirrus Logic Inc / American Superconductor Corp / Virtus Investment Partners Inc / Pool Corp / Cal-Maine Foods Inc / United Therapeutics Corp / Plug Power Inc / Marvell Technology Inc / PDF Solutions Inc / Trimble Inc / Quidel Corp / Itron Inc / National Instruments Corp / Amedisys Inc / Paylocity Holding Corp / LivePerson Inc / Netflix Inc / Johnson & Johnson / Comcast Corp / Carter's Inc / AtriCure Inc / SunPower Corp / ATN International Inc / eHealth Inc / Canadian Solar Inc / First Solar Inc / Ensign Group Inc / Ulta Beauty Inc / Transmedics Group Inc / Freshpet Inc / Twin Disc Inc / Blackline Safety Corp / Cardiovascular Systems Inc / AGCO Corp / Generac Holdings Inc / Tesla Inc / Ameresco Inc / Amyris Inc / Zynga Inc / Enphase Energy Inc / Meta Platforms Inc / Carlyle Group Inc / Five Below Inc / Globus Medical Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / RingCentral Inc / Mirati Therapeutics Inc / Fate Therapeutics Inc / Alphabet Inc / Paycom Software Inc / Ares Management Corp / Intersect Ent Inc / HubSpot Inc / Vericel Corp / Triumph Bancorp Inc / ETSY Inc / Shopify Inc / Uniqure NV / Solaredge Technologies Inc / Sunrun Inc / T-Mobile US Inc / Apellis Pharmaceuticals Inc / Mimecast Ltd / Workhorse Group Inc / Waste Connections Inc / Aqua Metals Inc / Alibaba Group Holding Ltd / Coupa Software Inc / Westport Fuel Systems Inc / PLx Pharma Inc / Alpine Immune Sciences Inc / Redfin Corp / Mustang Bio Inc / Workday Inc / Roku Inc / MongoDB Inc / Aptiv PLC / DocuSign Inc / Lovesac Co / Focus Financial Partners Inc / Clearway Energy Inc / Orchard Therapeutics PLC / Shockwave Medical Inc / Uber Technologies Inc / Fiverr International Ltd / Bill.com Holdings Inc / Avient Corp / Alphatec Holdings Inc / Forma Therapeutics Holdings Inc / Strathmore Plus Energy Corp / Great Elm Capital Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / China / Cayman Islands / Germany / United Kingdom / Ireland / Israel / Japan / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/17/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / BMY=US / DIS=US / TWTR=US / GBT=US / CL=US / AMZN=US / T=US / EBAY=US / INCY=US / GILD=US / VZ=US / IGT=US / VRM=US / BYD=US / SPOT=US / EXPE=US / MGM=US / AKR=US / PENN=US / W=US / DV=US / AMK=US / PATH=US / COLL=US / TREE=US / NOW=US / MCRI=US / REGN=US / SNAP=US / TRIP=US / TRUE=US / VRTX=US / WIX=US / PSA=US / SNOW=US / SGMS=US / NET=US / HIW=US / PYPL=US / BKNG=US / EGP=US / FB=US / MTCH=US / AUTL=US / BDSI=US / RRR=US / PTON=US / BIIB=US / RNG=US / CZR=US / EXR=US / GMS=US / PGTI=US / WH=US / TIL=US / IAC=US / 45665G303 / OLO=US / NLSN=US / ANGI=US / MEIP=US / SSTK=US / ABBV=US / VOYA=US / PTCT=US / FATE=US / GOOGL=US / COUP=US / BABA=US / CMPR=US / VCEL=US / GDDY=US / ETSY=US / ARGX=US / ZG=US / SQ=US / WVE=US / MIME=US / TTD=US / CRSP=US / TRVG=US / GDS=US / CVNA=US / YEXT=US / IOVA=US / RDFN=US / ROKU=US / CARG=US / SFIX=US / ROOT=US / COLD=US / FTDR=US / SVMK=US / EB=US / SITC=US / AMTB=US / LYFT=US / UBER=US / GMAB=US / DKNG=US / CRMD.US / BALY=US / ABNB=US / DASH=US / NGMS=US / COUR-US / KNBE=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Walt Disney Co / Twitter Inc / Global Blood Therapeutics Inc / Colgate-Palmolive Co / Amazon.com Inc / AT&T Inc / eBay Inc / Incyte Corp / Gilead Sciences Inc / Verizon Communications Inc / International Game Technology PLC / Vroom Inc / Boyd Gaming Corp / Spotify Technology SA / Expedia Group Inc / MGM Resorts International / Acadia Realty Trust / Penn National Gaming Inc / Wayfair Inc / DoubleVerify Holdings Inc / AssetMark Financial Holdings Inc / UiPath Inc / Collegium Pharmaceutical Inc / Lendingtree Inc / ServiceNow Inc / Monarch Casino & Resort Inc / Regeneron Pharmaceuticals Inc / Snap Inc / Tripadvisor Inc / TrueCar Inc / Vertex Pharmaceuticals Inc / Wix.Com Ltd / Public Storage / Snowflake Inc. / Scientific Games Corp / Cloudflare Inc / Highwoods Properties Inc / PayPal Holdings Inc / Booking Holdings Inc / Eastgroup Properties Inc / Meta Platforms Inc / Match Group Inc / Autolus Therapeutics PLC / BioDelivery Sciences International Inc / Red Rock Resorts Inc / Peloton Interactive Inc / Biogen Inc / RingCentral Inc / Caesars Entertainment Inc / Extra Space Storage Inc / GMS Inc / PGT Innovations Inc / Wyndham Hotels & Resorts Inc / Instil Bio Inc / IAC/Interactivecorp / Infinity Pharmaceuticals Inc / Olo Inc / Nielsen Holdings PLC / Angi Inc / MEI Pharma Inc / Shutterstock Inc / Abbvie Inc / Voya Financial Inc / PTC Therapeutics Inc / Fate Therapeutics Inc / Alphabet Inc / Coupa Software Inc / Alibaba Group Holding Ltd / Cimpress PLC / Vericel Corp / GoDaddy Inc / ETSY Inc / argenx SE / Zillow Group Inc / Block Inc / WAVE Life Sciences Ltd / Mimecast Ltd / Trade Desk Inc / CRISPR Therapeutics AG / Trivago NV / GDS Holdings Ltd / Carvana Co / Yext Inc / Iovance Biotherapeutics Inc / Redfin Corp / Roku Inc / CarGurus Inc / Stitch Fix Inc / Root Inc / Americold Realty Trust / Frontdoor Inc / Momentive Global Inc / Eventbrite Inc / Site Centers Corp / Amerant Bancorp Inc / Lyft Inc / Uber Technologies Inc / Genmab A/S / DraftKings Inc / CorMedix Inc / Bally's Corp / Airbnb Inc / DoorDash Inc / NeoGames SA / Coursera Inc / Knowbe4 Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / China / Cayman Islands / Denmark / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / Singapore / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/16/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">First Mover Advantage</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AMGN.O / MRTX.OQ</td><td class="leftalignment">Amgen Inc / Mirati Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="odd"><td class="leftalignment">05/16/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Too Little, Too Late—Down to Perform</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRTX.OQ / AMGN.O</td><td class="leftalignment">Mirati Therapeutics Inc / Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">05/16/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Key Questions for Management 5.16.21</td><td class="leftalignment">English</td><td class="rightalignment">67</td><td class="leftalignment">ABT / ACAD / 00365410 / 28176E10 / 62855J10 / 01988P10 / 45337C10 / 75991610 / 09061G10 / 86366710 / 71708110 / 00846U10 / 45253H10 / 12665010 / 07181310 / 10113710 / 92532F10 / 88355610 / 35802910 / 94184810 / 04635310 / 43644010 / 76115210 / 64125C10 / 87936910 / 37555810 / 15678210 / 03116210 / 66987V10 / 75886F10 / 46120E60 / M2572210 / 45232710 / 09062X10 / 01625510 / 30063P10 / 478160104 / 98956P10 / 159864107 / 640268108 / 075887109 / 02043Q10 / 67070410 / 207410101 / 205306103 / 45784P10 / 25213110 / 04963C20 / 03152W10 / 64049M20 / 58933Y10 / 14161910 / G0176710 / 45766930 / G5087110 / 80360710 / 74051N10 / 92337F10 / 05463X10 / 45780L10 / 92247510 / 09073M104 / 82621J10 / 31572Q80 / 87918A10 / 46185L10 / 00653A107 / 04351P101 / 75046920 / 74587V10 / 00287Y10 / 92346J10 / 98401F10 / 46071F10 / G5960L10 / 46222210 / 18946410 / 04004760 / 04280A10 / 92686J10 / 05337M104 / 23283X20 / 40131M10 / 63230710 / 89853L10 / 71944F10 / 45773010 / 05358830 / 38942Q10 / 76029N10 / 41358P10 / N9006410 / 42226A10 / 68269G10 / 00437E10 / 74939710 / 90041T10 / 09627Y10 / 68071010 / Y9530810 / 30052C10 / 09075V10 / 60770K10 / 74340E10 / 42225T10 / 87337910 / 00289Y10 / 00773U10 / 01981810 / 05455M10 / 09609G10 / 10806X10 / 45826J10 / 75901B10 / 77313F10 / 05464T10 / 05156V10 / 75615P10 / 16383L10 / 55609910 / N0104510 / 14843C10 / 01438T10 / 74374N10 / 51654410 / 31189P10 / 07725L10 / G3910J11 / H0026310 / 00847X10 / 24344T10 / 29428V10 / 37890U10 / 81181C10 / G1119610 / 40422M10 / 98978L20 / 92857F10 / 04685N10 / 13089P10 / 34633R10 / K3967W10 / 37242740 / 38341P10 / 43906K10 / 45781K20 / 46565G10 / 48576U10 / 50127T10 / 61776010 / 60468T10 / 03969F10 / 05370A10 / 78116T10 / 76155X10 / F5548N10 / 98887Q10 / 45845P10 / 4525EP10 / 78667J10 / 82710M10 / 46116X10 / 74366E10 / 37957720 / 22905030 / G8807B10 / 90400D10 / 64157F10 / 74766Q10 / 87537220 / 69014510 / 35961610 / 55886810 / 05454B10 / 49232710 / 22663K10 / 05465P10 / 00461U10 / 04539610 / 81727U10 / 59045L10 / 01671P10 / 68621F10 / 45249V10 / F4373810 / 80405P10 / N4482110 / 92765F10 / 75955J40 / 56400P70 / 28255910 / 87808K10 / 87166L10 / 03836N10 / 23257D10 / 40434H20 / 28617K10 / 29446K10 / 83422E10 / 03824M10 / N1976T10 / 23306J10 / 34385P10 / 36322Q10 / N4444510 / 45258J10 / 48349710 / 56854Q20 / 65343C10 / 74623710 / 75974E10 / H9060V101</td><td class="leftalignment">Abbott Laboratories / ACADIA Pharmaceuticals Inc / ABIOMED Inc / Edwards Lifesciences Corp / Myriad Genetics Inc / Allscripts Healthcare Solutions Inc / Incyte Corp / Repligen Corp / Biomarin Pharmaceutical Inc / Stryker Corp / Pfizer Inc / Agilent Technologies Inc / ImmunoGen Inc / CVS Health Corp / Baxter International Inc / Boston Scientific Corp / Vertex Pharmaceuticals Inc / Thermo Fisher Scientific Inc / Fresenius Medical Care AG & Co KGaA / Waters Corp / AstraZeneca PLC / Hologic Inc / Resmed Inc / Neurocrine Biosciences Inc / Teleflex Inc / Gilead Sciences Inc / Cerner Corp / Amgen Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Intuitive Surgical Inc / Compugen Ltd / Illumina Inc / Biogen Inc / Align Technology Inc / Exact Sciences Corp / Johnson & Johnson / Zimmer Biomet Holdings Inc / Charles River Laboratories International Inc / Nektar Therapeutics / Becton Dickinson and Co / Alnylam Pharmaceuticals Inc / NuVasive Inc / Conmed Corp / Computer Programs and Systems Inc / Insulet Corp / Dexcom Inc / AtriCure Inc / Amicus Therapeutics Inc / Neogenomics Inc / Merck & Co Inc / Cardiovascular Systems Inc / Alkermes Plc / Insmed Inc / Jazz Pharmaceuticals PLC / Sarepta Therapeutics Inc / Premier Inc / Veracyte Inc / AxoGen Inc / Inogen Inc / Veeva Systems Inc / Bio-Techne Corp / Sientra Inc / FibroGen Inc / Teladoc Health Inc / Invitae Corp / Adaptimmune Therapeutics PLC / Ascendis Pharma A/S / Radius Health Inc / Puma Biotechnology Inc / Abbvie Inc / Vericel Corp / Xencor Inc / Intersect Ent Inc / Medtronic PLC / Ionis Pharmaceuticals Inc / Clovis Oncology Inc / Arena Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Viking Therapeutics Inc / Avadel Pharmaceuticals PLC / Cytosorbents Corp / Guardant Health Inc / Natera Inc / T2 Biosystems Inc / Phreesia Inc / Inspire Medical Systems Inc / Aveo Pharmaceuticals Inc / Graybug Vision Inc / Replimune Group Inc / Harpoon Therapeutics Inc / Uniqure NV / Healthequity Inc / 1Life Healthcare Inc / Accolade Inc / R1 RCM Inc / Turning Point Therapeutics Inc / Blueprint Medicines Corp / Olink Holding AB (publ) / WAVE Life Sciences Ltd / Evolus Inc / BioNTech SE / Moderna Inc / Progyny Inc / Health Catalyst Inc / Tabula Rasa HealthCare Inc / Abeona Therapeutics Inc / Adverum Biotechnologies Inc / Allovir Inc / AVROBIO Inc / bluebird bio Inc / BridgeBio Pharma Inc / Intellia Therapeutics Inc / Regenxbio Inc / Rocket Pharmaceuticals Inc / Axsome Therapeutics Inc / Aurinia Pharmaceuticals Inc / Reata Pharmaceuticals Inc / ChemoCentryx Inc / MacroGenics Inc / Affimed NV / Castle Biosciences Inc / Aldeyra Therapeutics Inc / Provention Bio Inc / Lantheus Holdings Inc / Fate Therapeutics Inc / Beigene Ltd / GlaxoSmithKline PLC / AC Immune SA / Agios Pharmaceuticals Inc / Deciphera Pharmaceuticals Inc / Epizyme Inc / Global Blood Therapeutics Inc / Seagen Inc / Biohaven Pharmaceutical Holding Company Ltd / H Lundbeck A/S / Zogenix Inc / Vocera Communications Inc / Athenex Inc / Calithera Biosciences Inc / Forma Therapeutics Holdings Inc / Genmab A/S / Genocea Biosciences Inc / Gossamer Bio Inc / HOOKIPA Pharma Inc / Innate Pharma SA / Iteos Therapeutics Inc / Karyopharm Therapeutics Inc / Kura Oncology Inc / MorphoSys AG / Mirati Therapeutics Inc / Arcus Biosciences Inc / Avidity Biosciences Inc / Rubius Therapeutics Inc / Revolution Medicines Inc / Sanofi SA / Zai Lab Ltd / Intercept Pharmaceuticals Inc / Immunic Inc / SAGE Therapeutics Inc / Silk Road Medical Inc / Intra-Cellular Therapies Inc / Protagonist Therapeutics Inc / Globus Medical Inc / Cryoport Inc / Theravance Biopharma Inc / Ultragenyx Pharmaceutical Inc / Nevro Corp / Quanterix Corp / Tandem Diabetes Care Inc / Outset Medical Inc / Fulcrum Therapeutics Inc / Madrigal Pharmaceuticals Inc / Axcella Health Inc / Keros Therapeutics Inc / Crinetics Pharmaceuticals Inc / Axonics Inc / Aclaris Therapeutics Inc / Assembly Biosciences Inc / Senseonics Holdings Inc / Mersana Therapeutics Inc / Allakos Inc / Organogenesis Holdings Inc / Imara Inc / Genfit SA / Satsuma Pharmaceuticals Inc / InflaRx NV / Viracta Therapeutics Inc / Relmada Therapeutics Inc / MannKind Corp / 89Bio Inc / TCR2 Therapeutics Inc / Synlogic Inc / Aptinyx Inc / Cymabay Therapeutics Inc / HTG Molecular Diagnostics Inc / Eledon Pharmaceuticals Inc / Equillium Inc / Solid Biosciences Inc / Applied Molecular Transport Inc. / Centogene NV / DBV Technologies SA / Fluidigm Corp / Galecto Inc / Immatics NV / Immunovant Inc / Kalvista Pharmaceuticals Inc / Marinus Pharmaceuticals Inc / NextGen Healthcare Inc / PureTech Health PLC / Reneo Pharmaceuticals Inc / VectivBio Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / Singapore / Sweden / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">SVB Leerink Equ Research</td></tr>
<tr class="odd"><td class="leftalignment">05/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for AMGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">05/15/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Amgen Inc.</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">05/14/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 547</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">05/14/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech & Pharma: Truist EHA Planner v1.0 Highlights 100+ Datapoints of Interest</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / BMY=US / GBT=US / INCY=US / GILD=US / REGN=US / VRTX=US / AUTL=US / MEIP=US / ABBV=US / CRSP=US / GMAB=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Global Blood Therapeutics Inc / Incyte Corp / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Autolus Therapeutics PLC / MEI Pharma Inc / Abbvie Inc / CRISPR Therapeutics AG / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Asthika Goonewardene / Ms. Robyn S. Karnauskas / Mr. Gregg Gilbert / Ms. Srikripa Devarakonda, PHD / Mr. Joon Lee, MD</td></tr>
<tr class="odd"><td class="leftalignment">05/14/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended May 7, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">05/14/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="odd"><td class="leftalignment">05/14/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">05/13/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Never Mind The Tape - Inflows Continue</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">05/12/2021</td><td class="leftalignment">Crispidea</td><td class="leftalignment">Amgen Inc. (AMGN) - Biosimilars annualizing above $2bn mark</td><td class="leftalignment">English</td><td class="rightalignment">42</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">RESEARCH OVERVIEW</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / ASSET MANAGEMENT / CAPITALIZATION / EARNINGS/FINANCIAL STATEMENTS / MERGER/ACQUISITION/DIVESTITURE / MISCELLANEOUS / CHANGE IN RECOMMENDATION / GROWTH</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Rimi Murarka / Ms. Shejal Ajmera</td></tr>
<tr class="even"><td class="leftalignment">05/11/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">AMGN.OQ - Event Transcript of Amgen Inc conference call, May 11, 2021 / 11:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/11/2021</td><td class="leftalignment">UnivDatos Market Insights (UMI)</td><td class="leftalignment">Cancer Immunotherapy Market: Current Analysis and Forecast (2021-2027)</td><td class="leftalignment">English</td><td class="rightalignment">261</td><td class="leftalignment">FACT=US / MRK=US / PFE=US / AMGN=US / BMY=US / A=US / NOVN=CH / AZN=GB / BLUE=US / null / 500680=IN / 506820=IN / ABBV=US / CNTO=US</td><td class="leftalignment">Freedom Acquisition I Corp / Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Agilent Technologies Inc / Novartis AG / AstraZeneca PLC / bluebird bio Inc / One 97 Communications Ltd / Pfizer Ltd / Astrazeneca Pharma India Ltd / Abbvie Inc / Centor Energy Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / China / Cayman Islands / Germany / Spain / France / United Kingdom / India / Italy / Japan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE / INDUSTRY OVERVIEW / MERGER/ACQUISITION/DIVESTITURE / OPERATIONS / OPERATING RESULTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">univdatos Co / UMI Team</td></tr>
<tr class="even"><td class="leftalignment">05/11/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Vaccinations Reach 46%, Adolescent Approval Likely to Reverse Downward Trend in Administrations; Outbreak in India Continues</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Matt Phipps, PHD / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Mr. Rob Andrew, CFA / John Boyle / Sami Corwin, PHD / Lachlan Hanbury-Brown</td></tr>
<tr class="odd"><td class="leftalignment">05/11/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / OXY=US / ICLR=US / WEN=US / BLD=US / INCY=US / TEVA=US / KMI=US / CMA=US / REI=US / PLUG=US / CRM=US / LOW=US / ENR=US / FMS=US / VRM=US / CHRS=US / MAR=US / LEG=US / VMC=US / MLM=US / CBRL=US / ELY=US / CHH=US / CSGP=US / DRI=US / GFF=US / IBP=US / NOW=US / MAS=US / MPLX=US / MHK=US / SHOP=US / GOLF=US / SAGE=US / SPG=US / EPD=US / SGMS=US / BKNG=US / NLS=US / DIN=US / MGNI=US / PTON=US / RNG=US / TCBI=US / TPX=US / EXP=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / SCPL=US / CMG=US / PGTI=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / APEI=US / WH=US / JACK=US / TREX=US / APTS=US / FBHS=US / BCEI=US / ABBV=US / TILE=US / NDLS=US / LOCO=US / OSH=US / VCEL=US / SHAK=US / GSBD=US / WING=US / SQ=US / AXSM=US / 82982L103 / TTD=US / EVBG=US / JELD=US / ATNX=US / SWCH=US / SAIL=US / EQH=US / BTAI=US / SVMK=US / PLMR=US / FERG=US / RPAY=US / ARQT=US / REYN=US / SPCE=US / FBRX=US / AZEK=US / BALY=US / VTRS=US / ABNB=US / AFRM=US / RBLX=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Occidental Petroleum Corp / ICON PLC / Wendys Co / TopBuild Corp / Incyte Corp / Teva Pharmaceutical Industries Ltd / Kinder Morgan Inc / Comerica Inc / Ring Energy Inc / Plug Power Inc / Salesforce.Com Inc / Lowe's Companies Inc / Energizer Holdings Inc / Fresenius Medical Care AG & Co KGaA / Vroom Inc / Coherus BioSciences Inc / Marriott International Inc / Leggett & Platt Inc / Vulcan Materials Co / Martin Marietta Materials Inc / Cracker Barrel Old Country Store Inc / Callaway Golf Co / Choice Hotels International Inc / CoStar Group Inc / Darden Restaurants Inc / Griffon Corp / Installed Building Products Inc / ServiceNow Inc / Masco Corp / MPLX LP / Mohawk Industries Inc / Shopify Inc / Acushnet Holdings Corp / SAGE Therapeutics Inc / Simon Property Group Inc / Enterprise Products Partners LP / Scientific Games Corp / Booking Holdings Inc / Nautilus Inc / Dine Brands Global Inc / Magnite Inc / Peloton Interactive Inc / RingCentral Inc / Texas Capital Bancshares Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Sciplay Corp / Chipotle Mexican Grill Inc / PGT Innovations Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / American Public Education Inc / Wyndham Hotels & Resorts Inc / Jack in the Box Inc / Trex Company Inc / Preferred Apartment Communities Inc / Fortune Brands Home & Security Inc / Civitas Resources Inc / Abbvie Inc / Interface Inc / Noodles & Co / El Pollo Loco Holdings Inc / Oak Street Health Inc / Vericel Corp / Shake Shack Inc / Goldman Sachs BDC Inc / Wingstop Inc / Block Inc / Axsome Therapeutics Inc / SiteOne Landscape Supply Inc / Trade Desk Inc / Everbridge Inc / JELD-WEN Holding Inc / Athenex Inc / Switch Inc / SailPoint Technologies Holdings Inc / Equitable Holdings Inc / BioXcel Therapeutics Inc / Momentive Global Inc / Palomar Holdings Inc / Ferguson PLC / Repay Holdings Corp / Arcutis Biotherapeutics Inc / Reynolds Consumer Products Inc / Virgin Galactic Holdings Inc / Forte Biosciences Inc / Azek Company Inc / Bally's Corp / Viatris Inc / Airbnb Inc / Affirm Holdings Inc / Roblox Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Germany / Ireland / Israel / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/11/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2023607 / 2778844 / 2973821 / 2219224 / 2175672 / 2222631 / 2037170 / 2328915 / 2369174 / 2415204 / 2457864 / 2657802 / 2689560 / 2684703 / 2048804 / 2440637 / 2862532 / 4595739 / 7103065 / B1F76F9 / B121557 / B19FQ48 / B125XQ6 / B7TL820 / B4MG4Z6 / B7VD3F2 / BJ0XLZ3 / BDZCRX3 / BFH3N85 / BFZCHN7 / BVVN4Q8 / BYVY8G0 / BYVFC94 / BF4VBS8 / BK0VHF6 / BD9GVY0 / BJXPS33 / BD8DJ71 / BJFSR88 / BYZR4X4 / BP7RS48 / BKVDFF7 / BYXJQG9 / BZ1LFG7 / BL71K91 / BD6JX35 / BZ0P3Z5 / BYTJZL1 / BDD1B07 / BKT6B38 / BF3N4P3 / BM8MM05 / BLBLMD5 / BNG3RZ7 / BMDJ085 / BLR6S36</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Alliant Energy Corp / CMS Energy Corp / Cardinal Health Inc / Cooper Companies Inc / 8x8 Inc / Nextera Energy Inc / Gilead Sciences Inc / Hawaiian Electric Industries Inc / ImmunoGen Inc / OGE Energy Corp / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / CenterPoint Energy Inc / E W Scripps Co / Genmab A/S / Novartis AG / Western Union Co / Mastercard Inc / Amicus Therapeutics Inc / Portland General Electric Co / Meta Platforms Inc / AMC Networks Inc / Duke Energy Corp / Heron Therapeutics Inc / RingCentral Inc / Veeva Systems Inc / Wix.Com Ltd / Eversource Energy / Alphabet Inc / US Foods Holding Corp / BioXcel Therapeutics Inc / IDEAYA Biosciences Inc / Zai Lab Ltd / BELLUS Health Inc / Snap Inc / Uniqure NV / Axsome Therapeutics Inc / Intersect Ent Inc / Oric Pharmaceuticals Inc / Spire Inc / Roku Inc / Revolution Medicines Inc / Krystal Biotech Inc / Tegna Inc / Zogenix Inc / Rubius Therapeutics Inc / SmileDirectClub Inc / Arena Pharmaceuticals Inc / Madison Square Garden Entertainment Corp / Array Technologies Inc / Leslie's Inc / Shoals Technologies Group Inc / Longboard Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">RVMD (BUY) - Mgmt Takeaways Post-1Q Results; RMC-4630 (SHP2) Combos Enrolling; Pipeline w/ Pan-RAS, mTORC1, and SOS1 Inhibitors on Track; Maintain BUY</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BL71K91 / 0989529 / 2023607 / 7103065 / BBPK0J0</td><td class="leftalignment">Revolution Medicines Inc / AstraZeneca PLC / Amgen Inc / Novartis AG / Mirati Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Apr 30, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Tracking the JAKs</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / BMY=US / INCY=US / ABBV=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Abbvie Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">4031976 / 2126335 / 2023607 / 2640147 / 2973821 / 2219224 / 2216850 / 2328915 / 2415204 / 2459202 / 2459020 / 2630513 / 2657802 / 2680905 / 2684703 / 2048804 / 2440637 / 2799351 / 2825933 / 2795393 / B121557 / 2212922 / 2769796 / B125XQ6 / B0T7YX2 / B02R1L6 / B2R3PV1 / B1HJLW5 / B3P93Y7 / B570P91 / B7TL820 / B4MG4Z6 / BCDWBX6 / BJ3V905 / BBPK0J0 / BBGVT40 / BCGCR79 / BFLR866 / BFZCHN7 / B95WG16 / BVVN4Q8 / BYY8XK8 / BYW36M8 / BYQHP96 / BFNF1D6 / BF5L3T2 / BYNZGK1 / BD8DJ71 / BKDS4H5 / BR4T3B3 / BKVDFF7 / BMYML02 / BFMXGR0 / BYXJQG9 / BG31GH0 / BKTNTR9 / BJVR9Y9 / BD6D4Y5 / BZ1LFG7 / BL71K91 / BN0XTW4 / BN7K304 / BLBLMD5 / BD8QGD5 / BNTB3N8</td><td class="leftalignment">Adidas AG / Bristol-Myers Squibb Co / Amgen Inc / Nike Inc / Alliant Energy Corp / CMS Energy Corp / Consolidated Edison Inc / Nextera Energy Inc / Hawaiian Electric Industries Inc / IDEXX Laboratories Inc / Intuit Inc / New Jersey Resources Corp / OGE Energy Corp / PPL Corp / Pfizer Inc / Pinnacle West Capital Corp / CenterPoint Energy Inc / Sinclair Broadcast Group Inc / South Jersey Industries Inc / Amerisourcebergen Corp / Mastercard Inc / NRG Energy Inc / Fidelity National Information Services Inc / Portland General Electric Co / Live Nation Entertainment Inc / ALLETE Inc / American Water Works Company Inc / Emergent BioSolutions Inc / Anheuser Busch Inbev SA / Lear Corp / Meta Platforms Inc / AMC Networks Inc / ANI Pharmaceuticals Inc / Endo International PLC / Mirati Therapeutics Inc / News Corp / Sprouts Farmers Market Inc / Twitter Inc / Wix.Com Ltd / Zoetis Inc / Eversource Energy / WEC Energy Group Inc / PayPal Holdings Inc / Floor & Decor Holdings Inc / Amneal Pharmaceuticals Inc / Elanco Animal Health Inc / Block Inc / Snap Inc / Bill.com Holdings Inc / HubSpot Inc / Oric Pharmaceuticals Inc / DraftKings Inc / Evergy Inc / Spire Inc / Y-mAbs Therapeutics Inc / ViacomCBS Inc / iHeartMedia Inc / Altair Engineering Inc / Roku Inc / Revolution Medicines Inc / Orphazyme A/S / Academy Sports and Outdoors Inc / Array Technologies Inc / Liberty Media Corp / Vizio Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Germany / Denmark / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">05/07/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">HZNP-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">HZNP.O / MRK / PFE / AMGN.O / RDY / AZN.O / RDUS.O</td><td class="leftalignment">Horizon Therapeutics PLC / Merck & Co Inc / Pfizer Inc / Amgen Inc / Dr Reddy's Laboratories Ltd / AstraZeneca PLC / Radius Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / India / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">05/07/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">REGN-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">REGN.O / JNJ / NVS / AMGN.O / BIIB.O / ALNY.O / SNY.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Johnson & Johnson / Novartis AG / Amgen Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">05/07/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">IDRA-US - Fundamental Analysis, for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">IDRA.O / ABT / JNJ / MRK / PFE / AMGN.O / AGEN.O / LGND.O / BIIB.O / DVAX.O / CLDX.O</td><td class="leftalignment">Idera Pharmaceuticals Inc / Abbott Laboratories / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Amgen Inc / Agenus Inc / Ligand Pharmaceuticals Inc / Biogen Inc / Dynavax Technologies Corp / Celldex Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">05/07/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 546</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">05/07/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--May 07, 2021</td><td class="leftalignment">English</td><td class="rightalignment">48</td><td class="leftalignment">ACA / AMN / BAX / BSX / CHE / CI / CNC / CVS / GE / HUM / MDT / RAD / SGE.L / SYK / UNH / WMT / GILD.O / AMGN.O / AAPL.O / NOVN.S / HCA.N / CYH.N / INSP.N / EW.N / DRRX.O / INCY.OQ / NBIX.OQ / EPIX.OQ / ICPT.OQ / UTHR.OQ / EXEL.OQ / BLUE.OQ / VRTX.OQ / CCRN.O / LIFE.O / AMED.O / EXAS.O / BIIB.O / 478160104 / 00846U101 / 868168105 / MNKD.O / ACAD.O / ATRC.OQ / DXCM.O / LHCG.O / ALCLS.PA / BLRX.TA / PODD.O / 02043Q107 / ENSG.OQ / TNDM.O / 483548103 / SPRO.OQ / MRNA.O / TMDX.OQ / MD.N / 771195104 / CSII.O / ADUS.O / USPH.N / GLAXOSM.LG / SRPT.O / ENTA.O / FATE.OQ / AUP.TO / AERI.O / TRVN.O / GLMD.OQ / GOOGL.O / ALDX.OQ / MDWD.O / 02005N100 / AGRX.OQ / CBAY.OQ / APS.TO / VKTX.O / NVRO.N / VCEL.O / VRAY.OQ / EVH.N / TDOC.N / MCRB.OQ / GKOS.K / ZBH.N / CFMS.O / GBT.OQ / 100063846 / EDIT.OQ / NVTA.K / ADAP.O / NTLA.O / SYRS.OQ / TCMD.OQ / FLGT.OQ / IRTC.OQ / MDGL.O / VREX.OQ / SLNO.OQ / IOVA.OQ / VERU.OQ / KALA.O / ATNX.O / FIXX.OQ / 720795103 / PRVB.OQ / ARVN.OQ / ALLO.OQ / MRKR.OQ / CRSP.BN / XFOR.OQ / 21833P103 / DTIL.O / IMUX.O / TPTX.O / ONCT.OQ / KRTX.OQ / PSNL.O / PNTG.OQ / BXRX.OQ / ETNB.O / ORIC.OQ / PHGE.K / HGEN.O / REGW.M3 / 03823M100</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Baxter International Inc / Boston Scientific Corp / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / General Electric Co / Humana Inc / Medtronic PLC / Rite Aid Corp / Sage Group PLC / Stryker Corp / UnitedHealth Group Inc / Walmart Inc / Gilead Sciences Inc / Amgen Inc / Apple Inc / Novartis AG / HCA Healthcare Inc / Community Health Systems Inc / Inspire Medical Systems Inc / Edwards Lifesciences Corp / DURECT Corp / Incyte Corp / Neurocrine Biosciences Inc / ESSA Pharma Inc / Intercept Pharmaceuticals Inc / United Therapeutics Corp / Exelixis Inc / bluebird bio Inc / Vertex Pharmaceuticals Inc / Cross Country Healthcare Inc / aTyr Pharma Inc / Amedisys Inc / Exact Sciences Corp / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / MannKind Corp / ACADIA Pharmaceuticals Inc / AtriCure Inc / Dexcom Inc / LHC Group Inc / Cellectis SA / BioLine RX Ltd / Insulet Corp / Alnylam Pharmaceuticals Inc / Ensign Group Inc / Tandem Diabetes Care Inc / Kaman Corp / Spero Therapeutics Inc / Moderna Inc / Transmedics Group Inc / MEDNAX Inc / Roche Holding AG / Cardiovascular Systems Inc / Addus Homecare Corp / US Physical Therapy Inc / Glaxo Smithkline Consumer Nigeria PLC / Sarepta Therapeutics Inc / Enanta Pharmaceuticals Inc / Fate Therapeutics Inc / Aurinia Pharmaceuticals Inc / Aerie Pharmaceuticals Inc / Trevena Inc / Galmed Pharmaceuticals Ltd / Alphabet Inc / Aldeyra Therapeutics Inc / Mediwound Ltd / Ally Financial Inc / Agile Therapeutics Inc / Cymabay Therapeutics Inc / Aptose Biosciences Inc / Viking Therapeutics Inc / Nevro Corp / Vericel Corp / ViewRay Inc / Evolent Health Inc / Teladoc Health Inc / Seres Therapeutics Inc / Glaukos Corp / Zimmer Biomet Holdings Inc / Conformis Inc / Global Blood Therapeutics Inc / Truist Financial Corp / Editas Medicine Inc / Invitae Corp / Adaptimmune Therapeutics PLC / Intellia Therapeutics Inc / Syros Pharmaceuticals Inc / Tactile Systems Technology Inc / Fulgent Genetics Inc / iRhythm Technologies Inc / Madrigal Pharmaceuticals Inc / Varex Imaging Corp / Soleno Therapeutics Inc / Iovance Biotherapeutics Inc / Veru Inc / Kala Pharmaceuticals Inc / Athenex Inc / Homology Medicines Inc / Pieris Pharmaceuticals Inc / Provention Bio Inc / Arvinas Inc / Allogene Therapeutics Inc / Marker Therapeutics Inc / CRISPR Therapeutics AG / X4 Pharmaceuticals Inc / Corbus Pharmaceuticals Holdings Inc / Precision BioSciences Inc / Immunic Inc / Turning Point Therapeutics Inc / Oncternal Therapeutics Inc / Karuna Therapeutics Inc / Personalis Inc / Pennant Group Inc / Baudax Bio Inc / 89Bio Inc / Oric Pharmaceuticals Inc / Biomx Inc / Humanigen Inc / Regency World Consulting Ltd / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / India / Ireland / Israel / Nigeria / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="odd"><td class="leftalignment">05/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">What's Next in Biotech? Partners in Crime - Mutant p53 and KRAS Cooperate to Drive Tumor Metastasis</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">2023607 / BBPK0J0 / BL71K91</td><td class="leftalignment">Amgen Inc / Mirati Therapeutics Inc / Revolution Medicines Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Mr. Etzer Darout / Yige Guo, Ph.D. / Kelsey Goodwin / Paul Jeng, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">05/07/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended April 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">05/07/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="even"><td class="leftalignment">05/07/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto</td></tr>
<tr class="odd"><td class="leftalignment">05/07/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">DNB / AMGN=US / TWTR=US / BLD=US / DVN=US / RUN=US / GILD=US / EOG=US / WLL=US / PAA=US / DIOD=US / CHRS=US / EXPE=US / CLI=US / PENN=US / BKI=US / W=US / AMED=US / AMN=US / ARW=US / ATRO=US / AVT=US / ENV=US / KIDS=US / CW=US / DRH=US / EPC=US / EQT=US / HAIN=US / DOC=US / MCHP=US / ORCC=US / REGN=US / STOR=US / TRIP=US / GOLF=US / FOUR=US / NET=US / PYPL=US / LCI=US / EVOP=US / REG=US / AUTL=US / BDSI=US / PRAA=US / MNST=US / PTON=US / JRVR=US / NOMD=US / RPD=US / BECN=US / LHCG=US / THS=US / BLDR=US / FIS=US / HST=US / OC=US / PAGP=US / SEAS=US / ATSG=US / IAC=US / PSN=US / AGS=US / CLNY=US / HTA=US / KNSL=US / GDOT=US / NLSN=US / ESTE=US / ANGI=US / PDCE=US / NCLH=US / FOXF=US / FATE=US / QTWO=US / LOCO=US / SHAK=US / CHCT=US / CABO=US / SQ=US / NTLA=US / ADVM=US / CDEV=US / IRTC=US / CRSP=US / PK=US / CVNA=US / ROKU=US / CARG=US / FNKO=US / COLD=US / FOCS=US / SVMK=US / EB=US / AXNX=US / UBER=US / DDOG=US / BRBR=US / AHCO=US / PNTG=US / OPCH=US</td><td class="leftalignment">Dun & Bradstreet Holdings Inc / Amgen Inc / Twitter Inc / TopBuild Corp / Devon Energy Corp / Sunrun Inc / Gilead Sciences Inc / EOG Resources Inc / Whiting Petroleum Corp / Plains All American Pipeline LP / Diodes Inc / Coherus BioSciences Inc / Expedia Group Inc / Veris Residential Inc / Penn National Gaming Inc / Black Knight Inc / Wayfair Inc / Amedisys Inc / AMN Healthcare Services Inc / Arrow Electronics Inc / Astronics Corp / Avnet Inc / Envestnet Inc / OrthoPediatrics Corp / Curtiss-Wright Corp / Diamondrock Hospitality Co / Edgewell Personal Care Co / EQT Corp / Hain Celestial Group Inc / Physicians Realty Trust / Microchip Technology Inc / Owl Rock Capital Corp / Regeneron Pharmaceuticals Inc / STORE Capital Corp / Tripadvisor Inc / Acushnet Holdings Corp / Shift4 Payments Inc / Cloudflare Inc / PayPal Holdings Inc / Lannett Company Inc / EVO Payments Inc / Regency Centers Corp / Autolus Therapeutics PLC / BioDelivery Sciences International Inc / PRA Group Inc / Monster Beverage Corp / Peloton Interactive Inc / James River Group Holdings Ltd / Nomad Foods Ltd / Rapid7 Inc / Beacon Roofing Supply Inc / LHC Group Inc / TreeHouse Foods Inc / Builders FirstSource Inc / Fidelity National Information Services Inc / Host Hotels & Resorts Inc / Owens Corning / Plains GP Holdings LP / SeaWorld Entertainment Inc / Air Transport Services Group Inc / IAC/Interactivecorp / Parsons Corp / PlayAGS Inc / DigitalBridge Group Inc / Healthcare Trust Of America Inc / Kinsale Capital Group Inc / Green Dot Corp / Nielsen Holdings PLC / Earthstone Energy Inc / Angi Inc / PDC Energy Inc / Norwegian Cruise Line Holdings Ltd / Fox Factory Holding Corp / Fate Therapeutics Inc / Q2 Holdings Inc / El Pollo Loco Holdings Inc / Shake Shack Inc / Community Healthcare Trust Inc / Cable One Inc / Block Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / Centennial Resource Development Inc / iRhythm Technologies Inc / CRISPR Therapeutics AG / Park Hotels & Resorts Inc / Carvana Co / Roku Inc / CarGurus Inc / Funko Inc / Americold Realty Trust / Focus Financial Partners Inc / Momentive Global Inc / Eventbrite Inc / Axonics Inc / Uber Technologies Inc / Datadog Inc / Bellring Brands Inc / Adapthealth Corp / Pennant Group Inc / Option Care Health Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/07/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Lowering PT to $22 on lower Udenyca sales, higher spending</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">CHRS=US / AMGN=US</td><td class="leftalignment">Coherus BioSciences Inc / Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">05/06/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Didn’t See That Coming – Positive Fund Flow Continues</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">05/06/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">DNB / WMB=US / PFE=US / AMGN=US / BMY=US / GBT=US / INCY=US / RUN=US / AMT=US / PEB=US / APA=US / BR=US / CPE=US / H=US / V=US / MTN=US / CRK=US / WLL=US / PXD=US / MGY=US / MAR=US / MRO=US / TNL=US / VMC=US / HLT=US / BKI=US / MLM=US / AMK=US / AIZ=US / AMN=US / FUN=US / CENT=US / CHH=US / CSGP=US / CW=US / DRH=US / EQT=US / DOC=US / SMG=US / WW=US / WIX=US / CCRN=US / MANT=US / PYPL=US / BKNG=US / DCP=US / EPR=US / FRT=US / JAZZ=US / MTCH=US / SRC=US / SPR=US / CRTO=US / AUTL=US / DIN=US / ECPG=US / MGPI=US / PTON=US / IGMS=US / FLT=US / CZR=US / NUVA=US / KAR=US / BDC=US / HURN=US / SHO=US / LHCG=US / AAWW=US / SPWR=US / HST=US / MA=US / LUMN=US / KTOS=US / WH=US / ATSG=US / IAC=US / PSN=US / RCUS=US / VRSK=US / HTA=US / HGV=US / GDOT=US / SBRA=US / RLJ=US / ESTE=US / VAC=US / ZNGA=US / ENPH=US / PDCE=US / RHP=US / TSLX=US / HUBS=US / VCEL=US / NVRO=US / GDDY=US / ETSY=US / EVRI=US / EDIT=US / 82982L103 / CRSP=US / PK=US / TVTY=US / ANAB=US / PLYA=US / SBOW=US / IOVA=US / RDFN=US / PETQ=US / DCPH=US / ROOT=US / GSKY=US / HARP=US / UBER=US / TCRR=US / PLMR=US / NXTC=US / GMAB=US / ARQT=US / REYN=US / VTRS=US</td><td class="leftalignment">Dun & Bradstreet Holdings Inc / Williams Companies Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Global Blood Therapeutics Inc / Incyte Corp / Sunrun Inc / American Tower Corp / Pebblebrook Hotel Trust / APA Corp (US) / Broadridge Financial Solutions Inc / Callon Petroleum Co / Hyatt Hotels Corp / Visa Inc / Vail Resorts Inc / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Magnolia Oil & Gas Corp / Marriott International Inc / Marathon Oil Corp / Travel + Leisure Co / Vulcan Materials Co / Hilton Worldwide Holdings Inc / Black Knight Inc / Martin Marietta Materials Inc / AssetMark Financial Holdings Inc / Assurant Inc / AMN Healthcare Services Inc / Cedar Fair LP / Central Garden & Pet Co / Choice Hotels International Inc / CoStar Group Inc / Curtiss-Wright Corp / Diamondrock Hospitality Co / EQT Corp / Physicians Realty Trust / Scotts Miracle-Gro Co / WW International Inc / Wix.Com Ltd / Cross Country Healthcare Inc / ManTech International Corp / PayPal Holdings Inc / Booking Holdings Inc / DCP Midstream LP / EPR Properties / Federal Realty Investment Trust / Jazz Pharmaceuticals PLC / Match Group Inc / Spirit Realty Capital Inc / Spirit AeroSystems Holdings Inc / Criteo SA / Autolus Therapeutics PLC / Dine Brands Global Inc / Encore Capital Group Inc / MGP Ingredients Inc / Peloton Interactive Inc / IGM Biosciences Inc / Fleetcor Technologies Inc / Caesars Entertainment Inc / NuVasive Inc / KAR Auction Services Inc / Belden Inc / Huron Consulting Group Inc / Sunstone Hotel Investors Inc / LHC Group Inc / Atlas Air Worldwide Holdings Inc / SunPower Corp / Host Hotels & Resorts Inc / Mastercard Inc / Lumen Technologies Inc / Kratos Defense and Security Solutions Inc / Wyndham Hotels & Resorts Inc / Air Transport Services Group Inc / IAC/Interactivecorp / Parsons Corp / Arcus Biosciences Inc / Verisk Analytics Inc / Healthcare Trust Of America Inc / Hilton Grand Vacations Inc / Green Dot Corp / Sabra Health Care REIT Inc / RLJ Lodging Trust / Earthstone Energy Inc / Marriott Vacations Worldwide Corp / Zynga Inc / Enphase Energy Inc / PDC Energy Inc / Ryman Hospitality Properties Inc / Sixth Street Specialty Lending Inc / HubSpot Inc / Vericel Corp / Nevro Corp / GoDaddy Inc / ETSY Inc / Everi Holdings Inc / Editas Medicine Inc / SiteOne Landscape Supply Inc / CRISPR Therapeutics AG / Park Hotels & Resorts Inc / Tivity Health Inc / AnaptysBio Inc / Playa Hotels & Resorts NV / SilverBow Resources Inc / Iovance Biotherapeutics Inc / Redfin Corp / PetIQ Inc / Deciphera Pharmaceuticals Inc / Root Inc / GreenSky Inc / Harpoon Therapeutics Inc / Uber Technologies Inc / TCR2 Therapeutics Inc / Palomar Holdings Inc / NextCure Inc / Genmab A/S / Arcutis Biotherapeutics Inc / Reynolds Consumer Products Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/06/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Today's NeuroNavigator Calls: Hosting Christoph Correll, M.D. and Sanjay Mathew, M.D., May 6 at 10.00 a.m. ET and 2 p.m. ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Myles R. R. Minter / Mr. Tim F. Lugo / Matt Phipps, PHD / Lachlan Hanbury-Brown / Mr. Rob Andrew, CFA / John Boyle / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">05/06/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech Fireside Highlights: HARP, TCRR, IOVA, AUTL @ The Truist Life Sciences Summit (May 5)</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AUTL.OQ / HARP.OQ / IOVA.OQ / TCRR.OQ / PFE=US / AMGN=US / BMY=US / AUTL=US / IOVA=US / HARP=US / TCRR=US / NXTC=US</td><td class="leftalignment">Autolus Therapeutics PLC / Harpoon Therapeutics Inc / Iovance Biotherapeutics Inc / TCR2 Therapeutics Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Autolus Therapeutics PLC / Iovance Biotherapeutics Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / NextCure Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Asthika Goonewardene / Avi Dahan</td></tr>
<tr class="odd"><td class="leftalignment">05/05/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BMY-US -  Dividend Quality Analysis, for the period ended May 03,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY / JNJ / LLY / MRK / NVS / PFE / AMGN.O / AZN.O / BIIB.O / ABBV.K / SNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / AstraZeneca PLC / Biogen Inc / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">05/05/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US0311621009 / US2666051048 / US45337C1027 / US69366J2006 / US08180D1063 / US04335A1051 / US30068X1037</td><td class="leftalignment">Amgen Inc / DURECT Corp / Incyte Corp / PTC Therapeutics Inc / Benefitfocus Inc / Arvinas Inc / Exagen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">05/05/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PFE-US Company reports financial results for the quarter ended April 04,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PFE / ABT / BMY / JNJ / LLY / MRK / NVS / AMGN.O / GSK / AZN.O</td><td class="leftalignment">Pfizer Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">05/05/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">AME / CMI / CRM.N / CSL / CVS / GE / INTC.O / KKR / MDT / MSFT.O / NICE.TA / RXN / SGE.L / T.N / AMZN.O / AMGN.O / AAPL.O / WTS.N / NVDA.O / DISH.O / HEAR.O / OUT / MPWR.O / VECO.O / INSP.N / SMTC.O / GPN / DRRX.O / AOS.N / CSCO.OQ / CRUS.OQ / JKHY.OQ / ATVI.OQ / INCY.OQ / TTWO.OQ / AKAM.OQ / VRTX.OQ / TXN.OQ / LPSN.O / EXAS.O / BIIB.O / 478160104 / AYX / DENN.O / 36467W109 / AIMC.O / 02043Q107 / 514766104 / MRNA.O / TMDX.OQ / NXPI.O / AMRC.K / ZNGA.O / EA.O / ADI.OQ / FB.O / HASI.N / RNG.N / 82655M107 / PAYC.K / SABR.O / AGRX.OQ / ANET.K / APS.TO / MCRB.OQ / ZBH.N / ZG.OQ / TMUS.OQ / NVTA.K / APL.PS / UAA / VREX.OQ / EGHT.K / BILI.O / ARVN.OQ / ZM.OQ / VG.O / REGW.M3 / HUYA.K / 03823M100</td><td class="leftalignment">AMETEK Inc / Cummins Inc / Salesforce.Com Inc / Carlisle Companies Inc / CVS Health Corp / General Electric Co / Intel Corp / KKR & Co Inc / Medtronic PLC / Microsoft Corp / Nice Ltd / Zurn Water Solutions Corp / Sage Group PLC / AT&T Inc / Amazon.com Inc / Amgen Inc / Apple Inc / Watts Water Technologies Inc / NVIDIA Corp / DISH Network Corp / Turtle Beach Corp / OUTFRONT Media Inc / Monolithic Power Systems Inc / Veeco Instruments Inc / Inspire Medical Systems Inc / Semtech Corp / Global Payments Inc / DURECT Corp / A O Smith Corp / Cisco Systems Inc / Cirrus Logic Inc / Jack Henry & Associates Inc / Activision Blizzard Inc / Incyte Corp / Take-Two Interactive Software Inc / Akamai Technologies Inc / Vertex Pharmaceuticals Inc / Texas Instruments Inc / LivePerson Inc / Exact Sciences Corp / Biogen Inc / Johnson & Johnson / Alteryx Inc / Denny's Corp / GameStop Corp / Altra Industrial Motion Corp / Alnylam Pharmaceuticals Inc / Landec Corp / Moderna Inc / Transmedics Group Inc / NXP Semiconductors NV / Ameresco Inc / Zynga Inc / Electronic Arts Inc / Analog Devices Inc / Meta Platforms Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / RingCentral Inc / Sify Technologies Ltd / Paycom Software Inc / Sabre Corp / Agile Therapeutics Inc / Arista Networks Inc / Aptose Biosciences Inc / Seres Therapeutics Inc / Zimmer Biomet Holdings Inc / Zillow Group Inc / T-Mobile US Inc / Invitae Corp / Apollo Global Capital Inc / Under Armour Inc / Varex Imaging Corp / 8x8 Inc / Bilibili Inc / Arvinas Inc / Zoom Video Communications Inc / Vonage Holdings Corp / Regency World Consulting Ltd / HUYA Inc / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / United Kingdom / India / Ireland / Israel / Netherlands / Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/05/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">1Q21 Review: Biotech Jewel on the Cheap; Upgrading to Outperform with $205 PT</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">AMGN.O / VRTX.OQ / BIIB.O / 478160104 / 02043Q107 / MRNA.O / REGW.M3 / 03823M100</td><td class="leftalignment">Amgen Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Alnylam Pharmaceuticals Inc / Moderna Inc / Regency World Consulting Ltd / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">India / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim / Yichuan (Jackie Yan</td></tr>
<tr class="even"><td class="leftalignment">05/05/2021</td><td class="leftalignment">New Constructs, LLC</td><td class="leftalignment">1Q21 Earnings Reveal Plenty of Upside in These 3 Laggards</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AMGN / CL / MCD</td><td class="leftalignment">Amgen Inc / Colgate-Palmolive Co / McDonald's Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">ACCOUNTING / CORPORATE FINANCE / EARNINGS/FINANCIAL STATEMENTS / TAX ISSUES/ACCOUNTING</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">INCY 1Q Update: Topline miss attributed to COVID-19; focus on second quarter growth and key regulatory decisions; raising PT</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">INCY.O / US0311621009</td><td class="leftalignment">Incyte Corp / Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Emily Bodnar / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">05/04/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ARE-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMY / LLY / PFE / GILD.O / AMGN.O / ILMN.O / ALNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Alnylam Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Turkey / United States</td><td class="leftalignment">Real Estate</td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Acquisdata</td><td class="leftalignment">Amgen</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">AMGN=US</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Acquisdata Research Team</td></tr>
<tr class="even"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Amgen Inc.(AMGN) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">031162100</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">05/04/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">First-Dose Vaccinations Continue to Decline; Outbreak in India Continues, Showing Initial Signs of Slowing Growth</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">MRK=US / WMB=US / LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / OXY=US / RRC=US / WEN=US / MDT=US / BLD=US / DVN=US / INCY=US / GILD=US / APA=US / CPE=US / EOG=US / REI=US / VZ=US / XOM=US / CRK=US / LOW=US / WLL=US / PXD=US / DIOD=US / MGY=US / SWN=US / SCOR=US / MUR=US / CHRS=US / MRO=US / LEG=US / KFRC=US / VMC=US / MLM=US / CBRL=US / CNX=US / DRI=US / EQT=US / EXEL=US / GFF=US / IBP=US / HZO=US / MAS=US / MHK=US / HOOK=US / REGN=US / REGI=US / RHI=US / WIX=US / CVX=US / SAGE=US / PSA=US / EPD=US / CGEN=US / BXS=US / SNV=US / ADC=US / CUZ=US / OHI=US / VNO=US / CRTO=US / COP=US / BRX=US / DIN=US / STRO=US / TPX=US / EXP=US / FHN=US / CDLX=US / BECN=US / SHO=US / PLAY=US / FRPT=US / DENN=US / BLDR=US / GMS=US / NSP=US / SIBN=US / KBR=US / CMG=US / REX=US / CCOI=US / XPO=US / PGTI=US / GPRE=US / AWI=US / OC=US / TAST=US / QSR=US / CLR=US / PRPL=US / NOG=US / IAC=US / EPRT=US / JACK=US / RCUS=US / CLNY=US / TREX=US / AR=US / NLSN=US / WWD=US / ESTE=US / FBHS=US / ANGI=US / BCEI=US / MTDR=US / MEIP=US / PDCE=US / GMED=US / RHP=US / FANG=US / ABBV=US / TILE=US / NDLS=US / FATE=US / VRNS=US / 00770K202 / VNOM=US / LOCO=US / SHAK=US / ON=US / SEDG=US / BWXT=US / WING=US / SPNE=US / CABO=US / ACBI=US / AXSM=US / 82982L103 / CDEV=US / CRSP=US / PVAC=US / JELD=US / CVNA=US / SBOW=US / IOVA=US / ATNX=US / ROKU=US / SWCH=US / DCPH=US / MAXR=US / BTAI=US / FTDR=US / SVMK=US / ALLO=US / KOD=US / HARP=US / RTLR=US / FERG=US / GMAB=US / OVV=US / ARQT=US / ZI=US / AZEK=US</td><td class="leftalignment">Merck & Co Inc / Williams Companies Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Occidental Petroleum Corp / Range Resources Corp / Wendys Co / Medtronic PLC / TopBuild Corp / Devon Energy Corp / Incyte Corp / Gilead Sciences Inc / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Verizon Communications Inc / Exxon Mobil Corp / Comstock Resources Inc / Lowe's Companies Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Diodes Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Comscore Inc / Murphy Oil Corp / Coherus BioSciences Inc / Marathon Oil Corp / Leggett & Platt Inc / Kforce Inc / Vulcan Materials Co / Martin Marietta Materials Inc / Cracker Barrel Old Country Store Inc / CNX Resources Corp / Darden Restaurants Inc / EQT Corp / Exelixis Inc / Griffon Corp / Installed Building Products Inc / MarineMax Inc / Masco Corp / Mohawk Industries Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Renewable Energy Group Inc / Robert Half International Inc / Wix.Com Ltd / Chevron Corp / SAGE Therapeutics Inc / Public Storage / Enterprise Products Partners LP / Compugen Ltd / Cadence Bank / Synovus Financial Corp / Agree Realty Corp / Cousins Properties Inc / Omega Healthcare Investors Inc / Vornado Realty Trust / Criteo SA / Conocophillips / Brixmor Property Group Inc / Dine Brands Global Inc / Sutro Biopharma Inc / Tempur Sealy International Inc / Eagle Materials Inc / First Horizon Corp / Cardlytics Inc / Beacon Roofing Supply Inc / Sunstone Hotel Investors Inc / Dave & Buster's Entertainment Inc / Freshpet Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Insperity Inc / SI-BONE Inc / KBR Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Cogent Communications Holdings Inc / XPO Logistics Inc / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / Purple Innovation Inc / Northern Oil and Gas Inc / IAC/Interactivecorp / Essential Properties Realty Trust Inc / Jack in the Box Inc / Arcus Biosciences Inc / DigitalBridge Group Inc / Trex Company Inc / Antero Resources Corp / Nielsen Holdings PLC / Woodward Inc / Earthstone Energy Inc / Fortune Brands Home & Security Inc / Angi Inc / Civitas Resources Inc / Matador Resources Co / MEI Pharma Inc / PDC Energy Inc / Globus Medical Inc / Ryman Hospitality Properties Inc / Diamondback Energy Inc / Abbvie Inc / Interface Inc / Noodles & Co / Fate Therapeutics Inc / Varonis Systems Inc / Aemetis Inc / Viper Energy Partners LP / El Pollo Loco Holdings Inc / Shake Shack Inc / ON Semiconductor Corp / Solaredge Technologies Inc / BWX Technologies Inc / Wingstop Inc / SeaSpine Holdings Corp / Cable One Inc / Atlantic Capital Bancshares Inc / Axsome Therapeutics Inc / SiteOne Landscape Supply Inc / Centennial Resource Development Inc / CRISPR Therapeutics AG / Ranger Oil Corp / JELD-WEN Holding Inc / Carvana Co / SilverBow Resources Inc / Iovance Biotherapeutics Inc / Athenex Inc / Roku Inc / Switch Inc / Deciphera Pharmaceuticals Inc / Maxar Technologies Inc / BioXcel Therapeutics Inc / Frontdoor Inc / Momentive Global Inc / Allogene Therapeutics Inc / Kodiak Sciences Inc / Harpoon Therapeutics Inc / Rattler Midstream LP / Ferguson PLC / Genmab A/S / Ovintiv Inc / Arcutis Biotherapeutics Inc / ZoomInfo Technologies Inc / Azek Company Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / France / United Kingdom / Ireland / Israel / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/04/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - May 4, 2021</td><td class="leftalignment">English</td><td class="rightalignment">63</td><td class="leftalignment">CA4509131088 / US0234361089 / US0311621009 / US1270971039 / US3755581036 / US6267171022 / US6821891057 / US6937181088 / US7237871071 / US75281A1097 / US8454671095 / US9139031002 / CA0084741085 / US5658491064 / CA7392391016 / US35671D8570 / CA5734591046 / US14040H1059 / US9497461015 / US6174464486 / US38141G1040 / CA98462Y1007 / CA0010921058 / CA4495861060 / US42809H1077 / US74460D1090 / US3932221043 / US2120151012 / CA1254911003 / US78454L1008 / CA5527041084 / NL0009434992 / US98986T1088 / CA3748252069 / US00404A1097 / US5764852050 / CA46579R1047 / US03674X1063 / US1638511089 / CA8485101031 / US45688C1071 / US12653C1080 / US29261A1007 / US87484T1088 / US53814L1089 / US57778K1051 / CA14179V5036 / US69047Q1022 / CA89055A2039</td><td class="leftalignment">IAMGOLD Corp / Amedisys Inc / Amgen Inc / Coterra Energy Inc / Gilead Sciences Inc / Murphy Oil Corp / ON Semiconductor Corp / Paccar Inc / Pioneer Natural Resources Co / Range Resources Corp / Southwestern Energy Co / Universal Health Services Inc / Agnico Eagle Mines Ltd / Marathon Oil Corp / Power Corporation of Canada / Freeport-McMoRan Inc / Martinrea International Inc / Capital One Financial Corp / Wells Fargo & Co / Morgan Stanley / Goldman Sachs Group Inc / Yamana Gold Inc / AGF Management Ltd / IGM Financial Inc / Hess Corp / Public Storage / Green Plains Inc / Continental Resources Inc / CI Financial Corp / SM Energy Co / MEG Energy Corp / LyondellBasell Industries NV / Zynga Inc / Gibson Energy Inc / Acadia Healthcare Company Inc / Matador Resources Co / Ivanhoe Mines Ltd / Antero Resources Corp / Chemours Co / Spin Master Corp / Ingevity Corp / CNX Resources Corp / Encompass Health Corp / Talos Energy Inc / Livent Corp / Maxar Technologies Inc / Cargojet Inc / Ovintiv Inc / Topaz Energy Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">US Biotechnology: Termination of Coverage</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AMGN.OQ / CVAC.OQ / ICPT.OQ</td><td class="leftalignment">Amgen Inc / CureVac NV / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tiago Fauth / Mr. Thomas Deal / Matthew Terwelp / Roger Xu</td></tr>
<tr class="odd"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For the Week Ended Apr 23, 2021</td><td class="leftalignment">English</td><td class="rightalignment">44</td><td class="leftalignment">4502.T / BMY.N / JNJ.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / SUN.BO / NOVOB.CO / NOVN.S / 4768.T / GSK.L / UCB.BR / AMGN.OQ / ALKS.OQ / GILD.OQ / UTHR.OQ / BIIB.OQ / 4568.T / TEVA.N / ALM.MC / BAYGN.DE / 4578.T / ABBV.N</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / Otsuka Corp / GlaxoSmithKline PLC / Ucb SA / Amgen Inc / Alkermes Plc / Gilead Sciences Inc / United Therapeutics Corp / Biogen Inc / Daiichi Sankyo Co Ltd / Teva Pharmaceutical Industries Ltd / Almirall SA / Bayer AG / Otsuka Holdings Co Ltd / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / France / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Amgen Inc: Capital Deployment Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US0311621009 / US3755581036 / US03152W1099 / US03820J1007 / CA68620P1018 / US00289Y1073 / CA1380351009 / US00773U1088 / US8162121045 / US03969F1093 / US88688T1007 / CA39342L1085 / CA22587M1068 / CA89788C1041 / CA23126M1023 / CA05156X8843 / CA4283043079 / CA00489Y6001</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Amicus Therapeutics Inc / Applied Genetic Technologies Corp / OrganiGram Holdings Inc / Abeona Therapeutics Inc / Canopy Growth Corp / Adverum Biotechnologies Inc / Selecta Biosciences Inc / Arcus Biosciences Inc / Tilray Brands Inc / Green Thumb Industries Inc / Cresco Labs Inc / Trulieve Cannabis Corp / Curaleaf Holdings Inc / Aurora Cannabis Inc / Hexo Corp / Acreage Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Amgen Inc: Information Content of Earnings Releases 2015-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MRK-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK / ABT / BMY / JNJ / LLY / NVS / PFE / AMGN.O / GSK / TEVA.K / SNY.O</td><td class="leftalignment">Merck & Co Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech & Pharma: Truist ASCO Planner v1.0 Highlights ~200 Datapoints of Interest</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / INCY=US / GILD=US / CHRS=US / EXEL=US / HOOK=US / REGN=US / CGEN=US / STRO=US / RCUS=US / MEIP=US / ABBV=US / FATE=US / CRSP=US / IOVA=US / ATNX=US / DCPH=US / BTAI=US / ALLO=US / HARP=US / GMAB=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Gilead Sciences Inc / Coherus BioSciences Inc / Exelixis Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Compugen Ltd / Sutro Biopharma Inc / Arcus Biosciences Inc / MEI Pharma Inc / Abbvie Inc / Fate Therapeutics Inc / CRISPR Therapeutics AG / Iovance Biotherapeutics Inc / Athenex Inc / Deciphera Pharmaceuticals Inc / BioXcel Therapeutics Inc / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Asthika Goonewardene / Ms. Robyn S. Karnauskas / Mr. Gregg Gilbert / Ms. Srikripa Devarakonda, PHD / Mr. Joon Lee, MD</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Apr 23, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">ALB.N / BAX / BE / BSX / CAT / CLH / CMI / DAN / DE / ENS / INTC.O / JCI / MDT / NEP / ORA / RSG / SRCL.O / URI / WM / AMGN.O / BWA.N / GWW.N / EW.N / CWST.O / FCEL.O / CREE.O / B.N / AMSC.OQ / CHRW.OQ / PLUG.OQ / TRMB.O / ITRI.O / ATRC.OQ / DXCM.O / SPWR.O / CSIQ.O / FSLR.O / TWIN.O / AGCO.K / TSLA.O / AMRC.K / AMRS.OQ / QSR.TO / ENPH.O / HASI.N / 82655M107 / SEDG.O / RUN.O / WKHS.O / WCN.TO / AQMS.O / WPRT.TO / KALA.O / WSC.OQ / APTV.K / BILI.O / CBOE.Z / CWENa.K / TCOM.O / RRTS.PK / DKNG.O / AVNT.K / 02081G201 / RWRh.V</td><td class="leftalignment">Albemarle Corp / Baxter International Inc / Bloom Energy Corp / Boston Scientific Corp / Caterpillar Inc / Clean Harbors Inc / Cummins Inc / Dana Inc / Deere & Co / EnerSys / Intel Corp / Johnson Controls International PLC / Medtronic PLC / Nextera Energy Partners LP / Ormat Technologies Inc / Republic Services Inc / Stericycle Inc / United Rentals Inc / Waste Management Inc / Amgen Inc / Borgwarner Inc / W W Grainger Inc / Edwards Lifesciences Corp / Casella Waste Systems Inc / Fuelcell Energy Inc / Wolfspeed Inc / Barnes Group Inc / American Superconductor Corp / CH Robinson Worldwide Inc / Plug Power Inc / Trimble Inc / Itron Inc / AtriCure Inc / Dexcom Inc / SunPower Corp / Canadian Solar Inc / First Solar Inc / Twin Disc Inc / AGCO Corp / Tesla Inc / Ameresco Inc / Amyris Inc / Restaurant Brands International Inc / Enphase Energy Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / Sify Technologies Ltd / Solaredge Technologies Inc / Sunrun Inc / Workhorse Group Inc / Waste Connections Inc / Aqua Metals Inc / Westport Fuel Systems Inc / Kala Pharmaceuticals Inc / Willscot Mobile Mini Holdings Corp / Aptiv PLC / Bilibili Inc / Cboe Global Markets Inc / Clearway Energy Inc / Trip.com Group Ltd / Roadrunner Transportation Systems Inc / DraftKings Inc / Avient Corp / Alphatec Holdings Inc / Strathmore Plus Energy Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / India / Ireland / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">NeuroNavigator REMINDER: Hosting Christoph Correll, M.D. and Sanjay Mathew, M.D., May 6 at 10.00 a.m. ET and 2 p.m. ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Myles R. R. Minter / Mr. Tim F. Lugo / Matt Phipps, PHD / Lachlan Hanbury-Brown / Mr. Rob Andrew, CFA / John Boyle / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - May 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AEP.N / AES.N / AKER.OL / ALV.N / CL.N / ED.N / EL.N / ENI.MI / F.N / FLS.N / GM.N / KMB.N / KO.N / MRK.N / MSFT.O / NA / PFE.N / REP.MC / SO.N / STO.AX / T.N / TRV.N / VC.N / PEP.N / AVB.N / TRI.N / BFb.N / PG.N / WY.N / CNQ.TO / CPB.N / TEN.N / CMCSA.O / CHKP.O / AMGN.O / ETN.N / BWA.N / LEA.N / WCC.N / K.N / DT.N / DISH.O / SU.TO / CTXS.O / CLX.N / CAG.N / GIS.N / EMR.N / PCG.N / EPC.N / SBAC.O / AMT.N / JAZZ.O / CONE.O / GWW.N / VZ.N / EXEL.O / JCI.N / STZ.N / APH.N / FISV.O / EQT.N / EPD.N / CPT.N / CHTR.O / AXL.N / AWK.N / CHD.N / AME.N / BC.N / SAM.N / BMRN.O / OPTN.O / REGN.O / ENR.N / MHK.N / SM.N / NCR.N / NET.N / TEL.N / COP.N / ENDP.O / PII.N / ST.N / SWN.N / TT.N / LNG.A / SGEN.OQ / GPN.N / PFS.N / MNST.O / EFX.TO / WSBC.O / CASY.O / PCTY.O / FFIV.O / EQIX.O / ATDb.TO / 02209S103 / NVT.N / DLR.N / SCL.TO / 427866108 / MPW.N / RDSb.L / DRX.L / FIS.N / CCOI.O / MWA.N / HOG.N / MERC.O / BGS.N / PPL.TO / TDC.N / ENSG.O / DAN.N / ARX.TO / FTNT.O / SPB.N / NEE.N / LYB.N / TOU.TO / FRU.TO / PCRX.O / MTOR.N / PXT.TO / XYL.N / PSX.N / HTGC.N / FFHu.TO / MDLZ.OQ / APAM.N / ABBV.N / TSLA.N / PRMW.N / TMUS.N / COTY.N / PTCT.O / AGIO.O / PAYC.N / AGRX.O / SHLX.N / QSR.N / EVA.N / PYPL.OQ / AROC.N / SQ.N / WVE.OQ / MIME.OQ / OMF.N / MESO.O / IONS.O / RACE.MI / ADVM.OQ / TWLO.N / KNSL.OQ / ADNT.N / JELD.N / VST.N / ATUS.N / AQUA.N / APTV.N / GTES.N / WELL.N / BSIG.N / AMRX.N / VNE.N / KDP.N / AQST.O / CWEN.N / NWL.O / NBSE.OQ / PING.N / DDOG.O / CRNC.OQ / EPAC.N / 2222.SE / REYN.O / NKLA.OQ / FOUR.N / AKES.OL / NRIX.OQ / NAPA.N / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Aker ASA / Autoliv Inc / Colgate-Palmolive Co / Consolidated Edison Inc / Estee Lauder Companies Inc / Eni SpA / Ford Motor Co / Flowserve Corp / General Motors Co / Kimberly-Clark Corp / Coca-Cola Co / Merck & Co Inc / Microsoft Corp / National Bank of Canada / Pfizer Inc / Repsol SA / Southern Co / Santos Ltd / AT&T Inc / Travelers Companies Inc / Visteon Corp / PepsiCo Inc / Avalonbay Communities Inc / Thomson Reuters Corp / Brown-Forman Corp / Procter & Gamble Co / Weyerhaeuser Co / Canadian Natural Resources Ltd / Campbell Soup Co / Tenneco Inc / Comcast Corp / Check Point Software Technologies Ltd / Amgen Inc / Eaton Corporation PLC / Borgwarner Inc / Lear Corp / Wesco International Inc / Kellogg Co / Dynatrace Inc / DISH Network Corp / Suncor Energy Inc / Citrix Systems Inc / Clorox Co / Conagra Brands Inc / General Mills Inc / Emerson Electric Co / PG&E Corp / Edgewell Personal Care Co / SBA Communications Corp / American Tower Corp / Jazz Pharmaceuticals PLC / CyrusOne Inc / W W Grainger Inc / Verizon Communications Inc / Exelixis Inc / Johnson Controls International PLC / Constellation Brands Inc / Amphenol Corp / Fiserv Inc / EQT Corp / Enterprise Products Partners LP / Camden Property Trust / Charter Communications Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Church & Dwight Co Inc / AMETEK Inc / Brunswick Corp / Boston Beer Company Inc / Biomarin Pharmaceutical Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Mohawk Industries Inc / SM Energy Co / NCR Corp / Cloudflare Inc / TE Connectivity Ltd / Conocophillips / Endo International PLC / Polaris Inc / Sensata Technologies Holding PLC / Southwestern Energy Co / Trane Technologies PLC / Cheniere Energy Inc / Seagen Inc / Global Payments Inc / Provident Financial Services Inc / Monster Beverage Corp / Enerflex Ltd / WesBanco Inc / Caseys General Stores Inc / Paylocity Holding Corp / F5 Inc / Equinix Inc / Alimentation Couche-Tard Inc / Altria Group Inc / nVent Electric PLC / Digital Realty Trust Inc / Shawcor Ltd / Hershey Co / Medical Properties Trust Inc / Royal Dutch Shell PLC / Drax Group PLC / Fidelity National Information Services Inc / Cogent Communications Holdings Inc / Mueller Water Products Inc / Harley-Davidson Inc / Mercer International Inc / B&G Foods Inc / Pembina Pipeline Corp / Teradata Corp / Ensign Group Inc / Dana Inc / ARC Resources Ltd / Fortinet Inc / Spectrum Brands Holdings Inc / Nextera Energy Inc / LyondellBasell Industries NV / Tourmaline Oil Corp / Freehold Royalties Ltd / Pacira Biosciences Inc / Meritor Inc / Parex Resources Inc / Xylem Inc / Phillips 66 / Hercules Capital Inc / Fairfax Financial Holdings Ltd / Mondelez International Inc / Artisan Partners Asset Management Inc / Abbvie Inc / Tesla Inc / Primo Water Corp / T-Mobile US Inc / Coty Inc / PTC Therapeutics Inc / Agios Pharmaceuticals Inc / Paycom Software Inc / Agile Therapeutics Inc / Shell Midstream Partners LP / Restaurant Brands International Inc / Enviva Inc / PayPal Holdings Inc / Archrock Inc / Block Inc / WAVE Life Sciences Ltd / Mimecast Ltd / OneMain Holdings Inc / Mesoblast Ltd / Ionis Pharmaceuticals Inc / Ferrari NV / Adverum Biotechnologies Inc / Twilio Inc / Kinsale Capital Group Inc / Adient PLC / JELD-WEN Holding Inc / Vistra Corp / Altice USA Inc / Evoqua Water Technologies Corp / Aptiv PLC / Gates Industrial Corporation PLC / Welltower Inc / Brightsphere Investment Group Inc / Amneal Pharmaceuticals Inc / Veoneer Inc / Keurig Dr Pepper Inc / Aquestive Therapeutics Inc / Clearway Energy Inc / Newell Brands Inc / NeuBase Therapeutics Inc / Ping Identity Holding Corp / Datadog Inc / Cerence Inc / Enerpac Tool Group Corp / Saudi Arabian Oil Co / Reynolds Consumer Products Inc / Nikola Corp / Shift4 Payments Inc / Aker Solutions ASA / Nurix Therapeutics Inc / Duckhorn Portfolio Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / China / Spain / United Kingdom / Ireland / Israel / Italy / Netherlands / Norway / Saudi Arabia / Singapore / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">2021 Guggenheim ASCO Preview and Planner – Key Updates Across Our Global Pharma / Biotech Coverage</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2684703 / 7103065 / BD9GVY0</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Pfizer Inc / Novartis AG / Zai Lab Ltd</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Michael W. Schmidt, Ph.D., PHD / Mr. Etzer Darout / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">05/02/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">1Q Model Update</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Emily Bodnar / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">05/02/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Recent Weakness Provides Attractive Entry Point</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">05/02/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Amgen Inc: Peer Group Analytics - Q1 FY2021</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">05/01/2021</td><td class="leftalignment">Probes Reporter</td><td class="leftalignment">Watch List: 85 US Companies with Undisclosed SEC Probes</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">T.N / AEP.N / BAC.N / CL.N / COF.N / CRM.N / F.N / HLT.N / MDT.N / PNC.N / SLB.N / BEN.N / TRI.N / PG.N / THC.N / REV.N / ADM.N / VLO.N / UPS.N / KR.N / NWL.N / NKE.N / AMP.N / MTZ.N / ARW.N / ATO.N / TWTR.N / TUP.N / OMI.N / CVX.N / AMGN.OQ / CSCO.OQ / GNTX.OQ / MGPI.OQ / REGN.OQ / ROL.N / SEIC.OQ / RARE.OQ / MNRO.OQ / CAKE.OQ / GILD.OQ / COST.OQ / NKTR.OQ / AZPN.OQ / MYGN.OQ / SSNC.OQ / CTXS.OQ / AMZN.OQ / NVDA.OQ / CHTR.OQ / TNP.N / NFLX.OQ / EGBN.OQ / CVGI.OQ / RUSHA.OQ / NDAQ.OQ / MA.N / SIX.N / AON.N / BX.N / INO.OQ / BGCP.OQ / UTL.N / SCHW.N / MSI.N / MPC.N / GRPN.OQ / FB.OQ / COTY.N / CTG.OQ / ANTM.N / NTRA.OQ / PFX.N / 100088979 / MFIN.OQ / DXC.N / RYTM.OQ / SWCH.N / IQV.N / WELL.N / US29350E1047 / LYFT.O</td><td class="leftalignment">AT&T Inc / American Electric Power Company Inc / Bank of America Corp / Colgate-Palmolive Co / Capital One Financial Corp / Salesforce.Com Inc / Ford Motor Co / Hilton Worldwide Holdings Inc / Medtronic PLC / PNC Financial Services Group Inc / Schlumberger NV / Franklin Resources Inc / Thomson Reuters Corp / Procter & Gamble Co / Tenet Healthcare Corp / Revlon Inc / Archer-Daniels-Midland Co / Valero Energy Corp / United Parcel Service Inc / Kroger Co / Newell Brands Inc / Nike Inc / Ameriprise Financial Inc / MasTec Inc / Arrow Electronics Inc / Atmos Energy Corp / Twitter Inc / Tupperware Brands Corp / Owens & Minor Inc / Chevron Corp / Amgen Inc / Cisco Systems Inc / Gentex Corp / MGP Ingredients Inc / Regeneron Pharmaceuticals Inc / Rollins Inc / SEI Investments Co / Ultragenyx Pharmaceutical Inc / Monro Inc / Cheesecake Factory Inc / Gilead Sciences Inc / Costco Wholesale Corp / Nektar Therapeutics / Aspen Technology Inc / Myriad Genetics Inc / SS&C Technologies Holdings Inc / Citrix Systems Inc / Amazon.com Inc / NVIDIA Corp / Charter Communications Inc / Tsakos Energy Navigation Ltd / Netflix Inc / Eagle Bancorp Inc / Commercial Vehicle Group Inc / Rush Enterprises Inc / Nasdaq Inc / Mastercard Inc / Six Flags Entertainment Corp / Aon PLC / Blackstone Inc / Inovio Pharmaceuticals Inc / BGC Partners Inc / Unitil Corp / Charles Schwab Corp / Motorola Solutions Inc / Marathon Petroleum Corp / Groupon Inc / Meta Platforms Inc / Coty Inc / Computer Task Group Inc / Anthem Inc / Natera Inc / PhenixFIN Corp / Huntington Bancshares Inc / Medallion Financial Corp / DXC Technology Co / Rhythm Pharmaceuticals Inc / Switch Inc / IQVIA Holdings Inc / Welltower Inc / Enochian Biosciences Inc / Lyft Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Greece / Ireland / United States / Curaçao</td><td class="leftalignment">Agriculture / Air Transportation / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Consumer / Electronics / Engineering & Construction / Financial Services / Healthcare / Household Products / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Services / Technology / Telecommunications / Transportation / Utilities / Wholesale / Oil & Gas</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">05/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for AMGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">05/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Weekly Dose:</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / EXEL.O / BMRN.O / REGN.O / SGEN.OQ / AGIO.O / NRIX.OQ</td><td class="leftalignment">Amgen Inc / Exelixis Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Seagen Inc / Agios Pharmaceuticals Inc / Nurix Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Michael Murray</td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Monthly Update - Amgen (AMGN:$239.64) wipes off $5 billion in MCap in April, highest loser in Medical/Biomedical sector</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 545</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">Validea</td><td class="leftalignment">Validea Guru Analysis Report for AMGN. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">031162100</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / QUANANTITATIVE/TECH RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended April 23, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--April 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">BAX / BSX / CHE / CNC / CRY.N / HUM / MDT / SYK / UNH / GILD.O / AMGN.O / NOVN.S / RMD.N / CYH.N / EW.N / IART.OQ / NBIX.OQ / BMRN.OQ / EXEL.OQ / BLUE.OQ / VRTX.OQ / ICAD.O / LIFE.O / MMSI.O / AMED.O / BIIB.O / 478160104 / 881624209 / ALNY.OQ / ACAD.O / ATRC.OQ / DXCM.O / CYCC.OQ / PODD.O / 02043Q107 / ENSG.OQ / TNDM.O / MRNA.O / BBI.O / AGIO.OQ / ALDX.OQ / 02005N100 / CLRB.OQ / INO.O / VKTX.O / TDOC.N / CFMS.O / NVCR.OQ / APLS.OQ / MDGL.O / IOVA.OQ / 720795103 / ALLO.OQ / MRKR.OQ / ORTX.OQ / CRSP.BN / SWAV.O / BWAY.TA / KRTX.OQ / NBSE.O / CRDF.OQ / FMTX.O / REGW.M3 / 03823M100</td><td class="leftalignment">Baxter International Inc / Boston Scientific Corp / Chemed Corp / Centene Corp / CryoLife Inc / Humana Inc / Medtronic PLC / Stryker Corp / UnitedHealth Group Inc / Gilead Sciences Inc / Amgen Inc / Novartis AG / Resmed Inc / Community Health Systems Inc / Edwards Lifesciences Corp / Integra Lifesciences Holdings Corp / Neurocrine Biosciences Inc / Biomarin Pharmaceutical Inc / Exelixis Inc / bluebird bio Inc / Vertex Pharmaceuticals Inc / ICAD Inc / aTyr Pharma Inc / Merit Medical Systems Inc / Amedisys Inc / Biogen Inc / Johnson & Johnson / Teva Pharmaceutical Industries Ltd / Alnylam Pharmaceuticals Inc / ACADIA Pharmaceuticals Inc / AtriCure Inc / Dexcom Inc / Cyclacel Pharmaceuticals Inc / Insulet Corp / Alnylam Pharmaceuticals Inc / Ensign Group Inc / Tandem Diabetes Care Inc / Moderna Inc / Brickell Biotech Inc / Agios Pharmaceuticals Inc / Aldeyra Therapeutics Inc / Ally Financial Inc / Cellectar Biosciences Inc / Inovio Pharmaceuticals Inc / Viking Therapeutics Inc / Teladoc Health Inc / Conformis Inc / Novocure Ltd / Apellis Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / Iovance Biotherapeutics Inc / Pieris Pharmaceuticals Inc / Allogene Therapeutics Inc / Marker Therapeutics Inc / Orchard Therapeutics PLC / CRISPR Therapeutics AG / Shockwave Medical Inc / Brainsway Ltd / Karuna Therapeutics Inc / NeuBase Therapeutics Inc / Cardiff Oncology Inc / Forma Therapeutics Holdings Inc / Regency World Consulting Ltd / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / India / Ireland / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">2021 Virtual ASCO Planner</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">45337C10 / 75991610 / 71708110 / 45253H10 / 04635310 / 37555810 / 03116210 / 75886F10 / M2572210 / 45232710 / 30063P10 / 478160104 / 640268108 / 30161Q104 / 64049M20 / 58933Y10 / G0176710 / 53220K50 / 92337F10 / 46185L10 / 00653A107 / 74587V10 / 00287Y10 / 98401F10 / 18946410 / 40131M10 / 58490H10 / 63230710 / 05358830 / 76029N10 / 41358P10 / 09627Y10 / 09075V10 / 09609G10 / 55609910 / N0104510 / 31189P10 / 07725L10 / G3910J11 / 24344T10 / 29428V10 / 81181C10 / 04685N10 / 13089P10 / 22101510 / 34633R10 / K3967W10 / 37242740 / 38341P10 / 43906K10 / 45781K20 / 46565G10 / 48576U10 / 50127T10 / 61776010 / 60468T10 / 03969F10 / 05370A10 / 78116T10 / 76155X10 / F5548N10 / 89620X50 / 98887Q10 / 98943L10 / 98985W10</td><td class="leftalignment">Incyte Corp / Repligen Corp / Pfizer Inc / ImmunoGen Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Compugen Ltd / Illumina Inc / Exact Sciences Corp / Johnson & Johnson / Nektar Therapeutics / Exelixis Inc / Neogenomics Inc / Merck & Co Inc / Alkermes Plc / Ligand Pharmaceuticals Inc / Veracyte Inc / Invitae Corp / Adaptimmune Therapeutics PLC / Puma Biotechnology Inc / Abbvie Inc / Xencor Inc / Clovis Oncology Inc / Guardant Health Inc / Medicenna Therapeutics Corp / Natera Inc / Aveo Pharmaceuticals Inc / Replimune Group Inc / Harpoon Therapeutics Inc / Blueprint Medicines Corp / BioNTech SE / bluebird bio Inc / MacroGenics Inc / Affimed NV / Fate Therapeutics Inc / Beigene Ltd / GlaxoSmithKline PLC / Deciphera Pharmaceuticals Inc / Epizyme Inc / Seagen Inc / Athenex Inc / Calithera Biosciences Inc / Corvus Pharmaceuticals Inc / Forma Therapeutics Holdings Inc / Genmab A/S / Genocea Biosciences Inc / Gossamer Bio Inc / HOOKIPA Pharma Inc / Innate Pharma SA / Iteos Therapeutics Inc / Karyopharm Therapeutics Inc / Kura Oncology Inc / MorphoSys AG / Mirati Therapeutics Inc / Arcus Biosciences Inc / Avidity Biosciences Inc / Rubius Therapeutics Inc / Revolution Medicines Inc / Sanofi SA / Pfizer Inc / Zai Lab Ltd / Zentalis Pharmaceuticals Inc / Zymeworks Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Jonathan Chang, Ph.D., CFA / Daina Graybosch, Ph.D. / Andrew Berens, M.D. / Geoffrey Porges, MBBS / Mani Foroohar, M.D. / Mr. Puneet Souda</td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AMGN.O / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">LLY-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">LLY / BMY / JNJ / MRK / NVS / PFE / AMGN.O / GSK / AZN.O / ABBV.K / SNY.O</td><td class="leftalignment">Eli Lilly and Co / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Three in a Row - Biotech Fund Flows Stay Positive</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">04/29/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Biotechnology : 1Q Earnings Season: Read-Through from MRK's Results</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK.N / GILD.O / AMGN.O / REGN.O / SGEN.O / CLVS.O</td><td class="leftalignment">Merck & Co Inc / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Seagen Inc / Clovis Oncology Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Cory W. Kasimov / Mr. Turner Kufe / James Scott / Manish Jajoo</td></tr>
<tr class="even"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">BSX=US / PFE=US / AMGN=US / ICLR=US / PLD=US / AVB=US / EBAY=US / TEVA=US / PEB=US / H=US / CONE=US / V=US / MTN=US / IART=US / PB=US / BYD=US / MAR=US / SPOT=US / EXPE=US / TTWO=US / TTMI=US / TNL=US / ATVI=US / MGM=US / HLT=US / AKR=US / CI=US / ARCC=US / AMED=US / APH=US / AVT=US / CHH=US / CYH=US / DRH=US / EQIX=US / EEFT=US / NOW=US / MAIN=US / MAS=US / MCRI=US / ASGN=US / ORCC=US / PDM=US / VSEC=US / VRTX=US / PSA=US / R=US / FB=US / MKL=US / MAA=US / SSB=US / WRE=US / DRE=US / BCO=US / MOH=US / AINV=US / EXR=US / SHO=US / RNST=US / SCPL=US / CCOI=US / HST=US / MA=US / SIX=US / SAIA=US / WU=US / PAG=US / OC=US / CLR=US / PNNT=US / EHC=US / WH=US / 45665G303 / AR=US / HGV=US / RLJ=US / VAC=US / ZNGA=US / EA=US / MTDR=US / ENPH=US / RHP=US / TSLX=US / 70806A106 / GSBD=US / VKTX=US / WING=US / TDOC=US / CABO=US / VVV=US / CRSP=US / TRVG=US / PK=US / PLYA=US / HWC=US / FSK=US / OVV=US / FSKR=US / RBLX=US</td><td class="leftalignment">Boston Scientific Corp / Pfizer Inc / Amgen Inc / ICON PLC / Prologis Inc / Avalonbay Communities Inc / eBay Inc / Teva Pharmaceutical Industries Ltd / Pebblebrook Hotel Trust / Hyatt Hotels Corp / CyrusOne Inc / Visa Inc / Vail Resorts Inc / Integra Lifesciences Holdings Corp / Prosperity Bancshares Inc / Boyd Gaming Corp / Marriott International Inc / Spotify Technology SA / Expedia Group Inc / Take-Two Interactive Software Inc / TTM Technologies Inc / Travel + Leisure Co / Activision Blizzard Inc / MGM Resorts International / Hilton Worldwide Holdings Inc / Acadia Realty Trust / Cigna Corp / Ares Capital Corp / Amedisys Inc / Amphenol Corp / Avnet Inc / Choice Hotels International Inc / Community Health Systems Inc / Diamondrock Hospitality Co / Equinix Inc / Euronet Worldwide Inc / ServiceNow Inc / Main Street Capital Corp / Masco Corp / Monarch Casino & Resort Inc / ASGN Inc / Owl Rock Capital Corp / Piedmont Office Realty Trust Inc / VSE Corp / Vertex Pharmaceuticals Inc / Public Storage / Ryder System Inc / Meta Platforms Inc / Markel Corp / Mid-America Apartment Communities Inc / SouthState Corp / Washington Real Estate Investment Trust / Duke Realty Corp / Brinks Co / Molina Healthcare Inc / Apollo Investment Corp / Extra Space Storage Inc / Sunstone Hotel Investors Inc / Renasant Corp / Sciplay Corp / Cogent Communications Holdings Inc / Host Hotels & Resorts Inc / Mastercard Inc / Six Flags Entertainment Corp / Saia Inc / Western Union Co / Penske Automotive Group Inc / Owens Corning / Continental Resources Inc / Pennantpark Investment Corp / Encompass Health Corp / Wyndham Hotels & Resorts Inc / Infinity Pharmaceuticals Inc / Antero Resources Corp / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Zynga Inc / Electronic Arts Inc / Matador Resources Co / Enphase Energy Inc / Ryman Hospitality Properties Inc / Sixth Street Specialty Lending Inc / PennantPark Floating Rate Capital Ltd / Goldman Sachs BDC Inc / Viking Therapeutics Inc / Wingstop Inc / Teladoc Health Inc / Cable One Inc / Valvoline Inc / CRISPR Therapeutics AG / Trivago NV / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Hancock Whitney Corp / FS KKR Capital Corp / Ovintiv Inc / FS KKR Capital Corp / Roblox Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Ireland / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharma Feedback: Notes from Novartis CEO discussion</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">NOVN.S / LLY.N / APNJ.J / AMGN.OQ</td><td class="leftalignment">Novartis AG / Eli Lilly and Co / Aspen Pharmacare Holdings Ltd / Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States / South Africa</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">04/28/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">2021 Guggenheim ASCO Preview and Planner - Key Updates Across Our Biotech Coverage</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">2023607 / 2576941 / 2369174 / 2457864 / 2471950 / 4595739 / 5531000 / 2982924 / BCBVTX1 / BBFL7S1 / BCZS820 / BFDV8K0 / BBPK0J0 / BFZNYB7 / BK0VHF6 / BDHF4K6 / BZBY005 / BZ1LFB2 / BMQ5T49 / BGCYWN8 / BWFKZT2 / BKVDFF7 / BG31GH0 / BJXBP30 / BYQHPK7 / BYYWPW6 / BJ9NFQ3 / BWY52P3 / BL71K91 / BYWVTY5 / BWY4XV3 / BN2R582 / BMC5RV6 / BMDJ397</td><td class="leftalignment">Amgen Inc / Exelixis Inc / Gilead Sciences Inc / ImmunoGen Inc / Incyte Corp / Genmab A/S / MorphoSys AG / Spectrum Pharmaceuticals Inc / Agios Pharmaceuticals Inc / bluebird bio Inc / Fate Therapeutics Inc / MacroGenics Inc / Mirati Therapeutics Inc / Allogene Therapeutics Inc / IDEAYA Biosciences Inc / CRISPR Therapeutics AG / Merus NV / Deciphera Pharmaceuticals Inc / Zentalis Pharmaceuticals Inc / Xencor Inc / Cellectis SA / Oric Pharmaceuticals Inc / Y-mAbs Therapeutics Inc / Turning Point Therapeutics Inc / Zymeworks Inc / Beigene Ltd / Neoleukin Therapeutics Inc / Blueprint Medicines Corp / Revolution Medicines Inc / CytomX Therapeutics Inc / Adaptimmune Therapeutics PLC / Relay Therapeutics Inc / Adicet Bio Inc / Bolt Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Etzer Darout / Kelsey Goodwin / Yige Guo, Ph.D. / Mr. Charles Zhu, Ph.D., III / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">04/28/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US0311621009 / US4448591028 / IL0011313900 / US74374N1028</td><td class="leftalignment">Amgen Inc / Humana Inc / Galmed Pharmaceuticals Ltd / Provention Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">04/28/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">High Grade Healthcare : 1Q21 Earnings Highlights — What Mattered for Credit (AMGN, BSX, HUM, LLY)</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AMGN.O / BSX.N / HUM.N / LLY.N</td><td class="leftalignment">Amgen Inc / Boston Scientific Corp / Humana Inc / Eli Lilly and Co</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / FIXED INCOME/DEBT RESEARCH</td><td class="leftalignment">Brett Gibson / Mr. Matthew Bonner</td></tr>
<tr class="odd"><td class="leftalignment">04/28/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">1Q21 results; AMGN facing competitive foes; maintain Hold</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN=US / PFE=US</td><td class="leftalignment">Amgen Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">04/28/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Core Business Suffers Painful Price Erosion – Will Lumakras Be Enough? MP, $230</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">03116210 / 58933Y10</td><td class="leftalignment">Amgen Inc / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun</td></tr>
<tr class="odd"><td class="leftalignment">04/28/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Amgen Inc Investment Status Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="even"><td class="leftalignment">04/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Apr 28 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">US0079031078 / US0123481089 / US0231351067 / US0311621009 / US0382221051 / US22284P1057 / US2910111044 / US3156161024 / US3696041033 / US4385161066 / US45167R1041 / US4523271090 / US48203R1041 / US4824801009 / US5128071082 / US58155Q1031 / US5949181045 / US5951121038 / US8552441094 / US8636671013 / US8807701029 / US9113121068 / US9581021055 / US03073E1055 / US4771431016 / US83088M1027 / US4198791018 / US80105N1054 / US90385V1070 / US15135B1017 / US42330P1075 / US82706C1080 / US0043971052 / US64110D1046 / US92826C8394 / US13100M5094 / IE00B58JVZ52 / NL0009538784 / US7512121010 / US30303M1027 / NL0010273215 / US29355A1079 / US55345K1034 / US90184L1026 / US74736K1016 / US02079K1079 / US74624M1027 / IE00BY7QL619 / KYG4740B1059 / CA87241L1094 / GB00BDSFG982 / US05351X1019 / US68373M1071 / US1255231003 / US92537N1081 / US75513E1010 / US62955J1034 / US5738741041 / 120248964</td><td class="leftalignment">Advanced Micro Devices Inc / Albany International Corp / Amazon.com Inc / Amgen Inc / Applied Materials Inc / Covenant Logistics Group Inc / Emerson Electric Co / F5 Inc / General Electric Co / Honeywell International Inc / IDEX Corp / Illumina Inc / Juniper Networks Inc / KLA Corp / Lam Research Corp / Mckesson Corp / Microsoft Corp / Micron Technology Inc / Starbucks Corp / Stryker Corp / Teradyne Inc / United Parcel Service Inc / Western Digital Corp / Amerisourcebergen Corp / JetBlue Airways Corp / Skyworks Solutions Inc / Hawaiian Holdings Inc / Sanofi SA / Ultra Clean Holdings Inc / Centene Corp / Helix Energy Solutions Group Inc / Silicon Motion Technology Corp / Accuray Inc / NetApp Inc / Visa Inc / Calix Inc / Seagate Technology Holdings PLC / NXP Semiconductors NV / Ralph Lauren Corp / Meta Platforms Inc / ASML Holding NV / Enphase Energy Inc / MRC Global Inc / Twitter Inc / Qorvo Inc / Alphabet Inc / Pure Storage Inc / Johnson Controls International PLC / Ichor Holdings Ltd / TFI International Inc / TechnipFMC PLC / Avaya Holdings Corp / Opera Ltd / Cigna Corp / Vertiv Holdings Co / Raytheon Technologies Corp / Nov Inc / Marvell Technology Inc / Frontier Communications Parent Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / France / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">04/28/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">CHE / CNC / COF / FDX / GLW / IEX / INTC.O / MSFT.O / NCR / QCOM.O / ROP / RXN / ST / SYK / WM / TME / AMZN.O / AMGN.O / AAPL.O / NVDA.O / UPS.N / MPWR.O / VECO.O / SBUX.O / SYF / SMTC.O / V.N / AVGO.O / CRUS.OQ / XLNX.OQ / CHRW.OQ / VRTX.OQ / SWKS.OQ / TXN.OQ / MTCH.O / LECO.O / 0700.HK / ATRC.OQ / BIDU.O / 514766104 / ICLK.OQ / NXPI.O / AMD.OQ / ADI.OQ / ENPH.O / FB.O / GOOGL.O / CFMS.O / BABA.K / YUMC.K / SNAP.K / STM.BN / IQ.O / ALLO.OQ / CRSP.BN / SWAV.O / TCOM.O / RRTS.PK / DKNG.O / 84764T304 / HUYA.K</td><td class="leftalignment">Chemed Corp / Centene Corp / Capital One Financial Corp / FedEx Corp / Corning Inc / IDEX Corp / Intel Corp / Microsoft Corp / NCR Corp / Qualcomm Inc / Roper Technologies Inc / Zurn Water Solutions Corp / Sensata Technologies Holding PLC / Stryker Corp / Waste Management Inc / Tencent Music Entertainment Group / Amazon.com Inc / Amgen Inc / Apple Inc / NVIDIA Corp / United Parcel Service Inc / Monolithic Power Systems Inc / Veeco Instruments Inc / Starbucks Corp / Synchrony Financial / Semtech Corp / Visa Inc / Broadcom Inc / Cirrus Logic Inc / Xilinx Inc / CH Robinson Worldwide Inc / Vertex Pharmaceuticals Inc / Skyworks Solutions Inc / Texas Instruments Inc / Match Group Inc / Lincoln Electric Holdings Inc / Tencent Holdings Ltd / AtriCure Inc / Baidu Inc / Landec Corp / iClick Interactive Asia Group Ltd / NXP Semiconductors NV / Advanced Micro Devices Inc / Analog Devices Inc / Enphase Energy Inc / Meta Platforms Inc / Alphabet Inc / Conformis Inc / Alibaba Group Holding Ltd / Yum China Holdings Inc / Snap Inc / STMicroelectronics NV / iQIYI Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Shockwave Medical Inc / Trip.com Group Ltd / Roadrunner Transportation Systems Inc / DraftKings Inc / Speed Commerce Inc / HUYA Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">04/28/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - April 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">103</td><td class="leftalignment">US0079031078 / US0231351067 / US0311621009 / US0394831020 / US2333311072 / US2786421030 / US2788651006 / US5463471053 / US5949181045 / US6951561090 / US7310681025 / US7549071030 / US8243481061 / US8552441094 / US8825081040 / US9113121068 / US9311421039 / US94106L1098 / US9621661043 / CA9528451052 / IL0010824113 / CA1349211054 / CA3359341052 / US14040H1059 / US15135B1017 / US12541W2098 / US7376301039 / CA1375761048 / CA0966311064 / CA6179141065 / CA1999101001 / CA7669101031 / CA2271071094 / CA14068G1046 / CA46071W2058 / BMG491BT1088 / US89785X1019 / CA3518581051 / US3886891015 / US4778391049 / US91912E1055 / US34959E1091 / NL0009538784 / US30303M1027 / US6092071058 / CA0194561027 / CA04315L1058 / US09739D1000 / CA3874371147 / CA05651W2094 / CA16141A1030 / CA8661201167 / CA6674951059 / US6974351057 / CA0266951064 / CA58546R1091 / CA17039A1066 / US31816Q1013 / US02005N1000 / CA72820F1036 / US80283M1018 / CA45868C1095 / CA26153P1045 / CA1264621006 / LU1057788488 / US87165B1035 / BMG0750C1082 / CA8310211005 / CA82621K1021 / CA83179X1087 / CA05329M1041 / US02079K3059 / US68268W1036 / CA49410M1023 / GB00BDSFG982 / US92840M1027 / CA9628791027 / CA46136U1030 / IL0011417206 / CA05585D1033 / CA60448E1034 / CA4039254079 / AU0000018236 / US62921N1054 / CA7426943006 / CA33767E2024 / CA31890B1031 / US90278Q1085 / CA33843T1084 / CA00288U1066 / CA00076T1057</td><td class="leftalignment">Advanced Micro Devices Inc / Amazon.com Inc / Amgen Inc / Archer-Daniels-Midland Co / DTE Energy Co / eBay Inc / Ecolab Inc / Louisiana-Pacific Corp / Microsoft Corp / Packaging Corp of America / Polaris Inc / Rayonier Inc / Sherwin-Williams Co / Starbucks Corp / Texas Instruments Inc / United Parcel Service Inc / Walmart Inc / Waste Management Inc / Weyerhaeuser Co / West Fraser Timber Co Ltd / Check Point Software Technologies Ltd / Canadian Apartment Properties Real Estate Investment Trust / First Quantum Minerals Ltd / Capital One Financial Corp / Centene Corp / CH Robinson Worldwide Inc / Potlatchdeltic Corp / Canfor Corp / Boardwalk Real Estate Investment Trust / Morguard Real Estate Investment Trust / Cominar Real Estate Investment Trust / RioCan Real Estate Investment Trust / Crombie Real Estate Investment Trust / Capstone Mining Corp / InterRent Real Estate Investment Trust / Invesco Ltd / TrueBlue Inc / Franco-Nevada Corp / Graphic Packaging Holding Co / John Bean Technologies Corp / Vale SA / Fortinet Inc / NXP Semiconductors NV / Meta Platforms Inc / Mondelez International Inc / Allied Properties Real Estate Investment Trust / Artis Real Estate Investment Trust / Boise Cascade Co / Granite Real Estate Investment Trust / Badger Infrastructure Solutions Ltd / Chartwell Retirement Residences / Summit Industrial Income REIT / NorthWest Healthcare Properties REIT / Palo Alto Networks Inc / American Hotel Income Properties REIT LP / Melcor Real Estate Investment Trust / Choice Properties Real Estate Investment Trust / Mandiant Inc / Ally Financial Inc / Plaza Retail REIT / Santander Consumer USA Holdings Inc / Interfor Corp / Dream Office Real Estate Investment Trust / CT Real Estate Investment Trust / Trinseo PLC / Synchrony Financial / Axalta Coating Systems Ltd / Slate Office REIT / Sienna Senior Living Inc / SmartCentres Real Estate Investment Trust / Automotive Properties Real Estate Investment Trust / Alphabet Inc / OneMain Holdings Inc / Killam Apartment REIT / TechnipFMC PLC / Vistra Corp / Wheaton Precious Metals Corp / Invesque Inc / Sol Gel Technologies Ltd / BSR Real Estate Investment Trust / Minto Apartment Real Estate Investment Trust / H&R Real Estate Investment Trust / Nickel Mines Ltd / NGM Biopharmaceuticals Inc / PRO Real Estate Investment Trust / FirstService Corp / First Capital Real Estate Investment Trust / Ufp Industries Inc / Flagship Communities Real Estate Investment Trust / Abcellera Biologics Inc / Abc Technologies Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / United Kingdom / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">04/28/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Tough First Quarter With Pricing and COVID Impacts but Guidance Intact; Sotorasib Dose Comparison Study Raises Questions</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">04/28/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">V / 2516152 / 2023607 / 2219224 / 2280220 / 2270726 / 2829515 / 2670519 / 2342034 / 2613990 / 2689560 / 2707677 / 2440637 / 2853688 / 2931034 / 2503529 / 2181334 / 7103065 / B121557 / B125XQ6 / B4Y1MH7 / B8CKK03 / BYVY8G0 / BFZNYB7 / BDHF4K6 / BJ2Z0H2 / BWFKZT2 / BFZ1K46 / BZ8VJQ8 / BG31GH0 / BZ05388 / BYY88Y7 / BD6JX35 / BMH0MR7 / BLBLMD5 / BNG3RZ7</td><td class="leftalignment">Visa Inc / Eli Lilly and Co / Amgen Inc / CMS Energy Corp / DTE Energy Co / Walt Disney Co / Edison International / Exelon Corp / Fiserv Inc / Illumina Inc / PG&E Corp / Public Service Enterprise Group Inc / CenterPoint Energy Inc / Stryker Corp / Vertex Pharmaceuticals Inc / World Wrestling Entertainment Inc / Check Point Software Technologies Ltd / Novartis AG / Mastercard Inc / Portland General Electric Co / KAR Auction Services Inc / Mondelez International Inc / Alphabet Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Pinterest Inc / Cellectis SA / Spotify Technology SA / Vistra Corp / Y-mAbs Therapeutics Inc / Global Blood Therapeutics Inc / Alphabet Inc / Krystal Biotech Inc / Zendesk Inc / Array Technologies Inc / Leslie's Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / Israel / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">04/28/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">1Q experienced some COVID impacts, but we expect AMGN to keep on truckin' over rest of the year</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Emily Bodnar / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">04/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MOLN.S: Molecular Partners - Primary focus remains on Covid-19 partnership</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MOLN.S / LLY.N / ROG.S / NOVN.S / AMGN.OQ / REGN.OQ / ABBV.N</td><td class="leftalignment">Molecular Partners AG / Eli Lilly and Co / Roche Holding AG / Novartis AG / Amgen Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Fr. Barbora Blaha / Herr. Christoph Gretler / Ms Jo Walton</td></tr>
<tr class="odd"><td class="leftalignment">04/28/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">1Q Update: Recovery Weighted Toward 2nd Half</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">04/28/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Amgen Inc : 1Q Snapshot - Big Miss Though Focus Remains on Pipeline</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Mr. Turner Kufe</td></tr>
<tr class="odd"><td class="leftalignment">04/28/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">AMGN - AMGN 1Q21 postview: COVID continues to pressure the base, but a few bright spots</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">031162100</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">04/28/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">1Q21: Revenue Guidance Reaffirmed Despite 1Q Miss</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Do G. Kim / Jameson Kao / Ikechukwu Oji</td></tr>
<tr class="odd"><td class="leftalignment">04/28/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Q1:21 post-call: Q1 weakness likely seasonal, but highlights the cost of AMGN's volume focus</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Kennen MacKay, PHD / Michael Murray</td></tr>
<tr class="even"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">H2 Recovery Should Offset Weak Q1, Sotorasib Combo Delays Fuel Tox Concerns</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Yaron Werber, M.D., MD / Brendan Smith, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">AMGN (NEUTRAL) - Top & Bottom Line Miss Due to COVID-19 Impact and Seasonality; 2021 Guidance Intact as Mgmt Expects Pandemic Recovery Through 2H</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2023607 / BYYWPW6</td><td class="leftalignment">Amgen Inc / Beigene Ltd</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin</td></tr>
<tr class="even"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Ugly Quarter, No Matter How You Slice It, But We’re Staying With It</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">031162100</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">04/27/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">impt KRAS updates</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="even"><td class="leftalignment">04/27/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Amgen Inc : First Look at 1Q Results</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Mr. Turner Kufe</td></tr>
<tr class="odd"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">AMGN.OQ - Event Brief of Amgen Inc conference call, Apr. 27, 2021 / 5:00PM ET</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">AMGN.OQ - Event Transcript of Amgen Inc conference call, Apr. 27, 2021 / 5:00PM ET</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Q121 First Take: We Expected a Q121 Miss, But Not One Nearly This Ugly</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Amgen Inc: Peer Group Analytics - Q4 FY2020</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Zephirin Group, Inc.</td><td class="leftalignment">Zephirin Group View: The Dating Game - Key Quarterly Earnings on Apr 27, 2021</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PINS.N / BP.L / CNC.N / COF.N / EIX.N / GE.N / LLY.N / MMC.N / PHM.N / EQR.N / IEX.N / ROP.N / DTE.N / ADM.N / SYK.N / GLW.N / UPS.N / WM.N / MMM.N / SHW.N / V.N / OKE.N / BXP.N / EGP.N / UDR.N / JNPR.N / AMGN.OQ / FISV.OQ / MSFT.OQ / PCAR.OQ / SBUX.OQ / CHRW.OQ / FFIV.OQ / ILMN.OQ / JBLU.OQ / TXN.OQ / NOV.N / IVZ.N / MSCI.N / HAS.OQ / AMD.OQ / ENPH.OQ / MDLZ.OQ / GOOGL.OQ / SYF.N / PFG.OQ / TER.OQ / CB.BN / RTX.N</td><td class="leftalignment">Pinterest Inc / BP PLC / Centene Corp / Capital One Financial Corp / Edison International / General Electric Co / Eli Lilly and Co / Marsh & McLennan Companies Inc / Pultegroup Inc / Equity Residential / IDEX Corp / Roper Technologies Inc / DTE Energy Co / Archer-Daniels-Midland Co / Stryker Corp / Corning Inc / United Parcel Service Inc / Waste Management Inc / 3M Co / Sherwin-Williams Co / Visa Inc / ONEOK Inc / Boston Properties Inc / Eastgroup Properties Inc / UDR Inc / Juniper Networks Inc / Amgen Inc / Fiserv Inc / Microsoft Corp / Paccar Inc / Starbucks Corp / CH Robinson Worldwide Inc / F5 Inc / Illumina Inc / JetBlue Airways Corp / Texas Instruments Inc / Nov Inc / Invesco Ltd / MSCI Inc / Hasbro Inc / Advanced Micro Devices Inc / Enphase Energy Inc / Mondelez International Inc / Alphabet Inc / Synchrony Financial / Principal Financial Group Inc / Teradyne Inc / Chubb Ltd / Raytheon Technologies Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / United Kingdom / United States</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Communications / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Office Equipment / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Semiconductors / Services / Shipping & Shipbuilding / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Africa / Asia / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment">INVESTMENT STRATEGY / CAPITALIZATION / GOVERNMENT RELATIONS/REGULATIONS / MISCELLANEOUS / SMALL CAPITAL / GOVERNMENTS / RELATIVE VALUE / TRADING / GROWTH / INDEX / PORTFOLIO STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Longdley Zephirin</td></tr>
<tr class="even"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">MRK=US / LLY=US / PEP=US / PFE=US / AMGN=US / BMY=US / DIS=US / HD=US / KO=US / MCD=US / OXY=US / TWTR=US / RRC=US / CL=US / WEN=US / PLD=US / AMZN=US / BLD=US / DVN=US / INCY=US / KMI=US / APA=US / CPE=US / EOG=US / DGX=US / REI=US / XOM=US / CRK=US / LOW=US / WLL=US / CHKP=US / PXD=US / ENR=US / HSII=US / MGY=US / SWN=US / MUR=US / BRO=US / BYD=US / MRO=US / LEG=US / HCA=US / VMC=US / MGM=US / PENN=US / NWL=US / MLM=US / FLO=US / KFY=US / ARCC=US / CBRL=US / CENT=US / CHD=US / CNX=US / DRI=US / EPC=US / EQT=US / GFF=US / HAIN=US / IBP=US / SAFE=US / TREE=US / MAIN=US / MAS=US / MEDP=US / MHK=US / MCRI=US / ORCC=US / PACW=US / REGN=US / REGI=US / SBAC=US / SMG=US / SSNC=US / SNAP=US / VRTX=US / CVX=US / POST=US / BXS=US / BKNG=US / FBK=US / FR=US / FFIN=US / COP=US / VICI=US / DIN=US / MGP=US / MGPI=US / MNST=US / RRR=US / NOMD=US / TPX=US / FNB=US / EXP=US / CZR=US / NUVA=US / AINV=US / BECN=US / PLAY=US / FRPT=US / DENN=US / THS=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / ELF=US / AWI=US / OC=US / CADE=US / TAST=US / QSR=US / CLR=US / PNNT=US / PRPL=US / NOG=US / JACK=US / AAN=US / TREX=US / AR=US / NXPI=US / ESTE=US / FBHS=US / BCEI=US / MTDR=US / PDCE=US / FANG=US / ABBV=US / TILE=US / NDLS=US / GLPI=US / TSLX=US / 00770K202 / VNOM=US / 70806A106 / LOCO=US / ANTM=US / SHAK=US / AJRD=US / GSBD=US / WING=US / ARGX=US / 82982L103 / CDEV=US / PVAC=US / JELD=US / SBOW=US / PETQ=US / ROKU=US / CARG=US / COLD=US / EOLS=US / KDP=US / OZK=US / FSK=US / LYFT=US / RTLR=US / FERG=US / BRBR=US / OVV=US / ARQT=US / REYN=US / DKNG=US / FSKR=US / AZEK=US / BALY=US / HYFM=US / 100073616</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / PepsiCo Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Walt Disney Co / Home Depot Inc / Coca-Cola Co / McDonald's Corp / Occidental Petroleum Corp / Twitter Inc / Range Resources Corp / Colgate-Palmolive Co / Wendys Co / Prologis Inc / Amazon.com Inc / TopBuild Corp / Devon Energy Corp / Incyte Corp / Kinder Morgan Inc / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Quest Diagnostics Inc / Ring Energy Inc / Exxon Mobil Corp / Comstock Resources Inc / Lowe's Companies Inc / Whiting Petroleum Corp / Check Point Software Technologies Ltd / Pioneer Natural Resources Co / Energizer Holdings Inc / Heidrick & Struggles International Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / Brown & Brown Inc / Boyd Gaming Corp / Marathon Oil Corp / Leggett & Platt Inc / HCA Healthcare Inc / Vulcan Materials Co / MGM Resorts International / Penn National Gaming Inc / Newell Brands Inc / Martin Marietta Materials Inc / Flowers Foods Inc / Korn Ferry / Ares Capital Corp / Cracker Barrel Old Country Store Inc / Central Garden & Pet Co / Church & Dwight Co Inc / CNX Resources Corp / Darden Restaurants Inc / Edgewell Personal Care Co / EQT Corp / Griffon Corp / Hain Celestial Group Inc / Installed Building Products Inc / Safehold Inc / Lendingtree Inc / Main Street Capital Corp / Masco Corp / Medpace Holdings Inc / Mohawk Industries Inc / Monarch Casino & Resort Inc / Owl Rock Capital Corp / PacWest Bancorp / Regeneron Pharmaceuticals Inc / Renewable Energy Group Inc / SBA Communications Corp / Scotts Miracle-Gro Co / SS&C Technologies Holdings Inc / Snap Inc / Vertex Pharmaceuticals Inc / Chevron Corp / Post Holdings Inc / Cadence Bank / Booking Holdings Inc / FB Financial Corp / First Industrial Realty Trust Inc / First Financial Bankshares Inc / Conocophillips / VICI Properties Inc / Dine Brands Global Inc / MGM Growth Properties LLC / MGP Ingredients Inc / Monster Beverage Corp / Red Rock Resorts Inc / Nomad Foods Ltd / Tempur Sealy International Inc / FNB Corp / Eagle Materials Inc / Caesars Entertainment Inc / NuVasive Inc / Apollo Investment Corp / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Freshpet Inc / Denny's Corp / TreeHouse Foods Inc / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / elf Beauty Inc / Armstrong World Industries Inc / Owens Corning / Cadence Bank / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / Pennantpark Investment Corp / Purple Innovation Inc / Northern Oil and Gas Inc / Jack in the Box Inc / Aaron's Company Inc / Trex Company Inc / Antero Resources Corp / NXP Semiconductors NV / Earthstone Energy Inc / Fortune Brands Home & Security Inc / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Diamondback Energy Inc / Abbvie Inc / Interface Inc / Noodles & Co / Gaming and Leisure Properties Inc / Sixth Street Specialty Lending Inc / Aemetis Inc / Viper Energy Partners LP / PennantPark Floating Rate Capital Ltd / El Pollo Loco Holdings Inc / Anthem Inc / Shake Shack Inc / Aerojet Rocketdyne Holdings Inc / Goldman Sachs BDC Inc / Wingstop Inc / argenx SE / SiteOne Landscape Supply Inc / Centennial Resource Development Inc / Ranger Oil Corp / JELD-WEN Holding Inc / SilverBow Resources Inc / PetIQ Inc / Roku Inc / CarGurus Inc / Americold Realty Trust / Evolus Inc / Keurig Dr Pepper Inc / Bank Ozk / FS KKR Capital Corp / Lyft Inc / Rattler Midstream LP / Ferguson PLC / Bellring Brands Inc / Ovintiv Inc / Arcutis Biotherapeutics Inc / Reynolds Consumer Products Inc / DraftKings Inc / FS KKR Capital Corp / Azek Company Inc / Bally's Corp / Hydrofarm Holdings Group Inc / Kimco Realty Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / Luxembourg / Netherlands / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/27/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Key Takeaways from Prostate Cancer Pulse Call</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">03116210 / 66987V10 / 41358P10 / 55609910</td><td class="leftalignment">Amgen Inc / Novartis AG / Harpoon Therapeutics Inc / MacroGenics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Jonathan Chang, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">AMGN: Model Update Post 1Q21 Earnings</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tiago Fauth / Mr. Thomas Deal / Matthew Terwelp / Roger Xu</td></tr>
<tr class="odd"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US0311621009 / US09062X1037 / US03820J1007 / US00289Y1073 / US7310941080 / US40434H2031</td><td class="leftalignment">Amgen Inc / Biogen Inc / Applied Genetic Technologies Corp / Abeona Therapeutics Inc / PolarityTE Inc / HTG Molecular Diagnostics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Apr 16, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">AMGN - AMGN 1Q21 earnings preview</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">031162100</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">04/26/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Amgen climbs $15 billion (11%) in MCap in 2021, leads Medical/Biomedical sector gains</td><td class="leftalignment">English</td><td class="rightalignment">76</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Transcript from Expert call on LAG-3 inhibitors and BMY’s relatlimab</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">BMY=US / MRK=US / AMGN=US / INCY=US / REGN=US</td><td class="leftalignment">Bristol-Myers Squibb Co / Merck & Co Inc / Amgen Inc / Incyte Corp / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Apr 26 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">FR0000054470 / US00971T1016 / US0116591092 / US0311621009 / US0378331005 / US0463531089 / US0718131099 / US1101221083 / US1266501006 / US2855121099 / US37733W1053 / US45337C1027 / US4781601046 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / AN8068571086 / US8308791024 / US8447411088 / US8636671013 / US8740541094 / US98956P1021 / US4771431016 / US4198791018 / US80105N1054 / US2538681030 / US0491642056 / PAP310761054 / NL0000687663 / US01748X1028 / US2473617023 / US53261M1045 / US00922R1059 / US00507V1098 / US58933Y1055 / US9100471096 / US98986T1088 / US00287Y1091 / US00912X3026 / US23283R1005 / US8485771021 / US21240E1055 / US02376R1023 / CA0089118776 / US29444U7000 / US20717E1010 / US36165L1089 / US87105L1044 / US8760301072 / US19626G1085 / US5904791358 / CH0499880968 / US22041X1028 / US72815L1070 / US35909R1086</td><td class="leftalignment">Ubisoft Entertainment SA / Akamai Technologies Inc / Alaska Air Group Inc / Amgen Inc / Apple Inc / AstraZeneca PLC / Baxter International Inc / Bristol-Myers Squibb Co / CVS Health Corp / Electronic Arts Inc / GlaxoSmithKline PLC / Incyte Corp / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Schlumberger NV / SkyWest Inc / Southwest Airlines Co / Stryker Corp / Take-Two Interactive Software Inc / Zimmer Biomet Holdings Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Digital Realty Trust Inc / Atlas Air Worldwide Holdings Inc / Copa Holdings SA / AerCap Holdings NV / Allegiant Travel Co / Delta Air Lines Inc / Limelight Networks Inc / Air Transport Services Group Inc / Activision Blizzard Inc / Merck & Co Inc / United Airlines Holdings Inc / Zynga Inc / Abbvie Inc / Air Lease Corp / CyrusOne Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Air Canada / Equinix Inc / Conformis Inc / GDS Holdings Ltd / Switch Inc / Tapestry Inc / DigitalBridge Group Inc / Mesa Air Group Inc / ADC Therapeutics SA / Corsair Gaming Inc / Playtika Holding Corp / Frontier Group Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Mexico / Netherlands / Panama / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">PEP=US / AMGN=US / BMY=US / CAG=US / DIS=US / KO=US / OXY=US / RRC=US / CL=US / PG=US / AMZN=US / DVN=US / EBAY=US / INCY=US / U=US / APA=US / CPE=US / EOG=US / DGX=US / SLG=US / REI=US / MTN=US / XOM=US / CRK=US / WLL=US / PXD=US / ENR=US / MGY=US / SWN=US / MUR=US / SPOT=US / MRO=US / ATVI=US / MANH=US / NWL=US / FLO=US / STZ=US / AIR=US / ATRO=US / CENT=US / CHD=US / CSTR=US / COLL=US / CNX=US / DCO=US / EPC=US / EQT=US / HAIN=US / HEI=US / HXL=US / MAN=US / SMG=US / SHOP=US / TGI=US / CVX=US / POST=US / NET=US / SIVB=US / ABCB=US / BOKF=US / BDN=US / FB=US / SPR=US / RF=US / NLS=US / NFLX=US / COP=US / MGPI=US / SBCF=US / BDSI=US / MNST=US / PTON=US / NOMD=US / BIIB=US / RNG=US / NUVA=US / FRPT=US / THS=US / TDG=US / ELF=US / EIG=US / CLR=US / NOG=US / AAN=US / UTZ=US / OLO=US / AR=US / ESTE=US / BCEI=US / EA=US / MTDR=US / PDCE=US / FANG=US / GOOGL=US / FIVN=US / COUP=US / HUBS=US / ARGX=US / ACBI=US / AXSM=US / CDEV=US / PVAC=US / VRNA=US / SBOW=US / PETQ=US / ROKU=US / IQV=US / KDP=US / OZK=US / ARVN=US / BRBR=US / OVV=US / ARQT=US / REYN=US / DASH=US / HYFM=US / COUR-US</td><td class="leftalignment">PepsiCo Inc / Amgen Inc / Bristol-Myers Squibb Co / Conagra Brands Inc / Walt Disney Co / Coca-Cola Co / Occidental Petroleum Corp / Range Resources Corp / Colgate-Palmolive Co / Procter & Gamble Co / Amazon.com Inc / Devon Energy Corp / eBay Inc / Incyte Corp / Unity Software Inc / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Quest Diagnostics Inc / SL Green Realty Corp / Ring Energy Inc / Vail Resorts Inc / Exxon Mobil Corp / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Energizer Holdings Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / Spotify Technology SA / Marathon Oil Corp / Activision Blizzard Inc / Manhattan Associates Inc / Newell Brands Inc / Flowers Foods Inc / Constellation Brands Inc / AAR Corp / Astronics Corp / Central Garden & Pet Co / Church & Dwight Co Inc / CapStar Financial Holdings Inc / Collegium Pharmaceutical Inc / CNX Resources Corp / Ducommun Inc / Edgewell Personal Care Co / EQT Corp / Hain Celestial Group Inc / HEICO Corp / Hexcel Corp / ManpowerGroup Inc / Scotts Miracle-Gro Co / Shopify Inc / Triumph Group Inc / Chevron Corp / Post Holdings Inc / Cloudflare Inc / SVB Financial Group / Ameris Bancorp / BOK Financial Corp / Brandywine Realty Trust / Meta Platforms Inc / Spirit AeroSystems Holdings Inc / Regions Financial Corp / Nautilus Inc / Netflix Inc / Conocophillips / MGP Ingredients Inc / Seacoast Banking Corporation of Florida / BioDelivery Sciences International Inc / Monster Beverage Corp / Peloton Interactive Inc / Nomad Foods Ltd / Biogen Inc / RingCentral Inc / NuVasive Inc / Freshpet Inc / TreeHouse Foods Inc / TransDigm Group Inc / elf Beauty Inc / Employers Holdings Inc / Continental Resources Inc / Northern Oil and Gas Inc / Aaron's Company Inc / UTZ Brands Inc / Olo Inc / Antero Resources Corp / Earthstone Energy Inc / Civitas Resources Inc / Electronic Arts Inc / Matador Resources Co / PDC Energy Inc / Diamondback Energy Inc / Alphabet Inc / Five9 Inc / Coupa Software Inc / HubSpot Inc / argenx SE / Atlantic Capital Bancshares Inc / Axsome Therapeutics Inc / Centennial Resource Development Inc / Ranger Oil Corp / Verona Pharma PLC / SilverBow Resources Inc / PetIQ Inc / Roku Inc / IQVIA Holdings Inc / Keurig Dr Pepper Inc / Bank Ozk / Arvinas Inc / Bellring Brands Inc / Ovintiv Inc / Arcutis Biotherapeutics Inc / Reynolds Consumer Products Inc / DoorDash Inc / Hydrofarm Holdings Group Inc / Coursera Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Luxembourg / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">04/26/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">NeuroNavigator Call Miniseries: Hosting Christoph Correll, M.D. and Sanjay Mathew, M.D., May 6 at 10.00 a.m. ET and 2 p.m. ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Myles R. R. Minter / Mr. Tim F. Lugo / Matt Phipps, PHD / Lachlan Hanbury-Brown / Mr. Rob Andrew, CFA / John Boyle / Mr. Hunter Rogers</td></tr>
<tr class="odd"><td class="leftalignment">04/26/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">NeuroNavigator: DSM-VI Beta? Looking at Upstream Targets to Improve Neuropsychiatric Treatments</td><td class="leftalignment">English</td><td class="rightalignment">82</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Myles R. R. Minter / Mr. Tim F. Lugo / Matt Phipps, PHD / Lachlan Hanbury-Brown / Mr. Rob Andrew, CFA / John Boyle / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Amgen Inc: Valuation Landscape 2006-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">04/25/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Ph 3 data from Bristol’s deucravacitinib looks competitive, though Otezla is well established in the derm market</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Emily Bodnar / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">04/25/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">No Surprises In Otezla’s ADVANCE Mild/Mod PSO Data - TYK2 A Real Threat</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US0311621009 / US1101221083</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Yaron Werber, M.D., MD / Brendan Smith, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">04/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for AMGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">04/23/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BIIB-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BIIB.O / BIO / JNJ / PFE / GILD.O / AMGN.O / ILMN.O / ACOR.O / ABBV.K / QGEN.K / SNY.O</td><td class="leftalignment">Biogen Inc / Bio Rad Laboratories Inc / Johnson & Johnson / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Acorda Therapeutics Inc / Abbvie Inc / Qiagen NV / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">04/23/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Maintaining Buy post-deucra data and our Expert call</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY=US / AMGN=US</td><td class="leftalignment">Bristol-Myers Squibb Co / Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">04/23/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Scratching the surface on the psoriasis competitive landscape for Otezla</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AMGN=US / BMY=US / ARQT=US</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">04/23/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 544</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">04/23/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto</td></tr>
<tr class="odd"><td class="leftalignment">04/23/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="even"><td class="leftalignment">04/23/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">AAN 2021 Recap: Oral CGRPs Promising; Waiting for Adu PDUFA Decision; Innovation in Rare Disease; Talent Show Extraordinary</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Myles R. R. Minter / Mr. Hunter Rogers / Mr. Tim F. Lugo / Matt Phipps, PHD / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Sami Corwin, PHD / Lachlan Hanbury-Brown / John Boyle / Mr. Rob Andrew, CFA</td></tr>
<tr class="odd"><td class="leftalignment">04/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">AMGN: Assuming Coverage</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tiago Fauth / Mr. Thomas Deal / Matthew Terwelp / Roger Xu</td></tr>
<tr class="even"><td class="leftalignment">04/22/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Here Comes the Sun – Biotech Inflows Continue</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / 19240Q201</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / Cogent Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">04/22/2021</td><td class="leftalignment">S3 Partners</td><td class="leftalignment">S3 Analytics: Biotech - Pharma Short Selling Recap</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AZN.L / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / GSK.L / AMGN.OQ / CVM.A / CHRS.OQ / REGN.OQ / GILD.OQ / NVAX.OQ / UTHR.OQ / BMRN.OQ / ESPR.OQ / EXAS.OQ / VRTX.OQ / BIIB.OQ / CRTX.OQ / MNKD.OQ / RPRX.OQ / JAZZ.OQ / INO.OQ / MRNA.OQ / OMER.OQ / CYDY.PK / ABBV.N / ZTS.N / SRNE.OQ / HRTX.OQ / NVTA.N / IONS.OQ / EDIT.OQ / MDGL.OQ / KALA.OQ / VXRT.OQ / TLRY.OQ / 6160.HK / IGMS.OQ / OCGN.OQ / BEAM.OQ / PGEN.OQ / NRIX.OQ / 22UAy.DE / IBRX.OQ</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / GlaxoSmithKline PLC / Amgen Inc / CEL-SCI Corp / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Novavax Inc / United Therapeutics Corp / Biomarin Pharmaceutical Inc / Esperion Therapeutics Inc / Exact Sciences Corp / Vertex Pharmaceuticals Inc / Biogen Inc / Cortexyme Inc / MannKind Corp / Royalty Pharma PLC / Jazz Pharmaceuticals PLC / Inovio Pharmaceuticals Inc / Moderna Inc / Omeros Corp / Cytodyn Inc / Abbvie Inc / Zoetis Inc / Sorrento Therapeutics Inc / Heron Therapeutics Inc / Invitae Corp / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Madrigal Pharmaceuticals Inc / Kala Pharmaceuticals Inc / Vaxart Inc / Tilray Brands Inc / Beigene Ltd / IGM Biosciences Inc / Ocugen Inc / Beam Therapeutics Inc / Precigen Inc / Nurix Therapeutics Inc / BioNTech SE / Immunitybio Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / Germany / United Kingdom / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EQUITY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Ihor Dusaniwsky</td></tr>
<tr class="even"><td class="leftalignment">04/22/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Short Term Headwind - The FTC's Flawed Assumptions About Biopharma M&A</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">PFE=US / AMGN=US / BMY=US / GILD=US / AZN=US / GSK=US / JNJ=US / ILMN=US / VRTX=US / SNY=US / ABBV=US</td><td class="leftalignment">Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Illumina Inc / Vertex Pharmaceuticals Inc / Sanofi SA / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="odd"><td class="leftalignment">04/21/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AN=US / AMGN=US / BMY=US / DIS=US / PG=US / T=US / INCY=US / GILD=US / AMT=US / PEB=US / AKAM=US / CHTR=US / H=US / CONE=US / MTN=US / VZ=US / CCI=US / MGY=US / THC=US / MAR=US / SPOT=US / MRO=US / LEG=US / TNL=US / HLT=US / CMCSA=US / UNH=US / DISH=US / WTFC=US / BMRN=US / CHH=US / DRH=US / EQIX=US / HXL=US / MAN=US / PRGO=US / REGN=US / SBAC=US / VRTX=US / SNV=US / JAZZ=US / NFLX=US / PNFP=US / BIIB=US / TPX=US / EXP=US / SHO=US / DLR=US / PLAY=US / GMS=US / CCOI=US / HST=US / RPRX=US / LLNW=US / PRPL=US / LUMN=US / WH=US / CLNY=US / HGV=US / PCRX=US / RLJ=US / VAC=US / BCEI=US / RHP=US / ABBV=US / TMUS=US / SPNE=US / CABO=US / CRSP=US / PK=US / GDS=US / PLYA=US / SBOW=US / ROKU=US / SWCH=US / BHC=US / ARVN=US / AXNX=US / GMAB=US / 96758W101 / HIMS=US</td><td class="leftalignment">AutoNation Inc / Amgen Inc / Bristol-Myers Squibb Co / Walt Disney Co / Procter & Gamble Co / AT&T Inc / Incyte Corp / Gilead Sciences Inc / American Tower Corp / Pebblebrook Hotel Trust / Akamai Technologies Inc / Charter Communications Inc / Hyatt Hotels Corp / CyrusOne Inc / Vail Resorts Inc / Verizon Communications Inc / Crown Castle International Corp / Magnolia Oil & Gas Corp / Tenet Healthcare Corp / Marriott International Inc / Spotify Technology SA / Marathon Oil Corp / Leggett & Platt Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Comcast Corp / UnitedHealth Group Inc / DISH Network Corp / Wintrust Financial Corp / Biomarin Pharmaceutical Inc / Choice Hotels International Inc / Diamondrock Hospitality Co / Equinix Inc / Hexcel Corp / ManpowerGroup Inc / Perrigo Company PLC / Regeneron Pharmaceuticals Inc / SBA Communications Corp / Vertex Pharmaceuticals Inc / Synovus Financial Corp / Jazz Pharmaceuticals PLC / Netflix Inc / Pinnacle Financial Partners Inc / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Sunstone Hotel Investors Inc / Digital Realty Trust Inc / Dave & Buster's Entertainment Inc / GMS Inc / Cogent Communications Holdings Inc / Host Hotels & Resorts Inc / Royalty Pharma PLC / Limelight Networks Inc / Purple Innovation Inc / Lumen Technologies Inc / Wyndham Hotels & Resorts Inc / DigitalBridge Group Inc / Hilton Grand Vacations Inc / Pacira Biosciences Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Civitas Resources Inc / Ryman Hospitality Properties Inc / Abbvie Inc / T-Mobile US Inc / SeaSpine Holdings Corp / Cable One Inc / CRISPR Therapeutics AG / Park Hotels & Resorts Inc / GDS Holdings Ltd / Playa Hotels & Resorts NV / SilverBow Resources Inc / Roku Inc / Switch Inc / Bausch Health Companies Inc / Arvinas Inc / Axonics Inc / Genmab A/S / WideOpenWest Inc / Hims & Hers Health Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / United Kingdom / Ireland / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">04/21/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Read-Throughs from Roche's 1Q21 Results: Our Thoughts on REGN, BIIB, AMGN, and MRTX</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AMGN.OQ / BIIB.OQ / MRTX.OQ / REGN.OQ</td><td class="leftalignment">Amgen Inc / Biogen Inc / Mirati Therapeutics Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">04/21/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">N=54 prescriber poll on JAK inhibitors in atopic dermatitis</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">031162100 / 09062X103 / 5671735 / 0989529 / 0925288 / 7103065 / 7110388 / 717081103 / 375558103 / 110122108 / 532457108 / 75886F107 / 58933Y105 / 00287Y109</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">04/20/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Bringing investors back to Biotech -- What's on tap for 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AMGN=US / BIIB=US / INCY=US / GILD=US / BMRN=US / REGN=US / VRTX=US / CRSP=US</td><td class="leftalignment">Amgen Inc / Biogen Inc / Incyte Corp / Gilead Sciences Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / CRISPR Therapeutics AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino</td></tr>
<tr class="odd"><td class="leftalignment">04/20/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">Autos, Basic Resources, Healthcare & Transport Calendar : April - June 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ACF / AIRP.PA / BAX.N / BDX.N / BHP.AX / BMWG.DE / BMY.N / CC.N / CCK.N / CCL.N / CE.N / CRH.I / DSMN.AS / EPED.PA / F.N / FGP.L / GM.N / GOG.L / HEIG.DE / JNJ.N / LHAG.DE / LLY.N / MCK.N / MRK.N / MWDP.PA / NEX.L / PFE.N / PLOF.PA / RENA.PA / RIO.AX / RR.L / RYA.I / SAPJ.J / SAS.ST / SCHN.PA / SGC.L / SGOB.PA / SMIN.L / SOLB.BR / SYD.AX / TCFP.PA / TMO.N / VLLP.PA / VOLVb.ST / VOWG.DE / WBSV.VI / STERV.HE / AIRF.PA / CONG.DE / AZN.L / AMGN.O / AAL.L / SASY.PA / TKAG.DE / ROG.S / SIEGn.F / HON.N / NOVN.S / MG.TO / FMEG.DE / BZU.MI / MRCG.DE / MGA.N / PSHG_p.DE / OI.N / BLL.N / GLAX.NS / PKI.N / FREG.DE / RXL.PA / EZJ.L / SUP.N / GSK.L / ESI.N / CC@US / MHK.N / TAMO.BO / FLWS.O / VOES.VI / MT.N / LXSG.DE / HUN.N / SAF.PA / TUIGn.DE / LEGD.PA / TEVA.N / SKG.I / MNDI.L / DAIGn.DE / BAES.L / BAYGn.DE / BASFn.DE / GLEN.L / CAR.O / SDFGn.DE / METSB.HE / LKQ.O / XPO.N / GT.O / ABBV.N / GEST.MC / CSTM.N / EVKn.F / CTLT.N / EUCAR.PA / ZBH.N / 1COV.DE / HLAG.DE / NVGR.LS / ADNT.N / BHC.N / VTRS.O</td><td class="leftalignment">Acrow Formwork and Construction Services Ltd / L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Baxter International Inc / Becton Dickinson and Co / BHP Group Ltd / Bayerische Motoren Werke AG / Bristol-Myers Squibb Co / Chemours Co / Crown Holdings Inc / Carnival Corp / Celanese Corp / CRH PLC / Koninklijke DSM NV / Faurecia SE / Ford Motor Co / FirstGroup PLC / General Motors Co / Go-Ahead Group PLC / HeidelbergCement AG / Johnson & Johnson / Deutsche Lufthansa AG / Eli Lilly and Co / Mckesson Corp / Merck & Co Inc / Wendel SE / National Express Group PLC / Pfizer Inc / Compagnie Plastic Omnium SE / Renault SA / Rio Tinto Ltd / Rolls-Royce Holdings PLC / Ryanair Holdings PLC / Sappi Ltd / SAS AB / Schneider Electric SE / Stagecoach Group PLC / Compagnie de Saint Gobain SA / Smiths Group PLC / Solvay SA / Sydney Airport / Thales SA / Thermo Fisher Scientific Inc / Vallourec SA / Volvo AB / Volkswagen AG / Wienerberger AG / Stora Enso Oyj / Air France KLM SA / Continental AG / AstraZeneca PLC / Amgen Inc / Anglo American PLC / Sanofi SA / thyssenkrupp AG / Roche Holding AG / Siemens AG / Honeywell International Inc / Novartis AG / Magna International Inc / Fresenius Medical Care AG & Co KGaA / Buzzi Unicem SpA / Merck KGaA / Magna International Inc / Porsche Automobil Holding SE / O-I Glass Inc / Ball Corp / GlaxoSmithKline Pharmaceuticals Ltd / PerkinElmer Inc / Fresenius SE & Co KGaA / Rexel SA / Easyjet PLC / Superior Industries International Inc / GlaxoSmithKline PLC / Element Solutions Inc / Chemours Co / Mohawk Industries Inc / Tata Motors Ltd / 1-800-Flowers.Com Inc / voestalpine AG / ArcelorMittal SA / Lanxess AG / Huntsman Corp / Safran SA / TUI AG / Legrand SA / Teva Pharmaceutical Industries Ltd / Smurfit Kappa Group PLC / Mondi PLC / Daimler AG / BAE Systems PLC / Bayer AG / BASF SE / Glencore PLC / Avis Budget Group Inc / K&S AG / Metsa Board Oyj / LKQ Corp / XPO Logistics Inc / Goodyear Tire & Rubber Co / Abbvie Inc / Gestamp Automocion SA / Constellium SE / Evonik Industries AG / Catalent Inc / Europcar Mobility Group SA / Zimmer Biomet Holdings Inc / Covestro AG / Hapag Lloyd AG / Navigator Company SA / Adient PLC / Bausch Health Companies Inc / Viatris Inc</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">Australia / Austria / Belgium / Canada / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Hong Kong / India / Ireland / Israel / Italy / Luxembourg / Netherlands / Norway / Panama / Portugal / Sweden / United States / South Africa / Jersey</td><td class="leftalignment">Aerospace / Air Transportation / Automotive / Biotechnology / Building & Building Materials / Chemicals / Conglomerates / Consumer / Containers & Packing / Defense / Electrical / Energy / Engineering & Construction / Financial Services / Healthcare / Household Products / Industrial Materials / Leisure & Entertainment / Lodging & Restaurants / Machinery / Manufacturing / Metals & Minerals / Paper & Forest Products / Pharmaceuticals / Railroads / Retailing / Shipping & Shipbuilding / Tire & Rubber / Transportation / Wholesale / Oil & Gas</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Danielle Ward / Benjamin Defay / Stephanie Vincent / Mr. William W. Wade / Jemma Permalloo / Ed McGuinness / Mr. Adam Bodor</td></tr>
<tr class="even"><td class="leftalignment">04/20/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Upcoming Biopharma Regulatory Events to Watch Given Tougher Environment</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / INCY=US / GILD=US / MOR=DE / AZN=US / GSK=US / ALKS=US / BMRN=US / ICPT=US / VRTX=US / SGEN=US / SAGE=US / PRVB=US / SNY=US / BIIB=US / ACAD=US / ALNY=US / MNKD=US / FOLD=US / IFRX=US / ASND=US / CCXI=US / FGEN=US / ABBV=US / MRTX=US / MGNX=US / ITCI=US / QURE=US / AUPH=US / BPMC=US / AXSM=US / RETA=US / BHVN=US / BBIO=US / MIRM=US / GMAB=US / TVTX=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Incyte Corp / Gilead Sciences Inc / MorphoSys AG / AstraZeneca PLC / GlaxoSmithKline PLC / Alkermes Plc / Biomarin Pharmaceutical Inc / Intercept Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Seagen Inc / SAGE Therapeutics Inc / Provention Bio Inc / Sanofi SA / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / MannKind Corp / Amicus Therapeutics Inc / InflaRx NV / Ascendis Pharma A/S / ChemoCentryx Inc / FibroGen Inc / Abbvie Inc / Mirati Therapeutics Inc / MacroGenics Inc / Intra-Cellular Therapies Inc / Uniqure NV / Aurinia Pharmaceuticals Inc / Blueprint Medicines Corp / Axsome Therapeutics Inc / Reata Pharmaceuticals Inc / Biohaven Pharmaceutical Holding Company Ltd / BridgeBio Pharma Inc / Mirum Pharmaceuticals Inc / Genmab A/S / Travere Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Germany / Denmark / France / United Kingdom / Ireland / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/20/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Domestic Plateau Holds as First Dose Vaccinations Reach ~40% Overall and Breaking 50% in Adults; Outbreak in India Concerning</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">04/20/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Biotechnology : 1Q21 Earnings Preview</td><td class="leftalignment">English</td><td class="rightalignment">50</td><td class="leftalignment">ACAD.O / ALKS.O / GILD.O / AMGN.O / INCY.O / BMRN.O / REGN.O / VRTX.O / RARE.O / SGEN.O / BIIB.O / MRNA.O / CLVS.O / SAGE.O / NVCR.O / PBYI.O / BNTX.O</td><td class="leftalignment">ACADIA Pharmaceuticals Inc / Alkermes Plc / Gilead Sciences Inc / Amgen Inc / Incyte Corp / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Seagen Inc / Biogen Inc / Moderna Inc / Clovis Oncology Inc / SAGE Therapeutics Inc / Novocure Ltd / Puma Biotechnology Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / Ireland / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Mr. Turner Kufe / Manish Jajoo</td></tr>
<tr class="odd"><td class="leftalignment">04/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - JNJ 1Q21 Earnings Readthroughs to our Biotech Coverage</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">JNJ.N / AMGN.OQ / GILD.OQ / INCY.OQ / BIIB.OQ / SAGE.OQ</td><td class="leftalignment">Johnson & Johnson / Amgen Inc / Gilead Sciences Inc / Incyte Corp / Biogen Inc / SAGE Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">04/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IKNA: Targeted Oncology Company with Attractive Novel Therapy Candidates; Initiating with an Outperform Rating and a $30 Target Price</td><td class="leftalignment">English</td><td class="rightalignment">43</td><td class="leftalignment">IKNA.OQ / 4502.T / 4528.T / BMY.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVN.S / GSK.L / AMGN.OQ / INCY.OQ / A2.MI / BAYGN.DE / MRTX.OQ</td><td class="leftalignment">Ikena Oncology Inc / Takeda Pharmaceutical Co Ltd / Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novartis AG / GlaxoSmithKline PLC / Amgen Inc / Incyte Corp / A2A SpA / Bayer AG / Mirati Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Italy / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Yunhee Park / Jonathan Woo</td></tr>
<tr class="odd"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">SBUX=US / SQ=US / MGA=US / MRK=US / BSX=US / ABT=US / AMGN=US / CAT=US / TWTR=US / WM=US / BWA=US / MDT=US / GNSS=US / RUN=US / FCEL=US / PLUG=US / NVS=US / SMTC=US / MMC=US / TSM=US / HON=US / EXPE=US / JCI=US / DE=US / PGR=US / RSG=US / ALB=US / AMSC=US / ARRY=US / ATRC=US / AVNT=US / CMI=US / CREE=US / EW=US / AJG=US / LINK=US / ITRI=US / NVAX=US / PRGO=US / KWR=US / ROK=US / SNAP=US / TRMB=US / AYI=US / BKNG=US / FB=US / NEP=US / VMT=US / CRTO=US / ICAD=US / OSTK=US / BE=US / APPN=US / CLH=US / WCN=US / AON=US / ISR=US / CORT=US / ENS=US / GOOG=US / TWIN=US / ORA=US / AMRS=US / PERI=US / SPWR=US / CSIQ=US / FSLR=US / PUBM=US / DAN=US / WPRT=US / NEO=US / AGCO=US / 005930-KR=US / TSLA=US / AMRC=US / ENPH=US / HASI=US / CNHI=US / CHGG=US / NVRO=US / SEDG=US / AQMS=US / WKHS=US / ROKU=US / APTV=US / SAIL=US / VOW3-DE=US / CWEN=US / GRWG=US / TMDX=US / NKLA=US / XPEV=US / VLDR=US / VTRS=US / SHLS=US / CHPT=US / AEVA=US / IBRX=US / SCHNEIDER=US / 120248964</td><td class="leftalignment">Starbucks Corp / Block Inc / Magna International Inc / Merck & Co Inc / Boston Scientific Corp / Abbott Laboratories / Amgen Inc / Caterpillar Inc / Twitter Inc / Waste Management Inc / Borgwarner Inc / Medtronic PLC / Genasys Inc / Sunrun Inc / Fuelcell Energy Inc / Plug Power Inc / Novartis AG / Semtech Corp / Marsh & McLennan Companies Inc / Taiwan Semiconductor Manufacturing Co Ltd / Honeywell International Inc / Expedia Group Inc / Johnson Controls International PLC / Deere & Co / Progressive Corp / Republic Services Inc / Albemarle Corp / American Superconductor Corp / Array Technologies Inc / AtriCure Inc / Avient Corp / Cummins Inc / Wolfspeed Inc / Edwards Lifesciences Corp / Arthur J Gallagher & Co / Interlink Electronics Inc / Itron Inc / Novavax Inc / Perrigo Company PLC / Quaker Chemical Corp / Rockwell Automation Inc / Snap Inc / Trimble Inc / Acuity Brands Inc / Booking Holdings Inc / Meta Platforms Inc / Nextera Energy Partners LP / Vmoto Ltd / Criteo SA / ICAD Inc / Overstock.com Inc / Bloom Energy Corp / Appian Corp / Clean Harbors Inc / Waste Connections Inc / Aon PLC / IsoRay Inc / Corcept Therapeutics Inc / EnerSys / Alphabet Inc / Twin Disc Inc / Ormat Technologies Inc / Amyris Inc / Perion Network Ltd / SunPower Corp / Canadian Solar Inc / First Solar Inc / PubMatic Inc / Dana Inc / Westport Fuel Systems Inc / Neogenomics Inc / AGCO Corp / Farfetch Ltd / Tesla Inc / Ameresco Inc / Enphase Energy Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / CNH Industrial NV / Chegg Inc / Nevro Corp / Solaredge Technologies Inc / Aqua Metals Inc / Workhorse Group Inc / Roku Inc / Aptiv PLC / SailPoint Technologies Holdings Inc / Volkswagen AG / Clearway Energy Inc / GrowGeneration Corp / Transmedics Group Inc / Nikola Corp / Xpeng Inc / Velodyne Lidar Inc / Viatris Inc / Shoals Technologies Group Inc / ChargePoint Holdings Inc / Aeva Technologies Inc / Immunitybio Inc / Schneider Electric Infrastructure Ltd / Frontier Communications Parent Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / Cayman Islands / France / India / Ireland / Israel / Netherlands / Taiwan / United States / Jersey</td><td class="leftalignment">Biotechnology / Conglomerates / Consumer / Electrical / Financial Services / Healthcare / Lodging & Restaurants / Retailing / Semiconductors</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - April 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">AEP.N / AES.N / ALV.N / ANTO.L / BAC.N / BK.N / BP.L / C.N / CCI.N / CL.N / EIX.N / EL.N / ENI.MI / F.N / GM.N / JNJ.N / JPM.N / KMB.N / KO.N / MRK.N / NA / PFE.N / PNC.N / REP.MC / RIO.L / SO.N / T.N / TOTF.PA / VC.N / PEP.N / BFb.N / PG.N / CFP.TO / CPB.N / TEN.N / CMCSA.O / CHKP.O / AMGN.O / INCY.O / THC.N / UHS.N / AAL.L / DUK.N / UNH.N / BWA.N / LEA.N / K.N / DISH.O / GS.N / CLX.N / CAG.N / GIS.N / PCG.N / XOM.N / EPC.N / SBAC.O / AMT.N / JAZZ.O / BOL.ST / CONE.O / VZ.N / STT.N / HCA.N / CYH.N / ARNA.O / STZ.N / APH.N / FISV.O / V.N / CHTR.O / AXL.N / AWK.N / CHD.N / NWN.N / BC.N / SAM.N / REGN.O / ENR.N / CVX.N / NCR.N / TEL.N / CNP.N / APF.L / ENDP.O / BLU.N / CPK.N / PII.N / ST.N / GPN.N / MNST.O / CASY.O / ICPT.O / EQIX.O / ATDb.TO / 02209S103 / DLR.N / NESTE.HE / 416515104 / 427866108 / WEF.TO / WAL.N / RDSb.L / SJW.N / MS.N / FIS.N / MA.N / HOG.N / GALP.LS / 3IN.L / ATL.MI / BGS.N / PPL.TO / SLRS.MC / DAN.N / VALE.N / SPB.N / BHPB.L / NEE.N / CAML.L / PCRX.O / MTOR.N / GLEN.L / IFP.TO / MDLZ.OQ / ALLY.N / FANG.O / ABBV.N / TSLA.N / PRMW.N / TMUS.N / COTY.N / 81762P102 / CFF.TO / PTC.O / BTG.N / CFG.N / GLPG.O / TDOC.N / RACE.MI / TWLO.N / ADNT.N / VST.N / APTV.N / VNE.N / KDP.N / CWEN.N / OSMT.O / NWL.O / MORF.OQ / CRNC.OQ / 2222.SE / ETNB.O / WTRG.N / REYN.O / NKLA.OQ / FOUR.N / RXT.OQ / LUMN.N / MTCR.O / TLMD.OQ / WFG.N / AFRM.O / NAPA.N / CARE.TO / OSO.N / DSEY.O / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Autoliv Inc / Antofagasta PLC / Bank of America Corp / Bank of New York Mellon Corp / BP PLC / Citigroup Inc / Crown Castle International Corp / Colgate-Palmolive Co / Edison International / Estee Lauder Companies Inc / Eni SpA / Ford Motor Co / General Motors Co / Johnson & Johnson / JPMorgan Chase & Co / Kimberly-Clark Corp / Coca-Cola Co / Merck & Co Inc / National Bank of Canada / Pfizer Inc / PNC Financial Services Group Inc / Repsol SA / Rio Tinto PLC / Southern Co / AT&T Inc / TotalEnergies SE / Visteon Corp / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Canfor Corp / Campbell Soup Co / Tenneco Inc / Comcast Corp / Check Point Software Technologies Ltd / Amgen Inc / Incyte Corp / Tenet Healthcare Corp / Universal Health Services Inc / Anglo American PLC / Duke Energy Corp / UnitedHealth Group Inc / Borgwarner Inc / Lear Corp / Kellogg Co / DISH Network Corp / Goldman Sachs Group Inc / Clorox Co / Conagra Brands Inc / General Mills Inc / PG&E Corp / Exxon Mobil Corp / Edgewell Personal Care Co / SBA Communications Corp / American Tower Corp / Jazz Pharmaceuticals PLC / Boliden AB / CyrusOne Inc / Verizon Communications Inc / State Street Corp / HCA Healthcare Inc / Community Health Systems Inc / Arena Pharmaceuticals Inc / Constellation Brands Inc / Amphenol Corp / Fiserv Inc / Visa Inc / Charter Communications Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Church & Dwight Co Inc / Northwest Natural Holding Co / Brunswick Corp / Boston Beer Company Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Chevron Corp / NCR Corp / TE Connectivity Ltd / CenterPoint Energy Inc / Anglo Pacific Group PLC / Endo International PLC / BELLUS Health Inc / Chesapeake Utilities Corp / Polaris Inc / Sensata Technologies Holding PLC / Global Payments Inc / Monster Beverage Corp / Caseys General Stores Inc / Intercept Pharmaceuticals Inc / Equinix Inc / Alimentation Couche-Tard Inc / Altria Group Inc / Digital Realty Trust Inc / Neste Oyj / Hartford Financial Services Group Inc / Hershey Co / Western Forest Products Inc / Western Alliance Bancorp / Royal Dutch Shell PLC / SJW Group / Morgan Stanley / Fidelity National Information Services Inc / Mastercard Inc / Harley-Davidson Inc / Galp Energia SGPS SA / 3I Infrastructure PLC / Atlantia SpA / B&G Foods Inc / Pembina Pipeline Corp / Solaria Energia y Medio Ambiente SA / Dana Inc / Vale SA / Spectrum Brands Holdings Inc / BHP Group PLC / Nextera Energy Inc / Central Asia Metals PLC / Pacira Biosciences Inc / Meritor Inc / Glencore PLC / Interfor Corp / Mondelez International Inc / Ally Financial Inc / Diamondback Energy Inc / Abbvie Inc / Tesla Inc / Primo Water Corp / T-Mobile US Inc / Coty Inc / ServiceNow Inc / Conifex Timber Inc / PTC Inc / B2Gold Corp / Citizens Financial Group Inc / Galapagos NV / Teladoc Health Inc / Ferrari NV / Twilio Inc / Adient PLC / Vistra Corp / Aptiv PLC / Veoneer Inc / Keurig Dr Pepper Inc / Clearway Energy Inc / Osmotica Pharmaceuticals PLC / Newell Brands Inc / Morphic Holding Inc / Cerence Inc / Saudi Arabian Oil Co / 89Bio Inc / Essential Utilities Inc / Reynolds Consumer Products Inc / Nikola Corp / Shift4 Payments Inc / Rackspace Technology Inc / Lumen Technologies Inc / Metacrine Inc / Soc Telemed Inc / West Fraser Timber Co Ltd / Affirm Holdings Inc / Duckhorn Portfolio Inc / Dialogue Health Technologies Inc / Olo Inc / Diversey Holdings Ltd / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Brazil / Canada / Switzerland / Cayman Islands / Spain / Finland / France / United Kingdom / Ireland / Israel / Italy / Netherlands / Portugal / Saudi Arabia / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Apr 19 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US09061G1013 / US0028241000 / US0079731008 / US0116591092 / US0311621009 / US0382221051 / US0463531089 / US0556221044 / US1101221083 / US1924461023 / US1925761066 / US30161Q1040 / US30231G1022 / US3755581036 / US37733W1053 / US45337C1027 / US4567881085 / US4781601046 / US4824801009 / US5012421013 / US5128071082 / US5324571083 / US55306N1046 / US64125C1099 / US66987V1098 / US6701002056 / US7170811035 / US75886F1075 / US7711951043 / US8308791024 / US8447411088 / US8807701029 / US91307C1027 / US91347P1057 / US92532F1003 / US1667641005 / US89151E1091 / US4771431016 / US4198791018 / US2948216088 / US80105N1054 / US3463751087 / US09062X1037 / US90385V1070 / US0042251084 / US02043Q1076 / RDSa.AS / PAP310761054 / US16115Q3083 / US3020811044 / US29089Q1058 / US92932M1018 / US01748X1028 / US2473617023 / US87874R1005 / US03152W1099 / BMG3922B1072 / CH0102993182 / IE00B4BNMY34 / US58933Y1055 / US46333X1081 / US9100471096 / US03027X1000 / US29414B1044 / US00287Y1091 / NL0010273215 / US98978V1035 / US8036071004 / US4576693075 / US6951271005 / US74587V1070 / US45845P1084 / US29428V1044 / US69366J2006 / US29664W1053 / US8485771021 / US21240E1055 / US02376R1023 / US4277461020 / US5034596040 / US90400D1081 / KYG8807B1068 / LU0974299876 / US78667J1088 / CA0089118776 / US2681582019 / US31572Q8087 / US22822V1017 / IE00BTN1Y115 / US09627Y1091 / US37890U1088 / US4622221004 / US07725L1026 / KYG4740B1059 / US2067871036 / US78410G1040 / US23355L1061 / IL0011407140 / US76243J1051 / US89854H1023 / US05351X1019 / US05455M1009 / US29260V1052 / US5904791358 / CA39342L1085 / US28414H1032 / US61775R1059 / US92537N1081 / US39813G1094 / US44891N1090 / US12769G1004 / US81181C1045 / US05875B1061</td><td class="leftalignment">Biomarin Pharmaceutical Inc / Abbott Laboratories / Advanced Energy Industries Inc / Alaska Air Group Inc / Amgen Inc / Applied Materials Inc / AstraZeneca PLC / BP PLC / Bristol-Myers Squibb Co / Cognizant Technology Solutions Corp / Cohu Inc / Exelixis Inc / Exxon Mobil Corp / Gilead Sciences Inc / GlaxoSmithKline PLC / Incyte Corp / Infosys Ltd / Johnson & Johnson / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Eli Lilly and Co / MKS Instruments Inc / Neurocrine Biosciences Inc / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Regeneron Pharmaceuticals Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Teradyne Inc / United Therapeutics Corp / Universal Display Corp / Vertex Pharmaceuticals Inc / Chevron Corp / TotalEnergies SE / JetBlue Airways Corp / Hawaiian Holdings Inc / Telefonaktiebolaget LM Ericsson / Sanofi SA / FormFactor Inc / Biogen Inc / Ultra Clean Holdings Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Royal Dutch Shell PLC / Copa Holdings SA / Chart Industries Inc / Exlservice Holdings Inc / Emergent BioSolutions Inc / WNS (Holdings) Ltd / Allegiant Travel Co / Delta Air Lines Inc / TechTarget Inc / Amicus Therapeutics Inc / Genpact Ltd / TE Connectivity Ltd / Accenture PLC / Merck & Co Inc / Ironwood Pharmaceuticals Inc / United Airlines Holdings Inc / American Tower Corp / Epam Systems Inc / Abbvie Inc / ASML Holding NV / Zoetis Inc / Sarepta Therapeutics Inc / Insmed Inc / Pacira Biosciences Inc / Puma Biotechnology Inc / Intercept Pharmaceuticals Inc / Epizyme Inc / PTC Therapeutics Inc / Esperion Therapeutics Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Heron Therapeutics Inc / La Jolla Pharmaceutical Co / Ultragenyx Pharmaceutical Inc / Theravance Biopharma Inc / Globant SA / SAGE Therapeutics Inc / Air Canada / Dynavax Technologies Corp / FibroGen Inc / Crown Castle International Corp / Medtronic PLC / Blueprint Medicines Corp / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Beigene Ltd / Ichor Holdings Ltd / Conduent Inc / SBA Communications Corp / DXC Technology Co / Urogen Pharma Ltd / Rhythm Pharmaceuticals Inc / TTEC Holdings Inc / Avaya Holdings Corp / AVROBIO Inc / Endava PLC / Mesa Air Group Inc / Green Thumb Industries Inc / Elanco Animal Health Inc / Morphic Holding Inc / Vertiv Holdings Co / Grid Dynamics Holdings Inc / IAC/Interactivecorp / Caesars Entertainment Inc / Seagen Inc / Bally's Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / India / Ireland / Israel / Luxembourg / Mexico / Netherlands / Panama / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AXP / 2516152 / 2000019 / 2023607 / 2065159 / 2942605 / 2219224 / 2216850 / 2270726 / 2317087 / 2670519 / 2342034 / 2689560 / 2684703 / 2048804 / 2440637 / 2402121 / 2862532 / 2857817 / B125XQ6 / B02R1L6 / B3D7K31 / B7TL820 / BYNZGK1 / BK0VHF6 / B0SDJB4 / BJJMGL2 / BYXJQG9 / BKTNTR9 / BFWK4R7 / BZ1LFG7 / BN2R582 / BGKG6M3 / BJNQGL0 / BLBLMD5 / BMC8SQ7 / BNTB3N8 / BMFPJK6</td><td class="leftalignment">American Express Co / Eli Lilly and Co / Amazon.com Inc / Amgen Inc / Autodesk Inc / Avista Corp / CMS Energy Corp / Consolidated Edison Inc / Walt Disney Co / Entergy Corp / Exelon Corp / Fiserv Inc / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / CenterPoint Energy Inc / Nuance Communications Inc / E W Scripps Co / Netflix Inc / Portland General Electric Co / ALLETE Inc / Discovery Inc / Meta Platforms Inc / Block Inc / IDEAYA Biosciences Inc / Zealand Pharma A/S / Fox Corp / Spire Inc / ViacomCBS Inc / PagSeguro Digital Ltd / Roku Inc / Relay Therapeutics Inc / StoneCo Ltd / Rite Aid Corp / Array Technologies Inc / BTRS Holdings Inc / Vizio Holding Corp / ACV Auctions Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Denmark / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">04/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">BioPharma: RBC’s Rheum/Inflamm/Derm Day – Asthma/Allergy</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AMGN.O / REGN.O</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Lisa Walter / Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Daniel Busby / Mr. Luca Issi, PHD / Leonid Timashev / Steve Daddeo / David Szeto / Yinglu Zhang</td></tr>
<tr class="even"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology: 1Q21 EPS Preview: Biotech Headwinds Led to Underperformance in Q1, but M&A Could Provide Catalysts to Lift Sentiment</td><td class="leftalignment">English</td><td class="rightalignment">64</td><td class="leftalignment">AMGN.OQ / BIIB.OQ / 4502.T / LLY.N / AZN.L / REGN.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / EXEL.OQ / SGEN.OQ / VRTX.OQ / GLPG.AS / EPZM.OQ / MRTX.OQ / BPMC.OQ / DCPH.OQ / GRTX.OQ</td><td class="leftalignment">Amgen Inc / Biogen Inc / Takeda Pharmaceutical Co Ltd / Eli Lilly and Co / AstraZeneca PLC / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Exelixis Inc / Seagen Inc / Vertex Pharmaceuticals Inc / Galapagos NV / Epizyme Inc / Mirati Therapeutics Inc / Blueprint Medicines Corp / Deciphera Pharmaceuticals Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United Kingdom / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park / Mr. Bradley P. Canino</td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US0311621009 / US1266501006 / US3755581036 / US4448591028 / US45337C1027 / US75886F1075 / US92532F1003 / US09062X1037 / US15135B1017 / US69366J2006 / US0367521038 / US1255231003</td><td class="leftalignment">Amgen Inc / CVS Health Corp / Gilead Sciences Inc / Humana Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Centene Corp / PTC Therapeutics Inc / Anthem Inc / Cigna Corp</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">1Q21 Large Cap Preview: We see mostly solid prints across the board in spite of COVID</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US0311621009 / US09062X1037 / US3755581036 / US45337C1027 / US75886F1075 / US92532F1003</td><td class="leftalignment">Amgen Inc / Biogen Inc / Gilead Sciences Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Emily Bodnar / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 543</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--April 16, 2021</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">FSTX=US / GANX=US / MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / AMGN=US / BMY=US / MDT=US / WMT=US / INCY=US / CMS=US / DGX=US / NVS=US / AZN=US / GSK=US / CRY=US / RAD=US / JNJ=US / HCA=US / UCB=BE / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / APLS=US / ATRC=US / CHE=US / CYH=US / EW=US / ISEE=US / GEN=US / ISRG=US / PHG=US / LH=US / PRVL=US / REGN=US / USPH=US / UHS=US / VRTX=US / SGEN=US / SAGE=US / CCRN=US / RHHBY=US / CNC=US / ACA=US / ICAD=US / ENSG=US / MD=US / SLF=US / IGMS=US / BIIB=US / ISR=US / SLP=US / MRNA=US / ALNY=US / GOOG=US / INO=US / LHCG=US / CHNG=US / OSCR=US / FOLD=US / EHC=US / TMDI=US / ADXN=US / SWAV=US / ADUS=US / SRNE=US / RGNX=US / ANVS=US / ACHC=US / PRTA=US / MRTX=US / MGNX=US / AERI=US / XNCR=US / TRVN=US / FLXN=US / CTRE=US / VBIV=US / WBA=US / NVTA=US / EVH=US / TDOC=US / NVCR=US / VYGR=US / MRUS=US / APVO=US / IRTC=US / CRSP=US / IOVA=US / MTEM=US / SYBX=US / NCNA=US / MDNA=US / ALLO=US / IDYA=US / BCYC=US / PSNL=US / ONCT=US / NBSE=US / DMTK=US / BNTX=US / PNTG=US / PASG=US / LYS=US / ORIC=US / INBX=US / TSHA=US / KDNY=US / SIOX=US</td><td class="leftalignment">F-Star Therapeutics Inc / Gain Therapeutics Inc / Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Amgen Inc / Bristol-Myers Squibb Co / Medtronic PLC / Walmart Inc / Incyte Corp / CMS Energy Corp / Quest Diagnostics Inc / Novartis AG / AstraZeneca PLC / GlaxoSmithKline PLC / CryoLife Inc / Rite Aid Corp / Johnson & Johnson / HCA Healthcare Inc / Ucb SA / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / Apellis Pharmaceuticals Inc / AtriCure Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / Iveric Bio Inc / General Electric Co / Intuitive Surgical Inc / Koninklijke Philips NV / Laboratory Corporation of America Holdings / Porvair PLC / Regeneron Pharmaceuticals Inc / US Physical Therapy Inc / Universal Health Services Inc / Vertex Pharmaceuticals Inc / Seagen Inc / SAGE Therapeutics Inc / Cross Country Healthcare Inc / Roche Holding AG / Centene Corp / Arcosa Inc / ICAD Inc / Ensign Group Inc / MEDNAX Inc / Sun Life Financial Inc / IGM Biosciences Inc / Biogen Inc / IsoRay Inc / Simulations Plus Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Alphabet Inc / Inovio Pharmaceuticals Inc / LHC Group Inc / Change Healthcare Inc / Oscar Health Inc / Amicus Therapeutics Inc / Encompass Health Corp / Titan Medical Inc / Addex Therapeutics Ltd / Shockwave Medical Inc / Addus Homecare Corp / Sorrento Therapeutics Inc / Regenxbio Inc / Annovis Bio Inc / Acadia Healthcare Company Inc / Prothena Corporation PLC / Mirati Therapeutics Inc / MacroGenics Inc / Aerie Pharmaceuticals Inc / Xencor Inc / Trevena Inc / Pacira Biosciences Inc / CareTrust REIT Inc / VBI Vaccines Inc / Walgreens Boots Alliance Inc / Invitae Corp / Evolent Health Inc / Teladoc Health Inc / Novocure Ltd / Voyager Therapeutics Inc / Merus NV / Aptevo Therapeutics Inc / iRhythm Technologies Inc / CRISPR Therapeutics AG / Iovance Biotherapeutics Inc / Molecular Templates Inc / Synlogic Inc / NuCana PLC / Medicenna Therapeutics Corp / Allogene Therapeutics Inc / IDEAYA Biosciences Inc / Bicycle Therapeutics PLC / Personalis Inc / Oncternal Therapeutics Inc / NeuBase Therapeutics Inc / DermTech Inc / BioNTech SE / Pennant Group Inc / Passage Bio Inc / Lysogene SA / Oric Pharmaceuticals Inc / Inhibrx Inc / Taysha Gene Therapies Inc / Chinook Therapeutics Inc / Sio Gene Therapies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Germany / France / United Kingdom / Ireland / Netherlands / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">AACR Recap: Clinical and Preclinical Highlights Across Our Coverage and Beyond</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">110122108 / 30315R107 / 03116210 / 45253H101 / 00847G705 / 462222100 / 67022C106 / 49372L100 / 019770106 / H17182108 / 81181C104</td><td class="leftalignment">Bristol-Myers Squibb Co / F-Star Therapeutics Inc / Amgen Inc / ImmunoGen Inc / Agenus Inc / Ionis Pharmaceuticals Inc / NuCana PLC / Kezar Life Sciences Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Seagen Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Matt Phipps, PHD / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">April 2021 issue of "Monthly Controversies" report</td><td class="leftalignment">English</td><td class="rightalignment">171</td><td class="leftalignment">031162100 / 09062X103 / 5671735 / 0989529 / 0925288 / 7103065 / 7110388 / 717081103 / 375558103 / 110122108 / 532457108 / 75886F107 / 58933Y105 / 00287Y109</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ACI=US / FSTX=US / AAPL=US / IBM=US / MRK=US / PFE=US / AMGN=US / BMY=US / DIS=US / INTC=US / MSFT=US / C=US / GLW=US / AMZN=US / QCOM=US / T=US / ORCL=US / VOD=US / WMT=US / INCY=US / BAC=US / USB=US / AMT=US / DOX=US / NVDA=US / GS=US / AKAM=US / CHTR=US / NICE=US / NVS=US / VZ=US / URI=US / TSM=US / CCI=US / UPS=US / AZN=US / GSK=US / JNJ=US / TTWO=US / ATVI=US / PNC=US / CMCSA=US / UNH=US / DISH=US / INTU=US / NUAN=US / APPS=US / HRB=US / CTL=US / CME=US / EGAN=US / EGHT=US / EQIX=US / HEAR=US / QUIK=US / REGN=US / SBAC=US / VG=US / WSC=US / RDWR=US / SNOW=US / NET=US / CRNT=US / RHHBY=US / GME=US / FB=US / NFLX=US / VRNT=US / TWLO=US / ERIC=US / IGMS=US / RNG=US / CEVA=US / MRNA=US / GOOG=US / DLR=US / VIAC=US / INO=US / HSBC=US / DISCA=US / PDD=US / CCOI=US / LLNW=US / LUMN=US / BBVA=US / 700-HK=US / UBI-PAR=US / TSLA=US / ZNGA=US / EA=US / TMUS=US / MGNX=US / GTT=US / XNCR=US / AVYA=US / GOOGL=US / TSLX=US / FIVN=US / BABA=US / NVTA=US / MRUS=US / APVO=US / DZSI=US / TEUM=US / ATUS=US / BILI=US / HUYA=US / ZM=US / FSLY=US / ONCT=US / CMBM=US / DMTK=US / BNTX=US / DKNG=US / INBX=US / KDNY=US / CRSR=US / RXT=US / ONDS=US / PLTK=US / DOCN=US</td><td class="leftalignment">Albertsons Companies Inc / F-Star Therapeutics Inc / Apple Inc / International Business Machines Corp / Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Walt Disney Co / Intel Corp / Microsoft Corp / Citigroup Inc / Corning Inc / Amazon.com Inc / Qualcomm Inc / AT&T Inc / Oracle Corp / Vodafone Group PLC / Walmart Inc / Incyte Corp / Bank of America Corp / US Bancorp / American Tower Corp / Amdocs Ltd / NVIDIA Corp / Goldman Sachs Group Inc / Akamai Technologies Inc / Charter Communications Inc / Nice Ltd / Novartis AG / Verizon Communications Inc / United Rentals Inc / Taiwan Semiconductor Manufacturing Co Ltd / Crown Castle International Corp / United Parcel Service Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Take-Two Interactive Software Inc / Activision Blizzard Inc / PNC Financial Services Group Inc / Comcast Corp / UnitedHealth Group Inc / DISH Network Corp / Intuit Inc / Nuance Communications Inc / Digital Turbine Inc / H & R Block Inc / Lumen Technologies Inc / CME Group Inc / eGain Corp / 8x8 Inc / Equinix Inc / Turtle Beach Corp / QuickLogic Corp / Regeneron Pharmaceuticals Inc / SBA Communications Corp / Vonage Holdings Corp / Willscot Mobile Mini Holdings Corp / Radware Ltd / Snowflake Inc. / Cloudflare Inc / Ceragon Networks Ltd / Roche Holding AG / GameStop Corp / Meta Platforms Inc / Netflix Inc / Verint Systems Inc / Twilio Inc / Telefonaktiebolaget LM Ericsson / IGM Biosciences Inc / RingCentral Inc / CEVA Inc / Moderna Inc / Alphabet Inc / Digital Realty Trust Inc / ViacomCBS Inc / Inovio Pharmaceuticals Inc / HSBC Holdings PLC / Discovery Inc / Pinduoduo Inc / Cogent Communications Holdings Inc / Limelight Networks Inc / Lumen Technologies Inc / Banco Bilbao Vizcaya Argentaria SA / Tencent Holdings Ltd / Ubisoft Entertainment SA / Tesla Inc / Zynga Inc / Electronic Arts Inc / T-Mobile US Inc / MacroGenics Inc / GTT Communications Inc / Xencor Inc / Avaya Holdings Corp / Alphabet Inc / Sixth Street Specialty Lending Inc / Five9 Inc / Alibaba Group Holding Ltd / Invitae Corp / Merus NV / Aptevo Therapeutics Inc / DZS Inc / Pareteum Corp / Altice USA Inc / Bilibili Inc / HUYA Inc / Zoom Video Communications Inc / Fastly Inc / Oncternal Therapeutics Inc / Cambium Networks Corp / DermTech Inc / BioNTech SE / DraftKings Inc / Inhibrx Inc / Chinook Therapeutics Inc / Corsair Gaming Inc / Rackspace Technology Inc / Ondas Holdings Inc / Playtika Holding Corp / DigitalOcean Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / Cayman Islands / Germany / Spain / United Kingdom / Israel / Netherlands / Sweden / Taiwan / United States / Guernsey</td><td class="leftalignment">Banks / Biotechnology / Consumer / Financial Services / Healthcare / Info. Tech./Computers / Retailing / Semiconductors / Services / Telecommunications</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK=US / PEP=US / AMGN=US / BMY=US / DIS=US / PLD=US / AMZN=US / CPE=US / VRM=US / BRO=US / EXPE=US / UNH=US / KIDS=US / AJG=US / MAN=US / REGN=US / SNAP=US / TRIP=US / WIX=US / BKNG=US / FB=US / KIM=US / PTON=US / STRO=US / BIIB=US / AAWW=US / CLNY=US / GDOT=US / PCRX=US / ANGI=US / SPLK=US / PTCT=US / VCYT=US / QURE=US / GOOGL=US / BABA=US / CMPR=US / GDDY=US / WLTW=US / CVNA=US / SFIX=US / FTDR=US / SVMK=US / HARP=US / LYFT=US / UBER=US / TCRR=US / GMAB=US / CRMD.US</td><td class="leftalignment">Merck & Co Inc / PepsiCo Inc / Amgen Inc / Bristol-Myers Squibb Co / Walt Disney Co / Prologis Inc / Amazon.com Inc / Callon Petroleum Co / Vroom Inc / Brown & Brown Inc / Expedia Group Inc / UnitedHealth Group Inc / OrthoPediatrics Corp / Arthur J Gallagher & Co / ManpowerGroup Inc / Regeneron Pharmaceuticals Inc / Snap Inc / Tripadvisor Inc / Wix.Com Ltd / Booking Holdings Inc / Meta Platforms Inc / Kimco Realty Corp / Peloton Interactive Inc / Sutro Biopharma Inc / Biogen Inc / Atlas Air Worldwide Holdings Inc / DigitalBridge Group Inc / Green Dot Corp / Pacira Biosciences Inc / Angi Inc / Splunk Inc / PTC Therapeutics Inc / Veracyte Inc / Uniqure NV / Alphabet Inc / Alibaba Group Holding Ltd / Cimpress PLC / GoDaddy Inc / Willis Towers Watson PLC / Carvana Co / Stitch Fix Inc / Frontdoor Inc / Momentive Global Inc / Harpoon Therapeutics Inc / Lyft Inc / Uber Technologies Inc / TCR2 Therapeutics Inc / Genmab A/S / CorMedix Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Denmark / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Strong Volume Trends in Q1, but Currency and COVID Therapies Both Major Factors</td><td class="leftalignment">English</td><td class="rightalignment">101</td><td class="leftalignment">ABBV=US / PFE=US / AMGN=US / GILD=US / SAN=FR / GSK=GB / GSK=US / REGN=US / VRTX=US / SNY=US / RDUS=US</td><td class="leftalignment">Abbvie Inc / Pfizer Inc / Amgen Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Sanofi SA / Radius Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">AACR Takeaways: Rise Of The Immune-Cell Engagers (Biotech) (Updated)</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">MRK=US / AMGN=US / REGN=US / HARP=US / TCRR=US / GMAB=US</td><td class="leftalignment">Merck & Co Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Asthika Goonewardene / Avi Dahan</td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">AAN 2021 Schedule: Beyond Amyloid vs. Tau and Migraine, Emerging Science Points to Rare Disease Opportunities</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">G11196105 / 03116210 / 64125C109 / 803607100 / 76133010 / 98978L204 / 462222100 / 690469101 / 69366J200 / 98420N105 / 05464T104</td><td class="leftalignment">Biohaven Pharmaceutical Holding Company Ltd / Amgen Inc / Neurocrine Biosciences Inc / Sarepta Therapeutics Inc / Revance Therapeutics Inc / Zogenix Inc / Ionis Pharmaceuticals Inc / Ovid Therapeutics Inc / PTC Therapeutics Inc / Xenon Pharmaceuticals Inc / Axsome Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Matt Phipps, PHD / Mr. Raju Prasad, PHD / Mr. Rob Andrew, CFA / John Boyle / Sami Corwin, PHD / Lachlan Hanbury-Brown</td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BMY.N / JNJ.N / LLY.N / PFE.N / AZN.L / MRCG.DE / AMGN.OQ / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / MRNA.OQ / ACRX.OQ / ABBV.N / MGNX.OQ / SAGE.OQ / GRTX.OQ</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Merck KGaA / Amgen Inc / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Moderna Inc / AcelRx Pharmaceuticals Inc / Abbvie Inc / MacroGenics Inc / SAGE Therapeutics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">04/15/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ARE-US -  Dividend Quality Analysis, for the period ended April 15,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY / LLY / PFE / GILD.O / AMGN.O / ILMN.O / ALNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Alnylam Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Turkey / United States</td><td class="leftalignment">Real Estate</td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">04/15/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">AACR Takeaways: Rise Of The Immune-Cell Engagers</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / AMGN=US / REGN=US / HARP=US / TCRR=US / GMAB=US</td><td class="leftalignment">Merck & Co Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Asthika Goonewardene / Avi Dahan</td></tr>
<tr class="even"><td class="leftalignment">04/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for AMGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">04/15/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Small Biotech Inflows Break Up the Bleeding</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / 19240Q201</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / Cogent Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">04/15/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">A Potential North Star of Bispecific Antibody Engineering; Initiate at Outperform & $30 PT</td><td class="leftalignment">English</td><td class="rightalignment">43</td><td class="leftalignment">FSTX=US / MRK=US / AMGN=US / BMY=US / INCY=US / NVS=US / GSK=US / REGN=US / RHHBY=US / IGMS=US / MGNX=US / XNCR=US / MRUS=US / APVO=US / INBX=US</td><td class="leftalignment">F-Star Therapeutics Inc / Merck & Co Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Novartis AG / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Roche Holding AG / IGM Biosciences Inc / MacroGenics Inc / Xencor Inc / Merus NV / Aptevo Therapeutics Inc / Inhibrx Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/15/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - April 15, 2021</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AFL.N / AIG.N / BMWG.DE / CB.N / CNA.L / EPED.PA / JPM.N / MICP.PA / MMC.N / RENA.PA / TRV.N / VIEV.VI / VLOF.PA / VOLVb.ST / WFC.N / VOWG_p.DE / CONG.DE / SJRb.TO / AMGN.O / MET.N / AAL.L / GS.N / UNM.N / MTG.N / RDN.N / CINF.O / LNC.N / FRAG.DE / AJG.N / REGN.O / PFG.N / PRU.N / FRC.N / MKL.N / BRO.N / RLI.N / HCC.N / SIGI.O / ACGL.O / SJ.TO / MTL.TO / 416515104 / 025676206 / AEO.N / AON.N / ATL.MI / CLR.N / VMW.N / DAIGn.DE / WRB.N / 759351604 / AND.TO / SWI.N / CJT.TO / WTE.TO / FFHu.TO / FANG.O / VOYA.N / ESNT.N / NMIH.O / RACE.MI / KNSL.OQ / UN01.DE / BHF.O / EQH.N / GSHD.O / TFII.N / IGIC.OQ</td><td class="leftalignment">Aflac Inc / American International Group Inc / Bayerische Motoren Werke AG / Chubb Ltd / Centrica PLC / Faurecia SE / JPMorgan Chase & Co / Compagnie Generale des Etablissements Michelin SCA / Marsh & McLennan Companies Inc / Renault SA / Travelers Companies Inc / Flughafen Wien AG / Valeo SE / Volvo AB / Wells Fargo & Co / Volkswagen AG / Continental AG / Shaw Communications Inc / Amgen Inc / MetLife Inc / Anglo American PLC / Goldman Sachs Group Inc / Unum Group / MGIC Investment Corp / Radian Group Inc / Cincinnati Financial Corp / Lincoln National Corp / Fraport AG Frankfurt Airport Services Worldwide / Arthur J Gallagher & Co / Regeneron Pharmaceuticals Inc / Principal Financial Group Inc / Prudential Financial Inc / First Republic Bank / Markel Corp / Brown & Brown Inc / Rli Corp / Warrior Met Coal Inc / Selective Insurance Group Inc / Arch Capital Group Ltd / Stella-Jones Inc / Mullen Group Ltd / Hartford Financial Services Group Inc / American Equity Investment Life Holding Co / American Eagle Outfitters Inc / Aon PLC / Atlantia SpA / Continental Resources Inc / VMware Inc / Daimler AG / W R Berkley Corp / Reinsurance Group of America Inc / Andlauer Healthcare Group Inc / SolarWinds Corp / Cargojet Inc / Westshore Terminals Investment Corp / Fairfax Financial Holdings Ltd / Diamondback Energy Inc / Voya Financial Inc / Essent Group Ltd / NMI Holdings Inc / Ferrari NV / Kinsale Capital Group Inc / Uniper SE / Brighthouse Financial Inc / Equitable Holdings Inc / Goosehead Insurance Inc / TFI International Inc / International General Insurance Holdings Ltd</td><td class="leftalignment"></td><td class="leftalignment">Austria / Bermuda / Canada / Switzerland / Germany / France / United Kingdom / Ireland / Italy / Netherlands / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">04/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GSK.L: GlaxoSmithKline plc - Elliott Advisors takes stake in GSK</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GSK.L / JNJ.N / LLY.N / PFE.N / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / MRCG.DE / AMGN.OQ / REGN.OQ / ALKS.OQ / GILD.OQ / BMRN.OQ / VRTX.OQ / BAYGN.DE</td><td class="leftalignment">GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / Merck KGaA / Amgen Inc / Regeneron Pharmaceuticals Inc / Alkermes Plc / Gilead Sciences Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Bayer AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">04/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For the Week Ended Apr 02, 2021</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">04/14/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Short Interest Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AMGN.O / REGN.O</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Yinglu Zhang</td></tr>
<tr class="odd"><td class="leftalignment">04/13/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Michigan Hospitalizations Surge, Confirming We Are Not in the Clear Despite Strong Vaccination Pace; Global Cases Still Grow</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / China / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">04/13/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / OXY=US / RRC=US / WEN=US / BLD=US / DVN=US / INCY=US / TEVA=US / AMT=US / NVDA=US / APA=US / CPE=US / EOG=US / REI=US / VZ=US / XOM=US / CRK=US / LOW=US / WLL=US / PXD=US / CCI=US / MGY=US / SWN=US / MUR=US / CHRS=US / BRO=US / MRO=US / LEG=US / DISH=US / CBRL=US / CNX=US / DRI=US / EQT=US / GFF=US / IBP=US / MAS=US / MHK=US / REGI=US / SBAC=US / CVX=US / SAGE=US / BXS=US / MKL=US / COP=US / DIN=US / JRVR=US / BIIB=US / TPX=US / EXP=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / AWI=US / OC=US / AMRX=US / CADE=US / TAST=US / QSR=US / CLR=US / PRPL=US / NMTR=US / TIL=US / NOG=US / IAC=US / JACK=US / TREX=US / KNSL=US / AR=US / ESTE=US / FBHS=US / ANGI=US / BCEI=US / MTDR=US / PDCE=US / FANG=US / ABBV=US / TILE=US / TMUS=US / NDLS=US / 00770K202 / VNOM=US / LOCO=US / SHAK=US / WING=US / 82982L103 / CDEV=US / IRTC=US / CRSP=US / PVAC=US / JELD=US / SBOW=US / ALLO=US / LYFT=US / UBER=US / TCRR=US / RTLR=US / FERG=US / GMAB=US / OVV=US / ARQT=US / FBRX=US / AZEK=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Occidental Petroleum Corp / Range Resources Corp / Wendys Co / TopBuild Corp / Devon Energy Corp / Incyte Corp / Teva Pharmaceutical Industries Ltd / American Tower Corp / NVIDIA Corp / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Verizon Communications Inc / Exxon Mobil Corp / Comstock Resources Inc / Lowe's Companies Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Crown Castle International Corp / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / Coherus BioSciences Inc / Brown & Brown Inc / Marathon Oil Corp / Leggett & Platt Inc / DISH Network Corp / Cracker Barrel Old Country Store Inc / CNX Resources Corp / Darden Restaurants Inc / EQT Corp / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Renewable Energy Group Inc / SBA Communications Corp / Chevron Corp / SAGE Therapeutics Inc / Cadence Bank / Markel Corp / Conocophillips / Dine Brands Global Inc / James River Group Holdings Ltd / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Cadence Bank / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / Purple Innovation Inc / 9 Meters Biopharma Inc / Instil Bio Inc / Northern Oil and Gas Inc / IAC/Interactivecorp / Jack in the Box Inc / Trex Company Inc / Kinsale Capital Group Inc / Antero Resources Corp / Earthstone Energy Inc / Fortune Brands Home & Security Inc / Angi Inc / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Diamondback Energy Inc / Abbvie Inc / Interface Inc / T-Mobile US Inc / Noodles & Co / Aemetis Inc / Viper Energy Partners LP / El Pollo Loco Holdings Inc / Shake Shack Inc / Wingstop Inc / SiteOne Landscape Supply Inc / Centennial Resource Development Inc / iRhythm Technologies Inc / CRISPR Therapeutics AG / Ranger Oil Corp / JELD-WEN Holding Inc / SilverBow Resources Inc / Allogene Therapeutics Inc / Lyft Inc / Uber Technologies Inc / TCR2 Therapeutics Inc / Rattler Midstream LP / Ferguson PLC / Genmab A/S / Ovintiv Inc / Arcutis Biotherapeutics Inc / Forte Biosciences Inc / Azek Company Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Denmark / Israel / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/12/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">KNBWY-US -  Dividend Quality Analysis, for the period ended April 08,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">KNBWY.PK / BUD / CCU / CCU.SN / SAM / AMGN.O / STZb / TAPa / HEINY.PK</td><td class="leftalignment">Kirin Holdings Co Ltd / Anheuser Busch Inbev SA / Compania Cervecerias Unidas SA / Compania Cervecerias Unidas SA / Boston Beer Company Inc / Amgen Inc / Constellation Brands Inc / Molson Coors Beverage Co / Heineken NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Chile / Japan / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">FOCS=US / GANX=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / AMGN=US / CAT=US / DIS=US / MO=US / WM=US / BWA=US / MSFT=US / CL=US / MDT=US / C=US / AMZN=US / A=US / RUN=US / CG=US / CSR=US / DOX=US / GS=US / MPWR=US / TMX=US / FCEL=US / PLUG=US / AXL=US / NVS=US / SMTC=US / MET=US / VRTS=US / TSM=US / UPS=US / ENR=US / CRY=US / RAD=US / CSL=US / JCI=US / JNJ=US / UCB=BE / DE=US / FLO=US / HCC=US / NUAN=US / RSG=US / AAII=US / ALB=US / AMED=US / ECOL=US / AMSC=US / APLS=US / ARRY=US / ATRC=US / AVNT=US / AVT=US / BOX=US / B=US / BL=US / CMI=US / CALM=US / CSV=US / CENX=US / CME=US / CO=US / CRVL=US / CREE=US / DAKT=US / EW=US / EXAS=US / FDS=US / FIVE=US / HTLD=US / ITRI=US / MMS=US / MRCY=US / MS=US / MCO=US / ODFL=US / PZZA=US / PRVL=US / QDEL=US / RBC=US / ROK=US / POOL=US / TRMB=US / UTL=US / VCTR=US / VRTX=US / VG=US / WDFC=US / OSUR=US / PDFS=US / CCRN=US / RHHBY=US / PYPL=US / AGR=US / ACA=US / HR=US / NEP=US / PRA=US / UFCS=US / BIO=US / O=US / SWKS=US / ICAD=US / OSTK=US / ENSG=US / BE=US / AMSF=US / ARES=US / CLH=US / WCN=US / NDAQ=US / BIIB=US / RNG=US / CRI=US / ISR=US / NUVA=US / PBF=US / RMR=US / ENS=US / TWIN=US / ORA=US / WTI=US / FRPT=US / MORN=US / AMRS=US / PDD=US / SPWR=US / ICE=US / ATNI=US / EHTH=US / CSIQ=US / RSI=US / EBS=US / FSLR=US / FOLD=US / MASI=US / DAN=US / WPRT=US / ADXN=US / TBK=US / KKR=US / SWAV=US / AGCO=US / SWI=US / UTZ=US / ADUS=US / SRNE=US / GNRC=US / CBOE=US / TSLA=US / MSCI=US / AMRC=US / 2454-TW=US / HZNP=US / ANVS=US / ZNGA=US / ENPH=US / PRTA=US / HASI=US / CNHI=US / FATE=US / QURE=US / GOOGL=US / DNOW=US / COUP=US / BABA=US / LOVE=US / VCEL=US / BILL=US / ETSY=US / SEDG=US / WING=US / TDOC=US / AQMS=US / VYGR=US / MIME=US / NTNX=US / NGVT=US / WKHS=US / MDGL=US / IRTC=US / CRSP=US / HLNE=US / SNDR=US / IOVA=US / RDFN=US / PETQ=US / SYBX=US / ROKU=US / MDB=US / APTV=US / MDNA=US / VOW3-DE=US / SMAR=US / CWEN=US / FTDR=US / ALLO=US / ESTC=US / FVRR=US / NBSE=US / MPNGF=US / PASG=US / LYS=US / MSGS=US / MSGE=US / ORIC=US / VLDR=US / HYLN=US / SIOX=US / SHLS=US / CHPT=US / AEVA=US</td><td class="leftalignment">Focus Financial Partners Inc / Gain Therapeutics Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Amgen Inc / Caterpillar Inc / Walt Disney Co / Altria Group Inc / Waste Management Inc / Borgwarner Inc / Microsoft Corp / Colgate-Palmolive Co / Medtronic PLC / Citigroup Inc / Amazon.com Inc / Agilent Technologies Inc / Sunrun Inc / Carlyle Group Inc / Centerspace / Amdocs Ltd / Goldman Sachs Group Inc / Monolithic Power Systems Inc / Terminix Global Holdings Inc / Fuelcell Energy Inc / Plug Power Inc / American Axle & Manufacturing Holdings Inc / Novartis AG / Semtech Corp / MetLife Inc / Virtus Investment Partners Inc / Taiwan Semiconductor Manufacturing Co Ltd / United Parcel Service Inc / Energizer Holdings Inc / CryoLife Inc / Rite Aid Corp / Carlisle Companies Inc / Johnson Controls International PLC / Johnson & Johnson / Ucb SA / Deere & Co / Flowers Foods Inc / Warrior Met Coal Inc / Nuance Communications Inc / Republic Services Inc / Alabama Aircraft Industries Inc / Albemarle Corp / Amedisys Inc / US Ecology Inc / American Superconductor Corp / Apellis Pharmaceuticals Inc / Array Technologies Inc / AtriCure Inc / Avient Corp / Avnet Inc / Box Inc / Barnes Group Inc / Blackline Inc / Cummins Inc / Cal-Maine Foods Inc / Carriage Services Inc / Century Aluminum Co / CME Group Inc / Global Cord Blood Corp / CorVel Corp / Wolfspeed Inc / Daktronics Inc / Edwards Lifesciences Corp / Exact Sciences Corp / Factset Research Systems Inc / Five Below Inc / Heartland Express Inc / Itron Inc / Maximus Inc / Mercury Systems Inc / Morgan Stanley / Moody's Corp / Old Dominion Freight Line Inc / Papa John's International Inc / Porvair PLC / Quidel Corp / Regal Rexnord Corp / Rockwell Automation Inc / Pool Corp / Trimble Inc / Unitil Corp / Victory Capital Holdings Inc / Vertex Pharmaceuticals Inc / Vonage Holdings Corp / WD-40 Co / OraSure Technologies Inc / PDF Solutions Inc / Cross Country Healthcare Inc / Roche Holding AG / PayPal Holdings Inc / Avangrid Inc / Arcosa Inc / Healthcare Realty Trust Inc / Nextera Energy Partners LP / ProAssurance Corp / United Fire Group Inc / Bio Rad Laboratories Inc / Realty Income Corp / Skyworks Solutions Inc / ICAD Inc / Overstock.com Inc / Ensign Group Inc / Bloom Energy Corp / Amerisafe Inc / Ares Management Corp / Clean Harbors Inc / Waste Connections Inc / Nasdaq Inc / Biogen Inc / RingCentral Inc / Carter's Inc / IsoRay Inc / NuVasive Inc / PBF Energy Inc / RMR Group Inc / EnerSys / Twin Disc Inc / Ormat Technologies Inc / W&T Offshore Inc / Freshpet Inc / Morningstar Inc / Amyris Inc / Pinduoduo Inc / SunPower Corp / Intercontinental Exchange Inc / ATN International Inc / eHealth Inc / Canadian Solar Inc / Rush Street Interactive Inc / Emergent BioSolutions Inc / First Solar Inc / Amicus Therapeutics Inc / Masimo Corp / Dana Inc / Westport Fuel Systems Inc / Addex Therapeutics Ltd / Triumph Bancorp Inc / KKR & Co Inc / Shockwave Medical Inc / AGCO Corp / SolarWinds Corp / UTZ Brands Inc / Addus Homecare Corp / Sorrento Therapeutics Inc / Generac Holdings Inc / Cboe Global Markets Inc / Tesla Inc / MSCI Inc / Ameresco Inc / MediaTek Inc / Horizon Therapeutics PLC / Annovis Bio Inc / Zynga Inc / Enphase Energy Inc / Prothena Corporation PLC / Hannon Armstrong Sustainable Infrastructure Capital Inc / CNH Industrial NV / Fate Therapeutics Inc / Uniqure NV / Alphabet Inc / NOW Inc / Coupa Software Inc / Alibaba Group Holding Ltd / Lovesac Co / Vericel Corp / Bill.com Holdings Inc / ETSY Inc / Solaredge Technologies Inc / Wingstop Inc / Teladoc Health Inc / Aqua Metals Inc / Voyager Therapeutics Inc / Mimecast Ltd / Nutanix Inc / Ingevity Corp / Workhorse Group Inc / Madrigal Pharmaceuticals Inc / iRhythm Technologies Inc / CRISPR Therapeutics AG / Hamilton Lane Inc / Schneider National Inc / Iovance Biotherapeutics Inc / Redfin Corp / PetIQ Inc / Synlogic Inc / Roku Inc / MongoDB Inc / Aptiv PLC / Medicenna Therapeutics Corp / Volkswagen AG / Smartsheet Inc / Clearway Energy Inc / Frontdoor Inc / Allogene Therapeutics Inc / Elastic NV / Fiverr International Ltd / NeuBase Therapeutics Inc / Meituan / Passage Bio Inc / Lysogene SA / Madison Square Garden Sports Corp / Madison Square Garden Entertainment Corp / Oric Pharmaceuticals Inc / Velodyne Lidar Inc / Hyliion Holdings Corp / Sio Gene Therapies Inc / Shoals Technologies Group Inc / ChargePoint Holdings Inc / Aeva Technologies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / Netherlands / Taiwan / United States / Jersey / Guernsey</td><td class="leftalignment">Biotechnology / Electrical / Financial Services / Healthcare / Machinery / Retailing / Semiconductors / Telecommunications</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK=US / CACI=US / AMGN=US / CAG=US / DIS=US / DVN=US / INCY=US / GILD=US / BC=US / CRM=US / IGT=US / BYD=US / SPOT=US / MGM=US / PENN=US / BL=US / COLL=US / EXEL=US / HZO=US / MCRI=US / NTST=US / PII=US / HOOK=US / REGN=US / THO=US / WGO=US / CGEN=US / SGMS=US / MANT=US / CRTO=US / NFLX=US / AUTL=US / BDSI=US / RRR=US / IGMS=US / STRO=US / PRG=US / CZR=US / BAH=US / NSP=US / KBR=US / PGTI=US / ICFI=US / SAIC=US / CWH=US / PSN=US / RCUS=US / TREX=US / OLO=US / FBHS=US / ZNGA=US / MEIP=US / LDOS=US / FATE=US / MBUU=US / COUP=US / BABA=US / HUBS=US / MCFT=US / IRTC=US / CRSP=US / LGF.B=US / ROKU=US / NCNA=US / ALLO=US / TCRR=US / NXTC=US / GMAB=US / ONEW=US / DKNG=US / AZEK=US / NCNO=US / BALY=US / RBLX=US</td><td class="leftalignment">Merck & Co Inc / CACI International Inc / Amgen Inc / Conagra Brands Inc / Walt Disney Co / Devon Energy Corp / Incyte Corp / Gilead Sciences Inc / Brunswick Corp / Salesforce.Com Inc / International Game Technology PLC / Boyd Gaming Corp / Spotify Technology SA / MGM Resorts International / Penn National Gaming Inc / Blackline Inc / Collegium Pharmaceutical Inc / Exelixis Inc / MarineMax Inc / Monarch Casino & Resort Inc / Netstreit Corp / Polaris Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Thor Industries Inc / Winnebago Industries Inc / Compugen Ltd / Scientific Games Corp / ManTech International Corp / Criteo SA / Netflix Inc / Autolus Therapeutics PLC / BioDelivery Sciences International Inc / Red Rock Resorts Inc / IGM Biosciences Inc / Sutro Biopharma Inc / PROG Holdings Inc / Caesars Entertainment Inc / Booz Allen Hamilton Holding Corp / Insperity Inc / KBR Inc / PGT Innovations Inc / ICF International Inc / Science Applications International Corp / Camping World Holdings Inc / Parsons Corp / Arcus Biosciences Inc / Trex Company Inc / Olo Inc / Fortune Brands Home & Security Inc / Zynga Inc / MEI Pharma Inc / Leidos Holdings Inc / Fate Therapeutics Inc / Malibu Boats Inc / Coupa Software Inc / Alibaba Group Holding Ltd / HubSpot Inc / Mastercraft Boat Holdings Inc / iRhythm Technologies Inc / CRISPR Therapeutics AG / Lions Gate Entertainment Corp / Roku Inc / NuCana PLC / Allogene Therapeutics Inc / TCR2 Therapeutics Inc / NextCure Inc / Genmab A/S / OneWater Marine Inc / DraftKings Inc / Azek Company Inc / nCino Inc / Bally's Corp / Roblox Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/12/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - April 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AFL.N / AIG.N / ALV.N / AMAT.O / AMD.N / ANA.MC / CB.N / CCI.N / CRM.N / EIX.N / F.N / GM.N / LRCX.O / MMC.N / MRK.N / PB.N / PFE.N / SO.N / T.N / TRV.N / VC.N / ZION.O / CMA.N / CFP.TO / ASML.O / LPX.N / TEN.N / CMCSA.O / AMGN.O / MET.N / DUK.N / HBAN.O / BWA.N / LEA.N / NVDA.O / DISH.O / UNM.N / PCG.N / SBAC.O / AMT.N / CONE.O / ADI.O / VZ.N / VLY.N / SNV.N / EXEL.O / PACW.O / STZ.N / CINF.O / LNC.N / APH.N / FISV.O / SNPS.O / ADSK.O / V.N / AXL.N / AWK.N / NWN.N / BC.N / DB1Gn.DE / AJG.N / BMRN.O / STL.N / REGN.O / PFG.N / MU.O / PRU.N / NCR.N / TEL.N / CNP.N / ENDP.O / CFR.N / CPK.N / FRC.N / MKL.N / BRO.N / PII.N / RLI.N / ST.N / WBS.N / FCF.N / SGEN.OQ / GPN.N / PFS.N / FFBC.O / PBCT.O / SIGI.O / SIVB.O / WSBC.O / HOOK.O / CASY.O / BOKF.O / COLB.O / ACGL.O / WTFC.O / TCBI.O / ATDb.TO / FHN.N / DLR.N / 416515104 / WEF.TO / WAL.N / ALNY.O / DISCA.O / CDNS.O / FIS.N / 025676206 / ISBC.O / MA.N / HOG.N / AON.N / DAN.N / WRB.N / 759351604 / HOMB.O / NEE.N / BKU.N / PCRX.O / MTOR.N / IFP.TO / SPLK.OQ / PANW.N / FFHu.TO / NYCB.N / ABBV.N / TSLA.N / TMUS.N / VOYA.N / PRTA.O / ONB.OQ / 81762P102 / CFF.TO / XNCR.OQ / COUP.N / QURE.O / GWB.N / ASB.N / AENA.MC / RGNX.O / MESO.O / RACE.MI / ADVM.OQ / TWLO.N / KNSL.OQ / ADNT.N / UNIT.O / OKTA.OQ / CADE.N / ATUS.N / BHF.O / AY.O / APTV.N / 05971J102 / AMRX.N / EQH.N / GSHD.O / VNE.N / ESTC.N / FIXX.O / CRWD.O / GMAB.O / CRNC.OQ / IGIC.OQ / NKLA.OQ / FOUR.N / DCT.O / LUMN.N / WFG.N / NUVB.N / NAPA.N / OSO.N</td><td class="leftalignment">Aflac Inc / American International Group Inc / Autoliv Inc / Applied Materials Inc / Advanced Micro Devices Inc / Acciona SA / Chubb Ltd / Crown Castle International Corp / Salesforce.Com Inc / Edison International / Ford Motor Co / General Motors Co / Lam Research Corp / Marsh & McLennan Companies Inc / Merck & Co Inc / Prosperity Bancshares Inc / Pfizer Inc / Southern Co / AT&T Inc / Travelers Companies Inc / Visteon Corp / Zions Bancorporation NA / Comerica Inc / Canfor Corp / ASML Holding NV / Louisiana-Pacific Corp / Tenneco Inc / Comcast Corp / Amgen Inc / MetLife Inc / Duke Energy Corp / Huntington Bancshares Inc / Borgwarner Inc / Lear Corp / NVIDIA Corp / DISH Network Corp / Unum Group / PG&E Corp / SBA Communications Corp / American Tower Corp / CyrusOne Inc / Analog Devices Inc / Verizon Communications Inc / Valley National Bancorp / Synovus Financial Corp / Exelixis Inc / PacWest Bancorp / Constellation Brands Inc / Cincinnati Financial Corp / Lincoln National Corp / Amphenol Corp / Fiserv Inc / Synopsys Inc / Autodesk Inc / Visa Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Northwest Natural Holding Co / Brunswick Corp / Deutsche Boerse AG / Arthur J Gallagher & Co / Biomarin Pharmaceutical Inc / Sterling Bancorp / Regeneron Pharmaceuticals Inc / Principal Financial Group Inc / Micron Technology Inc / Prudential Financial Inc / NCR Corp / TE Connectivity Ltd / CenterPoint Energy Inc / Endo International PLC / Cullen/Frost Bankers Inc / Chesapeake Utilities Corp / First Republic Bank / Markel Corp / Brown & Brown Inc / Polaris Inc / Rli Corp / Sensata Technologies Holding PLC / Webster Financial Corp / First Commonwealth Financial Corp / Seagen Inc / Global Payments Inc / Provident Financial Services Inc / First Financial Bancorp / People's United Financial Inc / Selective Insurance Group Inc / SVB Financial Group / WesBanco Inc / HOOKIPA Pharma Inc / Caseys General Stores Inc / BOK Financial Corp / Columbia Banking System Inc / Arch Capital Group Ltd / Wintrust Financial Corp / Texas Capital Bancshares Inc / Alimentation Couche-Tard Inc / First Horizon Corp / Digital Realty Trust Inc / Hartford Financial Services Group Inc / Western Forest Products Inc / Western Alliance Bancorp / Alnylam Pharmaceuticals Inc / Discovery Inc / Cadence Design Systems Inc / Fidelity National Information Services Inc / American Equity Investment Life Holding Co / Investors Bancorp Inc / Mastercard Inc / Harley-Davidson Inc / Aon PLC / Dana Inc / W R Berkley Corp / Reinsurance Group of America Inc / Home BancShares Inc / Nextera Energy Inc / BankUnited Inc / Pacira Biosciences Inc / Meritor Inc / Interfor Corp / Splunk Inc / Palo Alto Networks Inc / Fairfax Financial Holdings Ltd / New York Community Bancorp Inc / Abbvie Inc / Tesla Inc / T-Mobile US Inc / Voya Financial Inc / Prothena Corporation PLC / Old National Bancorp / ServiceNow Inc / Conifex Timber Inc / Xencor Inc / Coupa Software Inc / Uniqure NV / Great Western Bancorp Inc / Associated Banc-Corp / Aena SME SA / Regenxbio Inc / Mesoblast Ltd / Ferrari NV / Adverum Biotechnologies Inc / Twilio Inc / Kinsale Capital Group Inc / Adient PLC / Uniti Group Inc / Okta Inc / Cadence Bank / Altice USA Inc / Brighthouse Financial Inc / Atlantica Sustainable Infrastructure PLC / Aptiv PLC / Cadence Bank / Amneal Pharmaceuticals Inc / Equitable Holdings Inc / Goosehead Insurance Inc / Veoneer Inc / Elastic NV / Homology Medicines Inc / CrowdStrike Holdings Inc / Genmab A/S / Cerence Inc / International General Insurance Holdings Ltd / Nikola Corp / Shift4 Payments Inc / Duck Creek Technologies Inc / Lumen Technologies Inc / West Fraser Timber Co Ltd / Nuvation Bio Inc / Duckhorn Portfolio Inc / Olo Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Germany / Denmark / Spain / United Kingdom / Ireland / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">AACR Takeaways - ZNTL In Investor's Focus Among Many Early and Mostly Preclinical Data Presentations Among Our Coverage</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">ZNTL.OQ / 5671735 / 0989529 / 2023607 / 2778844 / 2369174 / 2457864 / 2471950 / 4595739 / 7103065 / 2982924 / BCBVTX1 / BFDV8K0 / BBPK0J0 / BFZNYB7 / BK0VHF6 / BDHF4K6 / BZBY005 / BKS3SM8 / BMQ5T49 / BGCYWN8 / BKVDFF7 / BJXBP30 / BYQHPK7 / BYYWPW6 / BJ9NFQ3 / BWY52P3 / BL71K91 / BN2R582 / BDD1B07 / BMPRZV5 / BMDJ397</td><td class="leftalignment">Zentalis Pharmaceuticals Inc / Sanofi SA / AstraZeneca PLC / Amgen Inc / Merck & Co Inc / Gilead Sciences Inc / ImmunoGen Inc / Incyte Corp / Genmab A/S / Novartis AG / Spectrum Pharmaceuticals Inc / Agios Pharmaceuticals Inc / MacroGenics Inc / Mirati Therapeutics Inc / Allogene Therapeutics Inc / IDEAYA Biosciences Inc / CRISPR Therapeutics AG / Merus NV / IGM Biosciences Inc / Zentalis Pharmaceuticals Inc / Xencor Inc / Oric Pharmaceuticals Inc / Turning Point Therapeutics Inc / Zymeworks Inc / Beigene Ltd / Neoleukin Therapeutics Inc / Blueprint Medicines Corp / Revolution Medicines Inc / Relay Therapeutics Inc / Rubius Therapeutics Inc / Kymera Therapeutics Inc / Bolt Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin / Mr. Etzer Darout / Mr. Seamus Fernandez / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biopharma: Latest Short Interest for US Biopharma: Large Caps Stable; ACRX and NBIX See Moderate Increases Among SMid Caps</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BMY.N / LLY.N / MRK.N / PFE.N / AMGN.OQ / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / ACRX.OQ / ABBV.N / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / AcelRx Pharmaceuticals Inc / Abbvie Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">04/11/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Learnings from Previous Tax Act</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AMGN=US / BIIB=US</td><td class="leftalignment">Amgen Inc / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / ECONOMIC REPORTS / MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/10/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Mackay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AMGN.O / EXEL.O / REGN.O / SGEN.OQ / PRTA.O / MESO.O / GMAB.O / NUVB.N</td><td class="leftalignment">Amgen Inc / Exelixis Inc / Regeneron Pharmaceuticals Inc / Seagen Inc / Prothena Corporation PLC / Mesoblast Ltd / Genmab A/S / Nuvation Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Denmark / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Kennen MacKay, PHD / Michael Murray</td></tr>
<tr class="even"><td class="leftalignment">04/09/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 542</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">04/09/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Apr 09 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">DMAC=US / ONCT=US / MRK=US / BSX=US / CSII=US / PFE=US / ABT=US / AMGN=US / BMY=US / MDT=US / ADCT=US / WMT=US / INCY=US / CMS=US / GILD=US / DGX=US / NVS=US / AZN=US / RAD=US / JNJ=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / ATRC=US / CHE=US / CYH=US / EW=US / EXAS=US / GEN=US / ISRG=US / LH=US / LIFE=US / RKT=US / USPH=US / UTHR=US / UHS=US / PRVB=US / CCRN=US / CNC=US / ACA=US / ICAD=US / ENSG=US / MD=US / SLF=US / BIIB=US / ACAD=US / GOOG=US / LHCG=US / CHNG=US / BNGO=US / TPTX=US / EHC=US / ATHX=US / TMDI=US / SWAV=US / ADUS=US / SRNE=US / IRWD=US / SLRX=US / ACHC=US / CCXI=US / TGTX=US / ABBV=US / CTRE=US / OTIC=US / VBLT=US / CLRB=US / WBA=US / SNPHY=US / NVTA=US / EVH=US / GKOS=US / BGNE=US / RETA=US / APVO=US / FLGT=US / IRTC=US / PLXP=US / CYCN=US / TMDX=US / KRTX=US / PNTG=US / NNOX=US / KDNY=US / TVTX=US / EVAX=US</td><td class="leftalignment">DiaMedica Therapeutics Inc / Oncternal Therapeutics Inc / Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Pfizer Inc / Abbott Laboratories / Amgen Inc / Bristol-Myers Squibb Co / Medtronic PLC / ADC Therapeutics SA / Walmart Inc / Incyte Corp / CMS Energy Corp / Gilead Sciences Inc / Quest Diagnostics Inc / Novartis AG / AstraZeneca PLC / Rite Aid Corp / Johnson & Johnson / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / AtriCure Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / Exact Sciences Corp / General Electric Co / Intuitive Surgical Inc / Laboratory Corporation of America Holdings / aTyr Pharma Inc / Rocket Companies Inc / US Physical Therapy Inc / United Therapeutics Corp / Universal Health Services Inc / Provention Bio Inc / Cross Country Healthcare Inc / Centene Corp / Arcosa Inc / ICAD Inc / Ensign Group Inc / MEDNAX Inc / Sun Life Financial Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Alphabet Inc / LHC Group Inc / Change Healthcare Inc / Bionano Genomics Inc / Turning Point Therapeutics Inc / Encompass Health Corp / Athersys Inc / Titan Medical Inc / Shockwave Medical Inc / Addus Homecare Corp / Sorrento Therapeutics Inc / Ironwood Pharmaceuticals Inc / Salarius Pharmaceuticals Inc / Acadia Healthcare Company Inc / ChemoCentryx Inc / TG Therapeutics Inc / Abbvie Inc / CareTrust REIT Inc / Otonomy Inc / Vascular Biogenics Ltd / Cellectar Biosciences Inc / Walgreens Boots Alliance Inc / Santen Pharmaceutical Co Ltd / Invitae Corp / Evolent Health Inc / Glaukos Corp / Beigene Ltd / Reata Pharmaceuticals Inc / Aptevo Therapeutics Inc / Fulgent Genetics Inc / iRhythm Technologies Inc / PLx Pharma Inc / Cyclerion Therapeutics Inc / Transmedics Group Inc / Karuna Therapeutics Inc / Pennant Group Inc / Nano-X Imaging Ltd / Chinook Therapeutics Inc / Travere Therapeutics Inc / Evaxion Biotech A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Israel / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="even"><td class="leftalignment">04/09/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended April 2, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/09/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">04/08/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">When It Rains, It Pours - Biotech Outflows Continue</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / 039697107 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / 19240Q201</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Ardelyx Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / Cogent Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">04/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Ada's Insights-Quant Strategy: Portfolio Manager's Guide to ESG - April 2021</td><td class="leftalignment">English</td><td class="rightalignment">61</td><td class="leftalignment">A.N / AAP.N / ABT.N / AIG.N / ALB.N / ALK.N / APD.N / BA.N / BAC.N / BAX.N / BBY.N / BDX.N / BMY.N / BSX.N / CAH.N / CCL.N / CE.N / CF.N / CI.N / CL.N / CNC.N / CVS.N / DAL.N / DD.N / DOW.N / ECL.N / EL.N / EMN.N / EOG.N / F.N / FCX.N / FDX.N / FLS.N / FMC.N / GE.N / GM.N / GPS.N / HLT.N / IP.N / IR.N / KMB.N / KO.N / LMT.N / LUV.N / MAS.N / MO.N / NEM.N / NOC.N / NSC.N / OXY.N / PHM.N / PM.N / PPG.N / RHI.N / RL.N / SEE.N / SGEF.PA / SLB.N / SWK.N / TAP.N / TXT.N / WMB.N / WMT.N / PG.N / DGX.N / PXD.N / NUE.N / ROK.N / CPB.N / HAL.N / AAL.L / ADML.L / ETN.N / DHR.N / BWA.N / CMI.N / GD.N / URI.N / DE.N / DOV.N / IEX.N / PH.N / ROP.N / K.N / WAB.N / CAT.N / MGM.N / LEN.N / UNP.N / RCL.N / CLX.N / MCD.N / CAG.N / TSN.N / SYY.N / YUM.N / VLO.N / HD.N / LOW.N / MRO.N / UPS.N / WM.N / KR.N / ITW.N / MMM.N / GIS.N / EMR.N / VMC.N / XOM.N / HSY.N / DVN.N / WHR.N / NKE.N / LIN.N / TGT.N / AVY.N / SHW.N / PKG.N / BLL.N / GWW.N / PKI.N / MLM.N / HCA.N / JCI.N / COO.N / DHI.N / STZ.N / VFC.N / DVA.N / TJX.N / KMI.N / AZO.N / KMX.N / PWR.N / COG.N / EFX.N / EW.N / OKE.N / HWM.N / LEG.N / RSG.N / SNA.N / CHD.N / AME.N / GPC.N / MKC.N / HRL.N / PVH.N / LB.TO / ABC.N / CVX.N / MHK.N / TDY.N / COP.N / HAYS.L / AOS.N / ABMD.OQ / AMGN.OQ / CERN.OQ / CTAS.OQ / EXPD.OQ / FAST.OQ / HOLX.OQ / JBHT.OQ / PCAR.OQ / PNR.N / ROL.N / ROST.OQ / SJM.N / TT.N / SBUX.OQ / ODFL.OQ / ORLY.OQ / GILD.OQ / COST.OQ / TSCO.OQ / CPRT.OQ / PENN.OQ / DLTR.OQ / HSIC.OQ / POOL.OQ / TPR.N / AMZN.OQ / CHRW.OQ / EBAY.OQ / EXPE.OQ / GRMN.OQ / ALGN.OQ / WYNN.OQ / MNST.OQ / BIIB.OQ / DPZ.N / MOS.N / LVS.N / NDAQ.OQ / NOV.N / DXCM.OQ / CMG.N / TDG.N / HES.N / HBI.N / ULTA.OQ / NVR.N / BIO.N / VRSK.OQ / GNRC.N / TSLA.OQ / LYB.N / CZR.OQ / NLSN.N / HII.N / HFC.N / BKR.N / FBHS.N / XYL.N / PSX.N / LKQ.OQ / MDLZ.OQ / FANG.OQ / ABBV.N / LDOS.N / MAR.OQ / ALLE.N / NCLH.N / CTLT.N / ANTM.N / WBA.OQ / ETSY.OQ / WRK.N / KHC.OQ / CSX.OQ / FTV.N / LW.N / UAA.N / APTV.N / PEP.OQ / BKNG.OQ / UAL.OQ / NWL.OQ / CTVA.N / LHX.N / J.N / RTX.N / CARR.N / OTIS.N / APA.OQ / HON.OQ / 1U1.DE</td><td class="leftalignment">Agilent Technologies Inc / Advance Auto Parts Inc / Abbott Laboratories / American International Group Inc / Albemarle Corp / Alaska Air Group Inc / Air Products and Chemicals Inc / Boeing Co / Bank of America Corp / Baxter International Inc / Best Buy Co Inc / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Cardinal Health Inc / Carnival Corp / Celanese Corp / CF Industries Holdings Inc / Cigna Corp / Colgate-Palmolive Co / Centene Corp / CVS Health Corp / Delta Air Lines Inc / Dupont De Nemours Inc / Dow Inc / Ecolab Inc / Estee Lauder Companies Inc / Eastman Chemical Co / EOG Resources Inc / Ford Motor Co / Freeport-McMoRan Inc / FedEx Corp / Flowserve Corp / FMC Corp / General Electric Co / General Motors Co / Gap Inc / Hilton Worldwide Holdings Inc / International Paper Co / Ingersoll Rand Inc / Kimberly-Clark Corp / Coca-Cola Co / Lockheed Martin Corp / Southwest Airlines Co / Masco Corp / Altria Group Inc / Newmont Corporation / Northrop Grumman Corp / Norfolk Southern Corp / Occidental Petroleum Corp / Pultegroup Inc / Philip Morris International Inc / PPG Industries Inc / Robert Half International Inc / Ralph Lauren Corp / Sealed Air Corp / Vinci SA / Schlumberger NV / Stanley Black & Decker Inc / Molson Coors Beverage Co / Textron Inc / Williams Companies Inc / Walmart Inc / Procter & Gamble Co / Quest Diagnostics Inc / Pioneer Natural Resources Co / Nucor Corp / Rockwell Automation Inc / Campbell Soup Co / Halliburton Co / Anglo American PLC / Admiral Group PLC / Eaton Corporation PLC / Danaher Corp / Borgwarner Inc / Cummins Inc / General Dynamics Corp / United Rentals Inc / Deere & Co / Dover Corp / IDEX Corp / Parker-Hannifin Corp / Roper Technologies Inc / Kellogg Co / Westinghouse Air Brake Technologies Corp / Caterpillar Inc / MGM Resorts International / Lennar Corp / Union Pacific Corp / Royal Caribbean Cruises Ltd / Clorox Co / McDonald's Corp / Conagra Brands Inc / Tyson Foods Inc / Sysco Corp / Yum! Brands Inc / Valero Energy Corp / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / United Parcel Service Inc / Waste Management Inc / Kroger Co / Illinois Tool Works Inc / 3M Co / General Mills Inc / Emerson Electric Co / Vulcan Materials Co / Exxon Mobil Corp / Hershey Co / Devon Energy Corp / Whirlpool Corp / Nike Inc / Linde PLC / Target Corp / Avery Dennison Corp / Sherwin-Williams Co / Packaging Corp of America / Ball Corp / W W Grainger Inc / PerkinElmer Inc / Martin Marietta Materials Inc / HCA Healthcare Inc / Johnson Controls International PLC / Cooper Companies Inc / D R Horton Inc / Constellation Brands Inc / VF Corp / DaVita Inc / TJX Companies Inc / Kinder Morgan Inc / Autozone Inc / Carmax Inc / Quanta Services Inc / Coterra Energy Inc / Equifax Inc / Edwards Lifesciences Corp / ONEOK Inc / Howmet Aerospace Inc / Leggett & Platt Inc / Republic Services Inc / Snap-On Inc / Church & Dwight Co Inc / AMETEK Inc / Genuine Parts Co / McCormick & Company Inc / Hormel Foods Corp / PVH Corp / Laurentian Bank of Canada / Amerisourcebergen Corp / Chevron Corp / Mohawk Industries Inc / Teledyne Technologies Inc / Conocophillips / Hays PLC / A O Smith Corp / ABIOMED Inc / Amgen Inc / Cerner Corp / Cintas Corp / Expeditors International of Washington Inc / Fastenal Co / Hologic Inc / J B Hunt Transport Services Inc / Paccar Inc / Pentair PLC / Rollins Inc / Ross Stores Inc / J M Smucker Co / Trane Technologies PLC / Starbucks Corp / Old Dominion Freight Line Inc / O'Reilly Automotive Inc / Gilead Sciences Inc / Costco Wholesale Corp / Tractor Supply Co / Copart Inc / Penn National Gaming Inc / Dollar Tree Inc / Henry Schein Inc / Pool Corp / Tapestry Inc / Amazon.com Inc / CH Robinson Worldwide Inc / eBay Inc / Expedia Group Inc / Garmin Ltd / Align Technology Inc / Wynn Resorts Ltd / Monster Beverage Corp / Biogen Inc / Domino's Pizza Inc / Mosaic Co / Las Vegas Sands Corp / Nasdaq Inc / Nov Inc / Dexcom Inc / Chipotle Mexican Grill Inc / TransDigm Group Inc / Hess Corp / HanesBrands Inc / Ulta Beauty Inc / NVR Inc / Bio Rad Laboratories Inc / Verisk Analytics Inc / Generac Holdings Inc / Tesla Inc / LyondellBasell Industries NV / Caesars Entertainment Inc / Nielsen Holdings PLC / Huntington Ingalls Industries Inc / HollyFrontier Corp / Baker Hughes Co / Fortune Brands Home & Security Inc / Xylem Inc / Phillips 66 / LKQ Corp / Mondelez International Inc / Diamondback Energy Inc / Abbvie Inc / Leidos Holdings Inc / Marriott International Inc / Allegion PLC / Norwegian Cruise Line Holdings Ltd / Catalent Inc / Anthem Inc / Walgreens Boots Alliance Inc / ETSY Inc / Westrock Co / Kraft Heinz Co / CSX Corp / Fortive Corp / Lamb Weston Holdings Inc / Under Armour Inc / Aptiv PLC / PepsiCo Inc / Booking Holdings Inc / United Airlines Holdings Inc / Newell Brands Inc / Corteva Inc / L3harris Technologies Inc / Jacobs Engineering Group Inc / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / APA Corp (US) / Honeywell International Inc / 1&1 AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Germany / France / United Kingdom / Ireland / Liberia / Netherlands / Panama / United States / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / PORTFOLIO/ASSET STRATEGIES / QUANANTITATIVE/TECH RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Jonathan N. Golub, CFA / Mr. Manish G. Bangard / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">04/06/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Michigan Surge Highlights Race Between Variants and Vaccines; Global Case Growth Continues</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">04/06/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / MCD=US / WEN=US / TEVA=US / XOM=US / CHRS=US / RCL=US / CBRL=US / CCL=US / COLL=US / DRI=US / REGI=US / SHOP=US / STRA=US / BKNG=US / DIN=US / BDSI=US / PLAY=US / DENN=US / CMG=US / REX=US / GPRE=US / AMRX=US / TAST=US / QSR=US / APEI=US / JACK=US / CLNY=US / NCLH=US / NDLS=US / 00770K202 / COUP=US / LOCO=US / NVRO=US / WBA=US / SHAK=US / WING=US / SPNE=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / McDonald's Corp / Wendys Co / Teva Pharmaceutical Industries Ltd / Exxon Mobil Corp / Coherus BioSciences Inc / Royal Caribbean Cruises Ltd / Cracker Barrel Old Country Store Inc / Carnival Corp / Collegium Pharmaceutical Inc / Darden Restaurants Inc / Renewable Energy Group Inc / Shopify Inc / Strategic Education Inc / Booking Holdings Inc / Dine Brands Global Inc / BioDelivery Sciences International Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Chipotle Mexican Grill Inc / REX American Resources Corp / Green Plains Inc / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / American Public Education Inc / Jack in the Box Inc / DigitalBridge Group Inc / Norwegian Cruise Line Holdings Ltd / Noodles & Co / Aemetis Inc / Coupa Software Inc / El Pollo Loco Holdings Inc / Nevro Corp / Walgreens Boots Alliance Inc / Shake Shack Inc / Wingstop Inc / SeaSpine Holdings Corp / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Israel / Liberia / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">04/05/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Amgen Inc: Intraday vs Overnight Returns 2016-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">04/05/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Mar 26, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">04/05/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Amgen Inc.(AMGN) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">031162100</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended March 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/05/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">SPB=US / TSLA=US / AAPL=US / IBM=US / MRK=US / WMB=US / BSX=US / CSII=US / CSCO=US / ABT=US / AMGN=US / COST=US / INTC=US / KO=US / MCD=US / AMD=US / MSFT=US / MDT=US / K=US / AMZN=US / T=US / WMT=US / D=US / ED=US / NTRS=US / NVDA=US / AKAM=US / JPM=US / NVS=US / VZ=US / PBR=US / EL=US / SAP=US / URI=US / TSM=US / BAX=US / GSK=US / TTWO=US / LEG=US / LRCX=US / ATVI=US / KR=US / DLTR=US / EIX=US / CI=US / UNH=US / INTU=US / ABMD=US / ACI=US / ATRC=US / AVGO=US / HRB=US / CMI=US / CSGP=US / DHI=US / XRAY=US / DG=US / EW=US / EXAS=US / HEAR=US / ISRG=US / TREE=US / MS=US / MCO=US / ROK=US / ROP=US / HSIC=US / SJM=US / ALGN=US / GME=US / SIVB=US / ARE=US / O=US / SWKS=US / NFLX=US / MNST=US / PTON=US / SFM=US / DPZ=US / GOOG=US / DLR=US / MKTX=US / FRPT=US / FIS=US / RSI=US / QSR=US / BX=US / VMW=US / ULTA=US / KKR=US / SWAV=US / 700-HK=US / UBI-PAR=US / UTZ=US / 005930-KR=US / VRSK=US / TCEHY=US / NEE=US / MSCI=US / ZNGA=US / EA=US / ENPH=US / TMUS=US / NVTA=US / SQ=US / IRTC=US / UAA=US / OKTA=US / BILI=US / HUYA=US / UBER=US / TMDX=US / NLOK=US / DKNG=US / NNOX=US / CRSR=US / PLTK=US</td><td class="leftalignment">Spectrum Brands Holdings Inc / Tesla Inc / Apple Inc / International Business Machines Corp / Merck & Co Inc / Williams Companies Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Cisco Systems Inc / Abbott Laboratories / Amgen Inc / Costco Wholesale Corp / Intel Corp / Coca-Cola Co / McDonald's Corp / Advanced Micro Devices Inc / Microsoft Corp / Medtronic PLC / Kellogg Co / Amazon.com Inc / AT&T Inc / Walmart Inc / Dominion Energy Inc / Consolidated Edison Inc / Northern Trust Corp / NVIDIA Corp / Akamai Technologies Inc / JPMorgan Chase & Co / Novartis AG / Verizon Communications Inc / Petroleo Brasileiro SA Petrobras / Estee Lauder Companies Inc / SAP SE / United Rentals Inc / Taiwan Semiconductor Manufacturing Co Ltd / Baxter International Inc / GlaxoSmithKline PLC / Take-Two Interactive Software Inc / Leggett & Platt Inc / Lam Research Corp / Activision Blizzard Inc / Kroger Co / Dollar Tree Inc / Edison International / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / ABIOMED Inc / Albertsons Companies Inc / AtriCure Inc / Broadcom Inc / H & R Block Inc / Cummins Inc / CoStar Group Inc / D R Horton Inc / DENTSPLY SIRONA Inc / Dollar General Corp / Edwards Lifesciences Corp / Exact Sciences Corp / Turtle Beach Corp / Intuitive Surgical Inc / Lendingtree Inc / Morgan Stanley / Moody's Corp / Rockwell Automation Inc / Roper Technologies Inc / Henry Schein Inc / J M Smucker Co / Align Technology Inc / GameStop Corp / SVB Financial Group / Alexandria Real Estate Equities Inc / Realty Income Corp / Skyworks Solutions Inc / Netflix Inc / Monster Beverage Corp / Peloton Interactive Inc / Sprouts Farmers Market Inc / Domino's Pizza Inc / Alphabet Inc / Digital Realty Trust Inc / Marketaxess Holdings Inc / Freshpet Inc / Fidelity National Information Services Inc / Rush Street Interactive Inc / Restaurant Brands International Inc / Blackstone Inc / VMware Inc / Ulta Beauty Inc / KKR & Co Inc / Shockwave Medical Inc / Tencent Holdings Ltd / Ubisoft Entertainment SA / UTZ Brands Inc / Farfetch Ltd / Verisk Analytics Inc / Tencent Holdings Ltd / Nextera Energy Inc / MSCI Inc / Zynga Inc / Electronic Arts Inc / Enphase Energy Inc / T-Mobile US Inc / Invitae Corp / Block Inc / iRhythm Technologies Inc / Under Armour Inc / Okta Inc / Bilibili Inc / HUYA Inc / Uber Technologies Inc / Transmedics Group Inc / NortonLifeLock Inc / DraftKings Inc / Nano-X Imaging Ltd / Corsair Gaming Inc / Playtika Holding Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Brazil / Canada / Switzerland / Cayman Islands / Germany / United Kingdom / Ireland / Israel / Taiwan / United States</td><td class="leftalignment">Biotechnology / Consumer / Electrical / Financial Services / Healthcare / Info. Tech./Computers / Retailing / Semiconductors</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/05/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - April 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AEP.N / AES.N / AFL.N / AIG.N / AMAT.O / AMD.N / CB.N / CCO.TO / CRM.N / EIX.N / F.N / GM.N / INTC.O / LRCX.O / MMC.N / QCOM.O / RYN.N / SO.N / T.N / TRV.N / WY.N / PXD.N / GILD.O / ASML.O / CMCSA.O / AMGN.O / AAPL.O / MET.N / AAL.L / DIS.N / D.N / NVDA.O / DT.N / DISH.O / UNM.N / AMT.N / KGC.N / GIBa.TO / CONE.O / ADI.O / VZ.N / HCA.N / EXEL.O / XEL.N / PACW.O / CINF.O / LNC.N / KMX.N / FISV.O / SNPS.O / ADSK.O / CHTR.O / AWK.N / NBIX.O / NWN.N / TXN.O / AJG.N / REGN.O / VRTX.O / PFG.N / MU.O / PRU.N / NCR.N / NET.N / CNP.N / CPK.N / MKL.N / BRO.N / RLI.N / GPN.N / SIGI.O / CASY.O / ACGL.O / ICPT.O / FFIV.O / EQIX.O / ATDb.TO / BIIB.O / GOLD.N / FM.TO / NST.AX / 878742204 / NTR.N / MOS.N / DLR.N / ACAD.O / 416515104 / CDNS.O / SJW.N / FIS.N / 025676206 / CS.TO / 443628102 / AON.N / SLR.AX / WRB.N / 759351604 / CLW.N / VALE.N / FTNT.O / SPB.N / NEE.N / PCH.O / CTT.N / GLEN.L / ACHC.O / SPLK.OQ / WDC.O / PANW.N / QLYS.O / FFHu.TO / 505440107 / TSLA.N / ENTA.O / TMUS.N / VOYA.N / PRTA.O / AGIO.O / 81762P102 / 46579R104 / PTC.O / ITCI.O / COUP.N / VRNS.O / CIA.TO / BTG.N / NEP.N / S32.AX / PYPL.OQ / RPD.O / MESO.O / TWLO.N / OR.N / KNSL.OQ / GDS.O / ICHR.O / PBYI.OQ / OKTA.OQ / WPM.N / BHF.O / KL.N / SAIL.N / APTV.N / EHC.N / ZS.OQ / EQH.N / GSHD.O / VNE.N / ESTC.N / CRWD.O / GMAB.O / PING.N / DDOG.O / SBSW.N / IGIC.OQ / FOUR.N</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Aflac Inc / American International Group Inc / Applied Materials Inc / Advanced Micro Devices Inc / Chubb Ltd / Cameco Corp / Salesforce.Com Inc / Edison International / Ford Motor Co / General Motors Co / Intel Corp / Lam Research Corp / Marsh & McLennan Companies Inc / Qualcomm Inc / Rayonier Inc / Southern Co / AT&T Inc / Travelers Companies Inc / Weyerhaeuser Co / Pioneer Natural Resources Co / Gilead Sciences Inc / ASML Holding NV / Comcast Corp / Amgen Inc / Apple Inc / MetLife Inc / Anglo American PLC / Walt Disney Co / Dominion Energy Inc / NVIDIA Corp / Dynatrace Inc / DISH Network Corp / Unum Group / American Tower Corp / Kinross Gold Corp / CGI Inc / CyrusOne Inc / Analog Devices Inc / Verizon Communications Inc / HCA Healthcare Inc / Exelixis Inc / Xcel Energy Inc / PacWest Bancorp / Cincinnati Financial Corp / Lincoln National Corp / Carmax Inc / Fiserv Inc / Synopsys Inc / Autodesk Inc / Charter Communications Inc / American Water Works Company Inc / Neurocrine Biosciences Inc / Northwest Natural Holding Co / Texas Instruments Inc / Arthur J Gallagher & Co / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Principal Financial Group Inc / Micron Technology Inc / Prudential Financial Inc / NCR Corp / Cloudflare Inc / CenterPoint Energy Inc / Chesapeake Utilities Corp / Markel Corp / Brown & Brown Inc / Rli Corp / Global Payments Inc / Selective Insurance Group Inc / Caseys General Stores Inc / Arch Capital Group Ltd / Intercept Pharmaceuticals Inc / F5 Inc / Equinix Inc / Alimentation Couche-Tard Inc / Biogen Inc / Barrick Gold Corp / First Quantum Minerals Ltd / Northern Star Resources Ltd / Teck Resources Ltd / Nutrien Ltd / Mosaic Co / Digital Realty Trust Inc / ACADIA Pharmaceuticals Inc / Hartford Financial Services Group Inc / Cadence Design Systems Inc / SJW Group / Fidelity National Information Services Inc / American Equity Investment Life Holding Co / Capstone Mining Corp / Hudbay Minerals Inc / Aon PLC / Silver Lake Resources Ltd / W R Berkley Corp / Reinsurance Group of America Inc / Clearwater Paper Corp / Vale SA / Fortinet Inc / Spectrum Brands Holdings Inc / Nextera Energy Inc / Potlatchdeltic Corp / CatchMark Timber Trust Inc / Glencore PLC / Acadia Healthcare Company Inc / Splunk Inc / Western Digital Corp / Palo Alto Networks Inc / Qualys Inc / Fairfax Financial Holdings Ltd / Labrador Iron Ore Royalty Corp / Tesla Inc / Enanta Pharmaceuticals Inc / T-Mobile US Inc / Voya Financial Inc / Prothena Corporation PLC / Agios Pharmaceuticals Inc / ServiceNow Inc / Ivanhoe Mines Ltd / PTC Inc / Intra-Cellular Therapies Inc / Coupa Software Inc / Varonis Systems Inc / Champion Iron Ltd / B2Gold Corp / Nextera Energy Partners LP / South32 Ltd / PayPal Holdings Inc / Rapid7 Inc / Mesoblast Ltd / Twilio Inc / Osisko Gold Royalties Ltd / Kinsale Capital Group Inc / GDS Holdings Ltd / Ichor Holdings Ltd / Puma Biotechnology Inc / Okta Inc / Wheaton Precious Metals Corp / Brighthouse Financial Inc / Kirkland Lake Gold Ltd / SailPoint Technologies Holdings Inc / Aptiv PLC / Encompass Health Corp / Zscaler Inc / Equitable Holdings Inc / Goosehead Insurance Inc / Veoneer Inc / Elastic NV / CrowdStrike Holdings Inc / Genmab A/S / Ping Identity Holding Corp / Datadog Inc / Sibanye Stillwater Ltd / International General Insurance Holdings Ltd / Shift4 Payments Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / Cayman Islands / Denmark / United Kingdom / Ireland / Netherlands / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">04/04/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Leonid Timashev / Yinglu Zhang</td></tr>
<tr class="odd"><td class="leftalignment">04/04/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="even"><td class="leftalignment">04/03/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AMGN.O / EXEL.O / REGN.O / PRTA.O / AGIO.O / MESO.O / PBYI.OQ / GMAB.O</td><td class="leftalignment">Amgen Inc / Exelixis Inc / Regeneron Pharmaceuticals Inc / Prothena Corporation PLC / Agios Pharmaceuticals Inc / Mesoblast Ltd / Puma Biotechnology Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Australia / Denmark / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Edwin Delfin</td></tr>
<tr class="odd"><td class="leftalignment">04/01/2021</td><td class="leftalignment">Probes Reporter</td><td class="leftalignment">Watch List: 86 US Companies with Undisclosed SEC Probes</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">T.N / AEP.N / BAC.N / CL.N / COF.N / CRM.N / F.N / HLT.N / MDT.N / PNC.N / SLB.N / BEN.N / TRI.N / PG.N / THC.N / REV.N / ADM.N / VLO.N / UPS.N / NWL.N / NKE.N / AMP.N / MTZ.N / ARW.N / ATO.N / TWTR.N / TUP.N / OMI.N / CVX.N / AMGN.OQ / CSCO.OQ / GNTX.OQ / MGPI.OQ / REGN.OQ / ROL.N / SEIC.OQ / RARE.OQ / MNRO.OQ / CAKE.OQ / GILD.OQ / COST.OQ / NKTR.OQ / AZPN.OQ / MYGN.OQ / SSNC.OQ / CTXS.OQ / AMZN.OQ / MSTR.OQ / NVDA.OQ / CHTR.OQ / TNP.N / NFLX.OQ / EGBN.OQ / CVGI.OQ / NDAQ.OQ / TAL.N / MA.N / SIX.N / AON.N / BX.N / INO.OQ / BGCP.OQ / UTL.N / SCHW.N / MSI.N / MPC.N / GRPN.OQ / FB.OQ / XPO.N / COTY.N / CTG.OQ / ANTM.N / NTRA.OQ / PFX.N / 100088979 / MFIN.OQ / DXC.N / RYTM.OQ / SWCH.N / IQV.N / WELL.N / US29350E1047 / LYFT.O</td><td class="leftalignment">AT&T Inc / American Electric Power Company Inc / Bank of America Corp / Colgate-Palmolive Co / Capital One Financial Corp / Salesforce.Com Inc / Ford Motor Co / Hilton Worldwide Holdings Inc / Medtronic PLC / PNC Financial Services Group Inc / Schlumberger NV / Franklin Resources Inc / Thomson Reuters Corp / Procter & Gamble Co / Tenet Healthcare Corp / Revlon Inc / Archer-Daniels-Midland Co / Valero Energy Corp / United Parcel Service Inc / Newell Brands Inc / Nike Inc / Ameriprise Financial Inc / MasTec Inc / Arrow Electronics Inc / Atmos Energy Corp / Twitter Inc / Tupperware Brands Corp / Owens & Minor Inc / Chevron Corp / Amgen Inc / Cisco Systems Inc / Gentex Corp / MGP Ingredients Inc / Regeneron Pharmaceuticals Inc / Rollins Inc / SEI Investments Co / Ultragenyx Pharmaceutical Inc / Monro Inc / Cheesecake Factory Inc / Gilead Sciences Inc / Costco Wholesale Corp / Nektar Therapeutics / Aspen Technology Inc / Myriad Genetics Inc / SS&C Technologies Holdings Inc / Citrix Systems Inc / Amazon.com Inc / Microstrategy Inc / NVIDIA Corp / Charter Communications Inc / Tsakos Energy Navigation Ltd / Netflix Inc / Eagle Bancorp Inc / Commercial Vehicle Group Inc / Nasdaq Inc / TAL Education Group / Mastercard Inc / Six Flags Entertainment Corp / Aon PLC / Blackstone Inc / Inovio Pharmaceuticals Inc / BGC Partners Inc / Unitil Corp / Charles Schwab Corp / Motorola Solutions Inc / Marathon Petroleum Corp / Groupon Inc / Meta Platforms Inc / XPO Logistics Inc / Coty Inc / Computer Task Group Inc / Anthem Inc / Natera Inc / PhenixFIN Corp / Huntington Bancshares Inc / Medallion Financial Corp / DXC Technology Co / Rhythm Pharmaceuticals Inc / Switch Inc / IQVIA Holdings Inc / Welltower Inc / Enochian Biosciences Inc / Lyft Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / China / Cayman Islands / Greece / Ireland / United States / Curaçao</td><td class="leftalignment">Agriculture / Air Transportation / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Consumer / Education / Electronics / Engineering & Construction / Financial Services / Healthcare / Household Products / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Services / Technology / Telecommunications / Transportation / Utilities / Oil & Gas</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for AMGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">04/01/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 541</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">04/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">AMGN.OQ / ACRX.OQ / LLY.N / MRK.N / PFE.N / GSK.L / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / MRNA.OQ / MRTX.OQ / MGNX.OQ / GRTX.OQ / ABCL.OQ</td><td class="leftalignment">Amgen Inc / AcelRx Pharmaceuticals Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Moderna Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">03/31/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Amgen adds 9.0% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/31/2021</td><td class="leftalignment">UniCredit Research</td><td class="leftalignment">Euro Credit Pilot - Technical factors sitting in the driver’s seat (March 2021)</td><td class="leftalignment">English</td><td class="rightalignment">54</td><td class="leftalignment">US88579Y1010 / AEGN.AS / AIRP.PA / AKZO.AS / ALSO.PA / ALV.N / ALVG.DE / ANZ.AX / APD.N / ASML.AS / ATCOA.ST / AXAF.PA / BAC.N / BARC.L / BKT.MC / BMWG.DE / BNPP.PA / BNS.TO / BOUY.PA / BP.L / BT.L / C.N / CAPP.PA / CARR.PA / CBA.AX / CBKG.DE / CCH.L / CM.TO / CNPP.PA / CRH.I / DANO.PA / DEO.N / DSMN.AS / EDP.LS / ENI.MI / ERICb.ST / ERST.VI / FREG.F / GASI.MI / GE.N / GM.N / HEIG.F / HEIN.AS / HSBA.L / IBE.MC / IBM.N / KPN.AS / LLOY.L / LVMH.PA / MAP.MC / MDBI.MI / MGA / MICP.PA / MOLB.BU / MRK.N / MUVGn.DE / PRTP.PA / SAN.MC / T.N / CONG.DE / AZN.L / AMGN.O / FER.MC / AAL.L / GS.N / ACE.MI / DBKGn.DE / MCD.N / FMEG.DE / BZU.MI / ENEI.MI / MRCG.DE / DTEGn.F / BBVA.MC / BTI.N / IFXGn.DE / FR0000064578 / FR0000035081 / ISS.CO / CARLb.CO / ADEN.S / HNRGn.DE / DPWGn.DE / IG.MI / GSK.L / BAB.L / AMXL.MX / EUFI.PA / JCDX.PA / GB0008220112 / SE0000455057 / US1101221083 / US2987361092 / US3377381088 / US4943681035 / US5949181045 / JP3116000005 / CAGR.PA / AMA.MC / DANSKE.CO / CH0013841017 / ARLG.DE / ENAG.MC / AV.L / US20030N1019 / US02209S1033 / EBKG.DE / JYSK.CO / MAERSKb.CO / HRA.MI / CAIV.VI / US46625H1005 / INGA.AS / LXSG.DE / BTGGg.F / GB0033986497 / JP3885780001 / MTXGn.DE / ELI.BR / EDF.PA / ETL.PA / MS.N / GAZP.MM / US31620M1062 / AKE.PA / ISP.MI / DWNG.DE / DK0060079531 / AU000000GMG2 / SABE.MC / CNE1000001Z5 / CNE1000002H1 / FR0010690156 / BNRGN.DE / IREE.MI / CNE100000KC0 / CABK.MC / US03027X1000 / MDLZ.OQ / LEGN.DE / GYC.DE / 1COV.DE / IMB.L / SE0009922164 / BIRG.I / BMG2178K1009 / BAWG.VI / LU0251710041 / AT0000BAWAG2 / AIBG.I / AIG.A</td><td class="leftalignment">3M Co / Aegon NV / L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Akzo Nobel NV / Alstom SA / Autoliv Inc / Allianz SE / Australia and New Zealand Banking Group Ltd / Air Products and Chemicals Inc / ASML Holding NV / Atlas Copco AB / AXA SA / Bank of America Corp / Barclays PLC / Bankinter SA / Bayerische Motoren Werke AG / BNP Paribas SA / Bank of Nova Scotia / Bouygues SA / BP PLC / BT Group PLC / Citigroup Inc / Capgemini SE / Carrefour SA / Commonwealth Bank of Australia / Commerzbank AG / Coca Cola HBC AG / Canadian Imperial Bank of Commerce / CNP Assurances SA / CRH PLC / Danone SA / Diageo PLC / Koninklijke DSM NV / EDP Energias de Portugal SA / Eni SpA / Telefonaktiebolaget LM Ericsson / Erste Group Bank AG / Fresenius SE & Co KGaA / Assicurazioni Generali SpA / General Electric Co / General Motors Co / HeidelbergCement AG / Heineken NV / HSBC Holdings PLC / Iberdrola SA / International Business Machines Corp / Koninklijke KPN NV / Lloyds Banking Group PLC / LVMH Moet Hennessy Louis Vuitton SE / Mapfre SA / Mediobanca Banca di Credito Finanziario SpA / Magna International Inc / Compagnie Generale des Etablissements Michelin SCA / MOL Magyar Olajes Gazipari Nyrt / Merck & Co Inc / Muenchener Rueckversicherungs Gesellschaft in Muenchen AG / Kering SA / Banco Santander SA / AT&T Inc / Continental AG / AstraZeneca PLC / Amgen Inc / Ferrovial SA / Anglo American PLC / Goldman Sachs Group Inc / Acea SpA / Deutsche Bank AG / McDonald's Corp / Fresenius Medical Care AG & Co KGaA / Buzzi Unicem SpA / Enel SpA / Merck KGaA / Deutsche Telekom AG / Banco Bilbao Vizcaya Argentaria SA / British American Tobacco PLC / Infineon Technologies AG / Covivio SA / Icade SA / Iss A/S / Carlsberg A/S / Adecco Group AG / Hannover Rueck SE / Deutsche Post AG / Italgas SpA / GlaxoSmithKline PLC / Babcock International Group PLC / America Movil SAB de CV / Eurofins Scientific SE / JCDecaux SA / DS Smith PLC / Fastighets AB Balder / Bristol-Myers Squibb Co / Euronet Worldwide Inc / Fiserv Inc / Kimberly-Clark Corp / Microsoft Corp / Asahi Group Holdings Ltd / Credit Agricole SA / Amadeus IT Group SA / Danske Bank A/S / Lonza Group AG / Aareal Bank AG / Enagas SA / Aviva PLC / Comcast Corp / Altria Group Inc / EnBW Energie Baden Wuerttemberg AG / Jyske Bank A/S / AP Moeller - Maersk A/S / Hera SpA / CA Immobilien Anlagen AG / JPMorgan Chase & Co / ING Groep NV / Lanxess AG / Bertelsmann SE & Co KGaA / ITV PLC / Mizuho Financial Group Inc / MTU Aero Engines AG / Elia Group SA / Electricite de France SA / Eutelsat Communications SA / Morgan Stanley / Gazprom PAO / Fidelity National Information Services Inc / Arkema SA / Intesa Sanpaolo SpA / Deutsche Wohnen SE / DSV A/S / Goodman Group / Banco de Sabadell SA / Bank of China Ltd / China Construction Bank Corp / Aeroports de Paris SA / Brenntag SE / Iren SpA / China National Chemical Engineering Co Ltd / Caixabank SA / American Tower Corp / Mondelez International Inc / LEG Immobilien SE / Grand City Properties SA / Covestro AG / Imperial Brands PLC / Essity AB (publ) / Bank of Ireland Group PLC / CK Infrastructure Holdings Ltd / BAWAG Group AG / CPI Property Group SA / BAWAG Group AG / Aib Group PLC / American International Group Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Austria / Belgium / Bermuda / Canada / Switzerland / China / Czech Republic / Germany / Denmark / Spain / Finland / France / United Kingdom / Greece / Hungary / Ireland / Italy / Japan / Luxembourg / Mexico / Netherlands / Norway / New Zealand / Poland / Portugal / Russian Federation / Slovakia / Sweden / United States / Jersey</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Communications / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Office Equipment / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Semiconductors / Services / Shipping & Shipbuilding / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment">MISCELLANEOUS / CHANGE IN RECOMMENDATION / MODELS / PORTFOLIO STRATEGY / CREDIT</td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / MARKET / COUNTRY RESEARCH / PORTFOLIO/ASSET STRATEGIES / Equity</td><td class="leftalignment">Herr Gianfranco Arcovito / Herr Christian Aust / Herr Tobias Keller / Herr. Stefan Kolek / Herr Sven Kreitmair, CFA / Frau Silke Stegemann / Herr Natalie Tehrani Monfared / Herr. Michael Teig</td></tr>
<tr class="odd"><td class="leftalignment">03/31/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">SASY.PA: Sanofi - First look at THOR-707 - novel cancer immunotherapy</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">SASY.PA / LLY.N / MRK.N / AZN.L / ROG.S / NOVOB.CO / NOVN.S / GSK.L / AMGN.OQ / BAYGN.DE</td><td class="leftalignment">Sanofi SA / Eli Lilly and Co / Merck & Co Inc / AstraZeneca PLC / Roche Holding AG / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Amgen Inc / Bayer AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">03/31/2021</td><td class="leftalignment">CRD Global</td><td class="leftalignment">Sustco Score Report: Amgen Inc. MARCH 2021</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">MISCELLANEOUS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Environmental, Social, Governance</td><td class="leftalignment">CRD Global</td></tr>
<tr class="odd"><td class="leftalignment">03/30/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Year-End Earnings; Three Clinical Readouts From mRNAi GOLD Platform in 2021 Should Spotlight Undervalued Stock Here</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">03116210 / 462222100 / 04280A100</td><td class="leftalignment">Amgen Inc / Ionis Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Myles R. R. Minter</td></tr>
<tr class="even"><td class="leftalignment">03/30/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Vaccination Ramp-Up Continues to Accelerate as Spring Wave Driven by Variants Likely</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">ASND=US / VERO=US / NKE=US / CAH=US / FDX=US / AMGN=US / MO=US / TJX=US / WM=US / ETR=US / SNE=US / BLD=US / SFE=US / BAC=US / ONE=US / WB=US / PEB=US / BRKS=US / YUM=US / SO=US / PLUG=US / STM=FR / VRTS=US / CHKP=US / AIG=US / SAP=US / TTEK=US / MCK=US / EXC=US / CRY=US / SNPS=US / JCI=US / NCR=US / ETN=US / NWL=US / CMCSA=US / SRCL=US / FLWS=US / KEYS=US / ABMD=US / ATI=US / AMRN=US / ANSS=US / ADSK=US / AVNT=US / BHE=US / BL=US / BRC=US / CBRL=US / CENT=US / CSBR=US / CHH=US / CMCO=US / CYH=US / CPRT=US / CO=US / CRWS=US / DFS=US / DGII=US / DG=US / E=US / EGLE=US / EGHT=US / EXAS=US / FDS=US / FLS=US / HAE=US / ICUI=US / IDCC=US / INGN=US / JCOM=US / KVHI=US / KEX=US / LH=US / LGND=US / MVIS=US / MSA=US / MNRO=US / MCO=US / NL=US / NSSC=US / TEAM=US / NTCT=US / OSIS=US / OXM=US / PZZA=US / KWR=US / RFIL=US / RARE=US / RGEN=US / ROK=US / ROP=US / HSIC=US / SIRI=US / TDS=US / TTEC=US / TRIP=US / TRIL=US / TRMB=US / UTI=US / UG=US / UTHR=US / UTL=US / UHS=US / VRTX=US / WCC=US / WIX=US / PDFS=US / GPN=US / SYNA=US / PYPL=US / JEF=US / AOS=US / SIVB=US / ARE=US / CAC=US / HT=US / STKL=US / SF=US / TK=US / ALLE=US / NLS=US / ENSG=US / MGP=US / MGPI=US / WCN=US / GPRO=US / DKS=US / WYNN=US / ABT=CA / NDAQ=US / GLNG=US / NTGR=US / AHH=US / FLT=US / OPEN=US / CZR=US / MUSA=US / CYTK=US / ACAD=US / SFM=US / MNKD=US / ENS=US / CNS=US / DLR=US / HLF=US / VIAC=US / INO=US / DXCM=US / LHCG=US / THS=US / AMRS=US / PERI=US / IRBT=US / CLMT=US / HIMX=US / HST=US / HALO=US / MWA=US / SIX=US / ATEC=US / GPRE=US / INFI=US / TEL=US / ALLT=US / AIMC=US / CENTA=US / CPLP=US / LXRX=US / M=US / OPK=US / NWBO=US / PRPL=US / PRO=US / PZN=US / IDRA=US / GLPG=US / BEST=US / SB=US / LOPE=US / ADUS=US / FTNT=US / AVNW=US / STNG=US / CTSO=US / CBOE=US / AOSL=US / PLOW=US / MSCI=US / SAVA=US / AMRC=US / PRMW=US / WWD=US / FDUS=US / XYL=US / EA=US / ARCT=US / LXFR=US / HASI=US / CUBI=US / NDLS=US / REXR=US / MGNX=US / GLPI=US / BANX=US / ATEN=US / ARDX=US / IRMD=US / TTOO=US / BABA=US / LOVE=US / OUT=US / NVTA=US / ETSY=US / MCRB=US / BLBD=US / SPXC=US / SQ=US / IONS=US / NTLA=US / ADVM=US / WKHS=US / YUMC=US / 115450867 / ROKU=US / KRYS=US / RBBN=US / IQ=US / COCP=US / CPRI=US / XAIR=US / NLOK=US / FUBO=US / VIRX=US / 120681711</td><td class="leftalignment">Ascendis Pharma A/S / Venus Concept Inc / Nike Inc / Cardinal Health Inc / FedEx Corp / Amgen Inc / Altria Group Inc / TJX Companies Inc / Waste Management Inc / Entergy Corp / Sony Group Corp / TopBuild Corp / Safeguard Scientifics Inc / Bank of America Corp / OneSmart International Education Group Ltd / Weibo Corp / Pebblebrook Hotel Trust / Azenta Inc / Yum! Brands Inc / Southern Co / Plug Power Inc / STMicroelectronics NV / Virtus Investment Partners Inc / Check Point Software Technologies Ltd / American International Group Inc / SAP SE / Tetra Tech Inc / Mckesson Corp / Exelon Corp / CryoLife Inc / Synopsys Inc / Johnson Controls International PLC / NCR Corp / Eaton Corporation PLC / Newell Brands Inc / Comcast Corp / Stericycle Inc / 1-800-Flowers.Com Inc / Keysight Technologies Inc / ABIOMED Inc / Allegheny Technologies Inc / Amarin Corporation PLC / ANSYS Inc / Autodesk Inc / Avient Corp / Benchmark Electronics Inc / Blackline Inc / Brady Corp / Cracker Barrel Old Country Store Inc / Central Garden & Pet Co / Champions Oncology Inc / Choice Hotels International Inc / Columbus McKinnon Corp / Community Health Systems Inc / Copart Inc / Global Cord Blood Corp / Crown Crafts Inc / Discover Financial Services / Digi International Inc / Dollar General Corp / Eni SpA / Eagle Bulk Shipping Inc / 8x8 Inc / Exact Sciences Corp / Factset Research Systems Inc / Flowserve Corp / Haemonetics Corp / ICU Medical Inc / InterDigital Inc / Inogen Inc / Ziff Davis Inc / KVH Industries Inc / Kirby Corp / Laboratory Corporation of America Holdings / Ligand Pharmaceuticals Inc / MicroVision Inc / MSA Safety Inc / Monro Inc / Moody's Corp / NL Industries Inc / NAPCO Security Technologies Inc / Atlassian Corporation PLC / Netscout Systems Inc / OSI Systems Inc / Oxford Industries Inc / Papa John's International Inc / Quaker Chemical Corp / RF Industries Ltd / Ultragenyx Pharmaceutical Inc / Repligen Corp / Rockwell Automation Inc / Roper Technologies Inc / Henry Schein Inc / Sirius XM Holdings Inc / Telephone and Data Systems Inc / TTEC Holdings Inc / Tripadvisor Inc / Pfizer Inc / Trimble Inc / Universal Technical Institute Inc / United-Guardian Inc / United Therapeutics Corp / Unitil Corp / Universal Health Services Inc / Vertex Pharmaceuticals Inc / Wesco International Inc / Wix.Com Ltd / PDF Solutions Inc / Global Payments Inc / Synaptics Inc / PayPal Holdings Inc / Jefferies Financial Group Inc / A O Smith Corp / SVB Financial Group / Alexandria Real Estate Equities Inc / Camden National Corp / Hersha Hospitality Trust / Sunopta Inc / Stifel Financial Corp / Teekay Corp / Allegion PLC / Nautilus Inc / Ensign Group Inc / MGM Growth Properties LLC / MGP Ingredients Inc / Waste Connections Inc / GoPro Inc / DICK'S Sporting Goods Inc / Wynn Resorts Ltd / Absolute Software Corp / Nasdaq Inc / Golar LNG Ltd / NETGEAR Inc / Armada Hoffler Properties Inc / Fleetcor Technologies Inc / Opendoor Technologies Inc / Caesars Entertainment Inc / Murphy Usa Inc / Cytokinetics Inc / ACADIA Pharmaceuticals Inc / Sprouts Farmers Market Inc / MannKind Corp / EnerSys / Cohen & Steers Inc / Digital Realty Trust Inc / Herbalife Nutrition Ltd / ViacomCBS Inc / Inovio Pharmaceuticals Inc / Dexcom Inc / LHC Group Inc / TreeHouse Foods Inc / Amyris Inc / Perion Network Ltd / iRobot Corp / Calumet Specialty Products Partners LP / Himax Technologies Inc / Host Hotels & Resorts Inc / Halozyme Therapeutics Inc / Mueller Water Products Inc / Six Flags Entertainment Corp / Alphatec Holdings Inc / Green Plains Inc / Infinity Pharmaceuticals Inc / TE Connectivity Ltd / Allot Ltd / Altra Industrial Motion Corp / Central Garden & Pet Co / Capital Product Partners LP / Lexicon Pharmaceuticals Inc / Macy's Inc / OPKO Health Inc / Northwest Biotherapeutics Inc / Purple Innovation Inc / Pros Holdings Inc / Pzena Investment Management Inc / Idera Pharmaceuticals Inc / Galapagos NV / BEST Inc / Safe Bulkers Inc / Grand Canyon Education Inc / Addus Homecare Corp / Fortinet Inc / Aviat Networks Inc / Scorpio Tankers Inc / Cytosorbents Corp / Cboe Global Markets Inc / Alpha and Omega Semiconductor Ltd / Douglas Dynamics Inc / MSCI Inc / Cassava Sciences Inc / Ameresco Inc / Primo Water Corp / Woodward Inc / Fidus Investment Corp / Xylem Inc / Electronic Arts Inc / Arcturus Therapeutics Holdings Inc / Luxfer Holdings PLC / Hannon Armstrong Sustainable Infrastructure Capital Inc / Customers Bancorp Inc / Noodles & Co / Rexford Industrial Realty Inc / MacroGenics Inc / Gaming and Leisure Properties Inc / StoneCastle Financial Corp / A10 Networks Inc / Ardelyx Inc / IRadimed Corp / T2 Biosystems Inc / Alibaba Group Holding Ltd / Lovesac Co / OUTFRONT Media Inc / Invitae Corp / ETSY Inc / Seres Therapeutics Inc / Blue Bird Corp / SPX Corp / Block Inc / Ionis Pharmaceuticals Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / Workhorse Group Inc / Yum China Holdings Inc / Great Elm Capital Corp / Roku Inc / Krystal Biotech Inc / Ribbon Communications Inc / iQIYI Inc / Cocrystal Pharma Inc / Capri Holdings Ltd / Beyond Air Inc / NortonLifeLock Inc / Fubotv Inc / Viracta Therapeutics Inc / Primo Water Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / United Kingdom / Ireland / Israel / Italy / Japan / Netherlands / United States / Virgin Islands, British / Marshall Islands</td><td class="leftalignment">Biotechnology / Conglomerates / Consumer / Financial Services / Healthcare / Info. Tech./Computers / Pharmaceuticals / Retailing / Semiconductors</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / HD=US / MCD=US / WEN=US / BLD=US / DVN=US / TEVA=US / CMA=US / APA=US / LOW=US / PB=US / CHRS=US / EWBC=US / TRMK=US / UMPQ=US / LEG=US / ATVI=US / WTFC=US / CBRL=US / CSTR=US / CNX=US / DRI=US / FCN=US / GFF=US / IBP=US / MAS=US / MHK=US / PACW=US / WAL=US / HTH=US / BXS=US / CFB=US / CFR=US / FMBI=US / SNV=US / ZION=US / SIVB=US / ABCB=US / BOKF=US / FBK=US / ASB=US / SSB=US / RF=US / CATY=US / FFIN=US / GBCI=US / SBSI=US / AUTL=US / UCBI=US / DIN=US / PNFP=US / SBCF=US / NOMD=US / TCBI=US / TPX=US / FNB=US / EXP=US / FHN=US / BECN=US / PLAY=US / RNST=US / DENN=US / BLDR=US / GMS=US / CMG=US / PGTI=US / AWI=US / OC=US / AMRX=US / CADE=US / TAST=US / QSR=US / PRPL=US / JACK=US / TREX=US / FBHS=US / TILE=US / IBTX=US / NDLS=US / MTNB=US / LOCO=US / SHAK=US / WING=US / LOB=US / ACBI=US / ZS=US / WVE=US / NTLA=US / 82982L103 / JELD=US / ROKU=US / MBIN=US / HWC=US / OZK=US / AMTB=US / TCRR=US / CRWD=US / FERG=US / AZEK=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / McDonald's Corp / Wendys Co / TopBuild Corp / Devon Energy Corp / Teva Pharmaceutical Industries Ltd / Comerica Inc / APA Corp (US) / Lowe's Companies Inc / Prosperity Bancshares Inc / Coherus BioSciences Inc / East West Bancorp Inc / Trustmark Corp / Umpqua Holdings Corp / Leggett & Platt Inc / Activision Blizzard Inc / Wintrust Financial Corp / Cracker Barrel Old Country Store Inc / CapStar Financial Holdings Inc / CNX Resources Corp / Darden Restaurants Inc / FTI Consulting Inc / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / PacWest Bancorp / Western Alliance Bancorp / Hilltop Holdings Inc / Cadence Bank / Crossfirst Bankshares Inc / Cullen/Frost Bankers Inc / First Midwest Bancorp Inc / Synovus Financial Corp / Zions Bancorporation NA / SVB Financial Group / Ameris Bancorp / BOK Financial Corp / FB Financial Corp / Associated Banc-Corp / SouthState Corp / Regions Financial Corp / Cathay General Bancorp / First Financial Bankshares Inc / Glacier Bancorp Inc / Southside Bancshares Inc / Autolus Therapeutics PLC / United Community Banks Inc / Dine Brands Global Inc / Pinnacle Financial Partners Inc / Seacoast Banking Corporation of Florida / Nomad Foods Ltd / Texas Capital Bancshares Inc / Tempur Sealy International Inc / FNB Corp / Eagle Materials Inc / First Horizon Corp / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Renasant Corp / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / PGT Innovations Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Cadence Bank / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Jack in the Box Inc / Trex Company Inc / Fortune Brands Home & Security Inc / Interface Inc / Independent Bank Group Inc / Noodles & Co / Matinas BioPharma Holdings Inc / El Pollo Loco Holdings Inc / Shake Shack Inc / Wingstop Inc / Live Oak Bancshares Inc / Atlantic Capital Bancshares Inc / Zscaler Inc / WAVE Life Sciences Ltd / Intellia Therapeutics Inc / SiteOne Landscape Supply Inc / JELD-WEN Holding Inc / Roku Inc / Merchants Bancorp / Hancock Whitney Corp / Bank Ozk / Amerant Bancorp Inc / TCR2 Therapeutics Inc / CrowdStrike Holdings Inc / Ferguson PLC / Azek Company Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Israel / Singapore / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">AMGN: Amgen, Inc. - Acquisition of Rodeo Therapeutics Corporation; Small BD but Demonstrates Commitment to Bolstering Inflammation Franchise</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Global Biotechnology: What's an Oncology Drug Worth? Data from a Decade of Oncology M&A</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">4502.T / 4503.T / BMY.N / LLY.N / MRK.N / PFE.N / SASY.PA / ROG.S / NOVN.S / MRCG.DE / 4768.T / GSK.L / AMGN.OQ / GILD.OQ / SGEN.OQ / 4568.T / JAZZ.OQ / BAYGN.DE / ABBV.N</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Sanofi SA / Roche Holding AG / Novartis AG / Merck KGaA / Otsuka Corp / GlaxoSmithKline PLC / Amgen Inc / Gilead Sciences Inc / Seagen Inc / Daiichi Sankyo Co Ltd / Jazz Pharmaceuticals PLC / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Ireland / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Mr. Bradley P. Canino</td></tr>
<tr class="odd"><td class="leftalignment">03/29/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Key Takeaways from Discussion with Management</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AMGN=US / MRTX=US</td><td class="leftalignment">Amgen Inc / Mirati Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/29/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">EGRX-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">EGRX.O / BMY / JNJ / LLY / NVS / AMGN.O / GSK / TEVA.K</td><td class="leftalignment">Eagle Pharmaceuticals Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Amgen Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">03/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Mar 19, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Guggenheim Ther Research</td></tr>
<tr class="even"><td class="leftalignment">03/29/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">03/29/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">William Blair Biopharma Catalyst Watch Second Quarter 2021</td><td class="leftalignment">English</td><td class="rightalignment">48</td><td class="leftalignment">00847G705 / 00887A105 / 03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Agenus Inc / Aileron Therapeutics Inc / Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Matt Phipps, PHD / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">03/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">AXP / 2126335 / 2023607 / 2026242 / 2270726 / 2829515 / 2037170 / 2328915 / 2342034 / 2459020 / 2689560 / 2680905 / 2138158 / 2857817 / B7TL820 / BBFL7S1 / BFDV8K0 / BBGVT40 / BDZCRX3 / BFLR866 / BYVY8G0 / BF5L3T2 / BFZNYB7 / BDHF4K6 / BZBY005 / BKS3SM8 / BGCYWN8 / BLGJ610 / BYXJQG9 / BZ8VJQ8 / BG31GH0 / BKTNTR9 / BYQHPK7 / BG0Q4Y1 / BM8MM05</td><td class="leftalignment">American Express Co / Bristol-Myers Squibb Co / Amgen Inc / American Electric Power Company Inc / Walt Disney Co / Edison International / 8x8 Inc / Nextera Energy Inc / Fiserv Inc / Intuit Inc / PG&E Corp / PPL Corp / Sempra Energy / Netflix Inc / Meta Platforms Inc / bluebird bio Inc / MacroGenics Inc / News Corp / RingCentral Inc / Twitter Inc / Alphabet Inc / Elanco Animal Health Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Merus NV / IGM Biosciences Inc / Xencor Inc / Warner Music Group Corp / Spire Inc / Vistra Corp / Y-mAbs Therapeutics Inc / ViacomCBS Inc / Zymeworks Inc / Exicure Inc / Madison Square Garden Entertainment Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">03/26/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">CHRS-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">CHRS.O / AMGN.O / ARNA.O / RGEN.O / ACOR.O</td><td class="leftalignment">Coherus BioSciences Inc / Amgen Inc / Arena Pharmaceuticals Inc / Repligen Corp / Acorda Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">03/26/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Portfolio Manager's Weekly - March 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">NL0000226223 / DE0006231004 / US00846U1016 / US0116591092 / US0126531013 / US0231351067 / US02553E1064 / US0311621009 / US0378331005 / US0382221051 / US1264081035 / US1311931042 / US1727551004 / US1924221039 / US1985161066 / US22160K1051 / US22284P1057 / US2358511028 / US2371941053 / US2435371073 / US2786421030 / US3021301094 / US4433201062 / US4456581077 / US4581401001 / US4663671091 / US5150981018 / US5801351017 / US5951121038 / US6245801062 / US6541061031 / US6558441084 / US6795801009 / US7140461093 / US7392761034 / US7475251036 / US8168501018 / US8447411088 / US8552441094 / US8610121027 / US8725401090 / US8807701029 / US8835561023 / US9029251066 / US9078181081 / US91347P1057 / US92343V1044 / US9311421039 / US9418481035 / US9507551086 / US9581021055 / CA1363751027 / CA13645T1003 / US87157D1090 / US9884981013 / AU000000LYC6 / US4771431016 / US83088M1027 / US20030N1019 / US1167941087 / US3463751087 / US1572101053 / US25754A2015 / FI0009013296 / US19239V3024 / US2090341072 / US12541W2098 / US00206R1023 / US1696561059 / US82706C1080 / US78709Y1055 / US75025X1000 / US01748X1028 / US2473617023 / US1844991018 / US25470M1099 / DE000A1EWWW0 / US95058W1009 / US30303M1027 / US9837931008 / US75972A3014 / US00287Y1091 / NL0010273215 / US8725901040 / US1220171060 / US90184L1026 / US03937C1053 / US94419L1017 / US0994061002 / CA76131D1033 / US74736K1016 / US8190471016 / US00653A1079 / US9741551033 / US12685J1051 / US02079K1079 / US16119P1084 / US26856L1035 / US64104Y1064 / CA87241L1094 / NL0012169213 / CA35805P1071 / US83304A1060 / US91325V1089 / US23753F1075 / US80689H1023 / US04016X1019 / US02156K1034 / US4990491049 / CA53680Q2071 / US02083G1004 / US09354A1007 / US11135F1012 / CA39342L1085 / KY30744W1070 / US0197701065 / US53814L1089 / US98585X1046 / VGG1890L1076 / US05352A1007 / US76156B1070 / CA23126M1023 / US07373B1098 / US5533681012 / US74767V1098 / US7761531083 / US73739W1045 / US5502411037 / US55406W1036 / US15961R1059</td><td class="leftalignment">STMicroelectronics NV / Infineon Technologies AG / Agilent Technologies Inc / Alaska Air Group Inc / Albemarle Corp / Amazon.com Inc / American Eagle Outfitters Inc / Amgen Inc / Apple Inc / Applied Materials Inc / CSX Corp / Callaway Golf Co / Cirrus Logic Inc / Cognex Corp / Columbia Sportswear Co / Costco Wholesale Corp / Covenant Logistics Group Inc / Danaher Corp / Darden Restaurants Inc / Deckers Outdoor Corp / eBay Inc / Expeditors International of Washington Inc / Hub Group Inc / J B Hunt Transport Services Inc / Intel Corp / Jack in the Box Inc / Landstar System Inc / McDonald's Corp / Micron Technology Inc / Movado Group Inc / Nike Inc / Norfolk Southern Corp / Old Dominion Freight Line Inc / PerkinElmer Inc / Power Integrations Inc / Qualcomm Inc / Semtech Corp / Southwest Airlines Co / Starbucks Corp / STMicroelectronics NV / TJX Companies Inc / Teradyne Inc / Thermo Fisher Scientific Inc / USA Truck Inc / Union Pacific Corp / Universal Display Corp / Verizon Communications Inc / Walmart Inc / Waters Corp / Werner Enterprises Inc / Western Digital Corp / Canadian National Railway Co / Canadian Pacific Railway Ltd / Synaptics Inc / Yum! Brands Inc / Lynas Rare Earths Ltd / JetBlue Airways Corp / Skyworks Solutions Inc / Comcast Corp / Bruker Corp / FormFactor Inc / CEVA Inc / Domino's Pizza Inc / Neste Oyj / Cogent Communications Holdings Inc / Consolidated Communications Holdings Inc / CH Robinson Worldwide Inc / AT&T Inc / Chipotle Mexican Grill Inc / Silicon Motion Technology Corp / Saia Inc / Radiant Logistics Inc / Allegiant Travel Co / Delta Air Lines Inc / Clean Energy Fuels Corp / DISH Network Corp / Adidas AG / Wendys Co / Meta Platforms Inc / XPO Logistics Inc / Renewable Energy Group Inc / Abbvie Inc / ASML Holding NV / T-Mobile US Inc / Burlington Stores Inc / Twitter Inc / ArcBest Corp / Wayfair Inc / Boot Barn Holdings Inc / Restaurant Brands International Inc / Qorvo Inc / Shake Shack Inc / Adaptimmune Therapeutics PLC / Wingstop Inc / Cable One Inc / Alphabet Inc / Charter Communications Inc / elf Beauty Inc / Neste Oyj / TFI International Inc / Qiagen NV / Freshii Inc / Snap Inc / Uniti Group Inc / Daseke Inc / Schneider National Inc / argenx SE / Altice USA Inc / Knight-Swift Transportation Holdings Inc / Lithium Americas Corp / Alpine Immune Sciences Inc / Blink Charging Co / Broadcom Inc / Green Thumb Industries Inc / Farfetch Ltd / Allogene Therapeutics Inc / Livent Corp / Yeti Holdings Inc / Capri Holdings Ltd / Avantor Inc / Revolve Group Inc / Curaleaf Holdings Inc / Beam Global / Mp Materials Corp / Quantumscape Corp / Romeo Power Inc / Poshmark Inc / Lumen Technologies Inc / MYT Netherlands Parent BV / ChargePoint Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Cayman Islands / Germany / Finland / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">03/26/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 540</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">03/26/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="odd"><td class="leftalignment">03/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">03/26/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended March 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - March 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BAC.N / BAER.S / BARC.L / BB.N / BK.N / BNPP.PA / C.N / CBKG.DE / CSGN.S / FITB.O / HSBA.L / JPM.N / LLOY.L / RWEG.DE / SAN.MC / SGC.L / SOGN.PA / WFC.N / HUM.N / CPB.N / TA.TO / AMGN.O / DRI.N / GS.N / DBKGn.DE / BBVA.MC / OLN.N / MTG.N / RDN.N / STT.N / CYH.N / REGN.O / CVX.N / CAGR.PA / NWG.L / ACGL.O / INGA.AS / MS.N / 443628102 / CBRO.L / GTE.TO / EONGn.DE / PXT.TO / ACHC.O / TSLA.N / ESNT.N / NMIH.O / ABNd.AS / UBSG.S / MTRO.L / VMUK.L / PAGPA.L</td><td class="leftalignment">Bank of America Corp / Julius Baer Gruppe AG / Barclays PLC / BlackBerry Ltd / Bank of New York Mellon Corp / BNP Paribas SA / Citigroup Inc / Commerzbank AG / Credit Suisse Group AG / Fifth Third Bancorp / HSBC Holdings PLC / JPMorgan Chase & Co / Lloyds Banking Group PLC / Rwe AG / Banco Santander SA / Stagecoach Group PLC / Societe Generale SA / Wells Fargo & Co / Humana Inc / Campbell Soup Co / TransAlta Corp / Amgen Inc / Darden Restaurants Inc / Goldman Sachs Group Inc / Deutsche Bank AG / Banco Bilbao Vizcaya Argentaria SA / Olin Corp / MGIC Investment Corp / Radian Group Inc / State Street Corp / Community Health Systems Inc / Regeneron Pharmaceuticals Inc / Chevron Corp / Credit Agricole SA / Natwest Group PLC / Arch Capital Group Ltd / ING Groep NV / Morgan Stanley / Hudbay Minerals Inc / Close Brothers Group PLC / Gran Tierra Energy Inc / E.ON SE / Parex Resources Inc / Acadia Healthcare Company Inc / Tesla Inc / Essent Group Ltd / NMI Holdings Inc / ABN Amro Bank NV / UBS Group AG / Metro Bank PLC / Virgin Money UK PLC / Paragon Banking Group PLC</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Germany / Spain / France / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">03/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Canadian Research at a Glance - March 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BAER.S / BARC.L / BB.N / BNPP.PA / CBKG.DE / CSGN.S / HSBA.L / JNJ.N / LLOY.L / MRK.N / PFE.N / SAN.MC / SOGN.PA / GILD.O / TA.TO / AMGN.O / DBKGn.DE / BBVA.MC / 0989529 / CVX.N / CAGR.PA / NWG.L / INGA.AS / TEVA.N / CS.TO / 443628102 / CBRO.L / GTE.TO / PXT.TO / ABBV.N / PRGO.N / GUD.TO / ABNd.AS / UBSG.S / MTRO.L / APR_U.TO / VMUK.L / PAGPA.L</td><td class="leftalignment">Julius Baer Gruppe AG / Barclays PLC / BlackBerry Ltd / BNP Paribas SA / Commerzbank AG / Credit Suisse Group AG / HSBC Holdings PLC / Johnson & Johnson / Lloyds Banking Group PLC / Merck & Co Inc / Pfizer Inc / Banco Santander SA / Societe Generale SA / Gilead Sciences Inc / TransAlta Corp / Amgen Inc / Deutsche Bank AG / Banco Bilbao Vizcaya Argentaria SA / AstraZeneca PLC / Chevron Corp / Credit Agricole SA / Natwest Group PLC / ING Groep NV / Teva Pharmaceutical Industries Ltd / Capstone Mining Corp / Hudbay Minerals Inc / Close Brothers Group PLC / Gran Tierra Energy Inc / Parex Resources Inc / Abbvie Inc / Perrigo Company PLC / Knight Therapeutics Inc / ABN Amro Bank NV / UBS Group AG / Metro Bank PLC / Automotive Properties Real Estate Investment Trust / Virgin Money UK PLC / Paragon Banking Group PLC</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Germany / Spain / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">03/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AMGN.OQ / ACRX.OQ / BMY.N / MRK.N / PFE.N / AZN.L / REGN.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Amgen Inc / AcelRx Pharmaceuticals Inc / Bristol-Myers Squibb Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Yunhee Park / Jonathan Woo</td></tr>
<tr class="even"><td class="leftalignment">03/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharma Feedback: AstraZeneca BioPharma Meet Management event, March 2021</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AZN.L / JNJ.N / LLY.N / PFE.N / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / AMGN.OQ / REGN.OQ</td><td class="leftalignment">AstraZeneca PLC / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / Amgen Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">03/26/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">AACR Annual Meeting 2021 Congress Planner</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">375558103 / 031162100 / 75886F107 / 45337C102 / 45253H101 / 29667D104 / 00287Y109 / 189464100 / 31189P102 / 60468T105 / 09627Y109 / 52187K101 / 07725L102 / 462260100 / 67022C106 / 98401F105 / 23284F105 / 019770106 / H17182108 / 41358P106 / 87808K106 / 481116101 / 44975P103 / 02083G100 / 24344T101 / 04335A105 / 46565G104 / 14147L108 / 81181C104 / 03835L108 / 38406L103</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Incyte Corp / ImmunoGen Inc / ESSA Bancorp Inc / Abbvie Inc / Clovis Oncology Inc / Fate Therapeutics Inc / Mirati Therapeutics Inc / Blueprint Medicines Corp / Leap Therapeutics Inc / Beigene Ltd / Iovance Biotherapeutics Inc / NuCana PLC / Xencor Inc / CytomX Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / Jounce Therapeutics Inc / I-Mab / Alpine Immune Sciences Inc / Deciphera Pharmaceuticals Inc / Arvinas Inc / Iteos Therapeutics Inc / Cardiff Oncology Inc / Seagen Inc / Aptevo Therapeutics Inc / Gracell Biotechnologies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / China / Cayman Islands / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Eleanor Maughan, Ph.D. / Joseph Catanzaro, PhD / Mr. Christopher J. Raymond / Edward A. Tenthoff / Mr. Tyler M. Van Buren, M.SC</td></tr>
<tr class="even"><td class="leftalignment">03/26/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Amgen Inc.</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">03/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">UK & European Research at a Glance - March 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ABF.L / AEGN.AS / AHT.L / ALVG.DE / AXAF.PA / BAER.S / BARC.L / BNPP.PA / BNZL.L / BOY.L / BRW.L / CBKG.DE / CNA.L / CNE.L / CPI.L / CSGN.S / CWK.L / DANO.PA / DCC.L / DFDS.CO / DPLM.L / ECM.L / FGP.L / FOUG.PA / GOG.L / HMSO.L / HSBA.L / HSX.L / HTG.L / IMI.L / JD.L / JNJ.N / JSG.L / LAND.L / LLOY.L / MKS.L / MRK.N / MUVGn.DE / NA / NEX.L / NXT.L / OREP.PA / OXB.L / PFE.N / PFG.L / PNN.L / PRU.L / ROR.L / RPS.L / RTO.L / SAN.MC / SGC.L / SGEF.PA / SLA.L / SMWH.L / SOGN.PA / SRP.L / TLW.L / TPK.L / TTG.L / ULVR.L / VIEV.VI / WKP.L / ZURN.S / RAT.L / GILD.O / AMGN.O / DBKGn.DE / ESP.L / BBVA.MC / ENT.L / JTC.L / BYG.L / MORG.DE / DPH.L / IG.MI / 0989529 / IGG.L / FRAG.DE / CVX.N / CAGR.PA / CEY.L / ENAG.MC / AV.L / WG.L / FLS.CO / ASC.L / HAYS.L / APF.L / COA.L / NWG.L / SGSN.S / RTN.L / INGA.AS / HSV.L / NESN.S / SPI.L / BRK.L / NESTE.HE / BUCN.S / KOS.N / PFC.L / BVIC.L / DUFN.S / LRE.L / HICL.L / TEVA.N / DNLM.L / OERL.S / MARS.L / DLN.L / DWNG.DE / 3IN.L / ATL.MI / HFG.L / MONY.L / RENE.LS / CBRO.L / SLRS.MC / HOCM.L / XPS.L / BEZG.L / ABCA.L / CVSG.L / VGP1.BR / GTE.TO / INPP.L / FHZN.S / PHNX.L / SUBC.OL / CAML.L / PXT.TO / SMSS.L / BOSSn.DE / CLINC.L / DLGD.L / ABBV.N / LMPL.L / PRGO.N / MGAMM.L / UKWG.L / BOOH.L / BBOXT.L / NN.AS / DC.L / MOLN.S / FEVR.L / SNNS.L / G24N.DE / AMUN.PA / GYM.L / ABNd.AS / CMCX.L / UBSG.S / SRENH.S / MTRO.L / PAGE.L / BFIT.AS / CTEC.L / IWG.L / TCAPI.L / TKOO.PA / GREG.MC / JUSTJ.L / IHR.L / DHER.DE / GRPG.I / FERG.L / SUPR.L / WHRW.L / AFM.L / RHIM.L / SDRY.L / ENOG.L / QLT.L / HNSA.ST / TMV.DE / VMUK.L / UPR.IR / PAGPA.L / FRAS.L / JETJ.L / 001306785 / DOCS.L / TEEC.L</td><td class="leftalignment">Associated British Foods PLC / Aegon NV / Ashtead Group PLC / Allianz SE / AXA SA / Julius Baer Gruppe AG / Barclays PLC / BNP Paribas SA / Bunzl plc / Bodycote PLC / Brewin Dolphin Holdings PLC / Commerzbank AG / Centrica PLC / Capricorn Energy PLC / Capita PLC / Credit Suisse Group AG / Cranswick PLC / Danone SA / DCC PLC / DFDS AS / Diploma PLC / Electrocomponents PLC / FirstGroup PLC / Eiffage SA / Go-Ahead Group PLC / Hammerson PLC / HSBC Holdings PLC / Hiscox Ltd / Hunting PLC / IMI PLC / JD Sports Fashion PLC / Johnson & Johnson / Johnson Service Group PLC / Land Securities Group PLC / Lloyds Banking Group PLC / Marks and Spencer Group PLC / Merck & Co Inc / Muenchener Rueckversicherungs Gesellschaft in Muenchen AG / National Bank of Canada / National Express Group PLC / Next PLC / L'Oreal SA / Oxford BioMedica PLC / Pfizer Inc / Provident Financial PLC / Pennon Group PLC / Prudential PLC / Rotork PLC / RPS Group PLC / Rentokil Initial PLC / Banco Santander SA / Stagecoach Group PLC / Vinci SA / Abrdn PLC / WH Smith PLC / Societe Generale SA / Serco Group PLC / Tullow Oil PLC / Travis Perkins PLC / TT electronics PLC / Unilever PLC / Flughafen Wien AG / Workspace Group PLC / Zurich Insurance Group AG / Rathbones Group PLC / Gilead Sciences Inc / Amgen Inc / Deutsche Bank AG / Empiric Student Property PLC / Banco Bilbao Vizcaya Argentaria SA / Entain PLC / Jtc PLC / Big Yellow Group PLC / MorphoSys AG / Dechra Pharmaceuticals PLC / Italgas SpA / AstraZeneca PLC / IG Group Holdings PLC / Fraport AG Frankfurt Airport Services Worldwide / Chevron Corp / Credit Agricole SA / Centamin PLC / Enagas SA / Aviva PLC / John Wood Group PLC / FLSmidth & Co A/S / ASOS PLC / Hays PLC / Anglo Pacific Group PLC / Coats Group PLC / Natwest Group PLC / SGS SA / Restaurant Group PLC / ING Groep NV / HomeServe PLC / Nestle SA / Spire Healthcare Group PLC / Brooks Macdonald Group PLC / Neste Oyj / Bucher Industries AG / Kosmos Energy Ltd / Petrofac Ltd / Britvic PLC / Dufry AG / Lancashire Holdings Ltd / HICL Infrastructure PLC / Teva Pharmaceutical Industries Ltd / Dunelm Group PLC / OC Oerlikon Corporation AG Pfaeffikon / Marston's PLC / Derwent London PLC / Deutsche Wohnen SE / 3I Infrastructure PLC / Atlantia SpA / Hilton Food Group PLC / Moneysupermarket.Com Group PLC / Ren Redes Energeticas Nacionais SGPS SA / Close Brothers Group PLC / Solaria Energia y Medio Ambiente SA / Hochschild Mining PLC / XPS Pensions Group PLC / Beazley PLC / Abcam PLC / CVS Group PLC / VGP NV / Gran Tierra Energy Inc / International Public Partnerships Ltd / Flughafen Zuerich AG / Phoenix Group Holdings PLC / Subsea 7 SA / Central Asia Metals PLC / Parex Resources Inc / Smart Metering Systems PLC / Hugo Boss AG / Clinigen Group PLC / Direct Line Insurance Group PLC / Abbvie Inc / Londonmetric Property PLC / Perrigo Company PLC / Morgan Advanced Materials PLC / Greencoat UK Wind PLC / boohoo group plc / Tritax Big Box Reit PLC / NN Group NV / Currys PLC / Molecular Partners AG / Fevertree Drinks PLC / Sanne Group PLC / Scout24 SE / Amundi SA / GYM Group PLC / ABN Amro Bank NV / CMC Markets PLC / UBS Group AG / Swiss Re AG / Metro Bank PLC / Pagegroup PLC / Basic Fit NV / ConvaTec Group PLC / IWG Plc / TP ICAP Group PLC / Tikehau Capital SCA / Grenergy Renovables SA / Just Group PLC / Impact Healthcare REIT PLC / Delivery Hero SE / Greencoat Renewables PLC / Ferguson PLC / Supermarket Income REIT PLC / Warehouse REIT PLC / Alpha Financial Markets Consulting PLC / RHI Magnesita NV / Superdry PLC / Energean PLC / Quilter PLC / Hansa Biopharma AB / TeamViewer AG / Virgin Money UK PLC / Uniphar PLC / Paragon Banking Group PLC / Frasers Group PLC / Just Eat Takeaway.com NV / Bureau Veritas SA / Dr Martens PLC / Triple Point Energy Efficiency Infrastructure Company Plc</td><td class="leftalignment"></td><td class="leftalignment">Austria / Belgium / Bermuda / Canada / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Ireland / Israel / Italy / Luxembourg / Netherlands / Portugal / Sweden / United States / Isle of Man / Jersey / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">03/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for AMGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">03/25/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Green Shoots or Eye of the Hurricane? Biotech Inflows Return</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / 039697107 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / 19240Q201</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Ardelyx Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / Cogent Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">03/25/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">CTIC-US - Fundamental Analysis, for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">CTIC.O / BAX / BMY / LLY / NVS / AMGN.O / INCY.O / TEVA.K</td><td class="leftalignment">CTI Biopharma Corp / Baxter International Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Novartis AG / Amgen Inc / Incyte Corp / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">03/25/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Short Interest Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AMGN.O / REGN.O</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Yinglu Zhang</td></tr>
<tr class="even"><td class="leftalignment">03/25/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK=US / LSI=US / PFE=US / AMGN=US / KO=US / BLD=US / INCY=US / TEVA=US / PEB=US / H=US / MTN=US / CHRS=US / BRO=US / MAR=US / TNL=US / HLT=US / RCL=US / CCL=US / CHH=US / DRH=US / AJG=US / IBP=US / KBH=US / REGI=US / WGO=US / PSA=US / DCP=US / SBCF=US / APTX=US / EXR=US / BECN=US / SHO=US / GMS=US / HST=US / AWI=US / OC=US / WH=US / IAC=US / HGV=US / RLJ=US / VAC=US / CUBE=US / RHP=US / TILE=US / NCLH=US / NSA=US / PK=US / PLYA=US / FERG=US / OVV=US / ARQT=US / FBRX=US / BALY=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Life Storage Inc / Pfizer Inc / Amgen Inc / Coca-Cola Co / TopBuild Corp / Incyte Corp / Teva Pharmaceutical Industries Ltd / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Vail Resorts Inc / Coherus BioSciences Inc / Brown & Brown Inc / Marriott International Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Royal Caribbean Cruises Ltd / Carnival Corp / Choice Hotels International Inc / Diamondrock Hospitality Co / Arthur J Gallagher & Co / Installed Building Products Inc / KB Home / Renewable Energy Group Inc / Winnebago Industries Inc / Public Storage / DCP Midstream LP / Seacoast Banking Corporation of Florida / Aptinyx Inc / Extra Space Storage Inc / Beacon Roofing Supply Inc / Sunstone Hotel Investors Inc / GMS Inc / Host Hotels & Resorts Inc / Armstrong World Industries Inc / Owens Corning / Wyndham Hotels & Resorts Inc / IAC/Interactivecorp / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / CubeSmart / Ryman Hospitality Properties Inc / Interface Inc / Norwegian Cruise Line Holdings Ltd / National Storage Affiliates Trust / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Ferguson PLC / Ovintiv Inc / Arcutis Biotherapeutics Inc / Forte Biosciences Inc / Bally's Corp / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Israel / Liberia / Netherlands / Panama / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/25/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">ESG Stratify™: Is Pharma at a positive ESG inflection point?</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">JNJ.N / MRK.N / PFE.N / GILD.O / AMGN.O / 0989529 / TEVA.N / ABBV.N / PRGO.N</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / AstraZeneca PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Randall S. Stanicky, CFA / Sara Mahaffy / Mr. Daniel J. Busby / Steve Daddeo / James Hong</td></tr>
<tr class="even"><td class="leftalignment">03/25/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">JMP Planner: 2021 AACR Annual Virtual Meeting – April Edition</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">PGEN / 45337C10 / 03116210 / 84763A108 / M25722105 / 60468T105 / 09627Y109 / 462260100 / 019770106 / H17182108 / 90041T108 / 87184Q107 / 65343E108 / 22978P106 / 24344T101 / 75943R102 / 43906K100 / 81181C104</td><td class="leftalignment">Precigen Inc / Incyte Corp / Amgen Inc / Spectrum Pharmaceuticals Inc / Compugen Ltd / Mirati Therapeutics Inc / Blueprint Medicines Corp / Iovance Biotherapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Turning Point Therapeutics Inc / Syros Pharmaceuticals Inc / NextCure Inc / Cue Biopharma Inc / Deciphera Pharmaceuticals Inc / Relay Therapeutics Inc / HOOKIPA Pharma Inc / Seagen Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Reni J. J. Benjamin, PhD, PHD / Mr. Jason N. N. Butler, PhD, PHD / Mr. Silvan Tuerkcan / Mr. Roy Buchanan, PhD, PHD</td></tr>
<tr class="odd"><td class="leftalignment">03/24/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Latest ASP data provides some insight into biosimilar price trends</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">03/24/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology: Latest Short Interest for US Biotech: Large Cap Modestly Higher / STSA With Greatest Sequential Change Among SMid Cap</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AMGN.OQ / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / ACRX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / AcelRx Pharmaceuticals Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">03/23/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / HD=US / MCD=US / OXY=US / RRC=US / WEN=US / T=US / BLD=US / DVN=US / TEVA=US / CMA=US / PEB=US / APA=US / CPE=US / EOG=US / REI=US / CHTR=US / H=US / MTN=US / VZ=US / XOM=US / CRK=US / LOW=US / WLL=US / PXD=US / PB=US / MGY=US / SWN=US / MUR=US / CHRS=US / MAR=US / UMPQ=US / MRO=US / LEG=US / TNL=US / HLT=US / HUM=US / CMCSA=US / DISH=US / WTFC=US / CBRL=US / ELY=US / CHH=US / CNX=US / CW=US / DRI=US / DRH=US / EQT=US / GFF=US / IBP=US / MAS=US / MRCY=US / MHK=US / REGI=US / GOLF=US / HTH=US / CVX=US / SIVB=US / ABCB=US / FBK=US / NHI=US / COP=US / DIN=US / BCO=US / TCBI=US / TPX=US / EXP=US / FHN=US / BECN=US / SHO=US / PLAY=US / DENN=US / BLDR=US / GMS=US / NSP=US / CMG=US / REX=US / HST=US / PGTI=US / GPRE=US / EHTH=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / CLR=US / PRPL=US / LUMN=US / NMTR=US / WH=US / NOG=US / JACK=US / UTZ=US / TREX=US / AR=US / HGV=US / SBRA=US / PCRX=US / RLJ=US / ESTE=US / VAC=US / FBHS=US / BCEI=US / MTDR=US / PDCE=US / RHP=US / FANG=US / TILE=US / TMUS=US / NDLS=US / 00770K202 / VNOM=US / LOCO=US / SHAK=US / WING=US / SPNE=US / CABO=US / WVE=US / WLTW=US / 82982L103 / CDEV=US / IRTC=US / PK=US / PVAC=US / JELD=US / PLYA=US / SBOW=US / MBIN=US / BTAI=US / RTLR=US / FERG=US / GOCO=US / OVV=US / AZEK=US / 96758W101 / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / McDonald's Corp / Occidental Petroleum Corp / Range Resources Corp / Wendys Co / AT&T Inc / TopBuild Corp / Devon Energy Corp / Teva Pharmaceutical Industries Ltd / Comerica Inc / Pebblebrook Hotel Trust / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Charter Communications Inc / Hyatt Hotels Corp / Vail Resorts Inc / Verizon Communications Inc / Exxon Mobil Corp / Comstock Resources Inc / Lowe's Companies Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Prosperity Bancshares Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / Coherus BioSciences Inc / Marriott International Inc / Umpqua Holdings Corp / Marathon Oil Corp / Leggett & Platt Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Humana Inc / Comcast Corp / DISH Network Corp / Wintrust Financial Corp / Cracker Barrel Old Country Store Inc / Callaway Golf Co / Choice Hotels International Inc / CNX Resources Corp / Curtiss-Wright Corp / Darden Restaurants Inc / Diamondrock Hospitality Co / EQT Corp / Griffon Corp / Installed Building Products Inc / Masco Corp / Mercury Systems Inc / Mohawk Industries Inc / Renewable Energy Group Inc / Acushnet Holdings Corp / Hilltop Holdings Inc / Chevron Corp / SVB Financial Group / Ameris Bancorp / FB Financial Corp / National Health Investors Inc / Conocophillips / Dine Brands Global Inc / Brinks Co / Texas Capital Bancshares Inc / Tempur Sealy International Inc / Eagle Materials Inc / First Horizon Corp / Beacon Roofing Supply Inc / Sunstone Hotel Investors Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Insperity Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Host Hotels & Resorts Inc / PGT Innovations Inc / Green Plains Inc / eHealth Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / Purple Innovation Inc / Lumen Technologies Inc / 9 Meters Biopharma Inc / Wyndham Hotels & Resorts Inc / Northern Oil and Gas Inc / Jack in the Box Inc / UTZ Brands Inc / Trex Company Inc / Antero Resources Corp / Hilton Grand Vacations Inc / Sabra Health Care REIT Inc / Pacira Biosciences Inc / RLJ Lodging Trust / Earthstone Energy Inc / Marriott Vacations Worldwide Corp / Fortune Brands Home & Security Inc / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Ryman Hospitality Properties Inc / Diamondback Energy Inc / Interface Inc / T-Mobile US Inc / Noodles & Co / Aemetis Inc / Viper Energy Partners LP / El Pollo Loco Holdings Inc / Shake Shack Inc / Wingstop Inc / SeaSpine Holdings Corp / Cable One Inc / WAVE Life Sciences Ltd / Willis Towers Watson PLC / SiteOne Landscape Supply Inc / Centennial Resource Development Inc / iRhythm Technologies Inc / Park Hotels & Resorts Inc / Ranger Oil Corp / JELD-WEN Holding Inc / Playa Hotels & Resorts NV / SilverBow Resources Inc / Merchants Bancorp / BioXcel Therapeutics Inc / Rattler Midstream LP / Ferguson PLC / Gohealth Inc / Ovintiv Inc / Azek Company Inc / WideOpenWest Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Ireland / Israel / Netherlands / Singapore / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/23/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">With an End in Sight, Variants and Eagerness to Open Set Up for U.S. Spring Wave as Race to Ramp Up Vaccinations Continues</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / China / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">03/23/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AXP / V / 5671735 / 0989529 / 2126335 / 2516152 / 2023607 / 2026242 / 2317087 / 2670519 / 2100920 / 2455965 / 2680905 / 2684703 / 2707677 / 2440637 / 2573083 / 2138158 / 7103065 / B7VD3F2 / BVVN4Q8 / BYVY8G0 / BK7Y2V9 / B0SDJB4 / BJFSR88 / BKVDFF7 / BJJMGL2 / BZ8VJQ8 / BKTNTR9 / BZ1LFG7 / BMG75B4</td><td class="leftalignment">American Express Co / Visa Inc / Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / American Electric Power Company Inc / Entergy Corp / Exelon Corp / FirstEnergy Corp / Biogen Inc / PPL Corp / Pfizer Inc / Public Service Enterprise Group Inc / CenterPoint Energy Inc / Sangamo Therapeutics Inc / Sempra Energy / Novartis AG / Duke Energy Corp / Eversource Energy / Alphabet Inc / Akero Therapeutics Inc / Zealand Pharma A/S / Uniqure NV / Oric Pharmaceuticals Inc / Fox Corp / Vistra Corp / ViacomCBS Inc / Roku Inc / Inventiva SA</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">03/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">BGNE: BeiGene - 2021 AIC Live takeaways</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BGNE.OQ / NOVN.S / AMGN.OQ</td><td class="leftalignment">Beigene Ltd / Novartis AG / Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang</td></tr>
<tr class="odd"><td class="leftalignment">03/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For the Week Ended Mar 12, 2021: Focus on 1Q21 trends for EU Majors</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / RB.L / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / Reckitt Benckiser Group PLC / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Mar 12, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Guggenheim Ther Research</td></tr>
<tr class="odd"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">03/22/2021</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Amgen Inc (AMGN) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">443</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="odd"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Mar 22 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US0116591092 / US0126531013 / US0311621009 / US0463531089 / US1101221083 / US1264081035 / US22284P1057 / US3021301094 / US37733W1053 / US4433201062 / US4456581077 / US4581401001 / US4781601046 / US5150981018 / US5324571083 / US6558441084 / US66987V1098 / US6701002056 / US6795801009 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US9029251066 / US9078181081 / US9507551086 / CA1363751027 / CA13645T1003 / AU000000LYC6 / US4771431016 / US4198791018 / US80105N1054 / US3463751087 / US12541W2098 / US78709Y1055 / PAP310761054 / US75025X1000 / US01748X1028 / US2473617023 / US45784P1012 / US58933Y1055 / US9100471096 / US92335C1062 / US9837931008 / US00287Y1091 / NL0010273215 / US98978V1035 / US8485771021 / US21240E1055 / US02376R1023 / US03937C1053 / CA0089118776 / US00653A1079 / CA87241L1094 / US23753F1075 / US80689H1023 / US04016X1019 / US4990491049 / CA53680Q2071 / US02083G1004 / US09354A1007 / US5904791358 / US28414H1032 / US0197701065 / US53814L1089 / US07373B1098 / US5533681012 / US74767V1098 / US7761531083 / US15961R1059</td><td class="leftalignment">Alaska Air Group Inc / Albemarle Corp / Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / CSX Corp / Covenant Logistics Group Inc / Expeditors International of Washington Inc / GlaxoSmithKline PLC / Hub Group Inc / J B Hunt Transport Services Inc / Intel Corp / Johnson & Johnson / Landstar System Inc / Eli Lilly and Co / Norfolk Southern Corp / Novartis AG / Novo Nordisk A/S / Old Dominion Freight Line Inc / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / USA Truck Inc / Union Pacific Corp / Werner Enterprises Inc / Canadian National Railway Co / Canadian Pacific Railway Ltd / Lynas Rare Earths Ltd / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / FormFactor Inc / CH Robinson Worldwide Inc / Saia Inc / Copa Holdings SA / Radiant Logistics Inc / Allegiant Travel Co / Delta Air Lines Inc / Insulet Corp / Merck & Co Inc / United Airlines Holdings Inc / Vera Bradley Inc / XPO Logistics Inc / Abbvie Inc / ASML Holding NV / Zoetis Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / ArcBest Corp / Air Canada / Adaptimmune Therapeutics PLC / TFI International Inc / Daseke Inc / Schneider National Inc / argenx SE / Knight-Swift Transportation Holdings Inc / Lithium Americas Corp / Alpine Immune Sciences Inc / Blink Charging Co / Mesa Air Group Inc / Elanco Animal Health Inc / Allogene Therapeutics Inc / Livent Corp / Beam Global / Mp Materials Corp / Quantumscape Corp / Romeo Power Inc / ChargePoint Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / Denmark / France / United Kingdom / Mexico / Netherlands / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Investor's Guide To Immuno-Oncology: Focus On Novel Targets-Ahead Of The Curve</td><td class="leftalignment">English</td><td class="rightalignment">367</td><td class="leftalignment">US0311621009 / US00287Y1091 / US00653A1079 / US04016X1019 / US02083G1004 / US0197701065</td><td class="leftalignment">Amgen Inc / Abbvie Inc / Adaptimmune Therapeutics PLC / argenx SE / Alpine Immune Sciences Inc / Allogene Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / China / Denmark / United Kingdom / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Boris Peaker, Ph.D., CFA, Ph.D. / Mr. Marc A. Frahm, Ph.D., PHD / Mr. Phil M. Nadeau, Ph.D., PHD / Steve M. Scala, R.Ph., CFA, CFA / Mr. Joseph Thome / Yaron Werber, M.D., MD</td></tr>
<tr class="odd"><td class="leftalignment">03/21/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Catalyst Tracker 3.21.21: Highlights Top Catalysts</td><td class="leftalignment">English</td><td class="rightalignment">55</td><td class="leftalignment">MRK=US / ABT=US / AMGN=US / INSP=US / GILD=US / SAN=FR / ATRC=US / BLUE=US / CSTL=US / ILMN=US / TFX=US / PRVB=US / CGEN=US / BIIB=US / ACRS=US / ACAD=US / QTRX=US / FOLD=US / PODD=US / RCUS=US / SRPT=US / MRTX=US / MGNX=US / QURE=US / AFMD=US / NVRO=US / ZBH=US / LNTH=US / WVE=US / MRUS=US / RETA=US / BHVN=US / REPL=US / HARP=US / ETNB=US / KROS=US / FMTX=US / ITOS=US / CGEM=US</td><td class="leftalignment">Merck & Co Inc / Abbott Laboratories / Amgen Inc / Inspire Medical Systems Inc / Gilead Sciences Inc / Sanofi SA / AtriCure Inc / bluebird bio Inc / Castle Biosciences Inc / Illumina Inc / Teleflex Inc / Provention Bio Inc / Compugen Ltd / Biogen Inc / Aclaris Therapeutics Inc / ACADIA Pharmaceuticals Inc / Quanterix Corp / Amicus Therapeutics Inc / Insulet Corp / Arcus Biosciences Inc / Sarepta Therapeutics Inc / Mirati Therapeutics Inc / MacroGenics Inc / Uniqure NV / Affimed NV / Nevro Corp / Zimmer Biomet Holdings Inc / Lantheus Holdings Inc / WAVE Life Sciences Ltd / Merus NV / Reata Pharmaceuticals Inc / Biohaven Pharmaceutical Holding Company Ltd / Replimune Group Inc / Harpoon Therapeutics Inc / 89Bio Inc / Keros Therapeutics Inc / Forma Therapeutics Holdings Inc / Iteos Therapeutics Inc / Cullinan Oncology Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / Israel / Netherlands / Singapore / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/19/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 539</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">03/19/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Q4 2020: Amgen EPS falls 19%</td><td class="leftalignment">English</td><td class="rightalignment">72</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">03/19/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Mar 19 2021</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">BNGO=US / NBSE=US / MRK=US / CSII=US / PFE=US / ABT=US / AMGN=US / BMY=US / MDT=US / WMT=US / EPIX=US / CMS=US / DGX=US / SYK=US / IART=US / BAX=US / GSK=US / CRY=US / RAD=US / JNJ=US / MMSI=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / ANGN=US / APLS=US / ATRC=US / CHE=US / CYH=US / COO=US / DRRX=US / EW=US / EXEL=US / GEN=US / ICPT=US / LH=US / LIFE=US / NBIX=US / USPH=US / UTHR=US / UHS=US / VRTX=US / OPT=US / PRVB=US / CGEN=US / CCRN=US / CNC=US / ACA=US / ENSG=US / ALPN=US / MIST=US / MD=US / SLF=US / ISR=US / SLP=US / MRNA=US / ACAD=US / MBRX=US / MNKD=US / GOOG=US / INO=US / LHCG=US / AGRX=US / CBAY=US / CHNG=US / INFI=US / TPTX=US / ORTX=US / PODD=US / EHC=US / NMTR=US / TNDM=US / SWAV=US / ASND=US / ADUS=US / ALPMY=US / ACHC=US / PRTA=US / ENTA=US / AGIO=US / FATE=US / AERI=US / TRVN=US / FLXN=US / MDWD=US / CTRE=US / ALDX=US / VBIV=US / XENT=US / AUPH=US / OTIC=US / VCEL=US / WBA=US / SNPHY=US / RLMD=US / EVH=US / GKOS=US / CFMS=US / CATB=US / IONS=US / VRAY=US / TCMD=US / AVDL=US / SRRA=US / SVRA=US / SLNO=US / URGN=US / VREX=US / IOVA=US / MTEM=US / VERU=US / KALA=US / MBIO=US / MDNA=US / MOTS=US / VCNX=US / CUE=US / MRKR=US / ORGO=US / PDSB=US / IDYA=US / BCYC=US / KRTX=US / XAIR=US / DMTK=US / ETNB=US / VERO=US / PNTG=US / AYLA=US / FMTX=US / NNOX=US / KDNY=US / VRDN=US / EVAX=US / SOBE=US</td><td class="leftalignment">Bionano Genomics Inc / NeuBase Therapeutics Inc / Merck & Co Inc / Cardiovascular Systems Inc / Pfizer Inc / Abbott Laboratories / Amgen Inc / Bristol-Myers Squibb Co / Medtronic PLC / Walmart Inc / ESSA Pharma Inc / CMS Energy Corp / Quest Diagnostics Inc / Stryker Corp / Integra Lifesciences Holdings Corp / Baxter International Inc / GlaxoSmithKline PLC / CryoLife Inc / Rite Aid Corp / Johnson & Johnson / Merit Medical Systems Inc / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / Angion Biomedica Corp / Apellis Pharmaceuticals Inc / AtriCure Inc / Chemed Corp / Community Health Systems Inc / Cooper Companies Inc / DURECT Corp / Edwards Lifesciences Corp / Exelixis Inc / Genesis Healthcare Inc / Intercept Pharmaceuticals Inc / Laboratory Corporation of America Holdings / aTyr Pharma Inc / Neurocrine Biosciences Inc / US Physical Therapy Inc / United Therapeutics Corp / Universal Health Services Inc / Vertex Pharmaceuticals Inc / Opthea Ltd / Provention Bio Inc / Compugen Ltd / Cross Country Healthcare Inc / Centene Corp / Arcosa Inc / Ensign Group Inc / Alpine Immune Sciences Inc / Milestone Pharmaceuticals Inc / MEDNAX Inc / Sun Life Financial Inc / IsoRay Inc / Simulations Plus Inc / Moderna Inc / ACADIA Pharmaceuticals Inc / Moleculin Biotech Inc / MannKind Corp / Alphabet Inc / Inovio Pharmaceuticals Inc / LHC Group Inc / Agile Therapeutics Inc / Cymabay Therapeutics Inc / Change Healthcare Inc / Infinity Pharmaceuticals Inc / Turning Point Therapeutics Inc / Orchard Therapeutics PLC / Insulet Corp / Encompass Health Corp / 9 Meters Biopharma Inc / Tandem Diabetes Care Inc / Shockwave Medical Inc / Ascendis Pharma A/S / Addus Homecare Corp / Astellas Pharma Inc / Acadia Healthcare Company Inc / Prothena Corporation PLC / Enanta Pharmaceuticals Inc / Agios Pharmaceuticals Inc / Fate Therapeutics Inc / Aerie Pharmaceuticals Inc / Trevena Inc / Pacira Biosciences Inc / Mediwound Ltd / CareTrust REIT Inc / Aldeyra Therapeutics Inc / VBI Vaccines Inc / Intersect Ent Inc / Aurinia Pharmaceuticals Inc / Otonomy Inc / Vericel Corp / Walgreens Boots Alliance Inc / Santen Pharmaceutical Co Ltd / Relmada Therapeutics Inc / Evolent Health Inc / Glaukos Corp / Conformis Inc / Astria Therapeutics Inc / Ionis Pharmaceuticals Inc / ViewRay Inc / Tactile Systems Technology Inc / Avadel Pharmaceuticals PLC / Sierra Oncology Inc / Savara Inc / Soleno Therapeutics Inc / Urogen Pharma Ltd / Varex Imaging Corp / Iovance Biotherapeutics Inc / Molecular Templates Inc / Veru Inc / Kala Pharmaceuticals Inc / Mustang Bio Inc / Medicenna Therapeutics Corp / Motus GI Holdings Inc / Vaccinex Inc / Cue Biopharma Inc / Marker Therapeutics Inc / Organogenesis Holdings Inc / PDS Biotechnology Corp / IDEAYA Biosciences Inc / Bicycle Therapeutics PLC / Karuna Therapeutics Inc / Beyond Air Inc / DermTech Inc / 89Bio Inc / Venus Concept Inc / Pennant Group Inc / Ayala Pharmaceuticals Inc / Forma Therapeutics Holdings Inc / Nano-X Imaging Ltd / Chinook Therapeutics Inc / Viridian Therapeutics Inc / Evaxion Biotech A/S / AT&T Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Denmark / United Kingdom / Ireland / Israel / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="odd"><td class="leftalignment">03/19/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="even"><td class="leftalignment">03/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / David Szeto</td></tr>
<tr class="odd"><td class="leftalignment">03/19/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended March 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">BIIB.OQ / INCY.OQ / LLY.N / MRK.N / AZN.L / SASY.PA / AMGN.OQ / REGN.OQ / ALKS.OQ / STSA.OQ / GILD.OQ / NBIX.OQ / VRTX.OQ / GLPG.AS / TEVA.N / MRNA.OQ / ACRX.OQ / ABBV.N / MRTX.OQ / MGNX.OQ / SAGE.OQ / ZBH.N / GRTX.OQ</td><td class="leftalignment">Biogen Inc / Incyte Corp / Eli Lilly and Co / Merck & Co Inc / AstraZeneca PLC / Sanofi SA / Amgen Inc / Regeneron Pharmaceuticals Inc / Alkermes Plc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Moderna Inc / AcelRx Pharmaceuticals Inc / Abbvie Inc / Mirati Therapeutics Inc / MacroGenics Inc / SAGE Therapeutics Inc / Zimmer Biomet Holdings Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">03/18/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">The Case For Continued Value Recovery; Raising PT</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">03168L105 / 031162100 / 881624209</td><td class="leftalignment">Amneal Pharmaceuticals Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">David A. Amsellem / Zachary Sachar / Isaac C. Somekh</td></tr>
<tr class="even"><td class="leftalignment">03/18/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">You’re Going the Wrong Way! Outflows Continue</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / 039697107 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / 19240Q201</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Ardelyx Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / Cogent Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">03/16/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">IDRA-US - Fundamental Analysis, for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">IDRA.O / ABT / JNJ / MRK / PFE / AMGN.O / AGEN.O / LGND.O / BIIB.O / DVAX.O / CLDX.O</td><td class="leftalignment">Idera Pharmaceuticals Inc / Abbott Laboratories / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Amgen Inc / Agenus Inc / Ligand Pharmaceuticals Inc / Biogen Inc / Dynavax Technologies Corp / Celldex Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Takeaways from Targeted Protein Degradation Day - Fireside Chat with Jay Bradner, Head of Novartis Institutes for Biomedical Research (NIBR)</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">NOVN.S / 2023607 / 7103065 / BBPK0J0 / BL71K91</td><td class="leftalignment">Novartis AG / Amgen Inc / Novartis AG / Mirati Therapeutics Inc / Revolution Medicines Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Seamus Fernandez / Mr. Charles Zhu, Ph.D., III / Mr. Evan B. Wang / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">AMGN.OQ - Event Transcript of Amgen Inc conference call, Mar. 16, 2021 / 1:30PM ET</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Amgen Inc.(AMGN) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">031162100</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/16/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">AACR 2021 Virtual Meeting Planner</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">PFE=US / AMGN=US / INCY=US / GILD=US / SAN=FR / AZN=US / GSK=US / JNJ=US / IMGN=US / EXAS=US / ILMN=US / HOOK=US / REGN=US / NTRA=US / TPTX=US / BOLT=US / NEO=US / RCUS=US / VSTM=US / ABBV=US / MRTX=US / FATE=US / MGNX=US / KPTI=US / XNCR=US / AFMD=US / BPMC=US / BGNE=US / MRUS=US / MRSN=US / GH=US / BHC=US / REPL=US / RUBY=US / SBTX=US / TWST=US / HARP=US / TCRR=US / BNTX=US / GMAB=US / RVMD=US / ZNTL=US / ITOS=US / MOLN=DE</td><td class="leftalignment">Pfizer Inc / Amgen Inc / Incyte Corp / Gilead Sciences Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / ImmunoGen Inc / Exact Sciences Corp / Illumina Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Natera Inc / Turning Point Therapeutics Inc / Bolt Biotherapeutics Inc / Neogenomics Inc / Arcus Biosciences Inc / Verastem Inc / Abbvie Inc / Mirati Therapeutics Inc / Fate Therapeutics Inc / MacroGenics Inc / Karyopharm Therapeutics Inc / Xencor Inc / Affimed NV / Blueprint Medicines Corp / Beigene Ltd / Merus NV / Mersana Therapeutics Inc / Guardant Health Inc / Bausch Health Companies Inc / Replimune Group Inc / Rubius Therapeutics Inc / Silverback Therapeutics Inc / Twist Bioscience Corp / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / BioNTech SE / Genmab A/S / Revolution Medicines Inc / Zentalis Pharmaceuticals Inc / Iteos Therapeutics Inc / Molecular Partners AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Daina Graybosch, PHD / Mr. Geoffrey Porges / Dr. Andrew S. Berens, MD / Mr. Jonathan W. Chang, PHD / Mr. Puneet Souda</td></tr>
<tr class="even"><td class="leftalignment">03/16/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Domestic Improvements Continue, Though Signs of Deceleration as Variants Spread; IHME Warns of Easing Restrictions Too Early</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / HD=US / MCD=US / WEN=US / T=US / BLD=US / TEVA=US / GILD=US / AMT=US / VZ=US / LOW=US / PB=US / CHRS=US / LEG=US / DISH=US / BNL=US / CBRL=US / DRI=US / GFF=US / IBP=US / MAS=US / MHK=US / REGN=US / REGI=US / SBAC=US / STOR=US / ABCB=US / ADC=US / BOKF=US / FFIN=US / DIN=US / BIIB=US / TPX=US / EXP=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / AWI=US / OC=US / AMRX=US / CADE=US / TAST=US / QSR=US / PRPL=US / EPRT=US / JACK=US / TREX=US / CUBE=US / FBHS=US / TILE=US / TMUS=US / NDLS=US / CNCE=US / LOCO=US / HQY=US / SHAK=US / RLMD=US / WING=US / ZG=US / 82982L103 / ANAB=US / JELD=US / RDFN=US / BTAI=US / OPCH=US / AZEK=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / McDonald's Corp / Wendys Co / AT&T Inc / TopBuild Corp / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / American Tower Corp / Verizon Communications Inc / Lowe's Companies Inc / Prosperity Bancshares Inc / Coherus BioSciences Inc / Leggett & Platt Inc / DISH Network Corp / Bunzl plc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Regeneron Pharmaceuticals Inc / Renewable Energy Group Inc / SBA Communications Corp / STORE Capital Corp / Ameris Bancorp / Agree Realty Corp / BOK Financial Corp / First Financial Bankshares Inc / Dine Brands Global Inc / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Cadence Bank / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Essential Properties Realty Trust Inc / Jack in the Box Inc / Trex Company Inc / CubeSmart / Fortune Brands Home & Security Inc / Interface Inc / T-Mobile US Inc / Noodles & Co / Concert Pharmaceuticals Inc / El Pollo Loco Holdings Inc / Healthequity Inc / Shake Shack Inc / Relmada Therapeutics Inc / Wingstop Inc / Zillow Group Inc / SiteOne Landscape Supply Inc / AnaptysBio Inc / JELD-WEN Holding Inc / Redfin Corp / BioXcel Therapeutics Inc / Option Care Health Inc / Azek Company Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Mar 05, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Guggenheim Ther Research</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US0311621009 / US75886F1075 / US7665596034 / US09062X1037</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc / Rigel Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">Taiwan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Deep Dive: Highlighting the Knee Pain OA Market Ahead of TLC599 Phase 3 Results in 2H21E</td><td class="leftalignment">English</td><td class="rightalignment">57</td><td class="leftalignment">PFE / US0311621009 / US75886F1075</td><td class="leftalignment">Pfizer Inc / Amgen Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Taiwan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Kristen Kluska</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for AMGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">SVRA=US / TRVN=US / MRK=US / BSX=US / CSII=US / FDX=US / ABT=US / AMGN=US / BMY=US / CAT=US / WM=US / BWA=US / MDT=US / QCOM=US / T=US / DT=US / INCY=US / RUN=US / CG=US / BAC=US / GILD=US / FRC=US / MPWR=US / JPM=US / FCEL=US / PLUG=US / NVS=US / TROW=US / CRY=US / JCI=US / JNJ=US / DE=US / RSG=US / ALB=US / AMSC=US / ARNA=US / ARRY=US / ATRC=US / AVNT=US / CMI=US / CREE=US / DRI=US / DRRX=US / EW=US / INSM=US / ITRI=US / MS=US / ROK=US / TER=US / TRMB=US / RHHBY=US / SIVB=US / NEP=US / SWKS=US / ICAD=US / BE=US / CLH=US / WCN=US / BIIB=US / ISR=US / ENS=US / GOOG=US / TWIN=US / ORA=US / AMRS=US / PDD=US / SPWR=US / CSIQ=US / FSLR=US / ARAY=US / BX=US / DAN=US / WPRT=US / SWAV=US / AGCO=US / CPIX=US / TSLA=US / DANA=US / AMRC=US / PCRX=US / ENPH=US / SPLK=US / HASI=US / CNHI=US / HRTX=US / BABA=US / EKTAY=US / NEWR=US / SEDG=US / LIVN=US / AQMS=US / CERC=US / VRAY=US / WKHS=US / IRTC=US / VERU=US / ATXI=US / APTV=US / VOW3-DE=US / CWEN=US / ESTC=US / DDOG=US / BXRX=US / TARA=US / SUMO=US / VLDR=US / SHLS=US / CHPT=US / GOEV=US</td><td class="leftalignment">Savara Inc / Trevena Inc / Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / FedEx Corp / Abbott Laboratories / Amgen Inc / Bristol-Myers Squibb Co / Caterpillar Inc / Waste Management Inc / Borgwarner Inc / Medtronic PLC / Qualcomm Inc / AT&T Inc / Dynatrace Inc / Incyte Corp / Sunrun Inc / Carlyle Group Inc / Bank of America Corp / Gilead Sciences Inc / First Republic Bank / Monolithic Power Systems Inc / JPMorgan Chase & Co / Fuelcell Energy Inc / Plug Power Inc / Novartis AG / T Rowe Price Group Inc / CryoLife Inc / Johnson Controls International PLC / Johnson & Johnson / Deere & Co / Republic Services Inc / Albemarle Corp / American Superconductor Corp / Arena Pharmaceuticals Inc / Array Technologies Inc / AtriCure Inc / Avient Corp / Cummins Inc / Wolfspeed Inc / Darden Restaurants Inc / DURECT Corp / Edwards Lifesciences Corp / Insmed Inc / Itron Inc / Morgan Stanley / Rockwell Automation Inc / Teradyne Inc / Trimble Inc / Roche Holding AG / SVB Financial Group / Nextera Energy Partners LP / Skyworks Solutions Inc / ICAD Inc / Bloom Energy Corp / Clean Harbors Inc / Waste Connections Inc / Biogen Inc / IsoRay Inc / EnerSys / Alphabet Inc / Twin Disc Inc / Ormat Technologies Inc / Amyris Inc / Pinduoduo Inc / SunPower Corp / Canadian Solar Inc / First Solar Inc / Accuray Inc / Blackstone Inc / Dana Inc / Westport Fuel Systems Inc / Shockwave Medical Inc / AGCO Corp / Cumberland Pharmaceuticals Inc / Tesla Inc / Dana Gas PJSC / Ameresco Inc / Pacira Biosciences Inc / Enphase Energy Inc / Splunk Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / CNH Industrial NV / Heron Therapeutics Inc / Alibaba Group Holding Ltd / Elekta AB (publ) / New Relic Inc / Solaredge Technologies Inc / LivaNova PLC / Aqua Metals Inc / Avalo Therapeutics Inc / ViewRay Inc / Workhorse Group Inc / iRhythm Technologies Inc / Veru Inc / Avenue Therapeutics Inc / Aptiv PLC / Volkswagen AG / Clearway Energy Inc / Elastic NV / Datadog Inc / Baudax Bio Inc / Protara Therapeutics Inc / Sumo Logic Inc / Velodyne Lidar Inc / Shoals Technologies Group Inc / ChargePoint Holdings Inc / Canoo Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Arab Emirates / Canada / Switzerland / Cayman Islands / United Kingdom / Ireland / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment">Biotechnology / Electrical / Financial Services / Healthcare / Info. Tech./Software / Lodging & Restaurants / Pharmaceuticals / Retailing / Semiconductors / Telecommunications</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Covering When You Cough...New Drugs/Trials in Asthma & COPD - Good for REGN/SNY</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">AMGN=US / REGN=US / SAN=FR / AZN=US / SNY=US / AMGN.OQ</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc / Sanofi SA / AstraZeneca PLC / Sanofi SA / Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">2516152 / 2000019 / 2023607 / 2008154 / 2050832 / 2026242 / 2175672 / 2270726 / 2542049 / 2317087 / 2328915 / 2100920 / 2455965 / 2613990 / 2459020 / 2645409 / 2048804 / 2707677 / 2795393 / 2857817 / B2R3PV1 / B7TL820 / B85KFY9 / B7JYSG3 / BBPK0J0 / B95N910 / BFH3N85 / BYW36M8 / BFM2GV1 / BQT3XY6 / BFZ1K46 / BZ8VJQ8 / BKTNTR9 / BJVR9Y9 / BZ1LFG7 / BL71K91 / BGKG6M3 / BFY7DC4 / 021513106 / BNRQM83</td><td class="leftalignment">Eli Lilly and Co / Amazon.com Inc / Amgen Inc / Adobe Inc / Ameren Corp / American Electric Power Company Inc / Cardinal Health Inc / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Nextera Energy Inc / FirstEnergy Corp / Biogen Inc / Illumina Inc / Intuit Inc / NiSource Inc / Pinnacle West Capital Corp / Public Service Enterprise Group Inc / Amerisourcebergen Corp / Netflix Inc / American Water Works Company Inc / Meta Platforms Inc / Five Below Inc / Guidewire Software Inc / Mirati Therapeutics Inc / PTC Inc / Veeva Systems Inc / PayPal Holdings Inc / GreenSky Inc / Cyberark Software Ltd / Spotify Technology SA / Vistra Corp / ViacomCBS Inc / iHeartMedia Inc / Roku Inc / Revolution Medicines Inc / StoneCo Ltd / Altimmune Inc / Alto Ingredients Inc / Petco Health and Wellness Company Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Israel / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - March 15, 2021</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">ABF.L / AEP.N / ALV.N / AU.N / CAS.TO / CI.N / CL.N / CMS.N / EDP.LS / EIX.N / EL.N / F.N / FGP.L / GM.N / GOG.L / HMb.ST / IBE.MC / IP.N / JD.L / KBH.N / KMB.N / KO.N / MKS.L / MRK.N / NCM.AX / NEM.N / NXT.L / PD.N / PFE.N / PHM.N / RSG.AX / RYN.N / SO.N / T.N / TOL.N / VC.N / PEP.N / BFb.N / PG.N / WY.N / CFP.TO / GILD.O / FNV.N / CPB.N / LPX.N / TEN.N / CMCSA.O / AMGN.O / INCY.O / DUK.N / AGI.N / BWA.N / LEA.N / PNM.N / K.N / DT.N / DISH.O / LEN.N / CLX.N / CAG.N / GIS.N / AEM.N / EPC.N / SBM.AX / AMT.N / KGC.N / NKE.N / JAZZ.O / CONE.O / VZ.N / EXEL.O / DHI.N / STZ.N / APH.N / FISV.O / ADSK.O / V.N / AXL.N / AWK.N / CHD.N / NWN.N / BC.N / SAM.N / ITX.MC / BMRN.O / OPTN.O / REGN.O / ENR.N / JHX.AX / CEY.L / NCR.N / NET.N / TEL.N / GFI.N / ASC.L / CNP.N / ENDP.O / CPK.N / PII.N / ST.N / SEM.N / SGEN.OQ / GPN.N / MNST.O / RGLD.O / BLUE.O / CASY.O / EQIX.O / ATDb.TO / BIIB.O / GOLD.N / RMS.AX / NST.AX / 02209S103 / CWX.TO / RRL.AX / DLR.N / IAG.N / 427866108 / WEF.TO / FIS.N / ARWR.O / TEVA.N / MA.N / HOG.N / MERC.O / AUY.N / ATL.MI / BGS.N / HOCM.L / SLR.AX / ENSG.O / DAN.N / NOG.A / FRES.L / NGD.A / CLW.N / OGC.TO / ADUS.OQ / EGO.N / ADN.TO / SPB.N / NEE.N / GOR.AX / PCH.O / CFX.TO / PCRX.O / CTT.N / MTOR.N / IFP.TO / POLYP.L / EVN.AX / SPLK.OQ / RFP.N / BOSSn.DE / PANW.N / MDLZ.OQ / ABBV.N / KPT.TO / TPH.N / TSLA.N / PRGO.N / PRMW.N / TMUS.N / TMHC.N / COTY.N / PRTA.O / 81762P102 / CFF.TO / LB.N / KPTI.O / XNCR.OQ / VRNS.O / BOOH.L / BTG.N / AGRX.O / RYAM.N / ZALG.DE / 03835T200 / SHOP.N / WRK.N / SGRY.O / RACE.MI / TWLO.N / OR.N / ADNT.N / CRSP.OQ / GDS.O / SAND.N / AQN.N / OKTA.OQ / VST.N / WPM.N / KL.N / ATNX.O / SAIL.N / APTV.N / EHC.N / SDRY.L / ZS.OQ / AMRX.N / ITRM.O / VNE.N / NTGY.MC / KDP.N / XERS.O / AQST.O / FOCS.O / ESTC.N / GMDA.OQ / OSMT.O / NWL.O / OPI.OQ / CRWD.O / GMAB.O / PING.N / APRE.OQ / CRNC.OQ / IGMS.O / FRAS.L / REYN.O / SBSW.N / IGIC.OQ / NKLA.OQ / FOUR.N / GOCO.O / ALOO.O / MAX.N / WFG.N / AG1G.DE / 120291281 / 120681711</td><td class="leftalignment">Associated British Foods PLC / American Electric Power Company Inc / Autoliv Inc / AngloGold Ashanti Ltd / Cascades Inc / Cigna Corp / Colgate-Palmolive Co / CMS Energy Corp / EDP Energias de Portugal SA / Edison International / Estee Lauder Companies Inc / Ford Motor Co / FirstGroup PLC / General Motors Co / Go-Ahead Group PLC / H & M Hennes & Mauritz AB / Iberdrola SA / International Paper Co / JD Sports Fashion PLC / KB Home / Kimberly-Clark Corp / Coca-Cola Co / Marks and Spencer Group PLC / Merck & Co Inc / Newcrest Mining Ltd / Newmont Corporation / Next PLC / PagerDuty Inc / Pfizer Inc / Pultegroup Inc / Resolute Mining Ltd / Rayonier Inc / Southern Co / AT&T Inc / Toll Brothers Inc / Visteon Corp / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Weyerhaeuser Co / Canfor Corp / Gilead Sciences Inc / Franco-Nevada Corp / Campbell Soup Co / Louisiana-Pacific Corp / Tenneco Inc / Comcast Corp / Amgen Inc / Incyte Corp / Duke Energy Corp / Alamos Gold Inc / Borgwarner Inc / Lear Corp / PNM Resources Inc / Kellogg Co / Dynatrace Inc / DISH Network Corp / Lennar Corp / Clorox Co / Conagra Brands Inc / General Mills Inc / Agnico Eagle Mines Ltd / Edgewell Personal Care Co / St Barbara Ltd / American Tower Corp / Kinross Gold Corp / Nike Inc / Jazz Pharmaceuticals PLC / CyrusOne Inc / Verizon Communications Inc / Exelixis Inc / D R Horton Inc / Constellation Brands Inc / Amphenol Corp / Fiserv Inc / Autodesk Inc / Visa Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Church & Dwight Co Inc / Northwest Natural Holding Co / Brunswick Corp / Boston Beer Company Inc / Industria de Diseno Textil SA / Biomarin Pharmaceutical Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / James Hardie Industries PLC / Centamin PLC / NCR Corp / Cloudflare Inc / TE Connectivity Ltd / Gold Fields Ltd / ASOS PLC / CenterPoint Energy Inc / Endo International PLC / Chesapeake Utilities Corp / Polaris Inc / Sensata Technologies Holding PLC / Select Medical Holdings Corp / Seagen Inc / Global Payments Inc / Monster Beverage Corp / Royal Gold Inc / bluebird bio Inc / Caseys General Stores Inc / Equinix Inc / Alimentation Couche-Tard Inc / Biogen Inc / Barrick Gold Corp / Ramelius Resources Ltd / Northern Star Resources Ltd / Altria Group Inc / Doman Building Materials Group Ltd / Regis Resources Ltd / Digital Realty Trust Inc / IAMGOLD Corp / Hershey Co / Western Forest Products Inc / Fidelity National Information Services Inc / Arrowhead Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Mastercard Inc / Harley-Davidson Inc / Mercer International Inc / Yamana Gold Inc / Atlantia SpA / B&G Foods Inc / Hochschild Mining PLC / Silver Lake Resources Ltd / Ensign Group Inc / Dana Inc / Northern Oil and Gas Inc / Fresnillo PLC / New Gold Inc / Clearwater Paper Corp / OceanaGold Corp / Addus Homecare Corp / Eldorado Gold Corp / Acadian Timber Corp / Spectrum Brands Holdings Inc / Nextera Energy Inc / Gold Road Resources Ltd / Potlatchdeltic Corp / Canfor Pulp Products Inc / Pacira Biosciences Inc / CatchMark Timber Trust Inc / Meritor Inc / Interfor Corp / Polymetal International PLC / Evolution Mining Ltd / Splunk Inc / Resolute Forest Products Inc / Hugo Boss AG / Palo Alto Networks Inc / Mondelez International Inc / Abbvie Inc / KP Tissue Inc / Tri Pointe Homes Inc (Delaware) / Tesla Inc / Perrigo Company PLC / Primo Water Corp / T-Mobile US Inc / Taylor Morrison Home Corp / Coty Inc / Prothena Corporation PLC / ServiceNow Inc / Conifex Timber Inc / Bath & Body Works Inc / Karyopharm Therapeutics Inc / Xencor Inc / Varonis Systems Inc / boohoo group plc / B2Gold Corp / Agile Therapeutics Inc / Rayonier Advanced Materials Inc / Zalando SE / Aptose Biosciences Inc / Shopify Inc / Westrock Co / Surgery Partners Inc / Ferrari NV / Twilio Inc / Osisko Gold Royalties Ltd / Adient PLC / CRISPR Therapeutics AG / GDS Holdings Ltd / Sandstorm Gold Ltd / Algonquin Power & Utilities Corp / Okta Inc / Vistra Corp / Wheaton Precious Metals Corp / Kirkland Lake Gold Ltd / Athenex Inc / SailPoint Technologies Holdings Inc / Aptiv PLC / Encompass Health Corp / Superdry PLC / Zscaler Inc / Amneal Pharmaceuticals Inc / Iterum Therapeutics PLC / Veoneer Inc / Naturgy Energy Group SA / Keurig Dr Pepper Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / Focus Financial Partners Inc / Elastic NV / Gamida Cell Ltd / Osmotica Pharmaceuticals PLC / Newell Brands Inc / Office Properties Income Trust / CrowdStrike Holdings Inc / Genmab A/S / Ping Identity Holding Corp / Aprea Therapeutics Inc / Cerence Inc / IGM Biosciences Inc / Frasers Group PLC / Reynolds Consumer Products Inc / Sibanye Stillwater Ltd / International General Insurance Holdings Ltd / Nikola Corp / Shift4 Payments Inc / Gohealth Inc / Allogene Therapeutics Inc / Mediaalpha Inc / West Fraser Timber Co Ltd / AUTO1 Group SE / Cenovus Energy Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / Spain / United Kingdom / Ireland / Israel / Italy / Netherlands / Portugal / Sweden / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">03/14/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ARRY-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ARRY.O / LLY / NVS / AMGN.O / AZN.O / ONTX.O</td><td class="leftalignment">Array Technologies Inc / Eli Lilly and Co / Novartis AG / Amgen Inc / AstraZeneca PLC / Onconova Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Advertising / Media / Telecommunications</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">03/13/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AMGN.O / EXEL.O / BMRN.O / REGN.O / PRTA.O</td><td class="leftalignment">Amgen Inc / Exelixis Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Prothena Corporation PLC</td><td class="leftalignment"></td><td class="leftalignment">China / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Edwin Delfin</td></tr>
<tr class="odd"><td class="leftalignment">03/13/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Momentum Soon Set for Major Rebalance</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">AMGN=US / QCOM=US / INCY=US / CG=US / BAC=US / GILD=US / FRC=US / MPWR=US / JPM=US / TROW=US / MS=US / TER=US / SIVB=US / SWKS=US / BIIB=US / BX=US</td><td class="leftalignment">Amgen Inc / Qualcomm Inc / Incyte Corp / Carlyle Group Inc / Bank of America Corp / Gilead Sciences Inc / First Republic Bank / Monolithic Power Systems Inc / JPMorgan Chase & Co / T Rowe Price Group Inc / Morgan Stanley / Teradyne Inc / SVB Financial Group / Skyworks Solutions Inc / Biogen Inc / Blackstone Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Financial Services</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / QUANANTITATIVE/TECH RESEARCH / Research Digest / Investment Strategy / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/12/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Portfolio Manager's Weekly - March 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">FR0000121014 / US0028241000 / US00738A1060 / US00846U1016 / US0126531013 / US02553E1064 / US0311621009 / US0463531089 / US1101221083 / US17275R1023 / US22160K1051 / US2358511028 / US30226D1063 / US3156161024 / US3377381088 / US3647601083 / US3755581036 / US37733W1053 / US4364401012 / US4523271090 / US4781601046 / US48203R1041 / US5002551043 / US5324571083 / US6245801062 / US62855J1043 / US6549022043 / US6556641008 / US66987V1098 / US6701002056 / US7140461093 / US7170811035 / US75886F1075 / US87612E1064 / US8835561023 / US9021041085 / US91307C1027 / US9311421039 / US9418481035 / US30063P1057 / US37940X1028 / AU000000LYC6 / US2948216088 / US1167941087 / US31620M1062 / US57636Q1040 / US1717793095 / US79546E1047 / US55616P1049 / US90384S3031 / US92826C8394 / US58933Y1055 / US13100M5094 / US1920051067 / US9100471096 / US69404D1081 / US92335C1062 / US98978V1035 / US5017971046 / US64051T1007 / US45845P1084 / US69366J2006 / US63009R1095 / US03823U1025 / CH0210483332 / US09062W2044 / US0404131064 / US78667J1088 / US0994061002 / IE00BTN1Y115 / US46185L1035 / US6323071042 / US70450Y1038 / US72703H1014 / US8522341036 / US26856L1035 / US74967X1037 / NL0012169213 / CA1350861060 / US03236M2008 / US8760301072 / CA53680Q2071 / US74766Q1013 / US7625441040 / US09354A1007 / US26927E1047 / US46571Y1073 / VGG312491084 / KY30744W1070 / US40131M1099 / US53814L1089 / US90184D1000 / VGG1890L1076 / US05352A1007 / US76156B1070 / US71535D1063 / US39874R1014 / US00650F1093 / US88339P1012 / US24984K1051 / US88025U1097 / US30068X1037 / US92766K1060 / US14448C1045 / US12233L1070 / US57667L1070 / US0843101017 / US07373B1098 / CA67079A1021 / US5533681012 / US74767V1098 / US81578P1066 / US65443P1021 / US7761531083 / US73739W1045 / US55406W1036 / US12047B1052 / US15961R1059</td><td class="leftalignment">LVMH Moet Hennessy Louis Vuitton SE / Abbott Laboratories / ADTRAN Inc / Agilent Technologies Inc / Albemarle Corp / American Eagle Outfitters Inc / Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Cisco Systems Inc / Costco Wholesale Corp / Danaher Corp / Extreme Networks Inc / F5 Inc / Fiserv Inc / Gap Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Hologic Inc / Illumina Inc / Johnson & Johnson / Juniper Networks Inc / Kohls Corp / Eli Lilly and Co / Movado Group Inc / Myriad Genetics Inc / Nokia Oyj / Nordstrom Inc / Novartis AG / Novo Nordisk A/S / PerkinElmer Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Target Corp / Thermo Fisher Scientific Inc / II-VI Inc / United Therapeutics Corp / Walmart Inc / Waters Corp / Exact Sciences Corp / Global Payments Inc / Lynas Rare Earths Ltd / Telefonaktiebolaget LM Ericsson / Bruker Corp / Fidelity National Information Services Inc / Mastercard Inc / Ciena Corp / Sally Beauty Holdings Inc / Macy's Inc / Ulta Beauty Inc / Visa Inc / Merck & Co Inc / Calix Inc / Codexis Inc / United Airlines Holdings Inc / Pacific Biosciences of California Inc / Vera Bradley Inc / Zoetis Inc / Bath & Body Works Inc / NeoPhotonics Corp / Intercept Pharmaceuticals Inc / PTC Therapeutics Inc / NanoString Technologies Inc / Applied Optoelectronics Inc / Compagnie Financiere Richemont SA / BioLife Solutions Inc / Arista Networks Inc / SAGE Therapeutics Inc / Boot Barn Holdings Inc / Medtronic PLC / Invitae Corp / Natera Inc / PayPal Holdings Inc / Planet Fitness Inc / Block Inc / elf Beauty Inc / RH / Qiagen NV / Canada Goose Holdings Inc / Amyris Inc / Tapestry Inc / Lithium Americas Corp / Quanterix Corp / Ribbon Communications Inc / Blink Charging Co / EVO Payments Inc / I3 Verticals Inc / Establishment Labs Holdings Inc / Farfetch Ltd / Guardant Health Inc / Livent Corp / Twist Bioscience Corp / Capri Holdings Ltd / Avantor Inc / Revolve Group Inc / Personalis Inc / Grocery Outlet Holding Corp / Adaptive Biotechnologies Corp / RealReal Inc / DermTech Inc / 10X Genomics Inc / Exagen Inc / Virgin Galactic Holdings Inc / Carrier Global Corp / Burning Rock Biotech Ltd / Match Group Inc / Berkeley Lights Inc / Beam Global / Nuvei Corp / Mp Materials Corp / Quantumscape Corp / Seer Inc / 908 Devices Inc. / Romeo Power Inc / Poshmark Inc / MYT Netherlands Parent BV / Bumble Inc / ChargePoint Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / Cayman Islands / Denmark / Finland / France / United Kingdom / Ireland / Netherlands / Sweden / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">03/12/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 538</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">03/12/2021</td><td class="leftalignment">Argus Research Corporation</td><td class="leftalignment">Argus Analyst Report, AMGN</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AMGN</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / COMPANY UPDATE / COMPANY REPORT / ESTIMATE CHANGES</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David H. Toung</td></tr>
<tr class="odd"><td class="leftalignment">03/12/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended March 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/12/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="odd"><td class="leftalignment">03/12/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">03/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AMGN.OQ / ACRX.OQ / JNJ.N / LLY.N / AZN.L / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / MRNA.OQ / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Amgen Inc / AcelRx Pharmaceuticals Inc / Johnson & Johnson / Eli Lilly and Co / AstraZeneca PLC / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Moderna Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">03/11/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">The Bleeding Continues</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / 039697107 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / 19240Q201</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Ardelyx Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / Cogent Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">03/11/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">ReCode Therapeutics, Inc.: Our Q&A With Management</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Myles R. R. Minter</td></tr>
<tr class="odd"><td class="leftalignment">03/11/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Synthetic Lethality Primer - A Prelude to Innovative IDEAYAs in DNA Damage Repare and Next-Generation Targeted Oncology</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2576941 / 2369174 / 2457864 / 2471950 / 2730190 / 5531000 / 7103065 / 2982924 / BCBVTX1 / BBFL7S1 / B6RS2B3 / BCZS820 / BFDV8K0 / BBPK0J0 / B7F2TY6 / BFZNYB7 / BK0VHF6 / BDHF4K6 / BZBY005 / BZ1LFB2 / BKS3SM8 / BMQ5T49 / BGCYWN8 / BWFKZT2 / BKVDFF7 / BG31GH0 / BJXBP30 / BYQHPK7 / BYYWPW6 / BJ9NFQ3 / BWY52P3 / BL71K91 / BYWVTY5 / BDZ30Q0 / BWY4XV3 / BN2R582 / BDD1B07 / BMPRZV5 / BF3NP05 / BMDJ397</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Exelixis Inc / Gilead Sciences Inc / ImmunoGen Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / MorphoSys AG / Novartis AG / Spectrum Pharmaceuticals Inc / Agios Pharmaceuticals Inc / bluebird bio Inc / Clovis Oncology Inc / Fate Therapeutics Inc / MacroGenics Inc / Mirati Therapeutics Inc / Puma Biotechnology Inc / Allogene Therapeutics Inc / IDEAYA Biosciences Inc / CRISPR Therapeutics AG / Merus NV / Deciphera Pharmaceuticals Inc / IGM Biosciences Inc / Zentalis Pharmaceuticals Inc / Xencor Inc / Cellectis SA / Oric Pharmaceuticals Inc / Y-mAbs Therapeutics Inc / Turning Point Therapeutics Inc / Zymeworks Inc / Beigene Ltd / Neoleukin Therapeutics Inc / Blueprint Medicines Corp / Revolution Medicines Inc / CytomX Therapeutics Inc / Arvinas Inc / Adaptimmune Therapeutics PLC / Relay Therapeutics Inc / Rubius Therapeutics Inc / Kymera Therapeutics Inc / Mersana Therapeutics Inc / Bolt Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Mali / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/10/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Short Interest Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AMGN.O / REGN.O</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Yinglu Zhang</td></tr>
<tr class="odd"><td class="leftalignment">03/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">2023607 / 2778844 / 2026242 / 2732635 / 2216850 / 2208073 / 2270726 / 2317087 / 2328915 / 2100920 / 2366799 / 2459020 / 2515030 / 2645409 / 2680905 / 2931034 / 2503529 / 7103065 / B121557 / 2713317 / 2983563 / B2R3PV1 / B4Y1MH7 / 2598246 / B4N0JJ6 / BCDWBX6 / BDZCRX3 / BTN1Y44 / BYVY8G0 / BYW36M8 / BJF8Q81 / BD8DJ71 / BP7RS48 / BYXJQG9 / BZ8VJQ8 / BKTNTR9 / BYYWPW6 / BJDX8Y8 / BRJ3GY4 / BGDW0N7 / BLBLMD5</td><td class="leftalignment">Amgen Inc / Merck & Co Inc / American Electric Power Company Inc / AutoNation Inc / Consolidated Edison Inc / Copart Inc / Walt Disney Co / Entergy Corp / Nextera Energy Inc / FirstEnergy Corp / Gentex Corp / Intuit Inc / Lithia Motors Inc / NiSource Inc / PPL Corp / Vertex Pharmaceuticals Inc / World Wrestling Entertainment Inc / Novartis AG / Mastercard Inc / ACADIA Pharmaceuticals Inc / Carmax Inc / American Water Works Company Inc / KAR Auction Services Inc / Neogenomics Inc / Visteon Corp / ANI Pharmaceuticals Inc / RingCentral Inc / Walgreens Boots Alliance Inc / Alphabet Inc / PayPal Holdings Inc / IAA Inc / Snap Inc / Intersect Ent Inc / Spire Inc / Vistra Corp / ViacomCBS Inc / Beigene Ltd / Mirum Pharmaceuticals Inc / Xenon Pharmaceuticals Inc / Trevena Inc / Array Technologies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / China / Cayman Islands / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">03/10/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US -  Dividend Quality Analysis, for the period ended March 08,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BGNE (NEUTRAL) - Management Meeting Highlights Confidence in Gaining Leading Position in China Market</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BYYWPW6 / 2023607</td><td class="leftalignment">Beigene Ltd / Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin</td></tr>
<tr class="even"><td class="leftalignment">03/09/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Progress on Oral Antivirals as Domestic Improvements Continue and Declines in Global New Cases Plateau</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Mar 09 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">US0028241000 / US0231351067 / US0311621009 / US0463531089 / US1101221083 / US2358511028 / US3377381088 / US3755581036 / US37733W1053 / US4523271090 / US4781601046 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US75886F1075 / US87612E1064 / US9021041085 / US91307C1027 / US9311421039 / US37940X1028 / US0042251084 / US0491642056 / US31620M1062 / US57636Q1040 / US92826C8394 / US00922R1059 / US58933Y1055 / US69404D1081 / US30303M1027 / US98978V1035 / US45845P1084 / US69366J2006 / US63009R1095 / US90184L1026 / US0396971071 / US78667J1088 / IE00BTN1Y115 / US81750R1023 / US6323071042 / US70450Y1038 / US8522341036 / US87164F1057 / US03236M2008 / US8760301072 / US05351X1019 / US09354A1007 / US26927E1047 / US46571Y1073 / VGG312491084 / US68373M1071 / US90184D1000 / US1255231003 / US62921N1054 / US05352A1007 / US92537N1081 / US68902V1070 / US07373B1098 / US56854Q2003 / CA67079A1021 / US74767V1098 / US21077C1071 / US7761531083 / US73739W1045 / US15961R1059</td><td class="leftalignment">Abbott Laboratories / Amazon.com Inc / Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Danaher Corp / Fiserv Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Regeneron Pharmaceuticals Inc / Target Corp / II-VI Inc / United Therapeutics Corp / Walmart Inc / Global Payments Inc / ACADIA Pharmaceuticals Inc / Atlas Air Worldwide Holdings Inc / Fidelity National Information Services Inc / Mastercard Inc / Visa Inc / Air Transport Services Group Inc / Merck & Co Inc / Pacific Biosciences of California Inc / Meta Platforms Inc / Zoetis Inc / Intercept Pharmaceuticals Inc / PTC Therapeutics Inc / NanoString Technologies Inc / Twitter Inc / Ardelyx Inc / SAGE Therapeutics Inc / Medtronic PLC / Seres Therapeutics Inc / Natera Inc / PayPal Holdings Inc / Block Inc / Syndax Pharmaceuticals Inc / Amyris Inc / Tapestry Inc / Avaya Holdings Corp / Blink Charging Co / EVO Payments Inc / I3 Verticals Inc / Establishment Labs Holdings Inc / Opera Ltd / Twist Bioscience Corp / Cigna Corp / NGM Biopharmaceuticals Inc / Avantor Inc / Vertiv Holdings Co / Otis Worldwide Corp / Beam Global / Marinus Pharmaceuticals Inc / Nuvei Corp / Quantumscape Corp / ContextLogic Inc / Romeo Power Inc / Poshmark Inc / ChargePoint Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / United Kingdom / Ireland / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / HD=US / MCD=US / WEN=US / AMZN=US / BLD=US / TEVA=US / GILD=US / LOW=US / CHRS=US / LEG=US / CI=US / CBRL=US / DRI=US / GFF=US / IBP=US / MAS=US / MHK=US / REGI=US / AMSF=US / DIN=US / BIIB=US / TPX=US / EXP=US / CRD.B=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / SIBN=US / CMG=US / REX=US / RPRX=US / PGTI=US / GPRE=US / EHTH=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / JACK=US / TREX=US / FBHS=US / TILE=US / NDLS=US / LOCO=US / SHAK=US / WING=US / 82982L103 / PVAC=US / ANAB=US / JELD=US / SFIX=US / GOCO=US / AZEK=US / VTRS=US / DHT.UN=CA</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / McDonald's Corp / Wendys Co / Amazon.com Inc / TopBuild Corp / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Lowe's Companies Inc / Coherus BioSciences Inc / Leggett & Platt Inc / Cigna Corp / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Renewable Energy Group Inc / Amerisafe Inc / Dine Brands Global Inc / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Crawford & Co / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / SI-BONE Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Royalty Pharma PLC / PGT Innovations Inc / Green Plains Inc / eHealth Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Jack in the Box Inc / Trex Company Inc / Fortune Brands Home & Security Inc / Interface Inc / Noodles & Co / El Pollo Loco Holdings Inc / Shake Shack Inc / Wingstop Inc / SiteOne Landscape Supply Inc / Ranger Oil Corp / AnaptysBio Inc / JELD-WEN Holding Inc / Stitch Fix Inc / Gohealth Inc / Azek Company Inc / Viatris Inc / Dri Healthcare Trust</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2023607 / 2050832 / 2026242 / 2270726 / 2328915 / 2100920 / 2369174 / 2689560 / 2672689 / 2684703 / 2048804 / 2402121 / 2980906 / 7103065 / B1F76F9 / B121557 / 2769796 / B2R3PV1 / BCZS820 / BFZNYB7 / BDHF4K6 / BMQ5T49 / BWFKZT2 / BFMXGR0 / BYXJQG9 / BZ8VJQ8 / BDRW1L7 / BZ4CHH2 / BNG3RZ7 / BMC8SQ7</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Ameren Corp / American Electric Power Company Inc / Walt Disney Co / Nextera Energy Inc / FirstEnergy Corp / Gilead Sciences Inc / PG&E Corp / Patterson Companies Inc / Pfizer Inc / Pinnacle West Capital Corp / Nuance Communications Inc / Foot Locker Inc / Novartis AG / Western Union Co / Mastercard Inc / Fidelity National Information Services Inc / American Water Works Company Inc / Fate Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Zentalis Pharmaceuticals Inc / Cellectis SA / Evergy Inc / Spire Inc / Vistra Corp / AnaptysBio Inc / Soleno Therapeutics Inc / Leslie's Inc / BTRS Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology: Latest Short Interest for US Biotech: Relatively Stable for Large Cap and SMid Cap</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AMGN.OQ / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / ACRX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / AcelRx Pharmaceuticals Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Cowen Health Care Conference Topical Panel Wrap-Up</td><td class="leftalignment">English</td><td class="rightalignment">217</td><td class="leftalignment">US0028241000 / US0311621009 / US0463531089 / US1101221083 / US3755581036 / US37733W1053 / US4523271090 / US4781601046 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US75886F1075 / US91307C1027 / US58933Y1055 / US69404D1081 / US98978V1035 / US45845P1084 / US69366J2006 / US63009R1095 / US78667J1088 / IE00BTN1Y115 / US03236M2008 / VGG312491084 / US90184D1000</td><td class="leftalignment">Abbott Laboratories / Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Regeneron Pharmaceuticals Inc / United Therapeutics Corp / Merck & Co Inc / Pacific Biosciences of California Inc / Zoetis Inc / Intercept Pharmaceuticals Inc / PTC Therapeutics Inc / NanoString Technologies Inc / SAGE Therapeutics Inc / Medtronic PLC / Amyris Inc / Establishment Labs Holdings Inc / Twist Bioscience Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / United Kingdom / Ireland / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Cowen Health Care Team / Cowen Washington Research</td></tr>
<tr class="even"><td class="leftalignment">03/08/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Amgen down 0.15% from 1 week high</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">FPRX (NEUTRAL) - Downgrading to NEUTRAL on Pending AMGN Acquisition</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.OQ / 2023607</td><td class="leftalignment">Amgen Inc / Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Etzer Darout / Paul Jeng, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Feb 26, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Guggenheim Ther Research</td></tr>
<tr class="odd"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">03/08/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - March 8, 2021</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AEP.N / AES.N / ALV.N / BAC.N / BBDb.TO / BK.N / C.N / CL.N / CMS.N / COF.N / CP.TO / DFDS.CO / ED.N / EIX.N / EL.N / ELE.MC / F.N / FITB.O / GM.N / JPM.N / KEY.N / KMB.N / KO.N / MRK.N / NTRS.O / PEG.N / PNC.N / PNW.N / RWEG.DE / SO.N / T.N / USB.N / VC.N / WFC.N / PEP.N / CMA.N / BFb.N / PG.N / WY.N / CFP.TO / CPB.N / TEN.N / AMGN.O / ETR.N / CNR.TO / DUK.N / HBAN.O / BWA.N / LEA.N / D.N / FE.N / PNM.N / NVDA.O / K.N / DT.N / DISH.O / GS.N / CLX.N / CAG.N / GIS.N / PCG.N / PPL.N / EPC.N / MGA.N / AMT.N / JAZZ.O / CONE.O / VZ.N / STT.N / EXEL.O / XEL.N / ARNA.O / STZ.N / APH.N / SRE.N / EXC.N / FISV.O / ADSK.O / CHTR.O / AXL.N / AWK.N / CHD.N / NWN.N / WSP.TO / MTB.N / BC.N / SAM.N / BMRN.O / REGN.O / ENR.N / FTT.TO / NCR.N / NET.N / TEL.N / RF.N / CNP.N / WCN.N / BKH.N / CPK.N / FRC.N / PII.N / ST.N / SR.N / GPN.N / MNST.O / SIVB.O / CASY.O / EQIX.O / STN.TO / ATDb.TO / WPK.TO / SNC.TO / TFC.N / 02209S103 / DLR.N / 427866108 / WEF.TO / SJW.N / MS.N / FIS.N / TEVA.N / HOG.N / BGS.N / GETP.PA / DAN.N / UTL.N / SPB.N / NEE.N / PCH.O / CJT.TO / CFX.TO / MSP.N / MTOR.N / IFP.TO / SPLK.OQ / RFP.N / PANW.N / MDLZ.OQ / GRT_u.TO / TSLA.N / PRGO.N / PRMW.N / TMUS.N / DOO.TO / COTY.N / PRTA.O / AGIO.O / 81762P102 / VRNS.O / FLXN.O / NEP.N / CFG.N / PYPL.OQ / MESO.O / RACE.MI / MP1.AX / TWLO.N / ADNT.N / PBYI.OQ / AQN.N / UNIT.O / OKTA.OQ / VST.N / ATUS.N / ATNX.O / AY.O / SAIL.N / APTV.N / ILPT.O / ZS.OQ / SMAR.N / VNE.N / KDP.N / XERS.O / AQST.O / CWEN.N / ESTC.N / NWL.O / CRWD.O / PING.N / CRNC.OQ / WTRG.N / REYN.O / GFL.N / NKLA.OQ / FOUR.N / 77311W101 / LUMN.N / ASAN.N / SUMO.O / WFG.N / TIXT.TO / AFRM.O / ATC.N / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Autoliv Inc / Bank of America Corp / Bombardier Inc / Bank of New York Mellon Corp / Citigroup Inc / Colgate-Palmolive Co / CMS Energy Corp / Capital One Financial Corp / Canadian Pacific Railway Ltd / DFDS AS / Consolidated Edison Inc / Edison International / Estee Lauder Companies Inc / Endesa SA / Ford Motor Co / Fifth Third Bancorp / General Motors Co / JPMorgan Chase & Co / KeyCorp / Kimberly-Clark Corp / Coca-Cola Co / Merck & Co Inc / Northern Trust Corp / Public Service Enterprise Group Inc / PNC Financial Services Group Inc / Pinnacle West Capital Corp / Rwe AG / Southern Co / AT&T Inc / US Bancorp / Visteon Corp / Wells Fargo & Co / PepsiCo Inc / Comerica Inc / Brown-Forman Corp / Procter & Gamble Co / Weyerhaeuser Co / Canfor Corp / Campbell Soup Co / Tenneco Inc / Amgen Inc / Entergy Corp / Canadian National Railway Co / Duke Energy Corp / Huntington Bancshares Inc / Borgwarner Inc / Lear Corp / Dominion Energy Inc / FirstEnergy Corp / PNM Resources Inc / NVIDIA Corp / Kellogg Co / Dynatrace Inc / DISH Network Corp / Goldman Sachs Group Inc / Clorox Co / Conagra Brands Inc / General Mills Inc / PG&E Corp / PPL Corp / Edgewell Personal Care Co / Magna International Inc / American Tower Corp / Jazz Pharmaceuticals PLC / CyrusOne Inc / Verizon Communications Inc / State Street Corp / Exelixis Inc / Xcel Energy Inc / Arena Pharmaceuticals Inc / Constellation Brands Inc / Amphenol Corp / Sempra Energy / Exelon Corp / Fiserv Inc / Autodesk Inc / Charter Communications Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Church & Dwight Co Inc / Northwest Natural Holding Co / WSP Global Inc / M&T Bank Corp / Brunswick Corp / Boston Beer Company Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Finning International Inc / NCR Corp / Cloudflare Inc / TE Connectivity Ltd / Regions Financial Corp / CenterPoint Energy Inc / Waste Connections Inc / Black Hills Corp / Chesapeake Utilities Corp / First Republic Bank / Polaris Inc / Sensata Technologies Holding PLC / Spire Inc / Global Payments Inc / Monster Beverage Corp / SVB Financial Group / Caseys General Stores Inc / Equinix Inc / Stantec Inc / Alimentation Couche-Tard Inc / Winpak Ltd / SNC-Lavalin Group Inc / Truist Financial Corp / Altria Group Inc / Digital Realty Trust Inc / Hershey Co / Western Forest Products Inc / SJW Group / Morgan Stanley / Fidelity National Information Services Inc / Teva Pharmaceutical Industries Ltd / Harley-Davidson Inc / B&G Foods Inc / Getlink SE / Dana Inc / Unitil Corp / Spectrum Brands Holdings Inc / Nextera Energy Inc / Potlatchdeltic Corp / Cargojet Inc / Canfor Pulp Products Inc / Datto Holding Corp / Meritor Inc / Interfor Corp / Splunk Inc / Resolute Forest Products Inc / Palo Alto Networks Inc / Mondelez International Inc / Granite Real Estate Investment Trust / Tesla Inc / Perrigo Company PLC / Primo Water Corp / T-Mobile US Inc / BRP Inc / Coty Inc / Prothena Corporation PLC / Agios Pharmaceuticals Inc / ServiceNow Inc / Varonis Systems Inc / Pacira Biosciences Inc / Nextera Energy Partners LP / Citizens Financial Group Inc / PayPal Holdings Inc / Mesoblast Ltd / Ferrari NV / Megaport Ltd / Twilio Inc / Adient PLC / Puma Biotechnology Inc / Algonquin Power & Utilities Corp / Uniti Group Inc / Okta Inc / Vistra Corp / Altice USA Inc / Athenex Inc / Atlantica Sustainable Infrastructure PLC / SailPoint Technologies Holdings Inc / Aptiv PLC / Industrial Logistics Properties Trust / Zscaler Inc / Smartsheet Inc / Veoneer Inc / Keurig Dr Pepper Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / Clearway Energy Inc / Elastic NV / Newell Brands Inc / CrowdStrike Holdings Inc / Ping Identity Holding Corp / Cerence Inc / Essential Utilities Inc / Reynolds Consumer Products Inc / GFL Environmental Inc / Nikola Corp / Shift4 Payments Inc / Rocket Companies Inc / Lumen Technologies Inc / Asana Inc / Sumo Logic Inc / West Fraser Timber Co Ltd / Telus International Cda Inc / Affirm Holdings Inc / Atotech Ltd / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Ireland / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For the Week Ended Feb 26, 2021: Focus on Novo GLP-1s</td><td class="leftalignment">English</td><td class="rightalignment">47</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / RB.L / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ / MNK.N^J20</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / Reckitt Benckiser Group PLC / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc / Mallinckrodt PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">03/06/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AMGN.O / EXEL.O / ARNA.O / BMRN.O / REGN.O / PRTA.O / AGIO.O / MESO.O / PBYI.OQ / ATNX.O</td><td class="leftalignment">Amgen Inc / Exelixis Inc / Arena Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Prothena Corporation PLC / Agios Pharmaceuticals Inc / Mesoblast Ltd / Puma Biotechnology Inc / Athenex Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Edwin Delfin</td></tr>
<tr class="odd"><td class="leftalignment">03/05/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 537</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">03/05/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Amgen Inc: Valuation Landscape 2006-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">03/05/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Mar 05 2021</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">EVAX=US / SNSE=US / MRK=US / BSX=US / LLY=US / PFE=US / ABT=US / AMGN=US / BMY=US / MDT=US / WMT=US / INSP=US / CMS=US / DGX=US / CRIS=US / AZN=US / GSK=US / RAD=US / JNJ=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / ANGN=US / APLS=US / BCRX=US / BMRN=US / CHE=US / CYH=US / COO=US / DRRX=US / EW=US / GRTS=US / GEN=US / ICPT=US / PHG=US / LH=US / NBIX=US / PHAR=US / HOOK=US / USPH=US / UTHR=US / UHS=US / PRVB=US / CCRN=US / RHHBY=US / CNC=US / ACA=US / ENSG=US / MD=US / CMPI=US / SLF=US / ONCR=US / BIIB=US / MRNA=US / ACAD=US / GOOG=US / INO=US / LHCG=US / SNSS=US / AGRX=US / CHNG=US / TPTX=US / ORTX=US / EHC=US / CLDX=US / CVAC=US / ADUS=US / ACHC=US / SRPT=US / PRTA=US / MRTX=US / GNCA=US / CTRE=US / EKTAY=US / CLRB=US / WBA=US / NVTA=US / EVH=US / MCRB=US / CFMS=US / LIVN=US / CERC=US / IONS=US / SSKN=US / VRAY=US / SYRS=US / MDGL=US / FLGT=US / IRTC=US / AVDL=US / SLNO=US / VREX=US / ATNX=US / NCNA=US / RCKT=US / FIXX=US / ARVN=US / MRKR=US / XFOR=US / TMDX=US / BCYC=US / NEXI=US / KRTX=US / DMTK=US / BNTX=US / RCEL=US / PNTG=US / NNOX=US / TSHA=US / VIRX=US / PHVS=US</td><td class="leftalignment">Evaxion Biotech A/S / Sensei Biotherapeutics Inc / Merck & Co Inc / Boston Scientific Corp / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Amgen Inc / Bristol-Myers Squibb Co / Medtronic PLC / Walmart Inc / Inspire Medical Systems Inc / CMS Energy Corp / Quest Diagnostics Inc / Curis Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Rite Aid Corp / Johnson & Johnson / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / Angion Biomedica Corp / Apellis Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Chemed Corp / Community Health Systems Inc / Cooper Companies Inc / DURECT Corp / Edwards Lifesciences Corp / Gritstone bio Inc / Genesis Healthcare Inc / Intercept Pharmaceuticals Inc / Koninklijke Philips NV / Laboratory Corporation of America Holdings / Neurocrine Biosciences Inc / Pharming Group NV / HOOKIPA Pharma Inc / US Physical Therapy Inc / United Therapeutics Corp / Universal Health Services Inc / Provention Bio Inc / Cross Country Healthcare Inc / Roche Holding AG / Centene Corp / Arcosa Inc / Ensign Group Inc / MEDNAX Inc / Checkmate Pharmaceuticals Inc / Sun Life Financial Inc / Oncorus Inc / Biogen Inc / Moderna Inc / ACADIA Pharmaceuticals Inc / Alphabet Inc / Inovio Pharmaceuticals Inc / LHC Group Inc / Viracta Therapeutics Inc / Agile Therapeutics Inc / Change Healthcare Inc / Turning Point Therapeutics Inc / Orchard Therapeutics PLC / Encompass Health Corp / Celldex Therapeutics Inc / CureVac NV / Addus Homecare Corp / Acadia Healthcare Company Inc / Sarepta Therapeutics Inc / Prothena Corporation PLC / Mirati Therapeutics Inc / Genocea Biosciences Inc / CareTrust REIT Inc / Elekta AB (publ) / Cellectar Biosciences Inc / Walgreens Boots Alliance Inc / Invitae Corp / Evolent Health Inc / Seres Therapeutics Inc / Conformis Inc / LivaNova PLC / Avalo Therapeutics Inc / Ionis Pharmaceuticals Inc / STRATA Skin Sciences Inc / ViewRay Inc / Syros Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / Fulgent Genetics Inc / iRhythm Technologies Inc / Avadel Pharmaceuticals PLC / Soleno Therapeutics Inc / Varex Imaging Corp / Athenex Inc / NuCana PLC / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Arvinas Inc / Marker Therapeutics Inc / X4 Pharmaceuticals Inc / Transmedics Group Inc / Bicycle Therapeutics PLC / Neximmune Inc / Karuna Therapeutics Inc / DermTech Inc / BioNTech SE / AVITA Medical Inc / Pennant Group Inc / Nano-X Imaging Ltd / Taysha Gene Therapies Inc / Viracta Therapeutics Inc / Pharvaris NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Germany / Denmark / United Kingdom / Ireland / Israel / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="even"><td class="leftalignment">03/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Weekly: Gvoke Share of 12% a New High; Teva's Gx Nuvaring Gaining Share</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">TEVA.TA / MRK=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / GSK=US / ENDP=US / PRGO=US / BIIB=US / AMRX=US / ABBV=US / XERS=US / VTRS=US</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Merck & Co Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / GlaxoSmithKline PLC / Endo International PLC / Perrigo Company PLC / Biogen Inc / Amneal Pharmaceuticals Inc / Abbvie Inc / Xeris Biopharma Holdings Inc / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Ami Fadia</td></tr>
<tr class="odd"><td class="leftalignment">03/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended February 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / BMY=US / A=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Agilent Technologies Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/05/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="odd"><td class="leftalignment">03/05/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">03/05/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Mar 5 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">NL0000226223 / DE0006231004 / US0079031078 / US00971T1016 / US0311621009 / US0378331005 / US0382221051 / US1265011056 / US22160K1051 / US2910111044 / US4581401001 / US4824801009 / US5128071082 / US5184151042 / US5261071071 / US5324571083 / US5370081045 / US55306N1046 / US5950171042 / US5951121038 / US67066G1040 / US6821891057 / US7392761034 / US7475251036 / US8168501018 / US8610121027 / US9282981086 / US9581021055 / US9839191015 / CA0977512007 / US98956P1021 / US83088M1027 / US6098391054 / US19239V3024 / US82706C1080 / US1717793095 / US55616P1049 / NL0009538784 / US8725901040 / US55405Y1001 / US1220171060 / US14862Q1004 / US74736K1016 / US09627Y1091 / US20717E1010 / US74624M1027 / US87184Q1076 / US02081G2012 / IE00BY7QL619 / US36165L1089 / US67022C1062 / US89854H1023 / US11135F1012 / CA74319B5027 / IE00BK9ZQ967 / US39813G1094 / US14448C1045 / US8317541063 / US05380C1027 / US12769G1004 / US05479K1060 / US05875B1061 / US21077C1071 / 120404208</td><td class="leftalignment">STMicroelectronics NV / Infineon Technologies AG / Advanced Micro Devices Inc / Akamai Technologies Inc / Amgen Inc / Apple Inc / Applied Materials Inc / CTS Corp / Costco Wholesale Corp / Emerson Electric Co / Intel Corp / KLA Corp / Lam Research Corp / Lattice Semiconductor Corp / Lennox International Inc / Eli Lilly and Co / Littelfuse Inc / MKS Instruments Inc / Microchip Technology Inc / Micron Technology Inc / NVIDIA Corp / ON Semiconductor Corp / Power Integrations Inc / Qualcomm Inc / Semtech Corp / STMicroelectronics NV / Vishay Intertechnology Inc / Western Digital Corp / Xilinx Inc / Bombardier Inc / Zimmer Biomet Holdings Inc / Skyworks Solutions Inc / Monolithic Power Systems Inc / Cogent Communications Holdings Inc / Silicon Motion Technology Corp / Ciena Corp / Macy's Inc / NXP Semiconductors NV / T-Mobile US Inc / MACOM Technology Solutions Holdings Inc / Burlington Stores Inc / Castlight Health Inc / Qorvo Inc / Blueprint Medicines Corp / Conformis Inc / Pure Storage Inc / Syros Pharmaceuticals Inc / Alphatec Holdings Inc / Johnson Controls International PLC / GDS Holdings Ltd / NuCana PLC / TTEC Holdings Inc / Broadcom Inc / Profound Medical Corp / Trane Technologies PLC / Grid Dynamics Holdings Inc / Carrier Global Corp / Smith & Wesson Brands Inc / AVITA Medical Inc / Caesars Entertainment Inc / Aziyo Biologics Inc / Bally's Corp / ContextLogic Inc / MedAvail Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Cayman Islands / Germany / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">03/05/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">SPGI=US / TRIP=US / AAPL=US / IBM=US / LSI=US / PFE=US / AMGN=US / COST=US / DIS=US / INTC=US / TWTR=US / ADI=US / MSFT=US / AMZN=US / QCOM=US / T=US / ORCL=US / VOD=US / WMT=US / TXN=US / AMT=US / DOX=US / NVDA=US / GS=US / AKAM=US / CHTR=US / NICE=US / STM=FR / VZ=US / SMTC=US / CCI=US / UPS=US / XLNX=US / SYMC=US / ASML=US / CMCSA=US / DISH=US / INTU=US / NUAN=US / APPS=US / AVGO=US / HRB=US / CTL=US / COO=US / CME=US / DRRX=US / EGAN=US / EGHT=US / EQIX=US / HEAR=US / MCHP=US / MCO=US / PHAR=US / QUIK=US / SBAC=US / SNAP=US / VG=US / RDWR=US / SNOW=US / NET=US / CRNT=US / FB=US / SWKS=US / NFLX=US / VRNT=US / TWLO=US / ERIC=US / NDAQ=US / RNG=US / OPEN=US / CEVA=US / GOOG=US / BJRI=US / DLR=US / VIAC=US / DISCA=US / CCOI=US / LLNW=US / PRPL=US / LUMN=US / 005930-KR=US / GNRC=US / TSLA=US / MSCI=US / NXPI=US / MRAAY=US / TMUS=US / GTT=US / AVYA=US / GOOGL=US / FIVN=US / EKTAY=US / QRVO=US / VRAY=US / SYRS=US / DZSI=US / FLGT=US / TEUM=US / ATUS=US / NCNA=US / RCKT=US / FOCS=US / XFOR=US / ZM=US / FSLY=US / CMBM=US / DMTK=US / RCEL=US / DKNG=US / RXT=US / ONDS=US</td><td class="leftalignment">S&P Global Inc / Tripadvisor Inc / Apple Inc / International Business Machines Corp / Life Storage Inc / Pfizer Inc / Amgen Inc / Costco Wholesale Corp / Walt Disney Co / Intel Corp / Twitter Inc / Analog Devices Inc / Microsoft Corp / Amazon.com Inc / Qualcomm Inc / AT&T Inc / Oracle Corp / Vodafone Group PLC / Walmart Inc / Texas Instruments Inc / American Tower Corp / Amdocs Ltd / NVIDIA Corp / Goldman Sachs Group Inc / Akamai Technologies Inc / Charter Communications Inc / Nice Ltd / STMicroelectronics NV / Verizon Communications Inc / Semtech Corp / Crown Castle International Corp / United Parcel Service Inc / Xilinx Inc / NortonLifeLock Inc / ASML Holding NV / Comcast Corp / DISH Network Corp / Intuit Inc / Nuance Communications Inc / Digital Turbine Inc / Broadcom Inc / H & R Block Inc / Lumen Technologies Inc / Cooper Companies Inc / CME Group Inc / DURECT Corp / eGain Corp / 8x8 Inc / Equinix Inc / Turtle Beach Corp / Microchip Technology Inc / Moody's Corp / Pharming Group NV / QuickLogic Corp / SBA Communications Corp / Snap Inc / Vonage Holdings Corp / Radware Ltd / Snowflake Inc. / Cloudflare Inc / Ceragon Networks Ltd / Meta Platforms Inc / Skyworks Solutions Inc / Netflix Inc / Verint Systems Inc / Twilio Inc / Telefonaktiebolaget LM Ericsson / Nasdaq Inc / RingCentral Inc / Opendoor Technologies Inc / CEVA Inc / Alphabet Inc / BJ's Restaurants Inc / Digital Realty Trust Inc / ViacomCBS Inc / Discovery Inc / Cogent Communications Holdings Inc / Limelight Networks Inc / Purple Innovation Inc / Lumen Technologies Inc / Farfetch Ltd / Generac Holdings Inc / Tesla Inc / MSCI Inc / NXP Semiconductors NV / Murata Manufacturing Co Ltd / T-Mobile US Inc / GTT Communications Inc / Avaya Holdings Corp / Alphabet Inc / Five9 Inc / Elekta AB (publ) / Qorvo Inc / ViewRay Inc / Syros Pharmaceuticals Inc / DZS Inc / Fulgent Genetics Inc / Pareteum Corp / Altice USA Inc / NuCana PLC / Rocket Pharmaceuticals Inc / Focus Financial Partners Inc / X4 Pharmaceuticals Inc / Zoom Video Communications Inc / Fastly Inc / Cambium Networks Corp / DermTech Inc / AVITA Medical Inc / DraftKings Inc / Rackspace Technology Inc / Ondas Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Cayman Islands / United Kingdom / Israel / Japan / Netherlands / Sweden / United States / Guernsey</td><td class="leftalignment">Biotechnology / Conglomerates / Consumer / Financial Services / Healthcare / Info. Tech./Computers / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Pharmaceuticals / Retailing / Semiconductors / Telecommunications</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/05/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AMGN=US / PD=US / AMZN=US / DVN=US / GILD=US / EOG=US / CRM=US / V=US / SCOR=US / MRO=US / EXPE=US / TNL=US / MANH=US / AIR=US / AVGO=US / ELY=US / MAIN=US / NTST=US / SNAP=US / TRIP=US / VSEC=US / WIX=US / FOUR=US / CVX=US / EPD=US / SNOW=US / PYPL=US / BKNG=US / ADC=US / FB=US / CRTO=US / AUTL=US / VICI=US / PTON=US / FLT=US / LHCG=US / GMS=US / MA=US / GPRE=US / PAG=US / CLR=US / PRPL=US / NOG=US / ATSG=US / AGS=US / CLNY=US / KNSL=US / HGV=US / NXPI=US / ESTE=US / VAC=US / MTDR=US / SPLK=US / PDCE=US / FANG=US / FEYE=US / GOOGL=US / QTWO=US / BABA=US / CMPR=US / WK=US / GDDY=US / ON=US / ARGX=US / ZS=US / WVE=US / CRSP=US / TRVG=US / PLYA=US / OKTA=US / SBOW=US / SFIX=US / FTDR=US / SVMK=US / ALLO=US / ESTC=US / LYFT=US / UBER=US / NXTC=US / OVV=US / ZI=US / BIGC=US / BALY=US / ABNB=US</td><td class="leftalignment">Amgen Inc / PagerDuty Inc / Amazon.com Inc / Devon Energy Corp / Gilead Sciences Inc / EOG Resources Inc / Salesforce.Com Inc / Visa Inc / Comscore Inc / Marathon Oil Corp / Expedia Group Inc / Travel + Leisure Co / Manhattan Associates Inc / AAR Corp / Broadcom Inc / Callaway Golf Co / Main Street Capital Corp / Netstreit Corp / Snap Inc / Tripadvisor Inc / VSE Corp / Wix.Com Ltd / Shift4 Payments Inc / Chevron Corp / Enterprise Products Partners LP / Snowflake Inc. / PayPal Holdings Inc / Booking Holdings Inc / Agree Realty Corp / Meta Platforms Inc / Criteo SA / Autolus Therapeutics PLC / VICI Properties Inc / Peloton Interactive Inc / Fleetcor Technologies Inc / LHC Group Inc / GMS Inc / Mastercard Inc / Green Plains Inc / Penske Automotive Group Inc / Continental Resources Inc / Purple Innovation Inc / Northern Oil and Gas Inc / Air Transport Services Group Inc / PlayAGS Inc / DigitalBridge Group Inc / Kinsale Capital Group Inc / Hilton Grand Vacations Inc / NXP Semiconductors NV / Earthstone Energy Inc / Marriott Vacations Worldwide Corp / Matador Resources Co / Splunk Inc / PDC Energy Inc / Diamondback Energy Inc / Mandiant Inc / Alphabet Inc / Q2 Holdings Inc / Alibaba Group Holding Ltd / Cimpress PLC / Workiva Inc / GoDaddy Inc / ON Semiconductor Corp / argenx SE / Zscaler Inc / WAVE Life Sciences Ltd / CRISPR Therapeutics AG / Trivago NV / Playa Hotels & Resorts NV / Okta Inc / SilverBow Resources Inc / Stitch Fix Inc / Frontdoor Inc / Momentive Global Inc / Allogene Therapeutics Inc / Elastic NV / Lyft Inc / Uber Technologies Inc / NextCure Inc / Ovintiv Inc / ZoomInfo Technologies Inc / Bigcommerce Holdings Inc / Bally's Corp / Airbnb Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / Netherlands / Singapore / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">FPRX Acquisition Boosts Long-Term Growth, Fits Oncology Strategy; PT to $260</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">AMGN=US / AMGN.OQ</td><td class="leftalignment">Amgen Inc / Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="even"><td class="leftalignment">03/05/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - March 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">76</td><td class="leftalignment">GB0007188757 / CA4509131088 / US8336351056 / IL0006290147 / US0311621009 / US22160K1051 / US5010441013 / US92276F1003 / CA13321L1085 / CA0977512007 / CA97535P1045 / CA1363851017 / CA51925D1069 / CA13677F1018 / CA0641491075 / CA6330671034 / CA7800871021 / CA8765111064 / CA5734591046 / CA8911605092 / CA4436281022 / CA1360691010 / US9290421091 / CA2483561072 / US4219461047 / US5021751020 / US63633D1046 / CA14068G1046 / CA66510M2040 / JE00B4T3BW64 / CA3874371147 / CA0158571053 / CA3565001086 / CA09202D2077 / CA21750U1012 / CA89531J1093 / CA89612W1023 / US78573L1061 / US1716041017 / CA33812R1091 / US71943U1043 / US2921041065 / US14174T1079 / CA49448Q1090 / CA30606C1086 / US42225P5017 / CA74273V1067 / US95040Q1040 / CY0106002112 / CA31730E1016 / CA89621C1059 / GB00B67KBV28 / 116072310 / US8760301072 / IL0011417206 / US11135F1012 / US63253R2013 / AU0000018236 / US62921N1054 / CA5625684025 / CA29446Y5020 / AU0000004772 / US42250P1030 / US80810D1037 / CA9004352071 / CA1295844056 / US78440X8048 / JE00BMVMZ478</td><td class="leftalignment">Rio Tinto PLC / IAMGOLD Corp / Sociedad Quimica y Minera de Chile SA / Teva Pharmaceutical Industries Ltd / Amgen Inc / Costco Wholesale Corp / Kroger Co / Ventas Inc / Cameco Corp / Bombardier Inc / Winpak Ltd / Canadian Natural Resources Ltd / Laurentian Bank of Canada / Canadian Western Bank / Bank of Nova Scotia / National Bank of Canada / Royal Bank of Canada / Taseko Mines Ltd / Martinrea International Inc / Toronto-Dominion Bank / Hudbay Minerals Inc / Canadian Imperial Bank of Commerce / Vornado Realty Trust / Denison Mines Corp / Healthcare Realty Trust Inc / LTC Properties Inc / National Health Investors Inc / Capstone Mining Corp / Northern Dynasty Minerals Ltd / Glencore PLC / Granite Real Estate Investment Trust / Algonquin Power & Utilities Corp / Freehold Royalties Ltd / Black Diamond Group Ltd / Copper Mountain Mining Corp / Trevali Mining Corp / Tricon Residential Inc / Sabra Health Care REIT Inc / Chuy's Holdings Inc / Fission Uranium Corp / Physicians Realty Trust / Empire State Realty Trust Inc / CareTrust REIT Inc / Kinaxis Inc / Falco Resources Ltd / Healthcare Trust Of America Inc / Probe Metals Inc / Welltower Inc / Atalaya Mining PLC / Filo Mining Corp / Trilogy Metals Inc / Central Asia Metals PLC / Secure Energy Services Inc / Tapestry Inc / Sol Gel Technologies Ltd / Broadcom Inc / NAK Kazatomprom AO / Nickel Mines Ltd / NGM Biopharmaceuticals Inc / Mandalay Resources Corp / Equinox Gold Corp / Adriatic Metals PLC / Healthpeak Properties Inc / Schrodinger Inc / Turquoise Hill Resources Ltd / Calfrac Well Services Ltd / SL Green Realty Corp / Atotech Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Chile / Cyprus / United Kingdom / Israel / Kazakhstan / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">03/05/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">V / 2701271 / 2360326 / 2516152 / 2000019 / 2023607 / 2026242 / 2544960 / 2219224 / 2222631 / 2270726 / 2829515 / 2382892 / 2317087 / 2670519 / 2345022 / 2100920 / 2471950 / 2459020 / 2684703 / 2048804 / 2746711 / 2862532 / 2799351 / 2989301 / B121557 / 2212922 / B0T7YX2 / B2R3PV1 / 2390817 / 2949758 / BF311Y5 / B7VD3F2 / B7JYSG3 / B8L2798 / B424494 / BFLR866 / BYY8XK8 / BYVY8G0 / BD9GVY0 / BJ2Z0H2 / BFMXGR0 / BJJMGL2 / BZ8VJQ8 / BKTNTR9 / BDFZSP1 / BJVR9Y9 / BYSGPK2 / BDVLM39 / BZ0P3Z5 / BP84RX0 / BKT6B38 / BFY7DC4</td><td class="leftalignment">Visa Inc / Costco Wholesale Corp / Gap Inc / Eli Lilly and Co / Amazon.com Inc / Amgen Inc / American Electric Power Company Inc / Beasley Broadcast Group Inc / CMS Energy Corp / Cooper Companies Inc / Walt Disney Co / Edison International / Audacy Inc / Entergy Corp / Exelon Corp / Macy's Inc / FirstEnergy Corp / Incyte Corp / Intuit Inc / Pfizer Inc / Pinnacle West Capital Corp / Ross Stores Inc / E W Scripps Co / Sinclair Broadcast Group Inc / TJX Companies Inc / Mastercard Inc / NRG Energy Inc / Live Nation Entertainment Inc / American Water Works Company Inc / Gray Television Inc / Nexstar Media Group Inc / Burlington Stores Inc / Duke Energy Corp / Guidewire Software Inc / Hemisphere Media Group Inc / Splunk Inc / Twitter Inc / WEC Energy Group Inc / Alphabet Inc / Zai Lab Ltd / Pinterest Inc / Evergy Inc / Fox Corp / Vistra Corp / ViacomCBS Inc / Okta Inc / iHeartMedia Inc / ViewRay Inc / argenx SE / Tegna Inc / Townsquare Media Inc / SmileDirectClub Inc / Altimmune Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">03/05/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - March 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AFL.N / AIG.N / AXAF.PA / BAC.N / BAER.S / BARC.L / BK.N / BNS.TO / CM.TO / COST.O / CSGN.S / DFDS.CO / FITB.O / GPS.N / HSBA.L / KEY.N / LLOY.L / MMC.N / MUVGn.DE / NTRS.O / PB.N / PRU.L / RWEG.DE / SAN.MC / SOGN.PA / SVT.L / TRV.N / USB.N / ZION.O / CMA.N / CNQ.TO / CPB.N / POW.TO / AMGN.O / MET.N / AAL.L / HBAN.O / GS.N / MRO.N / UNM.N / BBVA.MC / RDN.N / VLY.N / PACW.O / AMP.N / CINF.O / LNC.N / RRC.N / NLY.N / EPD.N / NBIX.O / MTB.N / DB1Gn.DE / ARCC.O / CWB.TO / PFG.N / CIX.TO / SM.N / AV.L / RF.N / AVGO.O / CPE.N / CFR.N / BRO.N / RLI.N / WBS.N / FCF.N / MFA.N / PFS.N / X.TO / FFBC.O / SIGI.O / SIVB.O / WSBC.O / HOOK.O / BPOP.O / BOKF.O / COLB.O / ACGL.O / WTFC.O / TFC.N / INGA.AS / FHN.N / AINV.O / MAIN.N / IGM.TO / 416515104 / GMS.N / WAL.N / BAM.N / MS.N / 025676206 / ISBC.O / MA.N / GETP.PA / CIM.N / WRB.N / AGNC.O / HOMB.O / IFC.TO / BKU.N / FHI.N / TWO.N / SLM.OQ / EFN.TO / ALLY.N / SMLP.N / FANG.O / NYCB.N / APAM.N / ORCC.N / VOYA.N / DOC.N / ONB.OQ / 46579R104 / BURL.N / TSLX.N / ARES.N / VNOM.O / NMIH.O / CFG.N / GWB.N / ASB.N / BSM.N / WVE.OQ / OMF.N / RMR.OQ / UBSG.S / KNSL.OQ / BBU.N / UN01.DE / ONEX.TO / AQN.N / KRP.N / RCM.OQ / CADE.N / ORSTED.CO / 05971J102 / VCTR.N / BSIG.N / GSHD.O / FOCS.O / FLMN.OQ / MNRL.N / SBSW.N / AHCO.O / VMD.OQ / FOUR.N / JAMF.O / LSEG.L</td><td class="leftalignment">Aflac Inc / American International Group Inc / AXA SA / Bank of America Corp / Julius Baer Gruppe AG / Barclays PLC / Bank of New York Mellon Corp / Bank of Nova Scotia / Canadian Imperial Bank of Commerce / Costco Wholesale Corp / Credit Suisse Group AG / DFDS AS / Fifth Third Bancorp / Gap Inc / HSBC Holdings PLC / KeyCorp / Lloyds Banking Group PLC / Marsh & McLennan Companies Inc / Muenchener Rueckversicherungs Gesellschaft in Muenchen AG / Northern Trust Corp / Prosperity Bancshares Inc / Prudential PLC / Rwe AG / Banco Santander SA / Societe Generale SA / Severn Trent PLC / Travelers Companies Inc / US Bancorp / Zions Bancorporation NA / Comerica Inc / Canadian Natural Resources Ltd / Campbell Soup Co / Power Corporation of Canada / Amgen Inc / MetLife Inc / Anglo American PLC / Huntington Bancshares Inc / Goldman Sachs Group Inc / Marathon Oil Corp / Unum Group / Banco Bilbao Vizcaya Argentaria SA / Radian Group Inc / Valley National Bancorp / PacWest Bancorp / Ameriprise Financial Inc / Cincinnati Financial Corp / Lincoln National Corp / Range Resources Corp / Annaly Capital Management Inc / Enterprise Products Partners LP / Neurocrine Biosciences Inc / M&T Bank Corp / Deutsche Boerse AG / Ares Capital Corp / Canadian Western Bank / Principal Financial Group Inc / CI Financial Corp / SM Energy Co / Aviva PLC / Regions Financial Corp / Broadcom Inc / Callon Petroleum Co / Cullen/Frost Bankers Inc / Brown & Brown Inc / Rli Corp / Webster Financial Corp / First Commonwealth Financial Corp / MFA Financial Inc / Provident Financial Services Inc / TMX Group Ltd / First Financial Bancorp / Selective Insurance Group Inc / SVB Financial Group / WesBanco Inc / HOOKIPA Pharma Inc / Popular Inc / BOK Financial Corp / Columbia Banking System Inc / Arch Capital Group Ltd / Wintrust Financial Corp / Truist Financial Corp / ING Groep NV / First Horizon Corp / Apollo Investment Corp / Main Street Capital Corp / IGM Financial Inc / Hartford Financial Services Group Inc / GMS Inc / Western Alliance Bancorp / Brookfield Asset Management Inc / Morgan Stanley / American Equity Investment Life Holding Co / Investors Bancorp Inc / Mastercard Inc / Getlink SE / Chimera Investment Corp / W R Berkley Corp / AGNC Investment Corp / Home BancShares Inc / Intact Financial Corp / BankUnited Inc / Federated Hermes Inc / Two Harbors Investment Corp / SLM Corp / Element Fleet Management Corp / Ally Financial Inc / Summit Midstream Partners LP / Diamondback Energy Inc / New York Community Bancorp Inc / Artisan Partners Asset Management Inc / Owl Rock Capital Corp / Voya Financial Inc / Physicians Realty Trust / Old National Bancorp / Ivanhoe Mines Ltd / Burlington Stores Inc / Sixth Street Specialty Lending Inc / Ares Management Corp / Viper Energy Partners LP / NMI Holdings Inc / Citizens Financial Group Inc / Great Western Bancorp Inc / Associated Banc-Corp / Black Stone Minerals LP / WAVE Life Sciences Ltd / OneMain Holdings Inc / RMR Group Inc / UBS Group AG / Kinsale Capital Group Inc / Brookfield Business Partners LP / Uniper SE / Onex Corp / Algonquin Power & Utilities Corp / Kimbell Royalty Partners LP / R1 RCM Inc / Cadence Bank / Orsted A/S / Cadence Bank / Victory Capital Holdings Inc / Brightsphere Investment Group Inc / Goosehead Insurance Inc / Focus Financial Partners Inc / Falcon Minerals Corp / Brigham Minerals Inc / Sibanye Stillwater Ltd / Adapthealth Corp / Viemed Healthcare Inc / Shift4 Payments Inc / Jamf Holding Corp / London Stock Exchange Group PLC</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Netherlands / Puerto Rico / Singapore / United States / South Africa</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">03/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AMGN.OQ / BIIB.OQ / 4502.T / JNJ.N / LLY.N / MRK.N / AZN.L / SASY.PA / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / GLPG.AS / ACRX.OQ / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Amgen Inc / Biogen Inc / Takeda Pharmaceutical Co Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / AstraZeneca PLC / Sanofi SA / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Galapagos NV / AcelRx Pharmaceuticals Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / France / United Kingdom / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Yunhee Park / Jonathan Woo</td></tr>
<tr class="even"><td class="leftalignment">03/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Zai Lab: Amgen to acquire Five Prime for US$1.9 bn, suggesting high confidence and interest in GC drug - bemarituzumab. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.OQ / ZLAB.OQ / NVCR.OQ</td><td class="leftalignment">Amgen Inc / Zai Lab Ltd / Novocure Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang</td></tr>
<tr class="odd"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Five Prime Acquisition Adds De-Risked Asset To Late Stage Oncology Pipeline</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US0311621009 / AMGN.OQ</td><td class="leftalignment">Amgen Inc / Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Yaron Werber, M.D., MD / Brendan Smith, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Adding FPRX to our model with many caveats; PT up $3 to $266</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN=US</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Minh Vong</td></tr>
<tr class="odd"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Gut Check-Looks Like a (Five) Prime Deal</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AMGN=US</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/04/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Five Prime Acquisition Furthers Push Into Solid Tumors With Late-Stage Asset in Bemarituzumab</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">03116210</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="odd"><td class="leftalignment">03/04/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">FPRX acquisition expands oncology pipeline focus on gastric cancer & market opportunities in Asia</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Kennen MacKay, PHD / Edwin Delfin</td></tr>
<tr class="even"><td class="leftalignment">03/04/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Amgen Inc : FPRX Deal Checks Strategic Boxes But Unlikely to Move the Needle</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Mr. Turner Kufe</td></tr>
<tr class="odd"><td class="leftalignment">03/04/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Five Prime Acquisition Driven by Broader Asia Opportunity</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Do G. Kim / Jameson Kao / Ikechukwu Oji</td></tr>
<tr class="even"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Know the Ledge – Biggest Biotech Outflows So Far This Year</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / 039697107 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / 19240Q201</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Ardelyx Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / Cogent Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Five Prime Deal a Nice Tuck-in; More Please</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">031162100</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">FPRX (BUY) & AMGN (NEUTRAL): Deal Highlights Strategic Value of Genetic Drivers in Oncology and De-Risking Clinical Data</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">2023607</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Etzer Darout / Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Paul Jeng, Ph.D. / Yige Guo, Ph.D. / Kelsey Goodwin</td></tr>
<tr class="odd"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">AMGN.OQ - Event Transcript of Amgen Inc conference call, Mar. 04, 2021 / 12:50PM ET</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Amgen Offers To Acquire Five Prime for $38/Share</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.OQ / US0311621009</td><td class="leftalignment">Amgen Inc / Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Boris Peaker, Ph.D., CFA, Ph.D. / Cynthia Chen, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">AMGN.OQ - Event Brief of Amgen Inc conference call, Mar. 04, 2021 / 10:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">AMGN.OQ - Event Transcript of Amgen Inc conference call, Mar. 04, 2021 / 10:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/04/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Here We Go...FPRX Adds Ph3 Solid Tumor Asset at Modest Price. More M&A to Come?</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AMGN=US</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="even"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">China-sourced PD1s coming to a market near you!</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">031162100 / 09062X103 / 5671735 / 0989529 / 0925288 / 7103065 / 7110388 / 717081103 / 375558103 / 110122108 / 532457108 / 75886F107 / 58933Y105 / 00287Y109</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / China / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">FPRX acquisition makes sense and could contribute to AMGN’s growth through ex-US markets</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AMGN=US</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Minh Vong</td></tr>
<tr class="even"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">AMGN: Amgen, Inc. - Acquisition of Five Prime Therapeutics for $1.9B; Encouraged by diversification of pipeline with bemarituzumab but data are not a home-run</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AMGN.OQ / 9688.HK</td><td class="leftalignment">Amgen Inc / Zai Lab Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Credit Suisse Healthcare Conference: Day 2: Fireside discussion highlights</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">4502.T / 4507.T / CSL.AX / JNJ.N / PFE.N / PHG.AS / RECI.MI / AZN.L / SASY.PA / NOVN.S / LONN.S / QIA.DE / GSK.L / UCB.BR / GN.CO / AMGN.OQ / GLPG.AS / IPN.PA / SHLG.DE / MOLN.S / SKIN.S / ARGX.OQ / IDIA.S / IQV.N / MOVE.S</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Shionogi & Co Ltd / CSL Ltd / Johnson & Johnson / Pfizer Inc / Koninklijke Philips NV / Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sanofi SA / Novartis AG / Lonza Group AG / Qiagen NV / GlaxoSmithKline PLC / Ucb SA / GN Store Nord A/S / Amgen Inc / Galapagos NV / Ipsen SA / Siemens Healthineers AG / Molecular Partners AG / Cassiopea SpA / argenx SE / Idorsia Ltd / IQVIA Holdings Inc / Medacta Group SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / Germany / Denmark / France / United Kingdom / Italy / Japan / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Ms. Gretel Janu / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">03/03/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BIIB-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB.O / BIO / JNJ / PFE / GILD.O / AMGN.O / ILMN.O / ACOR.O / ABBV.K / QGEN.K / SNY.O</td><td class="leftalignment">Biogen Inc / Bio Rad Laboratories Inc / Johnson & Johnson / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Acorda Therapeutics Inc / Abbvie Inc / Qiagen NV / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">03/03/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Mar 3 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US00846U1016 / US0311621009 / US1985161066 / US2435371073 / US28176E1082 / US4448591028 / US5002551043 / US6752321025 / US75886F1075 / US7782961038 / US8636671013 / US2533931026 / US0043971052 / US58733R1023 / CH0048265513 / US8036071004 / US85916J4094 / KYG037AX1015 / US60468T1051 / US1220171060 / IL0011316309 / IE00BQPVQZ61 / US31572Q8087 / IE00BTN1Y115 / US87918A1051 / US07725L1026 / US81141R1005 / US74766Q1013 / VGG312491084 / US55087P1049 / US89377M1099 / US03828A1016 / US00650F1093 / CA74319B5027 / US68902V1070</td><td class="leftalignment">Agilent Technologies Inc / Amgen Inc / Columbia Sportswear Co / Deckers Outdoor Corp / Edwards Lifesciences Corp / Humana Inc / Kohls Corp / Oceaneering International Inc / Regeneron Pharmaceuticals Inc / Ross Stores Inc / Stryker Corp / DICK'S Sporting Goods Inc / Accuray Inc / Mercadolibre Inc / Transocean Ltd / Sarepta Therapeutics Inc / Stereotaxis Inc / Ambarella Inc / Mirati Therapeutics Inc / Burlington Stores Inc / Mediwound Ltd / Horizon Therapeutics PLC / FibroGen Inc / Medtronic PLC / Teladoc Health Inc / Beigene Ltd / Sea Ltd / Quanterix Corp / Establishment Labs Holdings Inc / Lyft Inc / Transmedics Group Inc / Applied Therapeutics Inc / Adaptive Biotechnologies Corp / Profound Medical Corp / Otis Worldwide Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Ireland / Israel / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">03/03/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">AXP / V / 0989529 / 2023607 / 2486813 / 2026242 / 2065955 / 2544960 / 2280220 / 2270726 / 2542049 / 2382892 / 2623911 / 2862532 / 2799351 / 7123870 / 2822019 / 2212922 / B1Y9TB3 / B2R3PV1 / 2390817 / 2949758 / B3SWPT2 / B65LWX6 / B7TL820 / B8L2798 / B8CKK03 / BFLR866 / B6WXT12 / BFH3N85 / BYRY499 / BYVY8G0 / BYW36M8 / BYNZGK1 / BK1KWF7 / BYZR4X4 / BJ5FZ74 / BFZ1K46 / BZ8VJQ8 / BDFZSP1 / BGSP7M9 / BJVR9Y9 / BZ1LFG7 / BL71K91 / BZ0P3Z5 / BKWD3M9 / BRJ3GY4 / BP84RX0 / BKLCX50 / BF3N4P3 / BN0XTW4 / BLBLMD5 / BMCC9R7</td><td class="leftalignment">American Express Co / Visa Inc / AstraZeneca PLC / Amgen Inc / Kellogg Co / American Electric Power Company Inc / Autozone Inc / Beasley Broadcast Group Inc / DTE Energy Co / Walt Disney Co / Dominion Energy Inc / Audacy Inc / Neurocrine Biosciences Inc / E W Scripps Co / Sinclair Broadcast Group Inc / Nestle SA / Advance Auto Parts Inc / NRG Energy Inc / Danone SA / American Water Works Company Inc / Gray Television Inc / Nexstar Media Group Inc / Ameresco Inc / O'Reilly Automotive Inc / Meta Platforms Inc / Hemisphere Media Group Inc / Mondelez International Inc / Twitter Inc / TherapeuticsMD Inc / Veeva Systems Inc / Kraft Heinz Co / Alphabet Inc / PayPal Holdings Inc / Block Inc / Grocery Outlet Holding Corp / Axsome Therapeutics Inc / Adaptive Biotechnologies Corp / Spotify Technology SA / Vistra Corp / Okta Inc / Zoom Video Communications Inc / iHeartMedia Inc / Roku Inc / Revolution Medicines Inc / Tegna Inc / Progyny Inc / Xenon Pharmaceuticals Inc / Townsquare Media Inc / Health Catalyst Inc / Arena Pharmaceuticals Inc / Orphazyme A/S / Array Technologies Inc / SCYNEXIS Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / France / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">03/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Global Pharmaceuticals: AZN/Amgen: Feedback from our expert call on tezepelumab P3 NAVIGATOR data</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AMGN.OQ / AZN.L / GSK.L</td><td class="leftalignment">Amgen Inc / AstraZeneca PLC / GlaxoSmithKline PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston / Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Yunhee Park / Jonathan Woo</td></tr>
<tr class="even"><td class="leftalignment">03/03/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Rating Update for Amgen Inc</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="odd"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Conf Highlights: REGN Bispecifics, FGEN AdCom, KRAS Update, Sitravatinib Solid</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">FGEN.OQ / REGN.OQ / US0311621009 / US75886F1075 / US60468T1051 / US31572Q8087 / US07725L1026</td><td class="leftalignment">FibroGen Inc / Regeneron Pharmaceuticals Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Mirati Therapeutics Inc / FibroGen Inc / Beigene Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Cayman Islands / Denmark / United Kingdom / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Yaron Werber, M.D., MD / Brendan Smith, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">RVMD (BUY) - Pipeline on Track Heading into Multiple 2021-2022 Milestones; Maintain BUY</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BL71K91 / 0989529 / 2516152 / 2023607 / 2778844 / BBPK0J0</td><td class="leftalignment">Revolution Medicines Inc / AstraZeneca PLC / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Mirati Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">03/02/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ARE-US -  Dividend Quality Analysis, for the period ended January 15,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY / LLY / PFE / GILD.O / AMGN.O / ILMN.O / ALNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Alnylam Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Turkey / United States</td><td class="leftalignment">Real Estate</td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">03/02/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">FY2020 Annual Report: Amgen Net Profit down 7.4%; Institutional Ownership down 3%</td><td class="leftalignment">English</td><td class="rightalignment">71</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Infinata</td><td class="leftalignment">Amgen, Inc. - Company Report</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Infinata</td></tr>
<tr class="even"><td class="leftalignment">03/02/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Third Vaccine EUA Should Expand Access, New Variant Boosters Developed, Domestic and Global Improvements Slowing</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">EVAX=US / SRCL=US / AAPL=US / MRK=US / BSX=US / PFE=US / AMGN=US / BMY=US / AMD=US / TSM=US / AZN=US / GSK=US / ETN=US / ANGN=US / ACI=US / AZO=US / BCRX=US / KMX=US / GRTS=US / ICPT=US / PHG=US / ORLY=US / PHAR=US / WSC=US / RHHBY=US / BIIB=US / MRNA=US / INO=US / AGRX=US / TPTX=US / PRPL=US / CVAC=US / AMRC=US / 2454-TW=US / PRTA=US / GNCA=US / IONS=US / MDGL=US / IRTC=US / UAA=US / AVDL=US / CVNA=US / CSPR=US / ATNX=US / ZM=US / TMDX=US / BNTX=US / PHVS=US</td><td class="leftalignment">Evaxion Biotech A/S / Stericycle Inc / Apple Inc / Merck & Co Inc / Boston Scientific Corp / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Advanced Micro Devices Inc / Taiwan Semiconductor Manufacturing Co Ltd / AstraZeneca PLC / GlaxoSmithKline PLC / Eaton Corporation PLC / Angion Biomedica Corp / Albertsons Companies Inc / Autozone Inc / BioCryst Pharmaceuticals Inc / Carmax Inc / Gritstone bio Inc / Intercept Pharmaceuticals Inc / Koninklijke Philips NV / O'Reilly Automotive Inc / Pharming Group NV / Willscot Mobile Mini Holdings Corp / Roche Holding AG / Biogen Inc / Moderna Inc / Inovio Pharmaceuticals Inc / Agile Therapeutics Inc / Turning Point Therapeutics Inc / Purple Innovation Inc / CureVac NV / Ameresco Inc / MediaTek Inc / Prothena Corporation PLC / Genocea Biosciences Inc / Ionis Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / iRhythm Technologies Inc / Under Armour Inc / Avadel Pharmaceuticals PLC / Carvana Co / Casper Sleep Inc / Athenex Inc / Zoom Video Communications Inc / Transmedics Group Inc / BioNTech SE / Pharvaris NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / United Kingdom / Ireland / Netherlands / Taiwan / United States</td><td class="leftalignment">Biotechnology / Conglomerates / Consumer / Electrical / Financial Services / Healthcare / Info. Tech./Software / Pharmaceuticals / Retailing / Semiconductors / Services</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRK=US / WMB=US / LLY=US / PFE=US / AMGN=US / HD=US / MCD=US / WEN=US / T=US / BLD=US / TEVA=US / KMI=US / AMT=US / AKAM=US / CHTR=US / CONE=US / VZ=US / LOW=US / PAA=US / CCI=US / HSII=US / CHRS=US / BYD=US / LEG=US / TNL=US / KFRC=US / MGM=US / PENN=US / CMCSA=US / DISH=US / AIR=US / KFY=US / AMN=US / CBRL=US / DRI=US / EQIX=US / GFF=US / IBP=US / MAN=US / MAS=US / MPLX=US / MHK=US / MCRI=US / ASGN=US / OKE=US / PRGO=US / REGI=US / RHI=US / SBAC=US / SGMO=US / TRGP=US / TRUE=US / VRTX=US / EPD=US / SNOW=US / SGMS=US / CCRN=US / DCP=US / DIN=US / MMP=US / TPX=US / EXP=US / CZR=US / CDLX=US / BECN=US / DLR=US / PLAY=US / DENN=US / BLDR=US / GMS=US / NSP=US / SPWR=US / SCPL=US / CMG=US / REX=US / CCOI=US / PGTI=US / GPRE=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / PAGP=US / JACK=US / CLNY=US / TREX=US / HGV=US / NLSN=US / APTS=US / VAC=US / FBHS=US / ENPH=US / SMLP=US / TILE=US / TMUS=US / NDLS=US / CEQP=US / ASMB=US / LOCO=US / VCEL=US / SHAK=US / WING=US / SPNE=US / AXSM=US / ADVM=US / 82982L103 / CRSP=US / PVAC=US / GDS=US / JELD=US / ATNX=US / SWCH=US / RTLR=US / LHX=US / FERGY=US / RPAY=US / AZEK=US / CRMD.US / BALY=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Williams Companies Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / McDonald's Corp / Wendys Co / AT&T Inc / TopBuild Corp / Teva Pharmaceutical Industries Ltd / Kinder Morgan Inc / American Tower Corp / Akamai Technologies Inc / Charter Communications Inc / CyrusOne Inc / Verizon Communications Inc / Lowe's Companies Inc / Plains All American Pipeline LP / Crown Castle International Corp / Heidrick & Struggles International Inc / Coherus BioSciences Inc / Boyd Gaming Corp / Leggett & Platt Inc / Travel + Leisure Co / Kforce Inc / MGM Resorts International / Penn National Gaming Inc / Comcast Corp / DISH Network Corp / AAR Corp / Korn Ferry / AMN Healthcare Services Inc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Equinix Inc / Griffon Corp / Installed Building Products Inc / ManpowerGroup Inc / Masco Corp / MPLX LP / Mohawk Industries Inc / Monarch Casino & Resort Inc / ASGN Inc / ONEOK Inc / Perrigo Company PLC / Renewable Energy Group Inc / Robert Half International Inc / SBA Communications Corp / Sangamo Therapeutics Inc / Targa Resources Corp / TrueCar Inc / Vertex Pharmaceuticals Inc / Enterprise Products Partners LP / Snowflake Inc. / Scientific Games Corp / Cross Country Healthcare Inc / DCP Midstream LP / Dine Brands Global Inc / Magellan Midstream Partners LP / Tempur Sealy International Inc / Eagle Materials Inc / Caesars Entertainment Inc / Cardlytics Inc / Beacon Roofing Supply Inc / Digital Realty Trust Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Insperity Inc / SunPower Corp / Sciplay Corp / Chipotle Mexican Grill Inc / REX American Resources Corp / Cogent Communications Holdings Inc / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Plains GP Holdings LP / Jack in the Box Inc / DigitalBridge Group Inc / Trex Company Inc / Hilton Grand Vacations Inc / Nielsen Holdings PLC / Preferred Apartment Communities Inc / Marriott Vacations Worldwide Corp / Fortune Brands Home & Security Inc / Enphase Energy Inc / Summit Midstream Partners LP / Interface Inc / T-Mobile US Inc / Noodles & Co / Crestwood Equity Partners LP / Assembly Biosciences Inc / El Pollo Loco Holdings Inc / Vericel Corp / Shake Shack Inc / Wingstop Inc / SeaSpine Holdings Corp / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / SiteOne Landscape Supply Inc / CRISPR Therapeutics AG / Ranger Oil Corp / GDS Holdings Ltd / JELD-WEN Holding Inc / Athenex Inc / Switch Inc / Rattler Midstream LP / L3harris Technologies Inc / Ferguson PLC / Repay Holdings Corp / Azek Company Inc / CorMedix Inc / Bally's Corp / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / Ireland / Israel / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BOLT (BUY) - Lightning Strikes Twice with Immune-Stimulating ADCs; Initiating with a BUY and $42 PT</td><td class="leftalignment">English</td><td class="rightalignment">68</td><td class="leftalignment">BMDJ397 / 5671735 / 0989529 / 2126335 / 2516152 / 2023607 / 2778844 / 2369174 / 2457864 / 2684703 / 7103065 / 2982924 / BFDV8K0 / BMQ5T49 / BKVDFF7 / BYQHPK7 / BL71K91 / BN2R582 / BG0Q4Y1 / BF3NP05</td><td class="leftalignment">Bolt Biotherapeutics Inc / Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Gilead Sciences Inc / ImmunoGen Inc / Pfizer Inc / Novartis AG / Spectrum Pharmaceuticals Inc / MacroGenics Inc / Zentalis Pharmaceuticals Inc / Oric Pharmaceuticals Inc / Zymeworks Inc / Revolution Medicines Inc / Relay Therapeutics Inc / Exicure Inc / Mersana Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="even"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">NAVIGATOR Results Support Differentiated Profile</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AMGN=US / AZN=US</td><td class="leftalignment">Amgen Inc / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">JNJ.N / PFIZ.NS / AMGN.OQ / HGEN.OQ</td><td class="leftalignment">Johnson & Johnson / Pfizer Ltd / Amgen Inc / Humanigen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">India / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for AMGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">AWK / C / CNI / CP / DVN / EOG / JNJ / MGY / NSC / OLN / PVH / PXD / RKT / UNP / WLK / ASND.O / GILD.O / AMGN.O / SGMO.O / ARNA.O / ISRG.O / REGN.O / TSCO.O / CALA.O / BLUE.O / ICPT.O / BIIB.O / INFI.O / HALO.O / MRNA.O / ZIOP.O / ARCT.O / RGLS.O / FANG.O / MEIP.O / RNA.O / FATE.O / QURE.O / AGTC.O / AFMD.O / BLCM.O / TCON.O / ZBH / CYAD.O / GBT.O / VYGR.O / CSX.O / IONS.O / ADAP.O / EDIT.O / AGLE.O / NTLA.O / CRSP.O / JNCE.O / CLLS.O / ZYME.K / IOVA.O / CDLX.O / AVRO.O / AUTL.O / KZR.O / STRO.O / CPRI.K / TPTX.O / RTLR.O / MORF.O / BCSF.K / IMV.O / PGEN.O / GHLD.K / GRCL.O / 87975H100</td><td class="leftalignment">American Water Works Company Inc / Citigroup Inc / Canadian National Railway Co / Canadian Pacific Railway Ltd / Devon Energy Corp / EOG Resources Inc / Johnson & Johnson / Magnolia Oil & Gas Corp / Norfolk Southern Corp / Olin Corp / PVH Corp / Pioneer Natural Resources Co / Rocket Companies Inc / Union Pacific Corp / Westlake Chemical Corp / Ascendis Pharma A/S / Gilead Sciences Inc / Amgen Inc / Sangamo Therapeutics Inc / Arena Pharmaceuticals Inc / Intuitive Surgical Inc / Regeneron Pharmaceuticals Inc / Tractor Supply Co / Calithera Biosciences Inc / bluebird bio Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Infinity Pharmaceuticals Inc / Halozyme Therapeutics Inc / Moderna Inc / ZIOPHARM Oncology Inc / Arcturus Therapeutics Holdings Inc / Regulus Therapeutics Inc / Diamondback Energy Inc / MEI Pharma Inc / Avidity Biosciences Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Affimed NV / Bellicum Pharmaceuticals Inc / TRACON Pharmaceuticals Inc / Zimmer Biomet Holdings Inc / Celyad Oncology SA / Global Blood Therapeutics Inc / Voyager Therapeutics Inc / CSX Corp / Ionis Pharmaceuticals Inc / Adaptimmune Therapeutics PLC / Editas Medicine Inc / Aeglea Bio Therapeutics Inc / Intellia Therapeutics Inc / CRISPR Therapeutics AG / Jounce Therapeutics Inc / Cellectis SA / Zymeworks Inc / Iovance Biotherapeutics Inc / Cardlytics Inc / AVROBIO Inc / Autolus Therapeutics PLC / Kezar Life Sciences Inc / Sutro Biopharma Inc / Capri Holdings Ltd / Turning Point Therapeutics Inc / Rattler Midstream LP / Morphic Holding Inc / Bain Capital Specialty Finance Inc / IMV Inc / Precigen Inc / Guild Holdings Co / Gracell Biotechnologies Inc / Telus International Cda Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Feb 19, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Guggenheim Ther Research</td></tr>
<tr class="odd"><td class="leftalignment">03/01/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Teze Phase III Confirms Broad Benefit; Lack of OCS Claim Limits High Eos Share</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">AMGN=US / AZN=US</td><td class="leftalignment">Amgen Inc / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="even"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Suspending Coverage: Biotechnology</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AMGN.O / BLCM.O / GILD.O / REGN.O / ICPT.O / BIIB.O / IMV.O</td><td class="leftalignment">Amgen Inc / Bellicum Pharmaceuticals Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / IMV Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Croatia / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / INDUSTRY REPORTS / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">SNSE=US / WSC=US / AAPL=US / IBM=US / WMB=US / BSX=US / LLY=US / CSCO=US / ABT=US / AMGN=US / CAT=US / COST=US / INTC=US / KO=US / MCD=US / AMD=US / WM=US / BWA=US / EFX=US / MSFT=US / MDT=US / JNPR=US / K=US / AMZN=US / T=US / ORCL=US / WMT=US / RUN=US / D=US / ED=US / NTRS=US / WFC=US / NVDA=US / HBI=US / AKAM=US / YUM=US / SO=US / NTAP=US / JPM=US / FCEL=US / PLUG=US / FSR=US / TRU=US / NVS=US / VZ=US / PWR=US / PBR=US / EL=US / BJ=US / SAP=US / URI=US / TSM=US / BAX=US / CRIS=US / GSK=US / HON=US / JCI=US / JNJ=US / TTWO=US / LEG=US / CTXS=US / LRCX=US / DLTR=US / DE=US / EIX=US / UNH=US / AAON=US / RSG=US / ABMD=US / ALB=US / AMSC=US / APPS=US / ARRY=US / AVNT=US / AVGO=US / BMRN=US / HRB=US / CMI=US / CHD=US / CSGP=US / CREE=US / DHI=US / XRAY=US / EW=US / EQIX=US / GRTS=US / ISRG=US / ITRI=US / TREE=US / MS=US / MCO=US / OSIS=US / HOOK=US / ROK=US / HSIC=US / SJM=US / TRMB=US / UTL=US / VCTR=US / ALGN=US / PFG=US / PRVB=US / CINF=US / SIVB=US / ARE=US / NEP=US / O=US / SWKS=US / NFLX=US / BE=US / CLH=US / WCN=US / CMPI=US / MNST=US / PTON=US / ONCR=US / ACAD=US / ENS=US / TWIN=US / ORA=US / LHCG=US / AMRS=US / SPWR=US / CSIQ=US / FSLR=US / QSR=US / BX=US / LULU=US / VMW=US / DAN=US / SPGI=US / WPRT=US / CLDX=US / KKR=US / AGCO=US / VRSK=US / TCEHY=US / NEE=US / TSLA=US / MSCI=US / AMRC=US / FDUS=US / 2454-TW=US / ENPH=US / TMUS=US / HASI=US / MRTX=US / CNHI=US / GNCA=US / BABA=US / SEDG=US / ZBH=US / PSTG=US / AQMS=US / HPE=US / SQ=US / WKHS=US / OKTA=US / APTV=US / CWEN=US / UBER=US / KRTX=US / BNTX=US / NLOK=US / DKNG=US / VLDR=US / SHLS=US / 116973221</td><td class="leftalignment">Sensei Biotherapeutics Inc / Willscot Mobile Mini Holdings Corp / Apple Inc / International Business Machines Corp / Williams Companies Inc / Boston Scientific Corp / Eli Lilly and Co / Cisco Systems Inc / Abbott Laboratories / Amgen Inc / Caterpillar Inc / Costco Wholesale Corp / Intel Corp / Coca-Cola Co / McDonald's Corp / Advanced Micro Devices Inc / Waste Management Inc / Borgwarner Inc / Equifax Inc / Microsoft Corp / Medtronic PLC / Juniper Networks Inc / Kellogg Co / Amazon.com Inc / AT&T Inc / Oracle Corp / Walmart Inc / Sunrun Inc / Dominion Energy Inc / Consolidated Edison Inc / Northern Trust Corp / Wells Fargo & Co / NVIDIA Corp / HanesBrands Inc / Akamai Technologies Inc / Yum! Brands Inc / Southern Co / NetApp Inc / JPMorgan Chase & Co / Fuelcell Energy Inc / Plug Power Inc / Fisker Inc / TransUnion / Novartis AG / Verizon Communications Inc / Quanta Services Inc / Petroleo Brasileiro SA Petrobras / Estee Lauder Companies Inc / BJ's Wholesale Club Holdings Inc / SAP SE / United Rentals Inc / Taiwan Semiconductor Manufacturing Co Ltd / Baxter International Inc / Curis Inc / GlaxoSmithKline PLC / Honeywell International Inc / Johnson Controls International PLC / Johnson & Johnson / Take-Two Interactive Software Inc / Leggett & Platt Inc / Citrix Systems Inc / Lam Research Corp / Dollar Tree Inc / Deere & Co / Edison International / UnitedHealth Group Inc / Aaon Inc / Republic Services Inc / ABIOMED Inc / Albemarle Corp / American Superconductor Corp / Digital Turbine Inc / Array Technologies Inc / Avient Corp / Broadcom Inc / Biomarin Pharmaceutical Inc / H & R Block Inc / Cummins Inc / Church & Dwight Co Inc / CoStar Group Inc / Wolfspeed Inc / D R Horton Inc / DENTSPLY SIRONA Inc / Edwards Lifesciences Corp / Equinix Inc / Gritstone bio Inc / Intuitive Surgical Inc / Itron Inc / Lendingtree Inc / Morgan Stanley / Moody's Corp / OSI Systems Inc / HOOKIPA Pharma Inc / Rockwell Automation Inc / Henry Schein Inc / J M Smucker Co / Trimble Inc / Unitil Corp / Victory Capital Holdings Inc / Align Technology Inc / Principal Financial Group Inc / Provention Bio Inc / Cincinnati Financial Corp / SVB Financial Group / Alexandria Real Estate Equities Inc / Nextera Energy Partners LP / Realty Income Corp / Skyworks Solutions Inc / Netflix Inc / Bloom Energy Corp / Clean Harbors Inc / Waste Connections Inc / Checkmate Pharmaceuticals Inc / Monster Beverage Corp / Peloton Interactive Inc / Oncorus Inc / ACADIA Pharmaceuticals Inc / EnerSys / Twin Disc Inc / Ormat Technologies Inc / LHC Group Inc / Amyris Inc / SunPower Corp / Canadian Solar Inc / First Solar Inc / Restaurant Brands International Inc / Blackstone Inc / Lululemon Athletica Inc / VMware Inc / Dana Inc / S&P Global Inc / Westport Fuel Systems Inc / Celldex Therapeutics Inc / KKR & Co Inc / AGCO Corp / Verisk Analytics Inc / Tencent Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Ameresco Inc / Fidus Investment Corp / MediaTek Inc / Enphase Energy Inc / T-Mobile US Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / Mirati Therapeutics Inc / CNH Industrial NV / Genocea Biosciences Inc / Alibaba Group Holding Ltd / Solaredge Technologies Inc / Zimmer Biomet Holdings Inc / Pure Storage Inc / Aqua Metals Inc / Hewlett Packard Enterprise Co / Block Inc / Workhorse Group Inc / Okta Inc / Aptiv PLC / Clearway Energy Inc / Uber Technologies Inc / Karuna Therapeutics Inc / BioNTech SE / NortonLifeLock Inc / DraftKings Inc / Velodyne Lidar Inc / Shoals Technologies Group Inc / Joby Aviation Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Brazil / Canada / Switzerland / Cayman Islands / Germany / United Kingdom / Ireland / Netherlands / Taiwan / United States / Jersey</td><td class="leftalignment">Biotechnology / Conglomerates / Electrical / Financial Services / Healthcare / Info. Tech./Software / Retailing / Semiconductors / Services / Telecommunications</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">WMB=US / PEP=US / AMGN=US / CAG=US / DIS=US / KO=US / OXY=US / TWTR=US / RRC=US / CL=US / PG=US / AMZN=US / DVN=US / APA=US / CPE=US / EOG=US / REI=US / CRM=US / XOM=US / CRK=US / WLL=US / PXD=US / ENR=US / MGY=US / SWN=US / VRM=US / MUR=US / SPOT=US / MRO=US / MDRX=US / ATVI=US / NWL=US / W=US / FLO=US / STZ=US / AMED=US / BMRN=US / CENT=US / CHD=US / COLL=US / CNX=US / ENDP=US / EPC=US / EQT=US / HAIN=US / PLAN=US / SMG=US / STRA=US / SNAP=US / WW=US / CVX=US / POST=US / CGEN=US / FNF=US / CNC=US / FB=US / COP=US / MGPI=US / BDSI=US / PRAA=US / MNST=US / PTON=US / JRVR=US / NOMD=US / MOH=US / FRPT=US / LHCG=US / XM=US / THS=US / BLDR=US / SCPL=US / ELF=US / AMRX=US / CLR=US / NOG=US / ATSG=US / AAN=US / AR=US / ESTE=US / ANGI=US / ZNGA=US / BCEI=US / EA=US / MTDR=US / PDCE=US / RHP=US / FANG=US / HCI=US / GOOGL=US / VNOM=US / BABA=US / EVH=US / CDEV=US / TRHC=US / PVAC=US / TVTY=US / YEXT=US / SBOW=US / PETQ=US / ROKU=US / SAIL=US / KDP=US / SVMK=US / AXNX=US / LYFT=US / UBER=US / RTLR=US / PSNL=US / HCAT=US / BRBR=US / OVV=US / REYN=US / DKNG=US / ZI=US / BIGC=US / BALY=US / HYFM=US / 100087548</td><td class="leftalignment">Williams Companies Inc / PepsiCo Inc / Amgen Inc / Conagra Brands Inc / Walt Disney Co / Coca-Cola Co / Occidental Petroleum Corp / Twitter Inc / Range Resources Corp / Colgate-Palmolive Co / Procter & Gamble Co / Amazon.com Inc / Devon Energy Corp / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Salesforce.Com Inc / Exxon Mobil Corp / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Energizer Holdings Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Vroom Inc / Murphy Oil Corp / Spotify Technology SA / Marathon Oil Corp / Allscripts Healthcare Solutions Inc / Activision Blizzard Inc / Newell Brands Inc / Wayfair Inc / Flowers Foods Inc / Constellation Brands Inc / Amedisys Inc / Biomarin Pharmaceutical Inc / Central Garden & Pet Co / Church & Dwight Co Inc / Collegium Pharmaceutical Inc / CNX Resources Corp / Endo International PLC / Edgewell Personal Care Co / EQT Corp / Hain Celestial Group Inc / Anaplan Inc / Scotts Miracle-Gro Co / Strategic Education Inc / Snap Inc / WW International Inc / Chevron Corp / Post Holdings Inc / Compugen Ltd / Fidelity National Financial Inc / Centene Corp / Meta Platforms Inc / Conocophillips / MGP Ingredients Inc / BioDelivery Sciences International Inc / PRA Group Inc / Monster Beverage Corp / Peloton Interactive Inc / James River Group Holdings Ltd / Nomad Foods Ltd / Molina Healthcare Inc / Freshpet Inc / LHC Group Inc / Qualtrics International Inc / TreeHouse Foods Inc / Builders FirstSource Inc / Sciplay Corp / elf Beauty Inc / Amneal Pharmaceuticals Inc / Continental Resources Inc / Northern Oil and Gas Inc / Air Transport Services Group Inc / Aaron's Company Inc / Antero Resources Corp / Earthstone Energy Inc / Angi Inc / Zynga Inc / Civitas Resources Inc / Electronic Arts Inc / Matador Resources Co / PDC Energy Inc / Ryman Hospitality Properties Inc / Diamondback Energy Inc / Hci Group Inc / Alphabet Inc / Viper Energy Partners LP / Alibaba Group Holding Ltd / Evolent Health Inc / Centennial Resource Development Inc / Tabula Rasa HealthCare Inc / Ranger Oil Corp / Tivity Health Inc / Yext Inc / SilverBow Resources Inc / PetIQ Inc / Roku Inc / SailPoint Technologies Holdings Inc / Keurig Dr Pepper Inc / Momentive Global Inc / Axonics Inc / Lyft Inc / Uber Technologies Inc / Rattler Midstream LP / Personalis Inc / Health Catalyst Inc / Bellring Brands Inc / Ovintiv Inc / Reynolds Consumer Products Inc / DraftKings Inc / ZoomInfo Technologies Inc / Bigcommerce Holdings Inc / Bally's Corp / Hydrofarm Holdings Group Inc / APA Corp (US)</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Cayman Islands / Ireland / Israel / Luxembourg / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/01/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - March 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">95</td><td class="leftalignment">US02553E1064 / US0311621009 / US2017231034 / US3647601083 / US6516391066 / US6541061031 / US6703461052 / US7445731067 / US7782961038 / US7802871084 / US8581191009 / US8725401090 / US9170471026 / US9182041080 / CA6979001089 / CA8787422044 / CA0084741085 / US9129091081 / CA13677F1018 / CA0641491075 / CA6330671034 / CA7800871021 / CA00762V1094 / US14040H1059 / CA98462Y1007 / US0534841012 / CA8911605092 / CA1360691010 / US9290421091 / US12008R1077 / US44107P1049 / US9043111072 / CA1375761048 / CA01626P4033 / US25960P1093 / US63633D1046 / CA0966311064 / CA2271071094 / US5500211090 / US90384S3031 / CA3518581051 / CA45790B1040 / US91912E1055 / US1921085049 / DE000BAY0017 / US18538R1032 / US1729674242 / US6936561009 / US7512121010 / CA00829Q1019 / US5017971046 / US92936U1097 / CA0213611001 / CA80013R2063 / CA04016A1012 / CA38045Y1025 / CA6674951059 / US16208T1025 / US4440971095 / US78573L1061 / CA2861812014 / US8486371045 / US23283R1005 / US71943U1043 / US1220171060 / US2921041065 / US02005N1000 / CA72820F1036 / US80283M1018 / CA49448Q1090 / CA68827L1013 / US87165B1035 / CA5503711080 / US29444U7000 / CA0115321089 / CA8485101031 / US72703H1014 / CA3803551074 / CA6882811046 / CA49741E1007 / US9490901041 / US92840M1027 / CA9628791027 / US8760301072 / US8608971078 / US63845R1077 / CA8585221051 / US11135F1012 / US03168L1052 / 117378606 / CA13000C2058 / CA2849025093 / VGG1890L1076 / US76156B1070 / US88339P1012 / CA5625684025 / US89421B1098 / US70614W1009 / CA59124U6051 / US15202L1070 / CA87975H1001 / JE00BMVMZ478</td><td class="leftalignment">American Eagle Outfitters Inc / Amgen Inc / Commercial Metals Co / Gap Inc / Newmont Corporation / Nike Inc / Nucor Corp / Public Service Enterprise Group Inc / Ross Stores Inc / Royal Gold Inc / Steel Dynamics Inc / TJX Companies Inc / Urban Outfitters Inc / VF Corp / Pan American Silver Corp / Teck Resources Ltd / Agnico Eagle Mines Ltd / United States Steel Corp / Canadian Western Bank / Bank of Nova Scotia / National Bank of Canada / Royal Bank of Canada / Aecon Group Inc / Capital One Financial Corp / Yamana Gold Inc / Avalonbay Communities Inc / Toronto-Dominion Bank / Canadian Imperial Bank of Commerce / Vornado Realty Trust / Builders FirstSource Inc / Host Hotels & Resorts Inc / Under Armour Inc / Canfor Corp / Alimentation Couche-Tard Inc / Douglas Emmett Inc / National Health Investors Inc / Boardwalk Real Estate Investment Trust / Crombie Real Estate Investment Trust / Lululemon Athletica Inc / Ulta Beauty Inc / Franco-Nevada Corp / Innergex Renewable Energy Inc / Vale SA / Coeur Mining Inc / Bayer AG / Clearwater Paper Corp / Citigroup Inc / PVH Corp / Ralph Lauren Corp / Africa Oil Corp / Bath & Body Works Inc / WP Carey Inc / AltaGas Ltd / Sandstorm Gold Ltd / Argonaut Gold Inc / GoGold Resources Inc / NorthWest Healthcare Properties REIT / Chatham Lodging Trust / Hudson Pacific Properties Inc / Sabra Health Care REIT Inc / Element Fleet Management Corp / Splunk Inc / CyrusOne Inc / Physicians Realty Trust / Burlington Stores Inc / Empire State Realty Trust Inc / Ally Financial Inc / Plaza Retail REIT / Santander Consumer USA Holdings Inc / Kinaxis Inc / Osisko Gold Royalties Ltd / Synchrony Financial / Lundin Gold Inc / Equinix Inc / Alamos Gold Inc / Spin Master Corp / Planet Fitness Inc / goeasy Ltd / Osisko Mining Inc / Kirkland Lake Gold Ltd / Welbilt Inc / Vistra Corp / Wheaton Precious Metals Corp / Tapestry Inc / Stitch Fix Inc / National Vision Holdings Inc / Stelco Holdings Inc / Broadcom Inc / Amneal Pharmaceuticals Inc / Whitecap Resources Inc / Calibre Mining Corp / Eldorado Gold Corp / Capri Holdings Ltd / Revolve Group Inc / RealReal Inc / Mandalay Resources Corp / Travelcenters of America Inc / Peloton Interactive Inc / Metalla Royalty & Streaming Ltd / Centerspace / Telus International Cda Inc / Atotech Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Brazil / Canada / Germany / United Kingdom / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">03/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - March 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">AEP.N / ALTR.O / ALV.N / AMAT.O / AMD.N / ANTO.L / BAC.N / BARC.L / BCE.TO / BK.N / BNPP.PA / C.N / CCI.N / CL.N / CMS.N / COF.N / CSGN.S / DGE.L / EIX.N / EL.N / EOG.N / F.N / FITB.O / GM.N / HSBA.L / JPM.N / KEY.N / KMB.N / KO.N / L.TO / MRK.N / NEM.N / NTRS.O / PFE.N / PNC.N / RIO.L / SO.N / SOGN.PA / T.N / T.TO / USB.N / VC.N / WFC.N / PEP.N / CMA.N / BFb.N / PG.N / WY.N / CNQ.TO / GILD.O / FNV.N / ASML.O / CPB.N / TEN.N / CMCSA.O / SJRb.TO / TA.TO / RCIb.TO / AMGN.O / FER.MC / AAL.L / CNR.TO / DUK.N / QBRb.TO / HBAN.O / BWA.N / LEA.N / PNM.N / ENB.TO / TRP.TO / NVDA.O / K.N / DT.N / DISH.O / IMO.TO / GS.N / DBKGn.DE / CLX.N / CAG.N / HON.N / MFC.TO / GIS.N / PCG.N / AEM.N / XOM.N / EPC.N / MGA.N / SBAC.O / AMT.N / BOL.ST / CONE.O / ADI.O / VZ.N / STT.N / EXEL.O / MDRX.O / ALA.TO / ARNA.O / STZ.N / APH.N / SRE.N / EXC.N / DSGX.O / FISV.O / SNPS.O / V.N / AXL.N / AWK.N / ARE.N / PLD.N / CHD.N / MTB.N / BC.N / FTS.TO / SAM.N / BMRN.O / OPTN.O / REGN.O / ENR.N / CVX.N / EMA.TO / MU.O / CAGR.PA / NCR.N / NET.N / TEL.N / RF.N / FLS.CO / CNP.N / APF.L / ENDP.O / MEOH.O / CPK.N / DOL.TO / FRC.N / PII.N / ST.N / SWN.N / WES.N / SEM.N / ADS.N / GPN.N / MNST.O / SIVB.O / CASY.O / EQIX.O / ATDb.TO / TFC.N / INGA.AS / 02209S103 / DLR.N / 427866108 / RDSb.L / BLDR.O / DISCA.O / CDNS.O / MS.N / FIS.N / CCOI.O / HICL.L / CTCa.TO / BLX.TO / MA.N / MWA.N / HOG.N / ATL.MI / BGS.N / PPL.TO / DAN.N / BIP.N / SII.TO / CLW.N / VALE.N / SPB.N / ENV.N / BHPB.L / NEE.N / NXT.AX / CAML.L / MTOR.N / GLEN.L / GEI.TO / PANW.N / MDLZ.OQ / ABBV.N / KPT.TO / TSLA.N / PRGO.N / PRMW.N / TMUS.N / DOO.TO / COTY.N / PRTA.O / BEP.N / AGIO.O / VRNS.O / AGRX.O / CFG.N / DEA.N / SHOP.N / PYPL.OQ / SQ.N / RACE.MI / UBSG.S / ADNT.N / FRTA.OQ / GDS.O / PBYI.OQ / AQN.N / VST.N / WOW.N / ATUS.N / GRPG.I / ATNX.O / AQUA.N / AY.O / SAIL.N / APTV.N / AMRX.N / VNE.N / KDP.N / ESTC.N / NWL.O / 269796108 / ZM.O / CRWD.O / GMAB.O / PING.N / CRNC.OQ / REYN.O / LUNE.ST / NKLA.OQ / APA.OQ / FOUR.N / 77311W101 / LUMN.N / PTVE.O / BSY.O / MAX.N / WFG.N / TIXT.TO / AFRM.O / ATC.N / 120681711</td><td class="leftalignment">American Electric Power Company Inc / Altair Engineering Inc / Autoliv Inc / Applied Materials Inc / Advanced Micro Devices Inc / Antofagasta PLC / Bank of America Corp / Barclays PLC / BCE Inc / Bank of New York Mellon Corp / BNP Paribas SA / Citigroup Inc / Crown Castle International Corp / Colgate-Palmolive Co / CMS Energy Corp / Capital One Financial Corp / Credit Suisse Group AG / Diageo PLC / Edison International / Estee Lauder Companies Inc / EOG Resources Inc / Ford Motor Co / Fifth Third Bancorp / General Motors Co / HSBC Holdings PLC / JPMorgan Chase & Co / KeyCorp / Kimberly-Clark Corp / Coca-Cola Co / Loblaw Companies Ltd / Merck & Co Inc / Newmont Corporation / Northern Trust Corp / Pfizer Inc / PNC Financial Services Group Inc / Rio Tinto PLC / Southern Co / Societe Generale SA / AT&T Inc / Telus Corp / US Bancorp / Visteon Corp / Wells Fargo & Co / PepsiCo Inc / Comerica Inc / Brown-Forman Corp / Procter & Gamble Co / Weyerhaeuser Co / Canadian Natural Resources Ltd / Gilead Sciences Inc / Franco-Nevada Corp / ASML Holding NV / Campbell Soup Co / Tenneco Inc / Comcast Corp / Shaw Communications Inc / TransAlta Corp / Rogers Communications Inc / Amgen Inc / Ferrovial SA / Anglo American PLC / Canadian National Railway Co / Duke Energy Corp / Quebecor Inc / Huntington Bancshares Inc / Borgwarner Inc / Lear Corp / PNM Resources Inc / Enbridge Inc / TC Energy Corp / NVIDIA Corp / Kellogg Co / Dynatrace Inc / DISH Network Corp / Imperial Oil Ltd / Goldman Sachs Group Inc / Deutsche Bank AG / Clorox Co / Conagra Brands Inc / Honeywell International Inc / Manulife Financial Corp / General Mills Inc / PG&E Corp / Agnico Eagle Mines Ltd / Exxon Mobil Corp / Edgewell Personal Care Co / Magna International Inc / SBA Communications Corp / American Tower Corp / Boliden AB / CyrusOne Inc / Analog Devices Inc / Verizon Communications Inc / State Street Corp / Exelixis Inc / Allscripts Healthcare Solutions Inc / AltaGas Ltd / Arena Pharmaceuticals Inc / Constellation Brands Inc / Amphenol Corp / Sempra Energy / Exelon Corp / Descartes Systems Group Inc / Fiserv Inc / Synopsys Inc / Visa Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Alexandria Real Estate Equities Inc / Prologis Inc / Church & Dwight Co Inc / M&T Bank Corp / Brunswick Corp / Fortis Inc / Boston Beer Company Inc / Biomarin Pharmaceutical Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Chevron Corp / Emera Inc / Micron Technology Inc / Credit Agricole SA / NCR Corp / Cloudflare Inc / TE Connectivity Ltd / Regions Financial Corp / FLSmidth & Co A/S / CenterPoint Energy Inc / Anglo Pacific Group PLC / Endo International PLC / Methanex Corp / Chesapeake Utilities Corp / Dollarama Inc / First Republic Bank / Polaris Inc / Sensata Technologies Holding PLC / Southwestern Energy Co / Western Midstream Partners LP / Select Medical Holdings Corp / Alliance Data Systems Corp / Global Payments Inc / Monster Beverage Corp / SVB Financial Group / Caseys General Stores Inc / Equinix Inc / Alimentation Couche-Tard Inc / Truist Financial Corp / ING Groep NV / Altria Group Inc / Digital Realty Trust Inc / Hershey Co / Royal Dutch Shell PLC / Builders FirstSource Inc / Discovery Inc / Cadence Design Systems Inc / Morgan Stanley / Fidelity National Information Services Inc / Cogent Communications Holdings Inc / HICL Infrastructure PLC / Canadian Tire Corporation Ltd / Boralex Inc / Mastercard Inc / Mueller Water Products Inc / Harley-Davidson Inc / Atlantia SpA / B&G Foods Inc / Pembina Pipeline Corp / Dana Inc / Brookfield Infrastructure Partners LP / Sprott Inc / Clearwater Paper Corp / Vale SA / Spectrum Brands Holdings Inc / Envestnet Inc / BHP Group PLC / Nextera Energy Inc / NEXTDC Ltd / Central Asia Metals PLC / Meritor Inc / Glencore PLC / Gibson Energy Inc / Palo Alto Networks Inc / Mondelez International Inc / Abbvie Inc / KP Tissue Inc / Tesla Inc / Perrigo Company PLC / Primo Water Corp / T-Mobile US Inc / BRP Inc / Coty Inc / Prothena Corporation PLC / Brookfield Renewable Partners LP / Agios Pharmaceuticals Inc / Varonis Systems Inc / Agile Therapeutics Inc / Citizens Financial Group Inc / Easterly Government Properties Inc / Shopify Inc / PayPal Holdings Inc / Block Inc / Ferrari NV / UBS Group AG / Adient PLC / Forterra Inc / GDS Holdings Ltd / Puma Biotechnology Inc / Algonquin Power & Utilities Corp / Vistra Corp / WideOpenWest Inc / Altice USA Inc / Greencoat Renewables PLC / Athenex Inc / Evoqua Water Technologies Corp / Atlantica Sustainable Infrastructure PLC / SailPoint Technologies Holdings Inc / Aptiv PLC / Amneal Pharmaceuticals Inc / Veoneer Inc / Keurig Dr Pepper Inc / Elastic NV / Newell Brands Inc / Eagle Pharmaceuticals Inc / Zoom Video Communications Inc / CrowdStrike Holdings Inc / Genmab A/S / Ping Identity Holding Corp / Cerence Inc / Reynolds Consumer Products Inc / Lundin Energy AB / Nikola Corp / APA Corp (US) / Shift4 Payments Inc / Rocket Companies Inc / Lumen Technologies Inc / Pactiv Evergreen Inc / Bentley Systems Inc / Mediaalpha Inc / West Fraser Timber Co Ltd / Telus International Cda Inc / Affirm Holdings Inc / Atotech Ltd / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Ireland / Italy / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">03/01/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Tezepelumab Continues to Show Strong Profile, Supporting Blockbuster Potential</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">03116210</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="odd"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Probes Reporter</td><td class="leftalignment">Watch List: 81 US Companies with Undisclosed SEC Probes - March 01, 2021</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">T.N / CL.N / COF.N / CRM.N / F.N / HLT.N / MDT.N / PNC.N / SLB.N / BEN.N / TRI.N / PG.N / REV.N / ADM.N / VLO.N / UPS.N / NWL.N / NKE.N / AMP.N / MTZ.N / ARW.N / ATO.N / TWTR.N / TUP.N / OMI.N / CVX.N / AMGN.OQ / CSCO.OQ / GNTX.OQ / REGN.OQ / ROL.N / SEIC.OQ / RARE.OQ / MNRO.OQ / CAKE.OQ / GILD.OQ / COST.OQ / NKTR.OQ / AZPN.OQ / MYGN.OQ / SSNC.OQ / CTXS.OQ / AMZN.OQ / MSTR.OQ / NVDA.OQ / CHTR.OQ / TNP.N / NFLX.OQ / EGBN.OQ / CVGI.OQ / NDAQ.OQ / TAL.N / MA.N / SIX.N / AON.N / BX.N / INO.OQ / BGCP.OQ / UTL.N / SCHW.N / MSI.N / MPC.N / FB.OQ / XPO.N / CTG.OQ / NTRA.OQ / PFX.N / 100088979 / MFIN.OQ / DXC.N / CVNA.N / RYTM.OQ / SWCH.N / IQV.N / WELL.N / US29350E1047 / LYFT.O</td><td class="leftalignment">AT&T Inc / Colgate-Palmolive Co / Capital One Financial Corp / Salesforce.Com Inc / Ford Motor Co / Hilton Worldwide Holdings Inc / Medtronic PLC / PNC Financial Services Group Inc / Schlumberger NV / Franklin Resources Inc / Thomson Reuters Corp / Procter & Gamble Co / Revlon Inc / Archer-Daniels-Midland Co / Valero Energy Corp / United Parcel Service Inc / Newell Brands Inc / Nike Inc / Ameriprise Financial Inc / MasTec Inc / Arrow Electronics Inc / Atmos Energy Corp / Twitter Inc / Tupperware Brands Corp / Owens & Minor Inc / Chevron Corp / Amgen Inc / Cisco Systems Inc / Gentex Corp / Regeneron Pharmaceuticals Inc / Rollins Inc / SEI Investments Co / Ultragenyx Pharmaceutical Inc / Monro Inc / Cheesecake Factory Inc / Gilead Sciences Inc / Costco Wholesale Corp / Nektar Therapeutics / Aspen Technology Inc / Myriad Genetics Inc / SS&C Technologies Holdings Inc / Citrix Systems Inc / Amazon.com Inc / Microstrategy Inc / NVIDIA Corp / Charter Communications Inc / Tsakos Energy Navigation Ltd / Netflix Inc / Eagle Bancorp Inc / Commercial Vehicle Group Inc / Nasdaq Inc / TAL Education Group / Mastercard Inc / Six Flags Entertainment Corp / Aon PLC / Blackstone Inc / Inovio Pharmaceuticals Inc / BGC Partners Inc / Unitil Corp / Charles Schwab Corp / Motorola Solutions Inc / Marathon Petroleum Corp / Meta Platforms Inc / XPO Logistics Inc / Computer Task Group Inc / Natera Inc / PhenixFIN Corp / Huntington Bancshares Inc / Medallion Financial Corp / DXC Technology Co / Carvana Co / Rhythm Pharmaceuticals Inc / Switch Inc / IQVIA Holdings Inc / Welltower Inc / Enochian Biosciences Inc / Lyft Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / China / Cayman Islands / Greece / Ireland / United States / Curaçao</td><td class="leftalignment">Agriculture / Air Transportation / Apparel & Textiles / Automotive / Banks / Biotechnology / Broadcasting & Cable / Consumer / Education / Electronics / Engineering & Construction / Financial Services / Healthcare / Household Products / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Services / Technology / Telecommunications / Transportation / Utilities / Oil & Gas</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">TZP Update a Bit Lacking in Detail But We’ve Seen Enough to Add to Model</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">031162100</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">02/28/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">4Q Update Highlights Adagrasib Timeline</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRTX=US / AMGN=US</td><td class="leftalignment">Mirati Therapeutics Inc / Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/28/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Detailed Tezepelumab Data Support Approval and Broad Label</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Do G. Kim / Jameson Kao / Ikechukwu Oji</td></tr>
<tr class="odd"><td class="leftalignment">02/27/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AMGN.O / EXEL.O / ARNA.O / BMRN.O / REGN.O / PRTA.O / AGIO.O / PBYI.OQ / ATNX.O / GMAB.O</td><td class="leftalignment">Amgen Inc / Exelixis Inc / Arena Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Prothena Corporation PLC / Agios Pharmaceuticals Inc / Puma Biotechnology Inc / Athenex Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Denmark / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Kennen MacKay, PHD / Edwin Delfin</td></tr>
<tr class="even"><td class="leftalignment">02/26/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">HZNP-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">HZNP.O / MRK / PFE / AMGN.O / RDY / AZN.O / RDUS.O</td><td class="leftalignment">Horizon Therapeutics PLC / Merck & Co Inc / Pfizer Inc / Amgen Inc / Dr Reddy's Laboratories Ltd / AstraZeneca PLC / Radius Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / India / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">AAAAI: KOLs note 1L potential on Ph3 NAVIGATOR conference call; PT increased by $3</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN=US</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Minh Vong</td></tr>
<tr class="even"><td class="leftalignment">02/26/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Detailed tezepelumab data in asthma looks robust in severe patients</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Emily Bodnar / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">02/26/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 536</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">02/26/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">AMGN.OQ - Event Transcript of Amgen Inc conference call, Feb. 26, 2021 / 1:00PM ET</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/26/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">The Launches Keep Coming; Another Year Of EBITDA Growth On Tap</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03168L105 / 717081103 / 031162100 / 881624209</td><td class="leftalignment">Amneal Pharmaceuticals Inc / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">David A. Amsellem / Zachary Sachar / Isaac C. Somekh</td></tr>
<tr class="even"><td class="leftalignment">02/26/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Feb 26 2021</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">ICAD=US / LHCG=US / MRK=US / BSX=US / LLY=US / PFE=US / ABT=US / AMGN=US / BMY=US / GBT=US / MDT=US / WMT=US / INCY=US / INSP=US / CMS=US / DGX=US / NVS=US / BWAY=US / SNN=US / RAD=US / JNJ=US / MMSI=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / APLS=US / ARNA=US / ATRC=US / BDX=US / BLUE=US / CHE=US / CYH=US / EW=US / GEN=US / ICPT=US / LH=US / NBIX=US / PHAR=US / REGN=US / SILK=US / USPH=US / UTHR=US / UHS=US / SAGE=US / CGEN=US / CCRN=US / CNC=US / ACA=US / ENSG=US / MD=US / NKTR=US / SLF=US / BIIB=US / MRNA=US / ACAD=US / ALNY=US / MNKD=US / GOOG=US / DXCM=US / SNSS=US / CHNG=US / PODD=US / EHC=US / TNDM=US / ADUS=US / BLRX=US / ACHC=US / ALSN=US / ABBV=US / AGIO=US / FATE=US / AERI=US / MDWD=US / CTRE=US / AUPH=US / OTIC=US / EKTAY=US / VBLT=US / VCEL=US / NVRO=US / WBA=US / EVH=US / GKOS=US / TDOC=US / NVCR=US / VYGR=US / IONS=US / EDIT=US / NTLA=US / SRTS=US / TCMD=US / IRTC=US / IOVA=US / KALA=US / ATNX=US / RCKT=US / ALLO=US / TMDX=US / PSNL=US / KRTX=US / PNTG=US / ARQT=US / FBRX=US / FMTX=US / CZMWY=US / BIOVF=US / VPAHF=US</td><td class="leftalignment">ICAD Inc / LHC Group Inc / Merck & Co Inc / Boston Scientific Corp / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Amgen Inc / Bristol-Myers Squibb Co / Global Blood Therapeutics Inc / Medtronic PLC / Walmart Inc / Incyte Corp / Inspire Medical Systems Inc / CMS Energy Corp / Quest Diagnostics Inc / Novartis AG / Brainsway Ltd / Smith & Nephew PLC / Rite Aid Corp / Johnson & Johnson / Merit Medical Systems Inc / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / Apellis Pharmaceuticals Inc / Arena Pharmaceuticals Inc / AtriCure Inc / Becton Dickinson and Co / bluebird bio Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / Genesis Healthcare Inc / Intercept Pharmaceuticals Inc / Laboratory Corporation of America Holdings / Neurocrine Biosciences Inc / Pharming Group NV / Regeneron Pharmaceuticals Inc / Silk Road Medical Inc / US Physical Therapy Inc / United Therapeutics Corp / Universal Health Services Inc / SAGE Therapeutics Inc / Compugen Ltd / Cross Country Healthcare Inc / Centene Corp / Arcosa Inc / Ensign Group Inc / MEDNAX Inc / Nektar Therapeutics / Sun Life Financial Inc / Biogen Inc / Moderna Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / MannKind Corp / Alphabet Inc / Dexcom Inc / Viracta Therapeutics Inc / Change Healthcare Inc / Insulet Corp / Encompass Health Corp / Tandem Diabetes Care Inc / Addus Homecare Corp / BioLine RX Ltd / Acadia Healthcare Company Inc / Allison Transmission Holdings Inc / Abbvie Inc / Agios Pharmaceuticals Inc / Fate Therapeutics Inc / Aerie Pharmaceuticals Inc / Mediwound Ltd / CareTrust REIT Inc / Aurinia Pharmaceuticals Inc / Otonomy Inc / Elekta AB (publ) / Vascular Biogenics Ltd / Vericel Corp / Nevro Corp / Walgreens Boots Alliance Inc / Evolent Health Inc / Glaukos Corp / Teladoc Health Inc / Novocure Ltd / Voyager Therapeutics Inc / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Sensus Healthcare Inc / Tactile Systems Technology Inc / iRhythm Technologies Inc / Iovance Biotherapeutics Inc / Kala Pharmaceuticals Inc / Athenex Inc / Rocket Pharmaceuticals Inc / Allogene Therapeutics Inc / Transmedics Group Inc / Personalis Inc / Karuna Therapeutics Inc / Pennant Group Inc / Arcutis Biotherapeutics Inc / Forte Biosciences Inc / Forma Therapeutics Holdings Inc / Carl Zeiss Meditec AG / Swedish Orphan Biovitrum AB (publ) / Volpara Health Technologies Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Germany / United Kingdom / Ireland / Israel / Netherlands / New Zealand / Sweden / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="odd"><td class="leftalignment">02/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Ph3 NAVIGATOR data: Broad activity and first to show a meaningful reduction in low EoE</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AMGN=US</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Minh Vong</td></tr>
<tr class="even"><td class="leftalignment">02/26/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended February 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / BMY=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">02/26/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="odd"><td class="leftalignment">02/26/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRK.N / PFE.N / GSK.L / AMGN.OQ / COLL.OQ / CERS.OQ / MDRX.OQ / ZIOP.OQ / AGIO.OQ / AERI.OQ / ITCI.OQ / CDTX.OQ / EVH.N / GOSS.OQ / HCAT.OQ / PCVX.OQ / FMTX.OQ / HGEN.OQ</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / GlaxoSmithKline PLC / Amgen Inc / Collegium Pharmaceutical Inc / Cerus Corp / Allscripts Healthcare Solutions Inc / ZIOPHARM Oncology Inc / Agios Pharmaceuticals Inc / Aerie Pharmaceuticals Inc / Intra-Cellular Therapies Inc / Cidara Therapeutics Inc / Evolent Health Inc / Gossamer Bio Inc / Health Catalyst Inc / Vaxcyte Inc / Forma Therapeutics Holdings Inc / Humanigen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">02/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">AMGN: Amgen, Inc. - Q&A Our Way: Highlights from Amgen's Tezepelumab Presentation and Q&A from AAAAI 2021</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AMGN.OQ / AZN.L / REGN.OQ</td><td class="leftalignment">Amgen Inc / AstraZeneca PLC / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / European Pharma Team / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">02/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Global Pharmaceuticals: AZN/Amgen: tezepelumab NAVIGATOR P3 data at AAAAI in line with abstract</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AMGN.OQ / AZN.L / SASY.PA / NOVN.S / GSK.L / REGN.OQ</td><td class="leftalignment">Amgen Inc / AstraZeneca PLC / Sanofi SA / Novartis AG / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston / Mr. Evan D. Seigerman / Yunhee Park / Jonathan Woo</td></tr>
<tr class="even"><td class="leftalignment">02/26/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">4Q Update: Adagrasib PoC Combination Datasets Are Focus in 2021</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">60468T105 / 03116210</td><td class="leftalignment">Mirati Therapeutics Inc / Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Silvan Tuerkcan</td></tr>
<tr class="odd"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">HCM.L / JNJ.N / LLY.N / MRK.N / PFE.N / NCOX.PA / AMGN.OQ / COLL.OQ / ICAD.OQ / ALKS.OQ / OPTN.OQ / GILD.OQ / CERS.OQ / RMTI.OQ / AMRN.OQ / BIIB.OQ / ACAD.OQ / MNKD.OQ / MSB.AX / EBS.N / SPRO.OQ / OMER.OQ / ARDX.OQ / ACRX.OQ / ZTS.N / ANIP.OQ / AXGN.OQ / FATE.OQ / AUP.TO / AERI.OQ / HRTX.OQ / TRVN.OQ / EGRX.OQ / ALDX.OQ / SCYX.OQ / CFRX.OQ / VRAY.OQ / CDTX.OQ / FBIO.OQ / TDOC.N / SPNE.OQ / GBT.OQ / ACRS.OQ / DRIO.OQ / TVTY.OQ / VERU.OQ / TXMD.OQ / EOLS.OQ / RCUS.N / UBX.OQ / ARDS.OQ / ETTX.OQ / ARAV.OQ / SIBN.OQ / ARQT.OQ / PCVX.OQ / SRGA.OQ / HGEN.OQ / VYNE.OQ / GRAY.OQ / 120551486</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Nicox SA / Amgen Inc / Collegium Pharmaceutical Inc / ICAD Inc / Alkermes Plc / OptiNose Inc / Gilead Sciences Inc / Cerus Corp / Rockwell Medical Inc / Amarin Corporation PLC / Biogen Inc / ACADIA Pharmaceuticals Inc / MannKind Corp / Mesoblast Ltd / Emergent BioSolutions Inc / Spero Therapeutics Inc / Omeros Corp / Ardelyx Inc / AcelRx Pharmaceuticals Inc / Zoetis Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Fate Therapeutics Inc / Aurinia Pharmaceuticals Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / Aldeyra Therapeutics Inc / SCYNEXIS Inc / ContraFect Corp / ViewRay Inc / Cidara Therapeutics Inc / Fortress Biotech Inc / Teladoc Health Inc / SeaSpine Holdings Corp / Global Blood Therapeutics Inc / Aclaris Therapeutics Inc / DarioHealth Corp / Tivity Health Inc / Veru Inc / TherapeuticsMD Inc / Evolus Inc / Arcus Biosciences Inc / UNITY Biotechnology Inc / Aridis Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Aravive Inc / SI-BONE Inc / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Humanigen Inc / Vyne Therapeutics Inc / Graybug Vision Inc / Opiant Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Biotechnology / Consumer / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">MRTX (NEUTRAL) - KRAS Programs On-Track as Company Steps Into Synthetic Lethality with a New PRMT5 Inhibitor</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BBPK0J0 / 2516152 / 2023607 / 7103065 / BCBVTX1</td><td class="leftalignment">Mirati Therapeutics Inc / Eli Lilly and Co / Amgen Inc / Novartis AG / Agios Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for AMGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Biotech Inflows Continue – At Least For Now</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / 039697107 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / 19240Q201</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Ardelyx Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / Cogent Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">PODD - Updating Estimates Following a Solid 4Q Performance</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">B1XGNW4 / 2023607 / BF3W461</td><td class="leftalignment">Insulet Corp / Amgen Inc / Tandem Diabetes Care Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Chris Pasquale / Chris Hartstein, CFA / Jenna Davidner</td></tr>
<tr class="even"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AMED=US / SPXC=US / AAPL=US / BSX=US / PFE=US / AMGN=US / COST=US / INTC=US / AMD=US / GBT=US / MSFT=US / MDT=US / QCOM=US / T=US / INCY=US / TXN=US / NVDA=US / CHTR=US / NVS=US / VZ=US / SMTC=US / TSM=US / EXPE=US / CTXS=US / CMCSA=US / UNH=US / AVGO=US / CHE=US / HEAR=US / ITRI=US / Z=US / SAGE=US / CCRN=US / BKNG=US / ACA=US / HPQ=US / CLH=US / BIIB=US / ALNY=US / GOOG=US / ORA=US / DXCM=US / PODD=US / VMW=US / TNDM=US / CDXC=US / 005930-KR=US / CHWY=US / MSCI=US / NXPI=US / 2454-TW=US / TMUS=US / FATE=US / AUPH=US / LOVE=US / NVRO=US / ETSY=US / TDOC=US / HPE=US / IONS=US / NTNX=US / RDFN=US / CWEN=US / ESTC=US / FVRR=US / XPEV=US / ABNB=US / BIOVF=US</td><td class="leftalignment">Amedisys Inc / SPX Corp / Apple Inc / Boston Scientific Corp / Pfizer Inc / Amgen Inc / Costco Wholesale Corp / Intel Corp / Advanced Micro Devices Inc / Global Blood Therapeutics Inc / Microsoft Corp / Medtronic PLC / Qualcomm Inc / AT&T Inc / Incyte Corp / Texas Instruments Inc / NVIDIA Corp / Charter Communications Inc / Novartis AG / Verizon Communications Inc / Semtech Corp / Taiwan Semiconductor Manufacturing Co Ltd / Expedia Group Inc / Citrix Systems Inc / Comcast Corp / UnitedHealth Group Inc / Broadcom Inc / Chemed Corp / Turtle Beach Corp / Itron Inc / Zillow Group Inc / SAGE Therapeutics Inc / Cross Country Healthcare Inc / Booking Holdings Inc / Arcosa Inc / HP Inc / Clean Harbors Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Alphabet Inc / Ormat Technologies Inc / Dexcom Inc / Insulet Corp / VMware Inc / Tandem Diabetes Care Inc / Chromadex Corp / Farfetch Ltd / Chewy Inc / MSCI Inc / NXP Semiconductors NV / MediaTek Inc / T-Mobile US Inc / Fate Therapeutics Inc / Aurinia Pharmaceuticals Inc / Lovesac Co / Nevro Corp / ETSY Inc / Teladoc Health Inc / Hewlett Packard Enterprise Co / Ionis Pharmaceuticals Inc / Nutanix Inc / Redfin Corp / Clearway Energy Inc / Elastic NV / Fiverr International Ltd / Xpeng Inc / Airbnb Inc / Swedish Orphan Biovitrum AB (publ)</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Ireland / Israel / Netherlands / Sweden / Taiwan / United States</td><td class="leftalignment">Biotechnology / Consumer / Electrical / Financial Services / Healthcare / Info. Tech./Computers / Info. Tech./Software / Leisure & Entertainment / Machinery / Retailing / Semiconductors / Telecommunications</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AMGN.OQ / ACRX.OQ / 4502.T / JNJ.N / PFE.N / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / MRNA.OQ / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Amgen Inc / AcelRx Pharmaceuticals Inc / Takeda Pharmaceutical Co Ltd / Johnson & Johnson / Pfizer Inc / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Moderna Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MRTX: 4Q20 Updates: Focus remains on G12C updates throughout 2021, with G12D entering the clinic</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRTX.OQ / AMGN.OQ</td><td class="leftalignment">Mirati Therapeutics Inc / Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Ada's Insights-Quant Strategy: Super-Cyclicals Revisited</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">A.N / AEE.N / AES.N / BAX.N / BG.N / BMY.N / BSX.N / CCI.N / CI.N / CL.N / EL.N / FLT.N / KMB.N / KO.N / LLY.N / LSI.N / MDT.N / PM.N / PNW.N / PPCJ.J / SO.N / TAP.N / TMO.N / WMT.N / DRE.N / EQR.N / FLO.N / PG.N / WY.N / DELL.N / CPB.N / W.N / ETR.N / ADML.L / DHR.N / DIS.N / UNH.N / TFX.N / D.N / OGE.N / IPG.N / CLX.N / CAG.N / VNO.N / GLW.N / LH.N / KR.N / GIS.N / XRX.N / NI.N / PCG.N / AMT.N / RMD.N / TDS.N / DTEGN.F / MTD.N / IT.N / PKI.N / WST.N / COO.N / STZ.N / APH.N / NNN.N / PSA.N / ARW.N / EW.N / CPT.N / BXP.N / ACN.N / ARE.N / CHD.N / NUS.N / TWTR.N / ESS.N / HAE.N / FRT.N / UGI.N / OFC.N / CUZ.N / HRL.N / BDN.N / SAM.N / ABC.N / JNPR.N / IRM.N / CNP.N / INTC.OQ / CTSH.OQ / ABMD.OQ / AMGN.OQ / AMAT.OQ / ADSK.OQ / CERN.OQ / CHE.N / CRUS.OQ / FISV.OQ / JKHY.OQ / LRCX.OQ / ATVI.OQ / PAYX.OQ / TEAM.OQ / REGN.OQ / SJM.N / TECH.OQ / TYL.N / QDEL.OQ / SNPS.OQ / ICUI.OQ / IDXX.OQ / QCOM.OQ / INTU.OQ / LFUS.OQ / COST.OQ / XRAY.OQ / NKTR.OQ / DISH.OQ / NTAP.OQ / AMED.OQ / PCTY.OQ / ANSS.OQ / LAMR.OQ / EEFT.OQ / VSAT.OQ / AMZN.OQ / LITE.OQ / TTWO.OQ / VRSN.OQ / MANH.OQ / ZBRA.OQ / NVDA.OQ / MKSI.OQ / UTHR.OQ / SBAC.OQ / BMRN.OQ / HAIN.OQ / BLUE.OQ / ILMN.OQ / EQIX.OQ / GPN.N / VRTX.OQ / MNST.OQ / TXN.OQ / CMCSA.OQ / NXST.OQ / ACAD.OQ / MPWR.OQ / ELS.N / HLF.N / OLED.OQ / SRC.N / CDNS.OQ / LYV.N / FIS.N / ADP.PA / MA.N / WU.N / DEI.N / FSLR.OQ / IPGP.OQ / QGEN.N / PODD.OQ / VMW.N / TDC.N / SATS.OQ / NWSA.OQ / CACI.N / FICO.N / FTNT.OQ / HPP.N / BAH.N / ADSGN.F / HHC.N / MSI.N / HZNP.OQ / ACHC.OQ / ENPH.OQ / EPAM.N / GWRE.N / ADI.OQ / SRPT.OQ / GMED.N / HTA.N / ABBV.N / PRGO.N / WEX.N / CDW.OQ / FOXA.O / SFM.OQ / REXR.N / LDOS.N / PINC.OQ / AGIO.OQ / RNG.N / GLPI.OQ / BRX.N / PTC.OQ / FIVN.OQ / GLOB.N / CTLT.N / CDK.OQ / KEYS.N / PGRE.N / OUT.N / STOR.N / ANTM.N / NEWR.N / QRVO.OQ / SEDG.OQ / ON.OQ / ETSY.OQ / LBRDK.OQ / TDOC.N / CABO.N / ZBH.N / KHC.OQ / GBT.OQ / PEN.N / NVCR.OQ / PSTG.N / SQ.N / IONS.OQ / RETA.OQ / EVBG.OQ / TTD.OQ / LW.N / PK.N / FWONA.OQ / ROKU.OQ / EHC.N / XEL.OQ / SYNH.OQ / BKNG.OQ / ZS.OQ / QRTEA.OQ / CBRE.N / CDAY.N / AVT.OQ / EVRG.N / ELAN.N / TER.OQ / LNT.OQ / EXC.OQ / MSGS.N / AEP.OQ / 120175706</td><td class="leftalignment">Agilent Technologies Inc / Ameren Corp / AES Corp / Baxter International Inc / Bunge Ltd / Bristol-Myers Squibb Co / Boston Scientific Corp / Crown Castle International Corp / Cigna Corp / Colgate-Palmolive Co / Estee Lauder Companies Inc / Fleetcor Technologies Inc / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Life Storage Inc / Medtronic PLC / Philip Morris International Inc / Pinnacle West Capital Corp / PPC Ltd / Southern Co / Molson Coors Beverage Co / Thermo Fisher Scientific Inc / Walmart Inc / Duke Realty Corp / Equity Residential / Flowers Foods Inc / Procter & Gamble Co / Weyerhaeuser Co / Dell Technologies Inc / Campbell Soup Co / Wayfair Inc / Entergy Corp / Admiral Group PLC / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Teleflex Inc / Dominion Energy Inc / OGE Energy Corp / Interpublic Group of Companies Inc / Clorox Co / Conagra Brands Inc / Vornado Realty Trust / Corning Inc / Laboratory Corporation of America Holdings / Kroger Co / General Mills Inc / Xerox Holdings Corp / NiSource Inc / PG&E Corp / American Tower Corp / Resmed Inc / Telephone and Data Systems Inc / Deutsche Telekom AG / Mettler-Toledo International Inc / Gartner Inc / PerkinElmer Inc / West Pharmaceutical Services Inc / Cooper Companies Inc / Constellation Brands Inc / Amphenol Corp / National Retail Properties Inc / Public Storage / Arrow Electronics Inc / Edwards Lifesciences Corp / Camden Property Trust / Boston Properties Inc / Accenture PLC / Alexandria Real Estate Equities Inc / Church & Dwight Co Inc / NU Skin Enterprises Inc / Twitter Inc / Essex Property Trust Inc / Haemonetics Corp / Federal Realty Investment Trust / UGI Corp / Corporate Office Properties Trust / Cousins Properties Inc / Hormel Foods Corp / Brandywine Realty Trust / Boston Beer Company Inc / Amerisourcebergen Corp / Juniper Networks Inc / Iron Mountain Inc / CenterPoint Energy Inc / Intel Corp / Cognizant Technology Solutions Corp / ABIOMED Inc / Amgen Inc / Applied Materials Inc / Autodesk Inc / Cerner Corp / Chemed Corp / Cirrus Logic Inc / Fiserv Inc / Jack Henry & Associates Inc / Lam Research Corp / Activision Blizzard Inc / Paychex Inc / Atlassian Corporation PLC / Regeneron Pharmaceuticals Inc / J M Smucker Co / Bio-Techne Corp / Tyler Technologies Inc / Quidel Corp / Synopsys Inc / ICU Medical Inc / IDEXX Laboratories Inc / Qualcomm Inc / Intuit Inc / Littelfuse Inc / Costco Wholesale Corp / DENTSPLY SIRONA Inc / Nektar Therapeutics / DISH Network Corp / NetApp Inc / Amedisys Inc / Paylocity Holding Corp / ANSYS Inc / Lamar Advertising Co / Euronet Worldwide Inc / ViaSat Inc / Amazon.com Inc / Lumentum Holdings Inc / Take-Two Interactive Software Inc / Verisign Inc / Manhattan Associates Inc / Zebra Technologies Corp / NVIDIA Corp / MKS Instruments Inc / United Therapeutics Corp / SBA Communications Corp / Biomarin Pharmaceutical Inc / Hain Celestial Group Inc / bluebird bio Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Texas Instruments Inc / Comcast Corp / Nexstar Media Group Inc / ACADIA Pharmaceuticals Inc / Monolithic Power Systems Inc / Equity LifeStyle Properties Inc / Herbalife Nutrition Ltd / Universal Display Corp / Spirit Realty Capital Inc / Cadence Design Systems Inc / Live Nation Entertainment Inc / Fidelity National Information Services Inc / Aeroports de Paris SA / Mastercard Inc / Western Union Co / Douglas Emmett Inc / First Solar Inc / IPG Photonics Corp / Qiagen NV / Insulet Corp / VMware Inc / Teradata Corp / EchoStar Corp / News Corp / CACI International Inc / Fair Isaac Corp / Fortinet Inc / Hudson Pacific Properties Inc / Booz Allen Hamilton Holding Corp / Adidas AG / Howard Hughes Corp / Motorola Solutions Inc / Horizon Therapeutics PLC / Acadia Healthcare Company Inc / Enphase Energy Inc / Epam Systems Inc / Guidewire Software Inc / Analog Devices Inc / Sarepta Therapeutics Inc / Globus Medical Inc / Healthcare Trust Of America Inc / Abbvie Inc / Perrigo Company PLC / WEX Inc / CDW Corp / Fox Corp / Sprouts Farmers Market Inc / Rexford Industrial Realty Inc / Leidos Holdings Inc / Premier Inc / Agios Pharmaceuticals Inc / RingCentral Inc / Gaming and Leisure Properties Inc / Brixmor Property Group Inc / PTC Inc / Five9 Inc / Globant SA / Catalent Inc / CDK Global Inc / Keysight Technologies Inc / Paramount Group Inc / OUTFRONT Media Inc / STORE Capital Corp / Anthem Inc / New Relic Inc / Qorvo Inc / Solaredge Technologies Inc / ON Semiconductor Corp / ETSY Inc / Liberty Broadband Corp / Teladoc Health Inc / Cable One Inc / Zimmer Biomet Holdings Inc / Kraft Heinz Co / Global Blood Therapeutics Inc / Penumbra Inc / Novocure Ltd / Pure Storage Inc / Block Inc / Ionis Pharmaceuticals Inc / Reata Pharmaceuticals Inc / Everbridge Inc / Trade Desk Inc / Lamb Weston Holdings Inc / Park Hotels & Resorts Inc / Liberty Media Corp / Roku Inc / Encompass Health Corp / Xcel Energy Inc / Syneos Health Inc / Booking Holdings Inc / Zscaler Inc / Qurate Retail Inc / CBRE Group Inc / Ceridian HCM Holding Inc / Avnet Inc / Evergy Inc / Elanco Animal Health Inc / Teradyne Inc / Alliant Energy Corp / Exelon Corp / Madison Square Garden Sports Corp / American Electric Power Company Inc / Cisco Systems Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Cayman Islands / Germany / France / United Kingdom / Ireland / Luxembourg / Netherlands / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Jonathan N. Golub, CFA / Mr. Manish G. Bangard / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Global Pharmaceuticals: AZN/Amgen: Framing expectations ahead of the tezepelumab NAVIGATOR P3 data at AAAAI</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AMGN.OQ / AZN.L / SASY.PA / NOVN.S / GSK.L / REGN.OQ</td><td class="leftalignment">Amgen Inc / AstraZeneca PLC / Sanofi SA / Novartis AG / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston / Mr. Evan D. Seigerman / Yunhee Park / Jonathan Woo</td></tr>
<tr class="odd"><td class="leftalignment">02/24/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Who Is Coming Up Short?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ACRS.OQ / AERI.OQ / 0715.HK / JNJ.N / LLY.N / MRK.N / PFE.N / NCOX.PA / AMGN.OQ / COLL.OQ / ALKS.OQ / OPTN.OQ / GILD.OQ / CERS.OQ / RMTI.OQ / BDSI.OQ / BIIB.OQ / BSLN.S / MNKD.OQ / MSB.AX / EBS.N / JAZZ.OQ / SPRO.OQ / NEOS.BO / OMER.OQ / ARDX.OQ / ACRX.OQ / AMRN.NS / ZTS.N / ANIP.OQ / AXGN.OQ / HRTX.OQ / TRVN.OQ / EGRX.OQ / ALDX.OQ / SCYX.OQ / CFRX.OQ / VRAY.OQ / CDTX.OQ / FBIO.OQ / SPNE.OQ / VERU.OQ / TXMD.OQ / EOLS.OQ / UBX.OQ / ARDS.OQ / ETTX.OQ / ARAV.OQ / SIBN.OQ / ARQT.OQ / PCVX.OQ / SRGA.OQ / HGEN.OQ / VYNE.OQ / GRAY.OQ / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / Aerie Pharmaceuticals Inc / China Oceanwide Holdings Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Nicox SA / Amgen Inc / Collegium Pharmaceutical Inc / Alkermes Plc / OptiNose Inc / Gilead Sciences Inc / Cerus Corp / Rockwell Medical Inc / BioDelivery Sciences International Inc / Biogen Inc / Basilea Pharmaceutica AG / MannKind Corp / Mesoblast Ltd / Emergent BioSolutions Inc / Jazz Pharmaceuticals PLC / Spero Therapeutics Inc / Neo Corp International Ltd / Omeros Corp / Ardelyx Inc / AcelRx Pharmaceuticals Inc / ADF Foods Ltd / Zoetis Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / Aldeyra Therapeutics Inc / SCYNEXIS Inc / ContraFect Corp / ViewRay Inc / Cidara Therapeutics Inc / Fortress Biotech Inc / SeaSpine Holdings Corp / Veru Inc / TherapeuticsMD Inc / Evolus Inc / UNITY Biotechnology Inc / Aridis Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Aravive Inc / SI-BONE Inc / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Humanigen Inc / Vyne Therapeutics Inc / Graybug Vision Inc / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Switzerland / France / United Kingdom / India / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">02/24/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">SIX=US / VCEL=US / AMGN=US / HD=US / LOW=US / TNL=US / ITRI=US / UTHR=US / CLH=US / MNKD=US / PODD=US / MDWD=US</td><td class="leftalignment">Six Flags Entertainment Corp / Vericel Corp / Amgen Inc / Home Depot Inc / Lowe's Companies Inc / Travel + Leisure Co / Itron Inc / United Therapeutics Corp / Clean Harbors Inc / MannKind Corp / Insulet Corp / Mediwound Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Biotechnology / Consumer / Electrical / Healthcare</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/24/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">4Q Beat; Omnipod 5 Remains on Track</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PODD=US / AMGN=US</td><td class="leftalignment">Insulet Corp / Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steven M. Lichtman</td></tr>
<tr class="even"><td class="leftalignment">02/24/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology: Latest Short Interest for US Biotech: Continued stability for Large Cap, Some SMid sequentially lower</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AMGN.OQ / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / ACRX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / AcelRx Pharmaceuticals Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">02/23/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">February 2021 issue of "Monthly Controversies" report</td><td class="leftalignment">English</td><td class="rightalignment">165</td><td class="leftalignment">031162100 / 09062X103 / 5671735 / 0989529 / 0925288 / 7103065 / 7110388 / 717081103 / 375558103 / 110122108 / 532457108 / 75886F107 / 58933Y105 / 00287Y109</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">02/23/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Domestic Trends Continue to Improve as Vaccine Rollout Progresses and Real-World Data Supports Efficacy, Safety of Vaccines</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">02/23/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRK=US / WMB=US / LLY=US / LSI=US / PFE=US / AMGN=US / MCD=US / OXY=US / WEN=US / TEVA=US / GL=US / AMT=US / REI=US / V=US / CCI=US / HSII=US / MGY=US / CHRS=US / SPOT=US / MRO=US / CVS=US / RCL=US / DISH=US / KFY=US / CBRL=US / ELY=US / DRI=US / ABG=US / OKE=US / REGI=US / SBAC=US / VRTX=US / GOLF=US / CVX=US / ADC=US / PRI=US / NHI=US / PRA=US / NLS=US / DIN=US / EXR=US / PLAY=US / DENN=US / XM=US / KBR=US / CMG=US / REX=US / MA=US / GPRE=US / AMRX=US / TAST=US / QSR=US / JACK=US / CLNY=US / HTA=US / TREX=US / GDOT=US / SBRA=US / PANW=US / FANG=US / TMUS=US / NDLS=US / FIVN=US / VNOM=US / LOCO=US / SHAK=US / SUM=US / NSA=US / BWXT=US / WING=US / ZG=US / SQ=US / FRTA=US / RDFN=US / BTAI=US / ZI=US / BIGC=US / VTRS=US / 100073616</td><td class="leftalignment">Merck & Co Inc / Williams Companies Inc / Eli Lilly and Co / Life Storage Inc / Pfizer Inc / Amgen Inc / McDonald's Corp / Occidental Petroleum Corp / Wendys Co / Teva Pharmaceutical Industries Ltd / Globe Life Inc / American Tower Corp / Ring Energy Inc / Visa Inc / Crown Castle International Corp / Heidrick & Struggles International Inc / Magnolia Oil & Gas Corp / Coherus BioSciences Inc / Spotify Technology SA / Marathon Oil Corp / CVS Health Corp / Royal Caribbean Cruises Ltd / DISH Network Corp / Korn Ferry / Cracker Barrel Old Country Store Inc / Callaway Golf Co / Darden Restaurants Inc / Asbury Automotive Group Inc / ONEOK Inc / Renewable Energy Group Inc / SBA Communications Corp / Vertex Pharmaceuticals Inc / Acushnet Holdings Corp / Chevron Corp / Agree Realty Corp / Primerica Inc / National Health Investors Inc / ProAssurance Corp / Nautilus Inc / Dine Brands Global Inc / Extra Space Storage Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Qualtrics International Inc / KBR Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Mastercard Inc / Green Plains Inc / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Jack in the Box Inc / DigitalBridge Group Inc / Healthcare Trust Of America Inc / Trex Company Inc / Green Dot Corp / Sabra Health Care REIT Inc / Palo Alto Networks Inc / Diamondback Energy Inc / T-Mobile US Inc / Noodles & Co / Five9 Inc / Viper Energy Partners LP / El Pollo Loco Holdings Inc / Shake Shack Inc / Summit Materials Inc / National Storage Affiliates Trust / BWX Technologies Inc / Wingstop Inc / Zillow Group Inc / Block Inc / Forterra Inc / Redfin Corp / BioXcel Therapeutics Inc / ZoomInfo Technologies Inc / Bigcommerce Holdings Inc / Viatris Inc / Kimco Realty Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / Liberia / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">02/23/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Takeaways on IO and Targeted Approaches from our GHC Lung Cancer Panel</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK=US / AMGN=US / AZN=US / JNJ=US / TPTX=US / MRTX=US / BPMC=US / HARP=US / BNTX=US / GMAB=US / RVMD=US</td><td class="leftalignment">Merck & Co Inc / Amgen Inc / AstraZeneca PLC / Johnson & Johnson / Turning Point Therapeutics Inc / Mirati Therapeutics Inc / Blueprint Medicines Corp / Harpoon Therapeutics Inc / BioNTech SE / Genmab A/S / Revolution Medicines Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Dr. Daina Graybosch, PHD / Dr. Andrew S. Berens, MD / Mr. Jonathan W. Chang, PHD</td></tr>
<tr class="odd"><td class="leftalignment">02/23/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Therapeutic Categories Outlook</td><td class="leftalignment">English</td><td class="rightalignment">3621</td><td class="leftalignment">US0311621009 / US0463531089 / US1101221083 / US30161Q1040 / US3755581036 / US37733W1053 / US4781601046 / US5324571083 / US66987V1098 / US7170811035 / US75886F1075 / US7711951043 / US91307C1027 / US92532F1003 / US80105N1054 / US09062X1037 / US58933Y1055 / IE00BJ3V9050</td><td class="leftalignment">Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Exelixis Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Regeneron Pharmaceuticals Inc / Roche Holding AG / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Sanofi SA / Biogen Inc / Merck & Co Inc / Endo International PLC</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Health Care Team</td></tr>
<tr class="even"><td class="leftalignment">02/22/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">FY2020 Annual Report: Amgen Net Profit down 7.4%; Institutional Ownership down 3%</td><td class="leftalignment">English</td><td class="rightalignment">73</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Feb 12, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Guggenheim Ther Research</td></tr>
<tr class="even"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">02/22/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - February 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">ALTR.O / ALV.N / AU.N / BP.L / CCI.N / CF.N / CL.N / CNA.L / CNE.L / EL.N / ENI.MI / EOG.N / F.N / FLS.N / FOUG.PA / GE.N / GM.N / KMB.N / KO.N / MRK.N / NA / NVA.TO / OXY.N / PD.TO / PFE.N / REP.MC / SGC.L / STO.AX / T.N / TLW.L / TOTF.PA / VC.N / WPL.AX / PEP.N / TRI.N / BFb.N / PG.N / PXD.N / CNQ.TO / CPB.N / TEN.N / CMCSA.O / AMGN.O / ETN.N / BWA.N / LEA.N / WCC.N / K.N / DISH.O / IMO.TO / SU.TO / BTE.TO / CLX.N / CAG.N / VLO.N / MRO.N / INTU.O / GIS.N / EMR.N / XOM.N / DVN.N / EPC.N / MGA.N / JAZZ.O / ORG.AX / CONE.O / GWW.N / VZ.N / EXEL.O / JCI.N / ARNA.O / STZ.N / APH.N / RRC.N / FISV.O / EQT.N / ADSK.O / CHTR.O / AXL.N / CHD.N / BC.N / DK.N / POU.TO / ESI.TO / SAM.N / FOG.L / BMRN.O / REGN.O / ENR.N / CVX.N / BPT.AX / SM.N / NCR.N / PSI.TO / TEL.N / COP.N / CPE.N / ENDP.O / PII.N / ST.N / SWN.N / TT.N / FCF.N / O.N / SGEN.OQ / GPN.N / MNST.O / EFX.TO / IMGN.O / CASY.O / ANSS.O / EQIX.O / ATDb.TO / FAR.AX / COE.AX / CVN.AX / TCW.TO / CFW.TO / 02209S103 / NTR.N / NVT.N / CR.TO / DLR.N / SCL.TO / NESTE.HE / 427866108 / WEF.TO / RDSb.L / KOS.N / DISCA.O / KAR.AX / FIS.N / SES.TO / ALD.AX / MWA.N / HOG.N / GALP.LS / BIR.TO / CLR.N / BGS.N / VMW.N / COI.AX / DAN.N / GTE.TO / NOG.A / PBF.N / EDPR.LS / WGO.AX / CPG.TO / AAV.TO / CEU.TO / SPB.N / ATH.TO / OAS.N / MEG.TO / VET.TO / TOU.TO / NXT.AX / ERF.TO / FRU.TO / PEY.TO / PCRX.O / MTOR.N / MPC.N / HFC.N / PXT.TO / MTDR.N / XYL.N / TVE.TO / PSX.N / PANW.N / MDLZ.OQ / FANG.O / KEL.TO / TSLA.N / PRMW.N / TMUS.N / DOO.TO / COTY.N / CJ.TO / QTWO.N / TSLX.N / PSK.TO / LXE.V / AXTA.N / SHOP.N / GLPG.O / SQ.N / MESO.O / RACE.MI / TWLO.N / ATKR.N / PARR.N / KNSL.OQ / ATS.AX / AKERBP.OL / NTNX.O / ADNT.N / GDS.O / CDEV.O / STEP.TO / ESTE.N / ATNX.O / APTV.N / ZS.OQ / ENOG.L / DBX.O / AMRX.N / VNE.N / KDP.N / FOCS.O / VEN.AX / ESTC.N / NWL.O / PIPE.V / LSPD.TO / 269796108 / CRWD.O / GMAB.O / PING.N / CRNC.OQ / EPAC.N / 2222.SE / OVV.N / REYN.O / CARR.N / LUNE.ST / NKLA.OQ / APA.OQ / FOUR.N / RXT.OQ / IBEX.O / LUMN.N / PLTR.N / MCFE.OQ / TPZ.TO / AFRM.O / 120291281 / 120681711</td><td class="leftalignment">Altair Engineering Inc / Autoliv Inc / AngloGold Ashanti Ltd / BP PLC / Crown Castle International Corp / CF Industries Holdings Inc / Colgate-Palmolive Co / Centrica PLC / Capricorn Energy PLC / Estee Lauder Companies Inc / Eni SpA / EOG Resources Inc / Ford Motor Co / Flowserve Corp / Eiffage SA / General Electric Co / General Motors Co / Kimberly-Clark Corp / Coca-Cola Co / Merck & Co Inc / National Bank of Canada / Nuvista Energy Ltd / Occidental Petroleum Corp / Precision Drilling Corp / Pfizer Inc / Repsol SA / Stagecoach Group PLC / Santos Ltd / AT&T Inc / Tullow Oil PLC / TotalEnergies SE / Visteon Corp / Woodside Petroleum Ltd / PepsiCo Inc / Thomson Reuters Corp / Brown-Forman Corp / Procter & Gamble Co / Pioneer Natural Resources Co / Canadian Natural Resources Ltd / Campbell Soup Co / Tenneco Inc / Comcast Corp / Amgen Inc / Eaton Corporation PLC / Borgwarner Inc / Lear Corp / Wesco International Inc / Kellogg Co / DISH Network Corp / Imperial Oil Ltd / Suncor Energy Inc / Baytex Energy Corp / Clorox Co / Conagra Brands Inc / Valero Energy Corp / Marathon Oil Corp / Intuit Inc / General Mills Inc / Emerson Electric Co / Exxon Mobil Corp / Devon Energy Corp / Edgewell Personal Care Co / Magna International Inc / Jazz Pharmaceuticals PLC / Origin Energy Ltd / CyrusOne Inc / W W Grainger Inc / Verizon Communications Inc / Exelixis Inc / Johnson Controls International PLC / Arena Pharmaceuticals Inc / Constellation Brands Inc / Amphenol Corp / Range Resources Corp / Fiserv Inc / EQT Corp / Autodesk Inc / Charter Communications Inc / American Axle & Manufacturing Holdings Inc / Church & Dwight Co Inc / Brunswick Corp / Delek US Holdings Inc / Paramount Resources Ltd / Ensign Energy Services Inc / Boston Beer Company Inc / Falcon Oil & Gas Ltd / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Chevron Corp / Beach Energy Ltd / SM Energy Co / NCR Corp / Pason Systems Inc / TE Connectivity Ltd / Conocophillips / Callon Petroleum Co / Endo International PLC / Polaris Inc / Sensata Technologies Holding PLC / Southwestern Energy Co / Trane Technologies PLC / First Commonwealth Financial Corp / Realty Income Corp / Seagen Inc / Global Payments Inc / Monster Beverage Corp / Enerflex Ltd / ImmunoGen Inc / Caseys General Stores Inc / ANSYS Inc / Equinix Inc / Alimentation Couche-Tard Inc / FAR Ltd / Cooper Energy Ltd / Carnarvon Energy Ltd / Trican Well Service Ltd / Calfrac Well Services Ltd / Altria Group Inc / Nutrien Ltd / nVent Electric PLC / Crew Energy Inc / Digital Realty Trust Inc / Shawcor Ltd / Neste Oyj / Hershey Co / Western Forest Products Inc / Royal Dutch Shell PLC / Kosmos Energy Ltd / Discovery Inc / Karoon Energy Ltd / Fidelity National Information Services Inc / Secure Energy Services Inc / Ampol Ltd / Mueller Water Products Inc / Harley-Davidson Inc / Galp Energia SGPS SA / Birchcliff Energy Ltd / Continental Resources Inc / B&G Foods Inc / VMware Inc / Comet Ridge Ltd / Dana Inc / Gran Tierra Energy Inc / Northern Oil and Gas Inc / PBF Energy Inc / EDP Renovaveis SA / Warrego Energy Ltd / Crescent Point Energy Corp / Advantage Energy Ltd / CES Energy Solutions Corp / Spectrum Brands Holdings Inc / Athabasca Oil Corp / Oasis Petroleum Inc / MEG Energy Corp / Vermilion Energy Inc / Tourmaline Oil Corp / NEXTDC Ltd / Enerplus Corp / Freehold Royalties Ltd / Peyto Exploration & Development Corp / Pacira Biosciences Inc / Meritor Inc / Marathon Petroleum Corp / HollyFrontier Corp / Parex Resources Inc / Matador Resources Co / Xylem Inc / Tamarack Valley Energy Ltd / Phillips 66 / Palo Alto Networks Inc / Mondelez International Inc / Diamondback Energy Inc / Kelt Exploration Ltd / Tesla Inc / Primo Water Corp / T-Mobile US Inc / BRP Inc / Coty Inc / Cardinal Energy Ltd (Alberta) / Q2 Holdings Inc / Sixth Street Specialty Lending Inc / Prairiesky Royalty Ltd / Leucrotta Exploration Inc / Axalta Coating Systems Ltd / Shopify Inc / Galapagos NV / Block Inc / Mesoblast Ltd / Ferrari NV / Twilio Inc / Atkore Inc / Par Pacific Holdings Inc / Kinsale Capital Group Inc / Australis Oil & Gas Ltd / Aker BP ASA / Nutanix Inc / Adient PLC / GDS Holdings Ltd / Centennial Resource Development Inc / Step Energy Services Ltd / Earthstone Energy Inc / Athenex Inc / Aptiv PLC / Zscaler Inc / Energean PLC / Dropbox Inc / Amneal Pharmaceuticals Inc / Veoneer Inc / Keurig Dr Pepper Inc / Focus Financial Partners Inc / Vintage Energy Ltd / Elastic NV / Newell Brands Inc / Pipestone Energy Corp / Lightspeed Commerce Inc / Eagle Pharmaceuticals Inc / CrowdStrike Holdings Inc / Genmab A/S / Ping Identity Holding Corp / Cerence Inc / Enerpac Tool Group Corp / Saudi Arabian Oil Co / Ovintiv Inc / Reynolds Consumer Products Inc / Carrier Global Corp / Lundin Energy AB / Nikola Corp / APA Corp (US) / Shift4 Payments Inc / Rackspace Technology Inc / Ibex Ltd / Lumen Technologies Inc / Palantir Technologies Inc / Mcafee Corp / Topaz Energy Corp / Affirm Holdings Inc / Cenovus Energy Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / Spain / Finland / France / United Kingdom / Ireland / Italy / Netherlands / Norway / Papua New Guinea / Portugal / Saudi Arabia / Sweden / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For the Week Ended Feb 12, 2021: Focus on Jan 2021 Rx volumes for branded and generic drugs</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / RB.L / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ / MNK.N^J20</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / Reckitt Benckiser Group PLC / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc / Mallinckrodt PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">02/21/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Key Questions for Management 2.21.21</td><td class="leftalignment">English</td><td class="rightalignment">76</td><td class="leftalignment">ADAP=US / MRK=US / BSX=US / CSII=US / PFE=US / ABT=US / AMGN=US / TMO=US / MDT=US / A=US / INCY=US / INSP=US / TEVA=US / GILD=US / MOR=DE / SAN=FR / GSK=GB / SYK=US / BAX=US / AZN=US / WAT=US / JNJ=US / MDRX=US / IMGN=US / NUAN=US / ABMD=US / ALKS=US / ALC=US / AMRN=US / ARNA=US / ATRC=US / BDX=US / BMRN=US / BLUE=US / CSTL=US / CALA=US / CERN=US / CNMD=US / EW=US / ENDP=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / INGN=US / ISRG=US / MYGN=US / NBIX=US / PRGO=US / PRTK=US / RARE=US / HOOK=US / REGN=US / RGEN=US / SENS=US / SIEN=US / SILK=US / TECH=US / TFX=US / VRTX=US / ALGN=US / SGEN=US / SAGE=US / OPT=US / PRVB=US / CGEN=US / ALVR=US / JAZZ=US / PHR=US / STSA=US / RNA=US / IMTX=US / MREO=US / NTRA=US / CPSI=US / NKTR=US / MRNS=US / AMTI=US / BIIB=US / ACRS=US / ARWR=US / APTX=US / NUVA=US / MRNA=US / ACAD=US / ALNY=US / MNKD=US / COGT=US / DXCM=US / CYRX=US / CBAY=US / GRAY=US / EQ=US / QTRX=US / AVRO=US / TPTX=US / AMRX=US / FOLD=US / PODD=US / TNDM=US / IFRX=US / ITRM=US / NXGN=US / FULC=US / LUN=US / ASND=US / AVEO=US / NEO=US / RCUS=US / MOLN / CTSO=US / ZGNX=US / PCRX=US / RGNX=US / CLVS=US / PBYI=US / AXGN=US / VCRA=US / CCXI=US / FGEN=US / SRPT=US / GMED=US / ABBV=US / EPZM=US / MRTX=US / AGIO=US / PINC=US / FATE=US / MGNX=US / VEEV=US / VCYT=US / KPTI=US / OM=US / ITCI=US / XNCR=US / HRTX=US / QURE=US / GNCA=US / TBPH=US / ARDX=US / RDUS=US / MASS=US / XENT=US / ASMB=US / HQY=US / TTOO=US / AUPH=US / AFMD=US / GNFT=US / DBVT=US / VCEL=US / XENE=US / NVRO=US / NVTA=US / RLMD=US / VKTX=US / BPMC=US / HTGM=US / ZBH=US / ABEO=US / TDOC=US / KURA=US / WVE=US / AXSM=US / IONS=US / BGNE=US / NTLA=US / ADVM=US / RETA=US / MDGL=US / PTGX=US / ACIU=US / TRHC=US / MYOV=US / ZYME=US / AVDL=US / OBSV=US / RCM=US / BHVN=US / MRSN=US / KALV=US / ATNX=US / SYBX=US / ZLAB=US / DCPH=US / SCPH=US / SLDB=US / GH=US / RCKT=US / EOLS=US / XERS=US / REPL=US / RUBY=US / CRNX=US / ALLK=US / SBTX=US / TWST=US / AXNX=US / MLND=US / OSMT=US / ORGO=US / HARP=US / GOSS=US / TCRR=US / IMUX=US / AXLA=US / BBIO=US / HCAT=US / BNTX=US / GMAB=US / IPHA=US / ETNB=US / PGNY=US / CNTG=US / IMVT=US / ONEM=US / RVMD=US / IMRA=US / ZNTL=US / KROS=US / FMTX=US / ACCD=US / ITOS=US / KDNY=US / GDRX=US / SPRB=US / SIOX=US / VTRS=US / ABCM=US / GLTO=US / TVTX=US / ABCL=US / KNTE=US / ELDN=US / PRTC=US / CGEM=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Pfizer Inc / Abbott Laboratories / Amgen Inc / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Incyte Corp / Inspire Medical Systems Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / MorphoSys AG / Sanofi SA / GlaxoSmithKline PLC / Stryker Corp / Baxter International Inc / AstraZeneca PLC / Waters Corp / Johnson & Johnson / Allscripts Healthcare Solutions Inc / ImmunoGen Inc / Nuance Communications Inc / ABIOMED Inc / Alkermes Plc / Alcon AG / Amarin Corporation PLC / Arena Pharmaceuticals Inc / AtriCure Inc / Becton Dickinson and Co / Biomarin Pharmaceutical Inc / bluebird bio Inc / Castle Biosciences Inc / Calithera Biosciences Inc / Cerner Corp / Conmed Corp / Edwards Lifesciences Corp / Endo International PLC / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Inogen Inc / Intuitive Surgical Inc / Myriad Genetics Inc / Neurocrine Biosciences Inc / Perrigo Company PLC / Paratek Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Senseonics Holdings Inc / Sientra Inc / Silk Road Medical Inc / Bio-Techne Corp / Teleflex Inc / Vertex Pharmaceuticals Inc / Align Technology Inc / Seagen Inc / SAGE Therapeutics Inc / Opthea Ltd / Provention Bio Inc / Compugen Ltd / Allovir Inc / Jazz Pharmaceuticals PLC / Phreesia Inc / Satsuma Pharmaceuticals Inc / Avidity Biosciences Inc / Immatics NV / Mereo Biopharma Group PLC / Natera Inc / Computer Programs and Systems Inc / Nektar Therapeutics / Marinus Pharmaceuticals Inc / Applied Molecular Transport Inc. / Biogen Inc / Aclaris Therapeutics Inc / Arrowhead Pharmaceuticals Inc / Aptinyx Inc / NuVasive Inc / Moderna Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / MannKind Corp / Cogent Biosciences Inc / Dexcom Inc / Cryoport Inc / Cymabay Therapeutics Inc / Graybug Vision Inc / Equillium Inc / Quanterix Corp / AVROBIO Inc / Turning Point Therapeutics Inc / Amneal Pharmaceuticals Inc / Amicus Therapeutics Inc / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Iterum Therapeutics PLC / NextGen Healthcare Inc / Fulcrum Therapeutics Inc / H Lundbeck A/S / Ascendis Pharma A/S / Aveo Pharmaceuticals Inc / Neogenomics Inc / Arcus Biosciences Inc / Molecular Partners AG / Cytosorbents Corp / Zogenix Inc / Pacira Biosciences Inc / Regenxbio Inc / Clovis Oncology Inc / Puma Biotechnology Inc / AxoGen Inc / Vocera Communications Inc / ChemoCentryx Inc / FibroGen Inc / Sarepta Therapeutics Inc / Globus Medical Inc / Abbvie Inc / Epizyme Inc / Mirati Therapeutics Inc / Agios Pharmaceuticals Inc / Premier Inc / Fate Therapeutics Inc / MacroGenics Inc / Veeva Systems Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Outset Medical Inc / Intra-Cellular Therapies Inc / Xencor Inc / Heron Therapeutics Inc / Uniqure NV / Genocea Biosciences Inc / Theravance Biopharma Inc / Ardelyx Inc / Radius Health Inc / 908 Devices Inc. / Intersect Ent Inc / Assembly Biosciences Inc / Healthequity Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Affimed NV / Genfit SA / DBV Technologies SA / Vericel Corp / Xenon Pharmaceuticals Inc / Nevro Corp / Invitae Corp / Relmada Therapeutics Inc / Viking Therapeutics Inc / Blueprint Medicines Corp / HTG Molecular Diagnostics Inc / Zimmer Biomet Holdings Inc / Abeona Therapeutics Inc / Teladoc Health Inc / Kura Oncology Inc / WAVE Life Sciences Ltd / Axsome Therapeutics Inc / Ionis Pharmaceuticals Inc / Beigene Ltd / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / Reata Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / Protagonist Therapeutics Inc / AC Immune SA / Tabula Rasa HealthCare Inc / Myovant Sciences Ltd / Zymeworks Inc / Avadel Pharmaceuticals PLC / Obseva SA / R1 RCM Inc / Biohaven Pharmaceutical Holding Company Ltd / Mersana Therapeutics Inc / Kalvista Pharmaceuticals Inc / Athenex Inc / Synlogic Inc / Zai Lab Ltd / Deciphera Pharmaceuticals Inc / scPharmaceuticals Inc / Solid Biosciences Inc / Guardant Health Inc / Rocket Pharmaceuticals Inc / Evolus Inc / Xeris Biopharma Holdings Inc / Replimune Group Inc / Rubius Therapeutics Inc / Crinetics Pharmaceuticals Inc / Allakos Inc / Silverback Therapeutics Inc / Twist Bioscience Corp / Axonics Inc / Tempest Therapeutics Inc / Osmotica Pharmaceuticals PLC / Organogenesis Holdings Inc / Harpoon Therapeutics Inc / Gossamer Bio Inc / TCR2 Therapeutics Inc / Immunic Inc / Axcella Health Inc / BridgeBio Pharma Inc / Health Catalyst Inc / BioNTech SE / Genmab A/S / Innate Pharma SA / 89Bio Inc / Progyny Inc / Centogene NV / Immunovant Inc / 1Life Healthcare Inc / Revolution Medicines Inc / Imara Inc / Zentalis Pharmaceuticals Inc / Keros Therapeutics Inc / Forma Therapeutics Holdings Inc / Accolade Inc / Iteos Therapeutics Inc / Chinook Therapeutics Inc / Goodrx Holdings Inc / Spruce Biosciences Inc / Sio Gene Therapies Inc / Viatris Inc / Abcam PLC / Galecto Inc / Travere Therapeutics Inc / Abcellera Biologics Inc / Kinnate Biopharma Inc / Eledon Pharmaceuticals Inc / PureTech Health PLC / Cullinan Oncology Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / Singapore / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AMGN.O / EXEL.O / ARNA.O / BMRN.O / REGN.O / SGEN.OQ / IMGN.O / MESO.O / ATNX.O / GMAB.O</td><td class="leftalignment">Amgen Inc / Exelixis Inc / Arena Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Seagen Inc / ImmunoGen Inc / Mesoblast Ltd / Athenex Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Australia / Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Kennen MacKay, PHD / Edwin Delfin</td></tr>
<tr class="odd"><td class="leftalignment">02/19/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">FY2020 Annual Report: Amgen Net Profit down 7.4%; Institutional Ownership down 3%</td><td class="leftalignment">English</td><td class="rightalignment">66</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">02/19/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Weekly: Gvoke Maintains 10% Share; Gx Vascepa Back to 10% Bottle Share</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / GSK=US / ENDP=US / PRGO=US / BIIB=US / AMRX=US / ABBV=US / XERS=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / GlaxoSmithKline PLC / Endo International PLC / Perrigo Company PLC / Biogen Inc / Amneal Pharmaceuticals Inc / Abbvie Inc / Xeris Biopharma Holdings Inc / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Ms. Ami Fadia</td></tr>
<tr class="odd"><td class="leftalignment">02/19/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Feb 19 2021</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">UTHR=US / XAIR=US / MRK=US / BSX=US / LLY=US / PFE=US / ABT=US / AMGN=US / BMY=US / GBT=US / MDT=US / WMT=US / TEVA=US / EPIX=US / CMS=US / DGX=US / SYK=US / IART=US / BWAY=US / RAD=US / JNJ=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / BLUE=US / CHE=US / CYH=US / EW=US / EXAS=US / EXEL=US / GEN=US / ICPT=US / PHG=US / LH=US / REGN=US / USPH=US / UHS=US / VRTX=US / CCRN=US / RHHBY=US / CNC=US / ACA=US / ENSG=US / MD=US / SLF=US / MNKD=US / GOOG=US / LHCG=US / CHNG=US / MASI=US / EHC=US / SWAV=US / ADUS=US / ALPMY=US / ACHC=US / SRPT=US / AGIO=US / CTRE=US / OTIC=US / VBLT=US / WBA=US / NVTA=US / CLLS=US / VKTX=US / EVH=US / CFMS=US / CERC=US / EDIT=US / MDGL=US / IRTC=US / CRSP=US / VERU=US / MBIO=US / MDNA=US / SESN=US / ARVN=US / FREQ=US / BXRX=US / PNTG=US / TARA=US / AYLA=US / FMTX=US / MNKKQ=US / CHGCY=US</td><td class="leftalignment">United Therapeutics Corp / Beyond Air Inc / Merck & Co Inc / Boston Scientific Corp / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Amgen Inc / Bristol-Myers Squibb Co / Global Blood Therapeutics Inc / Medtronic PLC / Walmart Inc / Teva Pharmaceutical Industries Ltd / ESSA Pharma Inc / CMS Energy Corp / Quest Diagnostics Inc / Stryker Corp / Integra Lifesciences Holdings Corp / Brainsway Ltd / Rite Aid Corp / Johnson & Johnson / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / bluebird bio Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / Exact Sciences Corp / Exelixis Inc / Genesis Healthcare Inc / Intercept Pharmaceuticals Inc / Koninklijke Philips NV / Laboratory Corporation of America Holdings / Regeneron Pharmaceuticals Inc / US Physical Therapy Inc / Universal Health Services Inc / Vertex Pharmaceuticals Inc / Cross Country Healthcare Inc / Roche Holding AG / Centene Corp / Arcosa Inc / Ensign Group Inc / MEDNAX Inc / Sun Life Financial Inc / MannKind Corp / Alphabet Inc / LHC Group Inc / Change Healthcare Inc / Masimo Corp / Encompass Health Corp / Shockwave Medical Inc / Addus Homecare Corp / Astellas Pharma Inc / Acadia Healthcare Company Inc / Sarepta Therapeutics Inc / Agios Pharmaceuticals Inc / CareTrust REIT Inc / Otonomy Inc / Vascular Biogenics Ltd / Walgreens Boots Alliance Inc / Invitae Corp / Cellectis SA / Viking Therapeutics Inc / Evolent Health Inc / Conformis Inc / Avalo Therapeutics Inc / Editas Medicine Inc / Madrigal Pharmaceuticals Inc / iRhythm Technologies Inc / CRISPR Therapeutics AG / Veru Inc / Mustang Bio Inc / Medicenna Therapeutics Corp / Sesen Bio Inc / Arvinas Inc / Frequency Therapeutics Inc / Baudax Bio Inc / Pennant Group Inc / Protara Therapeutics Inc / Ayala Pharmaceuticals Inc / Forma Therapeutics Holdings Inc / Mallinckrodt PLC / Chugai Pharmaceutical Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / France / Ireland / Israel / Japan / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="even"><td class="leftalignment">02/19/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 535</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">02/19/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Amgen Inc: Ownership Timelines & Shareholder Analytics (February 2021)</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">02/19/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended February 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / BMY=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/19/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="even"><td class="leftalignment">02/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Sustainable Growth With A Late Stage Innovative Pipeline</td><td class="leftalignment">English</td><td class="rightalignment">68</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Yaron Werber, M.D., MD / Brendan Smith, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">02/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">02/19/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AMGN=US / OXY=US / BLD=US / CRM=US / CONE=US / MTN=US / XOM=US / IART=US / MAR=US / SPOT=US / ATVI=US / VMC=US / MLM=US / AMN=US / B=US / KIDS=US / CHH=US / CYH=US / CPRT=US / CW=US / HEI=US / IBP=US / TRGP=US / TRIP=US / AEL=US / ADC=US / JAZZ=US / SPR=US / APPN=US / MD=US / TXRH=US / WMG=US / BLDR=US / SCPL=US / HST=US / GPRE=US / EHTH=US / CLR=US / KTOS=US / JACK=US / KNSL=US / AR=US / ZNGA=US / BCEI=US / EA=US / LKQ=US / QTWO=US / SUM=US / AJRD=US / BWXT=US / IBEX=US / TTD=US / EVBG=US / JELD=US / ROKU=US / SYNH=US / COLD=US / FTDR=US / SITC=US / TCRR=US / CRWD=US / ARQT=US</td><td class="leftalignment">Amgen Inc / Occidental Petroleum Corp / TopBuild Corp / Salesforce.Com Inc / CyrusOne Inc / Vail Resorts Inc / Exxon Mobil Corp / Integra Lifesciences Holdings Corp / Marriott International Inc / Spotify Technology SA / Activision Blizzard Inc / Vulcan Materials Co / Martin Marietta Materials Inc / AMN Healthcare Services Inc / Barnes Group Inc / OrthoPediatrics Corp / Choice Hotels International Inc / Community Health Systems Inc / Copart Inc / Curtiss-Wright Corp / HEICO Corp / Installed Building Products Inc / Targa Resources Corp / Tripadvisor Inc / American Equity Investment Life Holding Co / Agree Realty Corp / Jazz Pharmaceuticals PLC / Spirit AeroSystems Holdings Inc / Appian Corp / MEDNAX Inc / Texas Roadhouse Inc / Warner Music Group Corp / Builders FirstSource Inc / Sciplay Corp / Host Hotels & Resorts Inc / Green Plains Inc / eHealth Inc / Continental Resources Inc / Kratos Defense and Security Solutions Inc / Jack in the Box Inc / Kinsale Capital Group Inc / Antero Resources Corp / Zynga Inc / Civitas Resources Inc / Electronic Arts Inc / LKQ Corp / Q2 Holdings Inc / Summit Materials Inc / Aerojet Rocketdyne Holdings Inc / BWX Technologies Inc / Ibex Ltd / Trade Desk Inc / Everbridge Inc / JELD-WEN Holding Inc / Roku Inc / Syneos Health Inc / Americold Realty Trust / Frontdoor Inc / Site Centers Corp / TCR2 Therapeutics Inc / CrowdStrike Holdings Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Ireland / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">NBIX.OQ / VRTX.OQ / PFE.N / AZN.L / ROG.S / AMGN.OQ / REGN.OQ / STSA.OQ / GILD.OQ / BIIB.OQ / GLPG.AS / ACRX.OQ / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Pfizer Inc / AstraZeneca PLC / Roche Holding AG / Amgen Inc / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Biogen Inc / Galapagos NV / AcelRx Pharmaceuticals Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">02/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">PharmaValues - Website Introduction Slides</td><td class="leftalignment">English</td><td class="rightalignment">44</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / BMY.N / CSL.AX / JNJ.N / LLY.N / MRK.N / PFE.N / RECI.MI / AZN.L / 4506.T / 4536.T / SASY.PA / ROG.S / LUN.CO / 4151.T / NOVOB.CO / NOVN.S / MRCG.DE / GSK.L / UCB.BR / AMGN.OQ / REGN.OQ / ALKS.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / BMRN.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / 4568.T / IPN.PA / HIK.L / TEVA.N / ORNBV.HE / ALM.MC / GRLS.MC / BAYGN.DE / 4578.T / 4581.T / SRPT.OQ / ABBV.N / QURE.OQ / BGNE.OQ / VIFN.S / 6160.HK / GMAB.CO</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / CSL Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Kyowa Kirin Co Ltd / Novo Nordisk A/S / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Ucb SA / Amgen Inc / Regeneron Pharmaceuticals Inc / Alkermes Plc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Daiichi Sankyo Co Ltd / Ipsen SA / Hikma Pharmaceuticals PLC / Teva Pharmaceutical Industries Ltd / Orion Oyj / Almirall SA / Grifols SA / Bayer AG / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / Sarepta Therapeutics Inc / Abbvie Inc / Uniqure NV / Beigene Ltd / Vifor Pharma AG / Beigene Ltd / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / China / Cayman Islands / Germany / Denmark / Spain / Finland / France / United Kingdom / Ireland / Israel / Italy / Japan / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">02/18/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Dermavant's tapinarof cream adds more competition to Otezla in psoriasis</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AMGN=US / ARQT=US</td><td class="leftalignment">Amgen Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Minh Vong</td></tr>
<tr class="even"><td class="leftalignment">02/18/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Back in Black; Biotech Inflows Return</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / 039697107 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / 19240Q201</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Ardelyx Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / Cogent Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">02/18/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">ALSN=US / CYH=US / AAPL=US / PFE=US / AMGN=US / INTC=US / ADI=US / AMD=US / MSFT=US / AMZN=US / QCOM=US / TXN=US / NVDA=US / GS=US / MX=US / MPWR=US / SMTC=US / TSM=US / XLNX=US / MGM=US / PENN=US / AMED=US / AVGO=US / CAKE=US / CHE=US / CRUS=US / DRI=US / ECL=US / IFX=US / ICPT=US / NOW=US / MCHP=US / QUIK=US / SHOP=US / UTHR=US / WIX=US / JEF=US / SWKS=US / TWLO=US / WCN=US / PTON=US / TCOM=US / CZR=US / MRNA=US / LHCG=US / BIDU=US / SPWR=US / RSI=US / IAC=US / JACK=US / SWAV=US / 005930-KR=US / ADUS=US / MXL=US / NXPI=US / 2454-TW=US / SRPT=US / WDAY=US / YY=US / NVTA=US / CLLS=US / GDDY=US / ETSY=US / VKTX=US / WING=US / SQ=US / MDGL=US / MDNA=US / IQ=US / TLRY=US / FSLY=US / DKNG=US / FUBO=US / AYLA=US / XPEV=US</td><td class="leftalignment">Allison Transmission Holdings Inc / Community Health Systems Inc / Apple Inc / Pfizer Inc / Amgen Inc / Intel Corp / Analog Devices Inc / Advanced Micro Devices Inc / Microsoft Corp / Amazon.com Inc / Qualcomm Inc / Texas Instruments Inc / NVIDIA Corp / Goldman Sachs Group Inc / MagnaChip Semiconductor Corp / Monolithic Power Systems Inc / Semtech Corp / Taiwan Semiconductor Manufacturing Co Ltd / Xilinx Inc / MGM Resorts International / Penn National Gaming Inc / Amedisys Inc / Broadcom Inc / Cheesecake Factory Inc / Chemed Corp / Cirrus Logic Inc / Darden Restaurants Inc / Ecolab Inc / Infineon Technologies AG / Intercept Pharmaceuticals Inc / ServiceNow Inc / Microchip Technology Inc / QuickLogic Corp / Shopify Inc / United Therapeutics Corp / Wix.Com Ltd / Jefferies Financial Group Inc / Skyworks Solutions Inc / Twilio Inc / Waste Connections Inc / Peloton Interactive Inc / Trip.com Group Ltd / Caesars Entertainment Inc / Moderna Inc / LHC Group Inc / Baidu Inc / SunPower Corp / Rush Street Interactive Inc / IAC/Interactivecorp / Jack in the Box Inc / Shockwave Medical Inc / Farfetch Ltd / Addus Homecare Corp / Maxlinear Inc / NXP Semiconductors NV / MediaTek Inc / Sarepta Therapeutics Inc / Workday Inc / JOYY Inc / Invitae Corp / Cellectis SA / GoDaddy Inc / ETSY Inc / Viking Therapeutics Inc / Wingstop Inc / Block Inc / Madrigal Pharmaceuticals Inc / Medicenna Therapeutics Corp / iQIYI Inc / Tilray Brands Inc / Fastly Inc / DraftKings Inc / Fubotv Inc / Ayala Pharmaceuticals Inc / Xpeng Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / Germany / France / Israel / Netherlands / Taiwan / United States</td><td class="leftalignment">Biotechnology / Electrical / Financial Services / Healthcare / Info. Tech./Computers / Info. Tech./Software / Lodging & Restaurants / Pharmaceuticals / Retailing / Semiconductors / Services / Telecommunications</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GILD-US -  Dividend Quality Analysis, for the period ended December 30,2020.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD.O / JNJ / LLY / MRK / PFE / AMGN.O / ILMN.O / VRTX.O / BIIB.O / ABBV.K</td><td class="leftalignment">Gilead Sciences Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Illumina Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABBV-US -  Dividend Quality Analysis, for the period ended February 16,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ABBV.K / BMY / LLY / PFE / GILD.O / AMGN.O / GSK / NBIX.O / AZN.O / BIIB.O</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / GlaxoSmithKline PLC / Neurocrine Biosciences Inc / AstraZeneca PLC / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/17/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Virtual RTP Day: Biotechnology Manufacturing Panel</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PFE=US / AMGN=US / UTHR=US / SRPT=US / CLLS=US</td><td class="leftalignment">Pfizer Inc / Amgen Inc / United Therapeutics Corp / Sarepta Therapeutics Inc / Cellectis SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">KNBWY-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">KNBWY.PK / BUD / CCU / CCU.SN / SAM / AMGN.O / STZb / TAPa / HEINY.PK</td><td class="leftalignment">Kirin Holdings Co Ltd / Anheuser Busch Inbev SA / Compania Cervecerias Unidas SA / Compania Cervecerias Unidas SA / Boston Beer Company Inc / Amgen Inc / Constellation Brands Inc / Molson Coors Beverage Co / Heineken NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Chile / Japan / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/17/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">TARA=US / ULTA=US / MRK=US / PFE=US / AMGN=US / BMY=US / INTC=US / AMD=US / GBT=US / MSFT=US / QCOM=US / EPIX=US / NVDA=US / SCI=US / BWAY=US / TSM=US / EMR=US / HUM=US / BKI=US / CVS=US / BLUE=US / EXAS=US / RBC=US / UTHR=US / VRTX=US / RHHBY=US / RNG=US / CEVA=US / MNKD=US / GOOG=US / DENN=US / RXN=US / SFTBY=US / AGIO=US / SABR=US / SEDG=US / CERC=US / EDIT=US / CRSP=US / VERU=US / MBIO=US / SESN=US / ARVN=US / BXRX=US / FMTX=US / CHGCY=US</td><td class="leftalignment">Protara Therapeutics Inc / Ulta Beauty Inc / Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Intel Corp / Advanced Micro Devices Inc / Global Blood Therapeutics Inc / Microsoft Corp / Qualcomm Inc / ESSA Pharma Inc / NVIDIA Corp / Service Corporation International / Brainsway Ltd / Taiwan Semiconductor Manufacturing Co Ltd / Emerson Electric Co / Humana Inc / Black Knight Inc / CVS Health Corp / bluebird bio Inc / Exact Sciences Corp / Regal Rexnord Corp / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Roche Holding AG / RingCentral Inc / CEVA Inc / MannKind Corp / Alphabet Inc / Denny's Corp / Zurn Water Solutions Corp / SoftBank Group Corp / Agios Pharmaceuticals Inc / Sabre Corp / Solaredge Technologies Inc / Avalo Therapeutics Inc / Editas Medicine Inc / CRISPR Therapeutics AG / Veru Inc / Mustang Bio Inc / Sesen Bio Inc / Arvinas Inc / Baudax Bio Inc / Forma Therapeutics Holdings Inc / Chugai Pharmaceutical Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Israel / Japan / Taiwan / United States</td><td class="leftalignment">Biotechnology / Conglomerates / Consumer / Electrical / Financial Services / Healthcare / Household Products / Info. Tech./Computers / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Machinery / Pharmaceuticals / Semiconductors</td><td class="leftalignment">Asia / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/17/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">U.S./Global Declines Continue as Vaccine Rollout Progresses; Big Pharma’s Fourth-Quarter Earnings Review the Year That Was</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">02/17/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Building a Better Pipeline of Targeted Therapies; Initiate at Outperform</td><td class="leftalignment">English</td><td class="rightalignment">44</td><td class="leftalignment">FMTX=US / AMGN=US / GBT=US / EPIX=US / BLUE=US / VRTX=US / AGIO=US / EDIT=US / CRSP=US / VERU=US / MBIO=US / ARVN=US</td><td class="leftalignment">Forma Therapeutics Holdings Inc / Amgen Inc / Global Blood Therapeutics Inc / ESSA Pharma Inc / bluebird bio Inc / Vertex Pharmaceuticals Inc / Agios Pharmaceuticals Inc / Editas Medicine Inc / CRISPR Therapeutics AG / Veru Inc / Mustang Bio Inc / Arvinas Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/17/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">BioInsights KOL Day: NK Cell Therapies, Systemic Mastocytosis, GU Onc, Targeted Onc/Lung Cancer, Med Aesthetics, Rare Blood Disorders</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">031162100 / 45337C102 / 00287Y109 / G30401106 / 31189P102 / 60468T105 / 09627Y109 / 761330109 / 74366E102 / M47364100 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Incyte Corp / Abbvie Inc / Endo International PLC / Fate Therapeutics Inc / Mirati Therapeutics Inc / Blueprint Medicines Corp / Revance Therapeutics Inc / Protagonist Therapeutics Inc / Gamida Cell Ltd / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Eleanor Maughan, Ph.D. / David A. Amsellem / Joseph Catanzaro, PhD / Yasmeen Rahimi, Ph.D. / Mr. Christopher J. Raymond / Edward A. Tenthoff / Mr. Tyler M. Van Buren, M.SC</td></tr>
<tr class="even"><td class="leftalignment">02/16/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Annual Update - Amgen sinks 15.2% from 3 week high</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/16/2021</td><td class="leftalignment">Crispidea</td><td class="leftalignment">Amgen Inc. (AMGN) - Significant performance due to volume growth of key innovative products</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">RESEARCH OVERVIEW</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / ASSET MANAGEMENT / CAPITALIZATION / EARNINGS/FINANCIAL STATEMENTS / MERGER/ACQUISITION/DIVESTITURE / MISCELLANEOUS / CHANGE IN RECOMMENDATION / GROWTH</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Rimi Murarka / Ms. Shejal Ajmera</td></tr>
<tr class="even"><td class="leftalignment">02/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Feb 05, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Guggenheim Ther Research</td></tr>
<tr class="odd"><td class="leftalignment">02/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">2126335 / 2516152 / 2023607 / 2778844 / 2026242 / 2111955 / 2280220 / 2270726 / 2542049 / 2576941 / 2100920 / 2455965 / 2457864 / 2459020 / 2048804 / 2730190 / 2402121 / 7103065 / B121557 / 2212922 / 2857817 / B125XQ6 / B2R3PV1 / B3D7K31 / B03PGL4 / B7TL820 / B7VD3F2 / BFLR866 / B76LYJ2 / BFH3N85 / BYY8XK8 / BP4GNK9 / BYW36M8 / BFZNYB7 / BD9GVY0 / BDHF4K6 / BZBY005 / BKS3SM8 / BQT3XY6 / BZ1HM42 / BR4T3B3 / BMQ5T49 / BWFKZT2 / BZ8VJQ8 / BKTNTR9 / BK6N347 / BJXBP30 / BYQHPK7 / BJ9NFQ3 / BK71LY6 / BM8MM05 / BP8XZL1</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / American Electric Power Company Inc / Borgwarner Inc / DTE Energy Co / Walt Disney Co / Dominion Energy Inc / Exelixis Inc / FirstEnergy Corp / Biogen Inc / ImmunoGen Inc / Intuit Inc / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / Nuance Communications Inc / Novartis AG / Mastercard Inc / NRG Energy Inc / Netflix Inc / Portland General Electric Co / American Water Works Company Inc / Discovery Inc / NorthWestern Corp / Meta Platforms Inc / Duke Energy Corp / Twitter Inc / Vocera Communications Inc / Veeva Systems Inc / WEC Energy Group Inc / SAGE Therapeutics Inc / PayPal Holdings Inc / Allogene Therapeutics Inc / Zai Lab Ltd / CRISPR Therapeutics AG / Merus NV / IGM Biosciences Inc / Cyberark Software Ltd / Adyen NV / HubSpot Inc / Zentalis Pharmaceuticals Inc / Cellectis SA / Vistra Corp / ViacomCBS Inc / Uber Technologies Inc / Turning Point Therapeutics Inc / Zymeworks Inc / Neoleukin Therapeutics Inc / WW International Inc / Madison Square Garden Entertainment Corp / Healthequity Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">02/16/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - February 16, 2021</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">AC.TO / ALV.N / ANTO.L / BAER.S / BARC.L / BBDb.TO / BCE.TO / BHP.AX / BNPP.PA / CC.N / CI.N / CL.N / CP.TO / CSGN.S / EDP.LS / EL.N / ELE.MC / F.N / GM.N / HSBA.L / IBE.MC / IP.N / KBH.N / KMB.N / KO.N / LLOY.L / MRK.N / PFE.N / PHM.N / RIO.AX / RIO.L / RWEG.DE / SAN.MC / SOGN.PA / T.N / T.TO / TOL.N / VC.N / SSE.L / PEP.N / BFb.N / PG.N / HUM.N / CPB.N / TEN.N / CMCSA.O / CAE.TO / SJRb.TO / RCIb.TO / AMGN.O / THC.N / FER.MC / AAL.L / CNR.TO / QBRb.TO / UNH.N / BWA.N / LEA.N / CCA.TO / REE.MC / ENB.TO / K.N / DISH.O / LEN.N / TV.TO / DBKGn.DE / CLX.N / CAG.N / GIS.N / EPC.N / MGA.N / SBAC.O / BBVA.MC / JAZZ.O / ADI.O / NG.L / VZ.N / EXEL.O / DHI.N / STZ.N / APH.N / DVA.N / FISV.O / SNPS.O / CHTR.O / AXL.N / PLD.N / CHD.N / ATA.TO / BC.N / ARCC.O / SAM.N / FRAG.DE / REGN.O / ENR.N / VRTX.O / SWIR.O / FTT.TO / CAGR.PA / MHK.N / NCR.N / NET.N / TEL.N / APF.L / PII.N / ST.N / TYL.N / HCC.N / SGEN.OQ / GPN.N / MNST.O / NWG.L / CCLb.TO / IMGN.O / CASY.O / STN.TO / ATDb.TO / IGO.AX / TIH.TO / SNC.TO / FM.TO / INGA.AS / 02209S103 / 878742204 / DLR.N / HUN.N / 427866108 / 35671D857 / FIS.N / TEVA.N / CS.TO / HOG.N / 443628102 / 550372106 / ATL.MI / BGS.N / CBRO.L / DAN.N / EDPR.LS / OZL.AX / ABI.BR / SFR.AX / VALE.N / SPB.N / BHPB.L / CAML.L / MTOR.N / GLEN.L / TRL.TO / QLYS.O / FFHu.TO / MDLZ.OQ / 505440107 / TPH.N / TSLA.N / PRMW.N / TMUS.N / TMHC.N / DOO.TO / COTY.N / PRTA.O / 46579R104 / VRNS.O / CIA.TO / PAYC.N / RYAM.N / HUBS.N / ANTM.N / CIGI.O / PYPL.OQ / WRK.N / RPD.O / ABNd.AS / MESO.O / RACE.MI / UBSG.S / MTRO.L / MP1.AX / ADNT.N / GRPG.I / ATNX.O / ORSTED.CO / APTV.N / NEXA.TO / VNE.N / NTGY.MC / KDP.N / XERS.O / NWL.O / GMAB.O / DDOG.O / CRNC.OQ / VMUK.L / PEAK.N / PAGPA.L / REYN.O / SBSW.N / TFII.N / SLQT.N / NKLA.OQ / FOUR.N / LUMN.N / 900435207 / AFRM.O / 120681711</td><td class="leftalignment">Air Canada / Autoliv Inc / Antofagasta PLC / Julius Baer Gruppe AG / Barclays PLC / Bombardier Inc / BCE Inc / BHP Group Ltd / BNP Paribas SA / Chemours Co / Cigna Corp / Colgate-Palmolive Co / Canadian Pacific Railway Ltd / Credit Suisse Group AG / EDP Energias de Portugal SA / Estee Lauder Companies Inc / Endesa SA / Ford Motor Co / General Motors Co / HSBC Holdings PLC / Iberdrola SA / International Paper Co / KB Home / Kimberly-Clark Corp / Coca-Cola Co / Lloyds Banking Group PLC / Merck & Co Inc / Pfizer Inc / Pultegroup Inc / Rio Tinto Ltd / Rio Tinto PLC / Rwe AG / Banco Santander SA / Societe Generale SA / AT&T Inc / Telus Corp / Toll Brothers Inc / Visteon Corp / SSE PLC / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Humana Inc / Campbell Soup Co / Tenneco Inc / Comcast Corp / CAE Inc / Shaw Communications Inc / Rogers Communications Inc / Amgen Inc / Tenet Healthcare Corp / Ferrovial SA / Anglo American PLC / Canadian National Railway Co / Quebecor Inc / UnitedHealth Group Inc / Borgwarner Inc / Lear Corp / Cogeco Communications Inc / Red Electrica Corporacion SA / Enbridge Inc / Kellogg Co / DISH Network Corp / Lennar Corp / Trevali Mining Corp / Deutsche Bank AG / Clorox Co / Conagra Brands Inc / General Mills Inc / Edgewell Personal Care Co / Magna International Inc / SBA Communications Corp / Banco Bilbao Vizcaya Argentaria SA / Jazz Pharmaceuticals PLC / Analog Devices Inc / National Grid PLC / Verizon Communications Inc / Exelixis Inc / D R Horton Inc / Constellation Brands Inc / Amphenol Corp / DaVita Inc / Fiserv Inc / Synopsys Inc / Charter Communications Inc / American Axle & Manufacturing Holdings Inc / Prologis Inc / Church & Dwight Co Inc / ATS Automation Tooling Systems Inc / Brunswick Corp / Ares Capital Corp / Boston Beer Company Inc / Fraport AG Frankfurt Airport Services Worldwide / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Vertex Pharmaceuticals Inc / Sierra Wireless Inc / Finning International Inc / Credit Agricole SA / Mohawk Industries Inc / NCR Corp / Cloudflare Inc / TE Connectivity Ltd / Anglo Pacific Group PLC / Polaris Inc / Sensata Technologies Holding PLC / Tyler Technologies Inc / Warrior Met Coal Inc / Seagen Inc / Global Payments Inc / Monster Beverage Corp / Natwest Group PLC / CCL Industries Inc / ImmunoGen Inc / Caseys General Stores Inc / Stantec Inc / Alimentation Couche-Tard Inc / IGO Ltd / Toromont Industries Ltd / SNC-Lavalin Group Inc / First Quantum Minerals Ltd / ING Groep NV / Altria Group Inc / Teck Resources Ltd / Digital Realty Trust Inc / Huntsman Corp / Hershey Co / Freeport-McMoRan Inc / Fidelity National Information Services Inc / Teva Pharmaceutical Industries Ltd / Capstone Mining Corp / Harley-Davidson Inc / Hudbay Minerals Inc / Lundin Mining Corp / Atlantia SpA / B&G Foods Inc / Close Brothers Group PLC / Dana Inc / EDP Renovaveis SA / OZ Minerals Ltd / Anheuser Busch Inbev SA / Sandfire Resources Ltd / Vale SA / Spectrum Brands Holdings Inc / BHP Group PLC / Central Asia Metals PLC / Meritor Inc / Glencore PLC / Trilogy International Partners Inc / Qualys Inc / Fairfax Financial Holdings Ltd / Mondelez International Inc / Labrador Iron Ore Royalty Corp / Tri Pointe Homes Inc (Delaware) / Tesla Inc / Primo Water Corp / T-Mobile US Inc / Taylor Morrison Home Corp / BRP Inc / Coty Inc / Prothena Corporation PLC / Ivanhoe Mines Ltd / Varonis Systems Inc / Champion Iron Ltd / Paycom Software Inc / Rayonier Advanced Materials Inc / HubSpot Inc / Anthem Inc / Colliers International Group Inc / PayPal Holdings Inc / Westrock Co / Rapid7 Inc / ABN Amro Bank NV / Mesoblast Ltd / Ferrari NV / UBS Group AG / Metro Bank PLC / Megaport Ltd / Adient PLC / Greencoat Renewables PLC / Athenex Inc / Orsted A/S / Aptiv PLC / Nexa Resources SA / Veoneer Inc / Naturgy Energy Group SA / Keurig Dr Pepper Inc / Xeris Biopharma Holdings Inc / Newell Brands Inc / Genmab A/S / Datadog Inc / Cerence Inc / Virgin Money UK PLC / Healthpeak Properties Inc / Paragon Banking Group PLC / Reynolds Consumer Products Inc / Sibanye Stillwater Ltd / TFI International Inc / SelectQuote Inc / Nikola Corp / Shift4 Payments Inc / Lumen Technologies Inc / Turquoise Hill Resources Ltd / Affirm Holdings Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Brazil / Canada / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Ireland / Israel / Italy / Luxembourg / Netherlands / Portugal / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">02/15/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Model Update</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN=US</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/15/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Weekly: Gvoke Back Above 10% Mkt Share; Viatris' Gx Advair Share Steady</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">VTRS.OQ / MRK=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / ENDP=US / PRGO=US / BIIB=US / AMRX=US / ABBV=US / XERS=US / VTRS=US</td><td class="leftalignment">Viatris Inc / Merck & Co Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Endo International PLC / Perrigo Company PLC / Biogen Inc / Amneal Pharmaceuticals Inc / Abbvie Inc / Xeris Biopharma Holdings Inc / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Ami Fadia</td></tr>
<tr class="odd"><td class="leftalignment">02/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for AMGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">02/15/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">EXEL-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">EXEL.O / BMY / JNJ / MRK / PFE / AMGN.O / GSK / CRIS.O / AVEO.O / SNY.O</td><td class="leftalignment">Exelixis Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Curis Inc / Aveo Pharmaceuticals Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For the Week Ended Feb 05, 2021: Focus on Dupixent's resilience</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / RB.L / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / Reckitt Benckiser Group PLC / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">02/13/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AMGN.O / EXEL.O / REGN.O / SGEN.OQ / IMGN.O / PRTA.O / MESO.O / ATNX.O / GMAB.O</td><td class="leftalignment">Amgen Inc / Exelixis Inc / Regeneron Pharmaceuticals Inc / Seagen Inc / ImmunoGen Inc / Prothena Corporation PLC / Mesoblast Ltd / Athenex Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Australia / Denmark / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Kennen MacKay, PHD / Edwin Delfin</td></tr>
<tr class="odd"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">AMGN (NEUTRAL) – Takeaways from Guggenheim Oncology Day Fireside Chat with Mgmt: Oncology a Key Future Growth Driver</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2023607 / BBPK0J0 / BL71K91</td><td class="leftalignment">Amgen Inc / Mirati Therapeutics Inc / Revolution Medicines Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">AMGN.OQ - Event Transcript of Amgen Inc conference call, Feb. 12, 2021 / 12:30PM ET</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/12/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 534</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">02/12/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="odd"><td class="leftalignment">02/12/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended February 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / TEVA=US / GILD=US / SAN=FR / NVS=US / GSK=GB / AZN=US / GSK=US / JNJ=US / EXEL=US / ICPT=US / NVO=US / REGN=US / RHHBY=US / INVA=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / Novartis AG / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Exelixis Inc / Intercept Pharmaceuticals Inc / Novo Nordisk A/S / Regeneron Pharmaceuticals Inc / Roche Holding AG / Innoviva Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/12/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / David Szeto</td></tr>
<tr class="odd"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Amgen Inc.(AMGN) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">031162100</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">PEP=US / AMGN=US / DIS=US / EFX=US / PEB=US / AKAM=US / H=US / TRU=US / CRM=US / CONE=US / MTN=US / MAR=US / EXPE=US / VMC=US / HLT=US / AKR=US / MLM=US / FLO=US / MAC=US / CHH=US / DVA=US / DRH=US / DCO=US / EXEL=US / SAFE=US / LH=US / MHK=US / RARE=US / SHOP=US / STRA=US / NET=US / PYPL=US / FAF=US / R=US / CUZ=US / FRT=US / KIM=US / WRE=US / CRTO=US / GBCI=US / REG=US / BRX=US / PTON=US / MOH=US / TPX=US / SHO=US / DLR=US / THS=US / NSP=US / HST=US / RPRX=US / XPO=US / GPRE=US / QSR=US / LLNW=US / WH=US / WYND=US / TREX=US / HGV=US / RLJ=US / VAC=US / RHP=US / SSTK=US / HUBS=US / SUM=US / GDDY=US / WVE=US / PK=US / PLYA=US / CARG=US / DCPH=US / BTAI=US / BHC=US / SVMK=US / DDOG=US / AZEK=US / VTRS=US / AFRM=US</td><td class="leftalignment">PepsiCo Inc / Amgen Inc / Walt Disney Co / Equifax Inc / Pebblebrook Hotel Trust / Akamai Technologies Inc / Hyatt Hotels Corp / TransUnion / Salesforce.Com Inc / CyrusOne Inc / Vail Resorts Inc / Marriott International Inc / Expedia Group Inc / Vulcan Materials Co / Hilton Worldwide Holdings Inc / Acadia Realty Trust / Martin Marietta Materials Inc / Flowers Foods Inc / Macerich Co / Choice Hotels International Inc / DaVita Inc / Diamondrock Hospitality Co / Ducommun Inc / Exelixis Inc / Safehold Inc / Laboratory Corporation of America Holdings / Mohawk Industries Inc / Ultragenyx Pharmaceutical Inc / Shopify Inc / Strategic Education Inc / Cloudflare Inc / PayPal Holdings Inc / First American Financial Corp / Ryder System Inc / Cousins Properties Inc / Federal Realty Investment Trust / Kimco Realty Corp / Washington Real Estate Investment Trust / Criteo SA / Glacier Bancorp Inc / Regency Centers Corp / Brixmor Property Group Inc / Peloton Interactive Inc / Molina Healthcare Inc / Tempur Sealy International Inc / Sunstone Hotel Investors Inc / Digital Realty Trust Inc / TreeHouse Foods Inc / Insperity Inc / Host Hotels & Resorts Inc / Royalty Pharma PLC / XPO Logistics Inc / Green Plains Inc / Restaurant Brands International Inc / Limelight Networks Inc / Wyndham Hotels & Resorts Inc / Travel + Leisure Co / Trex Company Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Ryman Hospitality Properties Inc / Shutterstock Inc / HubSpot Inc / Summit Materials Inc / GoDaddy Inc / WAVE Life Sciences Ltd / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / CarGurus Inc / Deciphera Pharmaceuticals Inc / BioXcel Therapeutics Inc / Bausch Health Companies Inc / Momentive Global Inc / Datadog Inc / Azek Company Inc / Viatris Inc / Affirm Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / France / United Kingdom / Netherlands / Singapore / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">0925288 / 2126335 / 2681511 / 2023607 / 2486813 / 2973821 / 2050832 / 2111955 / 2216850 / 2222631 / 2270726 / 2542049 / 2576941 / 2328915 / 2100920 / 2613990 / 2471950 / 2707677 / 2503529 / 5531000 / 7103065 / B1F76F9 / B121557 / B067BM3 / B19FQ48 / 2216991 / 2857817 / B0T7YX2 / B2R3PV1 / B0796X4 / 2982924 / B65LWX6 / B7TL820 / B7VD3F2 / BFDV8K0 / BBPK0J0 / B76LYJ2 / BFZCHN7 / BYRY499 / BYY8XK8 / BYW36M8 / BF4VBS8 / BXDZ9Z0 / BFZNYB7 / BD9GVY0 / BZ1LFB2 / BD8DJ71 / BR4T3B3 / BJ2Z0H2 / BGCYWN8 / BKVDFF7 / BLGJ610 / BFNR303 / BYXJQG9 / BKTNTR9 / BGSP7M9 / BL71K91 / BYNQ369 / BYWVTY5 / BMVWYW8 / BDZ30Q0 / BMG75B4 / BWY4XV3 / BN2R582 / BDD1B07 / BMPRZV5</td><td class="leftalignment">GlaxoSmithKline PLC / Bristol-Myers Squibb Co / PepsiCo Inc / Amgen Inc / Kellogg Co / Alliant Energy Corp / Ameren Corp / Borgwarner Inc / Consolidated Edison Inc / Cooper Companies Inc / Walt Disney Co / Dominion Energy Inc / Exelixis Inc / Nextera Energy Inc / FirstEnergy Corp / Illumina Inc / Incyte Corp / Public Service Enterprise Group Inc / World Wrestling Entertainment Inc / MorphoSys AG / Novartis AG / Western Union Co / Mastercard Inc / Molson Coors Beverage Co / Amicus Therapeutics Inc / Tempur Sealy International Inc / Netflix Inc / Live Nation Entertainment Inc / American Water Works Company Inc / Dexcom Inc / Spectrum Pharmaceuticals Inc / O'Reilly Automotive Inc / Meta Platforms Inc / Duke Energy Corp / MacroGenics Inc / Mirati Therapeutics Inc / Vocera Communications Inc / Wix.Com Ltd / Kraft Heinz Co / WEC Energy Group Inc / PayPal Holdings Inc / BioXcel Therapeutics Inc / Shopify Inc / Allogene Therapeutics Inc / Zai Lab Ltd / Deciphera Pharmaceuticals Inc / Snap Inc / HubSpot Inc / Pinterest Inc / Xencor Inc / Oric Pharmaceuticals Inc / Warner Music Group Corp / Northwest Natural Holding Co / Spire Inc / ViacomCBS Inc / Zoom Video Communications Inc / Revolution Medicines Inc / Albertsons Companies Inc / CytomX Therapeutics Inc / Protara Therapeutics Inc / Arvinas Inc / Inventiva SA / Adaptimmune Therapeutics PLC / Relay Therapeutics Inc / Rubius Therapeutics Inc / Kymera Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update- Happy Lunar New Year!</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AMGN.OQ / ACRX.OQ / LLY.N / MRK.N / PFE.N / SASY.PA / ROG.S / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / MRNA.OQ / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Amgen Inc / AcelRx Pharmaceuticals Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Sanofi SA / Roche Holding AG / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Moderna Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">AZN.L: AstraZeneca - 4Q20 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">AZN.L / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / GSK.L / AMGN.OQ / REGN.OQ / GILD.OQ / BMRN.OQ / VRTX.OQ / BIIB.OQ / BAYGN.DE</td><td class="leftalignment">AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Amgen Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Bayer AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Small Biotech Outflows End the Four-Week Inflow Streak</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / 039697107 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / 19240Q201</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Ardelyx Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / Cogent Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Revisiting risk-reward into Phase 3 INTRIGUE data and modified our 2L GIST opp'y; PT $84 from $91</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">DCPH=US / AMGN=US</td><td class="leftalignment">Deciphera Pharmaceuticals Inc / Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Minh Vong</td></tr>
<tr class="even"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">RVMD (BUY) - Takeaways from Guggenheim Oncology Day Fireside Chat with Mgmt: Emerging Array of RAS Pathway Inhibitors</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BL71K91 / 2516152 / 2023607 / 7103065 / BBPK0J0 / BN2R582</td><td class="leftalignment">Revolution Medicines Inc / Eli Lilly and Co / Amgen Inc / Novartis AG / Mirati Therapeutics Inc / Relay Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">MRTX (NEUTRAL) – Takeaways from Guggenheim Oncology Day Fireside Chat with Mgmt: Confidence Across KRAS & Pipeline</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BBPK0J0 / 0989529 / 2516152 / 2023607 / 2778844 / 2684703 / 7103065</td><td class="leftalignment">Mirati Therapeutics Inc / AstraZeneca PLC / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Pfizer Inc / Novartis AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">02/10/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BMY-US -  Dividend Quality Analysis, for the period ended February 01,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY / JNJ / LLY / MRK / NVS / PFE / AMGN.O / AZN.O / BIIB.O / ABBV.K / SNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / AstraZeneca PLC / Biogen Inc / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/10/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US -  Dividend Quality Analysis, for the period ended December 08,2020.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/10/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABBV-US -  Dividend Quality Analysis, for the period ended November 16,2020.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ABBV.K / BMY / LLY / PFE / GILD.O / AMGN.O / GSK / NBIX.O / AZN.O / BIIB.O</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / GlaxoSmithKline PLC / Neurocrine Biosciences Inc / AstraZeneca PLC / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/10/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Amgen Inc: Intraday vs Overnight Returns 2016-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">02/10/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">So-So Guide; Difficult To Find To Good Reasons To Get More Constructive</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">881624209 / 375558103 / 031162100 / 03168L105</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Amgen Inc / Amneal Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">David A. Amsellem / Zachary Sachar / Isaac C. Somekh</td></tr>
<tr class="odd"><td class="leftalignment">02/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">1877.HK: Shanghai Junshi Biosciences Co., Ltd - Lilly's COVID-19 neutralising antibody cocktail (one antibody licensed from Junshi) receives FDA EUA</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">1877.HK / LLY.N / AMGN.OQ</td><td class="leftalignment">Shanghai Junshi Biosciences Co Ltd / Eli Lilly and Co / Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu</td></tr>
<tr class="even"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Jan 29, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Guggenheim Ther Research</td></tr>
<tr class="odd"><td class="leftalignment">02/09/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Domestic Declines Continue as Vaccine Rollout Ramps Up; IMHE Suggests New Variant Bump May Occur in March/April</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Brittany Woods / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">DNB / FISV=US / MRK=US / BSX=US / LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / ADI=US / WEN=US / AMZN=US / BLD=US / TEVA=US / NVDA=US / SLG=US / LOW=US / ENR=US / DIOD=US / IGT=US / CHRS=US / BYD=US / TTWO=US / LEG=US / TTMI=US / ATVI=US / KFRC=US / MGM=US / HUM=US / PENN=US / BKI=US / AVGO=US / CBRL=US / DRI=US / EXEL=US / GFF=US / HAS=US / IBP=US / MAS=US / MHK=US / MCRI=US / REGI=US / SGMO=US / SPG=US / SGMS=US / GPN=US / AUTL=US / DIN=US / ECPG=US / PRAA=US / RRR=US / BIIB=US / TPX=US / EXP=US / CZR=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / SCPL=US / CMG=US / REX=US / FIS=US / PGTI=US / GPRE=US / SAIA=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / JACK=US / CLNY=US / TREX=US / NXPI=US / FBHS=US / ZNGA=US / EA=US / ENPH=US / TILE=US / NDLS=US / VRNS=US / GOOGL=US / LOCO=US / HQY=US / OSH=US / SHAK=US / WING=US / TDOC=US / EDIT=US / 82982L103 / IRTC=US / JELD=US / MPWR-US / CARG=US / BTAI=US / ALLO=US / HARP=US / TCRR=US / FERGY=US / OPCH=US / DKNG=US / AZEK=US / BALY=US / VTRS=US</td><td class="leftalignment">Dun & Bradstreet Holdings Inc / Fiserv Inc / Merck & Co Inc / Boston Scientific Corp / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Analog Devices Inc / Wendys Co / Amazon.com Inc / TopBuild Corp / Teva Pharmaceutical Industries Ltd / NVIDIA Corp / SL Green Realty Corp / Lowe's Companies Inc / Energizer Holdings Inc / Diodes Inc / International Game Technology PLC / Coherus BioSciences Inc / Boyd Gaming Corp / Take-Two Interactive Software Inc / Leggett & Platt Inc / TTM Technologies Inc / Activision Blizzard Inc / Kforce Inc / MGM Resorts International / Humana Inc / Penn National Gaming Inc / Black Knight Inc / Broadcom Inc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Exelixis Inc / Griffon Corp / Hasbro Inc / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Monarch Casino & Resort Inc / Renewable Energy Group Inc / Sangamo Therapeutics Inc / Simon Property Group Inc / Scientific Games Corp / Global Payments Inc / Autolus Therapeutics PLC / Dine Brands Global Inc / Encore Capital Group Inc / PRA Group Inc / Red Rock Resorts Inc / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Caesars Entertainment Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Sciplay Corp / Chipotle Mexican Grill Inc / REX American Resources Corp / Fidelity National Information Services Inc / PGT Innovations Inc / Green Plains Inc / Saia Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Jack in the Box Inc / DigitalBridge Group Inc / Trex Company Inc / NXP Semiconductors NV / Fortune Brands Home & Security Inc / Zynga Inc / Electronic Arts Inc / Enphase Energy Inc / Interface Inc / Noodles & Co / Varonis Systems Inc / Alphabet Inc / El Pollo Loco Holdings Inc / Healthequity Inc / Oak Street Health Inc / Shake Shack Inc / Wingstop Inc / Teladoc Health Inc / Editas Medicine Inc / SiteOne Landscape Supply Inc / iRhythm Technologies Inc / JELD-WEN Holding Inc / Monolithic Power Systems Inc / CarGurus Inc / BioXcel Therapeutics Inc / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / Ferguson PLC / Option Care Health Inc / DraftKings Inc / Azek Company Inc / Bally's Corp / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology: Latest Short Interest for US Biotech: Some SMid incrementally higher, but stable for Large Cap</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AMGN.OQ / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / ACRX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / AcelRx Pharmaceuticals Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Amgen Inc: Capital Deployment Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Amgen Inc: Valuation Landscape 2006-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Amgen Inc: Information Content of Earnings Releases 2015-2020</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - February 8, 2021</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">AEP.N / AES.N / AFL.N / ALV.N / CB.N / CI.N / CL.N / CMS.N / CP.TO / EIX.N / EL.N / EMN.N / EOG.N / F.N / GM.N / IBE.MC / IP.N / JNJ.N / KMB.N / KO.N / MRK.N / NSC.N / PEG.N / PFE.N / RWEG.DE / SO.N / T.N / VC.N / PEP.N / BFb.N / PG.N / PXD.N / HUM.N / CPB.N / TEN.N / CMCSA.O / CAE.TO / CHKP.O / AMGN.O / AAPL.O / MET.N / FLEX.O / CNR.TO / DUK.N / DIS.N / BWA.N / LEA.N / K.N / DT.N / DISH.O / CSX.N / UNP.N / CLX.N / CAG.N / UNM.N / GIS.N / EPC.N / MGA.N / SBAC.O / JAZZ.O / NG.L / VZ.N / HCA.N / EXEL.O / ARNA.O / STZ.N / LNC.N / APH.N / FISV.O / CHTR.O / AXL.N / AWK.N / CHD.N / ATA.TO / BC.N / SAM.N / BMRN.O / REGN.O / ENR.N / PRU.N / NCR.N / TEL.N / CNP.N / CPK.N / MKL.N / PII.N / RLI.N / ST.N / SR.N / TT.N / SGEN.OQ / GPN.N / MNST.O / CCLb.TO / CASY.O / ORLY.O / ACGL.O / PCTY.O / ATDb.TO / 02209S103 / AINV.O / DLR.N / VIAC.O / 416515104 / 427866108 / DISCA.O / SJW.N / FIS.N / TEVA.N / HOG.N / AON.N / BGS.N / TDC.N / ENSG.O / DAN.N / VALE.N / FTNT.O / SPB.N / CHNG.O / CJT.TO / PCRX.O / MTOR.N / IFP.TO / AMCX.O / MDLZ.OQ / FANG.O / ABBV.N / TSLA.N / PRGO.N / PRMW.N / TMUS.N / DOO.TO / COTY.N / FOXA.OQ / PRTA.O / RYAM.N / SHOP.N / PYPL.OQ / WRK.N / MIME.OQ / RACE.MI / MP1.AX / BBU.N / ADNT.N / LGFB.N / TFII.TO / WOW.N / ATUS.N / ORSTED.CO / APTV.N / EAF.N / VNE.N / NTGY.MC / KDP.N / NWL.O / GMAB.O / DDOG.O / CRNC.OQ / NLOK.O / WTRG.N / REYN.O / NKLA.OQ / FOUR.N / LUMN.N / AFRM.O / TEEC.L / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Aflac Inc / Autoliv Inc / Chubb Ltd / Cigna Corp / Colgate-Palmolive Co / CMS Energy Corp / Canadian Pacific Railway Ltd / Edison International / Estee Lauder Companies Inc / Eastman Chemical Co / EOG Resources Inc / Ford Motor Co / General Motors Co / Iberdrola SA / International Paper Co / Johnson & Johnson / Kimberly-Clark Corp / Coca-Cola Co / Merck & Co Inc / Norfolk Southern Corp / Public Service Enterprise Group Inc / Pfizer Inc / Rwe AG / Southern Co / AT&T Inc / Visteon Corp / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Pioneer Natural Resources Co / Humana Inc / Campbell Soup Co / Tenneco Inc / Comcast Corp / CAE Inc / Check Point Software Technologies Ltd / Amgen Inc / Apple Inc / MetLife Inc / Flex Ltd / Canadian National Railway Co / Duke Energy Corp / Walt Disney Co / Borgwarner Inc / Lear Corp / Kellogg Co / Dynatrace Inc / DISH Network Corp / CSX Corp / Union Pacific Corp / Clorox Co / Conagra Brands Inc / Unum Group / General Mills Inc / Edgewell Personal Care Co / Magna International Inc / SBA Communications Corp / Jazz Pharmaceuticals PLC / National Grid PLC / Verizon Communications Inc / HCA Healthcare Inc / Exelixis Inc / Arena Pharmaceuticals Inc / Constellation Brands Inc / Lincoln National Corp / Amphenol Corp / Fiserv Inc / Charter Communications Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Church & Dwight Co Inc / ATS Automation Tooling Systems Inc / Brunswick Corp / Boston Beer Company Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Prudential Financial Inc / NCR Corp / TE Connectivity Ltd / CenterPoint Energy Inc / Chesapeake Utilities Corp / Markel Corp / Polaris Inc / Rli Corp / Sensata Technologies Holding PLC / Spire Inc / Trane Technologies PLC / Seagen Inc / Global Payments Inc / Monster Beverage Corp / CCL Industries Inc / Caseys General Stores Inc / O'Reilly Automotive Inc / Arch Capital Group Ltd / Paylocity Holding Corp / Alimentation Couche-Tard Inc / Altria Group Inc / Apollo Investment Corp / Digital Realty Trust Inc / ViacomCBS Inc / Hartford Financial Services Group Inc / Hershey Co / Discovery Inc / SJW Group / Fidelity National Information Services Inc / Teva Pharmaceutical Industries Ltd / Harley-Davidson Inc / Aon PLC / B&G Foods Inc / Teradata Corp / Ensign Group Inc / Dana Inc / Vale SA / Fortinet Inc / Spectrum Brands Holdings Inc / Change Healthcare Inc / Cargojet Inc / Pacira Biosciences Inc / Meritor Inc / Interfor Corp / AMC Networks Inc / Mondelez International Inc / Diamondback Energy Inc / Abbvie Inc / Tesla Inc / Perrigo Company PLC / Primo Water Corp / T-Mobile US Inc / BRP Inc / Coty Inc / Fox Corp / Prothena Corporation PLC / Rayonier Advanced Materials Inc / Shopify Inc / PayPal Holdings Inc / Westrock Co / Mimecast Ltd / Ferrari NV / Megaport Ltd / Brookfield Business Partners LP / Adient PLC / Lions Gate Entertainment Corp / TFI International Inc / WideOpenWest Inc / Altice USA Inc / Orsted A/S / Aptiv PLC / GrafTech International Ltd / Veoneer Inc / Naturgy Energy Group SA / Keurig Dr Pepper Inc / Newell Brands Inc / Genmab A/S / Datadog Inc / Cerence Inc / NortonLifeLock Inc / Essential Utilities Inc / Reynolds Consumer Products Inc / Nikola Corp / Shift4 Payments Inc / Lumen Technologies Inc / Affirm Holdings Inc / Triple Point Energy Efficiency Infrastructure Company Plc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / Germany / Denmark / Spain / United Kingdom / Ireland / Israel / Netherlands / Singapore / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">REGN-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">REGN.O / JNJ / NVS / AMGN.O / BIIB.O / ALNY.O / SNY.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Johnson & Johnson / Novartis AG / Amgen Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AMGN.O / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MRK-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK / ABT / BMY / JNJ / LLY / NVS / PFE / AMGN.O / GSK / TEVA.K / SNY.O</td><td class="leftalignment">Merck & Co Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/06/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AMGN.O / EXEL.O / ARNA.O / BMRN.O / REGN.O / SGEN.OQ / PRTA.O / GMAB.O</td><td class="leftalignment">Amgen Inc / Exelixis Inc / Arena Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Seagen Inc / Prothena Corporation PLC / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Denmark / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Edwin Delfin</td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">The Weekender</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ARNA / MRNS / 45337C10 / 03116210 / 09058V10 / 00422510 / IDRA / 84763A108 / 29251M106 / M25722105 / 89620X506 / 98978L204 / 60468T105 / 45845P108 / 09627Y109 / 690469101 / 29604W108 / 462260100 / 558868105 / 12648L601 / 89532E109 / 019770106 / 67576A100 / 483347100 / 299734103 / 90041T108 / 22053A107 / 50127T109 / 04016X101 / 87184Q107 / 185063104 / 869367102 / 02155H200 / 24344T101 / 48576A100 / 75943R102 / 03843E104 / 43906K100 / 81181C104 / G637AM102 / 007002108 / N71542109 / 206022105 / 72942A107 / 92790C104</td><td class="leftalignment">Arena Pharmaceuticals Inc / Marinus Pharmaceuticals Inc / Incyte Corp / Amgen Inc / BioCryst Pharmaceuticals Inc / ACADIA Pharmaceuticals Inc / Idera Pharmaceuticals Inc / Spectrum Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Compugen Ltd / Pfizer Inc / Zogenix Inc / Mirati Therapeutics Inc / Intercept Pharmaceuticals Inc / Blueprint Medicines Corp / Ovid Therapeutics Inc / Erytech Pharma SA / Iovance Biotherapeutics Inc / Madrigal Pharmaceuticals Inc / CTI Biopharma Corp / Trevena Inc / Allogene Therapeutics Inc / Ocular Therapeutix Inc / Kaleido Biosciences Inc / Evelo Biosciences Inc / Turning Point Therapeutics Inc / Cortexyme Inc / Kura Oncology Inc / argenx SE / Syros Pharmaceuticals Inc / Clearside Biomedical Inc / Sutro Biopharma Inc / Altimmune Inc / Deciphera Pharmaceuticals Inc / Karuna Therapeutics Inc / Relay Therapeutics Inc / Aquestive Therapeutics Inc / HOOKIPA Pharma Inc / Seagen Inc / Myovant Sciences Ltd / Adicet Bio Inc / ProQR Therapeutics NV / Concert Pharmaceuticals Inc / PLx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / France / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Reni J. J. Benjamin, PhD, PHD / Mr. Jason N. N. Butler, PhD, PHD / Mr. Silvan Tuerkcan / Mr. Jonathan P. Wolleben / Mr. Gobind Singh, MD, PhD / Mr. Roy Buchanan, PhD, PHD</td></tr>
<tr class="even"><td class="leftalignment">02/05/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 533</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Brittany Woods / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Weekly: Gx Vascepa Cracks 11% Mkt Share After Steady Growth in January</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / GSK=US / ENDP=US / PRGO=US / BIIB=US / AMRX=US / ABBV=US / XERS=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / GlaxoSmithKline PLC / Endo International PLC / Perrigo Company PLC / Biogen Inc / Amneal Pharmaceuticals Inc / Abbvie Inc / Xeris Biopharma Holdings Inc / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Ms. Ami Fadia</td></tr>
<tr class="even"><td class="leftalignment">02/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended January 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / TEVA=US / GILD=US / SAN=FR / NVS=US / GSK=GB / AZN=US / GSK=US / JNJ=US / EXEL=US / ICPT=US / NVO=US / REGN=US / RHHBY=US / INVA=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / Novartis AG / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Exelixis Inc / Intercept Pharmaceuticals Inc / Novo Nordisk A/S / Regeneron Pharmaceuticals Inc / Roche Holding AG / Innoviva Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">02/05/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update- 4Q20 Earnings Edition</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AMGN.OQ / BIIB.OQ / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / VRTX.OQ / GLPG.AS / ACRX.OQ / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Amgen Inc / Biogen Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Vertex Pharmaceuticals Inc / Galapagos NV / AcelRx Pharmaceuticals Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Mo Money, Mo Problems? 4th Consecutive Week of Inflows</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / 039697107 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / 19240Q201</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Ardelyx Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / Cogent Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Acquisdata</td><td class="leftalignment">Amgen</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">AMGN=US</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Acquisdata Research Team</td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">BSX=US / PFE=US / AMGN=US / AVB=US / AMZN=US / DT=US / EBAY=US / GL=US / CMA=US / PEB=US / H=US / V=US / MTN=US / CHKP=US / PB=US / VRM=US / EWBC=US / TRMK=US / MAR=US / UMPQ=US / TTMI=US / HLT=US / HUM=US / WTFC=US / FUN=US / CENT=US / CHH=US / CSTR=US / DRH=US / FCN=US / PACW=US / SMG=US / TGI=US / WAL=US / HTH=US / EPD=US / BXS=US / PYPL=US / CFB=US / CFR=US / FMBI=US / SNV=US / ZION=US / SIVB=US / ABCB=US / AVTR=US / BOKF=US / FBK=US / JAZZ=US / MKL=US / MTCH=US / MAA=US / ASB=US / SSB=US / RF=US / CATY=US / FFIN=US / GBCI=US / SBSI=US / ENSG=US / UCBI=US / PNFP=US / SBCF=US / JRVR=US / TCBI=US / FNB=US / FHN=US / SHO=US / WMG=US / RNST=US / HST=US / MA=US / SIX=US / ELF=US / ICFI=US / CADE=US / WH=US / SEAS=US / NXGN=US / WYND=US / IAC=US / KNSL=US / HGV=US / RLJ=US / VAC=US / ANGI=US / RHP=US / ABBV=US / IBTX=US / PINC=US / VCYT=US / LOB=US / ACBI=US / SQ=US / MIME=US / ADVM=US / VVV=US / CRSP=US / PK=US / PLYA=US / CVNA=US / MBIN=US / HWC=US / OZK=US / FOCS=US / AMTB=US / UBER=US / PLMR=US / FERGY=US / IMVT=US</td><td class="leftalignment">Boston Scientific Corp / Pfizer Inc / Amgen Inc / Avalonbay Communities Inc / Amazon.com Inc / Dynatrace Inc / eBay Inc / Globe Life Inc / Comerica Inc / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Visa Inc / Vail Resorts Inc / Check Point Software Technologies Ltd / Prosperity Bancshares Inc / Vroom Inc / East West Bancorp Inc / Trustmark Corp / Marriott International Inc / Umpqua Holdings Corp / TTM Technologies Inc / Hilton Worldwide Holdings Inc / Humana Inc / Wintrust Financial Corp / Cedar Fair LP / Central Garden & Pet Co / Choice Hotels International Inc / CapStar Financial Holdings Inc / Diamondrock Hospitality Co / FTI Consulting Inc / PacWest Bancorp / Scotts Miracle-Gro Co / Triumph Group Inc / Western Alliance Bancorp / Hilltop Holdings Inc / Enterprise Products Partners LP / Cadence Bank / PayPal Holdings Inc / Crossfirst Bankshares Inc / Cullen/Frost Bankers Inc / First Midwest Bancorp Inc / Synovus Financial Corp / Zions Bancorporation NA / SVB Financial Group / Ameris Bancorp / Avantor Inc / BOK Financial Corp / FB Financial Corp / Jazz Pharmaceuticals PLC / Markel Corp / Match Group Inc / Mid-America Apartment Communities Inc / Associated Banc-Corp / SouthState Corp / Regions Financial Corp / Cathay General Bancorp / First Financial Bankshares Inc / Glacier Bancorp Inc / Southside Bancshares Inc / Ensign Group Inc / United Community Banks Inc / Pinnacle Financial Partners Inc / Seacoast Banking Corporation of Florida / James River Group Holdings Ltd / Texas Capital Bancshares Inc / FNB Corp / First Horizon Corp / Sunstone Hotel Investors Inc / Warner Music Group Corp / Renasant Corp / Host Hotels & Resorts Inc / Mastercard Inc / Six Flags Entertainment Corp / elf Beauty Inc / ICF International Inc / Cadence Bank / Wyndham Hotels & Resorts Inc / SeaWorld Entertainment Inc / NextGen Healthcare Inc / Travel + Leisure Co / IAC/Interactivecorp / Kinsale Capital Group Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Angi Inc / Ryman Hospitality Properties Inc / Abbvie Inc / Independent Bank Group Inc / Premier Inc / Veracyte Inc / Live Oak Bancshares Inc / Atlantic Capital Bancshares Inc / Block Inc / Mimecast Ltd / Adverum Biotechnologies Inc / Valvoline Inc / CRISPR Therapeutics AG / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Carvana Co / Merchants Bancorp / Hancock Whitney Corp / Bank Ozk / Focus Financial Partners Inc / Amerant Bancorp Inc / Uber Technologies Inc / Palomar Holdings Inc / Ferguson PLC / Immunovant Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / Ireland / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PFE-US -  Dividend Quality Analysis, for the period ended December 01,2020.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE / ABT / BMY / JNJ / LLY / MRK / NVS / AMGN.O / GSK / AZN.O</td><td class="leftalignment">Pfizer Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MRK-US -  Dividend Quality Analysis, for the period ended January 08,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK / ABT / BMY / JNJ / LLY / NVS / PFE / AMGN.O / GSK / TEVA.K / SNY.O</td><td class="leftalignment">Merck & Co Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ARE-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BMY / LLY / PFE / GILD.O / AMGN.O / ILMN.O / ALNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Alnylam Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Egypt / Turkey / United States</td><td class="leftalignment">Real Estate</td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">On the cusp of growth; KRAS could be key. New PT $260/sh.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AMGN=US</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Minh Vong</td></tr>
<tr class="odd"><td class="leftalignment">02/03/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">High Grade Healthcare : 4Q20 Earnings Highlights — What Mattered for Credit Part III</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AMGN.O / ABBV.N / BSX.N / HUM.N / BIIB.O</td><td class="leftalignment">Amgen Inc / Abbvie Inc / Boston Scientific Corp / Humana Inc / Biogen Inc</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / FIXED INCOME/DEBT RESEARCH / INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brett Gibson / Mr. Matthew Bonner</td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PFE.N / AMGN.OQ / NVAX.OQ / DRRX.OQ / EVGN.TA / PRTA.OQ / VYGR.OQ / CVSI.PK / WEED.TO / GTII.CD / CWEB.TO / CURA.CD / TRUL.CD / SAVA.OQ / YCBD.A / OCGN.OQ / 120346301</td><td class="leftalignment">Pfizer Inc / Amgen Inc / Novavax Inc / DURECT Corp / Evogene Ltd / Prothena Corporation PLC / Voyager Therapeutics Inc / CV Sciences Inc / Canopy Growth Corp / Green Thumb Industries Inc / Charlotte's Web Holdings Inc / Curaleaf Holdings Inc / Trulieve Cannabis Corp / Cassava Sciences Inc / cbdMD Inc / Ocugen Inc / Ayr Wellness Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">02/03/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">2021 Guidance a Little Light but Potential for Two New Products Brings the Possibility of New Growth</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">CHKP=US / FEYE=US / AAPL=US / VECO=US / FDX=US / AMGN=US / INTC=US / ADI=US / AMZN=US / QCOM=US / T=US / TXN=US / DOX=US / NVDA=US / MPWR=US / SMTC=US / UPS=US / XLNX=US / KLAC=US / LRCX=US / HCA=US / ETN=US / ASML=US / ALB=US / AVGO=US / BYND=US / CGC=US / CRUS=US / MCHP=US / ST=US / WDC=US / SWKS=US / STX=US / RMR=US / GOOG=US / CMG=US / 005930-KR=US / MXL=US / NXPI=US / EA=US / TMUS=US / OGI=US / HLNE=US / MBIO=US / HEXO=US / TLRY=US / GRWG=US / ONTO=US</td><td class="leftalignment">Check Point Software Technologies Ltd / Mandiant Inc / Apple Inc / Veeco Instruments Inc / FedEx Corp / Amgen Inc / Intel Corp / Analog Devices Inc / Amazon.com Inc / Qualcomm Inc / AT&T Inc / Texas Instruments Inc / Amdocs Ltd / NVIDIA Corp / Monolithic Power Systems Inc / Semtech Corp / United Parcel Service Inc / Xilinx Inc / KLA Corp / Lam Research Corp / HCA Healthcare Inc / Eaton Corporation PLC / ASML Holding NV / Albemarle Corp / Broadcom Inc / Beyond Meat Inc / Canopy Growth Corp / Cirrus Logic Inc / Microchip Technology Inc / Sensata Technologies Holding PLC / Western Digital Corp / Skyworks Solutions Inc / Seagate Technology Holdings PLC / RMR Group Inc / Alphabet Inc / Chipotle Mexican Grill Inc / Farfetch Ltd / Maxlinear Inc / NXP Semiconductors NV / Electronic Arts Inc / T-Mobile US Inc / OrganiGram Holdings Inc / Hamilton Lane Inc / Mustang Bio Inc / Hexo Corp / Tilray Brands Inc / GrowGeneration Corp / Onto Innovation Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / United Kingdom / Ireland / Israel / Netherlands / United States / Guernsey</td><td class="leftalignment">Biotechnology / Conglomerates / Consumer / Electrical / Financial Services / Healthcare / Info. Tech./Computers / Info. Tech./Software / Lodging & Restaurants / Retailing / Semiconductors / Services / Telecommunications</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Feb 03 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">BE0165385973 / US8816242098 / US0231351067 / US0311621009 / US0366421065 / US22160K1051 / US2310211063 / US2435371073 / US2786421030 / US2855121099 / US30231G1022 / US5002551043 / US64125C1099 / US6541061031 / US6701002056 / US7140461093 / US7392761034 / US9311421039 / US20030N1019 / US2533931026 / US1696561059 / US4103451021 / US90384S3031 / US0231112063 / NL0009538784 / US6200763075 / US56585A1025 / US88338N1072 / IE00B4Q5ZN47 / US8684591089 / US00771V1089 / US7613301099 / IE00BJ3V9050 / US03937C1053 / IE00BQPVQZ61 / US19249H1032 / US02079K1079 / US92915B1061 / KYG4740B1059 / VGG111961055 / US8760301072 / US76243J1051 / US68404V1008 / US05351X1019 / CA0717341071 / US98585X1046 / US8740602052 / US92537N1081 / US57667L1070 / US12769G1004 / US92941V1008 / US05875B1061</td><td class="leftalignment">Melexis NV / Teva Pharmaceutical Industries Ltd / Amazon.com Inc / Amgen Inc / Antares Pharma Inc / Costco Wholesale Corp / Cummins Inc / Deckers Outdoor Corp / eBay Inc / Electronic Arts Inc / Exxon Mobil Corp / Kohls Corp / Neurocrine Biosciences Inc / Nike Inc / Novo Nordisk A/S / PerkinElmer Inc / Power Integrations Inc / Walmart Inc / Comcast Corp / DICK'S Sporting Goods Inc / Chipotle Mexican Grill Inc / HanesBrands Inc / Ulta Beauty Inc / Amarin Corporation PLC / NXP Semiconductors NV / Motorola Solutions Inc / Marathon Petroleum Corp / TherapeuticsMD Inc / Jazz Pharmaceuticals PLC / Supernus Pharmaceuticals Inc / Aerie Pharmaceuticals Inc / Revance Therapeutics Inc / Endo International PLC / ArcBest Corp / Horizon Therapeutics PLC / Coherus BioSciences Inc / Alphabet Inc / Voyager Therapeutics Inc / Ichor Holdings Ltd / Biohaven Pharmaceutical Holding Company Ltd / Tapestry Inc / Rhythm Pharmaceuticals Inc / OptiNose Inc / Avaya Holdings Corp / Bausch Health Companies Inc / Yeti Holdings Inc / Takeda Pharmaceutical Co Ltd / Vertiv Holdings Co / Match Group Inc / Caesars Entertainment Inc / Vyne Therapeutics Inc / Bally's Corp</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Cayman Islands / Denmark / United Kingdom / Ireland / Israel / Japan / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Clearing the Decks for Something w/ Pipeline & Commercial Cuts to Boost Margins</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AMGN=US</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="odd"><td class="leftalignment">02/03/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - February 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">59</td><td class="leftalignment">US0079031078 / US0126531013 / US0311621009 / US1475281036 / US22160K1051 / US4128221086 / US4581401001 / US4891701009 / US56418H1005 / US8718291078 / US87612E1064 / US9113121068 / US9311421039 / US9621661043 / CA4530384086 / CA0084741085 / IL0010824113 / CA1349211054 / US3546131018 / US7376301039 / US1696561059 / US2253101016 / CA0966311064 / CA46071W2058 / US3886891015 / US91912E1055 / US2566771059 / US34959E1091 / NL0009538784 / US40412C1018 / JE00B4T3BW64 / US1630861011 / US6974351057 / US31816Q1013 / US74736K1016 / US71377A1034 / CA49410M1023 / US9120081099 / CA60448E1034 / CA57776F4050 / US1628181083 / US89422G1076 / US0412421085</td><td class="leftalignment">Advanced Micro Devices Inc / Albemarle Corp / Amgen Inc / Caseys General Stores Inc / Costco Wholesale Corp / Harley-Davidson Inc / Intel Corp / Kennametal Inc / ManpowerGroup Inc / Sysco Corp / Target Corp / United Parcel Service Inc / Walmart Inc / Weyerhaeuser Co / Imperial Oil Ltd / Agnico Eagle Mines Ltd / Check Point Software Technologies Ltd / Canadian Apartment Properties Real Estate Investment Trust / Franklin Resources Inc / Potlatchdeltic Corp / Chipotle Mexican Grill Inc / Credit Acceptance Corp / Boardwalk Real Estate Investment Trust / InterRent Real Estate Investment Trust / Graphic Packaging Holding Co / Vale SA / Dollar General Corp / Fortinet Inc / NXP Semiconductors NV / HCA Healthcare Inc / Glencore PLC / Chefs' Warehouse Inc / Palo Alto Networks Inc / Mandiant Inc / Qorvo Inc / Performance Food Group Co / Killam Apartment REIT / US Foods Holding Corp / Minto Apartment Real Estate Investment Trust / Maverix Metals Inc / Checkmate Pharmaceuticals Inc / Travere Therapeutics Inc / Arko Corp.</td><td class="leftalignment"></td><td class="leftalignment">Brazil / Canada / Israel / Mexico / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AXP / 2868165 / 2367026 / 2000019 / 2023607 / 2026242 / 2113393 / 2280220 / 2542049 / 2100920 / 2459202 / 2378534 / 2638625 / 2645409 / 2680905 / 2707677 / B1F76F9 / 2769796 / 2857817 / 2951452 / B2R3PV1 / B5B2106 / B7TL820 / B4MG4Z6 / B7VD3F2 / B8CKK03 / BDZDRC5 / BZ07BW4 / BYRY499 / BYY8XK8 / BQPVQZ6 / BFZ1K46 / BLGJ610 / BZ1LFG7 / BYY88Y7 / BFWGXQ7 / BDVLM39 / BJRFSB7</td><td class="leftalignment">American Express Co / Sysco Corp / General Mills Inc / Amazon.com Inc / Amgen Inc / American Electric Power Company Inc / Boston Beer Company Inc / DTE Energy Co / Dominion Energy Inc / FirstEnergy Corp / IDEXX Laboratories Inc / Mckesson Corp / National Beverage Corp / NiSource Inc / PPL Corp / Public Service Enterprise Group Inc / Western Union Co / Fidelity National Information Services Inc / Netflix Inc / J M Smucker Co / American Water Works Company Inc / Fortinet Inc / Meta Platforms Inc / AMC Networks Inc / Duke Energy Corp / Mondelez International Inc / Premier Inc / Monster Beverage Corp / Kraft Heinz Co / WEC Energy Group Inc / Horizon Therapeutics PLC / Spotify Technology SA / Warner Music Group Corp / Roku Inc / Alphabet Inc / Container Store Group Inc / argenx SE / Immunovant Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">02/03/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - February 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">BP.L / EL.N / F.N / FLS.N / GE.N / GM.N / IBE.MC / PFE.N / WMT.N / SSE.L / AMGN.O / FER.MC / ETN.N / DHR.N / WCC.N / DOV.N / IEX.N / ROP.N / HON.N / MMM.N / EMR.N / HCA.N / JCI.N / EPAY.O / AME.N / APT.AX / VRTX.O / GGG.N / MKL.N / PNR.N / ST.N / SKY.N / TT.N / ICPT.O / MMP.N / BIIB.O / NVT.N / HOG.N / EHTH.O / AEO.N / SPB.N / PCH.O / PCRX.O / STAG.N / MPC.N / FBHS.N / XYL.N / MPLX.N / BPY.N / AGIO.O / VRNS.O / CTLT.N / GBT.OQ / RPD.O / TRHC.OQ / ATKR.N / ICHR.O / GOOS.TO / ESTE.N / ORSTED.CO / AQUA.N / SAIL.N / Z1P.AX / GSHD.O / NTGY.MC / NBSE.OQ / CRNC.OQ / IGMS.O / SLQT.N / FOUR.N / RXT.OQ / JAMF.O</td><td class="leftalignment">BP PLC / Estee Lauder Companies Inc / Ford Motor Co / Flowserve Corp / General Electric Co / General Motors Co / Iberdrola SA / Pfizer Inc / Walmart Inc / SSE PLC / Amgen Inc / Ferrovial SA / Eaton Corporation PLC / Danaher Corp / Wesco International Inc / Dover Corp / IDEX Corp / Roper Technologies Inc / Honeywell International Inc / 3M Co / Emerson Electric Co / HCA Healthcare Inc / Johnson Controls International PLC / Bottomline Technologies Inc / AMETEK Inc / Afterpay Ltd / Vertex Pharmaceuticals Inc / Graco Inc / Markel Corp / Pentair PLC / Sensata Technologies Holding PLC / Skyline Champion Corp / Trane Technologies PLC / Intercept Pharmaceuticals Inc / Magellan Midstream Partners LP / Biogen Inc / nVent Electric PLC / Harley-Davidson Inc / eHealth Inc / American Eagle Outfitters Inc / Spectrum Brands Holdings Inc / Potlatchdeltic Corp / Pacira Biosciences Inc / STAG Industrial Inc / Marathon Petroleum Corp / Fortune Brands Home & Security Inc / Xylem Inc / MPLX LP / Brookfield Property Partners LP / Agios Pharmaceuticals Inc / Varonis Systems Inc / Catalent Inc / Global Blood Therapeutics Inc / Rapid7 Inc / Tabula Rasa HealthCare Inc / Atkore Inc / Ichor Holdings Ltd / Canada Goose Holdings Inc / Earthstone Energy Inc / Orsted A/S / Evoqua Water Technologies Corp / SailPoint Technologies Holdings Inc / Zip Co Ltd / Goosehead Insurance Inc / Naturgy Energy Group SA / NeuBase Therapeutics Inc / Cerence Inc / IGM Biosciences Inc / SelectQuote Inc / Shift4 Payments Inc / Rackspace Technology Inc / Jamf Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Cayman Islands / Denmark / Spain / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">RBCCM Global Research</td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">BEN / CMG / COP / DD / KRP / MPC / PKI / UPS / AMGN.O / BSM / NVDA.O / XOM / SIRI.O / GPN / ARCC.O / AINV.O / SCHW.K / EA.O / MPLX.K / VNOM.O / BOOT.K / GBT.O / VYGR.O / HLNE.O / OCSL.O / BBDC.K / FLMN.O / MNRL.K / ALGM.O</td><td class="leftalignment">Franklin Resources Inc / Chipotle Mexican Grill Inc / Conocophillips / Dupont De Nemours Inc / Kimbell Royalty Partners LP / Marathon Petroleum Corp / PerkinElmer Inc / United Parcel Service Inc / Amgen Inc / Black Stone Minerals LP / NVIDIA Corp / Exxon Mobil Corp / Sirius XM Holdings Inc / Global Payments Inc / Ares Capital Corp / Apollo Investment Corp / Charles Schwab Corp / Electronic Arts Inc / MPLX LP / Viper Energy Partners LP / Boot Barn Holdings Inc / Global Blood Therapeutics Inc / Voyager Therapeutics Inc / Hamilton Lane Inc / Oaktree Specialty Lending Corp / Barings BDC Inc / Falcon Minerals Corp / Brigham Minerals Inc / Allegro Microsystems Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">4Q Take: Solid start to 2021 for AMGN</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Emily Bodnar / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: February 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BMY.N / BSX.N / CI.N / CNC.N / EL.N / GM.N / KO.N / MRK.N / PFE.N / PM.N / HUM.N / FE.N / ITW.N / XOM.N / LIN.N / TWTR.N / AMGN.OQ / FISV.OQ / JKHY.OQ / REGN.OQ / TT.N / QCOM.OQ / AMZN.OQ / TTWO.OQ / EQIX.OQ / GPN.N / FIS.N / TDG.N / CME.OQ / ABBV.N / GOOGL.OQ / PYPL.OQ / TMUS.OQ / SPG.NZ / IQV.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Boston Scientific Corp / Cigna Corp / Centene Corp / Estee Lauder Companies Inc / General Motors Co / Coca-Cola Co / Merck & Co Inc / Pfizer Inc / Philip Morris International Inc / Humana Inc / FirstEnergy Corp / Illinois Tool Works Inc / Exxon Mobil Corp / Linde PLC / Twitter Inc / Amgen Inc / Fiserv Inc / Jack Henry & Associates Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Qualcomm Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Equinix Inc / Global Payments Inc / Fidelity National Information Services Inc / TransDigm Group Inc / CME Group Inc / Abbvie Inc / Alphabet Inc / PayPal Holdings Inc / T-Mobile US Inc / Stride Property Ltd / IQVIA Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / New Zealand / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">AMGN: Our Thoughts Post the 4Q20 Call: 2020 wasn't terrible, but concerns lie ahead as headwinds mount</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AMGN.OQ / MRTX.OQ</td><td class="leftalignment">Amgen Inc / Mirati Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MRTX: Updating KRAS estimates in conjunction with AMGN 4Q earnings - expect 2022 launch for adagrasib</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRTX.OQ / AMGN.OQ</td><td class="leftalignment">Mirati Therapeutics Inc / Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">4Q Update Highlights Favorable Business Outlook</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AMGN=US</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">AMGN - AMGN 4Q20 postview: Decent quarter, but long-term growth outlook "iffier"</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">031162100</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">02/03/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Amgen Inc : 4Q Snapshot - Uneventful Quarter & Conservative Guide Ahead of an Approaching New Product Cycle</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Mr. Turner Kufe / Mr. Matthew T. Holt, P.Eng</td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">4Q20: Guidance Beatable with Ongoing Launch Preparations</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Do G. Kim / Jameson Kao / Ikechukwu Oji</td></tr>
<tr class="odd"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">AMGN: Solid 4Q20 Results With Pipeline Gains Notable</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Jim W. Birchenough, MD</td></tr>
<tr class="even"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Strong Execution in Q4 As Late Stage Pipeline Takes Center Stage–PT $288 (-$6)</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Yaron Werber, M.D., MD / Brendan Smith, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">AMGN (NEUTRAL) - Good Qtr, But Growth Slowing Significantly in 2021; Increasing Focus on Pipeline & Early Programs</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">2023607 / BYYWPW6</td><td class="leftalignment">Amgen Inc / Beigene Ltd</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">02/02/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Amgen Inc : First Look at 4Q Results</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Mr. Turner Kufe / Mr. Matthew T. Holt, P.Eng</td></tr>
<tr class="odd"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">More Active M&A – If Not Now, When?</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">031162100</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">AMGN.OQ - Event Brief of Amgen Inc conference call, Feb. 02, 2021 / 5:00PM ET</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">AMGN.OQ - Event Transcript of Amgen Inc conference call, Feb. 02, 2021 / 5:00PM ET</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">02/02/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Q4:20 at first blush: Q4 in-line but 2021 guide leaves something to be desired</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Kennen MacKay, PHD / Edwin Delfin</td></tr>
<tr class="odd"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Q420 Beat, FY21 Outlook Fine but BiTE Setbacks Have Our Attention</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Teze Competitive in High Eos with 70% AAER Reduction, Will Dominate in Low Eos</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Yaron Werber, M.D., MD / Brendan Smith, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">AMGN: 4Q20 First Read</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Jim W. Birchenough, MD</td></tr>
<tr class="even"><td class="leftalignment">02/02/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Data in AAAAI 2021 Abstract Shows Tezepelumab to Be Competitive, Potentially Differentiated Across Eosinophil Counts</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">03116210</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="odd"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Zephirin Group, Inc.</td><td class="leftalignment">Zephirin Group View: The Dating Game - Key Quarterly Earnings on Feb 2, 2021</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE.N / BP.L / BR.N / IBM.N / MCK.N / SLB.N / STE.N / WAT.N / BEN.N / HAL.N / ETN.N / IMO.TO / SYY.N / UPS.N / EMR.N / XOM.N / GWW.N / PKI.N / HCA.N / ATO.N / COP.N / AMGN.OQ / AAPL.OQ / MSFT.OQ / TECH.OQ / SBUX.OQ / IDXX.OQ / GL.N / AMZN.OQ / MTCH.OQ / 0700.HK / RDSa.L / CMG.N / 9999.HK / MPC.N / BKR.N / FBHS.N / EA.OQ / GOOGL.OQ / CTLT.N / LYFT.OQ / CB.BN / PINS.N / BYND.OQ / UBER.N / ZM.OQ / AMCR.N / 9988.HK / 9618.HK / ABNB.OQ</td><td class="leftalignment">Pfizer Inc / BP PLC / Broadridge Financial Solutions Inc / International Business Machines Corp / Mckesson Corp / Schlumberger NV / STERIS plc / Waters Corp / Franklin Resources Inc / Halliburton Co / Eaton Corporation PLC / Imperial Oil Ltd / Sysco Corp / United Parcel Service Inc / Emerson Electric Co / Exxon Mobil Corp / W W Grainger Inc / PerkinElmer Inc / HCA Healthcare Inc / Atmos Energy Corp / Conocophillips / Amgen Inc / Apple Inc / Microsoft Corp / Bio-Techne Corp / Starbucks Corp / IDEXX Laboratories Inc / Globe Life Inc / Amazon.com Inc / Match Group Inc / Tencent Holdings Ltd / Royal Dutch Shell PLC / Chipotle Mexican Grill Inc / NetEase Inc / Marathon Petroleum Corp / Baker Hughes Co / Fortune Brands Home & Security Inc / Electronic Arts Inc / Alphabet Inc / Catalent Inc / Lyft Inc / Chubb Ltd / Pinterest Inc / Beyond Meat Inc / Uber Technologies Inc / Zoom Video Communications Inc / Amcor PLC / Alibaba Group Holding Ltd / JD.Com Inc / Airbnb Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / Ireland / United States / Jersey / Curaçao</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Communications / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Office Equipment / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Semiconductors / Services / Shipping & Shipbuilding / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment">INVESTMENT STRATEGY / CAPITALIZATION / GOVERNMENT RELATIONS/REGULATIONS / MISCELLANEOUS / SMALL CAPITAL / GOVERNMENTS / RELATIVE VALUE / TRADING / GROWTH / INDEX / PORTFOLIO STRATEGY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Longdley Zephirin</td></tr>
<tr class="even"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">AMGN: POETYK PSO-2 Shows TYK2 Superior to OTEZLA...Again</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Jim W. Birchenough, MD</td></tr>
<tr class="odd"><td class="leftalignment">02/02/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Broad Domestic Declines Continue as Vaccine Rollout Continues to Ramp Up; IHME Projects Variants May Extend Pandemic Tail</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Brittany Woods / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Lachlan Hanbury-Brown / John Boyle / Mr. Rob Andrew, CFA</td></tr>
<tr class="even"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / WEN=US / BLD=US / EBAY=US / TXN=US / TEVA=US / GILD=US / PEB=US / CONE=US / LOW=US / FMS=US / HSII=US / DIOD=US / CHRS=US / TTWO=US / LEG=US / ATVI=US / KFRC=US / MAC=US / KFY=US / AMN=US / CBRL=US / CSTR=US / DRI=US / DRH=US / EQIX=US / GFF=US / IBP=US / MAN=US / MAS=US / MHK=US / ASGN=US / REGN=US / REGI=US / RHI=US / ROLL=US / SKY=US / THO=US / CCRN=US / MTCH=US / VNO=US / FFIN=US / GBCI=US / DIN=US / PTON=US / RPD=US / TPX=US / EXP=US / BECN=US / SHO=US / DLR=US / PLAY=US / BAH=US / WMG=US / DENN=US / BLDR=US / GMS=US / NSP=US / CMG=US / REX=US / HST=US / PGTI=US / GPRE=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / EHC=US / NMTR=US / IAC=US / JACK=US / RCUS=US / TREX=US / NXPI=US / WWD=US / RLJ=US / FBHS=US / ANGI=US / EA=US / RHP=US / TILE=US / IBTX=US / NDLS=US / PINC=US / CNCE=US / MTNB=US / LOCO=US / ANTM=US / WBA=US / SHAK=US / ON=US / WING=US / ARGX=US / 82982L103 / PK=US / GDS=US / JELD=US / SWCH=US / FERGY=US / ARQT=US / AZEK=US / CRMD.US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Wendys Co / TopBuild Corp / eBay Inc / Texas Instruments Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Pebblebrook Hotel Trust / CyrusOne Inc / Lowe's Companies Inc / Fresenius Medical Care AG & Co KGaA / Heidrick & Struggles International Inc / Diodes Inc / Coherus BioSciences Inc / Take-Two Interactive Software Inc / Leggett & Platt Inc / Activision Blizzard Inc / Kforce Inc / Macerich Co / Korn Ferry / AMN Healthcare Services Inc / Cracker Barrel Old Country Store Inc / CapStar Financial Holdings Inc / Darden Restaurants Inc / Diamondrock Hospitality Co / Equinix Inc / Griffon Corp / Installed Building Products Inc / ManpowerGroup Inc / Masco Corp / Mohawk Industries Inc / ASGN Inc / Regeneron Pharmaceuticals Inc / Renewable Energy Group Inc / Robert Half International Inc / RBC Bearings Inc / Skyline Champion Corp / Thor Industries Inc / Cross Country Healthcare Inc / Match Group Inc / Vornado Realty Trust / First Financial Bankshares Inc / Glacier Bancorp Inc / Dine Brands Global Inc / Peloton Interactive Inc / Rapid7 Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Sunstone Hotel Investors Inc / Digital Realty Trust Inc / Dave & Buster's Entertainment Inc / Booz Allen Hamilton Holding Corp / Warner Music Group Corp / Denny's Corp / Builders FirstSource Inc / GMS Inc / Insperity Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Host Hotels & Resorts Inc / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Encompass Health Corp / 9 Meters Biopharma Inc / IAC/Interactivecorp / Jack in the Box Inc / Arcus Biosciences Inc / Trex Company Inc / NXP Semiconductors NV / Woodward Inc / RLJ Lodging Trust / Fortune Brands Home & Security Inc / Angi Inc / Electronic Arts Inc / Ryman Hospitality Properties Inc / Interface Inc / Independent Bank Group Inc / Noodles & Co / Premier Inc / Concert Pharmaceuticals Inc / Matinas BioPharma Holdings Inc / El Pollo Loco Holdings Inc / Anthem Inc / Walgreens Boots Alliance Inc / Shake Shack Inc / ON Semiconductor Corp / Wingstop Inc / argenx SE / SiteOne Landscape Supply Inc / Park Hotels & Resorts Inc / GDS Holdings Ltd / JELD-WEN Holding Inc / Switch Inc / Ferguson PLC / Arcutis Biotherapeutics Inc / Azek Company Inc / CorMedix Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Brazil / Canada / Cayman Islands / Germany / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">AMGN: Amgen, Inc. - 4Q20 First Take: Eking out top and bottom line beats; focus shifting to potential Sotorasib approval near-term</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: February 2, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BDX.N / BMY.N / BSX.N / CI.N / EL.N / MRK.N / PFE.N / PM.N / TMO.N / HUM.N / FE.N / HD.N / ITW.N / XOM.N / LIN.N / ARE.N / AMGN.OQ / JKHY.OQ / ATVI.OQ / REGN.OQ / TT.N / QCOM.OQ / GILD.OQ / AMZN.OQ / TTWO.OQ / GPN.N / VRTX.OQ / ICE.N / TDG.N / ABBV.N / GOOGL.OQ / PYPL.OQ / TMUS.OQ / SPG.NZ / OTIS.N</td><td class="leftalignment">Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Cigna Corp / Estee Lauder Companies Inc / Merck & Co Inc / Pfizer Inc / Philip Morris International Inc / Thermo Fisher Scientific Inc / Humana Inc / FirstEnergy Corp / Home Depot Inc / Illinois Tool Works Inc / Exxon Mobil Corp / Linde PLC / Alexandria Real Estate Equities Inc / Amgen Inc / Jack Henry & Associates Inc / Activision Blizzard Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Qualcomm Inc / Gilead Sciences Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Intercontinental Exchange Inc / TransDigm Group Inc / Abbvie Inc / Alphabet Inc / PayPal Holdings Inc / T-Mobile US Inc / Stride Property Ltd / Otis Worldwide Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / New Zealand / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: January 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">ABT.N / ALB.N / AXP.N / BA.N / BAC.N / BSX.N / C.N / CCL.N / CIT.N / CL.N / CRM.N / CVS.N / DAL.N / DD.N / EL.N / EOG.N / F.N / FCX.N / FDX.N / FLT.N / GM.N / HLT.N / IBM.N / JNJ.N / JPM.N / KO.N / LLY.N / LMT.N / LUV.N / MDT.N / MO.N / MRK.N / OXY.N / SLB.N / T.N / TMO.N / USB.N / WFC.N / WMT.N / CMA.N / PG.N / W.N / RIG.N / DHR.N / DIS.N / UNH.N / DE.N / PGR.N / CAT.N / MGM.N / RCL.N / SYY.N / HON.N / VLO.N / HD.N / LOW.N / MRO.N / SYK.N / JWN.N / XOM.N / NKE.N / LIN.N / TGT.N / VZ.N / SNV.N / KSS.N / ORCL.N / VFC.N / HP.N / MAC.N / KMI.N / KMX.N / PWR.N / EQT.N / V.N / OKE.N / HWM.N / ACN.N / WSM.N / AIV.N / LB.TO / BLK.N / CVX.N / IRM.N / NCR.N / COP.N / INTC.OQ / ABMD.OQ / ADBE.OQ / AMGN.OQ / AAPL.OQ / AMAT.OQ / COHR.OQ / KLAC.OQ / ATVI.OQ / MSFT.OQ / PII.N / REGN.OQ / ROL.N / SIVB.OQ / THO.N / QDEL.OQ / SNPS.OQ / SBUX.OQ / IDXX.OQ / QCOM.OQ / CREE.OQ / GILD.OQ / COST.OQ / CPRT.OQ / TRU.N / ACGL.OQ / SSNC.OQ / EEFT.OQ / VSAT.OQ / AMZN.OQ / MRCY.OQ / EBAY.OQ / NVDA.OQ / MFA.N / CHTR.OQ / NUAN.OQ / ISRG.OQ / ILMN.OQ / ALGN.OQ / GPN.N / PTEN.OQ / NFLX.OQ / WYNN.OQ / CMCSA.OQ / BIIB.OQ / SBNY.OQ / OSH.N / MOS.N / LVS.N / VIAC.OQ / DISCA.OQ / KOS.N / CDNS.OQ / MS.N / FIS.N / MA.N / SIX.N / SPR.N / CNK.N / IVZ.N / M.N / BGCP.OQ / PBF.N / MRNA.OQ / MSCI.N / CHNG.OQ / AVGO.OQ / FICO.N / CLNY.N / VRSK.OQ / SCHW.N / MU.OQ / NEE.N / TSLA.OQ / ADSGN.F / HHC.N / TWO.N / SABR.OQ / MPC.N / HFC.N / HZNP.OQ / AMD.OQ / ENPH.OQ / PSX.N / NOW.N / SRPT.OQ / BERY.N / FANG.OQ / ABBV.N / BFAM.N / COTY.N / FEYE.OQ / MAR.OQ / AAL.OQ / NCLH.N / GOOGL.OQ / PAYC.N / SAGE.OQ / HUBS.N / WBA.OQ / SEDG.OQ / ETSY.OQ / TDOC.N / PYPL.OQ / PEN.N / NVCR.OQ / TMUS.OQ / SQ.N / RETA.OQ / TWLO.N / SPG.NZ / TTD.OQ / CDEV.OQ / UAA.N / FTI.PA / CVNA.N / AXON.OQ / ROKU.OQ / PEP.OQ / BKNG.OQ / ZS.OQ / QRTEA.OQ / FB.PS / CDAY.N / UAL.OQ / STNE.OQ / ETRN.N / NWL.OQ / CPRI.N / PINS.N / BYND.OQ / ZM.OQ / FSLY.N / CRWD.OQ / PTON.OQ / SVC.OQ / SPCE.N / RTX.N / CARR.N / LMND.N / CHK.N^F20 / AMWL.N / LUMN.N / CHX.OQ</td><td class="leftalignment">Abbott Laboratories / Albemarle Corp / American Express Co / Boeing Co / Bank of America Corp / Boston Scientific Corp / Citigroup Inc / Carnival Corp / First-Citizens Bank & Trust Co / Colgate-Palmolive Co / Salesforce.Com Inc / CVS Health Corp / Delta Air Lines Inc / Dupont De Nemours Inc / Estee Lauder Companies Inc / EOG Resources Inc / Ford Motor Co / Freeport-McMoRan Inc / FedEx Corp / Fleetcor Technologies Inc / General Motors Co / Hilton Worldwide Holdings Inc / International Business Machines Corp / Johnson & Johnson / JPMorgan Chase & Co / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Medtronic PLC / Altria Group Inc / Merck & Co Inc / Occidental Petroleum Corp / Schlumberger NV / AT&T Inc / Thermo Fisher Scientific Inc / US Bancorp / Wells Fargo & Co / Walmart Inc / Comerica Inc / Procter & Gamble Co / Wayfair Inc / Transocean Ltd / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Deere & Co / Progressive Corp / Caterpillar Inc / MGM Resorts International / Royal Caribbean Cruises Ltd / Sysco Corp / Honeywell International Inc / Valero Energy Corp / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / Stryker Corp / Nordstrom Inc / Exxon Mobil Corp / Nike Inc / Linde PLC / Target Corp / Verizon Communications Inc / Synovus Financial Corp / Kohls Corp / Oracle Corp / VF Corp / Helmerich and Payne Inc / Macerich Co / Kinder Morgan Inc / Carmax Inc / Quanta Services Inc / EQT Corp / Visa Inc / ONEOK Inc / Howmet Aerospace Inc / Accenture PLC / Williams-Sonoma Inc / Apartment Investment and Management Co / Laurentian Bank of Canada / BlackRock Inc / Chevron Corp / Iron Mountain Inc / NCR Corp / Conocophillips / Intel Corp / ABIOMED Inc / Adobe Inc / Amgen Inc / Apple Inc / Applied Materials Inc / Coherent Inc / KLA Corp / Activision Blizzard Inc / Microsoft Corp / Polaris Inc / Regeneron Pharmaceuticals Inc / Rollins Inc / SVB Financial Group / Thor Industries Inc / Quidel Corp / Synopsys Inc / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Wolfspeed Inc / Gilead Sciences Inc / Costco Wholesale Corp / Copart Inc / TransUnion / Arch Capital Group Ltd / SS&C Technologies Holdings Inc / Euronet Worldwide Inc / ViaSat Inc / Amazon.com Inc / Mercury Systems Inc / eBay Inc / NVIDIA Corp / MFA Financial Inc / Charter Communications Inc / Nuance Communications Inc / Intuitive Surgical Inc / Illumina Inc / Align Technology Inc / Global Payments Inc / Patterson-UTI Energy Inc / Netflix Inc / Wynn Resorts Ltd / Comcast Corp / Biogen Inc / Signature Bank / Oak Street Health Inc / Mosaic Co / Las Vegas Sands Corp / ViacomCBS Inc / Discovery Inc / Kosmos Energy Ltd / Cadence Design Systems Inc / Morgan Stanley / Fidelity National Information Services Inc / Mastercard Inc / Six Flags Entertainment Corp / Spirit AeroSystems Holdings Inc / Cinemark Holdings Inc / Invesco Ltd / Macy's Inc / BGC Partners Inc / PBF Energy Inc / Moderna Inc / MSCI Inc / Change Healthcare Inc / Broadcom Inc / Fair Isaac Corp / DigitalBridge Group Inc / Verisk Analytics Inc / Charles Schwab Corp / Micron Technology Inc / Nextera Energy Inc / Tesla Inc / Adidas AG / Howard Hughes Corp / Two Harbors Investment Corp / Sabre Corp / Marathon Petroleum Corp / HollyFrontier Corp / Horizon Therapeutics PLC / Advanced Micro Devices Inc / Enphase Energy Inc / Phillips 66 / ServiceNow Inc / Sarepta Therapeutics Inc / Berry Global Group Inc / Diamondback Energy Inc / Abbvie Inc / Bright Horizons Family Solutions Inc / Coty Inc / Mandiant Inc / Marriott International Inc / American Airlines Group Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / Paycom Software Inc / SAGE Therapeutics Inc / HubSpot Inc / Walgreens Boots Alliance Inc / Solaredge Technologies Inc / ETSY Inc / Teladoc Health Inc / PayPal Holdings Inc / Penumbra Inc / Novocure Ltd / T-Mobile US Inc / Block Inc / Reata Pharmaceuticals Inc / Twilio Inc / Stride Property Ltd / Trade Desk Inc / Centennial Resource Development Inc / Under Armour Inc / TechnipFMC PLC / Carvana Co / Axon Enterprise Inc / Roku Inc / PepsiCo Inc / Booking Holdings Inc / Zscaler Inc / Qurate Retail Inc / San Miguel Food and Beverage Inc / Ceridian HCM Holding Inc / United Airlines Holdings Inc / StoneCo Ltd / Equitrans Midstream Corp / Newell Brands Inc / Capri Holdings Ltd / Pinterest Inc / Beyond Meat Inc / Zoom Video Communications Inc / Fastly Inc / CrowdStrike Holdings Inc / Peloton Interactive Inc / Service Properties Trust / Virgin Galactic Holdings Inc / Raytheon Technologies Corp / Carrier Global Corp / Lemonade Inc / Chesapeake Energy Corp / American Well Corp / Lumen Technologies Inc / ChampionX Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Germany / United Kingdom / Ireland / Liberia / New Zealand / Panama / Philippines / United States / Virgin Islands, British / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">02/02/2021</td><td class="leftalignment">ValuEngine, Inc</td><td class="leftalignment">ValuEngine Rating and Forecast Report for AMGN</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Paul Henneman</td></tr>
<tr class="odd"><td class="leftalignment">02/02/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">AstraZeneca : Teze NAVIGATOR Phase III abstract: Competitive in high eosinophil, best in class, in low eosinophil patients</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AZN.L / AMGN.O / SASY.PA / GSK.L / REGN.O</td><td class="leftalignment">AstraZeneca PLC / Amgen Inc / Sanofi SA / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">James D. Gordon / Mr. Richard B. Vosser / Sarita Kapila / Ms. Laerke Engkilde</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">HCM.L / JNJ.N / LLY.N / MRK.N / PFE.N / AMGN.OQ / GILD.OQ / AMRN.OQ / BSLN.S / AXSM.OQ / BHVN.N / ARAV.OQ / IMAB.OQ / ALXO.OQ</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Gilead Sciences Inc / Amarin Corporation PLC / Basilea Pharmaceutica AG / Axsome Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aravive Inc / I-Mab / ALX Oncology Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Cayman Islands / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Probes Reporter</td><td class="leftalignment">Watch List: 77 US Companies with Undisclosed SEC Probes - February 01, 2021</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">AMGN.OQ / PG.N / CL.N / COF.N / CRM.N / F.N / HLT.N / MDT.N / PNC.N / SLB.N / T.N / BEN.N / TRI.N / REV.N / ADM.N / VLO.N / UPS.N / NWL.N / RMD.N / NKE.N / AMP.N / MTZ.N / ARW.N / TWTR.N / OMI.N / CVX.N / GNTX.OQ / REGN.OQ / ROL.N / SEIC.OQ / RARE.OQ / MNRO.OQ / CAKE.OQ / GILD.OQ / COST.OQ / NKTR.OQ / AZPN.OQ / MYGN.OQ / SSNC.OQ / CTXS.OQ / AMZN.OQ / MSTR.OQ / NVDA.OQ / CHTR.OQ / TNP.N / NFLX.OQ / EGBN.OQ / NDAQ.OQ / TAL.N / MA.N / SIX.N / AON.N / BX.N / BGCP.OQ / UTL.N / SCHW.N / MSI.N / MPC.N / FB.OQ / XPO.N / CTG.OQ / NTRA.OQ / 100088979 / MFIN.OQ / DXC.N / CVNA.N / RYTM.OQ / SWCH.N / IQV.N / WELL.N / LYFT.O / US71742W1036 / 120175706</td><td class="leftalignment">Amgen Inc / Procter & Gamble Co / Colgate-Palmolive Co / Capital One Financial Corp / Salesforce.Com Inc / Ford Motor Co / Hilton Worldwide Holdings Inc / Medtronic PLC / PNC Financial Services Group Inc / Schlumberger NV / AT&T Inc / Franklin Resources Inc / Thomson Reuters Corp / Revlon Inc / Archer-Daniels-Midland Co / Valero Energy Corp / United Parcel Service Inc / Newell Brands Inc / Resmed Inc / Nike Inc / Ameriprise Financial Inc / MasTec Inc / Arrow Electronics Inc / Twitter Inc / Owens & Minor Inc / Chevron Corp / Gentex Corp / Regeneron Pharmaceuticals Inc / Rollins Inc / SEI Investments Co / Ultragenyx Pharmaceutical Inc / Monro Inc / Cheesecake Factory Inc / Gilead Sciences Inc / Costco Wholesale Corp / Nektar Therapeutics / Aspen Technology Inc / Myriad Genetics Inc / SS&C Technologies Holdings Inc / Citrix Systems Inc / Amazon.com Inc / Microstrategy Inc / NVIDIA Corp / Charter Communications Inc / Tsakos Energy Navigation Ltd / Netflix Inc / Eagle Bancorp Inc / Nasdaq Inc / TAL Education Group / Mastercard Inc / Six Flags Entertainment Corp / Aon PLC / Blackstone Inc / BGC Partners Inc / Unitil Corp / Charles Schwab Corp / Motorola Solutions Inc / Marathon Petroleum Corp / Meta Platforms Inc / XPO Logistics Inc / Computer Task Group Inc / Natera Inc / Huntington Bancshares Inc / Medallion Financial Corp / DXC Technology Co / Carvana Co / Rhythm Pharmaceuticals Inc / Switch Inc / IQVIA Holdings Inc / Welltower Inc / Lyft Inc / PhenixFIN Corp / Cisco Systems Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Cayman Islands / Ireland / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for AMGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Tidbits From WCLC: Updates for Sotorasib and AMG 757 and Thoughts on Results From KEYNOTE-598</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">03116210 / 110122108</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">LLY-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">LLY / BMY / JNJ / MRK / NVS / PFE / AMGN.O / GSK / AZN.O / ABBV.K / SNY.O</td><td class="leftalignment">Eli Lilly and Co / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Jan 22, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Guggenheim Ther Research</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Arcutis roflumilast could be potential competition for Otezla in mild/mod plaque psoriasis</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AMGN=US / ARQT.OQ / BMY=US / AMGN.OQ / ARQT=US</td><td class="leftalignment">Amgen Inc / Arcutis Biotherapeutics Inc / Bristol-Myers Squibb Co / Amgen Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Minh Vong</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Feb 01 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MOGa / US0079731008 / US0116591092 / US0311621009 / US0378331005 / US0382221051 / US0463531089 / US1101221083 / US1264081035 / US14149Y1082 / US1925761066 / US22284P1057 / US2910111044 / US3021301094 / US3695501086 / US37733W1053 / US4385161066 / US4433201062 / US4448591028 / US4456581077 / US4824801009 / US5012421013 / US5128071082 / US5150981018 / US5324571083 / US55306N1046 / US58155Q1031 / US6558441084 / US6668071029 / US66987V1098 / US6701002056 / US6795801009 / US7170811035 / US7711951043 / US7766961061 / US8308791024 / US8447411088 / US8552441094 / US87612E1064 / US8807701029 / US9029251066 / US9078181081 / US91324P1021 / US91347P1057 / US9311421039 / US9507551086 / CA1363751027 / US03073E1055 / CA13645T1003 / US4771431016 / US4198791018 / US2948216088 / US80105N1054 / US3463751087 / US09062X1037 / US90385V1070 / US25754A2015 / US0042251084 / US02043Q1076 / US15135B1017 / US12541W2098 / ACOR.OQ / US1696561059 / US78709Y1055 / PAP310761054 / US75025X1000 / US01748X1028 / US2473617023 / US58933Y1055 / US9100471096 / US30303M1027 / US9837931008 / US00287Y1091 / NL0010273215 / US8485771021 / US60468T1051 / US21240E1055 / US02376R1023 / US03937C1053 / US0465131078 / CA0089118776 / US00653A1079 / US9741551033 / US70450Y1038 / US40434L1052 / US05464T1043 / US00773U1088 / US16119P1084 / IE00BY7QL619 / KYG4740B1059 / CA87241L1094 / US23753F1075 / US80689H1023 / US02156K1034 / US4990491049 / US1010441053 / US05351X1019 / US5904791358 / US0197701065 / US1255231003 / US8740602052 / US24703L2025 / US0144421072 / US55087P1049 / US90353T1007 / US18453H1068 / US70614W1009 / US09203E1055 / US4432011082 / CH0499880968</td><td class="leftalignment">Moog Inc / Advanced Energy Industries Inc / Alaska Air Group Inc / Amgen Inc / Apple Inc / Applied Materials Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / CSX Corp / Cardinal Health Inc / Cohu Inc / Covenant Logistics Group Inc / Emerson Electric Co / Expeditors International of Washington Inc / General Dynamics Corp / GlaxoSmithKline PLC / Honeywell International Inc / Hub Group Inc / Humana Inc / J B Hunt Transport Services Inc / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Landstar System Inc / Eli Lilly and Co / MKS Instruments Inc / Mckesson Corp / Norfolk Southern Corp / Northrop Grumman Corp / Novartis AG / Novo Nordisk A/S / Old Dominion Freight Line Inc / Pfizer Inc / Roche Holding AG / Roper Technologies Inc / SkyWest Inc / Southwest Airlines Co / Starbucks Corp / Target Corp / Teradyne Inc / USA Truck Inc / Union Pacific Corp / UnitedHealth Group Inc / Universal Display Corp / Walmart Inc / Werner Enterprises Inc / Canadian National Railway Co / Amerisourcebergen Corp / Canadian Pacific Railway Ltd / JetBlue Airways Corp / Hawaiian Holdings Inc / Telefonaktiebolaget LM Ericsson / Sanofi SA / FormFactor Inc / Biogen Inc / Ultra Clean Holdings Inc / Domino's Pizza Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Centene Corp / CH Robinson Worldwide Inc / Acorda Therapeutics Inc / Chipotle Mexican Grill Inc / Saia Inc / Copa Holdings SA / Radiant Logistics Inc / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / United Airlines Holdings Inc / Meta Platforms Inc / XPO Logistics Inc / Abbvie Inc / ASML Holding NV / Spirit Airlines Inc / Mirati Therapeutics Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / ArcBest Corp / Atara Biotherapeutics Inc / Air Canada / Adaptimmune Therapeutics PLC / Wingstop Inc / PayPal Holdings Inc / HP Inc / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / Charter Communications Inc / Johnson Controls International PLC / Ichor Holdings Ltd / TFI International Inc / Daseke Inc / Schneider National Inc / Altice USA Inc / Knight-Swift Transportation Holdings Inc / Boston Omaha Corp / Avaya Holdings Corp / Mesa Air Group Inc / Allogene Therapeutics Inc / Cigna Corp / Takeda Pharmaceutical Co Ltd / Dell Technologies Inc / Alector Inc / Lyft Inc / Uber Technologies Inc / Clear Channel Outdoor Holdings Inc / Peloton Interactive Inc / Black Diamond Therapeutics Inc / Howmet Aerospace Inc / ADC Therapeutics SA</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Japan / Mexico / Netherlands / Panama / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">WMB=US / LLY=US / AMGN=US / BMY=US / CL=US / AMZN=US / INCY=US / KMI=US / AMT=US / CHTR=US / CRM=US / PAA=US / CCI=US / BRO=US / MANH=US / CMCSA=US / CHD=US / COLL=US / AJG=US / MPLX=US / OKE=US / SBAC=US / TRGP=US / WIX=US / HTH=US / CVX=US / EPD=US / CGEN=US / CFR=US / SIVB=US / ABCB=US / DCP=US / SSB=US / BDSI=US / MMP=US / BIIB=US / MOG.A=US / EXP=US / BAH=US / EHTH=US / PAGP=US / SMLP=US / MODN=US / PTCT=US / CEQP=US / GOOGL=US / WVE=US / WLTW=US / EVBG=US / IRTC=US / RTLR=US / LHX=US</td><td class="leftalignment">Williams Companies Inc / Eli Lilly and Co / Amgen Inc / Bristol-Myers Squibb Co / Colgate-Palmolive Co / Amazon.com Inc / Incyte Corp / Kinder Morgan Inc / American Tower Corp / Charter Communications Inc / Salesforce.Com Inc / Plains All American Pipeline LP / Crown Castle International Corp / Brown & Brown Inc / Manhattan Associates Inc / Comcast Corp / Church & Dwight Co Inc / Collegium Pharmaceutical Inc / Arthur J Gallagher & Co / MPLX LP / ONEOK Inc / SBA Communications Corp / Targa Resources Corp / Wix.Com Ltd / Hilltop Holdings Inc / Chevron Corp / Enterprise Products Partners LP / Compugen Ltd / Cullen/Frost Bankers Inc / SVB Financial Group / Ameris Bancorp / DCP Midstream LP / SouthState Corp / BioDelivery Sciences International Inc / Magellan Midstream Partners LP / Biogen Inc / Moog Inc / Eagle Materials Inc / Booz Allen Hamilton Holding Corp / eHealth Inc / Plains GP Holdings LP / Summit Midstream Partners LP / Model N Inc / PTC Therapeutics Inc / Crestwood Equity Partners LP / Alphabet Inc / WAVE Life Sciences Ltd / Willis Towers Watson PLC / Everbridge Inc / iRhythm Technologies Inc / Rattler Midstream LP / L3harris Technologies Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / Singapore / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AOS=US / PNR=US / AAPL=US / MRK=US / BSX=US / PFE=US / ABT=US / AMGN=US / CAT=US / INTC=US / CHRW=US / WM=US / BWA=US / MDT=US / GLW=US / QCOM=US / RUN=US / MPWR=US / FCEL=US / PLUG=US / AXL=US / SBH=US / CRM=US / SMTC=US / UMC=US / VRTS=US / URI=US / TSM=US / UPS=US / ENR=US / CHRS=US / JCI=US / JNJ=US / LSTR=US / DE=US / DOV=US / FLO=US / RSG=US / ALB=US / AMED=US / ECOL=US / AMSC=US / ARRY=US / ATRC=US / AVNT=US / AVT=US / BOX=US / CMI=US / CALM=US / CENX=US / CREE=US / CYBR=US / DAKT=US / EW=US / EXAS=US / FIVE=US / HTLD=US / ITRI=US / LGND=US / MTRX=US / MMS=US / NVAX=US / ODFL=US / PZZA=US / RBC=US / ROK=US / ROP=US / POOL=US / TRMB=US / TYL=US / VG=US / WDFC=US / SGEN=US / CCRN=US / ACA=US / HR=US / NEP=US / UFCS=US / BIO=US / OSTK=US / ENSG=US / BE=US / AMSF=US / ARES=US / CLH=US / PETS=US / WCN=US / TCOM=US / RNG=US / CRI=US / NUVA=US / MRNA=US / DPZ=US / BDC=US / PBF=US / ENS=US / GOOG=US / TWIN=US / MKTX=US / ORA=US / FRPT=US / PBH=US / MORN=US / BIDU=US / AMRS=US / SPWR=US / ATNI=US / TPTX=US / TEL=US / CSIQ=US / EBS=US / FSLR=US / TRIT=US / MASI=US / DAN=US / WPRT=US / TBK=US / AGCO=US / 005930-KR=US / GNRC=US / RRTS=US / TSLA=US / AMRC=US / ENPH=US / YY=US / HASI=US / CNHI=US / QURE=US / DNOW=US / COUP=US / SYF=US / VCEL=US / NVTA=US / ETSY=US / SEDG=US / WING=US / TDOC=US / AQMS=US / WKHS=US / TRHC=US / FLGT=US / IRTC=US / HLNE=US / RDFN=US / ROKU=US / MDB=US / APTV=US / VOW3-DE=US / IQ=US / VNE=US / FOCS=US / CWEN=US / ZM=US / VLDR=US / 120376391</td><td class="leftalignment">A O Smith Corp / Pentair PLC / Apple Inc / Merck & Co Inc / Boston Scientific Corp / Pfizer Inc / Abbott Laboratories / Amgen Inc / Caterpillar Inc / Intel Corp / CH Robinson Worldwide Inc / Waste Management Inc / Borgwarner Inc / Medtronic PLC / Corning Inc / Qualcomm Inc / Sunrun Inc / Monolithic Power Systems Inc / Fuelcell Energy Inc / Plug Power Inc / American Axle & Manufacturing Holdings Inc / Sally Beauty Holdings Inc / Salesforce.Com Inc / Semtech Corp / United Microelectronics Corp / Virtus Investment Partners Inc / United Rentals Inc / Taiwan Semiconductor Manufacturing Co Ltd / United Parcel Service Inc / Energizer Holdings Inc / Coherus BioSciences Inc / Johnson Controls International PLC / Johnson & Johnson / Landstar System Inc / Deere & Co / Dover Corp / Flowers Foods Inc / Republic Services Inc / Albemarle Corp / Amedisys Inc / US Ecology Inc / American Superconductor Corp / Array Technologies Inc / AtriCure Inc / Avient Corp / Avnet Inc / Box Inc / Cummins Inc / Cal-Maine Foods Inc / Century Aluminum Co / Wolfspeed Inc / Cyberark Software Ltd / Daktronics Inc / Edwards Lifesciences Corp / Exact Sciences Corp / Five Below Inc / Heartland Express Inc / Itron Inc / Ligand Pharmaceuticals Inc / Matrix Service Co / Maximus Inc / Novavax Inc / Old Dominion Freight Line Inc / Papa John's International Inc / Regal Rexnord Corp / Rockwell Automation Inc / Roper Technologies Inc / Pool Corp / Trimble Inc / Tyler Technologies Inc / Vonage Holdings Corp / WD-40 Co / Seagen Inc / Cross Country Healthcare Inc / Arcosa Inc / Healthcare Realty Trust Inc / Nextera Energy Partners LP / United Fire Group Inc / Bio Rad Laboratories Inc / Overstock.com Inc / Ensign Group Inc / Bloom Energy Corp / Amerisafe Inc / Ares Management Corp / Clean Harbors Inc / Petmed Express Inc / Waste Connections Inc / Trip.com Group Ltd / RingCentral Inc / Carter's Inc / NuVasive Inc / Moderna Inc / Domino's Pizza Inc / Belden Inc / PBF Energy Inc / EnerSys / Alphabet Inc / Twin Disc Inc / Marketaxess Holdings Inc / Ormat Technologies Inc / Freshpet Inc / Prestige Consumer Healthcare Inc / Morningstar Inc / Baidu Inc / Amyris Inc / SunPower Corp / ATN International Inc / Turning Point Therapeutics Inc / TE Connectivity Ltd / Canadian Solar Inc / Emergent BioSolutions Inc / First Solar Inc / Triterras Inc / Masimo Corp / Dana Inc / Westport Fuel Systems Inc / Triumph Bancorp Inc / AGCO Corp / Farfetch Ltd / Generac Holdings Inc / Roadrunner Transportation Systems Inc / Tesla Inc / Ameresco Inc / Enphase Energy Inc / JOYY Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / CNH Industrial NV / Uniqure NV / NOW Inc / Coupa Software Inc / Synchrony Financial / Vericel Corp / Invitae Corp / ETSY Inc / Solaredge Technologies Inc / Wingstop Inc / Teladoc Health Inc / Aqua Metals Inc / Workhorse Group Inc / Tabula Rasa HealthCare Inc / Fulgent Genetics Inc / iRhythm Technologies Inc / Hamilton Lane Inc / Redfin Corp / Roku Inc / MongoDB Inc / Aptiv PLC / Volkswagen AG / iQIYI Inc / Veoneer Inc / Focus Financial Partners Inc / Clearway Energy Inc / Zoom Video Communications Inc / Velodyne Lidar Inc / Proterra Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Ireland / Israel / Netherlands / Taiwan / United States / Jersey</td><td class="leftalignment">Biotechnology / Conglomerates / Electrical / Financial Services / Healthcare / Info. Tech./Computers / Machinery / Retailing / Semiconductors / Services</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Sotorasib Shows Durable Responses, Potential for Patient Subsets & Combos</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">AMGN=US / MRTX=US</td><td class="leftalignment">Amgen Inc / Mirati Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - February 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">AEP.N / AFL.N / AIG.N / ALV.N / AMAT.O / AMD.N / ANA.MC / AU.N / BBDb.TO / BCE.TO / CB.N / CCI.N / CE.N / CL.N / CMS.N / CNA.L / CP.TO / DFDS.CO / EIX.N / EL.N / ELE.MC / F.N / FLT.N / GM.N / INTC.O / KMB.N / KO.N / MMC.N / MSFT.O / MUVGn.DE / NSC.N / PEG.N / PFE.N / SCOR.PA / SO.N / STO.AX / PEP.N / BFb.N / PG.N / WY.N / CFP.TO / CNQ.TO / ASML.O / CPB.N / CMCSA.O / SJRb.TO / RCIb.TO / CHKP.O / AMGN.O / MET.N / CNR.TO / DUK.N / QBRb.TO / DIS.N / BWA.N / LEA.N / ROP.N / DRI.N / NVDA.O / K.N / DT.N / DISH.O / CSX.N / LNR.TO / SU.TO / NICE.O / CLX.N / EAT.N / MCD.N / CAG.N / HON.N / GIS.N / EPC.N / MGA.N / AMT.N / JAZZ.O / BOL.ST / CONE.O / OLN.N / ADI.O / VLY.N / EXEL.O / SBUX.O / JCI.N / STZ.N / CINF.O / LNC.N / HNRGn.DE / APH.N / FISV.O / EQT.N / SNPS.O / ADSK.O / EPD.N / CHTR.O / AXL.N / AWK.N / CHD.N / ATA.TO / EPAY.O / BC.N / SAM.N / CTSH.O / AJG.N / BMRN.O / OPTN.O / REGN.O / ENR.N / PFG.N / MU.O / PRU.N / CEY.L / SM.N / NCR.N / NET.N / GFI.N / COP.N / CNP.N / ENDP.O / CPK.N / MKL.N / BRO.N / PII.N / RLI.N / ST.N / SR.N / LNG.A / NTCT.OQ / ADS.N / SGEN.OQ / GPN.N / PFS.N / MNST.O / EFX.TO / FFBC.O / IMGN.O / SIGI.O / CASY.O / ACGL.O / ICPT.O / FFIV.O / EQIX.O / ATDb.TO / MRE.TO / 02209S103 / DPZ.N / DLR.N / SCL.TO / 416515104 / 427866108 / RDSb.L / DISCA.O / CDNS.O / SJW.N / DRX.L / CMG.N / FIS.N / 025676206 / ISBC.O / MA.N / MWA.N / HOG.N / CVLT.O / EHTH.O / AON.N / BGS.N / PPL.TO / HOCM.L / GETP.PA / DAN.N / FRES.L / 759351604 / ACQ.TO / SPB.N / LYB.N / CFX.TO / FRU.TO / FHI.N / MTOR.N / NGL.N / PXT.TO / BKR.N / AMCX.O / POLYP.L / SPLK.OQ / PSX.N / PANW.N / FFHu.TO / MDLZ.OQ / ABBV.N / PRGO.N / PRMW.N / DOO.TO / COTY.N / FOXA.OQ / PSXP.N / AGIO.O / 81762P102 / PTC.O / QTWO.N / AGRX.O / SYF.N / QSR.N / EVA.N / PYPL.OQ / BYD.TO / RPD.O / MIME.OQ / RACE.MI / SRENH.S / KNSL.OQ / AKERBP.OL / NTNX.O / ADNT.N / LGFB.N / PBYI.OQ / DXC.N / ATUS.N / BHF.O / ATNX.O / SAIL.N / APTV.N / AMRX.N / EQH.N / GSHD.O / NTGY.MC / KDP.N / AQST.O / ESTC.N / NWL.O / RTLR.O / CRWD.O / GMAB.O / CRNC.OQ / ETNB.O / REYN.O / SBSW.N / IGIC.OQ / GFL.N / NKLA.OQ / FOUR.N / LUMN.N / MTCR.O / SUMO.O / 120681711</td><td class="leftalignment">American Electric Power Company Inc / Aflac Inc / American International Group Inc / Autoliv Inc / Applied Materials Inc / Advanced Micro Devices Inc / Acciona SA / AngloGold Ashanti Ltd / Bombardier Inc / BCE Inc / Chubb Ltd / Crown Castle International Corp / Celanese Corp / Colgate-Palmolive Co / CMS Energy Corp / Centrica PLC / Canadian Pacific Railway Ltd / DFDS AS / Edison International / Estee Lauder Companies Inc / Endesa SA / Ford Motor Co / Fleetcor Technologies Inc / General Motors Co / Intel Corp / Kimberly-Clark Corp / Coca-Cola Co / Marsh & McLennan Companies Inc / Microsoft Corp / Muenchener Rueckversicherungs Gesellschaft in Muenchen AG / Norfolk Southern Corp / Public Service Enterprise Group Inc / Pfizer Inc / Scor SE / Southern Co / Santos Ltd / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Weyerhaeuser Co / Canfor Corp / Canadian Natural Resources Ltd / ASML Holding NV / Campbell Soup Co / Comcast Corp / Shaw Communications Inc / Rogers Communications Inc / Check Point Software Technologies Ltd / Amgen Inc / MetLife Inc / Canadian National Railway Co / Duke Energy Corp / Quebecor Inc / Walt Disney Co / Borgwarner Inc / Lear Corp / Roper Technologies Inc / Darden Restaurants Inc / NVIDIA Corp / Kellogg Co / Dynatrace Inc / DISH Network Corp / CSX Corp / Linamar Corp / Suncor Energy Inc / Nice Ltd / Clorox Co / Brinker International Inc / McDonald's Corp / Conagra Brands Inc / Honeywell International Inc / General Mills Inc / Edgewell Personal Care Co / Magna International Inc / American Tower Corp / Jazz Pharmaceuticals PLC / Boliden AB / CyrusOne Inc / Olin Corp / Analog Devices Inc / Valley National Bancorp / Exelixis Inc / Starbucks Corp / Johnson Controls International PLC / Constellation Brands Inc / Cincinnati Financial Corp / Lincoln National Corp / Hannover Rueck SE / Amphenol Corp / Fiserv Inc / EQT Corp / Synopsys Inc / Autodesk Inc / Enterprise Products Partners LP / Charter Communications Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Church & Dwight Co Inc / ATS Automation Tooling Systems Inc / Bottomline Technologies Inc / Brunswick Corp / Boston Beer Company Inc / Cognizant Technology Solutions Corp / Arthur J Gallagher & Co / Biomarin Pharmaceutical Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Principal Financial Group Inc / Micron Technology Inc / Prudential Financial Inc / Centamin PLC / SM Energy Co / NCR Corp / Cloudflare Inc / Gold Fields Ltd / Conocophillips / CenterPoint Energy Inc / Endo International PLC / Chesapeake Utilities Corp / Markel Corp / Brown & Brown Inc / Polaris Inc / Rli Corp / Sensata Technologies Holding PLC / Spire Inc / Cheniere Energy Inc / Netscout Systems Inc / Alliance Data Systems Corp / Seagen Inc / Global Payments Inc / Provident Financial Services Inc / Monster Beverage Corp / Enerflex Ltd / First Financial Bancorp / ImmunoGen Inc / Selective Insurance Group Inc / Caseys General Stores Inc / Arch Capital Group Ltd / Intercept Pharmaceuticals Inc / F5 Inc / Equinix Inc / Alimentation Couche-Tard Inc / Martinrea International Inc / Altria Group Inc / Domino's Pizza Inc / Digital Realty Trust Inc / Shawcor Ltd / Hartford Financial Services Group Inc / Hershey Co / Royal Dutch Shell PLC / Discovery Inc / Cadence Design Systems Inc / SJW Group / Drax Group PLC / Chipotle Mexican Grill Inc / Fidelity National Information Services Inc / American Equity Investment Life Holding Co / Investors Bancorp Inc / Mastercard Inc / Mueller Water Products Inc / Harley-Davidson Inc / Commvault Systems Inc / eHealth Inc / Aon PLC / B&G Foods Inc / Pembina Pipeline Corp / Hochschild Mining PLC / Getlink SE / Dana Inc / Fresnillo PLC / Reinsurance Group of America Inc / AutoCanada Inc / Spectrum Brands Holdings Inc / LyondellBasell Industries NV / Canfor Pulp Products Inc / Freehold Royalties Ltd / Federated Hermes Inc / Meritor Inc / NGL Energy Partners LP / Parex Resources Inc / Baker Hughes Co / AMC Networks Inc / Polymetal International PLC / Splunk Inc / Phillips 66 / Palo Alto Networks Inc / Fairfax Financial Holdings Ltd / Mondelez International Inc / Abbvie Inc / Perrigo Company PLC / Primo Water Corp / BRP Inc / Coty Inc / Fox Corp / Phillips 66 Partners LP / Agios Pharmaceuticals Inc / ServiceNow Inc / PTC Inc / Q2 Holdings Inc / Agile Therapeutics Inc / Synchrony Financial / Restaurant Brands International Inc / Enviva Inc / PayPal Holdings Inc / Boyd Group Services Inc / Rapid7 Inc / Mimecast Ltd / Ferrari NV / Swiss Re AG / Kinsale Capital Group Inc / Aker BP ASA / Nutanix Inc / Adient PLC / Lions Gate Entertainment Corp / Puma Biotechnology Inc / DXC Technology Co / Altice USA Inc / Brighthouse Financial Inc / Athenex Inc / SailPoint Technologies Holdings Inc / Aptiv PLC / Amneal Pharmaceuticals Inc / Equitable Holdings Inc / Goosehead Insurance Inc / Naturgy Energy Group SA / Keurig Dr Pepper Inc / Aquestive Therapeutics Inc / Elastic NV / Newell Brands Inc / Rattler Midstream LP / CrowdStrike Holdings Inc / Genmab A/S / Cerence Inc / 89Bio Inc / Reynolds Consumer Products Inc / Sibanye Stillwater Ltd / International General Insurance Holdings Ltd / GFL Environmental Inc / Nikola Corp / Shift4 Payments Inc / Lumen Technologies Inc / Metacrine Inc / Sumo Logic Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Ireland / Israel / Netherlands / Norway / Sweden / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Global Research</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">ABT / ACI / ADS / AEE / AEP / AGR / ALC / ALE / ATO / AWK / AWR / AZO / BAX / BDX / BEP / BIG / BIP / BKH / BSX / CCK / CE / CHD / CL / CLR / CLX / CMG / CMS / CNP / COO / CPB / CPE / CPK / CVX / CWT / D / DANO.PA / DCP / DFS / DK / DRI / DTE / DUK / DVN / ED / EIX / EL / EPD / ES / ETR / FE / FND / GIS / GPS / HD / HE / HFC / HSY / IDA / JNJ / K / KDP / KMB / KO / KR / LOW / MDT / MPC / MRO / MSFT.O / NEP / NI / NJR / NKE / OGE / OI / OKE / OLN / PCG / PEG / PEN / PG / PNM / PNW / POR / PPL / PSX / PVH / PXD / RH / RL / ROP / SF / SJI / SJM / SJW / SO / SPB / SR / SRE / ST / STZ / SWX / SYK / SYY / T / TAP.N / TFX / THS / TPR / TRV / UPS / VLO / WEC / WES / WLK / WLL / YUM / AMZN.O / BYND.O / ET / AMGN.O / EW / IRM / OGS / KMI / EPC / NWE / PEB.N / PBF / SIRI.O / IART.O / VZ / NWN / SBUX.O / CHRW.O / BJ.N / ROST.O / EXPE.O / DLTR.O / FTS.TO / ISRG.O / EMA.TO / CAKE.O / NEE / TSCO.O / MNST.O / UMBF.O / MMSI.O / ORLY.O / HAIN.O / SBNY.O / NUVA.O / DXCM.O / H.TO / IBKR.O / PODD.O / TNDM.OQ / MRNA.O / FICO.K / AQN / SCHW.K / LUNG.O / ADSGn.DE / LNG.N / ANGI.O / MTDR.K / ARCT.O / FB.O / TRGP.K / PDCE.O / FIVE.O / GMED.K / MDLZ.O / FANG.O / MPLX.K / SMPL.O / POST.K / COTY.K / SFM.O / MAR.O / GOOGL.O / NVRO.K / GKOS.K / WING.O / ZBH / KHC.O / SPNE.O / OLLI.O / PFGC.K / NVCR.O / OMF / 100088979 / IAC.O / TTD.O / USFD.K / UAA / GOOS.TO / SNAP.K / CDEV.O / CVNA.K / HESM.K / IQV / PEP.O / XEL.O / INSP.K / EVRG.K / NOMD.K / RAMP.K / AXNX.O / NWL.O / LNT.O / CPRI.K / UNFI.K / SWAV.O / LYFT.O / TPTX.O / UBER.K / PINS.K / FTCH.K / CHWY.K / EXC.O / BRBR.K / OAS.O / OMP.O / WTRG.K / BIPC.K / VRM.O / NARI.O / BEPC.K / SFT.O / EAR.O / DASH.N</td><td class="leftalignment">Abbott Laboratories / Albertsons Companies Inc / Alliance Data Systems Corp / Ameren Corp / American Electric Power Company Inc / Avangrid Inc / Alcon AG / ALLETE Inc / Atmos Energy Corp / American Water Works Company Inc / American States Water Co / Autozone Inc / Baxter International Inc / Becton Dickinson and Co / Brookfield Renewable Partners LP / Big Lots Inc / Brookfield Infrastructure Partners LP / Black Hills Corp / Boston Scientific Corp / Crown Holdings Inc / Celanese Corp / Church & Dwight Co Inc / Colgate-Palmolive Co / Continental Resources Inc / Clorox Co / Chipotle Mexican Grill Inc / CMS Energy Corp / CenterPoint Energy Inc / Cooper Companies Inc / Campbell Soup Co / Callon Petroleum Co / Chesapeake Utilities Corp / Chevron Corp / California Water Service Group / Dominion Energy Inc / Danone SA / DCP Midstream LP / Discover Financial Services / Delek US Holdings Inc / Darden Restaurants Inc / DTE Energy Co / Duke Energy Corp / Devon Energy Corp / Consolidated Edison Inc / Edison International / Estee Lauder Companies Inc / Enterprise Products Partners LP / Eversource Energy / Entergy Corp / FirstEnergy Corp / Floor & Decor Holdings Inc / General Mills Inc / Gap Inc / Home Depot Inc / Hawaiian Electric Industries Inc / HollyFrontier Corp / Hershey Co / Idacorp Inc / Johnson & Johnson / Kellogg Co / Keurig Dr Pepper Inc / Kimberly-Clark Corp / Coca-Cola Co / Kroger Co / Lowe's Companies Inc / Medtronic PLC / Marathon Petroleum Corp / Marathon Oil Corp / Microsoft Corp / Nextera Energy Partners LP / NiSource Inc / New Jersey Resources Corp / Nike Inc / OGE Energy Corp / O-I Glass Inc / ONEOK Inc / Olin Corp / PG&E Corp / Public Service Enterprise Group Inc / Penumbra Inc / Procter & Gamble Co / PNM Resources Inc / Pinnacle West Capital Corp / Portland General Electric Co / PPL Corp / Phillips 66 / PVH Corp / Pioneer Natural Resources Co / RH / Ralph Lauren Corp / Roper Technologies Inc / Stifel Financial Corp / South Jersey Industries Inc / J M Smucker Co / SJW Group / Southern Co / Spectrum Brands Holdings Inc / Spire Inc / Sempra Energy / Sensata Technologies Holding PLC / Constellation Brands Inc / Southwest Gas Holdings Inc / Stryker Corp / Sysco Corp / AT&T Inc / Molson Coors Beverage Co / Teleflex Inc / TreeHouse Foods Inc / Tapestry Inc / Travelers Companies Inc / United Parcel Service Inc / Valero Energy Corp / WEC Energy Group Inc / Western Midstream Partners LP / Westlake Chemical Corp / Whiting Petroleum Corp / Yum! Brands Inc / Amazon.com Inc / Beyond Meat Inc / Energy Transfer LP / Amgen Inc / Edwards Lifesciences Corp / Iron Mountain Inc / ONE Gas Inc / Kinder Morgan Inc / Edgewell Personal Care Co / NorthWestern Corp / Pebblebrook Hotel Trust / PBF Energy Inc / Sirius XM Holdings Inc / Integra Lifesciences Holdings Corp / Verizon Communications Inc / Northwest Natural Holding Co / Starbucks Corp / CH Robinson Worldwide Inc / BJ's Wholesale Club Holdings Inc / Ross Stores Inc / Expedia Group Inc / Dollar Tree Inc / Fortis Inc / Intuitive Surgical Inc / Emera Inc / Cheesecake Factory Inc / Nextera Energy Inc / Tractor Supply Co / Monster Beverage Corp / UMB Financial Corp / Merit Medical Systems Inc / O'Reilly Automotive Inc / Hain Celestial Group Inc / Signature Bank / NuVasive Inc / Dexcom Inc / Hydro One Ltd / Interactive Brokers Group Inc / Insulet Corp / Tandem Diabetes Care Inc / Moderna Inc / Fair Isaac Corp / Algonquin Power & Utilities Corp / Charles Schwab Corp / Pulmonx Corp / Adidas AG / Cheniere Energy Inc / Angi Inc / Matador Resources Co / Arcturus Therapeutics Holdings Inc / Meta Platforms Inc / Targa Resources Corp / PDC Energy Inc / Five Below Inc / Globus Medical Inc / Mondelez International Inc / Diamondback Energy Inc / MPLX LP / Simply Good Foods Co / Post Holdings Inc / Coty Inc / Sprouts Farmers Market Inc / Marriott International Inc / Alphabet Inc / Nevro Corp / Glaukos Corp / Wingstop Inc / Zimmer Biomet Holdings Inc / Kraft Heinz Co / SeaSpine Holdings Corp / Ollie's Bargain Outlet Holdings Inc / Performance Food Group Co / Novocure Ltd / OneMain Holdings Inc / Huntington Bancshares Inc / IAC/Interactivecorp / Trade Desk Inc / US Foods Holding Corp / Under Armour Inc / Canada Goose Holdings Inc / Snap Inc / Centennial Resource Development Inc / Carvana Co / Hess Midstream LP / IQVIA Holdings Inc / PepsiCo Inc / Xcel Energy Inc / Inspire Medical Systems Inc / Evergy Inc / Nomad Foods Ltd / Liveramp Holdings Inc / Axonics Inc / Newell Brands Inc / Alliant Energy Corp / Capri Holdings Ltd / United Natural Foods Inc / Shockwave Medical Inc / Lyft Inc / Turning Point Therapeutics Inc / Uber Technologies Inc / Pinterest Inc / Farfetch Ltd / Chewy Inc / Exelon Corp / Bellring Brands Inc / Oasis Petroleum Inc / Oasis Midstream Partners LP / Essential Utilities Inc / Brookfield Infrastructure Corp / Vroom Inc / Inari Medical Inc / Brookfield Renewable Corp / Shift Technologies Inc / Eargo Inc / DoorDash Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Biotech Q4:20 Earnings Preview</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">AMGN.O / EXEL.O / BMRN.O / REGN.O / SGEN.OQ / IMGN.O / AGIO.O / PBYI.OQ / ATNX.O / GMAB.O</td><td class="leftalignment">Amgen Inc / Exelixis Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Seagen Inc / ImmunoGen Inc / Agios Pharmaceuticals Inc / Puma Biotechnology Inc / Athenex Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Edwin Delfin</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: February 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BMY.N / BSX.N / CI.N / EL.N / LLY.N / MRK.N / PFE.N / PM.N / TMO.N / HUM.N / FE.N / CAT.N / HON.N / ITW.N / XOM.N / LIN.N / ARE.N / CVX.N / AMGN.OQ / JKHY.OQ / REGN.OQ / TT.N / QCOM.OQ / AMZN.OQ / TTWO.OQ / CHTR.OQ / GPN.N / VRTX.OQ / ABBV.N / GOOGL.OQ / PYPL.OQ / TMUS.OQ / SPG.NZ / OTIS.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Boston Scientific Corp / Cigna Corp / Estee Lauder Companies Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Philip Morris International Inc / Thermo Fisher Scientific Inc / Humana Inc / FirstEnergy Corp / Caterpillar Inc / Honeywell International Inc / Illinois Tool Works Inc / Exxon Mobil Corp / Linde PLC / Alexandria Real Estate Equities Inc / Chevron Corp / Amgen Inc / Jack Henry & Associates Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Qualcomm Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Charter Communications Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Abbvie Inc / Alphabet Inc / PayPal Holdings Inc / T-Mobile US Inc / Stride Property Ltd / Otis Worldwide Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / New Zealand / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">Sotorasib Data Takeaways for KRAS Opportunity</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">60468T105 / 03116210</td><td class="leftalignment">Mirati Therapeutics Inc / Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Silvan Tuerkcan</td></tr>
<tr class="odd"><td class="leftalignment">01/31/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Biotechnology : 4Q20 Earnings Preview</td><td class="leftalignment">English</td><td class="rightalignment">53</td><td class="leftalignment">ACAD.O / ALKS.O / GILD.O / AMGN.O / INCY.O / BMRN.O / REGN.O / VRTX.O / RARE.O / SGEN.O / BIIB.O / MRNA.O / CLVS.O / SAGE.O / NVCR.O / PBYI.O / BNTX.O</td><td class="leftalignment">ACADIA Pharmaceuticals Inc / Alkermes Plc / Gilead Sciences Inc / Amgen Inc / Incyte Corp / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Seagen Inc / Biogen Inc / Moderna Inc / Clovis Oncology Inc / SAGE Therapeutics Inc / Novocure Ltd / Puma Biotechnology Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United Kingdom / Ireland / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / Mr. Matthew T. Holt, P.Eng / James Scott / Mr. Turner Kufe / Manish Jajoo</td></tr>
<tr class="even"><td class="leftalignment">01/31/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">KRASy for Sotorasib</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AMGN=US</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">01/31/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Adagrasib May Have Superior Activity in STK11mut — New Trials To Settle Debate</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US0311621009 / US60468T1051</td><td class="leftalignment">Amgen Inc / Mirati Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Yaron Werber, M.D., MD / Brendan Smith, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">01/31/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">What's New At WCLC This Year; Takeaways Keep Us Positive on MRK, JNJ and HCM</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">JNJ / MRK / HCM.L / LLY / PFE / AMGN.O / BSLN.S / ARAV.O / IMAB.O</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc / HUTCHMED (China) Ltd / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Basilea Pharmaceutica AG / Aravive Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">01/31/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">2020 WCLC takeaways: KRAS G12C “best-in-class” trophy still very much up in the air</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Kennen MacKay, PHD / Edwin Delfin</td></tr>
<tr class="even"><td class="leftalignment">01/31/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">AMGN: Summary of WCLC and Q&A Summary; Is AMGN edging ahead in the KRAS battle or will Mirati catch up and surpass?</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AMGN.OQ / MRTX.OQ</td><td class="leftalignment">Amgen Inc / Mirati Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">01/31/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology: 4Q20 Biotech Earnings Consensus Cheat Sheet for VRTX, AMGN, BIIB, GILD, NBIX, and REGN</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">LLY.N / PFE.N / AZN.L / NOVN.S / GSK.L / AMGN.OQ / GILD.OQ / INCY.OQ / VRTX.OQ / BIIB.OQ / ABBV.N</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Novartis AG / GlaxoSmithKline PLC / Amgen Inc / Gilead Sciences Inc / Incyte Corp / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">01/30/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">AMGN.O / REGN.O / AGIO.O / GMAB.O</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc / Agios Pharmaceuticals Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Edwin Delfin</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">WCLC: Tidbits from conference call on Ph2 sotorasib in 2L NSCLC</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AMGN=US</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Minh Vong</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">AMGN.OQ - Event Transcript of Amgen Inc conference call, Jan. 29, 2021 / 8:00PM ET</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Exploratory biomarker analyses also supportive for sotorasib</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AMGN=US</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Minh Vong</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 532</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Brittany Woods / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Lachlan Hanbury-Brown / John Boyle / Mr. Rob Andrew, CFA</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">30-sec Biotech Nightcap</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN=US / INCY=US / BIIB=US</td><td class="leftalignment">Amgen Inc / Incyte Corp / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino / Minh Vong</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--Jan. 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">CHE=US / HUM=US / BSX=US / CSII=US / LLY=US / ABT=US / AMGN=US / GBT=US / MDT=US / WMT=US / INCY=US / CMS=US / DGX=US / SYK=US / RMD=US / RAD=US / HCA=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / APLS=US / ATRC=US / CYH=US / EW=US / GEN=US / LH=US / LIFE=US / PHAR=US / PRVL=US / SILK=US / USPH=US / UTHR=US / UHS=US / SGEN=US / SAGE=US / OPT=US / CCRN=US / RHHBY=US / CNC=US / ACA=US / ENSG=US / MD=US / CASI=US / SLF=US / BIIB=US / MRNA=US / MNKD=US / GOOG=US / LHCG=US / SNSS=US / CHNG=US / EHC=US / NMTR=US / SWAV=US / ADUS=US / IRWD=US / ACHC=US / AGIO=US / CTRE=US / AUPH=US / VBLT=US / NVRO=US / WBA=US / CLLS=US / EVH=US / CATB=US / PEN=US / BGNE=US / IRTC=US / ZEAL=US / ZLAB=US / FIXX=US / BHC=US / NBSE=US / PNTG=US</td><td class="leftalignment">Chemed Corp / Humana Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Abbott Laboratories / Amgen Inc / Global Blood Therapeutics Inc / Medtronic PLC / Walmart Inc / Incyte Corp / CMS Energy Corp / Quest Diagnostics Inc / Stryker Corp / Resmed Inc / Rite Aid Corp / HCA Healthcare Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / Apellis Pharmaceuticals Inc / AtriCure Inc / Community Health Systems Inc / Edwards Lifesciences Corp / Genesis Healthcare Inc / Laboratory Corporation of America Holdings / aTyr Pharma Inc / Pharming Group NV / Porvair PLC / Silk Road Medical Inc / US Physical Therapy Inc / United Therapeutics Corp / Universal Health Services Inc / Seagen Inc / SAGE Therapeutics Inc / Opthea Ltd / Cross Country Healthcare Inc / Roche Holding AG / Centene Corp / Arcosa Inc / Ensign Group Inc / MEDNAX Inc / CASI Pharmaceuticals Inc / Sun Life Financial Inc / Biogen Inc / Moderna Inc / MannKind Corp / Alphabet Inc / LHC Group Inc / Viracta Therapeutics Inc / Change Healthcare Inc / Encompass Health Corp / 9 Meters Biopharma Inc / Shockwave Medical Inc / Addus Homecare Corp / Ironwood Pharmaceuticals Inc / Acadia Healthcare Company Inc / Agios Pharmaceuticals Inc / CareTrust REIT Inc / Aurinia Pharmaceuticals Inc / Vascular Biogenics Ltd / Nevro Corp / Walgreens Boots Alliance Inc / Cellectis SA / Evolent Health Inc / Astria Therapeutics Inc / Penumbra Inc / Beigene Ltd / iRhythm Technologies Inc / Zealand Pharma A/S / Zai Lab Ltd / Homology Medicines Inc / Bausch Health Companies Inc / NeuBase Therapeutics Inc / Pennant Group Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Weekly: EpiPen Mkt Growth Strong; Vascepa Gx at High-Single Digit Share</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / GSK=US / ENDP=US / PRGO=US / BIIB=US / AMRX=US / ABBV=US / XERS=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / GlaxoSmithKline PLC / Endo International PLC / Perrigo Company PLC / Biogen Inc / Amneal Pharmaceuticals Inc / Abbvie Inc / Xeris Biopharma Holdings Inc / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Ms. Ami Fadia</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">WCLC Pivotal Data Shows 50% ORR In STK11mut — mDOR Should Get Better</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Yaron Werber, M.D., MD / Brendan Smith, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended January 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / TEVA=US / GILD=US / SAN=FR / NVS=US / GSK=GB / AZN=US / GSK=US / JNJ=US / EXEL=US / ICPT=US / NVO=US / REGN=US / RHHBY=US / INVA=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / Novartis AG / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Exelixis Inc / Intercept Pharmaceuticals Inc / Novo Nordisk A/S / Regeneron Pharmaceuticals Inc / Roche Holding AG / Innoviva Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / David Szeto</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">CACI=US / AMGN=US / HD=US / MCD=US / TWTR=US / AMD=US / AMZN=US / T=US / DT=US / EBAY=US / KMI=US / AMT=US / BC=US / CHTR=US / V=US / VZ=US / LOW=US / CCI=US / XLNX=US / MUR=US / EWBC=US / EXPE=US / LSTR=US / MGM=US / CMCSA=US / W=US / DISH=US / CNX=US / DHI=US / AJG=US / GFF=US / TREE=US / HZO=US / TEAM=US / PHM=US / RHI=US / SBAC=US / SNAP=US / TRIP=US / TRUE=US / VRTX=US / WIX=US / MANT=US / BKNG=US / FMBI=US / ABCB=US / FB=US / MTCH=US / SSB=US / CATY=US / GBCI=US / SBCF=US / PTON=US / CZR=US / CDLX=US / BAH=US / RNST=US / SCPL=US / KBR=US / MA=US / ICFI=US / SAIC=US / KTOS=US / NMTR=US / IAC=US / PSN=US / ANGI=US / ZNGA=US / SSTK=US / TMUS=US / LDOS=US / GOOGL=US / BABA=US / CMPR=US / GDDY=US / ON=US / ETSY=US / LOB=US / ZG=US / NVCR=US / AXSM=US / TTD=US / TRVG=US / YEXT=US / RDFN=US / CARG=US / SFIX=US / ROOT=US / FTDR=US / SVMK=US / EB=US / LYFT=US / UBER=US / FBRX=US / ABNB=US / DASH=US</td><td class="leftalignment">CACI International Inc / Amgen Inc / Home Depot Inc / McDonald's Corp / Twitter Inc / Advanced Micro Devices Inc / Amazon.com Inc / AT&T Inc / Dynatrace Inc / eBay Inc / Kinder Morgan Inc / American Tower Corp / Brunswick Corp / Charter Communications Inc / Visa Inc / Verizon Communications Inc / Lowe's Companies Inc / Crown Castle International Corp / Xilinx Inc / Murphy Oil Corp / East West Bancorp Inc / Expedia Group Inc / Landstar System Inc / MGM Resorts International / Comcast Corp / Wayfair Inc / DISH Network Corp / CNX Resources Corp / D R Horton Inc / Arthur J Gallagher & Co / Griffon Corp / Lendingtree Inc / MarineMax Inc / Atlassian Corporation PLC / Pultegroup Inc / Robert Half International Inc / SBA Communications Corp / Snap Inc / Tripadvisor Inc / TrueCar Inc / Vertex Pharmaceuticals Inc / Wix.Com Ltd / ManTech International Corp / Booking Holdings Inc / First Midwest Bancorp Inc / Ameris Bancorp / Meta Platforms Inc / Match Group Inc / SouthState Corp / Cathay General Bancorp / Glacier Bancorp Inc / Seacoast Banking Corporation of Florida / Peloton Interactive Inc / Caesars Entertainment Inc / Cardlytics Inc / Booz Allen Hamilton Holding Corp / Renasant Corp / Sciplay Corp / KBR Inc / Mastercard Inc / ICF International Inc / Science Applications International Corp / Kratos Defense and Security Solutions Inc / 9 Meters Biopharma Inc / IAC/Interactivecorp / Parsons Corp / Angi Inc / Zynga Inc / Shutterstock Inc / T-Mobile US Inc / Leidos Holdings Inc / Alphabet Inc / Alibaba Group Holding Ltd / Cimpress PLC / GoDaddy Inc / ON Semiconductor Corp / ETSY Inc / Live Oak Bancshares Inc / Zillow Group Inc / Novocure Ltd / Axsome Therapeutics Inc / Trade Desk Inc / Trivago NV / Yext Inc / Redfin Corp / CarGurus Inc / Stitch Fix Inc / Root Inc / Frontdoor Inc / Momentive Global Inc / Eventbrite Inc / Lyft Inc / Uber Technologies Inc / Forte Biosciences Inc / Airbnb Inc / DoorDash Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United Kingdom / Ireland / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">AMGN.OQ / ICAD.OQ / SELB.OQ / NVAX.OQ / ICPT.OQ / RIGL.OQ / ALNY.OQ / DRRX.OQ / FOLD.OQ / INO.OQ / CLDX.OQ / EVGN.TA / IBIO.A / SRPT.OQ / PTCT.OQ / AGTC.OQ / PRQR.OQ / HTGM.OQ / ABEO.OQ / UQ1.F / GBT.OQ / APLS.OQ / PBYI.OQ / MBIO.OQ / GTII.CD / TER.CD / CWEB.TO / PTE.OQ / CURA.CD / TRUL.CD / GOSS.OQ / YCBD.A / OCGN.OQ / PHGE.A / AWH.OQ / FMTX.OQ / KDNY.OQ / SIOX.OQ</td><td class="leftalignment">Amgen Inc / ICAD Inc / Selecta Biosciences Inc / Novavax Inc / Intercept Pharmaceuticals Inc / Rigel Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / DURECT Corp / Amicus Therapeutics Inc / Inovio Pharmaceuticals Inc / Celldex Therapeutics Inc / Evogene Ltd / Ibio Inc / Sarepta Therapeutics Inc / PTC Therapeutics Inc / Applied Genetic Technologies Corp / ProQR Therapeutics NV / HTG Molecular Diagnostics Inc / Abeona Therapeutics Inc / Uniqure NV / Global Blood Therapeutics Inc / Apellis Pharmaceuticals Inc / Puma Biotechnology Inc / Mustang Bio Inc / Green Thumb Industries Inc / Terrascend Corp / Charlotte's Web Holdings Inc / PolarityTE Inc / Curaleaf Holdings Inc / Trulieve Cannabis Corp / Gossamer Bio Inc / cbdMD Inc / Ocugen Inc / Biomx Inc / Aspira Women's Health Inc / Forma Therapeutics Holdings Inc / Chinook Therapeutics Inc / Sio Gene Therapies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Israel / Netherlands / Taiwan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">V / 2023607 / 2002305 / 2003698 / 2050832 / 2026242 / 2542049 / 2670519 / 2645409 / 2684703 / 2048804 / 2440637 / 2138158 / 2900335 / 2980906 / B121557 / 2212922 / B2R3PV1 / B5B1S13 / 2949758 / B3SWPT2 / B7TL820 / B7VD3F2 / B8CKK03 / BBPK0J0 / B95N910 / BDZCRX3 / BFLR866 / BYY8XK8 / BYVY8G0 / BYW36M8 / BZ8VJQ8 / BKTNTR9 / BMH0MR7 / BYTJZL1 / 021513106</td><td class="leftalignment">Visa Inc / Amgen Inc / Abbott Laboratories / ABIOMED Inc / Ameren Corp / American Electric Power Company Inc / Dominion Energy Inc / Exelon Corp / NiSource Inc / Pfizer Inc / Pinnacle West Capital Corp / CenterPoint Energy Inc / Sempra Energy / Tractor Supply Co / Foot Locker Inc / Mastercard Inc / NRG Energy Inc / American Water Works Company Inc / Dollar General Corp / Nexstar Media Group Inc / Ameresco Inc / Meta Platforms Inc / Duke Energy Corp / Mondelez International Inc / Mirati Therapeutics Inc / PTC Inc / RingCentral Inc / Twitter Inc / WEC Energy Group Inc / Alphabet Inc / PayPal Holdings Inc / Vistra Corp / ViacomCBS Inc / Zendesk Inc / Zogenix Inc / Alto Ingredients Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - January 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">BAER.S / BNPP.PA / ENI.MI / EOG.N / FGP.L / MMC.N / PHM.N / TOTF.PA / PXD.N / RCIb.TO / AMGN.O / INCY.O / FER.MC / DHR.N / DOV.N / DT.N / EAT.N / MCD.N / VLO.N / WHR.N / SHW.N / AMP.N / V.N / BC.N / AJG.N / REGN.O / TSCO.O / CFR.N / MEOH.O / BLU.N / PNR.N / RLI.N / FCF.N / HCC.N / NTCT.OQ / ADS.N / SIGI.O / BPOP.O / COLB.O / 02209S103 / 878742204 / TEVA.N / MA.N / GALP.LS / AEO.N / NOG.A / SLM.OQ / WDC.O / FANG.O / ABBV.N / PRGO.N / UKWG.L / WRK.N / UBSG.S / GRPG.I / ORSTED.CO / NTGY.MC / 260557103 / IGMS.O / 120291281</td><td class="leftalignment">Julius Baer Gruppe AG / BNP Paribas SA / Eni SpA / EOG Resources Inc / FirstGroup PLC / Marsh & McLennan Companies Inc / Pultegroup Inc / TotalEnergies SE / Pioneer Natural Resources Co / Rogers Communications Inc / Amgen Inc / Incyte Corp / Ferrovial SA / Danaher Corp / Dover Corp / Dynatrace Inc / Brinker International Inc / McDonald's Corp / Valero Energy Corp / Whirlpool Corp / Sherwin-Williams Co / Ameriprise Financial Inc / Visa Inc / Brunswick Corp / Arthur J Gallagher & Co / Regeneron Pharmaceuticals Inc / Tractor Supply Co / Cullen/Frost Bankers Inc / Methanex Corp / BELLUS Health Inc / Pentair PLC / Rli Corp / First Commonwealth Financial Corp / Warrior Met Coal Inc / Netscout Systems Inc / Alliance Data Systems Corp / Selective Insurance Group Inc / Popular Inc / Columbia Banking System Inc / Altria Group Inc / Teck Resources Ltd / Teva Pharmaceutical Industries Ltd / Mastercard Inc / Galp Energia SGPS SA / American Eagle Outfitters Inc / Northern Oil and Gas Inc / SLM Corp / Western Digital Corp / Diamondback Energy Inc / Abbvie Inc / Perrigo Company PLC / Greencoat UK Wind PLC / Westrock Co / UBS Group AG / Greencoat Renewables PLC / Orsted A/S / Naturgy Energy Group SA / Dow Inc / IGM Biosciences Inc / Cenovus Energy Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / Spain / France / United Kingdom / Ireland / Israel / Italy / Puerto Rico / Portugal / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Global Research</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">AMGN: Sotorasib Presentation Analysis: Durable responses with a clean safety profile continue to support likely approval</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AMGN.OQ / MRTX.OQ</td><td class="leftalignment">Amgen Inc / Mirati Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update- 4Q20 Earnings Preview Edition</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AMGN.OQ / ACRX.OQ / 4523.T / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / GSK.L / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / UTHR.OQ / BMRN.OQ / INSM.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / BAYGN.DE / ABBV.N / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Amgen Inc / AcelRx Pharmaceuticals Inc / Eisai Co Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / United Therapeutics Corp / Biomarin Pharmaceutical Inc / Insmed Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Bayer AG / Abbvie Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / France / United Kingdom / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: January 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">BA.N / BMY.N / BSX.N / CI.N / EL.N / LLY.N / MRK.N / PFE.N / PM.N / TMO.N / HUM.N / DHR.N / CAT.N / MCD.N / HON.N / ITW.N / XOM.N / LIN.N / V.N / ARE.N / CVX.N / AMGN.OQ / REGN.OQ / TT.N / QCOM.OQ / AMZN.OQ / CHTR.OQ / EXPE.OQ / VRTX.OQ / CMCSA.OQ / MDLZ.OQ / ABBV.N / GOOGL.OQ / PYPL.OQ / TMUS.OQ / BKNG.OQ / OTIS.N</td><td class="leftalignment">Boeing Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Cigna Corp / Estee Lauder Companies Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Philip Morris International Inc / Thermo Fisher Scientific Inc / Humana Inc / Danaher Corp / Caterpillar Inc / McDonald's Corp / Honeywell International Inc / Illinois Tool Works Inc / Exxon Mobil Corp / Linde PLC / Visa Inc / Alexandria Real Estate Equities Inc / Chevron Corp / Amgen Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Qualcomm Inc / Amazon.com Inc / Charter Communications Inc / Expedia Group Inc / Vertex Pharmaceuticals Inc / Comcast Corp / Mondelez International Inc / Abbvie Inc / Alphabet Inc / PayPal Holdings Inc / T-Mobile US Inc / Booking Holdings Inc / Otis Worldwide Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Jonathan N. Golub, CFA / Mr. Manish G. Bangard / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Amgen Inc : Pivotal Sotorasib Data Look Solid But Differentiation Questions Remain</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Mr. Turner Kufe / Mr. Matthew T. Holt, P.Eng</td></tr>
<tr class="even"><td class="leftalignment">01/28/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Complete Responses Encouraging but No Real Surprises in Sotorasib Press Release; Data Mirror Phase I, as Guided</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="odd"><td class="leftalignment">01/28/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Sotorasib KRAS G12C continues durability in NSCLC; focus shifting to biomarkers & combos</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Kennen MacKay, PHD / Edwin Delfin</td></tr>
<tr class="even"><td class="leftalignment">01/28/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">30-sec Biotech Nightcap</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AMGN=US / VRTX=US / NMTR=US / FBRX=US</td><td class="leftalignment">Amgen Inc / Vertex Pharmaceuticals Inc / 9 Meters Biopharma Inc / Forte Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino / Minh Vong</td></tr>
<tr class="odd"><td class="leftalignment">01/28/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Pivotal Ph2 data of sotorasib paves the way toward near-term approval</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AMGN.O</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Emily Bodnar / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">01/28/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Three in a Row: Biotech Inflows Continue</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / 039697107 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / 19240Q201</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Ardelyx Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / Cogent Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">01/28/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Sotorasib durable data & favorable safety profile; we think this could be upside to model</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AMGN=US</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Minh Vong</td></tr>
<tr class="even"><td class="leftalignment">01/28/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Sotorasib NSCLC Pivotal Details Mirror Prior Data</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Do G. Kim / Jameson Kao / Ikechukwu Oji</td></tr>
<tr class="odd"><td class="leftalignment">01/28/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">CODEBREAK 100 Data Right Down the Middle of the Fairway</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">031162100</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">01/28/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">AMGN (NEUTRAL) - Sotorasib Registration Data at WCLC Looks Solid; Raises Bar for MRTX's Adagrasib</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2023607 / MRTX.OQ / 2516152 / 2778844 / 7103065 / BBPK0J0</td><td class="leftalignment">Amgen Inc / Mirati Therapeutics Inc / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Mirati Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">01/28/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Ph 2 Data for Sotorasib (KRAS) Mostly in Line w/ Ph 1; ORR Slightly Better</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AMGN=US / MRTX=US</td><td class="leftalignment">Amgen Inc / Mirati Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="even"><td class="leftalignment">01/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">WCLC Ph2 Sotorasib Data Solid With CRs Reported With Encouraging Durability</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Yaron Werber, M.D., MD / Brendan Smith, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">01/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - January 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">GB0004544929 / US09061G1013 / US0028241000 / US0079031078 / US0231351067 / US0311621009 / US0378331005 / US0382221051 / US0530151036 / US0970231058 / US1271903049 / US2254471012 / US28176E1082 / US30161Q1040 / US30226D1063 / US3696041033 / US3755581036 / US4364401012 / US45253H1014 / US45337C1027 / US4824801009 / US5128071082 / US55306N1046 / US5951121038 / US64125C1099 / US6558441084 / US75886F1075 / US8168501018 / US8636671013 / US8793601050 / US8807701029 / US8832031012 / US91307C1027 / US9138371003 / US9182041080 / US92532F1003 / US9581021055 / US9839191015 / NL0000200384 / US5658491064 / US83088M1027 / US09062X1037 / US90385V1070 / US0042251084 / US02043Q1076 / US12541W2098 / US00206R1023 / ACOR.OQ / US42809H1077 / US82706C1080 / US6247581084 / US29089Q1058 / US0043971052 / US03152W1099 / US64110D1046 / US2120151012 / US46333X1081 / US13100M5094 / IE00B58JVZ52 / US88160R1014 / US4361061082 / US56585A1025 / US7185461040 / US30303M1027 / NL0010273215 / US81762P1021 / US8036071004 / US4576693075 / US6951271005 / US74587V1070 / US45845P1084 / US29428V1044 / US69366J2006 / US29664W1053 / US4277461020 / US5034596040 / US90400D1081 / KYG8807B1068 / US78667J1088 / US69888T2078 / US2681582019 / US31572Q8087 / US22822V1017 / US74736K1016 / US09627Y1091 / US37890U1088 / US74624M1027 / US4622221004 / US07725L1026 / KYG4740B1059 / IL0011407140 / US4990491049 / US8760301072 / US76243J1051 / CH0371153492 / SE0009414576 / US05455M1009 / US61775R1059 / US81181C1045</td><td class="leftalignment">Imperial Brands PLC / Biomarin Pharmaceutical Inc / Abbott Laboratories / Advanced Micro Devices Inc / Amazon.com Inc / Amgen Inc / Apple Inc / Applied Materials Inc / Automatic Data Processing Inc / Boeing Co / CACI International Inc / Wolfspeed Inc / Edwards Lifesciences Corp / Exelixis Inc / Extreme Networks Inc / General Electric Co / Gilead Sciences Inc / Hologic Inc / ImmunoGen Inc / Incyte Corp / KLA Corp / Lam Research Corp / MKS Instruments Inc / Micron Technology Inc / Neurocrine Biosciences Inc / Norfolk Southern Corp / Regeneron Pharmaceuticals Inc / Semtech Corp / Stryker Corp / Teledyne Technologies Inc / Teradyne Inc / Textron Inc / United Therapeutics Corp / Universal Stainless & Alloy Products Inc / VF Corp / Vertex Pharmaceuticals Inc / Western Digital Corp / Xilinx Inc / Core Laboratories NV / Marathon Oil Corp / Skyworks Solutions Inc / Biogen Inc / Ultra Clean Holdings Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / CH Robinson Worldwide Inc / AT&T Inc / Acorda Therapeutics Inc / Hess Corp / Silicon Motion Technology Corp / Mueller Water Products Inc / Emergent BioSolutions Inc / Accuray Inc / Amicus Therapeutics Inc / NetApp Inc / Continental Resources Inc / Ironwood Pharmaceuticals Inc / Calix Inc / Seagate Technology Holdings PLC / Tesla Inc / HollyFrontier Corp / Marathon Petroleum Corp / Phillips 66 / Meta Platforms Inc / ASML Holding NV / ServiceNow Inc / Sarepta Therapeutics Inc / Insmed Inc / Pacira Biosciences Inc / Puma Biotechnology Inc / Intercept Pharmaceuticals Inc / Epizyme Inc / PTC Therapeutics Inc / Esperion Therapeutics Inc / Heron Therapeutics Inc / La Jolla Pharmaceutical Co / Ultragenyx Pharmaceutical Inc / Theravance Biopharma Inc / SAGE Therapeutics Inc / Par Pacific Holdings Inc / Dynavax Technologies Corp / FibroGen Inc / Crown Castle International Corp / Qorvo Inc / Blueprint Medicines Corp / Global Blood Therapeutics Inc / Pure Storage Inc / Ionis Pharmaceuticals Inc / Beigene Ltd / Ichor Holdings Ltd / Urogen Pharma Ltd / Knight-Swift Transportation Holdings Inc / Tapestry Inc / Rhythm Pharmaceuticals Inc / Landis+Gyr Group AG / Oncopeptides AB / AVROBIO Inc / Morphic Holding Inc / Seagen Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / Cayman Islands / United Kingdom / Ireland / Israel / Netherlands / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">01/28/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">CACI=US / PEP=US / PFE=US / AMGN=US / BMY=US / KO=US / AMD=US / CL=US / T=US / PEB=US / SLG=US / PLUG=US / H=US / MTN=US / VZ=US / SYK=US / CCI=US / ENR=US / PB=US / SWN=US / XLNX=US / BRO=US / MAR=US / LSTR=US / HLT=US / NWL=US / RCL=US / FLO=US / APH=US / ARW=US / AVT=US / CCL=US / CENT=US / CHH=US / CHD=US / DRH=US / EPC=US / EXAS=US / AJG=US / HAIN=US / NOW=US / MNRO=US / REGN=US / SMG=US / POST=US / R=US / FB=US / FBK=US / MKL=US / DRE=US / SBSI=US / NTRA=US / MGPI=US / MNST=US / JRVR=US / NOMD=US / STRO=US / SHO=US / FRPT=US / THS=US / HST=US / XPO=US / ELF=US / SAIA=US / TEL=US / NMTR=US / WH=US / NXGN=US / WYND=US / ATSG=US / NEO=US / AAN=US / KNSL=US / HGV=US / NXPI=US / RLJ=US / VAC=US / BCEI=US / RHP=US / ABBV=US / NCLH=US / VCYT=US / ARCB=US / LOB=US / WLTW=US / PK=US / PLYA=US / PETQ=US / KDP=US / HARP=US / PLMR=US / PSNL=US / BRBR=US / REYN=US / HYFM=US</td><td class="leftalignment">CACI International Inc / PepsiCo Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Coca-Cola Co / Advanced Micro Devices Inc / Colgate-Palmolive Co / AT&T Inc / Pebblebrook Hotel Trust / SL Green Realty Corp / Plug Power Inc / Hyatt Hotels Corp / Vail Resorts Inc / Verizon Communications Inc / Stryker Corp / Crown Castle International Corp / Energizer Holdings Inc / Prosperity Bancshares Inc / Southwestern Energy Co / Xilinx Inc / Brown & Brown Inc / Marriott International Inc / Landstar System Inc / Hilton Worldwide Holdings Inc / Newell Brands Inc / Royal Caribbean Cruises Ltd / Flowers Foods Inc / Amphenol Corp / Arrow Electronics Inc / Avnet Inc / Carnival Corp / Central Garden & Pet Co / Choice Hotels International Inc / Church & Dwight Co Inc / Diamondrock Hospitality Co / Edgewell Personal Care Co / Exact Sciences Corp / Arthur J Gallagher & Co / Hain Celestial Group Inc / ServiceNow Inc / Monro Inc / Regeneron Pharmaceuticals Inc / Scotts Miracle-Gro Co / Post Holdings Inc / Ryder System Inc / Meta Platforms Inc / FB Financial Corp / Markel Corp / Duke Realty Corp / Southside Bancshares Inc / Natera Inc / MGP Ingredients Inc / Monster Beverage Corp / James River Group Holdings Ltd / Nomad Foods Ltd / Sutro Biopharma Inc / Sunstone Hotel Investors Inc / Freshpet Inc / TreeHouse Foods Inc / Host Hotels & Resorts Inc / XPO Logistics Inc / elf Beauty Inc / Saia Inc / TE Connectivity Ltd / 9 Meters Biopharma Inc / Wyndham Hotels & Resorts Inc / NextGen Healthcare Inc / Travel + Leisure Co / Air Transport Services Group Inc / Neogenomics Inc / Aaron's Company Inc / Kinsale Capital Group Inc / Hilton Grand Vacations Inc / NXP Semiconductors NV / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Civitas Resources Inc / Ryman Hospitality Properties Inc / Abbvie Inc / Norwegian Cruise Line Holdings Ltd / Veracyte Inc / ArcBest Corp / Live Oak Bancshares Inc / Willis Towers Watson PLC / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / PetIQ Inc / Keurig Dr Pepper Inc / Harpoon Therapeutics Inc / Palomar Holdings Inc / Personalis Inc / Bellring Brands Inc / Reynolds Consumer Products Inc / Hydrofarm Holdings Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / Ireland / Liberia / Luxembourg / Netherlands / Panama / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/28/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AXP / 2259101 / 2000019 / 2023607 / 2002305 / 2026242 / 2216850 / 2542049 / 2567116 / 2328915 / 2600088 / 2680905 / 2684703 / 2048804 / 2440637 / 2862532 / 2138158 / 2853688 / 2928683 / B121557 / 2769796 / 2713317 / B2R3PV1 / B614LY3 / B7TL820 / B7VD3F2 / B95N910 / BVVN4Q8 / BYY8XK8 / BNGY4Q0 / BLGJ610 / BFMXGR0 / BYXJQG9 / BHRWS81 / BYQHPK7 / BZ1LFG7</td><td class="leftalignment">American Express Co / Target Corp / Amazon.com Inc / Amgen Inc / Abbott Laboratories / American Electric Power Company Inc / Consolidated Edison Inc / Dominion Energy Inc / Edwards Lifesciences Corp / Nextera Energy Inc / Monro Inc / PPL Corp / Pfizer Inc / Pinnacle West Capital Corp / CenterPoint Energy Inc / E W Scripps Co / Sempra Energy / Stryker Corp / VF Corp / Mastercard Inc / Fidelity National Information Services Inc / ACADIA Pharmaceuticals Inc / American Water Works Company Inc / Cielo SA / Meta Platforms Inc / Duke Energy Corp / PTC Inc / Eversource Energy / WEC Energy Group Inc / Nextera Energy Partners LP / Warner Music Group Corp / Evergy Inc / Spire Inc / Levi Strauss & Co / Zymeworks Inc / Roku Inc</td><td class="leftalignment"></td><td class="leftalignment">Brazil / Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">01/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q4+2021 Preview: Fundamentals Remain Strong, Should Provide Investment Oppy's</td><td class="leftalignment">English</td><td class="rightalignment">226</td><td class="leftalignment">US09061G1013 / US0311621009 / US30161Q1040 / US3755581036 / US45337C1027 / US64125C1099 / US75886F1075 / US91307C1027 / US92532F1003 / US09062X1037 / US0042251084 / US02043Q1076 / ACOR.OQ / US29089Q1058 / US03152W1099 / US46333X1081 / US8036071004 / US4576693075 / US6951271005 / US74587V1070 / US45845P1084 / US29428V1044 / US69366J2006 / US29664W1053 / US4277461020 / US5034596040 / US90400D1081 / KYG8807B1068 / US78667J1088 / US2681582019 / US31572Q8087 / US09627Y1091 / US37890U1088 / US4622221004 / US07725L1026 / IL0011407140 / US76243J1051 / US05455M1009 / US61775R1059 / US81181C1045</td><td class="leftalignment">Biomarin Pharmaceutical Inc / Amgen Inc / Exelixis Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Acorda Therapeutics Inc / Emergent BioSolutions Inc / Amicus Therapeutics Inc / Ironwood Pharmaceuticals Inc / Sarepta Therapeutics Inc / Insmed Inc / Pacira Biosciences Inc / Puma Biotechnology Inc / Intercept Pharmaceuticals Inc / Epizyme Inc / PTC Therapeutics Inc / Esperion Therapeutics Inc / Heron Therapeutics Inc / La Jolla Pharmaceutical Co / Ultragenyx Pharmaceutical Inc / Theravance Biopharma Inc / SAGE Therapeutics Inc / Dynavax Technologies Corp / FibroGen Inc / Blueprint Medicines Corp / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Beigene Ltd / Urogen Pharma Ltd / Rhythm Pharmaceuticals Inc / AVROBIO Inc / Morphic Holding Inc / Seagen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Cayman Islands / Denmark / United Kingdom / Israel / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Biotechnology Team</td></tr>
<tr class="odd"><td class="leftalignment">01/28/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Bases Loaded & HARP Is Up To Bat. Catalyst Rich 2021 Is A Great Set Up - Reiterate BUY</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">HARP=US / AMGN=US / ABBV=US</td><td class="leftalignment">Harpoon Therapeutics Inc / Amgen Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Asthika Goonewardene</td></tr>
<tr class="even"><td class="leftalignment">01/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">AMGN: Amgen, Inc. - Thursday Surprise: Sotorasib World Lung data generally in-line with expectations, but we are encouraged with the 3 CRs; rapid approval likely</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AMGN.OQ / MRTX.OQ</td><td class="leftalignment">Amgen Inc / Mirati Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">01/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: January 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ABT.N / BMY.N / BSX.N / CI.N / LLY.N / MRK.N / PFE.N / PM.N / T.N / TMO.N / HUM.N / DHR.N / CAT.N / MCD.N / HON.N / XOM.N / V.N / ARE.N / CVX.N / AMGN.OQ / AAPL.OQ / QCOM.OQ / GILD.OQ / AMZN.OQ / CHTR.OQ / VRTX.OQ / CMCSA.OQ / TSLA.OQ / EA.OQ / MDLZ.OQ / ABBV.N / GOOGL.OQ / PYPL.OQ / FB.PS / OTIS.N</td><td class="leftalignment">Abbott Laboratories / Bristol-Myers Squibb Co / Boston Scientific Corp / Cigna Corp / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Philip Morris International Inc / AT&T Inc / Thermo Fisher Scientific Inc / Humana Inc / Danaher Corp / Caterpillar Inc / McDonald's Corp / Honeywell International Inc / Exxon Mobil Corp / Visa Inc / Alexandria Real Estate Equities Inc / Chevron Corp / Amgen Inc / Apple Inc / Qualcomm Inc / Gilead Sciences Inc / Amazon.com Inc / Charter Communications Inc / Vertex Pharmaceuticals Inc / Comcast Corp / Tesla Inc / Electronic Arts Inc / Mondelez International Inc / Abbvie Inc / Alphabet Inc / PayPal Holdings Inc / San Miguel Food and Beverage Inc / Otis Worldwide Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">01/27/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">FISV=US / PFE=US / AMGN=US / INTC=US / ADI=US / AMD=US / BXP=US / PLD=US / T=US / DVN=US / INCY=US / TXN=US / TEVA=US / AMT=US / NVDA=US / EOG=US / BC=US / PLUG=US / H=US / VZ=US / WLL=US / CHKP=US / CCI=US / MGY=US / XLNX=US / BRO=US / MRO=US / DISH=US / DHI=US / ENDP=US / HXL=US / HZO=US / PACW=US / PRGO=US / PII=US / REGN=US / SBAC=US / ST=US / BXS=US / NET=US / GPN=US / FMBI=US / SNV=US / LCI=US / MKL=US / RPD=US / BIIB=US / FIS=US / TEL=US / AMRX=US / CLR=US / EHC=US / NOG=US / SWI=US / NXPI=US / PCRX=US / VAC=US / PANW=US / FANG=US / ABBV=US / TMUS=US / PTCT=US / FEYE=US / MBUU=US / VRNS=US / AJRD=US / MCFT=US / EVRI=US / ZS=US / OKTA=US / SAIL=US / BHC=US / TENB=US / PLMR=US / CRWD=US / ONEW=US / VTRS=US / 100073616</td><td class="leftalignment">Fiserv Inc / Pfizer Inc / Amgen Inc / Intel Corp / Analog Devices Inc / Advanced Micro Devices Inc / Boston Properties Inc / Prologis Inc / AT&T Inc / Devon Energy Corp / Incyte Corp / Texas Instruments Inc / Teva Pharmaceutical Industries Ltd / American Tower Corp / NVIDIA Corp / EOG Resources Inc / Brunswick Corp / Plug Power Inc / Hyatt Hotels Corp / Verizon Communications Inc / Whiting Petroleum Corp / Check Point Software Technologies Ltd / Crown Castle International Corp / Magnolia Oil & Gas Corp / Xilinx Inc / Brown & Brown Inc / Marathon Oil Corp / DISH Network Corp / D R Horton Inc / Endo International PLC / Hexcel Corp / MarineMax Inc / PacWest Bancorp / Perrigo Company PLC / Polaris Inc / Regeneron Pharmaceuticals Inc / SBA Communications Corp / Sensata Technologies Holding PLC / Cadence Bank / Cloudflare Inc / Global Payments Inc / First Midwest Bancorp Inc / Synovus Financial Corp / Lannett Company Inc / Markel Corp / Rapid7 Inc / Biogen Inc / Fidelity National Information Services Inc / TE Connectivity Ltd / Amneal Pharmaceuticals Inc / Continental Resources Inc / Encompass Health Corp / Northern Oil and Gas Inc / SolarWinds Corp / NXP Semiconductors NV / Pacira Biosciences Inc / Marriott Vacations Worldwide Corp / Palo Alto Networks Inc / Diamondback Energy Inc / Abbvie Inc / T-Mobile US Inc / PTC Therapeutics Inc / Mandiant Inc / Malibu Boats Inc / Varonis Systems Inc / Aerojet Rocketdyne Holdings Inc / Mastercraft Boat Holdings Inc / Everi Holdings Inc / Zscaler Inc / Okta Inc / SailPoint Technologies Holdings Inc / Bausch Health Companies Inc / Tenable Holdings Inc / Palomar Holdings Inc / CrowdStrike Holdings Inc / OneWater Marine Inc / Viatris Inc / Kimco Realty Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology: Latest Short Interest for US Biotech: Stable for Large Cap Stocks, SMid incrementally higher</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AMGN.OQ / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / ACRX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / AcelRx Pharmaceuticals Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">01/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: January 27, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ABT.N / BSX.N / JNJ.N / LLY.N / PFE.N / T.N / TMO.N / HUM.N / DHR.N / CAT.N / MCD.N / HON.N / XOM.N / VZ.N / V.N / ARE.N / CVX.N / AMGN.OQ / AAPL.OQ / MSFT.OQ / QCOM.OQ / AMZN.OQ / CHTR.OQ / VRTX.OQ / TXN.OQ / CMCSA.OQ / NEE.N / TSLA.OQ / EA.OQ / MDLZ.OQ / ABBV.N / GOOGL.OQ / PYPL.OQ / FB.PS / OTIS.N</td><td class="leftalignment">Abbott Laboratories / Boston Scientific Corp / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AT&T Inc / Thermo Fisher Scientific Inc / Humana Inc / Danaher Corp / Caterpillar Inc / McDonald's Corp / Honeywell International Inc / Exxon Mobil Corp / Verizon Communications Inc / Visa Inc / Alexandria Real Estate Equities Inc / Chevron Corp / Amgen Inc / Apple Inc / Microsoft Corp / Qualcomm Inc / Amazon.com Inc / Charter Communications Inc / Vertex Pharmaceuticals Inc / Texas Instruments Inc / Comcast Corp / Nextera Energy Inc / Tesla Inc / Electronic Arts Inc / Mondelez International Inc / Abbvie Inc / Alphabet Inc / PayPal Holdings Inc / San Miguel Food and Beverage Inc / Otis Worldwide Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">01/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology 4Q20 Preview: More of the same? Large Cap lethargy, SMid-Cap enthusiasm, against the continuing pandemic backdrop</td><td class="leftalignment">English</td><td class="rightalignment">72</td><td class="leftalignment">AMGN.OQ / GILD.OQ / BMY.N / LLY.N / PFE.N / REGN.OQ / RARE.OQ / INCY.OQ / NBIX.OQ / ICPT.OQ / UTHR.OQ / BMRN.OQ / INSM.OQ / ARNA.OQ / ESPR.OQ / VRTX.OQ / BIIB.OQ / CRTX.OQ / GLPG.AS / IRWD.OQ / SRPT.OQ / ABBV.N / PTCT.OQ / RNA.OQ / QURE.OQ / FLXN.OQ / ASND.OQ / ANAB.OQ / APLS.OQ / KURA.OQ / NTLA.OQ / ARGX.OQ / IFRX.OQ / SRRK.OQ / CYCN.OQ / ISEE.OQ / STOK.OQ / INBX.OQ / IMVT.OQ / FMTX.OQ / ALXO.OQ / CVAC.OQ / SPRB.OQ / GLTO.OQ / BCAB.OQ / ABCL.OQ</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Incyte Corp / Neurocrine Biosciences Inc / Intercept Pharmaceuticals Inc / United Therapeutics Corp / Biomarin Pharmaceutical Inc / Insmed Inc / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Cortexyme Inc / Galapagos NV / Ironwood Pharmaceuticals Inc / Sarepta Therapeutics Inc / Abbvie Inc / PTC Therapeutics Inc / Avidity Biosciences Inc / Uniqure NV / Pacira Biosciences Inc / Ascendis Pharma A/S / AnaptysBio Inc / Apellis Pharmaceuticals Inc / Kura Oncology Inc / Intellia Therapeutics Inc / argenx SE / InflaRx NV / Scholar Rock Holding Corp / Cyclerion Therapeutics Inc / Iveric Bio Inc / Stoke Therapeutics Inc / Inhibrx Inc / Immunovant Inc / Forma Therapeutics Holdings Inc / ALX Oncology Holdings Inc / CureVac NV / Spruce Biosciences Inc / Galecto Inc / Bioatla Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Denmark / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Dr. Martin Auster, M.D. / Ms. Judah C. Frommer / Mr. Tiago Fauth / Mark Connolly / Jonathan Woo / Yunhee Park / Mr. Thomas Deal / Matthew Terwelp / Roger Xu</td></tr>
<tr class="even"><td class="leftalignment">01/27/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Breaking the Code Ahead of CODEBREAK 100 at WCLC This Friday</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">031162100</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">01/26/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Amgen Inc Investment Status Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US0311621009</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="even"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">30-sec Biotech Nightcap</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AMGN=US / INCY=US / REGN=US / BIIB=US / PTCT=US</td><td class="leftalignment">Amgen Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Biogen Inc / PTC Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States / South Africa</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino / Minh Vong</td></tr>
<tr class="odd"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Jan 15, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Guggenheim Ther Research</td></tr>
<tr class="even"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">LLY's Antibody Combo Reduces Deaths and Hospitalizations Due To COVID-19</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">LLY / AMGN.O / REGN.O / HGEN.O</td><td class="leftalignment">Eli Lilly and Co / Amgen Inc / Regeneron Pharmaceuticals Inc / Humanigen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung</td></tr>
<tr class="odd"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Read-throughs to our large-cap Biotech coverage from NVS' earnings call</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AMGN=US / INCY=US / REGN=US / BIIB=US / PTCT=US</td><td class="leftalignment">Amgen Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Biogen Inc / PTC Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Minh Vong</td></tr>
<tr class="even"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AIMC=US / RXT=US / IBM=US / FDX=US / AMGN=US / MSFT=US / AMZN=US / INCY=US / SBH=US / CONE=US / SAP=US / TSM=US / UPS=US / NCR=US / DRRX=US / EQIX=US / GGG=US / ACN=US / STX=US / MRNA=US / GOOG=US / DLR=US / 005930-KR=US / DXC=US / 115525734</td><td class="leftalignment">Altra Industrial Motion Corp / Rackspace Technology Inc / International Business Machines Corp / FedEx Corp / Amgen Inc / Microsoft Corp / Amazon.com Inc / Incyte Corp / Sally Beauty Holdings Inc / CyrusOne Inc / SAP SE / Taiwan Semiconductor Manufacturing Co Ltd / United Parcel Service Inc / NCR Corp / DURECT Corp / Equinix Inc / Graco Inc / Accenture PLC / Seagate Technology Holdings PLC / Moderna Inc / Alphabet Inc / Digital Realty Trust Inc / Farfetch Ltd / DXC Technology Co / indie Semiconductor Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / Germany / United Kingdom / Ireland / Taiwan / United States</td><td class="leftalignment">Biotechnology / Financial Services / Household Products / Machinery / Semiconductors / Services / Telecommunications</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">01/26/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Declines in Domestic Cases, Hospitalizations, and Deaths Suggest the Beginning of the End as Threat of New Variant Looms</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Brittany Woods / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Lachlan Hanbury-Brown / John Boyle / Mr. Rob Andrew, CFA</td></tr>
<tr class="even"><td class="leftalignment">01/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Canadian Research at a Glance - January 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">CNR.TO / BB.N / CP.TO / NSC.N / GILD.O / AMGN.O / INCY.O / CSX.N / TV.TO / UNP.N / NBIX.O / VRTX.O / BIIB.O / ALNY.O / 35671D857 / CS.TO / AUY.N / 550372106 / SRPT.O / 505440107 / PTCT.O / CIA.TO / AUPH.O / GLPG.O / GBT.OQ / TFII.TO / NEXA.TO / 900435207</td><td class="leftalignment">Canadian National Railway Co / BlackBerry Ltd / Canadian Pacific Railway Ltd / Norfolk Southern Corp / Gilead Sciences Inc / Amgen Inc / Incyte Corp / CSX Corp / Trevali Mining Corp / Union Pacific Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Freeport-McMoRan Inc / Capstone Mining Corp / Yamana Gold Inc / Lundin Mining Corp / Sarepta Therapeutics Inc / Labrador Iron Ore Royalty Corp / PTC Therapeutics Inc / Champion Iron Ltd / Aurinia Pharmaceuticals Inc / Galapagos NV / Global Blood Therapeutics Inc / TFI International Inc / Nexa Resources SA / Turquoise Hill Resources Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Canada / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Global Research</td></tr>
<tr class="odd"><td class="leftalignment">01/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - January 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">ANA.MC / BB.N / CP.TO / DFDS.CO / F.N / GM.N / KMB.N / NSC.N / SGC.L / GILD.O / AMGN.O / INCY.O / AAPL.O / CNR.TO / CSX.N / TV.TO / UNP.N / NBIX.O / VRTX.O / BRO.N / BIIB.O / 02209S103 / ALNY.O / 35671D857 / CS.TO / AUY.N / 550372106 / NOG.A / SRPT.O / MDLZ.OQ / 505440107 / PTCT.O / PTC.O / CIA.TO / AUPH.O / GLPG.O / GBT.OQ / CADE.N / NEXA.TO / WMG.OQ / 900435207</td><td class="leftalignment">Acciona SA / BlackBerry Ltd / Canadian Pacific Railway Ltd / DFDS AS / Ford Motor Co / General Motors Co / Kimberly-Clark Corp / Norfolk Southern Corp / Stagecoach Group PLC / Gilead Sciences Inc / Amgen Inc / Incyte Corp / Apple Inc / Canadian National Railway Co / CSX Corp / Trevali Mining Corp / Union Pacific Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Brown & Brown Inc / Biogen Inc / Altria Group Inc / Alnylam Pharmaceuticals Inc / Freeport-McMoRan Inc / Capstone Mining Corp / Yamana Gold Inc / Lundin Mining Corp / Northern Oil and Gas Inc / Sarepta Therapeutics Inc / Mondelez International Inc / Labrador Iron Ore Royalty Corp / PTC Therapeutics Inc / PTC Inc / Champion Iron Ltd / Aurinia Pharmaceuticals Inc / Galapagos NV / Global Blood Therapeutics Inc / Cadence Bank / Nexa Resources SA / Warner Music Group Corp / Turquoise Hill Resources Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Canada / Denmark / Spain / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Global Research</td></tr>
<tr class="even"><td class="leftalignment">01/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">ESG Stratify™: Leading The Way On Innovation And Sustainability – Our Biotech ESG Scorecard</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">GILD.O / AMGN.O / INCY.O / NBIX.O / VRTX.O / BIIB.O / ALNY.O / SRPT.O / PTCT.O / GLPG.O / GBT.OQ</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Sarepta Therapeutics Inc / PTC Therapeutics Inc / Galapagos NV / Global Blood Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Lisa Walter / James Hong / Sara Mahaffy / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Leonid Timashev / David Szeto / Yinglu Zhang / Edwin Delfin</td></tr>
<tr class="odd"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Key Considerations Ahead of 4Q Results</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AMGN=US</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for AMGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">Wolfe Pharma & Biotech* 4Q20 EPS Preview - Model Changes and Updated Perspectives</td><td class="leftalignment">English</td><td class="rightalignment">89</td><td class="leftalignment">031162100 / 09062X103 / 5671735 / 0989529 / 0925288 / 7103065 / 7110388 / 717081103 / 375558103 / 110122108 / 532457108 / 75886F107 / 58933Y105 / 00287Y109</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">LSI=US / PEP=US / AMGN=US / CAG=US / KO=US / MCD=US / OXY=US / RRC=US / CL=US / PG=US / WEN=US / BXP=US / AVB=US / AMZN=US / T=US / DVN=US / EBAY=US / INCY=US / AMT=US / APA=US / CPE=US / EOG=US / SLG=US / REI=US / PLUG=US / CHTR=US / CRM=US / VZ=US / XOM=US / CRK=US / WLL=US / PXD=US / CCI=US / ENR=US / MGY=US / SWN=US / SCOR=US / MUR=US / UMPQ=US / MRO=US / ESS=US / CLI=US / MANH=US / AKR=US / TOL=US / NWL=US / CMCSA=US / EQR=US / FLO=US / MAC=US / STZ=US / CBRL=US / CENT=US / CHD=US / CNX=US / DHI=US / DRI=US / EPC=US / EQT=US / HAIN=US / SAFE=US / KBH=US / LEN=US / DOC=US / NTST=US / PDM=US / PHM=US / REGI=US / SBAC=US / SGMO=US / SMG=US / SHOP=US / WAL=US / WIX=US / CVX=US / POST=US / PSA=US / SPG=US / HIW=US / SIVB=US / ADC=US / BDN=US / CPT=US / OFC=US / CUZ=US / PRI=US / EPR=US / FRT=US / KIM=US / MAA=US / NHI=US / OHI=US / UDR=US / VNO=US / WRE=US / COP=US / BRX=US / DIN=US / MGNI=US / MGPI=US / MNST=US / NOMD=US / BIIB=US / EXR=US / TXRH=US / PLAY=US / FRPT=US / DENN=US / THS=US / MPW=US / CMG=US / REX=US / GPRE=US / ELF=US / TAST=US / CLR=US / NMTR=US / NOG=US / JACK=US / AAN=US / HTA=US / AR=US / SBRA=US / APTS=US / ESTE=US / CUBE=US / BCEI=US / MTDR=US / MEIP=US / PDCE=US / FANG=US / NDLS=US / GOOGL=US / VNOM=US / LOCO=US / CMPR=US / SHAK=US / DEA=US / NXRT=US / CHCT=US / WING=US / ZG=US / CDEV=US / PVAC=US / SBOW=US / RDFN=US / PETQ=US / COLD=US / SMAR=US / KDP=US / OZK=US / SITC=US / RTLR=US / BRBR=US / OVV=US / OPCH=US / REYN=US / FBRX=US / BIGC=US / AIRC=US / HYFM=US / 100087548</td><td class="leftalignment">Life Storage Inc / PepsiCo Inc / Amgen Inc / Conagra Brands Inc / Coca-Cola Co / McDonald's Corp / Occidental Petroleum Corp / Range Resources Corp / Colgate-Palmolive Co / Procter & Gamble Co / Wendys Co / Boston Properties Inc / Avalonbay Communities Inc / Amazon.com Inc / AT&T Inc / Devon Energy Corp / eBay Inc / Incyte Corp / American Tower Corp / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / SL Green Realty Corp / Ring Energy Inc / Plug Power Inc / Charter Communications Inc / Salesforce.Com Inc / Verizon Communications Inc / Exxon Mobil Corp / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Crown Castle International Corp / Energizer Holdings Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Comscore Inc / Murphy Oil Corp / Umpqua Holdings Corp / Marathon Oil Corp / Essex Property Trust Inc / Veris Residential Inc / Manhattan Associates Inc / Acadia Realty Trust / Toll Brothers Inc / Newell Brands Inc / Comcast Corp / Equity Residential / Flowers Foods Inc / Macerich Co / Constellation Brands Inc / Cracker Barrel Old Country Store Inc / Central Garden & Pet Co / Church & Dwight Co Inc / CNX Resources Corp / D R Horton Inc / Darden Restaurants Inc / Edgewell Personal Care Co / EQT Corp / Hain Celestial Group Inc / Safehold Inc / KB Home / Lennar Corp / Physicians Realty Trust / Netstreit Corp / Piedmont Office Realty Trust Inc / Pultegroup Inc / Renewable Energy Group Inc / SBA Communications Corp / Sangamo Therapeutics Inc / Scotts Miracle-Gro Co / Shopify Inc / Western Alliance Bancorp / Wix.Com Ltd / Chevron Corp / Post Holdings Inc / Public Storage / Simon Property Group Inc / Highwoods Properties Inc / SVB Financial Group / Agree Realty Corp / Brandywine Realty Trust / Camden Property Trust / Corporate Office Properties Trust / Cousins Properties Inc / Primerica Inc / EPR Properties / Federal Realty Investment Trust / Kimco Realty Corp / Mid-America Apartment Communities Inc / National Health Investors Inc / Omega Healthcare Investors Inc / UDR Inc / Vornado Realty Trust / Washington Real Estate Investment Trust / Conocophillips / Brixmor Property Group Inc / Dine Brands Global Inc / Magnite Inc / MGP Ingredients Inc / Monster Beverage Corp / Nomad Foods Ltd / Biogen Inc / Extra Space Storage Inc / Texas Roadhouse Inc / Dave & Buster's Entertainment Inc / Freshpet Inc / Denny's Corp / TreeHouse Foods Inc / Medical Properties Trust Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Green Plains Inc / elf Beauty Inc / Carrols Restaurant Group Inc / Continental Resources Inc / 9 Meters Biopharma Inc / Northern Oil and Gas Inc / Jack in the Box Inc / Aaron's Company Inc / Healthcare Trust Of America Inc / Antero Resources Corp / Sabra Health Care REIT Inc / Preferred Apartment Communities Inc / Earthstone Energy Inc / CubeSmart / Civitas Resources Inc / Matador Resources Co / MEI Pharma Inc / PDC Energy Inc / Diamondback Energy Inc / Noodles & Co / Alphabet Inc / Viper Energy Partners LP / El Pollo Loco Holdings Inc / Cimpress PLC / Shake Shack Inc / Easterly Government Properties Inc / NexPoint Residential Trust Inc / Community Healthcare Trust Inc / Wingstop Inc / Zillow Group Inc / Centennial Resource Development Inc / Ranger Oil Corp / SilverBow Resources Inc / Redfin Corp / PetIQ Inc / Americold Realty Trust / Smartsheet Inc / Keurig Dr Pepper Inc / Bank Ozk / Site Centers Corp / Rattler Midstream LP / Bellring Brands Inc / Ovintiv Inc / Option Care Health Inc / Reynolds Consumer Products Inc / Forte Biosciences Inc / Bigcommerce Holdings Inc / Apartment Income REIT Corp / Hydrofarm Holdings Group Inc / APA Corp (US)</td><td class="leftalignment"></td><td class="leftalignment">Canada / Ireland / Israel / Luxembourg / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Amgen Inc.(AMGN) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">031162100</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">01/25/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fourth Quarter 2020 Biotechnology Earnings Preview: Grace Notes to a Historic Year</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 45337C102 / 09060J106 / 803607100 / 26979610 / 268158201 / 76133010 / 462222100 / 19459J104 / G11196105 / 69366J200 / 37890U108 / 48576A100 / 04683R106</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Incyte Corp / BioDelivery Sciences International Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Dynavax Technologies Corp / Revance Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Biohaven Pharmaceutical Holding Company Ltd / PTC Therapeutics Inc / Global Blood Therapeutics Inc / Karuna Therapeutics Inc / Atea Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Brittany Woods / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">PharmaValues 2021 Strategic Conclusions. Summary slides</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / BMY.N / CSL.AX / JNJ.N / LLY.N / MRK.N / PFE.N / RECI.MI / AZN.L / 4506.T / 4536.T / SASY.PA / ROG.S / LUN.CO / 4151.T / NOVOB.CO / NOVN.S / MRCG.DE / GSK.L / UCB.BR / AMGN.OQ / REGN.OQ / ALKS.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / BMRN.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / 4568.T / IPN.PA / HIK.L / TEVA.N / ORNBV.HE / ALM.MC / GRLS.MC / BAYGN.DE / 4578.T / 4581.T / SRPT.OQ / ABBV.N / QURE.OQ / BGNE.OQ / VIFN.S / 6160.HK / GMAB.CO</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / CSL Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Kyowa Kirin Co Ltd / Novo Nordisk A/S / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Ucb SA / Amgen Inc / Regeneron Pharmaceuticals Inc / Alkermes Plc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Daiichi Sankyo Co Ltd / Ipsen SA / Hikma Pharmaceuticals PLC / Teva Pharmaceutical Industries Ltd / Orion Oyj / Almirall SA / Grifols SA / Bayer AG / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / Sarepta Therapeutics Inc / Abbvie Inc / Uniqure NV / Beigene Ltd / Vifor Pharma AG / Beigene Ltd / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / China / Cayman Islands / Germany / Denmark / Spain / Finland / France / United Kingdom / Ireland / Israel / Italy / Japan / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Ms Jo Walton / Mr Matthew J. Weston / Mr. Trung Huynh / Elizabeth Walton / Mr. Dominic Lunn</td></tr>
<tr class="odd"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology: Framing expectations into the next leg of the KRAS Race: Sotorasib phase 2 data at World Lung</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AMGN.OQ / MRTX.OQ</td><td class="leftalignment">Amgen Inc / Mirati Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">01/24/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Key products increased by 5.9%; Enbrel and Otezla +7.4%</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AMGN=US</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Minh Vong</td></tr>
<tr class="odd"><td class="leftalignment">01/23/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AMGN.O / EXEL.O / REGN.O</td><td class="leftalignment">Amgen Inc / Exelixis Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Edwin Delfin</td></tr>
<tr class="even"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">HCM.L / JNJ.N / LLY.N / MRK.N / PFE.N / AMGN.OQ / REGN.OQ / GILD.OQ / INCY.OQ / VRTX.OQ / BIIB.OQ / ACB.TO / IBIO.A / ZTS.N / WEED.TO / TLRY.OQ / OGI.TO / XGN.OQ / IMAB.OQ</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Vertex Pharmaceuticals Inc / Biogen Inc / Aurora Cannabis Inc / Ibio Inc / Zoetis Inc / Canopy Growth Corp / Tilray Brands Inc / OrganiGram Holdings Inc / Exagen Inc / I-Mab</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Discontinuing Coverage</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US0311621009 / US85205L1070</td><td class="leftalignment">Amgen Inc / SpringWorks Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Yaron Werber, M.D., MD / Brendan Smith, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">01/22/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Weekly: COVID Vaccine Rollout Driving Recent Growth in the EpiPen Market?</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / GSK=US / ENDP=US / PRGO=US / BIIB=US / AMRX=US / ABBV=US / XERS=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / GlaxoSmithKline PLC / Endo International PLC / Perrigo Company PLC / Biogen Inc / Amneal Pharmaceuticals Inc / Abbvie Inc / Xeris Biopharma Holdings Inc / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Ms. Ami Fadia</td></tr>
<tr class="odd"><td class="leftalignment">01/22/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">The Weekender</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">45337C10 / 03116210 / 09058V10 / 00422510 / IDRA / 84763A108 / 29251M106 / M25722105 / 89620X506 / 98978L204 / 60468T105 / 45845P108 / 09627Y109 / 690469101 / 29604W108 / 462260100 / 558868105 / 12648L601 / 89532E109 / 603380106 / 019770106 / 67576A100 / 483347100 / 299734103 / 90041T108 / 50127T109 / 04016X101 / 87184Q107 / 185063104 / 869367102 / 65343E108 / 22978P106 / 02155H200 / 24344T101 / 48576A100 / 75943R102 / 03843E104 / 43906K100 / 81181C104 / G637AM102 / 007002108 / N71542109 / 206022105 / 72942A107 / 92790C104</td><td class="leftalignment">Incyte Corp / Amgen Inc / BioCryst Pharmaceuticals Inc / ACADIA Pharmaceuticals Inc / Idera Pharmaceuticals Inc / Spectrum Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Compugen Ltd / Pfizer Inc / Zogenix Inc / Mirati Therapeutics Inc / Intercept Pharmaceuticals Inc / Blueprint Medicines Corp / Ovid Therapeutics Inc / Erytech Pharma SA / Iovance Biotherapeutics Inc / Madrigal Pharmaceuticals Inc / CTI Biopharma Corp / Trevena Inc / Minerva Neurosciences Inc / Allogene Therapeutics Inc / Ocular Therapeutix Inc / Kaleido Biosciences Inc / Evelo Biosciences Inc / Turning Point Therapeutics Inc / Kura Oncology Inc / argenx SE / Syros Pharmaceuticals Inc / Clearside Biomedical Inc / Sutro Biopharma Inc / NextCure Inc / Cue Biopharma Inc / Altimmune Inc / Deciphera Pharmaceuticals Inc / Karuna Therapeutics Inc / Relay Therapeutics Inc / Aquestive Therapeutics Inc / HOOKIPA Pharma Inc / Seagen Inc / Myovant Sciences Ltd / Adicet Bio Inc / ProQR Therapeutics NV / Concert Pharmaceuticals Inc / PLx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / France / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Reni J. J. Benjamin, PhD, PHD / Mr. Jason N. N. Butler, PhD, PHD / Mr. Silvan Tuerkcan / Mr. Jonathan P. Wolleben / Mr. Gobind Singh, MD, PhD / Mr. Roy Buchanan, PhD, PHD</td></tr>
<tr class="even"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--January 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">DMTK=US / VERU=US / BSX=US / LLY=US / PFE=US / ABT=US / AMGN=US / GBT=US / MDT=US / DYN=US / WMT=US / CMS=US / GILD=US / DGX=US / NVS=US / GSK=US / CRY=US / RAD=US / JNJ=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / ATRC=US / CSTL=US / CHE=US / CYH=US / EW=US / EXAS=US / GEN=US / ISRG=US / PHG=US / LH=US / REGN=US / USPH=US / UTHR=US / UHS=US / VRTX=US / OPT=US / CCRN=US / CNC=US / ACA=US / STSA=US / NTRA=US / ENSG=US / MIST=US / MD=US / NKTR=US / SLF=US / IGMS=US / AMTI=US / MRNA=US / CRTX=US / MNKD=US / GOOG=US / LHCG=US / CHNG=US / TPTX=US / IVA=US / EHC=US / NEO=US / ADUS=US / BEAM=US / ACHC=US / SRPT=US / AGIO=US / FATE=US / VCYT=US / CTRE=US / WBA=US / NVTA=US / VKTX=US / EVH=US / VRAY=US / MDGL=US / IRTC=US / NCNA=US / GH=US / ARVN=US / ALLO=US / ANCN=US / MITO=US / INMB=US / DTIL=US / BCDA=US / APLT=US / IDYA=US / BCYC=US / BCEL=US / KRTX=US / FREQ=US / ETNB=US / CABA=US / CNTG=US / GRTX=US / PNTG=US / PASG=US / ORIC=US / AYLA=US / LTRN=US / FMTX=US / PCVX=US / INBX=US / TSHA=US</td><td class="leftalignment">DermTech Inc / Veru Inc / Boston Scientific Corp / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Amgen Inc / Global Blood Therapeutics Inc / Medtronic PLC / Dyne Therapeutics Inc / Walmart Inc / CMS Energy Corp / Gilead Sciences Inc / Quest Diagnostics Inc / Novartis AG / GlaxoSmithKline PLC / CryoLife Inc / Rite Aid Corp / Johnson & Johnson / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / AtriCure Inc / Castle Biosciences Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / Exact Sciences Corp / Genesis Healthcare Inc / Intuitive Surgical Inc / Koninklijke Philips NV / Laboratory Corporation of America Holdings / Regeneron Pharmaceuticals Inc / US Physical Therapy Inc / United Therapeutics Corp / Universal Health Services Inc / Vertex Pharmaceuticals Inc / Opthea Ltd / Cross Country Healthcare Inc / Centene Corp / Arcosa Inc / Satsuma Pharmaceuticals Inc / Natera Inc / Ensign Group Inc / Milestone Pharmaceuticals Inc / MEDNAX Inc / Nektar Therapeutics / Sun Life Financial Inc / IGM Biosciences Inc / Applied Molecular Transport Inc. / Moderna Inc / Cortexyme Inc / MannKind Corp / Alphabet Inc / LHC Group Inc / Change Healthcare Inc / Turning Point Therapeutics Inc / Inventiva SA / Encompass Health Corp / Neogenomics Inc / Addus Homecare Corp / Beam Therapeutics Inc / Acadia Healthcare Company Inc / Sarepta Therapeutics Inc / Agios Pharmaceuticals Inc / Fate Therapeutics Inc / Veracyte Inc / CareTrust REIT Inc / Walgreens Boots Alliance Inc / Invitae Corp / Viking Therapeutics Inc / Evolent Health Inc / ViewRay Inc / Madrigal Pharmaceuticals Inc / iRhythm Technologies Inc / NuCana PLC / Guardant Health Inc / Arvinas Inc / Allogene Therapeutics Inc / Chemomab Therapeutics Ltd / Stealth BioTherapeutics Corp / INmune Bio Inc / Precision BioSciences Inc / BioCardia Inc / Applied Therapeutics Inc / IDEAYA Biosciences Inc / Bicycle Therapeutics PLC / Atreca Inc / Karuna Therapeutics Inc / Frequency Therapeutics Inc / 89Bio Inc / Cabaletta Bio Inc / Centogene NV / Galera Therapeutics Inc / Pennant Group Inc / Passage Bio Inc / Oric Pharmaceuticals Inc / Ayala Pharmaceuticals Inc / Lantern Pharma Inc. / Forma Therapeutics Holdings Inc / Vaxcyte Inc / Inhibrx Inc / Taysha Gene Therapies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="odd"><td class="leftalignment">01/22/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 531</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Brittany Woods / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Lachlan Hanbury-Brown / John Boyle / Mr. Rob Andrew, CFA</td></tr>
<tr class="even"><td class="leftalignment">01/22/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended January 15, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">01/22/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">01/22/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="odd"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">4Q Large Cap Preview:  We are paying most attention to BIIB and GILD outlooks around 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BIIB.O / GILD.O / AMGN.O / INCY.O / REGN.O / VRTX.O</td><td class="leftalignment">Biogen Inc / Gilead Sciences Inc / Amgen Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Emily Bodnar / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Will Amgen Inc Deliver Long-Term Returns?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AMGN.OQ</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="odd"><td class="leftalignment">01/21/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">I'm Hooked On a Feeling... Biotech Inflows Continue</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / 039697107 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / 19240Q201</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Ardelyx Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / Cogent Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">01/21/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Takeaways from Targeted Oncology Pulse Call #7:  Colorectal Cancer</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AMGN=US / MRTX=US / BGNE=US / KNTE=US</td><td class="leftalignment">Amgen Inc / Mirati Therapeutics Inc / Beigene Ltd / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Dr. Andrew S. Berens, MD</td></tr>
<tr class="odd"><td class="leftalignment">01/20/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">All the Vectors: New Cases Showing Signs of Slowing as U.S. Mortality Tops 400,000 and Vaccination Rollout Continues</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 05464T104 / 55234L105 / 74019P108 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Brittany Woods / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Lachlan Hanbury-Brown / John Boyle / Mr. Rob Andrew, CFA</td></tr>
<tr class="even"><td class="leftalignment">01/20/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AMGN=US / HD=US / MCD=US / WEN=US / PD=US / AMZN=US / DT=US / BLD=US / CMA=US / PEB=US / H=US / CRM=US / MTN=US / LOW=US / MAR=US / LEG=US / KFRC=US / HLT=US / AMN=US / CBRL=US / CHH=US / DRI=US / DRH=US / EXPO=US / GFF=US / IBP=US / NOW=US / MAN=US / MAS=US / MHK=US / TEAM=US / REGN=US / SNOW=US / ZION=US / NFLX=US / APPN=US / UCBI=US / DIN=US / PNFP=US / TPX=US / EXP=US / BDC=US / BECN=US / SHO=US / PLAY=US / DENN=US / BLDR=US / GMS=US / CMG=US / HST=US / PGTI=US / GPRE=US / AWI=US / OC=US / TAST=US / QSR=US / PRPL=US / WH=US / WYND=US / JACK=US / TREX=US / HGV=US / RLJ=US / VAC=US / FBHS=US / SPLK=US / RHP=US / TILE=US / NDLS=US / GOOGL=US / LOCO=US / NEWR=US / SHAK=US / WING=US / ZG=US / 82982L103 / PK=US / JELD=US / PLYA=US / AYX=US / RDFN=US / ESTC=US / FERGY=US / DDOG=US / AZEK=US</td><td class="leftalignment">Amgen Inc / Home Depot Inc / McDonald's Corp / Wendys Co / PagerDuty Inc / Amazon.com Inc / Dynatrace Inc / TopBuild Corp / Comerica Inc / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Salesforce.Com Inc / Vail Resorts Inc / Lowe's Companies Inc / Marriott International Inc / Leggett & Platt Inc / Kforce Inc / Hilton Worldwide Holdings Inc / AMN Healthcare Services Inc / Cracker Barrel Old Country Store Inc / Choice Hotels International Inc / Darden Restaurants Inc / Diamondrock Hospitality Co / Exponent Inc / Griffon Corp / Installed Building Products Inc / ServiceNow Inc / ManpowerGroup Inc / Masco Corp / Mohawk Industries Inc / Atlassian Corporation PLC / Regeneron Pharmaceuticals Inc / Snowflake Inc. / Zions Bancorporation NA / Netflix Inc / Appian Corp / United Community Banks Inc / Dine Brands Global Inc / Pinnacle Financial Partners Inc / Tempur Sealy International Inc / Eagle Materials Inc / Belden Inc / Beacon Roofing Supply Inc / Sunstone Hotel Investors Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / Host Hotels & Resorts Inc / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Wyndham Hotels & Resorts Inc / Travel + Leisure Co / Jack in the Box Inc / Trex Company Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Fortune Brands Home & Security Inc / Splunk Inc / Ryman Hospitality Properties Inc / Interface Inc / Noodles & Co / Alphabet Inc / El Pollo Loco Holdings Inc / New Relic Inc / Shake Shack Inc / Wingstop Inc / Zillow Group Inc / SiteOne Landscape Supply Inc / Park Hotels & Resorts Inc / JELD-WEN Holding Inc / Playa Hotels & Resorts NV / Alteryx Inc / Redfin Corp / Elastic NV / Ferguson PLC / Datadog Inc / Azek Company Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / United Kingdom / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Global Pharmaceuticals: PharmaValues 2021 strategic conclusions</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / BMY.N / CSL.AX / JNJ.N / LLY.N / MRK.N / PFE.N / RECI.MI / AZN.L / 4506.T / 4536.T / SASY.PA / ROG.S / LUN.CO / 4151.T / NOVOB.CO / NOVN.S / MRCG.DE / GSK.L / UCB.BR / AMGN.OQ / REGN.OQ / ALKS.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / BMRN.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / 4568.T / IPN.PA / HIK.L / TEVA.N / ORNBV.HE / ALM.MC / GRLS.MC / BAYGN.DE / 4578.T / 4581.T / SRPT.OQ / ABBV.N / QURE.OQ / BGNE.OQ / VIFN.S / 6160.HK / GMAB.CO</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / CSL Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Kyowa Kirin Co Ltd / Novo Nordisk A/S / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Ucb SA / Amgen Inc / Regeneron Pharmaceuticals Inc / Alkermes Plc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Daiichi Sankyo Co Ltd / Ipsen SA / Hikma Pharmaceuticals PLC / Teva Pharmaceutical Industries Ltd / Orion Oyj / Almirall SA / Grifols SA / Bayer AG / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / Sarepta Therapeutics Inc / Abbvie Inc / Uniqure NV / Beigene Ltd / Vifor Pharma AG / Beigene Ltd / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / Cayman Islands / Germany / Denmark / Spain / Finland / France / United Kingdom / Ireland / Israel / Italy / Japan / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Ms. Gretel Janu / Mr. Dominic Lunn / Mr. Matt S. Miksic / Mr. Fumiyoshi Sakai / Mr. Evan D. Seigerman / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Jan 8, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Guggenheim Ther Research</td></tr>
<tr class="odd"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BAC / CCO / CMA / CNI / CP / CPB / DANO.PA / EOG / ETM / FMC / GIS / HSY / IPG / K / MRO / NSC / OMC / SHW / SJM / SM / TFX / THS / UNP / BYND.O / GILD.O / AMGN.O / AAPL.O / INTU.O / SGMO.O / ARNA.O / ARGX.O / AXS / REGN.O / CALA.O / FAST.O / BLUE.O / ICPT.O / HAIN.O / BIIB.O / INFI.O / HALO.O / NOG.A / MRNA.O / ARCT.O / MDLZ.O / FANG.O / SMPL.O / POST.K / FATE.O / AFMD.O / BLCM.O / KHC.O / CYAD.O / OMF / CSX.O / IONS.O / CRSP.O / JNCE.O / CLLS.O / ZYME.K / NOMD.K / KZR.O / STRO.O / IHRT.O / IMV.O / BRBR.K / RAPT.O</td><td class="leftalignment">Bank of America Corp / Clear Channel Outdoor Holdings Inc / Comerica Inc / Canadian National Railway Co / Canadian Pacific Railway Ltd / Campbell Soup Co / Danone SA / EOG Resources Inc / Audacy Inc / FMC Corp / General Mills Inc / Hershey Co / Interpublic Group of Companies Inc / Kellogg Co / Marathon Oil Corp / Norfolk Southern Corp / Omnicom Group Inc / Sherwin-Williams Co / J M Smucker Co / SM Energy Co / Teleflex Inc / TreeHouse Foods Inc / Union Pacific Corp / Beyond Meat Inc / Gilead Sciences Inc / Amgen Inc / Apple Inc / Intuit Inc / Sangamo Therapeutics Inc / Arena Pharmaceuticals Inc / argenx SE / AXIS Capital Holdings Ltd / Regeneron Pharmaceuticals Inc / Calithera Biosciences Inc / Fastenal Co / bluebird bio Inc / Intercept Pharmaceuticals Inc / Hain Celestial Group Inc / Biogen Inc / Infinity Pharmaceuticals Inc / Halozyme Therapeutics Inc / Northern Oil and Gas Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Mondelez International Inc / Diamondback Energy Inc / Simply Good Foods Co / Post Holdings Inc / Fate Therapeutics Inc / Affimed NV / Bellicum Pharmaceuticals Inc / Kraft Heinz Co / Celyad Oncology SA / OneMain Holdings Inc / CSX Corp / Ionis Pharmaceuticals Inc / CRISPR Therapeutics AG / Jounce Therapeutics Inc / Cellectis SA / Zymeworks Inc / Nomad Foods Ltd / Kezar Life Sciences Inc / Sutro Biopharma Inc / iHeartMedia Inc / IMV Inc / Bellring Brands Inc / Rapt Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / France / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Wells Express: Morning Research Highlights - January 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">CCO / ETM / IPG / OMC / SHW / TFX / GILD.O / AMGN.O / INTU.O / SGMO.O / ARNA.O / ARGX.O / REGN.O / CALA.O / FAST.O / BLUE.O / ICPT.O / BIIB.O / INFI.O / HALO.O / MRNA.O / ARCT.O / FATE.O / AFMD.O / BLCM.O / CYAD.O / IONS.O / CRSP.O / JNCE.O / CLLS.O / ZYME.K / KZR.O / STRO.O / IHRT.O / IMV.O / RAPT.O</td><td class="leftalignment">Clear Channel Outdoor Holdings Inc / Audacy Inc / Interpublic Group of Companies Inc / Omnicom Group Inc / Sherwin-Williams Co / Teleflex Inc / Gilead Sciences Inc / Amgen Inc / Intuit Inc / Sangamo Therapeutics Inc / Arena Pharmaceuticals Inc / argenx SE / Regeneron Pharmaceuticals Inc / Calithera Biosciences Inc / Fastenal Co / bluebird bio Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Infinity Pharmaceuticals Inc / Halozyme Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Fate Therapeutics Inc / Affimed NV / Bellicum Pharmaceuticals Inc / Celyad Oncology SA / Ionis Pharmaceuticals Inc / CRISPR Therapeutics AG / Jounce Therapeutics Inc / Cellectis SA / Zymeworks Inc / Kezar Life Sciences Inc / Sutro Biopharma Inc / iHeartMedia Inc / IMV Inc / Rapt Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / France / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Adam Muro / Alexandra Green / Anne Bode</td></tr>
<tr class="even"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech: IQVIA NBRx Trends (AMGN, REGN)</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AMGN.OQ / REGN.OQ / AMGN=US / REGN=US</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc / Amgen Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Minh Vong / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">GE=US / VZ=US / NEM=US / X=US / BSX=US / FDX=US / PFE=US / ABT=US / AMGN=US / CAT=US / DIS=US / INTC=US / WM=US / BWA=US / GBT=US / MSFT=US / MDT=US / C=US / AA=US / FCX=US / KGC=US / AMZN=US / QCOM=US / T=US / AEM=US / RUN=US / BAC=US / USB=US / WFC=US / AMT=US / GS=US / AKAM=US / GGB=US / JPM=US / FCEL=US / PLUG=US / CHTR=US / NVS=US / GOLD=US / CCI=US / GSK=US / CRY=US / SPOT=US / JCI=US / PNC=US / HL=US / DE=US / CMCSA=US / BHP=US / COF=US / RGLD=US / DISH=US / RSG=US / ALB=US / ATI=US / AMSC=US / APPS=US / ARRY=US / AVNT=US / CMI=US / CRS=US / CENX=US / CLF=US / CDE=US / CMC=US / CREE=US / EW=US / EGHT=US / EQIX=US / ISRG=US / ITRI=US / MS=US / NUE=US / ZEUS=US / PKX=US / RS=US / ROK=US / SBAC=US / SCHN=US / SCCO=US / STLD=US / SYNL=US / TECH=US / TRMB=US / VALE=US / VG=US / WOR=US / PAAS=US / MTCH=US / NEP=US / RIO=US / NFLX=US / BE=US / TWLO=US / CLH=US / WCN=US / ERIC=US / BBL=US / RNG=US / ENS=US / GOOG=US / TWIN=US / DLR=US / ORA=US / MT=US / VIAC=US / BIDU=US / AMRS=US / SPWR=US / CCOI=US / KALU=US / CSIQ=US / FSLR=US / HAYN=US / LLNW=US / LUMN=US / DAN=US / MTRN=US / KLR=US / WPRT=US / AGCO=US / 005930-KR=US / FNV=US / TCEHY=US / TSLA=US / AMRC=US / ENPH=US / YY=US / TMUS=US / HASI=US / AGIO=US / CNHI=US / TME=US / TMST=US / MOMO=US / SEDG=US / VKTX=US / AQMS=US / VRAY=US / WKHS=US / MDGL=US / ATUS=US / SSRM=US / WPM=US / KL=US / NCNA=US / APTV=US / IQ=US / BILI=US / HUYA=US / CWEN=US / ARVN=US / UBER=US / ZM=US / FSLY=US / IDYA=US / DOYU=US / VLDR=US / ONDS=US</td><td class="leftalignment">General Electric Co / Verizon Communications Inc / Newmont Corporation / United States Steel Corp / Boston Scientific Corp / FedEx Corp / Pfizer Inc / Abbott Laboratories / Amgen Inc / Caterpillar Inc / Walt Disney Co / Intel Corp / Waste Management Inc / Borgwarner Inc / Global Blood Therapeutics Inc / Microsoft Corp / Medtronic PLC / Citigroup Inc / Alcoa Corp / Freeport-McMoRan Inc / Kinross Gold Corp / Amazon.com Inc / Qualcomm Inc / AT&T Inc / Agnico Eagle Mines Ltd / Sunrun Inc / Bank of America Corp / US Bancorp / Wells Fargo & Co / American Tower Corp / Goldman Sachs Group Inc / Akamai Technologies Inc / Gerdau SA / JPMorgan Chase & Co / Fuelcell Energy Inc / Plug Power Inc / Charter Communications Inc / Novartis AG / Barrick Gold Corp / Crown Castle International Corp / GlaxoSmithKline PLC / CryoLife Inc / Spotify Technology SA / Johnson Controls International PLC / PNC Financial Services Group Inc / Hecla Mining Co / Deere & Co / Comcast Corp / BHP Group Ltd / Capital One Financial Corp / Royal Gold Inc / DISH Network Corp / Republic Services Inc / Albemarle Corp / Allegheny Technologies Inc / American Superconductor Corp / Digital Turbine Inc / Array Technologies Inc / Avient Corp / Cummins Inc / Carpenter Technology Corp / Century Aluminum Co / Cleveland-Cliffs Inc / Coeur Mining Inc / Commercial Metals Co / Wolfspeed Inc / Edwards Lifesciences Corp / 8x8 Inc / Equinix Inc / Intuitive Surgical Inc / Itron Inc / Morgan Stanley / Nucor Corp / Olympic Steel Inc / Posco / Reliance Steel & Aluminum Co / Rockwell Automation Inc / SBA Communications Corp / Schnitzer Steel Industries Inc / Southern Copper Corp / Steel Dynamics Inc / Synalloy Corp / Bio-Techne Corp / Trimble Inc / Vale SA / Vonage Holdings Corp / Worthington Industries Inc / Pan American Silver Corp / Match Group Inc / Nextera Energy Partners LP / Rio Tinto PLC / Netflix Inc / Bloom Energy Corp / Twilio Inc / Clean Harbors Inc / Waste Connections Inc / Telefonaktiebolaget LM Ericsson / BHP Group PLC / RingCentral Inc / EnerSys / Alphabet Inc / Twin Disc Inc / Digital Realty Trust Inc / Ormat Technologies Inc / ArcelorMittal SA / ViacomCBS Inc / Baidu Inc / Amyris Inc / SunPower Corp / Cogent Communications Holdings Inc / Kaiser Aluminum Corp / Canadian Solar Inc / First Solar Inc / Haynes International Inc / Limelight Networks Inc / Lumen Technologies Inc / Dana Inc / Materion Corp / Kaleyra Inc / Westport Fuel Systems Inc / AGCO Corp / Farfetch Ltd / Franco-Nevada Corp / Tencent Holdings Ltd / Tesla Inc / Ameresco Inc / Enphase Energy Inc / JOYY Inc / T-Mobile US Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / Agios Pharmaceuticals Inc / CNH Industrial NV / Tencent Music Entertainment Group / TimkenSteel Corp / Hello Group Inc / Solaredge Technologies Inc / Viking Therapeutics Inc / Aqua Metals Inc / ViewRay Inc / Workhorse Group Inc / Madrigal Pharmaceuticals Inc / Altice USA Inc / SSR Mining Inc / Wheaton Precious Metals Corp / Kirkland Lake Gold Ltd / NuCana PLC / Aptiv PLC / iQIYI Inc / Bilibili Inc / HUYA Inc / Clearway Energy Inc / Arvinas Inc / Uber Technologies Inc / Zoom Video Communications Inc / Fastly Inc / IDEAYA Biosciences Inc / Douyu International Holdings Ltd / Velodyne Lidar Inc / Ondas Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Brazil / Canada / Switzerland / Cayman Islands / United Kingdom / Ireland / Korea, Republic of / Luxembourg / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment">Banks / Biotechnology / Conglomerates / Electrical / Financial Services / Healthcare / Pharmaceuticals / Retailing / Semiconductors / Telecommunications</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">01/19/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Normally Q4 is Solid, but COVID & Currency Cloud Outlook</td><td class="leftalignment">English</td><td class="rightalignment">118</td><td class="leftalignment">ABBV=US / PFE=US / AMGN=US / GILD=US / SAN=FR / GSK=GB / REGN=US / VRTX=US</td><td class="leftalignment">Abbvie Inc / Pfizer Inc / Amgen Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="odd"><td class="leftalignment">01/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - January 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">AC.TO / AEP.N / ALTR.O / ALV.N / AMAT.O / AMD.N / BARC.L / BBDb.TO / C.N / CI.N / CL.N / CMS.N / CNA.L / CP.TO / CVS.N / EDP.LS / EIX.N / EL.N / ELE.MC / EOG.N / F.N / GM.N / HSBA.L / HSX.L / INTC.O / IP.N / JPM.N / KBH.N / KMB.N / KO.N / LLOY.L / PD.N / PEG.N / PFE.N / PHM.N / PNC.N / SAN.MC / SGEF.PA / SO.N / T.N / TOL.N / VC.N / WFC.N / SSE.L / PEP.N / BFb.N / PG.N / PXD.N / HUM.N / CPB.N / TEN.N / CMCSA.O / CHKP.O / AMGN.O / INCY.O / THC.N / CNR.TO / DUK.N / UNH.N / BWA.N / LEA.N / TRP.TO / NVDA.O / K.N / DT.N / DISH.O / EPR.N / LEN.N / CTXS.O / CLX.N / CAG.N / MRO.N / GIS.N / DVN.N / EPC.N / MGA.N / AMT.N / JAZZ.O / VZ.N / EXEL.O / CYH.N / DHI.N / STZ.N / APH.N / FISV.O / EQT.N / ADSK.O / V.N / AXL.N / AWK.N / CHD.N / BC.N / SAM.N / FRAG.DE / BMRN.O / OPTN.O / REGN.O / ENR.N / MU.O / SM.N / NCR.N / NET.N / TEL.N / COP.N / CNP.N / CPE.N / ENDP.O / CPK.N / PII.N / ST.N / SWN.N / SR.N / NTCT.OQ / GPN.N / MNST.O / NWG.L / IMGN.O / CASY.O / ANSS.O / ICPT.O / FFIV.O / EQIX.O / ATDb.TO / BIIB.O / CHR.TO / 02209S103 / DLR.N / ACAD.O / 427866108 / SJW.N / BKD.N / FIS.N / HICL.L / ADP.PA / TEVA.N / MA.N / HOG.N / CVLT.O / ATL.MI / BGS.N / VMW.N / TDC.N / INO.OQ / DAN.N / EDPR.LS / SWI.N / EIF.TO / FTNT.O / SPB.N / FHZN.S / PCRX.O / MSP.N / MTOR.N / MTDR.N / SPLK.OQ / WDC.O / PANW.N / QLYS.O / MDLZ.OQ / FANG.O / ABBV.N / TPH.N / TSLA.N / PRGO.N / PRMW.N / TMUS.N / TMHC.N / DOO.TO / COTY.N / AGIO.O / PTC.O / VRNS.O / AGRX.O / ANTM.N / AENA.MC / SHOP.N / GLPG.O / WRK.N / RPD.O / SGRY.O / MIME.OQ / MESO.O / RACE.MI / MTRO.L / SCWX.O / TWLO.N / ADNT.N / PBYI.OQ / OKTA.OQ / CDEV.O / ESTE.N / SAIL.N / APTV.N / ZS.OQ / AMRX.N / VNE.N / NTGY.MC / KDP.N / XERS.O / AQST.O / PRVB.O / ESTC.N / NWL.O / ZM.O / CRWD.O / GMAB.O / DOCU.N / PING.N / DDOG.O / CRNC.OQ / VMUK.L / NLOK.O / WTRG.N / REYN.O / NKLA.OQ / APA.OQ / FOUR.N / JAMF.O / PLTR.N / ASAN.N / MTCR.O / SUMO.O / BSY.O / MCFE.OQ / 900435207 / 120681711</td><td class="leftalignment">Air Canada / American Electric Power Company Inc / Altair Engineering Inc / Autoliv Inc / Applied Materials Inc / Advanced Micro Devices Inc / Barclays PLC / Bombardier Inc / Citigroup Inc / Cigna Corp / Colgate-Palmolive Co / CMS Energy Corp / Centrica PLC / Canadian Pacific Railway Ltd / CVS Health Corp / EDP Energias de Portugal SA / Edison International / Estee Lauder Companies Inc / Endesa SA / EOG Resources Inc / Ford Motor Co / General Motors Co / HSBC Holdings PLC / Hiscox Ltd / Intel Corp / International Paper Co / JPMorgan Chase & Co / KB Home / Kimberly-Clark Corp / Coca-Cola Co / Lloyds Banking Group PLC / PagerDuty Inc / Public Service Enterprise Group Inc / Pfizer Inc / Pultegroup Inc / PNC Financial Services Group Inc / Banco Santander SA / Vinci SA / Southern Co / AT&T Inc / Toll Brothers Inc / Visteon Corp / Wells Fargo & Co / SSE PLC / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Pioneer Natural Resources Co / Humana Inc / Campbell Soup Co / Tenneco Inc / Comcast Corp / Check Point Software Technologies Ltd / Amgen Inc / Incyte Corp / Tenet Healthcare Corp / Canadian National Railway Co / Duke Energy Corp / UnitedHealth Group Inc / Borgwarner Inc / Lear Corp / TC Energy Corp / NVIDIA Corp / Kellogg Co / Dynatrace Inc / DISH Network Corp / EPR Properties / Lennar Corp / Citrix Systems Inc / Clorox Co / Conagra Brands Inc / Marathon Oil Corp / General Mills Inc / Devon Energy Corp / Edgewell Personal Care Co / Magna International Inc / American Tower Corp / Jazz Pharmaceuticals PLC / Verizon Communications Inc / Exelixis Inc / Community Health Systems Inc / D R Horton Inc / Constellation Brands Inc / Amphenol Corp / Fiserv Inc / EQT Corp / Autodesk Inc / Visa Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Church & Dwight Co Inc / Brunswick Corp / Boston Beer Company Inc / Fraport AG Frankfurt Airport Services Worldwide / Biomarin Pharmaceutical Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Micron Technology Inc / SM Energy Co / NCR Corp / Cloudflare Inc / TE Connectivity Ltd / Conocophillips / CenterPoint Energy Inc / Callon Petroleum Co / Endo International PLC / Chesapeake Utilities Corp / Polaris Inc / Sensata Technologies Holding PLC / Southwestern Energy Co / Spire Inc / Netscout Systems Inc / Global Payments Inc / Monster Beverage Corp / Natwest Group PLC / ImmunoGen Inc / Caseys General Stores Inc / ANSYS Inc / Intercept Pharmaceuticals Inc / F5 Inc / Equinix Inc / Alimentation Couche-Tard Inc / Biogen Inc / Chorus Aviation Inc / Altria Group Inc / Digital Realty Trust Inc / ACADIA Pharmaceuticals Inc / Hershey Co / SJW Group / Brookdale Senior Living Inc / Fidelity National Information Services Inc / HICL Infrastructure PLC / Aeroports de Paris SA / Teva Pharmaceutical Industries Ltd / Mastercard Inc / Harley-Davidson Inc / Commvault Systems Inc / Atlantia SpA / B&G Foods Inc / VMware Inc / Teradata Corp / Inovio Pharmaceuticals Inc / Dana Inc / EDP Renovaveis SA / SolarWinds Corp / Exchange Income Corp / Fortinet Inc / Spectrum Brands Holdings Inc / Flughafen Zuerich AG / Pacira Biosciences Inc / Datto Holding Corp / Meritor Inc / Matador Resources Co / Splunk Inc / Western Digital Corp / Palo Alto Networks Inc / Qualys Inc / Mondelez International Inc / Diamondback Energy Inc / Abbvie Inc / Tri Pointe Homes Inc (Delaware) / Tesla Inc / Perrigo Company PLC / Primo Water Corp / T-Mobile US Inc / Taylor Morrison Home Corp / BRP Inc / Coty Inc / Agios Pharmaceuticals Inc / PTC Inc / Varonis Systems Inc / Agile Therapeutics Inc / Anthem Inc / Aena SME SA / Shopify Inc / Galapagos NV / Westrock Co / Rapid7 Inc / Surgery Partners Inc / Mimecast Ltd / Mesoblast Ltd / Ferrari NV / Metro Bank PLC / SecureWorks Corp / Twilio Inc / Adient PLC / Puma Biotechnology Inc / Okta Inc / Centennial Resource Development Inc / Earthstone Energy Inc / SailPoint Technologies Holdings Inc / Aptiv PLC / Zscaler Inc / Amneal Pharmaceuticals Inc / Veoneer Inc / Naturgy Energy Group SA / Keurig Dr Pepper Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / Provention Bio Inc / Elastic NV / Newell Brands Inc / Zoom Video Communications Inc / CrowdStrike Holdings Inc / Genmab A/S / DocuSign Inc / Ping Identity Holding Corp / Datadog Inc / Cerence Inc / Virgin Money UK PLC / NortonLifeLock Inc / Essential Utilities Inc / Reynolds Consumer Products Inc / Nikola Corp / APA Corp (US) / Shift4 Payments Inc / Jamf Holding Corp / Palantir Technologies Inc / Asana Inc / Metacrine Inc / Sumo Logic Inc / Bentley Systems Inc / Mcafee Corp / Turquoise Hill Resources Ltd / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Canada / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Ireland / Israel / Italy / Netherlands / Portugal / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Global Research</td></tr>
<tr class="even"><td class="leftalignment">01/19/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Biotechnology : Putting a Wrap on The 2021 Healthcare Conference</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">CVS.N / JNJ.N / MCK.N / PFE.N / GILD.O / AMGN.O / INCY.O / ALKS.O / BMRN.O / REGN.O / VRTX.O / RARE.O / BLUE.O / NVAX.O / SGEN.O / BIIB.O / ACAD.O / MRNA.O / CLVS.O / SAGE.O / GBT.O / NVCR.O / EDIT.O / PBYI.O / JNCE.O / ALLO.O / BNTX.O / LEGN.O / BCAB.O</td><td class="leftalignment">CVS Health Corp / Johnson & Johnson / Mckesson Corp / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Incyte Corp / Alkermes Plc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / bluebird bio Inc / Novavax Inc / Seagen Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Moderna Inc / Clovis Oncology Inc / SAGE Therapeutics Inc / Global Blood Therapeutics Inc / Novocure Ltd / Editas Medicine Inc / Puma Biotechnology Inc / Jounce Therapeutics Inc / Allogene Therapeutics Inc / BioNTech SE / Legend Biotech Corp / Bioatla Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / Germany / United Kingdom / Ireland / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Cory W. Kasimov / James Scott / Mr. Matthew T. Holt, P.Eng / Mr. Turner Kufe</td></tr>
<tr class="odd"><td class="leftalignment">01/18/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Volume-Driven Growth Dispels ICER Report</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AMGN=US</td><td class="leftalignment">Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">01/18/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">Autos, Basic Resources, Healthcare & Transport Calendar : January - April 2020</td><td class="leftalignment">English</td><td class="rightalignment">43</td><td class="leftalignment">ACF / AIRP.PA / BAX.N / BDX.N / BHP.AX / BMWG.DE / BMY.N / CC.N / CCK.N / CCL.N / CE.N / CRH.I / DSMN.AS / EPED.PA / F.N / FGP.L / GM.N / GOG.L / HEIG.DE / JNJ.N / LHAG.DE / LLY.N / MCK.N / MRK.N / MWDP.PA / NEX.L / PFE.N / PLOF.PA / RENA.PA / RIO.AX / RR.L / RYA.I / SAPJ.J / SAS.ST / SCAb.ST / SCHN.PA / SGC.L / SGOB.PA / SMIN.L / SOLB.BR / SYD.AX / TCFP.PA / TMO.N / VLLP.PA / VOLVb.ST / VOWG.DE / WBSV.VI / STERV.HE / AIRF.PA / CONG.DE / AZN.L / AMGN.O / AAL.L / SASY.PA / TKAG.DE / ROG.S / SIEGn.F / HON.N / NOVN.S / MG.TO / FMEG.DE / BZU.MI / MRCG.DE / MGA.N / PSHG_p.DE / OI.N / BLL.N / GLAX.NS / PKI.N / FREG.DE / RXL.PA / EZJ.L / SUP.N / GSK.L / ESI.N / CC@US / MHK.N / TAMO.BO / FLWS.O / VOES.VI / MT.N / LXSG.DE / HUN.N / SAF.PA / TUIGn.DE / LEGD.PA / TEVA.N / SKG.I / MNDI.L / DAIGn.DE / BAES.L / BAYGn.DE / BASFn.DE / GLEN.L / CAR.O / SDFGn.DE / METSB.HE / LKQ.O / XPO.N / GT.O / ABBV.N / GEST.MC / CSTM.N / EVKn.F / CTLT.N / EUCAR.PA / ZBH.N / 1COV.DE / HLAG.DE / NVGR.LS / ADNT.N / BHC.N / 114556048 / VTRS.O</td><td class="leftalignment">Acrow Formwork and Construction Services Ltd / L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Baxter International Inc / Becton Dickinson and Co / BHP Group Ltd / Bayerische Motoren Werke AG / Bristol-Myers Squibb Co / Chemours Co / Crown Holdings Inc / Carnival Corp / Celanese Corp / CRH PLC / Koninklijke DSM NV / Faurecia SE / Ford Motor Co / FirstGroup PLC / General Motors Co / Go-Ahead Group PLC / HeidelbergCement AG / Johnson & Johnson / Deutsche Lufthansa AG / Eli Lilly and Co / Mckesson Corp / Merck & Co Inc / Wendel SE / National Express Group PLC / Pfizer Inc / Compagnie Plastic Omnium SE / Renault SA / Rio Tinto Ltd / Rolls-Royce Holdings PLC / Ryanair Holdings PLC / Sappi Ltd / SAS AB / Svenska Cellulosa SCA AB / Schneider Electric SE / Stagecoach Group PLC / Compagnie de Saint Gobain SA / Smiths Group PLC / Solvay SA / Sydney Airport / Thales SA / Thermo Fisher Scientific Inc / Vallourec SA / Volvo AB / Volkswagen AG / Wienerberger AG / Stora Enso Oyj / Air France KLM SA / Continental AG / AstraZeneca PLC / Amgen Inc / Anglo American PLC / Sanofi SA / thyssenkrupp AG / Roche Holding AG / Siemens AG / Honeywell International Inc / Novartis AG / Magna International Inc / Fresenius Medical Care AG & Co KGaA / Buzzi Unicem SpA / Merck KGaA / Magna International Inc / Porsche Automobil Holding SE / O-I Glass Inc / Ball Corp / GlaxoSmithKline Pharmaceuticals Ltd / PerkinElmer Inc / Fresenius SE & Co KGaA / Rexel SA / Easyjet PLC / Superior Industries International Inc / GlaxoSmithKline PLC / Element Solutions Inc / Chemours Co / Mohawk Industries Inc / Tata Motors Ltd / 1-800-Flowers.Com Inc / voestalpine AG / ArcelorMittal SA / Lanxess AG / Huntsman Corp / Safran SA / TUI AG / Legrand SA / Teva Pharmaceutical Industries Ltd / Smurfit Kappa Group PLC / Mondi PLC / Daimler AG / BAE Systems PLC / Bayer AG / BASF SE / Glencore PLC / Avis Budget Group Inc / K&S AG / Metsa Board Oyj / LKQ Corp / XPO Logistics Inc / Goodyear Tire & Rubber Co / Abbvie Inc / Gestamp Automocion SA / Constellium SE / Evonik Industries AG / Catalent Inc / Europcar Mobility Group SA / Zimmer Biomet Holdings Inc / Covestro AG / Hapag Lloyd AG / Navigator Company SA / Adient PLC / Bausch Health Companies Inc / Stellantis NV / Viatris Inc</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">Australia / Austria / Belgium / Canada / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Hong Kong / India / Ireland / Israel / Italy / Luxembourg / Netherlands / Norway / Panama / Portugal / Sweden / United States / South Africa / Jersey</td><td class="leftalignment">Aerospace / Air Transportation / Automotive / Biotechnology / Building & Building Materials / Chemicals / Conglomerates / Consumer / Containers & Packing / Defense / Electrical / Financial Services / Healthcare / Household Products / Industrial Materials / Leisure & Entertainment / Lodging & Restaurants / Machinery / Manufacturing / Metals & Minerals / Paper & Forest Products / Pharmaceuticals / Railroads / Retailing / Shipping & Shipbuilding / Tire & Rubber / Transportation / Wholesale</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Danielle Ward / Benjamin Defay / Stephanie Vincent / Mr. William W. Wade / Jemma Permalloo / Ed McGuinness / Mr. Adam Bodor</td></tr>
</tbody></table>
</body>
</html>